PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Carrigee, LA; Frick, JP; Karty, JA; Garczarek, L; Partensky, F; Schluchter, WM				Carrigee, Lyndsay A.; Frick, Jacob P.; Karty, Jonathan A.; Garczarek, Laurence; Partensky, Frederic; Schluchter, Wendy M.			MpeV is a lyase isomerase that ligates a doubly linked phycourobilin on the beta-subunit of phycoerythrin I and II in marine Synechococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIN LYASE; CHROMATIC ACCLIMATION; CHROMOPHORE ATTACHMENT; SP PCC-7002; CPCS-I; PHYCOCYANIN; PROTEIN; CYANOBACTERIA; PHYCOBILIPROTEINS; BIOSYNTHESIS	Synechococcus cyanobacteria are widespread in the marine environment, as the extensive pigment diversity within their light-harvesting phycobilisomes enables them to utilize various wavelengths of light for photosynthesis. The phycobilisomes of Synechococcus sp. RS9916 contain two forms of the protein phycoerythrin (PEI and PEII), each binding two chromophores, green-light absorbing phycoerythrobilin and blue-light absorbing phycourobilin. These chromophores are ligated to specific cysteines via bilin lyases, and some of these enzymes, called lyase isomerases, attach phycoerythrobilin and simultaneously isomerize it to phycourobilin. MpeV is a putative lyase isomerase whose role in PEI and PEII biosynthesis is not clear. We examined MpeV in RS9916 using recombinant protein expression, absorbance spectroscopy, and tandem mass spectrometry. Our results show that MpeV is the lyase isomerase that covalently attaches a doubly linked phycourobilin to two cysteine residues (C50, C61) on the beta-subunit of both PEI (CpeB) and PEII (MpeB). MpeV activity requires that CpeB or MpeB is first chromophorylated by the lyase CpeS (which adds phycoerythrobilin to C82). Its activity is further enhanced by CpeZ (a homolog of a chaperone-like protein first characterized in Fremyella diplosiphon). MpeV showed no detectable activity on the alpha-subunits of PEI or PEII. The mechanism by which MpeV links the A and D rings of phycourobilin to C50 and C61 of CpeB was also explored using site-directed mutants, revealing that linkage at the A ring to C50 is a critical step in chromophore attachment, isomerization, and stability. These data provide novel insights into beta-PE biosynthesis and advance our understanding of the mechanisms guiding lyase isomerases.	[Carrigee, Lyndsay A.; Frick, Jacob P.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Karty, Jonathan A.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Garczarek, Laurence; Partensky, Frederic] Sorbonne Univ, Stn Biol, Ecol Marine Plankton ECOMAP Team, Roscoff, France; [Garczarek, Laurence; Partensky, Frederic] CNRS, UMR 7144, Roscoff, France	University of Louisiana System; University of New Orleans; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	wschluch@uno.edu	Partensky, Frédéric/AAH-1170-2021; Partensky, Frédéric/B-9194-2018	Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Schluchter, Wendy/0000-0003-1687-1065; Frick, Jacob/0000-0002-2254-1479; Carrigee, Lyndsay/0000-0003-4182-8800; Karty, Jonathan/0000-0003-1022-9100; Garczarek, Laurence/0000-0002-8191-8395	National Science Foundation [MCB-1244339, MCB-2017164]; Agence Nationale de la Recherche (ANR) program EFFICACY [ANR-19-CE02-0019]	National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche (ANR) program EFFICACY(French National Research Agency (ANR))	This research was supported by National Science Foundation Grants to W. M. S. (MCB-1244339 and MCB-2017164) and by the Agence Nationale de la Recherche (ANR) program EFFICACY (ANR-19-CE02-0019) to F. P. and L. G.	Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Betz M, 1997, BIOL CHEM, V378, P167; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Carrigee LA, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148215; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Farrant GK, 2016, P NATL ACAD SCI USA, V113, pE3365, DOI 10.1073/pnas.1524865113; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Gasper R, 2017, J BIOL CHEM, V292, P3089, DOI 10.1074/jbc.M116.769703; Glazer A. N, 1994, ADV MOL CELL BIOL, V10, P119; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1988, METHOD ENZYMOL, V167, P304; Grebert T, 2018, P NATL ACAD SCI USA, V115, pE2010, DOI 10.1073/pnas.1717069115; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hess WR, 1999, PLANT MOL BIOL, V40, P507, DOI 10.1023/A:1006252013008; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humily F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084459; Hussain H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8041532; Kehoe DM, 2010, P NATL ACAD SCI USA, V107, P9029, DOI 10.1073/pnas.1004510107; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kronfel CM, 2019, BBA-BIOENERGETICS, V1860, P549, DOI 10.1016/j.bbabio.2019.06.001; Kronfel CM, 2019, J BIOL CHEM, V294, P3987, DOI 10.1074/jbc.RA118.007221; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levi M, 2018, PLANT J, V94, P813, DOI 10.1111/tpj.13896; Mahmoud RM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00243; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; Nguyen A., 2018, THESIS U NEW ORLEANS; ONG LJ, 1991, J BIOL CHEM, V266, P9515; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; PLANK T, 1995, J BACTERIOL, V177, P6798, DOI 10.1128/jb.177.23.6798-6803.1995; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Sanfilippo JE, 2019, ANNU REV MICROBIOL, V73, P407, DOI 10.1146/annurev-micro-020518-115738; Sanfilippo JE, 2019, P NATL ACAD SCI USA, V116, P6457, DOI 10.1073/pnas.1810491116; Sanfilippo JE, 2016, P NATL ACAD SCI USA, V113, P6077, DOI 10.1073/pnas.1600625113; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Zhao C, 2017, P NATL ACAD SCI USA, V114, P13170, DOI 10.1073/pnas.1715495114; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; ZHOU JH, 1992, J BIOL CHEM, V267, P16138; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	67	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100031	10.1074/jbc.RA120.015289	http://dx.doi.org/10.1074/jbc.RA120.015289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33154169	Green Published, gold			2022-12-26	WOS:000672866400015
J	Celard, P; Vieira, AS; Iglesias, EL; Borrajo, L				Celard, P.; Seara Vieira, A.; Iglesias, E. L.; Borrajo, L.			LDA filter: A Latent Dirichlet Allocation preprocess method for Weka	PLOS ONE			English	Article							CLASSIFICATION	This work presents an alternative method to represent documents based on LDA (Latent Dirichlet Allocation) and how it affects to classification algorithms, in comparison to common text representation. LDA assumes that each document deals with a set of predefined topics, which are distributions over an entire vocabulary. Our main objective is to use the probability of a document belonging to each topic to implement a new text representation model. This proposed technique is deployed as an extension of the Weka software as a new filter. To demonstrate its performance, the created filter is tested with different classifiers such as a Support Vector Machine (SVM), k-Nearest Neighbors (k-NN), and Naive Bayes in different documental corpora (OHSUMED, Reuters-21578, 20Newsgroup, Yahoo! Answers, YELP Polarity, and TREC Genomics 2015). Then, it is compared with the Bag of Words (BoW) representation technique. Results suggest that the application of our proposed filter achieves similar accuracy as BoW but greatly improves classification processing times.	[Celard, P.; Seara Vieira, A.; Iglesias, E. L.; Borrajo, L.] Univ Vigo, Comp Sci Dept, Escuela Super Ingn Informat, Orense, Spain; [Celard, P.; Seara Vieira, A.; Iglesias, E. L.; Borrajo, L.] Univ Vigo, CINBIO Biomed Res Ctr, Vigo, Spain; [Celard, P.; Seara Vieira, A.; Iglesias, E. L.; Borrajo, L.] Galicia Sur Hlth Res Inst IIS Galicia Sur, SERGAS UVIGO, SING Res Grp, Vigo, Spain	Universidade de Vigo; Universidade de Vigo; CINBIO	Celard, P (corresponding author), Univ Vigo, Comp Sci Dept, Escuela Super Ingn Informat, Orense, Spain.; Celard, P (corresponding author), Univ Vigo, CINBIO Biomed Res Ctr, Vigo, Spain.; Celard, P (corresponding author), Galicia Sur Hlth Res Inst IIS Galicia Sur, SERGAS UVIGO, SING Res Grp, Vigo, Spain.	pedro.celard.perez@uvigo.es	Celard, Pedro/AAT-3498-2021; Diz, Lourdes Borrajo/E-5228-2018; Borrajo Diz, Lourdes/GVS-2159-2022	Celard, Pedro/0000-0002-6972-8353; Diz, Lourdes Borrajo/0000-0002-6089-6166; Borrajo Diz, Lourdes/0000-0002-6089-6166; , IIS Galicia Sur/0000-0003-3812-7413	Conselleria de Educacion, Universidades e Formacion Profesional (Xunta de Galicia) under Competitive Reference Group [ED431C2018/55GRC]	Conselleria de Educacion, Universidades e Formacion Profesional (Xunta de Galicia) under Competitive Reference Group(Xunta de Galicia)	We also appreciate the support provided by Conselleria de Educacion, Universidades e Formacion Profesional (Xunta de Galicia) under the scope of the strategic funding of ED431C2018/55GRC Competitive Reference Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Yates RA, 1999, MODERN INFORM RETRIE; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Cheng XQ, 2014, IEEE T KNOWL DATA EN, V26, P2928, DOI 10.1109/TKDE.2014.2313872; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank Eibe, 2016, ONLINE APPENDIX DATA; Hersh W., 1994, P 17 ANN INT ACM SIG, P192, DOI DOI 10.1007/978-1-4471-2099-5_20; Hersh W., 2005, SPECIAL PUBLICATION, V500-266, P14; Huangfu L, 2018, LREC; Jin O., 2011, P 20 ACM INT C INF K, P775; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Kim D, 2019, INFORM SCIENCES, V477, P15, DOI 10.1016/j.ins.2018.10.006; Ko Y, 2009, INFORM PROCESS MANAG, V45, P70, DOI 10.1016/j.ipm.2008.07.004; Lang K, 1995, P 12 INT MACH LEARN; Lee S, 2015, INT CONF BIG DATA, P217, DOI 10.1109/35021BIGCOMP.2015.7072834; LOVINS JB, 1968, MECH TRANSL, V11, P22; McCallum, 2002, MALLET MACHINE LEARN; Nikolaos Tsimboukakis, 2008, Proceedings of the 5th International Conference on Soft Computing as Transdisciplinary Science and Technology 2008. In Memory of Professor Yasuhiko Dote, P7, DOI 10.1145/1456223.1456229; Prollochs N, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2018.05.003; Qu B, 2012, J AM SOC INF SCI TEC, V63, P889, DOI 10.1002/asi.22611; Quan X, 2015, IJCAI; Rui WK, 2016, LECT NOTES ARTIF INT, V9983, P3, DOI 10.1007/978-3-319-47650-6_1; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Tang D., 2015, PROC C EMPIRICAL MET, P1422, DOI DOI 10.18653/V1/D15-1167; Wang D, 2012, 2012 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY WORKSHOPS (WI-IAT WORKSHOPS 2012), VOL 3, P306, DOI 10.1109/WI-IAT.2012.211; Zhang X., 2015, ARXIV150901626; Zhou WT, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19173728	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241701	10.1371/journal.pone.0241701	http://dx.doi.org/10.1371/journal.pone.0241701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166342	Green Published, gold			2022-12-26	WOS:000592382600048
J	Hammami, S; Ghzaiel, I; Hammouda, S; Sakly, N; Hammami, M; Zarrouk, A				Hammami, Sonia; Ghzaiel, Imen; Hammouda, Souha; Sakly, Nabil; Hammami, Mohamed; Zarrouk, Amira			Evaluation of pro-inflammatory cytokines in frail Tunisian older adults	PLOS ONE			English	Article							MINI NUTRITIONAL ASSESSMENT; RISK-FACTORS; SHORT-FORM; ASSOCIATION; PREVALENCE; VALIDATION; MARKERS; IDENTIFICATION; PHENOTYPES; ALBUMIN	The present study was undertaken to evaluate serum levels of pro-inflammatory cytokines in Tunisian older adults and to examine the relationships between inflammatory marker levels, geriatric, and biochemical parameters. A cross-sectional study was conducted in a population of Tunisian older adults (N = 141, aged 65 and over). Patients were recruited from the Department of Internal Medicine, Fattouma Bourguiba University Hospital (Monastir, Tunisia) and from a nursing home (Sousse, Tunisia). Comprehensive geriatric assessment, history taking and examination including functional and nutritional assessment were done for each participant. Enzyme-linked immunosorbent assay (ELISA) test was used to measure serum cytokine (TNF-alpha, IL-8, IL-6) levels. The modified Short Emergency Geriatric Assessment score (SEGAm) were used to classify patients as 51 very-frail, 40 frail, and 50 non-frail. The age of the participants (80 men, 61 women) ranged from 65 to 97 years. Serum levels of TNF-alpha, IL-8 and C-reactive protein (CRP) were significantly higher in very-frail participants compared to frail and non-frail ones. However, no significant differences in IL-6 levels were detected among frailty groups. After adjustment for age, CRP and IL-8 levels remained significantly associated with frailty. Analysis of the receiver operating characteristic (ROC) curve corresponding to IL-8 showed an area under the curve of 0.7 (p = 0.003; 95% CI [0.58-0.81]) and a predictive threshold of 5.27 pg/ml. Positive correlations were found between frailty score, IL-6, and IL-8 levels. In addition, a significant positive correlation was observed between IL-8 levels and Timed Up and Go test results. However, a negative correlation was observed between Mini Nutritional Assessment Short-Form score, IL-6 and CRP levels, as well as between Activities of Daily Living score and serum levels of TNF-alpha, IL-6, and CRP. In conclusion, the key findings of this study collectively support a role of pro-inflammatory cytokines, TNF-alpha, CRP, and especially IL-8 in the development of frailty in older adults.	[Hammami, Sonia; Ghzaiel, Imen; Hammouda, Souha; Hammami, Mohamed; Zarrouk, Amira] Fac Med Monastir, Biochem Lab, LR NAFS Nutr Funct Food & Hlth LR12ES05, Monastir, Tunisia; [Hammami, Sonia] CHU Bourguiba Monastir, Geriatr Unit, Dept Internal Med, Monastir, Tunisia; [Ghzaiel, Imen] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Sakly, Nabil] Unity Immunol EPS Fattouma Bourguiba, Lab Microbiol, Monastir, Tunisia; [Zarrouk, Amira] Fac Med Sousse, Biochem Lab, Sousse, Tunisia	Universite de Monastir; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Sousse	Hammami, S (corresponding author), Fac Med Monastir, Biochem Lab, LR NAFS Nutr Funct Food & Hlth LR12ES05, Monastir, Tunisia.; Hammami, S (corresponding author), CHU Bourguiba Monastir, Geriatr Unit, Dept Internal Med, Monastir, Tunisia.	sonia.hammami@fmm.rnu.tn		hammouda, souha/0000-0001-5987-1909; Hammami, Sonia/0000-0002-0699-4988	CHU F Bourguiba	CHU F Bourguiba	The source of Funding (financial and material support) for our study was received from our institution (CHU F Bourguiba). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No salary received from any of our funders. The authors received no specific funding for this work.	Adriaensen W, 2014, AGE, V36, DOI 10.1007/s11357-014-9723-3; Baylis D, 2013, AGE, V35, P963, DOI 10.1007/s11357-012-9396-8; Bian AL, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0266-9; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Cabrerizo S, 2015, MATURITAS, V81, P17, DOI 10.1016/j.maturitas.2015.02.009; Chang SF, 2015, INT J NURS PRACT, V21, P321, DOI 10.1111/ijn.12280; Cimini FA, 2017, ACTA DIABETOL, V54, P961, DOI 10.1007/s00592-017-1039-1; Clement JP, 1997, ENCEPHALE, V23, P91; Daniele A, 2017, ANTICANCER RES, V37, P1281, DOI 10.21873/anticanres.11445; Jesus Isabela Thaís Machado de, 2018, Dement. neuropsychol., V12, P173, DOI 10.1590/1980-57642018dn12-020010; Ebeid SM, 2016, IJRSR, V2, P8902; Edvardsson M, 2019, SCAND J CLIN LAB INV, V79, P288, DOI 10.1080/00365513.2019.1609695; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Fulop T, 2015, INTERD T GERONT GERI, V41, P26, DOI 10.1159/000381134; Hammami S., 2020, HDB HEALTHCARE ARAB; Hammami S, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01545-4; Hammami S, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-15; Hong XF, 2019, CLIN INTERV AGING, V14, P105, DOI 10.2147/CIA.S189040; Hsu B, 2019, J GERONTOL A-BIOL, V74, P835, DOI 10.1093/gerona/glx142; Hubbard RE, 2009, J CELL MOL MED, V13, P3103, DOI 10.1111/j.1582-4934.2009.00733.x; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kurkcu M, 2018, CLIN NUTR ESPEN, V23, P112, DOI 10.1016/j.clnesp.2017.11.006; Lai HY, 2014, MATURITAS, V79, P329, DOI 10.1016/j.maturitas.2014.07.014; Li HF, 2011, AGING DIS, V2, P466; Ma LN, 2018, CLIN INTERV AGING, V13, P2013, DOI 10.2147/CIA.S180934; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Milan-Mattos JC, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198392, 10.1590/1414-431x20198392]; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Oe Y, 2015, J NUTR SCI VITAMINOL, V61, P263, DOI 10.3177/jnsv.61.263; Oubaya N, 2014, J NUTR HEALTH AGING, V18, P757, DOI [10.1007/s12603-014-0541-1, 10.1007/s12603-014-0466-8]; Piotrowicz K, 2020, ADV EXP MED BIOL, V1216, P39, DOI 10.1007/978-3-030-33330-0_5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reiner AP, 2009, AM J MED, V122, P947, DOI 10.1016/j.amjmed.2009.04.016; Rietman ML, 2018, J NUTR HEALTH AGING, V22, P8, DOI 10.1007/s12603-016-0854-3; Rosado-Artalejo C, 2017, J AM MED DIR ASSOC, V18, P785, DOI 10.1016/j.jamda.2017.04.008; Ruan Q, 2020, J NUTR HEALTH AGING, V24, P172, DOI 10.1007/s12603-019-1286-7; Shen XN, 2019, J NEUROL NEUROSUR PS, V90, P590, DOI 10.1136/jnnp-2018-319148; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Soysal P, 2019, CLIN INTERV AGING, V14, P693, DOI 10.2147/CIA.S196770; Soysal P, 2019, J AM MED DIR ASSOC, V20, P183, DOI 10.1016/j.jamda.2018.07.016; Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006; Starr KNP, 2014, J AM MED DIR ASSOC, V15, P240, DOI 10.1016/j.jamda.2013.11.008; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Sullivan DH, 2011, J NUTR HEALTH AGING, V15, P311, DOI 10.1007/s12603-010-0297-1; Tan CSY, 2015, SUPPORT CARE CANCER, V23, P385, DOI 10.1007/s00520-014-2385-y; Valentini A, 2018, CLIN INTERV AGING, V13, P1237, DOI 10.2147/CIA.S164174; Vavrova L, 2016, CLIN EXP MED, V16, P557, DOI 10.1007/s10238-015-0390-1; Velissaris Dimitrios, 2017, J Clin Med Res, V9, P461, DOI 10.14740/jocmr2959w; von Zglinicki T, 2016, MECH AGEING DEV, V160, P34, DOI 10.1016/j.mad.2016.07.004; Yao X, 2011, CLIN GERIATR MED, V27, P79, DOI 10.1016/j.cger.2010.08.002; Zazzetta MS, 2017, J FRALITY AGING, V6, P29, DOI 10.14283/jfa.2016.116	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242152	10.1371/journal.pone.0242152	http://dx.doi.org/10.1371/journal.pone.0242152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166358	Green Published, gold			2022-12-26	WOS:000592382600043
J	Lee, MH; Zhao, J; Sun, QQ; Pan, YX; Zhou, WY; Xiong, CF; Zhang, L				Lee, Minha; Zhao, Jun; Sun, Qianqian; Pan, Yixuan; Zhou, Weiyi; Xiong, Chenfeng; Zhang, Lei			Human mobility trends during the early stage of the COVID-19 pandemic in the United States	PLOS ONE			English	Article							CORONAVIRUS; CHINA	In March of this year, COVID-19 was declared a pandemic, and it continues to threaten public health. This global health crisis imposes limitations on daily movements, which have deteriorated every sector in our society. Understanding public reactions to the virus and the non-pharmaceutical interventions should be of great help to fight COVID-19 in a strategic way. We aim to provide tangible evidence of the human mobility trends by comparing the day-by-day variations across the U.S. from January 2020 to early April 2020. Large-scale public mobility at an aggregated level is observed by leveraging mobile device location data and the measures related to social distancing. Our study captures spatial and temporal heterogeneity as well as the sociodemographic variations and teleworking trends regarding the pandemic propagation and the non-pharmaceutical mobility interventions. All metrics adapted capture decreased public movements after the national emergency declaration. The population staying home has increased in all states before the stay-at-home mandates implemented and becomes more stable after the order with a smaller range of fluctuation. The public had been taking active responses, voluntarily staying home more, to the in-state confirmed cases while the stay-at-home orders stabilize the variations. As the estimated teleworking rates also continue to incline throughout the study period, the teleworking trend can be another driving factor for the growing stay-at-home population. We confirm that there exists overall mobility heterogeneity between the income or population density groups. The study suggests that public mobility trends are in line with the government message urging to stay home. We anticipate our data-driven analysis offers integrated perspectives and serves as evidence to raise public awareness and, consequently, reinforce the importance of social distancing while assisting policymakers.	[Lee, Minha; Zhao, Jun; Sun, Qianqian; Pan, Yixuan; Zhou, Weiyi; Xiong, Chenfeng; Zhang, Lei] Univ Maryland, Dept Civil & Environm Engn, Maryland Transportat Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Zhang, L (corresponding author), Univ Maryland, Dept Civil & Environm Engn, Maryland Transportat Inst, College Pk, MD 20742 USA.	lei@umd.edu	Pan, Yixuan/AHC-8675-2022		Maryland Transportation Institute; U.S. Department of Transportation's Bureau of Transportation Statistics	Maryland Transportation Institute; U.S. Department of Transportation's Bureau of Transportation Statistics	LZ. This research is funded by Maryland Transportation Institute, and partial financial support from the U.S. Department of Transportation's Bureau of Transportation Statistics. The URL of each funder website is as follows: https://mti.umd.edu/and https://www.bts.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UN INS WEEKL CLAIMS; [Anonymous], AM COMM SURV 5 YEAR; Apple, 2020, MOB TRENDS REP; Baker SR, 2020, REV ASSET PRICING ST, V10, P834, DOI 10.1093/rapstu/raaa009; Barrios J.M, 2020, 27320 NAT BUR EC RES; Binti Hamzah F., 2020, B WORLD HEALTH ORGAN, V1, P32, DOI [10.2471/BLT.20.255695, DOI 10.2471/BLT.20.255695]; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Center for Systems Science and Engineering at Johns Hopkins University, COVID 19 DASHB; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Ding W, 2020, NBER WORKING PAPERS, V27393, P33; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gallotti R, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00994-6; Google, 2020, SEE YOUR COMM IS MOV; Gupta S., 2020, NBER WORKING PAPERS, V27027; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hou C, 2020, J MED VIROL, V92, P841, DOI 10.1002/jmv.25827; Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lai Shengjie, 2020, medRxiv, DOI 10.1101/2020.02.04.20020479; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Li D., 2020, ESTIMATING SCALE COV, DOI 10.1101/2020.03.06.20031880v1; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu Q, 2020, ASSESSING GLOBAL TEN, DOI [10.1101/2020.03.18.20038224v3, DOI 10.1101/2020.03.18.20038224V3]; Maloney W., 2020, Policy Research Working Paper - World Bank; Mammarella M, 2020, ARXIV200406111; Maryland Transportation Institute, 2020, U MARYL COVID 19 IMP; Moro, 2020, EFFECTIVENESS SOCIAL; Oliver N., 2020, ARXIV200312347; Oosterhoff B., 2020, PSYARXIV, DOI [10.31234/osf.io/rpcy4, DOI 10.31234/OSF.IO/RPCY4, 10.31234/osf.io/rpcy4.]; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Unacast, 2020, SOC DIST SCOR; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zhang L., 2020, FHWAPROJ170020; Zhang L., 2020, INTERACTIVE COVID 19, DOI [10.1101/2020.04.29.20085472, DOI 10.1101/2020.04.29.20085472]; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	39	44	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241468	10.1371/journal.pone.0241468	http://dx.doi.org/10.1371/journal.pone.0241468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166301	Green Submitted, Green Published, gold			2022-12-26	WOS:000592382600051
J	Garcia, GG; Garcia, GG; Soto, JZ; Medina, AI; Rotzinger-Rodriguez, M; Aguilar, GAC; Pacheco, CPL; Aguayo, A; Aguilar-Hernandez, MM				Gutierrez Garcia, Gilberto; Galicia Garcia, Gabriela; Zalapa Soto, Jessica; Izquierdo Medina, Andrea; Rotzinger-Rodriguez, Mariana; Casas Aguilar, Gustavo Antonio; Lopez Pacheco, Cynthia Paola; Aguayo, Alvaro; Aguilar-Hernandez, Maria Montserrat			Analysis of RNA yield in extracellular vesicles isolated by membrane affinity column and differential ultracentrifugation	PLOS ONE			English	Article							NANOPARTICLE TRACKING ANALYSIS; MICROVESICLES; MICRORNAS; EXOSOMES; PLASMA	Extracellular vesicles (EV) have attracted much attention as potential biomarkers due to their protein, RNA and other nucleic acid content. The most common method used for EV isolation is differential ultracentrifugation (DU), however given the DU technical difficulties, other more practical methods have surged, such as membrane-affinity column commercial kits. Here, we assessed one commercial kit in terms of EV recovery and EV-derived RNA yield and compared it with a DU protocol. Our data shows that the commercial kit preparation results in a lower count of EV-like structures and a reduced expression of EV markers when compared to DU samples. Thus, apparently suggesting that the commercial kit had a lower EV yield. However, these findings did not reflect on RNA yield, which was greater with the commercial kit, even after an enzymatic treatment with proteinase K and RNAse A. We conclude that the kit has a higher EV-derived RNA yield in comparison to our DU protocol, suggesting that it may be the method of choice for RNA sequencing purposes.	[Gutierrez Garcia, Gilberto; Zalapa Soto, Jessica; Izquierdo Medina, Andrea; Aguayo, Alvaro; Aguilar-Hernandez, Maria Montserrat] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Gutierrez Garcia, Gilberto] Univ Nacl Autonoma Mexico, FES Zaragoza, Mexico City, DF, Mexico; [Galicia Garcia, Gabriela; Casas Aguilar, Gustavo Antonio] Univ Nacl Autonoma Mexico, PECEM, Fac Med, Mexico City, DF, Mexico; [Rotzinger-Rodriguez, Mariana] Univ Anahuac, Fac Med, Mexico City, DF, Mexico; [Lopez Pacheco, Cynthia Paola] Invest Biomed UNAM, Lab Nacl Citometria Flujo, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Anahuac	Aguilar-Hernandez, MM (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico.	mmaguilarhe@conacyt.mx		Aguilar Hernandez, Maria Montserrat/0000-0001-8449-4359	Fondo Sectorial de Investigacion en Salud y Seguridad Social FOSISS [290432]	Fondo Sectorial de Investigacion en Salud y Seguridad Social FOSISS	This work was funded by Fondo Sectorial de Investigacion en Salud y Seguridad Social FOSISS Ref. No. 290432. The funding was awarded to MMAH https://www.conacyt.gob.mx/index.php/fondos-sectoriales-constituidos2/item/ssa-imss-issste-conacyt The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2015, BMJ, V2015, ph1887; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bachurski D, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1596016; Bandu Raju, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0218-2; Brennan K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57497-7; Chen Y, 2018, GENOM PROTEOM BIOINF, V16, P50, DOI 10.1016/j.gpb.2017.03.006; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Dickhout A, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00113; Enderle D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136133; Endzelins E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3737-z; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Gheinani AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22142-x; Guan S, 2020, J PROTEOME RES, V19, P2217, DOI 10.1021/acs.jproteome.9b00693; Han L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0980-8; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Hornick NI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11295; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Karimi N, 2018, CELL MOL LIFE SCI, V75, P2873, DOI 10.1007/s00018-018-2773-4; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kosaka N, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0219-1; Lane RE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0192-7; Langevin SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229976; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Maas SLN, 2015, J CONTROL RELEASE, V200, P87, DOI 10.1016/j.jconrel.2014.12.041; Manna I, 2018, FASEB J, V32, P4241, DOI 10.1096/fj.201701533R; Martins TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198820; Michell DL, 2016, BBA-MOL CELL BIOL L, V1861, P2069, DOI 10.1016/j.bbalip.2016.01.011; Mills J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246109; Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094; Monserrat Castellvi, 2019, INDRET, V1, P22; Mussack Veronika, 2019, Biomol Detect Quantif, V17, P100089, DOI 10.1016/j.bdq.2019.100089; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Salehi M, 2018, J CELL PHYSIOL, V233, P6370, DOI 10.1002/jcp.26481; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Stranska R, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-017-1374-6; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turchinovich A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00202; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yagi Y, 2017, NEUROSCI LETT, V636, P48, DOI 10.1016/j.neulet.2016.10.042; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	51	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0238545	10.1371/journal.pone.0238545	http://dx.doi.org/10.1371/journal.pone.0238545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156858	gold, Green Published			2022-12-26	WOS:000591376400059
J	Ou, JH; Liu, HB; Nirala, NK; Stukalov, A; Acharya, U; Green, MR; Zhu, LJ				Ou, Jianhong; Liu, Haibo; Nirala, Niraj K.; Stukalov, Alexey; Acharya, Usha; Green, Michael R.; Zhu, Lihua Julie			dagLogo: An R/Bioconductor package for identifying and visualizing differential amino acid group usage in proteomics data	PLOS ONE			English	Article							N-TERMINAL ACETYLTRANSFERASES; GRANZYME-B REVEALS; PROTEIN-PHOSPHORYLATION; SUBSTRATE-SPECIFICITY; CONSENSUS SEQUENCES; MOTIFS; REPRESENTATION; DETERMINANTS; INFORMATION; RECOGNITION	Sequence logos have been widely used as graphical representations of conserved nucleic acid and protein motifs. Due to the complexity of the amino acid (AA) alphabet, rich post-translational modification, and diverse subcellular localization of proteins, few versatile tools are available for effective identification and visualization of protein motifs. In addition, various reduced AA alphabets based on physicochemical, structural, or functional properties have been valuable in the study of protein alignment, folding, structure prediction, and evolution. However, there is lack of tools for applying reduced AA alphabets to the identification and visualization of statistically significant motifs. To fill this gap, we developed an R/Bioconductor package dagLogo, which has several advantages over existing tools. First, dagLogo allows various formats for input sets and provides comprehensive options to build optimal background models. It implements different reduced AA alphabets to group AAs of similar properties. Furthermore, dagLogo provides statistical and visual solutions for differential AA (or AA group) usage analysis of both large and small data sets. Case studies showed that dagLogo can better identify and visualize conserved protein sequence patterns from different types of inputs and can potentially reveal the biological patterns that could be missed by other logo generators.	[Ou, Jianhong; Liu, Haibo; Acharya, Usha; Green, Michael R.; Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 02721 USA; [Ou, Jianhong] Duke Univ, Sch Med, Regenerat NEXT, Durham, NC USA; [Nirala, Niraj K.; Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 02721 USA; [Stukalov, Alexey] Tech Univ Munich, Inst Virol, Munich, Germany; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 02721 USA; [Acharya, Usha] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA	University of Massachusetts System; University of Massachusetts Worcester; Duke University; University of Massachusetts System; University of Massachusetts Worcester; Technical University of Munich; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhu, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 02721 USA.; Zhu, LJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 02721 USA.; Zhu, LJ (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 02721 USA.	Julie.Zhu@umassmed.edu	Nirala, Niraj/ABD-9648-2021; Nirala, Niraj Kumar/P-3504-2017	Nirala, Niraj/0000-0002-5226-0459; Nirala, Niraj Kumar/0000-0002-5226-0459; ou, jianhong/0000-0002-8652-2488; Zhu, Lihua/0000-0001-7416-0590				Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amano M, 2015, J CELL BIOL, V209, P895, DOI 10.1083/jcb.201412008; Ardito F, 2017, INT J MOL MED, V40, P271, DOI 10.3892/ijmm.2017.3036; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bacardit J, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P346; Bacardit J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-6; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bian YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03460; BIGELOW CC, 1967, J THEOR BIOL, V16, P187, DOI 10.1016/0022-5193(67)90004-5; Biro JC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-15; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Chan HS, 1999, NAT STRUCT BIOL, V6, P994, DOI 10.1038/14876; Chang TH, 2008, NUCLEIC ACIDS RES, V36, pW91, DOI 10.1093/nar/gkn258; Cheng FX, 2014, ONCOTARGET, V5, P3697, DOI 10.18632/oncotarget.1984; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Dey K.K., 2018, BIOSTATISTICS BIOMET, V6, P102; Dey KK, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2489-3; Estebanez-Perpina E, 2000, BIOL CHEM, V381, P1203, DOI 10.1515/BC.2000.148; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giansanti P, 2013, MOL CELL PROTEOMICS, V12, P3350, DOI 10.1074/mcp.O113.028456; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hasan S, 2006, NUCLEIC ACIDS RES, V34, P5124, DOI 10.1093/nar/gkl676; Hennrich ML, 2013, J PROTEOME RES, V12, P2214, DOI 10.1021/pr400074f; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hu X, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz118; Huang JT, 2015, PROTEINS, V83, P631, DOI 10.1002/prot.24762; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janostiak R, 2017, CELL REP, V21, P2829, DOI 10.1016/j.celrep.2017.11.033; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kosiol C, 2004, J THEOR BIOL, V228, P97, DOI 10.1016/j.jtbi.2003.12.010; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li J, 2007, SCI CHINA SER C, V50, P392, DOI 10.1007/s11427-007-0023-3; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Li WC, 2008, BIOINFORMATICS, V24, P2254, DOI 10.1093/bioinformatics/btn407; Linster E, 2018, J EXP BOT, V69, P4555, DOI 10.1093/jxb/ery241; Maddelein D, 2015, NUCLEIC ACIDS RES, V43, pW543, DOI 10.1093/nar/gkv385; MAIOROV VN, 1992, J MOL BIOL, V227, P876, DOI 10.1016/0022-2836(92)90228-C; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; McDonald J.H, 2014, HDB BIOL STAT, V3rd; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Melo F, 2006, PROTEINS, V63, P986, DOI 10.1002/prot.20881; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ouidir T, 2015, J PROTEOMICS, V114, P214, DOI 10.1016/j.jprot.2014.11.006; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; POE M, 1991, J BIOL CHEM, V266, P98; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Pratt H, 2020, BIOINFORMATICS, V36, P3573, DOI 10.1093/bioinformatics/btaa192; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Rusin SF, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00097; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Saethang T, 2019, BIOINFORMATICS, V35, P5313, DOI 10.1093/bioinformatics/btz568; Sahu I., 2019, 20191220883942 BIORX; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schreiber M, 2002, BIOINFORMATICS, V18, P507, DOI 10.1093/bioinformatics/18.4.507; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; St-Denis N, 2015, J PROTEOMICS, V118, P49, DOI 10.1016/j.jprot.2014.10.020; Stephenson JD, 2013, J MOL EVOL, V77, P159, DOI 10.1007/s00239-013-9565-0; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Trapani JA, 2001, GENOME BIOL, V2; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Wang J, 1999, NAT STRUCT BIOL, V6, P1033; Waugh SM, 2000, NAT STRUCT BIOL, V7, P762, DOI 10.1038/78992; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Wingfield P, 2017, CURR PROTOC PROTEIN, V88, DOI [10.1002/cpps.29, DOI 10.1002/CPPS.29]; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu XB, 2017, NUCLEIC ACIDS RES, V45, pW534, DOI 10.1093/nar/gkx323; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Ye ZQ, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1680-2; Zheng Lei, 2021, Brief Bioinform, V22, DOI 10.1093/bib/bbaa096; Zheng L, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz131; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	93	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0242030	10.1371/journal.pone.0242030	http://dx.doi.org/10.1371/journal.pone.0242030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156866	gold, Green Published, Green Submitted			2022-12-26	WOS:000591376400029
J	Gurnani, V; Singh, P; Haldar, P; Aggarwal, MK; Agrahari, K; Kashyap, S; Ghosh, S; Mohapatra, MK; Bhargava, R; Nandi, P; Dhalaria, P				Gurnani, Vandana; Singh, Prem; Haldar, Pradeep; Aggarwal, Mahesh Kumar; Agrahari, Kiran; Kashyap, Satabdi; Ghosh, Shreeparna; Mohapatra, Mrinal Kar; Bhargava, Ruma; Nandi, Partha; Dhalaria, Pritu			Programmatic assessment of electronic Vaccine Intelligence Network (eVIN)	PLOS ONE			English	Article								eVIN is a technology system that digitizes vaccine stocks through a smartphone application and builds the capacity of program managers and cold chain handlers to integrate technology in their regular work. To effectively manage the vaccine logistics, in 2015, this technology was rolled-out in 12 states of India. This study assessed the programmatic usefulness of eVIN implementation in the areas of vaccine utilization, vaccine stock and distribution management and documentation across selected cold chain points. A pre-post study design was used, where cold chain points (CCPs) were selected using two-stage sampling technique in eVIN states. Pre-post comparative analysis was carried out on the identified indicators using both primary and secondary data sources. The vaccine utilization data reflects that the utilization had reduced from 305.3 million doses in pre-eVIN period to 215.0 million doses in post-eVIN period across 12 eVIN states, resulting into savings of approximately 90 million doses of vaccines. Number of facilities having stock-out of any vaccine showed a significant reduction by 30.4% in post-eVIN period (p<0.001). There was a 4.0% drop in facilities reporting minimum stock of any vaccine after implementation of eVIN. Facilities with maximum stock of any vaccine had increased from 37.4% in pre-eVIN to 39.2% in post-eVIN. During the pre-eVIN period, only 38.6% facilities updated vaccine stock on a daily basis, while in post-eVIN period, 53.5% facilities updated vaccine stock on daily basis. The completeness of records in the vaccine stock registers, indent form and temperature logbook have been substantially improved in the post-eVIN period (p<0.001). eVIN had helped in streamlining the vaccine flow network and ensured equity through better vaccine management practices. It is a powerful contribution to strengthen the vaccine supply chain and management. Upscaling eVIN in the remaining states of India will be crucial in improving the efficacy of vaccines and cold chain management.	[Gurnani, Vandana; Haldar, Pradeep; Aggarwal, Mahesh Kumar] Govt India, Minist Hlth & Family Welf, Immunizat Div, New Delhi, India; [Singh, Prem; Agrahari, Kiran; Kashyap, Satabdi; Ghosh, Shreeparna; Mohapatra, Mrinal Kar; Bhargava, Ruma; Dhalaria, Pritu] Govt India, Minist Hlth & Family Welf, Immunizat Tech Support Unit, New Delhi, India; [Nandi, Partha] Mahatma Gandhi Med Coll & Res Inst, Pondicherry, India	Mahatma Gandhi Medical College & Research Institute	Dhalaria, P (corresponding author), Govt India, Minist Hlth & Family Welf, Immunizat Tech Support Unit, New Delhi, India.	pritu_dhalaria@in.jsi.com		Mohapatra, Mrinal Kar/0000-0001-7096-1753	Gavi Targeted Country Assistance (TCA) support provided to Ministry of Health and Family Welfare, Government of India	Gavi Targeted Country Assistance (TCA) support provided to Ministry of Health and Family Welfare, Government of India	The assessment was undertaken as a part of Gavi Targeted Country Assistance (TCA) support provided to Ministry of Health and Family Welfare, Government of India. These funds were utilized to collect the field level data. None of the authors received any monetary support for conducting this study from funders.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2015, EPIDEMIOLOGY PREVENT; Ashok A, 2017, VACCINE, V35, P2217, DOI 10.1016/j.vaccine.2016.08.045; Gravlee C. C., 2002, FIELD METHOD, V3, P322, DOI DOI 10.1177/1525822X0201400305; Iwu CJ, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-018-0922-3; Manohar M, 2017, ASIA-PAC POWER ENERG; Ministry of Health & Family Welfare Government of India (MoHFW-GoI)., 2018, TECHN EC ASS EL VACC; Ministry of Health & Family Welfare Government of India (MoHFW-GoI)., 2016, EL VACC INT NETW HDB; Ministry of Health & Family Welfare Government of India (MoHFW-GoI), 2016, HDB VACC COLD CHAIN; Ministry of Health & Family Welfare Government of India (MoHFW-GoI), 2018, COMPR MULT YEAR PLAN; National Cold Chain Vaccine Management Resource Center (NCCVMRC) at NIHFW, 2013, NAT EFF VACC MAN ASS; National Cold Chain Vaccine Management Resource Center- National Institute of Health & Family Welfare (NCCVMRC-NIHFW) & UNICEF, 2018, NAT EFF VACC MAN ASS; NIPI-UNOPS and NCHRC-NIHFW, VACC LOG MAN HLTH MA; OXFAM, 2018, GOING DIG IMPR DAT Q; Rajgopal J, 2011, VACCINE, V29, P5512, DOI 10.1016/j.vaccine.2011.05.044; Thiyagarajan A, 2019, CHRISMED J HLTH RES, V6, P128; Turner A.G., 2001, MEASURE EVALUATION M, V3; United Nations Development Programme India (UNDP-India), IMPR EFF VACC SYST M; World Health Organization (WHO), 2015, MON TEMP VACC SUPPL; World Health Organization (WHO), 2014, IMM SUPPL CHAIN LOG	20	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241369	10.1371/journal.pone.0241369	http://dx.doi.org/10.1371/journal.pone.0241369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151951	Green Published, gold			2022-12-26	WOS:000591376200008
J	Kohlberger, M; Wildner, S; Regl, C; Huber, CG; Gadermaier, G				Kohlberger, Michael; Wildner, Sabrina; Regl, Christof; Huber, Christian G.; Gadermaier, Gabriele			Rituximab-specific DNA aptamers are able to selectively recognize heat-treated antibodies	PLOS ONE			English	Article							CIRCULAR-DICHROISM; BINDING; PROTEIN; SELEX; TREHALOSE	The monoclonal anti-CD20 IgG1 antibody rituximab is used as a first-line treatment for B cell lymphoma. Like all therapeutic antibodies, it is a complex protein for which both safety and efficacy heavily depend on the integrity of its three-dimensional structure. Aptamers, short oligonucleotides with a distinct fold, can be used to detect minor modifications or structural variations of a molecule or protein. To detect antibody molecules in a fold state occurring prior to protein precipitation, we generated DNA aptamers that were selected for extensively heat-treated rituximab. Using the magnetic bead-based systematic evolution of ligands by exponential enrichment (SELEX), we obtained six DNA aptamer sequences (40-mers) specific for 80 degrees C heat-treated rituximab. In silico fold prediction and circular dichroism analysis revealed a G-quadruplex structure for one aptamer, while all others exhibited a B-DNA helix. Binding affinities ranging from 8.8-86.7 nM were determined by an enzyme-linked apta-sorbent assay (ELASA). Aptamers additionally detected structural changes in rituximab treated for 5 min at 70 degrees C, although with lower binding activity. Notably, none of the aptamers recognized rituximab in its native state nor did they detect the antibody after it was exposed to lower temperatures or different physical stressors. Aptamers also reacted with the therapeutic antibody adalimumab incubated at 80 degrees C suggesting similar aptamer binding motifs located on extensively heat-treated IgG1 antibodies. Within this work, we obtained the first aptamer panel, which is specific for an antibody fold state specifically present prior to protein aggregation. This study demonstrates the potential of aptamer selection for specific stress-based protein variants, which has potential impact for quality control of biopharmaceuticals.	[Kohlberger, Michael; Wildner, Sabrina; Regl, Christof; Huber, Christian G.; Gadermaier, Gabriele] Paris Lodron Univ Salzburg, Dept Biosci, Salzburg, Austria; [Kohlberger, Michael; Wildner, Sabrina; Regl, Christof; Huber, Christian G.; Gadermaier, Gabriele] Paris Lodron Univ Salzburg, Christian Doppler Lab Innovat Tools Biosimilar Ch, Salzburg, Austria	Salzburg University; Salzburg University	Gadermaier, G (corresponding author), Paris Lodron Univ Salzburg, Dept Biosci, Salzburg, Austria.; Gadermaier, G (corresponding author), Paris Lodron Univ Salzburg, Christian Doppler Lab Innovat Tools Biosimilar Ch, Salzburg, Austria.	Gabriele.Gadermaier@sbg.ac.at	Gadermaier, Gabriele/L-5997-2015; Huber, Christian G./E-5445-2011	Gadermaier, Gabriele/0000-0002-4886-417X; Huber, Christian G./0000-0001-8358-1880	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology and Development; Province of Salzburg; priority program "Allergy-Cancer-BioNano Research Centre" of the University of Salzburg; Doctorate School Biomolecules at PLUS	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology and Development; Province of Salzburg; priority program "Allergy-Cancer-BioNano Research Centre" of the University of Salzburg; Doctorate School Biomolecules at PLUS	MK, SW, CR, CGH, GG: This study was funded by the Austrian Federal Ministry for Digital and Economic Affairs; the National Foundation for Research, Technology and Development; a Startup Grant of the Province of Salzburg; the priority program "Allergy-Cancer-BioNano Research Centre" of the University of Salzburg and the Doctorate School Biomolecules at PLUS. "The funder provided support in the form of salaries for authors MK, SW, and CGH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akazawa-Ogawa Yoko, 2018, Biophys Rev, V10, P255, DOI 10.1007/s12551-017-0361-8; Andersen CB, 2010, PROTEIN SCI, V19, P279, DOI 10.1002/pro.309; [Anonymous], 2013, AJN, V113, P26; Civit L, 2018, BIOCHIMIE, V145, P53, DOI 10.1016/j.biochi.2017.10.007; Cowperthwaite MC, 2008, J MOL EVOL, V67, P95, DOI 10.1007/s00239-008-9130-4; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Ferapontova EE, 2008, J AM CHEM SOC, V130, P4256, DOI 10.1021/ja711326b; Hamula CLA, 2011, TRAC-TREND ANAL CHEM, V30, P1587, DOI 10.1016/j.trac.2011.08.006; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Le Basle Y, 2020, J PHARM SCI-US, V109, P169, DOI 10.1016/j.xphs.2019.08.009; Luo ZF, 2017, ANALYST, V142, P3136, DOI 10.1039/c7an01131h; Luyckx J, 2011, CLIN OPHTHALMOL, V5, P577, DOI 10.2147/OPTH.S18827; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Mei HC, 2012, ANAL CHEM, V84, P7323, DOI 10.1021/ac300281u; Moghadam M, 2016, INT IMMUNOPHARMACOL, V36, P324, DOI 10.1016/j.intimp.2016.04.042; Ozer A, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.34; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parr MK, 2016, J PHARMACEUT BIOMED, V130, P366, DOI 10.1016/j.jpba.2016.05.028; Patel DJ, 1997, J MOL BIOL, V272, P645, DOI 10.1006/jmbi.1997.1281; Pierpont TM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00163; Rader RA, 2008, NAT BIOTECHNOL, V26, P743, DOI 10.1038/nbt0708-743; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Rouah-Martin E, 2012, INT J MOL SCI, V13, P17138, DOI 10.3390/ijms131217138; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Suguitan Jr AL, 2011, PLOS ONE, V6; Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026; Vorobyeva MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020470; Wagner-Rousset E, 2008, J CHROMATOGR B, V872, P23, DOI 10.1016/j.jchromb.2008.03.032; Wang T, 2019, BIOTECHNOL ADV, V37, P28, DOI 10.1016/j.biotechadv.2018.11.001; Wieland M, 2009, ANGEW CHEM INT EDIT, V48, P2715, DOI 10.1002/anie.200805311; Wildner S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37624-1; Zichel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031948; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241560	10.1371/journal.pone.0241560	http://dx.doi.org/10.1371/journal.pone.0241560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151990	Green Published, gold			2022-12-26	WOS:000591376200055
J	Diaz-Valderrama, JR; Njoroge, AW; Macedo-Valdivia, D; Orihuela-Ordonez, N; Smith, BW; Casa-Coila, V; Ramirez-Calderon, N; Zanabria-Galvez, J; Woloshuk, C; Baributsa, D				Diaz-Valderrama, Jorge R.; Njoroge, Anastasia W.; Macedo-Valdivia, Dennis; Orihuela-Ordonez, Nancy; Smith, Bradley W.; Casa-Coila, Victor; Ramirez-Calderon, Nelly; Zanabria-Galvez, Jackeline; Woloshuk, Charles; Baributsa, Dieudonne			Postharvest practices, challenges and opportunities for grain producers in Arequipa, Peru	PLOS ONE			English	Article							MAIZE STORAGE; UNITED-STATES; FARMERS; LOSSES; BAGS	Little is known about the major issues leading to postharvest losses in Peru, which are estimated to be 15-27%. We surveyed 503 farmers from the lowlands and Andean regions of Arequipa to learn more about the major grains produced and issues encountered during drying and storage. Rice, common bean, and quinoa were the most grown crops in the lowlands while starchy maize was the most cultivated crop in the highlands. Most farmers (90%) dried their crops in-field directly on the ground, which exposes them to rodents, birds, and insect pests. The majority of farmers (92%) used subjective methods to assess grain moisture content. About 77% of farmers identified insects as a major challenge during storage but only 44% said they used preventive measures such as the application of insecticides. Among farmers who stored grain, the main reason was for household consumption (61%); while among those who did not store, the main reason was the need for immediate cash at harvest (75%). Farmers who experienced insect problems, who stored seed or grain for sale, who stored longer, or farmers from the lowlands were more likely to apply insecticides on their stored products. These findings provide an opportunity for researchers, development organizations, and government agencies to improve postharvest handling and storage in Arequipa by disseminating drying technologies, moisture assessment tools and hermetic storage solutions among farmers.	[Diaz-Valderrama, Jorge R.; Njoroge, Anastasia W.; Smith, Bradley W.; Baributsa, Dieudonne] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Macedo-Valdivia, Dennis; Casa-Coila, Victor] Univ Nacl San Agustin Arequipa, Fac Agron, Arequipa, Peru; [Orihuela-Ordonez, Nancy] Univ Nacl San Agustin Arequipa, Fac Ingn Elect, Arequipa, Peru; [Ramirez-Calderon, Nelly] Univ Nacl San Agustin Arequipa, Fac Psicol, Arequipa, Peru; [Zanabria-Galvez, Jackeline] Univ Nacl San Agustin Arequipa, Fac Ingn Proc, Arequipa, Peru; [Woloshuk, Charles] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidad Nacional de San Agustin de Arequipa; Universidad Nacional de San Agustin de Arequipa; Universidad Nacional de San Agustin de Arequipa; Universidad Nacional de San Agustin de Arequipa; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Baributsa, D (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	dbaribut@purdue.edu	Njoroge, Anastasia/L-5783-2019	Njoroge, Anastasia/0000-0001-9155-6423; Ramirez Calderon, Nelly/0000-0001-6133-9946; ORIHUELA ORDONEZ, NANCY IVON/0000-0002-2184-3109; Macedo Valdivia, Dennis Geoffrey/0000-0002-0442-9395; Diaz-Valderrama, Jorge R./0000-0002-1015-3751; Casa-Coila, Victor Hugo/0000-0001-5081-6401	Arequipa Nexus Institute for Food, Energy, Water by Universidad Nacional de San Agustin de Arequipa (UNSA), Peru	Arequipa Nexus Institute for Food, Energy, Water by Universidad Nacional de San Agustin de Arequipa (UNSA), Peru	Funds to support this study which is part of the research in the Arequipa Nexus Institute for Food, Energy, Water, and the Environment program were provided by the Universidad Nacional de San Agustin de Arequipa (UNSA), Peru. This study was part of a USD $537,219 `Capacity Strengthening for Postharvest Handling and Storage in Peru' project under the Arequipa Nexus Institute for Food, Energy, Water, and the Environment program. JRDV, SWB, AN, CW and DB received salary from the funder institution. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoulaye T, 2016, EC807W PURD EXT AGR; Acuna Rivera JM, 2017, THESIS; Adejumo O. A., 2014, Journal of Biology, Agriculture and Healthcare, V4, P31; AflaSTOP, 2016, PERF TEST PROC AFLAS; Ajao SK, 2018, ARID ZO J ENG TECHNO, V14, P219; Baributsa D, 2020, J STORED PROD RES, V87, DOI 10.1016/j.jspr.2020.101618; Bishaw Zewdie, 2010, Journal of New Seeds, V11, P281, DOI 10.1080/1522886X.2010.518302; Bokusheva R, 2012, FOOD SECUR, V4, P279, DOI 10.1007/s12571-012-0184-1; Brecheisen Z, 2018, CAPTURING 40 YEARS A; Coulter JP, 1994, GRAIN STORAGE TECHNI, P1; Dauenhauer P, 2018, 2018 IEEE GLOB HUM T, P1; De Groote H, 2013, J STORED PROD RES, V53, P27, DOI 10.1016/j.jspr.2013.01.001; Delgado L, 2017, MPRA MUNICH PERS REP; DeLisi M, 2018, INT J OFFENDER THER, V62, P1107, DOI 10.1177/0306624X16670178; Deng A. L., 2009, African Journal of Environmental Science and Technology, V3, P108; Escobal J, 2015, AGR PERUANA NUEVAS M, P295; FAO, 2020, GIEWS COUNTR BRIEF P; Fion Aguilar ME, 2018, THESIS; Fischler M, 2011, 5 YEAR EXPOST IMPACT; Gabriel AH, 2006, INT ASS AGR EC ANN M, P17; Garcia Quijano JF, 2018, THESIS; Gelles PH, 1992, KROEBER ANTHROPOL SO, P75; Gitonga ZM, 2013, FOOD POLICY, V43, P44, DOI 10.1016/j.foodpol.2013.08.005; GRAG, 2019, CAMP AGR 2018 2019; Hell K, 2000, J STORED PROD RES, V36, P365, DOI 10.1016/S0022-474X(99)00056-9; Hodges R, 2014, APHLIS POSTHARVEST C, DOI [10.2788/19582, DOI 10.2788/19582]; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Huamanchumo de la Cuba C, 2013, AN CAD VAL CAC REG S; Huamanchumo J, 2008, IRRIG DRAIN, V57, P300, DOI 10.1002/ird.432; INIA, 2014, FRIJ CAN CAM; Kadjo D, 2018, AGR ECON-BLACKWELL, V49, P435, DOI 10.1111/agec.12427; Kumar D, 2017, FOODS, V6, DOI 10.3390/foods6010008; Latorre Farfan JP, 2017, THESIS; Moreno LL, 2006, BIODIVERS CONSERV, V15, P1771, DOI 10.1007/s10531-004-6679-0; Carpio ALD, 2016, BIOAGRO, V28, P139; Lumley T., 2019, PACKAGE SURVEY; Lumley T., 2010, 2 PHASE SAMPLING COM, P157; Maletta H., 2017, 4 CENSO NACL AGROPEC, VIV, P208; Manrique Klinge K., 2017, ESTUDIO DETERMINAR P; Maos J. O., 1985, GEOJOURNAL, V11, P69, DOI [10.1007/bf00572940., DOI 10.1007/BF00572940]; Mendoza JP, 2003, THESIS; Meyhuay M., 1997, QUINUA OPERACIONES P; MINAGRI, 2018, ARR 2001 2017; MINAGRI, 2012, MAIZ AMILACEO PRINCI; Murdock LL, 2014, J STORED PROD RES, V58, P3, DOI 10.1016/j.jspr.2014.02.006; Mutungi C, 2015, J ECON ENTOMOL, V108, P2479, DOI 10.1093/jee/tov197; Neme K, 2017, FOOD CONTROL, V78, P412, DOI 10.1016/j.foodcont.2017.03.012; Ness-Edelstein B, 2019, AGRESULTS IMPACT EVA; Njoroge Anastasia W, 2019, J Agric Sci (Tor), V11, DOI 10.5539/jas.v11n3p33; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rai A. K., 2005, African Journal of Science and Technology, V6, P97; Revelle William, 2020, CRAN; Romero CA, 2015, QUINUA PERUANA SITUA; Saunders RM, 1980, 1978 SURVEY RICE POS, P1; SDC, 2012, FOOD SEC CENTR AM SM; Sharifzadeh MS, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8020024; Thompson JF, 2017, AIMS AGRIC FOOD, V2, P339, DOI 10.3934/agrfood.2017.4.339; Tubbs T, 2017, AIMS AGRIC FOOD, V2, P43, DOI 10.3934/agrfood.2017.1.43; ubeda J, 2008, ESPAC DESARRO, V20, P31; Verzijl A, 2015, INT J COMMONS, V9, P107, DOI 10.18352/ijc.537; Walker S., 2017, FEASIBILITY UP SCALI; Williams SB, 2014, J STORED PROD RES, V59, P190, DOI 10.1016/j.jspr.2014.08.003; World Bank, 2017, GAIN MOM PER AGR OPP; Yonas M, 2010, CROP PROT, V29, P532, DOI 10.1016/j.cropro.2009.12.006	64	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240857	10.1371/journal.pone.0240857	http://dx.doi.org/10.1371/journal.pone.0240857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147234	gold, Green Published			2022-12-26	WOS:000589609300084
J	Kaneko, S; Kurosaki, M; Nagata, K; Taki, R; Ueda, K; Hanada, S; Takayama, K; Suzaki, S; Harada, N; Sugiyama, T; Nagasawa, M; Izumi, N				Kaneko, Shun; Kurosaki, Masayuki; Nagata, Kaoru; Taki, Reiko; Ueda, Ken; Hanada, Satoko; Takayama, Koji; Suzaki, Shinichiro; Harada, Naoshige; Sugiyama, Toru; Nagasawa, Masayuki; Izumi, Namiki			Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity	PLOS ONE			English	Article							CORONAVIRUS	Background/Aim The coronavirus disease 2019 (COVID-19) had become a big threat worldwide. Liver injury is not uncommon in patients with COVID-19, and clarifying its characteristics is needed. This study aimed to identify factors associated with liver injury and to develop a new classification of predictive severity in patients with COVID-19. Methods Confirmed patients with COVID-19 (n = 60) were recruited retrospectively from Musashino Red Cross Hospital. The factors of liver injury especially on the elevation of liver enzymes (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) were analyzed. Grading was assessed according to the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Results During a median hospitalization follow-up of 15 (4-41) days, 51 (85.0%) patients had COVID-19 pneumonia. In clinical courses, oxygenation was needed for 25 (41.6%) patients and intubation was needed for 9 (15.0%) patients. A total of 27 (45.0%) patients had gastrointestinal symptoms (GS), such as appetite loss, diarrhea, and nausea. A logistic regression analysis revealed that C-reactive protein (CRP) at baseline, oxygenation, intubation, and GS were significant factors of liver injury. Based on these results, patients were classified into three groups: group 1, no oxygenation pneumonia; group 2, pneumonia with oxygenation or GS; and group 3, intubation. We classified 25 (41.7%), 26 (43.3%), and 9 (15.0%) patients into mild, moderate, and severe groups, respectively. The peak of AST and ALT levels was significantly stratified with this criteria (mild [median AST, 28 IU/L; median ALT, 33 IU/L], moderate [median AST, 48 IU/L; median ALT, 47.5 IU/L], and severe [median AST, 109 IU/L; median ALT, 106 IU/L]; P0.001 and P = 0.0114, respectively). Conclusion COVID-19-related liver injury was significantly stratified based on GS and severity of pneumonia.	[Kaneko, Shun; Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Nagata, Kaoru; Ueda, Ken] Musashino Red Cross Hosp, Dept Gen Med, Tokyo, Japan; [Taki, Reiko; Hanada, Satoko; Takayama, Koji] Musashino Red Cross Hosp, Dept Pulm Med, Tokyo, Japan; [Suzaki, Shinichiro; Harada, Naoshige] Musashino Red Cross Hosp, Dept Emergency & Intens Care, Tokyo, Japan; [Sugiyama, Toru] Musashino Red Cross Hosp, Dept Endocrinol & Metab, Tokyo, Japan; [Nagasawa, Masayuki] Musashino Red Cross Hosp, Div Infect Control & Prevent, Tokyo, Japan		Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Kaneko, Shun/AAO-1475-2020; Nagasawa, Masayuki/CAI-8101-2022	Kaneko, Shun/0000-0003-2660-6580; Nagasawa, Masayuki/0000-0002-8085-4940				[Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y; Bloom PP, 2021, HEPATOLOGY, V73, P890, DOI 10.1002/hep.31326; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100169; Cancer Institute N, 2017, COMMON TERMINOLOGY C; Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hu Y, 2020, NEW ENGL J MED, V382, P1708; Hu Y, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104371; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926; Luo SH, 2020, CLIN GASTROENTEROL H, V18, P1636, DOI 10.1016/j.cgh.2020.03.043; Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5; Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275; Parohan M, 2020, HEPATOL RES, V50, P924, DOI 10.1111/hepr.13510; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Shirato K, 2020, JPN J INFECT DIS, V73, P304, DOI 10.7883/yoken.JJID.2020.061; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, 151 WHO; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou ZL, 2020, GASTROENTEROLOGY, V158, P2294, DOI 10.1053/j.gastro.2020.03.020; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241663	10.1371/journal.pone.0241663	http://dx.doi.org/10.1371/journal.pone.0241663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147270	Green Published, gold			2022-12-26	WOS:000589609300053
J	Zhao, P; Deng, Y; Wu, Y; Guo, QH; Zhou, LT; Yang, XQ; Wang, CF				Zhao, Ping; Deng, Yu; Wu, Yong; Guo, Qinhao; Zhou, Luting; Yang, Xiaoqun; Wang, Chaofu			Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1 alpha in clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						clear cell renal cell carcinoma; SNHG6; YBX1	SMALL NUCLEOLAR RNA; CANCER CELLS; HOST GENES; PROLIFERATION; EXPRESSION; GLYCOLYSIS; MIGRATION; INVASION; HYPOXIA; EZH2	Recent studies have showed that Small nucleolar RNA host genes (SNHGs) acted as a subset of long noncoding RNAs (lncRNAs) have critical roles in human cancer carcinogenesis. However, the biological functions of SNHGs in clear cell renal cell carcinoma (ccRCC) have not been fully investigated. In this study, we screened an oncogenic lncRNA termed SNHG6 using RNA-Seq data of ccRCC from The Cancer Genome Atlas (TCGA). Quantitative real-time PCR was then used to demonstrate the expression of SNHG6 in ccRCC tissues. SNHG6 overexpression is highly associated with malignant features in patients and is a prognostic indicator. SNHG6 significantly promotes ccRCC cell proliferation and metastasis in vitro and in vivo. Mechanistic investigations identified that SNHG6 exerts oncogenic effects by interacting with YBX1, and then, enhancing HIF1 alpha translation. Taken together, SNHG6 promotes ccRCC progression by binding YBX1 and may serve as a novel molecular target for ccRCC therapy.	[Zhao, Ping; Zhou, Luting; Yang, Xiaoqun; Wang, Chaofu] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pathol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Deng, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ Shanghai, Dept Gynecol Oncol, Ctr Canc, Shanghai, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Wu, Yong; Guo, Qinhao] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Fudan University; Fudan University; Fudan University	Yang, XQ; Wang, CF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pathol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	yxq11964@rjh.com.cn; wangchaofu@126.com	Wang, Chao/GXF-8353-2022		National Natural Science Foundation of China [82002747, 81903050]; Science and Technology Commission of Shanghai Municipality [17ZR1417500]; Shanghai Sailing Program; Shanghai Anticancer Association EYAS Project [20YF1408000, SACA-CY19A07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Sailing Program; Shanghai Anticancer Association EYAS Project	This work was supported in part by grants from the National Natural Science Foundation of China to YXQ (81903050) and from the Science and Technology Commission of Shanghai Municipality to WCF (17ZR1417500), and from the Shanghai Sailing Program and Shanghai Anticancer Association EYAS Project to WY (20YF1408000, SACA-CY19A07) and the National Natural Science Foundation of China to WY (82002747).	Calle AS, 2018, CANCER SCI, V109, P2093, DOI 10.1111/cas.13642; Cao C, 2017, ONCOGENE, V36, P1112, DOI 10.1038/onc.2016.278; Chang L, 2016, CANCER LETT, V383, P183, DOI 10.1016/j.canlet.2016.09.034; Chen SY, 2019, BIOCHEM BIOPH RES CO, V519, P901, DOI 10.1016/j.bbrc.2019.09.091; Chow RD, 2018, ONCOGENE, V37, P6442, DOI 10.1038/s41388-018-0420-z; DeOcesano-Pereira C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072611; Dong JY, 2018, CELL PHYSIOL BIOCHEM, V51, P2262, DOI 10.1159/000495871; Duan JY, 2019, ONCOTARGETS THER, V12, P4729, DOI 10.2147/OTT.S202938; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Gluz O, 2009, J CLIN ONCOL, V27, P6144, DOI 10.1200/JCO.2008.19.6261; Gogolevskaya IK, 2002, GENE, V292, P199, DOI 10.1016/S0378-1119(02)00678-9; Han WF, 2018, BIOMED PHARMACOTHER, V97, P911, DOI 10.1016/j.biopha.2017.11.014; Hayashi Y, 2019, CANCER SCI, V110, P1510, DOI 10.1111/cas.13990; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Lee YK, 2017, J BIOL CHEM, V292, P20208, DOI 10.1074/jbc.M117.809012; Li WH, 2019, EBIOMEDICINE, V44, P298, DOI 10.1016/j.ebiom.2019.05.055; Malakar P, 2019, CANCER RES, V79, P2480, DOI 10.1158/0008-5472.CAN-18-1432; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qin Y, 2020, ONCOTARGETS THER, V13, P7699, DOI 10.2147/OTT.S267140; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song EL, 2019, AGING-US, V11, P5705, DOI 10.18632/aging.102154; Su LM, 2019, ARTIF CELL NANOMED B, V47, P2670, DOI 10.1080/21691401.2019.1633338; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Wu Y, 2019, J CELL MOL MED, V23, P5025, DOI 10.1111/jcmm.14359; Xie ZY, 2019, IUBMB LIFE, V71, P1962, DOI 10.1002/iub.2140; Xu M, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-018-0690-5; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074; Zhang MY, 2019, ONCOTARGETS THER, V12, P3349, DOI 10.2147/OTT.S197433; Zhang PF, 2016, EMBO REP, V17, P1204, DOI 10.15252/embr.201642067	34	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000732RR	http://dx.doi.org/10.1096/fj.202000732RR		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150667				2022-12-26	WOS:000589712400001
J	Grossmann, G; Bortolussi, L; Wolf, V				Grossmann, Gerrit; Bortolussi, Luca; Wolf, Verena			Efficient simulation of non-Markovian dynamics on complex networks	PLOS ONE			English	Article							EPIDEMIC PROCESSES; SPREADING MODEL; TRANSMISSION; PERIODS	We study continuous-time multi-agent models, where agents interact according to a network topology. At any point in time, each agent occupies a specific local node state. Agents change their state at random through interactions with neighboring agents. The time until a transition happens can follow an arbitrary probability density. Stochastic (Monte-Carlo) simulations are often the preferred-sometimes the only feasible-approach to study the complex emerging dynamical patterns of such systems. However, each simulation run comes with high computational costs mostly due to updating the instantaneous rates of interconnected agents after each transition. This work proposes a stochastic rejection-based, event-driven simulation algorithm that scales extremely well with the size and connectivity of the underlying contact network and produces statistically correct samples. We demonstrate the effectiveness of our method on different information spreading models.	[Grossmann, Gerrit; Bortolussi, Luca; Wolf, Verena] Saarland Univ, Saarland Informat Campus, Saarbrucken, Germany; [Bortolussi, Luca] Univ Trieste, Dept Math & Geosci, Trieste, Italy	Saarland University; University of Trieste	Grossmann, G (corresponding author), Saarland Univ, Saarland Informat Campus, Saarbrucken, Germany.	gerrit.grossmann@uni-saarland.de		BORTOLUSSI, Luca/0000-0001-8874-4001	German Research Foundation (DFG) [SFB 1223]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was partly funded by the German Research Foundation (DFG) under grant SFB 1223. There was no additional external funding received for this study.	[Anonymous], 2014, CANC DISCOV, V4, pOF5; [Anonymous], 2015, BR J ANAESTH, V115, pii34, DOI 10.1093/bja/aev375; Barabasi A.-L., 2016, NETWORK SCI; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; BiloB, 2016, ICTCS, V1720, P269; BLYTHE SP, 1988, IMA J MATH APPL MED, V5, P181; Boguna M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042108; Cota W, 2017, COMPUT PHYS COMMUN, V219, P303, DOI 10.1016/j.cpc.2017.06.007; Cox D. R., 1962, RENEWAL THEORY; Daley D., 2003, INTRO THEORY POINT P, V1; Dassios A, 2013, ELECT COMMUNICATIONS, V18; DELLA NATURA SDS, COMP CORR AN HIGH DI; Farajtabar M, 2015, ADV NEURAL INFORM PR, P1954; Feng ZL, 2000, SIAM J APPL MATH, V61, P803, DOI 10.1137/S0036139998347834; Fosdick BK, 2018, SIAM REV, V60, P315, DOI 10.1137/16M1087175; Gan CQ, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/106950; Gerhard F, 2010, ADV NEURAL INF PROCE, P703; Goltsev AV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061921; Goutsias J, 2013, PHYS REP, V529, P199, DOI 10.1016/j.physrep.2013.03.004; Gro mann G, 2019, INT C COMPL NETW THE, P349; Grossmann G, 2019, LECT NOTES COMPUT SC, V11705, P63, DOI 10.1007/978-3-030-28042-0_5; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jo HH, 2019, ARXIV190408795; Keeler P, 2019, SIMULATING INHOMOGEN; Kiss I.Z., 2016, MATH EPIDEMICS NETWO; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Ma D, 2011, APPL PROBABILITY STA; Masuda N, 2018, SIAM REV, V60, P95, DOI 10.1137/16M1055876; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Meier J, 2017, NEUROIMAGE, V152, P639, DOI 10.1016/j.neuroimage.2017.02.007; OGATA Y, 1981, IEEE T INFORM THEORY, V27, P23, DOI 10.1109/TIT.1981.1056305; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Pasupathy R, GENERATING NONHOMOGE; Peckham R, 2014, J PUBLIC HEALTH-UK, V36, P13, DOI 10.1093/pubmed/fdt083; Pellis L, 2015, J THEOR BIOL, V382, P160, DOI 10.1016/j.jtbi.2015.04.039; Porter M.A., 2016, DYNAMICAL SYSTEMS NE, V4; Rodrigues H. S., 2016, INT J APPL MATH INFO; Rost G., 2016, BIOMAT 2015 INT S MA, P40, DOI DOI 10.1142/9789813141919-0003; Sherborne N, 2016, ARXIV161104030; SOFTKY WR, 1993, J NEUROSCI, V13, P334; St-Onge G., 2018, ARXIV180805859; Starnini M, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.128301; Truccolo W, 2010, SPR SER COMPUT NEURO, V7, P321, DOI 10.1007/978-1-4419-5675-0_15; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wu W, 2019, ARXIV190801623; YANG G L, 1972, Mathematical Biosciences, V14, P65, DOI 10.1016/0025-5564(72)90009-0	49	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241394	10.1371/journal.pone.0241394	http://dx.doi.org/10.1371/journal.pone.0241394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125408	gold, Green Published, Green Submitted			2022-12-26	WOS:000588368900062
J	Warner, ET; Zhang, Y; Gu, Y; Taporoski, TP; Pereira, A; DeVivo, I; Spence, ND; Cozier, Y; Palmer, JR; Kanaya, AM; Kandula, NR; Cole, SA; Tworoger, S; Shields, A				Warner, Erica T.; Zhang, Ying; Gu, Yue; Taporoski, Tamara P.; Pereira, Alexandre; DeVivo, Immaculata; Spence, Nicholas D.; Cozier, Yvette; Palmer, Julie R.; Kanaya, Alka M.; Kandula, Namratha R.; Cole, Shelley A.; Tworoger, Shelley; Shields, Alexandra			Physical and sexual abuse in childhood and adolescence and leukocyte telomere length: A pooled analysis of the study on psychosocial stress, spirituality, and health	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; AMERICAN-INDIANS; RISK; MALTREATMENT; LIFE; RESILIENCE; INFLAMMATION; ASSOCIATION; EXPERIENCES	Introduction We examined whether abuse in childhood and/or adolescence was associated with shorter telomere length in a pooled analysis of 3,232 participants from five diverse cohorts. We also assessed whether religion or spirituality (R/S) could buffer deleterious effects of abuse. Methods Physical and sexual abuse in childhood (age <12) and adolescence (age 12-18) was assessed using the Revised Conflict Tactics Scale and questions from a 1995 Gallup survey. We measured relative leukocyte telomere lengths (RTL) using quantitative real time polymerase chain reaction. We used generalized estimating equations to assess associations of physical and sexual abuse with log-transformed RTL z-scores. Analyses were conducted in each cohort, overall, and stratified by extent of religiosity or spirituality and religious coping in adulthood. We pooled study-specific estimates using random-effects models and assessed between-study heterogeneity. Results Compared to no abuse, severe sexual abuse was associated with lower RTL z-scores, in childhood: -15.6%, 95% CI: -25.9, -4.9; p-trend = 0.04; p-heterogeneity = 0.58 and in adolescence: -16.5%, 95% CI: -28.1, -3.0; p-trend = 0.08; p-heterogeneity = 0.68. Sexual abuse experienced in both childhood and adolescence was associated with 11.3% lower RTL z-scores after adjustment for childhood and demographic covariates (95% CI: -20.5%, -2.0%; p-trend = 0.03; p-heterogeneity = 0.62). There was no evidence of effect modification by R/S. Physical abuse was not associated with telomere length. Conclusions Sexual abuse in childhood or adolescence was associated with a marker of accelerated biological aging, decreased telomere length. The lack of moderation by R/S may be due to inability to capture the appropriate time period for those beliefs and practices.	[Warner, Erica T.; Zhang, Ying; Gu, Yue; Spence, Nicholas D.; Shields, Alexandra] Massachusetts Gen Hosp, Mongan Inst, MGH Harvard Ctr Genom Vulnerable Populat & Hlth D, Boston, MA 02114 USA; [Warner, Erica T.; Zhang, Ying; Gu, Yue; DeVivo, Immaculata; Spence, Nicholas D.; Shields, Alexandra] Harvard Med Sch, Boston, MA 02115 USA; [Warner, Erica T.] Massachusetts Gen Hosp, Dept Med, Clin Translat Epidemiol Unit, Boston, MA 02114 USA; [Zhang, Ying] Harvard Med Sch, Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Taporoski, Tamara P.] Northwestern Univ, Dept Neurol Sleep Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Taporoski, Tamara P.; Pereira, Alexandre] Univ Sao Paulo, Heart Inst Incor, Lab Genet & Mol Cardiol, Med Sch, Sao Paulo, Brazil; [DeVivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02114 USA; [Spence, Nicholas D.] Univ Toronto, Dept Sociol, Toronto, ON, Canada; [Cozier, Yvette; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Kanaya, Alka M.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Kandula, Namratha R.] Northwestern Univ, Dept Med, Evanston, IL USA; [Cole, Shelley A.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Tworoger, Shelley] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Universidade de Sao Paulo; Harvard University; Brigham & Women's Hospital; University of Toronto; Boston University; University of California System; University of California San Francisco; Northwestern University; Texas Biomedical Research Institute; H Lee Moffitt Cancer Center & Research Institute	Warner, ET (corresponding author), Massachusetts Gen Hosp, Mongan Inst, MGH Harvard Ctr Genom Vulnerable Populat & Hlth D, Boston, MA 02114 USA.; Warner, ET (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Warner, ET (corresponding author), Massachusetts Gen Hosp, Dept Med, Clin Translat Epidemiol Unit, Boston, MA 02114 USA.	ewarner@mgh.harvard.edu	Pereira, Alexandre/HHN-1038-2022	Cozier, Yvette/0000-0003-0625-7256	John Templeton Foundation; National Institutes of Health [R01HL109315, R01HL109301, R01HL109284, R01HL109282, R01HL109319, U01HL41642, U01HL41652, U01HL41654, U01HL65520, U01HL65521]; The National Institutes of Health [K01CA188075, U01CA164974, R01CA098663, R01CA058420, 1R01HL093009, 2R01HL093009, R01HL120725, UL1RR024131, UL1TR001872, P30DK098722, U01CA176726, R01CA163451, R01CA67262, 75N92019D00027, 75N92019D00028, 75N92019D00029, 75N92019D00030]	John Templeton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The John Templeton Foundation https://www.templeton.org/[59607 to A.E.S] and the National Institutes of Health https://www.nih.gov/[K01CA188075 to E.T. W; U01CA164974, R01CA098663, and R01CA058420 to J.R.P (Black Women's Health Study); 1R01HL093009, 2R01HL093009, R01HL120725, UL1RR024131, UL1TR001872, and P30DK098722 to A.M.K and N.R.K (MASALA); U01CA176726, R01CA163451, and R01CA67262 to Nurses' Health Study II; 75N92019D00027, 75N92019D00028, 75N92019D00029, 75N92019D00030, R01HL109315, R01HL109301, R01HL109284, R01HL109282, R01HL109319, U01HL41642, U01HL41652, U01HL41654, U01HL65520, and U01HL65521 to Strong Heart Study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Indian Health Service (IHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi TO, 2011, CAN J PSYCHIAT, V56, P266, DOI 10.1177/070674371105600505; Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049; Anonymous, 2014, Berichte zum Vogelschutz, V51, P15; [Anonymous], 2016, EUR J TRANSL MYOL, V26, P37; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2019, CANCER DISCOV, V10, pOF5; Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038; Bao Y, AM J PUBLIC HLTH, V1062016, P1573; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20; Brown MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065524; Burgin D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00490; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egan KJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011598; Epel E, 2012, CANCER PREV RES, V5, P1163, DOI 10.1158/1940-6207.CAPR-12-0370; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Franco-de-Moraes AC, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0261-x; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Hansen MEB, 2016, HUM MOL GENET, V25, P2324, DOI 10.1093/hmg/ddw070; Hanssen LM, 2017, HEALTH PSYCHOL RES, V5, DOI 10.4081/hpr.2017.6378; Heindel JJ, 2015, ENDOCRINOLOGY, V156, P3416, DOI 10.1210/EN.2015-1394; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang TY, 2019, CANCER CAUSE CONTROL, V30, P779, DOI 10.1007/s10552-019-01176-0; Kanaya AM, 2013, CLIN CARDIOL, V36, P713, DOI 10.1002/clc.22219; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Lalande KM, 2011, PSYCHOL TRAUMA-US, V3, P165, DOI 10.1037/a0020847; Lang JS, 2020, EUR CHILD ADOLES PSY, V29, P1329, DOI 10.1007/s00787-019-01329-1; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Li ZC, 2017, J PSYCHIATR RES, V93, P64, DOI 10.1016/j.jpsychires.2017.06.002; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Lu D, 2019, ANN EPIDEMIOL, V36, P33, DOI 10.1016/j.annepidem.2019.06.003; Mason SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124493; Meng XF, 2018, SOC PSYCH PSYCH EPID, V53, P453, DOI 10.1007/s00127-018-1485-2; Merrick MT, 2018, JAMA PEDIATR, V172, P1038, DOI 10.1001/jamapediatrics.2018.2537; Moore DW., 1995, DISCIPLINING CHILDRE; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Pargament K, 2011, RELIGIONS, V2, P51, DOI 10.3390/rel2010051; Pitzer LM, 2010, J GERONTOL B-PSYCHOL, V65, P425, DOI 10.1093/geronb/gbq031; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Raschenberger J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25398; Reinert Katia G, 2016, J Child Adolesc Trauma, V9, P231; Rentscher KE, 2020, ANNU REV PUBL HEALTH, V41, P223, DOI 10.1146/annurev-publhealth-040119-094239; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Ridout KK, 2018, MOL PSYCHIATR, V23, P858, DOI 10.1038/mp.2017.26; Rosenberg L, 1995, J Am Med Womens Assoc (1972), V50, P56; Section on Breastfeeding, 2012, PEDIATRICS, V129, pe827; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Shields AE, 2016, EPIGENOMICS-UK, V8, P1507, DOI 10.2217/epi-2016-0074; Shonkoff JP, 2016, JAMA PEDIATR, V170, P1003, DOI 10.1001/jamapediatrics.2016.1559; Slopen N, 2010, PSYCHOSOM MED, V72, P694, DOI 10.1097/PSY.0b013e3181e9c16f; Straus M, 1990, VIOLENCE VICTIMS, V5, P297, DOI [DOI 10.2307/584883, 10.1891/0886-6708.5.4.29, DOI 10.1891/0886-6708.5.4.29]; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; Tolios A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143889; Tomasdottir MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130591; Topitzes J, 2013, CHILD YOUTH SERV REV, V35, P937, DOI 10.1016/j.childyouth.2013.03.004; Turner KJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010073; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vincent J, 2017, J AFFECT DISORDERS, V213, P16, DOI 10.1016/j.jad.2017.01.031; Walker DF, 2009, PSYCHOL TRAUMA-US, V1, P130, DOI 10.1037/a0016211; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Wise LA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.034; Wise LA, 2009, AM J PUBLIC HEALTH, V99, pS460, DOI 10.2105/AJPH.2008.149005; Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744	70	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241363	10.1371/journal.pone.0241363	http://dx.doi.org/10.1371/journal.pone.0241363			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125425	gold, Green Published			2022-12-26	WOS:000588368900001
J	Mayito, J; Meya, DB; Rhein, J; Sekaggya-Wiltshire, C				Mayito, Jonathan; Meya, David B.; Rhein, Joshua; Sekaggya-Wiltshire, Christine			Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen	PLOS ONE			English	Article							PERIPHERAL-BLOOD	Background Latent Tuberculosis Infection (LTBI) remains a major driver of the TB epidemic, and individuals with Human Immuno-deficiency Virus (HIV) are particularly at a heightened risk of developing LTBI. However, LTBI screening among HIV-infected individuals in resource limited setting is largely based on a negative symptom screen, which has low specificity. Methods In a cross sectional diagnostic study, 115 HIV infected participants with a negative symptom screen will be consented and enrolled. They will be requested to donate 5 ml of blood for complete blood count (CBC) and interferon gamma release assay (IGRA) testing. In a nested prospective study, the 115 participants will be initiated on Tuberculosis Preventive Therapy and the CBC testing repeated after 3 months. In the analysis of study finding, the monocyte to lymphocyte ratio (MLR) will be derived from the dividend of the absolute monocyte and lymphocyte counts. The optimal MLR positivity cut-off for elevated or normal MLR will be the highest value of Youden's index, J (sensitivity + specificity-1). The MLR will be cross tabulated with the IGRA status to determine the sensitivity, specificity, negative and positive predictive values of the MLR. The area under the receiver operating characteristic (ROC) curve will be determined to give the overall diagnostic accuracy of MLR. The baseline and 3 month CBC will be used to determine the change in MLR, and a random effect logistic regression will be used to determine factors associated with the change in the MLR. Discussion If positive results are realized from this study, the MLR could become an inexpensive alternative biomarker with potential to improve the specificity of the negative symptom screen in identifying individuals that should be targeted for TB preventive therapy.	[Mayito, Jonathan; Meya, David B.; Sekaggya-Wiltshire, Christine] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Rhein, Joshua] Univ Minnesota, USA Dept Res, Div Infect Dis & Int Med, Minneapolis, MN USA; [Meya, David B.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Makerere University; University of Minnesota System; University of Minnesota Twin Cities; Makerere University	Mayito, J (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.	jmayito@idi.co.ug		, David/0000-0002-8854-0321; Mayito, Jonathan/0000-0001-9611-2178	Fogarty International Center of the National Institutes of Health [D43TW009345]; DELTAS Africa Initiative via THRiVE-2 [DEL-15-011]; NEPAD Agency; Wellcome Trust [107742/Z/15/Z]; United Kingdom government	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); DELTAS Africa Initiative via THRiVE-2; NEPAD Agency; Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom government	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under grant #D43TW009345 awarded to the Northern Pacific Global Health Fellows Program. DELTAS Africa Initiative (ref. DEL-15-011, via THRiVE-2) funds JM's PhD studies. The DELTAS Africa Initiative is an independent funding scheme of the AAS's Alliance for Accelerating Excellence in Science in Africa and supported by the NEPAD Agency with funding from the Wellcome Trust Grant No. 107742/Z/15/Z and the United Kingdom government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biraro IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146098; Choudhary RK, 2019, JAIDS-J ACQ IMM DEF, V80, P174, DOI 10.1097/QAI.0000000000001893; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Du JP, 2017, CLIN RHEUMATOL, V36, P2689, DOI 10.1007/s10067-017-3815-2; Esmail H, 2012, DRUG DISCOV TODAY, V17, P514, DOI 10.1016/j.drudis.2011.12.013; Fahim, 2016, P 14 INT C STAT SCI, V29, P239; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kizza FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0904-1; La Manna MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171358; Luetkemeyer AF, 2013, CLIN INFECT DIS, V57, P586, DOI 10.1093/cid/cit246; Lynch M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0937-8; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; UN CBD, 2010, UN CONV BIOL DIV C P, V2011, P1; Wang J, 2015, BRAZ J INFECT DIS, V19, P125, DOI 10.1016/j.bjid.2014.10.008; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; World Health Organization, END TB STRAT; World Health Organization, 2018, LAT TUB INF UPD CONS; Yuan C, 2017, THORAC CANCER, V8, P350, DOI 10.1111/1759-7714.12454	21	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241786	10.1371/journal.pone.0241786	http://dx.doi.org/10.1371/journal.pone.0241786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166312	gold, Green Published			2022-12-26	WOS:000592382600053
J	Wu, XQ; Liu, Y; Mo, S; Wei, WL; Ye, ZL; Su, Q				Wu, Xianqiu; Liu, Yang; Mo, Song; Wei, Wuli; Ye, Ziliang; Su, Qiang			LncRNA TUG1 competitively binds to miR-340 to accelerate myocardial ischemia-reperfusion injury	FASEB JOURNAL			English	Article						GLUT1; HDAC4; long noncoding RNA TUG1; microRNA&#8208; 340; myocardial ischemia&#8208; reperfusion injury; &#946; &#8208; catenin	INHIBITION; APOPTOSIS	The aberrant expression of long noncoding RNA (lncRNA) taurine-upregulated gene 1 (TUG1) has been previously associated with myocardial ischemia-reperfusion injury (MIRI), but the underlying molecular mechanisms remain elusive. The current study aimed to clarify the functional role of TUG1/microRNA (miR)-340/histone deacetylase 4 (HDAC4)/beta-catenin/glucose transporter type 1 (GLUT1) axes in MIRI. The database-based analyses performed predicted the downstream factors of lncRNA TUG1. In the MIRI mouse models and hypoxia/reoxygenation (H/R)-induced cardiomyocyte models, the expression of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 was manipulated to examine their effects on the infarction area, cardiomyocyte viability and apoptosis employing the Evans blue/TTC double staining, CCK-8 and TUNEL assays. Furthermore, the dual luciferase reporter and RIP assays verified the binding affinity of miR-340 to TUG1 and HDAC4. Subsequently, a negative correlation between miR-340 and TUG1 or HDAC4 expression was identified in myocardial tissues of MIRI mice and H/R-induced cardiomyocyte models, along with a positive correlation between TUG1 and HDAC4. Additionally, it was established that TUG1 bound to miR-340, and miR-340 targeted HDAC4. TUG1 upregulated HDAC4 expression, thereby promoting MIRI in the mouse models. HDAC4 was proven to repress the expression of beta-catenin and its target gene GLUT1. Moreover, the in vivo experiments validated that the inhibition of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 axes alleviated MIRI in mice. Collectively, the current study uncovered the role of TUG1/miR-340/HDAC4/beta-catenin/GLUT1 axes in MIRI mouse models and H/R-induced cardiomyocyte models which may be a potential therapeutic target for MIRI treatment.	[Wu, Xianqiu; Wei, Wuli] Guangxi Med Univ, Affiliated Hosp 4, Dept Cardiothorac Surg, Liuzhou, Peoples R China; [Liu, Yang] Guangxi Med Univ, Affiliated Hosp 3, Nanning Peoples Hosp 2, Dept Cardiol, Nanning, Peoples R China; [Mo, Song] Guangxi Med Univ, Affiliated Hosp 4, Dept Intens Care Unit, Liuzhou, Peoples R China; [Ye, Ziliang; Su, Qiang] Guilin Med Univ, Affiliated Hosp, Dept Cardiol, 15 Lequn Rd, Guilin 541001, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guilin Medical University	Su, Q (corresponding author), Guilin Med Univ, Affiliated Hosp, Dept Cardiol, 15 Lequn Rd, Guilin 541001, Guangxi Zhuang, Peoples R China.	suqiang1983@foxmail.com	Zi, Ye/GWM-3932-2022		Key Research and Development Program of Guangxi; Guangxi Natural Science Foundation [2020GXNSFDA238007]	Key Research and Development Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the Key Research and Development Program of Guangxi (Grant No. AB20159005), and Guangxi Natural Science Foundation (Grant No. 2020GXNSFDA238007)	Abraham DM, 2014, CIRC RES, V114, P938, DOI 10.1161/CIRCRESAHA.113.303238; Barzegar M, 2019, STEM CELL RES, V37, DOI 10.1016/j.scr.2019.101421; Cai JY, 2018, INT J ONCOL, V53, P2758, DOI 10.3892/ijo.2018.4564; Cui XJ, 2017, J CARDIOVASC PHARM, V70, P225, DOI 10.1097/FJC.0000000000000507; De Cecco L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058849; Du JF, 2015, J CELL PHYSIOL, V230, P1321, DOI 10.1002/jcp.24871; Fang Y, 2019, NAT COMMUN, V10; Han Y, 2020, INT J MOL MED, V45, P858, DOI 10.3892/ijmm.2020.4471; Hu SQ, 2017, EXP THER MED, V14, P771, DOI 10.3892/etm.2017.4564; Li D, 2019, J CELL BIOCHEM, V120, P14618, DOI 10.1002/jcb.28723; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lu D, 2016, LAB INVEST, V96, P239, DOI 10.1038/labinvest.2015.145; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Pei YH, 2020, NANOTOXICOLOGY, V14, P638, DOI 10.1080/17435390.2020.1731857; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Ruan ZH, 2019, INT J CARDIOL, V286, P136, DOI 10.1016/j.ijcard.2019.03.046; Senchenkova EY, 2019, CIRCULATION, V140, P319, DOI 10.1161/CIRCULATIONAHA.118.039345; Song JK, 2018, J CELL BIOCHEM, V119, P6665, DOI 10.1002/jcb.26850; Su Q, 2020, AM J PHYSIOL-HEART C, V318, pH332, DOI 10.1152/ajpheart.00444.2019; Su Q, 2019, J MOL CELL CARDIOL, V133, P12, DOI 10.1016/j.yjmcc.2019.05.021; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Tan H, 2018, CELL PHYSIOL BIOCHEM, V51, P46, DOI 10.1159/000495161; Wang GH, 2019, MOL MED REP, V19, P994, DOI 10.3892/mmr.2018.9734; Wang K, 2016, CELL DEATH DIFFER, V23, P1394, DOI 10.1038/cdd.2016.28; Wang T, 2017, ONCOL REP, V37, P1059, DOI 10.3892/or.2016.5322; Wu ZW, 2018, MOL MED REP, V17, P2422, DOI 10.3892/mmr.2017.8116; Xu BH, 2019, FUTURE ONCOL, V15, P3243, DOI 10.2217/fon-2019-0222; Yang DR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11817-2; Yang J, 2016, EXP THER MED, V12, P3249, DOI 10.3892/etm.2016.3777; Yang M, 2019, J CELL PHYSIOL, V234, P17757, DOI 10.1002/jcp.28401; Yu SY, 2017, INT J CARDIOL, V247, P31, DOI 10.1016/j.ijcard.2017.05.055; Zhang L, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0037-2; Zhao ZM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9250; Zhu LJ, 2020, J CELL PHYSIOL, V235, P7791, DOI 10.1002/jcp.29427	35	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000827RR	http://dx.doi.org/10.1096/fj.202000827RR		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33164260				2022-12-26	WOS:000590785700001
J	Gerbier, R; Ndiaye-Lobry, D; de Morentin, PMB; Cecon, E; Heisler, LK; Delagrange, P; Gbahou, F; Jockers, R				Gerbier, Romain; Ndiaye-Lobry, Delphine; Martinez de Morentin, Pablo B.; Cecon, Erika; Heisler, Lora K.; Delagrange, Philippe; Gbahou, Florence; Jockers, Ralf			Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5-HT2C receptor heteromers in mouse brain	FASEB JOURNAL			English	Article						cerebellum; GPCR heteromerization; hypothalamus; melatonin receptors; receptor transactivation; 5&#8208; HT2C	MOLECULAR CHARACTERIZATION; INTERNATIONAL UNION; PHASE ADVANCES; RAT-BRAIN; PROTEIN; LOCALIZATION; ACTIVATION; IDENTIFICATION; EXPRESSION; AGONIST	Association of G protein-coupled receptors into heterodimeric complexes has been reported for over 50 receptor pairs in vitro but functional in vivo validation remains a challenge. Our recent in vitro studies defined the functional fingerprint of heteromers composed of G(i)-coupled melatonin MT2 receptors and G(q)-coupled serotonin 5-HT2C receptors, in which melatonin transactivates phospholipase C (PLC) through 5-HT2C. Here, we identified this functional fingerprint in the mouse brain. G(q) protein activation was probed by [S-35]GTP gamma S incorporation followed by G(q) immunoprecipitation, and PLC activation by determining the inositol phosphate levels in brain lysates of animals previously treated with melatonin. Melatonin concentration-dependently activated G(q) proteins and PLC in the hypothalamus and cerebellum but not in cortex. These effects were inhibited by the 5-HT2C receptor-specific inverse agonist SB-243213, and were absent in MT2 and 5-HT2C knockout mice, fully recapitulating previous in vitro data and indicating the involvement of MT2/5-HT2C heteromers. The antidepressant agomelatine had a similar effect than melatonin when applied alone but blocked the melatonin-promoted G(q) activation due to its 5-HT2C antagonistic component. Collectively, we provide strong functional evidence for the existence of MT2/5-HT2C heteromeric complexes in mouse brain. These heteromers might participate in the in vivo effects of agomelatine.	[Gerbier, Romain; Ndiaye-Lobry, Delphine; Cecon, Erika; Gbahou, Florence; Jockers, Ralf] Univ Paris, CNRS, Inst Cochin, INSERM, 22 Rue Mechain, F-75014 Paris, France; [Martinez de Morentin, Pablo B.; Heisler, Lora K.] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland; [Delagrange, Philippe] Inst Rech Servier, Croissy Sur Seine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Aberdeen; Servier; Institut de Recherches Internationales Servier	Jockers, R (corresponding author), Univ Paris, CNRS, Inst Cochin, INSERM, 22 Rue Mechain, F-75014 Paris, France.	ralf.jockers@inserm.fr	de Morentin, Pablo B Martinez/K-5403-2014; Cecon, Erika/F-9842-2014; Jockers, Ralf/P-2272-2017; Cecon, Erika/B-3444-2016; Gbahou, Florence/L-4664-2017	de Morentin, Pablo B Martinez/0000-0002-0684-3215; Cecon, Erika/0000-0003-2387-9313; Jockers, Ralf/0000-0002-4354-1750; Cecon, Erika/0000-0003-2387-9313; Gerbier, Romain/0000-0003-4617-4850	Fondation Recherche Medicale (Equipe FRM2013) [DEQ 20130326503]; Fondation Recherche Medicale (Equipe FRM 2019) [EQU201903008055]; French National Research Agency (ANR) [ANR-19-CE16-0025-01]; Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM; CNRS; Who am I? laboratory of excellence - French Government through its "Investments for the Future" program [ANR-11-LABX- 0071, ANR-11-IDEX-0005-01]; La Ligue Contre le Cancer [RS19/75-127]; Biotechnology and Biological Sciences Research Council [BB/R01857X/1, BB/N017838/1]	Fondation Recherche Medicale (Equipe FRM2013); Fondation Recherche Medicale (Equipe FRM 2019); French National Research Agency (ANR)(French National Research Agency (ANR)); Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Who am I? laboratory of excellence - French Government through its "Investments for the Future" program; La Ligue Contre le Cancer(Ligue nationale contre le cancer); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to E. Trinquet (Cisbio) for advice in the in vivo IP1 protocol. This work was supported by grants from the Fondation Recherche Medicale (Equipe FRM2013, DEQ 20130326503 and Equipe FRM 2019, EQU201903008055 to RJ); The French National Research Agency (ANR) ANR-19-CE16-0025-01 (Mito-GPCR) to RJ, Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2"; INSERM; CNRS and the Who am I? laboratory of excellence ANR-11-LABX- 0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under Grant ANR-11-IDEX-0005-01; La Ligue Contre le Cancer N/Ref: RS19/75-127 and the Biotechnology and Biological Sciences Research Council (BB/R01857X/1 and BB/N017838/1 to LKH).	Abramowski D, 1995, NEUROPHARMACOLOGY, V34, P1635, DOI 10.1016/0028-3908(95)00138-7; Al-Ghoul WM, 1998, NEUROREPORT, V9, P4063, DOI 10.1097/00001756-199812210-00011; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Benleulmi-Chaachoua A, 2018, CELL MOL LIFE SCI, V75, P4357, DOI 10.1007/s00018-018-2876-y; Bromidge SM, 2000, J MED CHEM, V43, P1123, DOI 10.1021/jm990388c; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Cecon E, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12540; Cecon E, 2018, BRIT J PHARMACOL, V175, P3263, DOI 10.1111/bph.13950; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubocovich ML, 2005, J PINEAL RES, V39, P113, DOI 10.1111/j.1600-079X.2005.00230.x; Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Franco DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106332; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Fujita W, 2014, BIOCHEM PHARMACOL, V92, P448, DOI 10.1016/j.bcp.2014.09.015; Gobbi G, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12544; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gomes I, 2013, P NATL ACAD SCI USA, V110, P12072, DOI 10.1073/pnas.1222044110; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guardiola-Lemaitre B, 2014, BRIT J PHARMACOL, V171, P3604, DOI 10.1111/bph.12720; Guitart X, 2019, MOL NEUROBIOL, V56, P6756, DOI 10.1007/s12035-019-1564-8; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Jiao S, 2004, J PINEAL RES, V36, P109, DOI 10.1046/j.1600-079X.2003.00104.x; Jockers R, 2016, BRIT J PHARMACOL, V173, P2702, DOI 10.1111/bph.13536; Johansson LC, 2019, NATURE, V569, P289, DOI 10.1038/s41586-019-1144-0; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Karamitri A, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan6622; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Klosen P, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12575; Lacoste B, 2015, J PINEAL RES, V58, P397, DOI 10.1111/jpi.12224; LAUDON M, 1988, NEUROENDOCRINOLOGY, V48, P577, DOI 10.1159/000125066; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; Luo Y, 2017, MED SCI MONITOR, V23, P5951, DOI 10.12659/MSM.907592; Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625; Maroteaux L, 2017, PHARMACOL THERAPEUT, V170, P14, DOI 10.1016/j.pharmthera.2016.10.008; Martinez-Pinilla E, 2015, BIOCHEM PHARMACOL, V96, P131, DOI 10.1016/j.bcp.2015.05.006; Mazzucchelli C, 1996, MOL BRAIN RES, V39, P117, DOI 10.1016/0169-328X(96)00017-4; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; Millan MJ, 2011, INT J NEUROPSYCHOPH, V14, P768, DOI 10.1017/S1461145710001045; Moyer RW, 1999, NEUROSCI LETT, V271, P147, DOI 10.1016/S0304-3940(99)00536-4; Palacios JM, 2017, PSYCHOPHARMACOLOGY, V234, P1395, DOI 10.1007/s00213-017-4545-5; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Racagni G, 2011, WORLD J BIOL PSYCHIA, V12, P574, DOI 10.3109/15622975.2011.595823; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Sleno R, 2019, NEUROPHARMACOLOGY, V152, P4, DOI 10.1016/j.neuropharm.2019.01.018; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Vischer HF, 2015, MOL PHARMACOL, V88, P561, DOI 10.1124/mol.115.099440; WEAVER DR, 1989, J NEUROSCI, V9, P2581; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022	58	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000305R	http://dx.doi.org/10.1096/fj.202000305R		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33156577				2022-12-26	WOS:000592447500001
J	Modzelewska, D; Sole-Navais, P; Sandstrom, A; Zhang, G; Muglia, LJ; Flatley, C; Nilsson, S; Jacobsson, B				Modzelewska, Dominika; Sole-Navais, Pol; Sandstrom, Anna; Zhang, Ge; Muglia, Louis J.; Flatley, Christopher; Nilsson, Staffan; Jacobsson, Bo			Changes in data management contribute to temporal variation in gestational duration distribution in the Swedish Medical Birth Registry	PLOS ONE			English	Article							PRETERM BIRTH; AGE; DELIVERY; WEIGHT; PREGNANCY; LENGTH; RATES; FETAL	Multiple factors contribute to gestational duration variability. Understanding the sources of variability allows to design better association studies and assess public health measures. Here, we aimed to assess geographical and temporal changes in the determination of gestational duration and its reporting in Sweden between 1973 and 2012. Singleton live births between 1973 and 2012 were retrieved from the Swedish Medical Birth Register. Gestational duration trends in percentiles and rates of pre- and post-term deliveries were analyzed by plotting the values over time. Temporal changes in gestational duration based on ultrasound and last menstrual period (LMP) estimation methods were compared. Intervals between LMP date and LMP-based due date were analyzed to assess changes in expected gestational duration. In total, 3 940 577 pregnancies were included. From 1973 until 1985, the median of gestational duration estimated based on LMP or ultrasound decreased from 283 to 278 days, and remained stable until 2012. The distribution was relatively stable when ultrasound-based estimates were used. Until the mid-1990s, there was a higher incidence than expected of births occurring on every seventh gestational day from day 157 onward. On an average, these gestational durations were reported 1.8 times more often than adjacent durations. Until 1989, the most common expected gestational duration was 280 days, and thereafter, it was 279 days. The expected gestational duration varied from 279 to 281 days across different Swedish counties. During leap years, the expected gestational duration was one day longer. Consequently, leap years were also associated with significantly higher preterm and lower post-term delivery rates than non-leap years. Changes in data handling and obstetrical practices over the years contribute to gestational duration variation. The resulting increase in variability might reduce precision in association studies and hamper the assessment of public health measures aimed to improve pregnancy outcomes.	[Modzelewska, Dominika; Sole-Navais, Pol; Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Sandstrom, Anna] Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden; [Sandstrom, Anna] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Sandstrom, Anna] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Zhang, Ge; Muglia, Louis J.] Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati Childrens Hosp Med Ctr,Dept Pediat, Cincinnati, OH USA; [Zhang, Ge; Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH 45229 USA; [Muglia, Louis J.] Off President, Burroughs Wellcome Fund, Res Triangle Pk, NC USA; [Flatley, Christopher; Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Hlth Data & Digitalizat, Dept Genet & Bioinformat, Oslo, Norway; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Region Vastra G, Sweden	University of Gothenburg; Karolinska Institutet; Uppsala University; Oregon Health & Science University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Burroughs Wellcome Fund; Norwegian Institute of Public Health (NIPH); Chalmers University of Technology; Sahlgrenska University Hospital	Modzelewska, D (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden.	dominika.modzelewska@gu.se	; Flatley, Christopher/D-9331-2016	Sole-Navais, Pol/0000-0002-3326-266X; Nilsson, Staffan/0000-0003-4748-0446; Flatley, Christopher/0000-0002-2225-0188	Swedish government [ALFGBG-717501, ALFGBG-507701, ALFGBG-426411]; Swedish Research Council [2015-02559]; March of Dimes Foundation [21-FY16-121]; Burroughs Wellcome Fund Preterm Birth Research Grant [10172896]; March of Dimes Prematurity Research Center Ohio Collaborative	Swedish government; Swedish Research Council(Swedish Research CouncilEuropean Commission); March of Dimes Foundation(March of Dimes); Burroughs Wellcome Fund Preterm Birth Research Grant; March of Dimes Prematurity Research Center Ohio Collaborative(March of Dimes)	BJ: 1. Swedish government grants to researchers in the public health sector, grants no.: ALFGBG-717501, ALFGBG-507701, ALFGBG-426411, URL: https://www.vr.se 2. The Swedish Research Council, grants no. 2015-02559, URL: https://www.vr.se, 3. The March of Dimes Foundation, grant no.: 21-FY16-121, URL: https://www.marchofdimes.org 4. The Burroughs Wellcome Fund Preterm Birth Research Grant, grants no.: 10172896, URL: https://www.bwfund.org LM: 1. The March of Dimes Prematurity Research Center Ohio Collaborative, URL: https://www.marchofdimes.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balchin I, 2004, BJOG-INT J OBSTET GY, V111, P160, DOI 10.1046/j.1471-0528.2003.00026.x; Bergsjo P, 1990, ACTA OBSTET GYN SCAN, V69, P197, DOI 10.3109/00016349009028681; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Ferrero DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162506; Gardosi J, 1997, BRIT J OBSTET GYNAEC, V104, P792, DOI 10.1111/j.1471-0528.1997.tb12022.x; Goldenberg RL, 2004, ANN NY ACAD SCI, V1038, P227, DOI 10.1196/annals.1315.032; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; K?ll?n, 2003, SOCIALSTYRELSEN; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Morken Nils-Halvdan, 2008, BMC Womens Health, V8, P16, DOI 10.1186/1472-6874-8-16; Murray SR, 2019, ACTA OBSTET GYN SCAN, V98, P106, DOI 10.1111/aogs.13455; Nassar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056238; Nguyen TH, 1999, ULTRASOUND OBST GYN, V14, P23, DOI 10.1046/j.1469-0705.1999.14010023.x; Persson PH, 1999, ULTRASOUND OBST GYN, V14, P9, DOI 10.1046/j.1469-0705.1999.14010009.x; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Stephansson O, 2015, ANN REPORT; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Tunon K, 1999, ULTRASOUND OBST GYN, V14, P17, DOI 10.1046/j.1469-0705.1999.14010017.x; Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1; Yang H, 2002, AM J OBSTET GYNECOL, V186, P433, DOI 10.1067/mob.2002.120487; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241911	10.1371/journal.pone.0241911	http://dx.doi.org/10.1371/journal.pone.0241911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156833	Green Published, gold			2022-12-26	WOS:000591376400012
J	Ogunbosi, BO; Moodley, C; Naicker, P; Nuttall, J; Bamford, C; Eley, B				Ogunbosi, Babatunde O.; Moodley, Clinton; Naicker, Preneshni; Nuttall, James; Bamford, Colleen; Eley, Brian			Colonisation with extended spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in children admitted to a paediatric referral hospital in South Africa	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; KLEBSIELLA-PNEUMONIAE ACQUISITION; BLOOD-STREAM INFECTION; GRAM-NEGATIVE BACILLI; ESCHERICHIA-COLI; RISK-FACTORS; RECTAL COLONIZATION; HEALTHY-CHILDREN; CARRIAGE; GENES	Introduction There are few studies describing colonisation with extended spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) and carbapenem-resistant Enterobacterales (CRE) among children in sub-Saharan Africa. Colonisation often precedes infection and multi-drug-resistant Enterobacterales are important causes of invasive infection. Methods In this prospective cross-sectional study, conducted between April and June 2017, 200 children in a tertiary academic hospital were screened by rectal swab for EBSL-PE and CRE. The resistance-conferring genes were identified using polymerase chain reaction technology. Risk factors for colonisation were also evaluated. Results Overall, 48% (96/200) of the children were colonised with at least one ESBL-PE, 8.3% (8/96) of these with 2 ESBL-PE, and one other child was colonised with a CRE (0.5% (1/200)). Common colonising ESBL-PE were Klebsiella pneumoniae (62.5%, 65/104) and Escherichia coli (34.6%, 36/104). The most frequent ESBL-conferring gene was blaCTX-M in 95% (76/80) of the isolates. No resistance- conferring gene was identified in the CRE isolate (Enterobacter cloacae). Most of the Klebsiella pneumoniae isolates were susceptible to piperacillin/tazobactam (86.2%) and amikacin (63.9%). Similarly, 94.4% and 97.2% of the Escherichia coli isolates were susceptible to piperacillin/tazobactam and amikacin, respectively. Hospitalisation for more than 7 days before study enrolment was associated with ESBL-PE colonisation. Conclusion Approximately half of the hospitalised children in this study were colonised with ESBL-PE. This highlights the need for improved infection prevention and control practices to limit the dissemination of these microorganisms.	[Ogunbosi, Babatunde O.; Nuttall, James; Eley, Brian] Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa; [Ogunbosi, Babatunde O.; Nuttall, James; Eley, Brian] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Moodley, Clinton; Naicker, Preneshni; Bamford, Colleen] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Moodley, Clinton; Naicker, Preneshni; Bamford, Colleen] Univ Cape Town, Div Med Microbiol, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Ogunbosi, BO (corresponding author), Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa.; Ogunbosi, BO (corresponding author), Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa.	tundeogunbosi@yahoo.com	Nuttall, James/CAF-4214-2022; Nuttall, James/CAE-8986-2022	Nuttall, James/0000-0002-9389-5880; Nuttall, James/0000-0002-9389-5880; Moodley, Clinton/0000-0001-7547-9026; Ogunbosi, Babatunde/0000-0002-7576-7367	Department of Paediatrics and Child Health, University of Cape Town	Department of Paediatrics and Child Health, University of Cape Town	1. Initials: BOO Grant Number: None Full name of Funder: Departmental Research Award, Department of Paediatrics and Child Health, University of Cape Town URL of Funder: http://www.paediatrics.uct.ac.za/departmental-funding Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Initials: BOO Grant Number: None Full name of Funder: African Paediatric Fellowship Programme, Department of Paediatrics and Child Health, University of Cape Town URL of Funder: http://www.paediatrics.uct.ac.za/scah/apfp Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. Initials: BE Grant Number: None Full name of Funder: Department of Paediatrics and Child Health, University of Cape Town URL of Funder: http://www.paediatrics.uct.ac.za/Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalhamid B., 2016, New Microbes and New Infections, V10, P77, DOI 10.1016/j.nmni.2016.01.014; Ahmed SF, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-22; Akturk H, 2016, BRAZ J INFECT DIS, V20, P134, DOI 10.1016/j.bjid.2015.12.004; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; [Anonymous], 2019, HUM REPROD; Arhoune B, 2017, J GLOB ANTIMICROB RE, V8, P90, DOI 10.1016/j.jgar.2016.11.004; Bartoloni A, 2013, CLIN MICROBIOL INFEC, V19, P356, DOI 10.1111/j.1469-0691.2012.03807.x; Birgy A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-315; Birgy A, 2011, J CLIN MICROBIOL, V49, P3085, DOI 10.1128/JCM.00540-11; Boo NY, 2005, J HOSP INFECT, V61, P68, DOI 10.1016/j.jhin.2005.01.025; Briere EC, 2014, MMWR RECOMM REP, V63, P1; Bulabula ANH, 2020, J HOSP INFECT, V104, P57, DOI 10.1016/j.jhin.2019.10.001; Buys H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1919-y; Caselli D, 2016, INFECT DIS-NOR, V48, P152, DOI 10.3109/23744235.2015.1087647; Cassettari VC, 2009, J HOSP INFECT, V71, P340, DOI 10.1016/j.jhin.2008.11.019; Clinical & Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; Demir S, 2008, J PAEDIATR CHILD H, V44, P548, DOI 10.1111/j.1440-1754.2008.01326.x; Denkel LA, 2020, CLIN MICROBIOL INFEC, V26, P1046, DOI 10.1016/j.cmi.2019.11.025; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Diaz A, 2016, PEDIATR INFECT DIS J, V35, P237, DOI 10.1097/INF.0000000000000987; Dirajlal-Fargo S, 2014, INFECT CONT HOSP EP, V35, P447, DOI 10.1086/675593; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Drew RJ, 2013, J HOSP INFECT, V84, P300, DOI 10.1016/j.jhin.2013.05.003; Essack SY, 2001, ANTIMICROB AGENTS CH, V45, P88, DOI 10.1128/AAC.45.1.88-95.2001; Giuffre M, 2013, J HOSP INFECT, V85, P233, DOI 10.1016/j.jhin.2013.08.004; Harris PNA, 2018, JAMA-J AM MED ASSOC, V320, P984, DOI 10.1001/jama.2018.12163; Karaaslan A, 2016, J HOSP INFECT, V92, P67, DOI 10.1016/j.jhin.2015.09.011; Liu H, 2015, FRONTIERS MICROBIOLO, P6, DOI [10.3389/fmicb.2015.00006, DOI 10.3389/FMICB.2015.00006]; Lochan H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2862-2; Malande O O, 2016, SAMJ, S. Afr. med. j., V106, P877, DOI [10.7196/SAMJ.2016.v106i9.11028, 10.7196/samj.2016.v106i9.11028]; Malande OO, 2019, PLOS ONE, V14; Mammina C, 2007, AM J INFECT CONTROL, V35, P222, DOI 10.1016/j.ajic.2006.04.210; Mougkou K, 2013, INFECT CONT HOSP EP, V34, P757, DOI 10.1086/670997; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Oren I, 2013, AM J INFECT CONTROL, V41, P1167, DOI 10.1016/j.ajic.2013.04.018; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P3135, DOI 10.1128/AAC.00139-09; Sanders CC, 2000, J CLIN MICROBIOL, V38, P570, DOI 10.1128/JCM.38.2.570-574.2000; Shakil S, 2010, J TROP PEDIATRICS, V56, P90, DOI 10.1093/tropej/fmp060; Souverein D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211016; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Ulu-Kilic A, 2014, J INFECT DEV COUNTR, V8, P1361, DOI 10.3855/jidc.4593; Viau RA, 2012, CLIN INFECT DIS, V54, P1314, DOI 10.1093/cid/cis036; Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241776	10.1371/journal.pone.0241776	http://dx.doi.org/10.1371/journal.pone.0241776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156820	gold, Green Published, Green Submitted			2022-12-26	WOS:000591376400021
J	Vueba, AN; Faria, CP; Almendra, R; Santana, P; Sousa, MD				Vueba, Amelia Nkutxi; Faria, Clarissa Perez; Almendra, Ricardo; Santana, Paula; Sousa, Maria do Ceu			Serological prevalence of toxoplasmosis in pregnant women in Luanda (Angola): Geospatial distribution and its association with socio-demographic and clinical-obstetric determinants	PLOS ONE			English	Article							RISK-FACTORS; CONGENITAL TOXOPLASMOSIS; GONDII INFECTION; SEROPREVALENCE; TRANSMISSION; HISTORY; SEROPOSITIVITY	We report a study on toxoplasmosis in pregnant women in Luanda, Angola, determining the seroprevalence, geospatial distribution and its association with socio-economic features, dietary habits and hygiene and health conditions. Anti-Toxoplasma gondii IgG and IgM were quantified in serum samples of women attended at the Lucrecia Paim Maternity Hospital between May 2016 and August 2017. The IgG avidity test and qPCR assay were used for dating the primary infection. Data were collected by questionnaire after written consent, and spatial distribution was assessed through a Kernel Density Function. The potential risk factors associated with Toxoplasma infection were evaluated using bivariate and multivariate binomial logistic regression analysis. Anti-T. gondii antibodies were quantified in 878 pregnant women, and 346 (39.4%) samples were IgG positive, 2 (0.2%) positive for IgM and IgG, and 530 (60.4%) negative for both immunoglobulins. The longitudinal study showed that none of the seronegative women seroconverted during the survey. Regarding other infections, 226 (25.7%) were positive for hepatitis B, while 118 (13.4%) were HIV-positive. The seroprevalence of toxoplasmosis was similar in most municipalities: 43.8% in Cazenga (28 of 64); 42.5% in Viana (88 of 207); 42.3% in Cacuaco (22 of 52); and 41.1% in Luanda ((179 of 435). In contrast, the seroprevalence in municipality of Belas was lower (25.8%; 31 of 120) and bivariate and multivariate analysis has shown a lower risk for toxoplasmosis in this area (OR 0.479, CI: 0.305-0.737; OR 0.471, CI: 0.299-0.728). The multivariate analysis has shown a significant increased risk for toxoplasmosis in women in the last trimester of pregnancy (OR 1.457, CI: 1.011-2.102), suffering spontaneous abortion (OR 1.863, CI: 1.014-3.465) and having pets at home (OR 1.658, CI: 1.212-2.269). Also, women who tested positive for hepatitis B (OR 1.375, CI: 1.008-1.874) and HIV (OR 1.833, CI: 1.233-2.730) had a significant increased risk for T. gondii infection. In conclusion, our study showed that a large number of pregnant women are not immunized for toxoplasmosis and identified the risk factors for this infection in Luanda. It is crucial to establish the diagnosis of primary maternal infection as well as the diagnosis of congenital toxoplasmosis. Our results underlined the need for diagnostic and clinical follow-up of toxoplasmosis, HIV and hepatitis B during pregnancy.	[Vueba, Amelia Nkutxi; Faria, Clarissa Perez; Sousa, Maria do Ceu] Univ Coimbra FFUC, Fac Pharm, Coimbra, Portugal; [Faria, Clarissa Perez; Sousa, Maria do Ceu] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Almendra, Ricardo; Santana, Paula] Univ Coimbra, Ctr Studies Geog & Spatial Planning CEGOT, Coimbra, Portugal; [Santana, Paula] Univ Coimbra, Dept Geog & Tourism, Ctr Studies Geog & Spatial Planning CEGOT, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Sousa, MD (corresponding author), Univ Coimbra FFUC, Fac Pharm, Coimbra, Portugal.; Sousa, MD (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal.	mcsousa@ci.uc.pt	FARIA, CLARISSA PEREZ/G-1148-2016; Almendra, Ricardo/I-6653-2019; Sousa, Maria do Céu/AGQ-8739-2022; Sousa, Maria/HCI-9642-2022	FARIA, CLARISSA PEREZ/0000-0002-5311-1308; Almendra, Ricardo/0000-0002-2712-9643; SOUSA, Maria do Ceu Rodrigues/0000-0003-4957-7831	European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme [CENTRO-01-0145-FEDER-000008:BrainHealth 2020]; European Regional Development Fund (ERDF), through COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia, I.P. [POCI-01-0145-FEDER-007440 (UID/NEU/04539/2013)]; Calouste Gulbenkian Foundation, Lisbon, Portugal [66/SBG/18]	European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme; European Regional Development Fund (ERDF), through COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia, I.P.; Calouste Gulbenkian Foundation, Lisbon, Portugal	MCS, CPF: This work was financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000008:BrainHealth 2020, and through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia, I.P., under strategic project POCI-01-0145-FEDER-007440 (UID/NEU/04539/2013); ANV: Calouste Gulbenkian Foundation, Lisbon, Portugal for the PhD scholarship grant (ref. 66/SBG/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abamecha F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1806-6; Agmas Birhan, 2015, BMC Res Notes, V8, P107, DOI 10.1186/s13104-015-1083-2; Al-Harthi SA, 2006, UMM AL QURA U J SCI, V18, P217; Alvarado-Esquivel C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010218; Andiappan H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-239; [Anonymous], 2015, MED LETT DRUGS THER, V57, P93; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Avelar JB, 2018, REV SOC BRAS MED TRO, V51, P57, DOI 10.1590/0037-8682-0112-2017; Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Ayi Irene, 2016, Trop Med Health, V44, P17, DOI 10.1186/s41182-016-0018-5; Bamba S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2583-6; Bata SI, 2009, RES J MED MED SCI, V4, P483, DOI DOI 10.9734/AJMAH/2017/31528; Belluco S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153856; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Cadermatori BG, 2008, REV PANAM INFECT, V10, P30; Chintapalli Suryamani, 2013, Trop Parasitol, V3, P62, DOI 10.4103/2229-5070.113915; Cong W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/170278; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Das Sarkar M, 2012, J HEALTH POPUL NUTR, V30, P87, DOI 10.3329/jhpn.v30i1.11287; Galvan-Ramirez MD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-271; Galvan-Ramirez MD, 2018, J MED MICROBIOL, V67, P499, DOI 10.1099/jmm.0.000694; de Wit LA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007040; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Dubey JP, 2000, BRIT MED J, V321, P127, DOI 10.1136/bmj.321.7254.127; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Ferreira FP, 2018, REV BRAS PARASITOL V, V27, P327, DOI [10.1590/S1984-296120180050, 10.1590/s1984-296120180050]; Frimpong C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2133-7; Gebremedhin EZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-101; Ghoneim N. H., 2009, Global Veterinaria, V3, P395; Gilot-Fromont E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-76; Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Ibrahim HM, 2017, ASIAN PAC J TROP MED, V10, P996, DOI 10.1016/j.apjtm.2017.09.012; Jiang RL, 2018, MICROB PATHOGENESIS, V123, P398, DOI 10.1016/j.micpath.2018.07.041; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Kamal AM, 2015, KOREAN J PARASITOL, V53, P605, DOI 10.3347/kjp.2015.53.5.605; Laboudi M, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.269.11822; Leeper C, 2018, PRIMARY CARE, V45, P567, DOI 10.1016/j.pop.2018.05.013; Lin YL, 2008, PARASITOL RES, V103, P67, DOI 10.1007/s00436-008-0928-1; Lobo ML, 2017, EPIDEMIOL INFECT, V145, P30, DOI 10.1017/S0950268816001904; LOPEZ R, 1992, Revista Latinoamericana de Microbiologia, V34, P49; Mareze M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212375; Martins J, 1976, An Inst Hig Med Trop (Lisb), V4, P111; Ministry of Health Government of Angola (MINSA), PLAN NAC DES SAN PND, VII; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mwambe B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-222; Nash JQ, 2005, EPIDEMIOL INFECT, V133, P475, DOI 10.1017/S0950268804003620; Nissapatorn V, 2011, AM J TROP MED HYG, V85, P243, DOI 10.4269/ajtmh.2011.10-0633; Ogoina D, 2013, J INFECT DEV COUNTR, V7, P398, DOI 10.3855/jidc.2797; Oliveira-Bahia LMG, 2001, INT J PARASITOL, V31, P115; Ortiz-Alegria LB, 2010, GENES IMMUN, V11, P363, DOI 10.1038/gene.2010.21; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Paul E, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0122-9; Pfaff AW, 2007, PARASITOLOGY, V134, P1895, DOI 10.1017/S0031182007000200; Piazza MJ, 2010, DIAGN TRATAMENTO, V15, P12; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rostami A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007807; Smit GSA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3885-7; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Varella Ivana S., 2003, J. Pediatr. (Rio J.), V79, P69, DOI 10.1590/S0021-75572003000100012; Varella IS, 2009, MEM I OSWALDO CRUZ, V104, P383, DOI 10.1590/S0074-02762009000200037; Weiss LM, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P1; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; Xiao XM, 2007, INT J GYNECOL OBSTET, V96, P167, DOI 10.1016/j.ijgo.2006.11.011; Yobi Doudou, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P69, DOI 10.1016/S2221-1691(14)60211-2	68	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241908	10.1371/journal.pone.0241908	http://dx.doi.org/10.1371/journal.pone.0241908			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156846	Green Published, gold			2022-12-26	WOS:000591376400061
J	Crissman, J; Lin, YH; Separa, K; Duquette, M; Cohen, M; Velasquez, C; Cujec, T				Crissman, John; Lin, Yuhao; Separa, Kevin; Duquette, Madeleine; Cohen, Michael; Velasquez, Candyd; Cujec, Thomas			RNase H-dependent PCR enables highly specific amplification of antibody variable domains from single B-cells	PLOS ONE			English	Article							DISCOVERY; HEAVY; REPERTOIRES; EXPRESSION	Immunization-based antibody discovery platforms require robust and effective protocols for the amplification, cloning, expression, and screening of antibodies from large numbers of B-cells in order to effectively capture the diversity of an experienced Ig-repertoire. Multiplex PCR using a series of forward and reverse primers designed to recover antibodies from a range of different germline sequences is challenging because primer design requires the recovery of full length antibody sequences, low starting template concentrations, and the need for all the primers to function under the same PCR conditions. Here we demonstrate several advantages to incorporating RNase H2-dependent PCR (rh-PCR) into a high-throughput, antibody-discovery platform. Firstly, rh-PCR eliminated primer dimer synthesis to below detectable levels, thereby eliminating clones with a false positive antibody titer. Secondly, by increasing the specificity of PCR, the rh-PCR primers increased the recovery of cognate antibody variable regions from single B-cells, as well as downstream recombinant antibody titers. Finally, we demonstrate that rh-PCR primers provide a more homogeneous sample pool and greater sequence quality in a Next Generation Sequencing-based approach to obtaining DNA sequence information from large numbers of cloned antibody cognate pairs. Furthermore, the higher specificity of the rh-PCR primers allowed for a better match between native antibody germline sequences and the VL/VH fragments amplified from single B-cells.	[Crissman, John; Separa, Kevin; Duquette, Madeleine; Cohen, Michael; Velasquez, Candyd; Cujec, Thomas] Eli Lilly & Co, Ctr Biotechnol, Dept Biol Automat & High Throughput Technol, San Diego, CA 92121 USA; [Lin, Yuhao] Eli Lilly & Co, Ctr Biotechnol, Dept Biol IT, San Diego, CA USA	Eli Lilly; Eli Lilly	Cujec, T (corresponding author), Eli Lilly & Co, Ctr Biotechnol, Dept Biol Automat & High Throughput Technol, San Diego, CA 92121 USA.	cujecth@lilly.com		Cujec, Thomas/0000-0002-6582-7848	Eli Lilly Company	Eli Lilly Company(Eli Lilly)	JC, YL, KS, MD, MC, CV and TC are, or were at the time of the work described here, employees of Eli Lilly & Company. Eli Lilly & Company provided support in the form of salaries for the authors and research funding. However, the authors received no specific funding for this work. The specific roles of these authors are articulated in the 'Authors Contribution' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Eli Lilly & Company approved the publication of this work.	Aharon L, 2020, BIOCHEM J, V477, P1701, DOI 10.1042/BCJ20200188; [Anonymous], 2014, NAT METHODS, V11, P1, DOI 10.1038/nmeth.2801; [Anonymous], MOV MON; Bailly M, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1743053; Beltz K., 2018, ADV BIOSCI BIOTECHNO, V9, P497, DOI [10.4236/abb.2018.99034, DOI 10.4236/ABB.2018.99034]; Broccanello C, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0295-6; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Coffman J, 2020, BIOTECHNOL BIOENG, V117, P2100, DOI 10.1002/bit.27349; Coronella JA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e85; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; D'Angelo S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00395; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Dunbar J, 2016, BIOINFORMATICS, V32, P298, DOI 10.1093/bioinformatics/btv552; Dunn-Walters D, 2018, IMMUNOL REV, V284, P132, DOI 10.1111/imr.12659; Ferrara F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049535; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Goulet DR, 2020, J PHARM SCI-US, V109, P74, DOI 10.1016/j.xphs.2019.05.031; Harris KE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00889; Jagers P, 2003, J THEOR BIOL, V224, P299, DOI 10.1016/S0022-5193(03)00166-8; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Kebschull JM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv717; Kennedy PJ, 2018, CRIT REV BIOTECHNOL, V38, P394, DOI 10.1080/07388551.2017.1357002; Kono N, 2017, BIOCHEM BIOPH RES CO, V487, P300, DOI 10.1016/j.bbrc.2017.04.054; Kuzuya Akinori, 2009, Nucleic Acids Symp Ser (Oxf), P75, DOI 10.1093/nass/nrp038; Labbe G, 2019, J MICROBIOL METH, V157, P81, DOI 10.1016/j.mimet.2018.12.021; Li SQ, 2019, NAT PROTOC, V14, P2571, DOI 10.1038/s41596-019-0195-x; Lu RM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0592-z; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Parola C, 2018, IMMUNOLOGY, V153, P31, DOI 10.1111/imm.12838; Rajendra Y, 2015, BIOTECHNOL BIOENG, V112, P977, DOI 10.1002/bit.25514; Rouet R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00118; Starkie DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152282; Stolovitzky G, 1996, P NATL ACAD SCI USA, V93, P12947, DOI 10.1073/pnas.93.23.12947; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Wang B, 2018, NAT BIOTECHNOL, V36, P152, DOI 10.1038/nbt.4052; WEIGHARDT F, 1993, PCR METH APPL, V3, P77; Xu YD, 2019, MABS-AUSTIN, V11, DOI 10.1080/19420862.2018.1553476	47	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241803	10.1371/journal.pone.0241803	http://dx.doi.org/10.1371/journal.pone.0241803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152031	Green Published, gold			2022-12-26	WOS:000591376200030
J	Grosser, M; Gellissen, S; Borchert, P; Sedlacik, J; Nawabi, J; Fiehler, J; Forkert, ND				Grosser, Malte; Gellissen, Susanne; Borchert, Patrick; Sedlacik, Jan; Nawabi, Jawed; Fiehler, Jens; Forkert, Nils D.			Localized prediction of tissue outcome in acute ischemic stroke patients using diffusion- and perfusion-weighted MRI datasets	PLOS ONE			English	Article							PERFORMANCE; THRESHOLDS; MISMATCH; MODELS; TIME	Background An accurate prediction of tissue outcome in acute ischemic stroke patients is of high interest for treatment decision making. To date, various machine learning models have been proposed that combine multi-parametric imaging data for this purpose. However, most of these machine learning models were trained using voxel information extracted from the whole brain, without taking differences in susceptibility to ischemia into account that exist between brain regions. The aim of this study was to develop and evaluate a local tissue outcome prediction approach, which makes predictions using locally trained machine learning models and thus accounts for regional differences. Material and methods Multi-parametric MRI data from 99 acute ischemic stroke patients were used for the development and evaluation of the local tissue outcome prediction approach. Diffusion (ADC) and perfusion parameter maps (CBF, CBV, MTT, Tmax) and corresponding follow-up lesion masks for each patient were registered to the MNI brain atlas. Logistic regression (LR) and random forest (RF) models were trained employing a local approach, which makes predictions using models individually trained for each specific voxel position using the corresponding local data. A global approach, which uses a single model trained using all voxels of the brain, was used for comparison. Tissue outcome predictions resulting from the global and local RF and LR models, as well as a combined (hybrid) approach were quantitatively evaluated and compared using the area under the receiver operating characteristic curve (ROC AUC), the Dice coefficient, and the sensitivity and specificity metrics. Results Statistical analysis revealed the highest ROC AUC and Dice values for the hybrid approach. With 0.872 (ROC AUC; LR) and 0.353 (Dice; RF), these values were significantly higher (p < 0.01) than the values of the two other approaches. In addition, the local approach achieved the highest sensitivity of 0.448 (LR). Overall, the hybrid approach was only outperformed in sensitivity (LR) by the local approach and in specificity by both other approaches. However, in these cases the effect sizes were comparatively small. Conclusion The results of this study suggest that using locally trained machine learning models can lead to better lesion outcome prediction results compared to a single global machine learning model trained using all voxel information independent of the location in the brain.	[Grosser, Malte; Gellissen, Susanne; Borchert, Patrick; Sedlacik, Jan; Nawabi, Jawed; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary	Grosser, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	malte.grosser@googlemail.com	; Forkert, Nils Daniel/K-6273-2012	Nawabi, Jawed/0000-0002-1137-0643; Forkert, Nils Daniel/0000-0003-2556-3224	Heart and Stroke Foundation of Canada [G-17-0018368]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Heart and Stroke Foundation of Canada Grant in aid (G-17-0018368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Arakawa S, 2006, STROKE, V37, P1211, DOI 10.1161/01.STR.0000217258.63925.6b; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Chen F, 2012, WORLD J RADIOL, V4, P63, DOI 10.4329/wjr.v4.i3.63; d'Esterre CD, 2015, STROKE, V46, P3390, DOI 10.1161/STROKEAHA.115.009250; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; Jonsdottir KY, 2009, STROKE, V40, P3006, DOI 10.1161/STROKEAHA.109.552216; Kemmling A, 2015, J CEREBR BLOOD F MET, V35, P1397, DOI 10.1038/jcbfm.2015.144; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Maier O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145118; Nielsen A, 2018, STROKE, V49, P1394, DOI 10.1161/STROKEAHA.117.019740; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; R Core Team, R LANG ENV STAT COMP; Sah RG, 2019, CLIN NEURORADIOL, V29, P135, DOI 10.1007/s00062-017-0634-4; Siemonsen S, 2014, J CEREBR BLOOD F MET, V34, P813, DOI 10.1038/jcbfm.2014.13; Sussman ES, 2013, FRONT NEUROL, P1, DOI [10.3389/fneur.2013.00001, DOI 10.3389/FNEUR.2013.00001]; Turc Guillaume, 2019, J Neurointerv Surg, DOI 10.1136/neurintsurg-2018-014569; Wang D, 2019, STROKE VASC NEUROL, V4, P1, DOI 10.1136/svn-2018-000211; Winzeck S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00679; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241917	10.1371/journal.pone.0241917	http://dx.doi.org/10.1371/journal.pone.0241917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152045	gold, Green Published			2022-12-26	WOS:000591376200012
J	Sopo, M; Sallinen, H; Hamalainen, K; Kivela, A; Yla-Herttuala, S; Kosma, VM; Keski-Nisula, L; Anttila, M				Sopo, Minna; Sallinen, Hanna; Hamalainen, Kirsi; Kivela, Annukka; Yla-Herttuala, Seppo; Kosma, Veli-Matti; Keski-Nisula, Leea; Anttila, Maarit			High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; DOUBLE-BLIND; VEGF-A; ANGIOPOIETIN-2; PHASE-3; GROWTH; PROGRESSION; TREBANANIB; TRIAL; OVEREXPRESSION	Background Antiangiogenic therapy, although part of standard treatment in ovarian cancer, has variable efficacy. Furthermore, little is known about the prognostic biomarkers and factors influencing angiogenesis in cancer tissue. We evaluated the expression of angiopoietin-2 and two endothelial tyrosine kinase receptors, Tie-1 and Tie-2, and assessed their value in the prediction of survival in patients with malignant epithelial ovarian cancer. We also compared the expression of these factors between primary high grade serous tumors and their distant metastasis. Materials and methods We evaluated 86 women with primary epithelial ovarian cancer. Matched distal omental metastasis were investigated in 18.6% cases (N = 16). The expression levels of angiogenic factors were evaluated by immunohistochemistry in 306 specimens and by qRT-PCR in 111 samples. Results A high epithelial expression level of Tie-2 is a significant prognostic factor in primary high grade serous ovarian cancer. It predicted significantly shorter overall survival both in univariate (p<0.001) and multivariate survival analyses (p = 0.022). Low angiopoietin-2 expression levels in primary ovarian tumors were significantly associated with shorter overall survival (p = 0.015) in the univariate survival analysis. A low expression of angiopoietin-2 was also significantly related to high grade tumors, size of residual tumor after primary surgery and the recurrence of cancer (p = 0.008; p = 0.012; p = 0.018) in the whole study population. The expression of angiopoietin-2 and Tie-2 was stronger in distal omental metastasis than in primary high grade serous tumors in matched-pair analysis (p = 0.001; p = 0.002). Conclusions The angiogenic factor, angiopoietin-2, and its receptor Tie-2 seem to be significant prognostic factors in primary epithelial ovarian cancer. Their expression levels are also increased in metastatic lesions in comparison with primary tumors.	[Sopo, Minna; Sallinen, Hanna; Keski-Nisula, Leea; Anttila, Maarit] Kuopio Univ Hosp, Dept Gynecol, Kuopio, Finland; [Sallinen, Hanna; Kivela, Annukka; Yla-Herttuala, Seppo] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland; [Sallinen, Hanna; Keski-Nisula, Leea; Anttila, Maarit] Univ Eastern Finland, Inst Clin Med, Sch Med, Gynaecol, Kuopio, Finland; [Sallinen, Hanna; Kivela, Annukka; Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland; [Hamalainen, Kirsi; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol & Forens Med, Kuopio, Finland; [Hamalainen, Kirsi; Kosma, Veli-Matti] Univ Eastern Finland, Pathol & Forens Med, Kuopio, Finland; [Kosma, Veli-Matti] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Sopo, M (corresponding author), Kuopio Univ Hosp, Dept Gynecol, Kuopio, Finland.	Minna.Sopo@kuh.fi			Emil Aaltonen Foundation; Cancer Foundation of the Northern Savo; Kuopio University Hospital Research Foundation; Finnish Medical Foundation; Kuopio University VTR grant	Emil Aaltonen Foundation; Cancer Foundation of the Northern Savo; Kuopio University Hospital Research Foundation; Finnish Medical Foundation; Kuopio University VTR grant	This work was supported by: MS: The Emil Aaltonen Foundation, MS: The Cancer Foundation of the Northern Savo, MS: The Kuopio University Hospital Research Foundation, HS: The Finnish Medical Foundation and Kuopio University VTR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla DR, 2015, RECENT PAT ANTI-CANC, V10, P298, DOI 10.2174/1574892810999150827153642; Abramovich D, 2012, ENDOCRINOLOGY, V153, P3446, DOI 10.1210/en.2012-1105; [Anonymous], 2004, OBESITY RES S2, p51S; Brunckhorst MK, 2014, AM J PATHOL, V184, P2285, DOI 10.1016/j.ajpath.2014.05.006; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Dales JP, 2003, INT J ONCOL, V22, P391; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; de Vries DK, 2013, TRANSPLANTATION, V96, P282, DOI 10.1097/TP.0b013e31829854d5; Dong Zhizhen, 2018, Oncotarget, V9, P12705, DOI 10.18632/oncotarget.24061; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Engels K, 2009, J CLIN PATHOL, V62, P448, DOI 10.1136/jcp.2008.063859; Gavalas NG, 2013, INT J MOL SCI, V14, P15885, DOI 10.3390/ijms140815885; Martin AG, 2019, GYNECOL ONCOL, V152, P53, DOI 10.1016/j.ygyno.2018.08.036; Heinonen SE, 2013, CARDIOVASC RES, V99, P716, DOI 10.1093/cvr/cvt148; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Hong S, 2017, ANN COLOPROCTOL, V33, P9, DOI 10.3393/ac.2017.33.1.9; Huang RX, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1307-4; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Jayson GC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07174-1; Li S, 2010, ONCOL REP, V23, P1063, DOI 10.3892/or_00000733; Lin WC, 1999, CLIN CANCER RES, V5, P1745; Lin ZJ, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-31; Marth C, 2017, EUR J CANCER, V70, P111, DOI 10.1016/j.ejca.2016.09.004; Monk BJ, 2016, ANN ONCOL, V27, P33, DOI 10.1093/annonc/mdw093; Monk BJ, 2016, GYNECOL ONCOL, V143, P27, DOI 10.1016/j.ygyno.2016.07.112; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sallinen H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-696; Sallinen H, 2010, INT J GYNECOL CANCER, V20, P1498, DOI 10.1111/IGC.0b013e3181f936e3; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Soong TR, 2019, GYNECOL ONCOL, V152, P426, DOI 10.1016/j.ygyno.2018.11.033; Sopo M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5757-3; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Sun XD, 2004, WORLD J GASTROENTERO, V10, P1382; Tewari KS, 2019, J CLIN ONCOL, V37, P2317, DOI 10.1200/JCO.19.01009; Torimura T, 2004, J HEPATOL, V40, P799, DOI 10.1016/j.jhep.2004.01.027; Tuppurainen L, 2017, INT J GYNECOL CANCER, V27, P879, DOI 10.1097/IGC.0000000000000973; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Vergote I, 2019, LANCET ONCOL, V20, P862, DOI 10.1016/S1470-2045(19)30178-0; Yang WJ, 2018, ONCOL LETT, V15, P8027, DOI 10.3892/ol.2018.8329; Zhang L, 2003, CANCER RES, V63, P3403; Zhou C, 2016, BRIT J CANCER, V115, P228, DOI 10.1038/bjc.2016.194	45	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241484	10.1371/journal.pone.0241484	http://dx.doi.org/10.1371/journal.pone.0241484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151982	Green Published, gold			2022-12-26	WOS:000591376200001
J	Ananthakrishnan, R; Thiagesan, R; Auguesteen, S; Karunakaran, N; Jayabal, L; Jagadeesan, M; Stevens, R; Codlin, A; Creswell, J				Ananthakrishnan, Ramya; Thiagesan, Rajeswaran; Auguesteen, Sheela; Karunakaran, Nalini; Jayabal, Lavanya; Jagadeesan, M.; Stevens, Robert; Codlin, Andrew; Creswell, Jacob			The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India	PLOS ONE			English	Article							TUBERCULOSIS PREVALENCE SURVEYS; TB	Tuberculosis prevalence surveys have demonstrated the benefit of screening with chest x-ray (CXR) and sensitive diagnostic tests compared to symptoms and smear microscopy. However, in programmatic practice there is little evidence on the yield of different algorithms. We implemented contact tracing in Chennai, India for adult sputum-positive TB patients registered from January 2015 to March 2016. Patients with symptoms or abnormal X-ray findings further underwent testing using Xpert MTB/RIF (Xpert) and smear microscopy. A retrospective cohort study was done to summarize the key findings. We verbally screened 5553 contacts for symptoms, CXR through private sector collaboration, Xpert, and smear microscopy. Overall, 1312 (23.6%) contacts screened positive. CXR alone identified 531 (40.5%) of them, 679 (51.8%) were symptom-positive only, while 102 (7.8%) were positive on both the symptom and CXR screen. Overall, 35 bacteriologically positive cases were identified (0.7%). A standard approach of symptoms screening followed by microscopy identified only 9 (25.7%) of the total number of bacteriologically positive cases, whereas the combination of a CRX screening followed by microscopy identified 13 (37.1%) of the cases. The algorithm of symptoms screening followed by Xpert testing, detected 20 cases, whereas the combination of symptoms and CXR followed by Xpert increased this number to 35 (75% increase compared to symptoms and Xpert). Optimal use of more sensitive screening tests, better diagnostic tests, and novel private sector engagement can improve diagnostic yield in a programmatic setting.	[Ananthakrishnan, Ramya; Thiagesan, Rajeswaran; Auguesteen, Sheela; Karunakaran, Nalini] REACH Resource Grp Educ & Advocacy Community Hlth, Chennai, Tamil Nadu, India; [Jayabal, Lavanya; Jagadeesan, M.] GCC RNTCP Greater Chennai Corp Revised Natl TB Co, Chennai, Tamil Nadu, India; [Codlin, Andrew; Creswell, Jacob] TB REACH, Stop TB Partnership, Geneva, Switzerland		Ananthakrishnan, R (corresponding author), REACH Resource Grp Educ & Advocacy Community Hlth, Chennai, Tamil Nadu, India.	ramyardr.reach@gmail.com			Global Affairs Canada (GAC) [CA-3-D000920001]	Global Affairs Canada (GAC)(CGIAR)	TB REACH - an initiative of Stop TB Partnership - supported this intervention and is funded by Global Affairs Canada (GAC) grant number CA-3-D000920001. https://w05.international.gc.ca/projectbrowserbanqueprojets/projectprojet/details/d000920001.The funder provided support in the form of salaries for authors AJC, RS and JC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. RS works as an independent consultant, not affiliated with any organization hence the designation, but it did not play a role in this study.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2017, LANCET HIV, V2, pe115; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Comm SP, 2017, AM J OBSTET GYNECOL, V216, pB8, DOI 10.1016/j.ajog.2017.01.006; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Fatima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165813; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Harris Allyssa L, 2016, Nurs Womens Health, V20, P211, DOI 10.1016/j.nwh.2016.01.002; Herbert N, 2014, LANCET, V383, P1016, DOI 10.1016/S0140-6736(14)60422-0; Hwang TJ, 2011, INT J TUBERC LUNG D, V15, P1620, DOI 10.5588/ijtld.11.0222; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khaparde Kshitij, 2015, Tuberc Res Treat, V2015, P670167, DOI 10.1155/2015/670167; McDowell A, 2016, T ROY SOC TROP MED H, V110, P192, DOI 10.1093/trstmh/trw009; Muyoyeta M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2388-7; Nair D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162090; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pedrazzoli D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01877-2016; Rahman MT, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02159-2016; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Somashekar N, 2014, INT J TUBERC LUNG D, V18, P1243, DOI 10.5588/ijtld.14.0141; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Wares DF, 2000, INT J TUBERC LUNG D, V4, P920; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2018, COMP WHO GUID ASS ST, V2nd; World Health Organization, 1999, COMM DIS CLUST WHAT; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241203	10.1371/journal.pone.0241203	http://dx.doi.org/10.1371/journal.pone.0241203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147240	Green Published, gold			2022-12-26	WOS:000589609300008
J	Saenz, AA; Van Schuerbeek, P; Baijot, S; Septier, M; Deconinck, N; Defresne, P; Delvenne, V; Passeri, G; Raeymaekers, H; Slama, H; Victoor, L; Willaye, E; Peigneux, P; Villemonteix, T; Massat, I				Saenz, Ariadna Albajara; Van Schuerbeek, Peter; Baijot, Simon; Septier, Mathilde; Deconinck, Nicolas; Defresne, Pierre; Delvenne, Veronique; Passeri, Gianfranco; Raeymaekers, Hubert; Slama, Hichem; Victoor, Laurent; Willaye, Eric; Peigneux, Philippe; Villemonteix, Thomas; Massat, Isabelle			Disorder-specific brain volumetric abnormalities in Attention-Deficit/Hyperactivity Disorder relative to Autism Spectrum Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; WHITE-MATTER; GREY-MATTER; CHILDREN; METAANALYSIS; ADULTS; AGE; CONNECTIVITY; RELIABILITY; SCHEDULE	The overlap/distinctiveness between Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) has been increasingly investigated in recent years, particularly since the DSM-5 allows the dual diagnosis of ASD and ADHD, but the underlying brain mechanisms remain unclear. Although both disorders are associated with brain volumetric abnormalities, it is necessary to unfold the shared and specific volume abnormalities that could contribute to explain the similarities and differences in the clinical and neurocognitive profiles between ADHD and ASD. In this voxel-based morphometry (VBM) study, regional grey matter volumes (GMV) were compared between 22 children with ADHD, 18 children with ASD and 17 typically developing (TD) children aged 8 to 12 years old, controlling for age and total intracranial volume. When compared to TD children or children with ASD, children with ADHD had a larger left precuneus, and a smaller right thalamus, suggesting that these brain abnormalities are specific to ADHD relative to ASD. Overall, this study contributes to the delineation of disorder-specific structural abnormalities in ADHD and ASD.	[Saenz, Ariadna Albajara; Baijot, Simon; Slama, Hichem; Peigneux, Philippe; Villemonteix, Thomas; Massat, Isabelle] Univ Libre Bruxelles ULB, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Ctr Res Cognit & Neurosci CRCN, Brussels, Belgium; [Van Schuerbeek, Peter; Raeymaekers, Hubert] Univ Ziekenhuis Brussel UZ Brussel, Dept Radiol, Brussels, Belgium; [Baijot, Simon; Deconinck, Nicolas; Delvenne, Veronique; Passeri, Gianfranco] Hop Univ Enfants Reine Fabiola HUDERF, Brussels, Belgium; [Septier, Mathilde] Hop Univ Robert Debre, Paris, France; [Septier, Mathilde] Inst Psychiat & Neurosci Paris, INSERM, U894, Team 1, Paris, France; [Defresne, Pierre; Willaye, Eric] Univ Mons, Fdn SUSA, Mons, Belgium; [Victoor, Laurent] Ctr Europeen Psychol Med, PsyPluriel, Brussels, Belgium; [Villemonteix, Thomas] Paris 8 Vincennes St Denis Univ, Lab Psychopathol & Neuropsychol, St Denis, France; [Massat, Isabelle] ULB, Lab Expt Neurol, Brussels, Belgium; [Massat, Isabelle] Natl Fund Sci Res FNRS, Brussels, Belgium; [Massat, Isabelle] Erasme Univ Hosp, Dept Neurol, Brussels, Belgium; [Septier, Mathilde] GHU Paris Psychiat & Neurosci, St Anne Hosp CMME, Paris, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Mons; Universite Libre de Bruxelles; Universite Libre de Bruxelles; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Saenz, AA (corresponding author), Univ Libre Bruxelles ULB, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, Ctr Res Cognit & Neurosci CRCN, Brussels, Belgium.	ariadna.albajara@gmail.com	Defresne, Pierre/AHC-6629-2022; Slama, Hichem/HGA-3213-2022	Slama, Hichem/0000-0003-3856-4488; Van Schuerbeek, Peter/0000-0003-3647-4446; Raeymaekers, Hubert/0000-0003-0041-6359	Shire Pharmaceutical Development Limited [IST-BEL-00520]; Belgian Kids' Fund; David et Alice Van Buuren Fund; Fondation Jaumotte-Demoulin; Fonds National de la Recherche Scientifique (FNRS)Belgium; Fonds Erasme	Shire Pharmaceutical Development Limited; Belgian Kids' Fund; David et Alice Van Buuren Fund; Fondation Jaumotte-Demoulin; Fonds National de la Recherche Scientifique (FNRS)Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme	IM received an investigator-initiated research grant from Shire Pharmaceutical Development Limited, a member of the Takeda group of companies (Study ID: IST-BEL-00520). AAS is supported by a grant from the Belgian Kids' Fund (www.belgiankidsfund.be), the David et Alice Van Buuren Fund and by the Fondation Jaumotte-Demoulin. IM and AAS are supported by the Fonds National de la Recherche Scientifique (FNRS)Belgium and the Fonds Erasme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2019, CJEM; [Anonymous], 2018, LANCET ONCOL, V19, pe581; Bailey T, 2015, APPL NEUROPSYCH-CHIL, V4, P89, DOI 10.1080/21622965.2015.1005475; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Carlisi CO, 2017, BIOL PSYCHIAT, V82, P83, DOI 10.1016/j.biopsych.2016.10.006; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Craig F, 2016, REV EXECUTIVE FUNCTI, P1191; Crawford JR, 2010, BRIT J CLIN PSYCHOL, V49, P235, DOI 10.1348/014466509X455470; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DeRamus TP, 2015, NEUROIMAGE-CLIN, V7, P525, DOI 10.1016/j.nicl.2014.11.004; Duerden EG, 2012, AUTISM RES, V5, P49, DOI 10.1002/aur.235; DuPaul GJ, 1998, ADHD RATING SCALE 4, V7006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fama R, 2015, NEUROSCI BIOBEHAV R, V54, P29, DOI 10.1016/j.neubiorev.2015.03.008; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Geurts HM, 2013, J AUTISM DEV DISORD, V43, P1630, DOI 10.1007/s10803-012-1708-4; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Hoogman Martine, 2017, Lancet Psychiatry, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Kaat AJ, 2013, J ABNORM CHILD PSYCH, V41, P959, DOI 10.1007/s10802-013-9739-7; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Lim L, 2015, PSYCHOL MED, V45, P965, DOI 10.1017/S0033291714001974; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mahajan R, 2016, AUTISM RES, V9, P67, DOI 10.1002/aur.1497; Medical Advisory Secretariat, 2008, Ont Health Technol Assess Ser, V8, P1; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700; O'Dwyer L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165620; Pievsky MA, 2018, ARCH CLIN NEUROPSYCH, V33, P143, DOI 10.1093/arclin/acx055; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Riddle K, 2017, BRAIN IMAGING BEHAV, V11, P541, DOI 10.1007/s11682-016-9534-5; Saenz AA, 2019, DEV MED CHILD NEUROL, V61, P399, DOI 10.1111/dmcn.14050; Salazar F, 2015, J AUTISM DEV DISORD, V45, P2283, DOI 10.1007/s10803-015-2361-5; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Silk TJ, 2016, CORTEX, V82, P1, DOI 10.1016/j.cortex.2016.05.012; Smith G.E., 1927, J ANAT, V61, P264; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Svatkova A, 2016, HUM BRAIN MAPP, V37, P3323, DOI 10.1002/hbm.23243; Traut N, 2018, BIOL PSYCHIAT, V83, P579, DOI 10.1016/j.biopsych.2017.09.029; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Wechsler D, 1974, WECHSLER INTELLIGENC; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wu ZM, 2017, NEUROPSYCHOPHARMACOL, V42, P572, DOI 10.1038/npp.2016.223; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241856	10.1371/journal.pone.0241856	http://dx.doi.org/10.1371/journal.pone.0241856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166335	Green Published, gold			2022-12-26	WOS:000592382600063
J	Ferraro, DO; Ghersa, F; de Paula, R; Vera, ADC; Pessah, S				Ferraro, Diego O.; Ghersa, Felipe; de Paula, Rodrigo; Duarte Vera, Alejandra C.; Pessah, Sebastian			Historical trends of the ecotoxicological pesticide risk from the main grain crops in Rolling Pampa (Argentina)	PLOS ONE			English	Article							AGRICULTURAL SUSTAINABILITY; CROPPING SYSTEMS; INDICATORS; TRANSFORMATION; COUNTRIES; FRAMEWORK; IMPACT; LINKS	We showed the results of the first long-term analysis (1987-2019) of pesticide (herbicides, fungicides and insecticides) impact in the Rolling Pampa, one of the main agricultural areas of Argentina. Using a clear and meaningful tool, based not only on acute toxicity but also on scaling up the results to total sown area, we identified time trends for both pesticide impact and the ecoefficiency of modal pesticide profiles. By the end of the time series, soybean showed a pesticide impact four times greater than maize crop in the studied area. However, the time trend in the subperiod (2012-2019) showed a sustainable pattern of pesticide use in soybean crop, with an improvement in its ecoefficiency. Oppositely, maize showed a relatively constant ecoefficiency value during most of the time series, suggesting a possible path towards an unsustainable cropping system. Findings from this study suggest that some efforts have to be made to improve the pest management decisions towards a more efficient pesticide profiles in maize crop and to keep improving the ecotoxicity pesticide profile in soybean crops because of its large sown area in the studied area.	[Ferraro, Diego O.; Ghersa, Felipe; de Paula, Rodrigo; Duarte Vera, Alejandra C.; Pessah, Sebastian] Univ Buenos Aires UBA, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Catedra Cerealicultura, Fac Agron,UBA CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ferraro, DO (corresponding author), Univ Buenos Aires UBA, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Catedra Cerealicultura, Fac Agron,UBA CONICET, Buenos Aires, DF, Argentina.	ferraro@agro.uba.ar		Ferraro, Diego Omar/0000-0003-0112-4876	University of Buenos Aires (UBA); National Council for Scientific Research (CONICET); National Agency for Science Promotion (ANPCyT) of Argentina	University of Buenos Aires (UBA)(University of Buenos Aires); National Council for Scientific Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Science Promotion (ANPCyT) of Argentina	This work was funded by the University of Buenos Aires (UBA); the National Council for Scientific Research (CONICET); and the National Agency for Science Promotion (ANPCyT) of Argentina.	AAPRESID, 2019, EV SUP SIEMBR DIR AR; Acosta-Alba I, 2011, SUSTAINABILITY-BASEL, V3, P424, DOI 10.3390/su3020424; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], 2005, KENDALL RANK CORRELA; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; Blanco CA, 2016, CURR OPIN INSECT SCI, V15, P131, DOI 10.1016/j.cois.2016.04.012; Burachik M, 2010, NEW BIOTECHNOL, V27, P588, DOI 10.1016/j.nbt.2010.05.011; Calliera M, 2013, PEST MANAG SCI, V69, P451, DOI 10.1002/ps.3430; Chantre E, 2014, AGROECOL SUST FOOD, V38, P573, DOI 10.1080/21683565.2013.876483; Cox LA, 2005, RISK ANAL, V25, P651, DOI 10.1111/j.1539-6924.2005.00615.x; Cross P, 2011, CROP PROT, V30, P1579, DOI 10.1016/j.cropro.2011.08.003; de Abelleyra D, 2020, REMOTE SENSING APPL, P100320; Dushoff Jonathan, 1994, American Entomologist, V40, P180; Feola G, 2011, AGR ECOSYST ENVIRON, V142, P238, DOI 10.1016/j.agee.2011.05.014; Ferraro DO, 2015, ECOL MODEL, V306, P121, DOI 10.1016/j.ecolmodel.2014.06.016; Ferraro DO, 2013, CROP PROT, V51, P32, DOI 10.1016/j.cropro.2013.04.004; Ferraro D.O., 2020, DECIS SUPPORT SYST, P191; Ferraro DO, 2017, ECOL INDIC, V83, P328, DOI 10.1016/j.ecolind.2017.08.020; Ferraro DO, 2009, ENVIRON MODELL SOFTW, V24, P359, DOI 10.1016/j.envsoft.2008.07.006; Ferraro DO, 2003, AGR ECOSYST ENVIRON, V96, P1, DOI 10.1016/S0167-8809(03)00017-3; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Iturburu FG, 2019, SCI TOTAL ENVIRON, V691, P476, DOI 10.1016/j.scitotenv.2019.07.044; Caiado RGG, 2017, J CLEAN PROD, V165, P890, DOI 10.1016/j.jclepro.2017.07.166; Hall A.J., 1992, P413; Hansen JW, 1996, AGR SYST, V50, P117, DOI 10.1016/0308-521X(95)00011-S; Hillocks RJ, 2012, CROP PROT, V31, P85, DOI 10.1016/j.cropro.2011.08.008; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; Juraske R, 2007, ENVIRON INT, V33, P886, DOI 10.1016/j.envint.2007.04.005; Kniss AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14865; Kniss AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131200; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; Kovach J., 1992, NEW YORKS FOOD LIFE, V139, P1; Kudsk P, 2020, WEED SCI, V68, P214, DOI 10.1017/wsc.2019.59; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Li ZJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070826; Mancini Francesca, 2019, Current Opinion in Environmental Science & Health, V11, P53, DOI 10.1016/j.coesh.2019.07.003; Manuel-Navarrete David, 2009, Environment Development and Sustainability, V11, P621, DOI 10.1007/s10668-007-9133-0; MinAgri, 2018, SER AGR STAT CROP YE; Mohring N, 2019, SCI TOTAL ENVIRON, V646, P503, DOI 10.1016/j.scitotenv.2018.07.287; Newman M, 2010, FUNDAMENTALS ECOTOXI, P247; NORTON SB, 1992, ENVIRON TOXICOL CHEM, V11, P1663, DOI 10.1897/1552-8618(1992)11[1663:AFFERA]2.0.CO;2; Osteen CD, 1989, AGR PESTICIDE USE TR; Peiretti R, 2014, INT SOIL WATER CONSE, V2, P14, DOI 10.1016/S2095-6339(15)30010-1; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Racovita M, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-015-0043-6; Rajaram T, 2010, EXPERT SYST APPL, V37, P1734, DOI 10.1016/j.eswa.2009.07.035; Reus J, 2002, AGR ECOSYST ENVIRON, V90, P177, DOI 10.1016/S0167-8809(01)00197-9; Rose DG, 1998, ENV TOXICOLOGY CURRE; Roussel O, 2000, AGR ECOSYST ENVIRON, V80, P143, DOI 10.1016/S0167-8809(00)00142-0; Rubione C, 2016, WEED SCI, V64, P641, DOI 10.1614/WS-D-16-00016.1; SENASA, 2018, NAT REG VEG THER; Smith CS, 1998, J ENVIRON MANAGE, V52, P15, DOI 10.1006/jema.1997.0162; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Thomson A., 2020, STRATEGIES SUSTAINAB, P133, DOI [10.1007/978-3-030-19550-2_7, DOI 10.1007/978-3-030-19550-2_7]; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Trigo E. J., 2003, AgBioForum, V6, P87; Valverde B.E., 2006, DEALING EVOLUTION SP, V1st ed.; Viglizzo EF, 2011, FIELD CROP RES, V124, P186, DOI 10.1016/j.fcr.2011.05.014; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	62	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0238676	10.1371/journal.pone.0238676	http://dx.doi.org/10.1371/journal.pone.0238676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151929	Green Published, gold, Green Submitted			2022-12-26	WOS:000591376200070
J	Shrestha, G; Mulmi, R; Phuyal, P; Thakur, RK; Siwakoti, B				Shrestha, Gambhir; Mulmi, Rashmi; Phuyal, Prabin; Thakur, Rahul Kumar; Siwakoti, Bhola			Experiences of cervical cancer survivors in Chitwan, Nepal: A qualitative study	PLOS ONE			English	Article							OF-LIFE; HUMAN-PAPILLOMAVIRUS; STIGMA; WOMEN; INFECTION; KNOWLEDGE	Introduction Cervical cancer is a global leading cause of morbidity and mortality. The majority of cervical cancer deaths occur in developing countries including Nepal. Though knowledge of cervical cancer is an important determinant of women's participation in prevention and screening for cervical cancer, little is known about this topic in Nepal. This study explores the experiences of cervical cancer survivors and assesses the attitude of family and community towards it and stigma related to this disease in Bharatpur, Nepal. Methods The study design was qualitative methods involving two focus-group discussions. A total of 17 cervical cancer survivors, who have completed two years of cancer treatment were selected purposively from Chitwan. All qualitative data were transcribed and translated into English and were thematically analyzed. Results The majority of the participants had scant knowledge about cervical cancer, its causative agent, showed less cervical cancer screening, delayed healthcare-seeking behavior despite having persistent symptoms before the diagnosis. The main reasons identified for not uptaking the cervical screening methods were an embarrassment and having no symptoms at all. Most of them endured social stigma related to cervical cancer in the form of physical isolation and verbal abuse. Conclusions There is an urgent need for interventions to make women and the public aware of cervical cancer and launch effective health education campaigns, policies for cervical cancer prevention programs. This implementation can save the lives of hundreds of women and help them avoid going through all the negative experiences related to cervical cancer. More studies are required to gain the perspectives, knowledge, experiences, and attitudes of cervical cancer survivors to add to the research.	[Shrestha, Gambhir] Tribhuvan Univ, Dept Community Med, Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal; [Mulmi, Rashmi; Siwakoti, Bhola] BP Koirala Mem Canc Hosp, Dept Canc Prevent Control & Res, Bharatpur, Chitwan, Nepal; [Phuyal, Prabin; Thakur, Rahul Kumar] BP Koirala Inst Hlth Sci, Dharan, Sunsari, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal; B.P. Koirala Institute of Health Sciences	Shrestha, G (corresponding author), Tribhuvan Univ, Dept Community Med, Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	gamvir.stha@gmail.com		Thakur, Rahul Kumar/0000-0003-1740-5939; Shrestha, Gambhir/0000-0002-9975-9804; Mulmi, Rashmi/0000-0002-4648-2231; Phuyal, Prabin/0000-0001-9785-9644				[Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; [Anonymous], 2017, ISMP MED SAFETY ALER, V22, P1, DOI DOI 10.1016/j.ebiom.2017.07.026; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Belglaiaa E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020343; Bhatta MP, 2020, J COMMUN HEALTH, V45, P516, DOI 10.1007/s10900-019-00770-2; Centers for Disease Control and Prevention, 2009, CERV CANC; Darj E, 2019, SEX REPROD HEALTHC, V20, P20, DOI 10.1016/j.srhc.2019.02.001; Dyer KE, 2010, HUM ORGAN, V69, P321, DOI 10.17730/humo.69.4.a750670h0784521j; Ferrandina G, 2012, GYNECOL ONCOL, V124, P389, DOI 10.1016/j.ygyno.2011.09.041; Gregg JL, 2011, MED ANTHROPOL Q, V25, P70, DOI 10.1111/j.1548-1387.2010.01137.x; Greimel ER, 2009, PSYCHO-ONCOLOGY, V18, P476, DOI 10.1002/pon.1426; Guilfoyle Sharon, 2007, Health Care Women Int, V28, P930, DOI 10.1080/07399330701615358; GYAWALI B, 2015, MED BIOETH, V5, P1, DOI DOI 10.2147/MB.S77507; ICO/IARC, 2018, NEP HUM PAP REL CANC; Khadka K, 2017, AM J CANC PREV, V5, P10; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Ma I-G, 2018, J GLOB ONCOL, V4, p146s, DOI [10.1200/jgo.18.55900, DOI 10.1200/JG0.18.55900]; Pfaendler KS, 2015, CLIN THER, V37, P39, DOI 10.1016/j.clinthera.2014.11.013; Ranjit A, 2016, INT J GYNECOL OBSTET, V134, P37, DOI 10.1016/j.ijgo.2015.11.019; Richman AR, 2016, J CANCER EDUC, V31, P314, DOI 10.1007/s13187-015-0809-0; Rosser JI, 2015, PATIENT EDUC COUNS, V98, P884, DOI 10.1016/j.pec.2015.03.017; Shakya S, 2016, J CANCER EDUC, V31, P547, DOI 10.1007/s13187-015-0863-7; Shepherd MA, 2014, PSYCHOL HEALTH, V29, P94, DOI 10.1080/08870446.2013.834057; Shrestha A, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.1553; Shrestha J, 2013, J MED SCI, V2, P85, DOI DOI 10.3126/NJMS.V2I2.8941; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stergiou-Kita M, 2016, J CANCER SURVIV, V10, P1035, DOI 10.1007/s11764-016-0547-2; Thapa N, 2018, J GYNECOL ONCOL, V29, DOI 10.3802/jgo.2018.29.e57; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; White Heather L, 2012, Soc Sci Med, V74, P1486, DOI 10.1016/j.socscimed.2012.01.028; Zhang DY, 2020, JCO GLOB ONCOL, V6, P617, DOI 10.1200/JGO.19.00201; 2018, METAL AM, V4, p26S	32	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0234834	10.1371/journal.pone.0234834	http://dx.doi.org/10.1371/journal.pone.0234834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151965	gold, Green Submitted, Green Published			2022-12-26	WOS:000591376200015
J	Southworth, F; James, T; Davidson, L; Williams, N; Finnie, T; Marczylo, T; Collins, S; Amlot, R				Southworth, Felicity; James, Thomas; Davidson, Louise; Williams, Natalie; Finnie, Thomas; Marczylo, Tim; Collins, Samuel; Amlot, Richard			A controlled cross-over study to evaluate the efficacy of improvised dry and wet emergency decontamination protocols for chemical incidents	PLOS ONE			English	Article								The UK Initial Operational Response (IOR) to chemical incidents includes improvised decontamination procedures, which use readily available materials to rapidly reduce risk to potentially exposed persons. A controlled, cross-over human volunteer study was conducted to investigate the effectiveness of improvised dry and wet decontamination procedures on skin, both alone, and in sequence. A simulant contaminant, methyl salicylate (MeS) in vegetable oil with a fluorophore was applied to three locations (shoulder, leg, arm). Participants then received no decontamination (control) or attempted to remove the simulant using one of three improvised protocols (dry decontamination; wet decontamination; combined dry and wet decontamination). Simulant remaining on the skin following decontamination was quantified using both Gas Chromatography Tandem Mass Spectrometry (GC-MSMS) for analysis of MeS and UV imaging to detect fluorophores. Additionally, urine samples were collected for 24 hours following application for analysis of MeS. Significantly less simulant was recovered from skin following each improvised decontamination protocol, compared to the no decontamination control. Further, combined dry and wet decontamination resulted in lower recovery of simulant when compared to either dry or wet decontamination alone. Irrespective of decontamination protocol, significantly more simulant remained on the shoulders compared to either the arms or legs, suggesting that improvised decontamination procedures are less effective for difficult to reach areas of the body. There was no effect of decontamination on excreted MeS in urine over 24 hours. Overall, findings indicate that improvised decontamination is an effective means of rapidly removing contaminants from skin, and combinations of improvised approaches can increase effectiveness in the early stages of decontamination and in the absence of specialist resources at an incident scene. However, the variable control and consistency of improvised decontamination techniques means that further intervention is likely to be needed, particularly for less accessible areas of the body.	[Southworth, Felicity; Davidson, Louise; Williams, Natalie; Finnie, Thomas; Amlot, Richard] Publ Hlth England, Emergency Response Dept Sci & Technol, Hlth Protect Directorate, London, England; [James, Thomas; Collins, Samuel] Publ Hlth England, Chem & Environm Effects Dept, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England; [Marczylo, Tim] Publ Hlth England, Toxicol Dept, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England	Public Health England; Public Health England; Public Health England	Amlot, R (corresponding author), Publ Hlth England, Emergency Response Dept Sci & Technol, Hlth Protect Directorate, London, England.	richard.amlot@phe.gov.uk		Marczylo, Tim/0000-0001-9744-473X; Collins, Samuel/0000-0003-4721-0040; Finnie, Thomas/0000-0001-5962-4211	National Institute for Health Research (NIHR) Policy Research Programme [PR-ST-1015-10016]	National Institute for Health Research (NIHR) Policy Research Programme(National Institute for Health Research (NIHR))	RA, PR-ST-1015-10016, National Institute for Health Research (NIHR) Policy Research Programme, https://www.nihr.ac.uk/ DHSC and NIHR agreed publication of manuscript.	Amlot R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179309; Amlot R, 2010, PREHOSP DISASTER MED, V25, P435, DOI 10.1017/S1049023X00008529; Carter H, 2019, DISASTER PREV MANAG, V28, P565, DOI 10.1108/DPM-10-2018-0342; Carter Holly, 2016, PLoS Curr, V8; Chilcott R, 2018, PRIMARY RESPONSE INC, V1; Chilcott RP, 2019, ANN EMERG MED, V73, P671, DOI 10.1016/j.annemergmed.2018.06.042; Finnie T, 2018, PUBL HLTH ENGL ANN C; Home Office, 2015, IN OP RESP CBRN INC; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; James T, 2020, PREHOSP DISASTER MED, V35, P482, DOI 10.1017/S1049023X20000825; James T, 2019, J CHROMATOGR B, V1129, DOI 10.1016/j.jchromb.2019.121818; James T, 2019, J CHROMATOGR B, V1109, P84, DOI 10.1016/j.jchromb.2019.01.030; James T, 2018, J APPL TOXICOL, V38, P113, DOI 10.1002/jat.3527; Kassouf N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170966; KAZENIAC S J, 1970, Journal of Food Science, V35, P519, DOI 10.1111/j.1365-2621.1970.tb04799.x; Larner J, 2007, 5 ORCHIDS; Larner J, 2020, PREHOSP EMERG CARE, V24, P355, DOI 10.1080/10903127.2019.1636912; Matar H, 2014, TOXICOL IN VITRO, V28, P492, DOI 10.1016/j.tiv.2014.01.001; Maynard RL, 2009, GEN APPL TOXICOLOGY	19	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0239845	10.1371/journal.pone.0239845	http://dx.doi.org/10.1371/journal.pone.0239845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147217	gold, Green Accepted, Green Published			2022-12-26	WOS:000589609300022
J	Turek-Hankins, LL; Hino, M; Mach, KJ				Turek-Hankins, Lynee L.; Hino, Miyuki; Mach, Katharine J.			Risk screening methods for extreme heat: Implications for equity-oriented adaptation	PLOS ONE			English	Article							SOCIAL VULNERABILITY; CLIMATE-CHANGE; ENVIRONMENTAL JUSTICE; UNITED-STATES; MORTALITY; WAVES; HOSPITALIZATIONS; TEMPERATURE; DISPARITIES; CALIFORNIA	Morbidity and mortality impacts of extreme heat amplified by climate change will be unequally distributed among communities given pre-existing differences in socioeconomic, health, and environmental conditions. Many governments are interested in adaptation policies that target those especially vulnerable to the risks, but there are important questions about how to effectively identify and support communities most in need of heat adaptations. Here, we use an equity-oriented adaptation program from the state of California as a case study to evaluate the implications of the currently used environmental justice index (CalEnviroScreen 3.0) for the identification of socially vulnerable communities with climate change adaptation needs. As CalEnviroScreen is geared towards air and water pollution, we assess how community heat risks and adaptation needs would be evaluated differently under two more adaptation-relevant vulnerability indices: the Social Vulnerability Index and the Heat-Health Action Index. Our analysis considers communities at the census tract scale, as well as the patterns emerging at the regional scale. Using the current index, the state designates 25% of its census tracts as "disadvantaged" communities eligible for special adaptation funds. However, an additional 12.6% of the state's communities could be considered vulnerable if the two other indices were considered instead. Only 13.4% of communities are vulnerable across all three vulnerability indices studied. Choice of vulnerability index shapes statewide trends in extreme heat risk and is linked to a community's likelihood of receiving heat-related California Climate Investments (CCI) projects. Tracts that are vulnerable under the current pollution-focused index, but not under the heat-health specific index, received four times the number of heat-related interventions as tracts vulnerable under the reverse scenario. This study demonstrates important nuances relevant to implementing equity-oriented adaptation and explores the challenges, trade-offs, and opportunities in quantifying vulnerability.	[Turek-Hankins, Lynee L.] Stanford Univ, Stanford Woods Inst Environm, Mentoring Undergrad Interdisciplinary Res MUIR Pr, Stanford, CA 94305 USA; [Turek-Hankins, Lynee L.] Univ Miami, Environm Sci & Policy Grad Program, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33146 USA; [Hino, Miyuki] Univ N Carolina, Dept City & Reg Planning, Chapel Hill, NC USA; [Hino, Miyuki] Univ N Carolina, Environm Ecol & Energy Program, Chapel Hill, NC USA; [Turek-Hankins, Lynee L.; Mach, Katharine J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Mach, Katharine J.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL USA	Stanford University; University of Miami; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; University of Miami	Turek-Hankins, LL (corresponding author), Stanford Univ, Stanford Woods Inst Environm, Mentoring Undergrad Interdisciplinary Res MUIR Pr, Stanford, CA 94305 USA.; Turek-Hankins, LL (corresponding author), Univ Miami, Environm Sci & Policy Grad Program, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33146 USA.; Turek-Hankins, LL (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA.	lturek@miami.edu	, 莺瑰之殇/ABG-2761-2020	Turek-Hankins, Lynee/0000-0003-3356-3283	Mentoring Undergraduates in Interdisciplinary Research (MUIR) Program at Stanford Woods Institute for the Environment; Abess Center for Ecosystem Science and Policy at the University of Miami; Rosenstiel School of Marine and Atmospheric Science at University of Miami	Mentoring Undergraduates in Interdisciplinary Research (MUIR) Program at Stanford Woods Institute for the Environment; Abess Center for Ecosystem Science and Policy at the University of Miami; Rosenstiel School of Marine and Atmospheric Science at University of Miami	This research was funded by the Mentoring Undergraduates in Interdisciplinary Research (MUIR) Program at the Stanford Woods Institute for the Environment, the Rosenstiel School of Marine and Atmospheric Science at the University of Miami, and the Abess Center for Ecosystem Science and Policy at the University of Miami.	Agency for Toxic Substances and Disease Registry, 2016, CDCS SOC VULN IND SV; Anderson GB, 2013, ENVIRON HEALTH PERSP, V121, P1111, DOI 10.1289/ehp.1206273; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; [Anonymous], 2020, LANCET RESP MED, V8, P1, DOI [10.1016/S2213-2600(19)30449-7, 10.1016/S22132600(19)30402-3]; Bakkensen LA, 2017, RISK ANAL, V37, P982, DOI 10.1111/risa.12677; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bedsworth L., 2018, STATEWIDE SUMMARY RE; Bergstrand K, 2015, SOC INDIC RES, V122, P391, DOI 10.1007/s11205-014-0698-3; Berrang-Ford L, 2015, REG ENVIRON CHANGE, V15, P755, DOI 10.1007/s10113-014-0708-7; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Bradford K, 2015, ENVIRON SCI TECHNOL, V49, P11303, DOI 10.1021/acs.est.5b03127; California Air Resources Board, 2018, PRIOR POP INV; California Climate Investments, 2019, CAL CLIM INV PROJ MA; California Climate Investments, 2019, ANN REP CAP AND TRAD; California Energy Commission, 2018, CAL HEAT ASS TOOL; CDC, 2014, HEAT REL ILLN PICT A; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Debortoli NS, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae24a; Eng T, 2018, CALENVIROSCREEN CRIT; Engle NL, 2014, MITIG ADAPT STRAT GL, V19, P1295, DOI 10.1007/s11027-013-9475-x; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Gershunov A., 2011, GEOGR RES FORUM, V31, P53; Gershunov A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052979; Gomez AB, 2016, AB 1550 GREENH GAS I, P1; Greene S, 2011, WEATHER CLIM SOC, V3, P281, DOI 10.1175/WCAS-D-11-00055.1; Gronlund CJ, 2014, ENVIRON HEALTH PERSP, V122, P1187, DOI 10.1289/ehp.1206132; Gubernot DM, 2014, INT J BIOMETEOROL, V58, P1779, DOI 10.1007/s00484-013-0752-x; Guirguis K, 2018, GEOHEALTH, V2, P212, DOI 10.1029/2017GH000127; Guirguis K, 2018, CLIM DYNAM, V50, P3853, DOI 10.1007/s00382-017-3850-3; Guirguis K, 2014, J APPL METEOROL CLIM, V53, P3, DOI 10.1175/JAMC-D-13-0130.1; Hall ES, 2014, R9 RARE FINAL PROJEC; Harlan SL, 2006, SOC SCI MED, V63, P2847, DOI 10.1016/j.socscimed.2006.07.030; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huang GL, 2016, LANDSCAPE ECOL, V31, P2507, DOI 10.1007/s10980-016-0437-z; Kinney PL, 2008, ENVIRON SCI POLICY, V11, P87, DOI 10.1016/j.envsci.2007.08.001; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Mach KJ, 2020, CURR OPIN ENV SUST, V42, P30, DOI 10.1016/j.cosust.2020.01.002; Marino EK, 2020, ANN ANTHROPL PRACT, V44, P33, DOI 10.1111/napa.12132; Mills D, 2015, CLIMATIC CHANGE, V131, P83, DOI 10.1007/s10584-014-1154-8; Mohai P., 2015, ENVIRON RES LETT, V10; National Weather Service, HEAT IND; National Weather Service, 2018, WEATH REL FAT INJ ST; Nayak SG, 2018, PUBLIC HEALTH, V161, P127, DOI 10.1016/j.puhe.2017.09.006; Nguyen TTX, 2016, OCEAN COAST MANAGE, V123, P18, DOI 10.1016/j.ocecoaman.2015.11.022; OEHHA, 2018, CALENVIROSCREEN 3 0; Ostro BD, 2009, ENVIRON RES, V109, P614, DOI 10.1016/j.envres.2009.03.010; Paveglio TB, 2017, LANDSCAPE URBAN PLAN, V160, P115, DOI 10.1016/j.landurbplan.2016.12.013; Pierce D, 2015, HUMIDITY DOWNSCALING; Pierce DW, 2016, CLIM DYNAM, V47, P411, DOI 10.1007/s00382-015-2845-1; Pierce D.W., 2018, CLIMATE DROUGHT SEA; Pierce DW, 2015, J HYDROMETEOROL, V16, P2421, DOI 10.1175/JHM-D-14-0236.1; Qiang Y, 2019, J ENVIRON MANAGE, V232, P295, DOI 10.1016/j.jenvman.2018.11.039; Reckien D, 2018, REG ENVIRON CHANGE, V18, P1439, DOI 10.1007/s10113-017-1273-7; Rodriquez M, 2017, UPDATE CALIFORNIA CO; Roos M, 2018, CLIMATE JUSTICE REPO; Rufat S, 2015, INT J DISAST RISK RE, V14, P470, DOI 10.1016/j.ijdrr.2015.09.013; Sadd J, 2014, HEALTH EDUC BEHAV, V41, P281, DOI 10.1177/1090198113511816; Sadd JL, 2011, INT J ENV RES PUB HE, V8, P1441, DOI 10.3390/ijerph8051441; Sherbakov T, 2018, ENVIRON RES, V160, P83, DOI 10.1016/j.envres.2017.08.052; Spielman SE, 2020, NAT HAZARDS, V100, P417, DOI 10.1007/s11069-019-03820-z; Steinberg N, 2018, PREPARING PUBLIC HLT; Taha H, 2015, CREATING MAPPING URB; Tate E, 2013, ANN ASSOC AM GEOGR, V103, P526, DOI 10.1080/00045608.2012.700616; Tate E, 2012, NAT HAZARDS, V63, P325, DOI 10.1007/s11069-012-0152-2; UC Berkeley Geospatial Innovation Facility, 2019, CLIMATE DATA; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y	69	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240841	10.1371/journal.pone.0240841	http://dx.doi.org/10.1371/journal.pone.0240841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147245	Green Published, gold			2022-12-26	WOS:000589609300032
J	Hailu, WS; Bayih, MT; Babble, NF				Hailu, Workineh Shume; Bayih, Mulat Tirfie; Babble, Netsanet Fentahun			Four in every ten infants in Northwest Ethiopia exposed to sub-optimal breastfeeding practice	PLOS ONE			English	Article							RURAL COMMUNITIES	Background Improper breastfeeding practices significantly impair the health, development, and survival of infants, children, and mothers. A Breastfeeding Performance Index (BPI) is a composite index to describe overall maternal breastfeeding practice with infants under six months of age. To date, there is insufficient evidence on breastfeeding performance index and its associated factors in Ethiopia. Objective To assess the breastfeeding performance index and its associated factors in Sekela District, Northwest Ethiopia, 2019. Methods A community-based cross-sectional study was conducted on 605 randomly selected mothers having infants aged 6 to 12 months from April 02, 2019 to May 13, 2019. Data was collected using a structured interviewer-administered questionnaire. Multivariable logistic regressions were used to identify independent predictors of BPI. Results Two hundred forty-six (40.7%) of mothers had low BPI scores. Mothers who lived alone (AOR = 3.18; 95%CI: 1.15, 8.82), mothers who were merchants (AOR = 2.75; 95%CI:1.05, 7.15), attended three antenatal care (ANC) visits (AOR = 0.42; 95% CI: 0.20, 0.82), attended four antenatal care visits (AOR = 0.35; 95%CI: 0.12, 0.82), received postnatal care (PNC) (AOR = 0.35; 95%CI: 0.19, 0.64), had poor knowledge on breastfeeding (AOR = 3.19;95%CI: 1.14, 8.89) or negative attitudes towards breastfeeding (AOR = 2.70;95%CI: 1.13, 6.45), were independent predictors of low BPI scores. Conclusions The prevalence of sub-optimal breastfeeding practice in northwest Ethiopia was very high. A mother living alone, maternal occupation, ANC visits, PNC, maternal breastfeeding knowledge, and attitude towards breastfeeding were independent predictors of low BPI scores. Nutrition promotion should be implemented by considering the above significant factors to decrease inappropriate breastfeeding practice in Northwest Ethiopia.	[Hailu, Workineh Shume] Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan Teferi, Ethiopia; [Bayih, Mulat Tirfie; Babble, Netsanet Fentahun] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia	Bahir Dar University	Bayih, MT (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia.	mulatbonny@gmail.com		Bayih, Mulat Tirfie/0000-0003-3735-4892				Abageda M, 2015, J PREG CHILD HLTH, V2, P182, DOI 10.4172/2376-127X.1000182; Adugna B, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0137-6; [Anonymous], 2018, AG SEX SPEC POP DIST; Arage G., 2016, ADV PUBLIC HLTH, V2016, P1; Asemahagn MA, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0081-x; Asim M, 2015, PROFESSIONAL MED J, V22, P978; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Chea N, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0149-x; Deavers K, 2010, CARING INFANTS THEN; Demographic EE., 2016, HLTH SURVEY HIV PREV; Ethiopian Public Health Institute (EPHI)[Ethiopia] and ICF, ETH MIN HLTH SURV 20; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Federal MO, 2004, NAT STRAT INF YOUNG; Gultie T, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0063-z; Haile D, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0057-2; Hoche S, 2018, ETHIOP J HEALTH SCI, V28, P49, DOI 10.4314/ejhs.v28i1.7; Hussien J, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1353-y; Jackson KM, 2006, J AM OSTEOPATH ASSOC, V106, P203; Kibebew A, 2012, B HLTH SCI, V4, P66; Kimani-Murage EW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-396; Lenja A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0091-8; Mekuria G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0027-0; Moghaddam HT, 2015, INT J PEDIATR-MASSHA, V3, P1083; Nigatu Y. T., 2014, E AFRICAN J PUBLIC H, V11, P704; Ogbo FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171792; Organisation mondiale de la sante World Health Organisation Staff World Health Organization UNICEF. UNAIDS, 2003, GLOB STRAT INF YOUNG; Profile IN, 1998, PROF IN, P216; Samodra G, 2014, EARTH SURF DYNAM, V2, P339, DOI 10.5194/esurf-2-339-2014; Senarath U, 2007, PUBLIC HEALTH NUTR, V10, P996, DOI 10.1017/S1368980007441428; Sorato MM, 2016, ETHIOPIA, V1, P77; Tamiru D, 2015, S AFR J CLIN NUTR, V28, P134, DOI 10.1080/16070658.2015.11734548; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; The UN refugee agency, 2015, STAND OP PROC HANDL; Tiwari S, 2016, INDIAN PEDIATR, V53, P703, DOI 10.1007/s13312-016-0914-0; UNICEF, 2013, BREASTF IS CHEAP MOS; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; White JM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12505; WHO, 2009, INF YOUNG CHILD FEED; WHO, 2017, GUID PROT PROM SUPP; WHO U, 2014, WHONMHNHD147; WHO/UNICEF, 2014, GLOB NUTR TARG 2025; Woldie TG., 2014, SCI J PUBLIC HLTH, V2, P330, DOI DOI 10.11648/J.SJPH.20140204.24; World Health Organization, 2017, SAUDI MED J, V38, P974; Yimer NB, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0134-4; Yonas F., 2015, OPEN ACCESS LIB J, V2, P1	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0238576	10.1371/journal.pone.0238576	http://dx.doi.org/10.1371/journal.pone.0238576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137137	Green Published, gold			2022-12-26	WOS:000588375500037
J	Alshami, A; Alattas, R; Anan, H; Alhalimi, A; Alfaraj, A; Al Qahtani, H				Alshami, Alanoud; Alattas, Rabab; Anan, Hadeel; Alhalimi, Abdulbary; Alfaraj, Ahmed; Al Qahtani, Hadi			Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia	PLOS ONE			English	Article								Objectives In this study, we aimed to study the clinical presentations, and viral clearance of SARS-COV-2 positive quarantined individuals. Design Cross-sectional study. Setting Governmental- designated facility in the eastern province, Saudi Arabia. Participants 128 laboratory-confirmed COVID-19 quarantined individuals who had a history of travel abroad in the last 14 days before the quarantine or were in direct contact with laboratory-confirmed cases. The study was from March 18th-till April 16th. Primary and secondary measures The clinical presentation, prevalence of asymptomatic carriers among SARS-COV-2 positive quarantined subjects, and the difference between virus clearance among symptomatic and asymptomatic individuals. Results Sixty-nine of the 128 residents (54%) were completely asymptomatic until the end of the study. The remaining 59 residents (46%) had only mild symptoms. The most common symptom was a sudden loss of smell and taste, accounting for 47.5%. The median time to virus clearance was significantly different between the two groups. Symptomatic residents cleared the virus at a median of 17 days (95% CI, 12.4-21.6) from the first positive PCR vs. 11days (95% CI, 8.7-13.3) in the asymptomatic group (P = 0.011). False-negative test results occurred in 18.8% of the total residents and false-positive results in 3%. Conclusion The prevalence of asymptomatic carriers among quarantined travelers and those identified by contact tracing is high in our study. Therefore, testing, tracing, and isolating travelers and contacts of laboratory-confirmed cases, regardless of symptoms, were very effective measures for early disease identification and containment. Loss of taste and smell were the most common presentations in our mild symptomatic residents and should be used as a screening tool for COVID-19. The persistent positive PCR beyond 14 days observed in the mild symptomatic residents despite being symptoms free, warrant further studies to determine its implications on disease spread and control.	[Alshami, Alanoud; Anan, Hadeel] King Fahad Specialist Hosp, Dept Epidemiol & Biostat, Dammam, Saudi Arabia; [Alattas, Rabab] King Fahad Specialist Hosp, Dept Pathol & Lab Med, Div Immunol, Dammam, Saudi Arabia; [Alhalimi, Abdulbary] King Faisal Univ, Al Hasa, Saudi Arabia; [Alfaraj, Ahmed] King Fahad Specialist Hosp, Dept Pediat, Dammam, Saudi Arabia; [Al Qahtani, Hadi] King Fahad Specialist Hosp, Dept Pediat, Div Infect Dis, Dammam, Saudi Arabia	King Faisal University	Alshami, A (corresponding author), King Fahad Specialist Hosp, Dept Epidemiol & Biostat, Dammam, Saudi Arabia.	Alanoud.shami@kfsh.med.sa		Alhalimi, Abdulbary/0000-0002-2810-7446; alshami, alanoud/0000-0002-6199-5174				Algaissi A, 2020, PREPAREDNESS RESPONS, DOI [10.20944/PREPRINTS202004.0018.V1, DOI 10.20944/PREPRINTS202004.0018.V1]; Angelo Vaira L, REMOTE PSYCHOPHYSICA, DOI [10.1017/S0022215120001358, DOI 10.1017/S0022215120001358]; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114; Hoehl Sebastian, NEW ENGL J MED, V382, P1278, DOI [10.1056/NEJMc2001899, DOI 10.1056/NEJMC2001899]; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Mao L, 2020, WUHAN CHINA, DOI [10.1001/jamaneurol.2020.1127, DOI 10.1001/JAMANEUROL.2020.1127]; Menni C, 2020, MEDRXIV, DOI [10.1101/2020.04.05.20048421, 10.1038/s41591-020-0916-2, DOI 10.1038/S41591-020-0916-2]; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Song JY, 2020, NEW ENGL J MED, V382, P1858, DOI 10.1056/NEJMc2001801; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; World Health Organization, 2020, TECHNICAL REPORT; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	17	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241258	10.1371/journal.pone.0241258	http://dx.doi.org/10.1371/journal.pone.0241258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125433	Green Published, Green Submitted, gold			2022-12-26	WOS:000588368900028
J	Coto, J; Restrepo, A; Cejas, I; Prentiss, S				Coto, Jennifer; Restrepo, Alicia; Cejas, Ivette; Prentiss, Sandra			The impact of COVID-19 on allied health professions	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PSYCHOLOGICAL IMPACT; HOSPITAL WORKERS; CARE PERSONNEL; SYNDROME SARS; EMERGENCY; STRESS; OUTBREAK; NURSES	The purpose of the current study was to examine the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19) on allied health professionals work environment, access to personal protective equipment (PPE) and COVID-19 testing, and mental health. A 34-question survey was developed and distributed electronically to allied health professionals through listservs of professional organizations and social media groups. A total of 921 responses from allied health professionals in a variety of work settings were analyzed. The majority of allied health professionals had access to medical-grade PPE and agreed with their clinics decisions to stay open or closed. Private practices appeared to be the most negatively impacted with regards to employment in the form of pay reductions, furloughs, lay-offs, or the requirement of using paid time off. Importantly, 86% of all respondents, irrespective of employment status, reported feeling stressed with regards to changes in their work environment and transmission of the virus. However, levels of stress were dependent upon access to PPE and mental health resources. Specifically, those with access to mental health support reported lower stress levels than those without such access. These results highlight the need for continuous monitoring of mental health for allied health professionals in order to inform clinic and hospital policies for PPE and the development of brief interventions to mitigate adverse long-term mental health outcomes.	[Coto, Jennifer] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Restrepo, Alicia; Cejas, Ivette; Prentiss, Sandra] Univ Miami, Dept Otolaryngol, Miller Sch Med, Ear Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Prentiss, S (corresponding author), Univ Miami, Dept Otolaryngol, Miller Sch Med, Ear Inst, Miami, FL 33136 USA.	s.prentiss@med.miami.edu		Restrepo, Alicia/0000-0003-0342-3837				Alexander AB, 2020, PREHOSP EMERG CARE, V24, P77, DOI 10.1080/10903127.2019.1601313; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Bentley MA, 2013, PREHOSP EMERG CARE, V17, P330, DOI 10.3109/10903127.2012.761307; Center for Disease Control and Prevention, 2020, EST INFL ILLN MED VI; Centers for Disease Control and Prevention, 2021, INT INF PREV CONTR G; Centers for Disease Control and Prevention, 2020, COR DIS 2019 CAS US; Centers for Disease Control and Prevention, 2020, US TEL EXP ACC ESS H; Centers for Disease Control and Prevention, 2020, US PERS PROT EQ PPE; CMS, 2020, CMS AD EL SURG PROC; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Devnani M, 2012, PREHOSP DISASTER MED, V27, P551, DOI 10.1017/S1049023X12001331; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Farsi D, 2020, ADV J EMERG MED, V4, DOI 10.22114/ajem.v0i0.378; Ho SMY, 2005, J CONSULT CLIN PSYCH, V73, P344, DOI 10.1037/0022-006X.73.2.344; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; MacIntyre CR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006577; Maheu MM, 2020, COVID 19 TELEHEALTH; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Onyeaka HK, 2020, CUREUS, V12, DOI 10.7759/cureus.7351; Orellana RC, 2016, PREHOSP EMERG CARE, V20, P184, DOI 10.3109/10903127.2015.1076098; Phua DH, 2005, ACAD EMERG MED, V12, P322, DOI 10.1197/j.aem.2004.11.015; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Safren S, 2020, COMMUNICATION; Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567; Strom K. E., 2020, HEARING REV, V27, P10; Strom K. E., 2020, HEARING REV; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Vaccaro AR, 2020, J AM ACAD ORTHOP SUR, V28, P464, DOI 10.5435/JAAOS-D-20-00379; van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618; Weinberg A, 2000, LANCET, V355, P533, DOI 10.1016/S0140-6736(99)07366-3; WHO, 2020, RAT US PERS PROT EQ; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067	36	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241328	10.1371/journal.pone.0241328	http://dx.doi.org/10.1371/journal.pone.0241328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125385	Green Published, gold			2022-12-26	WOS:000588368900036
J	Paskevicius, T; Jung, J; Pujol, M; Eggleton, P; Qin, WY; Robinson, A; Gutowski, N; Holley, J; Smallwood, M; Newcombe, J; Zochodne, D; Chen, XZ; Tang, JF; Kraus, A; Michalak, M; Agellon, LB				Paskevicius, Tautvydas; Jung, Joanna; Pujol, Myriam; Eggleton, Paul; Qin, Wenying; Robinson, Alison; Gutowski, Nick; Holley, Janet; Smallwood, Miranda; Newcombe, Jia; Zochodne, Douglas; Chen, Xing-Zhen; Tang, Jingfeng; Kraus, Allison; Michalak, Marek; Agellon, Luis B.			The Fabp5/calnexin complex is a prerequisite for sensitization of mice to experimental autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						blood brain barrier; calnexin; chaperone; fatty acid binding protein; multiple sclerosis	ACID-BINDING-PROTEIN; BLOOD-BRAIN-BARRIER; FLUORESCENCE COMPLEMENTATION BIFC; MULTIPLE-SCLEROSIS; QUALITY-CONTROL; CALNEXIN CONTROLS; DEFICIENT; FABP; ER; EXPRESSION	We previously showed that calnexin (Canx)-deficient mice are desensitized to experimental autoimmune encephalomyelitis (EAE) induction, a model that is frequently used to study inflammatory demyelinating diseases, due to increased resistance of the blood-brain barrier to immune cell transmigration. We also discovered that Fabp5, an abundant cytoplasmic lipid-binding protein found in brain endothelial cells, makes protein-protein contact with the cytoplasmic C-tail domain of Canx. Remarkably, both Canx-deficient and Fabp5-deficient mice commonly manifest resistance to EAE induction. Here, we evaluated the importance of Fabp5/Canx interactions on EAE pathogenesis and on the patency of a model blood-brain barrier to T-cell transcellular migration. The results demonstrate that formation of a complex comprised of Fabp5 and the C-tail domain of Canx dictates the permeability of the model blood-brain barrier to immune cells and is also a prerequisite for EAE pathogenesis.	[Paskevicius, Tautvydas; Jung, Joanna; Pujol, Myriam; Robinson, Alison; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Eggleton, Paul; Gutowski, Nick; Holley, Janet; Smallwood, Miranda] Univ Exeter, Dept Biomed & Clin Sci, Med Sch, Exeter, Devon, England; [Qin, Wenying; Chen, Xing-Zhen; Tang, Jingfeng; Michalak, Marek] Hubei Univ Technol, Natl Ctr Cellular Regulat & Mol Pharmaceut 111, Wuhan, Peoples R China; [Newcombe, Jia] UCL, UCL Queen Sq Inst Neurol, Dept Neuroinflammat, NeuroResource, London, England; [Zochodne, Douglas] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kraus, Allison] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Agellon, Luis B.] McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Alberta; University of Exeter; Hubei University of Technology; University of London; University College London; University of Alberta; University of Alberta; Case Western Reserve University; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.; Agellon, LB (corresponding author), McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	marek.michalak@ualberta.ca; luis.agellon@mcgill.ca	Pujol Moris, Myriam/AAC-9149-2022	Pujol Moris, Myriam/0000-0003-1833-3746; Tang, jingfeng/0000-0002-5524-4518; Newcombe, Jia/0000-0001-9609-7975	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [MOP-15291, MOP-15415, PS-153325, MOP-86750, PS 168843]; Multiple Sclerosis Society (MS Society) [207495]; Multiple Sclerosis Society of Canada (MSSOC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society (MS Society); Multiple Sclerosis Society of Canada (MSSOC)	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP-15291, MOP-15415, PS-153325, MOP-86750 and PS 168843; Multiple Sclerosis Society (MS Society), Grant/Award Number: 207495; Multiple Sclerosis Society of Canada (MSSOC)	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Agellon LB, 2017, ADV EXP MED BIOL, V981, P61, DOI 10.1007/978-3-319-55858-5_4; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Balasa R, 2020, HUM IMMUNOL, V81, P237, DOI 10.1016/j.humimm.2020.02.009; Bjelobaba I, 2018, J NEUROSCI RES, V96, P1021, DOI 10.1002/jnr.24224; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dudek E, 2015, BIOCHEM BIOPH RES CO, V468, P889, DOI 10.1016/j.bbrc.2015.11.052; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Glatigny S, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028977; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Hunegnaw R, 2016, ARTERIOSCL THROM VAS, V36, P1758, DOI 10.1161/ATVBAHA.116.307997; Jung J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98410; Jung J, 2017, BIOCHEM BIOPH RES CO, V493, P202, DOI 10.1016/j.bbrc.2017.09.046; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lee D, 2015, J BIOL CHEM, V290, P5725, DOI 10.1074/jbc.M114.635474; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Li H. Y., 2011, PLOS ONE, V6; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; MADSEN P, 1992, J INVEST DERMATOL, V99, P299, DOI 10.1111/1523-1747.ep12616641; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Miller KE, 2015, J MOL BIOL, V427, P2039, DOI 10.1016/j.jmb.2015.03.005; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Myrum C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00294; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Owada Y, 2002, MOL CELL BIOCHEM, V239, P83, DOI 10.1023/A:1020524621933; Owada Y, 2002, J INVEST DERMATOL, V118, P430, DOI 10.1046/j.0022-202x.2001.01616.x; Owada Y, 2008, TOHOKU J EXP MED, V214, P213, DOI 10.1620/tjem.214.213; Pan YJ, 2016, J NEUROSCI, V36, P11755, DOI 10.1523/JNEUROSCI.1583-16.2016; Rao EY, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0091-2; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; 't Hart Bert A, 2019, Primate Biol, V6, P17, DOI 10.5194/pb-6-17-2019; WADA I, 1991, J BIOL CHEM, V266, P19599; Watanabe T, 2013, BIOL PHARM BULL, V36, P492, DOI 10.1248/bpb.b12-00915; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	53	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16662	16675		10.1096/fj.202001539RR	http://dx.doi.org/10.1096/fj.202001539RR		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124722	Bronze			2022-12-26	WOS:000589709600001
J	Ulndreaj, A; Tzekou, A; Siddiqui, AM; Fehlings, MG				Ulndreaj, Antigona; Tzekou, Apostolia; Siddiqui, Ahad M.; Fehlings, Michael G.			Effects of experimental cervical spinal cord injury on peripheral adaptive immunity	PLOS ONE			English	Article							IMMUNOGLOBULIN CONCENTRATIONS; ABDOMINAL ULTRASONOGRAPHY; CEREBROSPINAL-FLUID; SUBARACHNOID SPACE; SPRAGUE-DAWLEY; LYMPH-NODES; BONE-MARROW; SYSTEM; INFLAMMATION; LEVEL	Adaptive immunity is critical for controlling infections, which are a leading cause of morbidity and mortality in patients with spinal cord injury (SCI). In rats and mice, compromised peripheral adaptive immune responses, as shown by splenic atrophy and lowered frequencies of peripheral lymphocytes, were shown to result from high-level thoracic SCI. However, whether cervical SCI, which is the most common level of SCI in humans, impairs adaptive immunity remains largely unknown. In the present study, we induced cervical SCI in rats at the C7/T1 level by clip compression and looked at changes in peripheral adaptive immunity at 2-, 10- and 20-weeks post-injury. Specifically, we quantified changes in the frequencies of T- and B- lymphocytes in the blood and the mandibular and deep cervical lymph nodes, which drain the cervical spinal cord. We also assessed changes in serum IgG and IgM immunoglobulin levels, as well as spleen size. We found a significant decline in circulating T- and B- cell frequencies at 10 weeks post-SCI, which returned to normal at 20 weeks after injury. We found no effect of cervical SCI on T- and B- cell frequencies in the draining lymph nodes. Moreover, cervical SCI had no effect on net spleen size, although injured rats had a higher spleen/body weight ratio than sham controls at all time points of the study. Lastly, IgG and IgM immunoglobulin declined at 2 weeks, followed by a significant increase in IgM levels at 10 weeks of injury. These data indicate that cervical SCI causes a significant imbalance in circulating lymphocytes and immunoglobulin levels at 2 and 10 weeks. As we discuss in this article, these findings are largely in line with clinical observations, and we anticipate that this study will fuel more research on the effect of adaptive immunity on SCI recovery.	[Ulndreaj, Antigona; Tzekou, Apostolia; Siddiqui, Ahad M.; Fehlings, Michael G.] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Ulndreaj, Antigona; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Spine Program, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Spine Program, Toronto, ON, Canada.	michael.fehlings@uhn.ca	Siddiqui, Ahad M./AET-0979-2022	Siddiqui, Ahad M./0000-0003-3334-1728; Fehlings, Michael/0000-0002-5722-6364	Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	MGF would like to acknowledge support from the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration as well as the DeZwirek Family Foundation. The authors thank Dr. Jared Wilcox for assistance with intrathecal dye injection and localization of draining lymph nodes and Dr. Tim Worden for copyediting this work.	[Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Arevalo-Martin A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02365; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Becker KJ, 2016, TRANSL STROKE RES, V7, P303, DOI 10.1007/s12975-016-0455-9; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; Boulton M, 1998, AM J PHYSIOL-REG I, V274, pR88, DOI 10.1152/ajpregu.1998.274.1.R88; Bracchi-Ricard V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0574-y; BRIERLEY JB, 1948, J ANAT, V82, P153; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; BUTTERWOM, 1967, NATURE, V214, P1224, DOI DOI 10.1038/2141224A0; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; CRUSE JM, 1993, PATHOBIOLOGY, V61, P183, DOI 10.1159/000163790; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; DAROUICHE RO, 1993, ARCH PHYS MED REHAB, V74, P1354, DOI 10.1016/0003-9993(93)90092-O; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Faaborg PM, 2014, SPINAL CORD, V52, P494, DOI 10.1038/sc.2014.45; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fehlings MG, 2017, GLOB SPINE J, V7, p203S, DOI 10.1177/2192568217703085; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Gorgey Ashraf S, 2007, Top Spinal Cord Inj Rehabil, V12, P1, DOI 10.1310/sci1204-1; Hong J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082167; Hurtgen BJ, 2016, J MUSCULOSKEL NEURON, V16, P122; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; Iversen PO, 2000, BLOOD, V96, P2081; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kohm AP, 2001, PHARMACOL REV, V53, P487; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kwon S, 2017, J IMMUNOL METHODS, V449, P37, DOI 10.1016/j.jim.2017.06.010; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Lynch AC, 2002, SPINAL CORD, V40, P627, DOI 10.1038/sj.sc.3101382; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mbanwi AN, 2017, EUR J IMMUNOL, V47, P94, DOI 10.1002/eji.201646666; MCMILLAN R, 1972, J IMMUNOL, V109, P1386; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Monahan R, 2015, IMMUNOL RES, V63, P3, DOI 10.1007/s12026-015-8698-1; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Noble BT, 2018, J NEUROIMMUNOL, V321, P1, DOI 10.1016/j.jneuroim.2018.05.007; Norden DM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1191-8; Pavlicek D, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0103-6; Pereira BP, 2012, J CELL BIOCHEM, V113, P2330, DOI 10.1002/jcb.24105; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Reina MA, 2004, ANESTH ANALG, V98, P1479, DOI 10.1213/01.ANE.0000113240.09354.E9; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sellers RS, 2007, TOXICOL PATHOL, V35, P751, DOI 10.1080/01926230701595300; Shin JC, 2006, J KOREAN MED SCI, V21, P927, DOI 10.3346/jkms.2006.21.5.927; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sipski ML, 2004, J REHABIL RES DEV, V41, P101, DOI 10.1682/JRRD.2004.01.0101; Soden RJ, 2000, SPINAL CORD, V38, P604, DOI 10.1038/sj.sc.3101080; STOICA G, 1978, REV ROUM MED-MED INT, V16, P23; STOICA G, 1980, REV ROUM MED-MED INT, V18, P323; Thompson SH, 2016, HEAD NECK OROFACIAL, P60; Thyagaraju GS, 2012, INT J PERVASIVE COMP, V8, P133, DOI 10.1108/17427371211245364; Trautner BW, 2004, ARCH PHYS MED REHAB, V85, P1886, DOI 10.1016/j.apmr.2004.03.022; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Ulndreaj A, 2016, EXPERT REV NEUROTHER, V16, P1127, DOI 10.1080/14737175.2016.1207532; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Vega JL, 2004, NEUROPATH APPL NEURO, V30, P416, DOI 10.1111/j.1365-2990.2004.00575.x; Vega JL, 2003, J NEUROPATH EXP NEUR, V62, P848, DOI 10.1093/jnen/62.8.848; ZENKER W, 1994, ANAT EMBRYOL, V189, P243; Zha J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-65; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013	75	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241285	10.1371/journal.pone.0241285	http://dx.doi.org/10.1371/journal.pone.0241285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125407	gold, Green Published			2022-12-26	WOS:000588368900002
J	Kundu, J; Bakshi, S; Joshi, H; Bhadada, SK; Verma, I; Sharma, S				Kundu, Jyoti; Bakshi, Shikha; Joshi, Himanshu; Bhadada, Sanjay K.; Verma, Indu; Sharma, Sadhna			Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis-A pilot study	PLOS ONE			English	Article							PHAGOSOME MATURATION; PREVALENCE; BINDING; MECHANISMS; VIMENTIN; PROTEINS	Background Diabetes is an important risk factor for developing tuberculosis. This association leads to exacerbation of tuberculosis symptoms and delayed treatment of both the diseases. Molecular mechanism and biomarkers/drug targets related to copathogenesis of tuberculosis and diabetes are still poorly understood. In this study, proteomics based 2D-MALDI/MS approach was employed to identify host signature proteins which are altered during copathogenesis of tuberculosis and diabetes. Methods Comparative proteome of human peripheral blood mononuclear cells (PBMCs) from healthy controls, tuberculosis and diabetes patients in comparison to comorbid diabetes and tuberculosis patients was analyzed. Gel based proteomics approach followed by in gel trypsin digestion and peptide identification by mass spectrometry was used for signature protein identification. Results Total of 18 protein spots with differential expression in tuberculosis and diabetes copathogenesis (TBDM) patients in comparison to other groups were identified. These proteins belonged to four functional categories i.e. structural, cell cycle/growth regulation, signaling and intermediary metabolism. These include Vimentin, tubulin beta chain protein, Actin related protein 2/3 complex subunit 2, coffilin 1 (Structural), PDZ LIM domain protein, Rho-GDP dissociation inhibitor, Ras related protein Rab (signaling), superoxide dismutase, dCTPpyrophosphatase 1, Transcription initiation factor TFIID subunit 12, three isoforms of Peptidylprolylcis-trans isomerase A, SH3 domain containing protein (metabolism), three isoforms of Protein S100A9 and S100A8 (cell cycle progression/growth regulation). Conclusion Proteins identified to be differentially expressed in TBDM patient can act as potent biomarkers and as predictors for copathogenesis of tuberculosis and diabetes.	[Kundu, Jyoti; Bakshi, Shikha; Verma, Indu; Sharma, Sadhna] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Joshi, Himanshu] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India; [Bhadada, Sanjay K.] Post Grad Inst Med Educ & Res, Dept Endocrinol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sharma, S (corresponding author), Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India.	sadhnabiochem@gmail.com		Sharma, Sadhna/0000-0002-6631-1704				[Anonymous], 2003, AUSTR MEAT IND B, V26, P30; Ansari M., 2006, Acta Medica Iranica, V44, P159; Balde NM, 2006, INT J TUBERC LUNG D, V10, P1036; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feleke Y, 1999, E AFR MED J, V76, P361; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kolonko M, 2014, CELL MICROBIOL, V16, P232, DOI 10.1111/cmi.12217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nijland HMJ, 2006, CLIN INFECT DIS, V43, P848, DOI 10.1086/507543; Ono R, SCI REP, V5, P18327; Pan SC, 2015, LANCET DIABETES ENDO, V3, P323, DOI 10.1016/S2213-8587(15)00042-X; Participants in the 2006 Georgetown University Workshop on the Ancillary-Care Obligations of Medical Researchers Working in Developing Countries, 2008, PLOS MED, V5, pe90; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramachandran S, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-38; Restrepo BI, 2007, CLIN INFECT DIS, V45, P436, DOI 10.1086/519939; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; Wang J, AM J TRANSL RES, V8, P1055; Webb EA, 2009, INT J TUBERC LUNG D, V13, P868; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; WHO, 2018, COLLABORATIVE FRAMEW; World Health Organization (WHO), GLOB TUB REP 2019; Xu DD, 2015, PROTEOMICS, V15, P58, DOI 10.1002/pmic.201400366; Yi CR, 2014, J BIOL CHEM, V289, P30101, DOI 10.1074/jbc.M114.595868; ZENKE G, 1993, ANN NY ACAD SCI, V685, P330, DOI 10.1111/j.1749-6632.1993.tb35882.x; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0233326	10.1371/journal.pone.0233326	http://dx.doi.org/10.1371/journal.pone.0233326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156824	Green Submitted, Green Published, gold			2022-12-26	WOS:000591376400039
J	Li, HB; Cui, XJ; Sun, LX; Deng, XY; Liu, S; Zou, XH; Li, BB; Wang, CL; Wang, YM; Liu, YM; Lu, BH; Cao, B				Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Deng, Xiaoyan; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin			High concentration of Cas12a effector tolerates more mismatches on ssDNA	FASEB JOURNAL			English	Article						Cas12a; CRISPR; Cas; Mycobacterium tuberculosis; pathogen detection; trans&#8208; cleavage activity	RNA; CRISPR-CAS9; DIAGNOSTICS; PCR	Rapid pathogen detection is critical for prompt treatment, interrupting transmission routes, and decreasing morbidity and mortality. The V-type CRISPR system had been used for rapid pathogen detection. However, whether single-stranded DNA in CRISPR system can cause false positives remains undetermined. Herein, we show that high molar concentration of Cas12a effector tolerated more mismatches on ssDNA and activated its trans-cleavage activity at six base matches. Reducing Cas12a and crRNA molar concentration increased the minimal base-match number required for Cas12a ssDNA activation to 11, which reducing nonspecific activation. We then established a Cas12a-based M tuberculosis detection system with a primer having an 8 bp overlap with crRNA. This system did not exhibit primer-induced false positives, and minimum detection copy reached 1 copy/uL (inputting 1-mu L sample) in standard strains. The Cas12a-based M tuberculosis detection system showed 80.0% sensitivity and 100.0% specificity in verification using clinical specimens, compared with Xpert MTB/RIF, which showed 72.0% sensitivity and 90.9% specificity. All these results prove that appropriate concentration of cas12a effector can effectively perform nucleic acid detection.	[Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Deng, Xiaoyan; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Lab Clin Microbiol & Infect Dis, 2 East Yinghua Rd, Beijing 100029, Peoples R China; [Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China; [Li, Haibo; Cui, Xiaojing; Sun, Lingxiao; Liu, Shuai; Zou, Xiaohui; Li, Binbin; Wang, Chunlei; Wang, Yeming; Liu, Yinmei; Lu, Binghuai; Cao, Bin] Capital Med Univ, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Deng, Xiaoyan; Liu, Shuai; Wang, Yeming; Cao, Bin] Capital Med Univ, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Clin Ctr Pulm Infect, Beijing, Peoples R China	China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Capital Medical University	Lu, BH; Cao, B (corresponding author), China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Lab Clin Microbiol & Infect Dis, 2 East Yinghua Rd, Beijing 100029, Peoples R China.	zs25041@126.com; caobin_ben@163.com	Li, Haibo/AAZ-5395-2021		Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019TX320004]; Sanming Project of Medicine in Shenzhen [SZSM201911009]	Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Sanming Project of Medicine in Shenzhen	This work supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2019TX320004) and Sanming Project of Medicine in Shenzhen (No. SZSM201911009).	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; Barrangou R, 2017, MOL CELL, V65, P582, DOI 10.1016/j.molcel.2017.02.002; Bhattacharyya RP, 2018, ACS INFECT DIS, V4, P1278, DOI 10.1021/acsinfecdis.8b00170; Bratovic M, 2020, NAT CHEM BIOL, V16, P587, DOI 10.1038/s41589-020-0490-4; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chertow DS, 2018, SCIENCE, V360, P381, DOI 10.1126/science.aat4982; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; de la Fuente-Nunez C, 2017, INTEGR BIOL-UK, V9, P109, DOI 10.1039/c6ib00140h; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Hamano-Hasegawa Keiko, 2008, Journal of Infection and Chemotherapy, V14, P424, DOI 10.1007/s10156-008-0648-6; Harrington LB, 2018, SCIENCE, V362, P839, DOI 10.1126/science.aav4294; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jain I, 2019, RNA BIOL, V16, P413, DOI 10.1080/15476286.2018.1495492; Kim S, 2020, NATURE, V579, P141, DOI 10.1038/s41586-020-2018-1; Kothari A, 2014, CLIN INFECT DIS, V59, P272, DOI 10.1093/cid/ciu292; Li HB, 2019, PROTEIN CELL, V10, P20, DOI 10.1007/s13238-018-0556-1; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Maxmen A, 2019, NATURE, V566, P437, DOI 10.1038/d41586-019-00601-3; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Piatek A, 2017, CRIT REV BIOTECHNOL, V37, P429, DOI 10.3109/07388551.2016.1165180; Rappo U, 2016, J CLIN MICROBIOL, V54, P2096, DOI 10.1128/JCM.00549-16; Sashital DG, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0543-4; Stower H, 2018, NAT MED, V24, P702, DOI 10.1038/s41591-018-0073-z; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1742-z; Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yan WX, 2018, MOL CELL, V70, P327, DOI 10.1016/j.molcel.2018.02.028; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang C, 2018, CELL, V175, P212, DOI 10.1016/j.cell.2018.09.001	31	2	2	13	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001475R	http://dx.doi.org/10.1096/fj.202001475R		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33159392				2022-12-26	WOS:000592448100001
J	Ajong, AB; Kenfack, B; Ali, IM; Yakum, MN; Aljerf, L; Telefo, PB				Ajong, Atem Bethel; Kenfack, Bruno; Ali, Innocent Mbulli; Yakum, Martin Ndinakie; Aljerf, Loai; Telefo, Phelix Bruno			Hypocalcaemia and calcium intake in pregnancy: A research protocol for critical analysis of risk factors, maternofoetal outcomes and evaluation of diagnostic methods in a third-category health facility, Cameroon	PLOS ONE			English	Article							BONE METABOLISM; DIETARY CALCIUM; SERUM; HOMEOSTASIS; DISORDERS; LACTATION; BLOOD; FETAL	Introduction Hypocalcaemia in pregnancy remains a major health issue, particularly in the developing world where daily calcium intakes are suboptimal. This electrolyte imbalance can lead to severe maternofoetal and childhood consequences. Calcium supplementation, amongst others, contributes significantly to meeting calcium demands in pregnancy. With ionised calcaemia as the gold standard for diagnosis, total calcaemia and albumin-corrected calcaemia in other pathological states have been found to overestimate the burden of hypocalcaemia. The main objectives of this study are to describe the blood calcium level (total, albumin corrected, and ionised calcaemia) and associated maternofoetal outcomes while identifying determinants of calcium supplementation and ionised hypocalcaemia. This study will also evaluate the sensitivity and specificity of albumin corrected calcaemia as a diagnostic tool for hypocalcaemia (ionised calcaemia as the gold standard) among pregnant women in the Nkongsamba Regional Hospital, Cameroon. Methods Our study will target a total of 1067 term pregnant women who shall be included consecutively into the study as they arrive the maternity of the Nkongsamba Regional Hospital for their last antenatal care visit. Data shall be collected using a semi-structured interview-administered questionnaire and blood samples collected for total plasma calcium, albumin and serum ionized calcium assays. Additional data will be collected at birth (maternal and foetal variables; foetal outcomes evaluated as secondary outcomes). Total calcaemia and albuminemia shall be measured by atomic absorption spectrophotometry, while ionised calcaemia will be measured by ion-selective electrode potentiometry(using MSLEA15-H electrolyte analyzer) per standard BIOLABO and MSLEA15 protocols, respectively. Data will be analysed using the statistical softwares epi-Info version 7.2.2.16 and STATA version 16. Expected research outcome This study will present a more precise estimate of the burden of hypocalcaemia in late pregnancy as well as identify and analyse the different factors associated with calcium supplementation and ionised hypocalcaemia among term pregnant women in a developing world setting. Maternofoetal outcomes associated with hypocalcaemia will be determined as well as the sensitivity and specificity of total and albumin-corrected calcaemia in diagnosing hypocalcaemia. Our findings will contribute significantly to designing or strengthening interventions to control this electrolyte imbalance.	[Ajong, Atem Bethel] Kekem Dist Hosp, Kekem, West Region, Cameroon; [Ajong, Atem Bethel; Ali, Innocent Mbulli; Telefo, Phelix Bruno] Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon; [Kenfack, Bruno] Univ Dschang, Fac Med & Pharmaceut Sci, Dept Obstet Gynaecol & Maternal Hlth, Dschang, West Region, Cameroon; [Yakum, Martin Ndinakie] Medecins Sans Frontieres Spain MSFOCBA, Maiduguri, Nigeria; [Aljerf, Loai] Damascus Univ, Fac Dent, Damascus, Syria		Ajong, AB (corresponding author), Kekem Dist Hosp, Kekem, West Region, Cameroon.; Ajong, AB (corresponding author), Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon.	christrah@yahoo.fr	Yakum, Martin/R-5738-2019; Aljerf, Loai/D-9843-2016	Yakum, Martin/0000-0003-3149-2020; Ali, Innocent/0000-0002-1112-6376; Aljerf, Loai/0000-0002-1132-9659				Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Almaghamsi Abdulrahman, 2018, Oman Med J, V33, P453, DOI 10.5001/omj.2018.85; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2012, GLOB TUB REP 2012; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Balk EM, 2017, OSTEOPOROSIS INT, V28, P3315, DOI 10.1007/s00198-017-4230-x; Benali A. I., 2014, J NUTR FOOD SCI, V4, P4, DOI [10.4172/2155-9600.1000318, DOI 10.4172/2155-9600.1000318]; BIOLABO, 2019, CALCIUM CPC METH REA, P1; BIOLABO, 2011, ALBUMIN BCG METH RAA, P1; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Chen Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016404; Chhabra S, 2017, J NUTR DISORD THER, V7, P1; Cormick G, 2018, BJOG-INT J OBSTET GY, V3, P1; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; Jafri L, 2014, INDIAN J CLIN BIOCHE, V29, P327, DOI 10.1007/s12291-013-0360-x; Kang SH, 2014, KOREAN J INTERN MED, V29, P226, DOI 10.3904/kjim.2014.29.2.226; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Kovacs CS, 2006, ENDOCRIN METAB CLIN, V35, P21, DOI 10.1016/j.ecl.2005.09.004; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210/jc.86.6.2344; Kumar A, 2010, BIOL TRACE ELEM RES, V136, P26, DOI 10.1007/s12011-009-8523-6; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; Nguyen PH, 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0179873; Olausson H, 2012, NUTR RES REV, V25, P40, DOI 10.1017/S0954422411000187; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; PAYNE RB, 1979, J CLIN PATHOL, V32, P56, DOI 10.1136/jcp.32.1.56; Ritchie LD, 2000, AM J CLIN NUTR, V71, p1371S, DOI 10.1093/ajcn/71.5.1371s; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Scholl TO, 2014, AM J CLIN NUTR, V99, P918, DOI 10.3945/ajcn.113.076034; Sharp CR, 2009, J VET EMERG CRIT CAR, V19, P571, DOI 10.1111/j.1476-4431.2009.00485.x	33	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241812	10.1371/journal.pone.0241812	http://dx.doi.org/10.1371/journal.pone.0241812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152011	gold, Green Published			2022-12-26	WOS:000591376200088
J	Ho, FK; Petermann-Rocha, F; Gray, SR; Jani, BD; Katikireddi, SV; Niedzwiedz, CL; Foster, H; Hastie, CE; Mackay, DF; Gill, JMR; O'Donnell, C; Welsh, P; Mair, F; Sattar, N; Celis-Morales, CA; Pell, JP				Ho, Frederick K.; Petermann-Rocha, Fanny; Gray, Stuart R.; Jani, Bhautesh D.; Katikireddi, S. Vittal; Niedzwiedz, Claire L.; Foster, Hamish; Hastie, Claire E.; Mackay, Daniel F.; Gill, Jason M. R.; O'Donnell, Catherine; Welsh, Paul; Mair, Frances; Sattar, Naveed; Celis-Morales, Carlos A.; Pell, Jill P.			Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants	PLOS ONE			English	Article							LUNG-FUNCTION; WOMEN; MEN	Introduction Older people have been reported to be at higher risk of COVID-19 mortality. This study explored the factors mediating this association and whether older age was associated with increased mortality risk in the absence of other risk factors. Methods In UK Biobank, a population cohort study, baseline data were linked to COVID-19 deaths. Poisson regression was used to study the association between current age and COVID-19 mortality. Results Among eligible participants, 438 (0.09%) died of COVID-19. Current age was associated exponentially with COVID-19 mortality. Overall, participants aged >= 75 years were at 13-fold (95% CI 9.13-17.85) mortality risk compared with those <65 years. Low forced expiratory volume in 1 second, high systolic blood pressure, low handgrip strength, and multiple long-term conditions were significant mediators, and collectively explained 39.3% of their excess risk. The associations between these risk factors and COVID-19 mortality were stronger among older participants. Participants aged >= 75 without additional risk factors were at 4-fold risk (95% CI 1.57-9.96, P = 0.004) compared with all participants aged <65 years. Conclusions Higher COVID-19 mortality among older adults was partially explained by other risk factors. 'Healthy' older adults were at much lower risk. Nonetheless, older age was an independent risk factor for COVID-19 mortality.	[Ho, Frederick K.; Petermann-Rocha, Fanny; Jani, Bhautesh D.; Katikireddi, S. Vittal; Niedzwiedz, Claire L.; Foster, Hamish; Hastie, Claire E.; Mackay, Daniel F.; O'Donnell, Catherine; Mair, Frances; Celis-Morales, Carlos A.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Petermann-Rocha, Fanny; Gray, Stuart R.; Gill, Jason M. R.; Welsh, Paul; Sattar, Naveed; Celis-Morales, Carlos A.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Jill.Pell@glasgow.ac.uk	Foster, Hamish/AAX-7703-2021; Ho, Frederick/AAS-2647-2021; Petermann-Rocha, Fanny/AAK-1230-2021; Gray, Stuart/L-2489-2017	Ho, Frederick/0000-0001-7190-9025; Katikireddi, Srinivasa/0000-0001-6593-9092; Gray, Stuart/0000-0001-8969-9636; Gill, Jason/0000-0003-3615-0986; Petermann Rocha, Fanny/0000-0002-4384-4962				Alqahtani FY, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002923; Batty GD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m131; Bhatnagar P, 2015, HEART; Binder H, 2013, STAT MED, V32, P2262, DOI 10.1002/sim.5639; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Hole DJ, 1996, BRIT MED J, V313, P711; Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Le Couteur DG, 2020, J GERONTOLOGY A; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Montero-Odasso Manuel, 2020, Can Geriatr J, V23, P152, DOI 10.5770/cgj.23.452; NHS Digital, 2020, COR COVID 19 SHIELD; Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Placzek HED, 2014, AM J PUBLIC HEALTH, V104, pE118, DOI 10.2105/AJPH.2014.302197; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Richardson S, 2020, JAMA; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8; Stepanova M, 2015, ONCOTARGET, V6, P1414, DOI 10.18632/oncotarget.2725; Tingley D, 2014, J STAT SOFTW, V59; Townsend PP., 1988, HLTH DEPRIVATION INE; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	106	107	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241824	10.1371/journal.pone.0241824	http://dx.doi.org/10.1371/journal.pone.0241824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152008	Green Published, Green Accepted, gold			2022-12-26	WOS:000591376200115
J	Sami, R; Soltaninejad, F; Amra, B; Naderi, Z; Javanmard, SH; Iraj, B; Ahmadi, SH; Shayganfar, A; Dehghan, M; Khademi, N; Hosseini, NS; Mortazavi, M; Mansourian, M; Mananas, MA; Marateb, HR; Adibi, P				Sami, Ramin; Soltaninejad, Forogh; Amra, Babak; Naderi, Zohre; Haghjooy Javanmard, Shaghayegh; Iraj, Bijan; Haji Ahmadi, Somayeh; Shayganfar, Azin; Dehghan, Mehrnegar; Khademi, Nilufar; Sadat Hosseini, Nastaran; Mortazavi, Mojgan; Mansourian, Marjan; Mananas, Miquel Angel; Marateb, Hamid Reza; Adibi, Peyman			A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019; HEALTH-CARE; MORTALITY; OUTBREAK; INFECTIONS; RESPONSES; PHQ-9; AGE	The COVID-19 is rapidly scattering worldwide, and the number of cases in the Eastern Mediterranean Region is rising. Thus, there is a need for immediate targeted actions. We designed a longitudinal study in a hot outbreak zone to analyze the serial findings between infected patients for detecting temporal changes from February 2020. In a hospital-based open-cohort study, patients are followed from admission until one year from their discharge (the 1st, 4th, 12th weeks, and the first year). The patient recruitment phase finished at the end of August 2020, and the follow-up continues by the end of August 2021. The measurements included demographic, socio-economics, symptoms, health service diagnosis and treatment, contact history, and psychological variables. The signs improvement, death, length of stay in hospital were considered primary, and impaired pulmonary function and psychotic disorders were considered main secondary outcomes. Moreover, clinical symptoms and respiratory functions are being determined in such follow-ups. Among the first 600 COVID-19 cases, 490 patients with complete information (39% female; the average age of 57 +/- 15 years) were analyzed. Seven percent of these patients died. The three main leading causes of admission were: fever (77%), dry cough (73%), and fatigue (69%). The most prevalent comorbidities between COVID-19 patients were hypertension (35%), diabetes (28%), and ischemic heart disease (14%). The percentage of primary composite endpoints (PCEP), defined as death, the use of mechanical ventilation, or admission to an intensive care unit was 18%. The Cox Proportional-Hazards Model for PCEP indicated the following significant risk factors: Oxygen saturation < 80% (HR = 6.3; [CI 95%: 2.5,15.5]), lymphopenia (HR = 3.5; [CI 95%: 2.2,5.5]), Oxygen saturation 80%-90% (HR = 2.5; [CI 95%: 1.1,5.8]), and thrombocytopenia (HR = 1.6; [CI 95%: 1.1,2.5]). This long-term prospective Cohort may support healthcare professionals in the management of resources following this pandemic.	[Sami, Ramin] Isfahan Univ Med Sci, Sch Med, Dept Internal Med, Esfahan, Iran; [Soltaninejad, Forogh] Isfahan Univ Med Sci, Resp Res Ctr, Div Pulm, Dept Internal Med,Sch Med, Esfahan, Iran; [Amra, Babak] Isfahan Univ Med Sci, Bamdad Resp Res Ctr, Esfahan, Iran; [Naderi, Zohre] Isfahan Univ Med Sci, Dept Internal Med, Esfahan, Iran; [Haghjooy Javanmard, Shaghayegh] Isfahan Univ Med Sci, Dept Physiol, Sch Med, Appl Physiol Res Ctr,Cardiovasc Res Inst, Esfahan, Iran; [Iraj, Bijan] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran; [Haji Ahmadi, Somayeh; Shayganfar, Azin] Isfahan Univ Med Sci, Dept Radiol, Esfahan, Iran; [Dehghan, Mehrnegar; Khademi, Nilufar; Sadat Hosseini, Nastaran] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran; [Mortazavi, Mojgan] Isfahan Univ Med Sci, Isfahan Kidney Dis Res Ctr, Esfahan, Iran; [Mansourian, Marjan] Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Sch Hlth, Esfahan, Iran; [Mansourian, Marjan; Mananas, Miquel Angel; Marateb, Hamid Reza] Univ Politecn Catalunya Barcelona Tech UPC, Biomed Engn Res Ctr CREB, Automat Control Dept ESAII, Barcelona, Spain; [Mananas, Miquel Angel] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Marateb, Hamid Reza] Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran; [Marateb, Hamid Reza] Isfahan Univ Med Sci, Machine Learning Dept, Isfahan Cardiovasc Res Ctr, WHO Collaborating Ctr, Esfahan, Iran; [Adibi, Peyman] Isfahan Univ Med Sci, Digest Dis Res Ctr, Esfahan, Iran	Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Isfahan; Isfahan University Medical Science; World Health Organization; Isfahan University Medical Science	Mansourian, M (corresponding author), Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Sch Hlth, Esfahan, Iran.; Mansourian, M (corresponding author), Univ Politecn Catalunya Barcelona Tech UPC, Biomed Engn Res Ctr CREB, Automat Control Dept ESAII, Barcelona, Spain.	marjan.mansourian@upc.edu	Marateb, Hamid Reza/G-5556-2013; Sedeh, Peyman Adibi/AAJ-4582-2020; Mansourian, Marjan/AAX-1011-2020; Sami, Ramin/AHC-2405-2022; Sami, Rokayya/AFP-5053-2022; sami, ramin/B-9779-2018; amra, Babak/K-1825-2019; Haghjooy Javanmard, Shaghayegh/W-5060-2017; Mañanas, Miguel Angel/AAI-2961-2021	Marateb, Hamid Reza/0000-0003-4408-2397; Sedeh, Peyman Adibi/0000-0001-6411-5235; Sami, Ramin/0000-0002-7521-4631; Sami, Rokayya/0000-0003-3162-9453; sami, ramin/0000-0002-7521-4631; amra, Babak/0000-0001-9606-7434; Haghjooy Javanmard, Shaghayegh/0000-0002-3853-5006; 	European Union [712949]; Agency for Business Competitiveness of the Government of Catalonia [TECSPR18-1-0017]; Spanish Ministry of Economy and Competitiveness - Spain [DPI2017-83989-R]; Isfahan University of Medical Sciences [IR.MUI.MED.REC.1399.029]; University of Isfahan; TECNIOspring PLUS	European Union(European Commission); Agency for Business Competitiveness of the Government of Catalonia; Spanish Ministry of Economy and Competitiveness - Spain(Spanish Government); Isfahan University of Medical Sciences; University of Isfahan; TECNIOspring PLUS	The research leading to these results has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 712949 (TECNIOspring PLUS), and from the Agency for Business Competitiveness of the Government of Catalonia (TECSPR18-1-0017), the Spanish Ministry of Economy and Competitiveness - Spain (DPI2017-83989-R), and Isfahan University of Medical Sciences (IR.MUI.MED.REC.1399.029), and University of Isfahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prof. Marjan Mansourian received a salary from TECNIOspring PLUS.	Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chan KS, 2003, RESPIROLOGY, V8, pS36, DOI 10.1046/j.1440-1843.2003.00522.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Ell Kathleen, 2005, Home Health Care Serv Q, V24, P1; European Centre for Disease Prevention and Control, 2020, GUID DISCH END IS CO; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1; Jiang SB, 2020, VIROL SIN, V35, P263, DOI 10.1007/s12250-020-00206-5; Khairat S, 2020, JMIR PUBLIC HLTH SUR, V6, P214, DOI 10.2196/18811; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Liu YL, 2020, PLATELETS, V31, P490, DOI 10.1080/09537104.2020.1754383; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; MacIntyre R, 2019, GLOBAL BIOSECURITY, P85, DOI [10.31646/gbio.36, DOI 10.31646/GBIO.36]; Montazeri A., 2014, PAYESH, V13, P589, DOI DOI 10.5812/IRCMJ.17(5)2015.25831; Nayak PK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13303; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Perez-Lopez FR, 2020, MATURITAS, V141, P59, DOI 10.1016/j.maturitas.2020.06.017; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rubin GJ, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m313; Sahebi A, 2005, J APPL DEV PSYCHOL; Sim K, 2010, J PSYCHOSOM RES, V68, P195, DOI 10.1016/j.jpsychores.2009.04.004; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Spencer-Segal JL, 2017, ANN AM THORAC SOC, V14, P960, DOI 10.1513/AnnalsATS.201606-468OC; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Le TA, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0223-4; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Yuhui, 2020, Radiology, V296, pE55, DOI 10.1148/radiol.2020200843; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434; Zhao QW, 2020, INT J INFECT DIS, V96, P131, DOI 10.1016/j.ijid.2020.04.086	45	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241537	10.1371/journal.pone.0241537	http://dx.doi.org/10.1371/journal.pone.0241537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151983	Green Published, gold			2022-12-26	WOS:000591376200089
J	Shabi, O; Natan, S; Kolel, A; Mukherjee, A; Tchaicheeyan, O; Wolfenson, H; Kiryati, N; Lesman, A				Shabi, Oren; Natan, Sari; Kolel, Avraham; Mukherjee, Abhishek; Tchaicheeyan, Oren; Wolfenson, Haguy; Kiryati, Nahum; Lesman, Ayelet			Motion magnification analysis of microscopy videos of biological cells	PLOS ONE			English	Article							SHAPE OSCILLATIONS; CONTRACTIONS; RIGIDITY; FLUCTUATIONS; FREQUENCY; VIBRATION; RANGE	It is well recognized that isolated cardiac muscle cells beat in a periodic manner. Recently, evidence indicates that other, non-muscle cells, also perform periodic motions that are either imperceptible under conventional lab microscope lens or practically not easily amenable for analysis of oscillation amplitude, frequency, phase of movement and its direction. Here, we create a real-time video analysis tool to visually magnify and explore sub-micron rhythmic movements performed by biological cells and the induced movements in their surroundings. Using this tool, we suggest that fibroblast cells perform small fluctuating movements with a dominant frequency that is dependent on their surrounding substrate and its stiffness.	[Shabi, Oren; Kiryati, Nahum] Tel Aviv Univ, Sch Elect Engn, Fac Engn, Tel Aviv, Israel; [Natan, Sari; Tchaicheeyan, Oren; Lesman, Ayelet] Tel Aviv Univ, Sch Mech Engn, Fac Engn, Tel Aviv, Israel; [Kolel, Avraham] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel; [Mukherjee, Abhishek; Wolfenson, Haguy] Technion IIT, Rappaport Fac Med, Haifa, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Lesman, A (corresponding author), Tel Aviv Univ, Sch Mech Engn, Fac Engn, Tel Aviv, Israel.	ayeletlesman@tauex.tau.ac.il	Lesman, Ayelet/ABB-1278-2020; Lesman, Ayelet/O-9100-2017	Kolel, Avraham/0000-0003-0626-4093; Kiryati, Nahum/0000-0003-1436-2275; mukherjee, abhishek/0000-0001-9071-2295	Zimin Institute for Engineering Solutions Advancing Better Lives at Tel-Aviv University, Israel; Israel Science Foundation [1738/17]; Rappaport Institute	Zimin Institute for Engineering Solutions Advancing Better Lives at Tel-Aviv University, Israel; Israel Science Foundation(Israel Science Foundation); Rappaport Institute	This project was supported by the Zimin Institute for Engineering Solutions Advancing Better Lives at Tel-Aviv University, Israel (http://tau.zimininstitutes.org/), given to the last two authors (N.K. and A.L). H.W. acknowledges support from the Israel Science Foundation (1738/17; https://www.isf.org.il/#/) and from the Rappaport Institute (http://www.rappaport.org.il/Home). H.W. is an incumbent of the David and Inez Myers Career Advancement Chair in Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, LANCET INFECT DIS, V20, P511; [Anonymous], 2012, ASSIST INFERM RIC, V31, P1, DOI DOI 10.1007/978-1-4614-0878-9_1; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Baird MA, 2017, MOL BIOL CELL, V28, P240, DOI 10.1091/mbc.E16-05-0335; Beta C, 2017, ANNU REV CONDEN MA P, V8, P239, DOI 10.1146/annurev-conmatphys-031016-025210; Blackman RB, 1959, MEASUREMENT POWER SP; Cannell MB, 2006, HDB BIOL CONFOCAL MI, P488, DOI DOI 10.1007/978-0-387-45524-2_25; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chandorkar Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11475-4; Cheng B, 2017, PHYS LIFE REV, V22-23, P88, DOI 10.1016/j.plrev.2017.06.016; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Durney CH, 2018, BIOPHYS J, V115, P2230, DOI 10.1016/j.bpj.2018.10.014; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Ehrengruber MU, 1996, J EXP BIOL, V199, P741; EHRENGRUBER MU, 1995, FEBS LETT, V359, P229, DOI 10.1016/0014-5793(95)00048-E; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Feld L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6997; Fujita H, 1998, BIOPHYS J, V75, P1439, DOI 10.1016/S0006-3495(98)74062-7; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Godbout C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064560; Goren S, 2020, BIOPHYS J, V118, P1152, DOI 10.1016/j.bpj.2019.12.033; Graham DM, 2016, CURR OPIN CELL BIOL, V40, P98, DOI 10.1016/j.ceb.2016.03.006; Holmes Timothy J., 1995, P389; Hutson MS, 2014, MEASURING MODELING M; Ijaz F, 2019, MICROSCOPY-JPN, V68, P99, DOI 10.1093/jmicro/dfy147; Kasas S, 2015, P NATL ACAD SCI USA, V112, P378, DOI 10.1073/pnas.1415348112; Kruse K, 2011, CURR TOP DEV BIOL, V95, P67, DOI 10.1016/B978-0-12-385065-2.00003-7; LIKENS GE, 1960, SCIENCE, V131, P1674, DOI 10.1126/science.131.3414.1674; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Livne A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4938; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; Markwirth A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12165-x; Martignac F, 2015, FISH FISH, V16, P486, DOI 10.1111/faf.12071; Mason FM, 2011, CURR OPIN GENET DEV, V21, P671, DOI 10.1016/j.gde.2011.08.002; Nalbant P, 2018, BIOL CHEM, V399, P809, DOI 10.1515/hsz-2017-0341; Natan S, 2020, MOL BIOL CELL, V31, P1474, DOI 10.1091/mbc.E20-01-0079; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Nikukar H, 2016, J BIOMED NANOTECHNOL, V12, P1478, DOI 10.1166/jbn.2016.2264; Nitsan I, 2016, NAT PHYS, V12, P472, DOI [10.1038/NPHYS3619, 10.1038/nphys3619]; P Leamy, 2019, IMVIP 2019 IRISH MAC; Pakshir P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09709-6; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; PAWLEY J B, 2006, HDB BIOL CONFOCAL MI, V3, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pelling AE, 2007, J MOL RECOGNIT, V20, P467, DOI 10.1002/jmr.832; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Qian H, 2002, BIOPHYS CHEM, V101, P565, DOI 10.1016/S0301-4622(02)00145-X; Riba AR, 2020, ANN BIOMED ENG, V48, P868, DOI 10.1007/s10439-019-02426-7; Saggiorato G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01462-y; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Schlosser F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0028; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Sheppard CJR, 2006, HDB BIOL CONFOCAL MI, P442, DOI DOI 10.1007/978-0-387-45524-2; Shi P, 2009, CELL MOL BIOENG, V2, P464, DOI 10.1007/s12195-009-0097-z; Shi Y, 2019, P NATL ACAD SCI USA, V116, P13839, DOI 10.1073/pnas.1900963116; Sokolow A, 2012, BIOPHYS J, V102, P969, DOI 10.1016/j.bpj.2012.01.027; Song IC, 2005, MEASUREMENT POINT SP, V2005; T Xue, 2018, EUR C COMP VIS ECCV; Takeda S, 2018, PROC CVPR IEEE, P1769, DOI 10.1109/CVPR.2018.00190; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Voleti V, 2019, NAT METHODS, V16, P1054, DOI 10.1038/s41592-019-0579-4; Wadhwa Neal, 2015, ACM Transactions on Graphics, V34, DOI 10.1145/2816795.2818109; Wadhwa N, 2014, PSEUDOCODE RIESZ PYR; Wadhwa N, 2014, IEEE INT CONF COMPUT; Wadhwa N, 2017, P NATL ACAD SCI USA, V114, P11639, DOI 10.1073/pnas.1703715114; Wadhwa N, 2017, COMMUN ACM, V60, P87, DOI 10.1145/3015573; Wadhwa N, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461966; Williams J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208223; Wolfenson H, 2016, NAT CELL BIOL, V18, P33, DOI 10.1038/ncb3277; Xiong D, 2016, NAT CHEM BIOL, V12, P159, DOI [10.1038/NCHEMBIO.2000, 10.1038/nchembio.2000]; Yang Y, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0116; Zhang Yuting, 2017, CVPR; 2015, GYNECOLOGICAL SURG, V12; 2016, CANC DISCOV, V6	78	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0240127	10.1371/journal.pone.0240127	http://dx.doi.org/10.1371/journal.pone.0240127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151976	gold, Green Published			2022-12-26	WOS:000591376200073
J	Timerga, A; Kelta, E; Kenenisa, C; Zawdie, B; Habte, A; Haile, K				Timerga, Abebe; Kelta, Endryas; Kenenisa, Chala; Zawdie, Belay; Habte, Aklilu; Haile, Kassahun			Serum electrolytes disorder and its associated factors among adults admitted with metabolic syndrome in Jimma Medical Center, South West Ethiopia: Facility based crossectional study	PLOS ONE			English	Article							HYPONATREMIA; PREVALENCE; HYPOKALEMIA; POTASSIUM	Background Electrolytes play an important role in controlling acid base balance, blood clotting, and body fluid and muscle contractions. Serum electrolytes concentrations are most commonly used tests for assessment of a patient's clinical conditions, and are associated with morbidity and mortality. Any derangements from the normal range of electrolyte levels in the body is described as electrolyte disorders. The Current study was aimed to determine serum electrolytes disorder and its associated factors among adults admitted with metabolic syndrome at Jimma medical center, South West Ethiopia. Methods A Facility based cross sectional study was conducted on 256 patients admitted medical center with metabolic syndrome during the study period. The World Health Organization stepwise assessment tools and patients' medical records were used to collect information on factors associated with electrolyte disorders. Bivariable and Multivariable logistic regression analyses were performed to identify factors associated with electrolyte disorder at the level of significance of p value <0.25 with 95% confidence interval of crude odds ratio and <0.05 with 95% confidence interval of adjusted odds ratio respectively. Results The overall prevalence of electrolyte disorders was 44.1% (95%CI:40.99-47.20) with hyponatremia 42.9% (95%CI:39.81-45.99) as the leading electrolyte disorder followed by hypokalemia 20.7% (95%CI:18.17-23.23), hypochloremia 17.6% (95%CI:15.22-19.98) and hypocalcemia 9.4% (95%CI:7.57-11.22). Non-formal education [AOR: 6.81; 95%CI:(3.48,17.01)] alcohol consumption [AOR: 4.28; 95%CI:(1.71,10.70)], diuretics, diuretics [AOR: 4.39; 95%CI:(2.10,9.15)], antidiabetics [AOR: 5.18; 95%CI:(2.44,11.00)], and body mass index [AOR: 11.51; 95%CI:(3.50,18.81)] were identified as independent factors for electrolyte disturbance in multivariable logistic regression. Conclusion The finding of the study revealed that nearly half the study participants with metabolic syndromes had electrolyte disorder. Educational status, habit of alcohol consumption, diuretics, antidiabetics, and having higher body mass index were the independent factors associated with electrolyte disorders. Determination of Serum electrolytes, proper administration of diuretic and health education on behavioral factors were the necessary measures that should be done by concerned bodies to reduce electrolytes disorder.	[Timerga, Abebe] Wolkite Univ, Biochem Unit, Dept Biomed Sci, Coll Med & Hlth Sci, Wolkite, Ethiopia; [Kelta, Endryas; Kenenisa, Chala; Zawdie, Belay] Jimma Univ, Biochem Unit, Fac Med Sci, Dept Biomed Sci,Inst Hlth, Jimma, Ethiopia; [Habte, Aklilu] Wachamo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Reprod Hlth Unit, Hosanna, Ethiopia; [Haile, Kassahun] Wolkite Univ, Coll Med & Hlth Sci, Hematol Unit, Dept Med Lab Sci, Wolkite, Ethiopia	Jimma University	Timerga, A (corresponding author), Wolkite Univ, Biochem Unit, Dept Biomed Sci, Coll Med & Hlth Sci, Wolkite, Ethiopia.	abebetimerga125@gmail.com	Habte, Aklilu/ABB-7649-2020; hailegebireal, aklilu habte/ABD-1527-2020	hailegebireal, aklilu habte/0000-0002-5719-4294; Haile, Kassahun/0000-0002-2520-9244				Ahmed SS, 2014, KYAMC J, V5, P458; Ali K, 2016, INT J GEN MED, V9, P267, DOI 10.2147/IJGM.S110872; [Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2015, NATL ASSEMBLY PAKIST, V2, P2; [Anonymous], 1995, WOOL RES ORG NZ NEWS, V2, P2; Atchley DW, 1933, J CLIN INVEST, V12, P297, DOI 10.1172/JCI100504; Babaliche P, 2017, INDIAN J CRIT CARE M, V21, P819, DOI 10.4103/ijccm.IJCCM_257_17; Cai XL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040183; CARL JC, 1985, PHYS ACTIVITY EXERCI, V100, P1; Chandini PJ, 2015, INT J CONT MED, V4, P12; Edae C. K., 2018, Journal of Nutrition Fasting and Health, V6, P60, DOI 10.22038/jnfh.2018.35602.1153; Editorial, 2016, NAT CLIM CHANGE, V6, P1, DOI [10.1038/nclimate2911, DOI 10.1038/s41598-016-0001-8]; Girdhar A, 2018, IET IMAGE PROCESS, V12, P1, DOI 10.1049/iet-ipr.2017.0162; Goldberg A, 2004, AM J MED, V117, P242, DOI 10.1016/j.amjmed.2004.03.022; Hawkins RC, 2003, CLIN CHIM ACTA, V331, P171, DOI 10.1016/S0009-8981(03)00112-8; Iqbal R, 2019, PAK HEART J, V52, P27; John M, 2011, ANN I SUPER SANITA, V47, P445; Kimura T, 2016, INTERNAL MED, V55, P3085, DOI 10.2169/internalmedicine.55.7000; Kwon H, 2016, INT UROL NEPHROL, V48, P451, DOI 10.1007/s11255-016-1215-1; Liamis G, 2014, WORLD J CLIN CASES, V2, P488, DOI 10.12998/wjcc.v2.i10.488; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; Longo DL, 2012, HARRISONS PRINCIPLES; Luo JC, 2016, CLIN J AM SOC NEPHRO, V11, P90, DOI 10.2215/CJN.01730215; Mannesse CK, 2013, AGEING RES REV, V12, P165, DOI 10.1016/j.arr.2012.04.006; McPhee S.J., 2010, CURRENT MED DIAGNOSI; MESSERLI FH, 1987, ARCH INTERN MED, V147, P1725, DOI 10.1001/archinte.147.10.1725; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Muller M, 2018, EUR J INTERN MED, V54, P46, DOI 10.1016/j.ejim.2018.04.008; Onyiriuka NA, 2018, SRI LANKA J DIABETES, V8, P8; Palmer BF, 2017, NEW ENGL J MED, V377, P1368, DOI 10.1056/NEJMra1704724; Perron P, 2016, PLOS ONE, V8, P1; REID A, 2012, JRSM SHORT REPORTS, V3, P1; Rossi Joseph, 2007, Acute Card Care, V9, P82, DOI 10.1080/17482940701210179; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Sarguru D, 2016, INT J PHARM SCI REV, V40, P251; Sharma R., 2013, INT J ADV PHARM SCI, V4, P1; Strong KL, 2004, SOZ PRAVENTIV MED, V49, P269, DOI 10.1007/s00038-004-3076-0; Thaman RG., 2013, J PHYS PHARM ADV, V3, P48, DOI [10.5455/jppa.20130317071355, DOI 10.5455/JPPA.20130317071355]; VIJAY PANDEY V, 2017, J APPL PHARM SCI, V7, P189; WHO, 1995, PROGRAMME SUBSTANCE	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241486	10.1371/journal.pone.0241486	http://dx.doi.org/10.1371/journal.pone.0241486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152003	Green Published, gold			2022-12-26	WOS:000591376200009
J	Trias-Llimos, S; Riffe, T; Bilal, U				Trias-Llimos, Sergi; Riffe, Tim; Bilal, Usama			Monitoring life expectancy levels during the COVID-19 pandemic: Example of the unequal impact of the first wave on Spanish regions	PLOS ONE			English	Article								Background To provide an interpretable summary of the impact on mortality of the COVID-19 pandemic we estimate weekly and annual life expectancies at birth in Spain and its regions. Methods We used daily death count data from the Spanish Daily Mortality Monitoring System (MoMo), and death counts from 2018, and population on July 1st, 2019 by region (CCAA), age groups, and sex from the Spanish National Statistics Institute. We estimated weekly and annual (2019 and 2020*, the shifted annual calendar period up to 5 July 2020) life expectancies at birth as well as their differences with respect to 2019. Results Weekly life expectancies at birth in Spain were lower in weeks 11-20, 2020 compared to the same weeks in 2019. This drop in weekly life expectancy was especially strong in weeks 13 and 14 (March 23(rd) to April 5(th)), with national declines ranging between 6.1 and 7.6 years and maximum regional weekly declines of up to 15 years in Madrid. Annual life expectancy differences between 2019 and 2020 also reflected an overall drop in annual life expectancy of 0.9 years for both men and women. These drops ranged between 0 years in several regions (e.g. Canary and Balearic Islands) to 2.8 years among men in Madrid. Conclusions Life expectancy is an easy to interpret measure for understanding the heterogeneity of mortality patterns across Spanish regions. Weekly and annual life expectancy are sensitive and useful indicators for understanding disparities and communicating the gravity of the situation because differences are expressed in intuitive year units.	[Trias-Llimos, Sergi] Ctr Demog Studies, Bellaterra, Spain; [Trias-Llimos, Sergi] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England; [Riffe, Tim] Max Planck Inst Demog Res, Rostock, Germany; [Bilal, Usama] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Bilal, Usama] Drexel Univ, Urban Hlth Collaborat, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA	Centre d'Estudis Demografics (CED); University of London; London School of Hygiene & Tropical Medicine; Max Planck Society; Drexel University; Drexel University	Trias-Llimos, S (corresponding author), Ctr Demog Studies, Bellaterra, Spain.; Trias-Llimos, S (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England.	strias@ced.uab.cat	Trias-Llimós, Sergi/AAG-9395-2021	Trias-Llimós, Sergi/0000-0002-8052-6736	HEALIN project (ERC-2019-COG) [864616]; Office of the Director of the National Institutes of Health [DP5OD26429]	HEALIN project (ERC-2019-COG); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	STL acknowledges research funding from the HEALIN project led by Inaki Permanyer (ERC-2019-COG agreement No 864616). UB was supported by the Office of the Director of the National Institutes of Health under award number DP5OD26429.	[Anonymous], 2020, THE ECONOMIST; [Anonymous], 2020, DISS INC DAT US; [Anonymous], SIST VIG MORT DIAR D; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; [Anonymous], 2020, ENFERMEDAD CORONAVIR; Camarda CG, CARLO GIOVANNI CAMAR; Chiang CL, 1984, LIFE TABLE ITS APPL; Comas-Herrera A, MORTALITY ASS COVID, V20; European Centre for Disease Prevention and Control, 2020, COVID 19 SITUATION U; EuroStat, LIF EXP BIRTH SEX; EUROSTAT, 2020, HLTH LIF YEARS AG 65; Financial Times, 2020, FINANCIAL TIMES; Garcia Rada A, BMJ; Ghislandi S, 2020, NEWS FRONT EXCESS MO; Instituto Nacional de Estadistica, 2020, RES SEM; Instituto Nacional de Estadistica, 2020, POP MORT TABL SPAIN; Instituto Nacional de Estadistica (INE), EST NUM DEF SEM DUR; Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Lima E., 2020, EXPLORING EXCESS MOR; Marois G, ASSESSING POTENTIAL, P13; Modig K, 2020, EXCESS MORTALITY COV, DOI [10.1101/2020.05.10.20096909, DOI 10.1101/2020.05.10.20096909]; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Olson DR, 2020, MMWR-MORBID MORTAL W, V69, P603, DOI 10.15585/mmwr.mm6919e5; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Prieto-Alhambra D, 2020, HOSPITALIZATION 30 D; Scholey J, 2020, ESTIMATING BURDEN CO; Trias-Llimos S, J PUBLIC HLTH, DOI [10.1093/pubmed/fdaa087, DOI 10.1093/PUBMED/FDAA08732542350]; World Health Organization, 2020, 181 WHO	30	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241952	10.1371/journal.pone.0241952	http://dx.doi.org/10.1371/journal.pone.0241952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152009	Green Published, gold			2022-12-26	WOS:000591376200101
J	Turrini, G; Chan, SIS; Klein, PW; Cohen, SM; Dempsey, A; Hauck, H; Cheever, LW; Chappel, AR				Turrini, Gina; Chan, Stephanie S.; Klein, Pamela W.; Cohen, Stacy M.; Dempsey, Antigone; Hauck, Heather; Cheever, Laura W.; Chappel, Andre R.			Assessing the health status and mortality of older people over 65 with HIV	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFECTED PERSONS; AGING POPULATION; UNITED-STATES; ADULTS; AGE; COMORBIDITY; HIV/AIDS; DISEASE; RISK	Background Nearly half of people with HIV in the United States are 50 years or older, and this proportion is growing. Between 2012 and 2016, the largest percent increase in the prevalence rate of HIV was among people aged 65 and older, the eligibility age for Medicare coverage for individuals without a disability or other qualifying condition. Previous work suggests that older people with HIV may have higher rates of chronic conditions and develop them more rapidly than older people who do not have HIV. This study compared the health status of older people with HIV with the older US population not living with HIV by comparing: (1) mortality; (2) prevalence of certain conditions, and (3) incidence of these conditions with increasing age. Methods and findings We used a sample of Medicare beneficiaries aged 65 and older from the Medicare Master Beneficiary Summary File for the years 2011 to 2016, including 100% of individuals with HIV (N = 43,708), as well as a random 1% sample of individuals without diagnosed HIV (N = 1,029,518). We conducted a survival analysis using a Cox proportional hazards model to assess mortality and to determine the need to adjust for differential mortality in our analyses of the incidence of certain chronic conditions. These results showed that Medicare beneficiaries living with HIV have a significantly higher hazard of mortality compared to older people without diagnosed HIV (3.6 times the hazard). We examined the prevalence of these conditions using logistic regression analysis and found that people with HIV have a statistically significant higher odds of depression, chronic kidney disease, chronic obstructive pulmonary disease (COPD), osteoporosis, hypertension, ischemic heart disease, diabetes, chronic hepatitis, end-stage liver disease, lung cancer, and colorectal cancer. To look at the rate at which older people are diagnosed with conditions as they age, we used a Fine-Gray competing risk model and showed that for individuals without diagnosis of a given condition at age 65, the future incidence of that condition over the remaining study period was higher for people with HIV even after adjusting for differential hazard of mortality and for other demographic characteristics. Many of these results also varied by personal characteristics including Medicaid dual enrollment, sex, and race and ethnicity, as well as by condition. Conclusions Increasing access to care and improving health outcomes for people with HIV is a critical goal of the National HIV/AIDS Strategy 2020. It is important for clinicians and policymakers to be aware that despite significant advances in the treatment and care of people with HIV, older people with HIV have a higher odds of having multiple chronic conditions at any point in time, a higher incidence of new diagnoses of these conditions over time, and a higher hazard of mortality than Medicare beneficiaries without HIV.	[Turrini, Gina; Chan, Stephanie S.; Chappel, Andre R.] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Off Hlth Policy, Washington, DC 20201 USA; [Klein, Pamela W.; Cohen, Stacy M.; Dempsey, Antigone; Hauck, Heather; Cheever, Laura W.] US Dept HHS, Div Policy & Dev, Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD USA	United States Health Resources & Service Administration (HRSA)	Turrini, G (corresponding author), US Dept HHS, Off Assistant Secretary Planning & Evaluat, Off Hlth Policy, Washington, DC 20201 USA.	gina.turrini@hhs.gov		Klein, Pamela/0000-0003-4613-3725; Dempsey, Antigone/0000-0001-8989-7800; Cohen, Stacy/0000-0002-0475-1122				Adekeye OA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043618; Althoff KN, 2019, LANCET HIV, V6, pE93, DOI 10.1016/S2352-3018(18)30295-9; Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Althoff KN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-45; American Academy of HIV Medicine AIDS Community Research Initiative American Geriatrics Society, 2012, REC TREATM STRAT CLI; [Anonymous], 2016, 1 LOOK HRSA HIV WORK, V8; [Anonymous], 2003, MED MAL INFECT, V33, p193s; Brazauskas R, 2016, BIOL BLOOD MARROW TR, V22, P557, DOI 10.1016/j.bbmt.2015.12.005; Brooks JT, 2012, AM J PUBLIC HEALTH, V102, P1516, DOI 10.2105/AJPH.2012.300844; Cahill S, 2013, AM J PUBLIC HEALTH, V103, pE7, DOI 10.2105/AJPH.2012.301161; Centers for Medicare and Medicaid Services, 2018, C RISK ADJ MED ADV; Cole MB, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz124; Cook TD, 2002, ACAD EMERG MED, V9, P1430; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Emlet CA, 2007, AIDS PATIENT CARE ST, V21, P740, DOI 10.1089/apc.2007.0010; Emlet CA, 2006, HEALTH SOC WORK, V31, P299, DOI 10.1093/hsw/31.4.299; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Freiberg MS, 2007, AIDS, V21, P193, DOI 10.1097/QAD.0b013e3280118a0d; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friedman EE, 2016, AIDS, V30, P2529, DOI 10.1097/QAD.0000000000001215; Gebo Kelly A, 2009, Curr Infect Dis Rep, V11, P246, DOI 10.1007/s11908-009-0036-0; Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Health Resources and Services Administration, 2016, RYAN WHIT HIV AIDS P; Hood JE, 2017, AIDS CARE, V29, P1543, DOI 10.1080/09540121.2017.1308466; Justice Amy C, 2012, AIDS, V26 Suppl 1, pS11; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; Kong AM, 2019, AIDS PATIENT CARE ST, V33, P93, DOI 10.1089/apc.2018.0190; Kumara KSJ, 2017, APPL ORGANOMET CHEM, V31, DOI 10.1002/aoc.3549; Langebeek N, 2017, AIDS, V31, P1471, DOI 10.1097/QAD.0000000000001511; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P39, DOI 10.1097/QAI.0000000000001014; Millar BM, 2017, AIDS BEHAV, V21, P1684, DOI 10.1007/s10461-016-1613-5; Nance RM, 2018, ANN INTERN MED, V169, P376, DOI 10.7326/M17-2242; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242; Palella FJ, 2019, AIDS, V33, P2327, DOI 10.1097/QAD.0000000000002349; Park LS, 2016, AIDS, V30, P273, DOI 10.1097/QAD.0000000000000922; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pellowski JA, 2013, AM PSYCHOL, V68, P197, DOI 10.1037/a0032694; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Poindexter C, 2008, AIDS PATIENT CARE ST, V22, P723, DOI 10.1089/apc.2007.0260; Quinn K, 2017, AIDS EDUC PREV, V29, P62, DOI 10.1521/aeap.2017.29.1.62; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sankar A, 2011, AIDS CARE, V23, P1187, DOI 10.1080/09540121.2011.564115; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shippy RA, 2005, AGING MENT HEALTH, V9, P246, DOI 10.1080/13607860412331336850; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Torres RA, 2014, LAB INVEST, V94, P120, DOI 10.1038/labinvest.2013.142; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Wilson SG, 2012, PATTERNS METROPOLITA; Youssef E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6118-x	63	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241833	10.1371/journal.pone.0241833	http://dx.doi.org/10.1371/journal.pone.0241833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152053	Green Published, gold			2022-12-26	WOS:000591376200098
J	Shiomi, M; Okumura, S; Kimoto, M; Iio, T; Shimohara, K				Shiomi, Masahiro; Okumura, Soto; Kimoto, Mitsuhiko; Iio, Takamasa; Shimohara, Katsunori			Two is better than one: Social rewards from two agents enhance offline improvements in motor skills more than single agent	PLOS ONE			English	Article							PHYSICALLY PRESENT; ROBOTS; PRAISE; EMBODIMENT; MOTIVATION; NEED	Social rewards as praise from others enhance offline improvements in human motor skills. Does praise from artificial beings, e.g., computer-graphics-based agents (displayed agents) and robots (collocated agents), also enhance offline improvements in motor skills as effectively as praise from humans? This paper answers this question via two subsequent days' experiment. We investigated the effect of the number of agents and their sense of presence toward offline improvement in motor skills because they are essential factors to change social effects and people's behaviors in human-agent and human-robot interaction. Our 96 participants performed a finger-tapping task. Our results showed that those who received praise from two agents showed significantly better offline motor skill improvement than people who were praised by just one agent and those who received no praise. However, we identified no significant effects related to the sense of presence.	[Shiomi, Masahiro; Okumura, Soto; Kimoto, Mitsuhiko; Iio, Takamasa] Adv Telecommun Res Inst Int, Dept Agent Interact Design Lab, Kyoto, Japan; [Okumura, Soto; Shimohara, Katsunori] Doshisha Univ, Dept Informat Syst Design, Kyoto, Japan; [Kimoto, Mitsuhiko] Keio Univ, Dept Informat & Comp Sci, Tokyo, Kanagawa, Japan; [Iio, Takamasa] Univ Tsukuba, Social Cognit Engn Lab, Ibaraki, Japan; [Iio, Takamasa] JST PRESTO, Kawaguchi, Saitama, Japan	Advanced Telecommunications Research Institute International; Doshisha University; Keio University; University of Tsukuba; Japan Science & Technology Agency (JST)	Shiomi, M (corresponding author), Adv Telecommun Res Inst Int, Dept Agent Interact Design Lab, Kyoto, Japan.	m-shiomi@atr.jp		Kimoto, Mitsuhiko/0000-0001-8441-8815; SHIOMI, Masahiro/0000-0003-4338-801X	JST CREST, Japan [JPMJCR18A1]; JSPS KAKENHI [JP19J01290, JP18H03311]; JST PRESTO, Japan [JPMJPR1851]	JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO, Japan	M.S. S.O. and K.S: JST CREST Grant, Number JPMJCR18A1, Japan M.K: JSPS KAKENHI Grant Numbers JP19J01290 T.I: JST PRESTO Grant Number JPMJPR1851, Japan, and JSPS KAKENHI Grant Numbers JP18H03311.	Aliyev R, 2013, ANTHROPOLOGIST, V16, P263, DOI 10.1080/09720073.2013.11891354; AMES CA, 1990, TEACH COLL REC, V91, P409; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Bainbridge WA, 2011, INT J SOC ROBOT, V3, P41, DOI 10.1007/s12369-010-0082-7; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Belpaeme T, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat5954; Buss AH., 2014, SOCIAL BEHAV PERSONA; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; CATANO VM, 1975, PERCEPT MOTOR SKILL, V41, P71, DOI 10.2466/pms.1975.41.1.71; Chalk K., 2004, ED PSYCHOL PRACTICE, V20, P335, DOI DOI 10.1080/0266736042000314277; Dennis A. R., EMERGING E COLLABORA, V1, P250; Hayashi K, 2012, IEEE T AUTON MENT DE, V4, P150, DOI 10.1109/TAMD.2011.2178846; Henderlong J, 2002, PSYCHOL BULL, V128, P774, DOI 10.1037//0033-2909.128.5.774; Iio T., 2016, PRESCHEDULED TURN TA, P19, DOI DOI 10.1145/2974804.2974819; Johnson D, 2004, INT J HUM-COMPUT ST, V61, P237, DOI 10.1016/j.ijhcs.2003.12.008; Jorgensen B. W., 1973, GROUP SIZE ITS EFFEC; Kahn PH, 2012, DEV PSYCHOL, V48, P303, DOI 10.1037/a0027033; Karau S. J., 1993, SOCIAL LOAFING METAA; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kim K, 2018, INT SYM MIX AUGMENT, P105, DOI 10.1109/ISMAR.2018.00039; Kohls G, 2009, DEVELOPMENTAL SCI, V12, P614, DOI 10.1111/j.1467-7687.2009.00816.x; Kulkarni S., 2010, GLOBAL LEARN, P2044, DOI https://www.learntechlib.org/p/34394/; Leyzberg D, 2014, ACMIEEE INT CONF HUM, P423, DOI 10.1145/2559636.2559671; Li J, 2015, INT J HUM-COMPUT ST, V77, P23, DOI 10.1016/j.ijhcs.2015.01.001; Llobera J, 2010, ACM T APPL PERCEPT, V8, DOI 10.1145/1857893.1857896; Mumm J, 2011, COMPUT HUM BEHAV, V27, P1643, DOI 10.1016/j.chb.2011.02.002; NASS C, 1994, HUMAN FACTORS IN COMPUTING SYSTEMS, CHI '94 CONFERENCE PROCEEDINGS - CELEBRATING INTERDEPENDENCE, P72, DOI 10.1145/191666.191703; Okumura S, 2017, LECT NOTES ARTIF INT, V10652, P32, DOI 10.1007/978-3-319-70022-9_4; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Powers A., 2007, 2007 2nd Annual Conference on Human-Robot Interaction (HRI), P145; Reeves B., 1996, PEOPLE TREAT COMPUTE; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sakamoto D, 2009, INT J SOC ROBOT, V1, P157, DOI 10.1007/s12369-009-0015-5; Shiomi M, 2016, P 4 INT C HUM AG INT, P27; Shiomi M, 2019, ADV ROBOTICS, V33, P756, DOI 10.1080/01691864.2019.1617781; Sugawara SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048174; THORNBURG TH, 1991, J CREATIVE BEHAV, V25, P324, DOI 10.1002/j.2162-6057.1991.tb01145.x; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Warren ZE, 2015, J AUTISM DEV DISORD, V45, P3726, DOI 10.1007/s10803-013-1918-4; Willemse CJAM, 2019, INT J SOC ROBOT, V11, P285, DOI 10.1007/s12369-018-0500-9; Zajonc, 1965, SOCIAL FACILITATION; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240622	10.1371/journal.pone.0240622	http://dx.doi.org/10.1371/journal.pone.0240622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147230	Green Published, gold			2022-12-26	WOS:000589609300071
J	Majeed, M; Bhatti, KH; Amjad, MS; Abbasi, AM; Bussmann, RW; Nawaz, F; Rashid, A; Mehmood, A; Mahmood, M; Khan, WM; Ahmad, KS				Majeed, Muhammad; Bhatti, Khizar Hayat; Amjad, Muhammad Shoaib; Abbasi, Arshad Mehmood; Bussmann, Rainer W.; Nawaz, Fahim; Rashid, Audil; Mehmood, Ansar; Mahmood, Majid; Khan, Wisal Muhammad; Ahmad, Khawaja Shafique			Ethno-veterinary uses of Poaceae in Punjab, Pakistan	PLOS ONE			English	Article							MEDICINAL-PLANTS; ETHNOVETERINARY PRACTICES; ETHNOMEDICINAL-USES; TRADITIONAL KNOWLEDGE; ETHNOBOTANICAL SURVEY; ETHNOPHARMACOLOGICAL FIELD; DIFFERENT AILMENTS; DAIRY ANIMALS; DISTRICT; INVENTORY	Plant species of the Poaceae family are not only used as fodder and forage but also contribute substantially to the treatment of various health disorders, particularly in livestock. Consequently, the present study was aimed to document the therapeutic uses of Poaceae practiced by the inhabitants of the Punjab Province for the treatment of various veterinary health disorders. Semi structured interviews, group discussion and field walks were conducted to collect the data. Quantitative indices including cultural significance index (CSI), relative frequency of citations (RFC), fidelity level (FL), relative popularity level (RPL), and Jaccard Index (JI) were used for the data analysis. Traditional uses of 149 species belonging to 60 genera and 16 tribes of 5 sub families of Poaceae were recorded. Whole plants and leaves were the most consistently used parts with 40.94 and 29.53%. The plants were mainly given orally as fodder (59 reports) without processing followed by decoction (35 reports). Most of the species were employed to treat infectious diseases (25.93%), and digestive disorders (14.10%). Triticum aestivum had the highest CSI, RFC and RPL levels at 8.00, 0.96, 1.00, respectively, followed by Oryza sativa and Poa annua. Likewise, T. aestivum and Saccharum spontaneum had 100% FL and ROP. Jaccard index ranged from 12.25 to 0.37. Twelve plant species namely Chrysopogon zizanioides (anti-inflammatory), Pennisetum lanatum (improve bull fertility), Cymbopogon citratus (glandular secretion), Sorghum saccharatum and Themeda triandra (malaria), Aristida funiculate (anticancer), Koeleria argentia (skin allergies), Tetrapogon villosus (antibacterial), Cynodon radiatus (eyes infection), Sporobolus nervosa (Jaundice), Enneapogon persicus (antifungal), and Panicum repens (dysfunctional cattle organs) were reported for the first time, with novel ethnoveterinary uses. The inhabitants of the study area had a strong association with their surrounding plant diversity and possessed significant knowledge on therapeutic uses of Poaceae to treat various health disorders in animals. Plant species with maximum cultural and medicinal values could be a potential source of novel drugs to cure health disorders in animals and human as well.	[Majeed, Muhammad; Bhatti, Khizar Hayat; Rashid, Audil] Univ Gujrat, Dept Bot, Hafiz Hayat Campus, Gujrat, Punjab, Pakistan; [Amjad, Muhammad Shoaib] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Ajk, Pakistan; [Abbasi, Arshad Mehmood] COMSATS Univ Islamabad, Dept Environm Sci, Abbottabad Campus, Abbottabad, Khyber Pakhtunk, Pakistan; [Bussmann, Rainer W.] Ilia State Univ, Inst Bot, Dept Ethnobot, La Paz, Bolivia; [Nawaz, Fahim] Univ Agr, Dept Agron, MNS, Multan, Pakistan; [Mehmood, Ansar; Ahmad, Khawaja Shafique] Univ Poonch Rawalakot UPR, Dept Bot, Azad Jammu Kashmir, Pakistan; [Mahmood, Majid] Univ Poonch Rawalakot UPR, Dept Zool, Azad Jammu Kashmir, Pakistan; [Khan, Wisal Muhammad] Islamia Coll Peshawar, Dept Bot, Peshawar, Pakistan	University of Gujrat; COMSATS University Islamabad (CUI); University of Peshawar	Ahmad, KS (corresponding author), Univ Poonch Rawalakot UPR, Dept Bot, Azad Jammu Kashmir, Pakistan.	shafiquebot@yahoo.com	Bussmann, Rainer W/A-6105-2010; Nawaz, Fahim/L-8954-2017; Ahmad, Khawaja Shafique/Q-4069-2019; Rashid, Audil/AET-5232-2022; Ahmad, Khawaja Shafique/A-8115-2016; Abbasi, Arshad Mehmood/J-9314-2015; Amjad, Muhammad Shoaib/GQQ-1505-2022; Mehmood, Ansar/N-9859-2017	Bussmann, Rainer W/0000-0002-3524-5273; Nawaz, Fahim/0000-0001-7753-5087; Ahmad, Khawaja Shafique/0000-0001-8814-9878; Rashid, Audil/0000-0003-3872-8681; Ahmad, Khawaja Shafique/0000-0001-8814-9878; Abbasi, Arshad Mehmood/0000-0001-9978-3866; Mahmood, Majid/0000-0001-6680-3541; Mehmood, Ansar/0000-0002-6120-5646				Abbasi AM, 2013, J ETHNOPHARMACOL, V148, P528, DOI 10.1016/j.jep.2013.04.050; Abubakar S, 1999, THESIS U EDINBURGH; Adebayo JO, 2011, J ETHNOPHARMACOL, V133, P289, DOI 10.1016/j.jep.2010.11.024; Ahmad F., 2012, J MED PLANTS RES, V6, P1955; Ahmad F, 2010, J MED PLANTS RES, V4, P362; Ahmad F, 2009, AFR J BIOTECHNOL, V8, P231; Ahmad I, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-75; Ahmad Rizwan, 2017, J Tradit Complement Med, V7, P195, DOI 10.1016/j.jtcme.2016.05.002; Ahmed MJ, 2015, J ETHNOPHARMACOL, V159, P209, DOI 10.1016/j.jep.2014.11.016; Akhtar MS, 2000, SMALL RUMINANT RES, V38, P99, DOI 10.1016/S0921-4488(00)00163-2; Akhtar N, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-25; Alawa JP, 2002, PREV VET MED, V54, P79, DOI 10.1016/S0167-5877(01)00273-2; Albuquerque Ulysses Paulino de, 2005, Acta Bot. Bras., V19, P27, DOI 10.1590/S0102-33062005000100004; Ali SI, 2015, FLORA PAKISTAN KARAC, P1993; Ali-Shtayeh MS, 2000, J ETHNOPHARMACOL, V73, P221, DOI 10.1016/S0378-8741(00)00316-0; [Anonymous], 2013, 2 AL MIZAN, V1, P18; [Anonymous], 2014, EVID-BASED COMPL ALT, DOI DOI 10.1155/2014/635371; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 1998, OFFICE OFFICIAL PUBL, V2, P125; [Anonymous], 2015, AM J ANAL CHEM, V6, P228; [Anonymous], 1996, J ORTHOP TRAUMA S1, V10, P1; Anyasor GN, 2010, AFR J BIOTECHNOL, V9, P4880; Asase A, 2005, J ETHNOPHARMACOL, V99, P273, DOI 10.1016/j.jep.2005.02.020; Aziz MA, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0212-0; Babu R. H., 2013, J PHARM RES, V1, P947; Bachaya HA, 2009, J ETHNOPHARMACOL, V123, P325, DOI 10.1016/j.jep.2009.02.043; Bano A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-43; Monteiro Maria Vivina Barros, 2011, Acta Amaz., V41, P233, DOI 10.1590/S0044-59672011000200007; Benitez G, 2012, J ETHNOPHARMACOL, V139, P429, DOI 10.1016/j.jep.2011.11.029; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Choudhary BA, 2014, INDIAN RES J PHARM S, V2, P124; Choudhury PR, 2015, J ETHNOPHARMACOL, V166, P135, DOI 10.1016/j.jep.2015.03.026; Church DC, 1993, DIGESTIVE PHYSL NUTR, V33; da Silva M, 2006, INT BIODETER BIODEGR, V57, P163, DOI 10.1016/j.ibiod.2006.02.003; Deeba F, 2009, DOCUMENTATION ETHNO; Deeba F, 2009, INT J AGRIC BIOL, V11, P535; Di Sanzo P, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-19; Dilshad SMR, 2010, PAK VET J, V30, P167; Dilshad SMR, 2008, J ETHNOPHARMACOL, V117, P393, DOI 10.1016/j.jep.2008.02.011; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Esakkimuthu S, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0240-9; Ettebong EO, 2012, ASIAN PAC J TROP MED, V5, P673, DOI 10.1016/S1995-7645(12)60105-9; Fahmeeda Rehman, 2017, Pure and Applied Biology, V6, P740, DOI 10.19045/bspab.2017.60079; Farooq Z, 2008, J ETHNOPHARMACOL, V118, P213, DOI 10.1016/j.jep.2008.03.015; Faruque MO, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00040; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Geng YF, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0153-z; Giday M, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-34; Gohre A, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0116-9; Harun N, 2017, J ETHNOBIOL ETHNOMED, P13, DOI 10.1186/s13002-017-0138-y; Hassan HU, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-6; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Hussain K., 2010, ETHNOBOTANICAL LEAFL, V14, P807; Hussain M, 2015, INDIAN RES J PHARM S, V6, P235; Ikram S., 2014, J MED PLANTS STUD, V2, P58; Iqbal Z, 2004, J ETHNOPHARMACOL, V93, P265, DOI 10.1016/j.jep.2004.03.046; Iqbal Z, 2002, PARASITIC RES DOMEST; Jabbar A, 2006, J ETHNOPHARMACOL, V108, P152, DOI 10.1016/j.jep.2006.04.015; JAIN S K, 1977, P157; Kayani S, 2014, J ETHNOPHARMACOL, V156, P47, DOI 10.1016/j.jep.2014.08.005; Kayani SA, 2007, PAK J BOT, V39, P1173; Khan FM, 2009, PAK VET J, V29, P75; Khan M. A., 2012, Pakistan Journal of Weed Science Research, V18, P495; Khan M. A., 2010, Ethnobotany Research and Applications, V8, P107; Khan MPZ, 2015, J ETHNOPHARMACOL, V173, P191, DOI 10.1016/j.jep.2015.07.029; Khan Z. R., 1997, Insect Science and its Application, V17, P143; Khattak NS, 2015, J ETHNOPHARMACOL, V171, P273, DOI 10.1016/j.jep.2015.05.048; Kumar V, 2015, IJPR, V5, P338; Kunwar RM, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0242-7; Ladio A, 2007, J ARID ENVIRON, V69, P695, DOI 10.1016/j.jaridenv.2006.11.008; Lans C., 2007, J ETHNOBIOL ETHNOMED, V3, P1, DOI DOI 10.1186/1746-4269-3-3; Lans C, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-21; Lapuz A. M. R., 2016, International Journal of Chemical Engineering and Applications, V7, P204, DOI 10.7763/IJCEA.2016.V7.573; Lateef M., 2003, INT J AGRIC BIOL, V5, P86; Leonti M, 2010, J ETHNOPHARMACOL, V130, P379, DOI 10.1016/j.jep.2010.05.021; Mahmood A, 2013, J ETHNOPHARMACOL, V148, P714, DOI 10.1016/j.jep.2013.05.035; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Martin GJ, 1995, ETHNOBOTANY METHODS, P268; Martinez E, 2011, ELECTRON PROC THEOR, P7, DOI 10.4204/EPTCS.68.3; Maryam Arshad, 2011, Middle East Journal of Scientific Research, V9, P209; Matekaire T., 2004, International Journal of Applied Research in Veterinary Medicine, V2, P269; Mayer M, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-016-0106-y; Mazhar-ul-Islam, 2012, International Journal of Animal and Veterinary Advances, V4, P221; Mcgaw LJ, 2008, J ETHNOPHARMACOL, V119, P559, DOI 10.1016/j.jep.2008.06.013; Muhammad F, 2005, TOXICOL PATHOL, V33, P258, DOI 10.1080/01926230590908222; Mussarat S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616858; Nahed J, 1997, ANIM FEED SCI TECH, V68, P213, DOI 10.1016/S0377-8401(97)00052-7; Nisar M. F., 2014, Middle East Journal of Scientific Research, V21, P1466; Njoroge GN, 2006, J ETHNOPHARMACOL, V108, P332, DOI 10.1016/j.jep.2006.05.031; Noor MJ, 2011, PAK J BOT, V43, P781; Nunes AT, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-12; Offiah NV, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-36; Okoli IC, 2003, AGR ECOSYST ENVIRON, V96, P147, DOI 10.1016/S0167-8809(02)00172-X; Ong HG, 2014, J ETHNOPHARMACOL, V157, P228, DOI 10.1016/j.jep.2014.09.015; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Parthiban R, 2016, REV BRAS FARMACOGN, V26, P109, DOI 10.1016/j.bjp.2015.07.016; Parvaiz M, 2014, AVICENNA J PHYTOMEDI, V4, P364; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Pieroni A, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-16; Pieroni A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-22; Prasad SK, 2013, BRIT J PHARM RES, V3, P135, DOI 10.9734/BJPR/2013/2661; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; Qureshi R, 2011, PAK J BOT, V43, P121; Qureshi R, 2009, PAK J BOT, V41, P529; Rahman A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1632-y; Raziq A, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-16; Rehman MN, 2017, REV BRAS FARMACOGN, V27, P751, DOI 10.1016/j.bjp.2017.09.004; Ritter RA, 2012, J ETHNOPHARMACOL, V144, P346, DOI 10.1016/j.jep.2012.09.018; Saha S, 2013, INT J PHARM SCI RES, V4, P512, DOI 10.13040/IJPSR.0975-8232.4(1).512-15; Sardar AA, 2015, AFR J TRADIT COMPLEM, V12, P9, DOI 10.4314/ajtcam.v12i4.2; Shah A, 2017, J ETHNOPHARMACOL, V200, P84, DOI 10.1016/j.jep.2017.02.005; Shah GM, 2012, J ANIM PLANT SCI, V22, P791; Sharma R, 2012, J ETHNOPHARMACOL, V141, P265, DOI 10.1016/j.jep.2012.02.027; Shen SC, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-24; Sher H., 2004, PAK J PLANT SCI, V10, P35; Shosan L. O., 2014, American Journal of Plant Sciences, V5, P3258, DOI 10.4236/ajps.2014.521340; Sindhu ZUD, 2012, INT J AGRIC BIOL, V14, P922; Sindhu ZUD, 2010, INT J AGRIC BIOL, V12, P353; Singh AG, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-19; Singh A, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0178-3; Somvanshi R., 2006, ASIAN AGRIHISTORY, V10, P133; Souto WMS, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-30; Stur W. W., 2000, Working with farmers: the key to adoption of forage technologies. Proceedings of an International Workshop held in Cagayan de Oro City, Mindanao, Philippines from 12-15 October 1999, P112; Sushama B., 2014, International Journal of Ayurvedic and Herbal Medicine, V4, P1480; Tariq A, 2014, SCI WORLD J, DOI [10.1155/2014/748490, 10.1155/2014/127526]; Tefera BN, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0302-7; Tipu M. A., 2006, Pakistan Veterinary Journal, V26, P144; Tomar A, 2009, INDIAN J TRADIT KNOW, V8, P298; TURNER NJ, 1988, AM ANTHROPOL, V90, P272, DOI 10.1525/aa.1988.90.2.02a00020; Ullah S, 2014, J ETHNOPHARMACOL, V158, P412, DOI 10.1016/j.jep.2014.09.048; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Vendruscolo Giovana Secretti, 2006, Iheringia Serie Botanica, V61, P83; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024; Winter K, 2008, FUNC ECOSYST COMMUN, V2, P1; Wong JL, 2000, BIOMETRICS NONTIMBER; Zafar Iqbal, 2005, Journal of Agriculture and Social Sciences, V1, P187; Zereen A., 2012, BIOL PAKISTAN, V58, P21; Zereen A, 2013, BIOL PAKISTAN, V59, P139	139	16	16	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241705	10.1371/journal.pone.0241705	http://dx.doi.org/10.1371/journal.pone.0241705			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33142315	gold, Green Published			2022-12-26	WOS:000588376700047
J	Fukushima, H; Yoshioka, M; Kawatou, M; Lopez-Davila, V; Takeda, M; Kanda, Y; Sekino, Y; Yoshida, Y; Yamashita, JK				Fukushima, Hiroyuki; Yoshioka, Miki; Kawatou, Masahide; Lopez-Davila, Victor; Takeda, Masafumi; Kanda, Yasunari; Sekino, Yuko; Yoshida, Yoshinori; Yamashita, Jun K.			Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; PROGENITORS; MOUSE; MESODERM; PURIFICATION; GENERATION; ENRICHMENT; MATURATION; ATRIAL	Currently, cardiomyocyte (CM) differentiation methods require a purification step after CM induction to ensure the high purity of the cell population. Here we show an improved human CM differentiation protocol with which high-purity ventricular-type CMs can be obtained and maintained without any CM purification process. We induced and collected a mesodermal cell population (platelet-derived growth factor receptor-alpha (PDGFR alpha)-positive cells) that can respond to CM differentiation cues, and then stimulated CM differentiation by means of Wnt inhibition. This method reproducibly generated CMs with purities above 95% in several human pluripotent stem cell lines. Furthermore, these CM populations were maintained in culture at such high purity without any further CM purification step for over 200 days. The majority of these CMs (>95%) exhibited a ventricular-like phenotype with a tendency to structural and electrophysiological maturation, including T-tubule-like structure formation and the ability to respond to QT prolongation drugs. This is a simple and valuable method to stably generate CM populations suitable for cardiac toxicology testing, disease modeling and regenerative medicine.	[Fukushima, Hiroyuki; Yoshioka, Miki; Kawatou, Masahide; Lopez-Davila, Victor; Takeda, Masafumi; Yamashita, Jun K.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Cell Growth & Differentiat, Lab Stem Cell Differentiat, Kyoto, Japan; [Kawatou, Masahide] Kyoto Univ, Dept Cardiovasc Surg, Grad Sch Med, Kyoto, Japan; [Kawatou, Masahide; Takeda, Masafumi] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci iACT, Kyoto, Japan; [Kanda, Yasunari; Sekino, Yuko] Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa, Japan; [Yoshida, Yoshinori] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Cell Growth & Differentiat, Kyoto, Japan; [Sekino, Yuko] Univ Tokyo, Grad Sch Pharmaceut Sci, Endowed Lab Human Cell Based Drug Discovery, Bunkyo Ku, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; National Institute of Health Sciences - Japan; Kyoto University; University of Tokyo	Yamashita, JK (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Cell Growth & Differentiat, Lab Stem Cell Differentiat, Kyoto, Japan.	juny@cira.kyoto-u.ac.jp	Kanda, Yasunari/AAD-7514-2019	Kanda, Yasunari/0000-0003-2527-3526	Japan Agency for Medical Research and Development (AMED) [JP15mk0104053h0101, JP16mk0104027h0402, JP17mk0104027h0403]; Japan Society for the Promotion of Science (JSPS) [JP18H04048]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Japan Agency for Medical Research and Development (AMED) in the form of grants awarded to JKY (JP15mk0104053h0101; JP16mk0104027h0402; JP17mk0104027h0403) and Japan Society for the Promotion of Science (JSPS) in the form of a grant awarded to JKY (JP18H04048). The funder provided financial support, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287; Ardehali R, 2013, P NATL ACAD SCI USA, V110, P3405, DOI 10.1073/pnas.1220832110; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bizy A, 2013, STEM CELL RES, V11, P1335, DOI 10.1016/j.scr.2013.09.003; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chan SSK, 2016, STEM CELL REP, V6, P26, DOI 10.1016/j.stemcr.2015.12.003; de Sousa Lopes SMC, 2006, DEV DYNAM, V235, P1994, DOI 10.1002/dvdy.20830; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Drouin E, 1998, J AM COLL CARDIOL, V32, P1063, DOI 10.1016/S0735-1097(98)00330-1; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Elsaesser T, 2009, SCREEN, V50, P100, DOI 10.1093/screen/hjn078; Fu JD, 2010, STEM CELLS DEV, V19, P773, DOI 10.1089/scd.2009.0184; Funakoshi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19111; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hidaka K, 2010, CIRC RES, V106, P111, DOI 10.1161/CIRCRESAHA.109.209478; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikuno T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173271; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kanda Y, 2018, J PHARMACOL SCI, V138, P233, DOI 10.1016/j.jphs.2018.10.010; Kawatou M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01125-y; Kitaguchi T, 2016, J PHARMACOL TOX MET, V78, P93, DOI 10.1016/j.vascn.2015.12.002; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lee JH, 2017, CELL STEM CELL, V21, P179, DOI 10.1016/j.stem.2017.07.003; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Liu J, 2016, ADV DRUG DELIVER REV, V96, P253, DOI 10.1016/j.addr.2015.12.023; Magli A, 2014, STEM CELLS, V32, P2072, DOI 10.1002/stem.1713; Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716; Miki K, 2015, CELL STEM CELL, V16, P699, DOI 10.1016/j.stem.2015.04.005; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Oikonomopoulos A, 2018, MOL THER, V26, P1624, DOI 10.1016/j.ymthe.2018.02.026; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pekkanen-Mattila M, 2010, EXP BIOL MED, V235, P522, DOI 10.1258/ebm.2010.009345; Prescrire editors, 2013, REV PRESCRIRE, V31, P829; Ronaldson-Bouchard K, 2018, NATURE, V556, P239, DOI 10.1038/s41586-018-0016-3; SCHATTEMAN GC, 1995, TERATOLOGY, V51, P351, DOI 10.1002/tera.1420510602; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Takeda M, 2018, CELL REP, V22, P546, DOI 10.1016/j.celrep.2017.12.057; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yamamoto W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167348; Yamazaki K, 2012, TOXICOL IN VITRO, V26, P335, DOI 10.1016/j.tiv.2011.12.005; Yoon C, 2018, STEM CELL REP, V10, P87, DOI 10.1016/j.stemcr.2017.11.008; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241287	10.1371/journal.pone.0241287	http://dx.doi.org/10.1371/journal.pone.0241287			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137106	gold, Green Published			2022-12-26	WOS:000588375500011
J	Yan, B; Luo, J; Kaltenmeier, C; Du, Q; Stolz, DB; Loughran, P; Yan, YH; Cui, X; Geller, DA				Yan, Bing; Luo, Jing; Kaltenmeier, Christof; Du, Qiang; Stolz, Donna B.; Loughran, Patricia; Yan, Yihe; Cui, Xiao; Geller, David A.			Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting beta-catenin in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HEPATIC ISCHEMIA; CELL-DEATH; MECHANISMS; APOPTOSIS; INNATE; GROWTH	Autophagy is an important factor in liver ischemia-reperfusion injury. In the current study we investigate the function of interferon regulatory factor-1 (IRF1) in regulating autophagy to promote hepatic ischemia reperfusion injury (IR). The high expression of IRF1 during hepatic IR exhibited increased liver damage and was associated with activation of autophagy shown by Western blot markers, as well as immunofluorescent staining for autophagosomes. These effects were diminished by IRF1 deficiency in IRF1 knock out (KO) mice. Moreover, the autophagy inhibitor 3-MA decreased IR-induced liver necrosis and markedly abrogated the rise in liver injury tests (AST/ALT). beta-catenin expression decreased during liver IR and was increased in the IRF1 KO mice. Immunoprecipitation assay showed the binding between IRF1 and beta-catenin. Overexpression of IRF1 induced autophagy and also inhibited the expression of beta-catenin. beta-catenin inhibitor increased autophagy while beta-catenin agonist suppressed autophagy in primary mouse hepatocytes. These results indicate that IRF1 induced autophagy aggravates hepatic IR injury in part by inhibiting beta-catenin and suggests that targeting IRF1 may be an effective strategy in reducing hepatic IR injury.	[Yan, Bing; Luo, Jing; Kaltenmeier, Christof; Du, Qiang; Yan, Yihe; Cui, Xiao; Geller, David A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Yan, Bing] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Stolz, Donna B.; Loughran, Patricia] Univ Pittsburgh, Ctr Biol Imaging, Med Sch, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhengzhou University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geller, DA (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	gellerda@upmc.edu	Loughran, Patricia/AAB-1184-2021; Geller, David A/AAV-8082-2020	Geller, David A/0000-0003-0735-1068	NIH [P30DK120531, HHSN27520100005C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Nicole Hays for experimental assistance. We would also like to acknowledge the Center for Biologic Imaging of University of Pittsburgh Medical School for their assistance in TEM imaging and Immunofluorescence data acquisition. This work was supported in part by NIH P30DK120531 and HHSN27520100005C grants (DAG).	[Anonymous], 2016, NEWS CE DRY REFORMIN, V94, P30; Boteon YL, 2017, WORLD J GASTROENTERO, V23, P8443, DOI 10.3748/wjg.v23.i48.8443; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cui ZL, 2018, CELL PHYSIOL BIOCHEM, V48, P328, DOI 10.1159/000491732; Cursio R, 2010, TRANSPL P, V42, P3977, DOI 10.1016/j.transproceed.2010.09.140; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Kang JW, 2014, CELL PHYSIOL BIOCHEM, V33, P23, DOI 10.1159/000356647; Ke BB, 2013, HEPATOLOGY, V57, P1203, DOI 10.1002/hep.26100; Kim KH, 2009, SURGERY, V146, P181, DOI 10.1016/j.surg.2009.06.011; Kim PKM, 2004, ONCOGENE, V23, P1125, DOI 10.1038/sj.onc.1207023; Klune JR, 2018, AM J PHYSIOL-GASTR L, V315, pG991, DOI 10.1152/ajpgi.00231.2018; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li PY, 2012, CANCER LETT, V314, P213, DOI 10.1016/j.canlet.2011.09.031; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Russell JO, 2018, ANNU REV PATHOL-MECH, V13, P351, DOI 10.1146/annurev-pathol-020117-044010; Saggi H, 2019, J HEPATOL, V70, P108, DOI 10.1016/j.jhep.2018.09.023; Schwartz-Roberts JL, 2015, CANCER RES, V75, P1046, DOI 10.1158/0008-5472.CAN-14-1851; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Sucre JMS, 2017, AM J PHYSIOL-LUNG C, V312, pL186, DOI 10.1152/ajplung.00477.2016; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Ueki S, 2010, HEPATOLOGY, V51, P1692, DOI 10.1002/hep.23501; Yang MQ, 2018, HEPATOLOGY, V67, P1056, DOI 10.1002/hep.29605; Yang MQ, 2018, BRIT J CANCER, V118, P62, DOI 10.1038/bjc.2017.389; Yokota S, 2015, J IMMUNOL, V194, P6045, DOI 10.4049/jimmunol.1402505; Yu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43684; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0239119	10.1371/journal.pone.0239119	http://dx.doi.org/10.1371/journal.pone.0239119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137133	gold, Green Published			2022-12-26	WOS:000588375500051
J	Yee, SW; Buitrago, D; Stecula, A; Ngo, HX; Chien, HC; Zou, L; Koleske, ML; Giacomini, KM				Yee, Sook Wah; Buitrago, Dina; Stecula, Adrian; Ngo, Huy X.; Chien, Huan-Chieh; Zou, Ling; Koleske, Megan L.; Giacomini, Kathleen M.			Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies	FASEB JOURNAL			English	Article						carnitine; carnosine; ergothioneine; metabolomic; transporter	THIAMINE TRANSPORTER; CARNITINE DEFICIENCY; CATION TRANSPORTERS; WIDE ASSOCIATION; PROTEIN-SEQUENCE; ERGOTHIONEINE; CARNOSINE; ACID; IDENTIFICATION; DISCOVERY	The human solute carrier 22A (SLC22A) family consists of 23 members, representing one of the largest families in the human SLC superfamily. Despite their pharmacological and physiological importance in the absorption and disposition of a range of solutes, eight SLC22A family members remain classified as orphans. In this study, we used a multifaceted approach to identify ligands of orphan SLC22A15. Ligands of SLC22A15 were proposed based on phylogenetic analysis and comparative modeling. The putative ligands were then confirmed by metabolomic screening and uptake assays in SLC22A15 transfected HEK293 cells. Metabolomic studies and transporter assays revealed that SLC22A15 prefers zwitterionic compounds over cations and anions. We identified eight zwitterions, including ergothioneine, carnitine, carnosine, gabapentin, as well as four cations, including MPP+, thiamine, and cimetidine, as substrates of SLC22A15. Carnosine was a specific substrate of SLC22A15 among the transporters in the SLC22A family. SLC22A15 transport of several substrates was sodium-dependent and exhibited a higher Km for ergothioneine, carnitine, and carnosine compared to previously identified transporters for these ligands. This is the first study to characterize the function of SLC22A15. Our studies demonstrate that SLC22A15 may play an important role in determining the systemic and tissue levels of ergothioneine, carnosine, and other zwitterions.	[Yee, Sook Wah; Buitrago, Dina; Stecula, Adrian; Ngo, Huy X.; Chien, Huan-Chieh; Zou, Ling; Koleske, Megan L.; Giacomini, Kathleen M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Giacomini, Kathleen M.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacomini, KM (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	kathy.giacomini@ucsf.edu	Giacomini, Kathleen/AEF-2452-2022	Koleske, Megan/0000-0002-9826-6442; Buitrago Silva, Dina/0000-0003-1656-2406	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK108722]; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK108722; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)	Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; BRIGGS I, 1972, J NEUROCHEM, V19, P27, DOI 10.1111/j.1471-4159.1972.tb01250.x; Chaleckis R, 2016, P NATL ACAD SCI USA, V113, P4252, DOI 10.1073/pnas.1603023113; Cheah IK, 2016, BIOCHEM BIOPH RES CO, V478, P162, DOI 10.1016/j.bbrc.2016.07.074; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Chmielewska K, 2020, CHEM RES TOXICOL, V33, P1561, DOI 10.1021/acs.chemrestox.0c00010; Christie David L., 2007, V46, P99; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Dodd JR, 2010, J NEUROCHEM, V115, P684, DOI 10.1111/j.1471-4159.2010.06957.x; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drake KA, 2014, J ALLERGY CLIN IMMUN, V133, P370, DOI 10.1016/j.jaci.2013.06.043; Dubail J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05191-8; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051791; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; Fernandes CF, 2007, BIOCHEM BIOPH RES CO, V361, P26, DOI 10.1016/j.bbrc.2007.06.160; Franzoni F, 2006, BIOMED PHARMACOTHER, V60, P453, DOI 10.1016/j.biopha.2006.07.015; Geier EG, 2013, P NATL ACAD SCI USA, V110, P5480, DOI 10.1073/pnas.1218165110; Ghodsi R, 2018, AMINO ACIDS, V50, P1177, DOI 10.1007/s00726-018-2592-9; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Goswami S, 2016, CLIN PHARMACOL THER, V100, P537, DOI 10.1002/cpt.428; Grigat S, 2007, BIOCHEM PHARMACOL, V74, P309, DOI 10.1016/j.bcp.2007.04.015; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Hatano T, 2016, J NEUROL NEUROSUR PS, V87, P295, DOI 10.1136/jnnp-2014-309676; Hipkiss AR, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-38; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Hwang B, 2019, J NUTR BIOCHEM, V74, DOI 10.1016/j.jnutbio.2019.108230; Ito S, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-018-2565-4; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kamal MA, 2009, AM J PHYSIOL-REG I, V296, pR986, DOI 10.1152/ajpregu.90744.2008; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim HI, 2017, AM J HUM GENET, V101, P489, DOI 10.1016/j.ajhg.2017.08.008; Knottnerus SJG, 2018, REV ENDOCR METAB DIS, V19, P93, DOI 10.1007/s11154-018-9448-1; Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578; Liang XM, 2015, MOL PHARMACEUT, V12, P4301, DOI 10.1021/acs.molpharmaceut.5b00501; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Maruyama SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36468; Masuo Y, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2507-1; Meixner E, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209652; Menon K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020623; Mikula-Pietrasik J, 2016, ANTICANCER RES, V36, P665; Mitsuyama H, 1999, CLIN SCI, V97, P407, DOI 10.1042/CS19990111; Morrissey KM, 2013, ANNU REV PHARMACOL, V53, P503, DOI 10.1146/annurev-pharmtox-011112-140317; MOTOHASHI N, 1986, J INORG BIOCHEM, V26, P205, DOI 10.1016/0162-0134(86)80042-3; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Okada R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121535; Parvez MM, 2016, ANTIMICROB AGENTS CH, V60, P6558, DOI 10.1128/AAC.01151-16; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perland E, 2017, TRENDS PHARMACOL SCI, V38, P305, DOI 10.1016/j.tips.2016.11.008; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; ROUGEE M, 1988, PHOTOCHEM PHOTOBIOL, V47, P485, DOI 10.1111/j.1751-1097.1988.tb08835.x; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; Sakrak O, 2008, J SURG RES, V144, P36, DOI 10.1016/j.jss.2007.04.020; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shen H, 1999, AM J PHYSIOL-RENAL, V276, pF658, DOI 10.1152/ajprenal.1999.276.5.F658; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Sugiura T, 2010, DRUG METAB DISPOS, V38, P1665, DOI 10.1124/dmd.110.032763; Superti-Furga G, 2020, NAT REV DRUG DISCOV, V19, P429, DOI 10.1038/d41573-020-00056-6; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Todesco L, 2008, CELL MOL LIFE SCI, V65, P1596, DOI 10.1007/s00018-008-8065-7; Tschirka J, 2018, DRUG METAB DISPOS, V46, P779, DOI 10.1124/dmd.118.080440; Uemura T, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-2779-0; Urban TJ, 2007, PHARMACOGENET GENOM, V17, P773, DOI 10.1097/FPC.0b013e3281c6d08e; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; WABER LJ, 1982, J PEDIATR-US, V101, P700, DOI 10.1016/S0022-3476(82)80294-1; Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584, DOI 10.1152/ajprenal.2000.279.3.F584; Wang LZ, 2013, J MASS SPECTROM, V48, P406, DOI 10.1002/jms.3150; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wright SH, 2019, AM J PHYSIOL-RENAL, V317, pF1669, DOI 10.1152/ajprenal.00422.2019; Wu GY, 2020, AMINO ACIDS, V52, P329, DOI 10.1007/s00726-020-02823-6; Xiang JM, 2006, BRAIN RES, V1122, P18, DOI 10.1016/j.brainres.2006.09.013; Yee SW, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008208; Zamek-Gliszczynski MJ, 2018, CLIN PHARMACOL THER, V104, P890, DOI 10.1002/cpt.1112; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang ZW, 2014, J CANCER, V5, P382, DOI 10.7150/jca.8024; Zhu GQ, 2019, CARCINOGENESIS, V40, P1121, DOI 10.1093/carcin/bgz010; Zou L, 2018, MOL PHARMACOL, V94, P689, DOI 10.1124/mol.117.111153	86	12	12	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15734	15752		10.1096/fj.202001497R	http://dx.doi.org/10.1096/fj.202001497R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124720	Green Accepted, Bronze			2022-12-26	WOS:000586276400001
J	Armoiry, X; Obadia, JF; Auguste, P; Connock, M				Armoiry, Xavier; Obadia, Jean-Francois; Auguste, Peter; Connock, Martin			Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICES; SURVIVAL; THERAPY; DISEASE; SURGERY; BRIDGE	Purpose Two randomized controlled trials (RCTs), Mitra-Fr and Coapt, evaluating the benefit of percutaneous repair (PR) for heart failure (HF) patients with severe mitral regurgitation, have led to conflicting results. We aimed to evaluate the impact of these trial results on the cost-effectiveness of PR using effectiveness inputs from the two RCTs. Methods We developed a time varying Markov type model with three mutually exclusive health states: alive without HF hospitalisation, alive with HF hospitalisation, and dead. Clinically plausible extrapolations beyond observed data were obtained by developing parametric modelling for overall survival and HF hospitalisations using published data from each trial. We adopted the perspective of the French Health System and used a 30-year time horizon. Results were expressed as euro / quality-adjusted life year (QALY) gained using utility inputs from literature. Findings Results are presented using treatment efficacy measures from Mitra-F and Coapt trials respectively. With the Mitra-Fr data, after annual discounting, the base case model generated an incremental 0.00387 QALY at a cost of euro25,010, yielding an incremental cost effectiveness ratio (ICER) of euro6,467,032 / QALY. The model was sensitive to changes made to model inputs. There was no potential of PR being cost-effective. With the Coapt data, the model generated 1.19 QALY gain at a cost of euro26,130 yielding an ICER of euro21,918 / QALY and at a threshold of >euro50,000/QALY PR had a probability of 1 of being cost-effective. Implications Cost effectiveness results were conflicting; reconciling differences between trials is a priority and could promote optimal cost effectiveness analyses and resource allocation.	[Armoiry, Xavier; Auguste, Peter; Connock, Martin] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Armoiry, Xavier] Univ Lyon, Sch Pharm ISPB UMR CNRS 5510 MATEIS, Pharm Dept, Edouard Herriot Hosp, Lyon, France; [Obadia, Jean-Francois] Hosp Civils Lyon, Chirurg Cardiovasc & Transplantat Cardiaque, Hop Cardiovasc Louis Pradel, Lyon, France; [Obadia, Jean-Francois] Claude Bernard Univ, Lyon, France	University of Warwick; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Armoiry, X (corresponding author), Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.; Armoiry, X (corresponding author), Univ Lyon, Sch Pharm ISPB UMR CNRS 5510 MATEIS, Pharm Dept, Edouard Herriot Hosp, Lyon, France.	xavier.armoiry@uni-lyon1.fr	Carmen, Team3/Y-7384-2019	Carmen, Team3/0000-0002-3614-0924; Auguste, Peter/0000-0001-5143-3218; Lab, Carmen/0000-0002-5935-3236				Alexandersson A, 2004, STATA J, V4, P242, DOI 10.1177/1536867X0400400302; [Anonymous], **NON-TRADITIONAL**; Armeni P, 2016, INT J CARDIOL, V209, P153, DOI 10.1016/j.ijcard.2016.01.212; Armoiry X, 2018, J THORAC CARDIOV SUR, V156, P2138, DOI 10.1016/j.jtcvs.2018.07.017; Baldus S, 2012, EUR J HEART FAIL, V14, P1050, DOI 10.1093/eurjhf/hfs079; Baron SJ, 2019, CIRCULATION, V140, P1881, DOI 10.1161/CIRCULATIONAHA.119.043275; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bertaina M, 2019, INT J CARDIOL, V290, P70, DOI 10.1016/j.ijcard.2019.05.015; Bonnet C, 2015, VALUE HEALTH, V18, pA340, DOI 10.1016/j.jval.2015.09.141; Bourguignon S, 2019, ESC HEART FAIL, V6, P559, DOI 10.1002/ehf2.12432; Cartier-Bechu C, 2016, VALUE HEALTH, V19, pA490, DOI 10.1016/j.jval.2016.09.830; Chang HH, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13124; Cheema PK, 2012, CURR ONCOL, V19, pE165, DOI 10.3747/co.19.946; Clarke A, 2014, INT J CARDIOL, V171, P338, DOI 10.1016/j.ijcard.2013.12.015; Crowther MJ, 2013, J STAT SOFTW, V53, P1; Di Tanna GL, 2019, PHARMACOECONOMICS, V37, P359, DOI 10.1007/s40273-018-0755-x; Enriquez-Sarano M, 2019, CIRCULATION, V139, P2289, DOI 10.1161/CIRCULATIONAHA.118.038207; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Gallacher D, 2018, STATA J, V18, P223, DOI 10.1177/1536867X1801800114; Grayburn PA, 2019, JACC-CARDIOVASC IMAG, V12, P353, DOI 10.1016/j.jcmg.2018.11.006; Griffiths A, 2014, HEART, V100, P1031, DOI 10.1136/heartjnl-2013-304598; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Haute Autorite de Sante, 2019, GUID METH CHOIX METH; Iung B, 2019, EUR J HEART FAIL, V21, P1619, DOI 10.1002/ejhf.1616; Mack MJ, 2019, COAPT 3 YEAR OUTCOME; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Muller DWM, 2018, J THORAC DIS, V10, pS1949, DOI 10.21037/jtd.2018.04.154; Nishimura RA, 2018, NEW ENGL J MED, V379, P2374, DOI 10.1056/NEJMe1812279; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Praz F, 2019, EUR HEART J, V40, P2189, DOI 10.1093/eurheartj/ehz222; Pulikottil-Jacob R, 2014, J HEART LUNG TRANSPL, V33, P350, DOI 10.1016/j.healun.2014.01.003; Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640; Stone GW, MORE 100 000 MITRACL; Tadmouri A, 2018, ESC HEART FAIL, V5, P75, DOI 10.1002/ehf2.12194; Taylor CJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l223	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241361	10.1371/journal.pone.0241361	http://dx.doi.org/10.1371/journal.pone.0241361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166308	gold, Green Published			2022-12-26	WOS:000592382600003
J	Fowler, Z; Moeller, E; Roa, L; Castaneda-Alcantara, ID; Uribe-Leitz, T; Meara, JG; Cervantes-Trejo, A				Fowler, Zachary; Moeller, Ellie; Roa, Lina; Castaneda-Alcantara, Isaac Deneb; Uribe-Leitz, Tarsicio; Meara, John G.; Cervantes-Trejo, Arturo			Projected impact of COVID-19 mitigation strategies on hospital services in the Mexico City Metropolitan Area	PLOS ONE			English	Article							UNIT	Evidence-based models may assist Mexican government officials and health authorities in determining the safest plans to respond to the coronavirus disease 2019 (COVID-19) pandemic in the most-affected region of the country, the Mexico City Metropolitan Area. This study aims to present the potential impacts of COVID-19 in this region and to model possible benefits of mitigation efforts. The COVID-19 Hospital Impact Model for Epidemics was used to estimate the probable evolution of COVID-19 in three scenarios: (i) no social distancing, (ii) social distancing in place at 50% effectiveness, and (iii) social distancing in place at 60% effectiveness. Projections of the number of inpatient hospitalizations, intensive care unit admissions, and patients requiring ventilators were made for each scenario. Using the model described, it was predicted that peak case volume at 0% mitigation was to occur on April 30, 2020 at 11,553,566 infected individuals. Peak case volume at 50% mitigation was predicted to occur on June 1, 2020 with 5,970,093 infected individuals and on June 21, 2020 for 60% mitigation with 4,128,574 infected individuals. Occupancy rates in hospitals during peak periods at 0%, 50%, and 60% mitigation would be 875.9%, 322.8%, and 203.5%, respectively, when all inpatient beds are included. Under these scenarios, peak daily hospital admissions would be 40,438, 13,820, and 8,650. Additionally, 60% mitigation would result in a decrease in peak intensive care beds from 94,706 to 23,116 beds and a decrease in peak ventilator need from 67,889 to 17,087 units. Mitigating the spread of COVID-19 through social distancing could have a dramatic impact on reducing the number of infected people and minimize hospital overcrowding. These evidence-based models may enable careful resource utilization and encourage targeted public health responses.	[Fowler, Zachary; Moeller, Ellie; Roa, Lina; Uribe-Leitz, Tarsicio; Meara, John G.] Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA; [Moeller, Ellie] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Roa, Lina] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Castaneda-Alcantara, Isaac Deneb; Cervantes-Trejo, Arturo] Anahuac Univ Mexico, Fac Hlth Sci, Anahuac Inst Publ Hlth, Huixquilucan, State Of Mexico, Mexico; [Uribe-Leitz, Tarsicio] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA; [Uribe-Leitz, Tarsicio] Tech Univ Munich, Dept Epidemiol, Munich, Bavaria, Germany; [Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA	Harvard University; Harvard Medical School; University of Miami; University of Alberta; Harvard University; Brigham & Women's Hospital; Technical University of Munich; Harvard University; Boston Children's Hospital	Fowler, Z (corresponding author), Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA.	zachary.g.fowler@gmail.com	Roa, Lina/S-8140-2019	Roa, Lina/0000-0001-6552-4452; Fowler, Zachary/0000-0002-4777-413X; Cervantes Trejo, Arturo/0000-0002-7107-9217				Abir M., 2020, RAND CRITICAL CARE S; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], CIR COVID 19 1; [Anonymous], EL EC; [Anonymous], 2020, REUTERS; [Anonymous], UND GLOB PAND WE NEE; [Anonymous], 2020, PROGRAMA RECONVERSIO; [Anonymous], 2020, EL UNIVERSAL; [Anonymous], COVID 19 MAP; Babidge WJ, 2020, ANZ J SURG, V90, P1558, DOI 10.1111/ans.16196; Bhat KRS, 2021, J ROBOT SURG, V15, P251, DOI 10.1007/s11701-020-01100-8; Burr T, 2009, MATH BIOSCI ENG, V6, P239, DOI 10.3934/mbe.2009.6.239; Caro Vega YN, 2020, ANALISIS MORTALIDAD; CDC, 2020, DUR IS PREC AD COVID; Chow TT, 2006, J HOSP INFECT, V64, P371, DOI 10.1016/j.jhin.2006.07.020; Comision Nacional Para La Mejora Continua De La Educacion, 2020, ACT COVID 19; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570; Dattilo W., 2020, COVID 19 MOST VULNER; Fort D, 2020, OCHSNER J, V20, P285, DOI 10.31486/toj.20.0073; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Graizbord B, 2019, POLITICS POLICY, V47, P178, DOI 10.1111/polp.12292; Herath N, 2020, RES SQUARE; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Instituto de Estudios Avanzados de las Americas; Departamento de Ciencias de la Salud Publica de la Facultad de Medicina Miller de la Universidad de Miami, OBS CONT COVID 19 AM; Khoshnaw SHA, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109932; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Klein MG, 2022, DISASTER MED PUBLIC, V16, P390, DOI 10.1017/dmp.2020.332; Latif S., 2020, IEEE T ARTIF INTELL, V1, P85, DOI 10.1109/TAI.2020.3020521; Leon UAP, 2020, ARXIV200408288, V5, P14; Lopez-Mejia M., 2020, MEDSCAPE; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mari GM, 2020, INT J SURG, V78, P113, DOI 10.1016/j.ijsu.2020.04.052; Michael Z.Levy, 2020, CODE PHILLY; Namendys-Silva SA, 2020, INTENS CARE MED, V46, P2086, DOI 10.1007/s00134-020-06256-3; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; OECD, 2015, OECD TERR REV VALL M; Oliveira H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134738; Poblacion CN de, 1915, PROYECC POBL MEX ENT; Presidencia de la Republica, 2020, INF DIAR COR COVID 1; Raffensperger JF, 2020, PLANNING HOSP NEEDS; Salud Sde., DATOS ABIERTOS DIREC; Siedner MJ, 2020, PLOS MED; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Vivanco-Lira A, 2020, ARXIV200306758QBIO; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260; World Health Organization, 2020, COVID 19 UPD 12 SUMM, DOI 10.21203/rs.3.rs-35816/v1	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241954	10.1371/journal.pone.0241954	http://dx.doi.org/10.1371/journal.pone.0241954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166336	Green Published, gold			2022-12-26	WOS:000592382600067
J	Florentini, EA; Angulo, N; Gilman, RH; Alcantara, R; Roncal, E; Antiparra, R; Toscano, E; Vallejos, K; Kirwan, D; Zimic, M; Sheen, P				Florentini, Edgar A.; Angulo, Noelia; Gilman, Robert H.; Alcantara, Roberto; Roncal, Elisa; Antiparra, Ricardo; Toscano, Emily; Vallejos, Katherine; Kirwan, Danni; Zimic, Mirko; Sheen, Patricia			Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							SUSCEPTIBILITY; IMMUNOASSAY	Pyrazinamide (PZA) susceptibility testing in Mycobacterium tuberculosis (Mtb) is a current area of development and PZA-resistant strains are increasingly prevalent. Previous studies have demonstrated that the detection of pyrazinoic acid (POA), the metabolite produced by the deamidation of PZA, is a good predictor for PZA resistance since a resistant strain would not convert PZA into POA at a critical required rate, whereas a susceptible strain will do, expelling POA to the extracellular environment at a certain rate, and allowing for quantification of this accumulated analyte. In order to quantify POA, an indirect competitive ELISA (icELISA) test using hyperimmune polyclonal rabbit serum against POA was developed: for this purpose, pure POA was first covalently linked to the highly immunogenic Keyhole Limpet Hemocyanine, and inoculated in rabbits. A construct made of bovine serum albumin (BSA) linked to pure POA and fixed at the bottom of wells was used as a competitor against spiked samples and liquid Mtb culture supernatants. When spiked samples (commercial POA alone) were analyzed, the half maximal inhibitory concentration (IC50) was 1.16 mg/mL, the limit of detection 200 mu g/mL and the assay was specific (it did not detect PZA, IC50 > 20 mg/mL). However, culture supernatants (7H9-OADC-PANTA medium) disrupted the competition and a proper icELISA curve was not obtainable. We consider that, although we have shown that it is feasible to induce antibodies against POA, matrix effects could damage its analytical usefulness; multiple, upcoming ways to solve this obstacle are suggested.	[Florentini, Edgar A.; Angulo, Noelia; Alcantara, Roberto; Roncal, Elisa; Antiparra, Ricardo; Toscano, Emily; Vallejos, Katherine; Kirwan, Danni; Zimic, Mirko; Sheen, Patricia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Invest & Desarrollo, Lab Bioinformat & Biol Mol, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sheen, P (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Invest & Desarrollo, Lab Bioinformat & Biol Mol, Lima, Peru.	patricia.sheen@upch.pe	Toscano Guerra, Emily/GRF-4712-2022	Toscano Guerra, Emily/0000-0003-2718-1684; Florentini, Edgar Alejandro/0000-0002-0052-7545; Roncal Rios, Elisa/0000-0001-8167-2770; Alcantara Estela, Roberto Hugo/0000-0003-2028-631X; Vallejos-Sanchez, Katherine/0000-0002-2434-5244	Wellcome Trust [099805/Z/112/Z]; MRC [MR/K007467/1, MR/P019978/2, MR/P019978/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust; PS received the Wellcome Trust 099805/Z/112/Z award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara R, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01162-18; [Anonymous], 2015, J OPER OCEANOGR, V8, ps80, DOI 10.1080/1755876X.2015.1022329; BELANGER L, 1973, CLIN CHIM ACTA, V48, P15, DOI 10.1016/0009-8981(73)90211-8; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Darwish Ibrahim A, 2006, Int J Biomed Sci, V2, P217; Demers AM, 2016, J CLIN MICROBIOL, V54, P1276, DOI 10.1128/JCM.03162-15; Girum T, 2018, TROP DIS TRAVEL MED, V4, DOI 10.1186/s40794-018-0065-5; Horne DJ, 2013, J CLIN MICROBIOL, V51, P393, DOI 10.1128/JCM.02724-12; KONNO K, 1967, AM REV RESPIR DIS, V95, P461; Li DG, 2016, ANTIMICROB AGENTS CH, V60, P5159, DOI 10.1128/AAC.02687-15; Li H, 2013, J ENTOMOL RES SOC, V15, P11; Malou N, 2011, TRENDS MICROBIOL, V19, P295, DOI 10.1016/j.tim.2011.03.004; MARCO MP, 1995, TRAC-TREND ANAL CHEM, V14, P415, DOI 10.1016/0165-9936(95)90920-I; Meinzen C, 2016, TUBERCULOSIS, V99, P41, DOI 10.1016/j.tube.2016.03.011; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Nishikawa S, 1996, CURR EYE RES, V15, P951, DOI 10.3109/02713689609017640; Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12; Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15; SALFINGER M, 1988, ANTIMICROB AGENTS CH, V32, P1002, DOI 10.1128/AAC.32.7.1002; Tang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085606; VALLEJO RP, 1982, J AGR FOOD CHEM, V30, P572, DOI 10.1021/jf00111a040; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; Wang L, 2010, J AGR FOOD CHEM, V58, P3265, DOI 10.1021/jf903940h; World Health Organization, 2018, GLOB TUB REP 2018; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027654; Zimic M, 2012, TUBERCULOSIS, V92, P84, DOI 10.1016/j.tube.2011.09.002	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241600	10.1371/journal.pone.0241600	http://dx.doi.org/10.1371/journal.pone.0241600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151985	Green Published, Green Accepted, gold			2022-12-26	WOS:000591376200062
J	Gao, C; Zhao, Z; Li, FY; Liu, JL; Xu, HY; Zeng, YY; Yang, L; Chen, JH; Lu, XT; Wang, C; Guo, Q				Gao, Chang; Zhao, Zhi; Li, Fengyuan; Liu, Jia-lin; Xu, Hongyang; Zeng, Yuanying; Yang, Ling; Chen, Jiahao; Lu, Xiaoting; Wang, Can; Guo, Qiang			The impact of individual lifestyle and status on the acquisition of COVID-19: A case-Control study	PLOS ONE			English	Article							SLEEP DURATION; CARDIOVASCULAR-DISEASE; HAIR LOSS; EPIDEMIOLOGY; PREVENTION; STATEMENT; QUALITY	Background Coronavirus disease 2019 (COVID-19) has spread to the world. Whether there is an association between lifestyle behaviors and the acquisition of COVID-19 remains unclear. Methods In this case-control study, we recruited 105 patients with SARS-CoV-2 infection as a case group from the Wuhan Tongji Hospital (Wuhan, China). For each case two control subjects were recruited. Participants were randomly selected from communities in Wuhan and matched for sex, age (+/- 2yrs), and pre-existing comorbidities (hypertension and diabetes). Results A total of 105 patients diagnosed with COVID-19 and 210 controls were included. Compared with control group, the case group had higher proportions of lack of sleep (30.5% vs. 14.8%, P = 0.001) and increased physical activities (56.2% vs. 32.9%, P < 0.001). And patients in the case group were more likely to have alopecia (28.6% vs. 10.0%, P < 0.001) than people from the control group. Overall, we found that lack of sleep [adjusted odds ratio (OR) 1.56, 95% confidence interval (CI) 1.03-2.39)], physical activities (>= 5 times a week) (adjusted OR 2.05, 95%CI 1.39-3.02) and alopecia (adjusted OR 1.73, 95%CI 1.13-2.66) were independent risk factors for COVID-19 infection. Conversely, low-dose alcohol intake (<100g alcohol per week), hand hygiene, and fruits intake (daily) were significantly associated with a decrease in morbidity. Conclusions Individual lifestyle behaviors and health status can affect the occurrence of COVID-19.	[Gao, Chang; Guo, Qiang] Soochow Univ, Dushu Lake Hosp, Suzhou Dushu Lake Hosp, Dept Crit Care Med, Suzhou, Jiangsu, Peoples R China; [Gao, Chang; Li, Fengyuan; Yang, Ling; Chen, Jiahao; Wang, Can; Guo, Qiang] Soochow Univ, Affiliated Hosp 1, Dept Crit Care Med, Suzhou, Jiangsu, Peoples R China; [Zhao, Zhi] Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Jiangsu, Peoples R China; [Li, Fengyuan; Yang, Ling; Chen, Jiahao] Soochow Univ, Suzhou, Jiangsu, Peoples R China; [Liu, Jia-lin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Crit Care Med, Shanghai, Peoples R China; [Xu, Hongyang] Nanjing Med Univ, Dept Crit Care Med, WuXi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Zeng, Yuanying] Suzhou Municipal Hosp, Dept Oncol, Suzhou, Jingsu, Peoples R China; [Lu, Xiaoting] Changshu 2 Peoples Hosp, Dept Crit Care Med, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Shanghai Jiao Tong University; Jiangnan University; Nanjing Medical University	Guo, Q (corresponding author), Soochow Univ, Dushu Lake Hosp, Suzhou Dushu Lake Hosp, Dept Crit Care Med, Suzhou, Jiangsu, Peoples R China.; Wang, C; Guo, Q (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Crit Care Med, Suzhou, Jiangsu, Peoples R China.	guojiang@suda.edu.cn; canw@suda.edu.cn			Jiangsu Province's Key Provincial Talents Program [ZDRCA2016046]; Key Health Talents in Gusu [GSWS2019009]; Suzhou Science and Technology Projects for Emergency Prevention and Treatment of SARS-CoV-2 infection [SYS2020014]	Jiangsu Province's Key Provincial Talents Program; Key Health Talents in Gusu; Suzhou Science and Technology Projects for Emergency Prevention and Treatment of SARS-CoV-2 infection	This work was supported by Jiangsu Province's Key Provincial Talents Program (ZDRCA2016046); Key Health Talents in Gusu (GSWS2019009); Suzhou Science and Technology Projects for Emergency Prevention and Treatment of SARS-CoV-2 infection (SYS2020014).	[Anonymous], 2020, SUPPRESSION ANDROGEN; Antunes BM, 2017, PHYSIOL BEHAV, V177, P252, DOI 10.1016/j.physbeh.2017.05.014; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; BLAIR SN, 2001, MED SCI SPORT EXER S, V33, pS37, DOI DOI 10.1097/00005768-200106001-00007; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211; Chambial S, 2013, INDIAN J CLIN BIOCHE, V28, P314, DOI 10.1007/s12291-013-0375-3; Columbus Cristie, 2020, Proc (Bayl Univ Med Cent), V33, P209, DOI 10.1080/08998280.2020.1731272; Covassin N, 2016, SLEEP MED CLIN, V11, P81, DOI 10.1016/j.jsmc.2015.10.007; Ferrara P, 2016, MINERVA PEDIAT; Furushima D, 2018, MOLECULES, V23, DOI 10.3390/molecules23071795; Gan DCC, 2005, J INVEST DERM SYMP P, V10, P184, DOI 10.1111/j.1087-0024.2005.10102.x; Goren A, 2020, J COSMET DERMATOL-US, V19, P1545, DOI 10.1111/jocd.13443; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94, 10.1016/S0140-6736(18)31310-2]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Herr C, 2007, EXPERT OPIN BIOL TH, V7, P1449, DOI 10.1517/14712598.7.9.1449; Hong CHL, 2018, INT J DENT HYG, V16, pE96, DOI 10.1111/idh.12321; Ibarra-Coronado EG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/678164; Jani Bhairvi, 2018, Mo Med, V115, P236; Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372; Kanzigg Lauren A, 2016, J Dent Hyg, V90 Suppl 1, P15; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mahalanabis D, 2002, EPIDEMIOL INFECT, V129, P65, DOI 10.1017/S0950268802006817; McGill JL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51684-x; Medrano-Martinez P, 2016, REV NEUROLOGIA, V62, P170, DOI 10.33588/rn.6204.2015334; Patel N, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100907; Phillips TG, 2017, AM FAM PHYSICIAN, V96, P371; Ren Qingfeng, 2015, Wei Sheng Yan Jiu, V44, P246; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Sharifi A, 2019, APMIS, V127, P681, DOI 10.1111/apm.12982; St-Onge MP, 2016, CIRCULATION, V134, pE367, DOI 10.1161/CIR.0000000000000444; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Weil BR, 2010, CAN J PHYSIOL PHARM, V88, P777, DOI 10.1139/Y10-046; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955	39	14	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241540	10.1371/journal.pone.0241540	http://dx.doi.org/10.1371/journal.pone.0241540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152004	Green Published, gold			2022-12-26	WOS:000591376200084
J	Guo, FJ; Lin, YL; Raji, M; Leonard, B; Chou, LN; Kuo, YF				Guo, Fangjian; Lin, Yu-Li; Raji, Mukaila; Leonard, Bruce; Chou, Lin-Na; Kuo, Yong-Fang			Processes and outcomes of diabetes mellitus care by different types of team primary care models	PLOS ONE			English	Article							NURSE-PRACTITIONERS; MEDICARE PATIENTS; CONTINUITY; STATES; TRIAL	Background Team care improves processes and outcomes of care, especially for patients with complex medical conditions that require coordination of care. This study aimed to compare the processes and outcomes of care provided to older patients with diabetes by primary care teams comprised of only primary care physicians (PCPs) versus team care that included nurse practitioners (NPs) or physician assistants (PAs). Methods We studied 3,524 primary care practices identified via social network analysis and 306,741 patients >= 66 years old diagnosed with diabetes in or before 2015 in Medicare data. Guideline-recommended diabetes care included eye examination, hemoglobin A1c test, and nephropathy monitoring. High-risk medications were based on recommendations from the American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Preventable hospitalizations were defined as hospitalizations for a potentially preventable condition. Results Compared with patients in the PCP only teams, patients in the team care practices with NPs or PAs received more guideline-recommended diabetes care (annual eye exam: adjusted odds ratio (aOR): 1.04 (95% CI: 1.00-1.08), 1.08 (95% CI: 1.03-1.13), and 1.10 (95% CI: 1.05-1.15), and HbA1C test: aOR: 1.11 (95% CI: 1.04-1.18), 1.11 (95% CI: 1.02-1.20), and 1.15 (95% CI: 1.06-1.25) for PCP/NP, PCP/NP/PA, and PCP/PA teams). Patients in the PCP/NP and the PCP/PA teams had a slightly higher likelihood of being prescribed high-risk medications (aOR: 1.03 (95% CI: 1.00-1.07), and 1.06 (95% CI: 1.02-1.11), respectively). The likelihood of preventable hospitalizations was similar among patients cared for by various types of practices. Conclusion The team care practices with NPs or PAs were associated with better adherence to clinical practice guideline recommendations for diabetes compared to PCP only practices. Both practices had similar outcomes. Further efforts are needed to explore new and cost-effective team-based care delivery models that improve process, outcomes, and continuity of care, as well as patient care experiences.	[Guo, Fangjian] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Guo, Fangjian; Kuo, Yong-Fang] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, Galveston, TX 77555 USA; [Lin, Yu-Li; Chou, Lin-Na; Kuo, Yong-Fang] Univ Texas Med Branch, Dept Prevent Med & Populat Hlth, Galveston, TX 77555 USA; [Raji, Mukaila; Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Raji, Mukaila; Kuo, Yong-Fang] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Leonard, Bruce] Univ Texas Med Branch, Sch Nursing, Galveston, TX 77555 USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kuo, YF (corresponding author), Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, Galveston, TX 77555 USA.; Kuo, YF (corresponding author), Univ Texas Med Branch, Dept Prevent Med & Populat Hlth, Galveston, TX 77555 USA.; Kuo, YF (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.; Kuo, YF (corresponding author), Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA.; Kuo, YF (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.	yokuo@utmb.edu			Agency for Healthcare Research and Quality (AHRQ) [R01-HS020642]; National Institutes of Health (NIH) [P30-AG024832, UL1TR001439]; National Cancer Institute of the NIH [K07CA222343]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants R01-HS020642 from the Agency for Healthcare Research and Quality (AHRQ), P30-AG024832, and UL1TR001439 from the National Institutes of Health (NIH). Dr. Guo is currently supported by the National Cancer Institute of the NIH under Award Number K07CA222343. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or AHRQ. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.	Ackroyd SA, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0471-z; American Diabetes Association, 2019, Clin Diabetes, V37, P11, DOI 10.2337/cd18-0105; [Anonymous], 2019, DIABETES CARE, V42, pS90, DOI [10.2337/dc19-S009, DOI 10.2337/DC19-S012]; Association A.D., 2019, DIABETES CARE, V42, pS29, DOI [10.2337/dc19-S003, DOI 10.2337/dc19-S004]; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2; Everett C, 2013, HEALTH AFFAIR, V32, P1942, DOI 10.1377/hlthaff.2013.0506; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Ghasemaghaei Maryam, 2019, GLIA, V104, P69, DOI [10.1016/j.jbusres.2019.07.006, 10.1016/j.ijheh.2019.05.004, DOI https://doi.org/10.5014/ajot.2019.73S201]; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Godfrey WW., 2017 C INF COMM TECH; Hendricks Glenmore, 2017, J Natl Black Nurses Assoc, V28, P60; Jackson GL, 2011, PRIM CARE DIABETES, V5, P25, DOI 10.1016/j.pcd.2010.09.005; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Kuo YF, 2019, MED CARE, V57, P905, DOI 10.1097/MLR.0000000000001201; Kuo YF, 2018, J CARD FAIL, V24, P9, DOI 10.1016/j.cardfail.2017.08.459; Kuo YF, 2015, J AM GERIATR SOC, V63, P1980, DOI 10.1111/jgs.13662; Kuo YF, 2015, MED CARE, V53, P776, DOI 10.1097/MLR.0000000000000406; Kuo YF, 2013, HEALTH AFFAIR, V32, P1236, DOI 10.1377/hlthaff.2013.0072; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Norful AA, 2019, HEALTH CARE MANAGE R, V44, P235, DOI 10.1097/HMR.0000000000000161; Ohman-Strickland PA, 2008, ANN FAM MED, V6, P14, DOI 10.1370/afm.758; Phillips SJ, 2016, NURSE PRACT, V41, P21, DOI 10.1097/01.NPR.0000475369.78429.54; Reuben DB, 2013, J AM GERIATR SOC, V61, P857, DOI 10.1111/jgs.12268; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Smith S, 2004, FAM PRACT, V21, P39, DOI 10.1093/fampra/cmh109; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Stewart M, 2004, ANN FAM MED, V2, P388, DOI 10.1370/afm.236; Taliani CA, 2013, AM J MANAG CARE, V19, P957; US Department of Agriculture, 2013, 2013 RUR URB CONT CO; Yang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30750	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241516	10.1371/journal.pone.0241516	http://dx.doi.org/10.1371/journal.pone.0241516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152002	Green Published, gold			2022-12-26	WOS:000591376200014
J	Intarakumthornchai, T; Kesvarakul, R				Intarakumthornchai, Thanasan; Kesvarakul, Ramil			Double yolk eggs detection using fuzzy logic	PLOS ONE			English	Article								Chicken egg products increased by 60% worldwide resulting in the farmers or traders egg industry. The double yolk (DY) eggs are priced higher than single yolk (SY) eggs around 35% at the same size. Although, separating DY from SY will increase more revenue but it has to be replaced at the higher cost from skilled labor for sorting. Normally, the separation of double yolk eggs required the expertise person by weigh and shape of egg but it is still high error. The purpose of this research is to detect double-yolked (DY) chicken eggs with weight and ratio of the egg's size using fuzzy logic and developing a low cost prototype to reduce the cost of separation. The K-means clustering is used for separating DY and SY, firstly. However, the error from this technique is still high as 15.05% because of its hard clustering. Therefore, the intersection zone scattering from using the weight and ratio of the egg's size to input of DY and SY is taken into consider with fuzzy logic algorithm, to improve the error. The results of errors from fuzzy logic are depended with input membership functions (MF). This research selects triangular MF of weight as low = 65 g, medium = 75 g and high = 85 g, while ratio of the egg is triangular MF as low = 1.30, medium = 1.40 and high = 1.50. This algorithm is not provide the minimum total error but it gives the low error to detect a double yolk while the real egg is SY as 1.43% of total eggs. This algorithm is applied to develop a double yolk egg detection prototype with Mbed platform by a load cell and OpenMV CAM, to measure the weight and ratio of the egg respectively.	[Intarakumthornchai, Thanasan] King Mongkuts Univ Technol North Bangkok, Dept Ind Engn, Fac Engn, Bangkok, Thailand; [Kesvarakul, Ramil] King Mongkuts Univ Technol North Bangkok, Dept Prod Engn, Fac Engn, Bangkok, Thailand	King Mongkuts University of Technology North Bangkok; King Mongkuts University of Technology North Bangkok	Kesvarakul, R (corresponding author), King Mongkuts Univ Technol North Bangkok, Dept Prod Engn, Fac Engn, Bangkok, Thailand.	ramil.k@eng.kmutnb.ac.th		kesvarakul, ramil/0000-0002-6497-0167				[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Bailey RL, 2014, PEERJ, V2, DOI 10.7717/peerj.273; CHRISTMAS RB, 1982, POULTRY SCI, V61, P1290, DOI 10.3382/ps.0611290; CONRAD R. M., 1940, POULTRY SCI, V19, P9, DOI 10.3382/ps.0190009; Damaziak K, 2015, REPROD DOMEST ANIM, V50, P341, DOI 10.1111/rda.12477; Fasenko GM, 2000, CAN J ANIM SCI, V80, P489, DOI 10.4141/A99-090; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Hamzah HH, 2018, ELECTROCHEM COMMUN, V96, P27, DOI 10.1016/j.elecom.2018.09.006; JAAP RG, 1968, POULTRY SCI, V47, P417, DOI 10.3382/ps.0470417; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Klir JG, 1995, FUZZY SETS FUZZY LOG; Krishna K, 1999, IEEE T SYST MAN CY B, V29, P433, DOI 10.1109/3477.764879; Miao JQ, 2018, INFORM SCIENCES, V447, P52, DOI 10.1016/j.ins.2018.02.007; Salamon A., 2013, International Journal of Poultry Science, V12, P254; Salamon A., 2015, THESIS; Wang J.D., 2012, AGR MECH RES, V9, P195; WARREN D. C, 1935, POULTRY SCI, V14, P195, DOI 10.3382/ps.0140195; Wei BC, 2015, MULTIMEDIA SYST, V21, P381, DOI 10.1007/s00530-014-0364-2; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088659; Zhou P., 2011, J COMPUT INF SYST, V7, P1516	20	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241888	10.1371/journal.pone.0241888	http://dx.doi.org/10.1371/journal.pone.0241888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152020	gold, Green Published			2022-12-26	WOS:000591376200003
J	Weber, LA; Funtan, A; Paschke, R; Delarocque, J; Kalbitz, J; Meissner, J; Feige, K; Kietzmann, M; Cavalleri, JMV				Weber, Lisa Annabel; Funtan, Anne; Paschke, Reinhard; Delarocque, Julien; Kalbitz, Jutta; Meissner, Jessica; Feige, Karsten; Kietzmann, Manfred; Cavalleri, Jessika-Maximiliane V.			In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer	PLOS ONE			English	Article							HUMAN-MELANOMA; DERMAL MELANOMATOSIS; METASTATIC MELANOMA; CUTANEOUS NEOPLASIA; CELL LINES; ACID; HORSES; ANTICANCER; TUMORS; DERIVATIVES	Equine sarcoid (ES) is the most prevalent skin tumor in equids worldwide. Additionally, aging grey horses frequently suffer from equine malignant melanoma (EMM). Current local therapies targeting these skin tumors remain challenging. Therefore, more feasible topical treatment options should be considered. In order to develop a topical therapy against ES and EMM, betulinyl-bis-sulfamate and NVX-207, derivatives of the naturally occurring betulin and betulinic acid, respectively, were evaluated for their antiproliferative (crystal violet staining assay), cytotoxic (MTS assay) and apoptotic (AnnexinV staining, cell cycle investigations) effects on primary ES cells, EMM cells and equine dermal fibroblasts in vitro. The more potent derivative was assessed for its in vitro penetration and permeation on isolated equine skin within 30 min and 24 h using Franz-type diffusion cells and HPLC analysis. Betulinyl-bis-sulfamate and NVX-207 inhibited the proliferation and metabolism in ES cells, EMM cells and fibroblasts significantly (p < 0.001) in a time- and dose-dependent manner. NVX-207 had superior anticancer effects compared to betulinyl-bis-sulfamate. Both compounds led to the externalization of phosphatidylserines on the cell membrane and DNA fragmentation, demonstrating that the effective mode of action was apoptosis. After 48 h of treatment with NVX-207, the number of necrotic cells was less than 2% in all cell types. Detected amounts of NVX-207 in the different skin layers exceeded the half-maximal inhibitory concentrations calculated by far. Even though data obtained in vitro are auspicious, the results are not unconditionally applicable to the clinical situation. Consequently, in vivo studies are required to address the antitumoral effects of topically applied NVX-207 in ES and EMM patients.	[Weber, Lisa Annabel; Delarocque, Julien; Feige, Karsten] Univ Vet Med Hannover, Clin Horses, Hannover, Germany; [Funtan, Anne; Paschke, Reinhard] Martin Luther Univ Halle Wittenberg, Biozentrum, Halle, Saale, Germany; [Kalbitz, Jutta] BioSolut Halle GmbH, Halle, Saale, Germany; [Meissner, Jessica; Kietzmann, Manfred] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Cavalleri, Jessika-Maximiliane V.] Univ Vet Med Vienna, Univ Equine Clin, Equine Internal Med, Vienna, Austria	University of Veterinary Medicine Hannover, Foundation; Martin Luther University Halle Wittenberg; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Vienna	Cavalleri, JMV (corresponding author), Univ Vet Med Vienna, Univ Equine Clin, Equine Internal Med, Vienna, Austria.	Jessika.Cavalleri@vetmeduni.ac.at	Delarocque, Julien/HHM-8412-2022; Meissner, Jessica/AFQ-9429-2022	Delarocque, Julien/0000-0002-4598-3499; Weber, Lisa Annabel/0000-0001-6185-1595; Meissner, Jessica/0000-0002-7263-848X; Cavalleri, Jessika/0000-0002-8575-7402	German Federal Ministry for Economic Affairs and Energy [TopiDrugHorse 16KN051526 BMWI, TopiDrugHorse 16KN051530 BMWI, TopiDrugHorse 16KN051524 BMWI]; BioSolutions Halle GmbH; Ministry of Economic Affairs and Energy	German Federal Ministry for Economic Affairs and Energy; BioSolutions Halle GmbH; Ministry of Economic Affairs and Energy	Some authors were funded by the Central Innovation Programme of the German Federal Ministry for Economic Affairs and Energy. LAW: Specific grant number: TopiDrugHorse 16KN051526 BMWI; AF: Specific grant number: TopiDrugHorse 16KN051530 BMWI; RP: Specific grant number: TopiDrugHorse 16KN051524 BMWI; JK: Specific grant number: TopiDrugHorse 16KN051524 BMWI. RP and JK were further funded by BioSolutions Halle GmbH (www.biosolutions-halle.de). The TopiDrugHorse project is a cooperation project between research institutions and a company. The participation of a company in this cooperation project is the prerequisite for the approval of the project funds by the Ministry of Economic Affairs and Energy. BioSolutions Halle GmbH is therefore not a commercial funder, but an equal partner. The rights and obligations of all partners are governed by a cooperation agreement. This applies in particular to publications and intellectual property. The funders provided support in the form of salaries and/or research materials for authors [LAW, AF, RP, JK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ali-Seyed M, 2016, CHEM BIOL DRUG DES, V87, P517, DOI 10.1111/cbdd.12682; ANGELOS J, 1988, ANIM GENET, V19, P417, DOI 10.1111/j.1365-2052.1988.tb00833.x; Bache M, 2014, INT J MOL SCI, V15, P19777, DOI 10.3390/ijms151119777; BAKER JR, 1975, VET REC, V96, P419, DOI 10.1136/vr.96.19.419; Bradley WM, 2017, EQUINE VET EDUC, V29, P293, DOI 10.1111/eve.12420; Chambers G, 2003, J GEN VIROL, V84, P1055, DOI 10.1099/vir.0.18947-0; CHOWDHURY AR, 2002, MED SCI MONITOR, V8, P254; Csuk R, 2014, EXPERT OPIN THER PAT, V24, P913, DOI 10.1517/13543776.2014.927441; Drag-Zalesinska M., 2019, WORLD SCI NEWS, V127, P123; Editorial, 2015, EUCONST, V11, P1, DOI DOI 10.1186/s12917-014-0312-6; FADOK VA, 1992, J IMMUNOL, V148, P2207; Federici C, 2016, J ENZYM INHIB MED CH, V31, P119, DOI 10.1080/14756366.2016.1177525; Ferreira F.A. Daniela, 2013, ONCOGENOMICS CANC PR, P139, DOI DOI 10.5772/53110; Fleury C, 2000, PIGM CELL RES, V13, P39, DOI 10.1034/j.1600-0749.2000.130108.x; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Gauthier C, 2006, BIOORGAN MED CHEM, V14, P6713, DOI 10.1016/j.bmc.2006.05.075; Gheorgheosu D, 2013, BIOL CHEM, V394, P773, DOI 10.1515/hsz-2013-0106; GOETZ TE, 1990, J AM VET MED ASSOC, V196, P449; Goodrich L, 1998, VET CLIN N AM-EQUINE, V14, P607; Gopal DVR, 2004, TOXICOL LETT, V153, P201, DOI 10.1016/j.toxlet.2004.03.027; Groom LM, 2018, EQUINE VET EDUC, V30, P438, DOI 10.1111/eve.12767; GUY RH, 1984, J PHARM SCI, V73, P883, DOI 10.1002/jps.2600730706; Hainisch EK, 2014, EQUINE SARCOID, DOI [10.1016/B978-1-4557-4555-5.00099-6, DOI 10.1016/B978-1-4557-4555-5.00099-6]; Haspeslagh M, 2016, RES VET SCI, V106, P107, DOI 10.1016/j.rvsc.2016.03.021; Haspeslagh M, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1215-0; Hewes CA, 2006, JAVMA-J AM VET MED A, V229, P1617, DOI 10.2460/javma.229.10.1617; Kapalczynska M, 2018, ARCH MED SCI, V14, P910, DOI 10.5114/aoms.2016.63743; Karna E, 2010, MOL CELL BIOCHEM, V340, P15, DOI 10.1007/s11010-010-0395-8; Knottenbelt DC, 2005, CLIN TECH EQUINE PRA, V4, P278, DOI DOI 10.1053/J.CTEP.2005.10.008; Knottenbelt DC, 2019, VET CLIN N AM-EQUINE, V35, P243, DOI 10.1016/j.cveq.2019.03.006; Kommera H, 2010, EUR J MED CHEM, V45, P3346, DOI 10.1016/j.ejmech.2010.04.018; Kommera H, 2010, CHEM-BIOL INTERACT, V185, P128, DOI 10.1016/j.cbi.2010.02.038; Laus F, 2010, ISR J VET MED, V65, P48; Liebscher G, 2016, CHEM-BIOL INTERACT, V246, P20, DOI 10.1016/j.cbi.2016.01.002; Rios JL, 2018, PLANTA MED, V84, P8, DOI 10.1055/s-0043-123472; MacGillivray KC, 2002, J VET INTERN MED, V16, P452, DOI 10.1892/0891-6640(2002)016&lt;0452:MMIH&gt;2.3.CO;2; Martens A, 2001, VET J, V161, P280, DOI 10.1053/tvjl.2000.0524; Martens A, 2000, RES VET SCI, V69, P295, DOI 10.1053/rvsc.2000.0432; MARTI E, 1993, EQUINE VET J, V25, P397, DOI 10.1111/j.2042-3306.1993.tb02981.x; McFADYEAN JOHN, 1933, JOUR COMP PATH AND THERAP, V46, P186; Mills PC, 2006, J VET PHARMACOL THER, V29, P25, DOI 10.1111/j.1365-2885.2006.00705.x; Moore JS, 2013, EQUINE VET EDUC, V25, P144, DOI 10.1111/j.2042-3292.2011.00368.x; Ruela ALM, 2016, BRAZ J PHARM SCI, V52, P527, DOI [10.1590/S1984-82502016000300018, 10.1590/s1984-82502016000300018]; Mourdjeva M, 2005, APOPTOSIS, V10, P209, DOI 10.1007/s10495-005-6076-5; Muller JMV, 2011, J IMMUNOTHER, V34, P58, DOI 10.1097/CJI.0b013e3181fe1997; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Nogueira SAF, 2006, VET DERMATOL, V17, P259, DOI 10.1111/j.1365-3164.2006.00526.x; PASCOE RR, 1981, EQUINE VET J, V13, P235, DOI 10.1111/j.2042-3306.1981.tb03504.x; Phillips JC, 2013, VET CLIN N AM-EQUINE, V29, P673, DOI 10.1016/j.cveq.2013.08.008; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Prausnitz MR., 2012, DERMATOLOGY, P2065; R Core Team, 2016, R FDN STAT COMP; Ren W., 2010, CHINESE GERMAN J CLI, V9, P153, DOI DOI 10.1007/S10330-010-0002-1; Rodriguez M, 1997, J EQUINE VET SCI, V17, P677, DOI 10.1016/S0737-0806(97)80270-5; Rowe EL, 2004, JAVMA-J AM VET MED A, V225, P94, DOI 10.2460/javma.2004.225.94; Sanderson BJS, 1996, MUTAT RES-FUND MOL M, V355, P59, DOI 10.1016/0027-5107(96)00022-X; Scacco L, 2013, J EQUINE VET SCI, V33, P637, DOI 10.1016/j.jevs.2012.09.006; Scott D., 1988, LARGE ANIM DERMATOLO, P448; Scott D, 2003, EQUINE DERMATOLOGY 1; Scott DW., 2011, EQUINE DERMATOLOGY, V2nd ed.; Seltenhammer MH, 2004, PIGM CELL RES, V17, P674, DOI 10.1111/j.1600-0749.2004.00192.x; Seltenhammer MH, 2003, EQUINE VET J, V35, P153, DOI 10.2746/042516403776114234; Smith SH, 2002, VET PATHOL, V39, P651, DOI 10.1354/vp.39-6-651; Spugnini EP, 2011, J EQUINE VET SCI, V31, P430, DOI 10.1016/j.jevs.2011.01.009; Stadler S, 2011, VET REC, V168, P187, DOI 10.1136/vr.c5430; Stahl J, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-138; Staiger EA, 2016, INT J CANCER, V139, P784, DOI 10.1002/ijc.30120; Sundstrom E, 2012, PIGM CELL MELANOMA R, V25, P28, DOI 10.1111/j.1755-148X.2011.00902.x; Supuran CT, 2018, EXPERT OPIN INV DRUG, V27, P963, DOI 10.1080/13543784.2018.1548608; Tan YM, 2003, CLIN CANCER RES, V9, P2866; TARWID JN, 1985, COMPEND CONTIN ED PR, V7, P293; Taylor S, 2013, EQUINE VET EDUC, V25, P210, DOI 10.1111/j.2042-3292.2012.00411.x; Teixeira RBC, 2013, J VET INTERN MED, V27, P1201, DOI 10.1111/jvim.12133; Theon AP, 2007, JAVMA-J AM VET MED A, V230, P1506, DOI 10.2460/javma.230.10.1506; Valentine BA, 2006, J VET DIAGN INVEST, V18, P123, DOI 10.1177/104063870601800121; VALENTINE BA, 1995, J VET INTERN MED, V9, P291, DOI 10.1111/j.1939-1676.1995.tb01087.x; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Weber LA, 2021, J VET PHARMACOL THER, V44, P47, DOI 10.1111/jvp.12903; Weber LA, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-2262-5; Wilford S, 2014, CAN VET J, V55, P683; Willmann M, 2009, EUR J CLIN INVEST, V39, P384, DOI 10.1111/j.1365-2362.2009.02105.x; Winum JY, 2005, BIOORG MED CHEM LETT, V15, P579, DOI 10.1016/j.bmcl.2004.11.058; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Yuan ZQ, 2011, J GEN VIROL, V92, P773, DOI 10.1099/vir.0.028191-0	88	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241448	10.1371/journal.pone.0241448	http://dx.doi.org/10.1371/journal.pone.0241448			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151949	Green Published, gold			2022-12-26	WOS:000591376200058
J	Yu, B; Jayavelu, ND; Battle, SL; Mar, JC; Schimmel, T; Cohen, J; Hawkins, RD				Yu, Bo; Doni Jayavelu, Naresh; Battle, Stephanie L.; Mar, Jessica C.; Schimmel, Timothy; Cohen, Jacques; Hawkins, R. David			Single-cell analysis of transcriptome and DNA methylome in human oocyte maturation	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; NON-CPG METHYLATION; GENE-EXPRESSION; GENOME-WIDE; TRANSITION; TUBB8; LOCALIZATION; MUTATIONS; LANDSCAPE; FOLLICLE	Oocyte maturation is a coordinated process that is tightly linked to reproductive potential. A better understanding of gene regulation during human oocyte maturation will not only answer an important question in biology, but also facilitate the development of in vitro maturation technology as a fertility treatment. We generated single-cell transcriptome and used our previously published single-cell methylome data from human oocytes at different maturation stages to investigate how genes are regulated during oocyte maturation, focusing on the potential regulatory role of non-CpG methylation. DNMT3B, a gene encoding a key non-CpG methylation enzyme, is one of the 1,077 genes upregulated in mature oocytes, which may be at least partially responsible for the increased non-CpG methylation as oocytes mature. Non-CpG differentially methylated regions (DMRs) between mature and immature oocytes have multiple binding motifs for transcription factors, some of which bind with DNMT3B and may be important regulators of oocyte maturation through non-CpG methylation. Over 98% of non-CpG DMRs locate in transposable elements, and these DMRs are correlated with expression changes of the nearby genes. Taken together, this data indicates that global non-CpG hypermethylation during oocyte maturation may play an active role in gene expression regulation, potentially through the interaction with transcription factors.	[Yu, Bo; Battle, Stephanie L.] Univ Washington, Sch Med, Dept OBGYN, Seattle, WA 98195 USA; [Yu, Bo; Hawkins, R. David] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Doni Jayavelu, Naresh; Battle, Stephanie L.; Hawkins, R. David] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Doni Jayavelu, Naresh; Battle, Stephanie L.; Hawkins, R. David] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Schimmel, Timothy; Cohen, Jacques] Reprogenetics LLC, Livingston, NJ USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine	Yu, B (corresponding author), Univ Washington, Sch Med, Dept OBGYN, Seattle, WA 98195 USA.; Yu, B; Hawkins, RD (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.; Hawkins, RD (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.; Hawkins, RD (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	boyumich2@gmail.com; rdhawk@uw.edu			Reproductive Scientist Development Program [NIH K12HD00849]; National Institutes of Health [K08CA222835, P30CA015704]; Society for Reproductive Investigation; American Society of Reproductive Medicine; Howard and Georgeanna Jones Foundation for Reproductive Medicine	Reproductive Scientist Development Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Reproductive Investigation; American Society of Reproductive Medicine; Howard and Georgeanna Jones Foundation for Reproductive Medicine	This study was funded by Reproductive Scientist Development Program (NIH K12HD00849), National Institutes of Health (K08CA222835, P30CA015704), Society for Reproductive Investigation, American Society of Reproductive Medicine, Howard and Georgeanna Jones Foundation for Reproductive Medicine (To B.Y.).	Ackermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019090; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bidin NA, 2012, J KOMUN, V28, P33; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Bouyioukos C, 2016, NUCLEIC ACIDS RES, V44, pW77, DOI 10.1093/nar/gkw384; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Collado-Fernandez E, 2012, INT J DEV BIOL, V56, P799, DOI 10.1387/ijdb.120140ec; Cui XS, 2007, J REPROD DEVELOP, V53, P405, DOI 10.1262/jrd.18113; Dade S, 2003, FEBS LETT, V555, P533, DOI 10.1016/S0014-5793(03)01341-3; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Dou XY, 2019, GENOME RES, V29, P1622, DOI 10.1101/gr.234021.117; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Feng RZ, 2016, J MED GENET, V53, P662, DOI 10.1136/jmedgenet-2016-103891; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7; Gatto S, 2017, NUCLEIC ACIDS RES, V45, P5739, DOI 10.1093/nar/gkx163; Geiman TM, 2004, BIOCHEM BIOPH RES CO, V318, P544, DOI 10.1016/j.bbrc.2004.04.058; Georgiou I, 2009, HUM MOL GENET, V18, P1221, DOI 10.1093/hmg/ddp022; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-116; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Han L, 2007, CANCER BIOL THER, V6, P1284; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Huang LL, 2017, REPROD BIOMED ONLINE, V35, P305, DOI 10.1016/j.rbmo.2017.05.017; Jones GM, 2008, HUM REPROD, V23, P1138, DOI 10.1093/humrep/den085; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo YB, 2016, HISTOCHEM CELL BIOL, V145, P93, DOI 10.1007/s00418-015-1369-4; Markholt S, 2012, MOL HUM REPROD, V18, P96, DOI 10.1093/molehr/gar083; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Senthilkumaran B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145182; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sutton ML, 2003, REPRODUCTION, V126, P27, DOI 10.1530/rep.0.1260027; Sutton-McDowall ML, 2004, REPRODUCTION, V128, P313, DOI 10.1530/rep.1.00225; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varghese VK, 2018, MOL CARCINOGEN, V57, P370, DOI 10.1002/mc.22761; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Vigneault C, 2009, REPRODUCTION, V137, P13, DOI 10.1530/REP-08-0077; VIRANTKLUN I, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/879489; Wang XY, 2017, GENOME RES, V27, P567, DOI 10.1101/gr.198044.115; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yu B, 2017, STEM CELL REP, V9, P397, DOI 10.1016/j.stemcr.2017.05.026; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; Zorrilla Michelle, 2013, Curr Genet Med Rep, V1, DOI 10.1007/s40142-013-0027-1	76	15	16	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241698	10.1371/journal.pone.0241698	http://dx.doi.org/10.1371/journal.pone.0241698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152014	gold, Green Published			2022-12-26	WOS:000591376200078
J	Venegas, P; Perez, N; Zapata, S; Mosquera, JD; Augot, D; Rojo-Alvarez, JL; Benitez, D				Venegas, Pablo; Perez, Noel; Zapata, Sonia; Daniel Mosquera, Juan; Augot, Denis; Luis Rojo-Alvarez, Jose; Benitez, Diego			An approach to automatic classification of Culicoides species by learning the wing morphology	PLOS ONE			English	Article							GROUP DIPTERA-CERATOPOGONIDAE; GEOMETRIC MORPHOMETRICS; BITING MIDGES	Fast and accurate identification of biting midges is crucial in the study of Culicoides-borne diseases. In this work, we propose a two-stage method for automatically analyzing Culicoides (Diptera: Ceratopogonidae) species. First, an image preprocessing task composed of median and Wiener filters followed by equalization and morphological operations is used to improve the quality of the wing image in order to allow an adequate segmentation of particles of interest. Then, the segmentation of the zones of interest inside the biting midge wing is made using the watershed transform. The proposed method is able to produce optimal feature vectors that help to identify Culicoides species. A database containing wing images of C. obsoletus, C. pusillus, C. foxi, and C. insignis species was used to test its performance. Feature relevance analysis indicated that the mean of hydraulic radius and eccentricity were relevant for the decision boundary between C. obsoletus and C. pusillus species. In contrast, the number of particles and the mean of the hydraulic radius was relevant for deciding between C. foxi and C. insignis species. Meanwhile, for distinguishing among the four species, the number of particles and zones, and the mean of circularity were the most relevant features. The linear discriminant analysis classifier was the best model for the three experimental classification scenarios previously described, achieving averaged areas under the receiver operating characteristic curve of 0.98, 0.90, and 0.96, respectively.	[Venegas, Pablo; Perez, Noel; Benitez, Diego] Univ San Francisco Quito USFQ, Colegio Ciencias & Ingenierias El Politecn, Quito, Ecuador; [Zapata, Sonia; Daniel Mosquera, Juan] Univ San Francisco Quito USFQ, Inst Microbiol, Colegio Ciencias Biol & Ambientales COCIBA, Quito, Ecuador; [Augot, Denis] Univ Reims, EA7510, ANSES LSA, Usc Vecpar, Reims, France; [Luis Rojo-Alvarez, Jose] Rey Juan Carlos Univ, Dept Signal Theory & Commun, Fuenlabrada, Spain	Universite de Reims Champagne-Ardenne; Universidad Rey Juan Carlos	Benitez, D (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias & Ingenierias El Politecn, Quito, Ecuador.	dbenitez@usfq.edu.ec	Zapata Mena, Sonia/AAF-3530-2020; Rojo-Álvarez, José-Luis/F-6520-2016; Perez, Noel/E-1894-2014; Benitez, Diego/E-5393-2015	Rojo-Álvarez, José-Luis/0000-0003-0426-8912; Perez, Noel/0000-0003-3166-745X; Venegas, Pablo/0000-0003-3297-4486; Benitez, Diego/0000-0001-6219-067X	Universidad San Francisco de Quito (USFQ) [12476, 1114]	Universidad San Francisco de Quito (USFQ)	DB. Collaboration Grants Program (Grant no. 12476), Universidad San Francisco de Quito (USFQ), https://www.usfq.edu.ec/DB.Chancellor Grants Program (Grant no. 1114), Universidad San Francisco de Quito (USFQ), https://www.usfq.edu.ec/Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augot D, 2010, INFECT GENET EVOL, V10, P629, DOI 10.1016/j.meegid.2010.03.016; Benalcazar DR, 2018, IEEE INT AUT MEET, DOI 10.1109/ROPEC.2018.8661447; Boorman JPT, 2007, NAME LIST WORLD CULI; Borkent A, 2016, SUBGENERIC CLASSIFIC; Borkent Art, 2005, P113; Wilke ABB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161643; Felippe-Bauer ML, 2003, MEM I OSWALDO CRUZ, V98, P1051, DOI 10.1590/S0074-02762003000800014; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Guerron A, 2016, IEEE INT AUT MEET; Haarlem C., 2018, BIORXIV PREPRINT, DOI [10.1101/410449v1.full, DOI 10.1101/410449V1.FULL]; Hadj-Henni L, 2015, INFECT GENET EVOL, V33, P324, DOI 10.1016/j.meegid.2015.05.024; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harrup LE, 2015, INFECT GENET EVOL, V30, P249, DOI 10.1016/j.meegid.2014.12.018; Henni LH, 2014, INFECT GENET EVOL, V21, P110, DOI 10.1016/j.meegid.2013.10.008; Lopez FG, 2006, EUR J OPER RES, V169, P477, DOI 10.1016/j.ejor.2004.08.010; Lorenz C, 2017, INFECT GENET EVOL, V54, P205, DOI 10.1016/j.meegid.2017.06.029; Lorenz C, 2015, ACTA TROP, V152, P165, DOI 10.1016/j.actatropica.2015.09.011; Mathieu B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-137; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mosquera JD, 2017, THESIS; Munoz-Munoz F, 2014, MED VET ENTOMOL, V28, P319, DOI 10.1111/mve.12042; Munoz-Munoz F, 2011, J MED ENTOMOL, V48, P129, DOI 10.1603/ME10110; Munoz-Munoz F, 2016, J INVERTEBR PATHOL, V135, P1, DOI 10.1016/j.jip.2016.01.008; Natick, 2019, MATLAB VERS 9 6 0 1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Papadopoulos A, 2005, ARTIF INTELL MED, V34, P141, DOI 10.1016/j.artmed.2004.10.001; Perez N, 2020, IEEE T GEOSCI REMOTE, V58, P6493, DOI 10.1109/TGRS.2020.2976896; Perez N, 2014, ACSIS-ANN COMPUT SCI, V2, P209; PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149; Rawlings Peter, 1996, Graellsia, V52, P57; ROSNER B, 1982, APPL STAT-J ROY ST C, V31, P9, DOI 10.2307/2347069; Sontigun N, 2019, ACTA TROP, V190, P312, DOI 10.1016/j.actatropica.2018.12.011; Spinelli Gustavo R., 1993, Contributions of the American Entomological Institute, V27, P1; Szadziewski R, 2016, ZOOTAXA, V4107, P413, DOI 10.11646/zootaxa.4107.3.9; Venegas P, 2019, 2019 IEEE CHILEAN CONFERENCE ON ELECTRICAL, ELECTRONICS ENGINEERING, INFORMATION AND COMMUNICATION TECHNOLOGIES (CHILECON); Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Wirth W.W., 1988, Contributions of the American Entomological Institute, V25, P1; Yang HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12786	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241798	10.1371/journal.pone.0241798	http://dx.doi.org/10.1371/journal.pone.0241798			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147271	gold, Green Published			2022-12-26	WOS:000589609300075
J	Kozdon, K; Caridi, B; Duru, I; Ezra, DG; Phillips, JB; Bailly, M				Kozdon, Katarzyna; Caridi, Bruna; Duru, Iheukwumere; Ezra, Daniel G.; Phillips, James B.; Bailly, Maryse			A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery	PLOS ONE			English	Article							MATRIX CONTRACTION; GLAUCOMA; COLLAGEN; CELL; PREVENTS; ARCHITECTURE; MODULATION; MORPHOLOGY; SURGERY; REPAIR	Glaucoma filtration surgery is one of the most effective methods for lowering intraocular pressure in glaucoma. The surgery efficiently reduces intra-ocular pressure but the most common cause of failure is scarring at the incision site. This occurs in the conjunctiva/Tenon's capsule layer overlying the scleral coat of the eye. Currently used antimetabolite treatments to prevent post-surgical scarring are non-selective and are associated with potentially blinding side effects. Developing new treatments to target scarring requires both a better understanding of wound healing and scarring in the conjunctiva, and new means of delivering anti-scarring drugs locally and sustainably. By combining plastic compression of collagen gels with a soft collagen-based layer, we have developed a physiologically relevant model of the sub-epithelial bulbar conjunctiva/Tenon's capsule interface, which allows a more holistic approach to the understanding of subconjunctival tissue behaviour and local drug delivery. The biomimetic tissue hosts both primary human conjunctival fibroblasts and an immune component in the form of macrophages, morphologically and structurally mimicking the mechanical proprieties and contraction kinetics of ex vivo porcine conjunctiva. We show that our model is suitable for the screening of drugs targeting scarring and/or inflammation, and amenable to the study of local drug delivery devices that can be inserted in between the two layers of the biomimetic. We propose that this multicellular-bilayer engineered tissue will be useful to study complex biological aspects of scarring and fibrosis, including the role of inflammation, with potentially significant implications for the management of scarring following glaucoma filtration surgery and other anterior ocular segment scarring conditions. Crucially, it uniquely allows the evaluation of new means of local drug delivery within a physiologically relevant tissue mimetic, mimicking intraoperative drug delivery in vivo.	[Kozdon, Katarzyna; Caridi, Bruna; Duru, Iheukwumere; Ezra, Daniel G.; Bailly, Maryse] UCL, UCL Inst Ophthalmol, London, England; [Ezra, Daniel G.] Moorfields Eye Hosp, London, England; [Phillips, James B.] UCL, Dept Pharmacol, UCL Sch Pharm, London, England; [Duru, Iheukwumere] Warrington & Halton Teaching Hosp NHS Fdn Trust, Warrington, Cheshire, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Bailly, M (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	m.bailly@ucl.ac.uk		Duru, Iheukwumere/0000-0002-8880-4278; Bailly, Maryse/0000-0002-0593-6356; Phillips, James/0000-0001-8117-3074	Moorfields Eye Charity [ST 12 11 B]; Department of Health by the National Institute for Health Research; UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology	Moorfields Eye Charity; Department of Health by the National Institute for Health Research; UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology	This work was supported by the Special Trustees of Moorfields Eye Hospital (now Moorfields Eye Charity; https://moorfieldseyecharity.org.uk/; grant ST 12 11 B to MB and DGE). DGE acknowledges financial support from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology (https://www.moorfieldsbrc.nihr.ac.uk/).The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almatlouh A, 2019, ACTA OPHTHALMOL, V97, P146, DOI 10.1111/aos.13919; Armstrong JJ, 2019, EXP EYE RES, V182, P65, DOI 10.1016/j.exer.2019.03.015; Awwad S, 2015, J PHARM SCI-US, V104, P3330, DOI 10.1002/jps.24480; BAUN O, 1995, ACTA OPHTHALMOL SCAN, V73, P242; Bensman TJ, 2012, PULM PHARMACOL THER, V25, P377, DOI 10.1016/j.pupt.2012.06.010; Bettin P., 2017, DEV OPHTHALMOL, Vxii; Broadway DC, 1998, AM J OPHTHALMOL, V125, P805, DOI 10.1016/S0002-9394(98)00045-2; Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x; Cheema U, 2013, ADV WOUND CARE, V2, P176, DOI 10.1089/wound.2012.0392; Cook C., 2018, S AFRICAN OPHTHALMOL, P11; Crespo-Moral M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227732; Dahlmann-Noor AH, 2007, EXP CELL RES, V313, P4158, DOI 10.1016/j.yexcr.2007.07.040; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Drechsler CC, 2017, J TISSUE ENG REGEN M, V11, P896, DOI 10.1002/term.1991; Gater R, 2019, INVEST OPHTH VIS SCI, V60, P605, DOI 10.1167/iovs.18-25335; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Kasbekar S, 2018, J TISSUE ENG REGEN M, V12, pE973, DOI 10.1002/term.2419; Kechagia JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28261; Khaw PT, 2001, CURR OPIN OPHTHALMOL, V12, P143, DOI 10.1097/00055735-200104000-00011; Lee RMH, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.3.58; Levis HJ, 2015, J FUNCT BIOMATER, V6, P50, DOI 10.3390/jfb6010050; Li H, 2013, INVEST OPHTH VIS SCI, V54, P4675, DOI 10.1167/iovs.13-11787; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Masoumpour Masoumeh B, 2016, Open Ophthalmol J, V10, P68, DOI 10.2174/1874364101610010068; Mukhey D, 2018, ACTA BIOMATER, V67, P229, DOI 10.1016/j.actbio.2017.11.047; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Panarelli JF, 2016, CURR OPIN OPHTHALMOL, V27, P170, DOI 10.1097/ICU.0000000000000240; Park CY, 2016, INVEST OPHTH VIS SCI, V57, P5602, DOI 10.1167/iovs.16-19706; Payne JB, 2011, J AM DENT ASSOC, V142, P262, DOI 10.14219/jada.archive.2011.0165; Quigley HA, 2018, METHODS MOL BIOL, V1695, P1, DOI 10.1007/978-1-4939-7407-8_1; Schlunck G, 2016, EXP EYE RES, V142, P76, DOI 10.1016/j.exer.2015.03.021; Seet LF, 2011, MOL MED, V17, P557, DOI 10.2119/molmed.2010.00188; SHERWOOD MB, 1989, OPHTHALMOLOGY, V96, P327, DOI 10.1016/S0161-6420(89)32888-0; SooHoo JR, 2012, MOL VIS, V18, P714; Su WR, 2011, INVEST OPHTH VIS SCI, V52, P9108, DOI 10.1167/iovs.11-7255; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Theodossiou TA, 2006, BIOPHYS J, V91, P4665, DOI 10.1529/biophysj.106.093740; Torrejon KY, 2016, BIOTECHNOL BIOENG, V113, P1357, DOI 10.1002/bit.25899; Tovell VE, 2012, INVEST OPHTH VIS SCI, V53, P4682, DOI 10.1167/iovs.11-8577; Tovell VE, 2011, ARCH OPHTHALMOL-CHIC, V129, P619, DOI 10.1001/archophthalmol.2011.91; Van de Velde S, 2015, PROG BRAIN RES, V221, P319, DOI 10.1016/bs.pbr.2015.05.002; Vernazza S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221942; Wu J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45510-7; Yang S, 2015, GENET MOL RES, V14, P14088, DOI 10.4238/2015.October.29.28; Yu-Wai-Man C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00212-w; Yu-Wai-Man C, 2015, EXPERT REV OPHTHALMO, V10, P65, DOI 10.1586/17469899.2015.983475	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241569	10.1371/journal.pone.0241569	http://dx.doi.org/10.1371/journal.pone.0241569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141875	Green Published, gold			2022-12-26	WOS:000588376700004
J	Sakina, A; Mir, S; Najeeb, S; Zargar, SM; Nehvi, FA; Rather, ZA; Salgotra, RK; Shikari, AB				Sakina, Aafreen; Mir, Saba; Najeeb, Sofi; Zargar, Sajad M.; Nehvi, Firdous A.; Rather, Zahoor A.; Salgotra, Romesh K.; Shikari, Asif B.			Improved protocol for efficacious in vitro androgenesis and development of doubled haploids in temperate japonica rice	PLOS ONE			English	Article							BARLEY HORDEUM-VULGARE; ANTHER CULTURE RESPONSE; ORYZA-SATIVA L.; INDICA RICE; COLD-PRETREATMENT; PLANT; REGENERATION; EMBRYOGENESIS; HYBRIDS; MALTOSE	DH (Doubled haploid) is the immortal mapping population and an outcome of single meiotic cycle, contributed from male partner. An improved procedure was developed for high frequency androgenesis in japonica genotypes, K-332 and GS-88 and their F(1)s. A total of 207 fertile, green, di-haploid plants were generated from K-332 x GS-88 hybrids using the improved anther culture protocol. The investigation was carried out to evaluate callus induction potential and regeneration response for the genotypes and the derived F(1)s on N6 media and modified N6 media (N6(M)). Whereas, N6 failed to induce callusing, agarose solidified N6(M) media supplemented with 4% maltose, growth regulators; NAA (2 mg/l), 2, 4-D (0.5 mg/l), Kinetin (0.5 mg/l), and silver nitrate induced high calli percentage of 27.6% in F(1)s, 9.5% and 6.7% in GS-88 and K-332 respectively. Murashige and Skoog (MS) media supplemented with 3% sucrose, and the hormonal combination BAP (2 mg/l), Kinetin (1 mg/l) and NAA (1 mg/l) induced high green shoot regeneration rates (0-60.0%). The effect of cold pre-treatment at 4 degrees C and the stage of anther collection and their interaction was studied. The effect of cold pre-treatment (CP) of collected boots at 4 degrees C (for CP2: 2, CP4: 4, CP6: 6 and CP8: 8 days) at different stages of panicle emergence (BES4-6: 4-6, BES7-10: 7-10, BES11-13: 11-13, BES13: more than 13 inches was worked out in relation to the effect on response of calli induction, albino regeneration, green plant regeneration and number of shoots/green calli. CP referred to the number of days for which the collected boots were incubated before they were inoculated. BES was the length (inches) between flag leaf and penultimate leaf at the time of boot collection. We concluded that CP6 and BES7-10 showed better response to callus proliferation and regeneration of plantlets across genotypes. The appropriate pre-treatment, stage of anther collection and favourable media composition resulted in high calli induction and green plant regeneration rates in recalcitrant japonica genotypes. The modified N6 media resulted into efficient callus induction and is expected to be useful for studies which aim at rapid generation of mapping populations for genetic studies.	[Sakina, Aafreen; Mir, Saba; Zargar, Sajad M.; Nehvi, Firdous A.; Shikari, Asif B.] Sher e Kashmir Univ Agr Sci & Technol Kashmir, Div Plant Biotechnol, Srinagar, J&K, India; [Najeeb, Sofi] Sher e Kashmir Univ Agr Sci & Technol Kashmir, Mt Res Ctr Field Crops, Srinagar, J&K, India; [Rather, Zahoor A.] Sher e Kashmir Univ Agr Sci & Technol Kashmir, Div Floriculture & Landscaping, Srinagar, J&K, India; [Salgotra, Romesh K.] Sher e Kashmir Univ Agr Sci & Technol Kashmir, Sch Biotechnol, Srinagar, J&K, India	Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Shikari, AB (corresponding author), Sher e Kashmir Univ Agr Sci & Technol Kashmir, Div Plant Biotechnol, Srinagar, J&K, India.	asifshikari@skuastkashmir.ac.in	Shikari, Asif/AAV-8846-2021	SHIKARI, ASIF/0000-0002-2911-5536; Salgotra, Romesh Kumar/0000-0001-7605-0926				Bishnoi U, 2000, EUPHYTICA, V114, P93, DOI 10.1023/A:1003915331143; Chen C-C, 1991, FACTORS AFFECTING AN, P193; Chu C.-C., 1981, Proceedings of symposium on plant tissue culture., P43; Datta S, 1988, ARCH FUER ZUECHTUNGS; DEAMBROGIO E, 1980, Cereal Research Communications, V8, P417; Faruque MO, 1998, PLANT CELL TISS ORG, V54, P191, DOI 10.1023/A:1006178730306; Gomez K.A., 1984, STAT PROCEDURES AGR; Gosal S, 1997, CEREALS IN VITRO HAP, P1; Grewal D, 2006, PLANT GROWTH REGUL, V49, P43, DOI 10.1007/s10725-006-0021-7; GUHA S, 1964, NATURE, V204, P497, DOI 10.1038/204497a0; Heberle-Bors Erwin, 1996, P85; Hooghvorst I, 2018, PLANT CELL TISS ORG, V134, P205, DOI 10.1007/s11240-018-1413-x; Khatun R, 2012, INDIAN J BIOTECHNOL, V11, P458; Kiviharju E, 1998, PLANT CELL TISS ORG, V54, P97, DOI 10.1023/A:1006167306638; LAST DI, 1990, PLANT CELL REP, V9, P14, DOI 10.1007/BF00232126; Lenka N., 1994, Proceedings of the Indian National Science Academy Part B Biological Sciences, V60, P87; LENTINI Z, 1995, PLANT SCI, V110, P127, DOI 10.1016/0168-9452(95)04180-3; Li M, 1992, ANTHER CULTURE BREED, P75; Lone Z, 2016, ORYZA AN INT J RICE, V53, P91; Lopez-Cristoffanini C, 2018, PLANT BIOTECHNOL-NAR, V35, P161, DOI 10.5511/plantbiotechnology.18.0409a; Lovelin Kaushal, 2014, International Journal of Agriculture Innovations and Research, V3, P218; Mishra R, 2016, RICE SCI, V23, P57, DOI 10.1016/j.rsci.2016.02.001; Mishra R, 2015, RICE SCI, V22, P290, DOI 10.1016/j.rsci.2015.07.002; MORDHORST AP, 1993, J PLANT PHYSIOL, V142, P485, DOI 10.1016/S0176-1617(11)81256-3; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; National Institutes of Health Consensus Development Conference Statement, 2002, HEPATOLOGY S1, V36, pS3; NAVARROALVAREZ W, 1994, PLANT BREEDING, V112, P53, DOI 10.1111/j.1439-0523.1994.tb01276.x; NIIZEKI H, 1968, P JPN ACAD, V44, P554, DOI 10.2183/pjab1945.44.554; Nurhasanah N, 2015, EFFECT GENOTYPE DEV; Pande H, 1999, BIOL PLANTARUM, V42, P125, DOI 10.1023/A:1002187930087; Raina SK, 1997, PLANT BREEDING, V116, P305, DOI 10.1111/j.1439-0523.1997.tb01004.x; REIFFERS I, 1990, PLANT CELL TISS ORG, V21, P165, DOI 10.1007/BF00033437; Sasrnita P, 2007, APLIKASI TEKNIK KULT; Shikari AB, 2018, SKUAST J RES, V20, P32; Shikari AB, EFFECT SILIQUA ORIEN; Silva T, 2009, ANOTHER CULTURE POTE, V250; Sripichitt Prapa, 2000, Plant Production Science, V3, P254, DOI 10.1626/pps.3.254; Torp AM, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P155, DOI 10.1007/978-1-4020-8854-4_12; Touraev A, 1997, TRENDS PLANT SCI, V2, P297, DOI 10.1016/S1360-1385(97)89951-7; Trejo-Tapia G, 2002, PLANT CELL TISS ORG, V71, P41, DOI 10.1023/A:1016558025840; Wojnarowiez G, 2002, PLANT SCI, V162, P843, DOI 10.1016/S0168-9452(02)00036-5; Yamagishi M, 2002, EUPHYTICA, V123, P67, DOI 10.1023/A:1014493316433; Yoshida S., 1981, Fundamentals of rice crop science.; ZIAUDDIN A, 1990, EUPHYTICA, V48, P279, DOI 10.1007/BF00023662	44	3	3	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241292	10.1371/journal.pone.0241292	http://dx.doi.org/10.1371/journal.pone.0241292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137812	gold, Green Published			2022-12-26	WOS:000588375500018
J	Kato, Y; Takahashi, M; Seki, M; Nashimoto, M; Shimizu-Ibuka, A				Kato, Yoshiki; Takahashi, Masayuki; Seki, Mineaki; Nashimoto, Masayuki; Shimizu-Ibuka, Akiko			RNA-hydrolyzing activity of metallo-beta-lactamase IMP-1	PLOS ONE			English	Article							STANDARD NUMBERING SCHEME; TRNASE-Z; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; SUBSTRATE; BINDING; FAMILY	Metallo-beta-lactamases (MBLs) hydrolyze a wide range of beta-lactam antibiotics. While all MBLs share a common alpha beta/beta alpha-fold, there are many other proteins with the same folding pattern that exhibit different enzymatic activities. These enzymes, together with MBLs, form the MBL superfamily. Thermotoga maritima tRNase Z, a tRNA 3 ' processing endoribonuclease of MBL-superfamily, and IMP-1, a clinically isolated MBL, showed a striking similarity in tertiary structure, despite low sequence homology. IMP-1 hydrolyzed both total cellular RNA and synthetic small unstructured RNAs. IMP-1 also hydrolyzed pre-tRNA, but its cleavage site was different from those of T. maritima tRNase Z and human tRNase Z long form, indicating a key difference in substrate recognition. Single-turnover kinetic assays suggested that substrate-binding affinity of T. maritima tRNase Z is much higher than that of IMP-1.	[Kato, Yoshiki; Shimizu-Ibuka, Akiko] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Takahashi, Masayuki; Seki, Mineaki; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan	Niigata University; Niigata University	Shimizu-Ibuka, A (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	ibuka@nupals.ac.jp			JSPS KAKENHI [JP19K07566]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant Number JP19K07566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Beaudoin GAW, 2018, BIOCHEM J, V475, P261, DOI 10.1042/BCJ20170817; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bush K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01076-18; Campos-Bermudez VA, 2007, BIOCHEMISTRY-US, V46, P11069, DOI 10.1021/bi7007245; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hou YM, 2015, METHOD ENZYMOL, V560, P91, DOI 10.1016/bs.mie.2015.04.012; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; Lee JH, 2019, EMERG MICROBES INFEC, V8, P1688, DOI 10.1080/22221751.2019.1692638; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Minagawa A, 2006, NUCLEIC ACIDS RES, V34, P3811, DOI 10.1093/nar/gkl517; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Shibata HS, 2006, BIOCHEMISTRY-US, V45, P5486, DOI 10.1021/bi051972s; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2	30	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241557	10.1371/journal.pone.0241557	http://dx.doi.org/10.1371/journal.pone.0241557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33126240	gold, Green Published			2022-12-26	WOS:000588368900063
J	Maksimowski, N; Williams, VR; Scholey, JW				Maksimowski, Nicholas; Williams, Vanessa R.; Scholey, James W.			Kidney ACE2 expression: Implications for chronic kidney disease	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; FUNCTIONAL RECEPTOR; MECHANISMS; INJURY; LEADS; MAS	Angiotensin-converting enzyme 2 (ACE2) has been implicated in the pathogenesis of chronic kidney disease (CKD) and is a membrane receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease (COVID-19), whereas transmembrane protease, serine 2 (TMPRSS2) is involved in viral attachment. Together, tissue expression of ACE2 and TMPRSS2 may determine infection. Sex, age, body mass index (BMI), and CKD are clinical risk factors for COVID-19 severity, but the relationships between kidney ACE2 and TMPRSS2 expression and these clinical variables are unknown. Accordingly, we obtained renal tubulointerstitial and glomerular microarray expression data and clinical variables from healthy living donors (HLD) and patients with CKD from the European Renal cDNA Bank. ACE2 expression was similar in the tubulointerstitium of the two groups, but greater in females than males in HLD (P = 0.005) and CKD (P < 0.0001). ACE2 expression was lower in glomeruli of CKD patients compared to HLD (P = 0.0002) and lower in males than females. TMPRSS2 expression was similar in the tubulointerstitium but lower in glomeruli of CKD patients compared to HLD (P < 0.0001). There was a strong relationship between ACE2 and TMPRSS2 expression in the glomerulus (r = 0.51, P < 0.0001). In CKD, there was a relationship between tubulointerstitial ACE2 expression and estimated glomerular filtration rate (r = 0.36, P < 0.0001) and age (r = -0.17, P = 0.03), but no relationship with BMI. There were no relationships between TMPRSS2 expression and clinical variables. Genes involved in inflammation (CCL2, IL6, and TNF) and fibrosis (COL1A1, TGFB1, and FN1) were inversely correlated with ACE2 expression. In summary, kidney expression of ACE2 and TMPRSS2 differs in HLD and CKD. ACE2 is related to sex and eGFR. ACE2 is also associated with expression of genes implicated in inflammation and fibrosis.	[Maksimowski, Nicholas; Williams, Vanessa R.; Scholey, James W.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Scholey, James W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Scholey, James W.] Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Scholey, James W.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Williams, VR (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	vanessa.williams@mail.utoronoto.ca						Bae EH, 2017, KIDNEY INT, V91, P1347, DOI 10.1016/j.kint.2016.12.022; Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071433; Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Gilbert RE, 2021, CAN J DIABETES, V45, DOI 10.1016/j.jcjd.2020.07.003; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lely AT, 2004, J PATHOL, V204, P587, DOI 10.1002/path.1670; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu Z, 2012, LAB INVEST, V92, P650, DOI 10.1038/labinvest.2012.2; Lytvyn Y, 2019, AM J KIDNEY DIS, V73, P786, DOI 10.1053/j.ajkd.2018.12.034; Mizuiri S, 2008, AM J KIDNEY DIS, V51, P613, DOI 10.1053/j.ajkd.2007.11.022; Mizuiri S, 2011, NEPHRON CLIN PRACT, V117, pC57, DOI 10.1159/000319648; Neugarten J, 2019, MAYO CLIN PROC, V94, P1339, DOI 10.1016/j.mayocp.2018.12.024; Ng JH, 2021, AM J KIDNEY DIS, V77, P204, DOI 10.1053/j.ajkd.2020.09.002; Ong SWX, 2020, CLIN INFECT DIS, V71, P2300, DOI 10.1093/cid/ciaa548; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shiota A, 2010, HYPERTENS RES, V33, P298, DOI 10.1038/hr.2009.231; Souza LL, 2012, J CELL PHYSIOL, V227, P2117, DOI 10.1002/jcp.22940; Sridhar VS, 2019, AM J PHYSIOL-RENAL, V317, pF1224, DOI 10.1152/ajprenal.00370.2019; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Velez JCQ, 2020, NAT REV NEPHROL, V16, P565, DOI 10.1038/s41581-020-0332-3; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang G, 2011, KIDNEY BLOOD PRESS R, V34, P141, DOI 10.1159/000324521; Williams VR, 2018, CURR OPIN NEPHROL HY, V27, P35, DOI 10.1097/MNH.0000000000000378; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; World Tourism Organization-UNWTO, 2022, UNWTO WORLD TOUR BAR, V17, P1, DOI [DOI 10.18111/WTOBAROMETERENG, 10.18111/wtobarometereng.2022.20.1.4, DOI 10.18111/WTOBAROMETERENG.2022.20.1.4]; Wysocki J, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.264; Yoshida M, 2002, THROMB RES, V105, P531, DOI 10.1016/S0049-3848(02)00056-7; Zhang FQ, 2020, J MED VIROL, V92, P2536, DOI 10.1002/jmv.26039; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	54	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241534	10.1371/journal.pone.0241534	http://dx.doi.org/10.1371/journal.pone.0241534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125431	Green Published, gold			2022-12-26	WOS:000588368900027
J	Matsuoka, T; Miyauchi, R; Nagaoka, N; Hasegawa, J				Matsuoka, Tatsuji; Miyauchi, Ryuki; Nagaoka, Nobumi; Hasegawa, Jun			Mitigation of liquid-liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface	PLOS ONE			English	Article							REVERSIBLE SELF-ASSOCIATION; THERAPEUTIC ANTIBODY; VISCOSITY; AGGREGATION; OPTIMIZATION; CHALLENGES; STABILITY; BEHAVIOR; MUTANTS	Some monoclonal antibodies undergo liquid-liquid phase separation owing to self-attractive associations involving electrostatic and other soft interactions, thereby rendering monoclonal antibodies unsuitable as therapeutics. To mitigate the phase separation, formulation optimization is often performed. However, this is sometimes unsuccessful because of the limited time for the development of therapeutic antibodies. Thus, protein mutations with appropriate design are required. In this report, we describe a case study involving the design of mutants of negatively charged surface residues to reduce liquid-liquid phase separation propensity. Physicochemical analysis of the resulting mutants demonstrated the mutual correlation between the sign of second virial coefficient B-2, the Fab dipole moment, and the reduction of liquid-liquid phase separation propensity. Moreover, both the magnitude and direction of the dipole moment appeared to be essential for liquid-liquid phase separation propensity, where electrostatic interaction was the dominant mechanism. These findings could contribute to a better design of mutants with reduced liquid-liquid phase separation propensity and improved drug-like biophysical properties.	[Matsuoka, Tatsuji; Miyauchi, Ryuki; Nagaoka, Nobumi; Hasegawa, Jun] Daiichi Sankyo Co Ltd, Modal Res Labs, Shinagawa Ku, Tokyo, Japan; [Matsuoka, Tatsuji] Daiichi Sankyo Co Ltd, Biol Technol Res Labs, Gunma, Japan; [Hasegawa, Jun] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Osaka University	Matsuoka, T (corresponding author), Daiichi Sankyo Co Ltd, Modal Res Labs, Shinagawa Ku, Tokyo, Japan.	matsuoka.tatsuji.bs@daiichisankyo.co.jp			Daiichi Sankyo Co., Ltd	Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited)	The authors received no specific funding for this work. Daiichi Sankyo Co., Ltd provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Buck PM, 2015, MOL PHARMACEUT, V12, P127, DOI 10.1021/mp500485w; Casaz P, 2014, MABS-AUSTIN, V6, P1533, DOI 10.4161/19420862.2014.975658; Chi EY, 2003, PROTEIN SCI, V12, P903, DOI 10.1110/ps.0235703; Chow CK, 2016, MOL PHARMACEUT, V13, P915, DOI 10.1021/acs.molpharmaceut.5b00817; Connolly BD, 2012, BIOPHYS J, V103, P69, DOI 10.1016/j.bpj.2012.04.047; Corbett D, 2019, METHODS MOL BIOL, V2039, P3, DOI 10.1007/978-1-4939-9678-0_1; Dengl S, 2013, PHARM RES-DORDR, V30, P1380, DOI 10.1007/s11095-013-0977-8; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Du Q, 2019, MABS-AUSTIN, V11, P789, DOI 10.1080/19420862.2019.1599634; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Fasnacht M, 2014, PROTEINS, V82, P1583, DOI 10.1002/prot.24604; Filtz IN, 2013, WHAT CARDIOLOGISTS N, V127, P2222, DOI [10.1161/CIRCULATIONAHA.113.002033, DOI 10.1161/CIRCULATIONAHA.113.002033]; Gagnon P, 2009, NEW BIOTECHNOL, V25, P287, DOI 10.1016/j.nbt.2009.03.017; Gentiluomo L, 2020, J PHARM SCI-US, V109, P443, DOI 10.1016/j.xphs.2019.09.021; Geoghegan JC, 2016, MABS-AUSTIN, V8, P941, DOI 10.1080/19420862.2016.1171444; Gibson TJ, 2011, J PHARM SCI-US, V100, P1009, DOI 10.1002/jps.22350; Grosshans S, 2019, BIOPROC BIOSYST ENG, V42, P513, DOI 10.1007/s00449-018-2054-5; HARDING SE, 1985, BIOCHEM J, V231, P543, DOI 10.1042/bj2310543; Jarasch A, 2015, J PHARM SCI-US, V104, P1885, DOI 10.1002/jps.24430; Jimenez M, 2007, BIOCHEMISTRY-US, V46, P8373, DOI 10.1021/bi7005515; Kanai S, 2008, J PHARM SCI-US, V97, P4219, DOI 10.1002/jps.21322; Kheddo P, 2017, MOL PHARMACEUT, V14, P2852, DOI 10.1021/acs.molpharmaceut.7b00418; Lehermayr C, 2011, J PHARM SCI-US, V100, P2551, DOI 10.1002/jps.22506; Liu J, 2005, J PHARM SCI-US, V94, P1928, DOI 10.1002/jps.20347; Nichols P, 2015, MABS-AUSTIN, V7, P212, DOI 10.4161/19420862.2014.985504; Nishi H, 2010, PHARM RES-DORDR, V27, P1348, DOI 10.1007/s11095-010-0125-7; Raut AS, 2016, MOL PHARMACEUT, V13, P774, DOI 10.1021/acs.molpharmaceut.5b00668; Reiche K, 2017, BIOPHYS CHEM, V220, P7, DOI 10.1016/j.bpc.2016.08.003; ROSS PD, 1977, BIOCHEM BIOPH RES CO, V76, P971, DOI 10.1016/0006-291X(77)90950-0; Saito S, 2016, BIOPHARMACEUTICAL EV, P419, DOI [10.1007/978-4-431-55985-6_21, DOI 10.1007/978-4-431-55985-6_21]; Saito S, 2013, PHARM RES-DORDR, V30, P1263, DOI 10.1007/s11095-012-0965-4; Saito S, 2012, PHARM RES-DORDR, V29, P397, DOI 10.1007/s11095-011-0563-x; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; Tomar DS, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2466-6; Wang Y, 2011, P NATL ACAD SCI USA, V108, P16606, DOI 10.1073/pnas.1112241108; Yadav S, 2012, MOL PHARMACEUT, V9, P791, DOI 10.1021/mp200566k; Zhang ZH, 2017, CURR OPIN CHEM ENG, V16, P48, DOI 10.1016/j.coche.2017.04.001; Zurdo J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605427	40	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240673	10.1371/journal.pone.0240673	http://dx.doi.org/10.1371/journal.pone.0240673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125371	gold, Green Published			2022-12-26	WOS:000588368900014
J	Chirathaworn, C; Sripramote, M; Chalongviriyalert, P; Jirajariyavej, S; Kiatpanabhikul, P; Saiyarin, J; Soudon, C; Thienfaidee, O; Ayuthaya, TPN; Brukesawan, C; Chaiwanichsiri, D; Intharasongkroh, D; Wanlapakorn, N; Chansaenroj, J; Puenpa, J; Yorsaeng, R; Thitithanyanont, A; Kitphati, R; Mungaomklang, A; Nagavajara, P; Poovorawan, Y				Chirathaworn, Chintana; Sripramote, Manit; Chalongviriyalert, Piti; Jirajariyavej, Supunnee; Kiatpanabhikul, Phatharaporn; Saiyarin, Jatuporn; Soudon, Chuleekorn; Thienfaidee, Orawan; Palakawong Na Ayuthaya, Thitisan; Brukesawan, Chantapat; Chaiwanichsiri, Dootchai; Intharasongkroh, Duangnapa; Wanlapakorn, Nasamon; Chansaenroj, Jira; Puenpa, Jiratchaya; Yorsaeng, Ritthideach; Thitithanyanont, Arunee; Kitphati, Rungrueng; Mungaomklang, Anek; Nagavajara, Pijaya; Poovorawan, Yong			SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020	PLOS ONE			English	Article							IGA	Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although Thailand has been fairly effective at controlling the spread of COVID-19, continued disease surveillance and information on antibody response in recovered patients and their close contacts remain necessary in the absence of approved vaccines and antivirals. Here, we examined 217 recovered COVID-19 patients to assess their viral RNA shedding and residual antibodies against SARS-CoV-2. We also evaluated antibodies in blood samples from 308 close contacts of recovered COVID-19 patients. We found that viral RNA remained detectable in 6.6% of recovered COVID-19 cases and up to 105 days. IgM, IgG, and IgA antibodies against SARS-CoV-2 were detected in 13.8%, 88.5%, and 83.4% of the recovered cases 4-12 weeks after disease onset, respectively. Higher levels of antibodies detected were associated with severe illness patients experienced while hospitalized. Fifteen of the 308 contacts (4.9%) of COVID-19 cases tested positive for IgG antibodies, suggesting probable exposure. Viral clearance and the pattern of antibody responses in infected individuals are both crucial for effectively combating SARS-CoV-2. Our study provides additional information on the natural history of this newly emerging disease related to both natural host defenses and antibody duration.	[Chirathaworn, Chintana; Wanlapakorn, Nasamon; Chansaenroj, Jira; Puenpa, Jiratchaya; Yorsaeng, Ritthideach; Poovorawan, Yong] Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Sripramote, Manit; Chalongviriyalert, Piti] Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Jirajariyavej, Supunnee] Taksin Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Kiatpanabhikul, Phatharaporn] Charoenkrung Pracharak Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Saiyarin, Jatuporn] Klang Gen Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Soudon, Chuleekorn] Sirindhorn Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Thienfaidee, Orawan] Ratchaphiphat Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Palakawong Na Ayuthaya, Thitisan] Bangkok Metropolitan Adm, Dept Hlth, Publ Hlth Ctr 28, Bangkok, Thailand; [Brukesawan, Chantapat] Bangkok Metropolitan Adm, Dept Hlth, Publ Hlth Ctr 26, Bangkok, Thailand; [Chaiwanichsiri, Dootchai; Intharasongkroh, Duangnapa] Thai Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Nakhon Pathom, Thailand; [Kitphati, Rungrueng; Mungaomklang, Anek] Minist Publ Hlth, Inst Urban Dis Control & Prevent, Dept Dis Control, Bangkok, Thailand; [Nagavajara, Pijaya] Bangkok Metropolitan Adm, Off Permanent Secretary, Bangkok, Thailand; [Chirathaworn, Chintana] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Wanlapakorn, Nasamon] Chulalongkorn Univ, Div Acad Affairs, Fac Med, Bangkok, Thailand	Chulalongkorn University; Thai Red Cross Society; Mahidol University; Ministry of Public Health - Thailand; Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.	Yong.P@chula.ac.th	Yorsaeng, Ritthideach/AAD-3153-2019; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Thitithanyanont, Arunee/AAN-4383-2021	Yorsaeng, Ritthideach/0000-0001-9391-663X; Thitithanyanont, Arunee/0000-0002-9756-4763; Kiatpanabhikul, Phatharaporn/0000-0001-6914-7092	National Research Council of Thailand; National Science and Technology Development Agency [P-15-50004]; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE 59-009-30-005]; King Chulalongkorn Memorial Hospital; Rachadapisek Sompote Fund for Postdoctoral Fellowship, Chulalongkorn University	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Science and Technology Development Agency; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Rachadapisek Sompote Fund for Postdoctoral Fellowship, Chulalongkorn University	This work was supported by 1. The National Research Council of Thailand; Yong Poovorawan 2. The Research Chair Grant from the National Science and Technology Development Agency (P-15-50004); Yong Poovorawan 3. The Center of Excellence in Clinical Virology, Chulalongkorn University (GCE 59-009-30-005); Yong Poovorawan 4. King Chulalongkorn Memorial Hospital; Yong Poovorawan 5. Rachadapisek Sompote Fund for Postdoctoral Fellowship, Chulalongkorn University; Jira Chansaenroj 6. Rachadapisek Sompote Fund for Postdoctoral Fellowship, Chulalongkorn University; Jiratchaya Puenpa.	Alshukairi AN, 2016, EMERG INFECT DIS, V22, P1113, DOI 10.3201/eid2206.160010; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Breedveld A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00553; Chao YX, 2020, BRAIN BEHAV IMMUN, V87, P182, DOI 10.1016/j.bbi.2020.05.057; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Department of Disease Control MoPH Thailand, COVID 19 SIT REP; Fu Y, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01190-2020; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee NY, 2020, J MICROBIOL IMMUNOL, V53, P485, DOI 10.1016/j.jmii.2020.03.003; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20; Liu WD, 2020, J INFECTION, V81, P329, DOI 10.1016/j.jinf.2020.03.063; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Pan YB, 2020, J INFECTION, V81, pE28, DOI 10.1016/j.jinf.2020.03.051; Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026; Qian GQ, 2020, INFECT DIS-NOR, V52, P511, DOI 10.1080/23744235.2020.1748705; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657; World Health Organization, COR DIS 2019 COVID 1; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Zhang YC, 2020, EMERG MICROBES INFEC, V9, P833, DOI 10.1080/22221751.2020.1756699; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	29	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0236905	10.1371/journal.pone.0236905	http://dx.doi.org/10.1371/journal.pone.0236905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119712	Green Submitted, gold, Green Published			2022-12-26	WOS:000600013600037
J	Jia, YF; Ding, XM; Zhou, LH; Zhang, L; Yang, XC				Jia, Yuefeng; Ding, Xuemei; Zhou, Lihua; Zhang, Li; Yang, Xuecheng			Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1	ONCOGENE			English	Article							IN-VITRO; GROWTH; MIR-139-5P; CYCLE	microRNAs (miRNAs) can be delivered to tumor cells where they exert their function via mesenchymal stem cells (MSCs)-derived exosomes. This study investigated exosomal transfer of miR-139-5p to bladder cancer cells and their role in the regulation of tumorigenesis. The dysregulation of polycomb repressor complex 1 (PRC1) in bladder cancer was characterized by RNA quantification, and its functional significance in bladder cancer cells was identified by loss-of-function experiments. We predicted the miR-139-5p that could play a role in regulating PRC1, which was further verified using dual-luciferase reporter gene assay. Next, we altered the expression of miR-139-5p and PRC1 in bladder cancer cells to identify their functions in cancer progression. Bladder cancer cells were co-cultured with exosomes isolated from human umbilical cord mesenchymal stem cells (hUCMSCs) over-expressing miR-139-5p. The intercellular transfer of miR-139-5p along with in vitro and in vivo functions was determined using gain- and loss-of-function approaches. Our results revealed that PRC1 levels were increased in bladder cancer tissues and cells, and silencing PRC1 appeared to impede the cell proliferation, migration, and invasion potentials. In addition, miR-139-5p was observed to be down-regulated in bladder cancer, which targeted PRC1 and reduced its expression, hereby resulting in ameliorated tumorigenic characteristics of bladder cancer cells in vitro. Furthermore, we noted that miR-139-5p from hUCMSCs-derived exosomes could be transferred into bladder cancer cells to down-regulate the PRC1 expression. Moreover, hUCMSCs-derived exosomal miR-139-5p conferred a suppressive role on bladder cancer development in vitro and in vivo. These data together supported the tumor-inhibiting role of MSCs-derived exosomal miR-139-5p in bladder cancer, highlighting a promising therapeutic strategy.	[Jia, Yuefeng; Yang, Xuecheng] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao 266003, Peoples R China; [Ding, Xuemei; Zhang, Li] Qingdao Univ, Affiliated Hosp, Dept Surg, Qingdao 266003, Peoples R China; [Zhou, Lihua] Qingdao Univ, Affiliated Hosp, Dept Pharm, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Yang, XC (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao 266003, Peoples R China.	m18661805062@163.com						Alzahrani FA, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8058979; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Chen Y, 2018, AM J PHYSIOL-CELL PH, V315, pC225, DOI 10.1152/ajpcell.00283.2017; Cosenza S, 2018, THERANOSTICS, V8, P1399, DOI 10.7150/thno.21072; Dai SP, 2015, BIOCHEM BIOPH RES CO, V467, P204, DOI 10.1016/j.bbrc.2015.10.006; De Faveri LE, 2015, TRANSL ONCOL, V8, P387, DOI 10.1016/j.tranon.2015.08.002; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Di Meo A, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0644-5; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Jiang C, 2018, J CELL BIOCHEM, V119, P6429, DOI 10.1002/jcb.26610; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kluth LA, 2015, EUR UROL, V68, P238, DOI 10.1016/j.eururo.2015.01.032; Li JB, 2014, CHEM SOC REV, V43, P506, DOI 10.1039/c3cs60312a; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liang W, 2013, MOL CELL BIOCHEM, V382, P283, DOI 10.1007/s11010-013-1745-0; Liu PF, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0021-9; Luo HB, 2015, J HUAZHONG U SCI-MED, V35, P730, DOI 10.1007/s11596-015-1498-y; Luo HB, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317718414; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Pakravan K, 2017, CELL ONCOL, V40, P457, DOI 10.1007/s13402-017-0335-7; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Shang S, 2019, CANCER MED-US, V8, P7728, DOI 10.1002/cam4.2633; Sun Q, 2018, ONCOL LETT, V16, P793, DOI 10.3892/ol.2018.8773; Tang H, 2019, DIGEST LIVER DIS, V51, P1314, DOI 10.1016/j.dld.2019.02.012; Wang B, 2018, INT J NANOMED, V13, P5257, DOI 10.2147/IJN.S167880; Wang K, 2017, J CELL MOL MED, V21, P3730, DOI 10.1111/jcmm.13282; Xu W, 2015, INT J CLIN EXP PATHO, V8, P3864; Xu XD, 2014, ASIAN PAC J CANCER P, V15, P3471, DOI 10.7314/APJCP.2014.15.8.3471; Yonemori M, 2016, CANCER SCI, V107, P1233, DOI 10.1111/cas.13002; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhan P, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0682-z; Zhang B, 2017, J CELL MOL MED, V21, P1329, DOI 10.1111/jcmm.13063; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124; Zhu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02863-3	35	38	39	2	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					246	261		10.1038/s41388-020-01486-7	http://dx.doi.org/10.1038/s41388-020-01486-7		OCT 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33122828				2022-12-26	WOS:000582827800005
J	Zhai, SY; Xu, ZW; Xie, JJ; Zhang, J; Wang, XJ; Peng, CH; Li, HW; Chen, H; Shen, BY; Deng, XX				Zhai, Shuyu; Xu, Zhiwei; Xie, Junjie; Zhang, Jun; Wang, Xinjing; Peng, Chenghong; Li, Hongwei; Chen, Hao; Shen, Baiyong; Deng, Xiaxing			Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1	ONCOGENE			English	Article							LONG NONCODING RNAS; SIGNALING PATHWAY; PANCREATIC-CANCER; METHYLATION; HIPK2	Long noncoding RNAs have been identified as key regulators in the progression of various cancers. LINC00261 has been reported as a tumor suppressor in multiple cancers. However, its function and underlying mechanisms in pancreatic cancer remain largely unclear. Quantitative real-time PCR was performed to detect RNA expression. In situ hybridization was used to discover the subcellular location. The direct binding of LINC00261 to miR-222-3p was verified using a dual-luciferase reporter assay and RNA immunoprecipitation. LINC00261-binding proteins were detected using an RNA pulldown assay. LINC00261 was downregulated in pancreatic cancer tissues and cell lines. Its reduced expression was correlated with advanced pathological stage and poor prognosis. Forced expression of LINC00261 suppressed pancreatic cancer glycolysis and proliferation and induced cell cycle arrest and apoptosis. Mechanistically, downregulation of LINC00261 was caused by hypermethylation of the CpG island in the promoter region and EZH2-mediated histone H3 lysine 27 trimethylation. Moreover, LINC00261 exerted its biological function by binding to miR-222-3p to activate the HIPK2/ERK/c-myc pathway. In addition, LINC00261 could also reduce c-myc expression by sequestering IGF2BP1. Our study suggests that LINC00261 functions as a tumor suppressor in pancreatic cancer and identifies novel epigenetic and posttranscriptional regulatory mechanisms of LINC00261, which contribute to the targeted therapy of pancreatic cancer.	[Zhai, Shuyu; Xu, Zhiwei; Xie, Junjie; Zhang, Jun; Wang, Xinjing; Peng, Chenghong; Li, Hongwei; Chen, Hao; Shen, Baiyong; Deng, Xiaxing] Shanghai Jiao Tong Univ, Ruijin Hosp, Res Inst Pancreat Dis, Dept Gen Surg,Pancreat Dis Ctr,Sch Med, Shanghai, Peoples R China; [Zhai, Shuyu; Xu, Zhiwei; Xie, Junjie; Zhang, Jun; Wang, Xinjing; Peng, Chenghong; Li, Hongwei; Chen, Hao; Shen, Baiyong; Deng, Xiaxing] Shanghai Jiao Tong Univ, Sch Med, Res Inst Pancreat Dis, Shanghai, Peoples R China; [Zhai, Shuyu; Xu, Zhiwei; Xie, Junjie; Zhang, Jun; Wang, Xinjing; Peng, Chenghong; Li, Hongwei; Chen, Hao; Shen, Baiyong; Deng, Xiaxing] Shanghai Jiao Tong Univ, Inst Translat Med, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, H; Shen, BY; Deng, XX (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Res Inst Pancreat Dis, Dept Gen Surg,Pancreat Dis Ctr,Sch Med, Shanghai, Peoples R China.; Chen, H; Shen, BY; Deng, XX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Res Inst Pancreat Dis, Shanghai, Peoples R China.; Chen, H; Shen, BY; Deng, XX (corresponding author), Shanghai Jiao Tong Univ, Inst Translat Med, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China.	haochendr@126.com; shenby@shsmu.edu.cn; dxx10716@rjh.com.cn		Peng, Chenghong/0000-0002-5573-7873				Amin V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7370; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chen TX, 2020, ONCOL REP, V43, P930, DOI 10.3892/or.2020.7480; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chiorean EG, 2015, DRUG DES DEV THER, V9, P3529, DOI 10.2147/DDDT.S60328; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gits CMM, 2013, BRIT J CANCER, V109, P1625, DOI 10.1038/bjc.2013.483; Guo CX, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01332-6; Guo JP, 2018, ONCOTARGETS THER, V11, P8643, DOI 10.2147/OTT.S175745; He J, 2019, CANCER LETT, V450, P98, DOI 10.1016/j.canlet.2019.02.033; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huang XW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0628-y; Ihle MA, 2015, MOL ONCOL, V9, P1421, DOI 10.1016/j.molonc.2015.03.013; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Luo H, 2015, BRAIN, V138, P3654, DOI 10.1093/brain/awv287; Muller S, 2018, NUCLEIC ACIDS RES, V46, P6285, DOI 10.1093/nar/gky229; MULLER S, 2015, MOL CANCER, V14; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qin Y, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12603; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Saul VV, 2013, J MOL MED, V91, P1051, DOI 10.1007/s00109-013-1042-0; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun SS, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819892256; Wang X, 2020, ARCH BIOCHEM BIOPHYS, V689, DOI 10.1016/j.abb.2020.108469; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yan DS, 2019, J CELL PHYSIOL, V234, P22648, DOI 10.1002/jcp.28831; Yang HJ, 2019, BIOCHIMIE, V165, P9, DOI 10.1016/j.biochi.2019.06.012; Yu YC, 2017, J CELL MOL MED, V21, P955, DOI 10.1111/jcmm.13035; Zeng LP, 2016, J CELL MOL MED, V20, P559, DOI 10.1111/jcmm.12760; Zhang BG, 2018, AM J TRANSL RES, V10, P2648; Zhu S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15403-9	37	38	39	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					277	291		10.1038/s41388-020-01525-3	http://dx.doi.org/10.1038/s41388-020-01525-3		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33122827	Green Published, hybrid			2022-12-26	WOS:000582827800004
J	Lee, SM; Park, Y; Kim, YJ; Hwang, HS; Seo, H; Min, BJ; Lee, KH; Kim, SY; Jung, YM; Lee, S; Park, CW; Kim, JH; Park, JS				Lee, Seung Mi; Park, Yoomi; Kim, Young Ju; Hwang, Han-Sung; Seo, Heewon; Min, Byung-Joo; Lee, Kye Hwa; Kim, So Yeon; Jung, Young Mi; Lee, Suehyun; Park, Chan-Wook; Kim, Ju Han; Park, Joong Shin			Identifying genetic variants associated with ritodrine-induced pulmonary edema	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-II; PRETERM LABOR; FRAMEWORK; HYDROCHLORIDE; POLYMORPHISMS; INFLUENZA; GENOME	Introduction Ritodrine is one of the most commonly used tocolytics in preterm labor, acting as a ss2-adrenergic agonist that reduces intracellular calcium levels and prevents myometrial activation. Ritodrine infusion can result in serious maternal complications, and pulmonary edema is a particular concern among these. The cause of pulmonary edema following ritodrine treatment is multifactorial; however, the contributing genetic factors remain poorly understood. This study investigates the genetic variants associated with ritodrine-induced pulmonary edema. Methods In this case-control study, 16 patients who developed pulmonary edema during ritodrine infusion [case], and 16 pregnant women who were treated with ritodrine and did not develop pulmonary edema [control] were included. The control pregnant women were selected after matching for plurality and gestational age at the time of tocolytic use. Maternal blood was collected during admission for tocolytic treatment, and whole exome sequencing was performed with the stored blood samples. Results Gene-wise variant burden (GVB) analysis resulted in a total of 71 candidate genes by comparing the cumulative effects of multiple coding variants for 19729 protein-coding genes between the patients with pulmonary edema and the matched controls. Subsequent data analysis selected only the statistically significant and deleterious variants compatible with ritodrine-induced pulmonary edema. Two final candidate variants in CPT2 and ADRA1A were confirmed by Sanger sequencing. Conclusions We identified new potential variants in genes that play a role in cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) regulation, which supports their putative involvement in the predisposition to ritodrine-induced pulmonary edema in pregnant women.	[Lee, Seung Mi; Kim, So Yeon; Jung, Young Mi; Park, Chan-Wook; Park, Joong Shin] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Park, Yoomi; Seo, Heewon; Min, Byung-Joo; Lee, Kye Hwa; Kim, Ju Han] Seoul Natl Univ, Div Biomed Informat, Coll Med, Seoul, South Korea; [Kim, Young Ju] Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Hwang, Han-Sung] Konkuk Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Seo, Heewon] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lee, Suehyun] Konyang Univ, Dept Biomed Informat, Daejeon, South Korea; [Lee, Kye Hwa] Univ Ulsan, Asan Med Ctr, Dept Informat Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University; Konkuk University; Konkuk University Medical Center; University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; Konyang University; University of Ulsan; Asan Medical Center	Park, JS (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Div Biomed Informat, Coll Med, Seoul, South Korea.	juhan@snu.ac.kr; jsparkmd@snu.ac.kr		Lee, Kye Hwa/0000-0002-7593-7020; Seo, Heewon/0000-0001-6218-8609	Ministry of Food and Drug Safety [14172MFDS178]; Korean Health Technology R&D Project by the Ministry of Health and Welfare in the Republic of Korea [HI18C2386]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korean Health Technology R&D Project by the Ministry of Health and Welfare in the Republic of Korea	This research was supported by a grant (14172MFDS178) from the Ministry of Food and Drug Safety and the Korean Health Technology R&D Project by the Ministry of Health and Welfare in the Republic of Korea (HI18C2386). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2001, AM J PHYSIOL-HEART C, V280, pH2674; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2000, INDIAN HIGHW, V28, P27; Arrowsmith Sarah, 2010, Obstet Gynaecol Reprod Med, V20, P241; Baek MY, 2017, EUR J CLIN PHARMACOL, V73, P837, DOI 10.1007/s00228-017-2222-6; Building Party, 2018, PARTY BUILDING, V11, P4; Chen QP, 1996, J BIOL CHEM, V271, P25277, DOI 10.1074/jbc.271.41.25277; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gaedigk A, 2016, GENET MED, V18, P1167, DOI 10.1038/gim.2016.80; Gluck C, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0854-7; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HANKINS GDV, 1988, AM J OBSTET GYNECOL, V158, P658, DOI 10.1016/0002-9378(88)90049-X; Hwang Han Sung, 2015, Obstet Gynecol Sci, V58, P203, DOI 10.5468/ogs.2015.58.3.203; Kaname T, 2014, J HUM GENET, V59, P117, DOI 10.1038/jhg.2014.7; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lamont RF, 2000, BRIT J OBSTET GYNAEC, V107, P439, DOI 10.1111/j.1471-0528.2000.tb13259.x; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; LEVENO KJ, 1986, LANCET, V1, P1293; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XM, 2005, INDIAN J MED RES, V121, P120; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOUTQUIN JM, 1992, NEW ENGL J MED, V327, P308; Mutlu GM, 2004, AM J RESP CRIT CARE, V170, P1270, DOI 10.1164/rccm.200404-470CP; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00654; Patterson CE, 2000, ENDOTHELIUM-NEW YORK, V7, P287, DOI 10.3109/10623320009072215; Pereyra AS, 2017, J BIOL CHEM, V292, P18443, DOI 10.1074/jbc.M117.800839; Roider HG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-68; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xiong JH, 2018, MOL CELL, V69, P689, DOI 10.1016/j.molcel.2018.01.010; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241215	10.1371/journal.pone.0241215	http://dx.doi.org/10.1371/journal.pone.0241215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166306	gold, Green Published			2022-12-26	WOS:000592382600029
J	Moreno-Torres, I; Nava, E				Moreno-Torres, Ignacio; Nava, Enrique			Consonant and vowel articulation accuracy in younger and middle-aged Spanish healthy adults	PLOS ONE			English	Article							SPEAKING CHILDREN; SPEECH; PERCEPTION; INTELLIGIBILITY; RECOGNITION; MODEL	Children acquire vowels earlier than consonants, and the former are less vulnerable to speech disorders than the latter. This study explores the hypothesis that a similar contrast exists later in life and that consonants are more vulnerable to ageing than vowels. Data was obtained with two experiments comparing the speech of Younger Adults (YAs) and Middle-aged Adults (MAs). In the first experiment an Automatic Speech Recognition (ASR) system was trained with a balanced corpus of 29 YAs and 27 MAs. The productions of each speaker were obtained in a Spanish language word (W) and non-word (NW) repetition task. The performance of the system was evaluated with the same corpus used for training using a cross validation approach. The ASR system recognized to a similar extent the Ws of both groups of speakers, but it was more successful with the NWs of the YAs than with those of the MAs. Detailed error analysis revealed that the MA speakers scored below the YA speakers for consonants and also for the place and manner of articulation features; the results were almost identical in both groups of speakers for vowels and for the voicing feature. In the second experiment a group of healthy native listeners was asked to recognize isolated syllables presented with background noise. The target speakers were one YA and one MA that had taken part in the first experiment. The results were consistent with those of the ASR experiment: the manner and place of articulation were better recognized, and vowels and voicing were worse recognized, in the YA speaker than in the MA speaker. We conclude that consonant articulation is more vulnerable to ageing than vowel articulation. Future studies should explore whether or not these early and selective changes in articulation accuracy might be caused by changes in speech perception skills (e.g., in auditory temporal processing).	[Moreno-Torres, Ignacio] Univ Malaga, Dept Spanish Language, Malaga, Spain; [Nava, Enrique] Univ Malaga, Dept Commun Engn, Malaga, Spain	Universidad de Malaga; Universidad de Malaga	Moreno-Torres, I (corresponding author), Univ Malaga, Dept Spanish Language, Malaga, Spain.	imoreno@uma.es	Nava-Baro, Enrique/R-4589-2019	Nava-Baro, Enrique/0000-0001-7817-6442; Moreno Torres Sanchez, Ignacio/0000-0002-2649-7145	Ministerio de Ciencia, Innovacion y Universidades [RTI2018-094846-B-I00]; Junta de Andalucia [UMA18-FEDERJA-021]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [PI16/01514]	Ministerio de Ciencia, Innovacion y Universidades; Junta de Andalucia(Junta de Andalucia); Ministerio de Economia, Industria y Competitividad, Gobierno de Espana	IMT an EN received a grant from Ministerio de Ciencia, Innovacion y Universidades (RTI2018-094846-B-I00) and a grant from Junta de Andalucia (UMA18-FEDERJA-021). Speech data acquisition was funded by Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, PI16/01514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Bensaid L, 2009, CLIN LINGUIST PHONET, V23, P122, DOI 10.1080/02699200802564961; BENJAMIN BJ, 1982, J PSYCHOLINGUIST RES, V11, P159; Bilodeau-Mercure M, 2016, J AM GERIATR SOC, V64, pE177, DOI 10.1111/jgs.14491; Bilodeau-Mercure M, 2015, AGE, V37, DOI 10.1007/s11357-015-9813-x; Boersma Paul, 2002, GLOT INT, V5, P341; Bouton S, 2012, J SPEECH LANG HEAR R, V55, P139, DOI 10.1044/1092-4388(2011/10-0330); Celdran EM, 2007, ARIEL LINGUISTICA; Cieri C, 2014, LANG LINGUIST COMPAS, V8, P472, DOI 10.1111/lnc3.12112; Cooke M, 2006, J ACOUST SOC AM, V119, P1562, DOI 10.1121/1.2166600; Eichhorn JT, 2018, J VOICE, V32, DOI 10.1016/j.jvoice.2017.08.003; Green KP, 1997, J SPEECH LANG HEAR R, V40, P646, DOI 10.1044/jslhr.4003.646; Harrington J., 2007, INTERSPEECH, P2753; Helfer KS, 2009, J AM ACAD AUDIOL, V20, P264, DOI 10.3766/jaaa.20.4.6; Kong X, 2017, INT CONF ACOUST SPEE, P5810, DOI 10.1109/ICASSP.2017.7953270; Le Normand MT, 2000, J CLIN EXP NEUROPSYC, V22, P408, DOI 10.1076/1380-3395(200006)22:3;1-V;FT408; LENORMAND MT, 1991, CLIN LINGUIST PHONET, V5, P99, DOI 10.3109/02699209108985508; McKechnie J, 2018, AUTOMATED SPEECH ANA; Metz D, 1980, SPEECH ASSESSMENT SP, P72; Meyer B.T., 2007, INTERSPEECH 2007, P1485; Meyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079279; Moreno-Torres I, 2017, J ACOUST SOC AM, V141, P3079, DOI 10.1121/1.4982251; PARNELL MM, 1987, J COMMUN DISORD, V20, P339, DOI 10.1016/0021-9924(87)90015-3; Phatak SA, 2007, J ACOUST SOC AM, V121, P2312, DOI 10.1121/1.2642397; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Povey  D., 2011, P ASRU; RASTATTER MP, 1990, FOLIA PHONIATR, V42, P312, DOI 10.1159/000266088; SHIPP T, 1992, J VOICE, V6, P211, DOI 10.1016/S0892-1997(05)80145-6; SHUEY EM, 1989, J COMMUN DISORD, V22, P437, DOI 10.1016/0021-9924(89)90036-1; Sroka JJ, 2005, SPEECH COMMUN, V45, P401, DOI 10.1016/j.specom.2004.11.009; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Tremblay P, 2019, EXP GERONTOL, V126, DOI 10.1016/j.exger.2019.110695; Tremblay P, 2018, PSYCHOL AGING, V33, P1022, DOI 10.1037/pag0000306; VanRavenhorst-Bell HA, 2017, TONGUE STRENGTH ENDU; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vipperla R, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/525783; WEISMER G, 1988, J ACOUST SOC AM, V84, P1281, DOI 10.1121/1.396627	36	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242018	10.1371/journal.pone.0242018	http://dx.doi.org/10.1371/journal.pone.0242018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166341	Green Published, gold			2022-12-26	WOS:000592382600008
J	Grzelak, S; Stachyra, A; Stefaniak, J; Mrowka, K; Moskwa, B; Bien-Kalinowska, J				Grzelak, Sylwia; Stachyra, Anna; Stefaniak, Jerzy; Mrowka, Karolina; Moskwa, Bozena; Bien-Kalinowska, Justyna			Immunoproteomic analysis of Trichinella spiralis and Trichinella britovi excretory-secretory muscle larvae proteins recognized by sera from humans infected with Trichinella	PLOS ONE			English	Article							HUMAN TRICHINOSIS; PROTEOMIC ANALYSIS; WESTERN-BLOT; ANTIGENS; ANTIBODIES; GENE; SERODIAGNOSIS; EXPRESSION; DIAGNOSIS; INVASION	The present study compares the immunogenic patterns of muscle larvae excretory-secretory proteins (ML E-S) from T. spiralis and T. britovi recognized by Trichinella-infected human sera. Samples were analyzed using two-dimensional electrophoresis (2-DE) coupled with 2D-immunoblot and liquid chromatography-tandem mass spectrometry LC-MS/MS analysis, two ELISA procedures and a confirmatory 1D-immunoblot test. Sera were obtained from nine patients with a history of ingestion of raw or undercooked meat who presented typical clinical manifestations of trichinellosis and from eleven healthy people. Specific anti-Trichinella IgG antibodies were detected in all samples tested with the Home-ELISA kits, but in only four samples for the commercially-available kit. The 1D-immunoblot results indicated that all nine serum samples were positive for T. spiralis ML E-S antigens, expressed as the presence of specific bands. In contrast, eight of the serum samples with T. britovi E-S ML antigens were positive, with one serum sample taken from a patient at 33dpi (days post infection) being negative. To identify immunoreactive proteins that are specifically recognized by host antibodies, both species of ML E-S proteins were subjected to 2D-immunoblotting with human serum taken at 49 dpi. The sera recognized 22 protein spots for T. spiralis and 18 for T. britovi in 2D-immunoblot analysis. Their molecular weights (MW) ranged from 50 to 60 kDa. LC-MS/MS analysis identified both common and specifically-recognized immunoreactive proteins: transmembrane serine protease 9, serine protease, antigen targeted by protective antibodies and Actin-1 partial were shared for both Trichinella species; hypothetical protein T01_7775 and P49 antigen, partial those specific to T. spiralis; deoxyribonuclease-2-alpha and hypothetical protein T03_17187/T12_7360 were specific to T. britovi. Our results demonstrate the value of 2-DE and 2D-immunblot as versatile tools for pinpointing factors contributing to the parasite-host relationship by comparing the secretomes of different Trichinella species.	[Grzelak, Sylwia; Stachyra, Anna; Moskwa, Bozena; Bien-Kalinowska, Justyna] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Stefaniak, Jerzy; Mrowka, Karolina] Univ Med Sci, Dept & Clin Trop & Parasit Dis, Poznan, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Grzelak, S (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	sylwia.grzelak@twarda.pan.pl		Stachyra, Anna/0000-0001-5582-972X; Bien-Kalinowska, Justyna/0000-0002-7789-2751; Grzelak, Sylwia/0000-0001-8329-841X; Moskwa, Bozena/0000-0001-8708-5307	National Science Centre Poland [UMO-2015/18/E/NZ6/00502]	National Science Centre Poland(National Science Centre, Poland)	Financial support for this study was provided by the National Science Centre Poland (grant UMO-2015/18/E/NZ6/00502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON JA, 1991, PARASITOL TODAY, V7, P190, DOI 10.1016/0169-4758(91)90135-B; Bien J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-10; Bolas-Fernandez F, 2006, RES VET SCI, V81, P297, DOI 10.1016/j.rvsc.2006.01.002; Bruschi F, 2002, POSTGRAD MED J, V78, P15, DOI 10.1136/pmj.78.915.15; Cabaj Wladyslaw, 2006, Wiadomosci Parazytologiczne, V52, P175; Cybulska A, 2019, INT J PARASITOL-PAR, V9, P149, DOI 10.1016/j.ijppaw.2019.05.003; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Dupouy-Camet J, 2001, PARASITE, V8, pS176, DOI 10.1051/parasite/200108s2176; Dupouy-Camet J, 2007, FAO WHO OIE GUIDELIN, P37; Gomez-Garcia V, 2003, AM J TROP MED HYG, V68, P463, DOI 10.4269/ajtmh.2003.68.463; Gomez-Morales MA, 2008, CLIN VACCINE IMMUNOL, V15, P1723, DOI 10.1128/CVI.00257-08; Gomez-Morales MA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3244-3; Gomez-Morales MA, 2012, INT J PARASITOL, V42, P1017, DOI 10.1016/j.ijpara.2012.08.003; Gondek M, 2018, VET IMMUNOL IMMUNOP, V203, P13, DOI 10.1016/j.vetimm.2018.07.010; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Grzelak S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3177-x; Jongwutiwes S, 1998, CLIN INFECT DIS, V26, P111, DOI 10.1086/516278; Liao CS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003097; Liu JY, 2016, VET PARASITOL, V231, P32, DOI 10.1016/j.vetpar.2016.06.021; Liu RD, 2016, VET PARASITOL, V231, P43, DOI 10.1016/j.vetpar.2016.10.008; Morales MAG, 2002, INFECT IMMUN, V70, P233, DOI 10.1128/IAI.70.1.233-239.2002; Moskwa B, 2009, VET PARASITOL, V159, P312, DOI 10.1016/j.vetpar.2008.10.069; Moskwa Bozena, 2006, Wiad Parazytol, V52, P231; Moskwa B, 2015, ACTA PARASITOL, V60, P530, DOI 10.1515/ap-2015-0075; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Murrell KD, 2000, VET PARASITOL, V93, P293, DOI 10.1016/S0304-4017(00)00347-2; Nagano I, 2003, J PARASITOL, V89, P92, DOI 10.1645/0022-3395(2003)089[0092:MCACOA]2.0.CO;2; OrtegaPierres MG, 1996, PARASITE IMMUNOL, V18, P273, DOI 10.1046/j.1365-3024.1996.d01-103.x; Pinelli E, 2001, PARASITE, V8, pS168, DOI 10.1051/parasite/200108s2168; POZIO E, 1993, AM J TROP MED HYG, V48, P568, DOI 10.4269/ajtmh.1993.48.568; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Qi X, 2018, VET RES, V49, DOI 10.1186/s13567-018-0614-y; Qi X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02504; Ren HN, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3198-5; S BE, 2018, J CROHNS COLITIS, V12, pS049; Somboonpatarakun C, 2018, PARASITOL RES, V117, P201, DOI 10.1007/s00436-017-5694-5; Song YY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01544; Stachyra A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02420; SU XZ, 1991, MOL BIOCHEM PARASIT, V45, P331, DOI 10.1016/0166-6851(91)90101-B; Sun GG, 2018, VET RES, V49, DOI 10.1186/s13567-018-0555-5; Tang B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0689-5; Todorova VK, 2000, PARASITOL RES, V86, P684, DOI 10.1007/PL00008552; Wang L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-40; Wang L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/139745; Wang Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2522-9; Wang ZQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00986; Wang ZQ, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0252-z; Wu XP, 2009, VET PARASITOL, V159, P272, DOI 10.1016/j.vetpar.2008.10.035; Yang J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0641-8; Zheng BL, 2007, HELMINTHOLOGIA, V44, P120, DOI 10.2478/s11687-007-0018-4	50	5	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241918	10.1371/journal.pone.0241918	http://dx.doi.org/10.1371/journal.pone.0241918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152047	Green Published, gold			2022-12-26	WOS:000591376200011
J	Lampignano, L; Zupo, R; Donghia, R; Guerra, V; Castellana, F; Murro, I; Di Noia, C; Sardone, R; Giannelli, G; De Pergola, G				Lampignano, Luisa; Zupo, Roberta; Donghia, Rossella; Guerra, Vito; Castellana, Fabio; Murro, Isanna; Di Noia, Carmen; Sardone, Rodolfo; Giannelli, Gianluigi; De Pergola, Giovanni			Cross-sectional relationship among different anthropometric parameters and cardio-metabolic risk factors in a cohort of patients with overweight or obesity	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; OBSTRUCTIVE SLEEP-APNEA; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; NECK CIRCUMFERENCE; ABDOMINAL ADIPOSITY; ASSOCIATIONS; MORTALITY; PARADOX	Background Body fat distribution influences the risk of cardio-metabolic disease in people with overweight. This study was aimed at identifying the anthropometric parameters more strongly associated with the majority of cardio-metabolic risk factors. Methods This study included 1214 subjects (840 women), with a body-mass-index (BMI) >= 25 Kg/m2, aged 39.2 +/- 13 years. Fasting blood glucose (FBG), triglycerides (TG), total, HDL- and LDL-cholesterol, uric acid, vitamin D, high-sensitive C-reactive protein (hs-CRP), white blood cells (WBC), platelets, insulin and insulin resistance (HOMA-IR), systolic (SBP) and diastolic blood pressure (DBP), smoking habit and snoring were evaluated as cardio-metabolic risk factors.We also included the Systematic COronary Risk Evaluation (SCORE) to estimate cardiovascular risk in our study population. BMI, waist circumference (WC), waist-to-height-ratio (WHtR) and neck circumference (NC) were evaluated as anthropometric parameters. Results All four anthropometric parameters were positively associated to SBP, DBP, TG, FBG, insulin, HOMA-IR, WBC, and snoring (p<0.001), and negatively associated with HDL-cholesterol (p<0.001). NC showed a positive association with LDL-cholesterol (beta = 0.76; p = 0.01; 95% C.I. 0.19 to 1.32), while vitamin D was negatively associated to WC (beta = -0.16; p<0.001; 95% C.I. -0.24 to -0.09), BMI (beta = 0.42); p<0.001; 95% C.I. -0.56 to -0.28) and WHtR (beta = -24.46; p<0.001; 95% C.I. -37 to -11.9). Hs-CRP was positively correlated with WC (beta = 0.003; p = 0.003; 95% C.I. 0.001 to 0.006), BMI (beta = 0.01; p = 0.02; 95% C.I. 0.001 to 0.012) and WHtR (beta = 0.55; p = 0.01; 95% C.I. 0.14 to 0.96). SCORE was associated to NC (beta = 0.15; 95% CI 0.12 to 0.18; p<0.001), BMI (beta = -0.18; 95% CI -0.22 to 0.14; p<0.001) and WHtR (beta = 7.56; 95% CI 5.30 to 9.82; p<0.001). Conclusions NC, combined with BMI and WC or WHtR could represent an essential tool for use in clinical practice to define the cardio-metabolic risk in individuals with excess body weight.	[Lampignano, Luisa; Zupo, Roberta; Donghia, Rossella; Guerra, Vito; Castellana, Fabio; Sardone, Rodolfo] Natl Inst Gastroenterol Saverio de Bellis, Populat Hlth Unit Salus Apulia Study, Res Hosp, Bari, Italy; [Murro, Isanna; Di Noia, Carmen; De Pergola, Giovanni] Univ Bari, Sch Med, Dept Biomed Sci & Human Oncol, Policlin, Bari, Italy; [Giannelli, Gianluigi] Natl Inst Gastroenterol Saverio de Bellis, Res Hosp, Sci Direct, Bari, Italy	Universita degli Studi di Bari Aldo Moro	De Pergola, G (corresponding author), Univ Bari, Sch Med, Dept Biomed Sci & Human Oncol, Policlin, Bari, Italy.	gdepergola@libero.it	Sardone, Rodolfo/AAM-2727-2020; Zupo, Roberta/AAO-9103-2020; Castellana, Fabio/AAC-4919-2022; Lampignano, Luisa/AAA-3108-2022; Zupo, Roberta/GPT-3724-2022	Sardone, Rodolfo/0000-0003-1383-1850; Zupo, Roberta/0000-0001-9885-1185; Castellana, Fabio/0000-0002-6439-8228; Donghia, Rossella/0000-0002-9140-673X; Lampignano, Luisa/0000-0001-9299-3211				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Ataie-Jafari A, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0373-y; Ben-Noun L, 2003, OBES RES, V11, P226, DOI 10.1038/oby.2003.35; Bluher M, 2020, ENDOCR REV, V41, P405, DOI 10.1210/endrev/bnaa004; Borel AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206617; Brenner DR, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-28; Carbone S, 2019, VASC HEALTH RISK MAN, V15, P89, DOI 10.2147/VHRM.S168946; Caro P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028305; Cheong KC, 2015, DIABETES METAB SYND, V9, P74, DOI 10.1016/j.dsx.2015.02.006; Chiu HY, 2017, SLEEP MED REV, V36, P57, DOI 10.1016/j.smrv.2016.10.004; Doumatey AP, 2014, CLIN BIOCHEM, V47, P315, DOI 10.1016/j.clinbiochem.2013.12.014; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Joshipura K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6058916; Khan SS, 2018, JAMA CARDIOL, V3, P280, DOI 10.1001/jamacardio.2018.0022; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Luo YQ, 2017, ENDOCRINE, V55, P822, DOI 10.1007/s12020-016-1151-y; Huerta JM, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-7; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke A, 2007, OBESITY, V15, P785, DOI 10.1038/oby.2007.593; Mongraw-Chaffin ML, 2015, LANCET DIABETES ENDO, V3, P437, DOI 10.1016/S2213-8587(15)00086-8; Muscogiuri G, 2017, INT J CARDIOL, V230, P577, DOI 10.1016/j.ijcard.2016.12.053; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Ormazabal V, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0762-4; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, pNP1, DOI 10.1177/2047487316653709; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ross R, 2020, NAT REV ENDOCRINOL, V16, P177, DOI 10.1038/s41574-019-0310-7; Roth GA, 2017, JAMA-J AM MED ASSOC, V317, P1976, DOI 10.1001/jama.2017.4150; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Ulijaszek SJ, 2003, J BIOSOC SCI, V35, P624, DOI 10.1017/S0021932003245508; van Dijk SB, 2012, NETH HEART J, V20, P208, DOI 10.1007/s12471-011-0237-7; Vardell Emily, 2020, Medical Reference Services Quarterly, V39, P67, DOI 10.1080/02763869.2019.1693231; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yoo Eun-Gyong, 2016, Korean J Pediatr, V59, P425	37	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241841	10.1371/journal.pone.0241841	http://dx.doi.org/10.1371/journal.pone.0241841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152746	Green Published, gold			2022-12-26	WOS:000591376200063
J	Wakashima, K; Asai, K; Kobayashi, D; Koiwa, K; Kamoshida, S; Sakuraba, M				Wakashima, Koubun; Asai, Keigo; Kobayashi, Daisuke; Koiwa, Kohei; Kamoshida, Saeko; Sakuraba, Mayumi			The Japanese version of the Fear of COVID-19 scale: Reliability, validity, and relation to coping behavior	PLOS ONE			English	Article							ANXIETY	COVID-19 is spreading worldwide, causing various social problems. The aim of the present study was to verify the reliability and validity of the Japanese version of the Fear of COVID-19 Scale (FCV-19S) and to ascertain FCV-19S effects on assessment of Japanese people's coping behavior. After back-translation of the scale, 450 Japanese participants were recruited from a crowdsourcing platform. These participants responded to the Japanese FCV-19S, the Japanese versions of the Hospital Anxiety and Depression scale (HADS) and the Japanese versions of the Perceived Vulnerability to Disease (PVD), which assesses coping behaviors such as stockpiling and health monitoring, reasons for coping behaviors, and socio-demographic variables. Results indicated the factor structure of the Japanese FCV-19S as including seven items and one factor that were equivalent to those of the original FCV-19S. The scale showed adequate internal reliability (alpha = .87; omega = .92) and concurrent validity, as indicated by significantly positive correlations with the Hospital Anxiety and Depression Scale (HADS; anxiety, r = .56; depression, r = .29) and Perceived Vulnerability to Disease (PVD; perceived infectability, r = .32; germ aversion, r = .29). Additionally, the FCV-19S not only directly increased all coping behaviors (beta = .21 - .36); it also indirectly increased stockpiling through conformity reason (indirect effect, beta = .04; total effect, beta = .31). These results suggest that the Japanese FCV-19S psychometric scale has equal reliability and validity to those of the original FCV-19S. These findings will contribute further to the investigation of various difficulties arising from fear about COVID-19 in Japan.	[Wakashima, Koubun; Kobayashi, Daisuke; Koiwa, Kohei; Kamoshida, Saeko; Sakuraba, Mayumi] Tohoku Univ, Grad Sch Educ, Sendai, Miyagi, Japan; [Asai, Keigo] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido, Japan	Tohoku University; Hokkaido University	Wakashima, K (corresponding author), Tohoku Univ, Grad Sch Educ, Sendai, Miyagi, Japan.	kobun.wakashima.d3@tohoku.ac.jp	ASAI, Keigo/A-1715-2017	ASAI, Keigo/0000-0002-7967-3595; Wakashima, Koubun/0000-0002-5575-4972				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Alyami M, 2021, INT J MENT HEALTH AD, V19, P2219, DOI 10.1007/s11469-020-00316-x; [Anonymous], 2020, COMMUN BIOL, V3, P1; Asahi Shimbun Digital, 2020, SHORT MASKS CHAOS SP; Asahi Shimbun Digital, STOCKP BUARD STAT EM; Bitan DT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113100; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Corbett GA, 2020, EUR J OBSTET GYN R B, V249, P96, DOI 10.1016/j.ejogrb.2020.04.022; Doshi D, 2021, INT J MENT HEALTH AD, V19, P2383, DOI 10.1007/s11469-020-00332-x; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Fukukawa Yasuyuki, 2014, Shinrigaku Kenkyu, V85, P188; Haktanir A, 2022, DEATH STUD, V46, P719, DOI 10.1080/07481187.2020.1773026; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Hatta H., 1998, JAPANESE J PSYCHOSOM, V38, P309; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johns Hopkins University, 2020, COR RES CTR 2020; Kawashima K, 2020, JAPANESE STEW FEELIN; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kumar A, 2020, IET SMART GRID, V3, P83, DOI 10.1049/iet-stg.2019.0178; Lee SA, 2020, BRAIN BEHAV IMMUN, V87, P97, DOI 10.1016/j.bbi.2020.04.067; Lee S, 2021, DIABETOLOGIA, V64, P410, DOI 10.1007/s00125-020-05296-0; Ministry of Health LaW, 2020, CONNECTION SURVEY CO; Ministry of Health Law, 2020, STAT COVID 19 PAT TR; Ministry of Health Law, 2020, OUTBR PNEUM ASS NEW; Muthen B., 2010, MPLUS USERS GUIDE; Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Pakpour AH, 2020, BRAIN BEHAV IMMUN, V89, P524, DOI 10.1016/j.bbi.2020.06.006; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman MA, 2020, FACTORS ASS PSYCHOL, DOI [10.21203/rs.3.rs-57952/v2, DOI 10.21203/RS.3.RS-57952/V2]; Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Sakib N, 2022, INT J MENT HEALTH AD, V20, P2623, DOI 10.1007/s11469-020-00289-x; Soraci P, 2022, INT J MENT HEALTH AD, V20, P1913, DOI 10.1007/s11469-020-00277-1; Taha S, 2014, BRIT J HEALTH PSYCH, V19, P592, DOI 10.1111/bjhp.12058; TAYLOR S, 2020, J ANXIETY DISORD, V72, DOI [DOI 10.1016/J.JANXDIS.2020.102232, 10.1016/j.janxdis.2020.102232(, 10.1016/j.janxdis.2020.102232]; The Asashi Shimbun, 2020, NAT STAT EM EXP ALL; Winter T, 2020, EVALUATION ENGLISH V; Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; World Health Organization, NOVEL CORONAVIRUS 20; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	62	62	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241958	10.1371/journal.pone.0241958	http://dx.doi.org/10.1371/journal.pone.0241958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152038	gold, Green Published			2022-12-26	WOS:000591376200068
J	Smith, LE; Mottershaw, AL; Egan, M; Waller, J; Marteau, TM; Rubin, GJ				Smith, Louise E.; Mottershaw, Abigail L.; Egan, Mark; Waller, Jo; Marteau, Theresa M.; Rubin, G. James			The impact of believing you have had COVID-19 on self-reported behaviour: Cross-sectional survey	PLOS ONE			English	Article								Objectives To investigate whether people who think they have had COVID-19 are less likely to report engaging with lockdown measures compared with those who think they have not had COVID-19. Design On-line cross-sectional survey. Setting Data were collected between 20(th) and 22(nd) April 2020. Participants 6149 participants living in the UK aged 18 years or over. Main outcome measures Perceived immunity to COVID-19, self-reported adherence to social distancing measures (going out for essential shopping, nonessential shopping, and meeting up with friends/family; total out-of-home activity), worry about COVID-19 and perceived risk of COVID-19 to oneself and people in the UK. Knowledge that cough and high temperature / fever are the main symptoms of COVID-19. We used logistic regression analyses and one-way ANOVAs to investigate associations between believing you had had COVID-19 and binary and continuous outcomes respectively. Results In this sample, 1493 people (24.3%) thought they had had COVID-19 but only 245 (4.0%) reported having received a positive test result. Reported test results were often incongruent with participants' belief that they had had COVID-19. People who believed that they had had COVID-19 were: more likely to agree that they had some immunity to COVID-19; less likely to report adhering to lockdown measures; less worried about COVID-19; and less likely to know that cough and high temperature / fever are two of the most common symptoms of COVID-19. Conclusions At the time of data collection, the percentage of people in the UK who thought they had already had COVID-19 was about twice the estimated infection rate. Those who believed they had had COVID-19 were more likely to report leaving home. This may contribute to transmission of the virus. Clear communications to this growing group are needed to explain why protective measures continue to be important and to encourage sustained adherence.	[Smith, Louise E.; Rubin, G. James] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Smith, Louise E.; Rubin, G. James] NIHR Hlth Protect Res Unit Emergency Preparedness, London, England; [Mottershaw, Abigail L.; Egan, Mark] Behav Insights Team, London, England; [Waller, Jo] Kings Coll London, Fac Life Sci & Med, London, England; [Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England	University of London; King's College London; University of London; King's College London; University of Cambridge	Smith, LE (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.; Smith, LE (corresponding author), NIHR Hlth Protect Res Unit Emergency Preparedness, London, England.	louise.e.smith@kcl.ac.uk		Smith, Louise/0000-0002-1277-2564; Waller, Jo/0000-0003-4025-9132	Cancer Research UK [C7492/A17219]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response	Cancer Research UK(Cancer Research UK); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response	JW is funded by a career development fellowship from Cancer Research UK (ref C7492/A17219). LS and GJR are supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response, a partnership between Public Health England, King's College London and the University of East Anglia. The views expressed are those of the authors and not necessarily those of the NIHR, Public Health England or the Department of Health and Social Care. Data collection was funded via a block Government grant to the Behavioural Insights Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, IMPACT FRAMING ANTIB; Barnes E, 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407v1.full.pdf; Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; Battaglia M., 2008, ENCY SURVEY RES METH; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Brooks SK, 2020, EUROSURVEILLANCE, V25, P21, DOI 10.2807/1560-7917.ES.2020.25.13.2000188; Cabinet Office, 2020, NEW RUL STAYING HOM; Department of Health and Social Care NHS Test and Trace, 2020, NHS TEST TRAC STAT; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Johnson B, 2020, COMMUNICTAION   0323; Keeter S, 2015, COVERAGE ERROR INTER; Kohler U., 2019, SURVEY METHODS INSIG, P1, DOI [10.13094/SMIF- 2019-00014, DOI 10.13094/SMIF-2019-00014, 10.13094/SMIF-2019-00014]; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Osborne H., 2020, GUARDIAN; Smith LE, PUBLIC HLTH, DOI [10.1016/j.puhe.2020.07.024, DOI 10.1016/J.PUHE.2020.07.02432898760]; UK Student Climate Network`, 2020, OUR DEM; Waller J, BMJ OPEN; WHO, 2020, CRIT REL COVID 19 PA; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]	22	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240399	10.1371/journal.pone.0240399	http://dx.doi.org/10.1371/journal.pone.0240399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147219	Green Published, gold			2022-12-26	WOS:000589609300010
J	Gao, J; Wei, T; Huang, CL; Sun, MW; Shen, WL				Gao, Jing; Wei, Tong; Huang, Chenglin; Sun, Mengwei; Shen, Weili			Sirtuin 3 governs autophagy-dependent glycolysis during Angiotensin II-induced endothelial-to-mesenchymal transition	FASEB JOURNAL			English	Article						autophagy; endothelial&#8208; to&#8208; mesenchymal transition; glycolysis; PKM2; SIRT3	CELL-METABOLISM; PKM2; DYSFUNCTION; GROWTH; FLUX	The impairment of autophagy can cause cellular metabolic perturbations involved in endothelial-to-mesenchymal transition (EndoMT). However, the interplay between the cellular autophagy machinery and endothelial metabolism remains elusive. Sirtuin 3 (SIRT3), an NAD-dependent deacetylase, is a major cellular sensor of energy metabolism. The aim of this work was to determine the role of SIRT3-mediated autophagy in cellular metabolism and the process of EndoMT. We demonstrated that Angiotensin II (Ang II) led to defective autophagic flux and high levels of glycolysis in endothelial cells (ECs) accompanied by a loss of mitochondrial SIRT3 during EndoMT. The loss of SIRT3 further induced the hyperacetylation of endogenous autophagy-regulated gene 5 (ATG5), which in turn inhibited autophagosome maturation and increased pyruvate kinase M2 (PKM2) dimer expression. The M2 dimer is the less active form of PKM2, which drives glucose through aerobic glycolysis. Additionally, TEPP-46, a selective PKM2 tetramer activator, produced lower concentrations of lactate and led to the reduction of EndoMT both in vitro and in vivo. In parallel, the blockade of lactate influx from ECs into vascular smooth muscle cells (VSMCs) downregulated synthetic VSMC markers. EC-specific SIRT3 transgenic mice exhibited reduced endothelial cell transition but partial rescue of vascular fibrosis and collagen accumulation. Taken together, these findings reveal that SIRT3 regulates EndoMT by improving the autophagic degradation of PKM2. Pharmacological targeting of glycolysis metabolism may, therefore, represent an effective therapeutic strategy for hypertensive vascular remodeling.	[Gao, Jing; Wei, Tong; Huang, Chenglin; Shen, Weili] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiovasc Med, Dept Hypertens,Sch Med, Shanghai, Peoples R China; [Gao, Jing; Wei, Tong; Huang, Chenglin; Shen, Weili] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai Key Lab Hypertens,Sch Med, Shanghai, Peoples R China; [Sun, Mengwei] Shanghai Res Inst Sports Sci, Key Lab State Gen Adm Sport, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Shen, WL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Hypertens, Dept Hypertens, Sch Med,Ruijin Hosp, Shanghai 200025, Peoples R China.	wlshen@sibs.ac.cn			National Natural Science Foundation of China (NSFC) [81970235, 81370255, 81472099, 91439113]; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [19ZR1443200, 20ZR1454300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81970235, 81370255, 81472099 and 91439113; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 19ZR1443200 and 20ZR1454300	Bender T, 2016, BBA-MOL CELL RES, V1863, P2436, DOI 10.1016/j.bbamcr.2016.01.017; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Bharath LP, 2017, ARTERIOSCL THROM VAS, V37, P1646, DOI 10.1161/ATVBAHA.117.309510; Cao Y, 2017, THERANOSTICS, V7, P3021, DOI 10.7150/thno.18992; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Cui Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129834; Dasgupta S, 2015, J CLIN INVEST, V125, P1174, DOI 10.1172/JCI76029; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Feng YL, 2018, INT J BIOL SCI, V14, P775, DOI 10.7150/ijbs.26077; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Kim B, 2018, J CLIN INVEST, V128, P4543, DOI 10.1172/JCI120912; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lin JR, 2015, ARTERIOSCL THROM VAS, V35, P1413, DOI 10.1161/ATVBAHA.115.305706; Liu PH, 2018, BBA-MOL BASIS DIS, V1864, P764, DOI 10.1016/j.bbadis.2017.12.027; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Moonen JRAJ, 2010, CARDIOVASC RES, V86, P506, DOI 10.1093/cvr/cvq012; Morciano G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030892; Mukherjee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057610; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Robinson GL, 2012, ONCOGENE, V31, P4996, DOI 10.1038/onc.2012.13; Ryter SW, 2019, ANTIOXID REDOX SIGN, V30, P138, DOI 10.1089/ars.2018.7518; Sasaki N, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00533-w; Schaaf MB, 2019, CELL DEATH DIFFER, V26, P665, DOI 10.1038/s41418-019-0287-8; Shan HY, 2014, APMIS, V122, P985, DOI 10.1111/apm.12242; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Singh KK, 2015, J BIOL CHEM, V290, P2547, DOI 10.1074/jbc.M114.604603; Takagaki Y, 2020, AUTOPHAGY, V16, P1905, DOI 10.1080/15548627.2020.1713641; Tan VP, 2015, AUTOPHAGY, V11, P963, DOI 10.1080/15548627.2015.1042195; Vandekeere S, 2015, MICROCIRCULATION, V22, P509, DOI 10.1111/micc.12229; Wei T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006114; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yang LB, 2017, CIRC RES, V121, P1251, DOI 10.1161/CIRCRESAHA.117.311819; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Yue ZB, 2016, EXP CELL RES, V347, P261, DOI 10.1016/j.yexcr.2016.07.006; Zhang T, 2020, CELL DEATH DIFFER, V27, P329, DOI 10.1038/s41418-019-0356-z	43	6	6	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16645	16661		10.1096/fj.202001494R	http://dx.doi.org/10.1096/fj.202001494R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131100	Bronze			2022-12-26	WOS:000586603900001
J	Ogura, Y; Kakehashi, C; Yoshihara, T; Kurosaka, M; Kakigi, R; Higashida, K; Fujiwara, SE; Akema, T; Funabashi, T				Ogura, Yuji; Kakehashi, Chiaki; Yoshihara, Toshinori; Kurosaka, Mitsutoshi; Kakigi, Ryo; Higashida, Kazuhiko; Fujiwara, Sei-Etsu; Akema, Tatsuo; Funabashi, Toshiya			Ketogenic diet feeding improves aerobic metabolism property in extensor digitorum longus muscle of sedentary male rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; LOW-CARBOHYDRATE; GENE-EXPRESSION; EXERCISE; MITOCHONDRIAL; ADAPTATIONS; PERFORMANCE; INDUCTION; ALPHA; FAT	Recent studies of the ketogenic diet, an extremely high-fat diet with extremely low carbohydrates, suggest that it changes the energy metabolism properties of skeletal muscle. However, ketogenic diet effects on muscle metabolic characteristics are diverse and sometimes countervailing. Furthermore, ketogenic diet effects on skeletal muscle performance are unknown. After male Wistar rats (8 weeks of age) were assigned randomly to a control group (CON) and a ketogenic diet group (KD), they were fed for 4 weeks respectively with a control diet (10% fat, 10% protein, 80% carbohydrate) and a ketogenic diet (90% fat, 10% protein, 0% carbohydrate). After the 4-week feeding period, the extensor digitorum longus (EDL) muscle was evaluated ex vivo for twitch force, tetanic force, and fatigue. We also analyzed the myosin heavy chain composition, protein expression of metabolic enzymes and regulatory factors, and citrate synthase activity. No significant difference was found between CON and KD in twitch or tetanic forces or muscle fatigue. However, the KD citrate synthase activity and the protein expression of Sema3A, citrate synthase, succinate dehydrogenase, cytochrome c oxidase subunit 4, and 3-hydroxyacyl-CoA dehydrogenase were significantly higher than those of CON. Moreover, a myosin heavy chain shift occurred from type IIb to IIx in KD. These results demonstrated that the 4-week ketogenic diet improves skeletal muscle aerobic capacity without obstructing muscle contractile function in sedentary male rats and suggest involvement of Sema3A in the myosin heavy chain shift of EDL muscle.	[Ogura, Yuji; Kakehashi, Chiaki; Kurosaka, Mitsutoshi; Fujiwara, Sei-Etsu; Akema, Tatsuo; Funabashi, Toshiya] St Marianna Univ, Dept Physiol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Yoshihara, Toshinori] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba, Japan; [Kakigi, Ryo] Josai Int Univ, Fac Management & Informat Sci, Togane, Chiba, Japan; [Higashida, Kazuhiko] Univ Shiga Prefecture, Dept Nutr, Hikone, Shiga, Japan	Saint Marianna University; Juntendo University; University Shiga Prefecture	Ogura, Y (corresponding author), St Marianna Univ, Dept Physiol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan.	yuji_ogura@marianna-u.ac.jp		Ogura, Yuji/0000-0002-3711-4947	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24650334, 18K17767]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Exploratory Research (24650334 to CK) and by a Grant-in-Aid for Scientific Research (18K17767 to CK) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Al-Khalifa A, 2011, EXP TOXICOL PATHOL, V63, P663, DOI 10.1016/j.etp.2010.05.008; Al-Khalifa A, 2009, NUTRITION, V25, P1177, DOI 10.1016/j.nut.2009.04.004; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 1986, AM J PHYSL, V250, pH822; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Beckett TL, 2013, BRAIN RES, V1505, P61, DOI 10.1016/j.brainres.2013.01.046; Bielohuby M, 2011, ENDOCRINOLOGY, V152, P1948, DOI 10.1210/en.2010-1423; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Brambilla A, 2014, JIMD REP, V17, P91, DOI 10.1007/8904_2014_343; Branco AF, 2016, EUR J CLIN INVEST, V46, P285, DOI 10.1111/eci.12591; Crumbley C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033804; Dashti HM, 2007, MOL CELL BIOCHEM, V302, P249, DOI 10.1007/s11010-007-9448-z; Demirel HA, 1999, J APPL PHYSIOL, V86, P1002, DOI 10.1152/jappl.1999.86.3.1002; Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x; Ellenbroek JH, 2014, AM J PHYSIOL-ENDOC M, V306, pE552, DOI 10.1152/ajpendo.00453.2013; Francini-Pesenti Francesco, 2019, Acta Myol, V38, P17; Freeman John M, 2010, Adv Pediatr, V57, P315, DOI 10.1016/j.yapd.2010.08.003; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Fukushima A, 2015, BRAIN RES, V1622, P36, DOI 10.1016/j.brainres.2015.06.016; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hussain TA, 2012, NUTRITION, V28, P1016, DOI 10.1016/j.nut.2012.01.016; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kephart WC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091019; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Krysciak K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195704; Kurosaka M, 2017, J CELL PHYSIOL, V232, P1114, DOI 10.1002/jcp.25574; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; McAinch AJ, 2003, OBES RES, V11, P1471, DOI 10.1038/oby.2003.197; McClelland GB, 2004, BBA-MOL BASIS DIS, V1688, P86, DOI 10.1016/j.bbadis.2003.10.006; Meira ID, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00005; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; Miyamoto-Mikami E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35115-x; Moreno CL, 2017, MOL CELL ENDOCRINOL, V455, P33, DOI 10.1016/j.mce.2016.11.013; Mortensen OH, 2006, AM J PHYSIOL-ENDOC M, V291, pE807, DOI 10.1152/ajpendo.00591.2005; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Ogura Y, 2009, ACTA PHYSIOL, V196, P341, DOI 10.1111/j.1748-1716.2008.01945.x; Ogura Y, 2008, BIOCHEM BIOPH RES CO, V372, P584, DOI 10.1016/j.bbrc.2008.05.059; Parker BA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082247; Parry HA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00975; Poplawski MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018604; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Shimizu K, 2018, NUTR RES, V60, P77, DOI 10.1016/j.nutres.2018.09.004; Skripnikova E., 2017, AM J PHYSL REGUL INT, V312, pR412; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Tanner CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE1018, DOI 10.1152/ajpendo.00227.2013; Tatsumi R, 2017, STEM CELLS, V35, P1815, DOI 10.1002/stem.2639; Vamecq J, 2005, PROG NEUROBIOL, V75, P1, DOI 10.1016/j.pneurobio.2004.11.003; Volek JS, 2016, METABOLISM, V65, P100, DOI 10.1016/j.metabol.2015.10.028; Wheless JW, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01821.x; Yamakuchi M, 2000, FEBS LETT, V477, P135, DOI 10.1016/S0014-5793(00)01715-4; Yang HJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00585; 2016, AM J PHYSL LUNG CELL, V311, pL970	60	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241382	10.1371/journal.pone.0241382	http://dx.doi.org/10.1371/journal.pone.0241382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125406	Green Published, gold			2022-12-26	WOS:000588368900038
J	Palander, O; Trimble, WS				Palander, Oliva; Trimble, William S.			DIAPH1 regulates ciliogenesis and trafficking in primary cilia	FASEB JOURNAL			English	Article						(3-5); DIAPH1; formin; ciliogenesis; primary cilia; intraflagellar transport	DIAPHANOUS-RELATED FORMIN; PLANAR CELL POLARITY; ADENOMATOUS POLYPOSIS-COLI; ACTIN NUCLEATION; RHO; PROTEIN; MDIA1; ROLES; GENE; EB1	Primary cilia are critical hubs for several signaling pathways, and defects in ciliogenesis or cilia maintenance produce a range of diseases collectively known as ciliopathies. Ciliogenesis requires vesicle trafficking along a network of microtubules and actin filaments to the basal body. The DIAPH1 (Diaphanous-related formin) family of formins promotes both actin polymerization and EB1-dependent microtubule (MT) stability. EB1 and EB3 have previously been implicated in cilia biogenesis to carry out centrosome-related functions. However, the role of DIAPH1 proteins had not been examined. Here we show that the depletion of DIAPH1 decreased ciliogenesis, cilia length, and reduced trafficking within cilia. Additionally, both actin nucleating and microtubule-stabilizing properties of DIAPH1 are important for their cilia functions. To assess their roles in ciliogenesis in isolation, we targeted DIAPH1 specifically to the basal body, which caused an increase in cilia length and increased trafficking within cilia. Intriguingly, expression of DIAPH1 mutants associated with human deafness and microcephaly impaired ciliation and caused cilia elongation and bulb formation. These results suggest that the actin and microtubule functions of DIAPH1 proteins regulate cilia maintenance in part by regulating vesicular trafficking to the base of the primary cilia.	[Palander, Oliva; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Palander, Oliva; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca			CIHR grant [PJT-162194]	CIHR grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from CIHR grant PJT-162194 to WST.	Al-Maawali A, 2016, AM J MED GENET A, V170, P435, DOI 10.1002/ajmg.a.37422; Baudoin JP, 2012, NEURON, V76, P1108, DOI 10.1016/j.neuron.2012.10.027; Cao MQ, 2015, ELIFE, V4, DOI 10.7554/eLife.05242; Chen HY, 2021, SEMIN CELL DEV BIOL, V110, P70, DOI 10.1016/j.semcdb.2020.07.013; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Copeland SJ, 2018, MOL BIOL CELL, V29, P1611, DOI 10.1091/mbc.E18-02-0088; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; Daou P, 2014, MOL BIOL CELL, V25, P658, DOI 10.1091/mbc.E13-08-0482; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08872-0; Jones C, 2008, CURR TOP DEV BIOL, V85, P197, DOI 10.1016/S0070-2153(08)00808-9; Kang TH, 2016, GENES GENET SYST, V91, P289, DOI 10.1266/ggs.16-00041; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lechtreck KF, 2018, CYTOSKELETON, V75, P352, DOI 10.1002/cm.21457; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Li Z, 2012, ONCOGENE, V31, P1475, DOI 10.1038/onc.2011.351; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; May-Simera HL, 2015, DEVELOPMENT, V142, P555, DOI 10.1242/dev.113696; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Nigg EA, 2017, COLD SH Q B, V82, P137, DOI 10.1101/sqb.2017.82.034421; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2016, TRENDS BIOCHEM SCI, V41, P784, DOI 10.1016/j.tibs.2016.06.002; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schoen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056520; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; Song L, 2014, INT J BIOCHEM CELL B, V55, P79, DOI 10.1016/j.biocel.2014.08.010; Soykan T, 2017, NEURON, V93, P854, DOI 10.1016/j.neuron.2017.02.011; Surel C, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0295-16.2016; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Ueyama T, 2016, EMBO MOL MED, V8, P1310, DOI 10.15252/emmm.201606609; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; Zilberman Y, 2011, MOL BIOL CELL, V22, P2900, DOI 10.1091/mbc.E11-01-0007	66	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16516	16535		10.1096/fj.202001178R	http://dx.doi.org/10.1096/fj.202001178R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124112	hybrid			2022-12-26	WOS:000589709400001
J	Rayl, JM; Allender, MC				Rayl, Jeremy M.; Allender, Matthew C.			Temperature affects the host hematological and cytokine response following experimental ranavirus infection in red-eared sliders (Trachemys scripta elegans)	PLOS ONE			English	Article							VIRUS 3-LIKE VIRUS; INNATE IMMUNE-RESPONSES; BOX TURTLES; QUANTITATIVE PCR; FROG; SUSCEPTIBILITY; STRESS; EXPRESSION; PROFILES; CAROLINA	Pathogen-host interactions are important components of epidemiological research, but are scarcely investigated in chelonians. Red-eared sliders (Trachemys scripta elegans), are recognized as a model for frog virus-3 infection (FV3), a ranavirus in the family Iridoviridae that infects multiple classes of ectothermic vertebrates. Previous challenge studies observed differences in disease outcome based on environmental temperature in this species, but the host response was minimally evaluated. We challenged red-eared sliders with an FV3-like ranavirus at both 28 degrees C and 22 degrees C. We monitored several host response variables for 30 days, including: survival (binary outcome and duration), clinical signs, total and differential leukocytes, and select cytokine transcription in the buffy coat (IL-1 beta, TNF alpha, IFYg, IL-10). After 30 days, 17% of challenged turtles survived at 28 degrees C (Median survival time [MST]: 15 days, range: 10-30 days) and 50% survived (MST: 28.5 days, range: 23-30 days) at 22 degrees C (range 23-30 days). The most common clinical signs were injection site swelling, palpebral swelling, and lethargy. The heterophil/lymphocyte ratio at 22 degrees C and interleukin-1 beta (IL1 beta) transcription at both 22 degrees C and 28 degrees C were significantly greater on days 9, 16, and 23 in FV3 challenged groups. Tumor necrosis factor alpha and interleukin-10 were transcribed at detectable levels, but did not display significant differences in mean relative transcription quantity over time. Overall, evidence indicates an over-robust immune response leading to death in the challenged turtles. FV3 remains a risk for captive and free-ranging chelonian populations, and insight to host/pathogen interaction through this model helps to elucidate the timing and intensity of the host response that contribute to mortality.	[Rayl, Jeremy M.; Allender, Matthew C.] Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Rayl, JM (corresponding author), Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	rayl2@illinois.edu		Rayl, Jeremy/0000-0003-2801-3180				Adamovicz L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195617; Allender MC, 2013, J COMP PATHOL, V149, P356, DOI 10.1016/j.jcpa.2013.01.007; Allender M.C, 2012, THESIS; Allender MC, 2018, J WILDLIFE DIS, V54, P716, DOI 10.7589/2017-07-181; Allender Matthew C., 2013, Journal of Herpetological Medicine and Surgery, V23, P25, DOI 10.5818/1529-9651-23.1.25; Allender MC, 2013, J VIROL METHODS, V188, P121, DOI 10.1016/j.jviromet.2012.12.012; Andino FD, 2012, VIROLOGY, V432, P435, DOI 10.1016/j.virol.2012.07.001; [Anonymous], **DATA OBJECT**; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2015, LANCET RESP MED, V3, P661, DOI DOI 10.1016/S2213-2600(15)00336-7; [Anonymous], **DATA OBJECT**; Banki E, 2013, PEPTIDES, V42, P125, DOI 10.1016/j.peptides.2013.02.002; Bienvenu J, 2000, CLIN CHEM LAB MED, V38, P267, DOI 10.1515/CCLM.2000.040; Brand MD, 2016, ECOHEALTH, V13, P350, DOI 10.1007/s10393-016-1120-1; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; Carolan LA, 2014, J VIROL METHODS, V205, P38, DOI 10.1016/j.jviromet.2014.04.014; Chen ZY, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020052; Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dean AG, OPENEPI OPEN SOURCE; Duffus A. L. J., 2015, RANAVIRUSES LETHAL P, P9, DOI DOI 10.1007/978-3-319-13755-1; Ferrante J.A., 2014, THESIS; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Goessling JM, 2015, FUNCT ECOL, V29, P1189, DOI 10.1111/1365-2435.12442; Grant EC, 2003, J AQUAT ANIM HEALTH, V15, P215, DOI 10.1577/H03-009; GRAVELL M, 1970, VIROLOGY, V41, P596, DOI 10.1016/0042-6822(70)90425-3; Grayfer L, 2015, J VIROL, V89, P5072, DOI 10.1128/JVI.00051-15; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Ke F, 2019, FISH SHELLFISH IMMUN, V86, P1096, DOI 10.1016/j.fsi.2018.12.027; Lesbarreres D, 2012, BIOL LETTERS, V8, P481, DOI 10.1098/rsbl.2011.0951; Lloyd TC, 2016, ECOHEALTH, V13, P467, DOI 10.1007/s10393-016-1142-8; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Morales HD, 2010, J VIROL, V84, P4912, DOI 10.1128/JVI.02486-09; Nardini Giordano, 2013, Vet Clin North Am Exot Anim Pract, V16, P1, DOI 10.1016/j.cvex.2012.09.001; Neul A, 2017, AM J VET RES, V78, P482, DOI 10.2460/ajvr.78.4.482; Rayl JM, 2019, CYTOKINE, V119, P16, DOI 10.1016/j.cyto.2019.02.011; Rojas S, 2005, DIS AQUAT ORGAN, V63, P95, DOI 10.3354/dao063095; Sim RR, 2016, J ZOO WILDLIFE MED, V47, P256, DOI 10.1638/2015-0048.1; Sutton WB, 2014, DIS AQUAT ORGAN, V112, P9, DOI 10.3354/dao02792; Svitek N, 2007, VIROLOGY, V362, P404, DOI 10.1016/j.virol.2007.01.002; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Whitehead KJ, 2010, BRAIN BEHAV IMMUN, V24, P569, DOI 10.1016/j.bbi.2009.12.007; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yabuki A, 2015, ANAT HISTOL EMBRYOL, V44, P317, DOI 10.1111/ahe.12143; Zimmerman LM, 2017, FUNCT ECOL, V31, P1383, DOI 10.1111/1365-2435.12867	50	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241414	10.1371/journal.pone.0241414	http://dx.doi.org/10.1371/journal.pone.0241414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119713	gold, Green Published			2022-12-26	WOS:000600013600022
J	Ejigu, BA				Ejigu, Bedilu Alamirie			Geostatistical analysis and mapping of malaria risk in children of Mozambique	PLOS ONE			English	Article							CARLO MAXIMUM-LIKELIHOOD; AFRICA; ANEMIA; BURDEN	Malaria remains one of the most prevalent infectious diseases in the tropics and subtropics, and Mozambique is not an exception. To design geographically targeted and effective intervention mechanisms of malaria, an up-to-date map that shows the spatial distribution of malaria is needed. This study analyzed 2018 Mozambique Malaria Indicator Survey using geostatistical methods to: i) explore individual, household, and community-level determinants of malaria in under-five children, ii) prepare a malaria prevalence map in Mozambique, and iii) produce prediction prevalence maps and exceedence probability across the country. The results show the overall weighted prevalence of malaria was 38.9% (N = 4347, with 95% CI: 36.9%-40.8%). Across different provinces of Mozambique, the prevalence of malaria ranges from 1% in Maputo city to 57.3% in Cabo Delgado province. Malaria prevalence was found to be higher in rural areas, increased with child's age, and decreased with household wealth index and mother's level of education. Given the high prevalence of childhood malaria observed in Mozambique there is an urgent need for effective public health interventions in malaria hot spot areas. The household determinants of malaria infection that are identified in this study as well as the maps of parasitaemia risk could be used by malaria control program implementers to define priority intervention areas.	[Ejigu, Bedilu Alamirie] Addis Ababa Univ, Coll Nat & Computat Sci, Dept Stat, Addis Ababa, Ethiopia	Addis Ababa University	Ejigu, BA (corresponding author), Addis Ababa Univ, Coll Nat & Computat Sci, Dept Stat, Addis Ababa, Ethiopia.	bedilu.alamierie@aau.edu.et		Ejigu, Bedilu Alamirie/0000-0003-1159-6308				Adigun AB, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0683-6; Afoakwah C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5428-3; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 2016, FORTUNE, V15, pF29; [Anonymous], 2014, ANN FAM MED, V12, piii; [Anonymous], 2017, EPLASTY, V17, pic25; [Anonymous], 2006, PLOS MED, V3, pe252; Benjamin M, 2018, DHS PROGRAM GEOSPATI, V2; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Chipeta M. G., 2019, Wellcome Open Research, V4, DOI 10.12688/wellcomeopenres.15193.2; daSaude M, 2011, MOCAMBIQUE INQUERITO; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Ejigu BA, 2020, SPAT STAT-NETH, V35, DOI 10.1016/j.spasta.2019.100397; Ejigu BA, 2020, SPAT STAT-NETH, V38, DOI 10.1016/j.spasta.2020.100454; Ejigu BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197171; Ferrao JL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040795; Fox Louise, 2012, ED REFORM MOZAMBIQUE; Franco C, 2019, J SURV STAT METHODOL, V7, P334, DOI 10.1093/jssam/smy019; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GEYER CJ, 1992, J R STAT SOC B, V54, P657; GEYER CJ, 1994, J ROY STAT SOC B MET, V56, P261; Giardina F, 2015, GEOSPATIAL HEALTH, V10, P232, DOI 10.4081/gh.2015.333; Giorgi E, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i08; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Instituto Nacional de Saude, 2019, INQ NAC IND MAL MOC; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Kott-Carr, 1997, J OFF STAT, V13, P367; Mabunda S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-216; Matern B., 1986, SPATIAL VARIATION; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003205; Nyarko Samuel Harrenson, 2014, Malar Res Treat, V2014, P304361, DOI 10.1155/2014/304361; PMI, 2019, PRES MAL IN PMI MAL, P321; R Core Team, 2018, R LANG ENV STAT COMP; Raso G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-160; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Roberts D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1290-x; Samadoulougou S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-350; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; SIDA, 2019, MOZ MULT POV AN STAT; Ssempiira J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174948; Stein M.L., 1999, INTERPOLATION SPATIA; WHO, 2018, WORLD MAL REP 2018; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization,, 2020, TAIL MAL INT COVID 1; World Health Organization, 2020, MAL ER BEN FUT SCEN; Yankson R, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2709-y; Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-189; Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-93	54	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241680	10.1371/journal.pone.0241680	http://dx.doi.org/10.1371/journal.pone.0241680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166322	Green Published, gold			2022-12-26	WOS:000592382600004
J	Zhang, XY; Guo, BY; Yi, NJ				Zhang, Xinyan; Guo, Boyi; Yi, Nengjun			Zero-Inflated gaussian mixed models for analyzing longitudinal microbiome data	PLOS ONE			English	Article							HEALTH	Motivation The human microbiome is variable and dynamic in nature. Longitudinal studies could explain the mechanisms in maintaining the microbiome in health or causing dysbiosis in disease. However, it remains challenging to properly analyze the longitudinal microbiome data from either 16S rRNA or metagenome shotgun sequencing studies, output as proportions or counts. Most microbiome data are sparse, requiring statistical models to handle zero-inflation. Moreover, longitudinal design induces correlation among the samples and thus further complicates the analysis and interpretation of the microbiome data. Results In this article, we propose zero-inflated Gaussian mixed models (ZIGMMs) to analyze longitudinal microbiome data. ZIGMMs is a robust and flexible method which can be applicable for longitudinal microbiome proportion data or count data generated with either 16S rRNA or shotgun sequencing technologies. It can include various types of fixed effects and random effects and account for various within-subject correlation structures, and can effectively handle zero-inflation. We developed an efficient Expectation-Maximization (EM) algorithm to fit the ZIGMMs by taking advantage of the standard procedure for fitting linear mixed models. We demonstrate the computational efficiency of our EM algorithm by comparing with two other zero-inflated methods. We show that ZIGMMs outperform the previously used linear mixed models (LMMs), negative binomial mixed models (NBMMs) and zero-inflated Beta regression mixed model (ZIBR) in detecting associated effects in longitudinal microbiome data through extensive simulations. We also apply our method to two public longitudinal microbiome datasets and compare with LMMs and NBMMs in detecting dynamic effects of associated taxa.	[Zhang, Xinyan] Kennesaw State Univ, Dept Stat & Data Analyt, Kennesaw, GA 30144 USA; [Guo, Boyi; Yi, Nengjun] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University System of Georgia; Kennesaw State University; University of Alabama System; University of Alabama Birmingham	Yi, NJ (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	nyi@uab.edu	Guo, Boyi/HHN-5962-2022	Guo, Boyi/0000-0003-2950-2349				Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chen E.Z., 2019, ZIBR ZERO INFLATED B; Chen EZ, 2016, BIOINFORMATICS, V32, P2611, DOI 10.1093/bioinformatics/btw308; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004; Gelman A., 2007, DATA ANAL USING REGR; Gerber G., 2015, METAGENOMICS MICROBI, P97; Gerber GK, 2014, FEBS LETT, V588, P4131, DOI 10.1016/j.febslet.2014.02.037; Hawinkel S, 2019, BRIEF BIOINFORM, V20, P210, DOI 10.1093/bib/bbx104; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McGeachie MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20359; Morris A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0183-0; Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; SCHALL R, 1991, BIOMETRIKA, V78, P719; Sohn MB, 2015, BIOINFORMATICS, V31, P2269, DOI 10.1093/bioinformatics/btv165; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Venables WN., 2002, MODERN APPL STAT S 4; Vincent C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0156-3; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440; Ward DV, 2016, CELL REP, V14, P2912, DOI 10.1016/j.celrep.2016.03.015; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Yang I, 2016, NURS RES, V65, P76, DOI 10.1097/NNR.0000000000000133; Zhang XY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01683; Zhang XY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1441-7; Zhou YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118632	42	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242073	10.1371/journal.pone.0242073	http://dx.doi.org/10.1371/journal.pone.0242073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166356	Green Published, gold			2022-12-26	WOS:000592382600044
J	Adelantado-Renau, M; Beltran-Valls, MR; Mota, J; Moliner-Urdiales, D				Adelantado-Renau, Mireia; Beltran-Valls, Maria Reyes; Mota, Jorge; Moliner-Urdiales, Diego			Circulating inflammatory biomarkers and academic performance in adolescents: DADOS study	PLOS ONE			English	Article							COGNITIVE FUNCTION; CHILDREN; ACHIEVEMENT; FITNESS; WEIGHT	Objective The present study aimed (1) to examine the association between circulating inflammatory biomarkers and academic performance in adolescents, and (2) to identify the ability of circulating inflammatory biomarkers to predict low academic performance. Methods A total of 244 adolescents (13.9 +/- 0.3 years, 112 girls) from the DADOS study were included in the analysis. Four inflammatory biomarkers were quantified: white blood cell (WBC) count, interleukin-6, tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP). Academic performance was assessed through academic grades and the Spanish version of the Science Research Associates Test of Educational Abilities. Results TNF-alpha was inversely associated with math, Spanish and grade point average (beta ranging from -0.166 to -0.124; all p<0.05), while CRP was inversely associated with verbal ability (beta = -0.128; p<0.05). Overall, receiver operating characteristic (ROC) curves analyses showed discriminatory ability of WBC and TNF-alpha in identifying low academic performance (all p<0.05). Moreover, logistic regression analyses indicated that students with levels of WBC and TNF-alpha above the ROC cut-offs values showed between 78% to 87% increased likelihood of lower academic performance (p<0.05). Conclusions Our findings suggested that some circulating inflammatory biomarkers were associated with academic performance in adolescents. Further larger longitudinal and interventional studies are needed to clarify the short-term and long-term relationship between inflammation and academic performance in youths.	[Adelantado-Renau, Mireia; Beltran-Valls, Maria Reyes; Moliner-Urdiales, Diego] Univ Jaume 1, LIFE Res Grp, Castellon De La Plana, Spain; [Mota, Jorge] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure CIAFEL, Porto, Portugal	Universitat Jaume I; Universidade do Porto	Moliner-Urdiales, D (corresponding author), Univ Jaume 1, LIFE Res Grp, Castellon De La Plana, Spain.	dmoliner@uji.es	mota, jorge/B-2980-2013; Valls, Maria Reyes Beltran/ABG-7890-2020; Adelantado-Renau, Mireia/R-4835-2019; Beltran-Valls, Maria Reyes/S-3673-2019	mota, jorge/0000-0001-7571-9181; Valls, Maria Reyes Beltran/0000-0003-1749-9330; Moliner-Urdiales, Diego/0000-0001-9868-3396; Adelantado-Renau, Mireia/0000-0001-6124-8876	Spanish Ministry of Economy and Competitiveness, MINECO [DEP2013-45515-R]; Jaume I University of Castellon, UJI [P1.1A2015-05, UJI-A2019-12]; Schweppes Suntory Spain Company; UJI [PREDOC/2015/13, E-2018-21]; FCT [SFRH/BSAB/142983/2018, UID/DTP/00617/2019]; Programa de Bolsas Santander Universidades 2018	Spanish Ministry of Economy and Competitiveness, MINECO; Jaume I University of Castellon, UJI; Schweppes Suntory Spain Company; UJI; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa de Bolsas Santander Universidades 2018	The DADOS Study is funded by the Spanish Ministry of Economy and Competitiveness, MINECO (DEP2013-45515-R) and by the Jaume I University of Castellon, UJI (P1.1A2015-05 and UJI-A2019-12). This work was partly supported by a Sunny Sport research grant from the Schweppes Suntory Spain Company. M.A.R was supported by a Predoctoral Research Grant from UJI (PREDOC/2015/13 and E-2018-21). J.M was supported by grants: FCT: SFRH/BSAB/142983/2018 and UID/DTP/00617/2019, as well as Programa de Bolsas Santander Universidades 2018.	Adelantado-Renau M, 2019, ACTA PAEDIATR, V108, P339, DOI 10.1111/apa.14472; Adelantado-Renau M, 2019, J PEDIAT-BRAZIL, V95, P410, DOI 10.1016/j.jped.2018.03.006; Al-Domi H, 2019, DIABETES METAB SYND, V13, P264, DOI 10.1016/j.dsx.2018.09.004; Artero EG, 2014, PEDIATR OBES, V9, P391, DOI 10.1111/j.2047-6310.2013.00186.x; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Correa-Burrows P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091133; Cullen AE, 2017, BRAIN BEHAV IMMUN, V66, P221, DOI 10.1016/j.bbi.2017.07.002; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Esteban-Cornejo I, 2016, BRAIN BEHAV IMMUN, V54, P122, DOI 10.1016/j.bbi.2016.01.010; French MT, 2015, EAST ECON J, V41, P370, DOI 10.1057/eej.2014.22; Frodl T, 2014, PROG NEURO-PSYCHOPH, V48, P295, DOI 10.1016/j.pnpbp.2012.12.013; Grigoleit JS, 2010, NEUROBIOL LEARN MEM, V94, P561, DOI 10.1016/j.nlm.2010.09.011; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jonker I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101549; Kuban KCK, 2017, J PEDIATR-US, V180, P116, DOI 10.1016/j.jpeds.2016.09.054; Kyriklaki A, 2019, CYTOKINE, V117, P1, DOI 10.1016/j.cyto.2019.01.010; Le-Scherban F, 2014, ANN EPIDEMIOL, V24, P344, DOI 10.1016/j.annepidem.2014.02.008; Lee SE, 2016, BRAIN BEHAV IMMUN, V56, P253, DOI 10.1016/j.bbi.2016.03.023; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Marsland AL, 2015, BRAIN BEHAV IMMUN, V48, P195, DOI 10.1016/j.bbi.2015.03.015; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; de Heredia FP, 2014, SLEEP MED, V15, P1251, DOI 10.1016/j.sleep.2014.04.010; Rose J, 2016, AM J PERINAT, V33, P71, DOI 10.1055/s-0035-1557106; Sartori AC, 2012, J NEUROSCI NURS, V44, P206, DOI 10.1097/JNN.0b013e3182527690; Schwingshackl L, 2014, NUTR METAB CARDIOVAS, V24, P929, DOI 10.1016/j.numecd.2014.03.003; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P931, DOI 10.1079/PHN2004556; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thurstone L, 2004, TEA TEST APTITUDES E; Vukojevic M, 2017, ACTA CLIN CROAT, V56, P742, DOI 10.20471/acc.2017.56.04.23; Windham BG, 2014, J AM GERIATR SOC, V62, P2303, DOI 10.1111/jgs.13165	33	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0242016	10.1371/journal.pone.0242016	http://dx.doi.org/10.1371/journal.pone.0242016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156854	Green Published, gold			2022-12-26	WOS:000591376400006
J	Park, H; Maruhashi, K; Yamaguchi, R; Imoto, S; Miyano, S				Park, Heewon; Maruhashi, Koji; Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru			Global gene network exploration based on explainable artificial intelligence approach	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; FEEDBACK LOOP; ACTIVATION; ZEB1; TRANSCRIPTION; SUPPRESSES; MEDIATOR; IFI16	In recent years, personalized gene regulatory networks have received significant attention, and interpretation of the multilayer networks has been a critical issue for a comprehensive understanding of gene regulatory systems. Although several statistical and machine learning approaches have been developed and applied to reveal sample-specific regulatory pathways, integrative understanding of the massive multilayer networks remains a challenge. To resolve this problem, we propose a novel artificial intelligence (AI) strategy for comprehensive gene regulatory network analysis. In our strategy, personalized gene networks corresponding specific clinical characteristic are constructed and the constructed network is considered as a second-order tensor. Then, an explainable AI method based on deep learning is applied to decompose the multilayer networks, thus we can reveal all-encompassing gene regulatory systems characterized by clinical features of patients. To evaluate the proposed methodology, we apply our method to the multilayer gene networks under varying conditions of an epithelial-mesenchymal transition (EMT) process. From the comprehensive analysis of multilayer networks, we identified novel markers, and the biological mechanisms of the identified genes and their reciprocal mechanisms are verified through the literature. Although any biological knowledge about the identified genes was not incorporated in our analysis, our data-driven approach based on AI approach provides biologically reliable results. Furthermore, the results provide crucial evidences to reveal biological mechanism related to various diseases, e.g., keratinocyte proliferation. The use of explainable AI method based on the tensor decomposition enables us to reveal global and novel mechanisms of gene regulatory system from the massive multiple networks, which cannot be demonstrated by existing methods. We expect that the proposed method provides a new insight into network biology and it will be a useful tool to integrative gene network analysis related complex architectures of diseases.	[Park, Heewon; Miyano, Satoru] Tokyo Med & Dent Univ, M&D Data Sci Ctr, Tokyo, Japan; [Maruhashi, Koji] Fujitsu Labs Ltd, Kawasaki, Kanagawa, Japan; [Yamaguchi, Rui] Aichi Canc Ctr Res Inst, Div Canc Syst Biol, Nagoya, Aichi, Japan; [Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Fujitsu Ltd; Fujitsu Laboratories Ltd; Aichi Cancer Center; University of Tokyo	Park, H (corresponding author), Tokyo Med & Dent Univ, M&D Data Sci Ctr, Tokyo, Japan.	hwpark.dsc@tmd.ac.jp						Alimirah F, 2007, MOL CANCER RES, V5, P251, DOI 10.1158/1541-7786.MCR-06-0269; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Cai J, 2015, CANCER LETT, V367, P129, DOI 10.1016/j.canlet.2015.07.001; Capsules EGoCASoB, 2016, J NEUROSCI MENT HLTH, V16, P142, DOI [10.3969/j.issn.1009-6574.2016.02.006, DOI 10.3969/J.ISSN.1009-6574.2016.02.006]; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; Chen W, 2016, CARCINOGENESIS, V37, P500, DOI 10.1093/carcin/bgw027; Chung VY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19943; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Dad T, 2015, SEMIN NEPHROL, V35, P311, DOI 10.1016/j.semnephrol.2015.06.003; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; De Pascalis C, 2017, MOL BIOL CELL, V28, P1833, DOI 10.1091/mbc.E17-03-0134; Dennis G, 2003, GENOME BIOL, V4; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Iwasaki H, 2013, CANCER SCI, V104, P328, DOI 10.1111/cas.12073; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Ke CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12791; Kishan KC, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-019-0694-y; Larsen JE, 2016, J CLIN INVEST, V126, P3219, DOI 10.1172/JCI76725; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Leopold PL, 2012, SEMIN CANCER BIOL, V22, P471, DOI 10.1016/j.semcancer.2012.07.003; Li DD, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00220; Lin W, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12392; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu JJ, 2018, ONCOTARGETS THER, V11, P2963, DOI 10.2147/OTT.S157119; Lo P.K., 2017, PRAS OPEN, V1, P9; Mak AB, 2012, CANCER RES, V72, P1929, DOI 10.1158/0008-5472.CAN-11-3589; Maruhashi K, 2020, ARXIV1200703912; Maruhashi K, 2018, AAAI CONF ARTIF INTE, P3770; Mehrazarin S, 2015, J BIOL CHEM, V290, P19999, DOI 10.1074/jbc.M115.659144; Mochida K, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01770; Mooney SM, 2017, J CELL BIOCHEM, V118, P2559, DOI 10.1002/jcb.25974; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Notario V, 2010, HDB CELL SIGN, VSecond, P2859; Olsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062547; Pallier K, 2012, TUMOR BIOL, V33, P41, DOI 10.1007/s13277-011-0239-5; Park H, 2018, J COMPUT BIOL, V25, P130, DOI 10.1089/cmb.2017.0120; Parsana P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3413-3; Reaves DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091747; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Roy A, 2019, ELIFE, V8, DOI 10.7554/eLife.49500; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Rodrigues MFSD, 2018, INT J ONCOL, V53, P2458, DOI 10.3892/ijo.2018.4572; Shimada H, 2017, SCI REP-UK, V7, DOI 10.1038/srep37049; Suguitan Jr AL, 2011, PLOS ONE, V6; Takano K, 2016, ANTICANCER RES, V36, P5895, DOI 10.21873/anticanres.11176; Thomas AM, 2017, BLOOD, V129, P2217; Tsai YC, 2018, BBA-MOL BASIS DIS, V1864, P1717, DOI 10.1016/j.bbadis.2018.02.016; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang SY, 2018, NEOPLASIA, V20, P996, DOI 10.1016/j.neo.2018.08.004; Wei HJ, 2014, ONCOTARGET, V5, P9514, DOI 10.18632/oncotarget.2413; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang Y, 2014, ONCOGENE, V33, P1548, DOI 10.1038/onc.2013.101; Zhang Y, 2019, SOLID EARTH SCI, V4, P1, DOI 10.1016/j.sesci.2018.12.001; Zhou CC, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.44; 2019, HUM REPROD, V34	61	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241508	10.1371/journal.pone.0241508	http://dx.doi.org/10.1371/journal.pone.0241508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156825	Green Published, gold			2022-12-26	WOS:000591376400055
J	Takakusagi, Y; Oike, T; Kano, K; Anno, W; Tsuchida, K; Mizoguchi, N; Serizawa, I; Yoshida, D; Katoh, H; Kamada, T				Takakusagi, Yosuke; Oike, Takahiro; Kano, Kio; Anno, Wataru; Tsuchida, Keisuke; Mizoguchi, Nobutaka; Serizawa, Itsuko; Yoshida, Daisaku; Katoh, Hiroyuki; Kamada, Tadashi			Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer	PLOS ONE			English	Article							EXTERNAL-BEAM RADIATION; FREE SURVIVAL; BOUNCE; BRACHYTHERAPY; ONCOLOGY; PROTON; SYSTEM; JAPAN	Background This study aimed to explain the dynamics of prostate-specific antigen (PSA) levels in patients with prostate cancer who were treated with carbon ion radiotherapy (CIRT) and neoadjuvant androgen-deprivation therapy (ADT). Methods Eighty-five patients with intermediate-risk prostate cancer who received CIRT and neoadjuvant ADT from December 2015 to December 2017 were analyzed in the present study. The total dose of CIRT was set at 51.6 Gy (relative biological effectiveness) delivered in 12 fractions over 3 weeks. The PSA bounce was defined as a >= 0.4 ng/ml increase of PSA levels from the nadir, followed by any decrease. PSA failure was defined using the Phoenix criteria. Results The median patient age was 68 (range, 48-81) years. The median follow-up duration was 33 (range, 20-48) months. The clinical T stage was T1c, T2a, and T2b in 27, 44, and 14 patients, respectively. The Gleason score was 6 in 3 patients and 7 in 82 patients. The median pretreatment PSA level was 7.37 (range, 3.33-19.0) ng/ml. All patients received neoadjuvant ADT for a median of 6 (range, 2-117) months. PSA bounces were observed in 39 patients (45.9%), occurring a median of 12 (range, 6-30) months after CIRT. PSA failure was observed in eight patients (9.4%), occurring a median of 21 (range, 15-33) months after CIRT. The 3-year PSA failure-free survival rate was 88.5%. No clinical recurrence was observed during the follow-up period. Younger age and lower T stage were significant predictors of PSA bounce. Younger age was a significant predictor of PSA failure. Conclusions In this study, we identified the significant predictors of the occurrence of PSA bounce and failure. Further follow-up is needed to reveal the clinical significance of PSA dynamics.	[Takakusagi, Yosuke; Kano, Kio; Anno, Wataru; Tsuchida, Keisuke; Mizoguchi, Nobutaka; Serizawa, Itsuko; Yoshida, Daisaku; Katoh, Hiroyuki; Kamada, Tadashi] Kanagawa Canc Ctr, Dept Radiat Oncol, Yokohama, Kanagawa, Japan; [Oike, Takahiro] Gunma Univ, Dept Radiat Oncol, Grad Sch Med, Maebashi, Gumma, Japan	Kanagawa Prefectural Cancer Center; Gunma University	Takakusagi, Y (corresponding author), Kanagawa Canc Ctr, Dept Radiat Oncol, Yokohama, Kanagawa, Japan.	y-takakusagi@kcch.jp	Tsuchida, Keisuke/ABG-7702-2021					Akakura K, 2004, PROSTATE, V58, P252, DOI 10.1002/pros.10328; [Anonymous], 1997, PROSTATE BRACHYTHERA; Astrom L, 2018, RADIOTHER ONCOL, V129, P561, DOI 10.1016/j.radonc.2018.08.011; Bryant C, 2016, INT J RADIAT ONCOL, V95, P422, DOI 10.1016/j.ijrobp.2016.02.038; Burchardt W, 2018, J CONTEMP BRACHYTHER, V10, P1, DOI 10.5114/jcb.2018.73786; Caloglu M, 2009, UROLOGY, V74, P1183, DOI 10.1016/j.urology.2009.01.043; Conroy AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028540; Crook J, 2007, INT J RADIAT ONCOL, V69, P426, DOI 10.1016/j.ijrobp.2007.03.031; Cuccia F, 2019, TUMORI J, V105, P516, DOI 10.1177/0300891619867846; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Darwis NDM, 2020, CANCERS, V12, DOI 10.3390/cancers12030589; Deutsch I, 2010, BRACHYTHERAPY, V9, P313, DOI 10.1016/j.brachy.2010.02.196; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freiberger C, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0837-5; Hinnen KA, 2012, INT J RADIAT ONCOL, V82, P883, DOI 10.1016/j.ijrobp.2010.11.049; Horwitz EM, 2006, CANCER, V107, P1496, DOI 10.1002/cncr.22183; Hung IFN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148493; Ishikawa H, 2006, RADIOTHER ONCOL, V81, P57, DOI 10.1016/j.radonc.2006.08.015; Ishikawa H, 2012, INT J UROL, V19, P296, DOI 10.1111/j.1442-2042.2012.02961.x; Jiang NY, 2019, INT J RADIAT ONCOL, V105, P628, DOI 10.1016/j.ijrobp.2019.06.2539; Kanai T, 2006, INT J RADIAT ONCOL, V64, P650, DOI 10.1016/j.ijrobp.2005.09.043; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Makarewicz Roman, 2009, J Contemp Brachytherapy, V1, P92; Mazeron R, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-46; McGrath SD, 2010, BRACHYTHERAPY, V9, P137, DOI 10.1016/j.brachy.2009.07.005; Mehta NH, 2013, INT J RADIAT ONCOL, V86, P729, DOI 10.1016/j.ijrobp.2013.02.032; Nakayama Yuko, 2016, Int J Part Ther, V2, P478, DOI 10.14338/IJPT-15-00024.1; Nicosia L, 2019, J CANCER RES CLIN, V145, P2547, DOI 10.1007/s00432-019-02983-3; Nomiya T, 2016, RADIOTHER ONCOL, V121, P288, DOI 10.1016/j.radonc.2016.10.009; Patel C, 2004, UROLOGY, V63, P110, DOI 10.1016/j.urology.2003.08.025; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Rosser CJ, 2005, UROLOGY, V66, P327, DOI 10.1016/j.urology.2005.02.026; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Sengoz M, 2003, EUR UROL, V43, P473, DOI 10.1016/S0302-2838(03)00138-6; Sheinbein C, 2010, UROLOGY, V76, P728, DOI 10.1016/j.urology.2009.04.074; Shibuya H, 2005, INT J RADIAT ONCOL, V62, P1472, DOI 10.1016/j.ijrobp.2004.12.082; Smith GD, 2015, INT J RADIAT ONCOL, V91, P505, DOI 10.1016/j.ijrobp.2014.11.018; Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X; Takakusagi Y, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01575-7; Tan YG, 2016, ASIAN J UROL, V3, P59, DOI 10.1016/j.ajur.2015.12.001; Tsuji H, 2005, INT J RADIAT ONCOL, V63, P1153, DOI 10.1016/j.ijrobp.2005.04.022; Zwahlen DR, 2011, INT J RADIAT ONCOL, V79, P179, DOI 10.1016/j.ijrobp.2009.10.016	42	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241636	10.1371/journal.pone.0241636	http://dx.doi.org/10.1371/journal.pone.0241636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156884	gold, Green Published			2022-12-26	WOS:000591376400013
J	Tripto, NI; Kabir, M; Bayzid, MS; Rahman, A				Tripto, Nafis Irtiza; Kabir, Mohimenul; Bayzid, Md. Shamsuzzoha; Rahman, Atif			Evaluation of classification and forecasting methods on time series gene expression data	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; NETWORKS; SUPPORT; SELECTION; CYCLE	Time series gene expression data is widely used to study different dynamic biological processes. Although gene expression datasets share many of the characteristics of time series data from other domains, most of the analyses in this field do not fully leverage the time-ordered nature of the data and focus on clustering the genes based on their expression values. Other domains, such as financial stock and weather prediction, utilize time series data for forecasting purposes. Moreover, many studies have been conducted to classify generic time series data based on trend, seasonality, and other patterns. Therefore, an assessment of these approaches on gene expression data would be of great interest to evaluate their adequacy in this domain. Here, we perform a comprehensive evaluation of different traditional unsupervised and supervised machine learning approaches as well as deep learning based techniques for time series gene expression classification and forecasting on five real datasets. In addition, we propose deep learning based methods for both classification and forecasting, and compare their performances with the state-of-the-art methods. We find that deep learning based methods generally outperform traditional approaches for time series classification. Experiments also suggest that supervised classification on gene expression is more effective than clustering when labels are available. In time series gene expression forecasting, we observe that an autoregressive statistical approach has the best performance for short term forecasting, whereas deep learning based methods are better suited for long term forecasting.	[Tripto, Nafis Irtiza; Kabir, Mohimenul; Bayzid, Md. Shamsuzzoha; Rahman, Atif] Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Tripto, NI; Kabir, M (corresponding author), Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh.	mahibuet045@gmail.com; nafisirtiza@cse.buet.ac.bd		Kabir, Mohimenul/0000-0001-7551-0337				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; [Anonymous], 2020, ZENODO, V21, P1; Araz OM, 2014, AM J EMERG MED, V32, P1016, DOI 10.1016/j.ajem.2014.05.052; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bar-Joseph Z, 2002, P 6 ANN INT C COMP B, P39, DOI DOI 10.1145/565196.565202; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Bhar A, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-9; Bryan J, 2004, J MULTIVARIATE ANAL, V90, P44, DOI 10.1016/j.jmva.2004.02.011; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cui P, 2018, BBA-MOL BASIS DIS, V1864, P2274, DOI 10.1016/j.bbadis.2017.12.004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El HM, 2008, CAN J CARDIOL, V24, pe28; ElBakry O, 2013, IEEE ACM T COMPUT BI, V10, P671, DOI 10.1109/TCBB.2013.73; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Fakoor R, P INT C MACH LEARN 2, V28; Fine T.L., 2006, FEEDFORWARD NEURAL N; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Kalekar P.S., 2004, TIME SERIES FORECAST, P1; Karim F, 2018, IEEE ACCESS, V6, P1662, DOI 10.1109/ACCESS.2017.2779939; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Kim K, 2010, J CLIN EPIDEMIOL, V63, P950, DOI 10.1016/j.jclinepi.2010.02.018; Kingma DP., 2014, ADAM METHOD STOCHAST; Kuremoto T, 2014, NEUROCOMPUTING, V137, P47, DOI 10.1016/j.neucom.2013.03.047; Lee CP, 2013, NEURAL COMPUT, V25, P1302, DOI 10.1162/NECO_a_00434; Malhotra P, 2015, P 2015 APR, P89; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Moloshok TD, 2002, BIOINFORMATICS, V18, P566, DOI 10.1093/bioinformatics/18.4.566; Orsenigo C, IAPR INT C PATT REC, P264; ozgul OF, 2020, IEEE ACM T COMPUTATI; Qiu XH, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2014, VOL 8; Rueda L., 2008, LECT NOTES COMPUTER, V5410; SAEZ M, 1995, INT J EPIDEMIOL, V24, P576, DOI 10.1093/ije/24.3.576; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Taylor SJ, 2018, AM STAT, V72, P37, DOI 10.1080/00031305.2017.1380080; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tsay R.S., 2002, ANAL FINANCIAL TIME; Tseng FM, 2002, FUZZY SET SYST, V126, P367, DOI 10.1016/S0165-0114(01)00047-1; Wei L., 2005, P 17 INT C SCI STAT, V5, P237; Yang PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S5; Zhao BD, 2017, J SYST ENG ELECTRON, V28, P162, DOI 10.21629/JSEE.2017.01.18	51	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241686	10.1371/journal.pone.0241686	http://dx.doi.org/10.1371/journal.pone.0241686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156855	Green Published, gold			2022-12-26	WOS:000591376400005
J	Jiang, WQ; Li, N; Zhang, DP; Meinhardt, L; Cao, B; Li, YJ; Song, LH				Jiang, Wenqian; Li, Na; Zhang, Dapeng; Meinhardt, Lyndel; Cao, Bing; Li, Yuanjing; Song, Lihua			Elevated temperature and drought stress significantly affect fruit quality and activity of anthocyanin-related enzymes in jujube (Ziziphus jujuba Mill. cv. 'Lingwuchangzao')	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; CLIMATE-CHANGE IMPACTS; TRANSCRIPTIONAL REGULATION; BIOSYNTHETIC-PATHWAY; PROCESSING TOMATO; WATER RELATIONS; BRAEBURN APPLE; SKIN COLOR; GRAPEVINE; GROWTH	The quality attributes of jujube fruit can be directly and indirectly affected by abiotic stresses associated with climate change. Increased temperature and drought are among the most important factors challenging sustainable jujube production in the temperate semi-arid region in northwest China. The main objective of the present study was to understand the effects of elevated air temperature and drought stress on sugar and acid accumulation and coloration of jujube fruits. The content of soluble sugar, organic acid and pigments of traditional jujube "Linwuchangzao" under different atmospheric temperatures and drought stresses were analyzed during three different fruit ripening stages. The elevated temperature (1.5-2.5 degrees C than normal temperature) significantly increased the fruit sugar content, sugar-acid ratio, anthocyanins, flavonoids and carotenoids content. Under the drought stress where the soil moisture was 30% -50% of the field capacity, sugar content, anthocyanin, flavonoid and carotenoid content of the fruit were significantly reduced at the same temperature, but the chlorophyll and organic acid content increased. No significant interaction of Temperature x Drought was observed for all the analyzed quality parameters. The current results showed that the fruit quality of jujube variety "Lingwuchangzao" could be improved when the atmospheric temperature increases by 2 degrees C in this region. However, drought stress had a negative impact on the fruit's sugar-acid ratio and pigment content. The present results also showed that the synthesis and accumulation of anthocyanins in jujube fruit were positively correlated with sugar content and related enzyme activities, especially Phenylalanine Ammonia-lyase (PAL) activity. This study, therefore, provides novel information for understanding the influence of growth environment on the quality properties of jujube fruits. This knowledge will help develop appropriate crop management practices for jujube production in arid and semi-arid areas in northwest China.	[Jiang, Wenqian; Li, Na; Cao, Bing; Li, Yuanjing; Song, Lihua] Ningxia Univ, Sch Agr, Yinchuan, Ningxia, Peoples R China; [Zhang, Dapeng; Meinhardt, Lyndel] USDA ARS, NEA, BARC, SPCL, Beltsville, MD USA	Ningxia University; United States Department of Agriculture (USDA)	Song, LH (corresponding author), Ningxia Univ, Sch Agr, Yinchuan, Ningxia, Peoples R China.	slh382@126.com	Li, Yuan/GXV-1310-2022	Zhang, Dapeng/0000-0001-8212-6114	National Natural Science Foundation of China [31760203]; Key Research and Development Projects in Ningxia (International cooperation project) [2018BFH03015]; Key Innovation Projects of First-Class University in Western China [ZKZD2017008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Projects in Ningxia (International cooperation project); Key Innovation Projects of First-Class University in Western China	This research was supported by the National Natural Science Foundation of China (Grant No. 31760203), Key Research and Development Projects in Ningxia (International cooperation project. Grant No.2018BFH03015) and the Key Innovation Projects of First-Class University in Western China (Grant No. ZKZD2017008).	Alcobendas R, 2013, SCI HORTIC-AMSTERDAM, V164, P340, DOI 10.1016/j.scienta.2013.09.048; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2006, J BRAS PNEUMOL S6, V32, pS403; [Anonymous], 2014, GASTROENTEROLOGY S1, V10, P1; Arora N.K., 2019, ENV SUSTAINABILITY, V2, P95, DOI [10.1007/s42398-019-00078-w, DOI 10.1007/S42398-019-00078-W]; Bahar E, 2011, AFR J AGR RES, V6, P1151; Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322; Bhardwaj R, 2014, PHYSL MECH ADAPTATIO, V2, P161, DOI DOI 10.1007/978-1-4614-8600-8_6; Boss P. K., 1996, Australian Journal of Grape and Wine Research, V2, P163, DOI 10.1111/j.1755-0238.1996.tb00104.x; Brown PT, 2017, NATURE, V552, P45, DOI 10.1038/nature24672; Carbone F, 2009, PLANT CELL ENVIRON, V32, P1117, DOI 10.1111/j.1365-3040.2009.01994.x; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; CHALMERS DJ, 1975, ANN BOT-LONDON, V39, P423, DOI 10.1093/oxfordjournals.aob.a084956; Change P.C., 2018, GLOBAL WARMING 1 5 C, DOI [10.1111/j.1365-3040.2007.01716.x, DOI 10.1111/J.1365-3040.2007.01716.X]; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Chen YN, 2015, ENVIRON RES, V139, P11, DOI 10.1016/j.envres.2014.12.029; CHENG GW, 1991, J AM SOC HORTIC SCI, V116, P865, DOI 10.21273/JASHS.116.5.865; Cox KA, 2004, POSTHARVEST BIOL TEC, V31, P287, DOI 10.1016/j.postharvbio.2003.09.008; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Cui NB, 2009, AGR WATER MANAGE, V96, P1237, DOI 10.1016/j.agwat.2009.03.015; Cui ZH, 2017, PLANT DIS, V101, P1606, DOI [10.1094/PDIS-01-17-0104-RE, 10.1094/pdis-01-17-0104-re]; de Mejia EG, 2020, ANNU REV FOOD SCI T, V11, P145, DOI 10.1146/annurev-food-032519-051729; Dhanya M.S., 2020, UNIT 12 INFRASTRUCTU; Diverse, 2006, DIVERSE ISSUES HIGHE, V22, P37; Doymaz I, 2016, J FOOD MEAS CHARACT, V10, P283, DOI 10.1007/s11694-016-9305-4; Du Lingtong, 2015, Journal of Natural Disasters, V24, P157, DOI 10.13577/j.jnd.2015.0220; Gao Y., 2011, HUNAN AGR SCI, P25; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Harker FR, 2008, POSTHARVEST BIOL TEC, V50, P70, DOI 10.1016/j.postharvbio.2008.03.020; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Ikeda T, 2009, ACTA HORTIC, V842, P679, DOI 10.17660/ActaHortic.2009.842.146; Ikeda Takashi, 2011, Environmental Control in Biology, V49, P209; Jeong ST, 2008, VITIS, V47, P135; Jiang W.Q., 2019, J NW FORES U, P18; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V61, P215, DOI 10.1016/0304-4238(94)00739-3; Ju ZG, 1997, SCI HORTIC-AMSTERDAM, V70, P31, DOI 10.1016/S0304-4238(97)00040-X; Kano Y, 2006, HORTSCIENCE, V41, P1431, DOI 10.21273/HORTSCI.41.6.1431; Kayesh E, 2013, ACTA PHYSIOL PLANT, V35, P2879, DOI 10.1007/s11738-013-1332-8; Kyraleou M, 2016, J SCI FOOD AGR, V96, P988, DOI 10.1002/jsfa.7175; Lancaster JE, 1997, J AM SOC HORTIC SCI, V122, P594, DOI 10.21273/JASHS.122.4.594; Laribi AI, 2013, AGR WATER MANAGE, V125, P61, DOI 10.1016/j.agwat.2013.04.009; Leisner CP, 2020, PLANT SCI, V293, DOI 10.1016/j.plantsci.2020.110412; Li BJ, 1994, J SHENYANG AGR U, V3; Li S, 2018, PEERJ PREPRINTS, DOI [10.7717/peerj-cs.147, DOI 10.7717/PEERJ-CS.147]; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Lister CE, 1996, J SCI FOOD AGR, V71, P313, DOI [10.1002/(SICI)1097-0010(199607)71:3<313::AID-JSFA586>3.0.CO;2-N, 10.1002/(SICI)1097-0010(199607)71:3&lt;313::AID-JSFA586&gt;3.0.CO;2-N]; Liu J, 2014, SCI HORTIC-AMSTERDAM, V165, P99, DOI 10.1016/j.scienta.2013.10.033; Liu ZP, 2019, INT J AGR BIOL ENG, V12, P52, DOI 10.25165/j.ijabe.20191203.4262; Lu R, 2002, APPL ENG AGRIC, V18, P585; Man YP, 2015, PHYSIOL PLANTARUM, V153, P565, DOI 10.1111/ppl.12263; Massonnet M, 2017, PLANT PHYSIOL, V174, P2376, DOI 10.1104/pp.17.00311; Matiu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178339; Matsushita Kohei, 2016, Environmental Control in Biology, V54, P101, DOI 10.2525/ecb.54.101; Mills TM, 1996, J AM SOC HORTIC SCI, V121, P286, DOI 10.21273/JASHS.121.2.286; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Movahed N, 2016, J PLANT RES, V129, P513, DOI 10.1007/s10265-016-0786-3; Mpelasoka BS, 2000, J HORTIC SCI BIOTECH, V75, P615, DOI 10.1080/14620316.2000.11511296; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Perez-Pastor A, 2007, J SCI FOOD AGR, V87, P2409, DOI 10.1002/jsfa.2905; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Ripoll J, 2014, J EXP BOT, V65, P4097, DOI 10.1093/jxb/eru197; Romero P, 2006, TREE PHYSIOL, V26, P1537, DOI 10.1093/treephys/26.12.1537; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Rugienius R., 2015, Sodininkyste ir Darzininkyste, V34, P3; Samykanno K, 2013, SCI HORTIC-AMSTERDAM, V164, P633, DOI 10.1016/j.scienta.2013.09.001; Santesteban LG, 2011, AGR WATER MANAGE, V98, P1171, DOI 10.1016/j.agwat.2011.02.011; Sarma B., 2020, INT J CURR MICROBIOL, V9, P504; Shi Qian-qian, 2015, Forest Research, V28, P570; Shi QQ, 2018, MOLECULES, V23, DOI 10.3390/molecules23081917; Shouqian F, 2008, SCI AGR SINICA; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; [宋丽华 Song Lihua], 2015, [西北林学院学报, Journal of Northwest Forestry University], V30, P129; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; STOCKER TF, 2013, CONTRIBUTION WORKING, V1535, P2013; Sun BaiLing, 2012, Journal of Jilin Agricultural University, V34, P423; Sun P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046095, 10.1371/journal.pone.0041000]; ToldamAndersen TB, 1997, J HORTIC SCI, V72, P155, DOI 10.1080/14620316.1997.11515502; Torrecillas A, 2000, SCI HORTIC-AMSTERDAM, V85, P201, DOI 10.1016/S0304-4238(99)00146-6; Tripathi A, 2016, AGR ECOSYST ENVIRON, V216, P356, DOI 10.1016/j.agee.2015.09.034; Vivaldi GA, 2019, WATER SUPPLY, V19, P1413, DOI 10.2166/ws.2019.008; Wang HY, 2007, PROCEEDINGS OF THE 26TH CHINESE CONTROL CONFERENCE, VOL 4, P149; Wang SY, 2000, SCI HORTIC-AMSTERDAM, V85, P183, DOI 10.1016/S0304-4238(99)00143-0; Wei HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121164; Yadav S.S., 2019, FOOD SECURITY CLIMAT; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Yang XM, 2018, 2018 ANN C CHIN HORT; Zegbe-Dominguez JA, 2003, SCI HORTIC-AMSTERDAM, V98, P505, DOI 10.1016/S0304-4238(03)00036-0; Zhang B, 2016, AGR SCI RES, V37, P34; Zhang K, 2003, SPRING INT SER ENG C, P3; [张丽萍 Zhang Liping], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P120; Zhang Q, 2020, FOOD CHEM, V312, DOI 10.1016/j.foodchem.2019.125903; Zhang YT, 2018, J PHOTOCH PHOTOBIO B, V186, P225, DOI 10.1016/j.jphotobiol.2018.07.024; [郑广芬 Zheng Guangfen], 2006, [气象科学, Scientia Meteorologlca Sinica], V26, P412; Zou Qi., 1995, PLANT PHYSL BIOCH EX, P105; 1996, IARC MONOGR EVAL CAR, V67, P1	96	17	18	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241491	10.1371/journal.pone.0241491	http://dx.doi.org/10.1371/journal.pone.0241491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152049	gold, Green Published			2022-12-26	WOS:000591376200018
J	Ku, Y; Kim, DY; Kwon, C; Noh, TS; Park, MK; Lee, JH; Oh, SH; Kim, HC; Suh, MW				Ku, Yunseo; Kim, Do Youn; Kwon, Chiheon; Noh, Tae Soo; Park, Moo Kyun; Lee, Jun Ho; Oh, Seung Ha; Kim, Hee Chan; Suh, Myung-Whan			Effect of age on the gap-prepulse inhibition of the cortical N1-P2 complex in humans as a step towards an objective measure of tinnitus	PLOS ONE			English	Article							STARTLE EYEBLINK RESPONSE; AUDITORY-EVOKED RESPONSE; NEURAL ACTIVITY; DISCRIMINATION; DURATION; HEARING; REFLEX; REPLICABILITY; SUPPRESSION; THRESHOLDS	The gap-prepulse inhibition of the acoustic startle reflex has been widely used as a behavioral method for tinnitus screening in animal studies. The cortical-evoked potential gap-induced inhibition has also been investigated in animals as well as in human subjects. The present study aimed to investigate the effect of age on the cortical N1-P2 complex in the gap-prepulse inhibition paradigm. Fifty-seven subjects, aged 20 to 68 years, without continuous tinnitus, were tested with two effective gap conditions (embedded gap of 50- or 20-ms duration). Retest sessions were performed within one month. A significant gap-induced inhibition of the N1-P2 complex was found in both gap durations. Age differently affected the inhibition, depending on gap duration. With a 50-ms gap, the inhibition decreased significantly with the increase in age. This age-inhibition relationship was not found when using a 20-ms gap. The results were reproducible in the retest session. Our findings suggest that the interaction between age and gap duration should be considered when applying the gap-induced inhibition of the cortical-evoked potential as an objective measure of tinnitus in human subjects. Further studies with tinnitus patients are warranted to identify gap duration that would minimize the effects of age and maximize the difference in the inhibition between those with and without tinnitus.	[Ku, Yunseo] Chungnam Natl Univ, Coll Med, Dept Biomed Engn, Daejeon, South Korea; [Kim, Do Youn; Kwon, Chiheon] Seoul Natl Univ, Grad Sch, Interdisciplinary Program Bioengn, Seoul, South Korea; [Noh, Tae Soo; Park, Moo Kyun; Lee, Jun Ho; Oh, Seung Ha; Suh, Myung-Whan] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Hee Chan] Coll Med, Grad Sch, Dept Biomed Engn, Interdisciplinary Program Bioengn, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Med Res Ctr, Inst Med & Biol Engn, Seoul, South Korea	Chungnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Suh, MW (corresponding author), Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	drmung@naver.com		Park, Moo Kyun/0000-0002-8635-797X; Kim, Hee Chan/0000-0002-2112-426X	Korea Health Industry Development Institute (KHDI) of Korean Ministry of Health and Welfare [HI18C0626]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2018R1C1B5085702]	Korea Health Industry Development Institute (KHDI) of Korean Ministry of Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Korea Health Industry Development Institute (KHDI) of Korean Ministry of Health and Welfare (HI18C0626) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2018R1C1B5085702).	Aghamolaei M, 2018, CLIN NEUROPHYSIOL, V129, P2252, DOI 10.1016/j.clinph.2018.08.006; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Bahmer A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00793; Baltes PB, 2000, AM PSYCHOL, V55, P122, DOI 10.1037/0003-066X.55.1.122; Berger JI, 2018, BRAIN RES, V1679, P101, DOI 10.1016/j.brainres.2017.11.026; Berger JI, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00061; Berger JI, 2013, J NEUROSCI METH, V213, P188, DOI 10.1016/j.jneumeth.2012.12.023; Boyen K, 2015, EAR HEARING, V36, pe138, DOI 10.1097/AUD.0000000000000156; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Browner W., 2013, DESIGNING CLIN RES, V4th, ppp65; Buus S, 1982, J ACOUST SOC AM S1, V72, pS89, DOI 10.1121/1.2020130; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; DAWSON ME, 1993, J ABNORM PSYCHOL, V102, P633, DOI 10.1037/0021-843X.102.4.633; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; DREIFUSS F, 1992, EPILEPSIA, V33, P195; Dushanova J, 2013, NEURAL REGEN RES, V8, P1390, DOI 10.3969/j.issn.1673-5374.2013.15.006; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Escera C, 1996, EVOKED POTENTIAL, V100, P549, DOI 10.1016/S0168-5597(96)95633-6; Fitzgibbons PJ, 2007, J ACOUST SOC AM, V122, P458, DOI 10.1121/1.2739409; Fitzgibbons PJ, 2010, HEARING RES, V264, P41, DOI 10.1016/j.heares.2009.11.008; FITZGIBBONS PJ, 1994, J SPEECH HEAR RES, V37, P662, DOI 10.1044/jshr.3703.662; Fournier P, 2016, PSYCHOPHYSIOLOGY, V53, P759, DOI 10.1111/psyp.12620; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Gmehlin D, 2011, J GERONTOL A-BIOL, V66, P1043, DOI 10.1093/gerona/glr067; Graham SJ, 2002, J PSYCHOPHARMACOL, V16, P15, DOI 10.1177/026988110201600101; Hall JW III, 2015, EHANDBOOK AUDITORY E; HARBIN TJ, 1983, PSYCHOPHYSIOLOGY, V20, P603, DOI 10.1111/j.1469-8986.1983.tb00926.x; Harris KC, 2012, EAR HEARING, V33, P330, DOI 10.1097/AUD.0b013e31823fb585; Harris KC, 2010, HEARING RES, V264, P21, DOI 10.1016/j.heares.2009.09.017; He NJ, 1999, J ACOUST SOC AM, V106, P966, DOI 10.1121/1.427109; Henry JA, 2016, OTOL NEUROTOL, V37, pE276, DOI 10.1097/MAO.0000000000001070; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Himberger KD, 2018, NEUROSCIENCE, V389, P161, DOI 10.1016/j.neuroscience.2018.04.030; Humes LE, 2009, ATTEN PERCEPT PSYCHO, V71, P860, DOI 10.3758/APP.71.4.860; Inui K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-135; ISON JR, 1983, PSYCHOL BULL, V94, P3, DOI 10.1037/0033-2909.94.1.3; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kodaira M, 2013, BEHAV BRAIN RES, V256, P27, DOI 10.1016/j.bbr.2013.07.045; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Ku Y, 2014, 2014 36 ANN INT C IE; Ku Y, 2017, HEARING RES, V348, P120, DOI 10.1016/j.heares.2017.03.003; Ku Y, 2015, PSYCHOPHYSIOLOGY, V52, P1511, DOI 10.1111/psyp.12507; Lobarinas E, 2015, JARO-J ASSOC RES OTO, V16, P263, DOI 10.1007/s10162-014-0500-x; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; MacLaren DAA, 2014, EUR J NEUROSCI, V40, P3526, DOI 10.1111/ejn.12716; Marks KL, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aal3175; Martin JS, 2005, J REHABIL RES DEV, V42, P25, DOI 10.1682/JRRD.2004.12.0164; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Norena A, 1999, CLIN NEUROPHYSIOL, V110, P666, DOI 10.1016/S1388-2457(98)00034-0; Oranje B, 2006, PSYCHIAT RES, V143, P147, DOI 10.1016/j.psychres.2005.11.002; 서명환, 2011, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V54, P48; PEKKONEN E, 1995, EVOKED POTENTIAL, V96, P546, DOI 10.1016/0013-4694(95)00148-R; PFEFFERBAUM A, 1980, ELECTROEN CLIN NEURO, V49, P266, DOI 10.1016/0013-4694(80)90221-7; Phillips MA, 2000, J PSYCHOPHARMACOL, V14, P258, DOI 10.1177/026988110001400308; Phillips S L, 1994, J Am Acad Audiol, V5, P210; Pichora-Fuller M Kathleen, 2006, Trends Amplif, V10, P29, DOI 10.1177/108471380601000103; Radziwon KE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00031; Schneider BA, 1999, J ACOUST SOC AM, V106, P371, DOI 10.1121/1.427062; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Snell KB, 1997, J ACOUST SOC AM, V101, P2214, DOI 10.1121/1.418205; Soros P, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-34; Swetter BJ, 2010, BEHAV NEUROSCI, V124, P370, DOI 10.1037/a0019519; Syka J, 2002, PHYSIOL REV, V82, P601, DOI 10.1152/physrev.00002.2002; Taylor D, 1999, EYE, V13, P3; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tun PA, 2012, AM J AUDIOL, V21, P344, DOI 10.1044/1059-0889(2012/12-0030); Wilson CA, 2019, HEARING RES, V374, P13, DOI 10.1016/j.heares.2019.01.009	71	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241136	10.1371/journal.pone.0241136	http://dx.doi.org/10.1371/journal.pone.0241136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152745	gold, Green Published			2022-12-26	WOS:000591376200024
J	Rouchka, EC; Chariker, JH; Chung, DH				Rouchka, Eric C.; Chariker, Julia H.; Chung, Donghoon			Variant analysis of 1,040 SARS-CoV-2 genomes	PLOS ONE			English	Article								The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) viral genome is an RNA virus consisting of approximately 30,000 bases. As part of testing efforts, whole genome sequencing of human isolates has resulted in over 1,600 complete genomes publicly available from GenBank. We have performed a comparative analysis of the sequences, in order to detect common mutations within the population. Analysis of variants occurring within the assembled genomes yields 417 variants occurring in at least 1% of the completed genomes, including 229 within the 5' untranslated region (UTR), 152 within the 3'UTR, 2 within intergenic regions and 34 within coding sequences.	[Rouchka, Eric C.] Univ Louisville, Dept Comp Sci & Engn, Louisville, KY 40292 USA; [Rouchka, Eric C.; Chariker, Julia H.] Univ Louisville, Kentucky Biomed Res Infrastruct Network Bioinform, Louisville, KY 40292 USA; [Chariker, Julia H.] Univ Louisville, Neurosci Training Program, Louisville, KY 40292 USA; [Chung, Donghoon] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Rouchka, EC (corresponding author), Univ Louisville, Dept Comp Sci & Engn, Louisville, KY 40292 USA.; Rouchka, EC (corresponding author), Univ Louisville, Kentucky Biomed Res Infrastruct Network Bioinform, Louisville, KY 40292 USA.	eric.rouchka@louisville.edu			National Institutes of Health (NIH) [P20GM103436]; University of Louisville Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases	This work was supported by the National Institutes of Health (NIH) grant P20GM103436 (ECR, JHC) and the University of Louisville Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (DC). Its contents are solely the responsibility of the authors and do not represent the official views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chung D, 2020, CHARACTERIZATON SARS; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Islam MT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64162-6; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Korber B, 2020, SPIKE MUTATION PIPEL; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lassmann T, 2020, BIOINFORMATICS, V36, P1928, DOI 10.1093/bioinformatics/btz795; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li X, 2020, LECT NOTES ELECTR EN, V574, P1, DOI [10.1007/978-981-13-9718-9_1, 10.1126/sciadv.abb9153, 10.1101/2020.03.20.000885]; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Rehman SU, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030240; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Shen ZJ, 2020, CLIN INFECT DIS, V71, P713, DOI 10.1093/cid/ciaa203; SwissProt, 2020, SEV AC RESP SYNDR CO; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Wang CT, 2020, J MED VIROL, V92, P667, DOI 10.1002/jmv.25762; Wang MJ, 2020, J VIROL, V94, DOI 10.1128/JVI.00567-20; World Health Organization, COR DIS COVID 19 PAN; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yin CC, 2020, GENOMICS, V112, P3588, DOI 10.1016/j.ygeno.2020.04.016; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	32	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241535	10.1371/journal.pone.0241535	http://dx.doi.org/10.1371/journal.pone.0241535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152019	gold, Green Published			2022-12-26	WOS:000591376200023
J	Shirai, R; Ogawa, H				Shirai, Risako; Ogawa, Hirokazu			Affective evaluation of images influences personality judgments through gaze perception	PLOS ONE			English	Article							TRUSTWORTHINESS; OBJECTS; TRUST; FACES; CUES; SET; EYE	Faces that consistently shifted the gaze to subsequent target locations in a gaze cueing task were chosen as being more trustworthy than faces that always looked away from the target, suggesting that the validity of a gaze cue influenced the viewers' judgments regarding the trustworthiness of human faces. We investigated whether the gaze cueing effect and judgments regarding the personality conveyed by a face would be affected by the valence of a target. A face image moved its eyes to the left or the right, and an emotional target image (positive, negative, or neutral) appeared to left or right of the face. Participants had to indicate the location of this target by pressing a key. The target image was preceded by a face that shifted its gaze to the target image (valid cue), a face that directed its gaze to the opposite side (invalid cue), or a face that did not move its eyes (no cue). The perceived trustworthiness of the face was evaluated after the gaze-cueing task. Results showed that faces that looked at positive targets were evaluated as more trustworthy than faces that looked at negative targets. However, the valence of the targets did not affect trustworthiness ratings in invalid and no-cue conditions. We suggest that integrated information about the predictability of the gaze cue and the valence of the gaze target modulates impressions about the personality of the face.	[Shirai, Risako; Ogawa, Hirokazu] Kwansei Gakuin Univ, Dept Integrated Psychol Sci, Nishinomiya, Hyogo, Japan; [Shirai, Risako] Japan Soc Promot Sci, Tokyo, Hyogo, Japan; [Shirai, Risako] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Kwansei Gakuin University; Japan Society for the Promotion of Science; Waseda University	Shirai, R (corresponding author), Kwansei Gakuin Univ, Dept Integrated Psychol Sci, Nishinomiya, Hyogo, Japan.; Shirai, R (corresponding author), Japan Soc Promot Sci, Tokyo, Hyogo, Japan.; Shirai, R (corresponding author), Waseda Univ, Fac Sci & Engn, Tokyo, Japan.	RisakoShirai@gmail.com		Ogawa, Hirokazu/0000-0002-6492-7580	Japan Society for the Promotion of Science (JSPS KAKENHI) [JP18J12574, JP20J00838, JP18K03191]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI) (https://www.jsps.go.jp/english/index.html) in the form of grants awarded to RS (JP18J12574, JP20J00838) and HO (JP18K03191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGEIER AR, 1979, J APPL SOC PSYCHOL, V9, P170, DOI 10.1111/j.1559-1816.1979.tb00802.x; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; BAEYENS F, 1992, BEHAV RES THER, V30, P133, DOI 10.1016/0005-7967(92)90136-5; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Bayliss AP, 2007, COGNITION, V104, P644, DOI 10.1016/j.cognition.2006.07.012; Bayliss AP, 2006, PSYCHON B REV, V13, P1061, DOI 10.3758/BF03213926; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2009, EUR J COGN PSYCHOL, V21, P1072, DOI 10.1080/09541440802553490; Bruner J, 1983, CHILDS TALK LEARNING; Capozzi F, 2015, PSYCHON B REV, V22, P850, DOI 10.3758/s13423-014-0717-z; Carter EJ, 2008, SOC NEUROSCI-UK, V3, P151, DOI 10.1080/17470910801903431; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; JASP Team, 2018, JASP VERS 0 9 COMP S; King D, 2011, SOC COGNITION, V29, P476, DOI 10.1521/soco.2011.29.4.476; Kirkham AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145731; Kocsor F, 2017, PERS INDIV DIFFER, V104, P215, DOI 10.1016/j.paid.2016.08.007; Kurdi B, 2017, BEHAV RES METHODS, V49, P457, DOI 10.3758/s13428-016-0715-3; Lang J.P., 1999, A4 U FLOR CTR RES PS; Ma DS, 2015, BEHAV RES METHODS, V47, P1122, DOI 10.3758/s13428-014-0532-5; Rogers RD, 2014, J EXP PSYCHOL GEN, V143, P763, DOI 10.1037/a0033677; Strachan JWA, 2017, Q J EXP PSYCHOL, V70, P2060, DOI 10.1080/17470218.2016.1220609; Treinen E, 2012, COGNITION, V122, P247, DOI 10.1016/j.cognition.2011.10.006; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Yamagishi T, 2003, EVOL HUM BEHAV, V24, P290, DOI 10.1016/S1090-5138(03)00035-7	29	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241351	10.1371/journal.pone.0241351	http://dx.doi.org/10.1371/journal.pone.0241351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151950	Green Published, gold			2022-12-26	WOS:000591376200044
J	Wahedi, K; Biddle, L; Bozorgmehr, K				Wahedi, Katharina; Biddle, Louise; Bozorgmehr, Kayvan			Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015)	PLOS ONE			English	Article							MIGRANTS; INFECTION; COUNTRIES; EU/EEA; EUROPE	Screening asylum-seekers for active pulmonary tuberculosis is common practice among many European countries with low incidence of tuberculosis. The reported yields vary substantially, partly due to the heterogeneous and dynamic nature of asylum-seeking populations. Rather than screening all new arrivals (indiscriminate screening), a few countries apply targeted screening based on incidence of tuberculosis in asylum-seekers' country of origin. However, evaluations of its cost-effectiveness have been scarce. The aim of this modelling study was to assess whether the introduction of a screening threshold based on the tuberculosis incidence in the country of origin is sensible from an economic perspective. To this end, we compare the current, indiscriminate screening policy for pulmonary tuberculosis in Germany with a hypothetical targeted screening programme using several potential screening thresholds based on WHO-reported incidence of tuberculosis in countries of origin. Screening data is taken from a large German federal state over 14 years (2002-2015). Incremental cost-effectiveness is measured as cost per case found and cost per case prevented. Our analysis shows that incremental cost-effectiveness ratios (ICERs) of screening asylum-seekers from countries with an incidence of 50 to 250/100,000 range between 15,000euro and 17,000euro per additional case found when compared to lower thresholds. The ICER for screening asylum-seekers from countries with an incidence <50/100,000 is 112,000euro per additional case found. Costs per case prevented show a similar increase in costs. The high cost per case found and per case prevented at the <50/100,000 threshold scenario suggests this threshold to be a sensible cut-off for targeted screening. Acknowledging that no screening measure can find all cases of tuberculosis, and that reactivation of latent infections makes up a large proportion of foreign-born cases, targeting asylum-seekers from countries with an incidence above 50/100,000 is likely to be a more reasonable screening measure for the prevention and control of tuberculosis than indiscriminate screening measures.	[Wahedi, Katharina; Biddle, Louise; Bozorgmehr, Kayvan] Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Bozorgmehr, Kayvan] Bielefeld Univ, Sch Publ Hlth, Dept Populat Med & Hlth Serv Res, Bielefeld, Germany	Ruprecht Karls University Heidelberg; University of Bielefeld	Bozorgmehr, K (corresponding author), Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.; Bozorgmehr, K (corresponding author), Bielefeld Univ, Sch Publ Hlth, Dept Populat Med & Hlth Serv Res, Bielefeld, Germany.	kayvan.bozorgmehr@uni-bielefeld.de		Bozorgmehr, Kayvan/0000-0002-1411-1209; Biddle, Louise/0000-0003-4521-4574	German Federal Ministry for Education and Research (BMBF) [01GY1611]	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry for Education and Research (BMBF) in the scope of the project RESPOND (Grant number: 01GY1611). The funder had no influence on study design, analysis or decision to publish.	Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Bozorgmehr K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3902-x; Bozorgmehr K, 2018, LANCET PUBLIC HEALTH, V3, pE359, DOI 10.1016/S2468-2667(18)30132-4; Bozorgmehr K, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02327-2016; Bozorgmehr K, 2016, BUNDESGESUNDHEITSBLA, V59, P545, DOI 10.1007/s00103-016-2329-4; Brynildsrud OB, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5869; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; de Vries Gerard, LOW YIELD SCREENING, P3; den Boon S, 2006, EVALUATION SYMPTOM C; Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002; Diel R, 2012, EUR RESPIR J, V40, P143, DOI 10.1183/09031936.00204611; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Einheitlicher Bewertungsma stab-EBM, EINH BEW STAB EBM; Garner-Purkis A, 2019, PUBLIC HEALTH, V168, P142, DOI 10.1016/j.puhe.2018.12.016; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; InEK, 2018, G DRG REP BROWS 2018; Klinkenberg E, 2009, EUR RESPIR J, V34, P1180, DOI 10.1183/09031936.00038009; Kruijshaar ME, 2013, THORAX, V68, P1172, DOI 10.1136/thoraxjnl-2013-203254; Kuehne A, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.11.17-00042; Kunst H, 2017, INT J TUBERC LUNG D, V21, P840, DOI 10.5588/ijtld.17.0036; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Organisation mondiale de la sante, 2018, GLOB TUB REP 2018; Oxlade O, INTERFERON GAMMA REL, P11; Sandgren A, 2014, EUR RESPIR J, V43, P1159, DOI 10.1183/09031936.00117213; Schaberg T, 2017, PNEUMOLOGIE, V71, P325, DOI 10.1055/s-0043-105954; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Smit GSA, 2017, B WORLD HEALTH ORGAN, V95, P27, DOI 10.2471/BLT.16.169383; van't Hoog AH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-532; Verband der privaten Krankenversicherung, GEB ARZT 2008; Verver S, SCREENING PULMONARY, P7; Verver S, EFFECT SCREENING IMM, P9; Walker TM, 2018, LANCET INFECT DIS, V18, P431, DOI 10.1016/S1473-3099(18)30004-5; WHO, WHO GLOB BURD DIS; Wilson JMG, 1968, PRINCIPLES PRACTICE; Wingate LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124116; World Health Organization, 2013, SYST SCREEN ACT TUB; Zenner D, 2017, INT J TUBERC LUNG D, V21, P965, DOI 10.5588/ijtld.16.0935	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241852	10.1371/journal.pone.0241852	http://dx.doi.org/10.1371/journal.pone.0241852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151980	Green Published, gold			2022-12-26	WOS:000591376200077
J	Wu, WY; Xia, XB; Tang, LS; Yao, F; Xu, HZ; Lei, HT				Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo; Lei, Hetian			Normal vitreous promotes angiogenesis via activation of Axl	FASEB JOURNAL			English	Article						Akt; Alx; angiogenesis; endothelial cell; vitreous	IN-VITRO; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; GROWTH; MODEL; AKT	Vitreous has been reported to prevent tumor angiogenesis, but our previous findings indicate that vitreous activate the signaling pathway of phosphoinositide 3-kinase (PI3K)/Akt, which plays a critical role in angiogenesis. The goal of this research is to determine which role of vitreous plays in angiogenesis-related cellular responses in vitro. We found that in human retinal microvascular endothelial cells (HRECs) vitreous activates a number of receptor tyrosine kinases including Anexelekto (Axl), which plays an important role in angiogenesis. Subsequently, we discovered that depletion of Axl using CRISPR/Cas9 and an Axl-specific inhibitor R428 suppress vitreous-induced Akt activation and cell proliferation, migration, and tuber formation of HRECs. Therefore, this line of research not only demonstrate that vitreous promotes angiogenesis in vitro, but also reveal that Axl is one of receptor tyrosine kinases to mediate vitreous-induced angiogenesis in vitro, thereby providing a molecular basis for removal of vitreous as cleanly as possible when vitrectomy is performed in treating patients with proliferative diabetic retinopathy.	[Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, 86 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Wu, Wenyi; Xia, Xiaobo; Tang, Luosheng; Yao, Fei; Xu, Huizuo] Hunan Key Lab Ophthalmol, Changsha, Peoples R China; [Wu, Wenyi; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA; [Tang, Luosheng] Cent South Univ, Second Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [Lei, Hetian] Shenzhen Eye Hosp, Shenzhen Eye Inst, 18 Zetain Rd, Shenzhen 518040, Peoples R China	Central South University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Central South University	Xu, HZ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Ophthalmol, 86 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.; Lei, HT (corresponding author), Shenzhen Eye Hosp, Shenzhen Eye Inst, 18 Zetain Rd, Shenzhen 518040, Peoples R China.	xhz1030@163.com; leihetian18@hotmail.com		Xia, Xiaobo/0000-0003-1720-7860; Lei, Hetian/0000-0003-4091-1936	Department of central laboratory (Xiangya hospital); Schepens eye research institute (Massachusetts Eye and Ear Infirmary); Science and Technology Plan Project of Hunan Province [2019RS2011]; National Natural Science Foundation of China [8197413, 81900893]; NIH [R01EY01250]; Natural Science Foundation of Hunan [33030135080]; Laboratory of Medical Genetics (Central South University); Department Research to Prevent Blindness	Department of central laboratory (Xiangya hospital); Schepens eye research institute (Massachusetts Eye and Ear Infirmary); Science and Technology Plan Project of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province); Laboratory of Medical Genetics (Central South University); Department Research to Prevent Blindness(Research to Prevent Blindness (RPB))	We thank Xueyan Yao, Lijun Dong and Jiantao Wang for animal experiment. Special thanks go to the Department of central laboratory (Xiangya hospital) and Laboratory of Medical Genetics (Central South University) and Schepens eye research institute (Massachusetts Eye and Ear Infirmary) for supporting this research. This work was supported by a grant to W.W. from National Natural Science Foundation of China (81900893) and Science and Technology Plan Project of Hunan Province (2019RS2011), National Natural Science Foundation of China (8197413) (X.X), NIH (R01EY01250) (H.L), Natural Science Foundation of Hunan 33030135080 (H.X), Department Research to Prevent Blindness (H.L).	Aranda J, 2012, DIABETES, V61, P1225, DOI 10.2337/db11-1189; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; BREM S, 1976, CANCER RES, V36, P2807; Carrel A, 1913, J EXP MED, V17, P14, DOI 10.1084/jem.17.1.14; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen N, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107716; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DAMORE PA, 1981, P NATL ACAD SCI-BIOL, V78, P3068, DOI 10.1073/pnas.78.5.3068; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GLASER BM, 1980, OPHTHALMOLOGY, V87, P440; Gupta SR, 2012, PLOS ONE, V6, P122, DOI 10.1097/ICB.0b013e31821608e8; Han HT, 2019, J BIOL CHEM, V294, P15408, DOI 10.1074/jbc.RA119.010130; Huang XG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00140-3; Kawamoto A, 2001, CIRCULATION, V103, P634; Lam JD, 2017, DIABETES, V66, P1950, DOI 10.2337/db16-1035; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; LUTTY GA, 1985, J CELL SCI, V76, P53; Nawaz IM, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.03.002; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Taniguchi H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08074-0; Wu WY, 2020, DIABETES, V69, P736, DOI 10.2337/db19-0713; Wu WY, 2017, INVEST OPHTH VIS SCI, V58, P6082, DOI 10.1167/iovs.17-21902	36	3	3	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201903105R	http://dx.doi.org/10.1096/fj.201903105R		NOV 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33151576	hybrid			2022-12-26	WOS:000589712000001
J	Ahmad, K; Erqou, S; Shah, N; Nazir, U; Morrison, AR; Choudhary, G; Wu, WC				Ahmad, Khansa; Erqou, Sebhat; Shah, Nishant; Nazir, Umair; Morrison, Alan R.; Choudhary, Gaurav; Wu, Wen-Chih			Association of poor housing conditions with COVID-19 incidence and mortality across US counties	PLOS ONE			English	Article							TRANSMISSION; HEALTH; ROUTES; IMPACT	Objective Poor housing conditions have been linked with worse health outcomes and infectious disease spread. Since the relationship of poor housing conditions with incidence and mortality of COVID-19 is unknown, we investigated the association between poor housing condition and COVID-19 incidence and mortality in US counties. Methods We conducted cross-sectional analysis of county-level data from the US Centers for Disease Control, US Census Bureau and John Hopkins Coronavirus Resource Center for 3135 US counties. The exposure of interest was percentage of households with poor housing conditions (one or greater of: overcrowding, high housing cost, incomplete kitchen facilities, or incomplete plumbing facilities). Outcomes were incidence rate ratios (IRR) and mortality rate ratios (MRR) of COVID-19 across US counties through 4/21/2020. Multilevel generalized linear modeling (with total population of each county as a denominator) was utilized to estimate relative risk of incidence and mortality related to poor housing conditions with adjustment for population density and county characteristics including demographics, income, education, prevalence of medical comorbidities, access to healthcare insurance and emergency rooms, and state-level COVID-19 test density. We report incidence rate ratios (IRRs) and mortality ratios (MRRs) for a 5% increase in prevalence in households with poor housing conditions. Results Across 3135 US counties, the mean percentage of households with poor housing conditions was 14.2% (range 2.7% to 60.2%). On April 21(st), the mean (SD) number of cases and deaths of COVID-19 were 255.68 (2877.03) cases and 13.90 (272.22) deaths per county, respectively. In the adjusted models standardized by county population, with each 5% increase in percent households with poor housing conditions, there was a 50% higher risk of COVID-19 incidence (IRR 1.50, 95% CI: 1.38-1.62) and a 42% higher risk of COVID-19 mortality (MRR 1.42, 95% CI: 1.25-1.61). Results remained similar using earlier timepoints (3/31/2020 and 4/10/2020). Conclusions and relevance Counties with a higher percentage of households with poor housing had higher incidence of, and mortality associated with, COVID-19. These findings suggest targeted health policies to support individuals living in poor housing conditions should be considered in further efforts to mitigate adverse outcomes associated with COVID-19.	[Ahmad, Khansa; Erqou, Sebhat; Shah, Nishant; Nazir, Umair; Morrison, Alan R.; Choudhary, Gaurav; Wu, Wen-Chih] Brown Univ, Providence Vet Affairs Med Ctr, Lifespan Hosp, Providence, RI 02912 USA; [Ahmad, Khansa; Erqou, Sebhat; Shah, Nishant; Nazir, Umair; Morrison, Alan R.; Choudhary, Gaurav; Wu, Wen-Chih] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Wu, WC (corresponding author), Brown Univ, Providence Vet Affairs Med Ctr, Lifespan Hosp, Providence, RI 02912 USA.	wen-chih.wu@va.gov	Morrison, Alan R./ABH-3831-2020; Choudhary, Gaurav/M-1643-2019	Morrison, Alan R./0000-0002-2412-7669; Choudhary, Gaurav/0000-0001-9343-5481; Ahmad, Khansa/0000-0003-4376-3043	VA HSRD grant [I01 HX002422-01A2]; Research Project Grant NIH NHLBI [R01HL139795]; NIH NIGMS [P20GM103652]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [7IK2BX002527]; Lifespan CVI Pilot Grant for Faculty; Department of Veterans Affairs, Veterans Health Administration, VISN 1 Career Development Award; Center for AIDS Research; Rhode Island Foundation; Lifespan Cardiovascular Institute	VA HSRD grant; Research Project Grant NIH NHLBI; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program; Lifespan CVI Pilot Grant for Faculty; Department of Veterans Affairs, Veterans Health Administration, VISN 1 Career Development Award(US Department of Veterans Affairs); Center for AIDS Research; Rhode Island Foundation; Lifespan Cardiovascular Institute	Research reported in this publication was supported by VA HSRD grant I01 HX002422-01A2 (WWC), Research Project Grant NIH NHLBI R01HL139795 (A.R.M.) and an Institutional Development Award (IDeA) from NIH NIGMS P20GM103652 (A.R.M.). This work was also supported by Career Development Award Number 7IK2BX002527 from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program (A.R.M.). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. This work was also supported by a Lifespan CVI Pilot Grant for Faculty (A.R.M.). Dr Erqou is supported by funding from the Department of Veterans Affairs, Veterans Health Administration, VISN 1 Career Development Award. Dr Erqou also received funding from Center for AIDS Research, The Rhode Island Foundation, and Lifespan Cardiovascular Institute.	Aligne CA, 2016, AM J PUBLIC HEALTH, V106, P642, DOI 10.2105/AJPH.2015.303018; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, THE ECONOMIST; [Anonymous], 2020, J KOREAN MED SCI, V35, pe112; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Crisanti AS, 2017, PSYCHOL SERV, V14, P141, DOI 10.1037/ser0000135; Dunn JR, 2000, SOC SCI MED, V51, P563, DOI 10.1016/S0277-9536(99)00496-7; Enarson DA, 2001, SCAND J INFECT DIS, V33, P9, DOI 10.1080/003655401753382459; Eric Morath RF, 2020, WALL STREET J; FALUDI E G, 1960, Can J Public Health, V51, P146; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Hua Qian TM, 2020, INDOOR TRANSMISSION; Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080; Killingray DPH, 2001, SPANISH INFLUENZA PA; Kolifarhood G, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.620; Kottke Thomas, 2018, Perm J, V22, P17, DOI 10.7812/TPP/17-079; Krieger J, 2002, AM J PUBLIC HEALTH, V92, P758, DOI 10.2105/AJPH.92.5.758; Lau JTF, 2004, EMERG INFECT DIS, V10, P235; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Long S. K., 2003, HARDSHIP UNINSURED C; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3; Richardson S, 2020, JAMA; RIMMER A, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1562; Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Schiavo R, 2014, PATHOG GLOB HEALTH, V108, P76, DOI 10.1179/2047773214Y.0000000127; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Stahre M, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140511; Team C-I, 2020, NAT MED; Thomas TK, 2016, J WATER HEALTH, V14, P132, DOI 10.2166/wh.2015.110; Vesoulis A., 2020, TIME; WHO Guidelines Approved by the Guidelines Review Committee, 2018, WHO HOUS HLTH GUID; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443	38	97	98	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241327	10.1371/journal.pone.0241327	http://dx.doi.org/10.1371/journal.pone.0241327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YA	33137155	Green Published, Green Submitted, gold			2022-12-26	WOS:000588375500003
J	Csillik, O; Asner, GP				Csillik, Ovidiu; Asner, Gregory P.			Near-real time aboveground carbon emissions in Peru	PLOS ONE			English	Article							BIOMASS ESTIMATION; TROPICAL FOREST; COVER; VEGETATION; LANDSAT; STOCKS; DEFORESTATION; CONSERVATION; CAPABILITIES; PERFORMANCE	Monitoring aboveground carbon stocks and fluxes from tropical deforestation and forest degradation is important for mitigating climate change and improving forest management. However, high temporal and spatial resolution analyses are rare. This study presents the most detailed tracking of aboveground carbon over time, with yearly, quarterly and monthly estimations of emissions using the stock-difference approach and masked by the forest loss layer of Global Forest Watch. We generated high spatial resolution (1-ha) monitoring of aboveground carbon density (ACD) and emissions (ACE) in Peru by incorporating hundreds of thousands of Planet Dove satellite images, Sentinel-1 radar, topography and airborne LiDAR, embedded into a deep learning regression workflow using high-performance computing. Consistent ACD results were obtained for all quarters and months analyzed, with R-2 values of 0.75-0.78, and root mean square errors (RMSE) between 20.6 and 22.0 Mg C ha(-1). A total of 7.138 Pg C was estimated for Peru with annual ACE of 20.08 Tg C between the third quarters of 2017 and 2018, respectively, or 23.4% higher than estimates from the FAO Global Forest Resources Assessment. Analyzed quarterly, the spatial evolution of ACE revealed 11.5 Tg C, 6.6 Tg C, 8.6 Tg C, and 10.1 Tg C lost between the third quarters of 2017 and 2018. Moreover, our monthly analysis for the dry season reveals the evolution of ACE at unprecedented temporal detail. We discuss environmental controls over ACE and provide a spatially explicit tool for enhanced forest carbon management at scale.	[Csillik, Ovidiu; Asner, Gregory P.] Arizona State Univ, Ctr Global Discovery & Conservat Sci, Tempe, AZ 85287 USA; [Csillik, Ovidiu] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Arizona State University; Arizona State University-Tempe; Wageningen University & Research	Csillik, O (corresponding author), Arizona State Univ, Ctr Global Discovery & Conservat Sci, Tempe, AZ 85287 USA.; Csillik, O (corresponding author), Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands.	ovidiu.csillik@gmail.com	Asner, Gregory/G-9268-2013; Csillik, Ovidiu/O-2957-2013	Asner, Gregory/0000-0001-7893-6421; Csillik, Ovidiu/0000-0002-4590-3807	Erol Foundation; Arizona State University	Erol Foundation; Arizona State University	This study was supported by a grant from the Erol Foundation awarded to G.P.A. The Global Airborne Observatory is made possible with support of private foundations, visionary individuals, and Arizona State University.	[Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Asner GP, 2018, BIOL CONSERV, V217, P289, DOI 10.1016/j.biocon.2017.10.020; Asner GP, 2014, P NATL ACAD SCI USA, V111, pE5016, DOI 10.1073/pnas.1419550111; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/021002; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Avitabile V, 2012, REMOTE SENS ENVIRON, V117, P366, DOI 10.1016/j.rse.2011.10.012; Baccini A, 2017, SCIENCE, V358, P230, DOI 10.1126/science.aam5962; Bastin JF, 2019, SCIENCE, V365, P76, DOI 10.1126/science.aax0848; Bos AB, 2019, INT J APPL EARTH OBS, V80, P295, DOI 10.1016/j.jag.2019.04.004; Brodrick PG, 2019, TRENDS ECOL EVOL, V34, P734, DOI 10.1016/j.tree.2019.03.006; Castillo JAA, 2017, ISPRS J PHOTOGRAMM, V134, P70, DOI 10.1016/j.isprsjprs.2017.10.016; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Csillik O, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071160; Csillik O, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab639c; Csillik O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54386-6; de Andrade RB, 2017, CARBON BAL MANAGE, V12, DOI 10.1186/s13021-017-0074-0; De Sy V, 2012, CURR OPIN ENV SUST, V4, P696, DOI 10.1016/j.cosust.2012.09.013; Duncanson L, 2019, SURV GEOPHYS, V40, P979, DOI 10.1007/s10712-019-09538-8; Fan L, 2019, NAT PLANTS, V5, P944, DOI 10.1038/s41477-019-0478-9; FAO, 2015, 163 FAO; Finer M, 2018, SCIENCE, V360, P1303, DOI 10.1126/science.aat1203; Forkuor G, 2020, REMOTE SENS ENVIRON, V236, DOI 10.1016/j.rse.2019.111496; Frampton WJ, 2013, ISPRS J PHOTOGRAMM, V82, P83, DOI 10.1016/j.isprsjprs.2013.04.007; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hansen MC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034008; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold M, 2019, SURV GEOPHYS, V40, P757, DOI 10.1007/s10712-019-09510-6; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; IPCC, 2006, ENERGY, V2; Jarvis A., 2008, HOLE FILLED SRTM GLO; Karlson M, 2015, REMOTE SENS-BASEL, V7, P10017, DOI 10.3390/rs70810017; Kingma DP., 2014, ADAM METHOD STOCHAST; Laurin GV, 2019, INT J APPL EARTH OBS, V82, DOI 10.1016/j.jag.2019.101899; Laurin GV, 2014, ISPRS J PHOTOGRAMM, V89, P49, DOI 10.1016/j.isprsjprs.2014.01.001; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lohberger S, 2018, GLOBAL CHANGE BIOL, V24, P644, DOI 10.1111/gcb.13841; Mascaro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085993; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Mitchard ETA, 2018, NATURE, V559, P527, DOI 10.1038/s41586-018-0300-2; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Narine LL, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11121503; Nguyen TH, 2020, INT J APPL EARTH OBS, V84, DOI 10.1016/j.jag.2019.101952; Nomura K, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aafc6b; Pandit S, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040601; Quegan S, 2019, REMOTE SENS ENVIRON, V227, P44, DOI 10.1016/j.rse.2019.03.032; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Reiche J, 2018, REMOTE SENS ENVIRON, V204, P147, DOI 10.1016/j.rse.2017.10.034; Reiche J, 2016, NAT CLIM CHANGE, V6, P120, DOI 10.1038/nclimate2919; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Shendryk Y, 2019, ISPRS J PHOTOGRAMM, V157, P124, DOI 10.1016/j.isprsjprs.2019.08.018; Shi Y, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061901; Tang XJ, 2020, SCI TOTAL ENVIRON, V720, DOI 10.1016/j.scitotenv.2020.137409; Team Planet, 2017, PLAN APL PROGR INT S; Team Planet, 2019, PLAN IM PROD SPEC; Team Planet, 2019, SURF REFL BAS TECHN; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Torres R, 2012, REMOTE SENS ENVIRON, V120, P9, DOI 10.1016/j.rse.2011.05.028; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Veci L., 2014, P IEEE INT GEOSCIENC, P1; Woodcock CE, 2020, REMOTE SENS ENVIRON, V238, DOI 10.1016/j.rse.2019.111558; Zhang LJ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11121459	64	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241418	10.1371/journal.pone.0241418	http://dx.doi.org/10.1371/journal.pone.0241418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137140	Green Published, gold			2022-12-26	WOS:000588375500032
J	Whitmore, HAB; Amarnani, D; O'Hare, M; Delgado-Tirado, S; Gonzalez-Buendia, L; An, M; Pedron, J; Bushweller, JH; Arboleda-Velasquez, JF; Kim, LA				Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Pedron, Julien; Bushweller, John H.; Arboleda-Velasquez, Joseph F.; Kim, Leo A.			TNF-alpha signaling regulates RUNX1 function in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; endothelial cell; RUNX1; TNF&#8208; &#945; signaling pathway	NECROSIS-FACTOR-ALPHA; PROLIFERATIVE DIABETIC-RETINOPATHY; SMALL-MOLECULE INHIBITOR; GROWTH-FACTOR; PANRETINAL PHOTOCOAGULATION; INTRAVITREAL BEVACIZUMAB; INDUCED APOPTOSIS; ACTIVATION; RANIBIZUMAB; KINASE	Runt-related transcription factor 1 (RUNX1) acts as a mediator of aberrant retinal angiogenesis and has been implicated in the progression of proliferative diabetic retinopathy (PDR). Patients with PDR, retinopathy of prematurity (ROP), and wet age-related macular degeneration (wet AMD) have been found to have elevated levels of Tumor Necrosis Factor-alpha (TNF-alpha) in the eye. In fibrovascular membranes (FVMs) taken from patients with PDR RUNX1 expression was increased in the vasculature, while in human retinal microvascular endothelial cells (HRMECs), TNF-alpha stimulation causes increased RUNX1 expression, which can be modulated by RUNX1 inhibitors. Using TNF-alpha pathway inhibitors, we determined that in HRMECs, TNF-alpha-induced RUNX1 expression occurs via JNK activation, while NF-kappa B and p38/MAPK inhibition did not affect RUNX1 expression. JNK inhibitors were also effective at stopping high D-glucose-stimulated RUNX1 expression. We further linked JNK to RUNX1 through Activator Protein 1 (AP-1) and investigated the JNK-AP-1-RUNX1 regulatory feedback loop, which can be modulated by VEGF. Additionally, stimulation with TNF-alpha and D-glucose had an additive effect on RUNX1 expression, which was downregulated by VEGF modulation. These data suggest that the downregulation of RUNX1 in conjunction with anti-VEGF agents may be important in future treatments for the management of diseases of pathologic ocular angiogenesis.	[Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Arboleda-Velasquez, Joseph F.; Kim, Leo A.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02143 USA; [Whitmore, Hannah A. B.; Amarnani, Dhanesh; O'Hare, Michael; Delgado-Tirado, Santiago; Gonzalez-Buendia, Lucia; An, Miranda; Arboleda-Velasquez, Joseph F.; Kim, Leo A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Pedron, Julien; Bushweller, John H.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Virginia	Kim, LA (corresponding author), Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02143 USA.	leo_kim@meei.harvard.edu	Gonzalez-Buendia, Lucia/AAC-9445-2022		National Eye Institute of the National Institutes of Health [R01EY027739]; E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; National Cancer Institute of the National Institutes of Health [R01CA234478]	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Eye Institute of the National Institutes of Health, Grant/Award Number: R01EY027739; E. Matilda Zieger Foundation for the Blind; Karl Kirchgessner Foundation; Michel Plantevin; National Cancer Institute of the National Institutes of Health, Grant/Award Number: R01CA234478	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Bressler SB, 2017, OPHTHALMOLOGY, V124, P431, DOI 10.1016/j.ophtha.2016.12.005; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; COSTAGLIOLA C, 2013, MEDIAT INFLAMM, V2013; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Elsasser A, 2003, ONCOGENE, V22, P5646, DOI 10.1038/sj.onc.1206673; Ennis BW, 2005, J PHARMACOL EXP THER, V313, P325, DOI 10.1124/jpet.104.078873; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fan YP, 2019, CANCERS, V11, DOI 10.3390/cancers11010022; Fernandez-Vega B, 2016, CASE REP OPHTHAL, V7, P154, DOI 10.1159/000445102; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hellgren G, 2018, GROWTH HORM IGF RES, V39, P19, DOI 10.1016/j.ghir.2017.11.006; Hernandez C, 2017, J ENDOCRINOL INVEST, V40, P925, DOI 10.1007/s40618-017-0648-4; Huang H. Y., 2014, J NANOMED NANOTECHNO, V5, P1, DOI DOI 10.4172/2157-7439.1000199; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Illendula A, 2016, EBIOMEDICINE, V8, P117, DOI 10.1016/j.ebiom.2016.04.032; Ishikawa M, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/138070; Jayakumar AR, 2018, NEUROCHEM RES, V43, P397, DOI 10.1007/s11064-017-2434-2; Khalilpourfarshbafi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218792; Krishnaswamy G, 1999, J INTERF CYTOK RES, V19, P91, DOI 10.1089/107999099314234; Lam JD, 2017, DIABETES, V66, P1950, DOI 10.2337/db16-1035; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Martinez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149119; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morita K, 2017, J CLIN INVEST, V127, P2815, DOI 10.1172/JCI91788; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Rivera JC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0943-1; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Sato T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19594-6; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Simo-Servat O, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5263798; Souvannaseng L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007418; Spandau U, 2019, PEDIAT RETINAL VASCU, P149; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Watanabe H, 2018, CELL REP, V23, P3721, DOI 10.1016/j.celrep.2018.05.081; Xiao GY, 2018, P NATL ACAD SCI USA, V115, pE9570, DOI 10.1073/pnas.1810209115; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Zhang BC, 2015, MOL MED REP, V11, P3101, DOI 10.3892/mmr.2014.3002; Zhao Yue, 2018, Drugs Context, V7, P212532, DOI 10.7573/dic.212532; Zhou P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00464; Zou WJ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193256	61	6	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001668R	http://dx.doi.org/10.1096/fj.202001668R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33135824	Green Published, hybrid			2022-12-26	WOS:000586610800001
J	Balderas, PMD; Nunez, MM; Picones, A; Hernandez-Cruz, A				de Oca Balderas, Pavel Montes; Matus Nunez, Mauricio; Picones, Arturo; Hernandez-Cruz, Arturo			NMDAR in cultured astrocytes: Flux-independent pH sensor and flux-dependent regulator of mitochondria and plasma membrane-mitochondria bridging	FASEB JOURNAL			English	Article						astrocyte; calcium; flux&#8208; independent; mitochondria; NMDAR; organelle communication	D-ASPARTATE RECEPTOR; GLUTAMATE UPTAKE; NERVOUS-SYSTEM; CALCIUM; MODULATION; CONTRIBUTES; SENSITIVITY; SECRETION; CHANNELS; DYNAMICS	Glutamate N-methyl-D-aspartate (NMDA) receptor (NMDAR) is critical for neurotransmission as a Ca2+ channel. Nonetheless, flux-independent signaling has also been demonstrated. Astrocytes express NMDAR distinct from its neuronal counterpart, but cultured astrocytes have no electrophysiological response to NMDA. We recently demonstrated that in cultured astrocytes, NMDA at pH6 (NMDA/pH6) acting through the NMDAR elicits flux-independent Ca2+ release from the Endoplasmic Reticulum (ER) and depletes mitochondrial membrane potential (m Delta psi). Here we show that Ca2+ release is due to pH6 sensing by NMDAR, whereas m Delta psi depletion requires both: pH6 and flux-dependent NMDAR signaling. Plasma membrane (PM) NMDAR guard a non-random distribution relative to the ER and mitochondria. Also, NMDA/pH6 induces ER stress, endocytosis, PM electrical capacitance reduction, mitochondria-ER, and -nuclear contacts. Strikingly, it also produces the formation of PM invaginations near mitochondria along with structures referred to here as PM-mitochondrial bridges (PM-m-br). These and earlier data strongly suggest PM-mitochondria communication. As proof of the concept of mass transfer, we found that NMDA/pH6 provoked mitochondria labeling by the PM dye FM-4-64FX. NMDA/pH6 caused PM depolarization, cell acidification, and Ca2+ release from most mitochondria. Finally, the MCU and microtubules were not involved in m Delta psi depletion, while actin cytoskeleton was partially involved. These findings demonstrate that NMDAR has concomitant flux-independent and flux-dependent actions in cultured astrocytes.	[de Oca Balderas, Pavel Montes] Inst Nacl Neurol & Neurocirug, Dept Neurochem, Unidad Neurobiol Dinam, Mexico City 14269, DF, Mexico; [de Oca Balderas, Pavel Montes; Matus Nunez, Mauricio; Picones, Arturo; Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Lab Nacl Canalopatias, Dept Cognit Neurosci, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Balderas, PMD (corresponding author), Inst Nacl Neurol & Neurocirug, Dept Neurochem, Unidad Neurobiol Dinam, Mexico City 14269, DF, Mexico.	pavel73@hotmail.com	Picones, Arturo/ABG-5749-2020		Consejo Nacional de Ciencia y Tecnologia (CONACYT) [132706]; UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [AG200119]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: 132706; UNAM | Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: AG200119	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Bondarenko A, 2001, GLIA, V34, P134, DOI 10.1002/glia.1048; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Christie DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037144; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Balderas PMD, 2018, BMC BIOPHYS, V11, DOI 10.1186/s13628-018-0043-3; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Dolgin E, 2019, NATURE, V567, P162, DOI 10.1038/d41586-019-00792-9; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elbaz-Alon Y, 2017, BIOCHEM SOC T, V45, P477, DOI 10.1042/BST20160130; Bastian-Eugenio CE, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0338-1; Fernandez-Tenorio M, 2011, CIRC RES, V108, P1348, DOI 10.1161/CIRCRESAHA.111.240127; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Gerard F, 2012, BRAIN RES, V1473, P1, DOI 10.1016/j.brainres.2012.07.032; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Hansen KB, 2018, J GEN PHYSIOL, V150, P1081, DOI 10.1085/jgp.201812032; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hogan-Cann AD, 2016, TRENDS PHARMACOL SCI, V37, P750, DOI 10.1016/j.tips.2016.05.012; Hu B, 2004, ACTA PHARMACOL SIN, V25, P714; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jimenez-Blasco D, 2015, CELL DEATH DIFFER, V22, P1877, DOI 10.1038/cdd.2015.49; Juaristi I, 2019, GLIA, V67, P759, DOI 10.1002/glia.23574; Kasymov V, 2013, J NEUROSCI, V33, P435, DOI 10.1523/JNEUROSCI.2813-12.2013; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; Kolikova J, 2006, BRAIN CELL BIOL, V35, P75, DOI 10.1007/s11068-006-9000-1; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; KOYAMA Y, 1991, NEUROSCI LETT, V124, P235, DOI 10.1016/0304-3940(91)90102-Y; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miro-Casas E, 2009, CARDIOVASC RES, V83, P747, DOI 10.1093/cvr/cvp157; Montes de Oca Balderas P, 2018, INT J MOL SCI, V19, P3800; Montes de Oca Balderas P, 2015, PLOS ONE, V10; Montes de Oca Balderas P, 2017, PROTEASES PHYSL PATH, P121; Montes de Oca Balderas P, 2019, BIORXIV, DOI [10.1101/633875, DOI 10.1101/633875]; Montes de Oca Balderas P, 2018, ASTROCYTE PHYSL PATH, P51, DOI [10.5772/intechopen.72975, DOI 10.5772/INTECHOPEN.72975]; Montes de Oca-B Pavel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P337; Ng AN, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0060-3; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Obara-Michlewska M, 2015, NEUROCHEM INT, V88, P20, DOI 10.1016/j.neuint.2014.10.006; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Patrushev I, 2013, CELL CALCIUM, V54, P343, DOI 10.1016/j.ceca.2013.08.003; Peng TI, 1998, MOL PHARMACOL, V53, P974; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Pivneva T, 2008, CELL CALCIUM, V43, P591, DOI 10.1016/j.ceca.2007.10.004; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valbuena S, 2016, NEURON, V92, P316, DOI 10.1016/j.neuron.2016.10.016; Vardjan N, 2016, GLIA, V64, P655, DOI 10.1002/glia.22920; Verkhratsky A, 2020, NEUROCHEM RES, V45, P122, DOI 10.1007/s11064-019-02750-3; Vickery ON, 2016, CURR OPIN PHARMACOL, V30, P44, DOI 10.1016/j.coph.2016.06.011; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WALZ W, 1989, BRAIN RES, V504, P82, DOI 10.1016/0006-8993(89)91600-4; Wang M, 2012, BRAIN RES, V1476, P154, DOI 10.1016/j.brainres.2012.03.029; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Zhang JB, 2018, CELL REP, V25, P3582, DOI 10.1016/j.celrep.2018.11.071	74	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16622	16644		10.1096/fj.202001300R	http://dx.doi.org/10.1096/fj.202001300R		NOV 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131132	Green Submitted, Bronze			2022-12-26	WOS:000586601800001
J	Mitiku, KW; Yenesew, MA; Bantie, GM; Aynie, AA				Mitiku, Kalkikan Worku; Yenesew, Muluken Azage; Bantie, Getasew Mulat; Aynie, Amare Alamirew			Magnitude of risky sexual practice and associated factors among big construction site daily laborers in Bahir Dar city, Amhara Region, Ethiopia	PLOS ONE			English	Article							BEHAVIOR	Background Young person's susceptibility to sexually transmitted infection has been consistently linked to intractable work places. In Ethiopia, different behavior related interventions had carried out to raise awareness of risky sexual behaviors and their consequences. However, there is still limited information on risky sexual practices. Methods A cross-sectional study was conducted among the big construction site daily laborers from April 1, 2019 to May 30, 2019. A pre-tested questionnaire was used for data collection, and data were entered into Epidata and transported to SPSS for analysis. Independent variables with p < 0.05 in the multivariate analysis were considered to have a statistically significant association with risky sexual practice. Result Among 627 sample respondents, the magnitude of risky sexual practice was found to be 24.2%. Labor workers who had a history of an STIs (AOR = 4.29; 95% CI: 2.56, 7.19), those who enjoy in the nightclubs (AOR = 2.33; 95% CI: 1.34, 4.08), those who started sex by peer pressure (AOR = 3.42; 95% CI: 2.06, 5.68), substance users (AOR = 2.03; 95% CI: 1.08, 3.82), those who were unable to read and write (AOR = 3.65; 95% CI: 1.41, 9.67), living independently (AOR = 3.71; 95% CI: 1.78, 7.77) and living with relatives (AOR = 3.12; 95% CI: 1.06, 9.20) were statistically associated with risky sexual practice. Conclusion The magnitude of risky sexual practice among big constriction daily laborers was high in Bahir Dar City likely to increase their vulnerability to HIV. The findings of this study show the need of targeted HIV prevention plan to give due attention for daily laborers who had a history of an STI, enjoy in the night clubs, peer pressure, substance users, educational status and living arrangement. The Amhara Education Bureau and the city education department have to design ways to deliver at least a high school education.	[Mitiku, Kalkikan Worku] GAMBY Med & Business Coll, Dept Midwifery, Bahir Dar, Ethiopia; [Yenesew, Muluken Azage] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Bantie, Getasew Mulat; Aynie, Amare Alamirew] ALKAN Hlth Sci Business & Technol Coll, Fac Community Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Aynie, AA (corresponding author), ALKAN Hlth Sci Business & Technol Coll, Fac Community Hlth, Bahir Dar, Ethiopia.	amarea0412@gmail.com	Bantie, Getasew/ABZ-4323-2022	Bantie, Getasew/0000-0002-5073-6767; worku.M, kalkidan/0000-0003-0996-7018; Azage, Muluken/0000-0003-3222-0158				Abera Mersha, 2018, Journal of Public Health and Epidemiology, V10, P429; Akwara PA, 2003, J BIOSOC SCI, V35, P385, DOI 10.1017/S0021932003003857; Alamrew Z., 2013, ISRN PUBLIC HLTH, V2013, P9, DOI [10.1155/2013/763051, DOI 10.1155/2013/763051]; Amare H., 2017, INT J HIVAIDS PREV E, V3, P41, DOI [10.11648/j.ijhpebs.20170304.12, DOI 10.11648/J.IJHPEBS.20170304.12]; Amare T, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/4852130; [Anonymous], 2018, HIV AIDS E SO AFRICA; [Anonymous], 2018, BIZNES, V10-11, P6; Bahir Dar City Municipal office, 2017, ASS HLTH HAZ S UNPUB; Blum Robert W., 2005, RISK PROTECTIVE FACT; Dahal S., 2013, WORLD J AIDS, V3, P305, DOI [10.4236/wja.2013.34039, DOI 10.4236/WJA.2013.34039]; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Girmay A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4714-1; Girum T, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0299-8; Hong YA, 2015, HEALTH PSYCHOL BEHAV, V3, P315, DOI 10.1080/21642850.2015.1100541; IOM UNAIDS, 2005, HIV MOB WORK REV RIS; IPAS, 2019, AB AD GIRLS; Kassa M, 2013, RISKY SEXUAL BEHAV B, P296; Malhotra S., 2008, J AM PHYS SURG, V13, P88; Mensch BS, 2008, STUD FAMILY PLANN, V39, P321, DOI 10.1111/j.1728-4465.2008.00178.x; Mph TN, 2020, J MIDWIFERY REPROD H, V8, P2096; Muche AA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0376-4; National Youth Policy, 2004, FED DEM REP DEM ETH; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Perera UAP, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0546-z; Rosenthal M, 2012, NELSON ED, V974, P134; Tiruneh K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1468-0; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; *UNAIDS, 2004, WOM HIV AIDS CONFR C; UNAIDS, 2019, FACT SHEET GLOB HIV; Waktole ZD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220235; William F., 2015, PRACTICAL ADVICE SEL	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241220	10.1371/journal.pone.0241220	http://dx.doi.org/10.1371/journal.pone.0241220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125414	gold, Green Published			2022-12-26	WOS:000588368900037
J	Tang, L; Xiong, W; Zhang, LS; Wang, D; Wang, Y; Wu, YF; Wei, F; Mo, YZ; Hou, XC; Shi, L; Xiong, F; Zhang, SS; Gong, ZJ; Liao, QJ; Xiang, B; Zhang, WL; Zhou, M; Li, XL; Li, GY; Guo, C; Zeng, ZY				Tang, Le; Xiong, Wei; Zhang, Lishen; Wang, Dan; Wang, Yian; Wu, Yingfen; Wei, Fang; Mo, Yongzhen; Hou, Xiangchan; Shi, Lei; Xiong, Fang; Zhang, Shanshan; Gong, Zhaojian; Liao, Qianjin; Xiang, Bo; Zhang, Wenling; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Guo, Can; Zeng, Zhaoyang			circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma	ONCOGENE			English	Article							CELL-PROLIFERATION; CIRCULAR RNAS; CANCER; EB1; GROWTH; ACTS; EXPRESSION; BIOMARKER; DYNAMICS; CIRCRNAS	Circular RNAs (circRNAs) play an essential role in tumorigenesis and development. However, they have rarely been investigated in nasopharyngeal carcinoma (NPC). This study aimed to investigate the role of circRNA in the invasion and metastasis of NPC. We screened and verified the high expression of circSETD3 in NPC cell lines using RNA sequencing (RNA-Seq) and verified the results of NPC biopsy samples using real-time quantitative polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH). In vivo and in vitro experiments indicated that circSETD3 could promote NPC cell invasion and migration. We compared the proteomic data of NPC cells before and after the overexpression or knockdown of circSETD3 in combination with bioinformatics prediction and experimental verification. It was found that circSETD3 competitively adsorbs to miR-615-5p and miR-1538 and negates their inhibitory effect on MAPRE1 mRNA, thereby upregulating the expression of MAPRE1. The upregulated MAPRE1 then inhibits the acetylation of alpha-tubulin, promotes the dynamic assembly of microtubules, and enhances the invasion and migration capabilities of NPC cells. The results of this study suggest that circSETD3 is a novel molecular marker and a potential target for NPC diagnosis and treatment.	[Tang, Le; Xiong, Wei; Liao, Qianjin; Xiang, Bo; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Zeng, Zhaoyang] Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Tang, Le; Xiong, Wei; Liao, Qianjin; Xiang, Bo; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Zeng, Zhaoyang] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Tang, Le; Xiong, Wei; Zhang, Lishen; Wang, Dan; Wang, Yian; Wu, Yingfen; Wei, Fang; Mo, Yongzhen; Hou, Xiangchan; Xiang, Bo; Zhang, Wenling; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Guo, Can; Zeng, Zhaoyang] Cent South Univ, Chinese Minist Educ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Tang, Le; Xiong, Wei; Xiang, Bo; Zhang, Wenling; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Zeng, Zhaoyang] Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Hunan, Peoples R China; [Shi, Lei; Gong, Zhaojian] Cent South Univ, Xiangya Hosp 2, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China; [Xiong, Fang; Zhang, Shanshan] Cent South Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Zeng, ZY (corresponding author), Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Zeng, ZY (corresponding author), Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China.; Zeng, ZY (corresponding author), Cent South Univ, Chinese Minist Educ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China.; Zeng, ZY (corresponding author), Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Hunan, Peoples R China.	zengzhaoyang@csu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022		National Natural Science Foundation of China [81672683, 81702907, 81772901, 81772928, 81803025, 81972776, 82072374]; Natural Science Foundation of Hunan Province [2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211, 2019JJ50872, 2019JJ50778, 2020JJ4125]; Fundamental Research Funds for the Central South University [2019zzts712, 2019zzts727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Fundamental Research Funds for the Central South University	This work was supported by grants from the National Natural Science Foundation of China (81672683, 81702907, 81772901, 81772928, 81803025, 81972776 and 82072374), the Natural Science Foundation of Hunan Province (2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211, 2019JJ50872, 2019JJ50778 and 2020JJ4125), and the Fundamental Research Funds for the Central South University (2019zzts712 and 2019zzts727).	Bai YX, 2019, EBIOMEDICINE, V42, P311, DOI 10.1016/j.ebiom.2019.03.045; Berges R, 2016, MOL CANCER THER, V15, P2740, DOI 10.1158/1535-7163.MCT-16-0252; Bo H, 2019, ONCOL REP, V41, P2431, DOI 10.3892/or.2019.7027; Bo H, 2018, J CANCER, V9, P4677, DOI 10.7150/jca.26461; Chen LJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0943-0; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chen NF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1594-y; Cheng HP, 2017, ONCOL RES, V25, P587, DOI 10.3727/096504016X14761811155298; Das M, 2018, RNA BIOL, V15, P214, DOI 10.1080/15476286.2017.1397261; Deng XY, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0428-0; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Fan CM, 2019, CANCER SCI, V110, P2180, DOI 10.1111/cas.14034; Fan CM, 2021, CANCER LETT, V496, P41, DOI 10.1016/j.canlet.2020.09.006; Fan CM, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07408-w; Fan CM, 2021, SCI CHINA LIFE SCI, V64, P534, DOI 10.1007/s11427-019-1735-4; Fan CM, 2019, J CANCER, V10, P3926, DOI 10.7150/jca.31345; Fan CM, 2019, CARCINOGENESIS, V40, P380, DOI 10.1093/carcin/bgy143; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gao W, 2015, ONCOGENE, V34, P1629, DOI 10.1038/onc.2014.101; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Han Y, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117140; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hauptmann J, 2013, DEV CELL, V25, P553, DOI 10.1016/j.devcel.2013.06.009; He RF, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0614-1; He Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0265-y; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jayatilaka H, 2018, FASEB J, V32, P1207, DOI 10.1096/fj.201700444RR; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jiang XJ, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01709-5; Jiang XJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0928-4; Jin K, 2019, CELL MOL LIFE SCI, V76, P4275, DOI 10.1007/s00018-019-03222-1; Kong Z, 2017, BIOCHEM BIOPH RES CO, V493, P1217, DOI 10.1016/j.bbrc.2017.07.162; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; Li HB, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6017-2; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Li PC, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12165; Li YW, 2017, EMBO REP, V18, P1646, DOI 10.15252/embr.201643581; Lian Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0918-9; Liu M, 2009, MOL CARCINOGEN, V48, P212, DOI 10.1002/mc.20471; Liu Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1894-5; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mo YZ, 2019, J CANCER, V10, P3789, DOI 10.7150/jca.31166; Mo YZ, 2019, J CANCER, V10, P2342, DOI 10.7150/jca.30454; Peng M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1055-6; Rodrigues-Ferreira S, 2019, BREAST CANCER RES TR, V173, P573, DOI 10.1007/s10549-018-5026-1; Serre L, 2019, J MOL BIOL, V431, P1993, DOI 10.1016/j.jmb.2019.03.028; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Sugihara Y, 2012, J PROTEOMICS, V75, P5342, DOI 10.1016/j.jprot.2012.06.013; Taguchi A, 2015, CANCER PREV RES, V8, P1112, DOI 10.1158/1940-6207.CAPR-15-0077; Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7; Tang T, 2020, MOL ONCOL, V14, P2251, DOI 10.1002/1878-0261.12703; Tang YY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0825-x; Tu CF, 2018, CARCINOGENESIS, V39, P1517, DOI 10.1093/carcin/bgy108; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; van Haren J, 2018, NAT CELL BIOL, V20, P252, DOI 10.1038/s41556-017-0028-5; Wan L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1579490; Wang D, 2020, FASEB J, V34, P8012, DOI 10.1096/fj.202000039RR; Wang D, 2020, CELL MOL LIFE SCI, V77, P2949, DOI 10.1007/s00018-020-03469-z; Wang JJ, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22379; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; Wang YA, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0913-y; Wang YM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0598-7; Wei F, 2021, CELL MOL LIFE SCI, V78, P173, DOI 10.1007/s00018-020-03581-0; Wei F, 2019, J CANCER, V10, P1145, DOI 10.7150/jca.29049; Wei F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0409-0; Wei F, 2018, BRIT J CANCER, V118, P233, DOI 10.1038/bjc.2017.385; Wieczorek M, 2015, NAT CELL BIOL, V17, P907, DOI 10.1038/ncb3188; Wu CC, 2019, SCI CHINA LIFE SCI, V62, P640, DOI 10.1007/s11427-018-9461-5; Wu P, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1147-3; Wu YF, 2020, FASEB J, V34, P16205, DOI 10.1096/fj.202001508R; Wu YF, 2019, J CANCER, V10, P2185, DOI 10.7150/jca.30222; Wu YZ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1007-1; Xiao L, 2019, CARCINOGENESIS, V40, P819, DOI 10.1093/carcin/bgz095; Xiong F, 2019, CHINESE MED J-PEKING, V132, P749, DOI 10.1097/CM9.0000000000000132; Xu LL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1041-2; Yang CD, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0771-7; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zhao J, 2020, CANCER LETT, V477, P131, DOI 10.1016/j.canlet.2020.02.010; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhou RY, 2018, CANCER LETT, V425, P134, DOI 10.1016/j.canlet.2018.03.035; Zhu KJ, 2020, CANCER LETT, V492, P11, DOI 10.1016/j.canlet.2020.07.028	86	36	37	3	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					307	321		10.1038/s41388-020-01531-5	http://dx.doi.org/10.1038/s41388-020-01531-5		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33122825				2022-12-26	WOS:000582827800002
J	Morais, LS; Dusi, RG; Demarque, DP; Silva, RL; Albernaz, LC; Bao, SN; Merten, C; Antinarelli, LMR; Coimbra, ES; Espindola, LS				Morais, Lais S.; Dusi, Renata G.; Demarque, Daniel P.; Silva, Raquel L.; Albernaz, Lorena C.; Bao, Sonia N.; Merten, Christian; Antinarelli, Luciana M. R.; Coimbra, Elaine S.; Espindola, Laila S.			Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action	PLOS ONE			English	Article							LEISHMANIA-AMAZONENSIS; DERIVATIVES; CONSTITUENTS; MITOCHONDRIA; ROOTS; DEATH	Leishmaniasis is a disease impacting public health worldwide due to its high incidence, morbidity and mortality. Available treatments are costly, lengthy and toxic, not to mention the problem of parasite resistance. The development of alternative treatments is warranted and natural products demonstrate promising activity. This study investigated the activity of Connarus suberosus extracts and compounds against Leishmania species. Several C. suberosus extracts were tested against L. amazonensis promastigotes. Active and inactive extracts were analyzed by UHPLC-MS and data evaluated using a metabolomics platform, revealing an unknown neoflavonoid (connarin, 3), isolated together with the pterocarpans: hemileiocarpin (1) and leiocarpin (2). The aforementioned compounds (1-3), together with the benzoquinones: rapanone (4), embelin (5) and suberonone (6) previously isolated by our group from the same species, were tested against: (i) L. amazonensis and L. infantum promastigotes, and (ii) L. amazonensis intracellular amastigotes, with the most active compound (3) also tested against L. infantum amastigotes. Cytotoxicity against murine peritoneal macrophages was also investigated. Compounds 2 and 3 presented an IC50 33.8 mu M and 11.4 mu M for L. amazonensis promastigotes; and 44.3 mu M and 13.3 mu M for L. infantum promastigotes, respectively. For L. amazonensis amastigotes, the IC50 of 2 was 20.4 mu M with a selectivity index (SI) of 5.7, while the IC50 of 3 was 2.9 mu M with an SI of 6.3. For L. infantum amastigotes, the IC50 of 3 was 7.7 mu M. Compounds 2 and 3 presented activity comparable with the miltefosine positive control, with compound 3 found to be 2-4 times more active than the positive control, depending on the Leishmania species and form. The extracts and isolated compounds showed moderate toxicity against macrophages. Compounds 2 and 3 altered the mitochondrial membrane potential (Delta psi m) and neutral lipid body accumulation, while 2 also impacted plasma membrane permeabilization, culminating in cellular disorder and parasite death. Transmission electron microscopy of L. amazonensis promastigotes treated with compound 3 confirmed the presence of lipid bodies. Leiocarpin (2) and connarin (3) demonstrated antileishmanial activity. This study provides knowledge of natural products with antileishmanial activity, paving the way for prototype development to fight this neglected tropical disease.	[Morais, Lais S.; Dusi, Renata G.; Demarque, Daniel P.; Silva, Raquel L.; Albernaz, Lorena C.; Espindola, Laila S.] Univ Brasilia, Lab Farmacognosia, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [Demarque, Daniel P.; Merten, Christian] Ruhr Univ Bochum, Fak Chem & Biochem, Organ Chem 2, Bochum, Germany; [Bao, Sonia N.] Univ Brasilia, Lab Microscopia & Microanal, Inst Ciencias Biol, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [Antinarelli, Luciana M. R.; Coimbra, Elaine S.] Univ Fed Juiz De Fora, Dept Parasitol Microbiol & Imunol, ICB, Campus Univ Juiz De Fora, Juiz De Fora, MG, Brazil	Universidade de Brasilia; Ruhr University Bochum; Universidade de Brasilia; Universidade Federal de Juiz de Fora	Espindola, LS (corresponding author), Univ Brasilia, Lab Farmacognosia, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.	darvenne@unb.br	Demarque, Daniel Pecoraro/K-7325-2014; Merten, Christian/I-2811-2012; Espindola, Laila Salmen/U-3378-2019	Demarque, Daniel Pecoraro/0000-0002-3576-5148; Merten, Christian/0000-0002-4106-1905; Espindola, Laila Salmen/0000-0002-1886-868X; Morais, Lais/0000-0002-1340-7681	Ministry of Health [TED74/2016, TED 42/2017]; FAPDF [0193.001482/2016, 0193.001219/2016]; CNPq; CAPES/Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) [ME 4267/5-1, 418661145]; Boehringer Ingelheim Foundation (BIS)	Ministry of Health; FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)(German Research Foundation (DFG)); Boehringer Ingelheim Foundation (BIS)	The authors wish to thank the ArboControlBrasil Project funded by the Ministry of Health (Process no. TED74/2016 and TED 42/2017) and FAPDF (Process no. 0193.001482/2016 and 0193.001219/2016) for financial support. We also express our gratitude to CNPq for the fellowships (E.S. Coimbra and L.M.R. Antinarelli), and CAPES/Alexander von Humboldt Foundation for co-funding the post-doctoral fellowship (D. P. Demarque). CM acknowledges support by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) through the Heisenberg programme (ME 4267/5-1/ project number 418661145) and the Boehringer Ingelheim Foundation (BIS) through the Plus 3-programme.	Antinarelli LMR, 2015, CHEM BIOL DRUG DES, V86, P704, DOI 10.1111/cbdd.12540; Araujo MV, 2019, ANALYST, V144, P5232, DOI 10.1039/c9an00948e; Aureliano DP, 2018, PHOTODIAGN PHOTODYN, V23, P1, DOI 10.1016/j.pdpdt.2018.05.005; Batista JM, 2015, NAT PROD REP, V32, P1280, DOI 10.1039/c5np00027k; Bekhit AA, 2018, EUR J MED CHEM, V160, P229, DOI 10.1016/j.ejmech.2018.10.022; Borges RM, 2018, PHYTOCHEM ANALYSIS, V29, P601, DOI 10.1002/pca.2773; BRAZ FILHO R, 1971, PHYTOCHEMISTRY, V10, P2433, DOI 10.1016/S0031-9422(00)89891-X; Brenzan MA, 2008, BIOMED PHARMACOTHER, V62, P651, DOI 10.1016/j.biopha.2008.08.024; Charneau S, 2016, NAT PROD RES, V30, P1320, DOI 10.1080/14786419.2015.1055264; Chin YW, 2007, J AGR FOOD CHEM, V55, P4691, DOI 10.1021/jf0703553; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cortes S, 2020, PATHOG GLOB HEALTH, V114, P170, DOI 10.1080/20477724.2020.1754655; da Costa RC, 2014, BIOORGAN MED CHEM, V22, P135, DOI 10.1016/j.bmc.2013.11.044; de Araujo Cintia F, 2014, BMC Res Notes, V7, P70, DOI 10.1186/1756-0500-7-70; de Oliveira GG, 2017, PLANTA MED, V83, P636, DOI 10.1055/s-0042-118712; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Demarque DP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58046-y; Cataneo AHD, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108745; Feresin GE, 2003, J ETHNOPHARMACOL, V88, P241, DOI 10.1016/S0378-8741(03)00258-7; Flora do Brasil, 2018, FLOR BRAS CONN SUB P; Fonseca-Silva F, 2015, J NAT PROD, V78, P880, DOI 10.1021/acs.jnatprod.5b00011; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gasparotto A, 2005, QUIM NOVA, V28, P575, DOI 10.1590/S0100-40422005000400003; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Inacio JDF, 2012, EXP PARASITOL, V132, P151, DOI 10.1016/j.exppara.2012.06.008; Kulshrestha A, 2013, PARASITOL RES, V112, P825, DOI 10.1007/s00436-012-3212-3; Lage PS, 2015, PARASITOL RES, V114, P4625, DOI 10.1007/s00436-015-4708-4; Mendes EA, 2016, CHEM-BIOL INTERACT, V256, P16, DOI 10.1016/j.cbi.2016.06.018; Merten C, 2019, J ORG CHEM, V84, P8797, DOI 10.1021/acs.joc.9b00466; Militao GCG, 2007, BIOORGAN MED CHEM, V15, P6687, DOI 10.1016/j.bmc.2007.08.011; Fidalgo LM, 2011, PHARM RES-DORDR, V28, P2758, DOI 10.1007/s11095-011-0586-3; Morimoto M, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700324; Nafie LA, 2006, HDB VIBRATIONAL SPEC, DOI [10.1002/0470027320.s0503, DOI 10.1002/0470027320.S0503]; Pan American Health Organization, 2019, LEISHM EP REP AM DEC; Antinarelli LMR, 2019, J PHARM PHARMACOL, V71, P1854, DOI 10.1111/jphp.13177; Antinarelli LMR, 2016, EXP PARASITOL, V171, P10, DOI 10.1016/j.exppara.2016.10.009; Menna-Barreto RFS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/614014; Sangenito LS, 2018, INT J ANTIMICROB AG, V52, P185, DOI 10.1016/j.ijantimicag.2018.03.021; Selvaraj S, 2015, PROG LIPID RES, V58, P1, DOI 10.1016/j.plipres.2014.11.002; Silva RL, 2020, MOLECULES, V25, DOI 10.3390/molecules25173978; Soyer TG, 2019, EXP PARASITOL, V199, P30, DOI 10.1016/j.exppara.2019.02.019; Takahashi M, 2006, CHEM PHARM BULL, V54, P915, DOI 10.1248/cpb.54.915; Tokunaga E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35457-6; Tomas AM, 2013, ANTIOXID REDOX SIGN, V19, P696, DOI 10.1089/ars.2012.4948; Torres-Guerrero Edoardo, 2017, F1000Res, V6, P750, DOI 10.12688/f1000research.11120.1; Uliana SRB, 2018, PARASITOLOGY, V145, P464, DOI 10.1017/S0031182016002523; WHO, 2020, LEISHM OV; World Health Organization, 2020, LEISHMANIASIS; Wu SF, 2011, J NAT PROD, V74, P989, DOI 10.1021/np100871g	49	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241855	10.1371/journal.pone.0241855	http://dx.doi.org/10.1371/journal.pone.0241855			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156835	gold, Green Published			2022-12-26	WOS:000591376400018
J	Ontiri, S; Were, V; Kabue, M; Biesma-Blanco, R; Stekelenburg, J				Ontiri, Susan; Were, Vincent; Kabue, Mark; Biesma-Blanco, Regien; Stekelenburg, Jelle			Patterns and determinants of modern contraceptive discontinuation among women of reproductive age: Analysis of Kenya Demographic Health Surveys, 2003-2014	PLOS ONE			English	Article							CALENDAR; QUALITY; CHOICE	Objectives This study aimed to examine patterns and determinants of modern contraceptive discontinuation among women in Kenya. Methods Secondary analysis was conducted using national representative Kenya Demographic and Health Surveys of 2003, 2008/9, and 2014. These household cross-sectional surveys targeted women of reproductive age from 15 to 49 years who had experienced an episode of modern contraceptive use within five years preceding the surveys from 2003 (n = 2686), 2008/9 (n = 2992), and 2014 (5919). The contraceptive discontinuation rate was defined as the number of episodes discontinued divided by the total number of episodes. Weighted descriptive statistics, multivariable logistic regression analysis, and Cox proportional hazards analysis were used to examine the determinants of contraceptive discontinuation. Results The 12-month contraceptive discontinuation rate for all methods declined from 37.5% in 2003 and 36.7% in 2008/9 to 30.5% in 2014. Consistently across the three surveys, intrauterine devices had the lowest 12-month discontinuation rate (6.4% in 2014) followed by implants (8.0%, in 2014). In 2014, higher rates were seen for pills (44.9%) and male condoms (42.9%). The determinants of contraceptive discontinuation among women of reproductive age in the 2003 survey included users of short-term contraception methods, specifically for those who used male condoms (hazard ratio [HR] = 3.30, 95% confidence interval [CI] = 2.13-5.11) and pills (HR = 2.68; 95CI = 1.79-4.00); and younger women aged 15-19 year (HR = 2.07; 95% CI = 1.49-2.87) and 20-24 years (HR = 1.94; 95% CI = 1.61-2.35). The trends in the most common reasons for discontinuation from 2003 to 2014 revealed an increase among those reporting side effects (p = 0.0002) and those wanting a more effective method (p<0.0001). A decrease was noted among those indicating method failure (p<0.0001) and husband disapproval (p<0.0001). Conclusions Family planning programs should focus on improving service quality to strengthen the continuation of contraceptive use among those in need. Women should be informed about potential side effects and reassured on health concerns, including being provided options for method switching. The health system should avail a wider range of contraceptive methods and ensure a constant supply of commodities for women to choose from. Short-term contraceptive method users and younger women may need greater support for continued use.	[Ontiri, Susan] Johns Hopkins Univ Affiliate, Jhpiego, Nairobi, Kenya; [Ontiri, Susan; Biesma-Blanco, Regien; Stekelenburg, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Global Hlth, Groningen, Netherlands; [Were, Vincent] Kenya Med Res Inst Wellcome Trust, Hlth Econ Res Unit, Nairobi, Kenya; [Kabue, Mark] Johns Hopkins Univ Affiliate, Jhpiego, Baltimore, MD USA; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Jhpiego; University of Groningen; Kenya Medical Research Institute; Jhpiego; Johns Hopkins University; Medical Center Leeuwarden	Ontiri, S (corresponding author), Johns Hopkins Univ Affiliate, Jhpiego, Nairobi, Kenya.; Ontiri, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Global Hlth, Groningen, Netherlands.	Susan.Ontiri@jhpiego.org	Kabue, Mark/ABD-3878-2021; Stekelenburg, Jelle/B-3129-2017	Kabue, Mark/0000-0002-4918-5558; Stekelenburg, Jelle/0000-0002-2732-6620				Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; ALI M, 1995, INT FAM PLAN PERSPEC, V21, P92, DOI 10.2307/2133181; Ali M., 2012, CAUSES CONSEQUENCES; Ali MM, 2010, CONTRACEPTION, V81, P22, DOI 10.1016/j.contraception.2009.06.009; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Barden-O'Fallon J, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0529-9; Becker S, 2003, STUD FAMILY PLANN, V34, P127, DOI 10.1111/j.1728-4465.2003.00127.x; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bradley SEK., 2009, DHS ANAL STUDIES, V20; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; Callahan RL, 2012, STUD FAMILY PLANN, V43, P213, DOI 10.1111/j.1728-4465.2012.00319.x; Castle S, 2015, CONTRACEPTIVE DISCON, DOI DOI 10.1108/JHASS-09-2019-0056/FULL/HTML; Central Bureau of Statistics-CBS/Kenya Ministry of Health-MOH/Kenya ORC Macro, 2004, KEN DEM HLTH SURV 20; Chakraborty NM, 2019, GLOB HEALTH-SCI PRAC, V7, P87, DOI 10.9745/GHSP-D-18-00407; Chebet JJ, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0255-5; Curtis SL., 1997, DETERMINANTS CONTRAC; Foreit J., 2011, INCREASING ACCESS FA; GOLDMAN N, 1989, STUD FAMILY PLANN, V20, P147, DOI 10.2307/1966569; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Jacobstein R, 2013, GLOB HEALTH-SCI PRAC, V1, P11, DOI 10.9745/GHSP-D-12-00003; Jain A, 2014, LEAKING BUCKET PHENO; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Leite IC, 2007, REPROD HEALTH, V1, P1, DOI [10.1186/1742-4755-4-6, DOI 10.1186/1742-4755-4-6]; Ministry of Health Kenya Ro., 2007, NAT REPR HLTH POL EN; Modey EJ, 2014, AFR J REPROD HEALTH, V18, P84; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Oteri Omae Malack, 2015, International Journal of Advanced Research in Artificial Intelligence, V4, P1; Radivojac P, 2011, BMC BIOINFORMATIC S3, V14, pS1; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; Steele F, 2003, DEMOGRAPHY, V40, P1, DOI 10.1353/dem.2003.0009; United Nations (UN). United Nations Department of Economic and Social Affairs PD, 2017, WORLD FAM PLANN 2017	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241605	10.1371/journal.pone.0241605	http://dx.doi.org/10.1371/journal.pone.0241605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151972	Green Published, gold			2022-12-26	WOS:000591376200079
J	Wong, WY; Gilman, K; Limesand, KH				Wong, Wen Yu; Gilman, Kristy; Limesand, Kirsten H.			Yap activation in irradiated parotid salivary glands is regulated by ROCK activity	PLOS ONE			English	Article							HIPPO PATHWAY; RADIATION; CELLS; HEAD; HOMEOSTASIS; INHIBITOR; YAP/TAZ; TAZ	Radiotherapy plays a major role in the curative treatment of head and neck cancer, either as a single modality therapy, or in combination with surgery or chemotherapy, or both. Despite advances to limit radiation-induced side-effects, the major salivary glands are often affected. This frequently leads to hyposalivation which causes an increased risk for xerostomia, dental caries, mucositis, and malnutrition culminating in a significant impact on patients' quality of life. Previous research demonstrated that loss of salivary function is associated with a decrease in polarity regulators and an increase in nuclear Yap localization in a putative stem and progenitor cell (SPC) population. Yap activation has been shown to be essential for regeneration in intestinal injury models; however, the highest levels of nuclear Yap are observed in irradiated salivary SPCs that do not regenerate the gland. Thus, elucidating the inputs that regulate nuclear Yap localization and determining the role that Yap plays within the entire tissue following radiation damage and during regeneration is critical. In this study, we demonstrate that radiation treatment increases nuclear Yap localization in acinar cells and Yap-regulated genes in parotid salivary tissues. Conversely, administration of insulin-like growth factor 1 (IGF1), known to restore salivary function in mouse models, reduces nuclear Yap localization and Yap transcriptional targets to levels similar to untreated tissues. Activation of Rho-associated protein kinase (ROCK) using calpeptin results in increased Yap-regulated genes in primary acinar cells while inhibition of ROCK activity (Y-27632) leads to decreased Yap transcriptional targets. These results suggest that Yap activity is dependent on ROCK activity and provides new mechanistic insights into the regulation of radiation-induced hyposalivation.	[Wong, Wen Yu; Limesand, Kirsten H.] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Gilman, Kristy; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA.; Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@arizona.edu		Limesand, Kirsten/0000-0003-4295-4665; Gilman, Kristy/0000-0002-8204-2399	National Institutes of Health [DE023534, DE029166]; Cancer Biology Training Grant [T32CA009213-38]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Training Grant	This work was supported in part by the National Institutes of Health (nih.gov) DE023534 and DE029166 to Kirsten Limesand and stipend support for Wen Yu Wong was provided by the Cancer Biology Training Grant, T32CA009213-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2019, BRIT J OPHTHALMOL, V103, P922, DOI 10.1136/bjophthalmol-2018-312244; [Anonymous], 2014, CANC DISCOV, V4, pOF1; Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Baker OJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/278948; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Boopathy GTK, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00049; Buglione M, 2016, CRIT REV ONCOL HEMAT, V97, P131, DOI 10.1016/j.critrevonc.2015.08.010; Chibly AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24678-4; Chibly AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107893; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Dobrokhotov O, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0202-9; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fujita M, 2015, SEMIN CANCER BIOL, V35, P45, DOI 10.1016/j.semcancer.2015.09.003; Gilman KE, 2019, AM J PHYSIOL-REG I, V316, pR687, DOI 10.1152/ajpregu.00192.2018; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Hwang SM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.77; Jensen Siri Beier, 2019, Journal of the National Cancer Institute Monographs, P95, DOI 10.1093/jncimonographs/lgz016; Kim KH, 2018, J CELL COMMUN SIGNAL, V12, P273, DOI 10.1007/s12079-018-0450-x; Kinoshita S, 2018, NEW ENGL J MED, V378, P995, DOI 10.1056/NEJMoa1712770; Krupska I, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0046-y; Kumar S, 2018, P NATL ACAD SCI USA, V115, pE9832, DOI 10.1073/pnas.1807522115; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Limesand KH, 2003, IN VITRO CELL DEV-AN, V39, P170; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Liu HR, 2018, ONCOL REP, V40, P16, DOI 10.3892/or.2018.6423; Liu XB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2526; Liu Z, 2016, CELL REP, V16, P1810, DOI 10.1016/j.celrep.2016.07.020; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mitin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041876; Morgan-Bathke M, 2015, J DENT RES, V94, P1035, DOI 10.1177/0022034515590796; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Rades D, 2004, RADIOTHER ONCOL, V70, P261, DOI 10.1016/j.radonc.2003.10.005; Schroeder MC, 2012, SEMIN CELL DEV BIOL, V23, P803, DOI 10.1016/j.semcdb.2012.06.001; Sonnylal S, 2013, J CELL SCI, V126, P2164, DOI 10.1242/jcs.111302; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang XS, 2016, J RADIAT RES, V57, pI69, DOI 10.1093/jrr/rrw047; Wang YM, 2018, CELL REP, V25, P1304, DOI 10.1016/j.celrep.2018.10.001; Wong WY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219572; Wong WY, 2018, AM J PHYSIOL-REG I, V315, pR656, DOI 10.1152/ajpregu.00388.2017; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zanconato F, 2016, CURR OPIN PHARMACOL, V29, P26, DOI 10.1016/j.coph.2016.05.002; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0232921	10.1371/journal.pone.0232921	http://dx.doi.org/10.1371/journal.pone.0232921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151927	Green Published, gold			2022-12-26	WOS:000591376200051
J	Menezes, RC; Ferreira, IBB; Carmo, TA; Telles, GP; Pugas, PLD; Otero, ML; Arriaga, MB; Fukutani, KF; Neto, LP; Agareno, S; Filgueiras, NM; Akrami, KM; Andrade, BB				Menezes, Rodrigo C.; Ferreira, Isabella B. B.; Carmo, Thomas A.; Telles, Gabriel P.; Pugas, Paula L. D.; Otero, Matheus L.; Arriaga, Maria B.; Fukutani, Kiyoshi F.; Neto, Licurgo P.; Agareno, Sydney; Filgueiras Filho, Nivaldo M.; Akrami, Kevan M.; Andrade, Bruno B.			Are prognostic tools losing accuracy? Development and performance of a novel age-calibrated severity scoring system for critically ill patients	PLOS ONE			English	Article							PREDICTIVE MODELS; ELDERLY-PATIENTS; MORTALITY; VALIDATION	Objective This study aimed to assess the performance of a commonly used ICU severity score (SAPS3) and determine whether an alternative scoring system may be more accurate across all age strata. Methods Retrospective cohort study in a general ICU in Brazil. A secondary analysis was performed with clinical and epidemiological data, present in the first 24 hours of unit admission. Then, a binary logistic regression, followed by cross-validation, was made to develop a novel prognostic tool. ICU mortality was the primary outcome evaluated. Results A total of 3042 patients were included over the study period between August 2015 and July 2018 with a median age of 67 +/- 18.4 years. SAPS3 performed fairly in prediction of ICU mortality, particularly in the 80 years or older subset. Multivariable regression identified variables independently associated with mortality that were used to develop the Age Calibrated ICU Score (ACIS) tool that performed similarly to SAPS3 across age categories, being slightly superior in the very elderly population (AUC 0.80 vs 0.72). Conclusions The ACIS offers a robust and simple tool to predict ICU mortality, particularly in an increasingly elderly critical care population.	[Menezes, Rodrigo C.; Filgueiras Filho, Nivaldo M.] Hosp Cidade, Nucleo Pesquisa Ensino & Comunicacao, Salvador, BA, Brazil; [Menezes, Rodrigo C.; Ferreira, Isabella B. B.; Carmo, Thomas A.; Arriaga, Maria B.; Fukutani, Kiyoshi F.; Andrade, Bruno B.] Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Menezes, Rodrigo C.; Arriaga, Maria B.; Fukutani, Kiyoshi F.; Akrami, Kevan M.; Andrade, Bruno B.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil; [Menezes, Rodrigo C.; Otero, Matheus L.; Arriaga, Maria B.; Akrami, Kevan M.; Andrade, Bruno B.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil; [Ferreira, Isabella B. B.; Filgueiras Filho, Nivaldo M.] Univ Estado Bahia UNEB, Salvador, BA, Brazil; [Carmo, Thomas A.; Filgueiras Filho, Nivaldo M.; Andrade, Bruno B.] Univ Salvador UNIFACS, Salvador, BA, Brazil; [Telles, Gabriel P.; Pugas, Paula L. D.; Andrade, Bruno B.] Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil; [Neto, Licurgo P.; Agareno, Sydney] Hosp Cidade, Intens Care Unit, Salvador, BA, Brazil; [Akrami, Kevan M.] Univ Calif San Diego, Dept Med, Div Infect Dis & Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade do Estado Bahia; Universidade Salvador (UNIFACS); Escola Bahiana de Medicina e Saude Publica; University of California System; University of California San Diego	Andrade, BB (corresponding author), Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Salvador UNIFACS, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil.	bruno.andrade@fiocruz.br		Arriaga Gutierrez, Maria Belen/0000-0001-6883-8422	Fundacao Oswaldo Cruz, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado da Bahia	Fundacao Oswaldo Cruz, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia	1. Funder: Fundacao Oswaldo Cruz, Brazil a. Award number: Intramural Research Program b. Recipient: Bruno B. Andrade 2. Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil a. Award number: senior fellowship b. Recipient: Bruno B. Andrade 3. Funder: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil a. Award number: fellowship (finance code 001) b. Recipient: Kiyoshi F. Fukutani 4. Funder: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior a. Award number: PhD fellowship b. Recipient: Rodrigo C. Menezes 5. Funder: Fundacao de Amparo a Pesquisa do Estado da Bahia a. Award number: PhD fellowship b. Recipient: Maria B. Arriaga Funding statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Hurtado LA, 2016, INDIAN J CRIT CARE M, V20, P695, DOI 10.4103/0972-5229.195702; [Anonymous], 2015, Crit Care, V19 Suppl 1, pP1; [Anonymous], 2017, NEW ENGL J MED, V376, P2223, DOI [10.1056/NEJMoa1701380, DOI 10.1056/NEJMoa1701380]; Boumendil A, 2007, INTENS CARE MED, V33, P1252, DOI 10.1007/s00134-007-0621-3; Farhat JS, 2012, J TRAUMA ACUTE CARE, V72, P1526, DOI 10.1097/TA.0b013e3182542fab; Flaatten H, 2017, INTENS CARE MED, V43, P1319, DOI 10.1007/s00134-017-4718-z; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; McDermid RC, 2011, CRIT CARE, V15, DOI 10.1186/cc10018; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Minne L, 2011, J AM GERIATR SOC, V59, P1110, DOI 10.1111/j.1532-5415.2011.03411.x; Muessig JM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007776; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Rochwerg B, 2018, CRIT CARE MED, V46, P1411, DOI 10.1097/CCM.0000000000003262; United Nations, 2019, WORLD POP PROSP 2019, VII, P1238	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240793	10.1371/journal.pone.0240793	http://dx.doi.org/10.1371/journal.pone.0240793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147243	Green Published, gold			2022-12-26	WOS:000589609300012
J	Moyo, S; Hunt, G; Zuma, K; Zungu, M; Marinda, E; Mabaso, M; Kana, V; Kalimashe, M; Ledwaba, J; Naidoo, I; Takatshana, S; Matjokotja, T; Dietrich, C; Raizes, E; Diallo, K; Kindra, G; Mugore, L; Rehle, T				Moyo, Sizulu; Hunt, Gillian; Zuma, Khangelani; Zungu, Mpumi; Marinda, Edmore; Mabaso, Musawenkosi; Kana, Vibha; Kalimashe, Monalisa; Ledwaba, Johanna; Naidoo, Inbarani; Takatshana, Sinovuyo; Matjokotja, Tebogo; Dietrich, Cheryl; Raizes, Elliot; Diallo, Karidia; Kindra, Gurpreet; Mugore, Linnetie; Rehle, Thomas			HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; NAIVE INDIVIDUALS; MORTALITY; PROVINCE; OUTCOMES; FAILURE; ROLLOUT	Background HIV drug resistance (HIVDR) testing was included in the 2017 South African national HIV household survey. We describe the prevalence of HIVDR by drug class, age, sex and antiretroviral drugs (ARV) status. Methods Dried blood were spots tested for HIV, with Viral load (VL), exposure to ARVs and HIVDR testing among those HIV positive. HIVDR testing was conducted on samples with VL >= 1000 copies/ml using Next Generation Sequencing. Weighted percentages of HIVDR are reported. Results 697/1,105 (63%) of HIV positive samples were sequenced. HIVDR was detected in samples from 200 respondents (27.4% (95% confidence interval (CI) 22.8-32.6)). Among these 130 (18.9% (95% CI 14.8-23.8)), had resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) only, 63 (7.8% (95% CI 5.6-10.9)) resistance to NNRTIs and nucleoside reverse transcriptase inhibitors, and 3 (0.5% (95% CI 0.1-2.1)) resistance to protease inhibitors. Sixty-five (55.7% (95% CI 42.6-67.9) of ARV-positive samples had HIVDR compared to 112 (22.8% (95% CI 17.7-28.7)), in ARV-negative samples. HIVDR was found in 75.6% (95% CI 59.2-87.3), n = 27, samples from respondents who reported ARV use but tested ARV-negative, and in 15.3% (95% CI 6.3-32.8), n = 7, respondents who reported no ARV use and tested ARV-negative. There were no significant age and sex differences in HIVDR. Conclusion 27% of virally unsuppressed respondents had HIVDR, increasing to 75% among those who had discontinued ARV. Our findings support strengthening first-line ARV regimens by including drugs with a higher resistance barrier and treatment adherence strategies, and close monitoring of HIVDR.	[Moyo, Sizulu; Zuma, Khangelani; Zungu, Mpumi; Marinda, Edmore; Mabaso, Musawenkosi; Naidoo, Inbarani; Takatshana, Sinovuyo; Matjokotja, Tebogo] Human Sci Res Council, Pretoria, South Africa; [Moyo, Sizulu; Rehle, Thomas] Univ Cape Town, Sch Publ Hlth, Cape Town, South Africa; [Hunt, Gillian; Kana, Vibha; Kalimashe, Monalisa; Ledwaba, Johanna] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Marinda, Edmore] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Dietrich, Cheryl; Diallo, Karidia; Kindra, Gurpreet; Mugore, Linnetie] Ctr Dis Control, Div Global HIV & TB, Pretoria, South Africa; [Raizes, Elliot] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA	Human Sciences Research Council-South Africa; University of Cape Town; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA	Moyo, S (corresponding author), Human Sci Res Council, Pretoria, South Africa.; Moyo, S (corresponding author), Univ Cape Town, Sch Publ Hlth, Cape Town, South Africa.	smoyo@hsrc.ac.za		Zuma, Khangelani/0000-0003-4492-5083; Naidoo, Inbarani/0000-0001-7590-0618; Moyo, Sizulu/0000-0002-5296-3242	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [NU2GGH001629]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project has been supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC), under the terms of Cooperative Agreement Number NU2GGH001629.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; [Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Carmona Maya SI, BETTER MONITORING HI; Chimukangara B, 2019, AIDS RES HUM RETROV, V35, P129, DOI [10.1089/AID.2018.0202, 10.1089/aid.2018.0202]; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Hunt GM, 2019, ANTIVIR THER, V24, P203, DOI 10.3851/IMP3294; Hunt GM, 2017, J ANTIMICROB CHEMOTH, V72, P3141, DOI 10.1093/jac/dkx252; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Mbugbaw L, 2017, SYSTEMATIC REV META; Meintjes G, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.776; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Parry CM, 2014, J CLIN MICROBIOL, V52, P2868, DOI 10.1128/JCM.00544-14; Pinoges L, 2015, JAIDS-J ACQ IMM DEF, V68, P527, DOI 10.1097/QAI.0000000000000513; Puren A, 2016, PROSPECTIVE SENTINEL, V25; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Rowley CF, 2016, J ANTIMICROB CHEMOTH, V71, P1361, DOI 10.1093/jac/dkv500; Shisana O., 2005, S AFRICAN NATL HIV P, DOI [10.1080/17290376.2005.9724855, DOI 10.1080/17290376.2005.9724855]; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC SURVE; Shisana O, 2014, S AFRICAN NATL HIV P; Singh A, 2011, JAIDS-J ACQ IMM DEF, V58, P233, DOI 10.1097/QAI.0b013e318228667f; South African National Aids Council (SANAC), 2017, LET OUR ACT COUNT S; Stats SA (Statistics South Africa), 2011, SPAT MET; Steegen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166305; UNAIDS, 2019, 2019 GLOB HIV STAT; UNAIDS, 2014, 90 90 90 AMB TREATM; Walmsley S, 2015, JAIDS-J ACQ IMM DEF, V70, P515, DOI 10.1097/QAI.0000000000000790; Wensing Annemarie M, 2016, Top Antivir Med, V24, P132; World Health Organisation (WHO), 2017, GUID PUBL HLTH RESP; World Health Organisation (WHO), 2017, HIV DRUG RES REP 201; World Health Organization, 2019, HIV DRUG RES REP 201; World Health Organization 2014, 2014, SURV HIV DRUGS RES A; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184; Zungu N., 2018, S AFRICAN NATL HIV P	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241071	10.1371/journal.pone.0241071	http://dx.doi.org/10.1371/journal.pone.0241071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147285	gold, Green Published			2022-12-26	WOS:000589609300069
J	Rossini, C; Rodrigo, F; Davyt, B; Umpierrez, ML; Gonzalez, A; Garrido, PM; Cuniolo, A; Porrini, LP; Eguaras, MJ; Porrini, MP				Rossini, Carmen; Rodrigo, Federico; Davyt, Belen; Laura Umpierrez, Maria; Gonzalez, Andres; Melisa Garrido, Paula; Cuniolo, Antonella; Porrini, Leonardo P.; Javier Eguaras, Martin; Porrini, Martin P.			Sub-lethal effects of the consumption of Eupatorium buniifolium essential oil in honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; CUTICULAR HYDROCARBONS; VARROA-JACOBSONI; BEE; PESTICIDES; DISEASE; MITE; DISCRIMINATION; NEONICOTINOIDS; HYMENOPTERA	When developing new products to be used in honeybee colonies, further than acute toxicity, it is imperative to perform an assessment of risks, including various sublethal effects. The long-term sublethal effects of xenobiotics on honeybees, more specifically of acaricides used in honeybee hives, have been scarcely studied, particularly so in the case of essential oils and their components. In this work, chronic effects of the ingestion of Eupatorium buniifolium (Asteraceae) essential oil were studied on nurse honeybees using laboratory assays. Survival, food consumption, and the effect on the composition of cuticular hydrocarbons (CHC) were assessed. CHC were chosen due to their key role as pheromones involved in honeybee social recognition. While food consumption and survival were not affected by the consumption of the essential oil, CHC amounts and profiles showed dose-dependent changes. All groups of CHC (linear and branched alkanes, alkenes and alkadienes) were altered when honeybees were fed with the highest essential oil dose tested (6000 ppm). The compounds that significantly varied include n-docosane, n-tricosane, n-tetracosane, n-triacontane, n-tritriacontane, 9-tricosene, 7-pentacosene, 9-pentacosene, 9-heptacosene, tritriacontene, pentacosadiene, hentriacontadiene, tritriacontadiene and all methyl alkanes. All of them but pentacosadiene were up-regulated. On the other hand, CHC profiles were similar in healthy and Nosema-infected honeybees when diets included the essential oil at 300 and 3000 ppm. Our results show that the ingestion of an essential oil can impact CHC and that the effect is dose-dependent. Changes in CHC could affect the signaling process mediated by these pheromonal compounds. To our knowledge this is the first report of changes in honeybee cuticular hydrocarbons as a result of essential oil ingestion.	[Rossini, Carmen; Rodrigo, Federico; Davyt, Belen; Laura Umpierrez, Maria; Gonzalez, Andres; Porrini, Martin P.] Univ Republ Uruguay, Fac Quim, Lab Ecol Quim, Montevideo, Uruguay; [Davyt, Belen; Laura Umpierrez, Maria; Melisa Garrido, Paula; Cuniolo, Antonella; Porrini, Leonardo P.; Javier Eguaras, Martin; Porrini, Martin P.] Univ Nacl Mar del Plata, Ctr Invest Abejas Sociales CIAS, Inst Invest Prod Sanidad & Ambiente IIPROSAM, Fac Ciencias Exactas & Nat, Mar Del Plata, Buenos Aires, Argentina	Universidad de la Republica, Uruguay; National University of Mar del Plata	Rossini, C (corresponding author), Univ Republ Uruguay, Fac Quim, Lab Ecol Quim, Montevideo, Uruguay.	crossini@fq.edu.uy		Gonzalez Ritzel, Andres/0000-0003-2527-2400; Rossini, Carmen/0000-0003-1222-5381	Comision Sectorial de Investigacion Cientifica, Universidad de la Republica-Uruguay [2018_2004, 2014_980, 1734]; Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); Agencia Nacional de Investigacion e Innovacion de Uruguay (Programa Regional MERCOSUR educativo, Argentina/Uruguay) [INNOVAGRO FSA_1_2013_12956, MRC_C_2011_1_7]; Agencia Nacional de Promocio'n Cienti'fica y Tecnologica (ANPCyT, Argentina); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) [PICT-2014-0394]	Comision Sectorial de Investigacion Cientifica, Universidad de la Republica-Uruguay; Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay); Agencia Nacional de Investigacion e Innovacion de Uruguay (Programa Regional MERCOSUR educativo, Argentina/Uruguay); Agencia Nacional de Promocio'n Cienti'fica y Tecnologica (ANPCyT, Argentina)(ANPCyT); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT)	The authors would like to acknowledge financial support from the Comision Sectorial de Investigacion Cientifica, Universidad de la Republica-Uruguay (Programa Grupos, https://www.csic.edu.uy/, Grants 2018_2004 and 2014_980, Grupo 1734), Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, Uruguay, http://www.pedeciba.edu.uy/indice.php; financial aid to CR), Agencia Nacional de Investigacion e Innovacion de Uruguay (Grant INNOVAGRO FSA_1_2013_12956 and Grant MRC_C_2011_1_7 from Programa Regional MERCOSUR educativo, Argentina/Uruguay; https://www.anii.org.uy/inicio/), and Agencia Nacional de Promocio ' n Cienti ' fica y Tecnologica (ANPCyT, Argentina; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT, Grant PICT-2014-0394; https://www.argentina.gob.ar/ciencia/agencia/fondo-para-la-investigacion-cientifica-y-tecnologica-foncyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Alayrangues J, 2016, ECOTOXICOLOGY, V25, P856, DOI 10.1007/s10646-016-1642-x; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alkassab AT, 2017, J PLANT DIS PROTECT, V124, P1, DOI 10.1007/s41348-016-0041-0; Annoscia D, 2012, J INSECT PHYSIOL, V58, P1548, DOI 10.1016/j.jinsphys.2012.09.008; [Anonymous], 2011, PHEROBASE DATABASE P; Bagneres AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P75, DOI 10.1017/CBO9780511711909.006; Balbuena MS, 2019, SOCIOBIOLOGY, V66, P97, DOI 10.13102/sociobiology.v66i1.2977; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bonnafe E, 2015, ENVIRON SCI POLLUT R, V22, P8022, DOI 10.1007/s11356-014-2616-2; Bravo J, 2017, J INVERTEBR PATHOL, V149, P141, DOI 10.1016/j.jip.2017.08.012; Cantwell G, 1970, AM BEE J; Castillo C, 2012, INSECT BIOCHEM MOLEC, V42, P404, DOI 10.1016/j.ibmb.2012.02.002; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dussaubat C, 2010, J CHEM ECOL, V36, P522, DOI 10.1007/s10886-010-9786-2; Ebert TA, 2007, J APICULT RES, V46, P220, DOI 10.1080/00218839.2007.11101398; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Falcon T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213796; FRANCIS BR, 1989, ANN ENTOMOL SOC AM, V82, P486, DOI 10.1093/aesa/82.4.486; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Fries I, 1988, CONTRIBUTION STUDY N; Gajger IT, 2013, ARCH BIOL SCI, V65, P1585, DOI 10.2298/ABS1304585G; Gashout HA, 2020, J INSECT PHYSIOL, V121, DOI 10.1016/j.jinsphys.2020.104014; Glavan G, 2020, PESTIC BIOCHEM PHYS, V166, DOI 10.1016/j.pestbp.2020.104567; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Greene M, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P244, DOI 10.1017/CBO9780511711909.013; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520; Isman MB, 2020, ANNU REV ENTOMOL, V65, P233, DOI 10.1146/annurev-ento-011019-025010; KULINCEVIC JM, 1969, J INVERTEBR PATHOL, V14, P13, DOI 10.1016/0022-2011(69)90004-4; Umpierrez ML, 2013, PARASITOL RES, V112, P3389, DOI 10.1007/s00436-013-3517-x; Li WF, 2018, INT J PARASITOL, V48, P433, DOI 10.1016/j.ijpara.2017.11.004; Linstrom P.J., 2019, NIST STANDARD REFERE; Lowry R, VASSARSTATS WEB SITE; Maistrello L, 2008, APIDOLOGIE, V39, P436, DOI 10.1051/apido:2008022; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Garrido PM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0335-z; Gonalons CM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.176644; Murray ZL, 2016, AUSTRAL ENTOMOL, V55, P147, DOI 10.1111/aen.12165; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; Naccarato A., 2019, Journal of Entomological and Acarological Research, V51, P16, DOI 10.4081/jear.2019.7874; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oliver CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133733; Porrini MP, 2017, J APICULT RES, V56, P616, DOI 10.1080/00218839.2017.1348714; Porrini MP, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.5.04; Porrini MP, 2011, APIDOLOGIE, V42, P700, DOI 10.1007/s13592-011-0076-y; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Salvy M, 2001, PARASITOLOGY, V122, P145, DOI 10.1017/S0031182001007181; Santos ACC, 2018, ECOTOX ENVIRON SAFE, V163, P28, DOI 10.1016/j.ecoenv.2018.07.048; Schal C, 1998, AM ZOOL, V38, P382; Scholl J, 2011, BEHAV ECOL SOCIOBIOL, V65, P1967, DOI 10.1007/s00265-011-1206-2; Balbuena MS, 2015, J EXP BIOL, V218, P2799, DOI 10.1242/jeb.117291; Sumner LW, 2014, METABOLOMICS, V10, P1047, DOI 10.1007/s11306-014-0739-6; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Thompson HM, 2007, PEST MANAG SCI, V63, P1058, DOI 10.1002/ps.1458; Tihelka E, 2018, SLOV VET RES, V55, P119, DOI [10.26873/svr-422-2017, 10.26873/SVR-422-2017]; Umpierrez ML, 2017, IND CROP PROD, V109, P686, DOI 10.1016/j.indcrop.2017.09.025; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vazquez DE, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114148; Vernier CL, 2019, ELIFE, V8, DOI 10.7554/eLife.41855; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931	70	3	3	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241666	10.1371/journal.pone.0241666	http://dx.doi.org/10.1371/journal.pone.0241666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147299	gold, Green Published			2022-12-26	WOS:000589609300048
J	Yarandi, SS; Robinson, JA; Vakili, S; Donadoni, M; Burdo, TH; Sariyer, IK				Yarandi, Shadan S.; Robinson, Jake A.; Vakili, Sarah; Donadoni, Martina; Burdo, Tricia H.; Sariyer, Ilker K.			Characterization of Nef expression in different brain regions of SIV-infected macaques	PLOS ONE			English	Article							TYPE-1 NEF; HIV NEF; DENDRITIC CELLS; IN-VITRO; T-CELLS; VIRUS; PROTEIN; EXOSOMES; PLASMA; IMMUNOGLOBULIN	Objective HIV-associated CNS dysfunction is a significant problem among people with HIV (PWH), who now live longer due to viral suppression from combined anti-retroviral therapy (ART). Over the course of infection, HIV generates toxic viral proteins and induces inflammatory cytokines that have toxic effects on neurons in the CNS. Among these viral proteins, HIV Nef has been found in neurons of postmortem brain specimens from PWH. However, the source of Nef and its impact on neuronal cell homeostasis are still elusive. Methods and results Here, in using a simian immunodeficiency virus (SIV) infected rhesus macaque model of neuroHIV, we find SIV Nef reactivity in the frontal cortex, hippocampus and cerebellum of SIV-infected animals using immunohistochemistry (IHC). Interestingly, SIV-infected macaques treated with ART also showed frequent Nef positive cells in the cerebellum and hippocampus. Using dual quantitative RNAscope and IHC, we observed cells that were positive for Nef, but were not for SIV RNA, suggesting that Nef protein is present in cells that are not actively infected with SIV. Using cell specific markers, we observed Nef protein in microglia/macrophages and astrocytes. Importantly, we also identified a number of NeuN-positive neurons, which are not permissive to SIV infection, but contained Nef protein. Further characterization of Nef-positive neurons showed caspase 3 activation, indicating late stage apoptosis in the CNS neurons. Conclusions Our results suggest that regardless of ART status, Nef is expressed in the brain of SIV infected macaques and may contribute to neurological complications seen in PWH.	[Yarandi, Shadan S.; Robinson, Jake A.; Vakili, Sarah; Donadoni, Martina; Burdo, Tricia H.; Sariyer, Ilker K.] Temple Univ, Ctr Neurovirol, Dept Neurosci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Burdo, TH; Sariyer, IK (corresponding author), Temple Univ, Ctr Neurovirol, Dept Neurosci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	burdot@temple.edu; isariyer@temple.edu	Donadoni, Martina/GNH-3627-2022		NIH; Comprehensive NeuroAIDS Center (CNAC NIMH) [P30MH092177]; Interdisciplinary and Translational Research Training in NeuroAIDS [T32MH079785]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive NeuroAIDS Center (CNAC NIMH); Interdisciplinary and Translational Research Training in NeuroAIDS	This work was supported, in part, by grants awarded by the NIH to IKS and THB. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH Grant Number P30MH092177). SSY and JAR are supported by Interdisciplinary and Translational Research Training in NeuroAIDS (T32MH079785).	AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alirezaei M, 2007, J NEUROSCI, V27, P11047, DOI 10.1523/JNEUROSCI.2733-07.2007; [Anonymous], 2018, CANCER DISCOV, V8, pOF6; [Anonymous], 2005, PANDORA REV ETUDES H, V8, P119; [Anonymous], 2011, CHIAN FORUM, V17, P3; BANDRES JC, 1994, J VIROL, V68, P3243, DOI 10.1128/JVI.68.5.3243-3249.1994; Bergonzini V, 2009, J NEUROVIROL, V15, P238, DOI 10.1080/13550280902939748; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Chistiakov DA, 2017, ACTA NEUROL BELG, V117, P43, DOI 10.1007/s13760-016-0679-1; Chompre G, 2013, NEUROBIOL DIS, V49, P128, DOI 10.1016/j.nbd.2012.08.007; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dominkus PP, 2017, J NEUROVIROL, V23, P713, DOI 10.1007/s13365-017-0552-x; Dupont M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00043; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; Fiala Milan, 2008, Open Virol J, V2, P24, DOI 10.2174/1874357900802010024; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hashimoto M, 2016, J IMMUNOL, V196, P1832, DOI 10.4049/jimmunol.1500845; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hoshino S, 2007, AIDS RES HUM RETROV, V23, P391, DOI 10.1089/aid.2006.0124; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; HUDSON L, 1976, J EXP MED, V143, P444, DOI 10.1084/jem.143.2.444; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Junior MAS, 2008, REV MED MINAS GER S1, V18, pS161; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kearns A, 2017, J AM COLL CARDIOL, V69, P3084, DOI 10.1016/j.jacc.2017.05.012; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Louboutin JP, 2012, NEUROSCIENCE, V214, P68, DOI 10.1016/j.neuroscience.2012.03.061; Maragos WF, 2003, NEUROSCIENCE, V117, P43, DOI 10.1016/S0306-4522(02)00713-3; McNamara RP, 2018, MBIO, V9, DOI 10.1128/mBio.02344-17; Mocchetti I, 2012, NEUROTOX RES, V21, P79, DOI 10.1007/s12640-011-9279-2; Mordelet E, 2004, FASEB J, V18, P1851, DOI 10.1096/fj.04-2308com; Mukhamedova N, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007907; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nowlin BT, 2015, AM J PATHOL, V185, P1649, DOI 10.1016/j.ajpath.2015.01.033; Park IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099545; Pleet ML, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00362; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Raymond AD, 2016, J NEUROVIROL, V22, P129, DOI 10.1007/s13365-015-0397-0; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sariyer IK, 2019, MOL THER, V27, P2067, DOI 10.1016/j.ymthe.2019.10.006; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Sengupta S, 2018, IMMUNITY, V48, P872, DOI 10.1016/j.immuni.2018.04.030; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson KA, 2003, J NEUROVIROL, V9, P442, DOI 10.1080/13550280390218715; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; Uhl J, 2019, J CELL COMMUN SIGNAL, V13, P209, DOI 10.1007/s12079-018-0493-z; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Vella LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020173; Wang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091063; WEISSMAN D, 1995, J IMMUNOL, V155, P4111; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753	71	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241667	10.1371/journal.pone.0241667	http://dx.doi.org/10.1371/journal.pone.0241667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137166	gold, Green Published			2022-12-26	WOS:000588375500027
J	Villefort, RF; Tribst, JPM; Dal Piva, AMD; Borges, AL; Binda, NC; Ferreira, CED; Bottino, MA; von Zeidler, SLV				Villefort, Regina Furbino; Mendes Tribst, Joao Paulo; de Oliveira Dal Piva, Amanda Maria; Borges, Alexandre Luiz; Binda, Nivia Castro; de Almeida Ferreira, Carlos Eduardo; Bottino, Marco Antonio; Ventorim von Zeidler, Sandra Lucia			Stress distribution on different bar materials in implant-retained palatal obturator	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; PROSTHETIC REHABILITATION; DENTAL IMPLANTS; RETENTION FORCE; PEEK; POLYETHERETHERKETONE; MAXILLECTOMY; RECONSTRUCTION; OVERDENTURES; ATTACHMENTS	Implant-retained custom-milled framework enhances the stability of palatal obturator prostheses. Therefore, to evaluate the mechanical response of implant-retained obturator prostheses with bar-clip attachment and milled bars, in three different materials under two load incidences were simulated. A maxilla model which Type IIb maxillary defect received five external hexagon implants (4.1 x 10 mm). An implant-supported palatal obturator prosthesis was simulated in three different materials: polyetheretherketone (PEEK), titanium (Ti:90%, Al:6%, V:4%) and Co-Cr (Co:60.6%, Cr:31.5%, Mo:6%) alloys. The model was imported into the analysis software and divided into a mesh composed of nodes and tetrahedral elements. Each material was assumed isotropic, elastic and homogeneous and all contacts were considered ideal. The bone was fixed and the load was applied in two different regions for each material: at the palatal face (cingulum area) of the central incisors (100 N magnitude at 45 degrees); and at the occlusal surface of the first left molar (150 N magnitude normal to the surface). The microstrain and von-Mises stress were selected as criteria for analysis. The posterior load showed a higher strain concentration in the posterior peri-implant tissue, near the load application side for cortical and cancellous bone, regardless the simulated material. The anterior load showed a lower strain concentration with reduced magnitude and more implants involving in the load dissipation. The stress peak was calculated during posterior loading, which 77.7 MPa in the prosthetic screws and 2,686 mu epsilon microstrain in the cortical bone. For bone tissue and bar, the material stiffness was inversely proportional to the calculated microstrain and stress. However, for the prosthetic screws and implants the PEEK showed higher stress concentration than the other materials. PEEK showed a promising behavior for the bone tissue and for the integrity of the bar and bar-clip attachments. However, the stress concentration in the prosthetic screws may represent an increase in failure risk. The use of Co-Cr alloy can reduce the stress in the prosthetic screw; however, it increases the bone strain; while the Titanium showed an intermediate behavior.	[Villefort, Regina Furbino; Binda, Nivia Castro; Ventorim von Zeidler, Sandra Lucia] Univ Fed Espirito Santo, Rede Nordeste Biotecnol RENORBIO, Biotechnol Program, Vitoria, ES, Brazil; [Mendes Tribst, Joao Paulo; de Oliveira Dal Piva, Amanda Maria; Borges, Alexandre Luiz; Bottino, Marco Antonio] Sao Paulo State Univ Unesp SJC, Inst Sci & Technol, Dept Dent Mat & Prosthodont, Postgrad Program Restorat Dent Prosthodont, Sao Jose Dos Campos, SP, Brazil	Universidade Federal do Espirito Santo; Universidade Estadual Paulista	Tribst, JPM (corresponding author), Sao Paulo State Univ Unesp SJC, Inst Sci & Technol, Dept Dent Mat & Prosthodont, Postgrad Program Restorat Dent Prosthodont, Sao Jose Dos Campos, SP, Brazil.	Joao.tribst@gmail.com	Tribst, João Paulo Mendes/AAS-6684-2020; Borges, Alexandre LS/A-9477-2014; Binda, Nívia Castro/AAZ-5330-2021; de Oliveira Dal Piva, Amanda Maria/R-6959-2019	Tribst, João Paulo Mendes/0000-0002-5412-3546; Borges, Alexandre LS/0000-0002-5707-7565; de Oliveira Dal Piva, Amanda Maria/0000-0002-3844-2053; Bottino, Marco Antonio/0000-0003-0077-3161; Castro Binda, Nivia/0000-0002-0409-4265	FAPES/CAPES [10/2018 -PROFIX 2018, 83574662]	FAPES/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	h This research was supported by FAPES/CAPES Grant: FAPES/CAPES N degrees 10/2018 -PROFIX 2018 Process number: 83574662 Funding granted to: Regina Furbino Villefort The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akay C, 2015, MED SCI MONITOR, V21, P604, DOI 10.12659/MSM.892680; Alonso-Rodriguez E, 2015, J CRANIO MAXILL SURG, V43, P1232, DOI 10.1016/j.jcms.2015.04.028; Alvarez-Arenal A, 2017, J ADV PROSTHODONT, V9, P371, DOI 10.4047/jap.2017.9.5.371; Andrikopoulou E, 2016, J ESTHET RESTOR DENT, V28, P201, DOI 10.1111/jerd.12221; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Artopoulou II, 2017, J PROSTHET DENT, V118, P783, DOI 10.1016/j.prosdent.2017.01.021; Bayer S, 2012, CLIN ORAL IMPLAN RES, V23, P1377, DOI 10.1111/j.1600-0501.2011.02312.x; Bhering CLB, 2016, MAT SCI ENG C-MATER, V69, P715, DOI 10.1016/j.msec.2016.07.059; Brown JS, 2010, LANCET ONCOL, V11, P1001, DOI 10.1016/S1470-2045(10)70113-3; Butnaru-Moldoveanu SA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10010401; Cakarer S, 2011, MED ORAL PATOL ORAL, V16, pC953, DOI 10.4317/medoral.17312; Cannizzaro G, 2017, EUR J ORAL IMPLANTOL, V10, P279; Chen C, 2016, BRAZ J OTORHINOLAR, V82, P177, DOI 10.1016/j.bjorl.2015.10.006; Costa-Palau S, 2014, J PROSTHET DENT, V112, P680, DOI 10.1016/j.prosdent.2013.10.026; Datte Carlos-Eduardo, 2018, J Clin Exp Dent, V10, pe439, DOI 10.4317/jced.54554; Dal Piva AMD, 2017, J ENDODONT, V43, P791, DOI 10.1016/j.joen.2016.11.020; de Sousa AA, 2014, J PROSTHET DENT, V112, P1578, DOI 10.1016/j.prosdent.2014.06.020; DOMINGUES Juliana Machado, 2016, RGO, Rev. Gaúch. Odontol., V64, P477, DOI 10.1590/1981-8637201600030000183177; Elias CN, 2019, J MATER RES TECHNOL, V8, P1060, DOI 10.1016/j.jmrt.2018.07.016; Erkmen E, 2011, J MECH BEHAV BIOMED, V4, P107, DOI 10.1016/j.jmbbm.2010.09.011; Fanuscu Mete I, 2004, J Prosthodont, V13, P214; Ferreira MB, 2014, MAT SCI ENG C-MATER, V35, P92, DOI 10.1016/j.msec.2013.10.022; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Goiato MC, 2017, J PROSTHET DENT, V117, P685, DOI 10.1016/j.prosdent.2016.07.025; Harder S, 2009, CLIN ORAL IMPLAN RES, V20, P48, DOI 10.1111/j.1600-0501.2009.01778.x; Jemt T, 1993, Int J Oral Maxillofac Implants, V8, P301; Kemmoku DT, 2012, P 5 INT C ADV RES RA, DOI [10.1201/b11341-113, DOI 10.1201/B11341-113]; Kim MJ, 2016, J ADV PROSTHODONT, V8, P85, DOI 10.4047/jap.2016.8.2.85; Kim S, 2018, IEEE INT C INT ROBOT, P7004, DOI 10.1109/IROS.2018.8594389; Malo P, 2018, CLIN IMPLANT DENT R, V20, P692, DOI 10.1111/cid.12662; Tribst JPM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114040; Tribst JPM, 2020, J ADV PROSTHODONT, V12, P67, DOI 10.4047/jap.2020.12.2.67; Mericske-Stern R, 2000, J PROSTHET DENT, V84, P535, DOI 10.1067/mpr.2000.110264; Mertens C, 2016, J CRANIO MAXILL SURG, V44, P1812, DOI 10.1016/j.jcms.2016.08.009; Miyamoto S, 2010, INT J ORAL MAX SURG, V39, P1120, DOI 10.1016/j.ijom.2010.06.011; Miyashita ER, 2012, J PROSTHET DENT, V107, P336, DOI 10.1016/S0022-3913(12)60086-9; Monteiro Jaiane Bandoli, 2018, Iran Endod J, V13, P188, DOI 10.22037/iej.v13i2.19089; Moreno MA, 2010, HEAD NECK-J SCI SPEC, V32, P860, DOI 10.1002/hed.21264; Moroi H H, 1993, Int J Prosthodont, V6, P564; Park JH, 2017, INT J PROSTHODONT, V30, P266, DOI 10.11607/ijp.5213; PEYTON FA, 1963, J PROSTHET DENT, V13, P743, DOI 10.1016/0022-3913(63)90147-1; Poorten VV, 2016, CURR OPIN OTOLARYNGO, V24, P98, DOI 10.1097/MOO.0000000000000241; REES J S, 1990, International Journal of Prosthodontics, V3, P238; Rodrigues Vinicius-Aneas, 2020, J Clin Exp Dent, V12, pe433, DOI 10.4317/jced.56292; Said MM, 2017, J INVESTIG CLIN DENT, V8, DOI 10.1111/jicd.12207; Sakuraba M, 2003, PLAST RECONSTR SURG, V111, P594, DOI 10.1097/01.PRS.0000041941.98504.B6; Shishesaz M, 2016, LAT AM J SOLIDS STRU, V13, P3126, DOI 10.1590/1679-78253212; SIEGELE D, 1989, International Journal of Oral and Maxillofacial Implants, V4, P333; Stock V, 2016, DENT MATER J, V35, P594, DOI 10.4012/dmj.2015-249; Suleiman SH, 2013, ACTA ODONTOL SCAND, V71, P1280, DOI 10.3109/00016357.2012.757650; Svanborg P, 2015, CLIN EXP DENT RES, V1, P49, DOI 10.1002/cre2.9; Tanoue M, 2016, J PROSTHET DENT, V115, P283, DOI 10.1016/j.prosdent.2015.07.017; Tetelman ED, 2008, IMPLANT DENT, V17, P51, DOI 10.1097/ID.0b013e318167648c; Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce; Vafaei F, 2011, J ORAL IMPLANTOL, V37, P421, DOI 10.1563/AAID-JOI-D-10-00057; WEDEL A, 1994, J PROSTHET DENT, V72, P303, DOI 10.1016/0022-3913(94)90344-1; Tretto PHW, 2020, COMPUT METHOD BIOMEC, V23, P372, DOI 10.1080/10255842.2020.1731481; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zoidis P, 2017, J PROSTHET DENT, V117, P335, DOI 10.1016/j.prosdent.2016.08.009; Zoidis P, 2016, J PROSTHODONT, V25, P580, DOI 10.1111/jopr.12325	60	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241589	10.1371/journal.pone.0241589	http://dx.doi.org/10.1371/journal.pone.0241589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125441	gold, Green Published			2022-12-26	WOS:000588368900040
J	Opitz, B; Brady, D; Leonard, HC				Opitz, Bertram; Brady, Daniel; Leonard, Hayley C.			Motor and non-motor sequence prediction is equally affected in children with developmental coordination disorder	PLOS ONE			English	Article							AUTOMATIZATION PROCESS; PROCESSING SPEED; WORKING-MEMORY; DIFFICULTIES; PERFORMANCE; DEFICITS; BRAIN; DCD	Children with Developmental Coordination Disorder (DCD) are diagnosed based on motor difficulties. However, they also exhibit difficulties in several other cognitive domains, including visuospatial processing, executive functioning and attention. One account of the difficulties seen in DCD proposes an impairment in internal forward modelling, i.e., the ability to (i) detect regularities of a repetitive perceptual or motor pattern, (ii) predict future outcomes of motor actions, and (iii) adapt behaviour accordingly. Using electroencephalographic recordings, the present study aimed to delineate these different aspects of internal forward modelling across several domains. To this end, 24 children with DCD and 23 typically-developing children (aged 7-10 years) completed a serial prediction task in the visual, temporal, spatial and motor domains. This task required them to learn short sequences and to indicate whether a sequence was disrupted towards its end. Analyses revealed that, across all domains, children with DCD showed poorer discrimination between intact and disrupted sequences, accompanied by a delayed late parietal positivity elicited by disrupted sequences. These results indicate an impairment in explicit sequence discrimination in DCD across motor and cognitive domains. However, there is no evidence for an impairment in implicit performance on the visuomotor task in DCD. These results suggest an impairment of the updating of an internal forward model in DCD resulting in a blurred representation of that model and, consequently, in a reduced ability to detect regularities in the environment (e.g., sequences). Such a detailed understanding of internal forward modelling in DCD could help to explain the wide range of co-occurring difficulties experienced by those with a diagnosis of DCD.	[Opitz, Bertram; Brady, Daniel; Leonard, Hayley C.] Univ Surrey, Sch Psychol, Guildford, Surrey, England; [Opitz, Bertram] Martin Luther Univ Halle Wittenberg, Ctr Multimedia Teaching & Learning, Halle, Germany; [Brady, Daniel] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Surrey; Martin Luther University Halle Wittenberg; University of Reading	Opitz, B (corresponding author), Univ Surrey, Sch Psychol, Guildford, Surrey, England.; Opitz, B (corresponding author), Martin Luther Univ Halle Wittenberg, Ctr Multimedia Teaching & Learning, Halle, Germany.	b.opitz@surrey.ac.uk		Opitz, Bertram/0000-0001-6553-0473; Brady, Daniel/0000-0003-4671-0676	Waterloo Foundation [404-3165]	Waterloo Foundation	the project was funded by the Waterloo Foundation (www.waterloofoundation.org.uk) to BO and HCL (Grant Number 404-3165). The funder had no influence on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ILJ, 2014, NEUROSCI BIOBEHAV R, V47, P225, DOI 10.1016/j.neubiorev.2014.08.011; Alloway TP, 2009, J LEARN DISABIL-US, V42, P372, DOI 10.1177/0022219409335214; American Psychiatric Association, 2013, DIAGN STAT MAN, P5; Bernardi M, 2016, CHILD NEUROPSYCHOL, V22, P627, DOI 10.1080/09297049.2015.1014898; Biotteau M., 2016, CURR DEV DISORD REP, V3, P152, DOI DOI 10.1007/S40474-016-0084-8; Biotteau M, 2017, EUR J PAEDIATR NEURO, V21, P286, DOI 10.1016/j.ejpn.2016.07.025; Biotteau M, 2015, HUM MOVEMENT SCI, V43, P78, DOI 10.1016/j.humov.2015.07.005; Bubic A, 2010, BRAIN RES, V1317, P192, DOI 10.1016/j.brainres.2009.12.072; Bubic A, 2009, J COGNITIVE NEUROSCI, V21, P155, DOI 10.1162/jocn.2009.21013; Conners CK., 2008, CONNERS 3 EDITION MA, V3rd; Debrabant J, 2013, RES DEV DISABIL, V34, P1478, DOI 10.1016/j.ridd.2013.02.008; Gheysen F, 2011, RES DEV DISABIL, V32, P749, DOI 10.1016/j.ridd.2010.11.005; Girdhar A, 2018, IET IMAGE PROCESS, V12, P1, DOI 10.1049/iet-ipr.2017.0162; Hands B., 2006, EUR J SPEC NEEDS EDU, V21, P447, DOI [DOI 10.1080/08856250600956410, 10.1080/08856250600956410]; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Kirby A, 2013, RES DEV DISABIL, V34, P1357, DOI 10.1016/j.ridd.2013.01.003; LANYI B, 1987, METHOD MICROBIOL, V19, P1; Leggio M, 2015, CEREBELLUM, V14, P35, DOI 10.1007/s12311-014-0616-x; Lejeune C, 2013, RES DEV DISABIL, V34, P1974, DOI 10.1016/j.ridd.2013.03.017; Leonard H. C., 2015, CURR DEV DISORD REP, V2, P141, DOI [10.1007/s40474-015-0044-8, DOI 10.1007/S40474-015-0044-8]; Leonard HC, 2015, DEV NEUROPSYCHOL, V40, P201, DOI 10.1080/87565641.2014.997933; Li YC, 2018, PSYCHOL SPORT EXERC, V37, P244, DOI 10.1016/j.psychsport.2017.11.001; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Mandich A, 2002, BRAIN COGNITION, V50, P150, DOI 10.1016/S0278-2626(02)00020-9; Missiuna C, 2008, DEV MED CHILD NEUROL, V50, P839, DOI 10.1111/j.1469-8749.2008.03140.x; Neuroscience H, 2014, FRONT HUM NEUROSCI, V8, P1; Omer S, 2019, J CHILD PSYCHOL PSYC, V60, P606, DOI 10.1111/jcpp.13001; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Piek JP, 2007, DEV MED CHILD NEUROL, V49, P678, DOI 10.1111/j.1469-8749.2007.00678.x; PLOS Medicine Editors, 2007, PLOS MED, V3, pe380; Rivilis I, 2011, RES DEV DISABIL, V32, P894, DOI 10.1016/j.ridd.2011.01.017; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Schubotz RI, 2004, NEUROPSYCHOLOGY, V18, P638, DOI 10.1037/0894-4105.18.4.638; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schubotz RI, 2015, ANTICIPATION DISCIPL, P81; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Torgensen J, 2011, TEST WORD READING EF; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wilson PH, 2017, DEV MED CHILD NEUROL, V59, P1117, DOI 10.1111/dmcn.13530; Wilson PH, 2013, DEV MED CHILD NEUROL, V55, P217, DOI 10.1111/j.1469-8749.2012.04436.x; Wilson PH, 2003, HUM MOVEMENT SCI, V22, P515, DOI 10.1016/j.humov.2003.09.007; Wilson PH, 2007, DEV COORDINATION DIS, P115; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	46	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0232562	10.1371/journal.pone.0232562	http://dx.doi.org/10.1371/journal.pone.0232562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166291	Green Published, gold, Green Submitted			2022-12-26	WOS:000592382600089
J	Doan, THD; Yen-Nicolay, S; Bernet-Camard, MF; Martin-Verstraete, I; Pechine, S				Tri-Hanh-Dung Doan; Yen-Nicolay, Stephanie; Bernet-Camard, Marie-Francoise; Martin-Verstraete, Isabelle; Pechine, Severine			Impact of subinhibitory concentrations of metronidazole on proteome of Clostridioides difficile strains with different levels of susceptibility	PLOS ONE			English	Article							HELICOBACTER-PYLORI; 5-NITROIMIDAZOLE RESISTANCE; ESCHERICHIA-COLI; SIGMA-FACTOR; INVOLVEMENT; INFECTION; UPDATE; GENES; OXIDOREDUCTASE; FIDAXOMICIN	Clostridioides difficile is responsible for various intestinal symptoms from mild diarrhea to severe pseudomembranous colitis and is the primary cause of antibiotic-associated diarrhea in adults. Metronidazole was the first-line treatment for mild to moderate C. difficile infections for 30 years. However, clinical failure and recurrence rates of metronidazole is superior to oral vancomycin and metronidazole is now recommended only as an alternative to vancomycin or fidaxomicin, for an initial non-severe infection. The mechanisms of treatment failure and infection recurrence remain unclear. Given the poor fecal concentrations of metronidazole, the bacteria may be exposed to subinhibitory concentrations of metronidazole and develop adaptation strategy, which is likely to be the origin of an increase in treatment failures. In this study, a proteomic approach was used to analyze changes in the proteome of two strains with different levels of susceptibility to metronidazole in the presence of subinhibitory concentrations of this antibiotic. The two strains were grown to stationary phase: CD17-146, a clinical C. difficile isolate with reduced susceptibility to metronidazole, and VPI 10463, a metronidazole susceptible strain. Our study revealed that, whatever the strain, subinhibitory concentrations of metronidazole modified the amount of proteins involved in protein biosynthesis, glycolysis, and protection against stress induced by metronidazole, as well as in DNA repair. Several proteins involved in stress response are known to be synthesized under the control of Sigma factor B, which suggests a close link between Sigma factor B and metronidazole. Interestingly, impact of metronidazole on protein production for VPI 10463 strain differed from CD17-146 strain, for which the amount of two proteins involved in biofilm formation of CD17-146 were modified by metronidazole.	[Tri-Hanh-Dung Doan; Bernet-Camard, Marie-Francoise; Pechine, Severine] Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France; [Yen-Nicolay, Stephanie] Univ Paris Saclay, UMS Ingn & Plateformes Serv Innovat Therapeut Pro, Chatenay Malabry, France; [Martin-Verstraete, Isabelle] Univ Paris, Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Martin-Verstraete, Isabelle] Inst Univ France, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Pechine, S (corresponding author), Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France.	severine.pechine@universite-paris-saclay.fr	PÉCHINÉ, SÉVERINE/ABD-1960-2021		Region Ile de France	Region Ile de France(Region Ile-de-France)	We thank Frederic Barbut, Saint Antoine hospital (Paris) for kindly providing us CD17-146 strain. The authors would like to thank Lydie Correia and Anne Aubert-Frambourg from PAPPSO facility for their involvement in proteomic analysis and Cyril Anjou for preliminary test with the sigB mutant. We also thank the Region Ile de France for financial support and co-funding for proteomic instrument.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Barkin JA, 2017, DIGEST DIS SCI, V62, P1035, DOI 10.1007/s10620-017-4462-9; Batah J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03621-z; Belouah I, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.105015; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Choi SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018236; Chong PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082622; CHURCH DL, 1995, ANAEROBE, V1, P81, DOI 10.1006/anae.1995.1002; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Cruz Martin Paspe, 2012, P T, V37, P278; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deshpande A, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00415-20; Dhand A, 2009, INFECT DIS, P223, DOI 10.1007/978-1-59745-180-2_19; Dingsdag SA, 2018, J ANTIMICROB CHEMOTH, V73, P265, DOI 10.1093/jac/dkx351; Diniz CG, 2004, J ANTIMICROB CHEMOTH, V54, P100, DOI 10.1093/jac/dkh256; EDWARDS DI, 1980, BRIT J VENER DIS, V56, P285; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; HAGGOUD A, 1994, ANTIMICROB AGENTS CH, V38, P1047, DOI 10.1128/AAC.38.5.1047; Hoffman PS, 1996, J BACTERIOL, V178, P4822, DOI 10.1128/jb.178.16.4822-4829.1996; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Jorgensen MA, 2001, ARCH BIOCHEM BIOPHYS, V392, P180, DOI 10.1006/abbi.2001.2427; Js C, 1979, ANAL BIOCH, V8, P2020; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Kint N, 2020, MBIO, V11, DOI 10.1128/mBio.01559-20; Kint N, 2017, ENVIRON MICROBIOL, V19, P1933, DOI 10.1111/1462-2920.13696; Kuijper EJ, 2008, CLIN INFECT DIS, V47, P63, DOI 10.1086/588294; Kwon DH, 2000, ANTIMICROB AGENTS CH, V44, P2133, DOI 10.1128/AAC.44.8.2133-2142.2000; Langella O, 2017, J PROTEOME RES, V16, P494, DOI 10.1021/acs.jproteome.6b00632; LEVETT PN, 1991, J ANTIMICROB CHEMOTH, V27, P55, DOI 10.1093/jac/27.1.55; Liao S, 2015, MOL ORAL MICROBIOL, V30, P255, DOI 10.1111/omi.12090; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; LORIAN V, 1975, B NEW YORK ACAD MED, V51, P1046; Louie TJ, 2015, CLIN INFECT DIS, V60, pS91, DOI 10.1093/cid/civ252; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Maass S, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110213; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Morikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P385, DOI 10.1006/bbrc.2001.5774; Moura I, 2014, ANTIMICROB AGENTS CH, V58, P4957, DOI 10.1128/AAC.02350-14; Moura I, 2013, J ANTIMICROB CHEMOTH, V68, P362, DOI 10.1093/jac/dks420; Neumann-Schaal M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00219; Ooijevaar RE, 2018, CLIN MICROBIOL INFEC, V24, P452, DOI 10.1016/j.cmi.2017.12.022; Pantaleon V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124971; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Reysset G, 1996, ANAEROBE, V2, P59, DOI 10.1006/anae.1996.0008; REYSSET G, 1993, CLIN INFECT DIS, V16, pS401, DOI 10.1093/clinids/16.Supplement_4.S401; SAKAI H, 1986, J BIOCHEM-TOKYO, V99, P1157, DOI 10.1093/oxfordjournals.jbchem.a135579; Schapiro JM, 2004, J CLIN MICROBIOL, V42, P4127, DOI 10.1128/JCM.42.9.4127-4129.2004; Shepherd J, 2013, FEBS LETT, V587, P2895, DOI 10.1016/j.febslet.2013.07.036; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; THOMPSON SA, 1995, INFECT IMMUN, V63, P2185, DOI 10.1128/IAI.63.6.2185-2193.1995; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Vuotto C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv114; WEXLER H, 1984, REV INFECT DIS, V6, pS229; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241903	10.1371/journal.pone.0241903	http://dx.doi.org/10.1371/journal.pone.0241903			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166349	Green Published, gold			2022-12-26	WOS:000592382600084
J	Hameed, S; Din, JU; Ali, H; Kabir, M; Younas, M; Rehman, EU; Bari, F; Hao, W; Bischof, R; Nawaz, MA				Hameed, Shoaib; Din, Jaffar Ud; Ali, Hussain; Kabir, Muhammad; Younas, Muhammad; Ur Rehman, Ejaz; Bari, Fathul; Hao, Wang; Bischof, Richard; Nawaz, Muhammad Ali			Identifying priority landscapes for conservation of snow leopards in Pakistan	PLOS ONE			English	Article							SPECIES DISTRIBUTION; CIRCUIT-THEORY; CLIMATE-CHANGE; SAMPLING BIAS; CONNECTIVITY; MAXENT; DISTRIBUTIONS; PREDICTION; CORRIDORS; IMPROVE	Pakistan's total estimated snow leopard habitat is about 80,000 km(2) of which about half is considered prime habitat. However, this preliminary demarcation was not always in close agreement with the actual distribution-the discrepancy may be huge at the local and regional level. Recent technological developments like camera trapping and molecular genetics allow for collecting reliable presence records that could be used to construct realistic species distribution based on empirical data and advanced mathematical approaches like MaxEnt. The current study followed this approach to construct an accurate distribution of the species in Pakistan. Moreover, movement corridors, among different landscapes, were also identified through circuit theory. The probability of habitat suitability, generated from 98 presence points and 11 environmental variables, scored the snow leopard's assumed range in Pakistan, from 0 to 0.97. A large portion of the known range represented low-quality habitat, including areas in lower Chitral, Swat, Astore, and Kashmir. Conversely, Khunjerab, Misgar, Chapursan, Qurumber, Broghil, and Central Karakoram represented high-quality habitats. Variables with higher contributions in the MaxEnt model were precipitation during the driest month (34%), annual mean temperature (19.5%), mean diurnal range of temperature (9.8%), annual precipitation (9.4%), and river density (9.2). The model was validated through receiver operating characteristic (ROC) plots and defined thresholds. The average test AUC in Maxent for the replicate runs was 0.933 while the value of AUC by ROC curve calculated at 0.15 threshold was 1.00. These validation tests suggested a good model fit and strong predictive power. The connectivity analysis revealed that the population in the Hindukush landscape appears to be more connected with the population in Afghanistan as compared to other populations in Pakistan. Similarly, the Pamir-Karakoram population is better connected with China and Tajikistan, while the Himalayan population was connected with the population in India. Based on our findings we propose three model landscapes to be considered under the Global Snow Leopard Ecosystem Protection Program (GSLEP) agenda as regional priority areas, to safeguard the future of the snow leopard in Pakistan and the region. These landscapes fall within mountain ranges of the Himalaya, Hindu Kush and Karakoram-Pamir, respectively. We also identified gaps in the existing protected areas network and suggest new protected areas in Chitral and Gilgit-Baltistan to protect critical habitats of snow leopard in Pakistan.	[Hameed, Shoaib; Ali, Hussain; Kabir, Muhammad; Ur Rehman, Ejaz; Bari, Fathul; Nawaz, Muhammad Ali] Quaid I Azam Univ, Dept Zool, Islamabad, Pakistan; [Din, Jaffar Ud; Younas, Muhammad; Nawaz, Muhammad Ali] Snow Leopard Trust, Pakistan Program, Islamabad, Pakistan; [Din, Jaffar Ud] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Kabir, Muhammad] Univ Haripur, Dept Forestry & Wildlife Management, Haripur, Pakistan; [Hao, Wang] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Bischof, Richard] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Nawaz, Muhammad Ali] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar	Quaid I Azam University; Universiti Malaya; Peking University; Norwegian University of Life Sciences; Qatar University	Nawaz, MA (corresponding author), Quaid I Azam Univ, Dept Zool, Islamabad, Pakistan.; Nawaz, MA (corresponding author), Snow Leopard Trust, Pakistan Program, Islamabad, Pakistan.; Nawaz, MA (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar.	nawazma@gmail.com	Din, Jaffar Ud/D-7748-2017; Nawaz, Muhammad Ali/C-1125-2012; Nawaz, Muhammad Ali/GQY-8578-2022	Nawaz, Muhammad Ali/0000-0001-5632-9014; Nawaz, Muhammad Ali/0000-0001-5632-9014; Bari, Fathul/0000-0002-1502-617X	Norwegian Research Council [204202/F20]; Pakistan Snow Leopard and Ecosystem Protection Program (PSLEP); Snow Leopard Trust; Panthera	Norwegian Research Council(Research Council of NorwayEuropean Commission); Pakistan Snow Leopard and Ecosystem Protection Program (PSLEP); Snow Leopard Trust; Panthera	Financially project was supported by the Norwegian Research Council (Grant 204202/F20), Pakistan Snow Leopard and Ecosystem Protection Program (PSLEP), Snow Leopard Trust, and Panthera.	Alexander JS, 2016, ORYX, V50, P239, DOI 10.1017/S0030605315001040; [Anonymous], 2010, MAPPING SPECIES DIST; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Bai DF, 2018, ZOOL RES, V39, P373, DOI 10.24272/j.issn.2095-8137.2018.057; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Beier P, 2006, CONNECTIVITY CONSERV, P555, DOI DOI 10.1046/J.1523-1739.2003.01458.X; Bentlage B, 2013, GLOBAL ECOL BIOGEOGR, V22, P952, DOI 10.1111/geb.12049; Bhatnagar Y.V., 2001, REGIONAL PERSPECTIVE; Bischof R, 2014, METHODS ECOL EVOL, V5, P44, DOI 10.1111/2041-210X.12115; BOOTH GD, 1994, USDA FOR SERV INT R, P1; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Downes SJ, 1997, CONSERV BIOL, V11, P718, DOI 10.1046/j.1523-1739.1997.96094.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fagan W. F., 2006, CONNECT CONSERV, DOI 10.1017/CBO9780511754821.014; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fox J, 1994, P 7 INT SNOW LEOP S, P3; Fox JL, 1989, PANTHERA UNCIA, V40; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hussain S, 2003, ORYX, V37, P26, DOI 10.1017/S0030605303000085; Jackson P., 1996, BIOL CONSERVATION; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson R. M., 1996, THESIS U LONDON, P233; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Karanth KU, 1998, ECOLOGY, V79, P2852; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kareiva P, 2006, CONSERV BIOL SER, V14, P293; Khan BU., 2019, EFFECT STUDY DESIGN; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Kriticos D. J., 2001, Weed risk assessment, P61; Kumar S, 2014, COMPUT ELECTRON AGR, V103, P55, DOI 10.1016/j.compag.2014.02.007; Maheshwari A., 2013, J ECOL NAT ENV, V5, P303, DOI DOI 10.5897/JENE2013.0382; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy T., 2017, PANTHERA UNCIA IUCN; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Nawaz MA, 2020, EMPIRICAL DEMONSTRAT; Network SL, 2014, SNOW LEOPARD SURVIVA, P1; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Reddy M. T., 2015, Journal of Agricultural Sciences (Sri Lanka), V10, P87, DOI 10.4038/jas.v10i2.8054; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Roberts TJd'Olanda, 1977, B PRINCIPE MAMMALS P; Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Saura S, 2011, ECOL INDIC, V11, P407, DOI 10.1016/j.ecolind.2010.06.011; Schaller GB, 1976, MOUNTAIN MAMMALS PAK, DOI [10.1017/S0030605300014071, DOI 10.1017/S0030605300014071]; Shah V.B.., 2008, PROC 7 PYTHON SCI C, V7, P62; Shehzad W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032104; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Sun W., 2010, CHIN AGR SCI B, V26, P233; Suryawanshi KR, 2019, POPUL ECOL, V61, P268, DOI 10.1002/1438-390X.1027; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Transferability sample selection bias and background data in presence-only modelling: a response to Peterson, 2008, ECOGRAPHY COP, V0, DOI 10.1111/j.2007.0906-7590.05378.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105086; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zakharenka A, 2016, BIODIVER WORL CONS, P559, DOI 10.1016/B978-0-12-802213-9.00045-6	77	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0228832	10.1371/journal.pone.0228832	http://dx.doi.org/10.1371/journal.pone.0228832			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151925	Green Published, Green Submitted, gold			2022-12-26	WOS:000591376200047
J	Li, QQS; Tian, C; Hinds, D; Seabrook, GR				Li, Qingqin S.; Tian, Chao; Hinds, David; Seabrook, Guy R.			The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; MENDELIAN RANDOMIZATION; MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; CANDIDATE GENE; AMYLOID-BETA; METAANALYSIS; VARIANTS	To elucidate how variants in genetic risk loci previously implicated in Alzheimer's Disease (AD) and/or frontotemporal dementia (FTD) contribute to expression of disease phenotypes, a phenome-wide association study was performed in two waves. In the first wave, we explored clinical traits associated with thirteen genetic variants previously reported to be linked to disease risk using both the 23andMe and UKB cohorts. We tested 30 additional AD variants in UKB cohort only in the second wave. APOE variants defining epsilon 2/epsilon 3/epsilon 4 alleles and rs646776 were identified to be significantly associated with metabolic/cardiovascular and longevity traits. APOE variants were also significantly associated with neurological traits. ABI3 variant rs28394864 was significantly associated with cardiovascular (e.g. (hypertension, ischemic heart disease, coronary atherosclerosis, angina) and immune-related trait asthma. Both APOE variants and CLU variant were significantly associated with nearsightedness. HLA- DRB1 variant was associated with diseases with immune-related traits. Additionally, variants from 10+ AD genes (BZRAP1-AS1, ADAMTS4, ADAM10, APH1B, SCIMP, ABI3, SPPL2A, ZNF232, GRN, CD2AP, and CD33) were associated with hematological measurements such as white blood cell (leukocyte) count, monocyte count, neutrophill count, platelet count, and/or mean platelet (thrombocyte) volume (an autoimmune disease biomarker). Many of these genes are expressed specifically in microglia. The associations of ABI3 variant with cardiovascular and immune-related traits are one of the novel findings from this study. Taken together, it is evidenced that at least some AD and FTD variants are associated with multiple clinical phenotypes and not just dementia. These findings were discussed in the context of causal relationship versus pleiotropy via Mendelian randomization analysis.	[Li, Qingqin S.] Janssen Res & Dev LLC, Titusville, NJ 08560 USA; [Tian, Chao; Hinds, David] 23andMe Inc, Mountain View, CA USA; [Seabrook, Guy R.] Johnson & Johnson Innovat, San Francisco, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Li, QQS (corresponding author), Janssen Res & Dev LLC, Titusville, NJ 08560 USA.	qli2@its.jnj.com	tian, chao/GYD-3462-2022	Li, Qingqin/0000-0003-4182-4535	Johnson & Johnson Innovation; 23andMe; Janssen Research & Development, LLC	Johnson & Johnson Innovation; 23andMe; Janssen Research & Development, LLC	The study was funded by Johnson & Johnson Innovation, 23andMe, and Janssen Research & Development, LLC. The funder Johnson & Johnson Innovation provided research funding to 23andMe. The funder Janssen Research & Development, LLC provided research funding to 23andMe and support in the form of salaries for authors QSL and GRS. The funder 23andMe provided support in the form of salaries for authors CT, DAH and members of the 23andMe Research Team. All funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2015, CML REV, V52, P1; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2016, EVIDENCE, V8, pe1000; [Anonymous], 2008, HOLLAND, V40, P189; Armstrong RA, 2009, J OPTOM, V2, P103, DOI [10.3921/joptom.2009.103, DOI 10.3921/JOPTOM.2009.103]; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Cerman E, 2015, TURK J MED SCI, V45, P1004, DOI 10.3906/sag-1406-146; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Diogo D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06540-3; Durand EY, ANCESTRY COMPOSITION; Eid A, 2019, PHARMACOL THERAPEUT, V199, P173, DOI 10.1016/j.pharmthera.2019.03.005; Emdin CA, 2017, JAMA-J AM MED ASSOC, V318, P1925, DOI 10.1001/jama.2017.17219; Ermilov V. V., 2013, Arkhiv Patologii, V75, P37; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Howard DM, 2019, NAT NEUROSCI, V22, P343, DOI 10.1038/s41593-018-0326-7; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irimata KE, 2018, CURR ALZHEIMER RES, V15, P1032, DOI 10.2174/1567205015666180702105119; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Larsson SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5375; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li QS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.171; Liu GY, 2014, MOL NEUROBIOL, V50, P757, DOI 10.1007/s12035-014-8670-4; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Olney NT, 2017, NEUROL CLIN, V35, P339, DOI [10.1016/j.ncl.2017.01.008, 10.1016/j.nc1.2017.01.008]; Olszewska DA, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0707-9; Pilling LC, 2017, AGING-US, V9, P2504, DOI 10.18632/aging.101334; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Pottier C, 2018, LANCET NEUROL, V17, P548, DOI 10.1016/S1474-4422(18)30126-1; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ratnayaka JA, 2015, EYE, V29, P1013, DOI 10.1038/eye.2015.100; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shoda C, 2018, J ALZHEIMERS DIS, V62, P239, DOI 10.3233/JAD-170956; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; Spierer O, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002423; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Teumer A, 2016, AGING CELL, V15, P811, DOI 10.1111/acel.12490; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45977; Wood AR, 2016, DIABETOLOGIA, V59, P1214, DOI 10.1007/s00125-016-3908-5; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Xu HM, 2017, MOL NEUROBIOL, V54, P1187, DOI 10.1007/s12035-016-9698-4; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	92	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241552	10.1371/journal.pone.0241552	http://dx.doi.org/10.1371/journal.pone.0241552			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152005	gold, Green Published			2022-12-26	WOS:000591376200104
J	Brown, AL; Bakke, AJ; Hopfer, H				Brown, Allison L.; Bakke, Alyssa J.; Hopfer, Helene			Understanding American premium chocolate consumer perception of craft chocolate and desirable product attributes using focus groups and projective mapping	PLOS ONE			English	Article							MULTIPLE FACTOR-ANALYSIS; WILLINGNESS-TO-PAY; SUSTAINABILITY LABELS; BRAND; FOOD; COFFEE; CONSUMPTION; PURCHASE; QUALITY; BEHAVIOR	Craft chocolate is a relatively new and fast-growing segment of the American chocolate market. To understand American premium chocolate consumer perception of craft chocolate and desirable chocolate product attributes, we conducted a mixed-methods study using focus groups and projective mapping. Projective mapping revealed that participants segmented products in terms of quality based upon usage occasion rather than cost or other factors. We found that American premium chocolate consumers use search attributes such as segmentation, price, availability, and packaging as quality determinants. Additionally, they desire credence attributes that convey trust through, for example, the presence or absence of sustainability certifications, or a semblance of meaning. Premium chocolate consumers seek out experience attributes such as utility and/or joy, which are achieved by purchasing a chocolate product as a gift, for its nostalgic purposes, or for desired post-ingestive effects. We propose a Desirable Chocolate Attribute Concept Map to explain our findings.	[Brown, Allison L.; Bakke, Alyssa J.; Hopfer, Helene] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA; [Bakke, Alyssa J.; Hopfer, Helene] Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hopfer, H (corresponding author), Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.; Hopfer, H (corresponding author), Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA.	hopfer@psu.edu		Brown, Allison/0000-0002-3731-6573; Hopfer, Helene/0000-0001-6925-0241	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Federal Appropriations [PEN04624, 1013412]	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Federal Appropriations	This work was supported by the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Federal Appropriations under Project PEN04624 and Accession number 1013412, awarded to H.H. (https://nifa.usda.gov/grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research did not receive any industry sponsorship. The products used were selected at the discretion of the authors.	Aaker JL, 1997, J MARKETING RES, V34, P347, DOI 10.2307/3151897; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Albert N, 2013, J CONSUM MARK, V30, P258, DOI 10.1108/07363761311328928; Allen LL, 2009, CHOCOLATE FORTUNES B; [Anonymous], 2015, ANAL SENSORY DATA R; Arora S, 2015, J BRAND MANAG, V22, P79, DOI 10.1057/bm.2015.8; Arvidsson A., 2006, BRANDS MEANING VALUE; Barber N., 2006, Journal of Foodservice Business Research, V9, P83, DOI 10.1300/J369v09n04_06; Butschli BJ, 2019, PACKAGING WORLD; Carrigan M, 2001, J CONSUM MARK, V18, P560, DOI 10.1108/07363760110410263; Charmaz K., 2006, CONSTRUCTING GROUNDE, V2nd, P42; Charters S, 2007, FOOD QUAL PREFER, V18, P997, DOI 10.1016/j.foodqual.2007.04.003; Chaudhuri A, 2001, J MARKETING, V65, P81, DOI 10.1509/jmkg.65.2.81.18255; Cidell JL, 2006, GEOFORUM, V37, P999, DOI 10.1016/j.geoforum.2006.02.006; Cranfield J, 2010, AGRIBUSINESS, V26, P307, DOI 10.1002/agr.20217; Crawford E., 2019, INVESTING FUTURE FOO; D'Antonio M., 2007, HERSHEYS EXTRAORDINA; Dahl R., 1964, CHARLIE CHOCOLATE FA; Dahl R, 2010, ENVIRON HEALTH PERSP, V118, pA246, DOI 10.1289/ehp.118-a246; DARBY MR, 1973, J LAW ECON, V16, P67, DOI 10.1086/466756; Silva ARD, 2017, J CLEAN PROD, V141, P11, DOI 10.1016/j.jclepro.2016.09.024; De Pelsmacker P, 2005, J CONSUM AFF, V39, P363, DOI 10.1111/j.1745-6606.2005.00019.x; Didier T, 2008, INT J CONSUM STUD, V32, P479, DOI 10.1111/j.1470-6431.2008.00714.x; Elder RS, 2010, J CONSUM RES, V36, P748, DOI 10.1086/605327; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; Esmerino EA, 2017, J DAIRY SCI, V100, P8849, DOI 10.3168/jds.2016-12533; Fine Chocolate Industry Association, 2018, FCIAS NAT RES CONS P; Fine Chocolate Industry Association, 2019, CORP MEMB; Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515; Frankl V. E., 1982, PSYKOLOGI EKSISTENS; GAMBETTA Diego, 2000, TRUST MAKING BREAKIN, V13, P213, DOI 10.2307/2234217; Giller M, 2017, BEAN TO BAR CHOCOLAT; Ginon E, 2014, FOOD RES INT, V62, P860, DOI 10.1016/j.foodres.2014.04.052; Glaser B.G., 1968, DISCOV GROUNDED THEO; Goldstein JE, 2011, FOOD FOODWAYS, V19, P135, DOI 10.1080/07409710.2011.544226; Gomez-Corona C, 2016, APPETITE, V96, P358, DOI 10.1016/j.appet.2015.10.002; Goulding C., 2002, GROUNDED THEORY PRAC; Grossman R. P., 1999, J MARKETING PRACTICE, V5, P78, DOI [DOI 10.1108/EUM0000000004565, 10.1108/EUM0000000004565]; Grunert KG, 2004, MEAT SCI, V66, P259, DOI 10.1016/S0309-1740(03)00130-X; Grunert KG, 2003, FOOD QUAL PREFER, V14, P39, DOI 10.1016/S0950-3293(02)00033-2; Grunert KG, 2014, FOOD POLICY, V44, P177, DOI 10.1016/j.foodpol.2013.12.001; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Gunaratne NM, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01696; Harrison R., 2005, ETHICAL CONSUMER, DOI 10.4135/9781446211991; Haynes J, 2012, SUSTAINABILITY-BASEL, V4, P1466, DOI 10.3390/su4071466; Hine Thomas, 1995, TOTAL PACKAGE EVOLUT; HOLBROOK MB, 1991, ADV CONSUM RES, V18, P330; Hughner R.S., 2007, J CONSUM BEHAV, V6, P94, DOI 10.1002/cb.210; Iweala S, 2019, J CLEAN PROD, V215, P315, DOI 10.1016/j.jclepro.2018.12.266; Jaffee D, 2016, AGR HUM VALUES, V33, P813, DOI 10.1007/s10460-015-9663-2; Januszewska R., 2000, Journal of Euro-Marketing, V9, P1, DOI 10.1300/J037v09n03_01; Kamberelis G, 2008, FOCUS GROUPS STRATEG, P375; Kauppinen-Raisanen H, 2010, QUAL MARK RES, V13, P287, DOI 10.1108/13522751011053644; King ES, 2013, FOOD QUAL PREFER, V28, P235, DOI 10.1016/j.foodqual.2012.08.013; Kostov B, 2014, FOOD QUAL PREFER, V32, P35, DOI 10.1016/j.foodqual.2013.06.009; Krishna A, 2017, J RETAILING, V93, P43, DOI 10.1016/j.jretai.2016.12.002; Krueger R, 2009, FOCUS GROUPS PRACTIC, P17; Krueger R. A., 2002, DESIGNING CONDUCTING; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Krueger RA, 1998, ANAL REPORTING FOCUS; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Labrecque LI, 2012, J ACAD MARKET SCI, V40, P711, DOI 10.1007/s11747-010-0245-y; Langen N, 2011, FOOD QUAL PREFER, V22, P412, DOI 10.1016/j.foodqual.2011.02.002; LASCU DN, 1991, ADV CONSUM RES, V18, P290; Lawless H., 2010, SENSORY EVALUATION F, P19, DOI [10.1007/978-1-4419-6488-5_2, DOI 10.1007/978-1-4419-6488-5_2]; Lawless H.T., 2010, SENSORY EVALUATION F, P57, DOI [10.1007/978-1-4419-6488-5_3, DOI 10.1007/978-1-4419-6488-5_3]; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leissle K., 2013, Gastronomica, V13, P22; Leissle K, 2017, FOOD CULT SOC, V20, P37, DOI 10.1080/15528014.2016.1272201; LICHTENSTEIN DR, 1993, J MARKETING RES, V30, P234, DOI 10.2307/3172830; Lockshin, 2000, AUSTRALASIAN MARKETI, V8, P45, DOI [10.1016/S1441-3582(00)70184-4, DOI 10.1016/S1441-3582(00)70184-4]; Lybeck A, 2006, INT REV RETAIL DISTR, V16, P471, DOI 10.1080/09593960600844343; MICHENER W, 1994, PHYSIOL BEHAV, V56, P419, DOI 10.1016/0031-9384(94)90283-6; Mielby LH, 2014, FOOD QUAL PREFER, V35, P86, DOI 10.1016/j.foodqual.2014.02.006; Mintel Group Limited, 2017, SNACK FOODS US JUN 2; Mintel Group Limited, 2018, BEER CRAFT BEER US O; Mintel Group Limited, 2018, CHOC CONF US APR; Mintel Group Limited, 2016, CHOC CONF US MARCH 2; Mintel Market Sizes, 2018, CHOC CONF US; Mishra P, 2015, DANDELION CHOCOLATE; Morgan DL, 2013, USE FOCUS GROUPS WHY, P3; National Confectioners Association Fine Chocolate Industry Association, 2019, GETT KNOW CHOC CONS; National Institute of Public Health and Chief Sanitary Inspectorate, 2016, IMPR EN PERF CAN, P1; Non-GMO Project, 2016, NON GMO PROJ STAND; Obermiller C, 2009, CORP REPUT REV, V12, P159, DOI 10.1057/crr.2009.11; Olson J.C., 1972, P 3 ANN C ASS CONS R, P167, DOI DOI 10.1108/EB026082; Osman JL, 2006, APPETITE, V47, P290, DOI 10.1016/j.appet.2006.04.008; Pages J, 2005, J CHEMOMETR, V19, P138, DOI 10.1002/cem.916; Pages J, 2005, FOOD QUAL PREFER, V16, P642, DOI 10.1016/j.foodqual.2005.01.006; Perrin L, 2008, FOOD QUAL PREFER, V19, P1, DOI 10.1016/j.foodqual.2007.06.005; Pink DH, 2006, MEANING WHOLE NEW MI, P217; Poelmans E, 2016, BRIT FOOD J, V118, P343, DOI 10.1108/BFJ-06-2015-0208; Pulizzi J, 2012, PUBLISH RES Q, V28, P116, DOI 10.1007/s12109-012-9264-5; R Core Team, 2018, R LANG ENV STAT COMP; Rainforest Alliance, 2019, WHAT DOES RAINF ALL; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Richelieu A, 2014, QUAL MARK RES, V17, P192, DOI 10.1108/QMR-06-2012-0032; Risvik E, 1997, FOOD QUAL PREFER, V8, P63, DOI 10.1016/S0950-3293(96)00016-X; Risvik E., 1994, Food Quality and Preference, V5, P263, DOI 10.1016/0950-3293(94)90051-5; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Rook D.W., 2007, FOCUS GROUPS THEORY, V2nd, P109; Rousseau S, 2015, FOOD QUAL PREFER, V44, P92, DOI 10.1016/j.foodqual.2015.04.002; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; Samoggia A, 2018, APPETITE, V129, P70, DOI 10.1016/j.appet.2018.07.002; Sarkar P., 2005, SF GATE         0726, P1; Shaw D., 2000, J MARK MANAG, V16, P879, DOI [DOI 10.1362/026725700784683672, 10.1362/026725700784683672]; Sherman S, 2011, INT J WINE BUS RES, V23, P221, DOI 10.1108/17511061111163050; Sinclair S., 2020, VOYANT TOOLS; Smit HJ, 2004, PSYCHOPHARMACOLOGY, V176, P412, DOI 10.1007/s00213-004-1898-3; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Sousa AG, 2016, FOOD SCI TECH-BRAZIL, V36, P432, DOI 10.1590/1678-457X.10015; Spence C, 2016, WOODHEAD PUBL FOOD S, V296, P1, DOI 10.1016/B978-0-08-100356-5.00001-2; Spence C., 2012, FLAVOUR, V1, P7, DOI [10.1186/2044-7248-1-7, DOI 10.1186/2044-7248-1-7]; Spinelli S, 2017, FOOD QUAL PREFER, V61, P63, DOI 10.1016/j.foodqual.2017.05.003; Stewart D., 2015, FOCUS GROUPS THEORY, Ved 3; Stone H, 2012, SENSORY EVALUATION P, DOI DOI 10.1016/B978-0-12-382086-0.00010-8; Strahilevitz M, 1998, J CONSUM RES, V24, P434, DOI 10.1086/209519; Stuart Mel, 1971, W WONKA CHOCOLATE FA; Terrio S, 2016, CRITICAL CRAFT: TECHNOLOGY, GLOBALIZATION, AND CAPITALISM, P135; Thaichon P, 2018, J FOOD PROD MARK, V24, P163, DOI 10.1080/10454446.2017.1266551; Thompson A., 2016, CANDY IND; Thompson D., 2018, ATLANTIC; Thomson DMH, 2015, FOOD QUAL PREFER, V40, P343, DOI 10.1016/j.foodqual.2014.04.013; Thomson DMH, 2010, FOOD QUAL PREFER, V21, P1117, DOI 10.1016/j.foodqual.2010.04.011; Torres-Moreno M, 2012, APPETITE, V58, P665, DOI 10.1016/j.appet.2011.12.005; Valentin D, 2012, INT J FOOD SCI TECH, V47, P1563, DOI 10.1111/j.1365-2621.2012.03022.x; van Esch P, 2019, J RETAIL CONSUM SERV, V50, P94, DOI 10.1016/j.jretconser.2019.05.003; van Herpen E, 2009, J CONSUM PSYCHOL, V19, P302, DOI 10.1016/j.jcps.2009.01.001; Van Loo EJ, 2015, ECOL ECON, V118, P215, DOI 10.1016/j.ecolecon.2015.07.011; VARADARAJAN PR, 1988, J MARKETING, V52, P58, DOI 10.2307/1251450; Veale R, 2009, INT BUS REV, V18, P134, DOI 10.1016/j.ibusrev.2009.01.004; Vecchio R, 2015, J CLEAN PROD, V86, P335, DOI 10.1016/j.jclepro.2014.08.006; Vlaeminck P, 2016, EC CHOCOLATE; Vreeland and Associates, 2016, US CHOC MARK FACTSH; WEINGARTEN HP, 1991, APPETITE, V17, P167, DOI 10.1016/0195-6663(91)90019-O; Woolley J, 2020, PREPRINT; Young ME, 2016, FOOD QUAL PREFER, V49, P42, DOI 10.1016/j.foodqual.2015.11.014; Zarantonello L, 2011, QUAL MARK RES, V14, P55, DOI 10.1108/13522751111099328; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446; Zellner DA, 2004, APPETITE, V42, P119, DOI 10.1016/j.appet.2003.11.004; Zepeda L, 2009, INT J CONSUM STUD, V33, P697, DOI 10.1111/j.1470-6431.2009.00814.x; 2008, FUJIAN PAPER IND INF, V23, P14	144	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240177	10.1371/journal.pone.0240177	http://dx.doi.org/10.1371/journal.pone.0240177			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147215	Green Published, gold, Green Submitted			2022-12-26	WOS:000589609300056
J	Guo, GG; Rao, YL; Zhu, FD; Xu, F				Guo, Ganggang; Rao, Yulei; Zhu, Feida; Xu, Fang			Innovative deep matching algorithm for stock portfolio selection using deep stock profiles	PLOS ONE			English	Article							SENTIMENT; MODEL	Construction of a reliable stock portfolio remains an open issue in quantitative investment. Multiple machine learning models have been trained for stock portfolio selection, but their practical applicability remains limited due to the challenges posed by the characteristic of a low signal-to-noise ratio (SNR), the nature of time-series data, and non-independent identical distribution in financial data. Here, we transformed the stock selection task into a matching problem between a group of stocks and a stock selection target. We proposed a novel representation algorithm of stock selection target and a novel deep matching algorithm (TS-Deep-LtM). Then we proposed a deep stock profiling method to extract the optimal feature combination and trained a deep matching model based on TS-Deep-LtM algorithm for stock portfolio selection. Especially, TS-Deep-LtM algorithm was obtained by setting statistical indicators to filter and integrate three deep text matching algorithms. This parallel framework design made it good at capturing signals from time-series data and adapting to non-independent identically distributed data. Finally, we applied the proposed model to stock selection and tested long-only portfolio strategies from 2010 to 2017. We demonstrated that the risk-adjusted returns obtained by our portfolio strategies outperformed those obtained by the CSI300 index and learning-to-rank approaches during the same period.	[Guo, Ganggang; Rao, Yulei] Cent South Univ, Business Sch, Changsha, Peoples R China; [Zhu, Feida] Singapore Management Univ, Sch Informat Syst, Stamford Rd, Singapore, Singapore; [Xu, Fang] Cent South Univ, Xiangtan Cent Hosp, Clin Practice Base, Xiangtan, Peoples R China	Central South University; Singapore Management University	Guo, GG (corresponding author), Cent South Univ, Business Sch, Changsha, Peoples R China.; Xu, F (corresponding author), Cent South Univ, Xiangtan Cent Hosp, Clin Practice Base, Xiangtan, Peoples R China.	ganggangguo66@gmail.com; wodedianziyouxiang88@126.com	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137; GUO, Ganggang/0000-0002-5580-241X	National Natural Science Foundation of China [71910107001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 71910107001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei D, 2015, REV FINANC STUD, V28, P33, DOI 10.1093/rfs/hhu059; [Anonymous], 2012, FURUKAWA REV, V41, P22; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Arevalo A, 2019, LECT NOTES COMPUT SC, V11538, P315, DOI 10.1007/978-3-030-22744-9_25; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges C., 2005, P 22 INT C MACH LEAR, V119, P89, DOI [10.1145/1102351.1102363, DOI 10.1145/1102351.1102363]; Cao Z., 2007, P 24 INT C MACH LEAR, P129, DOI DOI 10.1145/1273496.1273513; Carhart MM, 1997, J FINANC, V52, P57, DOI 10.2307/2329556; Chapelle O., 2009, P 18 ACM C INF KNOWL, P621, DOI DOI 10.1145/1645953.1646033; Chen C.-W., 2013, J FINANC RES, V36, P175, DOI [10.1111/j.1475-6803.2013.12007.x, DOI 10.1111/J.1475-6803.2013.12007.X]; Chen HL, 2014, REV FINANC STUD, V27, P1367, DOI 10.1093/rfs/hhu001; Cheng H-T., 2016, P 1 WORKSHOP DEEP LE, DOI 10.1145/2988450.2988454; Christopherson JA, 1999, J PORTFOLIO MANAGE, V26, P59, DOI 10.3905/jpm.1999.319774; Dai ZY, 2018, WSDM'18: PROCEEDINGS OF THE ELEVENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P126, DOI 10.1145/3159652.3159659; Deboeck G.J., 1994, TRADING EDGE NEURAL, VVolume 39; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; Deng SW, 2011, 2011 INTERNATIONAL CONFERENCE ON APPLIED SOCIAL SCIENCE (ICASS 2011), VOL V, P87; Dougal C, 2012, REV FINANC STUD, V25, P639, DOI 10.1093/rfs/hhr133; Droms WG, 1996, Q REV ECON FINANC, V36, P347, DOI 10.1016/S1062-9769(96)90020-4; Fama EF, 2004, J ECON PERSPECT, V18, P25, DOI 10.1257/0895330042162430; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; Fama EF, 2017, J FINANC ECON, V123, P441, DOI 10.1016/j.jfineco.2016.11.004; Fama EF, 2015, J FINANC ECON, V116, P1, DOI 10.1016/j.jfineco.2014.10.010; Fan Y, 2017, ARXIV170707270V1; Freund Y, 2004, J MACH LEARN RES, V4, P933, DOI 10.1162/1532443041827916; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fu X, 2018, ARXIV180601743V2; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Gudelek MU, 2017, 2017 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (SSCI), P74; Guerard JB, 2015, INT J FORECASTING, V31, P550, DOI 10.1016/j.ijforecast.2014.10.003; Guo JF, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P55, DOI 10.1145/2983323.2983769; Harvey CR, 2016, REV FINANC STUD, V29, P5, DOI [10.18845/tm.v29i8.2980, 10.1093/rfs/hhv059]; Hillert A, 2018, J FINANC MARK, V41, P57, DOI 10.1016/j.finmar.2018.09.002; Hu BT, 2014, ADV NEUR IN, V27; Huang PS, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P2333; Israelsen CL, 2005, J ASSET MANAG, V5, P423; Jun Xu, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P391; Kahneman D., 1973, ATTENTION EFFORT; Khaidem L., 2016, ARXIV160500003V1; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Krollner B., 2010, P 18 EUROPEAN S ARTI, P25; L?pez de Prado M., 2018, ADV FINANCIAL MACHIN; Leon D, 2017, PROCEDIA COMPUT SCI, V108, P1334, DOI 10.1016/j.procs.2017.05.185; Levin AU, 1996, ADV NEUR IN, V8, P966; Li Q, 2014, INFORM SCIENCES, V278, P826, DOI 10.1016/j.ins.2014.03.096; Liu T.-Y., 2009, FOUND TRENDS INF RET, V3, P225, DOI [DOI 10.1561/1500000016, DOI 10.1007/978-3-642-14267-3]; Lu Z., 2013, ADV NEURAL INFORM PR, P1367; Magdon-Ismail M, 2003, IEEE C COMP INTEL FI, P243, DOI 10.1109/CIFER.2003.1196267; Mahfoud S, 1996, APPL ARTIF INTELL, V10, P543, DOI 10.1080/088395196118425; Manski CF, 2000, J ECON PERSPECT, V14, P115, DOI 10.1257/jep.14.3.115; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mclean RD, 2016, J FINANC, V71, P5, DOI 10.1111/jofi.12365; MCLEAVEY D. W., 2015, QUANTITATIVE INVESTM, V3rd; Meng XT, 2020, INT REV FINANC ANAL, V67, DOI 10.1016/j.irfa.2019.101432; Metzler D, 2007, INFORM RETRIEVAL, V10, P257, DOI 10.1007/s10791-006-9019-z; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mitra B, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1291, DOI 10.1145/3038912.3052579; Nanda SR, 2010, EXPERT SYST APPL, V37, P8793, DOI 10.1016/j.eswa.2010.06.026; Nardo M, 2016, J ECON SURV, V30, P356, DOI 10.1111/joes.12102; Nassirtoussi AK, 2014, EXPERT SYST APPL, V41, P7653, DOI 10.1016/j.eswa.2014.06.009; Ng DWK, 2015, IEEE CONF COMM NETW, P1, DOI 10.1109/CNS.2015.7346803; O JM, 2006, INFORM SCIENCES, V176, P2121, DOI 10.1016/j.ins.2005.10.009; Palangi H, 2016, IEEE-ACM T AUDIO SPE, V24, P694, DOI 10.1109/TASLP.2016.2520371; [庞亮 Pang Liang], 2017, [计算机学报, Chinese Journal of Computers], V40, P985; Partridge M., 1998, Intelligent Data Analysis, V2; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Rabiul I, 2012, DISCRETE DYN NAT SOC, P1; Rasekhschaffe KC, 2019, FINANC ANAL J, V75, P70, DOI 10.1080/0015198X.2019.1596678; REFENES AN, 1994, NEURAL NETWORKS, V7, P375, DOI 10.1016/0893-6080(94)90030-2; ROSS SA, 1976, J ECON THEORY, V13, P341, DOI 10.1016/0022-0531(76)90046-6; Ruder S., 2016, ARXIV; Selvin S, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1643; Sharma A, 2017, 2017 INTERNATIONAL CONFERENCE OF ELECTRONICS, COMMUNICATION AND AEROSPACE TECHNOLOGY (ICECA), VOL 2, P506; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Song Q, 2017, NEUROCOMPUTING, V264, P20, DOI 10.1016/j.neucom.2017.02.097; Tan M, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P464, DOI 10.18653/v1/p16-1044; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Voorhees EM., 2005, TREC EXPT EVALUATION; Wan SX, 2016, AAAI CONF ARTIF INTE, P2835; Wang BH, 2012, NEUROCOMPUTING, V83, P136, DOI 10.1016/j.neucom.2011.12.013; Wang H, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1235, DOI 10.1145/2783258.2783273; Wang Y., 2013, EURASIP J ADV SIG PR, V2013, DOI DOI 10.1155/2013/189105; Wu QA, 2010, INFORM RETRIEVAL, V13, P254, DOI 10.1007/s10791-009-9112-1; Xiong CY, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P55, DOI 10.1145/3077136.3080809; Yang L, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P287, DOI 10.1145/2983323.2983818; Yang S.Y., 2015, J BUS EC, V6, P1682, DOI DOI 10.15341/JBE(2155-7950)/10.06.2015/002; Yang SY, 2015, QUANT FINANC, V15, P1637, DOI 10.1080/14697688.2015.1071078; Yang WD, 2017, 2017 2ND INTERNATIONAL CONFERENCE ON IMAGE, VISION AND COMPUTING (ICIVC 2017), P1152, DOI 10.1109/ICIVC.2017.7984734; Zhang H.P., 2003, P 2 SIGHAN WORKSH CH, P184, DOI [10.3115/1119250.1119280, DOI 10.3115/1119250.1119280]; Zhang R., 2018, INT J EC FINANCE, V10, P36	94	0	0	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241573	10.1371/journal.pone.0241573	http://dx.doi.org/10.1371/journal.pone.0241573			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147275	gold, Green Published			2022-12-26	WOS:000589609300037
J	Noh, K; Bach, DH; Choi, HJ; Kim, MS; Wu, SY; Pradeep, S; Ivan, C; Cho, MS; Bayraktar, E; Rodriguez-Aguayo, C; Dasari, SK; Stur, E; Mangala, LS; Lopez-Berestein, G; Sood, AK				Noh, Kyunghee; Duc-Hiep Bach; Choi, Hyun-Jin; Kim, Mark S.; Wu, Sherry Y.; Pradeep, Sunila; Ivan, Cristina; Cho, Min-Soon; Bayraktar, Emine; Rodriguez-Aguayo, Cristian; Dasari, Santosh K.; Stur, Elaine; Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.			The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis	ONCOGENE			English	Article							OVARIAN-CANCER METASTASIS; PLASMINOGEN-ACTIVATOR; SRC KINASES; KAPPA-B; EXPRESSION; PHOSPHORYLATION; PROTECTS; CELLS; FAK	Paxillin (PXN), a key component of the focal adhesion complex, has been associated with cancer progression, but the underlying mechanisms are poorly understood. The purpose of this study was to elucidate mechanisms by which PXN affects cancer growth and progression, which we addressed using cancer patient data, cell lines, and orthotopic mouse models. We demonstrated a previously unrecognized mechanism whereby nuclear PXN enhances angiogenesis by transcriptionally regulating SRC expression. SRC, in turn, increases PLAT expression through NF-kappa B activation; PLAT promotes angiogenesis via LRP1 in endothelial cells. PXN silencing in ovarian cancer mouse models reduced angiogenesis, tumor growth, and metastasis. These findings provide a new understanding of the role of PXN in regulating tumor angiogenesis and growth.	[Noh, Kyunghee; Duc-Hiep Bach; Choi, Hyun-Jin; Kim, Mark S.; Wu, Sherry Y.; Pradeep, Sunila; Bayraktar, Emine; Dasari, Santosh K.; Stur, Elaine; Mangala, Lingegowda S.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Noh, Kyunghee] Korea Res Inst Biosci & Biotechnol, 125 Gwahak Ro, Daejeon, South Korea; [Choi, Hyun-Jin] Chung Ang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Ivan, Cristina; Rodriguez-Aguayo, Cristian; Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Ivan, Cristina; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cho, Min-Soon] Univ Texas MD Anderson Canc Ctr, Dept Benign Hematol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University; Chung Ang University Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA.; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	asood@mdanderson.org	dasari, santosh kumar/V-3867-2019; Bach, Duc-Hiep/V-5276-2017; Sood, Anoop Kumar/A-7344-2013	dasari, santosh kumar/0000-0003-3078-3424; Bach, Duc-Hiep/0000-0002-9826-3137; Sood, Anoop Kumar/0000-0001-5702-4108; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Bayraktar, Emine/0000-0002-5189-1507; Ivan, Cristina/0000-0002-4848-0168	National Institutes of Health [P30 CA016672, P50 CA217685, P50 CA098258, R35 CA209904]; Frank McGraw Memorial Chair in Cancer Research; Ovarian Cancer Research Fund Alliance (OCRFA); Ovarian Cancer Research Alliance (OCRA) [FP00006137]; KRIBB Research Initiative Program; Blanton-Davis Ovarian Cancer Research Program; American Cancer Society Research Professor Award; Judy's Mission	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank McGraw Memorial Chair in Cancer Research; Ovarian Cancer Research Fund Alliance (OCRFA); Ovarian Cancer Research Alliance (OCRA); KRIBB Research Initiative Program; Blanton-Davis Ovarian Cancer Research Program; American Cancer Society Research Professor Award(American Cancer Society); Judy's Mission	Portions of this work were supported by the National Institutes of Health (P30 CA016672, P50 CA217685, P50 CA098258, and R35 CA209904), the Blanton-Davis Ovarian Cancer Research Program, American Cancer Society Research Professor Award, Judy's Mission, and the Frank McGraw Memorial Chair in Cancer Research. SP is supported by the Ovarian Cancer Research Fund Alliance (OCRFA). ES is supported by Ovarian Cancer Research Alliance (OCRA number FP00006137). KHN is supported by the KRIBB Research Initiative Program. We thank Dr. Bryan F. Tutt (Department of Scientific Publications) and Nicholas B. Jennings for kindly reviewing this manuscript.	Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Chen DL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-277; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Diaz VM, 2002, GASTROENTEROLOGY, V122, P806, DOI 10.1053/gast.2002.31885; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Ip CKM, 2014, ONCOTARGET, V5, P9133; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kratimenos P, 2017, PEDIATR HEMAT ONCOL, V34, P221, DOI 10.1080/08880018.2017.1360969; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Li BZ, 2008, J INT MED RES, V36, P273, DOI 10.1177/147323000803600209; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Noh KH, 2020, METABOLISM, V110, DOI 10.1016/j.metabol.2020.154302; Ohki M, 2010, BLOOD, V115, P4302, DOI 10.1182/blood-2009-08-236851; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; Phung CD, 2020, J CONTROL RELEASE, V324, P413, DOI 10.1016/j.jconrel.2020.05.029; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Sen A, 2012, J CLIN INVEST, V122, P2469, DOI 10.1172/JCI62044; Shi JN, 2010, J ORAL PATHOL MED, V39, P548, DOI 10.1111/j.1600-0714.2009.00859.x; Ulfhammer E, 2006, J THROMB HAEMOST, V4, P1781, DOI 10.1111/j.1538-7836.2006.02035.x; Wu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11169; Zhou J, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1265-1	34	11	11	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					384	395		10.1038/s41388-020-01517-3	http://dx.doi.org/10.1038/s41388-020-01517-3		NOV 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33149280	Green Accepted			2022-12-26	WOS:000585762500001
J	Ahinkorah, BO; Ameyaw, EK; Seidu, AA; Agbaglo, E; Budu, E; Mensah, F; Adu, C; Yaya, S				Ahinkorah, Bright Opoku; Ameyaw, Edward Kwabena; Seidu, Abdul-Aziz; Agbaglo, Ebenezer; Budu, Eugene; Mensah, Felix; Adu, Collins; Yaya, Sanni			Sexual violence and unmet need for contraception among married and cohabiting women in sub-Saharan Africa: Evidence from demographic and health surveys	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; UNINTENDED PREGNANCY; ASSOCIATIONS; YOUTH	Introduction Contraception plays a significant role in fertility regulation and determines the reproductive health rights of women. Studies in other parts of the world have found that sexual violence has negative effects on unmet need for contraception. There has not been any study on the association between these two phenomena in sub-Saharan Africa using current nationally-representative survey data. We investigated the association between sexual violence and unmet need for contraception among married and cohabiting women in sub-Saharan Africa. Materials and methods This study was based on secondary datasets from 26 sub-Saharan African countries' Demographic and Health Surveys conducted between 2010 and 2018. A sample of 101,968 women in sexual unions (married and cohabiting) with complete information on sexual violence and all the variables of interest were included in the analyses. Both bivariate and multilevel logistic regression analyses were carried out to examine the association between sexual violence and unmet need for contraception. Other individual and contextual level socio-economic and demographic variables were considered as covariates. Crude odds ratios [cOR] and adjusted odds ratios [aOR] with their corresponding 95% confidence intervals [CI], signifying precision, were presented. Level of statistical significance was declared at p<0.05. Results The overall prevalence of sexual violence and unmet need for contraception in the 26 sub-Saharan African countries were 8.7% and 28.7% respectively. Experience of sexual violence within the last 12 months resulted in 10% increase in unmet need for contraception [OR = 1.10, CI = 1.03-1.14] and 5% increase in unmet need for contraception after controlling for individual and contextual level factors [aOR = 1.05, CI = 1.01-1.11]. With the individual level factors, women with 4 or more births [aOR = 4.85, CI = 4.41-5.33], those cohabiting [aOR = 1.43, CI = 1.37-1.47], those in female headed households [aOR = 1.22, CI = 1.18-1.27] and those who watched television at least once a week [aOR = 1.12, CI = 1.07-1.16] had higher odds of unmet need for family planning. However, those aged 30-34 [aOR = 0.56, CI = 0.52-0.61], those with secondary/higher level of education [AOR = 0.80, CI = 0.77-0.84], those who read newspaper less than once a week [aOR = 0.75, CI = 0.71-0.79] and those who listened to radio at least once a week [aOR = 0.94, CI = 0.90-0.97] had lower odds of unmet need for contraception. In terms of the contextual factors, women in rural areas [aOR = 0.87, CI = 0.84-0.91] and those in the richest wealth quintile households [aOR = 0.80, CI = 0.75-0.85] had lower odds of unmet need for contraception. Conclusion Our study has shown an association between sexual violence and unmet need for contraception in sub-Saharan Africa. Experiencing sexual violence increases the likelihood of unmet need for contraception in sub-Saharan Africa. It is also worthy to note that having four or more children, cohabiting with a male partner, and living in female-headed households are some of the key variables associated with unmet need for contraception in sub-Saharan Africa. Our study recommends that, successful contraceptive initiatives should focus on reducing sexual violence, while taking into consideration other significant factors that increase unmet need for contraception. Meanwhile, in doing this, contextual factors ought to be prioritised.	[Ahinkorah, Bright Opoku; Ameyaw, Edward Kwabena] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Ultimo, Australia; [Seidu, Abdul-Aziz; Budu, Eugene] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Seidu, Abdul-Aziz] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Agbaglo, Ebenezer] Univ Cape Coast, Dept English, Cape Coast, Ghana; [Mensah, Felix] Fr Thomas Alan Rooney Mem Hosp, Asankrangwa, Western Region, Ghana; [Adu, Collins] Kwame Nkrumah Univ Sci & Technol, Dept Hlth Promot & Disabil Studies, Kumasi, Ghana; [Yaya, Sanni] Univ Oxford, George Inst Global Hlth, Oxford, England; [Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada	University of Technology Sydney; University of Cape Coast; James Cook University; University of Cape Coast; Kwame Nkrumah University Science & Technology; University of Oxford; University of Ottawa	Budu, E (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana.	budueugene@gmail.com	Yaya, Sanni/C-1079-2019; Agbaglo, Ebenezer/AAN-5804-2021	Yaya, Sanni/0000-0002-4876-6043; Budu, Eugene/0000-0002-8484-9225; Seidu, Abdul-Aziz/0000-0001-9734-9054; Mensah, Felix/0000-0003-3865-9321; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adebowale S. A., 2014, African Population Studies, V28, P499, DOI 10.11564/28-1-503; Adebowale S. A., 2013, African Population Studies, V27, P127, DOI 10.11564/27-2-435; Adebowale Stephen A, 2011, Afr J Reprod Health, V15, P60; Ahinkorah BO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236352; Alio AP, 2009, INT J GYNECOL OBSTET, V107, P35, DOI 10.1016/j.ijgo.2009.05.002; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; Asif MF., 2019, BMC PUBLIC HEALTH, V19, P1, DOI [10.1186/s12889-018-6343-3, DOI 10.1186/S12889-018-6343-3]; Bradley S.E.K., 2012, DHS ANAL STUDIES; Cappa C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233344; CDC, 2011, INT REPR HLTH SURV; Char A, 2010, REPROD HEALTH MATTER, V18, P154, DOI 10.1016/S0968-8080(10)35497-8; Choudhary S., 2011, INT J HLTH, V12, P1; Cilliers J, 2017, WHAT DRIVES INSTABIL; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Dalal K, 2012, J BIOSOC SCI, V44, P83, DOI 10.1017/S0021932011000307; Das S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-817; Dingeta T, 2019, OPEN ACCESS J CONTR, V10, P89, DOI 10.2147/OAJC.S227260; Fagbamigbe AF, 2018, SAGE OPEN, V8, DOI 10.1177/2158244017754023; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Gomez AM, 2009, J ADOLESCENT HEALTH, V44, P508, DOI 10.1016/j.jadohealth.2008.09.012; Gomez AM, 2011, J WOMENS HEALTH, V20, P1349, DOI 10.1089/jwh.2010.2518; Gurmu E., 2013, AFR POPUL STUD, V27, P140, DOI [10.11564/27-2-436, DOI 10.11564/27-2-436]; Guure C, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0340-6; International Planned Parenthood Federation (IPPF), 2019, REG DIR; Juarez F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5439-0; Kaneda T, 2016, INTIMATE PARTNER VIO; Kaneda T, 2015, INTIMATE PARTNER VIO; Khan SM., 2008, UNMET NEED DEMAND FA; Klijzing E, 2000, FAM PLANN PERSPECT, V32, P74, DOI 10.2307/2648215; Letamo G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006603; MacQuarrie, 2016, DHS ANAL STUDIES; Marston C, 2018, J HEALTH PSYCHOL, V23, P240, DOI 10.1177/1359105317726367; McCleary-Sills J., 2013, J INT WOMENS STUD, V14, P12; Moreira LR, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0805-7; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Ojakaa D, 2008, DHS WORKING PAPERS, V56; Okenwa L, 2011, EUR J CONTRACEP REPR, V16, P18, DOI 10.3109/13625187.2010.534515; Ongayo A.O., 2008, POLITICAL INSTABILIT; Oronje RN, 2013, ROLE POLITICAL WILL; Plecher H, 2020, SUBSAHARAN AFRICA FE; Raj A, 2015, CONTRACEPTION, V91, P456, DOI 10.1016/j.contraception.2015.03.008; Sedgh G., 2016, UNMET NEED CONTRACEP; Seidu AA, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2019.100459; Smit PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-102; Smith-Greenaway E, 2016, SSM-POPUL HLTH, V2, P164, DOI 10.1016/j.ssmph.2016.02.001; Stephenson R, 2008, STUD FAMILY PLANN, V39, P177, DOI 10.1111/j.1728-4465.2008.165.x; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Tenkorang EY, 2019, HEALTH EDUC BEHAV, V46, P969, DOI 10.1177/1090198119859420; Tsai Laura Cordisco, 2016, Glob J Health Sci, V8, P54382, DOI 10.5539/gjhs.v8n9p121; UN Population Division Population Reference Bureau, 2008, WORLD POP PROSP AFR; UNFPA, 2020, UNM NEED CONTR RIS S; Wang W., 2013, DHS ANAL STUDIES; WHO, 2019, PREV UNS AB; World Health Organization, UND ADDR VIOL WOM; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2018, UNM NEED FAM PLANN; World Health Organization [WHO], 2011, VIOL WOM INT PARTN S; Wulifan JK, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-018-0083-8; Wulifan JK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1614-z; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209801; [No title captured]	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240556	10.1371/journal.pone.0240556	http://dx.doi.org/10.1371/journal.pone.0240556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141830	Green Accepted, gold, Green Published			2022-12-26	WOS:000588376700005
J	Akin, M; Garcheva, V; Sieweke, JT; Flierl, U; Daum, HC; Bauersachs, J; Schafer, A				Akin, Muharrem; Garcheva, Vera; Sieweke, Jan-Thorben; Flierl, Ulrike; Daum, Hannah C.; Bauersachs, Johann; Schaefer, Andreas			Early use of hemoadsorption in patients after out-of hospital cardiac arrest - a matched pair analysis	PLOS ONE			English	Article							HYPOTHERMIA; MORTALITY	Background Pro- and anti-inflammatory mediators are released during and after cardiac arrest, which may be unfavourable. Small case-series and observational studies suggested that unselective hemoadsorption may reduce inadequately high cytokine levels during sepsis or cardiac surgery. We aimed to assess the effect of cytokine adsorbtion on mortality in patients following out-of-hospital cardiac arrest by comparing a patient cohort with hemoadsorption after resuscitation for out-of-hospital cardiac arrest to a control cohort without adsorption within the HAnnover COling REgistry (HACORE). Methods We adopted an early routine use of hemoadsorption in patients after out-of-hospital cardiac arrest with increased vasopressor need and performed a 1:2 match according to age, gender, time to return of spontaneous circulation, initial left-ventricular ejection fraction, extracorporeal membrane-oxygenation or left-ventricular unloading by Impella, need for renal replacement therapy, admission lactate, pH, glomerular filtration rate to patients without an adsorber from HACORE. The primary endpoint was 30-day mortality. Results Twenty-four patients receiving hemoadsorption were matched to 48 patients without hemoadsorption (mean age 62 +/- 13 years, 83% male). While there was no significant difference in baseline parameters, 30-day mortality was higher in patients treated with hemoadsorption than in the matched control group (83% vs 65%, Log rank p = 0.011). Conclusions Routine use of hemoadsorption did not reduce, but seems to be associated with higher 30-day mortality in patients after OHCA. Prior to routine adoption in daily practice, hemoadsorption should be evaluated in properly sized randomized controlled trials.	[Akin, Muharrem; Garcheva, Vera; Sieweke, Jan-Thorben; Flierl, Ulrike; Daum, Hannah C.; Bauersachs, Johann; Schaefer, Andreas] Hannover Med Sch, Cardiac Arrest Ctr, Dept Cardiol & Angiol, Hannover, Germany	Hannover Medical School	Akin, M (corresponding author), Hannover Med Sch, Cardiac Arrest Ctr, Dept Cardiol & Angiol, Hannover, Germany.	Akin.Muharrem@mh-hannover.de	Schäfer, Andreas/AAQ-9512-2021	Akin, Muharrem/0000-0002-0936-8755	Clinical Research Group (Klinische Forschergruppe (KFO) 311) of the Deutsche Forschungsgemeinschaft (DFG) [TP1]	Clinical Research Group (Klinische Forschergruppe (KFO) 311) of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was partly supported by the Clinical Research Group (Klinische Forschergruppe (KFO) 311, TP1) of the Deutsche Forschungsgemeinschaft (DFG) to JB. There was no additional external or internal funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Akin M, 2018, JACC-CARDIOVASC INTE, V11, P1811, DOI 10.1016/j.jcin.2018.06.022; Bassi E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/654708; Bernardi MH, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1270-0; Bisschops LLA, 2012, CRIT CARE MED, V40, P1136, DOI 10.1097/CCM.0b013e3182377050; Bro-Jeppesen J, 2016, RESUSCITATION, V107, P71, DOI 10.1016/j.resuscitation.2016.08.006; Brouwer WP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2588-1; Douek E., 2019, NC J TECH, V21, P1; Friesecke S, 2017, J ARTIF ORGANS, V20, P252, DOI 10.1007/s10047-017-0967-4; Gruda MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191676; Na SJ, 2019, REV ESP CARDIOL, V72, P40, DOI [10.1016/j.recesp.2017.12.020, 10.1016/j.rec.2018.01.003]; Napp LC, 2019, BLOOD PURIFICAT, V48, P203, DOI 10.1159/000500015; Nemeth E, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13211; Poli EC, 2019, INTENS CARE MED, V45, P236, DOI 10.1007/s00134-018-5464-6; Schadler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187015; Wang JH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013257; 2018, CURR OPIN TOXICOL, V10	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241709	10.1371/journal.pone.0241709	http://dx.doi.org/10.1371/journal.pone.0241709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141843	gold, Green Published			2022-12-26	WOS:000588376700044
J	Li, Y; Yong, YL; Yang, ML; Wang, WJ; Qu, XY; Dang, XM; Shang, D; Shao, YP; Liu, JK; Chang, Y				Li, Ying; Yong, Yu-Le; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Dang, Xiaomin; Shang, Dong; Shao, Yongping; Liu, Jiankang; Chang, Ying			Fine particulate matter inhibits phagocytosis of macrophages by disturbing autophagy	FASEB JOURNAL			English	Article						ATG2A; ERK1; 2; reactive oxygen species	OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR MACROPHAGES; V-ATPASE; INFLAMMATION; ACIDIFICATION; PARTICLES; PROTEINS; ASTHMA	Mounting evidence from epidemiological and clinical studies has revealed marked correlations between the air pollutant fine particulate matter (FPM) and respiratory diseases. FPM reaches distal airways and deposits in alveolar regions where it can act directly on alveolar macrophages. However, the detailed effect of FPM on the physiological function of alveolar macrophages and the underlying mechanisms remain unclear. In this study, we showed that exposing THP-1-derived macrophages to FPM led to autophagy dysfunction. FPM activated the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway, which promoted the expression of autophagy-related 2A (ATG2A) and reactive oxygen species generation. The overexpression of ATG2A enhanced the synthesis of autophagic membranes, and the excessive production of reactive oxygen species caused autophagy flux inhibition through disrupting the lysosomal activity. More importantly, FPM impaired the phagocytic ability of macrophages on Escherichia coli and apoptotic neutrophils. Finally, we showed that restoring autophagy rescued the impairment of phagocytic ability induced by FPM. In summary, these results reveal the molecular mechanism of autophagy dysfunction caused by FPM and provide a novel approach to resolve the impaired function of macrophages in respiratory diseases induced by FPM.	[Li, Ying; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Shao, Yongping; Chang, Ying] Xi An Jiao Tong Univ, Ctr Translat Med, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Li, Ying; Yang, Menglin; Wang, Weijia; Qu, Xiaoyan; Shao, Yongping; Chang, Ying] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Yong, Yu-Le] Fourth Mil Med Univ, Dept Cell Biol, Natl Translat Sci Ctr Mol Med, Xian, Peoples R China; [Dang, Xiaomin; Shang, Dong] Xi'an Jiaotong Univ, Affiliated Hosp 1, Dept Respirat, Xian, Peoples R China; [Liu, Jiankang] Xi'an Jiaotong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University	Chang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Translat Med, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.; Chang, Y (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China.; Liu, JK (corresponding author), Xi'an Jiaotong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China.	j.liu@mail.xjtu.edu.cn; changying0613@mail.xjtu.edu.cn			National Natural Science Foundation of China [31501044, 31770917, 31570777, 91649106]; National Basic Research Program [2015CB553602]; Natural Science Basic Research Plan in Shaanxi Province of China [2020JM-002]; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province [2020KW-046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Natural Science Basic Research Plan in Shaanxi Province of China; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province	National Natural Science Foundation of China, Grant/Award Number: 31501044, 31770917, 31570777 and 91649106; National Basic Research Program, Grant/Award Number: 2015CB553602; Natural Science Basic Research Plan in Shaanxi Province of China, Grant/Award Number: 2020JM-002; International Cooperation and Exchange Program of Science and Technology of Shaanxi Province, Grant/Award Number: 2020KW-046	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Almatroodi Saleh A, 2014, Lung Cancer Int, V2014, P721087, DOI 10.1155/2014/721087; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bewley MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163139; Brandstaetter H, 2014, AUTOPHAGY, V10, P2310, DOI 10.4161/15548627.2014.984272; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Chu X, 2016, ENVIRON TOXICOL PHAR, V48, P76, DOI 10.1016/j.etap.2016.10.006; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gong L, 2012, IUBMB LIFE, V64, P740, DOI 10.1002/iub.1070; Guo CL, 2019, EXP THER MED, V17, P3848, DOI 10.3892/etm.2019.7402; Hamanaka RB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00680; Hiraiwa K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/619523; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Jin M, 2004, AM J RESP CELL MOL, V31, P322, DOI 10.1165/rcmb.2004-0080OC; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Lund ME, 2016, J IMMUNOL METHODS, V430, P64, DOI 10.1016/j.jim.2016.01.012; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Palmer A, 2017, SHOCK, V48, P104, DOI 10.1097/SHK.0000000000000813; Pesonen M, 2019, TOXICOL LETT, V305, P1, DOI 10.1016/j.toxlet.2019.01.007; Racanelli AC, 2018, AUTOPHAGY, V14, P221, DOI 10.1080/15548627.2017.1389823; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Repnik Urska, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087106; Repnik U, 2017, J CELL SCI, V130, P3124, DOI 10.1242/jcs.204529; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shin IS, 2015, J PINEAL RES, V58, P50, DOI 10.1111/jpi.12192; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang YH, 2015, INT J CLIN EXP MED, V8, P58; Wei Y, 2018, TOXICOL MECH METHOD, V28, P302, DOI 10.1080/15376516.2017.1410743; Wilson WE, 2002, CHEMOSPHERE, V49, P1009, DOI 10.1016/S0045-6535(02)00270-9; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267; Xu X, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P194	52	7	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16716	16735		10.1096/fj.202000657R	http://dx.doi.org/10.1096/fj.202000657R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124742	Bronze			2022-12-26	WOS:000589710500001
J	Neicun, J; Yang, JC; Shih, H; Nadella, P; van Kessel, R; Negri, A; Czabanowska, K; Brayne, C; Roman-Urrestarazu, A				Neicun, Jessica; Yang, Justin Christopher; Shih, Hueyjong; Nadella, Pranay; van Kessel, Robin; Negri, Attilio; Czabanowska, Kasia; Brayne, Carol; Roman-Urrestarazu, Andres			Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014	PLOS ONE			English	Article							SEXUAL HEALTH; CHEMSEX; GAY	Introduction As Novel psychoactive substances (NPS) are conceived to mimic the effects of common illicit drugs, they represent a serious public health challenge due to the spike in intoxications and fatalities that have been linked to their use. This study aims to provide epidemiological data on NPS use in the USA, determining lifetime prevalence of use and defining demographic, socioeconomic, drug use patterns and mental health correlates. Methods This study uses secondary data from the US National Survey on Drug Use and Health (NSDUH), which is a large cross-sectional population-based survey carried out annually in the USA. We analysed data from 2007-14 (N = 307,935) using bivariate descriptive analysis and binary logistic regression to calculate prevalence and determine factors underlying NPS consumption. Adjusted odds ratios (OR) with 95% CI's were calculated for a set of selected independent variables. Results and discussion Our analysis NSDUH from 2007-14 highlights an increase in NPS use among adults, especially among white young men aged 18 to 25. Although the level of education of NPS users was relatively higher as compared to non-users, NPS users seemed to have a less wealthy situation. However, socioeconomic vulnerability appeared to be less important than mental health issues as a correlate to NPS use. NPS users seem to have followed a pattern of polysubstance use throughout their life, which involves both traditional illicit drugs and classic synthetic drugs. As NPS use seemed to be more prevalent among people having mental health issues, the rise in their use may have a negative impact on population mental health outcomes. Conclusion Further comparative research on trends in NPS use and potential public health responses would be instrumental for developing appropriate health interventions, including drug checking, education for users and training for healthcare professionals working both within emergency wards and in/outpatient addiction and mental health services.	[Neicun, Jessica; van Kessel, Robin; Czabanowska, Kasia; Brayne, Carol; Roman-Urrestarazu, Andres] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Int Hlth, Maastricht, Netherlands; [Neicun, Jessica; Yang, Justin Christopher; Shih, Hueyjong; Nadella, Pranay; Roman-Urrestarazu, Andres] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Negri, Attilio] Univ Hertfordshire, Ctr Clin & Hlth Res Serv, Novel Psychoact Subst Unit, Hatfield, Herts, England; [Czabanowska, Kasia] Natl Inst Publ Hlth, Warsaw, Poland	Maastricht University; University of Cambridge; University of Hertfordshire; National Institute of Public Health (NIPH)	Neicun, J (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Int Hlth, Maastricht, Netherlands.; Neicun, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge, England.	jessica.neicun@maastrichtuniversity.nl	Yang, Justin Christopher/H-1780-2018; van Kessel, Robin/GWV-1883-2022; van Kessel, Robin/GYD-7902-2022	Yang, Justin Christopher/0000-0003-2881-4906; van Kessel, Robin/0000-0001-6309-6343; van Kessel, Robin/0000-0001-6309-6343; NEGRI, ATTILIO/0000-0002-1035-8095; Brayne, Carol/0000-0001-5307-663X; Neicun, Jessica/0000-0002-8710-8238	Gillings Fellowship in Global Public Health [YOG054]	Gillings Fellowship in Global Public Health	AR-U's work received funding from the Gillings Fellowship in Global Public Health (Grant Award YOG054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahim D, 2018, MISUSE SYNTHETIC OPI; AL-Imam A, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2548; [Anonymous], 2020, NAT METHODS, V17, P1, DOI 10.1038/s41592-019-0703-5; [Anonymous], 2017, DUBL DRUG POL SUMM R; [Anonymous], 2017, AM J MED GENET C, V175, P1; Armenian P, 2018, NEUROPHARMACOLOGY, V134, P121, DOI 10.1016/j.neuropharm.2017.10.016; Arnold C, 2013, LANCET, V382, P15, DOI 10.1016/S0140-6736(13)61512-3; Baumann MH, 2018, NEUROPHARMACOLOGY, V134, P101, DOI 10.1016/j.neuropharm.2017.08.016; Benschop A, 2020, J PSYCHOPHARMACOL, V34, P600, DOI 10.1177/0269881120904951; Bourne A, 2015, SEX TRANSM INFECT, V91, P564, DOI 10.1136/sextrans-2015-052052; Center for Behavioral Health Statistics and Quality, 2015, NAT SURV DRUG US HLT, DOI [10.1186/1472-6807-9-19, DOI 10.1186/1472-6807-9-19]; Center for Behavioral Health Statistics and Quality, 2015, 2014 NAT SURV DRUGS; Center for Behavioral Health Statistics and Quality, 2013, NSDUH REP DAT SPOTL; Corazza O., 2017, NOVEL PSYCHOACTIVE S, P125, DOI DOI 10.1007/978-3-319-60600-2_9; Corazza O, 2017, NOVEL PSYCHOACTIVE S; Corazza O., 2019, HDB NOVEL PSYCHOACTI; Dart RC, 2015, ANN EMERG MED, V65, P416, DOI 10.1016/j.annemergmed.2014.11.001; Degenhardt L, 2018, ADDICTION, V113, P924, DOI 10.1111/add.14145; European Monitoring Centre for Drugs and Drug Addiction, 2020, EUR DRUG REP 2020 TR; Every-Palmer S, 2011, DRUG ALCOHOL DEPEN, V117, P152, DOI 10.1016/j.drugalcdep.2011.01.012; Fernandez-Calderon F, 2018, ADDICT BEHAV, V78, P85, DOI 10.1016/j.addbeh.2017.11.004; Hunter LJ, 2014, POSTGRAD MED J, V90, P133, DOI 10.1136/postgradmedj-2012-131428; Jann B, 2005, STATA J, V5, P92, DOI 10.1177/1536867X0500500113; Johnson LA, 2013, J EMERG MED, V44, P1108, DOI 10.1016/j.jemermed.2012.09.147; Johnston L.D., 2013, MONITORING FUTURE NA; Karila L, 2019, NEUROSCI BIOBEHAV R, V106, P133, DOI 10.1016/j.neubiorev.2018.06.010; King G, 2003, J STAT SOFTW, V8; Lucyk SN, 2017, ANN EMERG MED, V69, P91, DOI 10.1016/j.annemergmed.2016.08.445; Ma R, 2016, BRIT J GEN PRACT, V66, P4, DOI 10.3399/bjgp16X683029; Marrinan S, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2587; Martinotti G, 2019, HDB NOVEL PSYCHOACTI; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; Murphy CM, 2013, J MED TOXICOL, V9, P42, DOI 10.1007/s13181-012-0243-1; National Institute on Drug Abuse, 2014, P COMM EP WORK GROUP; Palamar JJ, 2016, AM J ADDICTION, V25, P400, DOI 10.1111/ajad.12403; Palamar JJ, 2016, AM J DRUG ALCOHOL AB, V42, P39, DOI 10.3109/00952990.2015.1106551; Patrick ME, 2016, DRUG ALCOHOL REV, V35, P586, DOI 10.1111/dar.12372; Peacock A, 2019, LANCET, V394, P1668, DOI 10.1016/S0140-6736(19)32231-7; Place C, 2017, ADV DUAL DIAGN, V10, P97, DOI 10.1108/ADD-10-2016-0018; Race K, 2017, SEX HEALTH, V14, P42, DOI 10.1071/SH16080; Riederer AM, 2016, MMWR-MORBID MORTAL W, V65, P692, DOI 10.15585/mmwr.mm6527a2; Schifano F, 2015, WORLD PSYCHIATRY, V14, P15, DOI 10.1002/wps.20174; Schmidt MM, 2011, FORENSIC SCI INT, V206, P92, DOI 10.1016/j.forsciint.2010.06.030; Simonato P, 2013, HUM PSYCHOPHARM CLIN, V28, P324, DOI 10.1002/hup.2300; Soussan C, 2018, INT J DRUG POLICY, V52, P71, DOI 10.1016/j.drugpo.2017.11.003; Soussan C, 2016, INT J DRUG POLICY, V32, P77, DOI 10.1016/j.drugpo.2016.03.007; U.S. Drug Enforcement Administration, 2018, NAT FOR LAB INF SYST; U.S. Drug Enforcement Administration, 2016, NAT FOR LAB INF SYST; U.S. Drug Enforcement Administration, 2014, NAT FOR LAB INF SYST; United Nations Office on Drugs and Crime, 2020, WORLD DRUG REP 2020; United Nations Office on Drugs and Crime, 2018, WORLD DRUG REP 2018; United Nations Office on Drugs and Crime, 2015, INT STAND DRUG US PR; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wilkins C, 2017, NOVEL PSYCHOACTIVE S, P57, DOI DOI 10.1007/978-3-319-60600-2_5; Winstock AR, 2017, 10 INT C NIGHTL SUBS; Wish E.D, 2015, COMMUNITY DRUG EARLY; Yang JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199741; Younger-Coleman N., 2016, 2016 NATL DRUG USE P	58	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241056	10.1371/journal.pone.0241056	http://dx.doi.org/10.1371/journal.pone.0241056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125395	gold, Green Published			2022-12-26	WOS:000588368900031
J	Zivcevska, M; Lei, SB; Blakeman, A; MacGregor, D; Goltz, HC; Wong, AMF				Zivcevska, Marija; Lei, Shaobo; Blakeman, Alan; MacGregor, Daune; Goltz, Herbert C.; Wong, Agnes M. F.			Investigation of light-induced lacrimation and pupillary responses in episodic migraine	PLOS ONE			English	Article							FIELD CHROMATIC PUPILLOMETRY; RETINAL GANGLION-CELLS; DRY EYE; NEURAL MECHANISM; BRIGHT LIGHT; HEADACHE; DRIVEN; PHOTOPHOBIA; SYMPTOMS; DISEASE	The purpose of this pilot study was to investigate the light-induced pupillary and lacrimation responses mediated by intrinsically photosensitive retinal ganglion cells (ipRGCs) in migraine. Ten participants with episodic migraine and normal tear production, as well as eleven visually normal controls participated in this study. Following an initial baseline trial (no light flash), participants received seven incremental and alternating red and blue light flashes. Pupillometry recording of the left eye and a 1-min anesthetized Schirmer's test of the right eye (using 0.5% proparacaine) were performed simultaneously. Intrinsic and extrinsic ipRGC photoactivities did not differ between migraine participants and controls across all intensities and wavelengths. Migraine participants, however, had significantly lower lacrimation than controls following the highest blue intensity. A positive correlation was found between melanopsin-driven post-illumination pupillary responses and lacrimation following blue stimulation in both groups. Our results show that participants with self-reported photophobia have normal ipRGC-driven responses, suggesting that photophobia and pupillary function may be mediated by distinct ipRGC circuits. The positive correlation between melanopsin-driven pupillary responses and light-induced lacrimation suggests the afferent arm of the light-induced lacrimation reflex is melanopsin-mediated and functions normally in migraine. Lastly, the reduced melanopsin-mediated lacrimation at the highest stimulus suggests the efferent arm of the lacrimation reflex is attenuated under certain conditions, which may be a harbinger of dry eye in migraine.	[Zivcevska, Marija; Goltz, Herbert C.; Wong, Agnes M. F.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Lei, Shaobo; Blakeman, Alan; Goltz, Herbert C.; Wong, Agnes M. F.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [MacGregor, Daune] Univ Toronto, Dept Pediat, Div Neurol, Toronto, ON, Canada; [MacGregor, Daune] Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON, Canada; [Wong, Agnes M. F.] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada; [Wong, Agnes M. F.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wong, AMF (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada.; Wong, AMF (corresponding author), Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.; Wong, AMF (corresponding author), Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada.; Wong, AMF (corresponding author), Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.	agnes.wong@sickkids.ca			John and Melinda Thomson Endowment Fund for Vision Neuroscience [AMFW] Department for Ophthalmology and Vision Sciences at the Hospital for Sick Children	John and Melinda Thomson Endowment Fund for Vision Neuroscience [AMFW] Department for Ophthalmology and Vision Sciences at the Hospital for Sick Children	John and Melinda Thomson Endowment Fund for Vision Neuroscience [AMFW] Department for Ophthalmology and Vision Sciences at the Hospital for Sick Children [AMFW] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Celikbilek A, 2015, ACTA NEUROL BELG, V115, P329, DOI 10.1007/s13760-014-0359-y; Chen FY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184916; Choi JY, 2009, CEPHALALGIA, V29, P953, DOI 10.1111/j.1468-2982.2008.01822.x; Cortez MM, 2017, CEPHALALGIA, V37, P801, DOI 10.1177/0333102416673205; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Delwig A, 2018, VISUAL NEUROSCI, V35, DOI 10.1017/S0952523817000359; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Ismail OM, 2019, JAMA OPHTHALMOL, V137, P532, DOI 10.1001/jamaophthalmol.2019.0170; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; Kinard KI, 2015, HEADACHE, V55, P543, DOI 10.1111/head.12547; Koktekir BE, 2012, CORNEA, V31, P1414, DOI 10.1097/ICO.0b013e318247ec2a; Lei SB, 2017, INVEST OPHTH VIS SCI, V58, P1449, DOI 10.1167/iovs.16-21285; Lei SB, 2015, INVEST OPHTH VIS SCI, V56, P1267, DOI 10.1167/iovs.14-15945; Lei SB, 2014, INVEST OPHTH VIS SCI, V55, P4496, DOI 10.1167/iovs.14-14103; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Main A, 2000, HEADACHE, V40, P194, DOI 10.1046/j.1526-4610.2000.00028.x; Marek V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00497; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Noseda R, 2017, P NATL ACAD SCI USA, V114, pE5683, DOI 10.1073/pnas.1708361114; Noseda R, 2011, CURR OPIN NEUROL, V24, P197, DOI 10.1097/WCO.0b013e3283466c8e; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Okamoto K, 2012, EUR J NEUROSCI, V36, P3492, DOI 10.1111/j.1460-9568.2012.08272.x; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; OP026, 2016, J CROHNS COLITIS, V10, pS21; Ozdemir M, 2010, EYE, V24, P79, DOI 10.1038/eye.2009.21; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; RASMUSSEN BK, 1991, CEPHALALGIA, V11, P129, DOI 10.1046/j.1468-2982.1991.1103129.x; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Sarac O, 2017, OCUL IMMUNOL INFLAMM, V25, P370, DOI 10.3109/09273948.2015.1132739; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Shetty R, 2018, CORNEA, V37, P72, DOI 10.1097/ICO.0000000000001403; Shetty R, 2017, EYE VISION, V4, DOI 10.1186/s40662-017-0070-1; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vanagaite J, 1997, CEPHALALGIA, V17, P733, DOI 10.1046/j.1468-2982.1997.1707733.x; Wong M, 2017, CAN J OPHTHALMOL, V52, P513, DOI 10.1016/j.jcjo.2017.02.019; Yang S, 2017, CURR EYE RES, V42, P837, DOI 10.1080/02713683.2016.1262876	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241490	10.1371/journal.pone.0241490	http://dx.doi.org/10.1371/journal.pone.0241490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125423	gold, Green Published			2022-12-26	WOS:000588368900023
J	Al-Waleedi, AA; Naiene, JD; Thabet, AAK; Dandarawe, A; Salem, H; Mohammed, N; Al Noban, M; Bin-Azoon, NS; Shawqi, A; Rajamanar, M; Al-Jariri, R; Al Hyubaishi, M; Khanbari, L; Thabit, N; Obaid, B; Baaees, M; Assaf, D; Senga, M; Bashir, IM; Mahmoud, N; Cosico, R; Smith, P; Musani, A				Al-Waleedi, Ali Ahmed; Naiene, Jeremias D.; Thabet, Ahmed A. K.; Dandarawe, Adham; Salem, Hanan; Mohammed, Nagat; Al Noban, Maysa; Bin-Azoon, Nasreen Salem; Shawqi, Ammar; Rajamanar, Mohammed; Al-Jariri, Riyadh; Al Hyubaishi, Mansoor; Khanbari, Lina; Thabit, Najib; Obaid, Basel; Baaees, Manal; Assaf, Denise; Senga, Mikiko; Bashir, Ismail Mahat; Mahmoud, Nuha; Cosico, Roy; Smith, Philip; Musani, Altaf			The first 2 months of the SARS-CoV-2 epidemic in Yemen: Analysis of the surveillance data	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; QAT; COVID-19; WUHAN	Introduction Yemen was one of the last countries in the world to declare the first case of the pandemic, on 10 April 2020. Fear and concerns of catastrophic outcomes of the epidemic in Yemen were immediately raised, as the country is facing a complex humanitarian crisis. The purpose of this report is to describe the epidemiological situation in Yemen during the first 2 months of the SARS-CoV-2 epidemic. Methods We analyzed the epidemiological data from 18 February to 05 June 2020, including the 2 months before the confirmation of the first case. We included in our analysis the data from 10 out of 23 governorates of Yemen, located in southern and eastern part of the country. Results A total of 469 laboratory confirmed, 552 probable and 55 suspected cases with onset of symptoms between 18 February and 5 June 2020 were reported through the surveillance system. The median age among confirmed cases was 46 years (range: 1-90 years), and 75% of the confirmed cases were male. A total of 111 deaths were reported among those with confirmed infection. The mean age among those who died was 53 years (range: 14-88 years), with 63% of deaths (n = 70) occurring in individuals under the age 60 years. A total of 268 individuals with confirmed SARS-CoV-2 infection were hospitalized (57%), among whom there were 95 in-hospital deaths, Conclusions The surveillance strategy implemented in the first 2 months of the SARS CoV 2 in the southern and eastern governorates of Yemen, captured mainly severe cases. The mild and moderate cases were not self-reported to the health facilities and surveillance system due to limited resources, stigma, and other barriers. The mortality appeared to be higher in individuals aged under 60 years, and most fatalities occurred in individuals who were in critical condition when they reached the health facilities. It is unclear whether the presence of other acute comorbidities contributed to the high death rate among SARS-CoV-2 cases. The findings only include the southern and eastern part of the country, which is home to 31% of the total population of Yemen, as the data from the northern part of the country was inaccessible for analysis. This makes our results not generalizable to the rest of the country.	[Al-Waleedi, Ali Ahmed; Dandarawe, Adham; Salem, Hanan; Mohammed, Nagat; Al Noban, Maysa; Bin-Azoon, Nasreen Salem; Shawqi, Ammar; Rajamanar, Mohammed; Al-Jariri, Riyadh; Al Hyubaishi, Mansoor] Minist Publ Hlth & Populat, Aden, Yemen; [Naiene, Jeremias D.; Thabet, Ahmed A. K.; Khanbari, Lina; Thabit, Najib; Obaid, Basel; Baaees, Manal; Assaf, Denise; Senga, Mikiko; Bashir, Ismail Mahat; Mahmoud, Nuha; Cosico, Roy; Smith, Philip; Musani, Altaf] WHO, Sanaa, Yemen	World Health Organization	Naiene, JD (corresponding author), WHO, Sanaa, Yemen.	naienej@who.int		Naiene, Jeremias/0000-0003-1594-0786; BASHIR, ISMAIL MAHAT/0000-0001-5614-2436				Abdi M, 2020, INFECT CONT HOSP EP, V41, P754, DOI 10.1017/ice.2020.86; Al-Awlaqi Sameh, 2020, Public Health Pract (Oxf), V1, P100015, DOI 10.1016/j.puhip.2020.100015; Ali Aiman A, 2007, Int J Environ Res Public Health, V4, P243, DOI 10.3390/ijerph2007030008; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; Breevoort A, 2020, NAT COMMUN, P19, DOI [10.1038/s41467-019-13842-7, DOI 10.1038/S41467-019-13842-7]; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Daw MA, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101652; Devi S, 2020, LANCET, V395, P1683, DOI 10.1016/S0140-6736(20)31235-6; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Favre G, 2020, LANCET INFECT DIS, V20, P776, DOI [10.1016/S1473-3099(20)30244-9 32224313, DOI 10.1016/S1473-3099(20)30244-9]; Guan W, 2020, EUR RESPIR J, V55, P2000562, DOI [10.1183/13993003.00562-2020, DOI 10.1183/13993003.00562-2020]; Gupta A, 2020, MODEL EARTH SYST ENV, V6, P2645, DOI 10.1007/s40808-020-00838-2; Hassan NAGM, 2002, ANN SAUDI MED, V22, P34, DOI 10.5144/0256-4947.2002.34; Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w; Kadi H, 2020, INT J CLIN VIROL, DOI [10.29328/journal.ijcv.1001012, DOI 10.29328/JOURNAL.IJCV.1001012]; KENNEDY JG, 1983, SOC SCI MED, V17, P783, DOI 10.1016/0277-9536(83)90029-1; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Li X, 2020, INT J INFECT DIS, V94, P128, DOI 10.1016/j.ijid.2020.03.053; MCKEE CM, 1987, J ROY SOC MED, V80, P762, DOI 10.1177/014107688708001213; Nagbe T, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.supp.2019.33.2.16820; Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378; Patel Jayshil J, 2018, J Intensive Care Soc, V19, P319, DOI 10.1177/1751143718765412; Poole DN, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01162-y; Rabi FA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030231; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722; Thabet A. A. K., 2012, Natural Science, V4, P803, DOI 10.4236/ns.2012.411107; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545, DOI DOI 10.1016/S2214-109X(20)30068-1; Vannabouathong C, 2020, J BONE JOINT SURG AM, V102, P734, DOI 10.2106/JBJS.20.00396; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Weah Vera Darling, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.2b7f352af0866accbd7e5a82f165432a; World Health Organization, 2020, GLOB SURV COVID 19 V; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Xydakis MS, 2020, LANCET INFECT DIS, V20, P1015, DOI 10.1016/S1473-3099(20)30293-0; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5	38	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241260	10.1371/journal.pone.0241260	http://dx.doi.org/10.1371/journal.pone.0241260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119720	Green Published, gold			2022-12-26	WOS:000600013600102
J	Kiaghadi, A; Rifai, HS; Liaw, W				Kiaghadi, Amin; Rifai, Hanadi S.; Liaw, Winston			Assessing COVID-19 risk, vulnerability and infection prevalence in communities	PLOS ONE			English	Article							IMPACTS; STATES; INCOME; OZONE; NOX	Background The spread of coronavirus in the United States with nearly five and half million confirmed cases and over 170,000 deaths has strained public health and health care systems. While many have focused on clinical outcomes, less attention has been paid to vulnerability and risk of infection. In this study, we developed a planning tool that examines factors that affect vulnerability to COVID-19. Methods Across 46 variables, we defined five broad categories: 1) access to medical services, 2) underlying health conditions, 3) environmental exposures, 4) vulnerability to natural disasters, and 5) sociodemographic, behavioral, and lifestyle factors. The developed tool was validated by comparing the estimated overall vulnerability with the real-time reported normalized confirmed cases of COVID-19. Analysis A principal component analysis was undertaken to reduce the dimensions. In order to identify vulnerable census tracts, we conducted rank-based exceedance and K-means cluster analyses. Results All of the 5 vulnerability categories, as well as the overall vulnerability, showed significant (P-values <<0.05) and relatively strong correlations (0.203<rho<0.57) with the normalized confirmed cases of COVID-19 at the census tract level. Our study showed a total of 722,357 (similar to 17% of the County population) people, including 171,403 between the ages of 45-65 (similar to 4% of County's population), and 76,719 seniors (similar to 2% of County population), are at a higher risk based on the aforementioned categories. The exceedance and K-means cluster analysis demonstrated that census tracts in the northeastern, eastern, southeastern and northwestern regions of the County are at highest risk. Conclusion Policymakers can use this planning tool to identify neighborhoods at high risk for becoming hot spots; efficiently match community resources with needs, and ensure that the most vulnerable have access to equipment, personnel, and medical interventions.	[Kiaghadi, Amin; Rifai, Hanadi S.] Univ Houston, Civil & Environm Engn, Houston, TX 77004 USA; [Kiaghadi, Amin] Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA; [Liaw, Winston] Univ Houston, Coll Med, Hlth Syst & Populat Hlth Sci, Houston, TX USA	University of Houston System; University of Houston; University of Texas System; University of Texas Austin; University of Houston System; University of Houston	Rifai, HS (corresponding author), Univ Houston, Civil & Environm Engn, Houston, TX 77004 USA.	rifai@uh.edu		Liaw, Winston/0000-0002-7865-1685	National Science Foundation [1759440, 1840607]; Hurricane Resilience Research Institute (HuRRI) [65686]	National Science Foundation(National Science Foundation (NSF)); Hurricane Resilience Research Institute (HuRRI)	HSR received National Science Foundation (nsf.gov) grant #1759440 and #1840607 and Hurricane Resilience Research Institute (HuRRI) grant #65686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla B., 2020, J INFRASTRUCT PRESER, V1, P6, DOI [10.1186/s43065-020-00004-z, DOI 10.1186/S43065-020-00006-X, DOI 10.1186/S43065-020-00004-Z]; Adams M. L., 2020, POPULATION BASED EST, DOI [10.1101/2020.03.30.20043919, DOI 10.1101/2020.03.30.20043919]; Bennett JE, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002856; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chin Taylor, 2020, medRxiv, DOI 10.1101/2020.04.08.20058248; COCC, 2020, CIT CORP CHRIST COVI; Conticini E, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114465; Currie J, 2014, ANNU REV RESOUR ECON, V6, P217, DOI 10.1146/annurev-resource-100913-012610; Erickson TB, 2019, J TOXICOL ENV HEAL B, V22, P157, DOI 10.1080/10937404.2019.1654422; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Harris County Health System, 2020, HARRIS HLTH SYSTEM L; HCPH, 2020, HARR COUNTH COVID 19; Health Resources and Services Administration (HRSA), 2020, HLTH CTR PROGR DAT C; HealthLanscape, 2020, 500 CITIES MAPPER; Hossain MS., 2020, INT J URBAN SUSTAIN, V99, P1; Institute of Medicine (US) Committee, 2001, CROSSING QUALITY CHA, P1, DOI [DOI 10.17226/10027, 10.17226/10027]; Islam MS, 2016, ENVIRON ENG SCI, V33, P270, DOI 10.1089/ees.2015.0564; Kiaghadi A, 2019, ENVIRON SCI TECHNOL, V53, P4832, DOI 10.1021/acs.est.9b00792; Landrigan PJ, 2015, ENVIRON HEALTH PERSP, V123, P909, DOI 10.1289/ehp.1409247; Lewnard JA, 2020, INCIDENCE CLIN OUTCO, DOI [10.1101/2020.04.12.20062943, DOI 10.1101/2020.04.12.20062943]; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Manson S, 2019, IPUMS NATL HIST GEOG, V14; Marcantonio RA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226958; Microsoft, 2020, MICROSOFT BING MAPS; Nayak Aditi, 2020, medRxiv, DOI 10.1101/2020.04.10.20060962; Nelson A, 2002, J NATL MED ASSOC, V94, P666; Nogee D, 2020, INFECT CONT HOSP EP, V41, P958, DOI 10.1017/ice.2020.124; Opportunity Zones, 2020, OPPORTUNITY ZONES; Parohan M, 2020, MEDRXIV, DOI [10.1101/2020.04.09.20056291, DOI 10.1101/2020.04.09.20056291]; Patanavanich Roengrudee, 2020, medRxiv, DOI 10.1101/2020.04.13.20063669; Patil VH., PARALLEL ANAL ENGINE; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794]; Ranjan R., 2020, ESTIMATING FINAL EPI, V1, P1, DOI [10.1101/2020.04.12.20061002, DOI 10.1101/2020.04.12.20061002, 10.1101/2020.04.12.20061002.]; Sadeghi B, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114345; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Souri AH, 2016, ATMOS RES, V174, P124, DOI 10.1016/j.atmosres.2016.02.007; Souri AH, 2016, ATMOS ENVIRON, V131, P371, DOI 10.1016/j.atmosenv.2016.02.020; Stephanie Lamm, 2020, HOUSTON CHRONICLE; Tahmasebi P., 2020, DO ENV EC HLTH FACTO, DOI [10.1101/2020.04.09.20059659, DOI 10.1101/2020.04.09.20059659]; Tang T., 2020, CLIN INFECT DIS, V71, P324, DOI [10.1093/cid/ciaa423, DOI 10.1093/CID/CIAA423]; Texas Commission on Environmental Quality, 2020, TEXAS AIR MONITORING; Texas Commission on Environmental Quality, 2020, TCEQ GIS DATA; The Department of Homeland Security, 2018, HOMELAND INFRASTRUCT; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; U.S. Census, 2019, NEW CENS BUR EST SHO; U.S. Environmental Protection Agency, 2019, SUPERFUND NATL PRIOR; U.S. Federal Emergency Management Administration (FEMA), 2018, FEMA HARVEY DAMAGE A, DOI 10.4211/hs.73c4f3dcff884a6da2c0982df769987c; Wang FH, 2008, APPL GEOGR, V28, P259, DOI 10.1016/j.apgeog.2008.07.004; Wang Y, 2020, MATER HIGH TEMP, V37, P155, DOI 10.1080/09603409.2020.1731257; Webber WB, 2017, J ENVIRON HEALTH, V80, P22; Wermund Benjamin, 2020, HOUSTON CHRONICLE; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Yang WT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072563	58	17	17	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241166	10.1371/journal.pone.0241166	http://dx.doi.org/10.1371/journal.pone.0241166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119721	gold, Green Published, Green Submitted			2022-12-26	WOS:000600013600079
J	Almeida-de-Oliveira, NK; de Abreu-Fernandes, R; Lima-Cury, L; de Lavigne, AR; de Pina-Costa, A; Perce-da-Silva, DD; Catanho, M; Rossi, AD; Brasil, P; Daniel-Ribeiro, CT; Ferreira-da-Cruz, MD				Almeida-de-Oliveira, Natalia Ketrin; de Abreu-Fernandes, Rebecca; Lima-Cury, Lidiane; de Lavigne, Aline Rosa; de Pina-Costa, Anielle; Perce-da-Silva, Daiana de Souza; Catanho, Marcos; Rossi, Atila Duque; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima			Balancing selection and high genetic diversity of Plasmodium vivax circumsporozoite central region in parasites from Brazilian Amazon and Rio de Janeiro Atlantic Forest	PLOS ONE			English	Article							POPULATION-GENETICS; CELL EPITOPES; MALARIA; PROTEIN; PVCSP; PVMSP-3-ALPHA; POLYMORPHISM; INDIVIDUALS; FREQUENCY; AREAS	Circumsporozoite protein (CSP) is the primary pre-erythrocytic vaccine target in Plasmodium species. Knowledge about their genetic diversity can help predict vaccine efficacy and the spread of novel parasite variants. Thus, we investigated pvcsp gene polymorphisms in 219 isolates (136 from Brazilian Amazon [BA], 71 from Rio de Janeiro Atlantic Forest [AF], and 12 from non-Brazilian countries [NB]). Forty-eight polymorphic sites were detected, 46 in the central repeat region (CR), and two in the C-terminal region. Also, the CR presents InDels and a variable number of repeats. All samples correspond to the VK210 variant, and 24 VK210 subtypes based on CR. Nucleotide diversity (pi = 0.0135) generated a significant number of haplotypes (168) with low genetic differentiation between the Brazilian regions (F-st = 0.208). The haplotype network revealed similar distances among the BA and AF regions. The linkage disequilibrium indicates that recombination does not seem to be acting in diversity, reinforcing natural selection's role in accelerating adaptive evolution. The high diversity (low F-st) and polymorphism frequencies could be indicators of balancing selection. Although malaria in BA and AF have distinct vector species and different host immune pressures, consistent genetic signature was found in two regions. The immunodominant B-cell epitope mapped in the CR varies from seven to 19 repeats. The CR T-cell epitope is conserved only in 39 samples. Concerning to C-terminal region, the Th2R epitope presented nonsynonymous SNP only in 6% of Brazilian samples, and the Th3R epitope remained conserved in all studied regions. We conclude that, although the uneven distribution of alleles may jeopardize the deployment of vaccines directed to a specific variable locus, a unique vaccine formulation could protect populations in all Brazilian regions.	[Almeida-de-Oliveira, Natalia Ketrin; de Abreu-Fernandes, Rebecca; Lima-Cury, Lidiane; de Lavigne, Aline Rosa; Perce-da-Silva, Daiana de Souza; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Lab Pesquisa Malaria, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil; [Almeida-de-Oliveira, Natalia Ketrin; de Abreu-Fernandes, Rebecca; Lima-Cury, Lidiane; de Lavigne, Aline Rosa; de Pina-Costa, Anielle; Perce-da-Silva, Daiana de Souza; Brasil, Patricia; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Reference Lab Malaria Extra Amazonian Reg Brazili, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil; [de Pina-Costa, Anielle; Brasil, Patricia] Fiocruz MS, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [de Pina-Costa, Anielle] Ctr Univ Serra Orgaos UNIFESO, Rio De Janeiro, Brazil; [Catanho, Marcos] Fiocruz MS, Lab Genet Mol Microrganismos, IOC, Rio De Janeiro, Brazil; [Rossi, Atila Duque] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Ferreira-da-Cruz, MD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Pesquisa Malaria, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.; Ferreira-da-Cruz, MD (corresponding author), Reference Lab Malaria Extra Amazonian Reg Brazili, Ctr Pesquisa Diagnost & Treinamento Malaria CPD M, Rio De Janeiro, Brazil.	mffcruz28@gmail.com	Brasil, Patricia/P-3536-2014; Rossi, Atila Duque/AAV-6079-2020; Oliveira, Natalia/AAJ-8331-2021	Rossi, Atila Duque/0000-0001-6235-8807; Oliveira, Natalia/0000-0002-3944-0439; Brasil, Patricia/0000-0001-9555-7976	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fiocruz/Centro de Integracao Empresa/Escola (CIEE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310445/2017-5, 306025/20183]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [E-26/202.921/2018, E-26/203.295/2015]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fiocruz/Centro de Integracao Empresa/Escola (CIEE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	NKAO is recipient of a Doctoral Fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; https://www.capes.gov.br/); RAF is recipient of a Scientific Initiation with support of Scholarship from the Fiocruz/Centro de Integracao Empresa/Escola (CIEE; https://portal.ciee.org.br/rj); CTDR (310445/2017-5) and MFFC (306025/20183) are recipients of Research Productivity Fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://www.cnpq.br/); CTDR (E-26/202.921/2018) and MFFC (E-26/203.295/2015) are "Cientistas do Nosso Estado" from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ; http://www.faperj.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-de-Oliveira NK, 2020, INFECT GENET EVOL, V86, DOI 10.1016/j.meegid.2020.104592; Almeida-de-Oliveira NK, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03159-y; Hernandez-Martinez MA, 2011, AM J TROP MED HYG, V84, P51, DOI 10.4269/ajtmh.2011.09-0785; Anon, 2013, MACQUARIE DISPATCH, V12, P1; [Anonymous], 2012, ANTITRUST SOURCE, V11, P1; Garrido-Cardenas JA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111928; Arevalo-Herrera M, 2002, PARASITE IMMUNOL, V24, P161, DOI 10.1046/j.1365-3024.2002.00449.x; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arevalo-Herrera M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005070; ARNOT DE, 1985, SCIENCE, V230, P815, DOI 10.1126/science.2414847; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Bonilla JA, 2006, AM J TROP MED HYG, V75, P830, DOI 10.4269/ajtmh.2006.75.830; Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9; Buery JC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2080-9; Chan CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119475; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-68; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Cowell AN, 2019, BRIEF FUNCT GENOMICS, V18, P314, DOI 10.1093/bfgp/elz008; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; de Oliveira TC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005824; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001; Dias S, 2013, GENE, V518, P381, DOI 10.1016/j.gene.2013.01.003; Fong MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137734; Fu F, 2019, INFECT GENET EVOL, V70, P9, DOI 10.1016/j.meegid.2019.02.008; George MT, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00194-19; Gonzalez-Ceron L, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3331-0; Herrera S, 2004, INT J PARASITOL, V34, P1535, DOI 10.1016/j.ijpara.2004.10.009; HERRERA S, 1992, J IMMUNOL, V148, P3986; Howes RE, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.16-0141; HUDSON RR, 1992, GENETICS, V132, P583; Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935; Kaur H, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2939-z; Kelly JK, 1997, GENETICS, V146, P1197; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Lewis C. F., 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Lim CS, 2001, ANN TROP MED PARASIT, V95, P229, DOI 10.1080/00034980120053997; Liu Y, 2018, MALAR J, V17, DOI [10.1186/s12936-017-2160-x, DOI 10.1186/S12936-017-2160-X]; Lopez C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00126; Machado Ricardo Luiz Dantas, 2003, Braz J Infect Dis, V7, P175, DOI 10.1590/S1413-86702003000300002; Machado RLD, 2000, T ROY SOC TROP MED H, V94, P377, DOI 10.1016/S0035-9203(00)90110-X; Miguel RB, 2014, MEM I OSWALDO CRUZ, V109, P634, DOI 10.1590/0074-0276130558; Ministerio da Saude, 2019, WHATS HAPP PENS REF; Moon SU, 2009, ACTA TROP, V109, P30, DOI 10.1016/j.actatropica.2008.09.006; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Pacheco MA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007310; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Patil A, 2010, INFECT GENET EVOL, V10, P298, DOI 10.1016/j.meegid.2010.01.006; Pereira S, 2018, 2018 INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND APPLICATIONS (ICBEA), P7; Pratt-Riccio LR, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190054; QARI SH, 1992, MOL BIOCHEM PARASIT, V55, P105, DOI 10.1016/0166-6851(92)90131-3; Raza A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-16; Ribeiro BD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004479; Rich SM, 1997, P NATL ACAD SCI USA, V94, P13040, DOI 10.1073/pnas.94.24.13040; Rodrigues PT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19554-0; Rozas J, 2001, GENETICS, V158, P1147; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Ruan W, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0302-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; de Abreu FVS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007906; Santos EDA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45809-5; Santos Erian de Almeida, 2016, Revista Pan-Amazonica de Saude, V7, P57; Saralamba N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2413-3; Shabani SH, 2016, ACTA TROP, V160, P23, DOI 10.1016/j.actatropica.2016.04.006; Souza-Neiras WC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-178; TAJIMA F, 1989, GENETICS, V123, P585; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Talha AA, 2015, INFECT GENET EVOL, V32, P12, DOI 10.1016/j.meegid.2015.02.004; Taylor WRJ, 2019, LANCET, V394, P929, DOI 10.1016/S0140-6736(19)31285-1; Tham WH, 2017, INT J PARASITOL, V47, P111, DOI 10.1016/j.ijpara.2016.09.006; Torres KL, 2006, PARASITOL RES, V98, P519, DOI 10.1007/s00436-005-0085-8; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; WHO, 2019, WORLD MALARIA REPORT; Zakeri S, 2010, PARASITOL INT, V59, P15, DOI 10.1016/j.parint.2009.06.006; Zhang LL, 2018, EXP PARASITOL, V188, P26, DOI 10.1016/j.exppara.2018.03.001	79	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241426	10.1371/journal.pone.0241426	http://dx.doi.org/10.1371/journal.pone.0241426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166298	gold, Green Published			2022-12-26	WOS:000592382600046
J	Gu, CH; Zhao, CY; Hofstaedter, C; Tebas, P; Glaser, L; Baldassano, R; Bittinger, K; Mattei, LM; Bushman, FD				Gu, Christopher H.; Zhao, Chunyu; Hofstaedter, Casey; Tebas, Pablo; Glaser, Laurel; Baldassano, Robert; Bittinger, Kyle; Mattei, Lisa M.; Bushman, Frederic D.			Investigating hospital Mycobacterium chelonae infection using whole genome sequencing and hybrid assembly	PLOS ONE			English	Article							RESISTANCE; TUBERCULOSIS; OUTBREAK; GENE; SMEGMATIS	Mycobacterium chelonae is a rapidly growing nontuberculous mycobacterium that is a common cause of nosocomial infections. Here we describe investigation of a possible nosocomial transmission of M. chelonae at the Hospital of the University of Pennsylvania (HUP). M. chelonae strains with similar high-level antibiotic resistance patterns were isolated from two patients who developed post-operative infections at HUP in 2017, suggesting a possible point source infection. The isolates, along with other clinical isolates from other patients, were sequenced using the Illumina and Oxford Nanopore technologies. The resulting short and long reads were hybrid assembled into draft genomes. The genomes were compared by quantifying single nucleotide variants in the core genome and assessed using a control dataset to quantify error rates in comparisons of identical genomes. We show that all M. chelonae isolates tested were highly dissimilar, as indicated by high pairwise SNV values, consistent with environmental acquisition and not a nosocomial point source. Our control dataset determined a threshold for evaluating identity between strains while controlling for sequencing error. Finally, antibiotic resistance genes were predicted for our isolates, and several single nucleotide variants were identified that have the potential to modulated drug resistance.	[Gu, Christopher H.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Zhao, Chunyu; Hofstaedter, Casey; Baldassano, Robert; Bittinger, Kyle; Mattei, Lisa M.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Tebas, Pablo] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Glaser, Laurel] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.; Bittinger, K; Mattei, LM (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.	bittingerk@email.chop.edu; matteil@email.chop.edu; bushman@pennmedicine.upenn.edu		Hofstaedter, Casey/0000-0003-2798-1382; GU, CHRISTOPHER/0000-0001-8604-1409; Mattei, Lisa/0000-0002-2238-0281	Penn Center for AIDS Research [P30 AI 045008]; PennCHOP Microbiome Program	Penn Center for AIDS Research; PennCHOP Microbiome Program	This work was supported by the Penn Center for AIDS Research P30 AI 045008 (https://www.med.upenn.edu/cfar)under FDB; and the PennCHOP Microbiome Program (https://pennchopmicrobiome.chop.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram SM, 2019, MYCOBACTERIUM CHELON; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Clarke EL, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0658-x; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Das S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30152-y; Donohue MJ, 2016, ANN AM THORAC SOC, V13, P2143, DOI 10.1513/AnnalsATS.201605-353OC; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freitas D, 2003, OPHTHALMOLOGY, V110, P276, DOI 10.1016/S0161-6420(02)01643-3; Hatakeyama S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2298-8; Hillemann D, 2008, ANTIMICROB AGENTS CH, V52, P800, DOI 10.1128/AAC.01189-07; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Lande L, 2019, EMERG INFECT DIS, V25, P473, DOI 10.3201/eid2503.180336; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Madsen CT, 2005, ANTIMICROB AGENTS CH, V49, P3803, DOI 10.1128/AAC.49.9.3803-3809.2005; McNabb A, 2004, J CLIN MICROBIOL, V42, P3000, DOI 10.1128/JCM.42.7.3000-3011.2004; Meyers H, 2002, CLIN INFECT DIS, V34, P1500, DOI 10.1086/340399; Monego F, 2012, MICROB DRUG RESIST, V18, P1, DOI 10.1089/mdr.2011.0047; Nash KA, 2003, ANTIMICROB AGENTS CH, V47, P3053, DOI 10.1128/AAC.47.10.3053-3060.2003; Nessar R, 2011, J ANTIMICROB CHEMOTH, V66, P1719, DOI 10.1093/jac/dkr209; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rouquette C, 1999, MOL MICROBIOL, V33, P651, DOI 10.1046/j.1365-2958.1999.01517.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Tuite AR, 2013, INT J TUBERC LUNG D, V17, P1322, DOI 10.5588/ijtld.13.0145; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Wallace RJ, 2002, ANTIMICROB AGENTS CH, V46, P3164, DOI 10.1128/AAC.46.10.3164-3167.2002; Wang HX, 2010, CHINESE MED J-PEKING, V123, P184, DOI 10.3760/cma.j.issn.0366-6999.2010.02.011; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0236533	10.1371/journal.pone.0236533	http://dx.doi.org/10.1371/journal.pone.0236533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166284	Green Published, Green Submitted, gold			2022-12-26	WOS:000592382600019
J	Kang, J; Lee, A; Lee, YS				Kang, Jun; Lee, Ahwon; Lee, Youn Soo			Prediction of PIK3CA mutations from cancer gene expression data	PLOS ONE			English	Article								Breast cancers with PIK3CA mutations can be treated with PIK3CA inhibitors in hormone receptor-positive HER2 negative subtypes. We applied a supervised elastic net penalized logistic regression model to predict PIK3CA mutations from gene expression data. This regression approach was applied to predict modeling using the TCGA pan-cancer dataset. Approximately 10,000 cases were available for PIK3CA mutation and mRNA expression data. In 10-fold cross-validation, the model with lambda = 0.01 and alpha = 1.0 (ridge regression) showed the best performance, in terms of area under the receiver operating characteristic (AUROC). The final model was developed with selected hyper-parameters using the entire training set. The training set AUROC was 0.93, and the test set AUROC was 0.84. The area under the precision-recall (AUPR) of the training set was 0.66, and the test set AUPR was 0.39. Cancer types were the most important predictors. Both insulin like growth factor 1 receptor (IGF1R) and the phosphatase and tensin homolog (PTEN) were the most significant genes in gene expression predictors. Our study suggests that predicting genomic alterations using gene expression data is possible, with good outcomes.	[Kang, Jun; Lee, Ahwon; Lee, Youn Soo] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Lee, YS (corresponding author), Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul St Marys Hosp, Seoul, South Korea.	lys9908@catholic.ac.kr		Kang, Jun/0000-0002-7967-0917				Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904; [Anonymous], HLTH C D R NUCL ACID; Asahara A, 2020, APPL PHYS EXPRESS, V13, DOI 10.35848/1882-0786/ab8b4f; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Dercle L, 2020, CLIN CANCER RES, V26, P2151, DOI 10.1158/1078-0432.CCR-19-2942; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; He XY, 2020, CANCER COMMUN, V40, P105, DOI 10.1002/cac2.12016; Jacobsen A., 2019, CGDSR R BASED API AC; Kuhn M., 2020, TIDYMODELS EASILY IN; Kuhn M, 2020, RECIPES PREPROCESSIN; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Mu Q, 2019, IEEE ACM T COMPUT BI, P1, DOI [10.1371/journal.pone.0015647, DOI 10.1371/JOURNAL.PONE.0015647]; Sahnane N, 2013, DIAGN MOL PATHOL, V22, P196, DOI 10.1097/PDM.0b013e3182893f55; Way GP, 2018, CELL REP, V23, P172, DOI 10.1016/j.celrep.2018.03.046	18	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241514	10.1371/journal.pone.0241514	http://dx.doi.org/10.1371/journal.pone.0241514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166334	Green Published, gold			2022-12-26	WOS:000592382600068
J	Ribeiro, JAM; Oliveira, AGD; Di Thommazo-Luporini, L; Monteiro, CI; Ocamoto, GN; Catai, AM; Borghi-Silva, A; Phillips, SA; Russo, TL				Matos Ribeiro, Jean Alex; da Silva Oliveira, Acson Gustavo; Di Thommazo-Luporini, Luciana; Monteiro, Clara Italiano; Ocamoto, Gabriela Nagai; Catai, Aparecida Maria; Borghi-Silva, Audrey; Phillips, Shane A.; Russo, Thiago Luiz			Underlying mechanisms of oxygen uptake kinetics in chronic post-stroke individuals: A correlational, cross-sectional pilot study	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; HEALTH-CARE PROFESSIONALS; AMBULATORY ACTIVITY; SKELETAL-MUSCLE; EXERCISE INTENSITY; PHYSICAL-ACTIVITY; STROKE; FITNESS; DURATION; RELIABILITY	Post-stroke individuals presented deleterious changes in skeletal muscle and in the cardiovascular system, which are related to reduced oxygen uptake (V9;O2) and take longer to produce energy from oxygen-dependent sources at the onset of exercise (mean response time, MTRON) and during post-exercise recovery (MRTOFF). However, to the best of our knowledge, no previous study has investigated the potential mechanisms related to VO2 kinetics response (MRTON and MRTOFF) in post-stroke populations. The main objective of this study was to determine whether the MTRON and MRTOFF are related to: 1) body composition; 2) arterial compliance; 3) endothelial function; and 4) hematological and inflammatory profiles in chronic post-stroke individuals. Data on oxygen uptake (VO2) were collected using a portable metabolic system (Oxycon Mobile(R)) during the six-minute walk test (6MWT). The time to achieve 63% of VO2 during a steady state (MTRON) and recovery (MRTOFF) were analyzed by the monoexponential model and corrected by a work rate (wMRT(ON) and wMRT(OFF)) during 6MWT. Correlation analyses were made using Spearman's rank correlation coefficient (r(s)) and the bias-corrected and accelerated bootstrap method was used to estimate the 95% confidence intervals. Twenty-four post-stroke participants who were physically inactive took part in the study. The wMRT(OFF) was correlated with the following: skeletal muscle mass (r(s) = -0.46), skeletal muscle mass index (r(s) = -0.45), augmentation index (r(s) = 0.44), augmentation index normalized to a heart rate of 75 bpm (r(s) = 0.64), reflection magnitude (r(s) = 0.43), erythrocyte (r(s) = -0.61), hemoglobin (r(s) = -0.54), hematocrit (r(s) = -0.52) and high-sensitivity C-reactive protein (r(s) = 0.58), all p < 0.05. A greater amount of oxygen uptake during post-walking recovery is partially related to lower skeletal muscle mass, greater arterial stiffness, reduced number of erythrocytes and higher systemic inflammation in post-stroke individuals.	[Matos Ribeiro, Jean Alex; da Silva Oliveira, Acson Gustavo; Di Thommazo-Luporini, Luciana; Monteiro, Clara Italiano; Ocamoto, Gabriela Nagai; Catai, Aparecida Maria; Borghi-Silva, Audrey; Russo, Thiago Luiz] Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, Brazil; [Phillips, Shane A.] Univ Illinois, Dept Phys Therapy, Coll Appl Hlth Sci, Chicago, IL USA	Universidade Federal de Sao Carlos; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Russo, TL (corresponding author), Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, Brazil.	russo@ufscar.br	Russo, Thiago/B-7555-2012	Russo, Thiago/0000-0002-5483-3097	Coordination for the Improvement of Higher Education Personnel CAPES [001]; Sao Paulo Research Foundation - FAPESP [2017/13655-6, 2017/22173-5]; National Council for Scientific and Technological Development - CNPq [442972/2014-8]	Coordination for the Improvement of Higher Education Personnel CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Brazilian Government Funding Agencies: Coordination for the Improvement of Higher Education Personnel CAPES (Finance Code 001), the Sao Paulo Research Foundation - FAPESP (funding: 2017/13655-6 and 2017/22173-5) and the National Council for Scientific and Technological Development - CNPq (funding: 442972/2014-8).	Agarwal N, 2009, ACTA HAEMATOL-BASEL, V122, P103, DOI 10.1159/000243794; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Billinger SA, 2018, J STROKE CEREBROVASC, V27, P957, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.039; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Billinger SA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/987637; Billinger SA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/959120; Blum A, 1998, AM HEART J, V135, P181, DOI 10.1016/S0002-8703(98)70080-8; Borsheim E, 2003, SPORTS MED, V33, P1037; Brouwer B, 2009, CLIN BIOMECH, V24, P729, DOI 10.1016/j.clinbiomech.2009.07.004; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Eikelboom John W, 2003, J Stroke Cerebrovasc Dis, V12, P74, DOI 10.1053/jscd.2003.16; Faturi FM, 2019, TOP STROKE REHABIL, V26, P73, DOI 10.1080/10749357.2018.1517511; Ferrucci L, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.06.039; Field A., 2017, DISCOVERING STAT USI; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Fulk GD, 2017, STROKE, V48, P406, DOI 10.1161/STROKEAHA.116.015309; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; George MA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00277; Haeuber E, 2004, ARCH PHYS MED REHAB, V85, P1997, DOI 10.1016/j.apmr.2003.11.035; Hall J.E., 2016, GUYTON HALL TXB MED, Vthirteenth; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; IJmker T, 2013, ARCH PHYS MED REHAB, V94, P2255, DOI 10.1016/j.apmr.2013.04.022; International Business Machines Corporation (IBM), PART RANK CORR SPSS; Jae SY, 2008, AM J CARDIOL, V102, P700, DOI 10.1016/j.amjcard.2008.05.012; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Katoh J, 2002, J PHYS THER SCI, V14, P77, DOI [10.1589/jpts.14.77, DOI 10.1589/JPTS.14.77]; Kern L, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-167; Korzeniewski B, 2013, J APPL PHYSIOL, V115, P605, DOI 10.1152/japplphysiol.00469.2013; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liu PJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-629; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Manns PJ, 2010, J REHABIL MED, V42, P259, DOI 10.2340/16501977-0498; Masahito M., 2002, J PHYS THER SCI, V14, P73, DOI DOI 10.1589/JPTS.14.73; McLay KM, 2017, AM J PHYSIOL-REG I, V312, pR467, DOI 10.1152/ajpregu.00399.2016; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Munro B. H., 2001, STAT METHODS HLTH CA, P223; Murias JM, 2016, SCAND J MED SCI SPOR, V26, P620, DOI 10.1111/sms.12487; Murias JM, 2011, AM J PHYSIOL-REG I, V301, pR218, DOI 10.1152/ajpregu.00060.2011; Myers J, 2017, PROG CARDIOVASC DIS, V60, P21, DOI 10.1016/j.pcad.2017.03.002; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Ribeiro JAM, 2019, PHYS THER, V99, P1656, DOI 10.1093/ptj/pzz122; Rosdahl H, 2010, EUR J APPL PHYSIOL, V109, P159, DOI 10.1007/s00421-009-1326-9; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Silva-Couto MD, 2014, PHYS THER, V94, P957, DOI 10.2522/ptj.20130322; Sions JM, 2012, J GERIATR PHYS THER, V35, P155, DOI 10.1519/JPT.0b013e318236db92; Tomczak CR, 2008, STROKE, V39, P3102, DOI 10.1161/STROKEAHA.108.515346; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; WHO, 2011, WHONMHNHDMNM111; Woodward JL, 2019, PHYS THER, V99, P86, DOI 10.1093/ptj/pzy128; WUYAM B, 1992, EUR RESPIR J, V5, P157; Jae SY, 2006, METABOLISM, V55, P825, DOI 10.1016/j.metabol.2006.02.010	62	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241872	10.1371/journal.pone.0241872	http://dx.doi.org/10.1371/journal.pone.0241872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166347	gold, Green Published			2022-12-26	WOS:000592382600073
J	Townsend, L; Dyer, AH; Jones, K; Dunne, J; Mooney, A; Gaffney, F; O'Connor, L; Leavy, D; O'Brien, K; Dowds, J; Sugrue, JA; Hopkins, D; Martin-Loeches, I; Cheallaigh, CN; Nadarajan, P; McLaughlin, AM; Bourke, NM; Bergin, C; O'Farrelly, C; Bannan, C; Conlon, N				Townsend, Liam; Dyer, Adam H.; Jones, Karen; Dunne, Jean; Mooney, Aoife; Gaffney, Fiona; O'Connor, Laura; Leavy, Deirdre; O'Brien, Kate; Dowds, Joanne; Sugrue, Jamie A.; Hopkins, David; Martin-Loeches, Ignacio; Cheallaigh, Cliona Ni; Nadarajan, Parthiban; McLaughlin, Anne Marie; Bourke, Nollaig M.; Bergin, Colm; O'Farrelly, Cliona; Bannan, Ciaran; Conlon, Niall			Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection	PLOS ONE			English	Article							CHALDER FATIGUE; EXPRESSION; SURVIVORS; SCALE; HIV	Fatigue is a common symptom in those presenting with symptomatic COVID-19 infection. However, it is unknown if COVID-19 results in persistent fatigue in those recovered from acute infection. We examined the prevalence of fatigue in individuals recovered from the acute phase of COVID-19 illness using the Chalder Fatigue Score (CFQ-11). We further examined potential predictors of fatigue following COVID-19 infection, evaluating indicators of COVID-19 severity, markers of peripheral immune activation and circulating pro-inflammatory cytokines. Of 128 participants (49.5 +/- 15 years; 54% female), more than half reported persistent fatigue (67/128; 52.3%) at median of 10 weeks after initial COVID-19 symptoms. There was no association between COVID-19 severity (need for inpatient admission, supplemental oxygen or critical care) and fatigue following COVID-19. Additionally, there was no association between routine laboratory markers of inflammation and cell turnover (leukocyte, neutrophil or lymphocyte counts, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, C-reactive protein) or pro-inflammatory molecules (IL-6 or sCD25) and fatigue post COVID-19. Female gender and those with a pre-existing diagnosis of depression/anxiety were over-represented in those with fatigue. Our findings demonstrate a significant burden of post-viral fatigue in individuals with previous SARS-CoV-2 infection after the acute phase of COVID-19 illness. This study highlights the importance of assessing those recovering from COVID-19 for symptoms of severe fatigue, irrespective of severity of initial illness, and may identify a group worthy of further study and early intervention.	[Townsend, Liam; Cheallaigh, Cliona Ni; Bergin, Colm; Bannan, Ciaran] St James Hosp, Dept Infect Dis, Dublin, Ireland; [Townsend, Liam; Cheallaigh, Cliona Ni; Bergin, Colm; Bannan, Ciaran] Trinity Coll Dublin, Sch Med, Trinity Translat Med Inst, Dept Clin Med, Dublin, Ireland; [Dyer, Adam H.; Jones, Karen; Dunne, Jean; Mooney, Aoife; Gaffney, Fiona; O'Connor, Laura; Leavy, Deirdre; Conlon, Niall] St James Hosp, Dept Immunol, Dublin, Ireland; [Dyer, Adam H.; Bourke, Nollaig M.] Trinity Coll Dublin, Sch Med, Trinity Translat Med Inst, Dept Med Gerontol, Dublin, Ireland; [O'Brien, Kate; Dowds, Joanne] St James Hosp, Dept Physiotherapy, Dublin, Ireland; [Sugrue, Jamie A.; O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Hopkins, David] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Martin-Loeches, Ignacio] St James Hosp, Dept Intens Care Med, Dublin, Ireland; [Nadarajan, Parthiban; McLaughlin, Anne Marie] St James Hosp, Dept Resp Med, Dublin, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Med, Dept Comparat Immunol, Dublin, Ireland; [Conlon, Niall] Trinity Coll Dublin, Sch Med, Dept Immunol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Townsend, L (corresponding author), St James Hosp, Dept Infect Dis, Dublin, Ireland.; Townsend, L (corresponding author), Trinity Coll Dublin, Sch Med, Trinity Translat Med Inst, Dept Clin Med, Dublin, Ireland.	townsenl@tcd.ie	Townsend, Liam/ABH-3502-2020; Bourke, Nollaig/AAE-7279-2019; martin-loeches, Prof. Ignacio/Q-6645-2018	Townsend, Liam/0000-0002-7089-0665; Bourke, Nollaig/0000-0003-4313-6859; Ni Cheallaigh, Cliona/0000-0002-0842-425X; Dyer, Adam/0000-0003-1356-510X; O'Farrelly, Cliona/0000-0002-0616-2874; Nadarajan, Parthiban/0000-0002-1685-1876; martin-loeches, Prof. Ignacio/0000-0002-5834-4063	Wellcome Trust; Health Research Board [203930/B/16/Z]; National Doctors Training and Planning; Health and Social Care, Research and Development Division, Northern Ireland; Science Foundation Ireland (SFI) [20/SPP/3685]	Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; National Doctors Training and Planning; Health and Social Care, Research and Development Division, Northern Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland)	LT has been awarded the Irish Clinical Academic Training (ICAT) Programme, supported by the Wellcome Trust and the Health Research Board (Grant Number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning and the Health and Social Care, Research and Development Division, Northern Ireland (https://icatprogramme.org/).NC is part-funded by a Science Foundation Ireland (SFI) grant, Grant Code 20/SPP/3685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Assessment RR., 2020, COR DIS 2019 COVID 1; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; Barroso J, 2015, J PAIN SYMPTOM MANAG, V50, P69, DOI 10.1016/j.jpainsymman.2015.02.006; Bradley AS, 2013, CLIN EXP IMMUNOL, V172, P73, DOI 10.1111/cei.12043; Brenu EW, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9064529; BUTLER S, 1991, J NEUROL NEUROSUR PS, V54, P153, DOI 10.1136/jnnp.54.2.153; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; CLUFF LE, 1991, REV INFECT DIS, V13, pS138; Coetzee B, 2018, VULNERABLE CHILD YOU, V13, P305, DOI 10.1080/17450128.2018.1510147; COPE H, 1994, LANCET, V344, P864, DOI 10.1016/S0140-6736(94)92833-9; De Vito A, 2020, MEDITERR J HEMATOL I, V12, DOI 10.4084/MJHID.2020.056; Eymard D, 1993, Can J Infect Dis, V4, P199; Faro M, 2016, REUMATOL CLIN, V12, P72, DOI 10.1016/j.reuma.2015.05.007; Galbraith S, 2011, J INFECT DIS, V204, P1632, DOI 10.1093/infdis/jir612; Galeoto G, 2018, CLIN TER, V169, pE184, DOI 10.7417/T.2018.2076; Hamzelou J, 2020, NEW SCI, V245, P10, DOI 10.1016/S0262-4079(20)30746-6; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Heneghan C, 2020, COVID 19 MANY HEALTH; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hunter E, 2020, LANCET, V395, pE77, DOI 10.1016/S0140-6736(20)30970-3; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Jackson C, 2015, OCCUP MED-OXFORD, V65, P86, DOI 10.1093/occmed/kqu168; Jason L, 2009, PATIENT EDUC COUNS, V77, P237, DOI 10.1016/j.pec.2009.02.015; Jeon HO, 2020, PSYCHOL HEALTH MED, V25, P940, DOI 10.1080/13548506.2019.1702218; Katz BZ, 2018, FATIGUE, V6, P106, DOI 10.1080/21641846.2018.1426086; Katz BZ, 2009, PEDIATRICS, V124, P189, DOI 10.1542/peds.2008-1879; Kerr H, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00620-2; Kim BH, 2015, PSYCHIAT RES-NEUROIM, V234, P292, DOI 10.1016/j.pscychresns.2015.10.014; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; Kokubun K, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00154; Komaroff AL, 2011, SEMIN NEUROL; Koopmans PC, 2010, OCCUP MED-OXFORD, V60, P249, DOI 10.1093/occmed/kqq061; Kruesi MJ, 1989, J CLIN PSYCHIAT; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Lee NY, 2020, J MICROBIOL IMMUNOL, V53, P485, DOI 10.1016/j.jmii.2020.03.003; Lee SH, 2019, PSYCHIAT INVEST, V16, P59, DOI 10.30773/pi.2018.10.22.3; Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; M C W., 2020, BMJ, V368, pm544, DOI 10.1136/bmj.l6968; Mihaylova I, 2007, NEUROENDOCRINOL LETT, V28, P477; Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37; Montoya JG, 2017, P NATL ACAD SCI USA, V114, pE7150, DOI 10.1073/pnas.1710519114; Moreh E, 2010, J GERONTOL A-BIOL, V65, P884, DOI 10.1093/gerona/glq064; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Natelson BH, 2002, CLIN DIAGN LAB IMMUN, V9, P747, DOI 10.1128/CDLI.9.4.747-752.2002; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rimes KA, 2010, J PSYCHOSOM RES, V68, P285, DOI 10.1016/j.jpsychores.2009.09.014; Robertson MJ, 2005, CLIN EXP IMMUNOL, V141, P326, DOI 10.1111/j.1365-2249.2005.02833.x; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Stubhaug B, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00720; TAERK GS, 1987, INT J PSYCHIAT MED, V17, P49; Takakura S, 2019, BIOPSYCHOSOC MED, V13, DOI 10.1186/s13030-019-0171-2; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Vink M, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9040124; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Watanabe K, 2022, SOC SCI COMPUT REV, V40, P346, DOI 10.1177/0894439320907027; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zhu JF, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00176	66	309	321	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0240784	10.1371/journal.pone.0240784	http://dx.doi.org/10.1371/journal.pone.0240784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166287	gold, Green Published, Green Submitted			2022-12-26	WOS:000592382600071
J	Rub, MA				Abdul Rub, Malik			Investigation of micellar and interfacial phenomenon of amitriptyline hydrochloride with cationic ester-bonded gemini surfactant mixture in different solvent media	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; CETYLTRIMETHYLAMMONIUM BROMIDE CTAB; DRUG NORTRIPTYLINE HYDROCHLORIDE; MIXED MICELLES; AGGREGATION BEHAVIOR; MOLECULAR-INTERACTIONS; ASSOCIATION BEHAVIOR; NONIONIC SURFACTANTS; PHENOTHIAZINE DRUGS; ANIONIC SURFACTANT	Herein, the interaction among the antidepressant drug amitriptyline hydrochloride (AMT) and a green gemini surfactant, ethane-1, 2-diyl bis(N,N-dimethyl-N-tetradecylammoniumacetoxy) dichloride (14-E2-14), via numerous techniques such as tensiometry, fluorimetry, FT-IR and UV-visible spectroscopy in three different media (aqueous 0.050 mol center dot kg(-1) NaCl, 0.50 and 1.0 mol center dot kg(-1) urea) were investigated. AMT is used to treat mental illness or mood problems, such as depression. The aggregation of biologically active ingredients can enhance the bioavailability of hydrophobic drugs. A significant interaction between AMT and 14-E2-14 was detected by tensiometric study as the critical micelle concentration (cmc) of AMT+14-E2-14 is reduced upon an increase of mole fraction (alpha(1)) of 14-E2-14. The decrease in cmc indicates the nonideality of studied mixtures of different compositions. Although, employed drug AMT is freely soluble in the aqueous and non-aqueous system but is not hydrophobic enough to act as its carrier. Instead, gemini surfactant formed spherical micelles in an aqueous system and their high solubilization capability, as well as their relatively lower cmc value, makes them highly stable in vivo. The cmc values of AMT+14-E-14 mixtures in all cases were further decreased and increased in NaCl and urea solutions respectively as compared with the aqueous system. Numerous micellar, interfacial, and thermodynamic parameters have been measured by applying various theoretical models. The obtained changes in the physicochemical assets of AMT upon adding of 14-E2-14 are likely to enhance the industrial and pharmaceutical applications of gemini surfactants. The negative interaction parameters (beta(m) and beta(sigma)), indicate synergistic attraction is occurring in the mixed systems. The aggregation number (N-agg), Stern-Volmer constant (K-sv), etc. are attained through the fluorescence method, also supporting the attractive interaction behavior of AMT+14-E2-14 mixtures in all solvents. The N-agg was found to increase in the salt solution and decrease in the urea system compared with the aqueous solution. FT-IR and UV-visible analysis also depict the interaction between the constituent alike tensiometry and fluorimetry methods. The results suggested that gemini surfactants may serve as a capable drug delivery agent for antidepressants, improving their bioavailability.	[Abdul Rub, Malik] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia	King Abdulaziz University	Rub, MA (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.	malikrub@gmail.com	Rub, Malik Abdul/H-6027-2012	Rub, Malik Abdul/0000-0002-4798-5308	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-015-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (130-015-D1433). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Akram M, 2016, J IND ENG CHEM, V40, P161, DOI 10.1016/j.jiec.2016.06.019; Akram M, 2016, COLLOID SURFACE A, V493, P32, DOI 10.1016/j.colsurfa.2016.01.005; Alam MS, 2007, J CHEM ENG DATA, V52, P1326, DOI 10.1021/je700045r; [Anonymous], 2011, Z POLITIKWISSENSCHAF, V21, P93; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, INT J COMMUN SYST, V30, pe2999; ASAKAWA T, 1995, LANGMUIR, V11, P2376, DOI 10.1021/la00007a010; Attwood D., 1983, SURFACTANT SYSTEMS T; Azum N, 2019, J MOL LIQ, V290, DOI 10.1016/j.molliq.2019.111187; Azum N, 2017, J MOL LIQ, V240, P189, DOI 10.1016/j.molliq.2017.05.066; Azum N, 2017, J DISPER SCI TECHNOL, V38, P96, DOI 10.1080/01932691.2016.1144197; Bagheri A, 2019, J MOL LIQ, V282, P466, DOI 10.1016/j.molliq.2019.03.015; Bagheri A, 2017, RSC ADV, V7, P18151, DOI 10.1039/c6ra27382c; Bagheri A, 2017, J MOL LIQ, V230, P254, DOI 10.1016/j.molliq.2017.01.024; CLINT JH, 1975, J CHEM SOC FARAD T 1, V71, P1327, DOI 10.1039/f19757101327; Costantino L, 2000, J PHYS CHEM B, V104, P7326, DOI 10.1021/jp0012808; Dar AA, 2008, J COLLOID INTERF SCI, V322, P572, DOI 10.1016/j.jcis.2008.03.022; Das S, 2014, SOFT MATTER, V10, P2863, DOI 10.1039/c3sm52938j; Fatma N, 2015, J MOL LIQ, V211, P247, DOI 10.1016/j.molliq.2015.06.064; Gaikar VG, 2008, J MOL LIQ, V138, P155, DOI 10.1016/j.molliq.2007.10.001; Ghasemi A, 2020, J MOL LIQ, V298, DOI 10.1016/j.molliq.2019.111948; Hierrezuelo JM, 2004, LANGMUIR, V20, P10419, DOI 10.1021/la048278i; Jakubowska A, 2010, J COLLOID INTERF SCI, V346, P398, DOI 10.1016/j.jcis.2010.03.043; Jojart B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102114; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Khan F, 2016, J MOL LIQ, V222, P1020, DOI 10.1016/j.molliq.2016.07.104; KUHARSKI RA, 1984, J AM CHEM SOC, V106, P5786, DOI 10.1021/ja00332a005; KUHARSKI RA, 1984, J AM CHEM SOC, V106, P5794, DOI 10.1021/ja00332a006; Kumar D, 2019, J PHYS ORG CHEM, V32, DOI 10.1002/poc.3918; Kumar D, 2019, J MOL LIQ, V274, P639, DOI 10.1016/j.molliq.2018.11.035; Kumar D, 2018, J MOL LIQ, V271, P254, DOI 10.1016/j.molliq.2018.08.147; Kumar D, 2018, J MOL LIQ, V262, P86, DOI 10.1016/j.molliq.2018.04.053; Kumar D, 2017, J MOL LIQ, V238, P389, DOI 10.1016/j.molliq.2017.05.027; Kumar D, 2016, J PHYS ORG CHEM, V29, P394, DOI 10.1002/poc.3546; Kumar H, 2018, J MOL LIQ, V266, P252, DOI 10.1016/j.molliq.2018.06.082; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; MAEDA H, 1995, J COLLOID INTERF SCI, V172, P98, DOI 10.1006/jcis.1995.1230; Mahajan RK, 2012, PHYS CHEM CHEM PHYS, V14, P887, DOI 10.1039/c1cp22448d; Mahajan S, 2013, ADV COLLOID INTERFAC, V199, P1, DOI 10.1016/j.cis.2013.06.008; Mahajan S, 2013, COLLOID SURFACE A, V424, P96, DOI 10.1016/j.colsurfa.2013.02.032; Mahajan S, 2012, J COLLOID INTERF SCI, V387, P194, DOI 10.1016/j.jcis.2012.07.085; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Motomura K, 1998, MIXED SURFACTANT SYS; Mukerjee P, 1967, ADV COLLOID INTERFAC, V1, P242, DOI [10.1016/0001-8686(67)80005-8, DOI 10.1016/0001-8686(67)80005-8]; Myers S, 2006, AMER MADE MUSIC SER, P3; Padalkar KV, 2009, J MOL LIQ, V144, P40, DOI 10.1016/j.molliq.2008.09.004; Patel H, 2010, BIOPHYS CHEM, V150, P119, DOI 10.1016/j.bpc.2010.03.015; Patel R, 2015, J SURFACTANTS DETERG, V18, P719, DOI 10.1007/s11743-015-1709-3; Ren ZH, 2017, J MOL LIQ, V236, P101, DOI 10.1016/j.molliq.2017.03.083; Rosen M. J., 1978, SURFACTANTS INTERFAC, DOI DOI 10.1002/0471670561; Rosen M.J., 1998, J SURFACTANT DETERG, V1, P547, DOI [10.1007/s11743-998-0057-8, DOI 10.1007/S11743-998-0057-8]; ROSEN MJ, 1982, J COLLOID INTERF SCI, V86, P164, DOI 10.1016/0021-9797(82)90052-2; Rub MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211077; Rub MA, 2018, J CHEM THERMODYN, V121, P199, DOI 10.1016/j.jct.2018.02.019; Rub MA, 2017, J CHEM ENG DATA, V62, P3216, DOI 10.1021/acs.jced.7b00298; Rub MA, 2017, J MOL LIQ, V241, P91, DOI 10.1016/j.molliq.2017.05.143; Rub MA, 2017, J MOL LIQ, V227, P1, DOI 10.1016/j.molliq.2016.11.113; Rub MA, 2016, RUSS J PHYS CHEM B+, V10, P1007, DOI 10.1134/S1990793116060257; Rub MA, 2016, J MOL LIQ, V218, P595, DOI 10.1016/j.molliq.2016.02.049; Rub MA, 2016, J CHEM THERMODYN, V96, P196, DOI 10.1016/j.jct.2016.01.001; Rubingh DN, 1979, MIXED MICELLE SOLUTI; Saha U, 2020, J MOL LIQ, V309, DOI 10.1016/j.molliq.2020.113164; Sharma R, 2017, ADV COLLOID INTERFAC, V248, P35, DOI 10.1016/j.cis.2017.07.032; Srivastava A, 2019, J MOL LIQ, V277, P349, DOI 10.1016/j.molliq.2018.12.070; Sugihara G., 2003, J OLEO SCI, V52, P449, DOI [10.5650/jos.52.449, DOI 10.5650/JOS.52.449]; Sulthana SB, 1998, J PHYS CHEM B, V102, P9653, DOI 10.1021/jp982060l; Taboada P, 2000, PHYS CHEM CHEM PHYS, V2, P5175, DOI 10.1039/b006400i; TACHIYA M, 1975, CHEM PHYS LETT, V33, P289, DOI 10.1016/0009-2614(75)80158-8; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Tehrani-Bagha AR, 2007, J COLLOID INTERF SCI, V312, P444, DOI 10.1016/j.jcis.2007.03.044; TURRO NJ, 1978, J AM CHEM SOC, V100, P5951, DOI 10.1021/ja00486a062; TURRO NJ, 1986, J PHYS CHEM-US, V90, P288, DOI 10.1021/j100274a017; Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001; Xia J, 2004, GEMINI SURFACTANTS S; Yousuf S, 2014, COLLOID SURFACE A, V463, P8, DOI 10.1016/j.colsurfa.2014.09.026; Zhinong G, 2008, J NAT SCI, V13, P227, DOI DOI 10.1007/S11859-008-0219-9; Zhou Q, 2003, LANGMUIR, V19, P4555, DOI 10.1021/la020789m; Zhu S, 2011, J SURFACTANTS DETERG, V14, P221, DOI 10.1007/s11743-010-1226-3; 2018, INT J COMMUN SYST, V0031, pE3812; 2018, INT J COMMUN SYST, V0031, pE3730	81	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241300	10.1371/journal.pone.0241300	http://dx.doi.org/10.1371/journal.pone.0241300			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156844	gold, Green Published			2022-12-26	WOS:000591376400036
J	Truche, P; NeMoyer, RE; Patino-Franco, S; Herrera-Escobar, JP; Torres, M; Pino, LF; Peck, GL				Truche, Paul; NeMoyer, Rachel E.; Patino-Franco, Sara; Herrera-Escobar, Juan P.; Torres, Myerlandi; Pino, Luis F.; Peck, Gregory L.			Publicly funded interfacility ambulance transfers for surgical and obstetrical conditions: A cross sectional analysis in an urban middle-income country setting	PLOS ONE			English	Article							PREHOSPITAL EMERGENCY CARE; MATERNAL MORTALITY; MEXICO-CITY; SYSTEMS; HEALTH; ACCESS; DELAYS	Introduction Interfacility transfers may reflect a time delay of definitive surgical care, but few studies have examined the prevalence of interfacility transfers in the urban low- and middle-income (LMIC) setting. The aim of this study was to determine the number of interfacility transfers required for surgical and obstetric conditions in an urban MIC setting to better understand access to definitive surgical care among LMIC patients. Methods A retrospective analysis of public interfacility transfer records was conducted from April 2015 to April 2016 in Cali, Colombia. Data were obtained from the single municipal ambulance agency providing publicly funded ambulance transfers in the city. Interfacility transfers were defined as any patient transfer between two healthcare facilities. We identified the number of transfers for patients with surgical conditions and categorized transfers based on patient ICD-9-CM codes. We compared surgical transfers from public vs. private healthcare facilities by condition type (surgical, obstetric, nonsurgical), transferring physician specialty, and transfer acuity (code blue, emergent, urgent and nonurgent) using logistic regression. Results 31,659 patient transports occurred over the 13-month study period. 22250 (70.2%) of all transfers were interfacility transfers and 7777 (35%) of transfers were for patients with surgical conditions with an additional 2,244 (10.3%) for obstetric conditions. 49% (8660/17675) of interfacility transfers from public hospitals were for surgical and obstetric conditions vs 32% (1466/4580) for private facilities (P<0.001). The most common surgical conditions requiring interfacility transfer were fractures (1,227, 5.4%), appendicitis (913, 4.1%), wounds (871, 3.9%), abdominal pain (818, 3.6%), trauma (652, 2.9%), and acute abdomen (271, 1.2%). Conclusion Surgical and obstetric conditions account for nearly half of all urban interfacility ambulance transfers. The most common reasons for transfer are basic surgical conditions with public healthcare facilities transferring a greater proportion of patient with surgical conditions than private facilities. Timely access to an initial healthcare facility may not be a reliable surrogate of definitive surgical care given the substantial need for interfacility transfers.	[Truche, Paul; NeMoyer, Rachel E.; Peck, Gregory L.] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA; [Patino-Franco, Sara] Univ Antioquia, Dept Surg, Medellin, Colombia; [Herrera-Escobar, Juan P.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA; [Torres, Myerlandi] Pool Ambulancias Publ, Red Salud Ctr, Cali, Colombia; [Pino, Luis F.] Univ Valle, Dept Surg, Cali, Colombia; [Peck, Gregory L.] Rutgers Sch Publ Hlth, Dept Hlth Syst & Policy, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad de Antioquia; Harvard University; Brigham & Women's Hospital; Universidad del Valle	Truche, P (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA.	Paul.truche@gmail.com	Herrera-Escobar, Juan Pablo/W-4515-2018	Herrera-Escobar, Juan Pablo/0000-0002-3496-1470; NeMoyer, Rachel/0000-0002-8228-2683				Albutt K, 2018, NATL SURG OBSTET ANA; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Arbelaez C, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0057-4; Arreola-Risa C, 2000, J TRAUMA, V48, P119, DOI 10.1097/00005373-200001000-00020; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bickler S.N., 2015, ESSENTIAL SURG DIS C, V1; Callese TE, 2015, J SURG RES, V193, P300, DOI 10.1016/j.jss.2014.09.040; Calvello EJ, 2015, B WORLD HEALTH ORGAN, V93, P417, DOI 10.2471/BLT.14.146571; Vera-Lopez JD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00144916, 10.1590/0102-311X00144916]; Debas HT, 2015, ESSENTIAL SURG DIS C, V1; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Juran S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000875; Kim J, 2017, PREHOSP DISASTER MED, V32, P642, DOI [10.1017/s1049023x1700677x, 10.1017/S1049023X1700677X]; Mallon W, 2017, REV MED CLIN LAS CON, V28, P163, DOI [10.1016/j.rmclc.2017.04.002, DOI 10.1016/J.RMCLC.2017.04.002]; Massenburg BB, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000226; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mehmood A, 2018, INT J EMERG MED, V11, DOI 10.1186/s12245-018-0207-6; Mgawadere F, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1406-5; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; Morgan R, 2016, INT J HEALTH PLAN M, V31, P49, DOI 10.1002/hpm.2257; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; OECD, 2015, POL PRIOR INCL DEV, DOI [10.1787/9789264233393-en, DOI 10.1787/9789264233393-EN]; Peralta LMP, 2006, PREHOSP DISASTER MED, V21, P104, DOI 10.1017/S1049023X00003447; Pinet LM, 2005, SALUD PUBLICA MEXICO, V47, P64, DOI 10.1590/S0036-36342005000100010; Pouramin P, 2020, LANCET GLOB HEALTH, V8, pE711, DOI 10.1016/S2214-109X(20)30067-X; Qian Maowei, 2003, MINGDAI SHIXUE LICHE; Raykar NP, 2015, LANCET, V385, P16, DOI 10.1016/S0140-6736(15)60811-X; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Sriram V, 2016, PUBLIC HEALTH, V137, P169, DOI 10.1016/j.puhe.2016.02.022; Suryanto MN, 2017, PREHOSP DISASTER MED, V32, P64, DOI 10.1017/S1049023X1600114X; Thind A, 2015, ESSENTIAL SURG DIS C, V1; Vargas I, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-297	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241553	10.1371/journal.pone.0241553	http://dx.doi.org/10.1371/journal.pone.0241553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156837	gold, Green Published			2022-12-26	WOS:000591376400050
J	Ndung'u, K; Murilla, GA; Thuita, JK; Ngae, GN; Auma, JE; Gitonga, PK; Thungu, DK; Kurgat, RK; Chemuliti, JK; Mdachi, RE				Ndung'u, Kariuki; Murilla, Grace Adira; Thuita, John Kibuthu; Ngae, Geoffrey Njuguna; Auma, Joanna Eseri; Gitonga, Purity Kaari; Thungu, Daniel Kahiga; Kurgat, Richard Kiptum; Chemuliti, Judith Kusimba; Mdachi, Raymond Ellie			Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; ENDEMIC AREA; RESISTANCE; GAMBIENSE; ANEMIA; MELARSOPROL; ISOENZYME; INFECTION; PATTERNS	We assessed the virulence and anti-trypanosomal drug sensitivity patterns of Trypanosoma brucei rhodesiense (Tbr) isolates in the Kenya Agricultural and Livestock Research Organization-Biotechnology Research Institute (KALRO-BioRI) cryobank. Specifically, the study focused on Tbr clones originally isolated from the western Kenya/eastern Uganda focus of human African Trypanosomiasis (HAT). Twelve (12) Tbr clones were assessed for virulence using groups(n = 10) of Swiss White Mice monitored for 60 days post infection (dpi). Based on survival time, four classes of virulence were identified: (a) very-acute: 0-15, (b) acute: 16-30, (c) sub-acute: 31-45 and (d) chronic: 46-60 dpi. Other virulence biomarkers identified included: pre-patent period (pp), parasitaemia progression, packed cell volume (PCV) and body weight changes. The test Tbr clones together with KALRO-BioRi reference drug-resistant and drug sensitive isolates were then tested for sensitivity to melarsoprol (mel B), pentamidine, diminazene aceturate and suramin, using mice groups (n = 5) treated with single doses of each drug at 24 hours post infection. Our results showed that the clones were distributed among four classes of virulence as follows: 3/12 (very-acute), 3/12 (acute), 2/12 (sub-acute) and 4/12 (chronic) isolates. Differences in survivorship, parasitaemia progression and PCV were significant (P<0.001) and correlated. The isolate considered to be drug resistant at KALRO-BioRI, KETRI 2538, was confirmed to be resistant to melarsoprol, pentamidine and diminazene aceturate but it was not resistant to suramin. A cure rate of at least 80% was achieved for all test isolates with melarsoprol (1mg/Kg and 20 mg/kg), pentamidine (5 and 20 mg/kg), diminazene aceturate (5 mg/kg) and suramin (5 mg/kg) indicating that the isolates were not resistant to any of the drugs despite the differences in virulence. This study provides evidence of variations in virulence of Tbr clones from a single HAT focus and confirms that this variations is not a significant determinant of isolate sensitivity to anti-trypanosomal drugs.	[Ndung'u, Kariuki; Murilla, Grace Adira; Thuita, John Kibuthu; Auma, Joanna Eseri; Gitonga, Purity Kaari; Thungu, Daniel Kahiga; Kurgat, Richard Kiptum; Chemuliti, Judith Kusimba; Mdachi, Raymond Ellie] Kenya Agr & Livestock Res Org, Biotechnol Res Inst, Kikuyu, Kenya; [Murilla, Grace Adira] KAG EAST Univ, Nairobi, Kenya; [Thuita, John Kibuthu] Meru Univ Sci & Technol, Meru, Kenya; [Ngae, Geoffrey Njuguna] Kenya Agr & Livestock Res Org, Food Crops Res Inst, Nairobi, Kenya		Ndung'u, K (corresponding author), Kenya Agr & Livestock Res Org, Biotechnol Res Inst, Kikuyu, Kenya.	Kariukindungu1960@gmail.com						AMOLE BO, 1982, INFECT IMMUN, V36, P1060, DOI 10.1128/IAI.36.3.1060-1068.1982; Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Chisi J E, 2004, East Afr Med J, V81, P505; Egbe-Nwiyi TN, 2005, J COMP PATHOL, V133, P286, DOI 10.1016/j.jcpa.2005.05.002; Everitt B, 1998, HDB STAT ANAL USING; Fairlamb AH, 2018, TRENDS PARASITOL, V34, P481, DOI 10.1016/j.pt.2018.04.002; Fisher S, 2016, J AM ASSOC LAB ANIM, V55, P811; Gehrig S, 2008, INT J MOL MED, V22, P411, DOI 10.3892/ijmm_00000037; Giroud C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000509; Gitonga PK, 2017, ONDERSTEPOORT J VET, V84, DOI 10.4102/ojvr.v84i1.1412; GOMES ML, 1991, MEM I OSWALDO CRUZ, V86, P379, DOI 10.1590/S0074-02761991000400001; Hamill L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0224-8; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Holzmuller P, 2008, MICROBES INFECT, V10, P79, DOI 10.1016/j.micinf.2007.10.008; Kagira JM, 2007, ONDERSTEPOORT J VET, V74, P17; Kamidi CM, 2018, PARASITOLOGY, V145, P1235, DOI 10.1017/S0031182017002359; Kennedy PGE, 2007, T ROY SOC TROP MED H, V101, P1061, DOI 10.1016/j.trstmh.2007.05.001; Kennedy PGE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00039; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; Korir SC, 2013, J NATURAL SCI RES, V3; Kuepfer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000968; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; MacLean L, 2004, INFECT IMMUN, V72, P7040, DOI 10.1128/IAI.72.12.7040-7044.2004; Magez S, 2011, PARASITE IMMUNOL, V33, P423, DOI 10.1111/j.1365-3024.2011.01293.x; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Maina N, 2007, ACTA TROP, V104, P84, DOI 10.1016/j.actatropica.2007.07.007; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Masumu J, 2006, INT J PARASITOL, V36, P497, DOI 10.1016/j.ijpara.2006.01.003; Matthews KR, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0288; Motloang M. Y., 2014, ONDERSTEPOORT J VET, V81, P679; Mwanakasale Victor, 2014, J Med Case Rep, V8, P53, DOI 10.1186/1752-1947-8-53; Naessens J, 2005, CLIN EXP IMMUNOL, V139, P405, DOI 10.1111/j.1365-2249.2004.02717.x; OTIENO LH, 1985, TROP MED PARASITOL, V36, P123; Pyana Pati Patient, 2014, PLoS Negl Trop Dis, V8, pe3212, DOI 10.1371/journal.pntd.0003212; SACKS DL, 1980, NATURE, V283, P476, DOI 10.1038/283476a0; Saito MS, 2016, INT J EXP PATHOL, V97, P285, DOI 10.1111/iep.12182; Sandra T, 2016, CELL HOST MICROBE, V19, P837, DOI [10.1016/j.chom.2016.05.002, DOI 10.1016/J.CHOM.2016.05.002]; SMITH CJ, 1982, AM J TROP MED HYG, V31, P1098, DOI 10.4269/ajtmh.1982.31.1098; Smith DH, 1997, ANN TROP MED PARASIT, V91, P851, DOI 10.1080/00034989760617; Sokolova AY, 2010, ANTIMICROB AGENTS CH, V54, P2893, DOI 10.1128/AAC.00332-10; Szempruch AJ, 2016, CELL, V164, P246, DOI 10.1016/j.cell.2015.11.051; Thuita JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001734; Thuita JK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000238; Toukam CMW, 2011, PARASITE, V18, P295, DOI 10.1051/parasite/2011184295; 2014, REG ANESTH PAIN MED, V9	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0229060	10.1371/journal.pone.0229060	http://dx.doi.org/10.1371/journal.pone.0229060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151938	Green Submitted, gold, Green Published			2022-12-26	WOS:000591376200032
J	Kasting, ML; Head, KJ; Hartsock, JA; Sturm, L; Zimet, GD				Kasting, Monica L.; Head, Katharine J.; Hartsock, Jane A.; Sturm, Lynne; Zimet, Gregory D.			Public perceptions of the effectiveness of recommended non-pharmaceutical intervention behaviors to mitigate the spread of SARS-CoV-2	PLOS ONE			English	Article							HEALTH BELIEFS; TRUST	Background The COVID-19 pandemic is an unprecedented public health threat, both in scope and response. With no vaccine available, the public is advised to practice non-pharmaceutical interventions (NPI) including social distancing, mask-wearing, and washing hands. However, little is known about public perceptions of the effectiveness of these measures, and high perceived effectiveness is likely to be critical in order to achieve widespread adoption of NPI. Methods In May 2020, we conducted a cross-sectional survey among U.S. adults (N = 3,474). The primary outcome was a six-item measure assessing perceived effectiveness of recommended behaviors to prevent SARS-CoV-2 infection from 1 (not at all effective) to 5 (extremely effective). The sample was divided into "higher" and "lower" perceived effectiveness groups. Covariates included demographics, healthcare characteristics, and health beliefs. Variables that were significant at p<0.01 in bivariate analyses were entered into a multivariable logistic regression and a best-fit model was created using a cutoff of p<0.01 to stay in the model. Results Mean age was 45.5 years and most participants were non-Hispanic White (63%) and female (52.4%). The high perceived effectiveness group was slightly larger than the low perceived effectiveness group (52.7% vs. 47.3%). Almost all health belief variables were significant in the best-fit regression model. COVID-19-related worry (aOR = 1.82; 95% CI = 1.64-2.02), and perceived threat to physical health (aOR = 1.32; 95% CI = 1.20-1.45) were positively associated with perceived effectiveness while perceived severity of COVID-19 (0.84; 95% CI = 0.73-0.96) and perceived likelihood of infection (0.85; 95% CI = 0.77-0.94) switched directions in the adjusted model and were negatively associated with perceived effectiveness. Conclusions This research indicates people generally believe NPI are effective, but there was variability based on health beliefs and there are mixed rates of engagement in these behaviors. Public health efforts should focus on increasing perceived severity and threat of SARS-CoV-2-related disease, while promoting NPI as effective in reducing threat.	[Kasting, Monica L.] Purdue Univ, Dept Publ Hlth, W Lafayette, IN 47907 USA; [Kasting, Monica L.] Indiana Univ, Canc Prevent & Control Program, Simon Comprehens Canc Ctr, Indianapolis, IN 47405 USA; [Head, Katharine J.] Indiana Univ Purdue Univ, Dept Commun Studies, Indianapolis, IN USA; [Hartsock, Jane A.] Indiana Univ Hlth, Dept Clin & Org Eth, Indianapolis, IN USA; [Hartsock, Jane A.] Indiana Univ, Ctr Bioeth, Indianapolis, IN USA; [Hartsock, Jane A.] Indiana Univ Purdue Univ, Med Humanities & Hlth Studies Program, Indianapolis, IN USA; [Sturm, Lynne; Zimet, Gregory D.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Kasting, ML (corresponding author), Purdue Univ, Dept Publ Hlth, W Lafayette, IN 47907 USA.; Kasting, ML (corresponding author), Indiana Univ, Canc Prevent & Control Program, Simon Comprehens Canc Ctr, Indianapolis, IN 47405 USA.	mlkastin@purdue.edu		Kasting, Monica/0000-0002-9879-7235	Purdue University; Indiana University-Purdue University Indianapolis; Indiana University Health; Indiana University School of Medicine	Purdue University; Indiana University-Purdue University Indianapolis; Indiana University Health; Indiana University School of Medicine	This study was funded by internal grants at Purdue University (MLK), Indiana University-Purdue University Indianapolis (KJH), Indiana University Health (JAH), and the Indiana University School of Medicine (GDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew S., 2020, THE CNN; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bayer R, 2007, EMBO REP, V8, P1099, DOI 10.1038/sj.embor.7401134; Beeken RJ, 2011, CANCER EPIDEM BIOMAR, V20, P2127, DOI 10.1158/1055-9965.EPI-11-0437; Bosman J, 2020, NY TIMES; Cahyanto I, 2016, TOUR MANAG PERSPECT, V20, P195, DOI 10.1016/j.tmp.2016.09.004; Centers for Disease Control and Prevention, 2020, COR COVID 19; Costa R, 2020, WASHINGTON POST; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Elving R, 2020, WHAT IT MEANS TRUMP; Fan H, 2018, AIDS CARE, V30, P1062, DOI 10.1080/09540121.2018.1442555; Freimuth VS, 2014, J HEALTH COMMUN, V19, P321, DOI 10.1080/10810730.2013.811323; Goodnough Abby, 2020, NY TIMES; Grabb E, 1999, CAN J SOCIOL, V24, P511, DOI 10.2307/3341789; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hauck G., 2020, US TODAY; Igielnik R, 2020, MOST AM SAY THEY REG; Lake PW, 2020, SUPPORTIVE CARE CANC; Lardieri A., 2020, US NEWS WORLD REPORT; Liau A, 1998, SEX TRANSM DIS, V25, P76, DOI 10.1097/00007435-199802000-00004; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Padilla M, 2020, NY TIMES; Rotkirch A., 2020, UNIVERSAL MASKING IS; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Saqr M, 2020, INT J HEALTH SCI-IJH, V14, P4; Skinner C.S., 2015, HLTH BEHAV THEORY RE, V5th ed., P75, DOI 10.1093/jnci/djv120; SteelFisher GK, 2012, LANCET INFECT DIS, V12, P845, DOI 10.1016/S1473-3099(12)70206-2; Teasdale E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-589; Thrush G, 2020, NY TIMES; Walters J, 2020, GUARDIAN; Weissert W, 2020, ASS PRESS; WHO, 2020, ADV US MASKS CONT CO, P1, DOI [10.1101/2020.04.01.20049528, DOI 10.1101/2020.04.01.20049528]; WHO, 2020, ARCHIVED WHO TIMELIN; Williams L, 2015, PSYCHOL HEALTH MED, V20, P832, DOI 10.1080/13548506.2015.1028946; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wong T., 2020, BBC NEWS; Wynne B, 2006, COMMUNITY GENET, V9, P211, DOI 10.1159/000092659	37	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241662	10.1371/journal.pone.0241662	http://dx.doi.org/10.1371/journal.pone.0241662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147261	Green Published, gold			2022-12-26	WOS:000589609300054
J	Liu, HL; Robinson, DS; Wu, ZY; Kuo, RT; Yoshikuni, Y; Blaby, IK; Cheng, JF				Liu, Hualan; Robinson, David S.; Wu, Zong-Yen; Kuo, Rita; Yoshikuni, Yasuo; Blaby, Ian K.; Cheng, Jan-Fang			Bacterial genome editing by coupling Cre-lox and CRISPR-Cas9 systems	PLOS ONE			English	Article							TOOL	The past decade has been a golden age for microbiology, marked by the discovery of an unprecedented increase in the number of novel bacterial species. Yet gaining biological knowledge of those organisms has not kept pace with sequencing efforts. To unlock this genetic potential there is an urgent need for generic (i.e. non-species specific) genetic toolboxes. Recently, we developed a method, termed chassis-independent recombinase-assisted genome engineering (CRAGE), enabling the integration and expression of large complex gene clusters directly into the chromosomes of diverse bacteria. Here we expand upon this technology by incorporating CRISPR-Cas9 allowing precise genome editing across multiple bacterial species. To do that we have developed a landing pad that carries one wild-type and two mutant lox sites to allow integration of foreign DNA at two locations through Cre-lox recombinase-mediated cassette exchange (RMCE). The first RMCE event is to integrate the Cas9 and the DNA repair protein genes RecET, and the second RMCE event enables the integration of customized sgRNA and a repair template. Following this workflow, we achieved precise genome editing in four different gammaproteobacterial species. We also show that the inserted landing pad and the entire editing machinery can be removed scarlessly after editing. We report here the construction of a single landing pad transposon and demonstrate its functionality across multiple species. The modular design of the landing pad and accessory vectors allows design and assembly of genome editing platforms for other organisms in a similar way. We believe this approach will greatly expand the list of bacteria amenable to genetic manipulation and provides the means to advance our understanding of the microbial world.	[Liu, Hualan; Robinson, David S.; Wu, Zong-Yen; Kuo, Rita; Yoshikuni, Yasuo; Blaby, Ian K.; Cheng, Jan-Fang] US DOE, Joint Genome Inst, Berkeley, CA 94720 USA; [Liu, Hualan; Yoshikuni, Yasuo; Blaby, Ian K.; Cheng, Jan-Fang] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Wu, Zong-Yen] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan; [Yoshikuni, Yasuo] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA	United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Chung Hsing University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cheng, JF (corresponding author), US DOE, Joint Genome Inst, Berkeley, CA 94720 USA.; Cheng, JF (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.	jfcheng@lbl.gov	Yoshikuni, Yasuo/A-8804-2019; Liu, Hualan/A-9382-2018	Liu, Hualan/0000-0002-9636-3855	U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231]	U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE))	The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported under Contract No. DE-AC02-05CH11231.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Adli M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04252-2; Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, pIII, DOI 10.1128/MMBR.00044-16; Berendsen RL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1632-z; Bober JR, 2018, ANNU REV BIOMED ENG, V20, P277, DOI 10.1146/annurev-bioeng-062117-121019; Cho S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041089; Dong C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04901-6; Pavan ME, 2019, APPL MICROBIOL BIOT, V103, P1865, DOI 10.1007/s00253-018-9545-9; Freed E, 2018, BIOTECHNOL BIOENG, V115, P2120, DOI 10.1002/bit.26727; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guo JH, 2018, NUCLEIC ACIDS RES, V46, P7052, DOI 10.1093/nar/gky572; Hadjithomas M, 2017, NUCLEIC ACIDS RES, V45, pD560, DOI 10.1093/nar/gkw1103; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Jensen MK, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy039; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kushwaha M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8832; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Liu HL, 2018, CURR OPIN BIOTECH, V51, P116, DOI 10.1016/j.copbio.2017.12.006; Martin Vincent J J, 2002, Methods Mol Biol, V192, P315; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Meyer JM, 2002, APPL ENVIRON MICROB, V68, P2745, DOI 10.1128/AEM.68.6.2745-2753.2002; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Pickar-Oliver A, 2019, NAT REV MOL CELL BIO, V20, P490, DOI 10.1038/s41580-019-0131-5; Price MN, 2018, NATURE, V557, P503, DOI 10.1038/s41586-018-0124-0; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sun DC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02154; Vento JM, 2019, J IND MICROBIOL BIOT, V46, P1327, DOI 10.1007/s10295-019-02195-1; Waller MC, 2017, CURR OPIN MICROBIOL, V38, P156, DOI 10.1016/j.mib.2017.05.006; Wang GY, 2019, NAT MICROBIOL, V4, P2498, DOI 10.1038/s41564-019-0573-8; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Wexler AG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.26; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Yan X, 2008, APPL ENVIRON MICROB, V74, P5556, DOI 10.1128/AEM.01156-08; Zou YQ, 2019, NAT BIOTECHNOL, V37, P179, DOI 10.1038/s41587-018-0008-8	42	3	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241867	10.1371/journal.pone.0241867	http://dx.doi.org/10.1371/journal.pone.0241867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147260	gold, Green Published			2022-12-26	WOS:000589609300085
J	Taylor, LS; Phillips, G; Bernard, EC; DeBruyn, JM				Taylor, Lois S.; Phillips, Gary; Bernard, Ernest C.; DeBruyn, Jennifer M.			Soil nematode functional diversity, successional patterns, and indicator taxa associated with vertebrate decomposition hotspots	PLOS ONE			English	Article							CADAVER DECOMPOSITION; MICROBIAL COMMUNITIES; SEASONAL-VARIATION; FAUNAL ANALYSIS; TESTATE AMEBAS; FEEDING-HABITS; MATURITY INDEX; MANAGEMENT; GENERA; CROP	Decomposition of vertebrate remains is a dynamic process that creates localized soil enrichment zones. A growing body of literature has documented effects of vertebrate decomposition on soil pH, electrical conductivity, oxygen levels, nitrogen and carbon speciation, microbial biomass, and microbial successional patterns. However, relatively few studies have examined the microfaunal members of the soil food web that function as secondary consumers, specifically nematodes. Nematodes are often used as indicators of enrichment in other systems, and initial observations from vertebrate decomposition zones have indicated there is an effect on nematode communities. Our goal was to catalog decomposition-induced nematode succession and changes to alpha, beta, and functional diversity, and identify potential indicator taxa associated with decomposition progression. Six adult beaver (Castor canadensis) carcasses were allowed to decompose in a forest ecosystem for one year. During this period soil temperature, moisture, and electrical conductivity were monitored. Soils samples were taken at two depths in order to assess nematode community dynamics: 30-cm cores and 1-cm interface samples. Nematode abundance, alpha, beta, and functional diversity all responded to soil enrichment at the onset of active decay, and impacts persisted through skeletonization. After one year, nematode abundances and alpha diversity had recovered to original levels, however both community membership and functional diversity remained significantly altered. We identified seven indicator taxa that marked major transitions in decomposition progression. Enrichment of Rhabditidae (B1) and Diplogasteridae (B1) coupled with depletion in Filenchus (F2) characterized active and advanced decay prior to skeletonization in both cores and interface soils. Enrichment of Acrobeloides (B2), Aphelenchoides (F2), Tylencholaimidae (F4) and Seinura (P2) occurred during a narrow period in mid-skeletonization (day 153). Our study has revealed soil nematode successional patterns during vertebrate decomposition and has identified organisms that may function as indicator taxa for certain periods during decomposition.	[Taylor, Lois S.; DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA; [Phillips, Gary; Bernard, Ernest C.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Taylor, LS; DeBruyn, JM (corresponding author), Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.	Ltaylo32@vols.utk.edu; jdebruyn@utk.edu	; DeBruyn, Jennifer/A-8813-2010	Taylor, Lois/0000-0002-2401-8382; DeBruyn, Jennifer/0000-0002-2993-4144	National Science Foundation [1549726]; National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2017-R2-CX-0008]	National Science Foundation(National Science Foundation (NSF)); National Institute of Justice, Office of Justice Programs, U.S. Department of Justice(US National Institute of Justice)	This study was supported by a National Science Foundation (https://www.nsf.gov) award 1549726 to JMD and by a National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (https://www.nij.ojp.gov) award 2017-R2-CX-0008 to LST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aitkenhead-Peterson JA, 2012, FORENSIC SCI INT, V216, P127, DOI 10.1016/j.forsciint.2011.09.007; Althoff PS, 2009, APPL SOIL ECOL, V43, P122, DOI 10.1016/j.apsoil.2009.06.011; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; Arieira GD, 2016, SEMIN-CIENC AGRAR, V37, P715, DOI 10.5433/1679-0359.2016v37n2p715; Benninger LA, 2008, FORENSIC SCI INT, V180, P70, DOI 10.1016/j.forsciint.2008.07.001; Blakely JK, 2002, APPL SOIL ECOL, V21, P71, DOI 10.1016/S0929-1393(02)00023-9; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers T, 1999, PLANT SOIL, V212, P13, DOI 10.1023/A:1004571900425; Braig HR, 2009, EXP APPL ACAROL, V49, P45, DOI 10.1007/s10493-009-9287-6; Briar S, 2009, J NEMATOL, V41, P313; Briar SS, 2012, J NEMATOL, V44, P245; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Carter DO, 2015, FORENSIC SCI MED PAT, V11, P202, DOI 10.1007/s12024-015-9667-7; Cobaugh KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130201; Crotty FV, 2016, SOIL BIOL BIOCHEM, V103, P241, DOI 10.1016/j.soilbio.2016.08.018; Dautartas A, 2018, J FORENSIC SCI, V63, P1673, DOI 10.1111/1556-4029.13784; DeBruyn JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3437; ETTEMA CH, 1993, BIOL FERT SOILS, V16, P79, DOI 10.1007/BF00369407; Fancher JP, 2017, FORENSIC SCI INT, V279, P130, DOI 10.1016/j.forsciint.2017.08.002; Felix MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200851; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2003, APPL SOIL ECOL, V23, P93, DOI 10.1016/S0929-1393(03)00044-1; Ferris H, 2006, J NEMATOL, V38, P3; Fiscus DA, 2002, ECOL APPL, V12, P565, DOI 10.1890/1051-0761(2002)012[0565:DSOFLS]2.0.CO;2; Hauther KA, 2015, J FORENSIC SCI, V60, P1234, DOI 10.1111/1556-4029.12828; Heaton V, 2014, J FORENSIC SCI, V59, P676, DOI 10.1111/1556-4029.12396; HECHLER HC, 1966, P HELM SOC WASH, V33, P71; Hoss S, 2011, SCI TOTAL ENVIRON, V409, P2674, DOI 10.1016/j.scitotenv.2011.03.041; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Keenan SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208845; Keenan SW, 2018, SOIL BIOL BIOCHEM, V121, P165, DOI 10.1016/j.soilbio.2018.03.005; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Macdonald BCT, 2014, SOIL BIOL BIOCHEM, V69, P132, DOI 10.1016/j.soilbio.2013.10.042; Meng FX, 2006, PEDOSPHERE, V16, P169, DOI 10.1016/S1002-0160(06)60040-4; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; Meyer J, 2013, J FORENSIC SCI, V58, P1175, DOI 10.1111/1556-4029.12169; Neher DA, 2001, J NEMATOL, V33, P161; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Okada H, 2005, SOIL BIOL BIOCHEM, V37, P1113, DOI 10.1016/j.soilbio.2004.11.010; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ortiz V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0109-5; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Porazinska DL, 1999, APPL SOIL ECOL, V13, P69, DOI 10.1016/S0929-1393(99)00018-9; Porazinska DL, 1998, J NEMATOL, V30, P170; Porazinska DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044641; Qing X, 2017, J NEMATOL, V49, P189, DOI 10.21307/jofnem-2017-064; R Core Team, 2013, R LANG ENV STAT COMP; Ruess L, 2003, NEMATOLOGY, V5, P179, DOI 10.1163/156854103767139662; Sechi V, 2018, BASIC APPL ECOL, V30, P76, DOI 10.1016/j.baae.2018.05.004; Seppey CVW, 2016, INT J LEGAL MED, V130, P551, DOI 10.1007/s00414-015-1149-7; Siddiqi M. R., 2000, Tylenchida: parasites of plants and insects, P122, DOI 10.1079/9780851992020.0122; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Steadman DW, 2018, J FORENSIC SCI, V63, P1684, DOI 10.1111/1556-4029.13786; Steel H, 2013, INVERTEBR BIOL, V132, P108, DOI 10.1111/ivb.12020; Steel H, 2013, EUR J SOIL BIOL, V56, P1, DOI 10.1016/j.ejsobi.2013.01.003; Steel H, 2010, PEDOBIOLOGIA, V53, P181, DOI 10.1016/j.pedobi.2009.09.003; Stokes KL, 2013, J FORENSIC SCI, V58, P583, DOI 10.1111/1556-4029.12115; Szelecz I, 2016, SOIL BIOL BIOCHEM, V103, P405, DOI 10.1016/j.soilbio.2016.09.011; Szelecz I, 2014, FORENSIC SCI INT, V236, P90, DOI 10.1016/j.forsciint.2013.12.030; Tenuta M, 2004, J NEMATOL, V36, P85; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; van den Hoogen J, 2019, NATURE, V572, P194, DOI 10.1038/s41586-019-1418-6; Venette RC, 1997, SOIL BIOL BIOCHEM, V29, P63, DOI 10.1016/S0038-0717(96)00259-3; von der Luhe B, 2018, ORG GEOCHEM, V124, P228, DOI 10.1016/j.orggeochem.2018.07.016; von der Luhe B, 2017, ORG GEOCHEM, V111, P26, DOI 10.1016/j.orggeochem.2017.06.004; Weiss S, 2016, INT J LEGAL MED, V130, P253, DOI 10.1007/s00414-015-1206-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOOD FH, 1974, NEMATOLOGICA, V20, P347, DOI 10.1163/187529274X00384; YEATES GW, 1993, J NEMATOL, V25, P315; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008	77	2	2	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241777	10.1371/journal.pone.0241777	http://dx.doi.org/10.1371/journal.pone.0241777			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147264	Green Published, gold			2022-12-26	WOS:000589609300031
J	Lin, HA; Lin, SF; Chang, HW; Lee, YJ; Chen, RJ; Hou, SK				Lin, Hui-An; Lin, Sheng-Feng; Chang, Hui-Wen; Lee, Yuarn-Jang; Chen, Ray-Jade; Hou, Sen-Kuang			Clinical impact of monocyte distribution width and neutrophil-to-lymphocyte ratio for distinguishing COVID-19 and influenza from other upper respiratory tract infections: A pilot study	PLOS ONE			English	Article							RED-BLOOD-CELL; DISEASE-ACTIVITY; NEUTROPHIL/LYMPHOCYTE RATIO; PLATELET; SEPSIS; CHINA; TRANSMISSION; WUHAN; PLR; NLR	The coronavirus disease 2019 (COVID-19) has become a pandemic. Rapidly distinguishing COVID-19 from other respiratory infections is a challenge for first-line health care providers. This retrospective study was conducted at the Taipei Medical University Hospital, Taiwan. Patients who visited the outdoor epidemic prevention screening station for respiratory infection from February 19 to April 30, 2020, were evaluated for blood biomarkers to distinguish COVID-19 from other respiratory infections. Monocyte distribution width (MDW) >= 20 (odds ratio [OR]: 8.39, p = 0.0110, area under curve [AUC]: 0.703) and neutrophil-to-lymphocyte ratio (NLR) < 3.2 (OR: 4.23, p = 0.0494, AUC: 0.673) could independently distinguish COVID-19 from common upper respiratory tract infections (URIs). Combining MDW >= 20 and NLR < 3.2 was more efficient in identifying COVID-19 (AUC: 0.840). Moreover, MDW >= 20 and NLR > 5 effectively identified influenza infection (AUC: 0.7055). Thus, MDW and NLR can distinguish COVID-19 from influenza and URIs.	[Lin, Hui-An; Hou, Sen-Kuang] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lin, Hui-An; Hou, Sen-Kuang] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Lin, Sheng-Feng] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Lin, Sheng-Feng] Far Eastern Mem Hosp, Div Phys Hospitalist, Dept Internal Med, New Taipei, Taiwan; [Lin, Sheng-Feng] Far Eastern Mem Hosp, Dept Neurol, New Taipei, Taiwan; [Chang, Hui-Wen] Taipei Med Univ Hosp, Dept Med Lab, Taipei, Taiwan; [Chang, Hui-Wen] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Lee, Yuarn-Jang] Taipei Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ Hosp, Dept Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Hou, SK (corresponding author), Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Hou, SK (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan.	992001@h.tmw.edu.tw	Chen, Ray/GRJ-6736-2022	Lin, Sheng-Feng/0000-0003-0470-2184				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Celik IH, 2012, PEDIATR RES, V71, P121, DOI 10.1038/pr.2011.16; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Chousterman BG, 2017, SEMIN IMMUNOPATHOL, V39, P517, DOI 10.1007/s00281-017-0639-8; Crouser ED, 2019, CRIT CARE MED, V47, P1018, DOI 10.1097/CCM.0000000000003799; Crouser ED, 2017, CHEST, V152, P518, DOI 10.1016/j.chest.2017.05.039; Duzlu M, 2018, NIGER J CLIN PRACT, V21, P49, DOI 10.4103/1119-3077.224796; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Gao K, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016793; Gao S., 2020, J INFECTION, V81, P1, DOI 10.1016/j.jinf.2020.04.011; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han CQ, 2020, AM J GASTROENTEROL, V115, P916, DOI 10.14309/ajg.0000000000000664; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Hu KM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006404; Hu ZD, 2014, CLIN BIOCHEM, V47, P287, DOI 10.1016/j.clinbiochem.2014.08.022; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hwang SY, 2017, AM J EMERG MED, V35, P234, DOI 10.1016/j.ajem.2016.10.055; Kara A, 2019, NIGER J CLIN PRACT, V22, P701, DOI 10.4103/njcp.njcp_478_18; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Li XG, 2020, J MED VIROL, V92, P448, DOI 10.1002/jmv.25693; Lu HZ, 2020, J MED VIROL, V92, P546, DOI 10.1002/jmv.25738; Mardi D, 2010, INT J LAB HEMATOL, V32, P410, DOI 10.1111/j.1751-553X.2009.01202.x; Mercan R, 2016, J CLIN LAB ANAL, V30, P597, DOI 10.1002/jcla.21908; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Polilli E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227300; Qin BD, 2016, MOD RHEUMATOL, V26, P372, DOI 10.3109/14397595.2015.1091136; Ramnath R. Devi, 2006, J ORGAN DYSFUNCTION, V2, P80, DOI DOI 10.1080/17471060500435662; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Su VYF, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101780; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu YX, 2016, INT IMMUNOPHARMACOL, V36, P94, DOI 10.1016/j.intimp.2016.04.006; Yayla ME, 2020, CLIN RHEUMATOL, V39, P77, DOI 10.1007/s10067-019-04685-0; Zhang JN, 2020, LANCET RESP MED, V8, pE11, DOI 10.1016/S2213-2600(20)30071-0; Zhao CY, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.106145	40	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241262	10.1371/journal.pone.0241262	http://dx.doi.org/10.1371/journal.pone.0241262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137167	Green Published, gold			2022-12-26	WOS:000588375500024
J	Hwang, IT; Ju, YS; Lee, HJ; Shim, YS; Jeong, HR; Kang, MJ				Hwang, Il Tae; Ju, Young-Su; Lee, Hye Jin; Shim, Young Suk; Jeong, Hwal Rim; Kang, Min Jae			Body mass index trajectories and adiposity rebound during the first 6 years in Korean children: Based on the National Health Information Database, 2008-2015	PLOS ONE			English	Article							LONG-TERM CHANGES; WEIGHT-GAIN; POSTNATAL WEIGHT; KRAKOW POLAND; GROWTH; CHILDHOOD; OBESITY; BMI; INFANCY; BIRTH	Purpose We analyzed the nationwide longitudinal data to explore body mass index (BMI) growth trajectories and the time of adiposity rebound (AR). Methods Personal data of 84,005 subjects born between 2008 and 2012 were obtained from infant health check-ups which were performed at 5, 11, 21, 33, 45, 57, and 69 months. BMI trajectories of each subject were made according to sex and the timing of AR, which was defined as the lowest BMI occurred. Subjects were divided according to birth weight and AR timing as follows: very low birth weight (VLBW), 0.5 kg <= Bwt <= 1.5 kg; low birth weight (LBW), 1.5 kg < Bwt <= 2.5 kg; non-LBW, 2.5 kg < Bwt <= 5.0 kg; very early AR, before 45 months; early AR, at 57 months; and moderate-to-late AR, not until 69 months. Main results Median time point of minimum BMI was 45 months, and the prevalence rates of very early, early, and moderate-to-late AR were 63.0%, 16.6%, and 20.4%, respectively. BMI at the age of 57 months showed a strong correlation with AR timing after controlling for birth weight (P < 0.001). Sugar-sweetened beverage intake at 21 months (P = 0.02) and no-exercise habit at 57 months (P < 0.001) showed correlations with early AR. When VLBW and LBW subjects were analyzed, BMI at 57 months and breastfeeding at 11 months were correlated with rapid weight gain during the first 5 months (both P < 0.001). Conclusions Based on this first longitudinal study, the majority of children showed AR before 57 months and the degree of obesity at the age of 57 months had a close correlation with early AR or rapid weight gain during infancy.	[Hwang, Il Tae; Lee, Hye Jin; Shim, Young Suk; Kang, Min Jae] Hallym Univ, Dept Pediat, Coll Med, Chunchon, South Korea; [Ju, Young-Su] Natl Med Ctr, Dept Occupat & Environm Med, Seoul, South Korea; [Jeong, Hwal Rim] Soonchunhyang Univ, Dept Pediat, Coll Med, Cheonan, South Korea	Hallym University; National Medical Center - Korea; Soonchunhyang University	Kang, MJ (corresponding author), Hallym Univ, Dept Pediat, Coll Med, Chunchon, South Korea.	remoni80@gmail.com	Shim, Young Suk/AFX-0329-2022	Shim, Young Suk/0000-0002-0850-5279; Kang, Min Jae/0000-0003-3080-0941	Kangdong Sacred Heart Hospital Fund [2018-03]	Kangdong Sacred Heart Hospital Fund	This study was supported by Grant no. 2018-03 from the Kangdong Sacred Heart Hospital Fund.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; [Anonymous], 2016, REGULATION EU 201667, V119, P1, DOI DOI 10.1016/J.WOCN.2016.08.005; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; de Wilde JA, 2018, INT J OBESITY, V42, P1230, DOI 10.1038/s41366-018-0135-9; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; DIETZ WH, 1985, PEDIATRICS, V75, P807; Dorosty AR, 2000, PEDIATRICS, V105, P1115, DOI 10.1542/peds.105.5.1115; Eriksson JG, 2007, J INTERN MED, V261, P418, DOI 10.1111/j.1365-2796.2007.01798.x; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Gillman MW, 2010, J DEV ORIG HLTH DIS, V1, P292, DOI 10.1017/S2040174410000358; Hughes AR, 2014, PEDIATRICS, V134, pE1354, DOI 10.1542/peds.2014-1908; Ip EH, 2017, J PEDIATR-US, V184, P151, DOI 10.1016/j.jpeds.2017.01.051; Johnson W, 2012, AM J CLIN NUTR, V95, P1136, DOI 10.3945/ajcn.111.022269; Kang Min Jae, 2018, Korean J Pediatr, V61, P375, DOI 10.3345/kjp.2018.07227; Kim Jae Hyun, 2018, Korean J Pediatr, V61, P135, DOI 10.3345/kjp.2018.61.5.135; Kowal M, 2015, AM J HUM BIOL, V27, P646, DOI 10.1002/ajhb.22704; Kowal M, 2013, AM J HUM BIOL, V25, P300, DOI 10.1002/ajhb.22359; Koyama S, 2014, PEDIATRICS, V133, pE114, DOI 10.1542/peds.2013-0966; Kroke A, 2006, INT J OBESITY, V30, P261, DOI 10.1038/sj.ijo.0803143; Luo ZC, 2003, EPIDEMIOLOGY, V14, P65, DOI 10.1097/00001648-200301000-00016; Maeyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38659; Min JW, 2018, INT J OBESITY, V42, P1661, DOI 10.1038/s41366-018-0091-4; Mo-suwan L, 2017, ACTA PAEDIATR, V106, P128, DOI 10.1111/apa.13639; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KK, 2004, J CLIN ENDOCR METAB, V89, P2647, DOI 10.1210/jc.2003-031848; PROKOPEC M, 1993, ANN HUM BIOL, V20, P517, DOI 10.1080/03014469300002922; Pusponegoro NH, 2017, PROCEDIA COMPUT SCI, V116, P284, DOI 10.1016/j.procs.2017.10.071; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; Scaglioni S, 2000, INT J OBESITY, V24, P777, DOI 10.1038/sj.ijo.0801225; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; SIERVOGEL RM, 1991, INT J OBESITY, V15, P479; Styne DM, 2017, J CLIN ENDOCR METAB, V102, P709, DOI 10.1210/jc.2016-2573; Sullivan MC, 2008, J PEDIATR HEALTH CAR, V22, P83, DOI 10.1016/j.pedhc.2007.02.008; Vignerova J, 2007, ECON HUM BIOL, V5, P409, DOI 10.1016/j.ehb.2007.07.003; WHITAKER RC, 1998, PEDIATRICS, V101; Williams SM, 2009, OBESITY, V17, P335, DOI 10.1038/oby.2008.547; Zheng M, 2018, OBES REV, V19, P321, DOI 10.1111/obr.12632	44	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0232810	10.1371/journal.pone.0232810	http://dx.doi.org/10.1371/journal.pone.0232810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125366	gold, Green Published, Green Submitted			2022-12-26	WOS:000588368900018
J	Chen, LF; Yuan, RF; Wen, CY; Liu, TD; Feng, Q; Deng, XQ; Du, YY; Peng, XG				Chen, Leifeng; Yuan, Rongfa; Wen, Chongyu; Liu, Tiande; Feng, Qian; Deng, Xueqiang; Du, Yunyan; Peng, Xiaogang			E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBP alpha	ONCOGENE			English	Article							PROTEIN; METASTASIS; SUPPRESSES; CELLS	Pancreatic cancer is one of the most fatal cancers in humans. While it thrives in a state of malnutrition, the mechanism by which pancreatic cancer cells adapt to metabolic stress through metabolic reprogramming remains unclear. Here, we showed that UBR5, an E3 ubiquitin ligase, was significantly upregulated in pancreatic cancer patient samples compared to the levels in adjacent normal tissues. Levels of UBR5 were closely related to a malignant phenotype and shorter survival among pancreatic cancer patients. Multivariate analyses also revealed that UBR5 overexpression was an independent predictor of poor outcomes among patients with pancreatic cancer. Functional assays revealed that UBR5 contributes to the growth of pancreatic cancer cells by inducing aerobic glycolysis. Furthermore, we demonstrated that UBR5 knockdown increased levels of fructose-1,6-bisphosphatase (FBP1), an important negative regulator in the process of aerobic glycolysis in many cancers. We found a significant negative correlation between levels of UBR5 and FBP1, further demonstrating that UBR5-induced aerobic glycolysis is dependent on FBP1 in pancreatic cancer cells. Mechanistically, UBR5 regulates FBP1 expression by modulating C/EBP alpha, directly binding to C/EBP alpha, and promoting its ubiquitination and degradation. Together, these results identify a mechanism used by pancreatic cancer cells to survive the nutrient-poor tumour microenvironment and also provide insight regarding the role of UBR5 in pancreatic cancer cell adaptation to metabolic stresses.	[Chen, Leifeng] Jiangxi Prov Clin Res Ctr Gen Surg Dis, Nanchang, Jiangxi, Peoples R China; [Chen, Leifeng; Yuan, Rongfa; Wen, Chongyu; Liu, Tiande; Feng, Qian; Deng, Xueqiang] Nanchang Univ, Affiliated Hosp 2, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China; [Du, Yunyan] Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Med, Nanchang, Jiangxi, Peoples R China; [Peng, Xiaogang] Nanchang Univ, Affiliated Hosp 2, Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Du, YY (corresponding author), Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Med, Nanchang, Jiangxi, Peoples R China.; Peng, XG (corresponding author), Nanchang Univ, Affiliated Hosp 2, Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China.	695728274@qq.com; pxg8205@163.com		Peng, Xiaogang/0000-0002-8173-5118	National Natural Science Foundation of China [81760523, 81560117, 32060166, 81960436, 81560396]; Project of the Jiangxi Provincial Department of Science and Technology [20171BAB215024, 20192BCB23023]; Project of the Jiangxi Provincial Department of Education [GJJ160251]; Project of the Jiangxi Provincial Health Commission [2017A264]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Jiangxi Provincial Department of Science and Technology; Project of the Jiangxi Provincial Department of Education; Project of the Jiangxi Provincial Health Commission	This study was supported by grants from the National Natural Science Foundation of China (nos. 81760523, 81560117, 32060166, 81960436 and 81560396), the Project of the Jiangxi Provincial Department of Science and Technology (nos. 20171BAB215024 and 20192BCB23023), the Project of the Jiangxi Provincial Department of Education (no. GJJ160251) and the Project of the Jiangxi Provincial Health Commission (no. 2017A264).	Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bolt MJ, 2015, ONCOGENE, V34, P154, DOI 10.1038/onc.2013.550; Breaux M, 2015, MOL CELL BIOL, V35, P3005, DOI 10.1128/MCB.00421-15; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Cong JJ, 2018, CELL METAB, V28, P243, DOI 10.1016/j.cmet.2018.06.021; Flint TR, 2017, TRENDS MOL MED, V23, P451, DOI 10.1016/j.molmed.2017.03.001; Gonzalez D, 2017, J BIOL CHEM, V292, P18924, DOI 10.1074/jbc.M117.811109; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu MY, 2019, J CANCER, V10, P1870, DOI 10.7150/jca.28299; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Liao LQ, 2017, CANCER RES, V77, P2090, DOI 10.1158/0008-5472.CAN-16-2409; Lin SC, 2017, J PATHOL, V241, P638, DOI 10.1002/path.4868; Liu GM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1165-x; Liu TD, 2012, EXP CELL RES, V318, P1994, DOI 10.1016/j.yexcr.2012.04.017; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maisonneuve P, 2019, PRESSE MED, V48, pE113, DOI 10.1016/j.lpm.2019.02.030; Matsuura K, 2017, ONCOGENE, V36, P1698, DOI 10.1038/onc.2016.336; Min HY, 2018, BIOMOL THER, V26, P45, DOI 10.4062/biomolther.2017.211; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Qin YY, 2014, ONCOL REP, V31, P2635, DOI 10.3892/or.2014.3145; Shearer RF, 2015, MOL CANCER RES, V13, P1523, DOI 10.1158/1541-7786.MCR-15-0383; Shi DB, 2015, CANCER LETT, V369, P376, DOI 10.1016/j.canlet.2015.08.029; Subbaiah VK, 2016, ONCOGENE, V35, P2062, DOI 10.1038/onc.2015.268; Tao YM, 2014, P NATL ACAD SCI USA, V111, pE4429, DOI 10.1073/pnas.1407139111; Wang B, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0888-y; Wang J, 2017, DIGEST DIS SCI, V62, P2781, DOI 10.1007/s10620-017-4732-6; Wattanavanitchakorn S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194252; Weng WH, 2014, ONCOL REP, V31, P1921, DOI 10.3892/or.2014.3005; Xie H, 2017, J BIOL CHEM, V292, P16825, DOI 10.1074/jbc.R117.799973; Yang J, 2017, CARCINOGENESIS, V38, P134, DOI 10.1093/carcin/bgw109; Yang M, 2016, BIOCHEM BIOPH RES CO, V478, P1624, DOI 10.1016/j.bbrc.2016.08.170; Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	34	16	18	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					262	276		10.1038/s41388-020-01527-1	http://dx.doi.org/10.1038/s41388-020-01527-1		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33122826				2022-12-26	WOS:000582827800003
J	Manning, SW; Lorentzen, B; Welton, L; Batiuk, S; Harrison, TP				Manning, Sturt W.; Lorentzen, Brita; Welton, Lynn; Batiuk, Stephen; Harrison, Timothy P.			Beyond megadrought and collapse in the Northern Levant: The chronology of Tell Tayinat and two historical inflection episodes, around 4.2ka BP, and following 3.2ka BP	PLOS ONE			English	Article							LATE BRONZE-AGE; CLIMATE-CHANGE; IRON-AGE; MEDITERRANEAN CHRONOLOGY; RESILIENCE; DROUGHT; RECORD; AMUQ; STRATIGRAPHY; VARIABILITY	There has been considerable focus on the main, expansionary, and inter-regionally linked or 'globalising' periods in Old World pre- and proto-history, with a focus on identifying, analyzing and dating collapse at the close of these pivotal periods. The end of the Early Bronze Age in the late third millennium BCE and a subsequent 'intermediate' or transitional period before the Middle Bronze Age (similar to 2200-1900 BCE), and the end of the Late Bronze Age in the late second millennium BCE and the ensuing period of transformation during the Early Iron Age (similar to 1200-900 BCE), are key examples. Among other issues, climate change is regularly invoked as a cause or factor in both cases. Recent considerations of "collapse" have emphasized the unpredictability and variability of responses during such periods of reorganization and transformation. Yet, a gap in scholarly attention remains in documenting the responses observed at important sites during these 'transformative' periods in the Old World region. Tell Tayinat in southeastern Turkey, as a major archaeological site occupied during these two major 'in between' periods of transformation, offers a unique case for comparing and contrasting differing responses to change. To enable scholarly assessment of associations between the local trajectory of the site and broader regional narratives, an essential preliminary need is a secure, resolved timeframe for the site. Here we report a large set of radiocarbon data and incorporate the stratigraphic sequence using Bayesian chronological modelling to create a refined timeframe for Tell Tayinat and a secure basis for analysis of the site with respect to its broader regional context and climate history.	[Manning, Sturt W.; Lorentzen, Brita] Cornell Univ, Dept Class, Cornell Tree Ring Lab, Ithaca, NY 14850 USA; [Welton, Lynn; Batiuk, Stephen; Harrison, Timothy P.] Univ Toronto, Dept Near & Middle Eastern Civilizat, Toronto, ON, Canada; [Welton, Lynn] Univ Durham, Dept Archaeol, Dawson Bldg, Durham, England	Cornell University; University of Toronto; Durham University	Manning, SW (corresponding author), Cornell Univ, Dept Class, Cornell Tree Ring Lab, Ithaca, NY 14850 USA.	sm456@cornell.edu		Manning, Sturt/0000-0002-6917-0927; Lorentzen, Brita/0000-0001-5379-288X	Social Sciences and Humanities Research Council, Canada [895-2011-1026]; University of Toronto, Canada [BCS 1219315]; National Science Foundation, USA; College of Arts & Sciences, Cornell University, USA; NSF [DMR-1719875]	Social Sciences and Humanities Research Council, Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of Toronto, Canada(University of Toronto); National Science Foundation, USA(National Science Foundation (NSF)); College of Arts & Sciences, Cornell University, USA; NSF(National Science Foundation (NSF))	TH, SWM, Award 895-2011-1026, Social Sciences and Humanities Research Council, Canada, https://www.sshrc-crsh.gc.ca/homeaccueil-eng.aspx.TH, University of Toronto, Canada, https://www.utoronto.ca/SWM, Award BCS 1219315, National Science Foundation, USA, https://www.nsf.gov/SWM, College of Arts & Sciences, Cornell University, USA, https://as.cornell.edu/BL, Use of the CCMR facilities, supported by NSF award DMR-1719875, for wood charcoal analysis, https://www.ccmr.cornell.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WH, 2003, HIST ARCHAEOL, V37, P38, DOI 10.1007/BF03376602; Akkemik ?., 2012, WOOD ANATOMY E MEDIT; [Anonymous], 2003, B AM SCH ORIENTAL RE, V332, P7, DOI [10.2307/1357808, DOI 10.2307/1357808]; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Archi A, 2006, ORIENTE OCCIDENTE ST, P2; Archi A., 2003, JCS, V55, P1, DOI DOI 10.2307/3515951; Armit I, 2014, P NATL ACAD SCI USA, V111, P17045, DOI 10.1073/pnas.1408028111; Batiuk S., 2005, AMUQ VALLEY REGIONAL, V131, P171; Bayliss A., 2004, TOOLS CONSTRUCTING C, P25; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Bini M, 2019, CLIM PAST, V15, P555, DOI 10.5194/cp-15-555-2019; Braidwood RJ, 1960, ORIENTAL I PUBLICATI; Brochier JE, 2020, ORIGINS STRUCTURE DE; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Broodbank Cyprian, 2013, MAKING MIDDLE SEA HI; Bruins HJ, 2011, RADIOCARBON, V53, P199, DOI 10.1017/S0033822200034470; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3628, DOI 10.1073/pnas.1114772109; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Calcagnile L, 2013, EBLA AND ITS LANDSCAPE: EARLY STATE FORMATION IN THE ANCIENT NEAR EAST, P450; Capper, 2011, ANATOLICA, V37, P147; Capper MM, 2012, THESIS; Carolin SA, 2019, P NATL ACAD SCI USA, V116, P67, DOI 10.1073/pnas.1808103115; Casana J. J., 2005, AMUQ VALLEY REGIONAL, V1, P153; Casana J. J., 2005, ORIENTAL I PUBLICATI, V131, P25; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; Cline EH, 2014, 1177 BC YEAR CIVILIZ; Cook ER, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500561; Cooper L, 2014, OXFORD HDB ARCHAEOLO, P278; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Czichon R. M., 2016, MITTEILUNGEN DTSCH O, V148, P5; Dalfes HN, 1997, P NATO ASI SERIES, V49; Davis P.H., 1965, FLORA TURKEY E AEGEA, V1; Dee M, 2000, NUCL INSTRUM METH B, V172, P449, DOI 10.1016/S0168-583X(00)00337-2; Dee MW, 2014, RADIOCARBON, V56, P83, DOI 10.2458/56.16685; Dee MW, 2010, J ARCHAEOL SCI, V37, P687, DOI 10.1016/j.jas.2009.09.003; Dee M, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0395; Dincol A., 2014, KARKEMISH ANCIENT CA, P127; Dincol B, 2015, ANATOL STUD, V65, P59, DOI 10.1017/S006615461500006X; Dolce R., 2009, SMEA, V51, P251; Dornemann R., 2008, P 4 INT C ARCH ANC N, V2, P81, DOI [10.1055/s-2008-1081337, DOI 10.1055/S-2008-108133718671196]; Drake BL, 2012, J ARCHAEOL SCI, V39, P1862, DOI 10.1016/j.jas.2012.01.029; Drews R., 1993, END BRONZE AGE CHANG; Durand Jean-Marie, 2012, REV DASSYRIOLOGIE, V106, P117; Eyre Christopher, 1995, CIVILIZATIONS ANCIEN, V1, P175; Fahn A., 1986, Wood anatomy and identification of trees and shrubs from Israel and adjacent regions., pplates; Fales Frederick M., 2012, RA, V106, P133; Fantalkin A, 2011, RADIOCARBON, V53, P179, DOI 10.1017/S0033822200034469; Finne M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189447; Flohr P, 2016, QUATERNARY SCI REV, V136, P23, DOI 10.1016/j.quascirev.2015.06.022; Forsberg S, 1995, BOREAS 19; Grayson Albert Kirk, 1996, ROYAL INSCRIPTIONS M; Griggs CB, 2009, RADIOCARBON, V51, P711, DOI 10.1017/S0033822200056046; Haines RC, 1971, ORIENTAL I PUBLICATI; Hamilton WD, 2018, AM ANTIQUITY, V83, P187, DOI 10.1017/aaq.2017.57; Harrison K, 2013, LAW RELATING TO FINANCIAL CRIME IN THE UNITED KINGDOM, P61; Harrison T. P., 2005, B CANADIAN SOC MESOP, V40, P23; Harrison T. P., 2009, EXPLORING LONGUE DUR, P171; Harrison T. P., 2001, B CANADIAN SOC MESOP, V36, P135; Harrison Timothy, 2012, JCS, V64, P125, DOI DOI 10.5615/JCUNESTUD.64.0125; Harrison TP, 2009, NEAR EAST ARCHAEOL, V72, P174, DOI 10.1086/NEA25754026; Harrison TP, 2016, PROVINCIAL ARCHAEOLO, P253; Harrison TP, 2001, WORLD ARAMAEANS, P115; Harrison TP, 2014, ARCHAEOLOGIES TEXT A, P80; Harrison TP, 2014, C VOLUME MUNICH 2013, P396; Hawkins JD, 2011, ANATOL STUD, V61, P35, DOI 10.1017/S0066154600008772; Hawkins JD, 2009, NEAR EAST ARCHAEOL, V72, P164, DOI 10.1086/NEA25754025; Hawkins JD, 2002, NAHOSTLICHEN KULTURE, P143; Hawkins JD, 2000, CORPUS LUWIAN INSCRI; Hoflmayer F, ROME SAPIENZA STUDIE, P117; Janeway B., 2018, REV BIBLICAL LIT, V2018; Jull AJT, 2018, RADIOCARBON, V60, P1237, DOI 10.1017/RDC.2018.53; Kaniewski D, 2010, QUATERNARY RES, V74, P207, DOI 10.1016/j.yqres.2010.07.010; Kaniewski D., 2017, MEGADROUGHT COLLAPSE, P161; Kaniewski D, 2019, REG ENVIRON CHANGE, V19, P2287, DOI 10.1007/s10113-018-01460-w; Kaniewski D, 2018, CLIM PAST, V14, P1529, DOI 10.5194/cp-14-1529-2018; Kaniewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071004; Karakaya D, 2019, IRON AGE I LEVANT 1, V50-51, P136; Karakaya D, 2019, THESIS; Kennett DJ, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0458; Kerner S., 2015, CLIMATE ANCIENT SOC, P69; Kintigh KW, 2018, J ARCHAEOL SCI, V89, P25, DOI 10.1016/j.jas.2017.09.006; Knapp AB, 2016, AM J ARCHAEOL, V120, P99, DOI 10.3764/aja.120.1.0099; Knapp AB., 2018, SEAFARING SEAFARERS; Kovalev VI, 2010, FRONTIERS IN GUIDED WAVE OPTICS AND OPTOELECTRONICS, P83; Laming MM, 2019, PALG STUD GENDER ED, P61, DOI 10.1007/978-3-030-24478-1_5; Langgut D, 2013, TEL AVIV, V40, P149, DOI 10.1179/033443513X13753505864205; Lauinger J., 2012, J CUNEIFORM STUDIES, V64, P87; Lauinger J., 2011, J CANADIAN SOC MESOP, V6, P5; Lehmann G, 2008, UGARIT FORSCHUNGEN, V39, P487; LIBBY WF, 1961, SCIENCE, V133, P621, DOI 10.1126/science.133.3453.621; Liverani M, 2001, INT RELATIONS ANCIEN; Liverani M., 1987, CTR PERIPHERY ANCIEN, P66; Manning SM., 2018, IEMA P, P279; Manning SW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1096; Manning SW, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav0280; Manning SW, 2018, P NATL ACAD SCI USA, V115, P6141, DOI 10.1073/pnas.1719420115; Manning SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157144; Manning SW, 2014, J ARCHAEOL SCI, V46, P401, DOI 10.1016/j.jas.2014.03.003; Manning SW, 2011, GORDION SPEC STUD, V6, P123; Manning SW, 2010, RADIOCARBON, V52, P1571, DOI 10.1017/S0033822200056320; Manning SW, 2013, ANCIENT MEDITERRANEA, P103; Manning SW, 2017, SEA PEOPLES DATE NEW, P95; Manning SW, 2017, ORIENTAL I SEMINARS, P443; Marston JM, 2015, J ETHNOBIOL, V35, P585, DOI 10.2993/etbi-35-03-585-605.1; Matthiae P, 2013, EBLA AND ITS LANDSCAPE: EARLY STATE FORMATION IN THE ANCIENT NEAR EAST, P35; Matthiae P., 2009, SCI ANTICHITA, V15, P43; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Mazzoni S., 2000, ANESS, V7, P31; Mazzoni S, 2014, OXFORD HDB ARCHAEOLO, P683; Mazzoni S, 2002, CERAMIQUE AGE BRONZE, V161, P69; Mazzoni Stefania, 2000, ISIMU, V3, P121; McCormick M, 2012, J INTERDISCIPL HIST, V43, P169, DOI 10.1162/JINH_a_00379; Meller H, 2015, 2200 BC KLIMASTURZ A; Middleton G.D., 2020, COLLAPSE TRANSFORMAT; Middleton Guy D., 2017, UNDERSTANDING COLLAP; Moeller N, 2015, AGYPTEN LEVANTE, V15, P153; Montesanto M, 2019, IRON AGE I LEVANT 1, V50-51, P93; Morandi Bonacossi D., 2008, AKKADICA, V129, P55; Murray SC, COLLAPSE MYCENAEAN E; Neugebauer I, 2015, HOLOCENE, V25, P1358, DOI 10.1177/0959683615584208; NEUMANN J, 1987, J NEAR EASTERN STUD, V46, P161, DOI 10.1086/373244; Osborne J. F., 2012, B AM SCH ORIENT RES, V368, P29; Osborne JF, 2019, B AM SCH ORIENTAL RE, V382, P261, DOI 10.1086/705728; Osborne JF, 2017, ANTIQUITY, V91, P90, DOI 10.15184/aqy.2016.254; Osborne JF, 2013, J ANTHROPOL ARCHAEOL, V32, P774, DOI 10.1016/j.jaa.2013.05.004; Pucci M., 2008, FUNCTIONAL ANAL SPAC; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Ramsey CB, 2010, SCIENCE, V328, P1554, DOI 10.1126/science.1189395; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Regev J, 2012, RADIOCARBON, V54, P525, DOI 10.1017/S003382220004724X; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riehl S, 2014, P NATL ACAD SCI USA, V111, P12348, DOI 10.1073/pnas.1409516111; Riehl S, 2009, QUATERN INT, V197, P93, DOI 10.1016/j.quaint.2007.08.005; Roberts K, 2015, HANDBOOK OF ROAD ECOLOGY, P27; Rollig W, 2013, ARCHEOLOGIE HIST SYR, P461; Sader H, 2014, OXFORD HDB ARCHAEOLO, P601; Salzer MW, 2014, CLIM DYNAM, V42, P1517, DOI 10.1007/s00382-013-1911-9; Schniedewind WM, 2005, BIBLE RADIOCARBON DA; Schwartz GM, 2017, ORIENTAL I SEMINARS, P87; Sconzo P, 2015, ASS REGIONAL CHRONOL, P85; Sharon I, 2007, RADIOCARBON, V49, P1, DOI 10.1017/S0033822200041886; Sinha A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax6656; Snodgrass A, 1983, SOURCES ANCIENT HIST, P137; Snow H, U CHICAGOS EXCAVATIO; Steiner, 2014, OXFORD HDB ARCHAEOLO, P414; Toffolo MB, 2014, RADIOCARBON, V56, P221, DOI 10.2458/56.16899; Toffolo MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083117; van der Plicht J, 2009, RADIOCARBON, V51, P213, DOI 10.1017/S0033822200033786; van Geel B, 2004, J ARCHAEOL SCI, V31, P1735, DOI 10.1016/j.jas.2004.05.004; VanGeel B, 1996, J QUATERNARY SCI, V11, P451, DOI 10.1002/(SICI)1099-1417(199611/12)11:6<451::AID-JQS275>3.0.CO;2-9; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Ward William A., 1992, CRISIS YEARS 12 CENT; Wardle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106672; Watson W. G. E., 1999, HDB UGARITIC STUDIES, V39, P603; Weeden M., 2015, NOUVELLES ASSYRIOLOG, V2015, P65; Weeden M., 2013, B I CLASS STUD, V56, P1; Weiberg E, 2018, WORLD ARCHAEOL, V50, P584, DOI 10.1080/00438243.2018.1515035; WEISS B, 1982, CLIMATIC CHANGE, V4, P173; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss H., 2012, STUDIA CHABURENSIA, P163; Weiss H., 2017, MEGADROUGHT COLLAPSE, P93; Weiss H, 2017, EARLY AGR ANGKOR; Weiss Harvey, 2016, J SALT LAKE RES, V24, P62; Weiss N, 2014, CAMB MG MEC, P367; Welton L., 2011, J CANADIAN SOC MESOP, V6, P15; Welton L, 2019, IRON AGE 1 LEVANT 1, V50-51, P70; Welton L, 2019, AM J ARCHAEOL, V123, P291, DOI 10.3764/aja.123.2.0291; Welton L, 2014, LEVANT, V46, P339, DOI 10.1179/0075891414Z.00000000050; Weninger B., 2009, LH 3 C CHRONOLOGY SY, V30, P373; White GC I, 2000, BLOOD COAGULATION FI, V11, pS53, DOI 10.1097/00001721-200004001-00012; Wilkinson TJ, 2014, J WORLD PREHIST, V27, P43, DOI 10.1007/s10963-014-9072-2; Wossink A., 2009, CHALLENGING CLIMATE; Yener K.A, 2013, BORDER LATE BRONZE I, P11; Yoffee Norman, 2019, EVOLUTION FRAGILITY	182	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240799	10.1371/journal.pone.0240799	http://dx.doi.org/10.1371/journal.pone.0240799			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119717	Green Accepted, Green Published, gold			2022-12-26	WOS:000600013600007
J	Wang, JQ; Lin, ZC; Li, LL; Zhang, SF; Li, WH; Liu, W; Song, BL; Luo, J				Wang, Ju-Qiong; Lin, Zi-Cun; Li, Liang-Liang; Zhang, Shao-Fang; Li, Wei-Hui; Liu, Wei; Song, Bao-Liang; Luo, Jie			SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; INDUCIBLE DEGRADER; CHOLESTEROL UPTAKE; LXR-BETA; DEGRADATION; SUMO; MECHANISMS; PROTEINS; CLATHRIN; IDENTIFICATION	Inducible degrader of the low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase mediating degradation of low-density lipoprotein (LDL) receptor (LDLR). IDOL also controls its own stability through autoubiquitination, primarily at lysine 293. Whether IDOL may undergo other forms of post-translational modification is unknown. In this study, we show that IDOL can be modified by small ubiquitin-like modifier 1 at the K293 residue at least. The SUMOylation of IDOL counteracts its ubiquitination and augments IDOL protein levels. SUMOylation and the associated increase of IDOL protein are effectively reversed by SUMO-specific peptidase 1 (SENP1) in an activity-dependent manner. We further demonstrate that SENP1 affects LDLR protein levels by modulating IDOL. Overexpression of SENP1 increases LDLR protein levels and enhances LDL uptake in cultured cells. On the contrary, loss of SENP1 lowers LDLR levels in an IDOL-dependent manner and reduces LDL endocytosis. Collectively, our results reveal SUMOylation as a new regulatory posttranslational modification of IDOL and suggest that SENP1 positively regulates the LDLR pathway via deSUMOylation of IDOL and may therefore be exploited for the treatment of cardiovascular disease.	[Wang, Ju-Qiong; Lin, Zi-Cun; Li, Liang-Liang; Zhang, Shao-Fang; Li, Wei-Hui; Liu, Wei; Song, Bao-Liang; Luo, Jie] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China	Wuhan University	Luo, J (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China.	jieluo@whu.edu.cn		Song, Bao-Liang/0000-0002-6397-5935; lin, zi-cun/0000-0002-4793-3938	NNSF of China [31690102, 31600651, 91954203]; Ministry of Science and Technology of China [2018YFA0800700]; 111 Project of Ministry of Education of China [B16036]	NNSF of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of Ministry of Education of China(Ministry of Education, China - 111 Project)	The work was supported by grants from NNSF of China (31690102 [to J. L.], 31600651 [to J. L.], 91954203 [to B.-L. S.]), the Ministry of Science and Technology of China (2018YFA0800700 [to J. L.]), and 111 Project of Ministry of Education of China (B16036 [to B.-L. S.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi D, 2019, ARTERIOSCL THROM VAS, V39, P2468, DOI 10.1161/ATVBAHA.119.312589; Azad P, 2016, J EXP MED, V213, P2729, DOI 10.1084/jem.20151920; Calkin AC, 2011, P NATL ACAD SCI USA, V108, P20107, DOI 10.1073/pnas.1111589108; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; Chen LG, 2019, SCI CHINA LIFE SCI, V62, P1420, DOI 10.1007/s11427-019-1563-3; Choi J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1904; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gao J, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00518-19; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Henderson R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0256-1; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hong C, 2014, CELL METAB, V20, P910, DOI 10.1016/j.cmet.2014.10.001; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jiang LY, 2018, J BIOL CHEM, V293, P4047, DOI 10.1074/jbc.RA117.001260; Kunz K, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211904; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf4850; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee SD, 2019, NAT METAB, V1, P1089, DOI 10.1038/s42255-019-0127-7; Liang YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26509; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Nelson JK, 2016, CIRC RES, V118, P410, DOI 10.1161/CIRCRESAHA.115.307298; Novoselova TV, 2013, J BIOL CHEM, V288, P10308, DOI 10.1074/jbc.M112.424234; Sabatine MS, 2019, NAT REV CARDIOL, V16, P155, DOI 10.1038/s41569-018-0107-8; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Sharma P, 2013, CELL REP, V3, P1640, DOI 10.1016/j.celrep.2013.04.016; Sorrentino V, 2013, J LIPID RES, V54, P2174, DOI 10.1194/jlr.M037713; Sorrentino V, 2013, EUR HEART J, V34, P1292, DOI 10.1093/eurheartj/ehs472; Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557; Stein S, 2014, CELL METAB, V20, P603, DOI 10.1016/j.cmet.2014.07.023; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Wei J, 2014, J BIOL CHEM, V289, P33689, DOI 10.1074/jbc.M114.593764; Weissglas-Volkov D, 2011, J CLIN INVEST, V121, P3062, DOI 10.1172/JCI45504; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xiao J, 2021, PROTEIN CELL, V12, P279, DOI 10.1007/s13238-020-00753-3; Xiao J, 2019, SCI CHINA LIFE SCI, V62, P1117, DOI 10.1007/s11427-019-9569-9; Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210; Yang YF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170167; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P2541, DOI 10.1161/ATVBAHA.112.250571; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211; Zhou D, 2013, AM J HUM GENET, V93, P452, DOI 10.1016/j.ajhg.2013.07.011; Zhou ZS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14231-w	55	6	8	4	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100032	10.1074/jbc.RA120.015420	http://dx.doi.org/10.1074/jbc.RA120.015420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33154164	gold, Green Published			2022-12-26	WOS:000672866400016
J	Huang, GL; Nampe, DP; Yi, J; Gabrelow, GB; Negri, KR; Kamb, A; Xu, H				Huang, Grace L.; Nampe, Daniel P.; Yi, Jason; Gabrelow, Grant B.; Negri, Kathleen R.; Kamb, Alexander; Xu, Han			A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitro	PLOS ONE			English	Article							CHIMERIC ANTIGEN; CYTOTOXICITY; RECEPTORS; THRESHOLD; CAPACITY	Cell therapy is poised to play a larger role in medicine, most notably for immuno-oncology. Despite the recent success of CAR-T therapeutics in the treatment of blood tumors and the rapid progress toward improved versions of both CAR- and TCR-Ts, important analytical aspects of preclinical development and manufacturing of engineered T cells remain immature. One limiting factor is the absence of robust multivariate assays to disentangle key parameters related to function of engineered effector cells, especially in the peptide-MHC (pMHC) target realm, the natural ligand for TCRs. Here we describe an imaging-based primary T cell assay that addresses several of these limitations. To our knowledge, this assay is the first quantitative, high-content assay that separates the key functional parameters of time- and antigen-dependent T cell proliferation from cytotoxicity. We show that the assay sheds light on relevant biology of CAR- and TCR-T cells, including response kinetics and the influence of effector:target ratio.	[Huang, Grace L.; Nampe, Daniel P.; Yi, Jason; Gabrelow, Grant B.; Negri, Kathleen R.; Kamb, Alexander; Xu, Han] A2 Biotherapeut Inc, Discovery Res, Agoura Hills, CA 91301 USA; [Yi, Jason] ImmPACT Bio Inc, Camarillo, CA USA		Xu, H (corresponding author), A2 Biotherapeut Inc, Discovery Res, Agoura Hills, CA 91301 USA.	hxu@a2biotherapeutics.com		Xu, Han/0000-0002-1530-2162	A2 Biotherapeutics	A2 Biotherapeutics	This study was funded by A2 Biotherapeutics. A2 Biotherapeutics provided support in the form of salary for authors GLH, DPN, KRN, JY, GBG, AK, and HX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Bersenev A, 2018, CELL GENE THER INSIG; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Draper LM, 2015, CLIN CANCER RES, V21, P4431, DOI 10.1158/1078-0432.CCR-14-3341; EMA, 2018, ASS REP YESCARTA, V44; FDA, 2017, FDA BRIEF DOC ONC DR; Garcia A, 2014, J IMMUNOL METHODS, V409, P99, DOI 10.1016/j.jim.2014.05.019; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; James SE, 2010, J IMMUNOL, V184, P4284, DOI 10.4049/jimmunol.0903701; Jensen MC, 2015, CURR OPIN IMMUNOL, V33, P9, DOI 10.1016/j.coi.2015.01.002; Locke FL, 2017, MOL THER, V25, P285, DOI 10.1016/j.ymthe.2016.10.020; Mehlhop-Williams ER, 2014, J EXP MED, V211, P345, DOI 10.1084/jem.20131271; Milone MC, 2018, MOL THER-METH CLIN D, V8, P210, DOI 10.1016/j.omtm.2018.01.010; Nazarian AA, 2015, J BIOMOL SCREEN, V20, P519, DOI 10.1177/1087057114561405; Nelson DL, 2001, CURR PROTOC IMMUNOL, V7, P27, DOI [10.1002/0471142735.im0727s08, 10.1002/0471142735.IM0727S08, DOI 10.1002/0471142735.IM0727S08]; Rossi J, 2018, BLOOD, V132, P804, DOI 10.1182/blood-2018-01-828343; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Siegler EL, 2018, HUM GENE THER, V29, P534, DOI 10.1089/hum.2017.243; Skommer J, 2010, CELL CYCLE, V9, P2330, DOI 10.4161/cc.9.12.11911; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vormittag P, 2018, CURR OPIN BIOTECH, V53, P164, DOI 10.1016/j.copbio.2018.01.025; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wlodkowic D, 2009, ANAL CHEM, V81, P6952, DOI 10.1021/ac9010217; Xu H, 2020, MOL IMMUNOL, V126, P56, DOI 10.1016/j.molimm.2020.07.020	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241421	10.1371/journal.pone.0241421	http://dx.doi.org/10.1371/journal.pone.0241421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166305	gold, Green Published			2022-12-26	WOS:000592382600054
J	Kai, W; Lin, D; Yu, Y; Dai, CGQ; Qu, MH; Dong, JY; Hao, XJ				Kai Wang; Lin Ding; Yu Yan; Dai, Chengguqiu; Qu, Minghan; Dong Jiayi; Hao, Xingjie			Modelling the initial epidemic trends of COVID-19 in Italy, Spain, Germany, and France	PLOS ONE			English	Article							CHINA; DYNAMICS; WUHAN	The Coronavirus Disease 2019 (COVID-19) has fast spread to over 200 countries and regions worldwide since its outbreak, while in March, Europe became the emerging epicentre. In this study, we aimed to model the epidemic trends and estimate the essential epidemic features of COVID-19 in Italy, Spain, Germany, and France at the initial stage. The numbers of daily confirmed cases and total confirmed cases were extracted from the Coronavirus disease (COVID-19) situation reports of WHO. We applied an extended Susceptible-Exposed-Infectious-Removed (SEIR) model to fit the epidemic trend and estimated corresponding epidemic features. The transmission rate estimates were 1.67 (95% credible interval (CrI), 1.64-1.71), 2.83 (2.72-2.85), 1.91 (1.84-1.98), and 1.89 (1.82-1.96) for Italy, Spain, Germany, and France, corresponding to the basic reproduction numbers (R-0) 3.44 (3.35-3.54), 6.25 (5.97-6.55), 4.03 (3.84-4.23), and 4.00 (3.82-4.19), respectively. We found Spain had the lowest ascertainment rate of 0.22 (0.19-0.25), followed by France, Germany, and Italy of 0.45 (0.40-0.50), 0.46 (0.40-0.52), and 0.59 (0.55-0.64). The peaks of daily new confirmed cases would reach on April 16, April 5, April 21, and April 19 for Italy, Spain, Germany, and France if no action was taken by the authorities. Given the high transmissibility and high covertness of COVID-19, strict countermeasures, such as national lockdown and social distancing, were essential to be implemented to reduce the spread of the disease.	[Kai Wang; Lin Ding; Yu Yan; Dai, Chengguqiu; Qu, Minghan; Dong Jiayi; Hao, Xingjie] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Key Lab Environm & Hlth, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology	Hao, XJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Key Lab Environm & Hlth, Wuhan 430030, Peoples R China.	xingjie@hust.edu.cn		Jiayi, Dong/0000-0002-2735-3653	Huazhong University of Science and Technology [3004513126]; Wuhan Health Committee [EG20B03]	Huazhong University of Science and Technology; Wuhan Health Committee	This research was supported by Huazhong University of Science and Technology in the form of funding awarded to XH (3004513126) and the Wuhan Health Committee in the form of funding awarded to XH (EG20B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JB, 2020, INVESTIGATING IMPACT, DOI DOI 10.1101/2020.03.18.20037994V1.FULL.PDF; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, 2020 CORONAVIRUS PAN; [Anonymous], 2020, SCHED AN; [Anonymous], 2020, SPAIN PLANS 2 WEEK L; Bohning D, 2020, INT J INFECT DIS, V97, P197, DOI 10.1016/j.ijid.2020.06.009; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Ganyani T, 2020, ESTIMATING GENERATIO, DOI DOI 10.1101/2020.03.05.20031815; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lin YF, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00321; Linka K, 2020, COMPUT METHOD BIOMEC, V23, P710, DOI 10.1080/10255842.2020.1759560; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu M, 2020, PUBLIC HEALTH, V183, P76, DOI 10.1016/j.puhe.2020.05.001; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Magal P, 2020, PREDICTING NUMBER RE, DOI [10.1016/j.jtbi.2020.110501, DOI 10.1016/J.JTBI.2020.110501]; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; Wei Y Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P470, DOI 10.3760/cma.j.cn112338-20200216-00106; WHO, 2020, 134 WHO; WHO, 2020, 33 WHO; World Health Organization, 2020, 64 WHO; World Health Organization, 2020, 38 WHO; World Health Organization, 2020, ARCH WHO TIM COVID 1; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xia W, 2020, TRANSMISSION CORONA, DOI 10.1101/2020.03.06.20031955; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241743	10.1371/journal.pone.0241743	http://dx.doi.org/10.1371/journal.pone.0241743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166344	Green Published, gold			2022-12-26	WOS:000592382600050
J	Oluwagbemi, OO; Oluwagbemi, FE; Jatto, A; Hui, C				Oluwagbemi, Olugbenga Oluseun; Oluwagbemi, Folakemi Etseoghena; Jatto, Abdulwahab; Hui, Cang			MAVSCOT: A fuzzy logic-based HIV diagnostic system with indigenous multi-lingual interfaces for rural Africa	PLOS ONE			English	Article							SOUTH-AFRICA; LANGUAGE POLICY; CONDOM USE; HIV/AIDS; PREVENTION; BARRIERS; CARE; DEFUZZIFICATION; TRANSMISSION; PREVALENCE	HIV still constitutes a major public health problem in Africa, where the highest incidence and prevalence of the disease can be found in many rural areas, with multiple indigenous languages being used for communication by locals. In many rural areas of the KwaZulu-Natal (KZN) in South Africa, for instance, the most widely used languages include Zulu and Xhosa, with only limited comprehension in English and Afrikaans. Health care practitioners for HIV diagnosis and treatment, often, cannot communicate efficiently with their indigenous ethnic patients. An informatics tool is urgently needed to facilitate these health care professionals for better communication with their patients during HIV diagnosis. Here, we apply fuzzy logic and speech technology and develop a fuzzy logic HIV diagnostic system with indigenous multi-lingual interfaces, named Multi-linguAl HIV indigenouS fuzzy logiC-based diagnOstic sysTem (MAVSCOT). This HIV multilingual informatics software can facilitate the diagnosis in underprivileged rural African communities. We provide examples on how MAVSCOT can be applied towards HIV diagnosis by using existing data from the literature. Compared to other similar tools, MAVSCOT can perform better due to its implementation of the fuzzy logic. We hope MAVSCOT would help health care practitioners working in indigenous communities of many African countries, to efficiently diagnose HIV and ultimately control its transmission.	[Oluwagbemi, Olugbenga Oluseun; Hui, Cang] Stellenbosch Univ, Dept Math Sci, Stellenbosch, South Africa; [Oluwagbemi, Olugbenga Oluseun] Sol Plaatje Univ, Dept Comp Sci & Informat Technol, Kimberley, South Africa; [Oluwagbemi, Olugbenga Oluseun] Univ Oxford, Big Data Inst, Nuffield Dept Med, Oxford, England; [Oluwagbemi, Olugbenga Oluseun] Stellenbosch Univ, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Oluwagbemi, Folakemi Etseoghena] Hagerhof, Andringa & Borched St, Stellenbosch, South Africa; [Jatto, Abdulwahab] Fed Univ Lokoja, Dept Comp Sci, Lokoja, Nigeria; [Hui, Cang] African Inst Math Sci, Cape Town, South Africa	Stellenbosch University; University of Oxford; National Research Foundation - South Africa; Stellenbosch University	Oluwagbemi, OO (corresponding author), Stellenbosch Univ, Dept Math Sci, Stellenbosch, South Africa.; Oluwagbemi, OO (corresponding author), Sol Plaatje Univ, Dept Comp Sci & Informat Technol, Kimberley, South Africa.; Oluwagbemi, OO (corresponding author), Univ Oxford, Big Data Inst, Nuffield Dept Med, Oxford, England.; Oluwagbemi, OO (corresponding author), Stellenbosch Univ, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa.	olugbenga.oluwagbemi@fulbrightmail.org	; Hui, Cang/A-1781-2008	Jatto, Abdulwahab/0000-0002-9351-8428; Oluwagbemi, Olugbenga/0000-0001-9085-3370; Hui, Cang/0000-0002-3660-8160	National Research Foundation (NRF) Innovation Postdoctoral fellowship research grant of the Republich of South Africa [111999]	National Research Foundation (NRF) Innovation Postdoctoral fellowship research grant of the Republich of South Africa	OOO received the National Research Foundation (NRF) Innovation Postdoctoral fellowship research grant of the Republich of South Africa, with Grant Number: 111999 https://www.nrf.ac.za/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLASSNIG KP, 1986, IEEE T SYST MAN CYB, V16, P260, DOI 10.1109/TSMC.1986.4308946; [Anonymous], 2017, PLASMONICS, V12, P1; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; Atalay B, 1999, P 12 IEEE S COMP BAS; Baisley K, 2018, HIGH HIV INCIDENCE L; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Deepa G., 2018, RES J PHARM TECHNOL, V11, P949, DOI DOI 10.5958/0974-360X.2018.00176.2; Dutta Palash, 2020, Computer Vision and Machine Intelligence in Medical Image Analysis. International Symposium, ISCMM 2019. Advances in Intelligent Systems and Computing (AISC 992), P127, DOI 10.1007/978-981-13-8798-2_13; Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9; Ebuenyi ID, 2018, AIDS CARE, V30, P296, DOI 10.1080/09540121.2017.1368443; Engelbrecht C, 2008, S AFR J AFR LANG, V28, P145, DOI 10.1080/02572117.2008.10587310; Gao H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020525; Geman O, 2011, P 2011 E HLTH BIOENG, P1; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gumbi P, 2015, S AFR J AFR LANG, V35, P157, DOI 10.1080/02572117.2015.1112999; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; Hernandez-Vargas EA, 2013, J THEOR BIOL, V320, P33, DOI 10.1016/j.jtbi.2012.11.028; Hudson AL, 2003, AIDS CARE, V15, P483, DOI 10.1080/0954012031000134728; Innocent PR, 2004, INFORM SCIENCES, V162, P81, DOI 10.1016/j.ins.2004.03.003; Janghorbani A, 2017, J BIOMED INFORM, V72, P96, DOI 10.1016/j.jbi.2017.07.004; John RI, 2005, IEEE T SYST MAN CY B, V35, P1340, DOI 10.1109/TSMCB.2005.855588; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; Kilembe W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124548; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Madiba S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1341597; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Martin D, 1997, EDUC REV, V49, P129, DOI 10.1080/0013191970490204; Matthews M, 2016, S AFR FAM PRACT, V58, P30, DOI 10.1080/20786190.2015.1083718; Mtenga SM, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.28941; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Novak V, 2005, FUZZY SET SYST, V156, P341, DOI 10.1016/j.fss.2005.05.029; Oluwagbemi Olugbenga, 2016, Informatics in Medicine Unlocked, V2, P12, DOI 10.1016/j.imu.2015.12.001; Oluwagbemi O., 2010, INT J NAT APPL SCI, V6, P181; Oluwagbemi OO, 2018, J KING SAUD UNIV-COM, V30, P185, DOI 10.1016/j.jksuci.2017.04.003; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pazzani MJ, 1997, J ACQ IMMUN DEF SYND, V15, P356, DOI 10.1097/00042560-199708150-00005; Pellowski JA, 2013, J ASSOC NURSE AIDS C, V24, P422, DOI 10.1016/j.jana.2012.08.007; Precup RE, 2020, IEEE T INSTRUM MEAS, V69, P4625, DOI 10.1109/TIM.2020.2983531; Quanguo Gongshang Xitong Fazhi Zhuanjiaxing Rencai Peixunban Diyi Keti Zu, 2013, GONGSHANG XINGZHENG, V2, P54; Riaz M, 2019, INT J BIOMATH, V12, DOI 10.1142/S1793524519500803; Ristic M, 2017, FACTA UNIV-SER MECH, V15, P133, DOI 10.22190/FUME160723004R; Sagili H, 2015, J OBSTET GYN INDIA, V65, P104, DOI 10.1007/s13224-014-0606-4; Schroder M., 2003, International Journal of Speech Technology, V6, P365, DOI 10.1023/A:1025708916924; Schroder M, 2009, BLIZZARD CHALLENGE; Schroder M., 4 ISCA WORKSH SPEECH, P200; Schuster RC, 2016, AIDS CARE, V28, P778, DOI 10.1080/09540121.2016.1139041; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; Shisana O, 2012, S AFRICAN NATL HIV P; Sowell RL, 1997, PUBLIC HEALTH NURS, V14, P302, DOI 10.1111/j.1525-1446.1997.tb00379.x; Tseng TL, 2016, J COMPUT DES ENG, V3, P1, DOI 10.1016/j.jcde.2015.04.002; Tucker JA, 2013, AIDS PATIENT CARE ST, V27, P280, DOI 10.1089/apc.2012.0322; Van Broekhoven E, 2006, FUZZY SET SYST, V157, P904, DOI 10.1016/j.fss.2005.11.005; Van Broekhoven E, 2004, IEEE INT CONF FUZZY, P1537; Van Leekwijck W, 1999, FUZZY SET SYST, V108, P159, DOI 10.1016/S0165-0114(97)00337-0; Versteeg M, 2008, SAHARA J-J SOC ASP H, V5, P83, DOI 10.1080/17290376.2008.9724905; Vilela M, 2019, PETROL SCI, V16, P1208, DOI 10.1007/s12182-019-0348-0; WHO, 2016, FACT SHEETS; Wilson NL, 2016, J ASSOC NURSE AIDS C, V27, P121, DOI 10.1016/j.jana.2015.11.009; Wilson NL, 2014, J ASSOC NURSE AIDS C, V25, P483, DOI 10.1016/j.jana.2014.07.004; Yates E, 2017, THINK SKILLS CREAT, V23, P42, DOI 10.1016/j.tsc.2016.11.001; Yazdi M, 2020, INT J OCCUP SAF ERGO, V26, P319, DOI 10.1080/10803548.2018.1454636; Yuhana U. L., 2020, INT J ARTIFICIAL INT, V18, P237; Zainiddinov H, 2016, EUR J PUBLIC HEALTH, V26, P1075, DOI 10.1093/eurpub/ckw077	66	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241864	10.1371/journal.pone.0241864	http://dx.doi.org/10.1371/journal.pone.0241864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156877	Green Published, gold			2022-12-26	WOS:000591376400034
J	Romano, S; Fierro, A; Liccardo, A				Romano, Silvio; Fierro, Annalisa; Liccardo, Antonella			Beyond the peak: A deterministic compartment model for exploring the Covid-19 evolution in Italy	PLOS ONE			English	Article							CORONAVIRUS; EPIDEMIC; WUHAN	Novel Covid-19 has had a huge impact on the world's population since December 2019. The very rapid spreading of the virus worldwide, with its heavy toll of death and overload of the healthcare systems, induced the scientific community to focus on understanding, monitoring and foreseeing the epidemic evolution, weighing up the impact of different containment measures. An immense literature was produced in few months. Many papers were focused on predicting the peak features through a variety of different models. In the present paper, combining the surveillance data-set with data on mobility and testing, we develop a deterministic compartment model aimed at performing a retrospective analysis to understand the main modifications occurred to the characteristic parameters that regulate the epidemic spreading. We find that, besides self-protective behaviors, a reduction of susceptibility should have occurred in order to explain the fast descent of the epidemic after the peak. A sensitivity analysis of the basic reproduction number, in response to variations of the epidemiological parameters that can be influenced by policy-makers, shows the primary importance of a rigid isolation procedure for the diagnosed cases, combined with an intensive effort in performing extended testing campaigns. Future scenarios depend on the ability to protect the population from the injection of new cases from abroad, and to pursue in applying rigid self-protective measures.	[Romano, Silvio; Liccardo, Antonella] Univ Napoli Federico II, Dept Phys, Naples, Italy; [Fierro, Annalisa] CNR SPIN, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR)	Fierro, A (corresponding author), CNR SPIN, Naples, Italy.	annalisa.fierro@spin.cnr.it	Fierro, Annalisa/G-8479-2013	Fierro, Annalisa/0000-0001-8431-942X; Liccardo, Antonella/0000-0002-7534-0574	MIUR [PRIN 2017WZFTZP]	MIUR(Ministry of Education, Universities and Research (MIUR))	A.L. and A.F. acknowledge financial support of the MIUR PRIN 2017WZFTZP "Stochastic forecasting in complex systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleta Alberto, 2020, medRxiv, DOI 10.1101/2020.05.06.20092841; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2020, AGENZIA NAZL ST 0221, V8, P15; Barmparis GD, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109842; Cereda D., 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)32154-1; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cuzzocrea A, 2020, LA REPUBBLICA; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Distante C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093025; DPCM, 2020, G U EDIZIONE STRAORD, V76; DPCM, 2020, G U G, V115; DPCM, 2020, G U G, V127; DPCM IoRestoaCasa, 2020, G U G 0308, V59; Duan SM, 2003, BIOMED ENVIRON SCI, V16, P246; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Fierro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083641; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gazzetta Ufficiale della Repubblica Italiana, 2020, GAZZETTA UFFICIALE G, V202; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Guzzetta G, 2020, ARXIV200412338; Guzzetta G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.12.2000293; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Jia WP, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00169; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lalwani S, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109939; Lerner G, 2020, LA REPUBBLICA; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Lopez L, 2021, RESULTS PHYS, V21, DOI 10.1016/j.rinp.2020.103746; Lopez L, 2020, NAT HUM BEHAV, V4, P746, DOI 10.1038/s41562-020-0908-8; Manivel C, 2020, HAL02579551; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Nishiura H., 2009, MATH STAT ESTIMATION, P103, DOI [DOI 10.1007/978-90-481-2313-1_5, 10.1007/978-90-481-2313-1_5]; Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274; Postnikov EB, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109841; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang TB, 2020, PRECIS CLIN MED, V3, P104, DOI 10.1093/pcmedi/pbaa018; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu Y, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139051; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Zhang XL, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109829	44	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241951	10.1371/journal.pone.0241951	http://dx.doi.org/10.1371/journal.pone.0241951			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156859	Green Published, gold			2022-12-26	WOS:000591376400046
J	Every-Palmer, S; Jenkins, M; Gendall, P; Hoek, J; Beaglehole, B; Bell, C; Williman, J; Rapsey, C; Stanley, J				Every-Palmer, Susanna; Jenkins, Matthew; Gendall, Philip; Hoek, Janet; Beaglehole, Ben; Bell, Caroline; Williman, Jonathan; Rapsey, Charlene; Stanley, James			Psychological distress, anxiety, family violence, suicidality, and wellbeing in New Zealand during the COVID-19 lockdown: A cross-sectional study	PLOS ONE			English	Article							TE-RAU-HINENGARO; MENTAL-HEALTH; UNEMPLOYMENT; DISORDERS; GENDER	New Zealand's early response to the novel coronavirus pandemic included a strict lockdown which eliminated community transmission of COVID-19. However, this success was not without cost, both economic and social. In our study, we examined the psychological wellbeing of New Zealanders during the COVID-19 lockdown when restrictions reduced social contact, limited recreation opportunities, and resulted in job losses and financial insecurity. We conducted an online panel survey of a demographically representative sample of 2010 adult New Zealanders in April 2020. The survey contained three standardised measures-the Kessler Psychological Distress Scale (K10), the GAD-7, and the Well-Being Index (WHO-5)-as well as questions designed specifically to measure family violence, suicidal ideation, and alcohol consumption. It also included items assessing positive aspects of the lockdown. Thirty percent of respondents reported moderate to severe psychological distress (K10), 16% moderate to high levels of anxiety, and 39% low wellbeing; well above baseline measures. Poorer outcomes were seen among young people and those who had lost jobs or had less work, those with poor health status, and who had past diagnoses of mental illness. Suicidal ideation was reported by 6%, with 2% reporting making plans for suicide and 2% reporting suicide attempts. Suicidality was highest in those aged 18-34. Just under 10% of participants had directly experienced some form of family harm over the lockdown period. However, not all consequences of the lockdown were negative, with 62% reporting 'silver linings', which included enjoying working from home, spending more time with family, and a quieter, less polluted environment. New Zealand's lockdown successfully eliminated COVID-19 from the community, but our results show this achievement brought a significant psychological toll. Although much of the debate about lockdown measures has focused on their economic effects, our findings emphasise the need to pay equal attention to their effects on psychological wellbeing.	[Every-Palmer, Susanna; Jenkins, Matthew] Univ Otago, Dept Psychol Med, Wellington, New Zealand; [Gendall, Philip; Hoek, Janet; Stanley, James] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Beaglehole, Ben; Bell, Caroline] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Williman, Jonathan] Univ Otago, Dept Populat Hlth, Christchurch, New Zealand; [Rapsey, Charlene] Univ Otago, Dept Psychol Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago	Every-Palmer, S (corresponding author), Univ Otago, Dept Psychol Med, Wellington, New Zealand.	susanna.every-palmer@otago.ac.nz		Jenkins, Matthew/0000-0002-3958-3739; Every-Palmer, Susanna/0000-0001-6455-9741	Dynata	Dynata	We would like to thank Dynata for their generous support of this research. Thank you to the NZ Ministry of Health, Ministry of Justice, Department of Statistics, and to Anaru Waa, Emma Sutich, Marcellus Paki, Fiona Mathieson, Giles Newton-Howes, and Elliot Bell for expert advice on survey content and design.	Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Ardern Jacinda, 2020, PM ADDRESS COVID 19; Artazcoz L, 2004, AM J PUBLIC HEALTH, V94, P82, DOI 10.2105/AJPH.94.1.82; Baker MG, 2020, MED J AUSTRALIA, V213, P198, DOI 10.5694/mja2.50735; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P253, DOI 10.1111/j.1440-1614.2006.01782.x; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P896, DOI 10.1111/j.1440-1614.2006.01909.x; Browne MAO, 2010, AUST NZ J PSYCHIAT, V44, P314, DOI 10.3109/00048670903279820; China's domestic abuse epidemic, 2020, AXIOS; Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7; Dalton H, 2020, STUFF; Dastagir A, 2020, US TODAY; de Bruin WB, 2021, J GERONTOL B-PSYCHOL, V76, pE24, DOI 10.1093/geronb/gbaa074; Foon E, 2020, RNZ 0423; Foon E, 2020, RNZ 0501; Global Adult Tobacco Survey Collaborative Group, 2010, GLOB AD TOB SURV GAT; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Health Information Standards Organisation, 2017, 100012017 HISO; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Hymas C., 2020, TELEGRAPH; Iasevoli F, 2021, PSYCHOL MED, V51, P1054, DOI 10.1017/S0033291720001841; Johnston ER, 2020, CONCEPT MAGN RESON A, V2020, DOI 10.1155/2020/8819956; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Jordan P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182162; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lumley T., 2019, ANAL COMPLEX SURVEY; McDowell RD, 2014, PSYCHOL MED, V44, P707, DOI 10.1017/S0033291713001116; New Zealand Government, 2020, COVID 19 NAT ACT PLA; New Zealand Ministry of Health, 2020, COVID 19 CURR CAS, P8; NZ Ministry of Health, 2020, KIA KAH KIA MAIA KIA; NZ Ministry of Health, 2020, COVID 19 EL STRAT AO; NZ Ministry of Justice, 2020, NZ CRIM VICT CRIM SU; NZ Ministry of Justice, 2019, NZ CRIM VICT SURV TO; Oxford COVID-19 Government Response Tracker Blavatnik School of Government, 2020, DAT US POL CREAT COM; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Panayi A, 2020, SCI AM; Petzold MB, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1745; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; RNZ, 2020, RNZ 0406; Rowney C, 2014, NEW ZEAL J PSYCHOL, V43, P4; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stanko KE, 2015, CURR PSYCHOL, V34, P564, DOI 10.1007/s12144-015-9366-2; Statistics NZ, 2020, NZ GEN SOC SURV INF; Strandh M, 2013, SOCIOL HEALTH ILL, V35, P649, DOI 10.1111/j.1467-9566.2012.01517.x; Sudman S, 1983, ASKING QUESTIONS; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; van Gelder N, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100348; Wade A, 2020, NZ HERALD; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wanqing Z, 2020, 6 TONE 0303; Wilson N, 2020, PUBLIC HLTH EXP 0727; World Health Organisation,, 2020, MENT HLTH PSYCH CONS; Zhang SX, 2020, 1 STUDY MENTAL DISTR	59	139	142	11	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241658	10.1371/journal.pone.0241658	http://dx.doi.org/10.1371/journal.pone.0241658			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147259	Green Published, gold			2022-12-26	WOS:000589609300061
J	Hazarika, AK; Kalita, U; Michael, RG; Panthi, S; Das, D				Hazarika, Arup Kumar; Kalita, Unmilan; Michael, Rev George; Panthi, Saroj; Das, Dulumoni			Ecological status of a freshwater tectonic lake of the indo-burmese province: Implications for livelihood development	PLOS ONE			English	Article							QUALITY INDEX; PHYTOPLANKTON; BIODIVERSITY; CONSERVATION; TEMPERATURE	Tectonic lakes are among the most geologically fascinating and environmentally versatile hydrobiological systems found on the earth's surface. We conducted a study on the limnology of Tasek Lake, a tectonic lake located in the Indo-Burma Province of the South Asian region. Physico-chemical parameters of the lake's water along with its plankton were considered for the study. Their relationship was analysed by understanding their seasonal variations and through linear regression models. The water quality index (WQI), plankton diversity indices and canonical correspondence analysis (CCA) were computed. The ichthyofaunal diversity was also studied to get an insight into the lake's fishery potential. A preliminary assessment on the economic feasibility of converting Tasek Lake into a fishery was also completed. Results indicate moderate eutrophication in the lake and the plankton population is observed to be rich and abundant. The WQI value confirms the water to be of "very poor" quality. The CCA was done to analyze the relationships of physico-chemical parameters with months and seasons, and the relation between seasons and plankton assemblages. Results corroborate the results of WQI. Identified fish population suggest ample fishery potential of the lake. The economic assessment reveals that in order to maintain the ecological sustainability of the lake, it should be transformed into a recreational fishery, following a catch-and-release model. The study calls for urgent restoration of the lake so that not only its pristine ecology is survived but also its fishery potential is sustainably harnessed and local livelihood is improved.	[Hazarika, Arup Kumar] Cotton Univ, Dept Zool, Gauhati, India; [Kalita, Unmilan] Cotton Univ, Dept Econ, Gauhati, India; [Michael, Rev George] North Eastern Hill Univ, Meghalaya, India; [Panthi, Saroj] Minist Ind Tourism Forest & Environm, Pokhara, Nepal; [Das, Dulumoni] Cotton Univ, Dept Stat, Gauhati, India	North Eastern Hill University	Panthi, S (corresponding author), Minist Ind Tourism Forest & Environm, Pokhara, Nepal.	mountsaroj@gmail.com		Kalita, Unmilan/0000-0002-1398-784X; Panthi, Saroj/0000-0002-1502-7711; Hazarika, Arup kumar/0000-0001-6206-3195				AGIUS C, 1982, HYDROBIOLOGIA, V87, P89, DOI 10.1007/BF00016666; Alam MGM, 2001, ENVIRON INT, V27, P363, DOI 10.1016/S0160-4120(01)00087-3; Alcamo J, 2019, CURR OPIN ENV SUST, V36, P126, DOI 10.1016/j.cosust.2018.11.005; APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Baba A.I., 2014, J ECOSYSTEM ECOGRAPH, V4, P142, DOI [DOI 10.4172/2157-7625.1000142, 10.4172/2157-7625.1000142]; BARUAH D, 2018, NACA NEWSL, V22, P1; Borthakur M, 1986, N E GEOGRAPHER, V18; Brenner A, 2019, DRINKING WATER MINERALS AND MINERAL BALANCE, P127, DOI 10.1007/978-3-030-18034-8_6; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Cheng TW, 2002, MINER ENG, V15, P271, DOI 10.1016/S0892-6875(02)00021-3; Choudhury BU., 2012, J AGR PHYS, V12, P12; Cukur D, 2017, INT J EARTH SCI, V106, P239, DOI 10.1007/s00531-016-1312-5; Das Kangabam R, 2019, ENVIRON TECHNOL, V40, P2232, DOI 10.1080/09593330.2017.1378267; Das P. K., 1996, Tropical Ecology, V37, P257; Deb S., 2019, EUROPEAN J BIOMEDICA, V6, P232; Duan YF, 2019, FISH SHELLFISH IMMUN, V88, P142, DOI 10.1016/j.fsi.2019.02.047; England P, 2015, TECTONICS, V34, P1792, DOI 10.1002/2015TC003902; Hammer O., PALEONTOLOGICAL STAT; Hazarika A K, 1997, THESIS; Hazarika AK, 1997, ENV ECOLOGY, V15, P397; Hughes RM, 2015, FISHERIES SCI, V81, P1, DOI 10.1007/s12562-014-0815-x; Kannan K, 1991, FUNDAMENTALS ENV POL; Khan ML, 1997, BIODIVERS CONSERV, V6, P853, DOI 10.1023/B:BIOC.0000010406.35667.c0; Khan S, 2017, TELEGRAPH; Khanday SA, 2018, STOCH ENV RES RISK A, V32, P3151, DOI 10.1007/s00477-018-1581-6; Kim JJ, 2019, WATER-SUI, V11, DOI 10.3390/w11010114; Kroupova H, VET MED PRAHA, V50, P461; Kumar Manoj, 2012, Indian J Occup Environ Med, V16, P40, DOI 10.4103/0019-5278.99696; MICHAEL R G, 1969, Hydrobiologia, V33, P144, DOI 10.1007/BF00181684; MICHAEL R G, 1968, Hydrobiologia, V32, P47, DOI 10.1007/BF00179538; Michael RG, 1975, SURVEY REPORT, P12; Mishra G. S., 2017, Current World Environment, V12, P630, DOI 10.12944/cwe.12.3.14; Mohanty BP, 2019, FOOD CHEM, V293, P561, DOI 10.1016/j.foodchem.2017.11.039; Nath B., 2012, Journal of Bio Innovation, V1, P148; Needham J G, 1962, GUIDE STUDY FRESHWAT, P108; Odongkara K, 2005, P LAK VICT STAK C M; Padisak J, 2016, HYDROBIOLOGIA, V764, P3, DOI 10.1007/s10750-015-2259-4; Prescott GW., 1962, ALGAE W GREAT LAKES, P977; Ramakrishnaiah CR, 2009, E-J CHEM, V6, P523, DOI 10.1155/2009/757424; Rasconi S, 2017, ECOL EVOL, V7, P2936, DOI 10.1002/ece3.2889; Shah JA, 2019, SCI TECHNOLOGY, V12, P149; Shentu Qingchun, 2000, Yingyong Shengtai Xuebao, V11, P449; Soldatov AA, 2003, J EVOL BIOCHEM PHYS+, V39, P159, DOI 10.1023/A:1025511315064; Sooraj MA, 2018, INT J PURE APPL MATH, V119, P4775; Sudarshan P., 2019, Environment and Ecology, V37, P309; Takarina ND, 2017, AIP CONF PROC, V1848, DOI 10.1063/1.4983932; Yang ZJ, 2017, FISHERIES, V42, P303, DOI 10.1080/03632415.2017.1324703; ZUTSHI DP, 1980, HYDROBIOLOGIA, V72, P101, DOI 10.1007/BF00016238	49	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240685	10.1371/journal.pone.0240685	http://dx.doi.org/10.1371/journal.pone.0240685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147227	Green Published, gold			2022-12-26	WOS:000589609300034
J	Javanbakht, M; Archer, R; Klausner, J				Javanbakht, Marjan; Archer, Roxanne; Klausner, Jeffrey			Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system	PLOS ONE			English	Article							HCV TREATMENT INITIATION; ACTING ANTIVIRAL AGENTS; VIRUS-INFECTION; THERAPY; ACCESS	Background The recent introduction of direct acting antivirals for the treatment of hepatitis C virus (HCV) has dramatically improved treatment options for HCV infected patients. However, in the United States (US) treatment uptake has been low and time to initiation of therapy has been long. We sought to examine provider perspectives of facilitators and barriers to HCV treatment delivery. Methods From June to August 2019, we conducted in-depth, semi-structured interviews with medical staff providing HCV care as part of a university medical center in Los Angeles, CA. In order to understand the HCV treatment process, we interviewed key staff members providing care to the majority of HCV patients seeking care at the university medical center, including hepatologists and infectious disease specialists as well as key nursing and pharmacy staff. The interviews focused on workload and activities required for HCV treatment initiation for non-cirrhotic, treatment naive patients. Results Providers noted that successful HCV treatment delivery was reliant on a care model involving close collaboration between a team of providers, in particular requiring a highly coordinated effort between dedicated nursing and pharmacy staff. The HCV care team overwhelmingly reported that the process of insurance authorization was the greatest obstacle delaying treatment initiation and noted that very few patient level factors served as a barrier to treatment uptake. Conclusions In the US, prior authorization for HCV treatment is a requirement for most public and private insurance plans. In an era with access to therapies that allow for a cure-and until revocation of prior authorization for HCV treatment is a reality-implementing strategies that can expedite authorization to accelerate treatment access are critical. Not only will this benefit patients, but it has the potential to help expand treatment to settings that are otherwise too resource strained to successfully deliver HCV care.	[Javanbakht, Marjan; Archer, Roxanne; Klausner, Jeffrey] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Klausner, Jeffrey] Univ Calif Los Angeles, Dept Med, Div Infect Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Javanbakht, M (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	javan@ucla.edu	Javanbakht, Marjan/Q-2183-2019	Javanbakht, Marjan/0000-0003-0088-3803	AbbVie Inc. [00101069.0]	AbbVie Inc.(AbbVie)	This work was supported by a grant from AbbVie Inc. (www.abbvie.com), award number 00101069.0 given to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2015, J HEPATOL, V63, P822, DOI 10.1016/j.jhep.2015.04.021; American Medical Association, 2018 AMA PRIOR AUTH; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2019, LANCET GASTROENTEROL, DOI DOI 10.1001/JAMA.2020.1123; Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027; Backus LI, 2017, ANTIVIR THER, V22, P481, DOI 10.3851/IMP3117; Bass SB, 2018, J HEALTH COMMUN, V23, P117, DOI 10.1080/10810730.2017.1414902; Bernard H., 2002, RES METHODS CULTURAL, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Butt AA, 2018, LIVER INT, V38, P1411, DOI 10.1111/liv.13672; Castrejon M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx109; CDC, 2019, SURV VIR HEP US 2017; Chou R, 2020, JAMA-J AM MED ASSOC, V323, P976, DOI 10.1001/jama.2019.20788; Chung RT, 2018, CLIN INFECT DIS, V67, P1477, DOI 10.1093/cid/ciy585; Geddawy A, 2017, J TRANSL INTERN MED, V5, P8, DOI 10.1515/jtim-2017-0007; Graham CS, 2020, JAMA-J AM MED ASSOC, V323, P936, DOI 10.1001/jama.2019.22313; Henry Brandy, 2018, J Health Biomed Law, V14, P265; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Kwo PY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218759; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lo Re V, 2016, CLIN GASTROENTEROL H, V14, P1035, DOI 10.1016/j.cgh.2016.03.040; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Malespin M, 2019, ANN HEPATOL, V18, P304, DOI 10.1016/j.aohep.2018.06.001; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; National Academy of Sciences, 2017, NAT AC SCI COMM NAT; North CS, 2013, GEN HOSP PSYCHIAT, V35, P122, DOI 10.1016/j.genhosppsych.2012.11.002; Patrick SW, 2017, MMWR-MORBID MORTAL W, V66, P470, DOI 10.15585/mmwr.mm6618a3; Resneck JS, 2020, JAMA-J AM MED ASSOC, V323, P703, DOI 10.1001/jama.2019.21428; Rosenthal ES, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0071-z; Santantonio T, 2003, DIGEST LIVER DIS, V35, P104, DOI 10.1016/S1590-8658(03)00007-0; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Seo S, 2020, CLIN GASTROENTEROL H, V18, P511, DOI 10.1016/j.cgh.2019.04.035; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Solund C, 2018, SCAND J GASTROENTERO, V53, P849, DOI 10.1080/00365521.2018.1467963; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; WHO, GLOB HEP REP 2017; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511; World Health Organization, 2016, COMB HEP B C REACH E; Younossi ZM, 2016, J VIRAL HEPATITIS, V23, P447, DOI 10.1111/jvh.12506	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241615	10.1371/journal.pone.0241615	http://dx.doi.org/10.1371/journal.pone.0241615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147293	Green Published, gold			2022-12-26	WOS:000589609300059
J	Fagbamigbe, AF; Kandala, NB; Uthman, OA				Fagbamigbe, Adeniyi Francis; Kandala, Ngianga-Bakwin; Uthman, Olalekan A.			Mind the gap: What explains the poor-non-poor inequalities in severe wasting among under-five children in low- and middle-income countries? Compositional and structural characteristics	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; NUTRITIONAL-STATUS; MALNUTRITION; UNDERNUTRITION; DECOMPOSITION; ETHIOPIA	A good understanding of the poor-non-poor gap in childhood development of severe wasting (SW) is a must in tackling the age-long critical challenge to health outcomes of vulnerable children in low- and middle-income countries (LMICs). There is a dearth of information about the factors explaining differentials in wealth inequalities in the distribution of SW in LMICs. This study is aimed at quantifying the contributions of demographic, contextual and proximate factors in explaining the poor-non-poor gap in SW in LMICs. We pooled successive secondary data from the Demographic and Health Survey conducted between 2010 and 2018 in LMICs. The final data consist of 532,680 under-five children nested within 55,823 neighbourhoods from 51 LMICs. Our outcome variable is having SW or not among under-five children. Oaxaca-Blinder decomposition was used to decipher poor-non-poor gap in the determinants of SW. Children from poor households ranged from 37.5% in Egypt to 52.1% in Myanmar. The overall prevalence of SW among children from poor households was 5.3% compared with 4.2% among those from non-poor households. Twenty-one countries had statistically significant pro-poor inequality (i.e. SW concentrated among children from poor households) while only three countries showed statistically significant pro-non-poor inequality. There were variations in the important factors responsible for the wealth inequalities across the countries. The major contributors to wealth inequalities in SW include neighbourhood socioeconomic status, media access, as well as maternal age and education. Socio-economic factors created the widest gaps in the inequalities between the children from poor and non-poor households in developing SW. A potential strategy to alleviate the burden of SW is to reduce wealth inequalities among mothers in the low- and middle-income countries through multi-sectoral and country-specific interventions with considerations for the factors identified in this study.	[Fagbamigbe, Adeniyi Francis] Univ Ibadan, Coll Med, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Fagbamigbe, Adeniyi Francis; Uthman, Olalekan A.] Univ Warwick, Div Hlth Sci, Populat Evidence & Technol Grp, Coventry, W Midlands, England; [Kandala, Ngianga-Bakwin] Northumbria Univ, Dept Math Phys & Elect Engn MPEE, Newcastle, NSW, Australia	University of Ibadan; University of Warwick	Fagbamigbe, AF (corresponding author), Univ Ibadan, Coll Med, Dept Epidemiol & Med Stat, Ibadan, Nigeria.; Fagbamigbe, AF (corresponding author), Univ Warwick, Div Hlth Sci, Populat Evidence & Technol Grp, Coventry, W Midlands, England.	franstel74@yahoo.com		Fagbamigbe, Adeniyi Francis/0000-0001-9184-8258				Abdulahi A, 2017, ETHIOP J HEALTH SCI, V27, P175, DOI 10.4314/ejhs.v27i2.10; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; Alemayehu M, 2015, NUTRITION, V31, P964, DOI 10.1016/j.nut.2015.01.013; Almasian Kia A, 2019, IRAN J PUBLIC HEALTH, V48, P748; [Anonymous], 2014, PAN AFR MED J, DOI DOI 10.11604/pamj.2014.17.161.2389; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2016, B NORMATIVNYKH AKTOV, V06. 06, P23; [Anonymous], 2015, INT J SCI STUD, V3, P29; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Arthur E, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-14; Azzarri C, 2011, FOOD POLICY, V36, P54, DOI 10.1016/j.foodpol.2010.11.004; Binns P, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0321-1; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Croft TN, 2018, GUIDE DHS STAT; Eshete H, 2017, ETHIOP J HEALTH SCI, V27, P155, DOI 10.4314/ejhs.v27i2.8; Fagbamigbe AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67570-w; Fagbamigbe AF, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08635-3; Fagbamigbe AF, 2020, NUTRITION, V75-76, DOI 10.1016/j.nut.2020.110768; Fagbamigbe AF, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0043-9; Galgamuwa LS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4311-y; Gebru KF, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1545-0; Global Nutrition Report, 2020, TIM LEST NUTR PROF, P1; Grebmer K. V., 2018, GLOBAL HUNGER INDEX; Hadzimustafa S, 2018, POVERTY REDUCING EFF; Health Canada, 2018, PRIM SUNSCR MON, P1; ICF International, 2012, DEM HLTH SURV SAMPL; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Jawaregowda S.K., 2015, INT J COMMUNITY MED, V2, P506, DOI [10.18203/2394-6040.ijcmph20151038, DOI 10.18203/2394-6040.IJCMPH20151038]; Kenya National Bureau of Statistics ICF International, 2015, KEN DEM HLTH SURV; Khan S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6688-2; Lenters L, 2016, REPROD MATERNAL NEWB, V2, P205, DOI [10.1596/978-1-4648-0348-2_ch11, DOI 10.1596/978-1-4648-0348-2_CH11]; Makoge V, 2019, HEALTH PROMOT INT, V34, P344, DOI 10.1093/heapro/dax088; Man S Lm, 2016, Beijing Da Xue Xue Bao Yi Xue Ban, V48, P418; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; McNamara K, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0170-8; Meshram II, 2012, ASIA PAC J CLIN NUTR, V21, P568; Mogeni P, 2011, B WORLD HEALTH ORGAN, V89, P900, DOI 10.2471/BLT.11.091280; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Motedayen Morteza, 2019, Clin Nutr Res, V8, P101, DOI 10.7762/cnr.2019.8.2.101; Muiru A, 2014, J ED PRACT; Musoke PM, 2011, AM J CLIN NUTR, V94, p1716S, DOI 10.3945/ajcn.111.018374; National Population Commission (NPC) [Nigeria] ICF, 2019, NIG DEM HLTH SURV 20; Ndwandwe D, 2018, HUM VACC IMMUNOTHER, V14, P2358, DOI 10.1080/21645515.2018.1467685; Nhampossa T, 2013, PUBLIC HEALTH NUTR, V16, P1565, DOI 10.1017/S1368980013001080; Novignon J, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0072-4; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Thompson DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173101; Titaley CR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051106; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; United Nations, 2015, SUST DEV GOAL SDG; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; USAID, 2018, TAJ NUTR PROF; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2019, SEV AC MALN; Woldehanna T., 2012, EFFECTS PRESCHOOL AT; World Economic Forum, 2020, TAJ OV, P1; World Health Organization, 2020, WHO MALN; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; World Health Organization (WHO), 2012, GLOBAL REPORT RES IN; Wuehler SE, 2011, MATERN CHILD NUTR, V7, P63, DOI 10.1111/j.1740-8709.2010.00311.x	62	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241416	10.1371/journal.pone.0241416	http://dx.doi.org/10.1371/journal.pone.0241416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141831	Green Accepted, gold, Green Published			2022-12-26	WOS:000588376700037
J	Han, C; Yu, GP; Mao, YS; Song, SQ; Li, L; Zhou, L; Wang, Z; Liu, YS; Li, ML; Xu, B				Han, Chao; Yu, Guopeng; Mao, Yuanshen; Song, Shangqing; Li, Long; Zhou, Lin; Wang, Zhong; Liu, Yushan; Li, Minglun; Xu, Bin			LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; RECEPTOR; PROTEIN; GROWTH; ACID	Our previously study shown that Lysophosphatidylcholine Acyltransferase1 (LPCAT1) is overexpressed in castration resistant prostate cancer (CRPC) relative to primary prostate cancer (PCa), and androgen controls its expression via the Wnt signaling pathway. While highly expressed in CRPC, the role of LPCAT1 remains unclear. In vitro cell experiments referred to cell transfection, mutagenesis, proliferation, migration, invasion, cell cycle progression and apoptosis, Western blotting, Pulse-chase RNA labeling. BALB/c nude mice were used for in vivo experiments. We found that LPCAT1 overexpression enhanced the proliferation, migration, and invasion of CRPC cells both in vitro and in vivo. Silencing of LPCAT1 reduced the proliferation and the invasive capabilities of CRPC cells. Providing exogenous PAF to LPCAT1 knockdown cells increased their invasive capabilities; however platelet activating factor acetylhydrolase (PAF-AH) and the PAFR antagonist ABT-491 both reversed this phenotype; proliferation of CRPC cells was not affected in either model. LPCAT1 was found to mediate CRPC growth via nuclear re-localization and Histone H4 palmitoylation in an androgen-dependent fashion, increasing mRNA synthesis rates. We also found that LPCAT1 overexpression led to CRPC cell resistance to treatment with paclitaxel. LPCAT1 overexpression in CRPC cells drives tumor progression via increased mRNA synthesis and PAF production. Our results highlight LPCAT1 as a viable therapeutic target in the context of CRPC.	[Han, Chao; Yu, Guopeng; Mao, Yuanshen; Song, Shangqing; Li, Long; Zhou, Lin; Wang, Zhong; Liu, Yushan; Xu, Bin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Urol, Sch Med, Shanghai, Peoples R China; [Li, Minglun] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Univ Hosp, Urol & Hematol Oncol, Munich, Germany	Shanghai Jiao Tong University; University of Munich	Liu, YS; Xu, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Urol, Sch Med, Shanghai, Peoples R China.; Li, ML (corresponding author), Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Univ Hosp, Urol & Hematol Oncol, Munich, Germany.	yushandoctor@163.com; Minglun.li@med.uni-muenchen.de; chxb2004@sina.com	Li, Minglun/A-8086-2019		National Natural Science Foundation of China [81472398]; Shanghai Rising-Star Program [15QA1404900, 201818042, JYZZ006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	The authors acknowledge funding from the National Natural Science Foundation of China, 81472398, to Dr. Bin Xu; Shanghai Rising-Star Program, 15QA1404900, to Dr. Bin Xu; Interdisciplinary research of 9th People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 201818042, to Dr. Bin Xu; and Fundamental Research Program Funding of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, JYZZ006, to Dr. Guopeng Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher E, 2015, TUMOR BIOL, V36, P5473, DOI 10.1007/s13277-015-3214-8; Al-Bakheit A, 2016, PROSTATE, V76, P1326, DOI 10.1002/pros.23222; Du YQ, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0525-1; Eigl BJ, 2015, INVEST NEW DRUG, V33, P969, DOI 10.1007/s10637-015-0252-4; Ellis Bryon, 2012, World J Biol Chem, V3, P159, DOI 10.4331/wjbc.v3.i7.159; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finones RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074438; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Jan CR, 2004, CELL SIGNAL, V16, P959, DOI 10.1016/j.cellsig.2004.01.011; Ji WB, 2016, INT J ONCOL, V49, P181, DOI 10.3892/ijo.2016.3519; Komiya A, 2010, ONCOL LETT, V1, P73, DOI 10.3892/ol_00000013; Kratiras Z, 2014, INT BRAZ J UROL, V40, P3, DOI 10.1590/S1677-5538.IBJU.2014.01.02; Moul JW, 2011, UROLOGY, V78, pS485, DOI 10.1016/j.urology.2011.05.051; Saraon Punit, 2014, EJIFCC, V25, P42; Shindou H, 2017, FASEB J, V31, P2973, DOI 10.1096/fj.201601183R; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tarui M, 2014, J LIPID RES, V55, P1386, DOI 10.1194/jlr.M049205; Uehara T, 2016, ANN SURG ONCOL, V23, P206, DOI 10.1245/s10434-015-4459-6; Wheler JJ, 2014, CANCER CHEMOTH PHARM, V73, P495, DOI 10.1007/s00280-014-2384-1; Williams KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004809; Wilson S, 2017, ONCOTARGET, V8, P30328, DOI 10.18632/oncotarget.15681; Wu YJ, 2014, NEUROSCI LETT, V558, P26, DOI 10.1016/j.neulet.2013.09.005; Xu B, 2013, BRIT J CANCER, V109, P1279, DOI 10.1038/bjc.2013.480; Zhang BT, 2016, ONCOTARGET, V7, P5702, DOI 10.18632/oncotarget.6790; Zhou XC, 2012, EXP MOL PATHOL, V92, P105, DOI 10.1016/j.yexmp.2011.11.001; Zhu XY, 2012, EUR UROL, V61, P652, DOI 10.1016/j.eururo.2011.11.029; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385	28	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0240801	10.1371/journal.pone.0240801	http://dx.doi.org/10.1371/journal.pone.0240801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137125	Green Published, gold			2022-12-26	WOS:000588375500035
J	Hu, YF; Yao, YH; Kou, ZX				Hu, Yufan; Yao, Yonghui; Kou, Zhixiang			Exploring on the climate regionalization of Qinling-Daba mountains based on Geodetector-SVM model	PLOS ONE			English	Article							CLASSIFICATION; CHINA; IDENTIFICATION; ZONES	Qinling-Daba Mountains (QDM), which are located in central China, are considered as a significant climatic boundary delimiting north and south. However, the influence of complex topographic and climatic features makes it challenging to identify the exact location of the boundary, and different scholars delimit the boundary with significant differences. In addition, there is a gradual transition between climate zones, and no real dividing line exists. To explore the climate regionalization of the QDM, we focused on the identification of the transition zone rather than the exact location of the boundary between subtropical and temperate zones. Thus, we proposed a new workflow for climate regionalization based on the Geodetector-SVM model (a combination of Geodetector and support vector machines). First, we selected the spatial distribution data of six vegetation types (including typical subtropical and temperate vegetation) to represent the spatial distribution of climatic zones. Environmental factors (such as topography, temperature, precipitation, and soil) were used as explanatory variables for the spatial distribution of vegetation. Second, using the Geodetector-SVM model, the distribution characteristics and suitable environment of typical vegetation in different climatic zones are comprehensively explored. By analyzing the multiple boundaries between subtropical and temperate vegetation, the location of the transition zone of the QDM was identified. The results revealed the following: (1) The new workflow for climate regionalization based on the Geodetector-SVM model is powerful for the identification of the transition zone. The q-statistics are generally greater than 0.35, indicating that the transition zone between subtropical and temperate zones can highly reflect the character of the QDM; (2) From west to east, the transition zone mainly passes through the cities of Heishui County, Kang County, Liuba County, and Yichuan County and is approximately 30 km wide.	[Hu, Yufan; Yao, Yonghui; Kou, Zhixiang] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Hu, Yufan; Kou, Zhixiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, YH (corresponding author), Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yaoyh@lreis.ac.cn		Hu, Yufan/0000-0002-7951-9774				Aliaga VS, 2017, INT J CLIMATOL, V37, P1237, DOI 10.1002/joc.5079; Almazroui M, 2015, INT J CLIMATOL, V35, P2555, DOI 10.1002/joc.4139; [Anonymous], 1984, POLITICAL GEOGRAPHY, V3, P69; [Anonymous], 2007, CRITICAL CARE, V11, pR17; [Anonymous], 2001, SILENO, V11, P80; [Anonymous], 1990, BAILAMME RIV SPIRITU, V8, P45; Bailey R.G, 2009, ECOSYSTEM GEOGRAPHY; Baker B, 2010, CLIMATIC CHANGE, V98, P113, DOI 10.1007/s10584-009-9622-2; Changwang T, 1938, ACTA METEOROLOGICA S, V4, P51; Conant GC, 1993, J HENAN U NATURAL SC, V4, P12; David M, SUPPORT VECTOR MACHI; Editorial Board of Vegetation Map of China Chinese Academy of Sciences, 2007, VEGETATION ATLAS CHI, P129; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001; FOVELL RG, 1993, J CLIMATE, V6, P2103, DOI 10.1175/1520-0442(1993)006<2103:CZOTCU>2.0.CO;2; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Guanghe W, 2004, INTEGRATED PHYS GEOG, V2nd; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021427; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huaxun L, 1981, ACTA GEOGRAPHICA SIN, V36, P267; Institute of botany The Chinese academy of sciences, FLOR REP POP SIN; Jacobeit J, 2010, PHYS CHEM EARTH, V35, P411, DOI 10.1016/j.pce.2009.11.010; Jiliang Q, 1965, ACTA GEOGRAPHICA SIN, V32; Jinquan Z, 1981, ACTA GEOGRAPHICA SIN, V48, P98; Jiuming Z, 2010, J PINGDINGSHAN U, V25, P115; Kezhen Z, 1958, CHINESE SCI B, V3, P938; Koppen W., 1930, HDB KLIMATOLOGIE; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kozjek K, 2017, INT J CLIMATOL, V37, P848, DOI 10.1002/joc.5042; Liu J, 2014, ADV ATMOS SCI, V31, P374, DOI 10.1007/s00376-013-3017-z; Manfred Domroes, 2003, Journal of Geographical Sciences, V13, P271; Mingde L, 1999, VEGETATION SHAANXI; Muyi K, 2007, ACTA ECOLOGICA SINIC, V27, P2774; Nanwei L, 1993, INTEGRATED PHYS GEOG; Nojarov P, 2017, J GEOGR SCI, V27, P43, DOI 10.1007/s11442-017-1363-y; Sadri S, 2011, J HYDROL, V401, P231, DOI 10.1016/j.jhydrol.2011.02.027; Shi PJ, 2016, INT J DISAST RISK SC, V7, P216, DOI 10.1007/s13753-016-0094-5; Sun YL, 2008, INT J CLIMATOL, V28, P1163, DOI 10.1002/joc.1509; Tao W, 2019, GEOGRAPHICAL RES, V38, P56; Toth GG, 2015, JACC-CARDIOVASC INTE, V8, P949, DOI 10.1016/j.jcin.2015.01.037; Unal Y, 2003, INT J CLIMATOL, V23, P1045, DOI 10.1002/joc.910; van der Linden S, 2009, REMOTE SENS ENVIRON, V113, P2298, DOI 10.1016/j.rse.2009.06.004; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; [王劲峰 Wang Jinfeng], 2017, [地理学报, Acta Geographica Sinica], V72, P116; Wu L, 1946, ACTA GEOGRAPHICA SIN, V13, P1; Xian SD, 2010, FUZZY INF ENG, V2, P75, DOI 10.1007/s12543-010-0038-5; Xianji C, 1980, ACTA METEOROLOGICA S, V40, P35; Xu Q, 2018, J GEOGR SCI, V28, P31, DOI 10.1007/s11442-018-1457-1; Xueyu H, 1964, CHINESE J PLANT ECOL, V2, P153; Yangcai Z, 1991, GEOGRAPHICAL RES, V10, P85; Ying L, 1964, CHINESE J PLANT ECOL, V1, P144; Zhan DS, 2018, J CLEAN PROD, V197, P1342, DOI 10.1016/j.jclepro.2018.06.108; [张百平 Zhang Baiping], 2019, [地理科学进展, Progress in Geography], V38, P305	54	6	6	10	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241047	10.1371/journal.pone.0241047	http://dx.doi.org/10.1371/journal.pone.0241047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137142	gold, Green Published			2022-12-26	WOS:000588375500009
J	Hung, WC; Lee, DY; Chiang, EPI; Syu, JN; Chao, CY; Yang, MD; Tsai, SY; Tang, FY				Hung, Wei-Chia; Lee, Der-Yen; Chiang, En-Pei Isabel; Syu, Jia-Ning; Chao, Che-Yi; Yang, Mei-Due; Tsai, Shu-Yao; Tang, Feng-Yao			Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis	PLOS ONE			English	Article							CANCER CELLS; IN-VITRO; APOPTOSIS; GROWTH; TRANSSULFURATION; GLUCOSE; NRF2; LINE	The treatment of cancer cells obtained by blocking cellular metabolism has received a lot of attention recently. Previous studies have demonstrated that Kras mutation-mediated abnormal glucose metabolism would lead to an aberrant cell proliferation in human pancreatic ductal adenocarcinoma (PDAC) cells. Previous literature has suggested that consumption of fish oil is associated with lower risk of pancreatic cancer. In this study, we investigated the anti-cancer effects of docosahexaenoic acid (DHA) in human PDAC cells in vitro and in vivo. Omega-3 polyunsaturated fatty acids (PUFAs) such as DHA and eicosapentaenoic acid (EPA) significantly inhibited the proliferation of human PDAC cells. The actions of DHA were evaluated through an induction of cell cycle arrest at G1 phase and noticed a decreased expression of cyclin A, cyclin E and cyclin B proteins in HPAF-II cells. Moreover, it was found that co-treatment of DHA and gemcitabine (GEM) effectively induced oxidative stress and cell death in HPAF-II cells. Interestingly, DHA leads to an increased oxidative glutathione /reduced glutathione (GSSG/GSH) ratio and induced cell apoptosis in HPAF-II cells. The findings in the study showed that supplementation of GSH or N-Acetyl Cysteine (NAC) could reverse DHA-mediated cell death in HPAF-II cells. Additionally, DHA significantly increased cellular level of cysteine, cellular NADP/NADPH ratio and the expression of cystathionase (CTH) and SLCA11/xCT antiporter proteins in HPAF-II cells. The action of DHA was, in part, associated with the inactivation of STAT3 cascade in HPAF-II cells. Treatment with xCT inhibitors, such as erastin or sulfasalazine (SSZ), inhibited the cell survival ability in DHA-treated HPAF-II cells. DHA also inhibited nucleotide synthesis in HPAF-II cells. It was demonstrated in a mouse-xenograft model that consumption of fish oil significantly inhibited the growth of pancreatic adenocarcinoma and decreased cellular nucleotide level in tumor tissues. Furthermore, fish oil consumption induced an increment of GSSG/GSH ratio, an upregulation of xCT and CTH proteins in tumor tissues. In conclusion, DHA significantly inhibited survival of PDAC cells both in vitro and in vivo through its recently identified novel mode of action, including an increment in the ratio of GSSG/GSH and NADP/NADPH respectively, and promoting reduction in the levels of nucleotide synthesis.	[Hung, Wei-Chia; Syu, Jia-Ning; Tang, Feng-Yao] China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan; [Lee, Der-Yen] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr IDCSA, Taichung, Taiwan; [Chao, Che-Yi; Tsai, Shu-Yao] Asia Univ, Dept Food Nutr & Hlth Biotechnol, Taichung, Taiwan; [Chao, Che-Yi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Mei-Due] China Med Univ Hosp, Dept Clin Nutr, Taichung, Taiwan; [Yang, Mei-Due] China Med Univ Hosp, Dept Surg, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, FY (corresponding author), China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan.	vincenttang@mail.cmu.edu.tw	Chiang, EnPei/K-1694-2013	Chiang, EnPei/0000-0002-0158-0962	Ministry of Science and Technology (MOST), Taiwan, R.O.C. [MOST-104-2320-B-039-041-MY3, 107-2320-B-039-008-MY3, 103-2811-B-039-009, 105-2811-B-039-005, 105-2811-B-039-031, 106-2811-B-039-002, 106-2811-B-039-016, MOST 107-2320-B 005 -003 -MY3, 107-2621-M-005-008 -MY3, MOST107-2321-B-005-009, 108-2321-B-005-004]; China Medical University (CMU) [CMU102-ASIA-23, CMU103-ASIA-20, CMU103-S-46, CMU104-S-32]; Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA	Ministry of Science and Technology (MOST), Taiwan, R.O.C.; China Medical University (CMU)(China Medical University); Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA	This research project is supported by the grant of Ministry of Science and Technology (MOST), Taiwan, R.O.C. under the agreements MOST-104-2320-B-039-041-MY3, 107-2320-B-039-008-MY3, 103-2811-B-039-009, 105-2811-B-039-005, 105-2811-B-039-031, 106-2811-B-039-002, 106-2811-B-039-016, MOST 107-2320-B 005 -003 -MY3, 107-2621-M-005-008 -MY3, MOST107-2321-B-005-009, 108-2321-B-005-004, China Medical University (CMU) grant under agreements CMU102-ASIA-23, CMU103-ASIA-20, CMU103-S-46, CMU104-S-32, and as well as in part by the Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA. Any results, conclusions, or implication described in this publication are from the author(s) of this manuscript and do not necessarily reflect the view of the MOST, MOE, Asia University and CMU.	[Anonymous], 2016, THE TOTAL AUDIENCE R; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Cazanave S, 2007, J HEPATOL, V46, P858, DOI 10.1016/j.jhep.2006.11.015; Chiang EPI, 2009, J CLIN ENDOCR METAB, V94, P1017, DOI 10.1210/jc.2008-2038; Cui XZ, 2017, INVEST OPHTH VIS SCI, V58, P1954, DOI 10.1167/iovs.16-21247; D'Eliseo D, 2012, J NUTR BIOCHEM, V23, P452, DOI 10.1016/j.jnutbio.2011.01.010; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Fujita M, 2017, CANCER SCI, V108, P961, DOI 10.1111/cas.13220; Fukui M, 2013, J CELL BIOCHEM, V114, P192, DOI 10.1002/jcb.24354; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Gebregiworgis T, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1452-7; Habib E, 2015, REDOX BIOL, V5, P33, DOI 10.1016/j.redox.2015.03.003; Hidaka A, 2015, AM J CLIN NUTR, V102, P1490, DOI 10.3945/ajcn.115.113597; Ishii T, 2014, REDOX BIOL, V2, P786, DOI 10.1016/j.redox.2014.04.008; Kang YW, 2018, CANCER LETT, V438, P174, DOI 10.1016/j.canlet.2018.09.013; Linher-Melville K, 2015, MOL CELL BIOCHEM, V405, P205, DOI 10.1007/s11010-015-2412-4; Liu DS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14844; Mailloux RJ, 2016, REDOX BIOL, V8, P110, DOI 10.1016/j.redox.2015.12.010; McBean GJ, 2012, AMINO ACIDS, V42, P199, DOI 10.1007/s00726-011-0864-8; Merendino N, 2005, NUTR CANCER, V52, P225, DOI 10.1207/s15327914nc5202_12; Modolell I, 1999, ANN ONCOL, V10, P82, DOI 10.1023/A:1008301206176; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Narayanankutty A, 2019, CURR PROTEIN PEPT SC, V20, P907, DOI 10.2174/1389203720666190206130003; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Santana-Codina N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07472-8; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Song KS, 2011, PANCREATOLOGY, V11, P574, DOI 10.1159/000334468; Tang FY, 2009, J NUTR BIOCHEM, V20, P426, DOI 10.1016/j.jnutbio.2008.05.001; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Werner K, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0495-5; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Wu MW, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00996; Xie TX, 2013, LARYNGOSCOPE, V123, P1416, DOI 10.1002/lary.23846; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	35	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241186	10.1371/journal.pone.0241186	http://dx.doi.org/10.1371/journal.pone.0241186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137095	Green Published, gold			2022-12-26	WOS:000588375500023
J	Loose, FN; Breitbach, A; Bertalan, I; Ruster, D; Truyen, U; Speck, S				Loose, Finn N.; Breitbach, Andre; Bertalan, Ivo; Ruester, Dana; Truyen, Uwe; Speck, Stephanie			Diagnostic validation of a rapid and field-applicable PCR-lateral flow test system for point-of-care detection of cyprinid herpesvirus 3 (CyHV-3)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; REAL-TIME PCR; KOI HERPESVIRUS; CARPIO-KOI; INFECTION; AMPLIFICATION; STRATEGIES; MORTALITY	Koi herpesvirus disease (KHVD) is a highly infectious disease leading to outbreaks and mass mortality in captive and free-ranging common carp and koi carp. Outbreaks may result in high morbidity and mortality which can have a severe economic impact along the supply chain. Currently, control and prevention of KHVD relies on avoiding exposure to the virus based on efficient hygiene and biosecurity measures. An early diagnosis of the disease is crucial to prevent its spread and to minimize economic losses. Therefore, an easy-to-handle, sensitive, specific and reliable test prototype for a point-of-care detection of KHV was developed and evaluated in this study. We used a multiplex-endpoint-PCR followed by a specific probe hybridization step. PCR-products/hybridization-products were visualized with a simple and universal lateral flow immunoassay (PCR-LFA). Fifty-four gill tissue samples (KHV-positive n = 33, KHV-negative n = 21) and 46 kidney samples (KHV-positive n = 24, KHV-negative n = 22) were used to determine diagnostic sensitivity and specificity of the PCR-LFA. In addition, the usability of PCR-LFA to detect CyHV-3-DNA in gill swabs taken from 20 perished common carp during a KHVD-outbreak in a commercial carp stock was examined. This assay gave test results within approximately 60 min. It revealed a detection limit of 9 KHV gene copies/mu l (95% probability), a diagnostic specificity of 100%, and diagnostic sensitivity of 94.81% if samples were tested in a single test run only. PCR inhibition was noticed when examining gill swab samples without preceding extraction of DNA or sample dilution. Test sensitivity coud be enhanced by examining samples in five replicates. Overall, our PCR-LFA proved to be a specific, easy-to-use and time-saving point-of-care-compatible test for the detection of KHV-DNA. Regarding gill swab samples, further test series using a higher number of clinical samples should be analyzed to confirm the number of replicates and the sample processing necessary to reveal a 100% diagnostic sensitivity.	[Loose, Finn N.] Frankenforder Forsch Gesell MbH FFG, Berlin, Germany; [Loose, Finn N.; Ruester, Dana; Truyen, Uwe; Speck, Stephanie] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany; [Breitbach, Andre] Martin Luther Univ Halle Wittenberg, Inst Plant Physiol, Halle, Germany; [Breitbach, Andre; Bertalan, Ivo] Milenia Biotec GmbH, Gieen, Germany	Leipzig University; Martin Luther University Halle Wittenberg	Speck, S (corresponding author), Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.	stephanie@speck-kaysser.de			Germany Federal Ministry for Economic Affairs and Energy (BMWi) [16KN062342, 16KN062343]; Central Innovation Program for SMEs (ZIM) [16KN062342, 16KN062343]	Germany Federal Ministry for Economic Affairs and Energy (BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi)); Central Innovation Program for SMEs (ZIM)	This study was supported by the Germany Federal Ministry for Economic Affairs and Energy (BMWi) (https://www.bmwi.de/Navigation/DE/Home/home.html), Central Innovation Program for SMEs (ZIM) (https://www.zim.de/ZIM/Navigation/DE/Home/home.html), via grants to Frankenforder Research Society (FFG, grant no. 16KN062342) and Milenia Biotec GmbH (grant no. 16KN062343). The funding provided salaries to FL and AB. Milenia Biotec GmbH provided support in the form of salaries for IB. The BMWi and the SME did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2011, AQUAC RES, V42, P93, DOI 10.1111/j.1365-2109.2010.02663.x; [Anonymous], 2011, VERORDNUNG ANZEIGEPF; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Baumer A, 2013, DIS AQUAT ORGAN, V105, P101, DOI 10.3354/dao02604; Bercovier H, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-13; Bretzinger A, 1999, BULL EUR ASSN FISH P, V19, P182; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; FAO, STAT WORLD FISH AQ 2; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Gaede L, 2017, J APPL ICHTHYOL, V33, P776, DOI 10.1111/jai.13368; Gilad O, 2002, DIS AQUAT ORGAN, V48, P101, DOI 10.3354/dao048101; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Gilad O, 2003, J GEN VIROL, V84, P2661, DOI 10.1099/vir.0.19323-0; Gonzalez-Gonzalez E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215642; Guevara EE, 2018, CONSERV GENET RESOUR, V10, P119, DOI 10.1007/s12686-017-0758-5; Haenen OLM, 2004, B EUR ASSOC FISH PAT, V24, P293; Hedrick RP, 2000, J AQUAT ANIM HEALTH, V12, P44, DOI [10.1577/1548-8667(2000)012<0044:AHAWMM>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0044:AHAWMM&gt;2.0.CO;2]; Hedrick RP, 2005, B FISH RES AGENCY, V2, P1; Janz V, 2018, BONE JOINT RES, V7, P12, DOI 10.1302/2046-3758.71.BJR-2017-0103.R2; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; Kulkarni RD, 2018, J LAB PHYS, V10, P68, DOI 10.4103/JLP.JLP_74_17; Liu WT, 2007, APPL ENVIRON MICROB, V73, P73, DOI 10.1128/AEM.01468-06; OIE World Organization for Animal Health, OIE LIST DIS INF INF; OIE World Organization for Animal Health, 2019, MAN DIAGN TESTS AQ A; OSTE C, 1988, BIOTECHNIQUES, V6, P162; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Perelberg A, 2003, ISR J AQUACULT-BAMID, V55, P5; R Core Team, R LANG ENV STAT COMP; Schmid T, 2016, J FISH DIS, V39, P1006, DOI 10.1111/jfd.12428; Soliman H, 2018, J FISH DIS, V41, P761, DOI 10.1111/jfd.12774; Soliman H, 2010, MOL CELL PROBE, V24, P38, DOI 10.1016/j.mcp.2009.09.002; Sullivan TJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56170-y; Sun JF, 2019, FISH PHYSIOL BIOCHEM, V45, P1367, DOI 10.1007/s10695-019-00673-y; Thrusfield M., 2018, VET EPIDEMIOLOGY; Venables WN., 2002, MODERN APPL STAT S 4; Walster C. I., 1999, Fish Veterinary Journal, P54; Waltzek TB, 2005, J GEN VIROL, V86, P1659, DOI 10.1099/vir.0.80982-0; Wang Yi, 2017, Front Microbiol, V8, P192, DOI 10.3389/fmicb.2017.00192; Weber EPS, 2014, AM J VET RES, V75, P899, DOI 10.2460/ajvr.75.10.899	39	1	1	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241420	10.1371/journal.pone.0241420	http://dx.doi.org/10.1371/journal.pone.0241420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125418	Green Published, gold			2022-12-26	WOS:000588368900046
J	Pimraksa, K; Setthaya, N; Thala, M; Chindaprasirt, P; Murayama, M				Pimraksa, Kedsarin; Setthaya, Naruemon; Thala, Maneerat; Chindaprasirt, Prinya; Murayama, Mitsuhiro			Geopolymer/Zeolite composite materials with adsorptive and photocatalytic properties for dye removal	PLOS ONE			English	Article							HYBRID BULK MATERIALS; METHYLENE-BLUE; ORGANIC-COMPOUNDS; ACTIVATED CARBON; AQUEOUS-SOLUTION; FLY-ASH; ZEOLITE; ADSORBENT; DEGRADATION; WASTE	This study investigated the adsorption capacities and photocatalytic activities of geopolymer-zeolite composite materials by incorporating different amounts of zeolite and TiO2 in a geopolymer matrix for dye removal. Geopolymers with SiO2/Al2O3 molar ratio of 2.5 were synthesized from metakaolin. The geopolymers containing zeolite and TiO2-doped zeolite exhibited similar behavior in terms of mineral compositions, microstructures and chemical frameworks. The compressive strength of geopolymer-zeolite composite materials decreased with increasing amount of zeolite and TiO2-doped zeolite (0-40 wt%) because of the increase in the porosity of composite materials. The maximum methylene blue adsorption capacity and photocatalytic efficiency of the powdered geopolymer composites with 40 wt% TiO2-doped zeolite was 99.1% and was higher than that of the composites with 40 wt% zeolite without TiO2-doping (92.5%). In addition, the geopolymer composites with TiO2-doped zeolite exhibited excellent stability after repeated usage as photocatalysts. The adsorption capacity and photocatalytic activity of pelletized geopolymer composites decreased because of the reduction in their specific surface area.	[Pimraksa, Kedsarin; Thala, Maneerat] Chiang Mai Univ, Fac Sci, Dept Ind Chem, Chiang Mai, Thailand; [Pimraksa, Kedsarin] Chiang Mai Univ, Fac Sci, Ctr Excellence Mat Sci & Technol, Chiang Mai, Thailand; [Setthaya, Naruemon] Univ Phayao, Sch Sci, Div Chem, Mae Ka, Phayao, Thailand; [Chindaprasirt, Prinya] Khon Kaen Univ, Fac Engn, Sustainable Infrastruct Res & Dev Ctr, Khon Kaen, Thailand; [Murayama, Mitsuhiro] Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA USA; [Murayama, Mitsuhiro] Virginia Tech, Natl Ctr Earth & Environm Nanotechnol Infrastruct, Blacksburg, VA USA	Chiang Mai University; Chiang Mai University; University of Phayao; Khon Kaen University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Pimraksa, K (corresponding author), Chiang Mai Univ, Fac Sci, Dept Ind Chem, Chiang Mai, Thailand.; Pimraksa, K (corresponding author), Chiang Mai Univ, Fac Sci, Ctr Excellence Mat Sci & Technol, Chiang Mai, Thailand.	kedsarin.p@cmu.ac.th	Chindaprasirt, Prinya/F-6768-2010; Murayama, Mitsuhiro/B-3472-2009	Chindaprasirt, Prinya/0000-0003-1062-3626; Murayama, Mitsuhiro/0000-0003-1965-4891	Center of Excellence in Materials Science and Technology, Faculty of Science, Chiang Mai University; Thailand Research Fund [DPG6180002 TRF]; US National Science Foundation [NSF ECCS 1542100]	Center of Excellence in Materials Science and Technology, Faculty of Science, Chiang Mai University; Thailand Research Fund(Thailand Research Fund (TRF)); US National Science Foundation(National Science Foundation (NSF))	KP received funding support from the Center of Excellence in Materials Science and Technology, Faculty of Science, Chiang Mai University. KP and PC received funding support (Grant Number DPG6180002 TRF) from the Thailand Research Fund for TRF Distinguished Research Professor. MM received funding support from the US National Science Foundation (Grant Number NSF ECCS 1542100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Danso E, 2020, J HAZARD MATER, V381, DOI 10.1016/j.jhazmat.2019.120871; Alwash A.H., 2013, INT SCHOL SCI RES IN, V7, P785; [Anonymous], 2011, MOL CELLULAR PROTEOM, V10, pR110; [Anonymous], 1918, LIBERATOR, V1, P7; Asghar A, 2015, J CLEAN PROD, V87, P826, DOI 10.1016/j.jclepro.2014.09.010; Bai CY, 2018, CERAM INT, V44, P16103, DOI 10.1016/j.ceramint.2018.05.219; Barbosa TR, 2018, CERAM INT, V44, P416, DOI 10.1016/j.ceramint.2017.09.193; Borges GA, 2016, J ENVIRON MANAGE, V183, P196, DOI 10.1016/j.jenvman.2016.08.056; Byrappa K., 2001, HDB HYDROTHERMAL TEC, DOI [10.1016/b978-081551445-9.50002-7, DOI 10.1016/B978-081551445-9.50002-7]; Chen JY, 2011, J HAZARD MATER, V190, P416, DOI 10.1016/j.jhazmat.2011.03.064; Davidovits DJ, 2002, GEOP 2002 C SAINT QU; Ferone C, 2013, APPL CLAY SCI, V73, P42, DOI 10.1016/j.clay.2012.11.001; Fukugaichi S, 2015, MATER CHEM PHYS, V160, P1, DOI 10.1016/j.matchemphys.2015.04.002; Gao K, 2013, CONSTR BUILD MATER, V48, P441, DOI 10.1016/j.conbuildmat.2013.07.027; Hammed AK, 2016, J ENVIRON CHEM ENG, V4, P2607, DOI 10.1016/j.jece.2016.05.008; Han RP, 2010, J HAZARD MATER, V175, P1056, DOI 10.1016/j.jhazmat.2009.10.118; He Y, 2013, J MEMBRANE SCI, V447, P66, DOI 10.1016/j.memsci.2013.07.027; Heah CY, 2012, CONSTR BUILD MATER, V35, P912, DOI 10.1016/j.conbuildmat.2012.04.102; Hu MY, 2009, CEMENT CONCRETE COMP, V31, P762, DOI 10.1016/j.cemconcomp.2009.07.006; IMEK A, 1995, MICROPOROUS MATER, V4, P159, DOI DOI 10.1016/0927-6513(94)00096-E; Javadian H, 2015, ARAB J CHEM, V8, P837, DOI 10.1016/j.arabjc.2013.02.018; Juengsuwattananon K, 2019, CONSTR BUILD MATER, V226, P406, DOI 10.1016/j.conbuildmat.2019.07.146; Khanday WA, 2017, J TAIWAN INST CHEM E, V70, P32, DOI 10.1016/j.jtice.2016.10.029; Khatri A, 2015, J CLEAN PROD, V87, P50, DOI 10.1016/j.jclepro.2014.09.017; Kumar A, 2016, J CLEAN PROD, V137, P1246, DOI 10.1016/j.jclepro.2016.07.177; Kuwahara Y, 2012, J CATAL, V285, P223, DOI 10.1016/j.jcat.2011.09.031; Lee S, 2014, CONSTR BUILD MATER, V52, P221, DOI 10.1016/j.conbuildmat.2013.10.072; Lee WKW, 2003, LANGMUIR, V19, P8726, DOI 10.1021/la026127e; Li L, 2006, J COLLOID INTERF SCI, V300, P52, DOI 10.1016/j.jcis.2006.03.062; Liu S, 2014, CHEM ENG SCI, V105, P46, DOI 10.1016/j.ces.2013.10.041; Liu Y, 2012, J ENVIRON SCI, V24, P1867, DOI 10.1016/S1001-0742(11)61008-5; Pan Z, 2014, J HAZARD MATER, V279, P17, DOI 10.1016/j.jhazmat.2014.06.040; Panagiotopoulou C, 2007, J MATER SCI, V42, P2967, DOI 10.1007/s10853-006-0531-8; Pelaez-Cid AA, 2013, J ENVIRON MANAGE, V130, P90, DOI 10.1016/j.jenvman.2013.08.059; Rida K, 2013, APPL CLAY SCI, V83-84, P99, DOI 10.1016/j.clay.2013.08.015; Setthaya Naruemon, 2016, Materials Science Forum, V872, P242, DOI 10.4028/www.scientific.net/MSF.872.242; Setthaya N, 2017, POWDER TECHNOL, V313, P417, DOI 10.1016/j.powtec.2017.01.014; Singh B, 2015, CONSTR BUILD MATER, V85, P78, DOI 10.1016/j.conbuildmat.2015.03.036; Sturm P, 2016, CONSTR BUILD MATER, V124, P961, DOI 10.1016/j.conbuildmat.2016.08.017; Takeda H, 2013, MATERIALS, V6, P1767, DOI 10.3390/ma6051767; Takeda H, 2010, J CERAM SOC JPN, V118, P771, DOI 10.2109/jcersj2.118.771; Trochez JJ, 2015, MATER CONSTRUCC, V65, DOI 10.3989/mc.2015.00814; Villa C, 2010, CONSTR BUILD MATER, V24, P2084, DOI 10.1016/j.conbuildmat.2010.04.052; Xu H, 2000, INT J MINER PROCESS, V59, P247, DOI 10.1016/S0301-7516(99)00074-5; Yuan WW, 2016, J COLLOID INTERF SCI, V462, P191, DOI 10.1016/j.jcis.2015.09.067; Zainudin NF, 2010, J HAZARD MATER, V174, P299, DOI 10.1016/j.jhazmat.2009.09.051; Zhang J, 2014, MATER LETT, V116, P167, DOI 10.1016/j.matlet.2013.11.008	47	18	18	19	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241603	10.1371/journal.pone.0241603	http://dx.doi.org/10.1371/journal.pone.0241603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125419	gold, Green Published			2022-12-26	WOS:000588368900034
J	Mioni, MDR; Costa, FB; Ribeiro, BLD; Teixeira, WSR; Pelicia, VC; Labruna, MB; Rousset, E; Sidi-Boumedine, K; Thiery, R; Megid, J				Ribeiro Mioni, Mateus de Souza; Costa, Francisco Borges; Devide Ribeiro, Bruna Leticia; Reis Teixeira, Wanderson Sirley; Pelicia, Vanessa Cristina; Labruna, Marcelo Bahia; Rousset, Elodie; Sidi-Boumedine, Karim; Thiery, Richard; Megid, Jane			Coxiella burnetii in slaughterhouses in Brazil: A public health concern	PLOS ONE			English	Article							Q-FEVER; BARTONELLA SPP.; SAO-PAULO; INFECTION; CATTLE; ENDOCARDITIS; DIAGNOSIS; PREVALENCE; ANTIBODIES; TICKS	Q fever is an important zoonosis, yet it is often neglected and can present large outbreaks, as observed in the Netherlands. In the past few years, cases of Q fever have been described in Brazil; however, the epidemiological situation of Q fever in ruminants, the main reservoir of the pathogen, is unknown in this country. Our study aimed to estimate the prevalence of C. burnetii in cattle sent to slaughterhouses using an immunofluorescence assay (IFA) and quantitative real-time PCR (qPCR). From 1515 cattle serum samples collected from nine slaughterhouses, 23.8% (360/1515) were serologically positive by IFA (cutoff titer>1:64), indicating past or recent exposure to C. burnetii infection. Among the 54 cities sampled during the study, 83.3% (45/54) had at least one seropositive animal. Subsequently, all seropositive samples were submitted to qPCR for C. burnetii DNA, and 12.2% (44/360) of the sera were qPCR positive, which indicates bacteremia and suggests active or recent infection. The results highlight the risk for abattoir workers that results from exposure to contaminated aerosols produced during slaughter procedures. Moreover, the heat maps that were construction from the positive samples demonstrate the widespread distribution of C. burnetii in the State of Sao Paulo, Brazil and denotes the need for surveillance and preventive measures to reduce the prevalence in cattle.	[Ribeiro Mioni, Mateus de Souza; Devide Ribeiro, Bruna Leticia; Reis Teixeira, Wanderson Sirley; Pelicia, Vanessa Cristina; Megid, Jane] Univ Estadual Paulista, Dept Higiene Vet & Saude Publ, Botucatu, SP, Brazil; [Costa, Francisco Borges] Univ Estadual Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil; [Reis Teixeira, Wanderson Sirley] Univ Sao Paulo, Inst Quim, Sao Paulo, SP, Brazil; [Labruna, Marcelo Bahia] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Sao Paulo, SP, Brazil; [Rousset, Elodie; Sidi-Boumedine, Karim; Thiery, Richard] French Agcy Food Environm & Occupat Hlth Safety, Sophia Antipolis Lab, Anses, Anim Q Fever Unit, Sophia Antipolis, France	Universidade Estadual Paulista; Universidade Estadual do Maranhao; Universidade de Sao Paulo; Universidade de Sao Paulo; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sophia-Antipolis	Megid, J (corresponding author), Univ Estadual Paulista, Dept Higiene Vet & Saude Publ, Botucatu, SP, Brazil.	jane.megid@unesp.br	Mioni, Mateus S. R./F-3699-2019; de Souza Ribeiro Mioni, Mateus/ABD-5237-2020; Thiery, Richard/GRR-1496-2022	Mioni, Mateus S. R./0000-0001-7886-1570; de Souza Ribeiro Mioni, Mateus/0000-0001-7886-1570; Megid, Jane/0000-0002-6540-7157; Thiery, Richard/0000-0003-2049-918X; Teixeira, Wanderson/0000-0002-7914-2567	General Program for International Cooperation (PGCI) from the Coordination of Improvement of Higher-Level Personnel (CAPES) [88887.137563/2017-00]; Program of Academic Excellence (PROEX) from the Coordination of Improvement of Higher-Level Personnel (CAPES) [88882.180556/2018-01]; FAPESP [2019/05300-9]	General Program for International Cooperation (PGCI) from the Coordination of Improvement of Higher-Level Personnel (CAPES); Program of Academic Excellence (PROEX) from the Coordination of Improvement of Higher-Level Personnel (CAPES); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MSR Mioni: The General Program for International Cooperation (PGCI) from the Coordination of Improvement of Higher-Level Personnel (CAPES) provided the scholarship number 88887.137563/2017-00, and scholarship 88882.180556/2018-01 was provided by the Program of Academic Excellence (PROEX) from the Coordination of Improvement of Higher-Level Personnel (CAPES) (https://www.capes.gov.br/).FAPESP, scholarship 2019/05300-9 (http://www.fapesp.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Anderson A, 2013, MMWR RECOMM REP, V62, P1; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2013, DIABETES S, V61, pA345; [Anonymous], 1990, ANIMAL BRUCELLOSIS; de Oliveira MB, 2018, ACTA TROP, V183, P19, DOI 10.1016/j.actatropica.2018.04.010; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CIEVS, 2015, INF EP CIEV PAR SEM; Cooper A, 2011, AUST VET J, V89, P260, DOI 10.1111/j.1751-0813.2011.00794.x; Costa Paulo Sérgio Gonçalves da, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P5, DOI 10.1590/S0036-46652006000100002; Mioni MDR, 2019, ZOONOSES PUBLIC HLTH, V66, P695, DOI 10.1111/zph.12609; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DERRICK EH, 1973, MED J AUSTRALIA, V1, P1051, DOI 10.5694/j.1326-5377.1973.tb110910.x; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Emery MP, 2014, J VET DIAGN INVEST, V26, P141, DOI 10.1177/1040638713517233; ESRI, 2011, ARCGIS DESKT REL 10; Folitse Raphael D, 2020, J Immunoassay Immunochem, V41, P152, DOI 10.1080/15321819.2019.1701012; Gache K, 2017, EPIDEMIOL INFECT, V145, P3131, DOI [10.1017/s0950268817002308, 10.1017/S0950268817002308]; Ghoneim NH, 2020, SMALL RUMINANT RES, V191, DOI 10.1016/j.smallrumres.2020.106173; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Goebell H, 1997, TAG DTSCH GES VERD S, V2, pS231; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hawker J I, 1998, Commun Dis Public Health, V1, P180; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; HOOVER TA, 1992, J BACTERIOL, V174, P5540, DOI 10.1128/JB.174.17.5540-5548.1992; Horigan MW, 2011, J VET DIAGN INVEST, V23, P924, DOI 10.1177/1040638711416971; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Horta MC, 2004, AM J TROP MED HYG, V71, P93, DOI 10.4269/ajtmh.2004.71.93; IBGE. IBGE, IBGE PORT IBGE; Jones RM, 2006, APPL BIOSAF, V11, P32; Kaufmann A F, 1980, Ann N Y Acad Sci, V353, P105, DOI 10.1111/j.1749-6632.1980.tb18912.x; Kirkan S, 2008, TURK J VET ANIM SCI, V32, P215; Komiya Tomoyoshi, 2003, Journal of Infection and Chemotherapy, V9, P151; Lemos ERS, 2011, VECTOR-BORNE ZOONOT, V11, P85, DOI 10.1089/vbz.2009.0261; Long CM, 2019, VIRULENCE, V10, P133, DOI 10.1080/21505594.2019.1575715; Mares-Guia MAMM, 2016, AM J TROP MED HYG, V94, P1090, DOI 10.4269/ajtmh.15-0575; Marrie TJ, 2015, MOL MED MICROBIOL, VSecond, P1941; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; OIE, 2018, Q FEV MAN DIAGN TEST, P1; Pacheco RC, 2013, EMERG INFECT DIS, V19, P344, DOI 10.3201/eid1902.120362; R Core Team, 2017, R R PROJ STAT COMP; Raoult D, 2012, GOLDMANS CECIL MED, V24th, P1954; Mioni MDR, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010030; RIEMANN HP, 1975, AM J EPIDEMIOL, V102, P386, DOI 10.1093/oxfordjournals.aje.a112177; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Rousset E., 2012, Bulletin des G.T.V., P53; Rozental T, 2018, REV MED MINAS GERAIS, V28, P85, DOI DOI 10.5935/2238-3182.20180122; de Lemos ERS, 2018, AM J TROP MED HYG, V99, P303, DOI 10.4269/ajtmh.17-0979; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shabbir MZ, 2016, ACTA TROP, V163, P61, DOI 10.1016/j.actatropica.2016.07.017; Shivaprasad HL, 2008, AVIAN DIS, V52, P426, DOI 10.1637/8192-120707-Reg; Siciliano RF, 2008, REV SOC BRAS MED TRO, V41, P409, DOI 10.1590/S0037-86822008000400017; Siciliano RF, 2006, ANN NY ACAD SCI, V1078, P215, DOI 10.1196/annals.1374.123; Siciliano RF, 2015, EMERG INFECT DIS, V21, P1429, DOI 10.3201/eid2108.140343; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Slaba K, 2005, ACTA VIROL, V49, P123; SPELMAN DW, 1982, MED J AUSTRALIA, V1, P547, DOI 10.5694/j.1326-5377.1982.tb124169.x; Stevenson M, 2018, R EPIR TOOLS ANAL EP; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; To H, 1998, J VET MED SCI, V60, P859, DOI 10.1292/jvms.60.859; Toman R, 2012, ADV EXPT MED BIOL, V1st; Vaidya VM, 2010, COMP IMMUNOL MICROB, V33, P307, DOI 10.1016/j.cimid.2008.10.006; Valle LAR, 1955, ARQ FAC HIG SAUD PUB, V9, P167, DOI [DOI 10.11606/ISSN.2358-792X.V9I1-2P167-180, 10.11606/issn.2358-792X.v9i1-2p167-180]; Vapniarsky N, 2012, VET PATHOL, V49, P717, DOI 10.1177/0300985811409251; Vilcins IME, 2009, EXP APPL ACAROL, V49, P229, DOI 10.1007/s10493-009-9260-4; Vincent GA, 2015, J MICROBIOL METH, V119, P74, DOI 10.1016/j.mimet.2015.10.008; von Ranke FM, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180292; Wielders CCH, 2013, J CLIN MICROBIOL, V51, P3192, DOI 10.1128/JCM.00993-13	75	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241246	10.1371/journal.pone.0241246	http://dx.doi.org/10.1371/journal.pone.0241246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125388	Green Published, gold			2022-12-26	WOS:000588368900010
J	Worku, MG; Tesema, GA; Teshale, AB				Worku, Misganaw Gebrie; Tesema, Getayeneh Antehunegn; Teshale, Achamyeleh Birhanu			Prevalence and determinants of anemia among young (15-24 years) women in Ethiopia: A multilevel analysis of the 2016 Ethiopian demographic and health survey data	PLOS ONE			English	Article							ADOLESCENT	Background Anemia is a major global public health problem that had tremendous impacts on human health, social and economic development. African countries contribute to the highest-burden of anemia among women, particularly in adolescent females and young women. Anemia among young women remains a public health problem in most parts of Africa, including Ethiopia. Therefore, this study aimed to investigate the prevalence and determinants of anemia among young women in Ethiopia. Methods` A secondary data analysis was conducted based on the 2016 Ethiopian Demographic and Health Survey (EDHS) data. A total weighted sample of 5796 young women (15-24 years) was included in this study. We employed a multilevel analysis to assess factors associated with anemia since the EDHS has hierarchical nature. Deviance, Intraclass Correlation Coefficient (ICC) and Median Odds Ratio (MOR) were used for model comparison as well as for assessing model fitness. Variables with a p-value of less than 0.20 at bivariable multilevel analysis were considered for the multivariable multilevel analysis. In the multivariable multilevel analysis variables with p-value <= 0.05 were declared to be a significant factor associated with anemia, and the Adjusted Odds Ratio (AOR) with the 95% Confidence Interval (CI) were reported to assess the strength and direction of the association. Results The overall prevalence of anemia among young women was 21.7% (95%CI = 20.7%, 22.8%). In the multivariable multilevel binary logistic regression analysis; being Muslim religion follower [adjusted odds ratio (AOR) = 1.31, 95%CI = 1.07, 1.70] and being protestant religion follower [AOR = 1.31; 95%CI = 1.01, 1.71], being rural dweller [AOR = 1.34; 95%CI = 1.02, 1.78], and being married [AOR = 1.46; 95%CI = 1.22, 1.74] were significantly associated with higher odds of anemia among young women. While, modern contraceptive use (AOR = 0.66; 95%CI = 0.53, 0.83) were significantly associated with lower odds of anemia among young women. Conclusion In this study, the prevalence of anemia among young women was high. Being a follower of Muslim and protestant religions, being married women, modern contraceptive use and being from the rural area were found to be significant determinants of anemia among young women. Therefore, giving special attention to these high-risk groups and distributing modern contraceptives for those in need of it could decrease this devastating public health problem in young women.	[Worku, Misganaw Gebrie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia; [Tesema, Getayeneh Antehunegn; Teshale, Achamyeleh Birhanu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar	Worku, MG (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia.	misgeb2008@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	gebrie, misganaw/0000-0002-7647-6449				[Anonymous], 2005, ANU HIST IGLESIA, V23, P9; [Anonymous], 2015, CANC DISCOV, V6, P6; de Benoist B, 2008, WHO GLOBAL DATABASE; DM Townsley, 2013, SEMINARS HEMATOLOGY; EDHS E., 2016, DHS PROGRAM ICF, V363, P364; Ejigu BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197171; FILIPPOV MP, 1992, FOOD HYDROCOLLOID, V6, P115; Gebreyesus SH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6422-0; Habib N, 2020, ANEMIA, V2020, DOI 10.1155/2020/1628357; Haile ZT, 2016, INT J GYNECOL OBSTET, V132, P50, DOI 10.1016/j.ijgo.2015.06.040; Hakizimana D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8019-z; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kibret KT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027276; PENIE JB, 2000, REV CUB ALIMENT NUTR, V14, P55; Regasa RT, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0791-5; Sadeghian Majid, 2013, J Family Reprod Health, V7, P139; SCHENKER JG, 1993, EUR J OBSTET GYN R B, V49, P15, DOI 10.1016/0028-2243(93)90102-I; Sen A, 2006, INDIAN PEDIATR, V43, P219; Soekarjo DD, 2001, EUR J CLIN NUTR, V55, P932, DOI 10.1038/sj.ejcn.1601247; Vasileska A, 2012, PROCD SOC BEHV, V44, P363, DOI 10.1016/j.sbspro.2012.05.040; Viana Marcos Borato, 2011, Rev. Bras. Hematol. Hemoter., V33, P90, DOI 10.5581/1516-8484.20110024; Win Hla Hla, 2018, WHO South East Asia J Public Health, V7, P107, DOI 10.4103/2224-3151.239422; World Health Organization, 2005, NUTR AD ISS CHALL HL; Yasutake S, 2013, INT J CHILD HEALTH N, V2, P105	24	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241342	10.1371/journal.pone.0241342	http://dx.doi.org/10.1371/journal.pone.0241342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125382	Green Published, gold			2022-12-26	WOS:000588368900048
J	Hao, Y; Crequer-Grandhomme, A; Javier, N; Singh, A; Chen, H; Manzanillo, P; Lo, MC; Huang, X				Hao, Yue; Crequer-Grandhomme, Amandine; Javier, Noelle; Singh, Aman; Chen, Hao; Manzanillo, Paolo; Lo, Mei-Chu; Huang, Xin			Structures and mechanism of human glycosyltransferase beta 1,3-N-acetylglucosaminyltransferase 2 (B3GNT2), an important player in immune homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE REFINEMENT; GOLGI LOCALIZATION; KIN RECOGNITION; STEM REGION; IDENTIFICATION; DOMAIN; POLYLACTOSAMINE; ASSOCIATION; RETENTION; FAMILIES	beta 1,3-N-acetylglucosaminyltransferases (B3GNTs) are Golgi-resident glycosyltransferases involved in the biosynthesis of poly-N-acetyl-lactosamine chains. They catalyze the addition of the N-acetylglucosamine to the N-acetyl-lactosamine repeat as a key step of the chain elongation process. Poly-N-acetyl-lactosamine is involved in the immune system in many ways. Particularly, its long chain has been demonstrated to suppress excessive immune responses. Among the characterized B3GNTs, B3GNT2 is the major poly-N-acetyl-lactosamine synthase, and deletion of its coding gene dramatically reduced the cell surface poly-N-acetyl-lactosamine and led to hypersensitive and hyperresponsive immunocytes. Despite the extensive functional studies, no structural information is available to understand the molecular mechanism of B3GNT2, as well as other B3GNTs. Here we present the structural and kinetic studies of the human B3GNT2. Five crystal structures of B3GNT2 have been determined in the unliganded, donor substrate-bound, acceptor substrate-bound, and product(s)-bound states at resolutions ranging from 1.85 to 2.35 angstrom. Kinetic study shows that the transglycosylation reaction follows a sequential mechanism. Critical residues involved in recognition of both donor and acceptor substrates as well as catalysis are identified. Mutations of these invariant residues impair B3GNT2 activity in cell assays. Structural comparison with other glycosyltransferases such as mouse Fringe reveals a novel N-terminal helical domain of B3GNTs that may stabilize the catalytic domain and distinguish among different acceptor substrates.	[Hao, Yue; Huang, Xin] Amgen Res, Dept Mol Engn, Cambridge, MA 02141 USA; [Hao, Yue] Amgen Res, Amgen Postdoctoral Fellow Program, Cambridge, MA 02141 USA; [Crequer-Grandhomme, Amandine; Manzanillo, Paolo] Amgen Res, Dept Inflammat & Oncol, San Francisco, CA USA; [Javier, Noelle; Lo, Mei-Chu] Amgen Res, Dept Discovery Technol, San Francisco, CA USA; [Singh, Aman] Amgen Res, Dept Discovery Attribute Sci, San Francisco, CA USA; [Chen, Hao] Amgen Res, Dept Prot Technol, Cambridge, MA USA		Hao, Y; Huang, X (corresponding author), Amgen Res, Dept Mol Engn, Cambridge, MA 02141 USA.	yhao@amgen.com; xinhuang_us@yahoo.com	Hao, Yue/AAA-3530-2022	Hao, Yue/0000-0003-0943-0499; SINGH, AMAN/0000-0003-0587-4017; Crequer-Grandhomme, Amandine/0000-0003-4866-7085				Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chang A, 2011, CURR OPIN BIOTECH, V22, P800, DOI 10.1016/j.copbio.2011.04.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Ha S, 1999, J AM CHEM SOC, V121, P8415, DOI 10.1021/ja991556t; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nilsson T, 1996, J CELL SCI, V109, P1975; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace KE, 1999, J IMMUNOL, V163, P3801; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Segel IH, 1975, ENZYME KINETICS BEHA; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Togayachi A., 2015, GLYCOSCIENCE BIOL ME, P691; Togayachi A, 2006, METHOD ENZYMOL, V416, P91, DOI 10.1016/S0076-6879(06)16006-1; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Venkitachalam S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23642; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100042	10.1074/jbc.RA120.015306	http://dx.doi.org/10.1074/jbc.RA120.015306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33158990	Green Published, gold			2022-12-26	WOS:000672866400026
J	Akay, SS; Ozcan, O; Sanli, FB; Gorum, T; Sen, OL; Bayram, B				Akay, Semih Sami; Ozcan, Orkan; Sanli, Fusun Balik; Gorum, Tolga; Sen, Omer Lutfi; Bayram, Bulent			UAV-based evaluation of morphological changes induced by extreme rainfall events in meandering rivers	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; BUYUK MENDERES GRABEN; MULTIRESOLUTION SEGMENTATION; WESTERN ANATOLIA; PRECIPITATION EVENTS; TOPOGRAPHIC SURVEYS; UNMANNED AIRCRAFT; SEDIMENT FLUX; LOW-COST; EROSION	Morphological changes, caused by the erosion and deposition processes due to water discharge and sediment flux occur, in the banks along the river channels and in the estuaries. Flow rate is one of the most important factors that can change river morphology. The geometric shapes of the meanders and the river flow parameters are crucial components in the areas where erosion or deposition occurs in the meandering rivers. Extreme precipitation triggers erosion on the slopes, which causes significant morphological changes in large areas during and after the event. The flow and sediment amount observed in a river basin with extreme precipitation increases and exceeds the long-term average value. Hereby, erosion severity can be determined by performing spatial analyses on remotely sensed imagery acquired before and after an extreme precipitation event. Changes of erosion and deposition along the river channels and overspill channels can be examined by comparing multi-temporal Unmanned Aerial Vehicle (UAV) based Digital Surface Model (DSM) data. In this study, morphological changes in the Buyuk Menderes River located in the western Turkey, were monitored with pre-flood (June 2018), during flood (January 2019), and post-flood (September 2019) UAV surveys, and the spatial and volumetric changes of eroded/deposited sediment were quantified. For this purpose, the DSAS (Digital Shoreline Analysis System) method and the DEM of Difference (DoD) method were used to determine the changes on the riverbank and to compare the periodic volumetric morphological changes. Hereby, Structure from Motion (SfM) photogrammetry technique was exploited to a low-cost UAV derived imagery to achieve riverbank, areal and volumetric changes following the extreme rainfall events extracted from the time series of Tropical Rainfall Measuring Mission (TRMM) satellite data. The change analyses were performed to figure out the periodic morphodynamic variations and the impact of the flood on the selected meandering structures. In conclusion, although the river water level increased by 0.4-5.9 meters with the flood occurred in January 2019, the sediment deposition areas reformed after the flood event, as the water level decreased. Two-year monitoring revealed that the sinuosity index (SI) values changed during the flood approached the pre-flood values over time. Moreover, it was observed that the amount of the deposited sediments in September 2019 approached that of June 2018.	[Akay, Semih Sami; Sanli, Fusun Balik; Bayram, Bulent] Yildiz Tech Univ, Dept Geomat Engn, Istanbul, Turkey; [Ozcan, Orkan; Gorum, Tolga; Sen, Omer Lutfi] Istanbul Tech Univ, Eurasia Inst Earth Sci, Istanbul, Turkey	Yildiz Technical University; Istanbul Technical University	Akay, SS (corresponding author), Yildiz Tech Univ, Dept Geomat Engn, Istanbul, Turkey.	semih.sami.akay@std.yildiz.edu.tr	Gorum, Tolga/U-9426-2017; Ozcan, Orkan/C-3770-2016; Akay, Semih Sami/AAB-1701-2022; Sanli, Fusun Balik/C-4862-2013	Gorum, Tolga/0000-0001-9407-7946; Ozcan, Orkan/0000-0002-7485-6157; Bayram, Bulent/0000-0002-4248-116X; Akay, Semih Sami/0000-0002-7367-8555; Balik Sanli, Fusun/0000-0003-1243-8299	Scientific and Technological Research Council of Turkey (TUBITAK-2232) [118C329]; Yildiz Technical University Scientific Research Project (YTU-BAP) [FDK-2019-3552]; Istanbul Technical University Scientific Research Project (ITU-BAP) [MGA-2017-40767]	Scientific and Technological Research Council of Turkey (TUBITAK-2232); Yildiz Technical University Scientific Research Project (YTU-BAP); Istanbul Technical University Scientific Research Project (ITU-BAP)	This research was funded by The Scientific and Technological Research Council of Turkey (TUBITAK-2232): [Grant No. 118C329] and supported by the Yildiz Technical University Scientific Research Project (YTU-BAP): [Grant No. FDK-2019-3552] and the Istanbul Technical University Scientific Research Project (ITU-BAP): Grant No. MGA-2017-40767.	Akay SS, 2016, INT ARCH PHOTOGRAMM, V41, P789, DOI 10.5194/isprsarchives-XLI-B8-789-2016; Altmana S., 2017, ISPRS GEOSPATIAL WEE, P199, DOI [10.5194/isprs-annals-IV-2-W4-199-2017, DOI 10.5194/ISPRS-ANNALS-IV-2-W4-199-2017]; [Anonymous], 2014, J CLIN DIAGN RES, V8; Baatz M., 2000, MULTIRESOLUTION SEGM, P12; Bae SH, 2018, QUATERN INT, V468, P49, DOI 10.1016/j.quaint.2017.03.053; Balaguer-Puig M, 2018, LAND DEGRAD DEV, V29, P825, DOI 10.1002/ldr.2826; Balc C, 2015, THESIS; Banko G, 1998, INTERIM REPORTS; Belgiu M, 2014, ISPRS J PHOTOGRAMM, V96, P67, DOI 10.1016/j.isprsjprs.2014.07.002; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Blaschke T, 2011, REMOTE SENS-BASEL, V3, P1743, DOI 10.3390/rs3081743; Boers N, 2013, GEOPHYS RES LETT, V40, P4386, DOI 10.1002/grl.50681; Bookhagen B, 2005, EARTH PLANET SC LETT, V231, P131, DOI 10.1016/j.epsl.2004.11.014; Bruckner H, 2017, J ARCHAEOL SCI-REP, V12, P876, DOI 10.1016/j.jasrep.2016.11.024; Cakmak O, 2015, 4 YAPL S NOV 19 20 A; Callow JN, 2018, EARTH SURF PROC LAND, V43, P2603, DOI 10.1002/esp.4419; Castillo C, 2012, SOIL SCI SOC AM J, V76, P1319, DOI 10.2136/sssaj2011.0390; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Clapuyt F, 2016, GEOMORPHOLOGY, V260, P4, DOI 10.1016/j.geomorph.2015.05.011; COB, 2007, BUYUK MEND NEH HAVZ; Cook KL, 2017, GEOMORPHOLOGY, V278, P195, DOI 10.1016/j.geomorph.2016.11.009; Crawford AJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040575; CSB, 2016, BUYUK MEND HAVZ KIRL; Cucchiaro S, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7817-4; da Silva AMF, 2006, J HYDRAUL ENG, V132, P1003, DOI 10.1061/(ASCE)0733-9429(2006)132:10(1003); Danandeh Mehr A., 2016, THESIS; Dewan TH, 2015, WEATHER CLIM EXTREME, V7, P36, DOI 10.1016/j.wace.2014.11.001; Duro G, 2018, EARTH SURF DYNAM, V6, P933, DOI 10.5194/esurf-6-933-2018; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; El-naggar AM, 2018, ALEX ENG J, V57, P3089, DOI 10.1016/j.aej.2018.10.001; Eltner A, 2015, EARTH SURF PROC LAND, V40, P741, DOI 10.1002/esp.3673; Embrechts P., 1999, N AM ACTUAR J, V3, P30, DOI [DOI 10.1080/10920277.1999.10595797, https://doi.org/10.1080/10920277.1999.10595797]; Esposito G, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6409-z; Flener C, 2013, REMOTE SENS-BASEL, V5, P6382, DOI 10.3390/rs5126382; Fonstad MA, 2013, EARTH SURF PROC LAND, V38, P421, DOI 10.1002/esp.3366; GCD, 2019, GEOM CHANG DET SOFTW; Gilli M., 2006, COMPUTATIONAL EC, V27, P1, DOI DOI 10.1007/S10614-005-9013-3; Girgin G., 2017, THESIS; Gurbuz A, 2019, WOR GEOMORPHOL LANDS, P509, DOI 10.1007/978-3-030-03515-0_29; Hamedianfar A, 2022, GEOCARTO INT, V37, P773, DOI 10.1080/10106049.2020.1737974; Hasfurther VR, 1985, RESTORATION RIVERS S, V2, P85; Hemmelder S, 2018, INT J APPL EARTH OBS, V73, P428, DOI 10.1016/j.jag.2018.07.016; Herold M, 2003, PHOTOGRAMM ENG REM S, V69, P991, DOI 10.14358/PERS.69.9.991; Huffman George J., 2019, CLIMATE DATA GUIDE T; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Ierodiaconou D, 2016, Z GEOMORPHOL, V60, P123, DOI 10.1127/zfg_suppl/2016/00247; James LA, 2012, GEOMORPHOLOGY, V137, P181, DOI 10.1016/j.geomorph.2010.10.039; James MR, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002289; Jaud M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060465; Javemick L, 2014, GEOMORPHOLOGY, V213, P166, DOI 10.1016/j.geomorph.2014.01.006; Jena SK., 2015, EXPT NUMERICAL INVES; JENKINSON AF, 1955, Q J ROY METEOR SOC, V81, P158, DOI 10.1002/qj.49708134804; Kaiser A, 2014, REMOTE SENS-BASEL, V6, P7050, DOI 10.3390/rs6087050; Kavzoglu T, 2018, INT J REMOTE SENS, V39, P6020, DOI 10.1080/01431161.2018.1506592; Kavzoglu T., 2016, ISPRS INT ARCH PH B7, V7, P241, DOI DOI 10.5194/ISPRS-ARCHIVES-XLI-B7-241-2016; Kayan, 1997, TURKIYENIN EGE VE AK, DOI [10.1111/j.1749-6632.1997.tb52238.x, DOI 10.1111/J.1749-6632.1997.TB52238.X]; Kazanci N, 2011, TURK JEOL BULT, V54, P25; Kazanci N, 2009, MAR GEOL, V264, P165, DOI 10.1016/j.margeo.2009.05.003; Koc C., 1998, THESIS; Kocman A, 1993, EGE U EDEBIYAT FAKUL; Kunkel KE, 1999, J CLIMATE, V12, P2515, DOI 10.1175/1520-0442(1999)012<2515:LTTIEP>2.0.CO;2; Lague D, 2013, ISPRS J PHOTOGRAMM, V82, P10, DOI 10.1016/j.isprsjprs.2013.04.009; Lambin EF, 1997, PROG PHYS GEOG, V21, P375, DOI 10.1177/030913339702100303; Langhammer J, 2018, PURE APPL GEOPHYS, V175, P3223, DOI 10.1007/s00024-018-1874-1; Maroulakis M, 2018, TR2009; Marteau B, 2017, EARTH SURF PROC LAND, V42, P503, DOI 10.1002/esp.4086; Martha TR, 2010, IEEE GEOSCI REMOTE S, V7, P582, DOI 10.1109/LGRS.2010.2041895; Meinel G, 2004, INT ARCH PHOTOGRAMME, P35; Meinen BU, 2020, INT J REMOTE SENS, V41, P1, DOI 10.1080/01431161.2019.1597294; Micheletti N, 2015, GEOMORPHOLOGICAL TEC, VOnline; Milani G, 2018, REMOTE SENS ENVIRON, V217, P491, DOI 10.1016/j.rse.2018.08.035; Morrison JE, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000502; Mullenhoff M, 2005, SELBSTVERLAG MARBURG; Myint SW, 2011, REMOTE SENS ENVIRON, V115, P1145, DOI 10.1016/j.rse.2010.12.017; Naithani AK, 2001, GAIA, V16, P145; National Aeronautics and Space Administration (NASA), 2019, GLOB PREC MEAS MISS; Niedzielski T, 2016, HYDROL EARTH SYST SC, V20, P3193, DOI 10.5194/hess-20-3193-2016; Nikfar M, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063592; Oostdijk A, GEOBIA 2008 PIXELS O, VXXXVIII-4/C1; Ouedraogo MM, 2014, GEOMORPHOLOGY, V214, P339, DOI 10.1016/j.geomorph.2014.02.016; Ozcan O, 2013, INT ARCH PHOTOGRAMM, V40-7-W2, P195, DOI 10.5194/isprsarchives-XL-7-W2-195-2013; Ozcan O, 2019, FRESENIUS ENV B, V28, P552; Ozcan O, 2019, FRESEN ENVIRON BULL, V28, P956; Ozcan O, 2018, BALT J ROAD BRIDGE E, V13, P192, DOI 10.7250/bjrbe.2018-13.412; Ozpolat E, 2020, J MAPS, V16, P405, DOI 10.1080/17445647.2020.1764874; Park HW, 2006, PROBABILIST ENG MECH, V21, P366, DOI 10.1016/j.probengmech.2005.11.009; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Posthumus H, 2009, J FLOOD RISK MANAG, V2, P182, DOI 10.1111/j.1753-318X.2009.01031.x; Rangel-Buitrago N, 2020, OCEAN COAST MANAGE, V186, DOI 10.1016/j.ocecoaman.2020.105099; Robinson JS, 1997, WATER RESOUR RES, V33, P1045, DOI 10.1029/97WR00044; Rusnak M, 2019, AREA, V51, P549, DOI 10.1111/area.12508; Saadi M, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/936468; Scaioni M., 2009, P 3 ISPRS INT WORKSH; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Song XP, 2016, REMOTE SENS ENVIRON, V175, P1, DOI 10.1016/j.rse.2015.12.027; Suzen ML, 2005, P 7 INT C MED COAST, V05, P1309; TANDEM X, 2019, TANDEM DAT; The European Space Agency (ESA), 2019, SENT 2A DAT; THUMSER Philipp, 2017, [Geography, Environment, Sustainability, Geography, Environment, Sustainability], V10, P31, DOI 10.24057/2071-9388-2017-10-3-31-43; Tonkin TN, 2014, GEOMORPHOLOGY, V226, P35, DOI 10.1016/j.geomorph.2014.07.021; Townsend PA, 2001, PLANT ECOL, V157, P129, DOI 10.1023/A:1013999513172; Trimble, 2014, 2014 TRIMBL ECOGNITI, P1; USGS, 2018, DIGITAL SHORELINE AN; Verhoeven G, 2012, J ARCHAEOL SCI, V39, P2060, DOI 10.1016/j.jas.2012.02.022; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Wheaton JM, 2010, EARTH SURF PROC LAND, V35, P136, DOI 10.1002/esp.1886; Witharana C, 2014, ISPRS J PHOTOGRAMM, V87, P108, DOI 10.1016/j.isprsjprs.2013.11.006; Wolman M. G., 1995, FLUVIAL PROCESSES GE; Wulf H, 2012, HYDROL EARTH SYST SC, V16, P2193, DOI 10.5194/hess-16-2193-2012; Wulf H, 2010, GEOMORPHOLOGY, V118, P13, DOI 10.1016/j.geomorph.2009.12.003; wwf, 2018, WORLD WILDLIFE FUND; Xiang J, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7383-9; Zhang Q, 2010, STOCH ENV RES RISK A, V24, P349, DOI 10.1007/s00477-009-0324-0; 2019, J CROHNS COLITIS S1, V13	116	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241293	10.1371/journal.pone.0241293	http://dx.doi.org/10.1371/journal.pone.0241293			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166295	gold, Green Published			2022-12-26	WOS:000592382600024
J	Awopegba, OE; Kalu, A; Ahinkorah, BO; Seidu, AA; Ajayi, AI				Awopegba, Oluwafemi Emmanuel; Kalu, Amarachi; Ahinkorah, Bright Opoku; Seidu, Abdul-Aziz; Ajayi, Anthony Idowu			Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; DECLINE; RATES; WOMEN	Background Prenatal screening of pregnant women for HIV is central to eliminating mother-to-child-transmission (MTCT) of HIV. While some countries in sub-Saharan Africa (SSA) have scaled up their prevention of MTCT programmes, ensuring a near-universal prenatal care HIV testing, and recording a significant reduction in new infection among children, several others have poor outcomes due to inadequate testing. We conducted a multi-country analysis of demographic and health surveys (DHS) to assess the coverage of HIV testing during pregnancy and also examine the factors associated with uptake. Methods We analysed data of 64,933 women from 16 SSA countries with recent DHS datasets (2015-2018) using Stata version 16. Adjusted and unadjusted logistic regression models were used to examine correlates of prenatal care uptake of HIV testing. Statistical significance was set at p<0.05. Results Progress in scaling up of prenatal care HIV testing was uneven across SSA, with only 6.1% of pregnant women tested in Chad compared to 98.1% in Rwanda. While inequality in access to HIV testing among pregnant women is pervasive in most SSA countries and particularly in West and Central Africa sub-regions, a few countries, including Rwanda, South Africa, Zimbabwe, Malawi and Zambia have managed to eliminate wealth and rural-urban inequalities in access to prenatal care HIV testing. Conclusion Our findings highlight the between countries and sub-regional disparities in prenatal care uptake of HIV testing in SSA. Even though no country has universal coverage of prenatal care HIV testing, East and Southern African regions have made remarkable progress towards ensuring no pregnant woman is left untested. However, the West and Central Africa regions had low coverage of prenatal care testing, with the rich and well educated having better access to testing, while the poor rarely tested. Addressing the inequitable access and coverage of HIV testing among pregnant women is vital in these sub-regions.	[Awopegba, Oluwafemi Emmanuel] Nigerian Inst Social & Econ Res, Econ & Business Policy Dept, Ibadan, Nigeria; [Kalu, Amarachi] Univ Ibadan, Fac Social Sci, Dept Sociol, Ibadan, Nigeria; [Ahinkorah, Bright Opoku] Univ Technol, Fac Hlth, Australian Ctr Publ & Populat Hlth Res ACPPHR, Sydney, NSW, Australia; [Seidu, Abdul-Aziz] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Seidu, Abdul-Aziz] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Ajayi, Anthony Idowu] African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Unit, APHRC Campus, Nairobi, Kenya	University of Ibadan; University of Technology Sydney; University of Cape Coast; James Cook University; African Population & Health Research Centre	Ajayi, AI (corresponding author), African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Unit, APHRC Campus, Nairobi, Kenya.	ajayianthony@gmail.com	Ajayi, Anthony Idowu/N-4272-2016	Ajayi, Anthony Idowu/0000-0002-6004-3972; Seidu, Abdul-Aziz/0000-0001-9734-9054; Awopegba, Oluwafemi/0000-0002-8023-3829				Abuogi LL, 2018, J VIRUS ERAD, V4, P33; Ajayi AI, 2021, J PUBLIC HEALTH-UK, V43, pE77, DOI 10.1093/pubmed/fdz152; Ajayi AI, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233368; Barr BAT, 2018, LANCET HIV, V5, pE688, DOI 10.1016/S2352-3018(18)30316-3; Baryamutuma Rose, 2017, East Afr J Appl Health Monitor Eval, V2017, P16; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; DHS program II, 2020, DHS METH; Gazimbi MM, 2019, J BIOSOC SCI, V51, P203, DOI 10.1017/S002193201800007X; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; Haas AD, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21947; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; HIV/AIDS JUNPo, 2017, END AIDS PROGR 90 90; Janz N, 2002, HLTH BEHAV HLTH ED T, P45; Jones CL, 2015, HEALTH COMMUN, V30, P566, DOI 10.1080/10410236.2013.873363; Kwapong GD, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-267; Maheu-Giroux M, 2019, AIDS, V33, pS255, DOI 10.1097/QAD.0000000000002386; McCoy SI, 2016, AIDS, V30, P1829, DOI 10.1097/QAD.0000000000001127; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Morley JE, 2013, J FRALITY AGING, V2, P121; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Peters H, 2018, HIV MED, V19, P280, DOI 10.1111/hiv.12577; Peters H, 2017, CLIN INFECT DIS, V64, P527, DOI 10.1093/cid/ciw791; Peterson, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2; Sherman GG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010701; Strecher VJ., 1997, CAMBRIDGE HDB PSYCHO, V113, P117; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Udoh EE, 2020, J BIOSOC SCI, V52, P473, DOI 10.1017/S0021932019000555; UNAIDS, 2018, GLOB AIDS UPD MIL GO; UNAIDS, 2020, SEIZ MOM TACKL ENTR; UNAIDS W, 2014, UNAIDSJC2686; van Lettow M, 2018, B WORLD HEALTH ORGAN, V96, P256, DOI 10.2471/BLT.17.203265; Whitmore SK, 2012, PEDIATRICS, V129, pE74, DOI 10.1542/peds.2010-3691; Yaya S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2540-z	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242001	10.1371/journal.pone.0242001	http://dx.doi.org/10.1371/journal.pone.0242001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166351	gold, Green Accepted, Green Published			2022-12-26	WOS:000592382600064
J	Kelly, SP; Huang, KP; Liao, CP; Khasanah, RAN; Shih-Sen Chien, F; Hu, JS; Wu, CL; Tso, IM				Kelly, Sean P.; Huang, Kun-Ping; Liao, Chen-Pan; Khasanah, Riza Ariyani Nur; Shih-Sen Chien, Forest; Hu, Jwu-Sheng; Wu, Chung-Lin; Tso, I-Min			Mechanical and structural properties of major ampullate silk from spiders fed carbon nanomaterials	PLOS ONE			English	Article							NANOTUBES; GRAPHENE; FIBERS	The dragline silk of spiders is of particular interest to science due to its unique properties that make it an exceptional biomaterial that has both high tensile strength and elasticity. To improve these natural fibers, researchers have begun to try infusing metals and carbon nanomaterials to improve mechanical properties of spider silk. The objective of this study was to incorporate carbon nanomaterials into the silk of an orb-weaving spider, Nephila pilipes, by feeding them solutions containing graphene and carbon nanotubes. Spiders were collected from the field and in the lab were fed solutions by pipette containing either graphene sheets or nanotubes. Major ampullate silk was collected and a tensile tester was used to determine mechanical properties for pre- and post-treatment samples. Raman spectroscopy was then used to test for the presence of nanomaterials in silk samples. There was no apparent incorporation of carbon nanomaterials in the silk fibers that could be detected with Raman spectroscopy and there were no significant improvements in mechanical properties. This study represents an example for the importance of attempting to replicate previously published research. Researchers should be encouraged to continue to do these types of investigations in order to build a strong consensus and solid foundation for how to go forward with these new methods for creating novel biomaterials.	[Kelly, Sean P.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Huang, Kun-Ping; Hu, Jwu-Sheng] Ind Technol Res Inst, Mech & Mechatron Syst Res Labs, Hsinchu, Taiwan; [Liao, Chen-Pan] Museum Nat Sci, Taichung, Taiwan; [Khasanah, Riza Ariyani Nur; Shih-Sen Chien, Forest] Tunghai Univ, Dept Appl Phys, Taichung, Taiwan; [Wu, Chung-Lin] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu, Taiwan	Tunghai University; Industrial Technology Research Institute - Taiwan; Tunghai University; Industrial Technology Research Institute - Taiwan	Tso, IM (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.	spider@thu.edu.tw	Chien, Forest Shih-Sen/V-9993-2017; Khasanah, Riza Ariyani Nur/HDM-1497-2022	Chien, Forest Shih-Sen/0000-0001-5994-0775; Khasanah, Riza Ariyani Nur/0000-0001-6996-8034; Kelly, Sean/0000-0002-8293-4784	Ministry of Science and Technology, R.O.C. [107-2811-B-029-001, 106-2311-B-029-003-MY3]; Ministry of Economic Affairs, R.O.C. [H301AR3300]	Ministry of Science and Technology, R.O.C.; Ministry of Economic Affairs, R.O.C.(Ministry of Economic Affairs, Taiwan)	This study was financially assisted by a postdoctoral fellowship to SPK through the Ministry of Science and Technology, R.O.C. #107-2811-B-029-001, along with additional funding to the labs of IMT from Ministry of Science and Technology, R.O.C. #106-2311-B-029-003-MY3 and to KPH from the Ministry of Economic Affairs, R.O.C., under contract #H301AR3300. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Andersson M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081290; [Anonymous], 2014, NAT PHOTONICS, V8, P1, DOI 10.1038/nphoton.2013.359; Blamires SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26383; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cheng HM, 1998, APPL PHYS LETT, V72, P3282, DOI 10.1063/1.121624; Coville NJ, 2011, S AFR J SCI, V107, P44, DOI 10.4102/sajs.v107i3/4.418; Foelix R. F, 2011, BIOL SPIDERS; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Giesa T, 2016, BIOMACROMOLECULES, V17, P427, DOI 10.1021/acs.biomac.5b01246; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jariwala D, 2013, CHEM SOC REV, V42, P2824, DOI 10.1039/c2cs35335k; Kerr GG, 2018, BIOL OPEN, V7, DOI 10.1242/bio.029249; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Lepore E, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa7cd3; Li XK, 2018, J MATER CHEM C, V6, P3212, DOI 10.1039/c8tc00265g; Malay AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183397; Paquet-Mercier F, 2013, SOFT MATTER, V9, P208, DOI 10.1039/c2sm26657a; R Core Team, 2021, R LANGUAGE ENV STAT; Ren J, 2019, MRS BULL, V44, P53, DOI 10.1557/mrs.2018.320; Riekel C, 2017, BIOMACROMOLECULES, V18, P231, DOI 10.1021/acs.biomac.6b01537; Steven E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3435; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; Wang Q, 2016, NANO LETT, V16, P6695, DOI 10.1021/acs.nanolett.6b03597; Xu H, 2019, RSC ADV, V9, P3558, DOI 10.1039/c8ra09934k	30	3	3	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241829	10.1371/journal.pone.0241829	http://dx.doi.org/10.1371/journal.pone.0241829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166360	Green Published, gold			2022-12-26	WOS:000592382600079
J	Shalaj, I; Gjaka, M; Bachl, N; Wessner, B; Tschan, H; Tishukaj, F				Shalaj, Ismet; Gjaka, Masar; Bachl, Norbert; Wessner, Barbara; Tschan, Harald; Tishukaj, Faton			Potential prognostic factors for hamstring muscle injury in elite male soccer players: A prospective study	PLOS ONE			English	Article							INTRINSIC RISK-FACTORS; PROFESSIONAL FOOTBALL; STRAIN INJURY; PREDICT INJURY; STRENGTH; PREVENTION; AMATEUR; SPORT; QUADRICEPS; OFFERS	Hamstring injuries remain the most common injury type across many professional sports. Despite a variety of intervention strategies, its incidence in soccer players playing in the UEFA Champions League has increased by 4% per year over the last decade. Test batteries trying to identify potential risk factors have produced inconclusive results. The purpose of the current study was to prospectively record hamstring injuries, to investigate the incidence and characteristics of the injuries, and to identify possible risk factors in elite male soccer players, playing in the Kosovo national premier league. A total of 143 soccer players from 11 teams in Kosovo were recruited. To identify possible prevalent musculoskeletal or medical conditions a widespread health and fitness assessment was performed including isokinetic strength testing, Nordic hamstring strength test, functional tests, and a comprehensive anamnesis surveying previous hamstring injuries. On average 27.9% of the players sustained at least one hamstring injury with three players suffering bilateral strains with the re-injury rate being 23%. Injured players were significantly older and heavier and had a higher body mass index compared to non-injured ones (p < 0.05). There was a lower passing rate in the Nordic hamstring strength test and a higher injury incidence among the previously injured players compared to non-injured ones (p < 0.05). Except for hamstring/quadriceps ratio and relative torque at 60 degrees/sec (p < 0.05) for dominant and non-dominant leg, there were no other significant differences in isokinetic strength regardless of the angular velocity. No differences were observed for functional tests between cohorts. Regression analysis revealed that age, Nordic hamstring strength test, previous injury history, and isokinetic concentric torque at 240 degrees/sec could determine hamstring injuries by 25.9%, with no other significant predicting risk factors. The battery of laboratory and field-based tests performed during preseason to determine performance related skills showed limited diagnostic conclusiveness, making it difficult to detect players at risk for future hamstring injuries.	[Shalaj, Ismet; Bachl, Norbert; Wessner, Barbara; Tschan, Harald; Tishukaj, Faton] Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria; [Gjaka, Masar] Univ Rome Foro Italico, Dept Human Movement & Sport Sci, Rome, Italy; [Gjaka, Masar] Univ Business & Technol, Dept Sport & Movement Sci, Pristina, Kosovo; [Wessner, Barbara] Univ Vienna, Res Platform Act Ageing, Vienna, Austria; [Tishukaj, Faton] Univ Pristina Hasan Prishtina, Fac Phys Educ & Sports, Pristina, Kosovo	University of Vienna; Foro Italico University of Rome; University of Vienna; Universiteti i Prishtines	Tschan, H (corresponding author), Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria.	harald.tschan@univie.ac.at	Wessner, Barbara/J-8244-2012	Wessner, Barbara/0000-0002-9061-7914; Tishukaj, Faton/0000-0003-4850-3849	University of Vienna	University of Vienna	Open access funding provided by University of Vienna. No additional external funding was received for this study.	[Anonymous], 2004, FDA Consum, V38, P36; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Bakken A, 2018, AM J SPORT MED, V46, P1481, DOI 10.1177/0363546518756028; Bakken A, 2016, BRIT J SPORT MED, V50, P1142, DOI 10.1136/bjsports-2015-095829; Bourne MN, 2015, AM J SPORT MED, V43, P2663, DOI 10.1177/0363546515599633; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Chelly MS, 2010, J STRENGTH COND RES, V24, P2670, DOI 10.1519/JSC.0b013e3181e2728f; Chumanov ES, 2007, J BIOMECH, V40, P3555, DOI 10.1016/j.jbiomech.2007.05.026; Cohen J., 2003, APPL MULTIPLE REGRES; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Dallinga JM, 2012, SPORTS MED, V42, P791, DOI 10.2165/11632730-000000000-00000; de la Motte SJ, 2019, J STRENGTH COND RES, V33, P1723, DOI 10.1519/JSC.0000000000002382; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; EC, 2014, OFFICIAL J EUROPEA L, V13, P1, DOI DOI 10.1186/1475-2891-13-1; Edouard P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01706; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Engebretsen AH, 2010, AM J SPORT MED, V38, P1147, DOI 10.1177/0363546509358381; Ertelt T, 2017, MED HYPOTHESES, V109, P119, DOI 10.1016/j.mehy.2017.10.002; Floreani M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194291; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Green B, 2018, BRIT J SPORT MED, V52, P329, DOI 10.1136/bjsports-2017-098101; Hachana Y, 2013, J STRENGTH COND RES, V27, P2752, DOI 10.1519/JSC.0b013e3182890ac3; Hagglund M, 2016, BRIT J SPORT MED, V50, P751, DOI 10.1136/bjsports-2015-095951; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Hickey J, 2014, BRIT J SPORT MED, V48, P729, DOI 10.1136/bjsports-2013-092884; Hughes T, 2017, BMJ OPEN SPORT EXERC, V3, P1; Hvid LG, 2014, EXP GERONTOL, V52, P1, DOI 10.1016/j.exger.2014.01.012; Iacovelli JN, 2013, BRIT J SPORT MED, V47, P789, DOI 10.1136/bjsports-2012-092113; Jewell C, 2019, EUR J SPORT SCI, V19, P1062, DOI 10.1080/17461391.2019.1575912; Kenneally-Dabrowski CJB, 2019, SCAND J MED SCI SPOR, V29, P1083, DOI 10.1111/sms.13437; Krist MR, 2013, J PHYSIOTHER, V59, P15, DOI 10.1016/S1836-9553(13)70142-5; Lee JWY, 2018, J SCI MED SPORT, V21, P789, DOI 10.1016/j.jsams.2017.11.017; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; Lehnert M, 2017, SCAND J MED SCI SPOR, V27, P975, DOI 10.1111/sms.12705; Malliaropoulos N, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0247-4; Malone S, 2018, J SCI MED SPORT, V21, P257, DOI 10.1016/j.jsams.2017.05.016; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Minozzo F, 2018, EUR J SPORT SCI, V18, P1398, DOI 10.1080/17461391.2018.1495271; Narouei S, 2018, J EXERC REHABIL, V14, P231, DOI 10.12965//jer.1835200.600; Opar DA, 2015, MED SCI SPORT EXER, V47, P857, DOI 10.1249/MSS.0000000000000465; Orchard JW, 2001, AM J SPORT MED, V29, P300, DOI 10.1177/03635465010290030801; PAVLOVIC M, 1989, Arhiv za Higijenu Rada i Toksikologiju, V40, P191; Pinto MD, 2018, SCAND J MED SCI SPOR, V28, P282, DOI 10.1111/sms.12891; Porter T, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-014-0004-6; Prescott JW, 2012, AM J ROENTGENOL, V199, pW294, DOI 10.2214/AJR.12.8912; Read PJ, 2018, J SPORT SCI, V36, P1423, DOI 10.1080/02640414.2017.1389515; Ribeiro N, 2019, EUR J SPORT SCI, V19, P287, DOI 10.1080/17461391.2018.1500643; Ribeiro-Alvares JB, 2020, J SPORT REHABIL, V29, P339, DOI 10.1123/jsr.2018-0084; Ruas CV, 2015, J STRENGTH COND RES, V29, P1220, DOI 10.1519/JSC.0000000000000766; SAHAI H, 1993, BIOMETRICAL J, V35, P857, DOI 10.1002/bimj.4710350716; Schache AG, 2009, GAIT POSTURE, V29, P332, DOI 10.1016/j.gaitpost.2008.10.054; Schuermans J, 2017, INT J SPORTS MED, V38, P696, DOI 10.1055/s-0043-103016; Schuermans J, 2017, GAIT POSTURE, V57, P270, DOI 10.1016/j.gaitpost.2017.06.268; Schuermans J, 2016, AM J SPORT MED, V44, P1276, DOI 10.1177/0363546515626538; Shadle IB, 2017, J SPORT REHABIL, V26, P573, DOI 10.1123/jsr.2015-0196; Shalaj I, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1202-9; Shield AJ, 2018, SPORTS MED, V48, P513, DOI 10.1007/s40279-017-0819-7; Sliwowski R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182177; Sugiura Y, 2008, J ORTHOP SPORT PHYS, V38, P457, DOI 10.2519/jospt.2008.2575; Sun YL, 2015, MED SCI SPORT EXER, V47, P373, DOI 10.1249/MSS.0000000000000404; Talpey SJ, 2017, SPORTS INJURY PREVEN; van Beijsterveldt AMC, 2013, SCAND J MED SCI SPOR, V23, P253, DOI 10.1111/j.1600-0838.2012.01487.x; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; van Dyk N, 2018, AM J SPORT MED, V46, P2203, DOI 10.1177/0363546518773057; van Dyk N, 2017, BRIT J SPORT MED, V51, P1695, DOI 10.1136/bjsports-2017-097754; van Dyk N, 2016, AM J SPORT MED, V44, P1789, DOI 10.1177/0363546516632526; van Melick N, 2019, KNEE SURG SPORT TR A, V27, P549, DOI 10.1007/s00167-018-5149-2; Verhagen EALM, 2013, CLIN J SPORT MED, V23, P500, DOI 10.1097/JSM.0000000000000040; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Winter E.M., 2009, KINANTHROPOMETRY EXE, V3rd ed., P307; Zhang SQ, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1596300; Zugel M, 2018, BRIT J SPORT MED, V52, P1497, DOI 10.1136/bjsports-2018-099308	77	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241127	10.1371/journal.pone.0241127	http://dx.doi.org/10.1371/journal.pone.0241127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166289	gold, Green Published			2022-12-26	WOS:000592382600009
J	Bonhomme, V; Picq, S; Ivorra, S; Evin, A; Pastor, T; Bacilieri, R; Lacombe, T; Figueiral, I; Terral, JF; Bouby, L				Bonhomme, Vincent; Picq, Sandrine; Ivorra, Sarah; Evin, Allowen; Pastor, Thierry; Bacilieri, Roberto; Lacombe, Thierry; Figueiral, Isabel; Terral, Jean-Frederic; Bouby, Laurent			Eco-evo-devo implications and archaeobiological perspectives of trait covariance in fruits of wild and domesticated grapevines	PLOS ONE			English	Article							VITIS-VINIFERA; HISTORICAL BIOGEOGRAPHY; BERRY DEVELOPMENT; L.; ORIGINS; SEED; INSIGHTS; SIZE; IDENTIFICATION; MORPHOMETRY	The phenotypic changes that occurred during the domestication and diversification of grapevine are well known, particularly changes in seed morphology, but the functional causes and consequences behind these variations are poorly understood. Wild and domesticate grapes differ, among others, in the form of their pips: wild grapes produce roundish pips with short stalks and cultivated varieties have more elongated pips with longer stalks. Such variations of form are of first importance for archaeobotany since the pip form is, most often, the only remaining information in archaeological settings. This study aims to enlighten archaeobotanical record and grapevine pip development by better understanding how size and shape (co)variates between pip and berry in both wild and domesticated Vitis vinifera. The covariation of berry size, number of seeds per berry ("piposity"), pip size and pip shape were explored on 49 grapevine accessions sampled among Euro-Mediterranean traditional cultivars and wild grapevines. We show that for wild grapevine, the higher the piposity, the bigger the berry and the more elongated the pip. For both wild and domesticated grapevine, the longer is the pip, the more it has a "domesticated" shape. Consequences for archaeobotanical studies are tested and discussed, and these covariations allowed the inference of berry dimensions from archaeological pips from a Southern France Roman site. This systematic exploration sheds light on new aspects of pip-berry relationship, in both size and shape, on grapevine eco-evo-devo changes during domestication, and invites to explore further the functional ecology of grapevine pip and berry and notably the impact of cultivation practices and human selection on grapevine morphology.	[Bonhomme, Vincent; Picq, Sandrine; Ivorra, Sarah; Evin, Allowen; Pastor, Thierry; Figueiral, Isabel; Terral, Jean-Frederic; Bouby, Laurent] Univ Montpellier, CNRS, EPHE, IRD,ISEM, Montpellier, France; [Bonhomme, Vincent; Picq, Sandrine; Ivorra, Sarah; Evin, Allowen; Pastor, Thierry; Figueiral, Isabel; Terral, Jean-Frederic; Bouby, Laurent] Equipe Dynam Biodivers Anthropoecol, CC065, Montpellier 5, France; [Picq, Sandrine] Nat Resources Canada, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Bacilieri, Roberto; Lacombe, Thierry] Univ Montpellier, UMR AGAP, Equipe Divers Adaptat & Ameliorat Vigne, CIRAD,INRA,Montpellier SupAgro, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Natural Resources Canada; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Bonhomme, V (corresponding author), Univ Montpellier, CNRS, EPHE, IRD,ISEM, Montpellier, France.; Bonhomme, V (corresponding author), Equipe Dynam Biodivers Anthropoecol, CC065, Montpellier 5, France.	bonhomme.vincent@gmail.com		EVIN, Allowen/0000-0003-4515-1649; Bouby, Laurent/0000-0002-3633-9829; Vincent, Bonhomme/0000-0002-2742-6349	ANR [ANR-16-CE27-0013]	ANR(French National Research Agency (ANR))	ANR project "Vignes et vins en France du Neolithique au MoyenAge. Approche integree en archeosciences" (PI: Laurent Bouby) https://anr.fr/Projet-ANR-16-CE27-0013.	[Anonymous], 2014, MED LETT DRUGS THER, V56, pe114; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Bacilieri R, 2017, VEG HIST ARCHAEOBOT, V26, P345, DOI 10.1007/s00334-016-0597-4; Bonhomme V, 2016, WEB ECOL, V16, P1, DOI 10.5194/we-16-1-2016; Bonnet A., 1912, ANN ECOLE NATL AGR M, V2, P5; Bouby L, 2018, ARCHAEOL ANTHROP SCI, V10, P943, DOI 10.1007/s12520-016-0425-x; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; Brun J.-P., 2003, VIN HUILE MEDITERRAN; Dokoozlian NK., 2000, RAISIN PRODUCTION MA, V3393, P30; Edwards W, 2006, EVOL ECOL, V20, P365, DOI 10.1007/s10682-006-0006-z; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; Figueiral I, 2010, J ARCHAEOL SCI, V37, P139, DOI 10.1016/j.jas.2009.09.024; Figueiral I, 2015, ARCHAEOL ANTHROP SCI, V7, P201, DOI 10.1007/s12520-014-0181-8; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; GALET P, 1988, CEPAGES VIGNOBLES FR; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; Houel C, 2013, AUST J GRAPE WINE R, V19, P208, DOI 10.1111/ajgw.12021; Imazio S, 2013, TREE GENET GENOMES, V9, P641, DOI 10.1007/s11295-013-0597-9; Jones G, 2000, VEG HIST ARCHAEOBOT, V9, P133, DOI 10.1007/BF01299798; Karasik A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24738-9; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Mangafa M, 1996, NEW METHOD IDENTIFIC, P409; McGovern P. E., 2007, ANCIENT WINE SEARCH; McGovern P, 2017, P NATL ACAD SCI USA, V114, pE10309, DOI 10.1073/pnas.1714728114; NEGRUL' A. M., 1960, Izv. timirjazev. sel'skohozjajstv. Akad. (News Timirjazev agric. Acad)., P167; Ojeda H, 1999, VITIS, V38, P145; Olmo HP, 1995, ORIGINS ANCIENT HIST, P31; Orru M, 2013, VEG HIST ARCHAEOBOT, V22, P231, DOI 10.1007/s00334-012-0362-2; Pagnoux C, 2015, VEG HIST ARCHAEOBOT, V24, P75, DOI 10.1007/s00334-014-0482-y; R Development Core Team, 2020, R LANG ENV STAT COMP; Ramos-Madrigal J, 2019, NAT PLANTS, V5, P595, DOI 10.1038/s41477-019-0437-5; Rasband W.S., 1997, IMAGEJ; Ristic R, 2005, AUST J GRAPE WINE R, V11, P43, DOI 10.1111/j.1755-0238.2005.tb00278.x; Ros J, 2014, J ARCHAEOL SCI, V41, P568, DOI 10.1016/j.jas.2013.09.015; SMITH H, 1990, J ARCHAEOL SCI, V17, P317, DOI 10.1016/0305-4403(90)90026-2; Sultan SE, 2007, TRENDS ECOL EVOL, V22, P575, DOI 10.1016/j.tree.2007.06.014; Terral JF, 2012, J BIOGEOGR, V39, P929, DOI 10.1111/j.1365-2699.2011.02649.x; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Ucchesu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149814; Wales N, 2016, J ARCHAEOL SCI, V72, P57, DOI 10.1016/j.jas.2016.05.014; Wallace M, 2019, J ARCHAEOL METHOD TH, V26, P1125, DOI 10.1007/s10816-018-9402-2; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Willcox G, 2004, J ARCHAEOL SCI, V31, P145, DOI 10.1016/j.jas.2003.07.003; Zohary D, 1993, DOMESTICATION PLANTS, DOI [10.1016/0042-6989(93)90127-i 8249327, DOI 10.1016/0042-6989(93)90127-I]	49	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0239863	10.1371/journal.pone.0239863	http://dx.doi.org/10.1371/journal.pone.0239863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156832	Green Published, gold			2022-12-26	WOS:000591376400042
J	Fox, AP; Wagner, KR; Towle, VL; Xie, KG; Xie, Z				Fox, Aaron P.; Wagner, Kyle R.; Towle, Vernon L.; Xie, Kelvin G.; Xie, Zheng			Caffeine reverses the unconsciousness produced by light anesthesia in the continued presence of isoflurane in rats	PLOS ONE			English	Article							ADENOSINE RECEPTOR ANTAGONISTS; MINIMUM ALVEOLAR CONCENTRATION; A(2A) RECEPTORS; ACCELERATES RECOVERY; GENERAL-ANESTHESIA; BISPECTRAL INDEX; EMERGENCE; PROPOFOL; CONSCIOUSNESS; NEUROTOXICITY	Currently no drugs are employed clinically to reverse the unconsciousness induced by general anesthetics. Our previous studies showed that caffeine, when given near the end of an anesthesia session, accelerated emergence from isoflurane anesthesia, likely caused by caffeine's ability to elevate intracellular cAMP levels and to block adenosine receptors. These earlier studies showed that caffeine did not rouse either rats or humans from deep anesthesia (>= 1 minimum alveolar concentration, MAC). In this current crossover study, we examined whether caffeine reversed the unconsciousness produced by light anesthesia (< 1 MAC) in the continued presence of isoflurane. The primary endpoint of this study was to measure isoflurane levels at the time of recovery of righting reflex, which was a proxy for consciousness. Rats were deeply anesthetized with 2% isoflurane (similar to 1.5 MAC) for 20 minutes. Subsequently, isoflurane was reduced to 1.2% for 10 minutes, then by 0.2% every 10 min; animals were monitored until the recovery of righting reflex occurred, in the continued presence of isoflurane. Respiration rate, heart rate and electroencephalogram (EEG) were monitored. Our results show that caffeine-treated rats recovered their righting reflex at a significantly higher inspired isoflurane concentration, corresponding to light anesthesia, than the same rats treated with saline (control). Respiration rate and heart rate increased initially after caffeine injection but were then unchanged for the rest of the anesthesia session. Deep anesthesia is correlated with burst suppression in EEG recordings. Our data showed that caffeine transiently reduced the burst suppression time produced by deep anesthesia, suggesting that caffeine altered neuronal circuit function but not to a point where it caused arousal. In contrast, under light anesthesia, caffeine shifted the EEG power to high frequency beta and gamma bands. These data suggest that caffeine may represent a clinically viable drug to reverse the unconsciousness produced by light anesthesia.	[Fox, Aaron P.; Xie, Kelvin G.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Wagner, Kyle R.; Xie, Zheng] Univ Chicago, Dept Anesthesia & Crit Care, Box 428, Chicago, IL 60637 USA; [Towle, Vernon L.] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Xie, Z (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, Box 428, Chicago, IL 60637 USA.	jxie@dacc.uchicago.edu		Wagner, Kyle/0000-0001-6093-0435; xie, zheng/0000-0001-8909-8339	National Institutes of Health (Bethesda, Marylarnd) [RO-1GM-116119]; Foundation for Anesthesia Education and Research (FAER)	National Institutes of Health (Bethesda, Marylarnd)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Anesthesia Education and Research (FAER)	This study is supported by National Institutes of Health (Bethesda, Marylarnd) grant No. RO-1GM-116119 to APF and ZX. This NIH grant covers all the cost of this study, including the cost of animals, laboratory equipment and medications. Foundation for Anesthesia Education and Research (FAER) awarded a medical student summer fellowship to KRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abu Baker F, 2019, ANN GASTROENTEROL, V32, P278, DOI 10.20524/aog.2019.0374; Abu Baker F, 2019, CLIN EXP GASTROENTER, V12, P105, DOI 10.2147/CEG.S186393; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; [Anonymous], 2000, JOINT PUB, pvii; Bhattacharyya S, 2013, COMPUT BIOL MED, V43, P1804, DOI 10.1016/j.compbiomed.2013.07.031; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6; COHN ML, 1975, NEUROPHARMACOLOGY, V14, P483, DOI 10.1016/0028-3908(75)90051-9; EGER EI, 1964, BRIT J ANAESTH, V36, P155, DOI 10.1093/bja/36.3.155; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; FDA, 2016, FDA ADVISORY; Fong R, 2018, ANESTHESIOLOGY, V129, P912, DOI 10.1097/ALN.0000000000002367; Fong R, 2017, J NEUROPHYSIOL, V118, P1591, DOI 10.1152/jn.00393.2017; Hambrecht-Wiedbusch VS, 2017, ANESTHESIOLOGY, V126, P482, DOI 10.1097/ALN.0000000000001512; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Hudetz AG, 2003, ANESTHESIOLOGY, V99, P1125, DOI 10.1097/00000542-200311000-00019; Hupfl M, 2008, ANAESTHESIA, V63, P583, DOI 10.1111/j.1365-2044.2008.05445.x; Kang JM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62915-x; Kelz MB, 2019, ANESTH ANALG, V128, P726, DOI 10.1213/ANE.0000000000004006; Kenny JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131914; Kenny JD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00237; Khalila A, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00098; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Li D, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00016; Loh PS, 2016, J CLIN ANESTH, V34, P216, DOI 10.1016/j.jclinane.2016.03.074; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Maloney SE, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2018.03.014; McCann ME, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6459; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Pal D, 2018, CURR BIOL, V28, P2145, DOI 10.1016/j.cub.2018.05.025; Pal D, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00041; Rang H.P., 2007, RANG DALES PHARM; Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379; Rivera-Oliver M, 2014, LIFE SCI, V101, P1, DOI 10.1016/j.lfs.2014.01.083; RUSSELL GB, 1995, PHARMACOLOGY, V50, P162, DOI 10.1159/000139278; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Snyder GL, 1998, J NEUROSCI, V18, P10297; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Svanborg E, 1996, SLEEP, V19, P248; Svenningsson P, 1997, NEUROSCIENCE, V79, P753, DOI 10.1016/S0306-4522(97)00046-8; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Turan A, 2010, ANESTH ANALG, V110, P449, DOI 10.1213/ANE.0b013e3181c6be7e; Van Dort CJ, 2009, J NEUROSCI, V29, P871, DOI 10.1523/JNEUROSCI.4111-08.2009; Wang LZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214093; Wang Q, 2014, J NEUROPHYSIOL, V111, P1331, DOI 10.1152/jn.00792.2013; Wang YH, 2007, P ANN INT IEEE EMBS, P553; Westover MB, 2013, IEEE ENG MED BIO, P7108, DOI 10.1109/EMBC.2013.6611196; Wu LZ, 2019, J ANESTH, V33, P321, DOI 10.1007/s00540-019-02623-7	51	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241818	10.1371/journal.pone.0241818	http://dx.doi.org/10.1371/journal.pone.0241818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152041	Green Published, gold			2022-12-26	WOS:000591376200086
J	Kim, KH; Park, JH; Ro, YS; Hong, KJ; Song, KJ; Shin, SD				Kim, Ki Hong; Park, Jeong Ho; Ro, Young Sun; Hong, Ki Jeong; Song, Kyoung Jun; Shin, Sang Do			Emergency department routine data and the diagnosis of acute ischemic heart disease in patients with atypical chest pain	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; RISK SCORE; PREDICTION; PREVALENCE; ACTIVATION; FAILURE; UPDATE; COUNT	Background Due to an aging population and the increasing proportion of patients with various comorbidities, the number of patients with acute ischemic heart disease (AIHD) who present to the emergency department (ED) with atypical chest pain is increasing. The aim of this study was to develop and validate a prediction model for AIHD in patients with atypical chest pain. Methods and results A chest pain workup registry, ED administrative database, and clinical data warehouse database were analyzed and integrated by using nonidentifiable key factors to create a comprehensive clinical dataset in a single academic ED from 2014 to 2018. Demographic findings, vital signs, and routine laboratory test results were assessed for their ability to predict AIHD. An extreme gradient boosting (XGB) model was developed and evaluated, and its performance was compared to that of a single-variable model and logistic regression model. The area under the receiver operating characteristic curve (AUROC) was calculated to assess discrimination. A calibration plot and partial dependence plots were also used in the analyses. Overall, 4,978 patients were analyzed. Of the 3,833 patients in the training cohort, 453 (11.8%) had AIHD; of the 1,145 patients in the validation cohort, 166 (14.5%) had AIHD. XGB, troponin (single-variable), and logistic regression models showed similar discrimination power (AUROC [95% confidence interval]: XGB model, 0.75 [0.71-0.79]; troponin model, 0.73 [0.69-0.77]; logistic regression model, 0.73 [0.70-0.79]). Most patients were classified as non-AIHD; calibration was good in patients with a low predicted probability of AIHD in all prediction models. Unlike in the logistic regression model, a nonlinear relationship-like threshold and U-shaped relationship between variables and the probability of AIHD were revealed in the XGB model. Conclusion We developed and validated an AIHD prediction model for patients with atypical chest pain by using an XGB model.	[Kim, Ki Hong; Park, Jeong Ho; Ro, Young Sun; Hong, Ki Jeong; Song, Kyoung Jun; Shin, Sang Do] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Kim, Ki Hong; Park, Jeong Ho; Ro, Young Sun; Hong, Ki Jeong; Shin, Sang Do] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Song, Kyoung Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Park, JH (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea.; Park, JH (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea.	timthe@gmail.com	Kim, Ki Hong/GXH-0871-2022	Park, Jeong Ho/0000-0001-6330-9820; Hong, Ki Jeong/0000-0003-3334-817X; KIM, KI HONG/0000-0003-2115-0078	Seoul National University Hospital [04-2018-0750]	Seoul National University Hospital	This study was financially supported by Seoul National University Hospital. (Grant No. 04-2018-0750)	Agnello L, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.020901; Agnello L, 2017, BIOCHEM MEDICA, V27, P562, DOI 10.11613/BM.2017.030709; Ahmed S, 2018, INDIAN HEART J, V70, P241, DOI 10.1016/j.ihj.2017.07.013; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P139, DOI [10.1016/j.jacc.2014.09.01725260718, DOI 10.1016/J.JACC.2014.09.01725260718]; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; [Anonymous], 1997, CAPLLETRA, V22, P11; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Barrabes JA, 2018, AM J CARDIOL, V122, P1604, DOI 10.1016/j.amjcard.2018.07.036; Batista GEAPA, 2003, APPL ARTIF INTELL, V17, P519, DOI 10.1080/08839510390219309; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bivona G, 2018, CLIN BIOCHEM, V58, P1, DOI 10.1016/j.clinbiochem.2018.04.021; Bivona G, 2016, ARCH MED RES, V47, P521, DOI 10.1016/j.arcmed.2016.12.009; Body R, 2018, TURK J EMERG MED, V18, P94, DOI 10.1016/j.tjem.2018.05.005; Body R, 2016, ACAD EMERG MED, V23, P1004, DOI 10.1111/acem.13012; CALLE P, 1994, CARDIOLOGY, V85, P111, DOI 10.1159/000176659; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; Fakhri Y, 2017, J ELECTROCARDIOL, V50, P90, DOI 10.1016/j.jelectrocard.2016.11.002; Fan Y, 2016, J AM COLL CARDIOL, V68, P1281, DOI 10.1016/j.jacc.2016.06.044; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; Godara H, 2013, WASHINGTON MANUAL ME; Hess EP, 2012, ANN EMERG MED, V59, P115, DOI 10.1016/j.annemergmed.2011.07.026; Hess EP, 2010, CAN MED ASSOC J, V182, P1039, DOI 10.1503/cmaj.092119; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; JOHNSON RD, 1995, AM J GASTROENTEROL, V90, P1244; Kang J, 2019, HEALTHC INFORM RES, V25, P124, DOI 10.4258/hir.2019.25.2.124; Kim JH, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0408-7; Kuhn L, 2013, AUSTRALAS EMERG NURS, V16, P160, DOI 10.1016/j.aenj.2013.08.002; Kwon H, 2018, INT J QUAL HLTH CARE; Laugaudin G, 2016, EUR HEART J-ACUTE CA, V5, P354, DOI 10.1177/2048872615585518; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Madjid M, 2013, TEX HEART I J, V40, P17; Mahler SA, 2013, INT J CARDIOL, V168, P795, DOI 10.1016/j.ijcard.2012.10.010; Nilsson T, 2020, J EMERG MED, V58, P874, DOI 10.1016/j.jemermed.2020.03.010; NISSEN NI, 1965, BRIT HEART J, V27, P520; Nunez J, 2006, CURR MED CHEM, V13, P2113, DOI 10.2174/092986706777935221; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Ricci B, 2016, CURR PHARM DESIGN, V22, P3877, DOI 10.2174/1381612822666160309115125; Schull MJ, 2004, ANN EMERG MED, V44, P577, DOI 10.1016/j.annemergmed.2004.05.004; Sharp AL, 2019, ANN EMERG MED, V74, P171, DOI 10.1016/j.annemergmed.2019.01.007; Shi XP, 2019, ACCIDENT ANAL PREV, V129, P170, DOI 10.1016/j.aap.2019.05.005; Shiraishi J, 2012, J CARDIOL, V60, P139, DOI 10.1016/j.jjcc.2012.02.008; Summers RL, 1999, AM J MED SCI, V318, P142, DOI 10.1097/00000441-199909000-00008; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282; Wu CC, 2019, COMPUT METH PROG BIO, V173, P109, DOI 10.1016/j.cmpb.2019.01.013; ZARLING EJ, 1983, JAMA-J AM MED ASSOC, V250, P1177; Zhang ZH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.03.29; Zhang ZZ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2411-z; Zhang ZH, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.09.39	58	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241920	10.1371/journal.pone.0241920	http://dx.doi.org/10.1371/journal.pone.0241920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152007	gold, Green Published			2022-12-26	WOS:000591376200005
J	Mofokeng, TRP; Ndlovu, KCZ; Beshyah, SA; Ross, IL				Mofokeng, Thabiso Rafaki Petrus; Ndlovu, Kwazi Celani Zwakele; Beshyah, Salem A.; Ross, Ian L.			Tiered healthcare in South Africa exposes deficiencies in management and more patients with infectious etiology of primary adrenal insufficiency	PLOS ONE			English	Article							ADDISONS-DISEASE; DIAGNOSIS	Objective We wished to determine the prevalence, etiology, presentation, and available management strategies for primary adrenal insufficiency (PAI) in South Africa (SA), hypothesizing a prevalence greater than the described 3.1 per million. There is great inequity in healthcare allocation, as two parallel healthcare systems exist, potentially modifying PAI patients' clinical profiles, private being better resourced than public healthcare. Methods An online survey of physicians' experience relating to PAI. Results The physicians were managing 811 patients, equal to a prevalence of 14.2 per million. Likely causes of PAI in public/ academic vs private settings included: AIDS-related [304 (44.8%) vs 5 (3.8%); p0.001], tuberculosis [288 (42.5%) vs 8 (6.0%); p0.001], autoimmune disease [50 (7.4%) vs 88 (66.2%); p0.001], malignancy [27 (4.0%) vs 7 (5.3%); p = 0.500], genetic including adrenoleukodystrophy (ALD) [5 (0.7%) vs 16 (12.0%); p0.001], respectively. Overall, more patients presented with nausea [101 (74.3%) and vomiting 89 (65.9%), than diarrhoea 76 (58.9%); p = 0.008 and 126 (15.5%) in adrenal crisis. Features suggestive of a crisis were hypoglycaemia [40 (78.4%) vs 42 (48.8%); p = 0.001], shock [36 (67.9%) vs 31(36.9%); p0.001], and loss of consciousness [25 (52.1%) vs 27 (32.9%); p = 0.031]. Greater unavailability of antibody testing in the public vs. the private sector [32 (66.7%) vs 30 (32.1%); p = 0.001], [serum-ACTH 25 (52.1%) vs 16 (19.5%); p0.001] and glucocorticoids were [26 (54.2%) vs 33 (40.2%); p = 0.015]. Many patients, 389(66.7%) were not using identification, indicating that they need steroids in an emergency. Conclusion A survey of South African physicians suggests a higher prevalence than previously reported. Patients presented with typical symptoms, and 15.5% presented in adrenal crisis. Significant disparities in the availability of physicians' expertise, diagnostic resources, and management options were noted in the public versus private settings. Greater awareness among health practitioners to timeously diagnose PAI is required to prevent a life-threatening outcome.	[Mofokeng, Thabiso Rafaki Petrus] Univ Free State, Dept Med, Div Endocrinol, Free State, South Africa; [Ndlovu, Kwazi Celani Zwakele] Univ Cape Town, Dept Med, Div Nephrol & Hypertens, Cape Town, South Africa; [Beshyah, Salem A.] Dubai Med Coll, Dubai, U Arab Emirates; [Beshyah, Salem A.] Med Airport Rd Hosp, Dept Endocrinol, Abu Dhabi, U Arab Emirates; [Ross, Ian L.] Univ Cape Town, Dept Med, Div Endocrinol, Cape Town, South Africa	University of the Free State; University of Cape Town; University of Cape Town	Mofokeng, TRP (corresponding author), Univ Free State, Dept Med, Div Endocrinol, Free State, South Africa.	mofokengtrp@ufs.ac.za	Ndlovu, Kwazi CZ/T-3588-2017; Mofokeng, Thabiso Rafaki Petrus/AAZ-5608-2020; Ross, Ian Louis/N-7420-2017	Ndlovu, Kwazi CZ/0000-0001-5283-2085; Mofokeng, Thabiso/0000-0001-5944-8350; Ross, Ian Louis/0000-0002-5308-7563				Alebiosu CO, 2003, ANN AFRICAN MED, V2, P85; [Anonymous], 2007, SPINE J S, V7, p1S; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Awan S, 2017, LUNG CANCER, V104, P75, DOI 10.1016/j.lungcan.2016.12.010; Betterle C, 2011, ENDOCR DEV, V20, P161, DOI 10.1159/000321239; Esposito D, 2018, J CLIN ENDOCR METAB, V103, P376, DOI 10.1210/jc.2017-01928; Falorni Alberto, 2009, Expert Rev Endocrinol Metab, V4, P333, DOI 10.1586/eem.09.20; FREDA PU, 1994, J CLIN ENDOCR METAB, V79, P1540, DOI 10.1210/jc.79.6.1540; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Husebye ES, 2014, J INTERN MED, V275, P104, DOI 10.1111/joim.12162; Laureti S, 1998, J CLIN ENDOCR METAB, V83, P3163, DOI 10.1210/jc.83.9.3163; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Margulies P, 1997, N AM SURVEY INDIVIDU; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mazziotti G, 2017, EUR J ENDOCRINOL, V177, pR231, DOI 10.1530/EJE-17-0154; Mofokeng TRP, 2020, ENDOCR CONNECT, V9, P445, DOI 10.1530/EC-20-0129; Oboni JB, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-3; Quinkler M, 2018, CLIN ENDOCRINOL, V89, P30, DOI 10.1111/cen.13609; Ross I, 2010, CLIN ENDOCRINOL, V73, P291, DOI 10.1111/j.1365-2265.2010.03807.x; Ross IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053526; Section27, HLTH DEM; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; STAT S, 2016, STAT REL P0M02 2016; Stats S, 2011, REP P0302 PRET STAT; Ueland GA, 2018, FRONT HORM RES, V49, P104, DOI 10.1159/000486004; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241845	10.1371/journal.pone.0241845	http://dx.doi.org/10.1371/journal.pone.0241845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152017	Green Published, gold			2022-12-26	WOS:000591376200080
J	O'Malley, KD; Kunin, WE; Town, M; Mgoola, WO; Stone, EL				O'Malley, Kieran D.; Kunin, William E.; Town, Matthew; Mgoola, William O.; Stone, Emma Louise			Roost selection by Mauritian tomb bats (Taphozus mauritianus) in Lilongwe city, Malawi - importance of woodland for sustainable urban planning	PLOS ONE			English	Article							BIG BROWN BATS; BUILDING ROOSTS; CONSERVATION; PIPISTRELLE	Increasing urbanisation has led to a greater use of artificial structures by bats as alternative roost sites. Despite the widespread presence of bats, roost availability may restrict their distribution and abundance in urban environments. There is limited quantitative information on the drivers of bat roost selection and roosting preferences, particularly in African bats. We explore the factors influencing roost selection in the Mauritian tomb bat (Taphozous mauritianus), within an urban landscape in Lilongwe city, Malawi. Eight building and five landscape features of roosts were compared with both adjacent and random control buildings throughout the city. Bat occupied buildings were situated closer to woodland (mean 709m) compared to random buildings (mean 1847m) but did not differ in any other landscape features explored. Roosts were situated on buildings with larger areas and taller walls, suggesting bats select features for predator-avoidance and acoustic perception when leaving the roost. Bats preferred buildings with exposed roof beams which may provide refuge from disturbance. Whilst roosts are situated more often on brick walls, this feature was also associated with landscape features, therefore its importance in roost selection is less clear. These results are indicative that T. mauritianus selects roosts at both the building and landscape level. The selectivity of T. mauritianus in relation to its roost sites implies that preferred roosts are a limited resource, and as such, conservation actions should focus on protecting roost sites and the woodland bats rely on.	[O'Malley, Kieran D.; Kunin, William E.] Univ Leeds, Sch Biol Sci, Leeds, W Yorkshire, England; [Town, Matthew; Stone, Emma Louise] African Bat Conservat, Lilongwe, Malawi; [Mgoola, William O.] Dept Natl PK & Wildlife Malawi, Lilongwe, Malawi; [Stone, Emma Louise] Univ West England, Dept Appl Sci, Bat Conservat Res Lab, Bristol, Avon, England; [O'Malley, Kieran D.] Univ Sussex, Dept Evolut Behav & Environm, Brighton, E Sussex, England	University of Leeds; University of West England; University of Sussex	Stone, EL (corresponding author), African Bat Conservat, Lilongwe, Malawi.; Stone, EL (corresponding author), Univ West England, Dept Appl Sci, Bat Conservat Res Lab, Bristol, Avon, England.	emma4.stone@uwe.ac.uk		Stone, Emma/0000-0002-3415-3967	Department of National Parks and Wildlife	Department of National Parks and Wildlife	We thank Department of National Parks and Wildlife for support and provision of research permits, African Bat Conservation (ABC) for logistical support, expertise, equipment and access to sites, ABC staff and volunteers for field assistance.	Ancillotto L, 2015, WILDLIFE RES, V42, P598, DOI 10.1071/WR15003; Ancillotto L, 2013, MAMM BIOL, V78, P369, DOI 10.1016/j.mambio.2013.01.003; [Anonymous], 1988, CONSERVATION EUROPEA; Bartonicka T, 2008, ANN ZOOL FENN, V45, P503, DOI 10.5735/086.045.0605; Bellamy C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128440; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; Corporation O, 2016, ORIGINPRO B9 3 2 30; Dengis Carol A., 1996, Mammalian Species, V522, P1; Deutsch L., 2013, URBANIZATION BIODIVE; Entwistle AC, 1997, J APPL ECOL, V34, P399, DOI 10.2307/2404885; Fagan KE, 2018, J WILDLIFE MANAGE, V82, P424, DOI 10.1002/jwmg.21372; Fenton MB, 2003, WILDLIFE SOC B, V31, P6; FENTON MB, 1992, TAPHOZOUS MAUITIANUS, V35, P49; Frick WF, 2020, ANN NY ACAD SCI, V1469, P5, DOI 10.1111/nyas.14045; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Government of Malawi National Statistical Office, 2018, POP HOUS CENS PREL R; Hair J., 2010, MULTIVARIATE DATA AN, V7; Haysom KA, 2010, SILENT SUMMER STATE; Hutson A, 2001, MICROCHIROPTERAN BAT; Jenkins EV, 1998, ANIM BEHAV, V56, P909, DOI 10.1006/anbe.1998.0858; Jung K, 2016, BATS ANTHROPOCENE CO; Jung K, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1222; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; Kunz TH, 2003, US GEOLOGICAL SURVEY; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Li H, 2015, ACTA CHIROPTEROL, V17, P321, DOI 10.3161/15081109ACC2015.17.2.007; Lintott PR, 2014, BIODIVERS CONSERV, V23, P2875, DOI 10.1007/s10531-014-0753-z; Lopez-Baucells A, 2017, HYSTRIX, V28, P28, DOI 10.4404/hystrix-28.1-12046; Manda MAZ., 2013, SITUATION URBANISATI; Monadjem A, 2017, ET21460A22111004; Moussy C, 2011, ACTA CHIROPTEROL, V13, P101, DOI 10.3161/150811011X578651; Neubaum DJ, 2007, J WILDLIFE MANAGE, V71, P728, DOI 10.2193/2005-684; Ngwira S, 2019, LAND-BASEL, V8, DOI 10.3390/land8030048; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; QGIS Development Team, 2018, QGIS GEOGR INF SYST, DOI 10.1038/nrg1769; Racey Paul A., 1998, P249; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Sagot M, 2015, CONSERV BIOL, V29, P1666, DOI 10.1111/cobi.12546; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Smithers R.H.N., 1971, MAMMALS BOTSWANA; Soper KD, 2007, ACTA CHIROPTEROL, V9, P542, DOI 10.3161/1733-5329(2007)9[542:AOBRFB]2.0.CO;2; Stone EL, 2017, AFRICA URBAN BIODIVE; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Taylor P. J., 1999, Durban Museum Novitates, V24, P62; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Taylor PJ, 1999, S AFR J ZOOL, V34, P19; TAYLOR PJ, 2000, BATS SO AFRICA; Team R, 2016, RSTUDIO INT DEV R 1; United Nations, 2018, STESASERA420 UN; Vonhof MJ, 1996, CAN J ZOOL, V74, P1797, DOI 10.1139/z96-200; Whitaker JO, 2000, AM MIDL NAT, V143, P389, DOI 10.1674/0003-0031(2000)143[0389:PSADOB]2.0.CO;2; Williams LM, 1997, J WILDLIFE MANAGE, V61, P359, DOI 10.2307/3802592; Willis CKR, 2006, J MAMMAL, V87, P345, DOI 10.1644/05-MAMM-A-118R1.1; World Bank Group, 2020, MAL COUNTR OV	58	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0240434	10.1371/journal.pone.0240434	http://dx.doi.org/10.1371/journal.pone.0240434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151973	Green Published, gold			2022-12-26	WOS:000591376200007
J	Sein, K; Damery, S; Baharani, J; Nicholas, J; Combes, G				Sein, Kim; Damery, Sarah; Baharani, Jyoti; Nicholas, Johann; Combes, Gill			Emotional distress and adjustment in patients with end-stage kidney disease: A qualitative exploration of patient experience in four hospital trusts in the West Midlands, UK	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; RENAL-DISEASE; DEPRESSION; HEMODIALYSIS	Objectives To explore patient perceptions and experiences of mild-to-moderate emotional distress and the support offered by kidney units to patients with end-stage kidney disease. Methods In-depth, semi-structured qualitative interviews with patients (n = 46) being treated for end-stage kidney disease in four hospital Trusts, with data analysed thematically. Results Patients described multiple sources of distress and talked about the substantial burden that emotional challenges raised for their ability to manage their condition and develop coping strategies. Many patients did not feel it appropriate to disclose their emotional issues to staff on the kidney unit, due to a perceived lack of time for staff to deal with such issues, or a perception that staff lacked the necessary skills to provide resolution. Five themes were identified from the patient interviews, broadly related to patients' experience of distress, and the support offered by the kidney unit: i) the emotional burden that distress placed on patients; ii) patients' relationship with the treatment for their condition; iii) strategies for coping and adjustment; iv) patient-staff interactions and the support offered by the kidney unit, and v) the mediating impact of the treatment environment on patient experience of distress and their ability to raise emotional issues with staff. Conclusions Many patients felt unprepared for the likelihood of experiencing emotional issues as part of their condition, for which pre-dialysis education could help in managing expectations, along with support to help patients to develop appropriate coping strategies and adjustments. These findings demonstrate the importance of recognising patient distress and ensuring that talking about distress becomes normalised for patients with end-stage kidney disease.	[Sein, Kim; Damery, Sarah; Combes, Gill] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Baharani, Jyoti] Birmingham Heartlands Hosp, Renal Unit, Birmingham, W Midlands, England; [Nicholas, Johann] Royal Shrewsbury Hosp, Renal Unit, Shrewsbury, Salop, England	University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham	Damery, S (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	s.l.damery@bham.ac.uk	Damery, Sarah/ABA-8641-2021	Damery, Sarah/0000-0003-3681-8608	NIHR Applied Research Collaboration West Midlands	NIHR Applied Research Collaboration West Midlands	This research was funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands (NIHR CLAHRC WM), now recommissioned as NIHR Applied Research Collaboration West Midlands. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chilcot J, 2014, TRANSPLANTATION, V97, P717, DOI 10.1097/01.TP.0000438212.72960.ae; Combes G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225269; Damery S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4808-4; Damery S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027982; Department of Health, 2012, LONG TERM CONDITIONS; Department of Health, 2005, NAT SERV FRAM REN SE; Evans D, 2009, PSYCHOL HEALTH, V24, P1181, DOI 10.1080/08870440802398188; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Gonzalez AM, 2020, AM J KIDNEY DIS, V76, P679, DOI 10.1053/j.ajkd.2020.03.022; Gregory DM, 1998, QUAL HEALTH RES, V8, P764, DOI 10.1177/104973239800800604; Kidney Health Advisory Group, 2013, DEL EXC KIDN HLTH RE; Kimmel PL, 2007, ADV CHRONIC KIDNEY D, V14, P328, DOI 10.1053/j.ackd.2007.07.007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Mitchell AJ, 2010, PSYCHO-ONCOLOGY, V19, P125, DOI 10.1002/pon.1523; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Moss-Morris R, 2013, BRIT J HEALTH PSYCH, V18, P681, DOI 10.1111/bjhp.12072; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; National Institute for Health and Care Excellence, 2011, CHRON KIDN DIS AD QU; Pena-Polanco JE, 2017, CLIN J AM SOC NEPHRO, V12, P298, DOI 10.2215/CJN.07720716; Pyart R, 2020, NEPHRON, V144, P59, DOI 10.1159/000504851; Reid K, 2012, J RENAL CARE, V38, P30, DOI 10.1111/j.1755-6686.2012.00278.x; Ryan H, 2005, EUR J CANCER CARE, V14, P7, DOI 10.1111/j.1365-2354.2005.00482.x; Schell JO, 2012, AM J KIDNEY DIS, V59, P495, DOI 10.1053/j.ajkd.2011.11.023; Shirazian S, 2017, INT J NEPHROL RENOV, V10, P11, DOI 10.2147/IJNRD.S108045; Stanton AL., 2012, ADJUSTMENT CHRONIC I; Taylor F, 2016, J RENAL CARE, V42, P212, DOI 10.1111/jorc.12182; Taylor F, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0327-2; Tong A, 2009, AM J KIDNEY DIS, V53, P689, DOI 10.1053/j.ajkd.2008.10.050; Trigwell P., 2008, MINDING GAP PROVISIO; Wagena EJ, 2005, EUR RESPIR J, V26, P242, DOI 10.1183/09031936.05.00010604; White K, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918793552; Wood E., 2014, J RENAL NURSING, V6, P239; Zalai D, 2012, SEMIN DIALYSIS, V25, P428, DOI 10.1111/j.1525-139X.2012.01100.x	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241629	10.1371/journal.pone.0241629	http://dx.doi.org/10.1371/journal.pone.0241629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152018	gold, Green Published			2022-12-26	WOS:000591376200050
J	Sikstrom, S; Stoinski, LM; Karlsson, K; Stille, L; Willander, J				Sikstrom, Sverker; Stoinski, Laura Mai; Karlsson, Kristina; Stille, Lotta; Willander, Johan			Weighting power by preference eliminates gender differences	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; DYNAMIC STEREOTYPES; SEX-DIFFERENCES; ROLE ATTITUDES; WOMEN; INVOLVEMENT; INTERNET; IMPACT; FATHER; LIFE	Power can be applied in different domains (e.g., politics, work, romantic relationships, family etc.), however, we do not always reflect on which domains we have power in and how important power in these domains is. A dominant idea is that men have more power than women. This notion may be biased because the concept of power is associated with public life. We introduce the concept of preference-weighted power (PWP), a measure of power that includes different domains in life, weighted by the domains' subjective importance. Two studies investigated power from this perspective. In Study 1, participants generated words related to power, which were quantified/categorized by latent semantic analysis to develop a semantic measure of the power construct. In Study 2, we computed a PWP index by weighting the participants' self-rated power in different power domains with the importance of having power in that domain. Together the studies suggest that men have more perceived power in the public domain, however, this domain has a lower preference weighting than the private domain where women have more power than men. Finally, when preferences for power in different domains were considered, no gender differences were observed. These results emphasize gender difference in different domains and may change how we perceive men's and women's power in our society.	[Sikstrom, Sverker; Stille, Lotta] Lund Univ, Lund, Sweden; [Stoinski, Laura Mai] Univ Konstanz, Constance, Germany; [Karlsson, Kristina] Stockholm Univ, Stockholm, Sweden; [Willander, Johan] Univ Gavle, Gavle, Sweden	Lund University; University of Konstanz; Stockholm University; University of Gavle	Sikstrom, S (corresponding author), Lund Univ, Lund, Sweden.	sverker.sikstrom@psy.lu.se		Sikstrom, Sverker/0000-0003-2644-9626	Swedish Research Council [2015-01229, 2017-00418]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	2015-19 The Swedish Research Council: The Advantages of Analysing Language: Developing Language-Based Methods for Measuring and Describing Psychological Constructs, 3 MSEK (2015-01229). Danilo Garcia & Sverker Sikstrom. 2018-21 The Swedish Research Council: Sprakets betydelse for jamstalldhet pa jobbet (2017-00418). 3.2 MSEK. Anna Lindqvist, Emma Back, Sverker Sikstrom & Marie Gustafsson-Seden.	Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Allen A, 2011, HIST HUM SCI, V24, P43, DOI 10.1177/0952695111411623; Allen TD, 2014, J OCCUP HEALTH PSYCH, V19, P376, DOI 10.1037/a0036941; [Anonymous], 2013, LANCET GLOB HLTH; Arvidsson D, 2011, PSYCHOTHER RES, V21, P430, DOI 10.1080/10503307.2011.577824; Banchefsky S, 2016, PSYCHOL MEN MASCULIN, V17, P103, DOI 10.1037/a0038945; Bayeh E., 2016, PACIFIC SCI REV B HU, V2, P37, DOI [10.1016/j.psrb.2016.09.013, DOI 10.1016/J.PSRB.2016.09.013]; Bianchi SM., 2006, CHANGING RHYTHMS AM; Bishu SG, 2017, ADMIN SOC, V49, P65, DOI 10.1177/0095399716636928; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cable N, 2013, J EPIDEMIOL COMMUN H, V67, P166, DOI 10.1136/jech-2012-201113; Carli L. L., 2002, J SOC ISSUES, V55, P81; Carli LL, 2001, J SOC ISSUES, V57, P725, DOI 10.1111/0022-4537.00238; Catalyst, 2012, BUYING POW; Diekman AB, 2004, SEX ROLES, V50, P201, DOI 10.1023/B:SERS.0000015552.22775.44; Diekman AB, 2000, PERS SOC PSYCHOL B, V26, P1171, DOI 10.1177/0146167200262001; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P926, DOI 10.1037/0022-3514.68.5.926; Elvevag B, 2007, SCHIZOPHR RES, V93, P304, DOI 10.1016/j.schres.2007.03.001; EMERSON RM, 1962, AM SOCIOL REV, V27, P31, DOI 10.2307/2089716; Farre L, 2013, ECONOMICA, V80, P219, DOI 10.1111/ecca.12008; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; Foltz P. W., 2000, Interactive Learning Environments, V8, P111, DOI 10.1076/1049-4820(200008)8:2;1-B;FT111; Friedman S.D., 2000, WORK FAMILY ALLIES E; Galinsky AD, 2011, SER ORGAN MANAGE, P17; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Guttentag M., 1983, TOO MANY WOMEN SEX R; Hearn Jeff, 1992, MEN PUBLIC EYE CONST; Henwood K, 2003, BRIT J SOC PSYCHOL, V42, P337, DOI 10.1348/014466603322438198; Hirigoyen G, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2016.100; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Karlsson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073378; Karlsson KP, 2019, J COGN PSYCHOL, V31, P651, DOI 10.1080/20445911.2019.1659281; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Kjell ONE, 2016, SOC INDIC RES, V126, P893, DOI 10.1007/s11205-015-0903-z; Kjell ONE, 2019, PSYCHOL METHODS, V24, P92, DOI 10.1037/met0000191; Landauer K. L., 2007, HDB LATENT SEMANTIC; Lawler S, 2004, SOCIOL REV MONOGR, P110; Lukes Stephen, 1986, POWER; McDuffie D, 2019, OBSERVER; Milazzo A., 2019, GOVERNANCE WOMENS EC; Mitra A., 2003, J SOCIOECONOMICS, V32, P317, DOI [10.1016/S1053-5357(03)00042-8, DOI 10.1016/S1053-5357(03)00042-8, https://doi.org/10.1016/S1053-5357(03)00042-8]; Odle-Dusseau HN, 2012, J BUS PSYCHOL, V27, P331, DOI 10.1007/s10869-011-9246-1; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Phillipson C, 1997, INT J GERIATR PSYCH, V12, P505, DOI 10.1002/(SICI)1099-1166(199705)12:5<505::AID-GPS577>3.0.CO;2-Q; Raley S, 2012, AM J SOCIOL, V117, P1422, DOI 10.1086/663354; SALAMON LM, 1977, AM POLIT SCI REV, V71, P1026, DOI 10.2307/1960105; Sani GMD, 2017, SEX ROLES, V77, P30, DOI 10.1007/s11199-016-0698-7; Silverstein M.J., 2009, WOMEN WANT MORE CAPT; Simpson J., 2015, POWER SOCIAL INFLUEN; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Smith J. A., 2009, DADDY SHIFT; Spence J.T., 1978, MASCULINITY FEMININI; Spencer G, 2015, J YOUTH STUD, V18, P900, DOI 10.1080/13676261.2014.1001827; Stewart AJ, 2004, ANNU REV PSYCHOL, V55, P519, DOI 10.1146/annurev.psych.55.090902.141537; Townsend J., 1999, WOMEN POWER FIGHTING; Valentova M, 2013, WORK EMPLOY SOC, V27, P639, DOI 10.1177/0950017013481638; WEF (World Economic Forum), 2017, GLOBAL GENDER GAP RE; Williams MJ, 2014, GROUP PROCESS INTERG, V17, P436, DOI 10.1177/1368430213497065; Women's Health Survey, 2018, JEAN HAILES WOMEN; Wood W, 2012, ADV EXP SOC PSYCHOL, V46, P55, DOI 10.1016/B978-0-12-394281-4.00002-7; YODER JD, 1992, PSYCHOL WOMEN QUART, V16, P381, DOI 10.1111/j.1471-6402.1992.tb00263.x	61	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0234961	10.1371/journal.pone.0234961	http://dx.doi.org/10.1371/journal.pone.0234961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151957	gold, Green Published			2022-12-26	WOS:000591376200033
J	Zdravkovic, M; Berger-Estilita, J; Zdravkovic, B; Berger, D				Zdravkovic, Marko; Berger-Estilita, Joana; Zdravkovic, Bogdan; Berger, David			Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study	PLOS ONE			English	Article							GOOGLE-SCHOLAR; TRIALS; CHINA	Background A debate about the scientific quality of COVID-19 themed research has emerged. We explored whether the quality of evidence of COVID-19 publications is lower when compared to nonCOVID-19 publications in the three highest ranked scientific medical journals. Methods We searched the PubMed Database from March 12 to April 12, 2020 and identified 559 publications in the New England Journal of Medicine, the Journal of the American Medical Association, and The Lancet which were divided into COVID-19 (cases, n = 204) and nonCOVID-19 (controls, n = 355) associated content. After exclusion of secondary, unauthored, response letters and non-matching article types, 155 COVID-19 publications (including 13 original articles) and 130 nonCOVID-19 publications (including 52 original articles) were included in the comparative analysis. The hierarchical level of evidence was determined for each publication included and compared between cases and controls as the main outcome. A quantitative scoring of quality was carried out for the subgroup of original articles. The numbers of authors and citation rates were also compared between groups. Results The 130 nonCOVID-19 publications were associated with higher levels of evidence on the level of evidence pyramid, with a strong association measure (Cramer's V: 0.452, P <0.001). The 155 COVID-19 publications were 186-fold more likely to be of lower evidence (95% confidence interval [CI] for odds ratio, 7.0-47; P <0.001). The quantitative quality score (maximum possible score, 28) was significantly different in favor of nonCOVID-19 (mean difference, 11.1; 95% CI, 8.5-13.7; P <0.001). There was a significant difference in the early citation rate of the original articles that favored the COVID-19 original articles (median [interquartile range], 45 [30-244] vs. 2 [1-4] citations; P <0.001). Conclusions We conclude that the quality of COVID-19 publications in the three highest ranked scientific medical journals is below the quality average of these journals. These findings need to be verified at a later stage of the pandemic.	[Zdravkovic, Marko; Zdravkovic, Bogdan] Univ Med Ctr Maribor, Dept Anaesthesiol Intens Care & Pain Management, Maribor, Slovenia; [Berger-Estilita, Joana] Univ Bern, Bern Univ Hosp, Inselspital, Dept Anaesthesiol & Pain Med, Bern, Switzerland; [Berger, David] Univ Bern, Dept Intens Care Med, Inselspital, Bern Univ Hosp, Bern, Switzerland	University of Maribor; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Berger, D (corresponding author), Univ Bern, Dept Intens Care Med, Inselspital, Bern Univ Hosp, Bern, Switzerland.	david.berger@insel.ch	Berger-Estilita, Joana/AAB-4497-2021; Zdravkovic, Marko/AAH-8337-2019; Berger, David C/GVU-6950-2022	Berger-Estilita, Joana/0000-0002-8695-4264; Berger, David C/0000-0003-0705-6341; Zdravkovic, Marko/0000-0002-0033-7071				a R-M, 2020, J CLIN MED, V9; Adare A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.132301; Alhazzani W, 2020, INTENS CARE MED, V46, P1977, DOI 10.1007/s00134-020-06227-8; Alwan NA, 2020, LANCET, V395, P1036, DOI 10.1016/S0140-6736(20)30667-X; Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984; [Anonymous], 2017, Drug Ther Bull, V55, P21, DOI 10.1136/dtb.2017.2.0457; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30528-6; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Bradshaw CJA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149852; Brennan ME, 2014, BRIT J CANCER, V111, P1899, DOI 10.1038/bjc.2014.505; Brown A, 2020, LANCET PLANET HLTH; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; COVID-19 Clinical Res Coalition, 2020, LANCET, V395, P1322, DOI 10.1016/S0140-6736(20)30798-4; Djulbegovic B, 2017, LANCET, V390, P415, DOI 10.1016/S0140-6736(16)31592-6; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Glen S., 2020, HEGDES G DEFINITION; Goodman JL, 2020, JAMA; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Greaves S, 2020, SHARING FINDINGS REL; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Hossain M.M., 2020, F1000RESEARCH; Hossain MM., 2020, F1000RESEARCH; Ioannidis JPA, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13151; Ioannidis JPA, EUR J CLIN INVEST, V2020, pe13223; Ivanova M, 2009, HANDBOOK OF TRANSNATIONAL ECONOMIC GOVERNANCE REGIMES, P1009; Johansson MA, 2020, NATURE, V579, P29, DOI [10.1038/d41586-020-00614-3, 10.1038/d41586-020-00613-4]; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kalil AC, 2020, JAMA; Kalil AC, 2020, JAMA, DOI DOI 10.1016/j.cct.2020.106123; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; KHAN K, 2001, UNDERTAKING SYSTEMAT; Kim AHJ, 2020, ANN INTERN MED; Kmet L.M., 2004, STANDARD QUALITY ASS; Kupferschmidt K, STUDY CLAIMING NEW C; Lamontagne F, 2020, JAMA-J AM MED ASSOC, V323, P1786, DOI 10.1001/jama.2020.5110; Lander B, 2019, J MED INTERNET RES, V21, DOI 10.2196/10769; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731; Maguire Brittany J, 2020, Wellcome Open Res, V5, P60, DOI 10.12688/wellcomeopenres.15821.1; Martin-Martin A, 2017, J INFORMETR, V11, P152, DOI 10.1016/j.joi.2016.11.008; Mcrvlichael IM, 2020, N ENGL J MED; Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Shamoo AE, 2020, ACCOUNT RES, V27, P325, DOI 10.1080/08989621.2020.1787838; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Zagury-Orly I, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2009405; Zdravkovic M, 2020, BR J ANAESTH; Zeng Yingchun, 2020, Lancet Glob Health, DOI 10.1016/S2214-109X(20)30065-6; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; [No title captured]; [No title captured]	62	43	45	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241826	10.1371/journal.pone.0241826	http://dx.doi.org/10.1371/journal.pone.0241826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152034	Green Published, gold			2022-12-26	WOS:000591376200112
J	Hanel, R; Thurner, S				Hanel, Rudolf; Thurner, Stefan			Boosting test-efficiency by pooled testing for SARS-CoV-2-Formula for optimal pool size	PLOS ONE			English	Article							IDENTIFICATION	In the current COVID19 crisis many national healthcare systems are confronted with an acute shortage of tests for confirming SARS-CoV-2 infections. For low overall infection levels in the population the pooling of samples can drastically amplify the testing capacity. Here we present a formula to estimate the optimal group-size for pooling, the efficiency gain (tested persons per test), and the expected upper bound of missed infections in pooled testing, all as a function of the population-wide infection levels and the false negative/positive rates of the currently used PCR tests. Assuming an infection level of 0.1% and a false negative rate of 2%, the optimal pool-size is about 34, and an efficiency gain of about 15 tested persons per test is possible. For an infection level of 1% the optimal pool-size is 11, the efficiency gain is 5.1 tested persons per test. For an infection level of 10% the optimal pool-size reduces to about 4, the efficiency gain is about 1.7 tested persons per test. For infection levels of 30% and higher there is no more benefit from pooling. To see to what extent replicates of the pooled tests improve the estimate of the maximal number of missed infections, we present results for 1 to 5 replicates.	[Hanel, Rudolf; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria; [Hanel, Rudolf; Thurner, Stefan] Complex Sci Hub Vienna, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria.; Thurner, S (corresponding author), Complex Sci Hub Vienna, Vienna, Austria.; Thurner, S (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Thurner, S (corresponding author), IIASA, Laxenburg, Austria.	stefan.thurner@meduniwein.ac.at		Hanel, Rudolf/0000-0002-4045-9532	Austrian Research Promotion Agency, FFG [ST 857136]	Austrian Research Promotion Agency, FFG(Austrian Science Fund (FWF))	ST 857136 Austrian Research Promotion Agency, FFG https://www.ffg.at/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprahamian H, 2019, MANAGE SCI, V65, P4365, DOI 10.1287/mnsc.2018.3138; Atia GK, 2012, IEEE T INFORM THEORY, V58, P1880, DOI 10.1109/TIT.2011.2178156; Broder AZ, NOTE DOUBLE POOLING; Centers for Disease Control and Prevention, INT GUID US POOL PRO; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; European Centre for Disease prevention and Control, METH EST POINT PREV; Gan Yichuan, VIEW ORCID PROFILEX, DOI [10.1101/2020.05.18.20106138, DOI 10.1101/2020.05.18.20106138]; Gupta E, POOLED RNA SAMPLE RE, DOI [10.1101/2020.04.25.20079095, DOI 10.1101/2020.04.25.20079095]; Hudgens MG, 2011, COMMUN STAT-THEOR M, V40, P436, DOI 10.1080/03610920903391303; Husch PA, 2020, POOL SIZE CALCULATOR; Jeffay N, 2020, EASE GLOBAL VIRUS TE, P18; Kim HY, 2007, BIOMETRICS, V63, P1152, DOI 10.1111/j.1541-0420.2007.00817.x; Kim HY, 2009, BIOMETRICS, V65, P903, DOI 10.1111/j.1541-0420.2008.01158.x; Labratory Corporation of America, ACC EMM US AUTH EUA; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; PJ M, 2006, CURR OPIN RHEUMAT S1, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; Puchhammer E, 2020, COMMUNICATION   0321; Rambam Medical Center and the Technion in Haifa, POOL METH ACC TEST C; Saraniti Brett A, 2006, Health Care Manag Sci, V9, P143, DOI 10.1007/s10729-006-7662-y; UNGAR P, 1960, COMMUN PUR APPL MATH, V13, P49, DOI 10.1002/cpa.3160130105; Verdun CM, 2020, GROUP TESTING SARS C, DOI [10.1101/2020.04.30.20085290v2.full.pdf, 10.1101/2020.04.30.20085290]; Xu RS, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0080-z; Yao Y. C., 1988, SIAM J DISCRETE MATH, V1, P256, DOI DOI 10.1137/0401026; Zhu J, NOISY POOLED PCR VIR	25	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240652	10.1371/journal.pone.0240652	http://dx.doi.org/10.1371/journal.pone.0240652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147228	Green Published, gold, Green Accepted			2022-12-26	WOS:000589609300049
J	Kato-Unoki, Y; Umemura, K; Tashiro, K				Kato-Unoki, Yoko; Umemura, Keitaro; Tashiro, Kosuke			Fingerprinting of hatchery haplotypes and acquisition of genetic information by whole-mitogenome sequencing of masu salmon, Oncorhynchus masou masou, in the Kase River system, Japan	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATIONS; STOCKING	Stocking hatchery fish can lead to disturbance and extinction of the local indigenous population. Masu salmon Oncorhynchus masou masou, which is endemic across Japan, is a commonly stocked fish for recreational fishing in Japan. To conserve the indigenous resource, their genetic information is required, however, especially on Kyushu Island, the paucity of genetic information for this species has hindered proper resource management. Here, to identify hatchery mitogenome haplotypes of this species, stocked in the Kase River system, Kyushu Island, Japan, and to provide mitogenomic information for the resource management of this species, we analyzed the whole-mitogenome of masu salmon in this river system and several hatcheries potentially used for stocking. Whole-mitogenome sequencing clearly identified hatchery haplotypes, like fingerprints: among the 21 whole-mitogenome haplotypes obtained, six were determined to be hatchery haplotypes. These hatchery haplotypes were distributed in 13 out of 17 sites, suggesting that informal stocking of O. m. masou has been performed widely across this river system. The population of no hatchery haplotypes mainly belonged to clade I, a clade not found in Hokkaido Island in previous studies. Sites without hatchery haplotypes, and the non-hatchery haplotypes in clade I might be candidates for conservation as putative indigenous resources. The whole-mitogenome haplotype analysis also clarified that the same reared strain was used in multiple hatcheries. Analysis of molecular variance suggested that stocked hatchery haplotypes reduce the genetic variation among populations in this river system. It will be necessary to pay attention to genetic fluctuations so that the resources of this river system will not deteriorate further. The single nucleotide polymorphism data obtained here could be used for resource management in this and other rivers: e.g., for monitoring of informal stocking and stocked hatchery fishes, and/or putative indigenous resources.	[Kato-Unoki, Yoko] Kyushu Univ, Fac Agr, Ctr Adv Instrumental & Educ Supports, Fukuoka, Japan; [Umemura, Keitaro] Kyushu Univ, Fishery Res Lab, Fukuoka, Japan; [Tashiro, Kosuke] Kyushu Univ, Fac Agr, Lab Mol Gene Technol, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kato-Unoki, Y (corresponding author), Kyushu Univ, Fac Agr, Ctr Adv Instrumental & Educ Supports, Fukuoka, Japan.	unoki.yoko.659@m.kyushu-u.ac.jp		ti mu, yang zi/0000-0003-1745-8897	JSPS KAKENHI [JP16H00474]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/) Grant Number JP16H00474 to Yoko Kato-Unoki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AQUACULT SCI; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Bishop CR, 2018, CONSERV GENET, V19, P587, DOI 10.1007/s10592-017-1034-7; Bourret V, 2020, EVOL APPL, V13, P1420, DOI 10.1111/eva.12977; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feutry P, 2015, MAR ECOL PROG SER, V533, P237, DOI 10.3354/meps11354; Finnegan AK, 2008, FISHERIES MANAG ECOL, V15, P315, DOI 10.1111/j.1365-2400.2008.00616.x; Forgacs D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166081; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; Ineno T, 2007, B MIYAZAKIPREF FISH, V1, P311; Iwatsuki Y, 2019, P INT S 100 ANN DISC, P101; Kato F., 1991, P447; Kimura S., 1976, ANIMALS KYUSYU OKINA, V2, P36; Kitanishi S, 2007, J FISH BIOL, V71, P437, DOI 10.1111/j.1095-8649.2007.01689.x; Kitanishi S, 2009, ECOL FRESHW FISH, V18, P65, DOI 10.1111/j.1600-0633.2008.00325.x; Kitanishi S, 2018, ENVIRON BIOL FISH, V101, P699, DOI 10.1007/s10641-018-0730-6; Kitanishi S, 2012, ECOL EVOL, V2, P920, DOI 10.1002/ece3.228; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lever C, 1996, NATURALIZED FISHES W; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mayama H., 1990, FISH EGG, V159, P7; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Miyakoshi Yasuyuki, 2012, Scientific Reports of Hokkaido Fisheries Research Institutes, V81, P125; Noguchi D., 2007, AQUAC SCI, V55, P521, DOI DOI 10.10233/AQUACULTURESCI1953.55.521; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Shamblin BM, 2012, MOL ECOL, V21, P2330, DOI 10.1111/j.1365-294X.2012.05530.x; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tsuji S, 2020, MOL ECOL RESOUR, V20, P1248, DOI 10.1111/1755-0998.13165; Ueda H, 2012, J FISH BIOL, V81, P543, DOI 10.1111/j.1095-8649.2012.03354.x; Ueda H, 2019, J FISH BIOL, V95, P293, DOI 10.1111/jfb.13775; Yamamoto S, 2020, FRESHWATER BIOL, V65, P698, DOI 10.1111/fwb.13460; Yu JN, 2010, ZOOL SCI, V27, P375, DOI 10.2108/zsj.27.375	37	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240823	10.1371/journal.pone.0240823	http://dx.doi.org/10.1371/journal.pone.0240823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147284	Green Submitted, gold, Green Published			2022-12-26	WOS:000589609300016
J	Onsamrarn, W; Chittamart, N; Tawornpruek, S				Onsamrarn, Wattanai; Chittamart, Natthapol; Tawornpruek, Saowanuch			Performances of the WEPP and WaNuLCAS models on soil erosion simulation in a tropical hillslope, Thailand	PLOS ONE			English	Article							RUNOFF; WATER; PREDICTION; SEDIMENT; SPAIN; FIELD; VALIDATION; CATCHMENT; ACCURACY; IMPACTS	Effective soil erosion prediction models and proper conservation practices are important tools to mitigate soil erosion in hillside agricultural areas. The Water Nutrient and Light Capture in Agroforestry Systems (WaNuLCAS) and Water Erosion Prediction Project (WEPP) models are capable tools in soil erosion simulation in the conventional and conservation cropping systems in hillslopes. We calibrated both the models in maize monocropping and simultaneously validated them in maize-chili intercropping with Leucaena hedgerow for nine rainfall events in 2010, with the aim to evaluate their performances in runoff and sediment prediction on a skeleton soil in a hillslope, Western Thailand. The results showed that the calibrated WaNuLCAS model poorly predicts runoff prediction in the validation. In contrast, the calibrated WEPP model had a better performance in runoff prediction in the validation. For sediment prediction, the calibrated WaNuLCAS model predicted sediment yield better than the calibrated WEPP model in the validation because the WEPP model shows more variability of the sediment yield in the calibration (5.84 kg m(-2)) than the WaNuLCAS (5.18 kg m(-2)). Thus, the WEPP model was more suitable for runoff prediction than sediment prediction in the monocropping system, whereas the WaNuLCAS model was better suited for sediment yield prediction than runoff prediction, especially in complex intercropping systems.	[Onsamrarn, Wattanai; Chittamart, Natthapol; Tawornpruek, Saowanuch] Kasetsart Univ, Fac Agr, Dept Soil Sci, Bangkok, Thailand; [Onsamrarn, Wattanai; Chittamart, Natthapol] Kasetsart Univ, Ctr Adv Studies Agr & Food, Inst Adv Studies, Bangkok, Thailand	Kasetsart University; Kasetsart University	Chittamart, N (corresponding author), Kasetsart Univ, Fac Agr, Dept Soil Sci, Bangkok, Thailand.; Chittamart, N (corresponding author), Kasetsart Univ, Ctr Adv Studies Agr & Food, Inst Adv Studies, Bangkok, Thailand.	fagmpc@ku.ac.th	Chittamart, Natthapol/A-3824-2017	Chittamart, Natthapol/0000-0002-0839-9816	Center for Advanced Studies for Agriculture and Food, Institute for Advanced Studies, Kasetsart University under the Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission, Ministry of Education, Thailand	Center for Advanced Studies for Agriculture and Food, Institute for Advanced Studies, Kasetsart University under the Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission, Ministry of Education, Thailand	Center for Advanced Studies for Agriculture and Food, Institute for Advanced Studies, Kasetsart University under the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Ministry of Education, Thailand.	Akbari A, 2015, ENVIRON EARTH SCI, V74, P5827, DOI 10.1007/s12665-015-4600-7; Atucha A, 2013, PLANT SOIL, V368, P393, DOI 10.1007/s11104-012-1520-0; Brazier RE, 2000, EARTH SURF PROC LAND, V25, P825, DOI [10.1002/1096-9837(200008)25:8<825::AID-ESP101>3.0.CO;2-3, 10.1002/1096-9837(200008)25:8&lt;825::AID-ESP101&gt;3.0.CO;2-3]; Brevik EC, 2015, SOIL-GERMANY, V1, P35, DOI 10.5194/soil-1-35-2015; Cerda A, 2017, ECOL ENG, V108, P162, DOI 10.1016/j.ecoleng.2017.08.028; Cerda A, 2016, SOIL RES, V54, P154, DOI 10.1071/SR15092; Cerda A, 2009, BIOLOGIA, V64, P527, DOI 10.2478/s11756-009-0114-7; Chahinian N, 2005, J HYDROL, V306, P191, DOI 10.1016/j.jhydrol.2004.09.009; Feng XM, 2010, GEOMORPHOLOGY, V118, P239, DOI 10.1016/j.geomorph.2010.01.004; Flanagan D, 1995, 10 NAT SOIL ER RES L; Garcia-Ruiz JM, 2010, CATENA, V81, P1, DOI 10.1016/j.catena.2010.01.001; Garre S, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0129; Gomez JA, 2014, AGRICULTURE-BASEL, V4, P170, DOI 10.3390/agriculture4020170; Graves A, 2004, ADV AGRON, V82, P473, DOI 10.1016/S0065-2113(03)82007-2; Homaee M, 2002, AGR WATER MANAGE, V57, P89, DOI 10.1016/S0378-3774(02)00072-0; Huang CH, 1996, SOIL SCI SOC AM J, V60, P734, DOI 10.2136/sssaj1996.03615995006000030008x; Hussain K, 2015, PLANT SOIL, V393, P1, DOI 10.1007/s11104-015-2455-z; Keesstra SD, 2007, EARTH SURF PROC LAND, V32, P49, DOI 10.1002/esp.1360; Keesstra SD, 2014, GEOMORPHOLOGY, V212, P97, DOI 10.1016/j.geomorph.2013.04.021; Keesstra S, 2016, SCI TOTAL ENVIRON, V551, P357, DOI 10.1016/j.scitotenv.2016.01.182; Keesstra SD, 2016, SOIL-GERMANY, V2, P111, DOI 10.5194/soil-2-111-2016; Khetdan C, 2017, GEODERMA REG, V10, P21, DOI 10.1016/j.geodrs.2017.04.001; Laflen JM, 2004, J AM WATER RESOUR AS, V40, P289, DOI 10.1111/j.1752-1688.2004.tb01029.x; Lal R, 2007, ADV AGRON, V93, P69, DOI 10.1016/S0065-2113(06)93002-8; Laudicina VA, 2015, LAND DEGRAD DEV, V26, P45, DOI 10.1002/ldr.2293; Ma B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099717; Matthews R, 2002, ADV AGRON, V76, P31, DOI 10.1016/S0065-2113(02)76003-3; Melville N, 2001, SOIL USE MANAGE, V17, P278, DOI 10.1079/SUM200192; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Motovilov YG, 1999, AGR FOREST METEOROL, V98-9, P257, DOI 10.1016/S0168-1923(99)00102-1; Nearing MA, 2004, J SOIL WATER CONSERV, V59, P43; NEARING MA, 1989, T ASAE, V32, P1587; Novara A, 2011, SOIL TILL RES, V117, P140, DOI 10.1016/j.still.2011.09.007; Pandey A, 2008, J HYDROL, V348, P305, DOI 10.1016/j.jhydrol.2007.10.010; Pansak W, 2008, AGR ECOSYST ENVIRON, V128, P167, DOI 10.1016/j.agee.2008.06.002; Pansak W, 2010, AGROFOREST SYST, V79, P123, DOI 10.1007/s10457-010-9290-2; Pieri L, 2007, J HYDROL, V336, P84, DOI 10.1016/j.jhydrol.2006.12.014; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; Rose C. W., 1985, Soil erosion and conservation, P549; Rose C. W., 1985, Advances in Soil Science, USA, V2, P1; Rose C.W., 2017, SOIL EROSION RES MET, P159, DOI [10.1201/9780203739358, DOI 10.1201/9780203739358]; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; SAVABI MR, 1993, J IRRIG DRAIN ENG, V119, P801, DOI 10.1061/(ASCE)0733-9437(1993)119:5(801); SAVABI MR, 1995, J SOIL WATER CONSERV, V50, P477; Sharma NK, 2017, AGR ECOSYST ENVIRON, V247, P43, DOI 10.1016/j.agee.2017.06.026; Shen ZY, 2009, AGR WATER MANAGE, V96, P1435, DOI 10.1016/j.agwat.2009.04.017; Taddese G, 2001, ENVIRON MANAGE, V27, P815, DOI 10.1007/s002670010190; THOMANN RV, 1982, J ENV ENG DIV-ASCE, V108, P923; Trabaquini K, 2015, LAND DEGRAD DEV, V26, P397, DOI 10.1002/ldr.2222; Van Eck CM, 2016, LAND DEGRAD DEV, V27, P1535, DOI 10.1002/ldr.2507; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vasconcellos RLF, 2016, LAND DEGRAD DEV, V27, P325, DOI 10.1002/ldr.2228; Walker AP, 2008, AGROFOREST SYST, V74, P143, DOI 10.1007/s10457-008-9137-2; Warner GS, 1997, T ASAE, V40, P585, DOI 10.13031/2013.21317; Wischmeier W. H., 1978, U. S. Department of Agriculture, Agriculture Handbook; WISCHMEIER WH, 1976, J SOIL WATER CONSERV, V31, P5; Yang DW, 2003, HYDROL PROCESS, V17, P2913, DOI 10.1002/hyp.1441; Yu B, 2001, AUST J SOIL RES, V39, P1131, DOI 10.1071/SR00091; Zuazo V. H. Duran, 2006, Environmentalist, V26, P309, DOI 10.1007/s10669-006-0160-4	59	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241689	10.1371/journal.pone.0241689	http://dx.doi.org/10.1371/journal.pone.0241689			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147263	gold, Green Published			2022-12-26	WOS:000589609300007
J	Sangkaew, O; Phaonakrop, N; Roytrakul, S; Yompakdee, C				Sangkaew, Orrarat; Phaonakrop, Narumon; Roytrakul, Sittiruk; Yompakdee, Chulee			Metaproteomic investigation of functional insight into special defined microbial starter on production of fermented rice with melanogenesis inhibition activity	PLOS ONE			English	Article							ASPERGILLUS-ORYZAE; LACTIC-ACID; TYROSINASE; GLUTATHIONE; METABOLITES; COMPONENTS; SESAMIN; EXTRACT; PROTEIN; SKIN	Fermentation of rice grains requires diverse metabolic enzymes to be synchronously synthesized by the microbial community. Although many studies have used a metaproteomic approach to investigate the roles of microorganisms in improving the flavor of fermented foods, their roles in producing compounds with biological activity have not yet been reported. In a previous study the ferment obtained from unpolished black rice (UBR) fermented with a defined microbial starter (De-E11), comprised of Rhizopus oryzae, Saccharomycopsis fibuligera, Saccharomyces cerevisiae, and Pediococcus pentosaceus, (fermented UBR; FUBR) showed a strong melanogenesis inhibition activity in B16F10 melanoma cells. Hence, in this study, the roles of these microorganisms in producing the melanogenesis inhibitor(s) in FUBR was investigated using a metaproteomic approach. The melanogenesis inhibition activity of the FUBR liquid (FR-Liq) was found to increase with longer fermentation times. R. oryzae and S. cerevisiae were the major hosts of proteins related to the biosynthesis of melanogenesis inhibitor(s) in the FUBR. During fermentation, the enzymes involved in the degradation of UBR and in the carbohydrate metabolic process were identified. These enzymes were associated with the process of releasing of bioactive compound(s) from UBR and the synthesis of organic acids from the microorganisms, respectively. In addition, enzymes involved in the synthesis of some known melanogenesis inhibitor(s) and in the degradation of the melanogenesis stimulator (arsenate) were detected. Varying the combination of microorganisms in the De-E11 starter to produce the FR-Liq revealed that all four microorganisms were required to produce the most potent melanogenesis inhibition activity. Taken together with the metaproteomics results, this suggested that the microorganisms in De-E11 synchronously synthesize the FR-Liq with melanogenesis inhibition activity. In conclusion, this information on the metaproteome in FUBR will increase our understanding of the microbial metabolic modes and could lead to knowledge-based improvements in the fermented rice process to produce melanogenesis inhibitor(s).	[Sangkaew, Orrarat; Yompakdee, Chulee] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Phaonakrop, Narumon; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Funct Ingredients & Food Innovat Res Grp, Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathumthani, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Yompakdee, C (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.	chulee.y@chula.ac.th		Roytrakul, Sittiruk/0000-0003-3696-8390; Yompakdee, Chulee/0000-0003-4690-4809	Grant for Innovation of Chulalongkorn University Fund [CU-GI_62_02_23_01]	Grant for Innovation of Chulalongkorn University Fund	This research was obtained financial support from Grant for Innovation of Chulalongkorn University Fund (https://www.research.chula.ac.th/funds/5804/), grant no. CU-GI_62_02_23_01 to CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J AM GERIATR SOC; [Anonymous], 2016, BALKAN J GEOM APPL, V21, piii; [Anonymous], 2010, NATURE MAT, V9, pS5; Aoki Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1879, DOI 10.1271/bbb.70099; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Benabda O, 2019, J CHEM-NY, V2019, DOI 10.1155/2019/3738181; Biterova EI, 2009, J BIOL CHEM, V284, P32700, DOI 10.1074/jbc.M109.025114; Blandino A, 2003, FOOD RES INT, V36, P527, DOI 10.1016/S0963-9969(03)00009-7; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Cerda A, 2013, FOOD CHEM, V139, P138, DOI 10.1016/j.foodchem.2012.12.044; Chang TS, 2012, MATERIALS, V5, P1661, DOI 10.3390/ma5091661; Chen, 2013, MODERN SOLID STATE F, DOI [10.1007/978-94-007-6043-1, DOI 10.1007/978-94-007-6043-1]; Chen YM, 2013, J FUNCT FOODS, V5, P395, DOI 10.1016/j.jff.2012.11.012; Dang Lelamurni A. R., 2017, Journal of the Saudi Society of Agricultural Sciences, V16, P127, DOI 10.1016/j.jssas.2015.04.001; Digre KB, 2019, HEADACHE, V59, P1, DOI 10.1111/head.13456; Gagnaire V, 2004, INT J FOOD MICROBIOL, V94, P185, DOI 10.1016/j.ijfoodmicro.2004.01.010; Garcia-Molina F, 2011, J AGR FOOD CHEM, V59, P1383, DOI 10.1021/jf1035433; Guldener U, 2004, MOL BIOL CELL, V15, P3811, DOI 10.1091/mbc.E03-09-0680; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Huang YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01747; Ji CF, 2017, LWT-FOOD SCI TECHNOL, V80, P479, DOI 10.1016/j.lwt.2017.03.022; Jun HJ, 2011, FOOD SCI BIOTECHNOL, V20, P1051, DOI 10.1007/s10068-011-0143-1; Kim MJ, 2013, FOOD RES INT, V53, P670, DOI 10.1016/j.foodres.2012.12.053; Kiriyama K, 2012, APPL MICROBIOL BIOT, V96, P1021, DOI 10.1007/s00253-012-4075-3; Koseki T, 1996, J FERMENT BIOENG, V82, P46, DOI 10.1016/0922-338X(96)89453-0; Kum SJ, 2015, J AGR FOOD CHEM, V63, P1401, DOI 10.1021/jf5056002; Kwak YJ, 2011, BIOSCI BIOTECH BIOCH, V75, P841, DOI 10.1271/bbb.100641; Langner HW, 2000, ENVIRON SCI TECHNOL, V34, P3131, DOI 10.1021/es991414z; LEE JW, 2017, FASEB J S1, V31, DOI DOI 10.1096/FASEBJ.31.1_SUPPLEMENT.972.7; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Lin YW, 2008, PROCESS BIOCHEM, V43, P244, DOI 10.1016/j.procbio.2007.11.020; Luangkhlaypho A, 2014, SCIENCEASIA, V40, P125, DOI 10.2306/scienceasia1513-1874.2014.40.125; Miyake Y, 2005, J AGR FOOD CHEM, V53, P22, DOI 10.1021/jf048743h; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; Nakajima H, 2014, ARCH DERMATOL RES, V306, P37, DOI 10.1007/s00403-013-1376-z; Nakano D, 2006, J PHARMACOL EXP THER, V318, P328, DOI 10.1124/jpet.105.100149; Nam DH, 2011, J FOOD SCI, V76, pH194, DOI 10.1111/j.1750-3841.2011.02350.x; Nigam P, 2009, SOLID STATE FERMENTA, P197; Oberst L, 2018, ARSENIC RICE CONCERN; Ochiai A, 2016, J NAT PROD, V79, P2545, DOI 10.1021/acs.jnatprod.6b00449; Onuma K, 2015, NUTRIENTS, V7, P10237, DOI 10.3390/nu7125531; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Pinelo M, 2006, TRENDS FOOD SCI TECH, V17, P579, DOI 10.1016/j.tifs.2006.05.003; Plaitho Y., 2013, Journal of Medicinal Plants Research, V7, P91; Ponnusamy K, 2013, BIOSCI BIOTECH BIOCH, V77, P683, DOI 10.1271/bbb.120665; Sangkaew O, 2020, J MICROBIOL BIOTECHN, V30, P1184, DOI 10.4014/jmb.2003.03019; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Seo Jae Ok, 2016, Natural Product Sciences, V22, P168, DOI 10.20307/nps.2016.22.3.168; Shin HW, 2016, J FOOD SCI TECH MYS, V53, P1004, DOI 10.1007/s13197-015-2162-z; Taechavansonyoo A, 2013, ASIAN J FOOD AGROIND, V6, P24; Tamang JP, 2015, HLTH BENEFITS FERMEN, DOI DOI 10.1201/B18279; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Usuki A, 2003, EXP DERMATOL, V12, P43, DOI 10.1034/j.1600-0625.12.s2.7.x; Vattem DA, 2003, PROCESS BIOCHEM, V39, P367, DOI 10.1016/S0032-9592(03)00089-X; Walker GM, 2016, BEVERAGES, V2, DOI 10.3390/beverages2040030; Xie MX, 2019, J SCI FOOD AGR, V99, P6522, DOI 10.1002/jsfa.9932; Yajima I, 2017, ARCH TOXICOL, V91, P3507, DOI 10.1007/s00204-017-1975-0; Zarubina IV, 2012, B EXP BIOL MED+, V153, P336, DOI 10.1007/s10517-012-1709-5; Zhang B, 2012, FOOD CHEM, V134, P387, DOI 10.1016/j.foodchem.2012.02.057; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10117	61	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241819	10.1371/journal.pone.0241819	http://dx.doi.org/10.1371/journal.pone.0241819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147601	Green Published, gold			2022-12-26	WOS:000589609300057
J	Tichelman, E; Henrichs, J; Schellevis, FG; Berger, MY; Burger, H				Tichelman, Elke; Henrichs, Jens; Schellevis, Francois G.; Berger, Marjolein Y.; Burger, Huibert			Development of a risk classification model in early pregnancy to screen for suboptimal postnatal mother-to-infant bonding: A prospective cohort study	PLOS ONE			English	Article							ADULT ATTACHMENT STYLE; MATERNAL-FETAL ATTACHMENT; DEPRESSION; ASSOCIATIONS; STABILITY; SYMPTOMS; DELIVERY; VALIDITY; ANXIETY; SCALE	Background Previous studies identified demographic, reproduction-related and psychosocial correlates of suboptimal mother-to-infant bonding. Their joint informative value was still unknown. This study aimed to develop a multivariable model to screen early in pregnancy for suboptimal postnatal mother-to-infant bonding and to transform it into a risk classification model. Methods Prospective cohort study conducted at 116 midwifery centers between 2010-2014. 634 women reported on the Mother-to-Infant Bonding questionnaire in 2015-2016. A broad range of determinants before 13 weeks of gestation were considered. Missing data were described, analyzed and imputed by multiple imputation. Multivariable logistic regression with backward elimination was used to develop a screening model. The explained variance, the Area Under the Curve of the final model were calculated and a Hosmer and Lemeshow test performed. Finally, we designed a risk classification model. Results The prevalence of suboptimal mother-to-infant bonding was 11%. The estimated probability of suboptimal mother-to-infant can be calculated: P(MIBS >= 4) = 1/(1+exp(-(-4.391+(parityx 0.519)+(Adult attachment avoidance scorex 0.040))). The explained variance was 14% and the Area Under the Curve was 0.750 (95%CI 0.690-0.809). The Hosmer and Lemeshow test had a p-value of 0.21. This resulted in a risk classification model. Conclusion Parity and adult attachment avoidance were the strongest independent determinants. Higher parity and higher levels of adult attachment avoidance are associated with an increased risk of suboptimal mother-to-infant bonding. The model and risk classification model should be externally validated and optimized before use in daily practice. Future research should include an external validation study, a study into the additional value of non-included determinants and finally a study on the impact and feasibility of the screening model.	[Tichelman, Elke; Henrichs, Jens] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Midwifery Sci, AVAG, Amsterdam, Netherlands; [Tichelman, Elke; Berger, Marjolein Y.; Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands; [Schellevis, Francois G.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, Amsterdam UMC, Amsterdam, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Burger, Huibert] Univ Amsterdam, Amsterdam Univ Med Ctr, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Groningen; University of Amsterdam; Vrije Universiteit Amsterdam; Netherlands Institute for Health Services Research; University of Amsterdam; Academic Medical Center Amsterdam	Tichelman, E (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Midwifery Sci, AVAG, Amsterdam, Netherlands.; Tichelman, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands.	e.tichelman@umcg.nl	Henrichs, Jens/H-7678-2013	Henrichs, Jens/0000-0003-2238-4060; Tichelman, Elke/0000-0002-4690-6188	Midwifery Academy Amsterdam Groningen; department of Midwifery Science	Midwifery Academy Amsterdam Groningen; department of Midwifery Science	This work was funded by the Midwifery Academy Amsterdam Groningen and the department of Midwifery Science which is located in Amsterdam (VU Medical Center Amsterdam) and Groningen (University Medical Center Groningen). The funding organizations had no role in study design, data collection, analysis, interpretation, in writing of the paper, or in the decision to submit the paper for publication.; We thank all participating primary and secondary obstetric care centers for the screening of participants, and all women for their participation. We also thank the International Confederation of Midwives for awarding our research proposal [53].	Aceti F, 2012, J PSYCHOPATHOL-G PSI, V18, P328; Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Alhusen JL, 2008, JOGNN-J OBST GYN NEO, V37, P315, DOI 10.1111/j.1552-6909.2008.00241.x; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Benoit Diane, 2004, Paediatr Child Health, V9, P541; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bienfait M, 2011, EARLY HUM DEV, V87, P281, DOI 10.1016/j.earlhumdev.2011.01.031; Bifulco A, 2006, SOC PSYCH PSYCH EPID, V41, P796, DOI 10.1007/s00127-006-0101-z; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Cannella BL, 2005, J ADV NURS, V50, P60, DOI 10.1111/j.1365-2648.2004.03349.x; Cowan PA, 2019, ATTACH HUM DEV, V21, P532, DOI 10.1080/14616734.2019.1582600; Cunen NB, 2017, WOMEN BIRTH, V30, pE141, DOI 10.1016/j.wombi.2016.11.005; de Cock ESA, 2017, J CHILD FAM STUD, V26, P1723, DOI 10.1007/s10826-017-0679-7; de Cock ESA, 2016, J FAM PSYCHOL, V30, P125, DOI 10.1037/fam0000138; Farre-Sender B, 2018, ARCH WOMEN MENT HLTH, V21, P287, DOI 10.1007/s00737-017-0785-y; Furukawa TA, 1999, SOC PSYCH PSYCH EPID, V34, P216, DOI 10.1007/s001270050136; Gobel A, 2019, MIDWIFERY, V79, DOI 10.1016/j.midw.2019.102549; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kinsey CB, 2013, MIDWIFERY, V29, P1314, DOI 10.1016/j.midw.2012.12.019; Kooiman CG, 2013, J PERS ASSESS, V95, P217, DOI 10.1080/00223891.2012.740540; Le Bas GA, 2020, SOC DEV, V29, P3, DOI 10.1111/sode.12392; Lindgren K, 2001, RES NURS HEALTH, V24, P203, DOI 10.1002/nur.1023; Malm MC, 2016, WOMEN BIRTH, V29, P482, DOI 10.1016/j.wombi.2016.04.005; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mason ZS, 2011, J REPROD INFANT PSYC, V29, P382, DOI 10.1080/02646838.2011.629994; Matsunaga A, 2017, EARLY HUM DEV, V111, P1, DOI 10.1016/j.earlhumdev.2017.04.008; McConnell M, 2011, AUST J EDUC DEV PSYC, V11, P60; Meijer JL, 2014, MIDWIFERY, V30, P526, DOI 10.1016/j.midw.2013.06.008; Meijer JL, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-157; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Ng KM, 2006, FAM J, V14, P430, DOI 10.1177/1066480706290976; Nordahl D, 2020, BMC PSYCHOL, V8, DOI 10.1186/s40359-020-00424-2; O'Higgins M, 2013, ARCH WOMEN MENT HLTH, V16, P381, DOI 10.1007/s00737-013-0354-y; Obegi JH, 2004, J SOC PERS RELAT, V21, P625, DOI 10.1177/0265407504045891; Or Nick H. K., 2017, POLICY STUDIES J, V45, pS67; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Roseth I, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1490621; Schmid B, 2011, J PSYCHIATR RES, V45, P1387, DOI 10.1016/j.jpsychires.2011.05.010; Slagt-Tichelman E, 2019, TIJDSCHR VERLOS, V3, P16; Stern JA, 2018, DEV PSYCHOL, V54, P975, DOI 10.1037/dev0000481; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tichelman E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222998; Tichelman E, 2019, MIDWIFERY, V69, P76, DOI 10.1016/j.midw.2018.10.021; van Bussel JCH, 2010, ARCH WOMEN MENT HLTH, V13, P373, DOI 10.1007/s00737-009-0140-z; Van den Bergh B, 2009, J REPROD INFANT PSYC, V27, P114, DOI 10.1080/02646830802007480; van Diepen M, 2017, NEPHROL DIAL TRANSPL, V32, P1, DOI 10.1093/ndt/gfw459; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Widom CS, 2018, CHILD ABUSE NEGLECT, V76, P533, DOI 10.1016/j.chiabu.2017.05.002; Yarcheski A, 2009, INT J NURS STUD, V46, P708, DOI 10.1016/j.ijnurstu.2008.10.013; Zanardo V, 2016, EARLY HUM DEV, V99, P17, DOI 10.1016/j.earlhumdev.2016.05.006	53	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241574	10.1371/journal.pone.0241574	http://dx.doi.org/10.1371/journal.pone.0241574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147253	Green Published, gold			2022-12-26	WOS:000589609300036
J	Zhou, J; Zhang, JY; Zhou, J; Yi, HG; Lin, ZC; Liu, Y; Zhu, M; Wang, HY; Zhang, W; Xu, H; Jiang, HP; Xiang, ZZ; Qu, Z; Yang, YM; Lu, LJ; Guo, S; Fu, H; Adcock, IM; Wei, Y; Yao, X				Zhou, Ji; Zhang, Jingying; Zhou, Juan; Yi, Honggang; Lin, Zichen; Liu, Yu; Zhu, Min; Wang, Hongyu; Zhang, Wei; Xu, Hai; Jiang, Hangping; Xiang, Zhengzhong; Qu, Ze; Yang, Yuemei; Lu, Linjuan; Guo, Shuai; Fu, Heng; Adcock, Ian M.; Wei, Yu; Yao, Xin			Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: A retrospective cohort study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SARS	A cluster of patients with coronavirus disease 2019 (COVID-19) underwent repeated positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA tests after they were discharged from the hospital. We referred to them as re-positive (RP) patients in this study. We aimed to describe the clinical characteristics of these patients in a retrospective cohort study. After being treated for COVID-19, the patients underwent 14 days of quarantine following their discharge from the Huangshi Hospital of Traditional Chinese Medicine and the Huangshi Hospital of Youse. Two additional sequential SARS-CoV-2 RNA tests were performed at the end of quarantine. The median age of the 368 patients was 51 years, and 184 (50%) patients were female. A total of 23 RP patients were observed at follow-up. Using multivariate Cox regression analysis, risk factors associated with RP included a higher ratio of lymphocyte/white blood cell on admission (adjusted HR 7.038; 95% CI, 1.911-25.932; P = 0.0034), lower peak temperature during hospitalization (adjusted HR, 0.203; 95% CI, 0.093-0.443; P<0.0001), and the presence of comorbidities, particularly hypertension or chronic diseases in the respiratory system (adjusted HR, 3.883; 95% CI, 1.468-10.273; P = 0.0063). Antivirus treatment with arbidol was associated with a lower likelihood of re-positive outcomes (adjusted HR, 0.178; 95% CI, 0.045-0.709; P = 0.0144).	[Zhou, Ji; Zhang, Jingying; Zhou, Juan; Yao, Xin] Nanjing Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanjing, Peoples R China; [Zhou, Ji; Yao, Xin] Huangshi Hosp Tradit Chinese Med, Huangshi, Hubei, Peoples R China; [Zhang, Jingying; Wei, Yu] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Resp Med, Affiliated Hosp, Nanjing, Peoples R China; [Zhou, Juan] Nantong Univ, Dept Resp & Crit Care Med, Affiliated Hosp, Nantong, Peoples R China; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Peoples R China; [Lin, Zichen; Zhu, Min; Wang, Hongyu; Yang, Yuemei; Lu, Linjuan; Guo, Shuai; Fu, Heng] Nanjing Med Univ, Dept Internal Med, Nanjing, Peoples R China; [Liu, Yu] Jurong Ctr Dis Control & Prevent, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Wei; Xu, Hai] Nanjing Med Univ, Dept Radiol, Affiliated Hosp 1, Nanjing, Peoples R China; [Jiang, Hangping] Huangshi Hosp Youse, Dept Cardiol, Huangshi, Hubei, Peoples R China; [Xiang, Zhengzhong] Huangshi Hosp Youse, Dept Resp, Huangshi, Hubei, Peoples R China; [Qu, Ze] Huangshi Hosp Youse, Dept Med Serv, Huangshi, Hubei, Peoples R China; [Adcock, Ian M.] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England	Nanjing Medical University; Nanjing University of Chinese Medicine; Nantong University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Imperial College London	Yao, X (corresponding author), Nanjing Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanjing, Peoples R China.; Yao, X (corresponding author), Huangshi Hosp Tradit Chinese Med, Huangshi, Hubei, Peoples R China.; Wei, Y (corresponding author), Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Resp Med, Affiliated Hosp, Nanjing, Peoples R China.	jsszyyhxk@163.com; yaoxin@njmu.edu.cn		Adcock, Ian/0000-0003-2101-8843				Abbasi J, 2020, JAMA-J AM MED ASSOC, V323, P1881, DOI 10.1001/jama.2020.6170; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072; Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gravitt PE, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100267; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Islam N, 2017, LANCET GASTROENTEROL, V2, P200, DOI 10.1016/S2468-1253(16)30182-0; Kang HYJ, 2020, J MED VIROL, V92, P2263, DOI 10.1002/jmv.26114; Kang YJ, 2020, DISASTER MED PUBLIC, V14, P762, DOI 10.1017/dmp.2020.168; Khamitov R. A., 2008, Voprosy Virusologii, V53, P9; Li DS, 2020, KOREAN J RADIOL, V21, P505, DOI 10.3348/kjr.2020.0146; Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, COR DIS COVID 19 OUT; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	28	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241896	10.1371/journal.pone.0241896	http://dx.doi.org/10.1371/journal.pone.0241896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147282	Green Published, gold			2022-12-26	WOS:000589609300033
J	Alula, KM; Delgado-Deida, Y; Jackson, DN; Venuprasad, K; Theiss, AL				Alula, Kibrom M.; Delgado-Deida, Yaritza; Jackson, Dakota N.; Venuprasad, K.; Theiss, Arianne L.			Nuclear partitioning of Prohibitin 1 inhibits Wnt/beta-catenin-dependent intestinal tumorigenesis	ONCOGENE			English	Article							BETA-CATENIN; PATHWAY; ACTIVATION; CELLS; AXIN; APC; EXPRESSION; CARCINOMA; PROTEINS; SURVIVAL	The Wnt/beta-catenin signaling pathway is aberrantly activated in the majority of colorectal cancer cases due to somatic mutations in the adenomatous polyposis coli (APC) gene. Prohibitin 1 (PHB1) serves pleiotropic cellular functions with dynamic subcellular trafficking, facilitating signaling crosstalk between organelles. Nuclear-localized PHB1 is an important regulator of gene transcription. Using mice with inducible intestinal epithelial cell (IEC)-specific deletion of Phb1 (Phb1(i Delta IEC)) and mice with IEC-specific overexpression of Phb1 (Phb1Tg), we demonstrate that IEC-specific PHB1 combats intestinal tumorigenesis in the Apc(Min/+) mouse model by inhibiting Wnt/beta-catenin signaling. Forced nuclear accumulation of PHB1 in human RKO or SW48 CRC cell lines increased AXIN1 expression and decreased cell viability. PHB1 deficiency in CRC cells decreased AXIN1 expression and increased beta-catenin activation that was abolished by XAV939, a pharmacological AXIN stabilizer. These results define a role of PHB1 in inhibiting the Wnt/beta-catenin pathway to influence the development of intestinal tumorigenesis. Induction of nuclear PHB1 trafficking provides a novel therapeutic option to influence AXIN1 expression and the beta-catenin destruction complex in Wnt-driven intestinal tumorigenesis.	[Alula, Kibrom M.; Delgado-Deida, Yaritza; Theiss, Arianne L.] Univ Colorado, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Jackson, Dakota N.] Baylor Univ, Med Ctr, Baylor Scott & White Res Inst, Dept Internal Med,Div Gastroenterol, Dallas, TX USA; [Venuprasad, K.] Univ Texas Southwestern Med Ctr Dallas, Coll Med, Dallas, TX 75390 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor Health Care System; Baylor University; Baylor University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Theiss, AL (corresponding author), Univ Colorado, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA.	arianne.theiss@cuanschutz.edu		poojary, venuprasd/0000-0001-8986-9092	National Institutes of Health [R01-DK117001]; Litwin IBD Pioneers Crohn's Colitis Foundation [301869]; GI & Liver Innate Immune Program (GALIIP)-University of Colorado Anschutz	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Litwin IBD Pioneers Crohn's Colitis Foundation; GI & Liver Innate Immune Program (GALIIP)-University of Colorado Anschutz	We thank Jie Han (Baylor Scott & White Research Institute) for technical assistance. This work was supported by National Institutes of Health grants R01-DK117001 (ALT), Litwin IBD Pioneers Crohn's Colitis Foundation 301869 (ALT), and GI & Liver Innate Immune Program (GALIIP)-University of Colorado Anschutz (ALT).	Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Chen DB, 2010, INT J ONCOL, V37, P355, DOI 10.3892/ijo_00000684; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Chowdhury D, 2017, CURR DRUG TARGETS, V18, P1836, DOI 10.2174/1389450117666160824161225; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; Delgado-Deida Y, 2020, GASTROENTEROL REP, V8, P215, DOI 10.1093/gastro/goaa025; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hammoudi A, 2013, BIOCHEM BIOPH RES CO, V440, P364, DOI 10.1016/j.bbrc.2013.08.076; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Jackson DN, 2020, CANCER RES, V80, P3519, DOI 10.1158/0008-5472.CAN-20-0216; Jackson DN, 2020, GUT, V69, P1928, DOI 10.1136/gutjnl-2019-319523; Jackson DN, 2020, GUT MICROBES, V11, P285, DOI 10.1080/19490976.2019.1592421; Kathiria AS, 2012, CANCER RES, V72, P5778, DOI 10.1158/0008-5472.CAN-12-0603; Kim DM, 2017, ONCOL REP, V37, P3201, DOI 10.3892/or.2017.5599; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Ma LL, 2017, ONCOTARGET, V8, P76340, DOI 10.18632/oncotarget.19394; Mavila N, 2018, HEPATOL COMMUN, V2, P1583, DOI 10.1002/hep4.1257; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Schatoff EM, 2017, CURR COLORECT CANC R, V13, P101, DOI 10.1007/s11888-017-0354-9; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Tortelote GG, 2017, CELL SIGNAL, V40, P30, DOI 10.1016/j.cellsig.2017.08.008; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Wang D, 2020, CELL MOL LIFE SCI, V77, P3525, DOI 10.1007/s00018-020-03475-1; Wang ZH, 2016, GENETICS, V203, P269, DOI 10.1534/genetics.115.183244; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074; Zhou TB, 2013, J RECEPT SIG TRANSD, V33, P28, DOI 10.3109/10799893.2012.752006	41	4	4	3	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					369	383		10.1038/s41388-020-01538-y	http://dx.doi.org/10.1038/s41388-020-01538-y		NOV 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33144683	Green Accepted			2022-12-26	WOS:000585016500002
J	Tanveer, MH; Wu, XW; Thomas, A; Ming, C; Muller, R; Tokekar, P; Zhu, HX				Tanveer, M. Hassan; Wu, Xiaowei; Thomas, Antony; Ming, Chen; Mueller, Rolf; Tokekar, Pratap; Zhu, Hongxiao			A simulation framework for bio-inspired sonar sensing with Unmanned Aerial Vehicles	PLOS ONE			English	Article							INFERENCE; DYNAMICS; MODELS; RADAR; FORM	We introduce a unified simulation framework that generates natural sensing environments and produces biosonar echoes under various sensing scenarios. This framework produces rich sensory data with environmental information completely known, thus can be used for the training of robotic algorithms for biosonar-based Unmanned Aerial Vehicles. The simulated environment consists of random trees with full geometry of the tree foliage. To simulate a single tree, we adopt the Lindenmayer system to generate the initial branching pattern and integrate that with the available measurements of the 3D computer-aided design object files to create natural-looking branches, sub-branches, and leaves. A forest is formed by simulating trees at random locations generated by using an inhomogeneous Poisson process. While our simulated environments can be generally used for testing other sensors and training robotic algorithms, in this study we focus on testing bat-inspired Unmanned Aerial Vehicles that recreate bat's flying behavior through biosonar sensors. To this end, we also introduce an foliage echo simulator that produces biosonar echoes while mimicking bat's biosonar system. We demonstrate the application of the proposed simulation framework by generating real-world scenarios with multiple trees and computing the resulting impulse responses under static or dynamic motions of an Unmanned Aerial Vehicle.	[Wu, Xiaowei; Zhu, Hongxiao] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA; [Tanveer, M. Hassan] Kennesaw State Univ, Dept Robot & Mechatron Engn, Marietta, GA USA; [Thomas, Antony] Univ Genoa, DIBRIS, Genoa, Italy; [Ming, Chen] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Mueller, Rolf] Virginia Tech, Dept Mech Engn, Blacksburg, VA USA; [Tokekar, Pratap] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	Virginia Polytechnic Institute & State University; University System of Georgia; Kennesaw State University; University of Genoa; Brown University; Virginia Polytechnic Institute & State University; University System of Maryland; University of Maryland College Park	Zhu, HX (corresponding author), Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA.	hongxiao@vt.edu		Thomas, Antony/0000-0003-1285-0048	National Science Foundation of the United States [1762577]	National Science Foundation of the United States(National Science Foundation (NSF))	XW, RM, PT and HZ were funded by National Science Foundation of the United States grant number 1762577. URL: https://www.nsf.gov/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah R., 2019, THESIS U TECHNOLOGIE; Amato NM, 2019, INT J ROBOT RES, V38, P1327, DOI 10.1177/0278364919877027; Andrews MM, 2003, ACTA CHIROPTEROL, V5, P221, DOI 10.3161/001.005.0212; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Beigi MM, 2008, IEEE INT CONF ROBOT, P3270, DOI 10.1109/ROBOT.2008.4543709; Bogue R, 2015, IND ROBOT, V42, P98, DOI 10.1108/IR-11-2014-0409; Bowman JJ, 1987, ELECTROMAGNETIC ACOU; Carmena JM, 2001, P 9 INT S INT ROB SY, P467; Chiba N, 1997, J VISUAL COMP ANIMAT, V8, P191, DOI 10.1002/(SICI)1099-1778(199710/12)8:4<191::AID-VIS160>3.0.CO;2-1; Coleman D., 2015, P AM HE LICOPTER SOC, P5; CRESSIE N., 1994, METHODS EXPT PHYS, V28, P93; De Croon G, 2016, THE DELFLY; DEREFFYE P, 1995, AGROFOREST SYST, V30, P175, DOI 10.1007/BF00708920; Dey D, 2011, INT J ROBOT RES, V30, P1527, DOI 10.1177/0278364911412807; Duan HB, 2014, INT J INTELL COMPUT, V7, P24, DOI 10.1108/IJICC-02-2014-0005; Eliakim I, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006406; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; FIRBANK LG, 1985, J THEOR BIOL, V116, P291, DOI 10.1016/S0022-5193(85)80269-1; Flammer C, 2014, SPHEROIDAL WAVE FUNC; Folkertsma GA, 2017, IEEE ROBOT AUTOM MAG, V24, P22, DOI 10.1109/MRA.2016.2636368; Georgiev K, 2018, IET RADAR SONAR NAV, V12, P1402, DOI 10.1049/iet-rsn.2018.5241; GitHub I, 2017, OP SOURC SURV; Griffin DR, 1958, LISTENING DARK; Hamon L, 2012, VIRTUAL REAL-LONDON, V16, P151, DOI 10.1007/s10055-011-0193-y; HONDA H, 1971, J THEOR BIOL, V31, P331, DOI 10.1016/0022-5193(71)90191-3; Ijiri T, 2006, LECT NOTES COMPUT SC, V4073, P138; Leighton TG, 2012, IET RADAR SONAR NAV, V6, P507, DOI 10.1049/iet-rsn.2012.0146; LEWIS PAW, 1979, OPER RES, V27, P1026, DOI 10.1287/opre.27.5.1026; Linnenschmidt M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29222; Lo SY, 2018, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS AND MULTIAGENT SYSTEMS (AAMAS' 18), P220; Matias CN, 2012, MAGNESIUM RES, V25, P120, DOI 10.1684/mrh.2012.0317; Ming C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182824; Neyret F, 1996, EUR REND WORKSH, P215; PACALA SW, 1985, AM NAT, V125, P385, DOI 10.1086/284349; Papa U, 2015, 2015 2ND IEEE INTERNATIONAL WORKSHOP ON METROLOGY FOR AEROSPACE (METROAEROSPACE), P346, DOI 10.1109/MetroAeroSpace.2015.7180680; Paproki A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-63; Perttunen J, 2005, ECOL MODEL, V181, P479, DOI 10.1016/j.ecolmodel.2004.06.034; Prusinkiewicz P., 1988, Computer Graphics, V22, P141, DOI 10.1145/378456.378503; Ramezani A, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aal2505; Rao V. A., 2011, ADV NEURAL INFORM PR, P2474; Reeves W. T., 1985, Computer Graphics, V19, P313, DOI 10.1145/325165.325250; Reijniers J, 2004, FROM ANIMALS TO ANIMATS 8, P77; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schillebeeckx F, 2011, INT J ROBOT RES, V30, P975, DOI 10.1177/0278364910380474; Simmons JA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57632-4; Simpson D, 2016, BIOMETRIKA, V103, P49, DOI 10.1093/biomet/asv064; Tanveer MH, 2019, ROBOTICA, V37, P80, DOI 10.1017/S0263574718000875; Todd BD, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aa9a0f; van Lieshout MCNM, 2012, METHODOL COMPUT APPL, V14, P567, DOI 10.1007/s11009-011-9244-9; Wang MS, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON SAFETY, SECURITY AND RESCUE ROBOTS, P137; Wang MS, 2005, 2005 IEEE International Symposium on Computational Intelligence in Robotics and Automation, Proceedings, P3; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yamada Y, 2017, 2017 56TH ANNUAL CONFERENCE OF THE SOCIETY OF INSTRUMENT AND CONTROL ENGINEERS OF JAPAN (SICE), P3, DOI 10.23919/SICE.2017.8105502; Yamada Y, 2015, LECT NOTES ARTIF INT, V9222, P135, DOI 10.1007/978-3-319-22979-9_14; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; Zhou XD, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/041001	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241443	10.1371/journal.pone.0241443	http://dx.doi.org/10.1371/journal.pone.0241443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141848	Green Published, gold			2022-12-26	WOS:000588376700009
J	Abd-Elrahman, I; Nassar, T; Khairi, N; Perlman, R; Benita, S; Ben Yehuda, D				Abd-Elrahman, Ihab; Nassar, Taher; Khairi, Noha; Perlman, Riki; Benita, Simon; Ben Yehuda, Dina			Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma	ONCOGENE			English	Article							GAUSSIA LUCIFERASE; PROTEIN LIVIN; CD40 ANTIGEN; CANCER; APOPTOSIS; DELIVERY; RESISTANCE; INHIBITOR; THERAPY; SYSTEM	We previously showed that Livin, an inhibitor of apoptosis protein, is specifically cleaved to produce a truncated protein, tLivin, and demonstrated its paradoxical proapoptotic activity. We further demonstrated that mini-tLivin (MTV), a 70 amino acids derivative of tLivin, is a proapoptotic protein as potent as tLivin. Based on these findings, in this study we aimed to develop a venue to target MTV for the treatment of diffuse large B-cell lymphoma (DLBCL). MTV was conjugated to poly (lactide-co-glycolic acid) surface-activated nanoparticles (NPs). In order to target MTV-NPs we also conjugated CD40 ligand (CD40L) to the surface of the NPs and evaluated the efficacy of the bifunctional CD40L-MTV-NPs. In vitro, CD40L-MTV-NPs elicited significant apoptosis of DLBCL cells. In a disseminated mouse model of DLBCL, 37.5% of MTV-NPs treated mice survived at the end of the experiment. Targeting MTV-NPs using CD40L greatly improved survival and 71.4% of these mice survived. CD40L-MTV-NPs also greatly reduced CNS involvement of DLBCL. Only 20% of these mice presented infiltration of lymphoma to the brain in comparison to 77% of the MTV-NPs treated mice. In a subcutaneous mouse model, CD40L-MTV-NPs significantly reduced tumor volume in correlation with significant increased caspase-3 activity. Thus, targeted MTV-NPs suggest a novel approach to overcome apoptosis resistance in cancer.	[Abd-Elrahman, Ihab; Khairi, Noha; Perlman, Riki; Ben Yehuda, Dina] Hadassah Med Org, Dept Hematol, Jerusalem, Israel; [Nassar, Taher; Benita, Simon] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, Jerusalem, Israel; [Ben Yehuda, Dina] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ben Yehuda, D (corresponding author), Hadassah Med Org, Dept Hematol, Jerusalem, Israel.; Ben Yehuda, D (corresponding author), Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.	Dbyehuda@hadassah.org.il		abd-elrahman, ihab/0000-0003-2012-2024	Kamin Incentive Program, Israel Innovation Authority; Dorot foundation; Eleanor Fox; Aleen and David M. Epstein Fund for Hematology/oncology research	Kamin Incentive Program, Israel Innovation Authority; Dorot foundation; Eleanor Fox; Aleen and David M. Epstein Fund for Hematology/oncology research	We thank Galina Skarzinski for immunohistochemistry. This work was supported by Kamin Incentive Program, Israel Innovation Authority (DBY and SB), Dorot foundation (DBY), Eleanor Fox (DBY), and Aleen and David M. Epstein Fund for Hematology/oncology research (DBY).	Abd-Elrahman I, 2009, CANCER RES, V69, P5475, DOI 10.1158/0008-5472.CAN-09-0424; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Bicho A, 2010, INT J PHARMACEUT, V399, P80, DOI 10.1016/j.ijpharm.2010.08.005; Bierman P, 2005, HEMATOL ONCOL CLIN N, V19, P597, DOI 10.1016/j.hoc.2005.05.003; Bovenberg MSS, 2012, ANAL CHEM, V84, P1189, DOI 10.1021/ac202833r; Bugajska U, 2002, J NATL CANCER I, V94, P1381; Calimeri T., 2019, ANN LYMPHOMA, V3, P7, DOI DOI 10.21037/AOL.2019.06.01; Carreno BM, 2009, CLIN CANCER RES, V15, P3277, DOI 10.1158/1078-0432.CCR-08-2502; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chavez JC, 2019, THER ADV HEMATOL, V10, DOI 10.1177/2040620719841581; Chen WC, 2010, BLOOD, V115, P4778, DOI 10.1182/blood-2009-12-257386; Choi J, 2007, BLOOD, V109, P471, DOI 10.1182/blood-2006-07-032557; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; Foo J, 2014, J THEOR BIOL, V355, P10, DOI 10.1016/j.jtbi.2014.02.025; FUNAKOSHI S, 1994, BLOOD, V83, P2787, DOI 10.1182/blood.V83.10.2787.2787; Georgopoulos NT, 2007, INT J CANCER, V121, P1373, DOI 10.1002/ijc.22846; Ghose A, 2015, CL LYMPH MYELOM LEUK, V15, P451, DOI 10.1016/j.clml.2015.02.026; Girotti MR, 2013, CANCER DISCOV, V3, P487, DOI 10.1158/2159-8290.CD-13-0131; Goldstein D, 2007, BIOMED PHARMACOTHER, V61, P97, DOI 10.1016/j.biopha.2006.08.005; Harush-Frenkel O, 2010, TOXICOL APPL PHARM, V246, P83, DOI 10.1016/j.taap.2010.04.011; Hostager BS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00376; Huang LF, 2020, BIOMATER SCI-UK, V8, P2376, DOI 10.1039/d0bm00129e; Inoue Y, 2011, MOL IMAGING, V10, P377, DOI 10.2310/7290.2010.00057; Jia J, 2015, MOL MED REP, V11, P1623, DOI 10.3892/mmr.2014.2953; Jin Y, 2010, MOL PHARMACEUT, V7, P196, DOI 10.1021/mp900205r; Karra N, 2013, SMALL, V9, P4221, DOI 10.1002/smll.201301417; Kojima C, 2013, NANOMED-NANOTECHNOL, V9, P767, DOI 10.1016/j.nano.2013.01.004; Lazar I, 2012, ONCOLOGY-BASEL, V82, P197, DOI 10.1159/000334234; Liang XJ, 2010, METHODS MOL BIOL, V596, P467, DOI 10.1007/978-1-60761-416-6_21; Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Milane L, 2011, MOL PHARMACEUT, V8, P185, DOI 10.1021/mp1002653; Muhamad N, 2018, INT J NANOMED, V13, P3921, DOI 10.2147/IJN.S165210; Nachmias B, 2004, SEMIN CANCER BIOL, V14, P231, DOI 10.1016/j.semcancer.2004.04.002; Nachmias B, 2003, CANCER RES, V63, P6340; Nachmias B, 2007, APOPTOSIS; Nagamitsu A, 2009, JPN J CLIN ONCOL, V39, P756, DOI 10.1093/jjco/hyp074; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Phongpradist R, 2010, CURR PHARM DESIGN, V16, P2321, DOI 10.2174/138161210791920450; Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schultze J, 1999, LANCET, V354, P1225, DOI 10.1016/S0140-6736(99)90130-7; SCHULTZE JL, 1995, P NATL ACAD SCI USA, V92, P8200, DOI 10.1073/pnas.92.18.8200; Shi JQ, 2012, MOL CANCER THER, V11, P2045, DOI 10.1158/1535-7163.MCT-11-1036; Shiloach T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101075; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Stiff PJ, 2013, NEW ENGL J MED, V369, P1681, DOI 10.1056/NEJMoa1301077; Szocinski JL, 2002, BLOOD, V100, P217, DOI 10.1182/blood.V100.1.217; T Georgopoulos N, 2006, CELL DEATH DIFFER, V13, P1789, DOI 10.1038/sj.cdd.4401859; UCKUN FM, 1990, BLOOD, V76, P2449; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang SN, 2010, BIOSENS BIOELECTRON, V26, P778, DOI 10.1016/j.bios.2010.06.025; Wennhold K, 2017, ONCOTARGET, V8, P27740, DOI 10.18632/oncotarget.7720; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Young LS, 1998, IMMUNOL TODAY, V19, P502, DOI 10.1016/S0167-5699(98)01340-1	61	0	0	5	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					334	344		10.1038/s41388-020-01529-z	http://dx.doi.org/10.1038/s41388-020-01529-z		OCT 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33128043				2022-12-26	WOS:000585769600001
J	Fu, YQ; Sun, YL; Lu, SW; Yang, Y; Wang, Y; Xu, F				Fu, Yue-Qiang; Sun, Yue-Lin; Lu, Si-Wei; Yang, Yang; Wang, Yi; Xu, Feng			Effect of blood analysis and immune function on the prognosis of patients with COVID-19	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; PNEUMONIA; WUHAN; SARS	Introduction This retrospective study investigated the implications of changes in blood parameters and cellular immune function in patients with Coronavirus Disease 2019 (COVID-19). Methods Records were reviewed of 85 patients admitted with COVID-19 between February 4 and 16, 2020. The primary outcome was in-hospital death. Results Fourteen patients died. The baseline leukocyte count, neutrophil count and hemoglobin was significantly higher in non-survivors compared with survivors, while the reverse was true of lymphocyte count, platelet, PaO2/FiO(2), CD3+ count and CD4+ count. The percentage of neutrophil count > 6.3x10(9)/L in death group was significantly higher than that in survival group, and multivariate logistic regression showed neutrophil count > 6.3x10(9)/L was independently associated with mortality. However, there were not significant difference in IgG, IgM, IgA, C3, C4 and the percentage of IgE > 100 IU/ml between the death group and survival group. Areas under the receiver operating characteristic curves of the following at baseline could significantly predict mortality: leukocyte, neutrophil, lymphocyte, CD3+ and CD4+ counts. Conclusions For hospitalized patients with COVID-19, lymphocyte, CD3+ and CD4+ counts that marked decrease suggest a poor outcome. Admission neutrophil count > 6.3 x10(9)/L is independently associated with mortality. At admission, leukocyte, neutrophil, lymphocyte, CD3+ and CD4+ counts should receive added attention.	[Fu, Yue-Qiang; Sun, Yue-Lin; Lu, Si-Wei; Wang, Yi; Xu, Feng] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Fu, Yue-Qiang; Wang, Yi] Third Batch Chongqing Med Aid Team Wuhan City Hub, Chongqing, Peoples R China; [Fu, Yue-Qiang; Sun, Yue-Lin; Lu, Si-Wei; Wang, Yi; Xu, Feng] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Fu, Yue-Qiang; Sun, Yue-Lin; Lu, Si-Wei; Wang, Yi; Xu, Feng] Natl Clin Res Ctr Child Hlth & Disorders Chongqin, Chongqing, Peoples R China; [Yang, Yang] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Peoples R China	Chongqing Medical University; Wuhan University	Xu, F (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China.; Xu, F (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Xu, F (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders Chongqin, Chongqing, Peoples R China.	400500@hospital.cqmu.edu.cn		Yang, Yang/0000-0002-6307-1602	Medjaden Academy AMP; Research Foundation for Young Scientists [COVID-19MJA20200323]; clinical research project of COVID-19 in Chongqing Medical University [0064]	Medjaden Academy AMP; Research Foundation for Young Scientists; clinical research project of COVID-19 in Chongqing Medical University	This project was supported by the Medjaden Academy & Research Foundation for Young Scientists (Grant No. COVID-19MJA20200323) and the clinical research project of COVID-19 in Chongqing Medical University (Grant No. 0064).	[Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2020, LANCET, V395, P507; [Anonymous], 2008, CHEM BIOL DRUG DES, V71, P298; Chang HL, 2006, J FORMOS MED ASSOC, V105, P439, DOI 10.1016/S0929-6646(09)60183-2; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Deng YT, 2020, CAMB CHINA LIBR, P1; Eickmann M, 2020, VOX SANG, V115, P146, DOI 10.1111/vox.12888; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo LX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02752; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lam Christopher W K, 2004, Clin Biochem Rev, V25, P121; Leong HN, 2006, ANN ACAD MED SINGAP, V35, P326; Li TS, 2003, CHINESE MED J-PEKING, V116, P985; Novel CPERE, 2020, CHINA CDC WEEKLY, V41, P145, DOI [DOI 10.1056/NEJMcp2009249, 10.4258/hir.2022.28.2.160]; Pilaczynska-Cemel M, 2019, CENT EUR J IMMUNOL, V44, P292, DOI 10.5114/ceji.2019.87498; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Tang XP, 2003, CHINESE MED J-PEKING, V116, P827; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; World Health Organization, COR DIS COVID 19 OUT; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yuan ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230548; Zhang GM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01338-8; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238	26	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240751	10.1371/journal.pone.0240751	http://dx.doi.org/10.1371/journal.pone.0240751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125396	Green Published, gold, Green Submitted			2022-12-26	WOS:000588368900011
J	Kim, JH; Lee, J				Kim, Jong-Hyun; Lee, Jung			Controlling your contents with the breath: Interactive breath interface for VR, games, and animations	PLOS ONE			English	Article							VIRTUAL OBJECTS	In this paper, we propose a new interface to control VR(Virtual reality) contents, games, and animations in real-time using the user's breath and the acceleration sensor of a mobile device. Although interaction techniques are very important in VR and physically-based animations, UI(User interface) methods using different types of devices or controllers have not been covered. Most of the proposed interaction techniques have focused on screen touch and motion recognition. The direction of the breath is calculated using the position and angle between the user and the mobile device, and the control position to handle the contents is determined using the acceleration sensor built into the mobile device. Finally, to remove the noise contained in the input breath, the magnitude of the wind is filtered using a kernel modeling a pattern similar to the actual breath. To demonstrate the superiority of this study, we produced real-time interaction results by applying the breath as an external force of VR contents, games, and animations.	[Kim, Jong-Hyun] Kangnam Univ, Sch Software Applicat, Yongin, Gyeonggi, South Korea; [Lee, Jung] Hallym Univ, Sch Software, Chunchon, Gangwon, South Korea	Kangnam University; Hallym University	Lee, J (corresponding author), Hallym Univ, Sch Software, Chunchon, Gangwon, South Korea.	airjung@hallym.ac.kr		Lee, Jung/0000-0003-0458-1474; Kim, Jong-Hyun/0000-0003-1603-2675	Ministry of Science, ICT & Future Planning [2017R1C1B5074984]; Hallym University Research Fund [HRF-201909-018]; Basic Science Research Program through the National Research Foundation of Korea(NRF)	Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Hallym University Research Fund; Basic Science Research Program through the National Research Foundation of Korea(NRF)(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) and funded by the Ministry of Science, ICT & Future Planning (No.2017R1C1B5074984). This research was also supported by a Hallym University Research Fund (HRF-201909-018).	Abduo M, 2015, MYO GESTURE CONTROL; Anders Henrysson, 2005, P 2005 INT C AUGM TE, P164, DOI DOI 10.1145/1152399.1152430; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Arisandi R, 2014, P IEEE, V102, P185, DOI 10.1109/JPROC.2013.2294243; Asteriadis S., 2013, P 6 INT C COMP VIS C, P1, DOI DOI 10.1145/2466715.2466727; Bharath VG, 2018, MATEC WEB CONF, V144, DOI 10.1051/matecconf/201814401008; Cai WW, 2014, ROTATING ELECTRODE METHODS AND OXYGEN REDUCTION ELECTROCATALYSTS, P33, DOI 10.1016/B978-0-444-63278-4.00002-1; Cakmak T., 2014, ACM SIGGRAPH 2014 EM, DOI [10.1145/2614066.2614105, DOI 10.1145/2614066.2614105]; Carvalheiro C, 2016, MM'16: PROCEEDINGS OF THE 2016 ACM MULTIMEDIA CONFERENCE, P1146, DOI 10.1145/2964284.2964293; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, JJAAM, V28, ps1; Han S, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9020022; Hincapie-Ramos J.D., 2013, P SIGCHI C HUMAN FAC, P3385, DOI DOI 10.1145/2470654.2466463; Hoffman HG, 1998, P IEEE VIRT REAL ANN, P59, DOI 10.1109/VRAIS.1998.658423; Jayasiri A, 2015, P IEEE VIRT REAL ANN, P199, DOI 10.1109/VR.2015.7223364; Jeong K, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12010053; Kang H, 2019, 25TH ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY (VRST 2019), DOI [10.1109/IVEC.2019.8744769, 10.1145/3359996.3364256]; Katzakis N., 2013, P 11 ASIA PACIFIC C, P199, DOI [10.1145/2525194.2525275, DOI 10.1145/2525194.2525275]; Ken Hinckley, 2000, S US INT SOFTW TECHN, V2000, P91; Kenji Sugihara, 2011, P 24 ANN ACM S ADJ U, P13; Kim M, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9090189; Kitamura Y, 1999, P IEEE VIRT REAL ANN, P198, DOI 10.1109/VR.1999.756951; Lindemann P, 2017, P IEEE VIRT REAL ANN, P305, DOI 10.1109/VR.2017.7892298; Liu XF, 2017, IEEE T MOBILE COMPUT, V16, P394, DOI 10.1109/TMC.2016.2550447; Marat Shigapov, 2018, IEEE E W DES TEST S, P1; Nicholas Katzakis, 2011, P 74 HIS SIGVR WORKS; Pfeiffer, 2011, THESIS; Pfeiffer T, 2012, IEEE VIRTUAL REALITY CONFERENCE 2012 PROCEEDINGS, P83, DOI 10.1109/VR.2012.6180893; Potter L E, 2013, P 25 AUSTR COMP HUM, P175, DOI DOI 10.1145/2541016.2541072; Rawat S, 2016, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON SYSTEM MODELING & ADVANCEMENT IN RESEARCH TRENDS (SMART-2016), P115, DOI 10.1109/SYSMART.2016.7894501; Salkevicius J, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8091039; Schissler C, 2016, IEEE T VIS COMPUT GR, V22, P1356, DOI 10.1109/TVCG.2016.2518134; Shin BS, 2007, LECT NOTES COMPUT SC, V4813, P78; Shin HC, 2017, ADV COMPUT VIS PATT, P305, DOI 10.1007/978-3-319-42999-1_17; Stam J, 1999, COMP GRAPH, P121, DOI 10.1145/311535.311548; Sutherland I.E., 1968, P DECEMBER 9 11 1968, P757, DOI DOI 10.1145/1476589.1476686; Tang MZ, 2016, IEEE INT CONF MOB, P84, DOI [10.1109/MASS.2016.55, 10.1109/MASS.2016.021]; Tesic R, 1999, J MANUF SYST, V18, P367, DOI 10.1016/S0278-6125(00)87639-6; Uwe Gruenefeld, 2019, IEEE INT S MIX AUGM, P127; Visell Y, 2009, INT J HUM-COMPUT ST, V67, P947, DOI 10.1016/j.ijhcs.2009.07.007; Visell Y, 2010, P IEEE VIRT REAL ANN, P313, DOI 10.1109/VR.2010.5444748; Wang T., 2012, P 12 WORKSHOP MOBILE, P1, DOI [10.1145/2162081.2162089, DOI 10.1145/2162081.2162089]; Wen JQ, 2015, INT CONF PERVAS COMP, P105, DOI 10.1109/PERCOM.2015.7146516; Yang J, 2018, UIST 2018: PROCEEDINGS OF THE 31ST ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P889, DOI 10.1145/3242587.3242643; Yusuke Takami, 2009, SIGGRAPH ASIA ART GA, P64	44	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241498	10.1371/journal.pone.0241498	http://dx.doi.org/10.1371/journal.pone.0241498			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119709	gold, Green Published			2022-12-26	WOS:000600013600030
J	Pascual-Ramos, V; Contreras-Yanez, I; Ortiz-Haro, AB; Albert, CM; Obrador, GT; Agazzi, E				Pascual-Ramos, Virginia; Contreras-Yanez, Irazu; Ortiz-Haro, Ana Belen; Albert, Christiaan Molewijk; Obrador, Gregorio Tomas; Agazzi, Evandro			Concordance among patients and physicians about their ideal of autonomy impacts the patient-doctor relationship: A cross-sectional study of Mexican patients with rheumatic diseases	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; PREFERRED ROLES; HEALTH-STATUS; COMMUNICATION; ARTHRITIS; CANCER; CARE; PREFERENCES; OUTCOMES; PARTICIPATION	Introduction In patient-doctor interaction both parties play a role. Primary objective was to determine if the concordance among rheumatologists and their patients of their ideal of autonomy was associated with a better patient-doctor relationship. Secondary objective was to describe factors associated to a patient paternalistic ideal of autonomy (PPIA). Materials and methods This cross-sectional study had 3 steps. Step-1 consisted in translation/cultural local adaption of Ideal Patient Autonomy Scale (IPAS), a 14-items Dutch questionnaire. Step-2 consisted of IPAS validity and reliability in 201 outpatients. Step-3 consisted of the application of IPAS and the patient-doctor relationship questionnaire (PDRQ) to 601 outpatients with a medical encounter, and of IPAS to the 21 attending rheumatologists. Each patient-physician encounter was classified into with/without concordance in the ideal of autonomy and PRDQ scores were compared (Man Whitney U test). Regression analysis was used for associations. Results Step-1 followed ISPOR task force recommendations. Patients from Step-2 and Step-3 were representative outpatients with rheumatic diseases. IPAS structure underwent a modification; the 14 items were redistributed into four subscales, further combined into PPIA vs. patient-centered autonomy ideal. IPAS was valid and reliable. There were 497 patients with a preferred ideal of autonomy, primarily (84.9%) PPIA. There were 363 patient-doctor encounters with concordance in the autonomy ideal and their PDRQ-9 scores were higher. Religious beliefs and higher PDRQ-9 item 8 score ("I feel pleased with my doctor ' s treatment") were associated to a PPIA. Conclusions Concordance of autonomy ideal among patients and their rheumatologists positively impacts on the patient-doctor relationship.	[Pascual-Ramos, Virginia; Contreras-Yanez, Irazu; Ortiz-Haro, Ana Belen] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Albert, Christiaan Molewijk] UMC, VUmc, Dept Med Humanities, Amsterdam, Netherlands; [Obrador, Gregorio Tomas; Agazzi, Evandro] Univ Panamericana, Interdisciplinary Ctr Bioeth, Mexico City, DF, Mexico; [Obrador, Gregorio Tomas] Univ Panamericana, Sch Med, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Panamericana - Ciudad de Mexico; Universidad Panamericana - Ciudad de Mexico	Pascual-Ramos, V (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico.	virtichu@gmail.com						AGICH GJ, 1990, HASTINGS CENT REP, V20, P12, DOI 10.2307/3563417; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Bartlett S. J., 2019, RHEUMATOLOGY, P1; Beauchamp TL, 1994, PRINCIPLE BIOMEDICAL; Berrios-Rivera JP, 2006, ARTHRIT RHEUM-ARTHR, V55, P385, DOI 10.1002/art.21988; Beusterien K, 2013, LUPUS, V22, P1038, DOI 10.1177/0961203313499958; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Breen GM, 2009, J MED SYST, V33, P155, DOI 10.1007/s10916-008-9175-3; CARDIEL MH, 1993, CLIN EXP RHEUMATOL, V11, P117; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colmenares-Roa T, 2016, QUAL HEALTH RES, V26, P1674, DOI 10.1177/1049732315588742; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Culliford L, 2002, BRIT MED J, V325, P1434, DOI 10.1136/bmj.325.7378.1434; DALTROY LH, 1993, BAILLIERE CLIN RHEUM, V7, P221, DOI 10.1016/S0950-3579(05)80087-1; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Dworkin G., 1988, THEORY PRACTICE AUTO; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Gao G, 2009, QUAL HEALTH RES, V19, P778, DOI 10.1177/1049732309335269; Garcia-Gonzalez A, 2009, JCR-J CLIN RHEUMATOL, V15, P120, DOI 10.1097/RHU.0b013e31819d89bf; Greasley P, 2001, J ADV NURS, V33, P629, DOI 10.1046/j.1365-2648.2001.01695.x; Haugli L, 2004, PATIENT EDUC COUNS, V52, P169, DOI 10.1016/S0738-3991(03)00023-5; Hochberg MC, 2015, RHEUMATOLOGY; Ishikawa H, 2006, ARTHRIT RHEUM-ARTHR, V55, P878, DOI 10.1002/art.22355; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Krageloh CU, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0212-x; Lazcano-Ponce E, 2004, ARCH MED RES, V35, P66, DOI 10.1016/j.arcmed.2003.06.007; Lertsithichai Panuwat, 2005, Journal of the Medical Association of Thailand, V88, P275; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Martin-Fernandez J, 2010, ATEN PRIM, V42, P196, DOI 10.1016/j.aprim.2009.09.026; McHughs S, 1986, ILLNESS BEHAV MULTID; Meezenbroek ED, 2012, J RELIG HEALTH, V51, P336, DOI 10.1007/s10943-010-9376-1; O<prime>Neill, 2002, AUTONOMY TRUST BIOET; Pascual-Ramos V, 2019, CLIN EXP RHEUMATOL, V37, P608; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Riedl D, 2017, Z PSYCHOSOM MED PSYC, V63, P131, DOI 10.13109/zptm.2017.63.2.131; Singh JA, 2010, AM J MANAG CARE, V16, P688; Steiner DL, 2003, PRACTICAL GUIDE THEI; Stiggelbout AM, 2004, J MED ETHICS, V30, P268, DOI 10.1136/jme.2003.003095; Street RL, 2005, MED CARE, V43, P960, DOI 10.1097/01.mlr.0000178172.40344.70; Suarez-Almazor ME, 2004, CURR OPIN RHEUMATOL, V16, P91, DOI 10.1097/00002281-200403000-00003; SUTHERLAND HJ, 1989, J ROY SOC MED, V82, P260, DOI 10.1177/014107688908200506; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thompson GA, 2018, QUAL HEALTH RES, P1; Vilagut Gemma, 2005, Gac Sanit, V19, P135, DOI 10.1157/13074370; Ward MM, 2015, ANN RHEUM DIS, V74, P1691, DOI 10.1136/annrheumdis-2013-205079; Ward MM, 2003, ARTHRIT RHEUM-ARTHR, V49, P810, DOI 10.1002/art.11467; Wen HY, 2012, INT J RHEUM DIS, V15, P380, DOI 10.1111/j.1756-185X.2012.01752.x; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Yen JC, 1999, LUPUS, V8, P660, DOI 10.1191/096120399680411362; 2016, CIRE ANTILLES GUYANE, V4, P1	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240897	10.1371/journal.pone.0240897	http://dx.doi.org/10.1371/journal.pone.0240897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119715	Green Published, gold			2022-12-26	WOS:000600013600046
J	Sajib, AM; Sandey, M; Morici, S; Schuler, B; Agarwal, P; Smith, BF				Sajib, Abdul Mohin; Sandey, Maninder; Morici, Samantha; Schuler, Bradley; Agarwal, Payal; Smith, Bruce F.			Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors	PLOS ONE			English	Article							SURVIVIN MESSENGER-RNA; TARGETED GENE-THERAPY; ANTI-APOPTOSIS GENE; T-CELL LYMPHOMA; TRANSCRIPTIONAL INTERFERENCE; CANCER; CXCR4; MODEL; RECEPTOR; DOG	Gene therapy is a promising treatment option for cancer. However, its utility may be limited due to expression in off-target cells. Cancer-specific promoters such as telomerase reverse transcriptase (TERT), survivin, and chemokine receptor 4 (CXCR4) have enhanced activity in a variety of human and murine cancers, however, little has been published regarding these promoters in dogs. Given the utility of canine cancer models, the activity of these promoters along with adenoviral E2F enhanced E1a promoter (EEE) was evaluated in a variety of canine tumors, both from the endogenous gene and from exogenously administered constructs. Endogenous expression levels were measured for cTERT, cSurvivin, and cCXCR4 and were low for all three, with some non-malignant and some tumor cell lines and tissues expressing the gene. Expression levels from exogenously supplied promoters were measured by both the number of cells expressing the construct and the intensity of expression in individual cells. Exogenously supplied promoters were active in more cells in all tumor lines than in normal cells, with the EEE promoter being most active, followed by cTERT. The intensity of expression varied more with cell type than with specific promoters. Ultimately, no single promoter was identified that would result in reliable expression, regardless of the tumor type. Thus, these findings imply that identification of a pan-cancer promoter may be difficult. In addition, this data raises the concern that endogenous expression analysis may not accurately predict exogenous promoter activity.	[Sajib, Abdul Mohin; Sandey, Maninder; Morici, Samantha; Schuler, Bradley; Agarwal, Payal; Smith, Bruce F.] Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA; [Agarwal, Payal; Smith, Bruce F.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Smith, BF (corresponding author), Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA.; Smith, BF (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	smithbf@auburn.edu	Sajib, Abdul Mohin/AAO-1031-2021	Sajib, Abdul Mohin/0000-0001-5655-3147; Smith, Bruce/0000-0001-8523-0355; Agarwal, Payal/0000-0002-1688-2680	nonprofit organization "Auburn University Research Initiative for cancer (AURIC)"	nonprofit organization "Auburn University Research Initiative for cancer (AURIC)"	This study is funded by the nonprofit organization titled "Auburn University Research Initiative for cancer (AURIC)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Akincilar SC, 2016, CELL MOL LIFE SCI, V73, P1659, DOI 10.1007/s00018-016-2146-9; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; [Anonymous], 2010, RES PRODUCTIVITY, V02, P100; Bonnefont-Rebeix C, 2016, IMMUNOBIOLOGY, V221, P12, DOI 10.1016/j.imbio.2015.08.007; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Cekanova M, 2014, DRUG DES DEV THER, V8, P1911, DOI 10.2147/DDDT.S49584; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chen C, 2018, MOL THER-NUCL ACIDS, V11, P508, DOI 10.1016/j.omtn.2018.04.003; Chen XG, 2016, J GENE MED, V18, P89, DOI 10.1002/jgm.2882; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Cross D, 2006, CLIN MED RES, V4, P218, DOI 10.3121/cmr.4.3.218; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; Eckert F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03018; Fukazawa T, 2006, CANCER RES, V66; Furuhata S, 2003, MOL THER, V7, P366, DOI 10.1016/S1525-0016(02)00059-X; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garden OA, 2018, VET J, V240, P6, DOI 10.1016/j.tvjl.2018.08.008; Gardner HL, 2016, ANNU REV ANIM BIOSCI, V4, P199, DOI 10.1146/annurev-animal-022114-110911; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Gu J, 2002, GENE THER, V9, P30, DOI 10.1038/sj.gt.3301619; Haviv YS, 2004, MOL CANCER THER, V3, P687; Jaiswal PK, 2015, INDIAN J MED RES, V141, P389, DOI 10.4103/0971-5916.159250; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Moreno MJ, 2015, J PATHOL, V235, P445, DOI 10.1002/path.4446; Kavya N, 2017, VET WORLD, V10, P1286, DOI 10.14202/vetworld.2017.1286-1291; Kawaguchi N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020185; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; Konopka K, 2009, CELL MOL BIOL LETT, V14, P70, DOI 10.2478/s11658-008-0034-5; Kurtova AV, 2009, BLOOD, V113, P4604, DOI 10.1182/blood-2008-10-185827; Laborda E, 2014, MOL THER, V22, P986, DOI 10.1038/mt.2014.7; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Leao R, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0422-8; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-49; Lu B, 2005, GENE THER, V12, P330, DOI 10.1038/sj.gt.3302385; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Moriuchi M, 1997, J IMMUNOL, V159, P4322; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NAKABAYASHI H, 1991, MOL CELL BIOL, V11, P5885, DOI 10.1128/MCB.11.12.5885; Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; PIERREPOINT CG, 1985, J SMALL ANIM PRACT, V26, P43, DOI 10.1111/j.1748-5827.1985.tb02082.x; Robson T, 2003, J BIOMED BIOTECHNOL, P110, DOI 10.1155/S1110724303209074; Rojas JJ, 2010, MOL THER, V18, P1960, DOI 10.1038/mt.2010.173; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Sakaguchi M, 2017, ONCOL REP, V38, P1108, DOI 10.3892/or.2017.5710; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shepelev MV, 2016, ONCOL LETT, V12, P1204, DOI 10.3892/ol.2016.4718; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Uchide T, 2005, DNA SEQUENCE, V16, P329, DOI 10.1080/10425170500213696; Ulasov IV, 2007, CANCER BIOL THER, V6, P679, DOI 10.4161/cbt.6.5.3957; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; van Houdt WJ, 2006, J NEUROSURG, V104, P583, DOI 10.3171/jns.2006.104.4.583; VILE RG, 1993, CANCER RES, V53, P3860; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011794; Weng AP, 2003, AM J CLIN PATHOL, V119, P424, DOI 10.1309/RF4PVCEGGN2XAF86; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Xu C, 2015, DRUG DES DEV THER, V9, P4953, DOI 10.2147/DDDT.S84932; Yao X, 2007, BIOCHEM BIOPH RES CO, V362, P419, DOI 10.1016/j.bbrc.2007.08.001; Yoon AR, 2018, SCI REP-UK, V7, DOI 10.1038/s41598-018-20268-6; Yuan XT, 2019, ONCOGENE, V38, P6172, DOI 10.1038/s41388-019-0872-9; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zhao HL, 2015, ONCOTARGET, V6, P5022, DOI 10.18632/oncotarget.3217; Zhu ZB, 2004, CANCER GENE THER, V11, P256, DOI 10.1038/sj.cgt.7700679; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	74	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0240807	10.1371/journal.pone.0240807	http://dx.doi.org/10.1371/journal.pone.0240807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166332	gold, Green Published			2022-12-26	WOS:000592382600059
J	El-Ashram, S; Kheirallah, DAM; El-Samad, LM; Toto, NA				El-Ashram, Saeed; Kheirallah, Dalia Abdel Moneim; El-Samad, Lamia Moustafa; Toto, Noura A.			Relative expression of microRNAs, apoptosis, and ultrastructure anomalies induced by gold nanoparticles in Trachyderma hispida (Coleoptera: Tenebrionidae)	PLOS ONE			English	Article							SILVER NANOPARTICLES; IN-VITRO; CELL-PROLIFERATION; BLAPS-POLYCRESTA; TOXICITY; TRANSPORT; CYTOTOXICITY; REPRODUCTION; OOGENESIS; EXPOSURE	The extensive use of nanomaterials generates toxic effects on non-target species and the ecosystem. Although gold nanoparticles (Au-NPs) are generally expected to be safe, the recent study contains conflicting data regarding their cytotoxicity in the darkling beetles Trachyderma hispida. The study postulated cellular perturbation in the ovarian tissue of the beetles induced by a sublethal dose of Au-NPs (0.01 mg/g). When compared with the controls, a significant inhibition in the activities of the antioxidant enzymes selenium-dependent (GPOX) and selenium-independent (GSTP) glutathione peroxidases (GPx) was observed in the treated beetles. The study proposed microRNAs (miRNA-282 and miRNA-989) as genotoxic markers for the first time, reporting a significant suppression in their transcriptional levels in the treated beetles. Furthermore, TUNEL (Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) and flow cytometry assays (annexin V-Fitc) indicated a significant increase in ovarian cell apoptosis in the treated beetles. Additionally, an ultrastructure examination revealed pathological changes in the ovarian cells of the treated beetles. The resulting anomalies in the present study may interrupt the fecundity of the beetles and lead to the future suppression of beetle populations.	[El-Ashram, Saeed] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China; [El-Ashram, Saeed] Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt; [Kheirallah, Dalia Abdel Moneim; El-Samad, Lamia Moustafa] Alexandria Univ, Dept Zool, Fac Sci, Alexandria, Egypt; [Toto, Noura A.] Damanhour Univ, Fac Sci, Dept Zool, Abadiyyat Damanhur, El Beheira, Egypt	Foshan University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Damanhour University	El-Ashram, S (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.; El-Ashram, S (corresponding author), Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt.; Kheirallah, DAM (corresponding author), Alexandria Univ, Dept Zool, Fac Sci, Alexandria, Egypt.	saeed_elashram@yahoo.com; Daliakheirallah@yahoo.com	ElSamad, Lamia M/AAT-3379-2020; Kheirallah, Dalia Abdel Moneim/ABE-1232-2021; El-Ashram, Saeed/AAC-6060-2021	ElSamad, Lamia M/0000-0002-4352-5742; Kheirallah, Dalia Abdel Moneim/0000-0002-8747-2478; El-Ashram, Saeed/0000-0003-0389-1980	Foshan University, Foshan city, Guangdong province for distinguished researchers; Guangdong Science and Technology Plan Project [1244 0600 4560 7389XC]; School of Life Science and Engineering fund [KLPREAD201801-02]	Foshan University, Foshan city, Guangdong province for distinguished researchers; Guangdong Science and Technology Plan Project; School of Life Science and Engineering fund	S.E. Start-up Research Grant Program provided by Foshan University, Foshan city, Guangdong province for distinguished researchers, Guangdong Science and Technology Plan Project (Grant No:1244 0600 4560 7389XC) and School of Life Science and Engineering fund (Grant No: KLPREAD201801-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Zeid MAM, 2015, CYTOLOGIA, V80, P173, DOI 10.1508/cytologia.80.173; Adewale OB, 2019, INT J TOXICOL, V38, P357, DOI 10.1177/1091581819863130; Ahamed M, 2016, ENVIRON TOXICOL, V31, P1344, DOI 10.1002/tox.22140; [Anonymous], 2010, OFFICIAL J L, V27, P1; [Anonymous], 2007, PEFC NEWS, V37, P3; Bednarska AJ, 2016, ENVIRON SCI POLLUT R, V23, P22047, DOI 10.1007/s11356-016-7412-8; Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10149, DOI 10.1007/s11356-017-9960-y; Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chaudhary AK, 2016, DRUG DISCOV TODAY, V21, P38, DOI 10.1016/j.drudis.2015.07.014; Chifiriuc MC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020036; Cho WS, 2009, TOXICOL LETT, V191, P96, DOI 10.1016/j.toxlet.2009.08.010; Dabour K, 2019, SCI TOTAL ENVIRON, V651, P1356, DOI 10.1016/j.scitotenv.2018.09.311; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Di Bucchianico S, 2014, INT J NANOMED, V9, P2191, DOI 10.2147/IJN.S58397; Dong LY, 2015, SMALL, V11, P2571, DOI 10.1002/smll.201403481; El-Ashram Saeed, 2016, Biotechnol Rep (Amst), V12, P33, DOI 10.1016/j.btre.2016.10.001; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fratoddi I, 2015, NANO RES, V8, P1771, DOI 10.1007/s12274-014-0697-3; Hou CC, 2017, ONCOTARGET, V8, P109799, DOI 10.18632/oncotarget.19087; Jia YP, 2017, CHINESE CHEM LETT, V28, P691, DOI 10.1016/j.cclet.2017.01.021; Jiang XM, 2015, NANOTOXICOLOGY, V9, P181, DOI 10.3109/17435390.2014.907457; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Judy JD, 2011, ENVIRON SCI TECHNOL, V45, P776, DOI 10.1021/es103031a; Karpeta-Kaczmarek J, 2018, ENVIRON RES, V166, P602, DOI 10.1016/j.envres.2018.05.027; Karpeta-Kaczmarek J, 2016, ENVIRON POLLUT, V215, P266, DOI 10.1016/j.envpol.2016.05.032; Karthikeyan B, 2010, EXP EYE RES, V91, P769, DOI 10.1016/j.exer.2010.09.003; Kheirallah DA, 2019, FOLIA BIOL-KRAKOW, V67, P9, DOI 10.3409/fb_67-1.02; Kheirallah DAM, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.141743; KRESSEL M, 1994, CELL TISSUE RES, V278, P549; Kulvietis V, 2011, TOHOKU J EXP MED, V225, P225, DOI 10.1620/tjem.225.225; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lehman SE, 2016, ENVIRON SCI-NANO, V3, P56, DOI 10.1039/c5en00179j; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Leon K, 2013, FRONT CELL DEV BIOL, V1, DOI 10.3389/fcell.2013.00003; Manshian BB, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0413-7; Mao BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20728-z; Morin MD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122728; Muoth C, 2016, NANOMEDICINE-UK, V11, P941, DOI 10.2217/nnm-2015-0012; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Osman W, 2015, ENVIRON SCI POLLUT R, V22, P14104, DOI 10.1007/s11356-015-4606-4; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Patil CD, 2016, ENZYME MICROB TECH, V92, P18, DOI 10.1016/j.enzmictec.2016.06.005; Rai M, 2014, APPL MICROBIOL BIOT, V98, P1951, DOI 10.1007/s00253-013-5473-x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Savolainen K, 2010, TOXICOLOGY, V269, P92, DOI 10.1016/j.tox.2010.01.013; SIMMONS TW, 1989, COMP BIOCHEM PHYS B, V94, P323, DOI 10.1016/0305-0491(89)90350-7; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Small T, 2016, SCI TOTAL ENVIRON, V565, P882, DOI 10.1016/j.scitotenv.2016.02.032; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Stelzer R, 2009, J REPROD DEVELOP, V55, P685, DOI 10.1262/jrd.20241; Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004; Sun HN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030754; Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008; Talebi AR, 2013, J SPINAL CORD MED, V36, P140, DOI 10.1179/2045772312Y.0000000055; Torrano AA, 2013, COLLOID SURFACE B, V108, P120, DOI 10.1016/j.colsurfb.2013.02.014; Wang Y, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13601; Xu GX, 2012, THERANOSTICS, V2, P734, DOI 10.7150/thno.4290; Yadav T, 2014, REV ENVIRON CONTAM T, V230, P83, DOI 10.1007/978-3-319-04411-8_4; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P771, DOI 10.1007/s12013-015-0529-4; Zoroddu MA, 2014, CURR MED CHEM, V21, P3837, DOI 10.2174/0929867321666140601162314; Zuckerberg M, 2013, DU-Z KULTUR, P20	65	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241837	10.1371/journal.pone.0241837	http://dx.doi.org/10.1371/journal.pone.0241837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156883	gold, Green Published			2022-12-26	WOS:000591376400009
J	Leung, CCT; Wong, CKC				Leung, Cherry C. T.; Wong, Chris K. C.			Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration	PLOS ONE			English	Article							LIM-KINASE 1; GENE-EXPRESSION; TRANSENDOTHELIAL MIGRATION; TUMOR PROGRESSION; KAPPA-B; PHOSPHORYLATION; ACTIVATION; RHOA; INFILTRATION; DLC-1	Human stanniocalcin-1 (STC1) is a glycoprotein known to participate in inflammation and tumor progression. However, its role in cancer-macrophage interaction at the tumor environment is not known. In this study, the co-culture of the human metastatic hepatocellular carcinoma cell line (MHCC97L) stably transfected with a control vector (MHCC97L/P), or STC1-overexpressing vector (MHCC97L/S1) with human leukemia monocytic cell line (THP-1) was conducted. We reported that MHCC97L/S1 suppressed the migratory activity of THP-1. Real-time PCR analysis revealed the downregulation of the pro-migratory factors, monocyte-chemoattractant protein receptors, CCR2 and CCR4, and macrophage-migratory cytokine receptor, CSF-1R. Transcriptomic analysis of the THP-1 cells co-cultured with either MHCC97L/P or MHCC97L/S1, detected 1784 differentially expressed genes. The Ingenuity Canonical Pathway analysis predicted that RhoA signaling was associated with the inhibition of the cell migration. Western blot analysis revealed a significant reduction of Ser19-phosphorylation on MLC2, a Rho-A downstream target, in the THP-1 cells. Xenograft tumors derived from MHCC97/S1 in mice showed a remarkable decrease in infiltrating macrophages. Collectively, this is the first report to demonstrate the inhibitory effect of STC1-overexpressing cancer cells on macrophage migration/infiltration. Our data support further investigations on the relationship between tumor STC1 level and macrophage infiltration.	[Leung, Cherry C. T.; Wong, Chris K. C.] Hong Kong Baptist Univ, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Peoples R China	Hong Kong Baptist University	Wong, CKC (corresponding author), Hong Kong Baptist Univ, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Peoples R China.	ckcwong@hkbu.edu.hk	wong, chris/GSN-0962-2022		Research Grant Council, Hong Kong [HKBU12103817]	Research Grant Council, Hong Kong(Hong Kong Research Grants Council)	This work was supported by the General Research Fund [HKBU12103817] to CKCW, Research Grant Council, Hong Kong. https://cerg1.ugc.edu.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; [Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Chughtai SA, 1999, ONCOGENE, V18, P657, DOI 10.1038/sj.onc.1202340; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Leung Cherry Ct, 2018, Oncotarget, V9, P6852, DOI 10.18632/oncotarget.23566; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; Martinez-Bauer E, 2008, J HEPATOL, V48, P20, DOI 10.1016/j.jhep.2007.07.031; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta M, 2003, INT J ONCOL, V22, P773; Ohta M, 2002, INT J CANCER, V102, P220, DOI 10.1002/ijc.10705; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Wang SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12114; Wong CM, 2003, CANCER RES, V63, P7646; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Yeung BHY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139977; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241932	10.1371/journal.pone.0241932	http://dx.doi.org/10.1371/journal.pone.0241932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156861	Green Published, gold			2022-12-26	WOS:000591376400020
J	Kheyri, E; Morovati, M; Neshat, A; Siahati, G				Kheyri, Ebrahim; Morovati, Maryam; Neshat, Akram; Siahati, Gholamreza			Economic valuation of natural promenades in Iran using zonal travel costs method (Case study area: Gahar Lake in Lorestan Province in western Iran)	PLOS ONE			English	Article							ECOSYSTEM SERVICES; WILLINGNESS; QUALITY	Gahar Lake is located within Oshtorankooh Protected Area (east of Lorestan Province in Iran), which has extensive potentials for the development of the tourism industry. The aim of the present research was to determine the economic value of the Gohar Lake resort using the zonal travel cost method. Therefore, at first, 380 questionnaires were distributed among the tourists by the simple random sampling method based on appropriate spatiotemporal distribution during the visiting seasons. The questionnaire items were categorized as economic, social, and miscellaneous parts. The calculation results revealed a value of USD 84.538 per visitor and a value of USD 1,986,657.163 per year, indicating the high value and importance of the region. The analysis showed that socio-economic variables have a significant role in the use or non-use of the resort. The obtained R2 coefficient was 0.82, indicating that around 82% of the changes in the number of visitors can be justified by the variables introduced in the model. The results also revealed the need to pay more attention to this region and formulate a tourism development plan.	[Kheyri, Ebrahim] Ardakan Univ, Fac Agr & Nat Resources, MSc Assessment & Land Use Planning, Ardakan, Iran; [Morovati, Maryam; Siahati, Gholamreza] Ardakan Univ, Fac Agr & Nat Resources, Dept Environm Sci & Engn, Ardakan, Iran; [Morovati, Maryam] Ardakan Univ, Med & Ind Plants Res Inst, Ardakan, Iran; [Neshat, Akram] Ardakan Univ, Fac Agr & Nat Resources, Dept Agr Econ, Ardakan, Iran		Morovati, M (corresponding author), Ardakan Univ, Fac Agr & Nat Resources, Dept Environm Sci & Engn, Ardakan, Iran.; Morovati, M (corresponding author), Ardakan Univ, Med & Ind Plants Res Inst, Ardakan, Iran.	mymorovati@ardakan.ac.ir	Morovati, Maryam/ABF-3834-2021	morovati, maryam/0000-0002-2225-0823				Asadzadeh A., 2017, ELECTRON J BIOL, V13, P152; Bastian Olaf, 2017, International Journal of Biodiversity Science Ecosystem Services & Management, V13, P51, DOI 10.1080/21513732.2016.1248865; Cavasos KE, 2020, OCEAN COAST MANAGE, V193, DOI 10.1016/j.ocecoaman.2020.105244; Elmi B, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100580; Enriquez-Acevedo T, 2018, OCEAN COAST MANAGE, V161, P96, DOI 10.1016/j.ocecoaman.2018.04.025; Ezzy E, 2011, AARES 2011 AUSTR AGR; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Holden A., 2016, ENV TOURISM, V3rd ed.,; Keeler BL, 2012, P NATL ACAD SCI USA, V109, P18619, DOI 10.1073/pnas.1215991109; King N. A., 2007, Water Policy, V9, P51; Kronenberg J, 2014, ENVIRON MANAGE, V54, P617, DOI 10.1007/s00267-014-0317-8; Lankia T, 2014, J FOREST ECON, V20, P141, DOI 10.1016/j.jfe.2014.04.001; Mafi-Gholami D, 2014, ENV SCI TECHNOLOGY Q, V16, P95; Ofori RO, 2020, OCEAN COAST MANAGE, V192, DOI 10.1016/j.ocecoaman.2020.105224; Organization EP, 2005, COMPR STUD ESHT PROT, P102; Park SH, 2016, NUCL ENG TECHNOL, V48, P559, DOI 10.1016/j.net.2015.12.012; Rewitzer S, 2017, ECOSYST SERV, V26, P197, DOI 10.1016/j.ecoser.2017.06.014; Schallenberg M, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P203; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tian YQ, 2020, J ENVIRON MANAGE, V260, DOI 10.1016/j.jenvman.2020.110140; Uhel R, 2010, ECOSYSTEM ACCOUNTING, P20151841; Vakili Ghasirian N, 2017, SCI RES Q AGR EC RES, V9, P183; Vuletic D, 2009, PERIOD BIOL, V111, P515; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.1890/1051-0761(1999)009[0772:EVOFES]2.0.CO;2; XIE S-y, 2008, TOURISM TRIBUNE, V2; Xu F, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105053; Young R.A., 2014, DETERMINING EC VALUE, V2nd; Zarandian A, 2014, ENV RES SPECIAL ISSU, V1, P111	28	0	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241396	10.1371/journal.pone.0241396	http://dx.doi.org/10.1371/journal.pone.0241396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147600	Green Published, gold			2022-12-26	WOS:000589609300066
J	Miura, K				Miura, Katsutoshi			Tunica intima compensation for reduced stiffness of the tunica media in aging renal arteries as measured with scanning acoustic microscopy	PLOS ONE			English	Article								Objectives Aging causes stiffness and decreased function of the renal artery (RA). Histological study with light microscopy can reveal microscopic structural remodeling but no functional changes. The present study aimed to clarify the association between structural and functional aging of the RA through the use of scanning acoustic microscopy. Methods Formalin-fixed, paraffin-embedded cross-sections of renal arteries from 64 autopsy cases were examined. Speed-of-sound (SOS) values of three layers, which correspond to the stiffness, were compared among different age groups. SOS of the tunica media was examined in terms of blood pressure (BP) and SOS of the ascending aorta. Vulnerability to proteases was assessed by SOS reduction after collagenase treatment. Results The tunica intima presented inward hypertrophy with luminal narrowing, and the tunica media showed outward hypertrophic remodeling with aging. SOS of the tunica media and internal and external elastic laminae showed a reverse correlation with age. SOS of the tunica media was negatively correlated with BP and strongly associated with that of the aorta. The tunica media of young RAs were more sensitive to collagenase compared with the old ones. Conclusions Scanning acoustic microscopy is useful for observing the aging process of the RA. This technique simultaneously shows structural and mechanical information from each portion of the RA. In the process of aging, the RA loses contractile function and elasticity as a result of protease digestion. The tunica media and the internal and external elastic laminae exhibit reduced stiffness, but the tunica intima stiffens with atherosclerosis. As a consequence, the RA's outer shape changes from round to oval with inward and outward hypertrophy. This indicates that the inner resistant intima supports the mechanical weakness of the tunica media to compensate for an increase in BP with aging.	[Miura, Katsutoshi] Hamamatsu Univ, Dept Hlth Sci Pathol & Anat, Sch Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine	Miura, K (corresponding author), Hamamatsu Univ, Dept Hlth Sci Pathol & Anat, Sch Med, Hamamatsu, Shizuoka, Japan.	kmiura.hama.med@gmail.com	Miura, katsutoshi/K-1454-2017	Miura, katsutoshi/0000-0002-9262-7702	Japan Society for the Promotion of Science KAKENHI [17K1088901, 15K08375]; Toukai Foundation for Technology	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toukai Foundation for Technology	This study was funded by the Japan Society for the Promotion of Science KAKENHI (grant no. 17K1088901 and 15K08375), and by the Toukai Foundation for Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar R, 2014, ACTA BIOMATER, V10, P4843, DOI 10.1016/j.actbio.2014.07.001; Akhtar R, 2016, ARTERY RES, V13, P1, DOI 10.1016/j.artres.2015.11.001; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2011, CANC DISCOV; Antonio F, 2013, ANAL SENSITIVITY SPE, P423, DOI [10.5935/abc.20130191, DOI 10.5935/ABC.20130191]; Chiaganam NO, 2013, S AFRICAN RADIOGRAPH, V51, P23; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; Hasgall P. A., 2018, VERSION 4 0 ITIS FOU, DOI [10.13099/VIP21000-04-0, DOI 10.13099/VIP21000-04-0]; Hozumi N, 2004, ULTRASONICS, V42, P717, DOI 10.1016/j.ultras.2003.11.005; Jia GH, 2014, CARDIORENAL MED, V4, P60, DOI 10.1159/000360867; Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Miura K, 2013, PROTOC EXCH, DOI [10.1038/protex.2013.040, DOI 10.1038/PR0TEX.2013.040]; Miura K, 2019, ULTRASOUND MED BIOL, V45, P3102, DOI 10.1016/j.ultrasmedbio.2019.08.012; Miura K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6125204; Miura K, 2014, PATHOL LAB MED INT, V6, P1, DOI 10.2147/PLMI.S58343; Miura K, 2015, PATHOL INT, V65, P355, DOI 10.1111/pin.12288; Miura K, 2012, LAB INVEST, V92, P1760, DOI 10.1038/labinvest.2012.135; Miyawaki NB, 2009, GERIATRIC NEPHROLOGY, P1; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Safar ME, 2015, AM J HYPERTENS, V28, P561, DOI 10.1093/ajh/hpu206; Saijo Y, 2001, ANN BIOMED ENG, V29, P1048, DOI 10.1114/1.1424912; Saijo Y., 2009, IMAG MED, V1, P47, DOI [DOI 10.2217/IIM.09.8, 10.2217/iim.09.8]; Sasaki H, 1996, ULTRASOUND MED BIOL, V22, P1261, DOI 10.1016/S0301-5629(96)00150-0; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054	26	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0234759	10.1371/journal.pone.0234759	http://dx.doi.org/10.1371/journal.pone.0234759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147291	gold, Green Submitted, Green Published			2022-12-26	WOS:000589609300015
J	Yu, L; Zheng, YX; Liu, BJ; Kang, MH; Millar, JC; Rhee, DJ				Yu, Ling; Zheng, Yuxi; Liu, Brian J.; Kang, Min Hyung; Millar, J. Cameron; Rhee, Douglas J.			Secreted protein acidic and rich in cysteine (SPARC) knockout mice have greater outflow facility	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; AQUEOUS-HUMOR DYNAMICS; EXTRACELLULAR-MATRIX COMPONENTS; GROWTH-FACTOR BETA-2; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; GLAUCOMATOUS EYES; JUXTACANALICULAR TISSUE; GENE-EXPRESSION; MOUSE	Purpose Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that regulates intraocular pressure (IOP) by altering extracellular matrix (ECM) homeostasis within the trabecular meshwork (TM). We hypothesized that the lower IOP previously observed in SPARC -/- mice is due to a greater outflow facility. Methods Mouse outflow facility (C-live) was determined by multiple flow rate infusion, and episcleral venous pressure (P-e) was estimated by manometry. The animals were then euthanized, eliminating aqueous formation rate (F-in) and P-e. The C value was determined again (C-dead) while F-in was reduced to zero. Additional mice were euthanized for immunohistochemistry to analyze ECM components of the TM. Results The C-live and C-dead of SPARC -/- mice were 0.014 +/- 0.002 mu L/min/mmHg and 0.015 +/- 0.002 mu L/min/mmHg, respectively (p = 0.376, N/S). Compared to the C-live = 0.010 +/- 0.002 mu L/min/mmHg and C-dead = 0.011 +/- 0.002 mu L/min/mmHg in the WT mice (p = 0.548, N/S), the C-live and C-dead values for the SPARC -/- mice were higher. P-e values were estimated to be 8.0 +/- 0.2 mmHg and 8.3 +/- 0.7 mmHg in SPARC -/- and WT mice, respectively (p = 0.304, N/S). Uveoscleral outflow (F-u) was 0.019 +/- 0.007 mu L/min and 0.022 +/- 0.006 mu L/min for SPARC -/- and WT mice, respectively (p = 0.561, N/S). F-in was 0.114 +/- 0.002 mu L/min and 0.120 +/- 0.016 mu L/min for SPARC -/- and WT mice (p = 0.591, N/S). Immunohistochemistry demonstrated decreases of collagen types IV and VI, fibronectin, laminin, PAI-1, and tenascin-C within the TM of SPARC -/- mice (p < 0.05). Conclusions The lower IOP of SPARC -/- mice is due to greater aqueous humor outflow facility through the conventional pathway. Corresponding changes in several matricellular proteins and ECM structural components were noted in the TM of SPARC -/- mice.	[Yu, Ling; Zheng, Yuxi; Liu, Brian J.; Kang, Min Hyung; Rhee, Douglas J.] Case Western Reserve Univ, Univ Hosp Eye Inst, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA; [Yu, Ling] Southwest Med Univ, Dept Ophthalmol, Affiliated Hosp, Luzhou, Peoples R China; [Millar, J. Cameron] Univ North Texas, North Texas Eye Res Inst NTERI, Dept Pharmacol & Neurosci, Hlth Sci Ctr, Ft Worth, TX USA	Case Western Reserve University; Southwest Medical University; University of North Texas System; University of North Texas Denton	Rhee, DJ (corresponding author), Case Western Reserve Univ, Univ Hosp Eye Inst, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA.	dougrhee@aol.com		Liu, Brian/0000-0002-7587-3813; Yu, Ling/0000-0001-6395-6630	National Eye Institute; Cleveland Eye Bank Foundation [P30-EY11373]; Research to Prevent Blindness	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cleveland Eye Bank Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	DJR received grant EY 019654-01 from the National Eye Institute, https://www.nei.nih.gov and a grant from the Cleveland Eye Bank Foundation, https://cleyebankfoundation.org (unrestricted). This study was also supported by a P30 Core Grant P30-EY11373 from the National Eye Institute and a grant from Research to Prevent Blindness, https://www.rpbusa.org/rpb/(unrestricted). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; [Anonymous], 2004, ARCH OPHTHALMOL-CHIC, V122, P532; [Anonymous], 2013, J PRACTICAL ETHICS; BARANY EH, 1954, ACTA PHYSIOL SCAND, V30, P240, DOI 10.1111/j.1748-1716.1954.tb01092.x; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Boussommier-Calleja A, 2013, INVEST OPHTH VIS SCI, V54, P8251, DOI 10.1167/iovs.13-13025; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Camras LJ, 2010, CURR EYE RES, V35, P819, DOI 10.3109/02713683.2010.494241; Chatterjee A, 2013, EXP EYE RES, V115, P106, DOI 10.1016/j.exer.2013.06.017; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; [Collaborative Normal-Tension Glaucoma Study Group Collaborative Normal-Tension Glaucoma Study Group], 1999, AM J OPHTHALMOL, V127, p[625, 623]; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; ETHIER CR, 1986, INVEST OPHTH VIS SCI, V27, P1741; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Guideline O.O., 2001, OECD GUID TEST CHEM, V2, P12; GUM GG, 1992, AM J VET RES, V53, P767; Haddadin RI, 2012, INVEST OPHTH VIS SCI, V53, P6708, DOI 10.1167/iovs.11-9013; Haddadin RI, 2009, INVEST OPHTH VIS SCI, V50, P3771, DOI 10.1167/iovs.08-2489; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; JOHNSON DH, 1990, INVEST OPHTH VIS SCI, V31, P2568; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Kang MH, 2013, INVEST OPHTH VIS SCI, V54, P2523, DOI 10.1167/iovs.12-11474; Kang MH, 2011, INVEST OPHTH VIS SCI, V52, P2187, DOI 10.1167/iovs.10-5428; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Keller KE, 2008, INVEST OPHTH VIS SCI, V49, P2495, DOI 10.1167/iovs.07-0903; Keller KE, 2013, INVEST OPHTH VIS SCI, V54, P5613, DOI 10.1167/iovs.13-11620; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; KNEPPER PA, 1984, INVEST OPHTH VIS SCI, V25, P286; LARSSON LI, 1995, ARCH OPHTHALMOL-CHIC, V113, P283, DOI 10.1001/archopht.1995.01100030037018; Liton PB, 2009, EXP EYE RES, V88, P724, DOI 10.1016/j.exer.2008.11.002; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Mao WM, 2013, INVEST OPHTH VIS SCI, V54, P3600, DOI 10.1167/iovs.13-12033; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; Millar JC, 2015, INVEST OPHTH VIS SCI, V56, P5764, DOI 10.1167/iovs.15-16720; Millar JC, 2011, INVEST OPHTH VIS SCI, V52, P685, DOI 10.1167/iovs.10-6069; Nissirios N, 2007, J GLAUCOMA, V16, P57, DOI 10.1097/IJG.0b013e31802b3547; Ochiai Y, 2002, JPN J OPHTHALMOL, V46, P249, DOI 10.1016/S0021-5155(01)00523-8; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; Pang IH, 2003, INVEST OPHTH VIS SCI, V44, P3502, DOI 10.1167/iovs.02-0758; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rhee DJ, 2003, EXP EYE RES, V77, P601, DOI 10.1016/S0014-4835(03)00190-8; Rhee DJ, 2009, EXP EYE RES, V88, P694, DOI 10.1016/j.exer.2008.11.032; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; SEILER T, 1985, GRAEF ARCH CLIN EXP, V223, P88, DOI 10.1007/BF02150951; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Swaminathan SS, 2014, INVEST OPHTH VIS SCI, V55, P4084, DOI 10.1167/iovs.13-12463; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Tane N, 2007, EXP EYE RES, V84, P832, DOI 10.1016/j.exer.2007.01.002; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Weinreb RN, 2007, CAN J OPHTHALMOL, V42, P396, DOI 10.3129/i07-045; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	70	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241294	10.1371/journal.pone.0241294	http://dx.doi.org/10.1371/journal.pone.0241294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147244	gold, Green Published			2022-12-26	WOS:000589609300028
J	Iannone, LF; Bennardo, L; Palleria, C; Roberti, R; De Sarro, C; Naturale, MD; Dastoli, S; Donato, L; Manti, A; Valenti, G; D'Amico, D; D'Attola, S; De Francesco, AE; Bosco, V; Di Paola, ED; Nistico, SP; Citraro, R; Russo, E; De Sarro, G				Iannone, Luigi Francesco; Bennardo, Luigi; Palleria, Caterina; Roberti, Roberta; De Sarro, Caterina; Naturale, Maria Diana; Dastoli, Stefano; Donato, Luca; Manti, Antonia; Valenti, Giancarlo; D'Amico, Domenico; D'Attola, Santo; De Francesco, Adele Emanuela; Bosco, Vincenzo; Di Paola, Eugenio Donato; Nistico, Steven Paul; Citraro, Rita; Russo, Emilio; De Sarro, Giovambattista			Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study	PLOS ONE			English	Article							ADVERSE; PROJECT	Psoriasis is an inflammatory and chronic skin disorder associated with physical and psychological burden impairing patients' quality of life. In the last decade, biologic drugs have widely changed treatment of moderate-severe psoriasis and their number is increasing overtime. To early identify expected/unexpected adverse events (AEs) with biologic treatments, pharmacovigilance programs are needed. We designed a post-marketing active pharmacovigilance program to monitor and analyse AEs and/or serious adverse events (SAEs) reports. All consecutive patients treated with one biologic drug during a two-years period and satisfying inclusion criteria have been enrolled in five Dermatology tertiary units. Demographic and clinical features of patients, type of treatment used, therapy discontinuation, failures, switch/swap to another biologic, and possible onset of AEs were collected. Overall, 512 patients with a diagnosis of psoriasis (286; 55.9%) or arthropathic psoriasis (226; 44.1%) have been enrolled. Eighty-two (16%) patients with AEs and 5 (1%) with SAEs have been identified. Further, 59 (11.5%) had a primary/secondary failure (mainly on infliximab and etanercept). The adverse events and SAEs were reported with golimumab (4/12), adalimumab (32/167), infliximab (9/48), etanercept (31/175) and ustekinumab (11/73), no adverse events have occurred with secukinumab (0/37). Infliximab and etanercept were significantly associated with primary/secondary failures, whereas no differences have been highlighted for AEs insurgence. On the other hand, ustekinumab seems to be associated with a low rate of AEs (p = 0.01) and no adverse events or failures have been reported with secukinumab (p = 0.04 and 0.03, respectively). Our study, even though limited by a small sample size and a brief follow-up period, provide useful data on widely used biologic drugs and their tolerability, discontinuation rate and the incurrence of severe adverse events. Further studies are necessary to include the recently approved biologic drugs and to increase the sample size for more detailed analysis.	[Iannone, Luigi Francesco; Bennardo, Luigi; Palleria, Caterina; Roberti, Roberta; De Sarro, Caterina; Naturale, Maria Diana; Dastoli, Stefano; Manti, Antonia; Bosco, Vincenzo; Di Paola, Eugenio Donato; Nistico, Steven Paul; Citraro, Rita; Russo, Emilio; De Sarro, Giovambattista] Magna Graecia Univ Catanzaro, Sch Med, Sci Hlth Dept, Catanzaro, Italy; [Donato, Luca] Azienda Sanit Prov Crotone, Dermatol Outpatient Clin, Crotone, Italy; [Valenti, Giancarlo; D'Amico, Domenico] Ciaccio Pugliese Hosp, Div Dermatol, Catanzaro, Italy; [D'Attola, Santo] Grande Osped Metropolitano Bianchi Melacrino More, Dermatol Unit, Reggio Di Calabria, Italy; [De Francesco, Adele Emanuela] Mater Domini Hosp, UOC Pharm, Catanzaro, Italy	Magna Graecia University of Catanzaro	Russo, E (corresponding author), Magna Graecia Univ Catanzaro, Sch Med, Sci Hlth Dept, Catanzaro, Italy.	erusso@unicz.it	Russo, Emilio/G-5241-2010	Russo, Emilio/0000-0002-1279-8123; De Sarro, Caterina/0000-0002-3596-0090				[Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2012, ICSID REV, V27, P443; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Carretero G, 2015, J EUR ACAD DERMATOL, V29, P156, DOI 10.1111/jdv.12492; Cutroneo PM, 2014, DRUG SAFETY, V37, P961, DOI 10.1007/s40264-014-0224-1; Dauden E, 2013, J EUR ACAD DERMATOL, V27, P1387, DOI 10.1111/jdv.12024; Felix T, 2019, EXPERT OPIN DRUG SAF, V18, P231, DOI 10.1080/14740338.2019.1577818; Ferner RE, 2015, CLIN EXP DERMATOL, V40, P105, DOI 10.1111/ced.12572; Fracchiolla NS, 2018, HEMATOL ONCOL, V36, P299, DOI 10.1002/hon.2451; French JB, 2016, DRUG SAFETY, V39, P199, DOI 10.1007/s40264-015-0366-9; Grupo de Trabajo de GesEPOC, 2017, ARCH BRONCONEUMOL, V53, P1, DOI DOI 10.1109/JQE.2016.2643289; Haas JS, 2012, AM J MANAG CARE, V18; Hsu S, 2012, ARCH DERMATOL, V148, P95, DOI 10.1001/archdermatol.2011.1410; Kalden JR, 2017, NAT REV RHEUMATOL, V13, P707, DOI 10.1038/nrrheum.2017.187; KIMBALL AB, 2015, BRIT J DERMATOL, V173, pNIL_0272, DOI [DOI 10.1111/bjd.14068, DOI 10.1111/BJD.14068]; Leporini C, 2017, EXPERT OPIN DRUG SAF, V16, P515, DOI 10.1080/14740338.2017.1316486; Mason KJ, 2018, JAMA DERMATOL, V154, P581, DOI 10.1001/jamadermatol.2018.0183; Momen SE, 2017, BRIT J DERMATOL, V177, P1519, DOI 10.1111/bjd.15866; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nast A, 2017, J EUR ACAD DERMATOL, V31, P1951, DOI 10.1111/jdv.14454; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Palleria C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205134; Palleria C, 2013, J PHARMACOL PHARMACO, V4, pS66, DOI 10.4103/0976-500X.120955; Roberti R, 2020, CURR MED RES OPIN, V36, P1457, DOI 10.1080/03007995.2020.1786681; Ronholt K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112297; Scavone C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00607; Sehgal VN, 2015, INT J DERMATOL, V54, P1442, DOI 10.1111/ijd.12802; Vilarrasa E, 2014, WORLD J DERMATOL, V3, P76	28	31	31	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241575	10.1371/journal.pone.0241575	http://dx.doi.org/10.1371/journal.pone.0241575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141869	gold, Green Published			2022-12-26	WOS:000588376700021
J	Jackson, MI; Waldy, C; Jewell, DE				Jackson, Matthew, I; Waldy, Christopher; Jewell, Dennis E.			Dietary resistant starch preserved through mild extrusion of grain alters fecal microbiome metabolism of dietary macronutrients while increasing immunoglobulin A in the cat	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; BILE-ACIDS; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; BETA-HYDROXYBUTYRATE; STICKLAND REACTION; INDOXYL SULFATE; GUT MICROBIOTA; COLONIC-MUCOSA; LINOLEIC-ACID; AMINO-ACIDS	Dietary digestion-resistant starch (RS) provides health benefits to the host via gut microbiome-mediated metabolism. The degree to which cats manifest beneficial changes in response to RS intake was examined. Healthy cats (N = 36) were fed identically formulated foods processed under high (n = 17) or low (n = 19) shear extrusion conditions (low and high RS levels [LRS and HRS], respectively). Fecal samples collected after 3 and 6 weeks' feeding were assayed for stool firmness score, short-chain fatty acids, ammonia, and changes to the global metabolome and microbiome; fecal immunoglobulin A (IgA) was analyzed at week 6. Few differences were seen in proximate analyses of the foods; stool firmness scores did not differ. In cats consuming HRS food, concentrations of fecal butyrate and the straight chain:branched chain fatty acid ratio were significantly greater in feces at both weeks 3 and 6, while fecal ammonia was reduced at week 6 relative to feces from LRS-fed cats. Fecal IgA concentrations were significantly higher at week 6 with HRS food. RS consumption altered 47% of the fecal metabolome; RS-derived sugars and metabolites associated with greater gut health, including indoles and polyamines, increased in the cats consuming HRS food relative to those fed the LS food, while endocannabinoid N-acylethanolamines decreased. Consumption of HRS food increased concentrations of the ketone body 3-hydroxybutyrate in feces and elevated concentrations of reduced members of NADH-coupled redox congeners and NADH precursors. At the microbiome genus-level, 21% of operational taxonomic units were significantly different between food types; many involved taxa with known saccharolytic or proteolytic proclivities. Microbiome taxa richness and Shannon and Simpson alpha diversity were significantly higher in the HRS group at both weeks. These data show that feline consumption of grain-derived RS produces potentially beneficial shifts in microbiota-mediated metabolism and increases IgA production.	[Jackson, Matthew, I; Waldy, Christopher; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS 66603 USA		Jackson, MI (corresponding author), Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS 66603 USA.	matthew_jackson@hillspet.com	Jewell, Dennis/AAS-8563-2020	Jackson, Matthew/0000-0001-7535-1831; Jewell, Dennis/0000-0003-2305-1014	Hill's Pet Nutrition	Hill's Pet Nutrition	Hill's Pet Nutrition provided funding for this study in the form of salaries for MIJ, CW, and DEJ. The specific roles of these authors are articulated in the 'author contributions' section. The funder was given the opportunity to read the manuscript prior to publication, but played no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agans R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01525-18; Aguilar-Toala JE, 2018, TRENDS FOOD SCI TECH, V75, P105, DOI 10.1016/j.tifs.2018.03.009; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Aitchison J, 1994, INST MATH S, V24, P73, DOI 10.1214/lnms/1215463786; Aneja P, 2002, J BACTERIOL, V184, P1571, DOI 10.1128/JB.184.6.1571-1577.2002; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], **DATA OBJECT**; [Anonymous], 2019, PACKAGE LAVAAN; [Anonymous], 2007, THE RVA HDB; [Anonymous], **DATA OBJECT**; [Anonymous], 2017, MISEQ SOP; [Anonymous], **DATA OBJECT**; Aoki-Yoshida A, 2013, BIOSCI BIOTECH BIOCH, V77, P1766, DOI 10.1271/bbb.120979; ARAGOZZINI F, 1979, APPL ENVIRON MICROB, V38, P544, DOI 10.1128/AEM.38.3.544-546.1979; Association of American Feed Control Officials, 2019 OFF PUBL CHAMP; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Brahma S, 2017, FOOD RES INT, V97, P209, DOI 10.1016/j.foodres.2017.04.019; BRITZ ML, 1982, CAN J MICROBIOL, V28, P291, DOI 10.1139/m82-043; Burstein SH, 2018, MOL PHARMACOL, V93, P228, DOI 10.1124/mol.117.110841; Butowski CF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216072; Cavaleri F, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7195760; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Clarke E, 2007, BRIT POULTRY SCI, V48, P703, DOI 10.1080/00071660701684255; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112; Cohen MS, 2018, NAT CHEM BIOL, V14, P236, DOI [10.1038/NCHEMBIO.2568, 10.1038/nchembio.2568]; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diether NE, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010019; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Eshar D, 2019, CAN J VET RES, V83, P42; Felizardo RJF, 2019, FASEB J, V33, P11894, DOI 10.1096/fj.201901080R; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fitch MD, 1999, AM J PHYSIOL-GASTR L, V277, pG31, DOI 10.1152/ajpgi.1999.277.1.G31; Galligan JJ, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13283; Gao HC, 2017, LIFE SCI, V185, P23, DOI 10.1016/j.lfs.2017.07.027; Ghani QP, 2004, METHOD ENZYMOL, V381, P565; Gloor G, 2017, ALDEX2 PACKAGE R PAC; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Guha M, 2002, INT J FOOD PROP, V5, P509, DOI 10.1081/JFP-120015488; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; He XY, 2017, ANIM NUTR, V3, P219, DOI 10.1016/j.aninu.2017.06.004; Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002; Herrmann E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020179; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOSKINS L C, 1992, Microbial Ecology in Health and Disease, V5, P193; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Jackson MI, 2019, GUT MICROBES, V10, P298, DOI 10.1080/19490976.2018.1526580; Jimenez-Diaz L, 2017, AEROBIC UTILIZATION; Jorgensen JR, 2001, GASTROENTEROLOGY, V120, P1152, DOI 10.1053/gast.2001.23259; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Jost Lou, 2011, P66; Kaikiri H, 2017, INT J FOOD SCI NUTR, V68, P941, DOI 10.1080/09637486.2017.1318116; Kato N, 2002, J NUTR SCI VITAMINOL, V48, P1, DOI 10.3177/jnsv.48.1; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kieffer DA, 2016, AM J PHYSIOL-RENAL, V310, pF857, DOI 10.1152/ajprenal.00513.2015; Kieler IN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41195-0; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Kim YJ, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1479-4; Koay YC, 2019, FASEB J, V33, P8033, DOI 10.1096/fj.201900177R; Kovacs T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37664-7; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Krukenberg KA, 2015, CHEM BIOL, V22, P446, DOI 10.1016/j.chembiol.2015.03.007; Lynch A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13774-6; Magotti P, 2015, STRUCTURE, V23, P598, DOI 10.1016/j.str.2014.12.018; Martin-Fernandez JA, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535524; Martinez KB, 2017, J BIOL CHEM, V292, P8553, DOI 10.1074/jbc.R116.752899; Martinez MM, 2015, APPL RAPID VISCO ANA; Matsumoto J, 2007, J NUTR SCI VITAMINOL, V53, P508, DOI 10.3177/jnsv.53.508; Matsumoto M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051188; Matsumoto M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169207; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mikulic J, 2017, CELL MOL IMMUNOL, V14, P546, DOI 10.1038/cmi.2015.110; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Moludi J, 2018, J CARDIOVASC THORAC, V10, P129, DOI 10.15171/jcvtr.2018.21; Morita T, 1999, J NUTR, V129, P1333, DOI 10.1093/jn/129.7.1333; Morita T, 2004, BIOSCI BIOTECH BIOCH, V68, P2155, DOI 10.1271/bbb.68.2155; Morita T, 2004, J GASTROEN HEPATOL, V19, P303, DOI 10.1111/j.1440-1746.2003.03208.x; Morita T, 1998, J NUTR, V128, P1156, DOI 10.1093/jn/128.7.1156; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nakamura A, 2019, GUT MICROBES, V10, P159, DOI 10.1080/19490976.2018.1494466; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory, 2011, PREC MED BUILD KNOWL, V8; NAUMANN E, 1983, APPL ENVIRON MICROB, V45, P474, DOI 10.1128/AEM.45.2.474-483.1983; Negatu DA, 2019, MBIO, V10, DOI 10.1128/mBio.02781-18; Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Okazaki Y, 2011, J NUTR, V141, P1975, DOI 10.3945/jn.111.144246; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; Peixoto MC, 2018, J ANIM PHYSIOL AN N, V102, pE111, DOI 10.1111/jpn.12711; Pickard JM, 2015, J IMMUNOL, V194, P5588, DOI 10.4049/jimmunol.1500395; Pinna C, 2014, J ANIM SCI, V92, P5593, DOI 10.2527/jas.2013-7459; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; RALET MC, 1991, FOOD SCI TECHNOL-LEB, V24, P107; Rettger LF, 1906, J BIOL CHEM, V2, P71; Richardson AJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-6; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rochus K, 2014, NUTR RES REV, V27, P295, DOI 10.1017/S0954422414000213; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; Schauf S, 2018, J ANIM SCI, V96, P3684, DOI 10.1093/jas/sky264; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Storey JD, 2014, QVALUE QVALUE ESTIMA; SUGANO M, 1990, J NUTR, V120, P977, DOI 10.1093/jn/120.9.977; Summers SC, 2019, J VET INTERN MED, V33, P662, DOI 10.1111/jvim.15389; Sun J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01179; Tanaka M, 2019, J FOOD SCI, V84, P1180, DOI 10.1111/1750-3841.14583; Tang W, 2019, CLIN CANCER RES, V25, P5972, DOI 10.1158/1078-0432.CCR-19-0094; Nguyen TT, 2018, WORLD J CLIN CASES, V6, P577, DOI 10.12998/wjcc.v6.i13.577; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Trachsel J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01381; Tran QD, 2008, J SCI FOOD AGR, V88, P1487, DOI 10.1002/jsfa.3247; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005	124	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241037	10.1371/journal.pone.0241037	http://dx.doi.org/10.1371/journal.pone.0241037			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141838	gold, Green Published			2022-12-26	WOS:000588376700043
J	Unceta, I; Nin, J; Pujol, O				Unceta, Irene; Nin, Jordi; Pujol, Oriol			Risk mitigation in algorithmic accountability: The role of machine learning copies	PLOS ONE			English	Article								Machine learning plays an increasingly important role in our society and economy and is already having an impact on our daily life in many different ways. From several perspectives, machine learning is seen as the new engine of productivity and economic growth. It can increase the business efficiency and improve any decision-making process, and of course, spawn the creation of new products and services by using complex machine learning algorithms. In this scenario, the lack of actionable accountability-related guidance is potentially the single most important challenge facing the machine learning community. Machine learning systems are often composed of many parts and ingredients, mixing third party components or software-as-a-service APIs, among others. In this paper we study the role of copies for risk mitigation in such machine learning systems. Formally, a copy can be regarded as an approximated projection operator of a model into a target model hypothesis set. Under the conceptual framework of actionable accountability, we explore the use of copies as a viable alternative in circumstances where models cannot be re-trained, nor enhanced by means of a wrapper. We use a real residential mortgage default dataset as a use case to illustrate the feasibility of this approach.	[Unceta, Irene] BBVA Data & Analyt, Barcelona, Spain; [Unceta, Irene; Pujol, Oriol] Univ Barcelona, Dept Math & Comp Sci, Barcelona, Spain; [Nin, Jordi] Univ Ramon Llull, Dept Operat Innovat & Data Sci, ESADE, Barcelona, Spain	University of Barcelona; Universitat Ramon Llull; Escuela Superior de Administracion y Direccion de Empresas (ESADE)	Unceta, I (corresponding author), BBVA Data & Analyt, Barcelona, Spain.; Unceta, I (corresponding author), Univ Barcelona, Dept Math & Comp Sci, Barcelona, Spain.	irene.unceta@bbvadata.com	Pujol, Oriol/F-7146-2016; Unceta, Irene/AAO-3995-2021	Pujol, Oriol/0000-0001-7573-009X; Unceta, Irene/0000-0002-7422-1493	BBVA Data Analytics	BBVA Data Analytics	We acknowledge the support of BBVA Data & Analytics for sponsoring the Industrial PhD.	Abebe R, 2020, FAT* '20: PROCEEDINGS OF THE 2020 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P252, DOI 10.1145/3351095.3372871; Adler P, 2018, KNOWL INF SYST, V54, P95, DOI 10.1007/s10115-017-1116-3; Angwin J, 2016, NY TIMES; Angwin Julia, 2016, MACHINE BIAS THERES; [Anonymous], 2016, XINHUA NEWS; [Anonymous], 2008, FORENSIC MAGAZINE, V5, P37, DOI DOI 10.1214/07-PS121; Barocas S, 2017, COMMUN ACM, V60, P23, DOI 10.1145/3144172; Barocas S, 2016, CALIF LAW REV, V104, P671, DOI 10.15779/Z38BG31; Barreno M, 2002, P ACM S INF COMP COM, P16; BBVA Research, 2018, PRIM SEM 2018; Beijing Academy of Artificial Intelligence (BAAI), 2019, BEIJ AI PRINC; Berk R, 2021, SOCIOL METHOD RES, V50, P3, DOI 10.1177/0049124118782533; Blodgett SL, 2016, ARXIV200514050; Bolukbasi Tolga, 2016, NIPS, DOI DOI 10.5555/3157382; Bostrom Nick, 2009, SCI FICTION PHILOS T, P277; Bucilua C., 2006, P 12 ACM SIGKDD INT, P535, DOI [DOI 10.1145/1150402.1150464, DOI 10.1145/1150402]; Buolamwini J., 2018, C FAIRNESS ACCOUNTAB, P77; Carr B, 2018, MACHINE LEARNING PAP; Chen CH, 2015, IEEE I CONF COMP VIS, P855, DOI [10.1109/ICCV.2015.104, 10.1109/ICCV.2015.312]; Clark A, 2018, MACHINE LEARNING AUD; Craven M, 1993, P 10 INT C MACH LEAR, P73; Craven M. W., 1995, ADV NEURAL INFORM PR, P24; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Datta Amit, 2015, Proceedings on Privacy Enhancing Technologies, V1, P92, DOI 10.1515/popets-2015-0007; Diakopoulos N, 2016, MITS TECHNOL REV; Diakopoulos N, 2016, FAIRNESS ACCOUNTABIL; Docherty A, 2013, BETTER BANKING UNDER; European Parliament, 2017, 20170051 PBTAPROV EU; Executive Office of the President, 2016, PREP FUT ART INT; Executive Office of the President, 2016, BIG DATA REPORT ALGO; Ferrari M, 2019, P ACM C REC SYST 201; FU LM, 1991, PROCEEDINGS : NINTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P590; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goodman BW, 2016, P INT C NEUR INF PRO; Guha S, 2010, P ACM INT C DAT COMM; Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009; Hansson SO, 2008, STANFORD ENCY PHILOS; Hardt M., 2014, BIG DATA IS UNFAIR M; High-Level Expert Group on AI, 2019, ETH GUID TRUSTW AI; Hinton G., 2015, DISTILLING KNOWLEDGE; Hundepool A., 2012, STAT DISCLOSURE CONT; ISO, 2018, 310002018 ISO; Jia Q, 2018, IEEE T PARALL DISTR, V29, P1808, DOI 10.1109/TPDS.2018.2809624; Klare BF, 2012, IEEE T INF FOREN SEC, V7, P1789, DOI 10.1109/TIFS.2012.2214212; Kleinberg J, 2018, J LEGAL ANAL, V10, P113, DOI 10.1093/jla/laz001; Kroll JA, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2018.0084; Kuttichira DP, 2019, LECT NOTES ARTIF INT, V11670, P3, DOI 10.1007/978-3-030-29908-8_1; Lipton Z. C., 2016, ARXIV160603490; Lisboa P. J., 2000, ARTIFICIAL NEURAL NE; Livingston J, 2018, AUDITING ARTIFICIAL; Luca M, TOO HARV BUS REV, V94, P20; Maestre R, 2018, DELIVERING ADV ARTIF; Maurer M., 2016, AUTONOMOUS DRIVING T, DOI [10.1007/978-3-662-48847-8, DOI 10.1007/978-3-662-48847-8]; Melo LSS, 2017, BRAZ ORAL RES, V31, P1, DOI DOI 10.1007/S00162-017-0430-4; Mena J, 2019, LECT NOTES COMPUTER, P29; Mena J, 2020, IEEE ACCESS, V8, P101721, DOI 10.1109/ACCESS.2020.2996495; Miller C. C, 2015, NEW YORK TIMES; Papernot N., 2016, ARXIV160507277, DOI 10.48550/arXiv.1605.07277; Papernot N, 2017, PROCEEDINGS OF THE 2017 ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (ASIA CCS'17), P506, DOI 10.1145/3052973.3053009; Podesta J., 2014, BIG DATA SEIZING OPP; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rudin C, 2018, WORKSH CRIT CORR TRE; Sandvig Christian, 2014, DATA DISCRIM, V22, P4349; Sculley D, 2014, WORKSH SOFTW ENG MAC, P8; Selbst AD, 2018, FORDHAM LAW REV, V87, P1085; Shokri R, 2017, P IEEE S SECUR PRIV, P3, DOI 10.1109/SP.2017.41; Sweeney L., 2013, DISCRIMINATION ONLIN, V11, P10, DOI [DOI 10.1145/2460276.2460278, 10.1145/2447976.2447990]; Szegedy C, 2014, P INT C LEARN REPR 2; Thrun S, 1994, P 7 INT C NEUR INF P, P505; Torra V, 2017, DATA PRIVACY FDN NEW; Tramer F, 2016, PROCEEDINGS OF THE 25TH USENIX SECURITY SYMPOSIUM, P601; Unceta I, 2018, WORKSH CHALL OPP AI, P3; Unceta I, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22101122; Unceta I, 2020, IEEE ACCESS, V8, P160268, DOI 10.1109/ACCESS.2020.3020638; Unceta I, 2019, FRONT ARTIF INTEL AP, V319, P125, DOI 10.3233/FAIA190115; Unceta I, 2020, LECT NOTES COMPUT SC, V11867, P182, DOI 10.1007/978-3-030-31332-6_16; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Veale M, 2017, BIG DATA SOC, V4, DOI 10.1177/2053951717743530; Wachter S, 2017, ROBOTICS SCI ROBOTIC, V2, P1223; World Economic Forum, 2018, PREV DISCR OUTC MACH	85	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241286	10.1371/journal.pone.0241286	http://dx.doi.org/10.1371/journal.pone.0241286			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141844	Green Published, gold			2022-12-26	WOS:000588376700001
J	Windes, P; Tafti, DK; Muller, R				Windes, Peter; Tafti, Danesh K.; Mueller, Rolf			Analysis of a 180-degree U-turn maneuver executed by a hipposiderid bat	PLOS ONE			English	Article							FLIGHT	Bats possess wings comprised of a flexible membrane and a jointed skeletal structure allowing them to execute complex flight maneuvers such as rapid tight turns. The extent of a bat's tight turning capability can be explored by analyzing a 180-degree U-turn. Prior studies have investigated more subtle flight maneuvers, but the kinematic and aerodynamic mechanisms of a U-turn have not been characterized. In this work, we use 3D optical motion capture and aerodynamic simulations to investigate a U-turn maneuver executed by a great roundleaf bat (Hipposideros armiger: mass = 55 g, span = 51 cm). The bat was observed to decrease its flight velocity and gain approximately 20 cm of altitude entering the U-turn. By lowering its velocity from 2.0 m/s to 0.5 m/s, the centripetal force requirement to execute a tight turn was substantially reduced. Centripetal force was generated by tilting the lift force vector laterally through banking. During the initiation of the U-turn, the bank angle increased from 20 degrees to 40 degrees. During the initiation and persisting throughout the U-turn, the flap amplitude of the right wing (inside of the turn) increased relative to the left wing. In addition, the right wing moved more laterally closer to the centerline of the body during the end of the downstroke and the beginning of the upstroke compared to the left wing. Reorientation of the body into the turn happened prior to a change in the flight path of the bat. Once the bat entered the U-turn and the bank angle increased, the change in flight path of the bat began to change rapidly as the bat negotiated the apex of the turn. During this phase of the turn, the minimum radius of curvature of the bat was 5.5 cm. During the egress of the turn, the bat accelerated and expended stored potential energy by descending. The cycle averaged total power expenditure by the bat during the six wingbeat cycle U-turn maneuver was 0.51 W which was approximately 40% above the power expenditure calculated for a nominally straight flight by the same bat. Future work on the topic of bat maneuverability may investigate a broader array of maneuvering flights characterizing the commonalities and differences across flights. In addition, the interplay between aerodynamic moments and inertial moments are of interest in order to more robustly characterize maneuvering mechanisms.	[Windes, Peter; Tafti, Danesh K.; Mueller, Rolf] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tafti, DK (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	dtafti@exchange.vt.edu		Windes, Peter/0000-0002-6059-5128	NSF CBET [1510797]; NSF IRES [1658620]; VT ICTAS/BIST Center, National Natural Science Foundation of China [11374192, 11574183]; Chinese Ministry of Education Tese Grant	NSF CBET(National Science Foundation (NSF)); NSF IRES(National Science Foundation (NSF)NSF - Office of the Director (OD)); VT ICTAS/BIST Center, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education Tese Grant	This research received financial support from NSF CBET Grant No. 1510797, NSF IRES Grant No. 1658620, support from VT ICTAS/BIST Center, National Natural Science Foundation of China (Grant Nos. 11374192 & 11574183), and Chinese Ministry of Education Tese Grant for international faculty exchange.	ALDRIDGE HDJN, 1987, J EXP BIOL, V128, P419; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Gutierrez E, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/12/1/016004; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015001; Henningsson P, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0441; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Nagendra K, 2014, J COMPUT PHYS, V267, P225, DOI 10.1016/j.jcp.2014.02.045; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pennycuick C., 1989, BIRD FLIGHT PERFOMAN; Sekhar S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218672; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tafti D.K., 2001, P ASME FLUIDS ENG DI, V256, P347; Wang SZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0821; Windes P., 2020, BIOINSPIR BIOMIM, V16, DOI [10.1088/1748-3190/abb78d, DOI 10.1088/1748-3190/ABB78D]; Windes P, 2019, BIOINSPIR BIOMIM, V14, DOI 10.1088/1748-3190/ab3e2a; Windes P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207613	20	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241489	10.1371/journal.pone.0241489	http://dx.doi.org/10.1371/journal.pone.0241489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141874	Green Published, gold			2022-12-26	WOS:000588376700006
J	Lee, BC; Choi, J; Martin, BJ				Lee, Beom-Chan; Choi, Jongkwan; Martin, Bernard J.			Roles of the prefrontal cortex in learning to time the onset of pre-existing motor programs	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; ORBITOFRONTAL CORTEX; WORKING-MEMORY; CORTICAL ACTIVATION; GAIT; MECHANISMS; TREADMILL; WALKING; OBESITY; SPEED	The prefrontal cortex (PFC) is involved in cognitive control of motor activities and timing of future intensions. This study investigated the cognitive control of balance recovery in response to unpredictable gait perturbations and the role of PFC subregions in learning by repetition. Bilateral dorsolateral (DLPFC), ventrolateral (VLPFC), frontopolar (FPFC) and orbitofrontal (OFC) cortex hemodynamic changes induced by unpredictable slips were analyzed as a function of successive trials in ten healthy young adults. Slips were induced by the acceleration of one belt as the participant walked on a split-belt treadmill. A portable functional near-infrared spectroscope monitored PFC activities quantified by oxyhemoglobin (Delta O(2)Hb) and deoxyhemoglobin (Delta HbR) during the consecutive trial phases: standing, walking, slip-recovery. During the first 3 trials, the average oxyhemoglobin (Delta O(2)Hb(avg)) in the DLPFC, VLPFC, FPFC, and OFC cortex was significantly higher during slip-recovery than unperturbed walking or the standing baseline. Then, Delta O(2)Hb(avg) decreased progressively from trial-to-trial in the DLPFC, VLPFC, and FPFC, but increased and then remained constant in the OFC. The average deoxyhemoglobin (Delta HbR(avg)) presented mirror patterns. These changes after the third trial were paralleled by the progressive improvement of recovery revealed by kinematic variables. The results corroborate our previous hypothesis that only timing of the onset of a "good enough recovery motor program" is learned with practice. They also strongly support the assumption that the PFC contributes to the recall of pre-existing motor programs whose onset timing is adjusted by the OFC. Hence, learning is clearly divided into two steps delineated by the switch in activity of the OFC. Additionally, motor processes appear to share the working memory as well as decisional and predictive resources of the cognitive system.	[Lee, Beom-Chan] Univ Houston, Dept Hlth & Human Performance, Houston, TX USA; [Choi, Jongkwan] OBELAB Inc, Seoul, South Korea; [Martin, Bernard J.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA	University of Houston System; University of Houston; University of Michigan System; University of Michigan	Martin, BJ (corresponding author), Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA.	martinbj@umich.edu			Ministry of Science, ICT and Future Planning south Korea/Institute for Information and Communications Technology Promotion (IITP) [2017-0-01724]	Ministry of Science, ICT and Future Planning south Korea/Institute for Information and Communications Technology Promotion (IITP)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea)	BCL received the following funding. This work was supported by the Ministry of Science, ICT and Future Planning south Korea/Institute for Information and Communications Technology Promotion (IITP): #2017-0-01724. The funding agency provided support in the form of salaries for author BCL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Anguera JA, 2007, BRAIN RES, V1185, P136, DOI 10.1016/j.brainres.2007.09.088; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103; Baltz ET, 2018, ELIFE, V7, DOI 10.7554/eLife.35988; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; Choi JK, 2016, IEEE J SOLID-ST CIRC, V51, P484, DOI 10.1109/JSSC.2015.2504412; Choi JK, 2013, IEEE T BIOMED CIRC S, V7, P169, DOI 10.1109/TBCAS.2013.2255052; Conen KE, 2016, NAT NEUROSCI, V19, P866, DOI 10.1038/nn.4329; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Cui RF, 2014, MICROVASC RES, V93, P14, DOI 10.1016/j.mvr.2014.02.008; Curtis Clayton E., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P528, DOI 10.3758/CABN.4.4.528; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; de Xivry JJO, 2016, J NEUROPHYSIOL, V116, P2857, DOI 10.1152/jn.00319.2016; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dravida S, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.1.011006; Durantin G, 2014, IEEE ENG MED BIO, P2107, DOI 10.1109/EMBC.2014.6944032; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Floresco SB, 2003, J NEUROSCI, V23, P3930; Gourley SL, 2016, J NEUROSCI, V36, P4600, DOI 10.1523/JNEUROSCI.4253-15.2016; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; Herold F, 2019, BRAIN TOPOGR, V32, P472, DOI 10.1007/s10548-019-00699-8; Herold F, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041403; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Ikegami T, 2008, EXP BRAIN RES, V191, P221, DOI 10.1007/s00221-008-1518-2; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; Jensen JL, 2001, EXP AGING RES, V27, P361, DOI 10.1080/03610730109342354; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Khambhati AN, 2018, NEUROIMAGE, V166, P385, DOI 10.1016/j.neuroimage.2017.11.015; Kim J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30481-y; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lara AH, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00173; Lee BC, 2019, IEEE T NEUR SYS REH, V27, P1389, DOI 10.1109/TNSRE.2019.2921710; Lee BC, 2017, IEEE ENG MED BIO, P3777, DOI 10.1109/EMBC.2017.8037679; Lee BC, 2017, IEEE T NEUR SYS REH, V25, P235, DOI 10.1109/TNSRE.2016.2556690; Lee BC, 2016, EXP BRAIN RES, V234, P3523, DOI 10.1007/s00221-016-4750-1; Leff DR, 2008, NEUROIMAGE, V39, P805, DOI 10.1016/j.neuroimage.2007.09.032; Lichtenberg NT, 2017, J NEUROSCI, V37, P8374, DOI 10.1523/JNEUROSCI.0486-17.2017; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mawase F, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00060; MCILROY WE, 1993, BRAIN RES, V616, P30, DOI 10.1016/0006-8993(93)90188-S; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Momennejad I, 2012, NEUROIMAGE, V61, P139, DOI 10.1016/j.neuroimage.2012.02.079; Padoa-Schioppa C, 2017, NEURON, V96, P736, DOI 10.1016/j.neuron.2017.09.031; Patel R, 2013, NEUROREHAB NEURAL RE, V27, P187, DOI 10.1177/1545968312461718; Pfeifer MD, 2018, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00641; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Reddy PG, 2018, NEUROIMAGE, V171, P135, DOI 10.1016/j.neuroimage.2017.12.093; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Sagari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140552; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Seidler RD, 2012, J MOTOR BEHAV, V44, P445, DOI 10.1080/00222895.2012.672348; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shobe JL, 2017, J NEUROSCI, V37, P9415, DOI 10.1523/JNEUROSCI.0572-17.2017; Solbakk AK, 2014, SCAND J PSYCHOL, V55, P233, DOI 10.1111/sjop.12106; Solis-Escalante T, 2019, NEUROIMAGE, V188, P557, DOI 10.1016/j.neuroimage.2018.12.045; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Vicon motion systems Ltd, FULL BOD MOD PLUG IN; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Vitorio R, 2017, NEUROSCI BIOBEHAV R, V83, P160, DOI 10.1016/j.neubiorev.2017.10.002; Wikenheiser AM, 2016, NAT REV NEUROSCI, V17, P513, DOI 10.1038/nrn.2016.56; Winter D. A, 2009, BIOMECHANICS MOTOR C; Wittenberg E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00170; Wu XF, 2012, J BIOMECH, V45, P1042, DOI 10.1016/j.jbiomech.2011.12.021; Yoo D, 2019, GAIT POSTURE, V71, P98, DOI 10.1016/j.gaitpost.2019.04.013; 2015, GYNECOLOGICAL SURG, V12	84	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241562	10.1371/journal.pone.0241562	http://dx.doi.org/10.1371/journal.pone.0241562			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166309	Green Published, gold			2022-12-26	WOS:000592382600015
J	Weld, KA; Oliveira, RC; Bertics, SJ; Erb, SJ; White, HM				Weld, Kristina A.; Oliveira, Rafael Caputo; Bertics, Sandra J.; Erb, Sophia J.; White, Heather M.			Hepatic pyruvate carboxylase expression differed prior to hyperketonemia onset in transition dairy cows	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; MESSENGER-RNA EXPRESSION; BETA-HYDROXYBUTYRATE; STEARIC-ACID; GLUCONEOGENIC ENZYMES; ADIPOSE-TISSUE; LINOLEIC-ACID; OLEIC ACIDS; FEED-INTAKE; LIVER	Fatty acids (FA) provide an energy source to the liver during negative energy balance; however, when FA influx is excessive, FA can be stored as liver lipids or incompletely oxidized to beta-hydroxybutyrate (BHB). The objectives of this study were to quantify plasma and liver FA profiles and hepatic gene expression in cows diagnosed with hyperketonemia (HYK; BHB >= 1.2 mM) or not (nonHYK; BHB < 1.2 mM) to determine a relationship between FA profile and expression of hepatic genes related to oxidation and gluconeogenesis. Production parameters, blood samples (-28, -3, 1, 3, 5, 7, 9, 11, and 14 d relative to parturition; n = 28 cows), and liver biopsies (1, 14, and 28 d postpartum; n = 22 cows) were collected from Holstein cows. Cows were retrospectively grouped as HYK or nonHYK based on BHB concentrations in postpartum blood samples. Average first positive test (BHB >= 1.2 mM) was 9 +/- 5 d (+/- SD). Cows diagnosed with HYK had greater C18:1 and lower C18:2 plasma proportions. Liver FA proportions of C16:0 and C18:1 were related to proportions in plasma, but C18:0 and C18:2 were not. Some interactions between plasma FA and HYK on liver FA proportion suggests that there may be preferential use depending upon metabolic state. Cows diagnosed with HYK had decreased pyruvate carboxylase (PC) expression, but no difference at 1 d postpartum in either cytosolic or mitochondrial isoforms of phosphoenolpyruvate carboxykinase (PCK). The increased PC to PCK ratios in nonHYK cows suggests the potential for greater hepatic oxidative capacity, coinciding with decreased circulating BHB. Interestingly, FA, known regulators of PC expression, were not correlated with PC expression at 1 d postpartum. Taken together, these data demonstrate that HYK cows experience a decrease in the ratio of hepatic PC to PCK at 1 day postpartum prior to HYK diagnosis which, on average, manifested a week later. The differential regulation of PC involved in HYK diagnosis may not be completely due to shifts in FA profiles and warrants further investigation.	[Weld, Kristina A.; Oliveira, Rafael Caputo; Bertics, Sandra J.; Erb, Sophia J.; White, Heather M.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	White, HM (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu		CAPUTO OLIVEIRA, RAFAEL/0000-0002-9688-5418; Kendall, Sophia/0000-0001-8259-4866	USDA Hatch from the Wisconsin Agricultural Experiment Station (Madison, WI) [WIS01877]; Fermented Nutrition Corporation (Luxemburg, WI); Purina Animal Nutrition, LLC	USDA Hatch from the Wisconsin Agricultural Experiment Station (Madison, WI); Fermented Nutrition Corporation (Luxemburg, WI); Purina Animal Nutrition, LLC	Funding for this research was provided by USDA Hatch grant number WIS01877 from the Wisconsin Agricultural Experiment Station (Madison, WI; HW received funding) and Fermented Nutrition Corporation (Luxemburg, WI; HW received funding). Graduate student fellowship support was provided by Purina Animal Nutrition, LLC (KW received funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agca C, 2004, ANIM BIOTECHNOL, V15, P47, DOI 10.1081/ABIO-120037897; Al-Trad B, 2010, J ANIM SCI, V88, P2998, DOI 10.2527/jas.2009-2463; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; BAIRD GD, 1968, BIOCHEM J, V107, P683, DOI 10.1042/bj1070683; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Bruce JS, 1996, BIOCHEM J, V316, P847, DOI 10.1042/bj3160847; CHEN ZY, 1992, AM J PHYSIOL, V263, pR233, DOI 10.1152/ajpregu.1992.263.2.R233; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; Duffield TF, 1998, J DAIRY SCI, V81, P2866, DOI 10.3168/jds.S0022-0302(98)75846-1; Enjalbert F, 1998, J NUTR, V128, P1525, DOI 10.1093/jn/128.9.1525; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOSTER LB, 1973, CLIN CHEM, V19, P338; Glasser F, 2008, ANIMAL, V2, P691, DOI 10.1017/S1751731108002036; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Janovick-Guretzky NA, 2007, J DAIRY SCI, V90, P2246, DOI 10.3168/jds.2006-640; Ji P, 2014, J DAIRY SCI, V97, P3441, DOI 10.3168/jds.2013-7296; KATZ ML, 1969, AM J PHYSIOL, V216, P953, DOI 10.1152/ajplegacy.1969.216.4.953; Li P, 2012, J DAIRY SCI, V95, P1759, DOI 10.3168/jds.2011-4580; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McCarthy MM, 2015, J DAIRY SCI, V98, P6284, DOI 10.3168/jds.2015-9446; Meier S, 2013, J DAIRY RES, V80, P197, DOI 10.1017/S0022029913000034; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Oliveira RC, 2020, J DAIRY SCI, V103, P7055, DOI 10.3168/jds.2019-17790; Oliveira RC, 2019, J DAIRY SCI, V102, P2283, DOI 10.3168/jds.2018-15519; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Ospina PA, 2010, J DAIRY SCI, V93, P546, DOI 10.3168/jds.2009-2277; Pralle RS, 2019, J DAIRY SCI, V102, P271; Rathbun FM, 2017, J DAIRY SCI, V100, P3685, DOI 10.3168/jds.2016-12085; REID IM, 1979, J AGR SCI, V93, P253, DOI 10.1017/S0021859600086366; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Rodriguez-Jimenez S, 2018, J DAIRY SCI, V101, P8224, DOI 10.3168/jds.2017-14254; Rukkwamsuk T, 2000, J DAIRY SCI, V83, P52, DOI 10.3168/jds.S0022-0302(00)74854-5; Sato H, 2006, ANIM SCI J, V77, P347, DOI 10.1111/j.1740-0929.2006.00358.x; Schafers S, 2017, J DAIRY SCI, V100, P3193, DOI 10.3168/jds.2016-11882; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; THOMPSON GE, 1975, Q J EXP PHYSIOL CMS, V60, P107, DOI 10.1113/expphysiol.1975.sp002297; THOMPSON GE, 1975, RES VET SCI, V18, P325, DOI 10.1016/S0034-5288(18)33586-0; WANG S, 1993, J NUTR BIOCHEM, V4, P594, DOI 10.1016/0955-2863(93)90028-U; Weld A.K., 2018, J DAIRY SCI, V10, P270; Weld KA, 2019, J DAIRY SCI, V102, P7576, DOI 10.3168/jds.2018-16150; Weld KA, 2018, J DAIRY SCI, V101, P9768, DOI 10.3168/jds.2018-14498; White HM, 2012, J DAIRY SCI, V95, P1249, DOI 10.3168/jds.2011-4644; White HM, 2011, J ANIM SCI, V89, P1763, DOI 10.2527/jas.2010-3407; White HM, 2015, ANIMALS-BASEL, V5, P793, DOI 10.3390/ani5030384; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Xu C, 2010, ASIAN AUSTRAL J ANIM, V23, P312, DOI 10.5713/ajas.2010.90416; Zhang GS, 2016, RES VET SCI, V107, P246, DOI 10.1016/j.rvsc.2016.06.012; Zhang Q, 2017, J DAIRY SCI, V100, P8565, DOI 10.3168/jds.2017-12932; Zhang Q, 2016, J DAIRY SCI, V99, P3908, DOI 10.3168/jds.2015-10312	51	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241929	10.1371/journal.pone.0241929	http://dx.doi.org/10.1371/journal.pone.0241929			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166331	gold, Green Published			2022-12-26	WOS:000592382600035
J	Adem, GD; Ueda, Y; Hayes, PE; Wissuwa, M				Adem, Getnet Dino; Ueda, Yoshiaki; Hayes, Patrick Enrico; Wissuwa, Matthias			Genetic and physiological traits for internal phosphorus utilization efficiency in rice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PHOSPHATE STARVATION; PHR1; SUSTAINABILITY; MICRORNA399; EXPRESSION	Phosphorus (P) is an essential macronutrient for plant growth and development. Phosphorus is usually applied as fertilizer obtained from rock phosphate which is a non-renewable resource. Therefore, developing rice varieties that can use P more efficiently is crucial. Here, we investigated genotypic differences in traits related to internal Phosphorus Utilization Efficiency (PUE) in five rice genotypes grown under P-deficient conditions. P-efficient rice genotypes showed higher total biomass. This was partly due to higher root biomass, which in turn relied on preferential allocation of P to roots in these genotypes. Changes in P content and tissue P concentrations were analyzed in individual leaves at different time points. Genotypes belonging to the high-PUE group responded more quickly to P starvation in terms of reducing leaf P concentrations and they were able to reduce these concentrations to a lower level compared to the low-PUE group. Changes in P concentrations were reflected in gene expression levels for genes involved in lipid remodeling. Sulfolipid (OsSQD2) and galactolipid (OsMGD and OsDGD) synthesis-related genes were generally induced due to P starvation with most pronounced up-regulation in OsDGD1 and OsMGD3, but patterns differed between genotypes. A significantly higher expression of OsDGD5 and OsMGD1 & 2 was detected in the youngest fully expanded leaf of the high-PUE genotype group, whereas expression levels were reversed in older leaves. This pattern would confirm that P efficient genotypes react faster to P starvation in terms of freeing P for redistribution to growing tissues and replacing phospholipids with galactolipids in younger leaves may contribute to this aspect.	[Adem, Getnet Dino; Ueda, Yoshiaki; Hayes, Patrick Enrico; Wissuwa, Matthias] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan; [Hayes, Patrick Enrico] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia	Japan International Research Center for Agricultural Sciences; University of Western Australia	Wissuwa, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan.	wissuwa@affrc.go.jp	Hayes, Patrick E./D-4679-2014	Hayes, Patrick E./0000-0001-7554-4588; Wissuwa, Matthias/0000-0003-3505-9398; Ueda, Yoshiaki/0000-0002-4304-368X	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this work was provided by the Japan Society for the Promotion of Science (JSPS), https://www.jsps.go.jp/english/, in the form of postdoctoral fellowships to GDA and PEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzola C, 2020, INTRO S HMISC DESIGN; [Anonymous], 2005, MINERAL NUTR PLANTS; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Cassman K. G., 1995, Geojournal, V35, P299, DOI 10.1007/BF00989137; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Childers DL, 2011, BIOSCIENCE, V61, P117, DOI 10.1525/bio.2011.61.2.6; CRAFTSBRANDNER SJ, 1992, PLANT PHYSIOL, V98, P1128, DOI 10.1104/pp.98.3.1128; De Mendiburu F, 2009, THESIS; Dissanayaka DMSB, 2018, PLANT CELL ENVIRON, V41, P1483, DOI 10.1111/pce.13191; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Hadley W, 2016, ELEGANT GRAPHICS DAT; Holler S, 2014, PLANTA, V239, P367, DOI 10.1007/s00425-013-1978-x; Jeong K, 2017, PLANT BIOTECHNOL J, V15, P15, DOI 10.1111/pbi.12586; Lambers H, 2012, NEW PHYTOL, V196, P1098, DOI 10.1111/j.1469-8137.2012.04285.x; Mew MC, 2016, SCI TOTAL ENVIRON, V542, P1008, DOI 10.1016/j.scitotenv.2015.08.045; Mori A, 2016, J EXP BOT, V67, P1179, DOI 10.1093/jxb/erv557; MOTOMIZU S, 1983, ANALYST, V108, P361, DOI 10.1039/an9830800361; Murdoch DJ, 1996, AM STAT, V50, P178, DOI 10.2307/2684435; Nakamura Y, 2013, PROG LIPID RES, V52, P43, DOI 10.1016/j.plipres.2012.07.002; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Pant BD, 2015, J EXP BOT, V66, P1907, DOI 10.1093/jxb/eru535; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; RCore Team, 2020, R LANG ENV STAT COMP; Rose TJ, 2016, PLANT SOIL, V401, P79, DOI 10.1007/s11104-015-2565-7; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Watanabe M, 2020, PLANT CELL ENVIRON, V43, P2066, DOI 10.1111/pce.13777; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wissuwa M, 2020, PLANT SOIL, V448, P523, DOI 10.1007/s11104-020-04453-z; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Yoshida S, 1971, INT RICE RES I; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499	39	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241842	10.1371/journal.pone.0241842	http://dx.doi.org/10.1371/journal.pone.0241842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152024	gold, Green Published			2022-12-26	WOS:000591376200061
J	Al Salameen, F; Habibi, N; Uddin, S; Al Mataqi, K; Kumar, V; Al Doaij, B; Al Amad, S; Al Ali, E; Shirshikhar, F				Al Salameen, Fadila; Habibi, Nazima; Uddin, Saif; Al Mataqi, Khalil; Kumar, Vinod; Al Doaij, Bashayer; Al Amad, Sami; Al Ali, Ebtisam; Shirshikhar, Faiz			Spatio-temporal variations in bacterial and fungal community associated with dust aerosol in Kuwait	PLOS ONE			English	Article							METEOROLOGICAL FACTORS; PARTICULATE MATTER; AIRBORNE BACTERIA; SIZE DISTRIBUTION; DESERT DUST; AREA; ASTHMA; VARIABILITY; URBAN; STORMS	Kuwait is a country with a very high dust loading; in fact it bears the world's highest particulate matter concentration in the outdoor air. The airborne dust often has associated biological materials, including pathogenic microbes that pose a serious risk to the urban ecosystem and public health. This study has established the baseline taxonomic characterization of microbes associated with dust transported into Kuwait from different trajectories. A high volume air sampler with six-stage cascade impactor was deployed for sample collection at a remote as well as an urban site. Samples from three different seasons (autumn, spring and summer) were subjected to targeted amplicon sequencing. A set of similar to 50 and 60 bacterial and fungal genera, respectively, established the core air microbiome. The predominant bacterial genera (relative abundance >= 1%) were Brevundimonas (12.5%), Sphingobium (3.3%), Sphingopyxis (2.7%), Pseudomonas (2.5%), Sphingomonas (2.4%), Massilia (2.3%), Acidovorax (2.0%), Allorhizobium (1.8%), Halomonas (1.3%), and Mesorhizobium (1.1%), and the fungal taxa were Cryptococcus (12%) followed by Alternaria (9%), Aspergillus (7%), Candida (3%), Cladosporium (2.9%), Schizophyllum (1.6%), Fusarium (1.4%), Gleotinia (1.3%) and Penicillium (1.15%). Significant spatio-temporal variations were recorded in terms of relative abundances, alpha-diversities, and beta-diversities of bacterial communities. The dissimilarities were less pronounced and instead the communities were fairly homogenous. Linear discrimant analysis revealed three fungal genera known to be significantly differentially abundant with respect to different size fractions of dust. Our results shed light on the spatio-temporal distribution of airborne microbes and their implications in general health.	[Al Salameen, Fadila; Habibi, Nazima; Al Mataqi, Khalil; Kumar, Vinod; Al Doaij, Bashayer; Al Amad, Sami; Al Ali, Ebtisam] Kuwait Inst Sci Res, Environm & Life Sci Res Ctr, Biotechnol Program, Shuwaikh, Kuwait; [Uddin, Saif; Shirshikhar, Faiz] Kuwait Inst Sci Res, Environm & Life Sci Res Ctr, Environm & Climate Change Program, Shuwaikh, Kuwait	Kuwait Institute for Scientific Research; Kuwait Institute for Scientific Research	Al Salameen, F; Habibi, N (corresponding author), Kuwait Inst Sci Res, Environm & Life Sci Res Ctr, Biotechnol Program, Shuwaikh, Kuwait.	fslamian@kisr.edu.kw; nhabibi@kisr.edu.kw	Habibi, Nazima/AAH-6425-2021; Uddin, Saif/J-4772-2013	Habibi, Nazima/0000-0003-0752-4774; Uddin, Saif/0000-0003-4698-2225; Kumar, Vinod/0000-0003-3733-4197	Kuwait Foundation for Advancement of Sciences (KFAS) [PR17-42SL-01]; Kuwait Institute for Scientific Research (KISR) [EM075C]	Kuwait Foundation for Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS)); Kuwait Institute for Scientific Research (KISR)	We thank Kuwait Foundation for Advancement of Sciences (KFAS; Grant No. PR17-42SL-01) and Kuwait Institute for Scientific Research (KISR; Grant No. EM075C) for funding this research.	Abal AT, 2010, MED PRIN PRACT, V19, P295, DOI 10.1159/000312716; Abu-Dieyeh MH, 2010, AEROBIOLOGIA, V26, P263, DOI 10.1007/s10453-010-9162-2; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Al-Awadhi JM, 2005, KUWAIT J SCI ENG, V32, P135; Al-Barakah F, 2014, INT J CURR MICROBIOL, V3, P647; ALDOUSARI A, 2010, EUR J SCI RES, V41, P526; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 1906, SOCIOLOGICAL PAPERS, V1, P284; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bragoszewska E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183308; Bragoszewska E, 2016, ATMOSPHERE-BASEL, V7, DOI 10.3390/atmos7110142; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Bryan NC, 2019, ISME J, V13, P2789, DOI 10.1038/s41396-019-0474-0; Caliz J, 2018, P NATL ACAD SCI USA, V115, P12229, DOI 10.1073/pnas.1812826115; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cheung MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32529-5; Din SU, 2008, J ARID ENVIRON, V72, P1320, DOI 10.1016/j.jaridenv.2007.12.013; Doguen A, 2017, MED MYCOL, V55, P813, DOI 10.1093/mmy/myx008; Ezeamuzie CI, 1998, ENVIRON INT, V24, P213, DOI 10.1016/S0160-4120(97)00138-4; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; FODA MA, 1985, SEDIMENTOLOGY, V32, P595, DOI 10.1111/j.1365-3091.1985.tb00473.x; Gandolfi I, 2015, APPL MICROBIOL BIOT, V99, P4867, DOI 10.1007/s00253-014-6348-5; Genitsaris S, 2017, ATMOS ENVIRON, V157, P101, DOI 10.1016/j.atmosenv.2017.03.018; Green BJ., 2011, J ALLERGY CAIRO, V11, DOI [10.1155/2011/682574, DOI 10.1155/2011/682574]; Griffin D.W., 2001, AEROBIOLOGIA BOLOGNA, V17, P203, DOI [10.1023/A:1011868218901, DOI 10.1023/A:1011868218901]; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Jinadu B.A., 1995, VALLEY FEVER TASK FO; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Katra I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05265; Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb; Khadadah M, 2013, MED PRIN PRACT, V22, P87, DOI 10.1159/000341154; Khaniabadi YO, 2017, ATMOS POLLUT RES, V8, P606, DOI 10.1016/j.apr.2016.11.005; Leppanen HK, 2018, J EXPO SCI ENV EPID, V28, P231, DOI 10.1038/jes.2017.24; Leski TA, 2011, APPL ENVIRON MICROB, V77, P4285, DOI 10.1128/AEM.00021-11; Leung MHY, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0165-2; M.HARTIVIANN, 2012, T ENTOMOLOGICAL SOC, P303; Machowicz-Matejko E, 2018, POL J MICROBIOL, V67, P407, DOI 10.21307/pjm-2018-049; Maki T, 2017, AIR QUAL ATMOS HLTH, V10, P249, DOI 10.1007/s11869-016-0430-3; MESCIOGLU E, 2019, ATMOSPHERE-BASEL, V10, DOI DOI 10.3390/ATMOS10080440; MIDDLETON NJ, 1986, J ARID ENVIRON, V10, P83, DOI 10.1016/S0140-1963(18)31249-7; Mitakakis TZ, 2001, GRANA, V40, P230, DOI 10.1080/001731301317223268; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Nunez A, 2019, ATMOS ENVIRON, V217, DOI 10.1016/j.atmosenv.2019.116972; Nygaard AB, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0553-x; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Qasem JA, 2008, ANN SAUDI MED, V28, P435; Shaffer BT, 1997, MICROBIAL ECOL, V34, P167, DOI 10.1007/s002489900046; Thalib L, 2012, SCI TOTAL ENVIRON, V433, P347, DOI 10.1016/j.scitotenv.2012.06.082; This influence is not necessarily benign, 2001, HARVARD HLTH POLICY, V2, P20; Tong YY, 2000, AEROSOL SCI TECH, V32, P393, DOI 10.1080/027868200303533; Uddin S, 2012, AQUAT ECOSYST HEALTH, V15, P41, DOI 10.1080/14634988.2012.668114; Uddin S., 2010, International Journal of Sustainable Development and Planning, V5, P367, DOI 10.2495/SDP-V5-N4-367-377; Uddin S, ATINERS C PAPER 2016, VENV2016-1938; Uddin S., 2013, ESTIMATION PM2 5 CON, P1; Uetake J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01572; Weikl F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154131; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z; Yan D, 2015, TECHNOLOGY, V49, P5098, DOI [10.1021/es506165z, DOI 10.1021/ES506165Z]; Yan D, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00004-18	66	11	11	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241283	10.1371/journal.pone.0241283	http://dx.doi.org/10.1371/journal.pone.0241283			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151966	gold, Green Published			2022-12-26	WOS:000591376200056
J	Fields, FR; Suresh, N; Hiller, M; Freed, SD; Haldar, K; Lee, SW				Fields, Francisco R.; Suresh, Niraja; Hiller, Morgan; Freed, Stefan D.; Haldar, Kasturi; Lee, Shaun W.			Algorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; TUMOR-SUPPRESSOR PROTEIN; ELONGIN-B; DISEASE; GENE; IDENTIFICATION; PEPTIDES; COMPLEX; STABILITY; BINDING	Von Hippel-Lindau disease (VHL) is an autosomal dominant rare disease that causes the formation of angiogenic tumors. When functional, pVHL acts as an E3 ubiquitin ligase that negatively regulates hypoxia inducible factor (HIF). Genetic mutations that perturb the structure of pVHL result in dysregulation of HIF, causing a wide array of tumor pathologies including retinal angioma, pheochromocytoma, central nervous system hemangioblastoma, and clear cell renal carcinoma. These VHL-related cancers occur throughout the lifetime of the patient, requiring frequent intervention procedures, such as surgery, to remove the tumors. Although VHL is classified as a rare disease (1 in 39,000 to 1 in 91,000 affected) there is a large heterogeneity in genetic mutations listed for observed pathologies. Understanding how these specific mutations correlate with the myriad of observed pathologies for VHL could provide clinicians insight into the potential severity and onset of disease. Using a select set of 285 ClinVar mutations in VHL, we developed a multiparametric scoring algorithm to evaluate the overall clinical severity of missense mutations in pVHL. The mutations were assessed according to eight weighted parameters as a comprehensive evaluation of protein misfolding and malfunction. Higher mutation scores were strongly associated with pathogenicity. Our approach establishes a novel in silico method by which VHL-specific mutations can be assessed for their severity and effect on the biophysical functions of the VHL protein.	[Fields, Francisco R.; Suresh, Niraja; Hiller, Morgan; Freed, Stefan D.; Haldar, Kasturi; Lee, Shaun W.] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Fields, Francisco R.; Suresh, Niraja; Hiller, Morgan; Freed, Stefan D.; Haldar, Kasturi; Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Freed, Stefan D.; Lee, Shaun W.] Univ Notre Dame, Chem Biol Biochem Interfaces, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Fields, Francisco R.] Univ Toronto, Mol Genet, Toronto, OH USA; [Freed, Stefan D.] Elanco, Greenfield, IN USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Toronto	Lee, SW (corresponding author), Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.; Lee, SW (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Lee, SW (corresponding author), Univ Notre Dame, Chem Biol Biochem Interfaces, Notre Dame, IN 46556 USA.; Lee, SW (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	lee.310@nd.edu		Fields, Francisco/0000-0002-9029-5150	Boler-Parseghian Center for Rare and Neglected Diseases	Boler-Parseghian Center for Rare and Neglected Diseases	The study was funded partially through a Pilot Study Proposal by the Boler-Parseghian Center for Rare and Neglected Diseases funded to FF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2004, REV PRESCRIRE, V24, P215; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; Bader HL, 2012, FEBS LETT, V586, P1562, DOI 10.1016/j.febslet.2012.04.032; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Basak S, 2016, CURR MED CHEM, V23, P714, DOI 10.2174/0929867323666160118095620; Binderup MLM, 2018, DAN MED J, V65; Binderup MLM, 2017, J MED GENET, V54, P11, DOI 10.1136/jmedgenet-2016-104058; Blankenship C, 1999, ONCOGENE, V18, P1529, DOI 10.1038/sj.onc.1202473; Cardote TAF, 2017, STRUCTURE, V25, P901, DOI 10.1016/j.str.2017.04.009; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clarke TF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-118; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; CROSSEY PA, 1994, HUM GENET, V93, P53; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Flores SK, 2019, J CLIN ENDOCR METAB, V104, P3826, DOI 10.1210/jc.2019-00235; Gallou C, 2004, HUM MUTAT, V24, P215, DOI 10.1002/humu.20082; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Haase VH, 2009, CURR PHARM DESIGN, V15, P3895, DOI 10.2174/138161209789649394; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JX, 2019, NAT METHODS, V16, P894, DOI 10.1038/s41592-019-0499-3; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lenglet M, 2018, BLOOD, V132, P469, DOI 10.1182/blood-2018-03-838235; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu SJ, 2018, GENET MED, V20, P1266, DOI 10.1038/gim.2017.261; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metelo AM, 2015, J CLIN INVEST, V125, P1987, DOI 10.1172/JCI73665; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minervini G, 2014, DESIGN ANAL PETRI NE; Minervini G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006478; Minervini G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12605; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ong KR, 2007, HUM MUTAT, V28, P143, DOI 10.1002/humu.20385; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Peng SH, 2017, ONCOTARGET, V8, P38456, DOI 10.18632/oncotarget.16594; Razafinjatovo C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2688-0; Rechsteiner MP, 2011, CANCER RES, V71, P5500, DOI 10.1158/0008-5472.CAN-11-0757; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sanchez-Ruiz JM, 2010, BIOPHYSICAL CHEM; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stebbins CE, 2009, SCIENCE, V455, P455; Tabaro F, 2016, NAT PUBL GR; Tarade D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05554-1; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; TORY K, 1989, J NATL CANCER I, V81, P1097, DOI 10.1093/jnci/81.14.1097; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsuchiya H, 1996, CANCER RES, V56, P2881; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572	68	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0234100	10.1371/journal.pone.0234100	http://dx.doi.org/10.1371/journal.pone.0234100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151962	Green Submitted, Green Published, gold			2022-12-26	WOS:000591376200118
J	Ribbat, N; Roughan, M; Powell, B; Rao, S; Kerry, CG				Ribbat, Nina; Roughan, Moninya; Powell, Brian; Rao, Shivanesh; Kerry, Colette Gabrielle			Transport variability over the Hawkesbury Shelf (31.5-34.5 degrees S) driven by the East Australian Current	PLOS ONE			English	Article							MODELING SYSTEM ROMS; CURRENT SEPARATION; COASTAL OCEAN; EDDY; CIRCULATION; REANALYSIS; EDDIES; SUBMESOSCALE; FRONT	The Hawkesbury Bioregion located off southeastern Australia (31.5-34.5(o)S) is a region of highly variable circulation. The region spans the typical separation point of the East Australian Current (EAC), the western boundary current that dominates the flow along the coast of SE Australia. It lies adjacent to a known ocean warming hotspot in the Tasman Sea, and is a region of high productivity. However, we have limited understanding of the circulation, temperature regimes and shelf transport in this region, and the drivers of variability. We configure a high resolution (750m) numerical model for the Hawkesbury Shelf region nested inside 2 data assimilating models of decreasing resolution, to obtain the best estimate of the shelf circulation and transport over a 2-yr period (2012-2013). Here we show that the transport is driven by the mesoscale EAC circulation that strengthens in summer and is related to the separation of the EAC jet from the coast. Transport estimates show strong offshore export is a maximum between 32-33(o)S. Median offshore transports range 2.5-8.4Sv seasonally and are a maximum during in summer driven by the separation of the EAC jet from the coast. The transport is more variable downstream of the EAC separation, driven by the EAC eddy field. Onshore transport occurs more frequently off Sydney 33.5-34.5(o)S; seasonal medians range -1.7 to 2.3Sv, with an onshore maximum in winter. The region is biologically productive, and it is a known white shark nursery area despite the dominance of the oligotrophic western boundary current. Hence an understanding of the drivers of circulation and cross-shelf exchange is important.	[Ribbat, Nina; Roughan, Moninya; Rao, Shivanesh; Kerry, Colette Gabrielle] UNSW Sydney, Sch Math & Stat, Coastal & Reg Oceanog Lab, Sydney, NSW, Australia; [Powell, Brian] Univ Hawaii, Dept Oceanog, Honolulu, HI USA	University of New South Wales Sydney; University of Hawaii System	Roughan, M (corresponding author), UNSW Sydney, Sch Math & Stat, Coastal & Reg Oceanog Lab, Sydney, NSW, Australia.	mroughan@unsw.edu.au	Roughan, Moninya/B-5563-2009	Roughan, Moninya/0000-0003-3825-7533; Kerry, Colette/0000-0001-5321-2611	Australian Research Council Industry Linkage Grant [LP12010059]; Australian Research Council [DP140102337]; Australian Government	Australian Research Council Industry Linkage Grant(Australian Research Council); Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This research and NR were partially supported by Australian Research Council Industry Linkage Grant #LP12010059 to MR. The development of the EAC model and CK were partially funded by Australian Research Council Discovery Grant #DP140102337 to MR and BP. https://www.arc.gov.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Australian Integrated Marine Observing System (IMOS, www.imos.org.au) is enabled by the national collaborative research infrastructure (NCRIS), supported by Australian Government. It is operated by a consortium of institutions as an unincorporated joint venture, with the University of Tasmania as Lead Agent.	[Anonymous], 2001, INTEGRATOR, V3, P1; Archer MR, 2018, GEOPHYS RES LETT, V45, P6176, DOI 10.1029/2018GL078429; Archer M, 2020, J PHYS OCEANOGR, V50, P1509, DOI 10.1175/JPO-D-19-0131.1; Archer MR, 2017, J GEOPHYS RES-OCEANS, V122, P8464, DOI 10.1002/2017JC013097; Baird ME, 2008, DEEP-SEA RES PT I, V55, P1438, DOI 10.1016/j.dsr.2008.06.011; Beardsley R. C., 1983, CODE 1 MOORED ARRAY; Bowen MM, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002533; Cetina-Heredia P, 2014, J GEOPHYS RES-OCEANS, V119, P4351, DOI 10.1002/2014JC010071; CHAPMAN DC, 1985, J PHYS OCEANOGR, V15, P1060, DOI 10.1175/1520-0485(1985)015<1060:NTOCSO>2.0.CO;2; Churchill JH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007995; Cummins PF, 1997, J PHYS OCEANOGR, V27, P762, DOI 10.1175/1520-0485(1997)027<0762:SOBABT>2.0.CO;2; Deng X, 2011, COASTAL ALTIMETRY, P473, DOI 10.1007/978-3-642-12796-0_18; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Flather R. A., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V10, P141; Gawarkiewicz G, 1996, CONT SHELF RES, V16, P1751, DOI 10.1016/0278-4343(96)00014-3; Gibbs MT, 2000, CONT SHELF RES, V20, P763, DOI 10.1016/S0278-4343(99)00090-4; Kerry C., 2020, HIGH RESOLUTION REAN; Kerry C, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015227; Kerry C, 2020, J MARINE SYST, V204, DOI 10.1016/j.jmarsys.2019.103286; Kerry C, 2018, J GEOPHYS RES-OCEANS, V123, P7511, DOI 10.1029/2017JC013685; Kerry C, 2016, GEOSCI MODEL DEV, V9, P3779, DOI 10.5194/gmd-9-3779-2016; Lee KA, 2018, MAR ECOL PROG SER, V599, P157, DOI 10.3354/meps12611; Lentz SJ, 2008, J PHYS OCEANOGR, V38, P1203, DOI 10.1175/2007JPO3768.1; Malan N, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015613; Mantovanelli A, 2017, J GEOPHYS RES-OCEANS, V122, P4902, DOI 10.1002/2016JC011968; Mason E, 2010, OCEAN MODEL, V35, P1, DOI 10.1016/j.ocemod.2010.05.007; Mata MM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003592; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Mullaney TJ, 2013, LIMNOL OCEANOGR, V58, P1546, DOI 10.4319/lo.2013.58.5.1546; Oke P. R., 2006, QUART J R MET SOC, V131, P3301; Oke PR, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.102139; Oke PR, 2011, DEEP-SEA RES PT II, V58, P574, DOI 10.1016/j.dsr2.2010.06.006; Oke PR, 2000, J PHYS OCEANOGR, V30, P512, DOI 10.1175/1520-0485(2000)030<0512:TIUOEA>2.0.CO;2; Oke PR, 2001, CONT SHELF RES, V21, P587, DOI 10.1016/S0278-4343(00)00127-8; Pawlowicz R, 2002, COMPUT GEOSCI-UK, V28, P929, DOI 10.1016/S0098-3004(02)00013-4; Penven P, 2006, OCEAN MODEL, V12, P157, DOI 10.1016/j.ocemod.2005.05.002; Puri K, 2013, AUST METEOROL OCEAN, V63, P265, DOI 10.22499/2.6302.001; Ridgway KR, 1997, J GEOPHYS RES-OCEANS, V102, P22921, DOI 10.1029/97JC00227; Rossi V, 2014, J GEOPHYS RES-OCEANS, V119, P445, DOI 10.1002/2013JC009284; Roughan M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001833; Roughan M, 2017, J GEOPHYS RES-OCEANS, V122, P2494, DOI 10.1002/2016JC012241; Roughan M, 2003, J PHYS OCEANOGR, V33, P2551, DOI 10.1175/1520-0485(2003)033<2551:AMSOTC>2.0.CO;2; Roughan M, 2002, CONT SHELF RES, V22, P2551, DOI 10.1016/S0278-4343(02)00101-2; Roughan M, 2013, OCEANS-IEEE; Roughan M, 2011, OCEANS 2011; Schaeffer A, 2014, J GEOPHYS RES-OCEANS, V119, P4922, DOI 10.1002/2013JC009735; Schaeffer A, 2017, J GEOPHYS RES-OCEANS, V122, P3964, DOI 10.1002/2016JC012171; Schaeffer A, 2016, BIOGEOSCIENCES, V13, P1967, DOI 10.5194/bg-13-1967-2016; Schaeffer A, 2014, J PHYS OCEANOGR, V44, P2812, DOI 10.1175/JPO-D-14-0091.1; Schaeffer A, 2013, J PHYS OCEANOGR, V43, P1042, DOI 10.1175/JPO-D-12-0177.1; Schiller A, 2008, PROG OCEANOGR, V76, P334, DOI 10.1016/j.pocean.2008.01.003; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; Sikiric MD, 2009, OCEAN MODEL, V29, P128, DOI 10.1016/j.ocemod.2009.03.009; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Whiteway T. G., 2009, GEOSCI AUST REC, V21, P46; Wood JE, 2016, CONT SHELF RES, V112, P92, DOI 10.1016/j.csr.2015.11.006; Wood J. E., 2013, P COASTS PORTS 21 AU, V2013, P866; Yuan YP, 2017, CONT SHELF RES, V134, P52, DOI 10.1016/j.csr.2017.01.006	61	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241622	10.1371/journal.pone.0241622	http://dx.doi.org/10.1371/journal.pone.0241622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152021	Green Published, gold			2022-12-26	WOS:000591376200039
J	Brace, AW; George, K; Lovell, GP				Brace, Anthony W.; George, Kendall; Lovell, Geoff P.			Mental toughness and self-efficacy of elite ultra-marathon runners	PLOS ONE			English	Article							PERFORMANCE; VALIDATION; HARDINESS	Minimal research has examined psychological processes underpinning ultra-marathon runners' performance. This study examined the relationships between mental toughness and self-efficacy with performance in an elite sample of ultra-marathon runners competing in the 2019 Hawaiian Ultra Running Team's Trail 100-mile endurance run (HURT100). The Mental Toughness Questionnaire (SMTQ) and the Endurance Sport Self-Efficacy Scale (ESSES) were completed by 56 elite ultra-marathon runners in the HURT100 (38 males, 18 females; M-age = 38.86 years, SDage = 9.23). Findings revealed mental toughness and self-efficacy are highly related constructs (r(54) = 0.72, p < 0.001). Mental toughness and self-efficacy did not significantly relate to ultra-marathon performance (mental toughness and self-efficacy with Ultra-Trail World Tour (UTWT) rank F(2, 53) = 0.738, p = 0.483; mental toughness and self-efficacy with likelihood would finish the HURT100 chi(2) = 0.56, p = 0.756; mental toughness and self-efficacy with HURT100 placing and time F(2, 53) = 1.738, p = 0.186 and F(2, 30) = 2.046, p = 0.147, respectively). However, participants had significantly and meaningfully higher mental toughness (M = 45.42, SD = 4.26, medium and large effect sizes) than athletes from other sports previously published. Our interpretation is that these results taken in conjunction, suggest a threshold of mental toughness that performers require to be of the standard needed to be able to prepare for and compete in elite ultra-marathon events such as the HURT100; once this mental toughness threshold is met, other factors are likely to be more influential in determining elite level ultra-marathon performance.	[Brace, Anthony W.; Lovell, Geoff P.] Univ Sunshine Coast, Sch Hlth & Behav Sci, Sippy Downs, Qld, Australia; [George, Kendall] Univ Sunshine Coast, Sch Nursing Midwifery & Paramed, Sippy Downs, Qld, Australia; [Lovell, Geoff P.] Hartpury Univ, Dept Sport, Gloucester, England	University of the Sunshine Coast; University of the Sunshine Coast	Lovell, GP (corresponding author), Univ Sunshine Coast, Sch Hlth & Behav Sci, Sippy Downs, Qld, Australia.; Lovell, GP (corresponding author), Hartpury Univ, Dept Sport, Gloucester, England.	Geoff.lovell@Hartpury.ac.uk		Lovell, Geoff/0000-0002-1432-9873				Annual ranking 2018-Ultra-Trail World Tour, ANN RANK 2018 ULTR W; Anstiss PA, 2018, PSYCHOL SPORT EXERC, V38, P176, DOI 10.1016/j.psychsport.2018.06.015; BANDURA A, 1987, J PERS SOC PSYCHOL, V53, P563, DOI 10.1037/0022-3514.53.3.563; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Birkenhead K, 2018, J PHYS ACTIVITY RES, V3, P11; Birkenhead KL, 2019, J SPORT MED PHYS FIT, V59, P798, DOI [10.23736/S0022-4707.18.08882-5, 10.23736/s0022-4707.18.08882-5]; Birrer D, 2010, SCAND J MED SCI SPOR, V20, P78, DOI 10.1111/j.1600-0838.2010.01188.x; Burke S. T., 1996, Journal of Sport Behavior, V19, P272; Cejka N, 2014, J SPORT SCI, V32, P354, DOI 10.1080/02640414.2013.825729; Chen MA, 2013, PERCEPT MOTOR SKILL, V116, P905, DOI 10.2466/29.30.PMS.116.3.905-917; Clough P., 2002, SOLUTIONS SPORT PSYC; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corrion K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206498; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cowden RG, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00320; Cowden RG, 2016, PERCEPT MOTOR SKILL, V123, P737, DOI 10.1177/0031512516666027; Crust L, 2005, PERCEPT MOTOR SKILL, V100, P192; DeVellis RF, 2016, SCALE DEV THEORY APP; Dorgan J.F., 2010, BREAST CANC RES, V12, pR98; Field A.P., 2020, DISCOVERING STAT USI, V4th; George D, 2003, SPSS WINDOWS STEP ST; Golby J, 2004, PERS INDIV DIFFER, V37, P933, DOI 10.1016/j.paid.2003.10.015; Golby J, 2007, PERCEPT MOTOR SKILL, V105, P309, DOI 10.2466/PMS.105.5.309-325; Gucciardi DF, 2008, J APPL SPORT PSYCHOL, V20, P261, DOI 10.1080/10413200801998556; Gucciardi DF, 2015, J PERS, V83, P26, DOI 10.1111/jopy.12079; Gucciardi DF, 2009, J SPORT SCI, V27, P1293, DOI 10.1080/02640410903242306; Hardy L, 2014, J PERS, V82, P69, DOI 10.1111/jopy.12034; Hoffman MD, 2012, RES SPORTS MED, V20, P59, DOI 10.1080/15438627.2012.634707; Holt NL, 2014, SPORT PSYCHOL, V28, P22, DOI 10.1123/tsp.2013-0008; Jaeschke AMC, 2016, SPORT PSYCHOL, V30, P242, DOI 10.1123/tsp.2014-0153; Kline P., 2000, HDB PSYCHOL TESTING; Knechtle B, 2012, INT J SPORT PHYSIOL, V7, P310, DOI 10.1123/ijspp.7.4.310; LAGUARDIA R, 1993, PERCEPT MOTOR SKILL, V77, P27, DOI 10.2466/pms.1993.77.1.27; MARTIN JJ, 1995, J APPL SPORT PSYCHOL, V7, P50, DOI 10.1080/10413209508406300; MILLER M, 1993, INT J SPORT PSYCHOL, V24, P284; Nicholls AR, 2008, PERS INDIV DIFFER, V44, P1182, DOI 10.1016/j.paid.2007.11.011; Sheard M, 2009, EUR J PSYCHOL ASSESS, V25, P186, DOI 10.1027/1015-5759.25.3.186; Swann C, 2015, PSYCHOL SPORT EXERC, V16, P3, DOI 10.1016/j.psychsport.2014.07.004; Thom BT, 2020, MENTAL TOUGHNESS SPO, DOI [10.1080/10413200.2020.1808736, DOI 10.1080/10413200.2020.1808736]; Walker SP, 2016, SA J. Sports Med., V28, P46, DOI [10.17159/2078-516X/2016/v28i2a1576, 10.17159/2078-516x/2016/v28i2a1110]; WHITMARSH BG, 1993, SPORT PSYCHOL, V7, P388, DOI 10.1123/tsp.7.4.388; Wieser R, 2014, CHIROPR MAN THER, V22, DOI 10.1186/2045-709X-22-17; Zaryski Calvin, 2005, Curr Sports Med Rep, V4, P165; Zeiger JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193071; 2011, HIST EC SOC, V2, P21	45	5	5	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241284	10.1371/journal.pone.0241284	http://dx.doi.org/10.1371/journal.pone.0241284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147236	Green Accepted, Green Published, gold			2022-12-26	WOS:000589609300004
J	de Carvalho, AB; Ware, SL; Lei, FT; Bush, HM; Sprang, R; Higgins, EB				de Carvalho, Ana Bastos; Ware, S. Lee; Lei, Feitong; Bush, Heather M.; Sprang, Robert; Higgins, Eric B.			Implementation and sustainment of a statewide telemedicine diabetic retinopathy screening network for federally designated safety-net clinics	PLOS ONE			English	Article							RETINAL IMAGING TECHNOLOGY; EYE-CARE; MACULAR EDEMA; UNITED-STATES; RISK-FACTORS; PHOTOGRAPHY; DISPARITIES; PROGRAM; SURVEILLANCE; PREVALENCE	Context Diabetic retinopathy (DR) is the leading cause of incident blindness among working-age adults in the United States. Federally designated safety-net clinics (FDSC) often serve as point-of-contact for patients least likely to receive recommended DR screenings, creating opportunity for targeted interventions to increase screening access and compliance. Study design and methods With such a goal, we implemented and assessed the longitudinal performance of an FDSC-based telemedicine DR screening (TDRS) network of 22 clinical sites providing nonmydriatic fundus photography with remote interpretation and reporting. Retrospective analysis of patient encounters between February 2014 and January 2019 was performed to assess rates of pathology and referral. A generalized estimating equation logistic regression model was used for subset analysis from audits of pre- and post-implementation screening rates. Finally, patient surveys were conducted and assessed as a measure of intervention acceptability. Results Of the 13,923 individual telescreening encounters (4327 female, 4220 male, and 5376 unspecified; mean [SD] age, 54.9 [12.5] years) studied, 10,540 were of adequate quality to identify 3532 (33.5%) patients with ocular pathology: 2319 (22.0%) patients had some level of DR with 1604 (15.2%) requiring specialist referral, and 808 (7.7%) patients required referral for other ocular pathologies. The mean screening rate for audited clinics in the year prior to program implementation was 29.9% (641/2147), which increased to 47.7% (1012/2124) in the program's first year, doubling patients' odds of being screened (OR 2.2; 95% CI: 1.3-3.7; P = .003). These gains were sustained over four years following implementation (OR 1.9; 95% CI: 1.1-3.1; P = .018) despite varied clinic screening performance (4-year averaged range, 22.9-55.1%). Odds of early detection likewise doubled for patients with consecutive screenings (OR 2.2, 95% CI: 2.0-2.4; P < .001). Finally, surveyed patients preferred TDRS to specialist exams (82.5%; 776/941) and would recommend the service to friends (92.7%; 868/936). Conclusion and relevance A statewide, FDSC-centered TDRS network was successfully established and sustained in a medically underserved region of the United States. Our results suggest that large TDRS networks in FDSCs can increase screening access and compliance for otherwise unscreened populations, but outcomes can vary greatly among clinics. Further work to optimize program implementation is needed to maximize this model's impact.	[de Carvalho, Ana Bastos; Ware, S. Lee; Higgins, Eric B.] Univ Kentucky, Dept Ophthalmol & Visual Sci, Coll Med, Lexington, KY 40506 USA; [Lei, Feitong; Bush, Heather M.] Univ Kentucky, Dept Biostat, Coll Publ Hlth, Lexington, KY USA; [Sprang, Robert] Univ Kentucky, Kentucky Telecare, Coll Med, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Higgins, EB (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Coll Med, Lexington, KY 40506 USA.	ebhigg2@uky.edu		Ware, Stacy/0000-0002-7538-2205; Lei, Feitong/0000-0002-1757-4858	Health Resources and Services Administration [H2ARH260330304]; National Center for Advancing Translational Sciences [UL1TR001998]	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Health Resources and Services Administration (https://www.hrsa.gov/) supported RRS, EBH with grant number H2ARH260330304. The National Center for Advancing Translational Sciences (https://ncats.nih.gov/) supported ABC, FL, HMB with grant number UL1TR001998. This funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Bedard C, 2017, DIABETES RES CLIN PR, V129, P154, DOI 10.1016/j.diabres.2017.04.024; Benoit SR, 2019, DIABETES CARE, V42, P427, DOI 10.2337/dc18-0828; Bragge P, 2011, ARCH OPHTHALMOL-CHIC, V129, P435, DOI 10.1001/archophthalmol.2010.319; Cavallerano AA, 2005, AM J OPHTHALMOL, V139, P597, DOI 10.1016/j.ajo.2004.10.064; Chin EK, 2014, TELEMED E-HEALTH, V20, P102, DOI 10.1089/tmj.2013.0042; Comprehensive Diabetes Care, COMPR DIAB CAR; Conlin PR, 2006, J REHABIL RES DEV, V43, P733, DOI 10.1682/JRRD.2005.07.0117; Daskivich LP, 2017, JAMA INTERN MED, V177, P642, DOI 10.1001/jamainternmed.2017.0204; Davis RM, 2003, DIABETES CARE, V26, P2476, DOI 10.2337/diacare.26.8.2476; Diabetic Retinopathy PPP 2019, 2019, DIAB RET PPP 2019; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Fathy C, 2016, SEMIN OPHTHALMOL, V31, P364, DOI 10.3109/08820538.2016.1154170; Gao XX, 2019, TELEMED E-HEALTH, V25, P802, DOI 10.1089/tmj.2018.0016; Gibson DM, 2019, JAMA OPHTHALMOL, V137, P440, DOI 10.1001/jamaophthalmol.2018.6909; Graham-Rowe E, 2018, DIABETIC MED, V35, P1308, DOI 10.1111/dme.13686; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Group TDC and CTR, 2010, EFF INT TREATM DIAB, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; Gu DV, 2020, TELEMED E-HEALTH, V26, P1252, DOI 10.1089/tmj.2019.0206; Gupta A, 2017, SEMIN OPHTHALMOL, V32, P22, DOI 10.1080/08820538.2016.1228403; Hartnett ME, 2005, ARCH OPHTHALMOL-CHIC, V123, P387, DOI 10.1001/archopht.123.3.387; Hatef E, 2017, MIDDLE EAST AFR J OP, V24, P207, DOI 10.4103/meajo.MEAJO_19_16; Hill JO, 2013, DIABETES CARE, V36, P2430, DOI 10.2337/dc13-1161; Jani PD, 2017, JAMA OPHTHALMOL, V135, P706, DOI 10.1001/jamaophthalmol.2017.1150; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Li HK, 2011, TELEMED E-HEALTH, V17, P814, DOI 10.1089/tmj.2011.0075; Liu Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022594; Lu Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160193; Lu Y, 2016, DIABETES CARE, V39, pE31, DOI 10.2337/dc15-2198; Lundeen EA, 2019, MMWR-MORBID MORTAL W, V68, P1020, DOI 10.15585/mmwr.mm6845a3; Mansberger SL, 2015, JAMA OPHTHALMOL, V133, P518, DOI 10.1001/jamaophthalmol.2015.1; Mansberger SL, 2013, TELEMED E-HEALTH, V19, P942, DOI 10.1089/tmj.2012.0313; Nichols GA, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160056; Ogunyemi Omolola, 2013, AMIA Annu Symp Proc, V2013, P1082; OHare JP, 1996, BRIT MED J, V312, P679; Owens DR, 1998, DIABETIC MED, V15, P170, DOI 10.1002/(SICI)1096-9136(199802)15:2<170::AID-DIA518>3.0.CO;2-H; Owsley C, 2015, JAMA OPHTHALMOL, V133, P174, DOI 10.1001/jamaophthalmol.2014.4652; Piyasena MMPN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0198979; Ramchandran RS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225300; Scanlon PH, 2005, DIABETES CARE, V28, P2448, DOI 10.2337/diacare.28.10.2448; Schmier JK, 2009, RETINA-J RET VIT DIS, V29, P199, DOI 10.1097/IAE.0b013e3181884f2d; Shah VA, 2004, OPHTHAL EPIDEMIOL, V11, P43, DOI 10.1076/opep.11.1.43.26436; Shi LL, 2015, BRIT J OPHTHALMOL, V99, P823, DOI 10.1136/bjophthalmol-2014-305631; Shi Q, 2014, DIABETES CARE, V37, P1321, DOI 10.2337/dc13-1038; Taylor CR, 2007, DIABETES CARE, V30, P574, DOI 10.2337/dc06-1509; Toy BC, 2016, OSLI RETINA, V47, P636, DOI 10.3928/23258160-20160707-05; van Eijk KND, 2012, DIABETES RES CLIN PR, V96, P10, DOI 10.1016/j.diabres.2011.11.003; Varma R, 2014, JAMA OPHTHALMOL, V132, P1334, DOI 10.1001/jamaophthalmol.2014.2854; Venkatesh P, 2014, INDIAN J MED RES, V140, P77; Wells JA, 2016, OPHTHALMOLOGY, V123, P1351, DOI 10.1016/j.ophtha.2016.02.022; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wilson C, 2005, DIABETES CARE, V28, P318, DOI 10.2337/diacare.28.2.318; Zhang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180949; Zimmer-Galler IE, 2015, CURR OPIN OPHTHALMOL, V26, P167, DOI 10.1097/ICU.0000000000000142	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241767	10.1371/journal.pone.0241767	http://dx.doi.org/10.1371/journal.pone.0241767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147290	gold, Green Published			2022-12-26	WOS:000589609300006
J	Mai, BHA; Barbieri, R; Chenal, T; Castex, D; Jonvel, R; Tanasi, D; Georges-Zimmermann, P; Dutour, O; Peressinotto, D; Demangeot, C; Drancourt, M; Aboudharam, G				Mai, Ba-Hoang-Anh; Barbieri, Remi; Chenal, Thomas; Castex, Dominique; Jonvel, Richard; Tanasi, Davide; Georges-Zimmermann, Patrice; Dutour, Olivier; Peressinotto, David; Demangeot, Coralie; Drancourt, Michel; Aboudharam, Gerard			Five millennia of Bartonella quintana bacteraemia	PLOS ONE			English	Article							TRENCH FEVER; MOLECULAR-DETECTION; RICKETTSIA-FELIS; YERSINIA-PESTIS; HOMELESS PEOPLE; DENTAL-PULP; DISEASES; DNA; SEROPREVALENCE; ENDOCARDITIS	During the two World Wars, Bartonella quintana was responsible for trench fever and is now recognised as an agent of re-emerging infection. Many reports have indicated widespread B. quintana exposure since the 1990s. In order to evaluate its prevalence in ancient populations, we used real-time PCR to detect B. quintana DNA in 400 teeth collected from 145 individuals dating from the 1(st) to 19(th) centuries in nine archaeological sites, with the presence of negative controls. Fisher's exact test was used to compare the prevalence of B. quintana in civil and military populations. B. quintana DNA was confirmed in a total of 28/145 (19.3%) individuals, comprising 78 citizens and 67 soldiers, 20.1% and 17.9% of which were positive for B. quintana bacteraemia, respectively. This study analysed previous studies on these ancient samples and showed that the presence of B. quintana infection followed the course of time in human history; a total of 14/15 sites from five European countries had a positive prevalence. The positive rate in soldiers was higher than those of civilians, with 20% and 18.8%, respectively, in the 18(th) and 19(th) centuries, but the difference in frequency was not significant. These results confirmed the role of dental pulp in diagnosing B. quintana bacteraemia in ancient populations and showed the incidence of B. quintana in both civilians and soldiers.	[Mai, Ba-Hoang-Anh; Barbieri, Remi; Drancourt, Michel; Aboudharam, Gerard] Aix Marseille Univ, Inst Hosp Univ IHU Mediterranee Infect, AP HM, UM63,Inst Rech Dev IRD 198,Microbes Evolut Phylog, Marseille, France; [Mai, Ba-Hoang-Anh] Hue Univ Med & Pharm, Hue, Vietnam; [Chenal, Thomas] CNRS, UMR ArTeHiS 6298, Paris, France; [Castex, Dominique; Peressinotto, David; Demangeot, Coralie] Univ Bordeaux, Anthropol Populat Passees & Presentes, PACEA, UMR 5199,CNRS, Pessac, France; [Jonvel, Richard] Amiens Metropole Serv Archeol Prevent, Amiens, France; [Tanasi, Davide] Univ S Florida, Dept Hist, Tampa, FL 33620 USA; [Georges-Zimmermann, Patrice] INRAP, TRACES, UMR 5608, CNRS, Toulouse, France; [Dutour, Olivier] Univ Bordeaux, Univ Paris Sci Lettres, PACEA, Ecole Prat Hautes Etud,UMR 5199,CNRS, Pessac, France; [Peressinotto, David; Demangeot, Coralie] HADES Bur Invest Archeol, Bordeaux, France; [Aboudharam, Gerard] Aix Marseille Univ, UFR Odontol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hue University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; State University System of Florida; University of South Florida; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite	Aboudharam, G (corresponding author), Aix Marseille Univ, Inst Hosp Univ IHU Mediterranee Infect, AP HM, UM63,Inst Rech Dev IRD 198,Microbes Evolut Phylog, Marseille, France.; Aboudharam, G (corresponding author), Aix Marseille Univ, UFR Odontol, Marseille, France.	gerard.aboudharam@wanadoo.fr		Jonvel, Richard/0000-0002-7644-8026	French Government under the Investments for the Future program [Mediterranee Infection 10-IAHU-03]; Region Le Sud (Provence Alpes Cote d'Azur); European funding (FEDER BIOTK)	French Government under the Investments for the Future program; Region Le Sud (Provence Alpes Cote d'Azur); European funding (FEDER BIOTK)	This study was supported by the French Government under the Investments for the Future program, managed by the Agence Nationale de la Recherche (ANR) (ref: Mediterranee Infection 10-IAHU-03). This study was also supported by Region Le Sud (Provence Alpes Cote d'Azur) and European funding (FEDER BIOTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudharam G, 2004, EUR J CLIN MICROBIOL, V23, P920, DOI 10.1007/s10096-004-1244-z; Angelakis E, 2014, INT J ANTIMICROB AG, V44, P16, DOI 10.1016/j.ijantimicag.2014.04.006; Anstead GM, 2016, LANCET INFECT DIS, V16, pE164, DOI 10.1016/S1473-3099(16)30003-2; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Atenstaedt RL, 2006, J ROY SOC MED, V99, P564, DOI 10.1258/jrsm.99.11.564; Barnett R, 2012, METHODS MOL BIOL, V840, P13, DOI 10.1007/978-1-61779-516-9_2; Bergmans A. M. C., 1997, Clin Microbiol Infect, V3, P692, DOI 10.1111/j.1469-0691.1997.tb00480.x; Bos KI, 2019, ANNU REV MICROBIOL, V73, P639, DOI 10.1146/annurev-micro-090817-062436; Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06; Brouqui P, 2005, MEDICINE, V84, P61, DOI 10.1097/01.md.0000152373.07500.6e; Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303; da Costa PSG, 2005, MEM I OSWALDO CRUZ, V100, P853, DOI 10.1590/S0074-02762005000800006; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; DRANCOURT M, 1995, NEW ENGL J MED, V332, P419, DOI 10.1056/NEJM199502163320702; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Foucault C, 2006, EMERG INFECT DIS, V12, P217, DOI 10.3201/eid1202.050874; Foucault C, 2002, CLIN INFECT DIS, V35, P684, DOI 10.1086/342065; Fournier PE, 2015, MICROBES INFECT, V17, P879, DOI 10.1016/j.micinf.2015.09.002; Graham JHP, 1915, LANCET, V2, P703; Guibal F, 2001, J AM ACAD DERMATOL, V44, P219, DOI 10.1067/mjd.2001.110062; Huang RT, 2011, EMERG INFECT DIS, V17, P1707, DOI 10.3201/eid1709.110133; Hurst A, 1944, MED DIS WAR; Kelly P, 2006, EMERG INFECT DIS, V12, P1869; Kernif T, 2014, MOL ECOL, V23, P1204, DOI 10.1111/mec.12663; La VD, 2005, EMERG INFECT DIS, V11, P1287, DOI 10.3201/eid1108.050101; Li H, 2013, EMERG INFECT DIS, V19, P297, DOI 10.3201/eid1902.120816; Mai BHA, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1202; Maurin M, 1996, CLIN MICROBIOL REV, V9, P273, DOI 10.1128/CMR.9.3.273; Muller A, 2016, TICKS TICK-BORNE DIS, V7, P763, DOI 10.1016/j.ttbdis.2016.03.009; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Ohl ME, 2000, CLIN INFECT DIS, V31, P131, DOI 10.1086/313890; Oteo JA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2483-z; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; Rolain JM, 2005, EMERG INFECT DIS, V11, P1742, DOI 10.3201/eid1111.050861; Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278; Ruhli FJ, 2016, CLIN ANAT, V29, P816, DOI 10.1002/ca.22709; Sato S, 2015, EMERG INFECT DIS, V21, P2168, DOI 10.3201/eid2112.150632; Seki N, 2006, JPN J INFECT DIS, V59, P31; Tanasi D, 2016, RECENTI ESPLORAZIONI, P31; Tran TNN, 2011, AM J PHYS ANTHROPOL, V145, P489, DOI 10.1002/ajpa.21510; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Pitassi LHU, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003467; von Grumbkow P, 2011, AM J PHYS ANTHROPOL, V146, P134, DOI 10.1002/ajpa.21551	44	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0239526	10.1371/journal.pone.0239526	http://dx.doi.org/10.1371/journal.pone.0239526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147255	Green Published, gold			2022-12-26	WOS:000589609300021
J	Minias, P; Gach, K; Wlodarczyk, R; Bartos, M; Drzewinska-Chanko, J; Rembowski, M; Jakubas, D; Janiszewski, T				Minias, Piotr; Gach, Kamila; Wlodarczyk, Radoslaw; Bartos, Maciej; Drzewinska-Chanko, Joanna; Rembowski, Milosz; Jakubas, Dariusz; Janiszewski, Tomasz			Colony size as a predictor of breeding behaviour in a common waterbird	PLOS ONE			English	Article							INFORMATION-CENTERS; VIGILANCE; FOOD; COLONIALITY; DENSITY; DEFENSE; COMPETITION; PREDATION; SELECTION; PATTERNS	The choice of colony size may have profound consequences for individual fitness in colonially breeding birds, but at the same time it may require certain behavioural adaptations. Here, we aimed to examine behavioural divergence of common terns Sterna hirundo nesting in colonies of different size. For this purpose, we promoted establishment of small (<35 pairs) and large (>100 pairs) tern colonies under uniform ecological and environmental conditions by providing attractive patches of nesting substrate (floating rafts) at a single site. We combined video recording and GPS-tracking to assess communal and individual defence initiation rate, intra-specific aggression rate, and foraging flight characteristics. We found that birds from larger colonies more frequently engaged in communal defence and they performed longer foraging flights, while terns from smaller colonies more frequently showed individual defence behaviours. Also, intra-specific aggression rate was higher in smaller colonies, but this effect was primarily attributed to a higher proportion of edge breeding pairs, which were more aggressive. Our results suggest that various colony sizes may be associated with different behavioural syndromes, which comprise of diverse personality traits, such as social responsiveness, social tolerance, or propensity for aggression. It remains to be tested whether these behavioural differences reflect processes of phenotypic sorting among colonies of different size or whether they are a result of behavioural plasticity under different social contexts.	[Minias, Piotr; Gach, Kamila; Wlodarczyk, Radoslaw; Bartos, Maciej; Drzewinska-Chanko, Joanna; Rembowski, Milosz; Janiszewski, Tomasz] Univ Lodz, Fac Biol & Environm Protect, Dept Biodivers Studies & Bioeduc, Lodz, Poland; [Jakubas, Dariusz] Univ Gdansk, Fac Biol, Dept Vertebrate Ecol & Zool, Gdansk, Poland	University of Lodz; Fahrenheit Universities; University of Gdansk	Minias, P (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Biodivers Studies & Bioeduc, Lodz, Poland.	pminias@op.pl	Jakubas, Dariusz/N-3680-2019	Jakubas, Dariusz/0000-0002-1879-4342; Wlodarczyk, Radoslaw/0000-0001-5932-0226; Bartos, Maciej/0000-0002-0667-2348; Drzewinska-Chanko, Joanna/0000-0001-5641-5254; Minias, Piotr/0000-0002-7742-6750	National Science Centre in Poland [2016/23/B/NZ8/02374]	National Science Centre in Poland(National Science Centre, Poland)	The study was financially supported by the research grant of the National Science Centre in Poland (2016/23/B/NZ8/02374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2001, ETHOL ECOL EVOL, V13, P341, DOI 10.1080/08927014.2001.9522765; Arroyo B, 2001, BEHAV ECOL SOCIOBIOL, V50, P109, DOI 10.1007/s002650100342; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Brown CR, 2016, BEHAV ECOL SOCIOBIOL, V70, P1613, DOI 10.1007/s00265-016-2196-x; BROWN CR, 1990, TRENDS ECOL EVOL, V5, P398, DOI 10.1016/0169-5347(90)90023-7; BROWN CR, 1986, ANIM BEHAV, V34, P1319, DOI 10.1016/S0003-3472(86)80203-2; BROWN CR, 1987, BEHAV ECOL SOCIOBIOL, V21, P97, DOI 10.1007/BF02395437; BROWN CR, 1988, ECOLOGY, V69, P602, DOI 10.2307/1941009; Burger J., 1991, COMMON TERN ITS BREE; Cantarero A, 2015, ETHOLOGY, V121, P946, DOI 10.1111/eth.12407; Clode D, 2000, J ZOOL, V252, P53, DOI 10.1017/S0952836900009067; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; Edwards S, 2011, AFR J ECOL, V49, P286, DOI 10.1111/j.1365-2028.2011.01262.x; Fernandez GJ, 2003, ETHOLOGY, V109, P413, DOI 10.1046/j.1439-0310.2003.00887.x; Forero MG, 2002, ECOLOGY, V83, P3466, DOI 10.1890/0012-9658(2002)083[3466:CFCEVI]2.0.CO;2; FRETWELL S D, 1972, P217; GOTMARK F, 1984, ANIM BEHAV, V32, P485, DOI 10.1016/S0003-3472(84)80285-7; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; Hotker H, 2000, J AVIAN BIOL, V31, P387, DOI 10.1034/j.1600-048X.2000.310315.x; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Jovani R, 2012, J AVIAN BIOL, V43, P397, DOI 10.1111/j.1600-048X.2012.05643.x; Jovani R, 2008, OIKOS, V117, P1774, DOI 10.1111/j.1600-0706.2008.17065.x; Krama T, 2012, ACTA ETHOL, V15, P127, DOI 10.1007/s10211-011-0117-6; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Magrath MJL, 2009, BEHAV ECOL SOCIOBIOL, V63, P661, DOI 10.1007/s00265-008-0700-7; Mattison PM, 2006, THESIS; MAYER PM, 1991, CONDOR, V93, P753, DOI 10.2307/1368208; Minias P, 2015, EVOL ECOL, V29, P283, DOI 10.1007/s10682-014-9752-5; NISBET ICT, 1983, J FIELD ORNITHOL, V54, P190; Nuechterlein GL, 2003, CONDOR, V105, P80, DOI 10.1650/0010-5422(2003)105[80:RNGBSW]2.0.CO;2; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Portugal SJ, 2018, METHODS ECOL EVOL, V9, P1662, DOI 10.1111/2041-210X.13013; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rendon MA, 2001, BEHAV ECOL SOCIOBIOL, V50, P55, DOI 10.1007/s002650100326; ROBINSON SK, 1985, AUK, V102, P506, DOI 10.1093/auk/102.3.506; Rolland C, 1998, AM NAT, V151, P514, DOI 10.1086/286137; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Serrano D, 2007, AM NAT, V169, pE53, DOI 10.1086/510598; SHIELDS WM, 1984, ANIM BEHAV, V32, P132, DOI 10.1016/S0003-3472(84)80331-0; Skaug H, 2012, GLMMADMB GEN LINEAR; Szostek KL, 2014, IBIS, V156, P48, DOI 10.1111/ibi.12116; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; WIKLUND CG, 1982, BEHAV ECOL SOCIOBIOL, V11, P165, DOI 10.1007/BF00300059; WIKLUND CG, 1994, J ANIM ECOL, V63, P765, DOI 10.2307/5254; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; YABER MC, 1994, ANIM BEHAV, V48, P1301, DOI 10.1006/anbe.1994.1366	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241602	10.1371/journal.pone.0241602	http://dx.doi.org/10.1371/journal.pone.0241602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137151	Green Published, gold			2022-12-26	WOS:000588375500005
J	Russo, L; Anastassopoulou, C; Tsakris, A; Bifulco, GN; Campana, EF; Toraldo, G; Siettos, C				Russo, Lucia; Anastassopoulou, Cleo; Tsakris, Athanasios; Bifulco, Gennaro Nicola; Campana, Emilio Fortunato; Toraldo, Gerardo; Siettos, Constantinos			Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach	PLOS ONE			English	Article								Introduction Italy became the second epicenter of the novel coronavirus disease 2019 (COVID-19) pandemic after China, surpassing by far China's death toll. The disease swept through Lombardy, which remained in lockdown for about two months, starting from the 8th of March. As of that day, the isolation measures taken in Lombardy were extended to the entire country. Here, assuming that effectively there was one case "zero" that introduced the virus to the region, we provide estimates for: (a) the day-zero of the outbreak in Lombardy, Italy; (b) the actual number of asymptomatic infected cases in the total population until March 8; (c) the basic (R-0)and the effective reproduction number (R-e) based on the estimation of the actual number of infected cases. To demonstrate the efficiency of the model and approach, we also provide a tentative forecast two months ahead of time, i.e. until May 4, the date on which relaxation of the measures commenced, on the basis of the COVID-19 Community Mobility Reports released by Google on March 29. Methods To deal with the uncertainty in the number of the actual asymptomatic infected cases in the total population Volpert et al. (2020), we address a modified compartmental Susceptible/ Exposed/ Infectious Asymptomatic/ Infected Symptomatic/ Recovered/ Dead (SEIIRD) model with two compartments of infectious persons: one modelling the cases in the population that are asymptomatic or experience very mild symptoms and another modelling the infected cases with mild to severe symptoms. The parameters of the model corresponding to the recovery period, the time from the onset of symptoms to death and the time from exposure to the time that an individual starts to be infectious, have been set as reported from clinical studies on COVID-19. For the estimation of the day-zero of the outbreak in Lombardy, as well as of the "effective" per-day transmission rate for which no clinical data are available, we have used the proposed SEIIRD simulator to fit the numbers of new daily cases from February 21 to the 8th of March. This was accomplished by solving a mixed-integer optimization problem. Based on the computed parameters, we also provide an estimation of the basic reproduction number R-0 and the evolution of the effective reproduction number R-e. To examine the efficiency of the model and approach, we ran the simulator to "forecast" the epidemic two months ahead of time, i.e. from March 8 to May 4. For this purpose, we considered the reduction in mobility in Lombardy as released on March 29 by Google COVID-19 Community Mobility Reports, and the effects of social distancing and of the very strict measures taken by the government on March 20 and March 21, 2020. Results Based on the proposed methodological procedure, we estimated that the expected day-zero was January 14 (min-max rage: January 5 to January 23, interquartile range: January 11 to January 18). The actual cumulative number of asymptomatic infected cases in the total population in Lombardy on March 8 was of the order of 15 times the confirmed cumulative number of infected cases, while the expected value of the basic reproduction number R-0 was found to be 4.53 (min-max range: 4.40- 4.65). On May 4, the date on which relaxation of the measures commenced the effective reproduction number was found to be 0.987 (interquartiles: 0.857, 1.133). The model approximated adequately two months ahead of time the evolution of reported cases of infected until May 4, the day on which the phase I of the relaxation of measures was implemented over all of Italy. Furthermore the model predicted that until May 4, around 20% of the population in Lombardy has recovered (interquartile range: similar to 10% to similar to 30%).	[Russo, Lucia] CNR, Ist Sci & Tecnol Energia & Mobilita Sostenibile, Naples, Italy; [Anastassopoulou, Cleo; Tsakris, Athanasios] Univ Athens, Med Sch, Dept Microbiol, Athens, Greece; [Bifulco, Gennaro Nicola] Univ Napoli Federico II, Dipartimento Ingn Civile Edile & Ambientale, Naples, Italy; [Campana, Emilio Fortunato] CNR, Dipartimento Ingn ICT & Tecnol Energia & Trasport, Rome, Italy; [Toraldo, Gerardo] Univ Campania Luigi Vanvitelli, Dipartimento Matemat & Fis, Caserta, Italy; [Siettos, Constantinos] Univ Napoli Federico II, Dipartimento Matemat & Applicaz Renato Caccioppol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); National & Kapodistrian University of Athens; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Universita della Campania Vanvitelli; University of Naples Federico II	Siettos, C (corresponding author), Univ Napoli Federico II, Dipartimento Matemat & Applicaz Renato Caccioppol, Naples, Italy.	constantinos.siettos@unina.it	Anastassopoulou, Cleo/AAO-8539-2020; Bifulco, Gennaro Nicola/F-8303-2015	Anastassopoulou, Cleo/0000-0001-7666-9198; Bifulco, Gennaro Nicola/0000-0002-9661-2014; Siettos, Constantinos/0000-0002-9568-3355; CAMPANA, EMILIO FORTUNATO/0000-0002-8234-0089				Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2019, NAT MED, V25, P1, DOI 10.1038/s41591-018-0322-1; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2020, CNBC; [Anonymous], 2020, CHINA CDC WKLY, V8, P113; [Anonymous], BBC; [Anonymous], 2020, POST; [Anonymous], 2020, MESSAGGERO; Baud D, LANCET INFECT DIS; BIRNBAUM ZW, 1969, J APPL PROBAB, V6, P319, DOI 10.2307/3212003; Burr IW, 1942, ANN MATH STAT, V13, P215, DOI 10.1214/aoms/1177731607; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Carinci F., BMJ, V368; Centers for Disease Control and Prevention, 2020, COVID 19 SPREADS; Cereda D., 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)32154-1; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; D'Arienzo Marco, 2020, Biosaf Health, V2, P57, DOI 10.1016/j.bsheal.2020.03.004; De Salazar P. M., 2019, USING PREDICTED IMPO; della Salute M., 2020, COV 19 SIT IT; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DOnofrio A, 2013, BOUNDED NOISES IN PHYSICS, BIOLOGY, AND ENGINEERING, P1, DOI 10.1007/978-1-4614-7385-5; F. Times, 2020, F TIMES; Fong M. W., EMERGING INFECT DIS, V26, DOI 10.3201%2Feid2605.190995; Google, 2021, COMM MOB REP HELP; Guardian T., 2020, T GUARDIAN; I. Istituto Superiore di Sanit, 2020, I SUPERIORE SANIT CH; Imai N., INT J INFECT DIS; J. H. C. for Health Security, 2020, COR COVID 19 GLOB CA; Jury E. I., 1976, IEEE T SYST MAN CYB, VSMC-6, P724, DOI [10.1109%2Ftsmc.1976.4309436, DOI 10.1109/TSMC.1976.4309436, 10.1109/TSMC.1976.4309436]; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Li D., ESTIMATING SCALE COV; Li Q., 2020, NANO RES, DOI DOI 10.1007/S12274-022-4292-8; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Manfredi P., 2013, MODELING INTERPLAY H; Mathworks inc, 2018, MATLAB R2018B; Ming W.-K., BREAKING HEALTHCARE, DOI 10.1101%2F2020.01.27.922443; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Participants in the 2006 Georgetown University Workshop on the Ancillary-Care Obligations of Medical Researchers Working in Developing Countries, 2008, PLOS MED, V5, pe90; Preuss M, 2015, NAT COMPUT SER, P1, DOI 10.1007/978-3-319-07407-8; R. News, 2020, R NEWS; Remuzzi A, LANCET, DOI 10.1016%2Fs0140-6736%2820%2930627-9; Russo L., TRACING DAY ZERO FOR; S. Tg4, 2020, CORONAVIRUS LOMBARDI; Su CP, 2019, EMERG INFECT DIS, V25, P397, DOI 10.3201/eid2503.180708; Volpert V, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020010; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WHO, 2020, 108 WHO; WHO, 2016, ADV RIGHT HLTH VIT R; WHO, 2020, WHO STAT REG CLUST P; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; Wu J. T., LANCET, DOI 10.1016%2Fs0140-6736%2820%2930260-9; Yuan H.-Y., ESTIMATING RISK OUTB; Zehender G, 2020, J MED VIROL, V92, P1637, DOI 10.1002/jmv.25794; Zhao S., INT J INFECT DIS, DOI 10.1101%2F2020.01.23.916395	55	29	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240649	10.1371/journal.pone.0240649	http://dx.doi.org/10.1371/journal.pone.0240649			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125393	Green Published, Green Submitted, gold			2022-12-26	WOS:000588368900050
J	Zhang, H; Deng, XY; Cui, BY; Shao, ZR; Zhao, XL; Yang, Q; Song, SN; Wang, Z; Wang, Y; Wang, YZ; Liu, ZF; Sheng, JL; Chen, CF				Zhang, Huan; Deng, Xiaoyu; Cui, Buyun; Shao, Zhiran; Zhao, Xiaoli; Yang, Qin; Song, Shengnan; Wang, Zhen; Wang, Yong; Wang, Yuanzhi; Liu, Zhengfei; Sheng, Jinliang; Chen, Chuangfu			Abortion and various associated risk factors in dairy cow and sheep in Ili, China	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BOVINE BRUCELLOSIS; SMALL RUMINANTS; SPECIFICITY; DIAGNOSIS; EPIDEMIOLOGY; SENSITIVITY; PREVALENCE; INFECTION; MASTITIS	We studied livestock abortion and various associated risk factors in the Ili region of northwest China. Livestock abortion prevalence was estimated and correlated with infections (Brucellosis, Salmonellosis, Mycoplasma and Chlamydia seropositivity) and management (farming type and contact with other herds/flocks) risk factors. A total of 2996 serum samples (1406 cow, 1590 sheep) were identified by RBPT (Rose Bengal Plate Test) and c-ELISA (competitive-enzyme linked immunosorbent assay), and they showed the overall seroprevalence of brucellosis in the study area was cow 6.76%, sheep 9.50%. The seroprevalence of brucellosis in X county was cow 7.06%, sheep 9.12%; in H county was cow 11.70%, sheep 10.80%; and in Q county was cow 4.22%, sheep 9.11%. The overall seroprevalence of Mycoplasma in the study area was cow 3.20%, sheep 6.42%. The seroprevalence of Mycoplasma in X county was cow 3.39%, sheep 7.98%; in H county was cow 5.26%, sheep 9.97%; and in Q county was cow 2.11%, sheep 4.33%. The Odds ratio of brucellosis for cow and sheep, respectively, were 45.909 [95% CI 26.912-78.317, P0.001] and 70.507 [95% CI 43.783-113.544, P0.001] times higher than other abortion-related factors including mixed farming, contact with other flocks and Mycoplasma infection. A total of 54 samples, including aborted cow (22), sheep (30) fetuses and milk samples (2), were identified as Brucella melitensis (B. melitensis) positive. A total of 38 Brucella were isolated from 16 aborted cow, 20 sheep fetuses and 2 milk samples. All of these isolates were identified, and confirmed, as B. melitensis. A phylogenetic tree showed that the Brucella isolates closely matched the B. melitensis biovar 3 isolated in Inner Mongolia, China, and B. melitensis isolated from Norway and India. These results suggest that B. melitensis biovar 3 is the main pathogen responsible for cow and sheep abortion and also pose a human health risk. Additionally, livestock reproduction can also be influenced by Mycoplasma infection and managerial factors (farming type and contact with other herds/flocks), especially in remote areas.	[Zhang, Huan; Deng, Xiaoyu; Shao, Zhiran; Zhao, Xiaoli; Yang, Qin; Song, Shengnan; Wang, Zhen; Wang, Yong; Sheng, Jinliang; Chen, Chuangfu] Shihezi Univ, Sch Anim Sci & Technol, Shihezi City, Xinjiang, Peoples R China; [Cui, Buyun] Chinese Ctr Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Yuanzhi] Shihezi Univ, Sch Med, Shihezi City, Xinjiang, Peoples R China; [Liu, Zhengfei] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Shihezi University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Shihezi University; Huazhong Agricultural University	Sheng, JL; Chen, CF (corresponding author), Shihezi Univ, Sch Anim Sci & Technol, Shihezi City, Xinjiang, Peoples R China.	1572621211@qq.com; chuangfu_chen@163.com			National Natural Science Foundation of China [U1803236, 31572491]; National key research and development plan project in China [2017YFD0500304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key research and development plan project in China	This work was supported by the National Natural Science Foundation of China (Granted No. U1803236, 31572491), National key research and development plan project in China (Granted No.2017YFD0500304).	Al Dahouk Sascha, 2003, Clin Lab, V49, P487; ALTON GG, 1975, AUST VET J, V51, P57, DOI 10.1111/j.1751-0813.1975.tb09404.x; [Anonymous], 2017, JAMA-J AM MED ASSOC, V318, P1533, DOI 10.1001/jama.2017.15338; [Anonymous], 2018, J MANAG CARE SPEC PH, V24; [Anonymous], 2001, AM J KIDNEY DIS S1, V37, pS65; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Arif S, 2018, PREV VET MED, V149, P21, DOI 10.1016/j.prevetmed.2017.11.002; Barua A, 2016, INDIAN J MED RES, V143, P652, DOI 10.4103/0971-5916.187115; Benkirane A, 2015, VET ITAL, V51, P25, DOI 10.12834/VetIt.389.1814.1; Buendia AJ, 2001, VET MICROBIOL, V78, P229, DOI 10.1016/S0378-1135(00)00298-4; Casanas MC, 2001, EUR J CLIN MICROBIOL, V20, P127, DOI 10.1007/PL00011242; Cremonesi P, 2006, J DAIRY SCI, V89, P163, DOI 10.3168/jds.S0022-0302(06)72080-X; DaCosta M, 1996, J APPL BACTERIOL, V81, P267; Diallo A., 2006, Journal of Veterinary Medicine. Series B, V53, P11, DOI 10.1111/j.1439-0450.2006.01012.x; Dietz HH, 2006, CAN VET J, V47, P1201; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Dohoo IR, 1997, PREV VET MED, V29, P221, DOI 10.1016/S0167-5877(96)01074-4; Entrican G, 2009, INFECT CAUSES REPROD; Flora HNB, 2019, FACTORS AFFECTING RE; Gebremedhin EZ, 2013, RES VET SCI, V95, P894, DOI 10.1016/j.rvsc.2013.08.007; Gee JE, 2004, J CLIN MICROBIOL, V42, P3649, DOI 10.1128/jcm.42.8.3649-3654.2004; Geoffrey HA, 1992, VET REPROD OBSTET, Vsixth; Gioia G, 2016, J DAIRY SCI, V99, P4668, DOI 10.3168/jds.2015-10724; Gorsich EE, 2015, J WILDLIFE DIS, V51, P9, DOI 10.7589/2013-12-334; Holler LD, 2012, VET CLIN N AM-FOOD A, V28, P407, DOI 10.1016/j.cvfa.2012.07.007; Hum S, 2000, AUST VET J, V78, P744, DOI 10.1111/j.1751-0813.2000.tb10444.x; Jinping LI, 2012, PATHOGENIC INVESTIGA; Kardjadj M, 2016, PREV VET MED, V123, P97, DOI 10.1016/j.prevetmed.2015.11.015; Kothalawala KAC, 2017, PREV VET MED, V147, P117, DOI 10.1016/j.prevetmed.2017.08.014; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labernia J., 1996, INFLUENCE MANAGEMENT; Li YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-547; Li Z, 2015, IDENTIFICATION CHARA; Lopez-Gatius F, 2002, THERIOGENOLOGY, V57, P1251, DOI 10.1016/S0093-691X(01)00715-4; Ma X J JK, 2016, ANIMAL HUSBANDRY VET, V48, P111; MarkusfeldNir O, 1997, PREV VET MED, V31, P245, DOI 10.1016/S0167-5877(96)01142-7; Masala G, 2007, J VET DIAGN INVEST, V19, P96, DOI 10.1177/104063870701900116; Matope G, 2010, PREV VET MED, V94, P213, DOI 10.1016/j.prevetmed.2010.01.003; Mellado M, 2006, SMALL RUMINANT RES, V63, P110, DOI 10.1016/j.smallrumres.2005.02.016; Naseri Z, 2016, IRAN J MED SCI, V41, P422; Navarro JA, 2004, VET PATHOL, V41, P498, DOI 10.1354/vp.41-5-498; Perera K, 2009, J MED MICROBIOL, V58, P1576, DOI 10.1099/jmm.0.010090-0; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Sevik M, 2018, ROLE PESTIVIRUSES BD; Singh A K, 2013, RES REV J ECOLOGY EN, V1, P1, DOI DOI 10.1145/2463209.2488734; Sudda M. M., 2016, African Journal of Microbiology Research, V10, P1944, DOI 10.5897/ajmr2016.8209; Tian GZ, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0296-0; van Engelen E, 2014, VET REC, V174, DOI 10.1136/vr.102244; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wang ChangHan, 2009, Xinjiang Agricultural Sciences, V46, P657; Wawegama NK, 2014, CLIN VACCINE IMMUNOL, V21, P196, DOI 10.1128/CVI.00670-13; Wen-Hao NI, 2019, GRASS FEEDING LIVEST; Zhang JH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004470	54	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0232568	10.1371/journal.pone.0232568	http://dx.doi.org/10.1371/journal.pone.0232568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125372	Green Published, Green Submitted, gold			2022-12-26	WOS:000588368900068
J	Bandini, G; Agop-Nersesian, C; van der Wel, H; Mandalasi, M; Kim, HW; West, CM; Samuelson, J				Bandini, Giulia; Agop-Nersesian, Carolina; van der Wel, Hanke; Mandalasi, Msano; Kim, Hyun W.; West, Christopher M.; Samuelson, John			The nucleocytosolic O-fucosyltransferase SPINDLY affects protein expression and virulence in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; CYTOSOLIC PROTEINS; NUCLEAR; CLONING; DIFFERENTIATION; IDENTIFICATION; GLYCOSYLATION; TRANSCRIPTION; LOCALIZATION; PLASMODIUM	Once considered unusual, nucleocytoplasmic glycosylation is now recognized as a conserved feature of eukaryotes. While in animals, O-GlcNAc transferase (OGT) modifies thousands of intracellular proteins, the human pathogen Toxoplasma gondii transfers a different sugar, fucose, to proteins involved in transcription, mRNA processing, and signaling. Knockout experiments showed that TgSPY, an ortholog of plant SPINDLY and paralog of host OGT, is required for nuclear O-fucosylation. Here we verify that TgSPY is the nucleocytoplasmic O-fucosyltransferase (OFT) by 1) complementation with TgSPY-MYC3, 2) its functional dependence on amino acids critical for OGT activity, and 3) its ability to O-fucosylate itself and a model substrate and to specifically hydrolyze GDP-Fuc. While many of the endogenous proteins modified by O-Fuc are important for tachyzoite fitness, O-fucosylation by TgSPY is not essential. Growth of Delta spy tachyzoites in fibroblasts is modestly affected, despite marked reductions in the levels of ectopically expressed proteins normally modified with O-fucose. Intact TgSPY-MYC3 localizes to the nucleus and cytoplasm, whereas catalytic mutants often displayed reduced abundance. Delta spy tachyzoites of a luciferase-expressing type II strain exhibited infection kinetics in mice similar to wild-type but increased persistence in the chronic brain phase, potentially due to an imbalance of regulatory protein levels. The modest changes in parasite fitness in vitro and in mice, despite profound effects on reporter protein accumulation, and the characteristic punctate localization of O-fucosylated proteins suggest that TgSPY controls the levels of proteins to be held in reserve for response to novel stresses.	[Bandini, Giulia; Agop-Nersesian, Carolina; Samuelson, John] Boston Univ, Henry Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA; [van der Wel, Hanke; Mandalasi, Msano; Kim, Hyun W.; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Mandalasi, Msano; West, Christopher M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [West, Christopher M.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Bandini, Giulia] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Boston University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of York - UK	Bandini, G (corresponding author), Boston Univ, Henry Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.; Bandini, G (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	giulia.bandini@york.ac.uk	Bandini, Giulia/ABC-4413-2021	Bandini, Giulia/0000-0002-8885-3643; Kim, Hyun Woo/0000-0002-5002-6300; Mandalasi, Msano/0000-0002-5906-7387	Mizutani Foundation for Glycoscience [18-0117, 13-0111]; NIH grants from NIAID [R21 AI123161, R21 AI110638]; NIH grants from NIGMS [R01 GM084383, R01 GM129324]	Mizutani Foundation for Glycoscience; NIH grants from NIAID; NIH grants from NIGMS	This work was supported in part by grants from the Mizutani Foundation for Glycoscience to G. B. (18-0117) and to J. S. (13-0111), by NIH grants from NIAID to C. M. W. (R21 AI123161) and to J. S. (R21 AI110638), and by NIH grants from NIGMS to C. M. W. (R01 GM084383) and to J. S. and C. M. W. (R01 GM129324). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Barrett MP, 2019, NAT REV MICROBIOL, V17, P607, DOI 10.1038/s41579-019-0238-x; Behnke MS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-350; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Collart MA, 2017, SUBCELL BIOCHEM, V83, P349, DOI 10.1007/978-3-319-46503-6_13; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Dunay IR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00057-17; El Bissati K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0164-4; Farhat DC, 2020, NAT MICROBIOL, V5, P570, DOI 10.1038/s41564-020-0674-4; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Garcia-Contreras R, 2012, FEBS J, V279, P4145, DOI 10.1111/febs.12007; Garinot-Schneider C, 2000, J BIOL CHEM, V275, P31407, DOI 10.1074/jbc.M004524200; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gras S, 2007, EMBO REP, V8, P569, DOI 10.1038/sj.embor.7400958; Guo M, 2015, J FOOD PROTECT, V78, P457, DOI 10.4315/0362-028X.JFP-14-328; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hehl AB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1225-x; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Joiner CM, 2019, J AM CHEM SOC, V141, P12974, DOI 10.1021/jacs.9b06061; Kim HW, 2020, BIOCHEMISTRY-US, V59, P1527, DOI 10.1021/acs.biochem.0c00094; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liang YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016004; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lykins J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006536; Mandalasi M, 2020, J BIOL CHEM, V295, P9223, DOI 10.1074/jbc.RA120.013792; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Niesser J, 2016, MOL CELL BIOL, V36, P820, DOI 10.1128/MCB.01009-15; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Rezaei F, 2019, MICROB PATHOGENESIS, V126, P172, DOI 10.1016/j.micpath.2018.11.003; Rougier S, 2017, TRENDS PARASITOL, V33, P93, DOI 10.1016/j.pt.2016.10.007; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Tomita T, 2017, MBIO, V8, DOI [10.1128/mBio.02048-16, 10.1128/mbio.02048-16]; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tyebji S, 2019, NEUROSCI BIOBEHAV R, V96, P72, DOI 10.1016/j.neubiorev.2018.11.012; Vanagas L, 2013, PARASITOLOGY, V140, P1104, DOI 10.1017/S0031182013000504; Waldman BS, 2020, CELL, V180, P359, DOI 10.1016/j.cell.2019.12.013; Wang Y, 2020, MOL PLANT, V13, P446, DOI 10.1016/j.molp.2019.12.013; Yakubu RR, 2018, MOL MICROBIOL, V107, P1, DOI 10.1111/mmi.13867; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zentella R, 2017, NAT CHEM BIOL, V13, P479, DOI [10.1038/NCHEMBIO.2320, 10.1038/nchembio.2320]; Zhang M, 2013, EUKARYOT CELL, V12, P161, DOI 10.1128/EC.00296-12	60	2	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100039	10.1074/jbc.RA120.015883	http://dx.doi.org/10.1074/jbc.RA120.015883			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33158988	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400023
J	Holdbrooks, AT; Ankenbauer, KE; Hwang, J; Bellis, SL				Holdbrooks, Andrew T.; Ankenbauer, Katherine E.; Hwang, Jihye; Bellis, Susan L.			Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; DENDRITIC CELLS; P1 PROMOTER; MONOCYTES; SURFACE; DESIALYLATION; SIALYLATION; DEFICIENCY; ACTIVATION	The ST6Gal-I sialyltransferase, an enzyme that adds alpha 2-6-linked sialic acids to N-glycosylated proteins, regulates multiple immunological processes. However, the contribution of receptor sialylation to inflammatory signaling has been under-investigated. In the current study, we uncovered a role for ST6Gal-I in promoting sustained signaling through two prominent inflammatory pathways, NF kappa B and JAK/STAT. Using the U937 monocytic cell model, we determined that knockdown (KD) of ST6Gal-I expression had no effect on the rapid activation of NF kappa B by TNF (<= 30 min), whereas long-term TNF-induced NF kappa B activation (2-6 hr) was diminished in ST6Gal-I-KD cells. These data align with prior work in epithelial cells showing that alpha 2-6 sialylation of TNFR1 prolongs TNF-dependent NF kappa B activation. Similar to TNF, long-term, but not short-term, LPS-induced activation of NF kappa B was suppressed by ST6Gal-I KD. ST6Gal-I KD cells also exhibited reduced long-term IRF3 and STAT3 activation by LPS. Given that ST6Gal-I activity modulated LPS-dependent signaling, we conducted pull-down assays using SNA (a lectin specific for alpha 2-6 sialic acids) to show that the LPS receptor, TLR4, is a substrate for sialylation by ST6Gal-I. We next assessed signaling by IFN gamma, IL-6 and GM-CSF, and found that ST6Gal-I-KD had a limited effect on STAT activation induced by these cytokines. To corroborate these findings, signaling was monitored in bone marrow derived macrophages (BMDMs) from mice with myeloid-specific deletion of ST6Gal-I (LysMCre/ST6Gal-I-fl/fl). In agreement with data from U937 cells, BMDMs with ST6Gal-I knockout displayed reduced long-term activation of NF kappa B by both TNF and LPS, and diminished long-term LPS-dependent STAT3 activation. However, STAT activation induced by IFN gamma, IL-6 and GM-CSF was comparable in wild-type and ST6Gal-I knockout BMDMs. These results implicate ST6Gal-I-mediated receptor sialylation in prolonging the activity of select signaling cascades including TNF/NF kappa B, LPS/NF kappa B, and LPS/STAT3, providing new insights into ST6Gal-I's role in modulating the inflammatory phenotype of monocytic cells.	[Holdbrooks, Andrew T.; Ankenbauer, Katherine E.; Hwang, Jihye; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	bellis@uab.edu		Bellis, Susan/0000-0002-5071-527X; Hwang, Jihye/0000-0001-8224-0240	American Heart Association [GRNT7710013]; National Institutes of Health [R01 CA225177]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by grants from the: (1) American Heart Association (GRNT7710013 to S.L.B), www.heart.org, and (2) National Institutes of Health (R01 CA225177 to S.L. B), www.nih.gov. Andrew Holdbrooks (ATH) was supported an American Heart Association Predoctoral Fellowship, www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; [Anonymous], 2012, DIABETES CARE S1, V35, pS11; [Anonymous], 2017, LANCET HIV, V2, pe115; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Dorrington MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00705; Dougher CWL, 2017, J LEUKOCYTE BIOL, V102, P507, DOI 10.1189/jlb.3A1216-538RR; Feng CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032359; Garnham R, 2019, ONCOL LETT, V18, P983, DOI 10.3892/ol.2019.10458; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Lane K, 2017, CELL SYST, V4, P458, DOI 10.1016/j.cels.2017.03.010; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8270; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Saade S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029427; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schroeder J, 2007, J PAIN S, V8, pS66; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shin BY, 2018, J EXP MED, V215, P1803, DOI 10.1084/jem.20172335; Sikorski Krzysztof, 2012, JAKSTAT, V1, P241, DOI 10.4161/jkst.22469; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wang D, 2016, GLYCOCONJUGATE J, V33, P725, DOI 10.1007/s10719-016-9664-4	48	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241850	10.1371/journal.pone.0241850	http://dx.doi.org/10.1371/journal.pone.0241850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166339	Green Published, gold			2022-12-26	WOS:000592382600032
J	Komatsu, T; Chen-Yoshikawa, TF; Ikeda, M; Takahashi, K; Nishimura, A; Harashima, S; Date, H				Komatsu, Teruya; Chen-Yoshikawa, Toyofumi F.; Ikeda, Masaki; Takahashi, Koji; Nishimura, Akiko; Harashima, Shin-ichi; Date, Hiroshi			Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; RISK-FACTORS; SURVIVAL; GLUCOSE	Objectives Studies showing that individuals with non-small cell lung cancer (NSCLC) and diabetes mellitus (DM) have reported poor outcomes after pulmonary resection with varying results. Therefore, we investigated the clinical impact of preoperative DM on postoperative morbidity and survival in individuals with resectable NSCLC. Patients and methods Data of individuals who underwent pulmonary resection for NSCLC from 2000 to 2015 were extracted from the database of Kyoto University Hospital. The primary endpoint was the incidence of postoperative complications, and secondary endpoints were postoperative length of hospital stay and overall survival. The survival rate was analyzed using the Kaplan-Meier method. Results A total of 2,219 patients were eligible for the study. The median age of participants was 67 years. Among them, 39.5% were women, and 259 (11.7%) presented with DM. The effect of DM on the incidence of postoperative complications and postoperative length of hospital stay was not significant. Although the 5-year survival rates were similar in both patients with and without DM (80.2% versus 79.4%; p = 0.158), those with DM who had a hemoglobin A1c level >= 8.0% had the worst survival. Conclusions In individuals with resectable NSCLC, preoperative DM does not influence the acute phase postoperative recovery. However, poorly controlled preoperative DM could lead to low postoperative survival rates.	[Komatsu, Teruya] Natl Hosp Org Nagara Med Ctr, Div Thorac Surg, Gifu, Japan; [Komatsu, Teruya; Chen-Yoshikawa, Toyofumi F.; Ikeda, Masaki; Takahashi, Koji; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan; [Nishimura, Akiko; Harashima, Shin-ichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Nishimura, Akiko] Nara Med Univ, Fac Nursing, Sch Med, Nara, Japan; [Harashima, Shin-ichi] Goshominami Harashima Clin, Kyoto, Japan	Kyoto University; Kyoto University; Nara Medical University	Date, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan.	hdate@kuhp.kyoto-u.ac.jp		Komatsu, Teruya/0000-0001-6321-2973				[Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Bartling B, 2011, GERONTOLOGY, V57, P497, DOI 10.1159/000323856; Blankush JM, 2016, ANN MED SURG, V10, P77, DOI 10.1016/j.amsu.2016.07.025; Bordoni A, 2017, EUR J CANCER PREV, V26, pS70, DOI 10.1097/CEJ.0000000000000299; Chen Y, 2017, DIABETOLOGIA, V60, P1022, DOI 10.1007/s00125-017-4229-z; Dankner R, 2018, CANCER EPIDEMIOL, V57, P104, DOI 10.1016/j.canep.2018.10.010; Deng HY, 2019, THORAC CANCER, V10, P571, DOI 10.1111/1759-7714.12985; Dhillon Samjot Singh, 2014, J Cancer Sci Ther, V6, P217; Federation. ID, 2017, IDF DIABETES ATLAS; Hatlen P, 2011, J THORAC ONCOL, V6, P1810, DOI 10.1097/JTO.0b013e31822a75be; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ikeda Y, 2018, J DIABETES INVEST, V9, P925, DOI 10.1111/jdi.12778; Imai H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2012-4; Katayama H, 2016, SURG TODAY, V46, P668, DOI 10.1007/s00595-015-1236-x; Kurishima K, 2017, MOL CLIN ONCOL, V6, P907, DOI 10.3892/mco.2017.1224; Lee JY, 2013, EUR J CANCER, V49, P2411, DOI 10.1016/j.ejca.2013.02.025; Li SJ, 2016, ANN THORAC SURG, V102, P328, DOI 10.1016/j.athoracsur.2016.01.013; Motoishi M, 2018, SURG TODAY, V48, P517, DOI 10.1007/s00595-017-1612-9; Nakagawa K, 2017, JPN J CLIN ONCOL, V47, P194, DOI 10.1093/jjco/hyw169; Nakamura J, 2017, J DIABETES INVEST, V8, P397, DOI 10.1111/jdi.12645; Okami J, 2009, J THORAC ONCOL, V4, P1247, DOI 10.1097/JTO.0b013e3181ae285d; Qadan M, 2010, J AM COLL SURGEONS, V210, P966, DOI 10.1016/j.jamcollsurg.2010.02.001; Rezaei Hachesu Peyman, 2017, Asian Pac J Cancer Prev, V18, P1531; Sheehy Ann M, 2009, J Diabetes Sci Technol, V3, P1261; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; The ASCO Post, 2013, ASCO POST, V4, P105; Wang Z, 2014, ASIAN PAC J CANCER P, V15, P3071, DOI 10.7314/APJCP.2014.15.7.3071; Washington I, 2013, THORAC CANCER, V4, P123, DOI 10.1111/j.1759-7714.2012.00162.x; Yu WS, 2018, J SURG ONCOL, V117, P985, DOI 10.1002/jso.24989	30	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241930	10.1371/journal.pone.0241930	http://dx.doi.org/10.1371/journal.pone.0241930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166327	Green Published, gold			2022-12-26	WOS:000592382600027
J	Jhun, J; Moon, J; Ryu, J; Shin, Y; Lee, S; Cho, KH; Kang, T; Cho, ML; Park, SH				Jhun, Jooyeon; Moon, Jeonghyeon; Ryu, Jaeyoon; Shin, Yonghee; Lee, Seangyoun; Cho, Keun-Hyung; Kang, Taewook; Cho, Mi-La; Park, Sung-Hwan			Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting	PLOS ONE			English	Article							COENZYME Q(10); GOLD NANOCAGES; SUPPLEMENTATION; IMPROVEMENT; ABSORPTION; DELIVERY; THERAPY; CELLS; JOINT	Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant. Although CoQ10 has not been approved as medication by the Food and Drug Administration, it is widely used in dietary supplements. Some studies have shown that CoQ10 has anti-inflammatory effects on various autoimmune disorders. In this study, we investigated the anti-inflammatory effects of liposome/gold hybrid nanoparticles encoded with CoQ10 (LGNP-CoQ10). Both CoQ10 and LGNP-CoQ10 were administered orally to mice with collagen-induced arthritis (CIA) for 10 weeks. The inflammation pathology of joint tissues of CIA mice was then analyzed using hematoxylin and eosin and Safranin O staining, as well as immunohistochemistry analysis. We obtained immunofluorescence staining images of spleen tissues using confocal microscopy. We found that pro-inflammatory cytokines were significantly decreased in LGNP-CoQ10 injected mice. Th17 cell and phosphorylated STAT3-expressed cell populations were also decreased in LGNP-CoQ10 injected mice. When human peripheral blood mononuclear cells (PBMCs) were treated with CoQ10 and LGNP-CoQ10, the IL-17 expression of PBMCs in the LGNP-CoQ10-treated group was significantly reduced. Together, these results suggest that LGNP-CoQ10 has therapeutic potential for the treatment of rheumatoid arthritis.	[Jhun, Jooyeon; Ryu, Jaeyoon; Lee, Seangyoun; Cho, Keun-Hyung; Cho, Mi-La; Park, Sung-Hwan] Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Rheumatism Res Ctr, Seoul, South Korea; [Moon, Jeonghyeon; Cho, Mi-La] Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea; [Shin, Yonghee; Kang, Taewook] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea; [Kang, Taewook] Sogang Univ, Inst Integrated Biotechnol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Sogang University; Sogang University	Cho, ML; Park, SH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Rheumatism Res Ctr, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea.; Kang, T (corresponding author), Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea.; Kang, T (corresponding author), Sogang Univ, Inst Integrated Biotechnol, Seoul, South Korea.	twkang@sogang.ac.kr; iammila@catholic.ac.kr; rapark@catholic.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1062]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C1062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahzad H, 2015, ARCH MED RES, V46, P527, DOI 10.1016/j.arcmed.2015.08.006; AL-Megrin WA, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00064; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Bauerova Katarina, 2011, Interdiscip Toxicol, V4, P33, DOI 10.2478/v10102-011-0007-9; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen HC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112550; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dhaouadi T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194883; El Agamy DF, 2019, BMC UROL, V19, DOI 10.1186/s12894-019-0534-9; Hernandez VA, 2015, BBA-BIOMEMBRANES, V1848, P2233, DOI 10.1016/j.bbamem.2015.05.002; Jhun J, 2016, IMMUNOPHARM IMMUNOT, V38, P103, DOI 10.3109/08923973.2015.1122619; Jhun J, 2015, IMMUNOL LETT, V166, P92, DOI 10.1016/j.imlet.2015.05.012; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Lajunen T, 2015, J CONTROL RELEASE, V203, P85, DOI 10.1016/j.jconrel.2015.02.028; Lee JH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601838; Lee SY, 2017, J MED FOOD, V20, P821, DOI 10.1089/jmf.2016.3859; Lee SH, 2016, J MED FOOD, V19, P238, DOI 10.1089/jmf.2015.3535; Lee YC, 2007, J ETHNOPHARMACOL, V112, P40, DOI 10.1016/j.jep.2007.01.033; Lee Y, 2019, CHEM COMMUN, V55, P3195, DOI 10.1039/c8cc10037c; Liang RJ, 2017, BIOMATERIALS, V149, P41, DOI 10.1016/j.biomaterials.2017.09.029; Liu SS, 2019, BRAIN BEHAV IMMUN, V80, P711, DOI 10.1016/j.bbi.2019.05.020; Mohammadi FS, 2019, J CELL PHYSIOL, V234, P17159, DOI 10.1002/jcp.28495; Ochiai A, 2007, YAKUGAKU ZASSHI, V127, P1251, DOI 10.1248/yakushi.127.1251; Rengan AK, 2015, NANO LETT, V15, P842, DOI 10.1021/nl5045378; SANBE A, 1994, J PHARMACOL EXP THER, V269, P51; Sarmiento A, 2016, CURR DRUG METAB, V17, P345, DOI 10.2174/1389200216666151103115654; Song YZ, 2016, DRUG DEV IND PHARM, V42, P2044, DOI 10.1080/03639045.2016.1195399; Takekawa Y, 2016, BIOL PHARM BULL, V39, P301, DOI 10.1248/bpb.b15-00359; Weber C, 1997, MOL ASPECTS MED, V18, pS251; Weng L, 2010, ANN RHEUM DIS, V69, P1519, DOI 10.1136/ard.2009.121111; Xu N, 2019, BIOMATERIALS, V197, P380, DOI 10.1016/j.biomaterials.2019.01.034; Yap HY, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100161	32	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241080	10.1371/journal.pone.0241080	http://dx.doi.org/10.1371/journal.pone.0241080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156836	Green Published, Green Submitted, gold			2022-12-26	WOS:000591376400014
J	Vipin, C; Saptami, K; Fida, F; Mujeeburahiman, M; Rao, SES; Athmika; Arun, AB; Rekha, PD				Vipin, Chembili; Saptami, Kanekar; Fida, Fathima; Mujeeburahiman, Musliyarakath; Rao, Sneha S.; Athmika; Arun, Ananthapadmanabha Bhagwath; Rekha, Punchappady Devasya			Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa	PLOS ONE			English	Article							BIOFILM FORMATION; CELL-MEMBRANE; COMBINATION; TOLERANCE; VIRULENCE	Development of drug resistance in opportunistic pathogens is one of the major healthcare challenges associated with infection management. Combination therapy has many advantages due to the simultaneous action of two drugs on two separate cellular targets. However, selection of the drugs should offer safety and synergistic interaction against most of the strains. Here, the efficacy of antibiotics in combination with quercetin, a natural flavonoid capable of targeting quorum sensing was tested against biofilm-forming Pseudomonas aeruginosa strains previously isolated from catheter associated urinary tract infection. Based on the antibiotic susceptibility pattern, synergistic effect of quercetin with selected antibiotics (levofloxacin, ceftriaxone, gentamycin, tobramycin and amikacin) was tested at the fractional concentrations of MIC by the checkerboard method and the fractional inhibitory concentration index (FICi) was calculated to estimate the synergistic effect. Effect of the synergistic combinations were further tested using time-kill assay, and against biofilm formation and biofilm cell viability. Cytotoxicity assays were performed using Human Embryonic Kidney 293T cells (HEK-293T) using the effective drug combinations with respective controls. The biofilm formation and biofilm cell viability were drastically affected with quercetin and selected antibiotics combinations with >= 80% inhibition. In vitro infection studies showed that all the strains could exert significant cell killing (68 to 85%) and the drug combinations decreased the infection rate significantly by reducing the cell killing effect of P. aeruginosa (p<0.05). The synergistic effect of quercetin is attributed to its quorum sensing inhibitory properties. These findings indicate that quercetin along with existing antibiotics can potentiate the treatment against P. aeruginosa infection and may reduce the selection pressure due to antibiotic overuse.	[Vipin, Chembili; Saptami, Kanekar; Fida, Fathima; Rao, Sneha S.; Athmika; Arun, Ananthapadmanabha Bhagwath; Rekha, Punchappady Devasya] Yenepoya Deemed Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India; [Mujeeburahiman, Musliyarakath] Yenepoya Deemed Univ, Dept Urol, Mangalore, Karnataka, India	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Rekha, PD (corresponding author), Yenepoya Deemed Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India.	rekhapd@yenepoya.edu.in	Bhagwath, Arun Ananthapadmanabha/X-7604-2019; Kanekar, Saptami/ABF-4643-2021	Bhagwath, Arun Ananthapadmanabha/0000-0003-3140-9266; KANEKAR, SAPTAMI/0000-0002-1508-5305; Rekha, PD/0000-0002-9187-6395	Indian Council of Medical Research [OMI-Fellowship/32/2018-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	CV and KS are recipients of Indian Council of Medical Research-Senior Research Fellowship (OMI-Fellowship/32/2018-ECD-I).	Ahmed A, 2014, INDIAN J CRIT CARE M, V18, P310, DOI 10.4103/0972-5229.132495; Ahmed B, 2018, ADV POWDER TECHNOL, V29, P1601, DOI 10.1016/j.apt.2018.03.025; Amin MU, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0580-0; Bedard E, 2014, FEMS MICROBIOL LETT, V356, P226, DOI 10.1111/1574-6968.12494; Bouyahya A, 2017, ASIAN PAC J TROP MED, V10, P795, DOI 10.1016/j.apjtm.2017.07.021; Brackman G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20321; Castaneda P, 2016, CLIN ORTHOP RELAT R, V474, P1659, DOI 10.1007/s11999-016-4700-z; Ciofu O, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00913; Clinical and Laboratory Standards Institute, 2018, PERFORMANCE STANDARD; Crone S, 2020, APMIS, V128, P220, DOI 10.1111/apm.13010; Fallah F, 2017, MICROB PATHOGENESIS, V108, P85, DOI 10.1016/j.micpath.2017.05.014; Gopu V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134684; Kamath KS, 2016, J PROTEOME RES, V15, P2152, DOI 10.1021/acs.jproteome.6b00058; Kim MK, 2018, B KOREAN CHEM SOC, V39, P879, DOI 10.1002/bkcs.11493; Kraemer SA, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7060180; Lee JH, 2013, BIOFOULING, V29, P491, DOI 10.1080/08927014.2013.788692; Lin J, 2020, J INVEST SURG, V33, P876, DOI 10.1080/08941939.2018.1556753; Louie A, 2011, ANTIMICROB AGENTS CH, V55, P3295, DOI 10.1128/AAC.01324-10; Lu NT, 2016, PHYTOTHER RES, V30, P160, DOI 10.1002/ptr.5518; Muzny CA, 2015, CLIN INFECT DIS, V61, P601, DOI 10.1093/cid/civ353; Olga P, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw042; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Ouyang J, 2016, J APPL MICROBIOL, V120, P966, DOI 10.1111/jam.13073; Pachori P, 2019, GENES DIS, V6, P109, DOI 10.1016/j.gendis.2019.04.001; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Pournaras S, 2011, INT J ANTIMICROB AG, V37, P244, DOI 10.1016/j.ijantimicag.2010.10.031; Qu SQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02536; Saurav K, 2017, MAR DRUGS, V15, DOI 10.3390/md15030053; Siriwong S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/759459; Siriwong S, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0083-8; Bustos PS, 2016, ENVIRON TOXICOL PHAR, V48, P253, DOI 10.1016/j.etap.2016.11.004; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Vasavi HS, 2016, J MICROBIOL IMMUNOL, V49, P8, DOI 10.1016/j.jmii.2014.03.012; Winstanley C, 2016, TRENDS MICROBIOL, V24, P327, DOI 10.1016/j.tim.2016.01.008; Yan J, 2019, CELL HOST MICROBE, V26, P15, DOI 10.1016/j.chom.2019.06.002	36	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241304	10.1371/journal.pone.0241304	http://dx.doi.org/10.1371/journal.pone.0241304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156838	Green Published, gold			2022-12-26	WOS:000591376400032
J	Carranza, J; de la Pena, E; Mateos, C; Perez-Gonzalez, J; Alarcos, S; Torres-Porras, J; Valencia, J; Sanchez-Prieto, C; Castillo, L				Carranza, Juan; de la Pena, Eva; Mateos, Concha; Perez-Gonzalez, Javier; Alarcos, Susana; Torres-Porras, Jeronimo; Valencia, Juliana; Sanchez-Prieto, Cristina; Castillo, Leticia			The dark ventral patch: A bimodal flexible trait related to male competition in red deer	PLOS ONE			English	Article							POPULATION-STRUCTURE; REPRODUCTIVE EFFORT; SEXUAL TRAITS; GROWTH LAYERS; AGE; SIGNALS; COLOR; TERRITORIALITY; TESTOSTERONE; SELECTION	Sexual signals play a central role in male-male competition in polygynous species. In red deer (Cervus elaphus), male's ventral area become dark during the rutting season due to urine spraying behaviour and retains many chemical compounds potentially revealing individual features. Here we investigate the variation in size of this trait, exploring its relationship with age and male competitive features such as antlers or body size, as well as populational level of intrasexual competition for mates. We found that the size of the dark ventral patch followed a clearly bimodal distribution, i.e. males mostly expressed the full-size trait or just developed a very small one. For these two groups of males according to trait expression, the relationships of trait size with age and antler size differed. Populational level of intrasexual competition appeared to affect the relationship between antler size and the probability of a fully developed ventral patch. These results indicate that the trait encodes information on body size, antler size, age and populational level of mate competition, thus suggesting a role in signalling male's competitive features and willingness to allocate reproductive effort within a particular season.	[Carranza, Juan; de la Pena, Eva] Univ Cordoba, Wildlife Res Unit UiRCP, Cordoba, Spain; [Mateos, Concha; Perez-Gonzalez, Javier; Alarcos, Susana; Sanchez-Prieto, Cristina; Castillo, Leticia] Univ Extremadura, Biol & Ethol, Caceres, Spain; [Torres-Porras, Jeronimo] Univ Cordoba, Fac Educ Sci, Dept Social & Expt Sci Teaching, Cordoba, Spain; [Valencia, Juliana] Univ Malaga, Fac Educ Sci, Expt Sci Teaching, Malaga, Spain	Universidad de Cordoba; Universidad de Extremadura; Universidad de Cordoba; Universidad de Malaga	Carranza, J (corresponding author), Univ Cordoba, Wildlife Res Unit UiRCP, Cordoba, Spain.	jcarranza@uco.es	De la Peña, Eva/ABI-7470-2020; Pérez-González, Javier/AAF-6106-2020; Torres-Porras, Jeronimo/L-3005-2015	De la Peña, Eva/0000-0001-9567-1111; Carranza, Juan/0000-0002-0368-7173; Perez-Gonzalez, Javier/0000-0003-0624-835X; Torres-Porras, Jeronimo/0000-0003-1900-7870	Spanish Ministry of Science [CGL2013-48122-P, CGL2016-77052-P]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support came from projects CGL2013-48122-P and CGL2016-77052-P from the Spanish Ministry of Science to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos J., 2016, BEHAVIOUR, V153, P607, DOI DOI 10.1163/1568539X-00003366; Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Andersson Malte, 1994; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; Badyaev AV, 2002, AUK, V119, P301, DOI 10.1642/0004-8038(2002)119[0301:PSTITC]2.0.CO;2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bogaardt L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0324; Bradbury Jack W., 1998, pi; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; CARRANZA J, 1995, ANIM BEHAV, V50, P445, DOI 10.1006/anbe.1995.0258; Carranza J, 1996, ETHOLOGY, V102, P793; Carranza J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65578-w; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; Cover T.M., 1991, ELEMENTS INFORM THEO, P224; CULLEN JM, 1966, PHILOS T R SOC B, V251, P363, DOI 10.1098/rstb.1966.0022; Darwin C., 1871, P423; de la Pena E., 2020, MAMMAL BIO UNPUB; de la Pena E., 2020, ANIM BEHAV UNPUB; de la Pena E, 2020, SCI NAT-HEIDELBERG, V107, DOI 10.1007/s00114-020-01674-1; De La Pena E, 2020, INTEGR ZOOL, V15, P262, DOI 10.1111/1749-4877.12427; de la Pena E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221980; Enquist M, 1998, ANIM BEHAV, V56, P749, DOI 10.1006/anbe.1998.0820; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Galvan I, 2019, CELL MOL LIFE SCI, V76, P397, DOI 10.1007/s00018-018-2962-1; Gautier P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1159, DOI 10.1007/s00265-008-0544-1; Goss R.J., 1983, DEER ANTLERS REGENER; Harvey P.H., 1991, P203; Hau M, 2001, HORM BEHAV, V40, P281, DOI 10.1006/hbeh.2001.1673; JOHNSTONE RA, 1994, P ROY SOC B-BIOL SCI, V256, P169, DOI 10.1098/rspb.1994.0066; JOHNSTONE RA, 1995, J THEOR BIOL, V177, P87, DOI 10.1016/S0022-5193(05)80006-2; Johnstone Rufus A., 1997, P155; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Laredo SA, 2014, FRONT NEUROENDOCRIN, V35, P447, DOI 10.1016/j.yfrne.2014.03.005; Ludecke D., 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [10.21105/joss.00772, DOI 10.21105/JOSS.00772]; Maechler M, 2016, HARTIGANS DIP TEST S; Malo AF, 2009, P R SOC B, V276, P971, DOI 10.1098/rspb.2008.1367; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Martin J, 2014, MAMM BIOL, V79, P362, DOI 10.1016/j.mambio.2014.07.005; Martinez M, 2005, BIOL LETTERS, V1, P353, DOI 10.1098/rsbl.2005.0330; Mateos C, 1997, ANIM BEHAV, V53, P471, DOI 10.1006/anbe.1996.0297; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; MITCHELL B, 1963, NATURE, V198, P350, DOI 10.1038/198350a0; MITCHELL B, 1967, J ANIM ECOL, V36, P279, DOI 10.2307/2912; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Perez-Barberia FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142707; Perez-Barberia FJ, 2014, J ZOOL, V294, P180, DOI 10.1111/jzo.12166; Perez-Gonzalez J, 2012, EUR J WILDLIFE RES, V58, P933, DOI 10.1007/s10344-012-0636-0; Perez-Gonzalez J, 2009, MOL ECOL, V18, P4617, DOI 10.1111/j.1365-294X.2009.04386.x; Perez-Gonzalez J, 2011, ANIM BEHAV, V82, P957, DOI 10.1016/j.anbehav.2011.07.023; Perez-Rodriguez L, 2008, NATURWISSENSCHAFTEN, V95, P821, DOI 10.1007/s00114-008-0389-5; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Rosen RF, 2006, ETHOLOGY, V112, P1008, DOI 10.1111/j.1439-0310.2006.01257.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SENAR JC, 1993, AUK, V110, P924, DOI 10.2307/4088649; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0347; Torres-Porras J, 2014, EUR J WILDLIFE RES, V60, P351, DOI 10.1007/s10344-013-0793-9; Torres-Porras J, 2009, EUR J WILDLIFE RES, V55, P117, DOI 10.1007/s10344-008-0225-4; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	74	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241374	10.1371/journal.pone.0241374	http://dx.doi.org/10.1371/journal.pone.0241374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151970	gold, Green Published			2022-12-26	WOS:000591376200016
J	Lelescu, CA; Urda-Cimpean, AE; Dumitras, DA; Taulescu, M; Muresan, C				Lelescu, Cristina A.; Urda-Cimpean, Andrada E.; Dumitras, Daria A.; Taulescu, Marian; Muresan, Cosmin			Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats	PLOS ONE			English	Article							0.5-PERCENT PROPARACAINE HYDROCHLORIDE; PERIBULBAR ANESTHESIA; LIDOCAINE; DURATION; BUPIVACAINE; SURGERY; MIXTURE	The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conducted on 20 healthy adult Wistar rats, following complete physical and ophthalmological examination. Baseline corneal touch threshold (CTT) was determined in the central corneal area of both eyes with a Cochet-Bonnet aesthesiometer, in mm filament length. Oxybuprocaine was randomly applied to one eye and 0.9% sterile sodium chloride solution was instilled into the contralateral eye. Subsequent CTT measurements were performed in both eyes 5 minutes after topical application and at 5-minute intervals thereafter for 75-minutes in the anesthetized eye. Following a 2-week washout period, this protocol was repeated with ropivacaine. Quantitative data were summarized as mean +/- standard deviation, median and inter-quartile range (Q1-Q3). Repeated measures data were analyzed over time and between treatments using Friedman test and Wilcoxon signed-rank test with Bonferroni adjustment (p < 0.05). Baseline CTT values were 60 mm in all eyes. With oxybuprocaine, CTT values decreased significantly for 65 minutes (0-55 mm; p = 0.002) when compared with baseline; the maximal anesthetic effect (no blink response at 5 mm filament length) was maintained for up to 15 minutes (p < 0.0001). With ropivacaine, CTT values were significantly lower than baseline for 30 minutes (0-55 mm; p = 0.002), with a maximal anesthetic effect recorded at 5 minutes in 18 eyes (p < 0.0001). Oxybuprocaine induced a significantly lower CTT than ropivacaine (p = 0.002) from 10 to 65 minutes following topical application. Both anesthetic agents induced significant corneal anesthesia; however, oxybuprocaine provided a greater and longer anesthetic effect, making it more suitable for potentially painful ophthalmologic procedures.	[Lelescu, Cristina A.] VisionVet, Bologna, Italy; [Urda-Cimpean, Andrada E.] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Med Informat & Biostat, Cluj Napoca, Romania; [Dumitras, Daria A.] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Biochem, Cluj Napoca, Romania; [Taulescu, Marian] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania; [Muresan, Cosmin] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Surg, Cluj Napoca, Romania	Iuliu Hatieganu University of Medicine & Pharmacy; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Muresan, C (corresponding author), Univ Agr Sci & Vet Med, Fac Vet Med, Dept Surg, Cluj Napoca, Romania.	muresanscosmin@gmail.com	Dumitras, Daria Antonia/X-6667-2018	Dumitras, Daria Antonia/0000-0001-8940-9651; muresan, cosmin/0000-0002-5064-6841	National Research Development Projects to finance excellence (PFE); Romanian Ministry of Research and Innovation [37/2018-2020]	National Research Development Projects to finance excellence (PFE); Romanian Ministry of Research and Innovation(Ministry of Research, Innovation and Digitization - Romania)	The publication was supported by funds from the National Research Development Projects to finance excellence (PFE) granted by the Romanian Ministry of Research and Innovation and awarded to CM (37/2018-2020). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SMU SCI TECH L REV, V16, P43; Belyamani L, 2003, J FR OPHTALMOL, V26, P953; Binder DR, 2006, AM J VET RES, V67, P1780, DOI 10.2460/ajvr.67.10.1780; Borazan M, 2007, ACTA OPHTHALMOL SCAN, V85, P844, DOI 10.1111/j.1600-0420.2007.00976.x; Bryda Elizabeth C, 2013, Mo Med, V110, P207; Costa D, 2014, VET REC, V174, P478, DOI 10.1136/vr.102189; Douet JY, 2013, AM J VET RES, V74, P1321, DOI 10.2460/ajvr.74.10.1321; Drasner K, 2002, SCHNIDER LEVINSONS A, P73; Farkouh A, 2016, CLIN OPHTHALMOL, V10, P2433, DOI 10.2147/OPTH.S118409; Featherstone HJ., 2013, VET OPHTHALMOLOGY, V5th ed., P533; Giudici V, 2015, VET OPHTHALMOL, V18, P141, DOI 10.1111/vop.12179; Golebiowski B, 2011, EXP EYE RES, V92, P408, DOI 10.1016/j.exer.2011.02.016; Herring I, 2013, VET OPHTHALMOLOGY, P423; Herring IP, 2005, AM J VET RES, V66, P77, DOI 10.2460/ajvr.2005.66.77; Kashyap A, 2018, INDIAN J OPHTHALMOL, V66, P1268, DOI 10.4103/ijo.IJO_100_18; Kinra R, 2013, MEDIEV HIST J, V16, P251, DOI 10.1177/0971945813514887; Li M, 2014, DRUG DES DEV THER, V8, P1269, DOI 10.2147/DDDT.S57258; Little E, 2016, CAN J VET RES, V80, P329; Little WB, 2016, AUST VET J, V94, P181, DOI 10.1111/avj.12443; LYTLE J, 1992, ANAESTHESIA, V47, P616, DOI 10.1111/j.1365-2044.1992.tb02339.x; Martini E, 2002, J CATARACT REFR SURG, V28, P1018, DOI 10.1016/S0886-3350(01)01225-1; Meng ID, 2015, INVEST OPHTH VIS SCI, V56, P3347, DOI 10.1167/iovs.15-16717; MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P79; Romero A.M., 2004, Anales Sis San Navarra, V27, P45, DOI 10.4321/s1137-66272004000200005; Wagatsuma JT, 2014, AM J VET RES, V75, P1040, DOI 10.2460/ajvr.75.12.1040; Williams D, 2007, EUR J COMPANION ANIM, V17, P242	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241567	10.1371/journal.pone.0241567	http://dx.doi.org/10.1371/journal.pone.0241567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151993	gold, Green Published			2022-12-26	WOS:000591376200060
J	Jacobs, MC; Lankelma, JM; Wolff, NS; Hugenholtz, F; de Vos, AF; van der Poll, T; Wiersinga, WJ				Jacobs, Max C.; Lankelma, Jacqueline M.; Wolff, Nora S.; Hugenholtz, Floor; de Vos, Alex F.; van der Poll, Tom; Wiersinga, W. Joost			Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; MICE	Background An increasing body of evidence is indicating that the gut microbiota modulates pulmonary inflammatory responses. This so-called gut-lung axis might be of importance in a whole spectrum of inflammatory pulmonary diseases such as acute respiratory distress syndrome, chronic obstructive pulmonary disease and pneumonia. Here, we investigate the effect of antibiotic disruption of gut microbiota on immune responses in the lung after a intranasal challenge with lipopolysaccharide (LPS). Methods/results C57Bl/6 mice were treated for two weeks with broad-spectrum antibiotics supplemented to their drinking water. Afterwards, mice and untreated control mice were inoculated intranasally with LPS. Mice were sacrificed 2 and 6 hours post-challenge, after which bronchoalveolar lavage fluid (BALF) and lung tissues were taken. Gut microbiota analysis showed that antibiotic-treated mice had a pronounced reduction in numbers and diversity of bacteria. A modest, but time consistent, significant increase of interleukin (IL)-6 release was seen in BALF of antibiotic treated mice. Release of tumor necrosis factor alpha (TNF alpha), however, was not statistically different between groups. Conclusion Antibiotic induced microbiota disruption is associated with alterations in host responses during LPS-induced lung inflammation. Further studies are required to determine the clinical relevance of the gut-lung axis in pulmonary infection and inflammation.	[Jacobs, Max C.; Lankelma, Jacqueline M.; Wolff, Nora S.; Hugenholtz, Floor; de Vos, Alex F.; van der Poll, Tom; Wiersinga, W. Joost] Univ Amsterdam, Locat Acad Med Ctr AMC, Ctr Expt & Mol Med, Amsterdam UMC,Amsterdam Infect & Immun Inst, Amsterdam, Netherlands; [van der Poll, Tom; Wiersinga, W. Joost] Univ Amsterdam, Locat Acad Med Ctr AMC, Amsterdam Infect & Immun Inst, Div Infect Dis,Amsterdam UMC,Dept Med, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Jacobs, MC (corresponding author), Univ Amsterdam, Locat Acad Med Ctr AMC, Ctr Expt & Mol Med, Amsterdam UMC,Amsterdam Infect & Immun Inst, Amsterdam, Netherlands.	m.c.jacobs@amsterdamumc.nl		Wolff, Nora/0000-0003-4495-2292; Wiersinga, Willem/0000-0003-2277-1343	Netherlands Organisation for Scientific Research (NWO) [91716475]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organisation for Scientific Research (NWO; grant number 91716475) to WJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010183; Bernard H, 2015, J INFECT DIS, V211, P156, DOI 10.1093/infdis/jiu391; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.113, 10.1038/NMICROBIOL.2016.113]; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Hilbert T, 2017, J SURG RES, V211, P126, DOI 10.1016/j.jss.2016.12.008; Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lankelma JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005548; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wienhold SM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2213-8; Young RP, 2016, AM J RESP CELL MOL, V54, P161, DOI 10.1165/rcmb.2015-0250PS; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	23	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241748	10.1371/journal.pone.0241748	http://dx.doi.org/10.1371/journal.pone.0241748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147273	gold, Green Published			2022-12-26	WOS:000589609300083
J	Tekle, YI; Wang, F; Heidari, A; Stewart, AJ				Tekle, Yonas, I; Wang, Fang; Heidari, Alireza; Stewart, Alanna Johnson			Differential gene expression analysis and cytological evidence reveal a sexual stage of an amoeba with multiparental cellular and nuclear fusion	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; SYNAPTONEMAL COMPLEX; MACROCYST FORMATION; MATING TYPES; CHROMOSOME SYNAPSIS; MEIOSIS; PROTEIN; RECOMBINATION; ENTAMOEBA; LIFE	Sex is a hallmark of eukaryotes but its evolution in microbial eukaryotes is poorly elucidated. Recent genomic studies revealed microbial eukaryotes possess a genetic toolkit necessary for sexual reproduction. However, the mechanism of sexual development in a majority of microbial eukaryotes including amoebozoans is poorly characterized. The major hurdle in studying sex in microbial eukaryotes is a lack of observational evidence, primarily due to its cryptic nature. In this study, we used a tractable fusing amoeba, Cochliopodium, to investigate sexual development using stage-specific Differential Gene Expression (DGE) and cytological analyses. Both DGE and cytological results showed that most of the meiosis and sex-related genes are upregulated in Cochliopodium undergoing fusion in laboratory culture. Relative gene ontology (GO) category representations in unfused and fused cells revealed a functional skew of the fused transcriptome toward DNA metabolism, nucleus and ligases that are suggestive of a commitment to sexual development. However, the GO categories of unfused cells were dominated by metabolic pathways and other processes indicative of a vegetative phase. Our study provides strong evidence that the fused cells represent a sexual stage in Cochliopodium. Our findings have further implications in understanding the evolution and mechanism of inheritance involving multiparents in other eukaryotes with a similar reproductive strategy.	[Tekle, Yonas, I; Wang, Fang; Heidari, Alireza; Stewart, Alanna Johnson] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA	Spelman College	Tekle, YI (corresponding author), Spelman Coll, Dept Biol, Atlanta, GA 30314 USA.	ytekle@spelman.edu			National Institutes of Health [1R15GM116103-02]; National Science Foundation EiR [1831958]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EiR	This work is supported by the National Institutes of Health (1R15GM116103-02) and National Science Foundation EiR (1831958) to YIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PN, 1975, DEV BIOL, V43, P240, DOI 10.1016/0012-1606(75)90024-X; Ahmed EA, 2013, J CELL SCI, V126, P3095, DOI 10.1242/jcs.122788; ALDRICH HC, 1967, MYCOLOGIA, V59, P127, DOI 10.2307/3756947; Anderson OR, 2013, ACTA PROTOZOOL, V52, P55, DOI 10.4467/16890027AP.13.006.1085; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BELL G, 1991, PHILOS T R SOC B, V332, P81, DOI 10.1098/rstb.1991.0035; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomfield G, 2019, P NATL ACAD SCI USA, V116, P2187, DOI 10.1073/pnas.1814425116; Bloomfield G, 2018, ANNU REV MICROBIOL, V72, P293, DOI 10.1146/annurev-micro-090817-062232; Bloomfield G, 2010, SCIENCE, V330, P1533, DOI 10.1126/science.1197423; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; BYERS TJ, 1986, INT REV CYTOL, V99, P311; Cavalier-Smith T, 2002, HEREDITY, V88, P125, DOI 10.1038/sj.hdy.6800034; CHANG MT, 1981, J BACTERIOL, V147, P1049, DOI 10.1128/JB.147.3.1049-1053.1981; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; De Cadiz AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074840; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; Eddy S., 2001, HMMER PROFILE HIDDEN; ERDOS GW, 1975, P NATL ACAD SCI USA, V72, P970, DOI 10.1073/pnas.72.3.970; ERDOS GW, 1976, J BACTERIOL, V128, P495, DOI 10.1128/JB.128.1.495-497.1976; ERDOS GW, 1972, CYTOBIOLOGIE, V6, P351; ERDOS GW, 1973, P NATL ACAD SCI USA, V70, P1828, DOI 10.1073/pnas.70.6.1828; FALLIS AM, 1965, AM ZOOL, V5, P85; FRIZ CT, 1968, COMP BIOCHEM PHYSIOL, V26, P81, DOI 10.1016/0010-406X(68)90314-9; FURTADO JS, 1971, MYCOLOGIA, V63, P413, DOI 10.2307/3757772; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; GOODFELLOW L P, 1974, Protistologica, V10, P207; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HASKINS EF, 1971, J CELL BIOL, V51, P898, DOI 10.1083/jcb.51.3.898; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Hofstatter PG, 2018, GENOME BIOL EVOL, V10, P3118, DOI 10.1093/gbe/evy241; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lahr DJG, 2011, P ROY SOC B-BIOL SCI, V278, P2081, DOI 10.1098/rspb.2011.0289; Lohia A, 2003, MOL CELL BIOCHEM, V253, P217, DOI 10.1023/A:1026055631421; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Maciver SK, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900152; Maciver SK, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0871; Maciver SK, 2016, TRENDS PARASITOL, V32, P855, DOI 10.1016/j.pt.2016.08.006; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Margulis L., 1985, OXFORD SURVEYS EVOLU, P30; MARTIN G W, 1969, P560; Melton JT, 2020, J EUKARYOT MICROBIOL, V67, P154, DOI 10.1111/jeu.12764; MIGNOT JP, 1992, J PROTOZOOL, V39, P287, DOI 10.1111/j.1550-7408.1992.tb01316.x; Mukherjee C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000281; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nakagawa T, 2002, J BIOL CHEM, V277, P28019, DOI 10.1074/jbc.M204165200; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pyatnitskaya A, 2019, CHROMOSOMA, V128, P181, DOI 10.1007/s00412-019-00714-8; RAIKOV IB, 1995, EUR J PROTISTOL, V31, P1, DOI 10.1016/S0932-4739(11)80349-4; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schaudinn F, 1899, UNTERSUCHUNGEN GENER, P93; SCHENSNOVICH V. B., 1967, MED PARAZITOL PARAZIT BOLEZ, V36, P712; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074465; SMITH JM, 1986, NATURE, V324, P300; Stanley SL, 2005, TRENDS PARASITOL, V21, P451, DOI 10.1016/j.pt.2005.08.006; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SZABO SP, 1982, DEV BIOL, V90, P375, DOI 10.1016/0012-1606(82)90387-6; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tekle YI, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1283-1; Tekle YI, 2017, MOL PHYLOGENET EVOL, V114, P249, DOI 10.1016/j.ympev.2017.06.019; Tekle YI, 2017, GENOME BIOL EVOL, V9, P375, DOI 10.1093/gbe/evx002; Tekle YI, 2016, MOL PHYLOGENET EVOL, V99, P144, DOI 10.1016/j.ympev.2016.03.029; Tekle YI, 2015, J EUKARYOT MICROBIOL, V62, P623, DOI 10.1111/jeu.12218; Tekle YI, 2014, PROTIST, V165, P676, DOI 10.1016/j.protis.2014.07.008; Tekle YI, 2013, J EUKARYOT MICROBIOL, V60, P342, DOI 10.1111/jeu.12038; Urushihara H, 2006, EUR J CELL BIOL, V85, P961, DOI 10.1016/j.ejcb.2006.05.012; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Wenrich D.H, 1954, SEX PROTOZOA COMP RE; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Wood FC, 2017, J HERED, V108, P769, DOI 10.1093/jhered/esx078; Yang XH, 2003, PLANT CELL, V15, P1281, DOI 10.1105/tpc.010447; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zanders S, 2011, GENETICS, V188, P511, DOI 10.1534/genetics.111.129031; Zuhl L, 2019, J EXP BOT, V70, P5643, DOI 10.1093/jxb/erz323; 2019, J CROHNS COLITIS S1, V13	85	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0235725	10.1371/journal.pone.0235725	http://dx.doi.org/10.1371/journal.pone.0235725			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147262	Green Submitted, Green Published, gold			2022-12-26	WOS:000589609300018
J	Bavishi, A; Lloyd-Jones, DM; Ning, HY; Vu, THT; Yancy, CW; Shah, SJ; Carnethon, M; Khan, SS				Bavishi, Aakash; Lloyd-Jones, Donald M.; Ning, Hongyan; Vu, Thanh Huyen T.; Yancy, Clyde W.; Shah, Sanjiv J.; Carnethon, Mercedes; Khan, Sadiya S.			Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RACIAL-DIFFERENCES; OBESITY PARADOX; US ADULTS; MORTALITY; EMPAGLIFLOZIN; GUIDELINES; MANAGEMENT; MECHANISMS	Identification of individuals at risk for heart failure is needed to deliver targeted preventive strategies and maximize net benefit of interventions. To examine the clinical utility of the recently published heart failure-specific risk prediction model, the Pooled Cohort Equations to Prevent Heart Failure, we sought to demonstrate the range of risk values associated with diverse risk factor combinations in White and Black men and women. We varied individual risk factors while holding the other risk factors constant at age-adjusted national mean values for risk factors in each race-sex and age group. We also examined multiple combinations of risk factor levels and examined the range of predicted 10-year heart failure risk using the Pooled Cohort Equations to Prevent Heart Failure risk tool. Ten-year predicted heart failure risk varied widely for each race-sex group across a range of ages and risk factor scenarios. For example, predicted 10-year heart failure risk in a hypothetical 40 year old varied from 0.1% to 9.7% in a White man, 0.5% to 12.3% in a Black man, <0.1% to 9.3% in a White woman, and 0.2% to 28.0% in a Black woman. Higher risk factor burden (e.g. diabetes and hypertension requiring treatment) consistently drove higher risk estimates in all race-sex groups and across all ages. Our analysis highlights the importance of a race and sex-specific multivariable risk prediction model for heart failure to personalize the clinician-patient discussion, inform future practice guidelines, and provide a framework for future risk-based prevention trials for heart failure.	[Bavishi, Aakash] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Lloyd-Jones, Donald M.; Ning, Hongyan; Vu, Thanh Huyen T.; Carnethon, Mercedes; Khan, Sadiya S.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Lloyd-Jones, Donald M.; Yancy, Clyde W.; Shah, Sanjiv J.; Khan, Sadiya S.] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Khan, SS (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.; Khan, SS (corresponding author), Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-khan-1@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022	Khan, Sadiya/0000-0003-0643-1859; Lloyd-Jones, Donald/0000-0003-0847-6110	National Institutes of Health's National Center for Advancing Translational Sciences [KL2TR001424]; American Heart Association [19TPA34890060]; National Institutes of Health (NIH) [R01 HL107577, R01 HL127028, R01 HL140731]; American Heart Association (AHA) [16SFRN28780016, 15CVGPSD27260148]	National Institutes of Health's National Center for Advancing Translational Sciences; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association)	Research reported in this publication was supported, in part, by the National Institutes of Health's National Center for Advancing Translational Sciences, Grant Number KL2TR001424 and the American Heart Association (#19TPA34890060) to SSK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Sanjiv J. Shah is supported by grants from the National Institutes of Health (NIH; R01 HL107577, R01 HL127028, and R01 HL140731) and the American Heart Association (AHA; #16SFRN28780016 and #15CVGPSD27260148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; BARRETTCONNOR E, 1985, CIRCULATION, V72, P53, DOI 10.1161/01.CIR.72.1.53; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Coats AJ, 2016, EUR HEART J, V37, P2129, DOI DOI 10.1093/eurheartj/ehw128; Connelly KA, 2019, JACC-BASIC TRANSL SC, V4, P27, DOI 10.1016/j.jacbts.2018.11.010; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dhingra R, 2006, HYPERTENSION, V47, P861, DOI 10.1161/01.HYP.0000217141.20163.23; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Glynn P, 2019, J AM COLL CARDIOL, V73, P2354, DOI 10.1016/j.jacc.2019.02.042; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Hink U, 2001, CIRC RES, V88, pE14; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Howard G, 2017, J AM GERIATR SOC, V65, P83, DOI 10.1111/jgs.14472; Ingelheim B Lilly E Company, 2017, EMPAGLIFLOZIN OUTCOM; Ishii Masanobu, 2017, JACC Basic Transl Sci, V2, P655, DOI 10.1016/j.jacbts.2017.08.001; Jackson CL, 2014, J GEN INTERN MED, V29, P25, DOI 10.1007/s11606-013-2553-7; Jackson SL, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004873; Karmali KN, 2014, J AM COLL CARDIOL, V64, P959, DOI 10.1016/j.jacc.2014.06.1186; Khan SS, 2019, J AM COLL CARDIOL, V73, P2388, DOI 10.1016/j.jacc.2019.02.057; Ledwidge M, 2013, JAMA-J AM MED ASSOC, V310, P66, DOI 10.1001/jama.2013.7588; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Marma AK, 2010, CIRC-CARDIOVASC QUAL, V3, P8, DOI 10.1161/CIRCOUTCOMES.109.869727; Marma AK, 2009, CIRCULATION, V120, P384, DOI 10.1161/CIRCULATIONAHA.108.835470; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; Muntner P, 2020, JAMA-J AM MED ASSOC, V324, P1190, DOI 10.1001/jama.2020.14545; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Patorno E, 2019, CIRCULATION, V140; Persell SD, 2006, PREV MED, V43, P368, DOI 10.1016/j.ypmed.2006.06.017; Santos-Gallego CG, 2019, J AM COLL CARDIOL, V73, P1931, DOI 10.1016/j.jacc.2019.01.056; Schmieder RE, 2017, EUR HEART J, V38, P3308, DOI 10.1093/eurheartj/ehx525; Shah RV, 2014, J CLIN HYPERTENS, V16, P451, DOI 10.1111/jch.12325; Sidney S, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0630-2; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Trust TH Ltd NI, 2015, ARNI AS PAT EL NATR; Upadhya B, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003613; Velagaleti RS, 2009, CIRCULATION, V120, P2345, DOI 10.1161/CIRCULATIONAHA.109.830984; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Yang H, 2016, EUR J HEART FAIL, V18, P1331, DOI 10.1002/ejhf.643; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoppini G, 2003, INT J OBESITY, V27, P281, DOI 10.1038/sj.ijo.802199	51	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240567	10.1371/journal.pone.0240567	http://dx.doi.org/10.1371/journal.pone.0240567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141828	Green Published, gold			2022-12-26	WOS:000588376700015
J	Vilches, TN; Shoukat, A; Ferreira, CP; Moghadas, SM				Vilches, Thomas N.; Shoukat, Affan; Ferreira, Claudia Pio; Moghadas, Seyed M.			Projecting influenza vaccine effectiveness: A simulation study	PLOS ONE			English	Article							DESIGN; EFFICACY; METAANALYSIS; SELECTION; CHILDREN; ILLNESS; FRAILTY; PEOPLE; ADULTS; HEALTH	The impact of influenza vaccination is largely measured by estimating vaccine effectiveness (VE), which vary in different seasons. Strain mutations and waning immunity present two key mechanisms affecting VE. We sought to quantify the relative effect of these mechanisms by projecting VE and the reduction of illness due to vaccination. We developed a stochastic age-structured agent-based simulation model of influenza transmission dynamics to encapsulate intraseason waning of immunity post-vaccination, and mutation-induced antigenic distance between circulating strains and vaccine strains. Parameterizing the model with published estimates, we projected the temporal and overall VE during an epidemic season, and estimated the reduction of infection for high (70%) and low (30%) vaccine efficacies to reflect the levels of vaccine-induced protection in randomized control trials. Both temporal and overall VE decreased as the attack rate increased, with lower median values for epidemics starting with strains that were antigenically more distant from vaccine strains. We observed a higher rate of temporal decline with considerably lower median values of the overall VE in the presence of intraseason waning of immunity compared with only the antigenic distance effect. The highest benefit of vaccination in preventing influenza infection was achieved at moderate attack rates in the range of 6%-15%. The results show that even when VE is relatively low in the population and almost negligible for older age groups (i.e., 50+ years), vaccination can still prevent significant illness in high-risk individuals; thereby reducing healthcare resource utilization and economic burden. Our study indicates that early vaccination remains an important strategy for alleviating the burden of seasonal influenza. Policy discussions on optimal timing of vaccination to reduce the effect of intraseason waning of immunity should be considered in the context of strain mutations within the epidemic course.	[Vilches, Thomas N.] Univ Estadual Campinas, Inst Math Stat & Sci Comp, Campinas, SP, Brazil; [Shoukat, Affan] Yale Univ, Ctr Infect Dis Modeling & Anal, Sch Publ Hlth, New Haven, CT USA; [Ferreira, Claudia Pio] Sao Paulo State Univ, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [Moghadas, Seyed M.] York Univ, Agent Based Modelling Lab, Toronto, ON, Canada	Universidade Estadual de Campinas; Yale University; Universidade Estadual Paulista; York University - Canada	Moghadas, SM (corresponding author), York Univ, Agent Based Modelling Lab, Toronto, ON, Canada.	Moghadas@yorku.ca	Shoukat, Affan/AAA-5574-2021; ferreira, claudia P/C-8016-2012	Shoukat, Affan/0000-0001-9280-8311; ferreira, claudia P/0000-0002-9404-6098; Nogueira Vilches, Thomas/0000-0002-4980-7564	Natural Sciences and Engineering Research Council of Canada (NSERC); Mathematics of Information Technology and Complex Systems (Mitacs); Canadian Foundation for Innovation; Sao Paulo Research Foundation (FAPESP) [18/24390-6, 2018/24811-1]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems (Mitacs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work of SMM was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Mathematics of Information Technology and Complex Systems (Mitacs), and the Canadian Foundation for Innovation. CPF acknowledges the support from Sao Paulo Research Foundation (FAPESP), Grant #18/24390-6. TNV acknowledges the support from Sao Paulo Research Foundation (FAPESP), Grant #2018/24811-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2042-4; Andrew MK, 2017, J INFECT DIS, V216, P405, DOI 10.1093/infdis/jix282; [Anonymous], 1999, LANCET, V354, P1277; Belongia EA, 2015, VACCINE, V33, P246, DOI 10.1016/j.vaccine.2014.06.052; Bonomo ME, 2018, CLIN INFECT DIS, V67, P1129, DOI 10.1093/cid/ciy323; Canada Revenue Agency, 2016, TYP REG CHAR DES; Champredon D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24764-7; Chung JR, 2020, CLIN INFECT DIS, V71, pE368, DOI 10.1093/cid/ciz1244; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Couch Robert B., 1997, American Journal of Medicine, V102, P2, DOI 10.1016/S0002-9343(97)00003-X; Feng S, 2018, AM J EPIDEMIOL, V187, P389, DOI 10.1093/aje/kwx251; Ferdinands JM, 2017, CLIN INFECT DIS, V64, P544, DOI 10.1093/cid/ciw816; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Johnstone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108481; Laskowski M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18062; Lipowski A, 2012, PHYSICA A, V391, P2193, DOI 10.1016/j.physa.2011.12.004; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Monto AS, 2001, AM J EPIDEMIOL, V154, P155, DOI 10.1093/aje/154.2.155; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Nevin-Woods C, 2013, PUBLIC HEALTH REP, V128, P7; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Poland GA, 2018, EXPERT REV VACCINES, V17, P495, DOI 10.1080/14760584.2018.1484284; Public Health England, 2018, NAT CHILDH FLU IMM P; Ray GT, 2019, CLIN INFECT DIS, V68, P1623, DOI 10.1093/cid/ciy770; Rondy M, 2017, J INFECTION, V75, P381, DOI 10.1016/j.jinf.2017.09.010; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Somes MP, 2018, VACCINE, V36, P3199, DOI 10.1016/j.vaccine.2018.04.063; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Vilches TN, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818003540; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; World Health Organization, 2017, VACCINES BIOL; Xiao YY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-589; Xu YF, 2019, CLIN INFECT DIS, V68, P346, DOI 10.1093/cid/ciy560; Young B, 2018, J INFECT DIS, V217, P731, DOI 10.1093/infdis/jix632	39	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241549	10.1371/journal.pone.0241549	http://dx.doi.org/10.1371/journal.pone.0241549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141871	Green Published, gold			2022-12-26	WOS:000588376700048
J	Webb, JL; Bries, AE; Vogel, B; Carrillo, C; Harvison, L; Day, TA; Kimber, MJ; Valentine, RJ; Rowling, MJ; Clark, S; McNeill, EM; Schalinske, KL				Webb, Joe L.; Bries, Amanda E.; Vogel, Brooke; Carrillo, Claudia; Harvison, Lily; Day, Timothy A.; Kimber, Michael J.; Valentine, Rudy J.; Rowling, Matthew J.; Clark, Stephanie; McNeill, Elizabeth M.; Schalinske, Kevin L.			Whole egg consumption increases gene expression within the glutathione pathway in the liver of Zucker Diabetic Fatty rats	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; GUT MICROBIOME; DIET; METABOLISM; INSULIN; PEOPLE; RISK; MELLITUS	Nutrigenomic evidence supports the idea that Type 2 Diabetes Mellitus (T2DM) arises due to the interactions between the transcriptome, individual genetic profiles, lifestyle, and diet. Since eggs are a nutrient dense food containing bioactive ingredients that modify gene expression, our goal was to examine the role of whole egg consumption on the transcriptome during T2DM. We analyzed whether whole egg consumption in Zucker Diabetic Fatty (ZDF) rats alters microRNA and mRNA expression across the adipose, liver, kidney, and prefrontal cortex tissue. Male ZDF (fa/fa) rats (n = 12) and their lean controls (fa/+) (n = 12) were obtained at 6 wk of age. Rats had ad libitum access to water and were randomly assigned to a modified semi-purified AIN93G casein-based diet or a whole egg-based diet, both providing 20% protein (w/w). TotalRNA libraries were prepared using QuantSeq 3' mRNA-Seq and Lexogen smallRNA library prep kits and were further sequenced on an Illumina HighSeq3000. Differential gene expression was conducted using DESeq2 in R and Benjamini-Hochberg adjusted P-values controlling for false discovery rate at 5%. We identified 9 microRNAs and 583 genes that were differentially expressed in response to 8 wk of consuming whole egg-based diets. Kyto Encyclopedia of Genes and Genomes/Gene ontology pathway analyses demonstrated that 12 genes in the glutathione metabolism pathway were upregulated in the liver and kidney of ZDF rats fed whole egg. Whole egg consumption primarily altered glutathione pathways such as conjugation, methylation, glucuronidation, and detoxification of reactive oxygen species. These pathways are often negatively affected during T2DM, therefore this data provides unique insight into the nutrigenomic response of dietary whole egg consumption during the progression of T2DM.	[Webb, Joe L.; Bries, Amanda E.; Vogel, Brooke; Carrillo, Claudia; Harvison, Lily; Rowling, Matthew J.; Clark, Stephanie; McNeill, Elizabeth M.; Schalinske, Kevin L.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Webb, Joe L.; Bries, Amanda E.; Rowling, Matthew J.; McNeill, Elizabeth M.; Schalinske, Kevin L.] Iowa State Univ, Interdept Grad Program Nutr Sci, Ames, IA 50011 USA; [Day, Timothy A.; Kimber, Michael J.] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA USA; [Valentine, Rudy J.] Iowa State Univ, Dept Kinesiol, Ames, IA USA; [McNeill, Elizabeth M.] Iowa State Univ, Genet & Genom Grad Program, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University	Schalinske, KL (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.; Schalinske, KL (corresponding author), Iowa State Univ, Interdept Grad Program Nutr Sci, Ames, IA 50011 USA.	kschalin@iastate.edu		Clark, Stephanie/0000-0002-3253-3042; Kimber, Michael/0000-0002-4715-9313	College of Human Sciences Intramural Collaborative Grant; Presidential Interdisciplinary Research Seed Grant Program at Iowa State University	College of Human Sciences Intramural Collaborative Grant; Presidential Interdisciplinary Research Seed Grant Program at Iowa State University	This study was supported by the College of Human Sciences Intramural Collaborative Grant (SC, KS, MR, TD, MK, RV, EM) and the Presidential Interdisciplinary Research Seed Grant Program (KS, SC, MR, TD, MK, RV, EM) at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Chen J, 2014, J FOOD SCI, V79, pR442, DOI 10.1111/1750-3841.12397; Chen XY, 2019, J SCI FOOD AGR, V99, P3879, DOI 10.1002/jsfa.9610; CORBETT SW, 1986, AM J CLIN NUTR, V44, P173, DOI 10.1093/ajcn/44.2.173; Cordero-Herrera I, 2015, FOOD RES INT, V69, P194, DOI 10.1016/j.foodres.2014.12.039; Dehghan M, 2020, AM J CLIN NUTR, V111, P795, DOI 10.1093/ajcn/nqz348; Dhas Yogita, 2016, Cardiovascular & Hematological Agents in Medicinal Chemistry, V14, P82, DOI 10.2174/1871525714666160426150233; Djousse L, 2016, AM J CLIN NUTR, V103, P474, DOI 10.3945/ajcn.115.119933; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Farrell D, 2017, SMALLRNASEQ SHORT NO, DOI [10.1101/110585, DOI 10.1101/110585]; Folli F, 2011, CURR DIABETES REV, V7, P313, DOI 10.2174/157339911797415585; Fuller NR, 2015, NUTRIENTS, V7, P7399, DOI 10.3390/nu7095344; Fuller NR, 2015, AM J CLIN NUTR, V101, P705, DOI 10.3945/ajcn.114.096925; Garces-Rimon M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151193; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Geiker NRW, 2018, EUR J CLIN NUTR, V72, P44, DOI 10.1038/ejcn.2017.153; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Kanikarla-Marie P, 2019, MOL CELL BIOCHEM, V459, P151, DOI 10.1007/s11010-019-03558-z; KARST H, 1984, ANN NUTR METAB, V28, P245, DOI 10.1159/000176811; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leary S, 2020, AVMA GUIDELINES EUTH; Li Tiangang, 2010, FASEB J PHARM THER, DOI [10.1096/fasebj.24.1_supplement.570.4, DOI 10.1096/FASEBJ.24.1_SUPPLEMENT.570.4]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montero D, 2013, REDOX BIOL, V1, P508, DOI 10.1016/j.redox.2013.10.005; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Patel D, GENE EXPRESSION PROF; Pourafshar S, 2018, FOOD FUNCT, V9, P4469, DOI [10.1039/c8fo00194d, 10.1039/C8FO00194D]; Quigley JD, 2002, J DAIRY SCI, V85, P198, DOI 10.3168/jds.S0022-0302(02)74068-X; Raza H, 2000, J BIOCHEM MOL TOXIC, V14, P131, DOI 10.1002/(SICI)1099-0461(2000)14:3<131::AID-JBT2>3.0.CO;2-Q; Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947; Raza H, 2012, INT J MOL SCI, V13, P16241, DOI 10.3390/ijms131216241; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Saande CJ, 2019, J NUTR, V149, P1766, DOI 10.1093/jn/nxz143; Saande CJ, 2018, J AGR FOOD CHEM, V66, P866, DOI 10.1021/acs.jafc.7b04774; Saande CJ., 2019, CURR DEV NUTR, V3, pnzz015, DOI [10.1093/cdn/nzz015, DOI 10.1093/CDN/NZZ015, 10.1093/cdn/nzz099, DOI 10.1093/CDN/NZZ099]; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Shahbandeh Melissa, 2020, AV ANN CAP CONS SEAF; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; TESSARI P, 1994, DIABETES METAB REV, V10, P253, DOI 10.1002/dmr.5610100304; Tran NL, 2014, DIABET METAB SYND OB, V7, P121, DOI 10.2147/DMSO.S58668; Virtanen JK, 2015, AM J CLIN NUTR, V101, P1088, DOI 10.3945/ajcn.114.104109; Yousr M, 2015, INT J MOL SCI, V16, P29161, DOI 10.3390/ijms161226155; Zhang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01476; Zhang M, 2018, INT J CLIN EXP MED; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhu CH, 2020, NUTR RES, V78, P36, DOI 10.1016/j.nutres.2020.04.002; Zou XR, 2019, J BIOL REG HOMEOS AG, V33, P1695, DOI 10.23812/19-207-A; [No title captured]	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240885	10.1371/journal.pone.0240885	http://dx.doi.org/10.1371/journal.pone.0240885			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141822	gold, Green Published			2022-12-26	WOS:000588376700017
J	Blanco, JC; Ballesteros, F; Palomero, G; Lopez-Bao, JV				Carlos Blanco, Juan; Ballesteros, Fernando; Palomero, Guillermo; Vicente Lopez-Bao, Jose			Not exodus, but population increase and gene flow restoration in Cantabrian brown bear (Ursus arctos) subpopulations. Comment on Gregorio et al. 2020	PLOS ONE			English	Article							NATAL DISPERSAL; MOUNTAINS; CONSERVATION; MODELS; TRENDS; SINKS	In a genetic study on brown bears (Ursus arctos) in the Cantabrian Mountains, Gregorio et al. (2020) interpreted the asymmetrical gene flow they found from the eastern subpopulation towards the western one as an exodus of bears forced to flee from the eastern nucleus "with higher human disturbance and poaching", concluding that connectivity may be operating as a means for eastern Cantabrian bears to find more suitable territories. In this reply, we maintain that the explanations of Gregorio et al. contradict the source-sink theory and we also present demographic data not considered by these authors showing that the eastern subpopulation is not declining, but persistently increasing. After reviewing the demographic and genetic studies published during the last 20 years, we conclude that the connectivity between the two subpopulations is operating as a route which allows the regular movement of males and the restoration of the gene flow across the whole Cantabrian population.	[Carlos Blanco, Juan; Ballesteros, Fernando; Palomero, Guillermo] Fdn Oso Pardo, Santander, Spain; [Vicente Lopez-Bao, Jose] Oviedo Univ, Res Unit Biodivers UO CSIC PA, Mieres, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Blanco, JC (corresponding author), Fdn Oso Pardo, Santander, Spain.	jc.blanco2503@gamil.com	VICENTE, LIERN/B-6112-2008	VICENTE, LIERN/0000-0001-5883-9640; Blanco, Juan Carlos/0000-0002-8542-7809	Spanish Ministry of Environment (MITECO); Spanish Ministry of Economy, Industry and Competitiveness [RYC-2015-18932]	Spanish Ministry of Environment (MITECO); Spanish Ministry of Economy, Industry and Competitiveness	This research received financial support from the Spanish Ministry of Environment (MITECO). JVLB was supported by a Ramon y Cajal research contract (RYC-2015-18932) from the Spanish Ministry of Economy, Industry and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **NON-TRADITIONAL**; [Anonymous], 1989, ENV ENCOUNTERS SERIE; Blanco JC., 2020, ORYX; Blanco JC, 2019, OSOS BASURA CORDILLE; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cooley H. S., 2009, ANIM CONSERV, V1, P1; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Doak DF, 1995, CONSERV BIOL, V9, P1370, DOI 10.1046/j.1523-1739.1995.09061370.x; Fundacion Oso Pardo, 2020, WEB PAG NUMB BEARS T; Garcia-Garitagoitia JL., 2006, DEMOGRAF A DISTRIBUC, P71; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; Gosselin J, 2017, J ANIM ECOL, V86, P35, DOI 10.1111/1365-2656.12576; Gregorio I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227302; Hansen S. J., 2014, THESIS; Lamamy C, 2019, MAMMAL RES, V64, P559, DOI 10.1007/s13364-019-00440-7; Lamb CT, 2020, P NATL ACAD SCI USA, V117, P17876, DOI 10.1073/pnas.1922097117; Lamb CT, 2017, J ANIM ECOL, V86, P55, DOI 10.1111/1365-2656.12589; Leclerc M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45222; Lindgren Finn, 2018, INLA FULL BAYESIAN A; Lopez-Bao JV, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108651; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Maletzke BT, 2014, ECOL EVOL, V4, P2178, DOI 10.1002/ece3.1089; Matosiuk M, 2019, ECOL EVOL, V9, P1501, DOI 10.1002/ece3.4872; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Minnie L, 2018, OECOLOGIA, V186, P939, DOI 10.1007/s00442-018-4072-z; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Mueller C, 2004, URSUS, V15, P35, DOI 10.2192/1537-6176(2004)015<0035:DOSGBI>2.0.CO;2; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Nevin OT, 2005, BIOL CONSERV, V121, P611, DOI 10.1016/j.biocon.2004.06.011; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; nores c., 1993, OSO PARDO URSUSARCTO, P13; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Palomero G, 2007, URSUS, V18, P145, DOI 10.2192/1537-6176(2007)18[145:TINADO]2.0.CO;2; Palomero G, 2010, URSUS, V21, P125, DOI 10.2192/URSUS-D-10-00001.1; Pease CM, 1999, ECOLOGY, V80, P957, DOI 10.1890/0012-9658(1999)080[0957:DOTYGB]2.0.CO;2; Penteriani V, 2018, EUR ZOOL J, V85, P313, DOI 10.1080/24750263.2018.1499826; Penteriani V, 2018, MAMMAL REV, V48, P180, DOI 10.1111/mam.12123; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; Perez T, 2010, URSUS, V21, P104, DOI 10.2192/09SC018.1; Perez T, 2009, CONSERV GENET, V10, P291, DOI 10.1007/s10592-008-9578-1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rey I., 2000, P23; Sahlen V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121576; Schregel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180701; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Theberge JB, 2006, ENVIRON MANAGE, V37, P451, DOI 10.1007/s00267-004-1041-6; Xu J, 2018, THESIS JILIN U CHANG; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015	54	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0240698	10.1371/journal.pone.0240698	http://dx.doi.org/10.1371/journal.pone.0240698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137146	Green Published, gold			2022-12-26	WOS:000588375500028
J	Liu, EM; Luna, A; Dong, GL; Sander, C				Liu, Eric Minwei; Luna, Augustin; Dong, Guanlan; Sander, Chris			netboxr: Automated discovery of biological process modules by network analysis in R	PLOS ONE			English	Article								Large-scale sequencing projects, such as The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC), have generated high throughput sequencing and molecular profiling data sets, but it is still challenging to identify potentially causal changes in cellular processes in cancer as well as in other diseases in an automated fashion. We developed the netboxr package written in the R programming language, which makes use of the NetBox algorithm to identify candidate cancer-related functional modules. The algorithm makes use of a data-driven, network-based approach that combines prior knowledge with a network clustering algorithm, obviating the need for and the limitation of independently curated functionally labeled gene sets. The method can combine multiple data types, such as mutations and copy number alterations, leading to more reliable identification of functional modules. We make the tool available in the Bioconductor R ecosystem for applications in cancer research and cell biology.	[Liu, Eric Minwei] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA; [Luna, Augustin; Sander, Chris] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Luna, Augustin; Sander, Chris] Dana Farber Canc Inst, cBio Ctr, Dept Data Sci, Boston, MA 02115 USA; [Luna, Augustin; Sander, Chris] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dong, Guanlan] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Liu, EM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA.; Luna, A; Sander, C (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Luna, A; Sander, C (corresponding author), Dana Farber Canc Inst, cBio Ctr, Dept Data Sci, Boston, MA 02115 USA.; Luna, A; Sander, C (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	lium2@mskcc.org; aluna@jimmy.harvard.edu; sander.research@gmail.com		Liu, Eric Minwei/0000-0002-3594-6678; Dong, Guanlan/0000-0002-4747-6036; Luna, Augustin/0000-0001-5709-371X	US National Institutes of Health [U41 HG006623-02]; Ruth L. Kirschstein National Research Service Award [F32 CA192901]; National Institute of General Medical Sciences [NIGMS -P41 GM103504]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health grant (U41 HG006623-02), the Ruth L. Kirschstein National Research Service Award (F32 CA192901), and through funding for the National Resource for Network Biology (NRNB) from the National Institute of General Medical Sciences (NIGMS -P41 GM103504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PHYS REV E, DOI DOI 10.1103/PhysRevE.69.026113; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jensen MA, 2017, BLOOD, V130, P453, DOI 10.1182/blood-2017-03-735654; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Rodchenkov I, 2020, NUCLEIC ACIDS RES, V48, pD489, DOI 10.1093/nar/gkz946; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	12	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0234669	10.1371/journal.pone.0234669	http://dx.doi.org/10.1371/journal.pone.0234669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137091	Green Submitted, gold, Green Published			2022-12-26	WOS:000588375500050
J	Peng, Y; Yue, F; Chen, JJ; Xia, W; Huang, KL; Yang, GS; Kuang, SH				Peng, Ying; Yue, Feng; Chen, Jingjuan; Xia, Wei; Huang, Kuilong; Yang, Gongshe; Kuang, Shihuan			Phosphatase orphan 1 inhibits myoblast proliferation and promotes myogenic differentiation	FASEB JOURNAL			English	Article						mitochondria; MyoG; myogenesis; Phospho1	SKELETAL-MUSCLE; MYOD FAMILY; MECHANISMS; CREATINE; PHOSPHO1; PHOSPHOETHANOLAMINE; PHOSPHOCHOLINE; ACTIVATION; NETWORKS; LEADS	Myogenesis includes sequential stages of progenitor cell proliferation, myogenic commitment and differentiation, myocyte fusion, and myotube maturation. Different stages of myogenesis are orchestrated and regulated by myogenic regulatory factors and various downstream cellular signaling. Here we identify phosphatase orphan 1 (Phospho1) as a new player in myogenesis. During activation, proliferation, and differentiation of quiescent satellite cells, the expression of Phospho1 gradually increases. Overexpression of Phospho1 inhibits myoblast proliferation but promotes their differentiation and fusion. Conversely, knockdown of Phospho1 accelerates myoblast proliferation but impairs myotube formation. Moreover, knockdown of Phospho1 decreases the OXPHO protein levels and mitochondria density, whereas overexpression of Phospho1 upregulates OXPHO protein levels and promotes mitochondrial oxygen consumption. Finally, we show that Phospho1 expression is controlled by myogenin, which binds to the promoter of Phospho1 to regulate its transcription. These results indicate a key role of Phospho1 in regulating myogenic differentiation and mitochondrial function.	[Peng, Ying; Huang, Kuilong; Yang, Gongshe] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Peng, Ying; Yue, Feng; Chen, Jingjuan; Xia, Wei; Huang, Kuilong; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA; [Xia, Wei] Southwest Minzu Univ, Coll Life Sci & Technol, Chengdu, Peoples R China	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Southwest Minzu University	Yang, GS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, Hobart & Russell Creighton Hall Anim Sci, W Lafayette, IN 47907 USA.	gsyang@nwafu.edu.cn; skuang@purdue.edu	PENG, YING/AAW-8159-2021		HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; National Science and Technology Major Project of China [2016ZX08006003]; China Scholarship Council (CSC) [CSC201706300078]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Science and Technology Major Project of China; China Scholarship Council (CSC)(China Scholarship Council)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR071649; National Science and Technology Major Project of China, Grant/Award Number: 2016ZX08006003; China Scholarship Council (CSC), Grant/Award Number: CSC201706300078	Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cheng X, 2018, EXP THER MED, V15, P247, DOI 10.3892/etm.2017.5391; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Granata F, 2000, BBA-MOL CELL BIOL L, V1483, P334, DOI 10.1016/S1388-1981(99)00186-9; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Houston B, 1999, BBA-MOL CELL RES, V1448, P500, DOI 10.1016/S0167-4889(98)00153-0; Huesa C, 2011, BONE, V48, P1066, DOI 10.1016/j.bone.2011.01.010; Ijuin T, 2012, J BIOL CHEM, V287, P31330, DOI 10.1074/jbc.M112.388785; JANSSON E, 1985, EUR J APPL PHYSIOL O, V54, P207, DOI 10.1007/BF02335931; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; KIM SJ, 1992, J BIOL CHEM, V267, P15140; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b; Li YY, 2018, CANCER LETT, V417, P58, DOI 10.1016/j.canlet.2017.12.015; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Moretti I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12397; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schiaffino S, 2015, SCAND J MED SCI SPOR, V25, P41, DOI 10.1111/sms.12606; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shan TZ, 2014, STEM CELLS, V32, P2893, DOI 10.1002/stem.1788; Shi H, 2013, J CLIN INVEST, V123, P2064, DOI 10.1172/JCI64375; Stewart AJ, 2003, PROTEIN ENG, V16, P889, DOI 10.1093/protein/gzg126; Sumariwalla VM, 2001, GENESIS, V30, P239, DOI 10.1002/gene.1070; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Yue F, 2016, CELL REP, V17, P2340, DOI 10.1016/j.celrep.2016.11.002	46	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001672R	http://dx.doi.org/10.1096/fj.202001672R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33140469	Green Accepted			2022-12-26	WOS:000586613000001
J	Zerga, AA; Bezabih, AM				Zerga, Aregash Abebayehu; Bezabih, Afework Mulugeta			Metabolic syndrome and lifestyle factors among type 2 diabetes mellitus patients in Dessie Referral Hospital, Amhara region, Ethiopia	PLOS ONE			English	Article							COFFEE CONSUMPTION; PHYSICAL-ACTIVITY; RISK; PREVALENCE; OBESITY; ASSOCIATION; EVENTS	Background The prevalence of metabolic syndrome is rising at an alarming rate and more common among Type 2 Diabetes Mellitus patients in the world. The risk for cardiovascular disease is greater among individuals who have a combination of Type 2 Diabetes Mellitus and metabolic syndrome compared to those who have either alone. Objective To assess the proportion of metabolic syndrome and lifestyle factors among Type 2 Diabetes Mellitus Patients in Dessie Referral Hospital, Amhara Region, Ethiopia. Methods A hospital-based cross-sectional study was conducted from February to March 2017 among 343 randomly selected Type 2 Diabetes Mellitus patients. Three definitions of Metabolic syndrome were considered. Multivariable logistic regression analysis was conducted to identify factors associated with metabolic syndrome. Adjusted odds ratio (AOR) with 95% confidence intervals (CI) were reported to show the strength of association. Statistical significance was declared at P-value < 0.05. Result The proportion of metabolic syndrome was 50.3%, 59.4% and 64.5% according to 2005 International Diabetes Federation, revised ATP III and 2009 harmonized criteria, respectively. Being female (AOR = 2.43; 95% CI = 1.40, 4.21), consumption of red meat (AOR = 2.61; 95% CI = 1.28, 5.33), sedentary leisure time activity (AOR = 2.65; 95% CI = 1.47, 4.78), coffee intake (AOR = 0.43; 95% CI = 0.21, 0.86), BMI >= 25 kg/m(2) (AOR = 9.59; 95% CI = 4.98, 18.47), 40-49 years of age (AOR = 2.74, 95% CI = (1.02, 7.37), 50-59 years of age (AOR = 4.22; 95% CI = 1.60, 11.11) and >= 70 years of age (AOR = 4.51, 95% CI = 1.44, 14.15) were significantly associated with metabolic syndrome. Conclusion and recommendation The proportion of metabolic syndrome was high among Type 2 Diabetes Mellitus patients. Overweight and obesity, being female, age of respondent, intake of coffee, regular red meat consumption, and sedentary leisure-time activity were factors associated with metabolic syndrome. Counseling of Type 2 Diabetes Mellitus patients on the need for spending leisure time with activities, intake of coffee, control of body weight, and avoidance of regular red meat consumption is recommended.	[Zerga, Aregash Abebayehu] Wollo Univ, Coll Med & Hlth Sci, Dept Nutr, Dessie, Ethiopia; [Bezabih, Afework Mulugeta] Mekelle Univ, Coll Hlth Sci, Dept Nutr & Dietet, Mekelle, Ethiopia	Mekelle University	Zerga, AA (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Nutr, Dessie, Ethiopia.	aregashina@gmail.com		Mulugeta, Afework/0000-0003-0707-4363				Abda E, 2016, DIABETES METAB SYNDR, V9, P47, DOI 10.2147/DMSO.S97561; Agyemang-Yeboah F, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4562904; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alwan AH, ASSESSMENT METABOLIC; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/C7FO00388A, 10.1039/c7fo00388a]; Bhatti GK, 2016, J DIABETES COMPLICAT, V30, P72, DOI 10.1016/j.jdiacomp.2015.07.008; Biadgo B, 2018, ETHIOP J HEALTH SCI, V28, P645, DOI 10.4314/ejhs.v28i5.16; Buscemi S., 2016, NFS Journal, V3, P1, DOI 10.1016/j.nfs.2016.02.001; Devers MC, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000195; Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Efaishat R, 2016, TROP J PHARM RES, V15, P2001, DOI 10.4314/tjpr.v15i9.26; FAO F, 2007, GUID MEAS HOUS IND D; Fezeu L, 2007, ATHEROSCLEROSIS, V193, P70, DOI 10.1016/j.atherosclerosis.2006.08.037; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gebremeskel GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4609-1; Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hsu YW, 2011, MED SCI SPORT EXER, V43, P2307, DOI 10.1249/MSS.0b013e318222020f; Kaur J., 2014, MED SCI, V2, P140, DOI [10.3390/medsci2030140, DOI 10.3390/MEDSCI2030140]; Kengne AP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-22; Kylin E., 1923, ZENTRALBLATT INNERE, V44, P105, DOI DOI 10.1002/(SICI)1096-9136(199807)15:7<539::; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083; Nsiah Kwabena, 2015, Int J Appl Basic Med Res, V5, P133, DOI 10.4103/2229-516X.157170; Organization WH, 2000, WHO TECHN REP SER; Organization WH, 2005, WHO STEPS SURV MAN W; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Puepet F, 2009, AFR J ENDOCRINOL MET, V8, P12; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shiferaw WS, 2020, METABOLIC SYNDROME T, DOI [10.1101/2020.05.14.20101410, DOI 10.1101/2020.05.14.20101410]; Shin S, 2019, APPL PHYSIOL NUTR ME, V44, P1371, DOI 10.1139/apnm-2018-0880; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tadewos A, 2017, SO ETHIOPIA HLTH SCI, V11, P3, DOI DOI 10.21767/1791-809x.1000509; Unadike B, 2009, AFR J ENDOCRINOL MET, V8, P9; WHO, 2008, WAIST CIRCUMFERENCE; Wube TB, 2019, DIABETES METAB SYNDR, V12, P1877, DOI 10.2147/DMSO.S221429; Yahia N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-111; Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241432	10.1371/journal.pone.0241432	http://dx.doi.org/10.1371/journal.pone.0241432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137150	gold, Green Published			2022-12-26	WOS:000588375500044
J	Espinoza, P; Varela, CA; Vargas, IE; Ortega, G; Silva, PA; Boehmer, KB; Montori, VM				Espinoza, Pilar; Varela, Camila A.; Vargas, Ivonne E.; Ortega, Galo; Silva, Paulo A.; Boehmer, Kasey B.; Montori, Victor M.			The burden of treatment in people living with type 2 diabetes: A qualitative study of patients and their primary care clinicians	PLOS ONE			English	Article							MINIMALLY DISRUPTIVE MEDICINE; DECISION-MAKING; ADHERENCE; SUPPORT	Background The burden of treatment can overwhelm people living with type 2 diabetes and lead to poor treatment fidelity and outcomes. Chronic care programs must consider and mitigate the burden of treatment while supporting patients in achieving their goals. Objective To explore what patients with type 2 diabetes and their health providers consider are the workload and the resources they must mobilize, i.e., their capacity, to shoulder it. Methods We conducted focus groups comprised of 30 patients and 32 clinicians from three community health centers in Chile implementing the Chronic Care Model to reduce cardiovascular risk in patients with type 2 diabetes. Transcripts were analyzed using thematic content analysis techniques illuminated by the Minimally Disruptive Medicine framework. Findings Gaining access to and working with their clinicians, implementing complex medication regimens, and changing lifestyles burdened patients. To deal with the distress of the diagnosis, difficulties achieving disease control, and fear of complications, patients drew capacity from their family (mostly men), social environment (mostly women), lay expertise, and spirituality. Clinicians found that administrative tasks, limited formulary, and protocol rigidity hindered their ability to modify care plans to reduce patient workload and support their capacity. Conclusions Chronic primary care programs burden patients living with type 2 diabetes while hindering clinicians' ability to reduce treatment workloads or support patient capacity. A collaborative approach toward Minimally Disruptive Medicine may result in treatments that fit the lives and loves of patients and improve outcomes.	[Espinoza, Pilar; Vargas, Ivonne E.] Pontificia Univ Catolica Chile, Sch Nursing, Santiago, Chile; [Varela, Camila A.] Mental Community Hlth Ctr Pedro Aguirre Cerda, Santiago, Chile; [Ortega, Galo] Andes Family Hlth Ctr, Santiago, Chile; [Silva, Paulo A.] Univ San Sebastian, Sch Nutr, Santiago, Chile; [Boehmer, Kasey B.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Div Endocrinol Metab & Nutr, New York, NY USA; [Espinoza, Pilar] Univ San Sebastian, Fac Hlth Care Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad San Sebastian; Mayo Clinic; Universidad San Sebastian	Espinoza, P (corresponding author), Pontificia Univ Catolica Chile, Sch Nursing, Santiago, Chile.; Espinoza, P (corresponding author), Univ San Sebastian, Fac Hlth Care Sci, Santiago, Chile.	pilar.espinoza@uss.cl	espinoza, pilar/AAC-4086-2019; Varela, Camila/GWC-6277-2022	Espinoza, Pilar/0000-0003-2533-6566; Vargas Celis, Ivonne/0000-0003-2756-7640	National Health Research Fund CONICYT FONIS [SA15I10213]	National Health Research Fund CONICYT FONIS	PE. The source of funding for this research is the National Health Research Fund CONICYT FONIS 2015, through the award of project no. SA15I10213. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dabrh AM, 2015, J ROY COLL PHYS EDIN, V45, P114, DOI 10.4997/JRCPE.2015.205; Albanese AM, 2019, SOC WORK HEALTH CARE, V58, P304, DOI 10.1080/00981389.2018.1563846; American Diabetes Association, 2019, Clin Diabetes, V37, P11, DOI 10.2337/cd18-0105; [Anonymous], 2010, SER GUIAS CLIN MINS; Barcelo A., 2013, CUIDADOS INNOVADORES; Boehmer KR, 2019, MAYO CLIN PROC, V94, P278, DOI 10.1016/j.mayocp.2018.08.021; Boehmer KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190852; Boehmer KR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1742-6; Boehmer KR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0525-9; Cabrera S, 2015, REV MED CHILE, V143, P679, DOI 10.4067/S0034-98872015000500019; Departamento de Epidemiologia Division de Planificacion Sanitaria Subsecretaria de Salud Publica, 2017, ENC NAC SAL 2016 201; Escobar J, 2009, CUADERNOS HISPANOAM, V9, P51; Eton DT, 2012, PATIENT-RELAT OUTCOM, V3, P39, DOI 10.2147/PROM.S34681; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Heisler M, 2014, ANN INTERN MED, V161, pS13, DOI 10.7326/M13-3012; Lafata JE, 2015, CONTROL PATIENTS DIA, V92, P94; Leppin AL, 2015, HEALTHCARE-BASEL, V3, P50, DOI 10.3390/healthcare3010050; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; Polonsky WH, 2016, PATIENT PREFER ADHER, V10, P1299, DOI 10.2147/PPA.S106821; Safford MM, 2005, J AM BOARD FAM PRACT, V18, P262, DOI 10.3122/jabfm.18.4.262; Serrano V, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0935-7; Serrano V, 2017, REV MED CHILE, V145, P641, DOI 10.4067/S0034-98872017000500012; Song Y, 2017, DIABETES EDUCATOR, V43, P396, DOI 10.1177/0145721717712457; Spencer-Bonilla G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016506; Spencer-Bonilla G, 2017, J GEN INTERN MED, V32, P1141, DOI 10.1007/s11606-017-4117-8; Streubert Helen, 2011, QUALITATIVE RES NURS; Tran VT, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-68; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Zeballos-Palacios Claudia, 2014, Rev. perú. med. exp. salud publica, V31, P111	30	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241485	10.1371/journal.pone.0241485	http://dx.doi.org/10.1371/journal.pone.0241485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125426	Green Published, gold			2022-12-26	WOS:000588368900015
J	Ramos-Perez, VI; Castellanos, I; Robinson-Fuentes, VA; Macias-Ordonez, R; Mendoza-Cuenca, L				Ramos-Perez, Velia, I; Castellanos, Ignacio; Robinson-Fuentes, Virginia A.; Macias-Ordonez, Rogelio; Mendoza-Cuenca, Luis			Sex-related interannual plasticity in wing morphological design in Heliconius charithonia enhances flight metabolic performance	PLOS ONE			English	Article							LEPIDOPTERA NYMPHALIDAE; DIETARY RESTRICTION; SEASONAL-VARIATION; LIFE-SPAN; BUTTERFLIES; POLLEN; OVIPOSITION; PHYSIOLOGY; SELECTION; RATES	Flight morphological variations and its consequences on animal performance are common in winged insects. In the butterfly Heliconius charithonia, sex-related differences in the wing morphological design have been described resulting in differences in foraging behavior, daily flight distances and flight aerodynamics. It has been suggested that these differences should be reflected in the metabolic capacities and energetic budgets associated with flight in both sexes. In this study, we analyzed the relationship between wing morphological variation and metabolic performance, flight aerodynamics and energetic reserves in females and males of Heliconius charithonia over two years. The results confirm the presence of wing shape sexual dimorphism, but also show an unexpected sex-related annual variation in wing shape, mirrored in the metabolic condition (resting metabolic rate) of individuals. However, contrary to expectation, intersexual variations in wing shape are not related to differences between the sexes in terms of flight aerodynamics, flight metabolic rates, or energetic reserves (carbohydrates, lipids and proteins). Our results indicate a considerable plasticity in H. charithonia wing shape, which we suggest is determined by a trade-off between environmental pressures and reproductive restriction of each sex, maintaining an optimum flight design. Finally, similarities in metabolic rates between young and older males and females in both years may be a consequence of the ability of Heliconius species to feed on pollen.	[Ramos-Perez, Velia, I; Mendoza-Cuenca, Luis] Univ Michoacana, Fac Biol, Lab Ecol Conducta, Morelia, Michoacan, Mexico; [Ramos-Perez, Velia, I; Mendoza-Cuenca, Luis] UNAM, Lab Nacl Anal & Sintesis Ecol, ENES, Morelia, Michoacan, Mexico; [Castellanos, Ignacio] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Mineral De La Reforma, Hidalgo, Mexico; [Robinson-Fuentes, Virginia A.] Univ Michoacana, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico; [Macias-Ordonez, Rogelio] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Instituto de Ecologia - Mexico	Mendoza-Cuenca, L (corresponding author), Univ Michoacana, Fac Biol, Lab Ecol Conducta, Morelia, Michoacan, Mexico.; Mendoza-Cuenca, L (corresponding author), UNAM, Lab Nacl Anal & Sintesis Ecol, ENES, Morelia, Michoacan, Mexico.	lfmendoza@umich.mx	Castellanos, Ignacio/GOH-1905-2022; Macías-Ordóñez, Rogelio/AAO-3447-2020; MENDOZA-CUENCA, LUIS/AHA-4631-2022; Macias-Ordonez, Rogelio/E-8286-2010	MENDOZA-CUENCA, LUIS/0000-0002-2749-8369; Macias-Ordonez, Rogelio/0000-0003-1101-6289; Perez, Ramos/0000-0003-2734-9053	CONACyT [598613]; LANASE (Laboratorio Nacional de Sintesis Ecologica) [280505]; Coordinacion de la Investigacion Cientifica UMSNH [2016-2017]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); LANASE (Laboratorio Nacional de Sintesis Ecologica); Coordinacion de la Investigacion Cientifica UMSNH	VIRP thanks for the funding provided by CONACyT (grant no. 598613). LMC thanks for funding provided by LANASE (Laboratorio Nacional de Sintesis Ecologica; project no. 280505) and Coordinacion de la Investigacion Cientifica UMSNH (projects 2016-2017). We thank the Division de Estudios de Posgrado de la Universidad Michoacana de San Nicola ' s de Hidalgo 2019 for providing economic resources for proofreading of the English version of the manuscript to VIRP.	Adams D.C., 2017, GEOMORPH SOFTWARE GE; [Anonymous], 2021, LANG ENV STAT COMP; Ansari SA, 2006, P I MECH ENG G-J AER, V220, P61, DOI 10.1243/09544100JAERO49; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; BETTS CR, 1988, J EXP BIOL, V138, P271; Boggs CL, 2016, ENTOMOL EXP APPL, V159, P189, DOI 10.1111/eea.12420; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BOGGS CL, 1981, OECOLOGIA, V48, P284, DOI 10.1007/BF00347978; BOGGS CL, 1981, EVOLUTION, V35, P931, DOI 10.1111/j.1558-5646.1981.tb04959.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canzano AA, 2006, PHYSIOL ENTOMOL, V31, P184, DOI 10.1111/j.1365-3032.2006.00506.x; Cespedes A, 2015, J ANIM ECOL, V84, P808, DOI 10.1111/1365-2656.12325; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chazot N, 2016, EVOLUTION, V70, P181, DOI 10.1111/evo.12842; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Corbet SA, 2000, ENTOMOL EXP APPL, V96, P289, DOI 10.1023/A:1004096432758; Crawford LA, 2018, ECOL ENTOMOL, V43, P629, DOI 10.1111/een.12639; Davis ALV, 2000, J INSECT PHYSIOL, V46, P553, DOI 10.1016/S0022-1910(99)00141-9; DEINERT EI, 1994, NATURE, V370, P23, DOI 10.1038/370023a0; DUDLEY R, 1994, J EXP BIOL, V191, P125; Dudley R., 2000, BIOMECHANICS INSECT; DUNLAPPIANKA HL, 1979, J INSECT PHYSIOL, V25, P741, DOI 10.1016/0022-1910(79)90126-4; Feldman A, 2015, ASTE SER SCI EDUC, P3, DOI 10.1007/978-3-319-16411-3_1; Fountain T, 2016, J EXP BIOL, V219, P1488, DOI 10.1242/jeb.138180; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Gilbert L.E., 1991, P403; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; GOLDSWORTHY GJ, 1972, GEN COMP ENDOCR, V18, P545, DOI 10.1016/0016-6480(72)90034-2; Harpel D, 2015, INSECT BIOCHEM MOLEC, V63, P7, DOI 10.1016/j.ibmb.2015.04.004; Hernandez MIM, 1998, ANIM BEHAV, V56, P533, DOI 10.1006/anbe.1998.0840; Jugovic J, 2018, EUR J ENTOMOL, V115, P339, DOI 10.14411/eje.2018.034; Kemp DJ, 2002, BEHAV ECOL, V13, P456, DOI 10.1093/beheco/13.4.456; Kerpel SM, 2006, NEOTROP ENTOMOL, V35, P192, DOI 10.1590/S1519-566X2006000200006; Klowden MJ, 2008, PHYSL SYSTEMS INSECT, V2nd, DOI [10.1037/a0012793, DOI 10.1037/A0012793]; Le Roy C, 2019, BIOL REV, V94, P1261, DOI 10.1111/brv.12500; LEBRAS S, 1977, B SOC ZOOL FR, V102, P95; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Martinez-Lendech N, 2007, J ETHOL, V25, P195, DOI 10.1007/s10164-007-0040-5; Mattila ALK, 2014, J EVOLUTION BIOL, V27, P1733, DOI 10.1111/jeb.12426; Mendoza-Cuenca L, 2005, J TROP ECOL, V21, P407, DOI 10.1017/S0266467405002385; Mendoza-Cuenca L, 2005, THESIS; Mendoza-Cuenca L, 2010, BEHAV ECOL, V21, P144, DOI 10.1093/beheco/arp163; Millan C, 2010, REV COLOMB ENTOMOL, V36, P158; MOKRASCH LC, 1954, J BIOL CHEM, V208, P55; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nespolo RF, 2008, FUNCT ECOL, V22, P624, DOI 10.1111/j.1365-2435.2008.01394.x; Niitepold K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140104; Niitepold K, 2014, PHYSIOL BIOCHEM ZOOL, V87, P684, DOI 10.1086/677570; Niitepold K, 2013, J EXP BIOL, V216, P1388, DOI 10.1242/jeb.080739; Niitepold K, 2011, OECOLOGIA, V165, P847, DOI 10.1007/s00442-010-1886-8; O'Brien DM, 2003, P ROY SOC B-BIOL SCI, V270, P2631, DOI 10.1098/rspb.2003.2552; Penz CM, 2000, J INSECT BEHAV, V13, P865, DOI 10.1023/A:1007814618149; Ribeiro DB, 2011, BIOL J LINN SOC, V104, P820, DOI 10.1111/j.1095-8312.2011.01771.x; RODRIGUES D., 2002, Braz. J. Biol., V62, P321, DOI 10.1590/S1519-69842002000200016; Rodrigues D, 2004, AUSTRAL ECOL, V29, P437, DOI 10.1111/j.1442-9993.2004.01381.x; Rohlf FJ, 2018, TPSDIG DIGITALIZE LA; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Schroeder H, 2020, ECOL ENTOMOL, V45, P562, DOI 10.1111/een.12828; Sheets HD, 2014, IMP8; Shkurikhin AO, 2016, RUSS J ECOL+, V47, P296, DOI 10.1134/S1067413616030115; Snelling EP, 2012, J EXP BIOL, V215, P3317, DOI 10.1242/jeb.069799; Srygley RB, 1999, P ROY SOC B-BIOL SCI, V266, P2239, DOI 10.1098/rspb.1999.0914; Srygley RB, 1999, PHILOS T ROY SOC B, V354, P203, DOI 10.1098/rstb.1999.0372; SRYGLEY RB, 1993, J EXP BIOL, V174, P155; Takeuchi T, 2006, BEHAVIOUR, V143, P393, DOI 10.1163/156853906775897879; Velde LV, 2013, OIKOS, V122, P555, DOI 10.1111/j.1600-0706.2012.20747.x; Woods WA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P858, DOI 10.1086/656216	69	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0239620	10.1371/journal.pone.0239620	http://dx.doi.org/10.1371/journal.pone.0239620			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125377	Green Published, gold			2022-12-26	WOS:000588368900056
J	Saeed, A; Hussain, A; Khan, MI; Arif, M; Maqbool, MM; Mehmood, H; Iqbal, M; Alkahtani, J; Elshikh, MS				Saeed, Amna; Hussain, Ansar; Khan, Muhammad Ifnan; Arif, Muhammad; Maqbool, Muhammad Mudassar; Mehmood, Hassan; Iqbal, Muhammad; Alkahtani, Jawaher; Elshikh, Mohamed Soliman			The influence of environmental factors on seed germination of Xanthium strumarium L.: Implications for management	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; COCKLEBUR SEEDS; RANGE EXPANSION; DORMANCY; PLANT; POPULATIONS; MAIZE; WEEDS; WATER; SORGHUM	Xanthium strumarium L. (Common cocklebur) is a noxious weed prevailing in different ecosystems around the world. It incurs significant yield and economic losses in different cropping systems globally. Successful management of any weed species depends on sound knowledge of seed germination biology. However, detailed knowledge on seed germination biology of the species is missing. Therefore, we investigated the impact of different environmental factors on seed germination and seed burial depths on seedling emergence of two X. strumarium populations. The impact of different sorghum mulch doses (0-10 t ha(-1)) on seedling emergence of the tested populations was also explored. Seed germination was evaluated under different photoperiods (0, 12 and 24), constant temperatures (0-50 degrees C with 5 degrees C stepwise rise), and different levels of pH (3-12), salinity (0-600 mM) and osmotic potential (0 to -1.6 MPa). Seedling emergence was observed for seeds buried at different depths (0-15 cm). Seeds of both populations proved non-photoblastic; however, higher germination was recorded under 12-hour photoperiod. The seeds germinated under a wide range of constant temperatures (10-45 degrees C), pH (4-10), osmotic potentials (0 to -0.8 MPa) and salinity levels (0-400 mM NaCl). However, the highest germination was observed under 30-31 degrees C temperature and neutral pH (7.51-7.52). Seeds were able to withstand 400 mM salinity and -1.00 MPa osmotic potential. Seedling emergence was initially improved with increasing burial depth and then a sharp decline was noted for the seeds buried >3 cm depth. Most of the seeds of both populations did not emerge from >8 cm depth. Different sorghum mulch doses linearly suppressed seedling emergence of tested populations, and 5.83-5.89 t ha(-1) mulch application suppressed 50% of seedling emergence. Seedling emergence was completely retarded with 8 t ha(-1) sorghum mulch. The tested populations germinated under diverse environmental circumstances indicating that the species can become troublesome in marginal habitats and cropped lands. Deep burial of seeds and application of sorghum mulches suppressed seedling emergence. Thus, deep burial followed by shallow tillage and application of sorghum mulches could be used as a successful strategy to manage the species in agricultural fields. Nonetheless, management strategies must be developed to control the species in other habitats.	[Saeed, Amna] Govt Reclamat Res Stn, Mian Channu, Pakistan; [Hussain, Ansar; Khan, Muhammad Ifnan] Ghazi Univ, Dept Plant Breeding & Genet, Dg Khan, Pakistan; [Arif, Muhammad] Ghazi Univ, Dept Plant Protect, Dg Khan, Pakistan; [Maqbool, Muhammad Mudassar] Ghazi Univ, Dept Agron, Dg Khan, Pakistan; [Mehmood, Hassan] Bahauddin Zakariya Univ, Dept Soil Sci, Multan, Pakistan; [Iqbal, Muhammad] Cotton Res Inst, Multan, Pakistan; [Alkahtani, Jawaher; Elshikh, Mohamed Soliman] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia	Bahauddin Zakariya University; King Saud University	Saeed, A (corresponding author), Govt Reclamat Res Stn, Mian Channu, Pakistan.	emishahidhu@gmail.com	Alsheikh, Mohamed Soliman/AAO-3264-2021; Elshikh, Mohamed S/R-6046-2016	Alsheikh, Mohamed Soliman/0000-0002-6710-0458; Elshikh, Mohamed S/0000-0002-6710-0458; Saeed, Amna/0000-0002-4293-1992	Directorate of Land Reclamation, Government of Punjab, Pakistan [RSP-2020/193]; King Saud University, Riyadh, Saudi Arabia	Directorate of Land Reclamation, Government of Punjab, Pakistan; King Saud University, Riyadh, Saudi Arabia(King Saud University)	The current study was partially supported by Directorate of Land Reclamation, Government of Punjab, Pakistan. There was no additional external funding received for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors extend their appreciation to the Researchers supporting project number (RSP-2020/193) King Saud University, Riyadh, Saudi Arabia.	Amini R, 2020, ARCH AGRON SOIL SCI, V66, P679, DOI 10.1080/03650340.2019.1632438; [Anonymous], 2015, EUR HEART J S, V17, pD2; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; BECKETT TH, 1988, WEED SCI, V36, P764, DOI 10.1017/S0043174500075792; BYRD JD, 1991, WEED TECHNOL, V5, P270, DOI 10.1017/S0890037X00028098; Cervera JC, 2009, PLANT ECOL, V205, P285, DOI 10.1007/s11258-009-9617-0; Chakraboyty D, 2008, AGR WATER MANAGE, V95, P1323, DOI 10.1016/j.agwat.2008.06.001; Chauhan BS, 2010, WEED SCI, V58, P132, DOI 10.1614/WS-D-09-00016.1; Chauhan BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26006; Chauhan BS, 2006, WEED SCI, V54, P471, DOI 10.1614/WS-05-176R1.1; Cheema ZA, 2000, AGR ECOSYST ENVIRON, V79, P105, DOI 10.1016/S0167-8809(99)00140-1; Cheema ZA, 1997, J ANIM PLANT SCI-PAK; Chikuruwo C, 2017, APPL ECOL ENV RES, V15, P17, DOI 10.15666/aeer/1501_017032; Davis WE, 1930, AM J BOT, V17, P77, DOI 10.2307/2446381; Dong HD, 2015, J ENVIRON BIOL, V36, P677; Esashi Y, 1975, PLANT CELL PHYSL, DOI [10.1093/oxfordjournals.pcp.a075191, DOI 10.1093/OXFORDJOURNALS.PCP.A075191]; Eslami SV, 2011, WEED SCI, V59, P90, DOI 10.1614/WS-D-10-00059.1; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Farooq M, 2017, FIELD CROP RES, V214, P211, DOI 10.1016/j.fcr.2017.09.017; Farooq S, 2019, S AFR J BOT, V123, P361, DOI 10.1016/j.sajb.2019.03.031; Farooq S, 2017, ACTA OECOL, V84, P23, DOI 10.1016/j.actao.2017.08.004; Fenner M, 2005, ANN BOT-LONDON, DOI 10.1093/aob/mcj016; Foroughi A, 2014, PLANTA DANINHA, V32, P61, DOI 10.1590/S0100-83582014000100007; Guvensen Aykut, 2002, Aerobiologia, V18, P229, DOI 10.1023/A:1021313329367; HARE JD, 1980, OECOLOGIA, V46, P217, DOI 10.1007/BF00540129; HOCKING PJ, 1986, J AUST I AGR SCI, V52, P191; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Iqbal M, 2020, COMPETITIVE APPROACH; Jabran K, 2015, J AGRON CROP SCI, V201, P389, DOI 10.1111/jac.12099; Jabran K, 2017, SPRINGERBR PLANT SCI, P65, DOI 10.1007/978-3-319-53186-1_8; JAGGI KS, 1987, MOL CELL BIOCHEM, V78, P177, DOI 10.1007/BF00229692; James T. K., 2016, New Zealand Plant Protection, V69, P270; Jones RE, 1997, WEED SCI, V45, P409, DOI 10.1017/S0043174500093061; Karimmojeni H, 2010, WEED RES, V50, P253, DOI 10.1111/j.1365-3180.2010.00766.x; KATOH H, 1975, PLANT CELL PHYSIOL, V16, P697; KATOH H, 1975, PLANT CELL PHYSIOL, V16, P687; KAUL V, 1968, Tropical Ecology, V9, P88; Khan MB, 2012, J ANIM PLANT SCI, V22, P339; KING L. J., 1966, Weeds of the world. Biology and control.; Martin T., 1992, Poisonous plants. Proceedings of the Third International Symposium., P489; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; NEARY PE, 1990, WEED TECHNOL, V4, P743, DOI 10.1017/S0890037X00026324; Nel JL, 2004, S AFR J SCI, V100, P53; Onen H., 2020, Agriculture and Forestry, V66, P169, DOI 10.17707/AgricultForest.66.3.14; Onen H, 2018, WEED SCI, V66, P494, DOI 10.1017/wsc.2018.20; Ortmans W, 2016, ACTA OECOL, V71, P39, DOI 10.1016/j.actao.2016.01.008; Oveisi M, 2013, CROP PROT, V45, P15, DOI 10.1016/j.cropro.2012.11.008; Ozaslan C., 2016, VII International Scientific Agriculture Symposium, "Agrosym 2016", 6-9 October 2016, Jahorina, Bosnia and Herzegovina. Proceedings, P1682; Ozaslan C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17169-5; Qin W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16210; Qureshi H, 2019, ANN BOT-COENOL PLANT, V9, P73, DOI 10.13133/2239-3129/14411; Rahman M, 2015, ENVIRON CHEM LETT, V13, P239, DOI 10.1007/s10311-015-0508-4; REDDI C S, 1980, Indian Journal of Ecology, V7, P171; Royal SS, 1997, WEED SCI, V45, P38, DOI 10.1017/S0043174500092456; Royal SS, 1997, WEED TECHNOL, V11, P51, DOI 10.1017/S0890037X00041336; Salman Ahmad, 2015, Journal of Agricultural and Biological Science, V10, P299; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SNIPES CE, 1982, WEED SCI, V30, P553, DOI 10.1017/S0043174500041151; SNIPES CE, 1987, WEED SCI, V35, P529, DOI 10.1017/S0043174500060501; Steadman KJ, 2004, AUST J AGR RES, V55, P1047, DOI 10.1071/AR04083; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; STOLLER EW, 1973, WEED SCI, V21, P574, DOI 10.1017/S0043174500032513; THOMPSON JN, 1984, ECOLOGY, V65, P626, DOI 10.2307/1941425; Van Klinken RD, 2003, BIOCONTROL SCI TECHN, V13, P139, DOI 10.1080/0958315021000073420; Venodha P. M., 2016, International Journal of Environmental Science and Development, V7, P229, DOI 10.7763/IJESD.2016.V7.774; WAPSHERE AJ, 1974, AUST J AGR RES, V25, P275, DOI 10.1071/AR9740275; WAPSHERE AJ, 1974, AUST J AGR RES, V25, P775, DOI 10.1071/AR9740775; WAREING PF, 1957, PHYSIOL PLANTARUM, V10, P266, DOI 10.1111/j.1399-3054.1957.tb06949.x; Watanabe Osamu, 2002, Grassland Science, V48, P440; WEAVER SE, 1983, CAN J PLANT SCI, V63, P211, DOI 10.4141/cjps83-021; Weston LA, 2013, J CHEM ECOL, V39, P142, DOI 10.1007/s10886-013-0245-8; Zimdahl R.L., 2018, FUNDAMENTALS WEED SC, DOI [10.1016/B978-0-12-811143-7.00014-7, DOI 10.1016/B978-0-12-811143-7.00014-7]	73	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241601	10.1371/journal.pone.0241601	http://dx.doi.org/10.1371/journal.pone.0241601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125445	Green Published, gold			2022-12-26	WOS:000588368900004
J	Kordbacheh, F; Liebman, M; Harris, M				Kordbacheh, Farnaz; Liebman, Matt; Harris, Mary			Strips of prairie vegetation placed within row crops can sustain native bee communities	PLOS ONE			English	Article							FLORAL RESOURCES; FILTER STRIPS; HYMENOPTERA; POLLINATION; LANDSCAPE; DIVERSITY; RESTORATION; NETWORKS; PLANTS; EXTRAPOLATION	As landscapes have become increasingly dominated by intensive agricultural production, plant diversity has declined steeply along with communities of pollinating insects including bees. Semi-natural habitats, such as field edge meadows and hedgerows, can be maintained to provide a diversity of flowering plants that can increase floral resources required by bees. An additional habitat enhancement practice is that of sowing strips of native prairie vegetation within row-cropped fields. In this study, conducted in Iowa, USA, we found that increases in both the abundance and diversity of floral resources in strips of native prairie vegetation within agricultural production fields greatly and positively influenced the bee community. The benefits to the bee community were important for both common and uncommon species and the effect may be strongest early in the season. Using networks of co-occurrence between plant and bee species, we were able to identify two native prairie plants, Ratibida pinnata and Zizia aurea, as potentially keystone resources that can be used to support native bees. When we evaluated the effect of reconstructed prairie strips on bees in the context of the surrounding landscape, we found that these conservation practices had positive effects on bees in agriculturally-dominated areas and that these effects were detectable in low to high complexity landscapes with 8-69% natural habitat. In landscapes dominated by crops with few pollen and nectar resources the inclusion of native prairie strips can buffer the decline of bees and effectively increase bee abundance and diversity.	[Kordbacheh, Farnaz; Liebman, Matt] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Harris, Mary] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA	Iowa State University; Iowa State University	Kordbacheh, F (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	fnzk226@gmail.com		Kordbacheh, Farnaz/0000-0002-6211-8501; Liebman, Matt/0000-0001-6193-3849	U.S. Department of Agriculture (USDA), Agriculture and Food Research Initiative [2015-67019-23002]	U.S. Department of Agriculture (USDA), Agriculture and Food Research Initiative	Financial support for this study was received by ML and MH and provided by a grant from the U.S. Department of Agriculture (USDA), Agriculture and Food Research Initiative (Project 2015-67019-23002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2016, MANC MEDIEV LIT CULT, P1; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 1989, JMP VERS, P1989; [Anonymous], 2019, NIHON NAIBUNPI GAK S, V95, P1, DOI DOI 10.1507/ENDOCRINE.95.S.MAY_1; Arduser M, 2016, IDENTIFICATION ECOLO; Ascher J. S., 2018, DISCOVER LIFE BEE SP; Ballantyne G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08798-x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Beil M, 2008, APIDOLOGIE, V39, P456, DOI 10.1051/apido:2008021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Carre G, 2009, AGR ECOSYST ENVIRON, V133, P40, DOI 10.1016/j.agee.2009.05.001; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Dormann C.F., 2008, R NEWS, V8, P8; Droege S, 2010, INSECT CONSERV DIVER, V3, P15, DOI 10.1111/j.1752-4598.2009.00074.x; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gibbs J, 2011, ZOOTAXA, P1; Harmon-Threatt AN, 2015, BASIC APPL ECOL, V16, P64, DOI 10.1016/j.baae.2014.11.001; Heinrich B, 1979, BUMBLEBEE EC, P245; Helmers MJ, 2012, J ENVIRON QUAL, V41, P1531, DOI 10.2134/jeq2011.0473; Hines HM, 2005, ENVIRON ENTOMOL, V34, P1477, DOI 10.1603/0046-225X-34.6.1477; Hirsh S. M., 2013, Ecological Restoration, V31, P201, DOI 10.3368/er.31.2.201; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; HUANG SQ, 2006, TRENDS ECOL EVOL, V21, P233; Hurd P.D. Jr, 1980, Smithsonian Contributions to Zoology, P1; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein Alexandra-Maria, 2009, P195; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2015, J APPL ECOL, V52, P602, DOI 10.1111/1365-2664.12418; Kwaiser KS, 2008, AGR ECOSYST ENVIRON, V124, P200, DOI 10.1016/j.agee.2007.09.012; McCune B., 2011, PC ORD MULTIVARIATE; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Milberg P, 1997, FLORA, V192, P361; MITCHELL THEODORE B., 1960, N CAROLINA AGRIC EXPT STA TECH BULL, V141, P1; Moorhouse AL, 2015, THESIS; Morandin LA, 2013, RESTOR ECOL, V21, P26, DOI 10.1111/j.1526-100X.2012.00876.x; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Patricio-Roberto Gleiciani B., 2014, Diversity-Basel, V6, P158, DOI 10.3390/d6010158; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pywell RF, 2011, J INSECT CONSERV, V15, P853, DOI 10.1007/s10841-011-9383-x; R Core Team, 2021, R LANGUAGE ENV STAT; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.2307/3868443; Rodger JG, 2010, INT J PLANT SCI, V171, P382, DOI 10.1086/651226; Rogers SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097307; Rollin O, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-015-0342-x; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; SAS, 1999, SAS SYST WIND; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schulte LA, 2017, P NATL ACAD SCI USA, V114, P11247, DOI 10.1073/pnas.1620229114; Senapathi D, 2015, P ROYAL SOC B, V282, P2015; Senapathi D, 2017, FUNCT ECOL, V31, P26, DOI 10.1111/1365-2435.12809; SIPES SD, 1995, CONSERV BIOL, V9, P929, DOI 10.1046/j.1523-1739.1995.09040929.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; USDA National Agricultural Statistics Service Cropland Data Layer, 2018, PUBL CROP SPEC DAT L; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wood TJ, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2697; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zhou X, 2014, J SOIL WATER CONSERV, V69, P54, DOI 10.2489/jswc.69.1.54; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	80	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240354	10.1371/journal.pone.0240354	http://dx.doi.org/10.1371/journal.pone.0240354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33120405	Green Published, gold			2022-12-26	WOS:000600013600077
J	Britain, CM; Bhalerao, N; Silva, AD; Chakraborty, A; Buchsbaum, DJ; Crowley, MR; Crossman, DK; Edwards, YJK; Bellis, SL				Britain, Colleen M.; Bhalerao, Nikita; Silva, Austin D.; Chakraborty, Asmi; Buchsbaum, Donald J.; Crowley, Michael R.; Crossman, David K.; Edwards, Yvonne J. K.; Bellis, Susan L.			Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTECTS TUMOR-CELLS; SIALIC ACIDS; SIALYLATION; EXPRESSION; SIALYLTRANSFERASE; ADENOCARCINOMA; GLYCOSYLATION; SURVIVAL; EMT	ST6Gal-I, an enzyme upregulated in numerous malignancies, adds alpha 2-6-linked sialic acids to select membrane receptors, thereby modulating receptor signaling and cell phenotype. In this study, we investigated ST6Gal-I's role in epithelial to mesenchymal transition (EMT) using the Suit2 pancreatic cancer cell line, which has low endogenous ST6Gal-I and limited metastatic potential, along with two metastatic Suit2-derived subclones, S2-013 and S2-LM7AA, which have upregulated ST6Gal-I. RNA-Seq results suggested that the metastatic subclones had greater activation of EMT-related gene networks than parental Suit2 cells, and forced overexpression of ST6Gal-I in the Suit2 line was sufficient to activate EMT pathways. Accordingly, we evaluated expression of EMT markers and cell invasiveness (a key phenotypic feature of EMT) in Suit2 cells with or without ST6Gal-I overexpression, as well as S2-013 and S2-LM7AA cells with or without ST6Gal-I knockdown. Cells with high ST6Gal-I expression displayed enrichment in mesenchymal markers (N-cadherin, slug, snail, fibronectin) and cell invasiveness, relative to ST6Gal-I-low cells. Contrarily, epithelial markers (E-cadherin, occludin) were suppressed in ST6Gal-I-high cells. To gain mechanistic insight into ST6Gal-I's role in EMT, we examined the activity of epidermal growth factor receptor (EGFR), a known EMT driver. ST6Gal-I-high cells had greater alpha 2-6 sialylation and activation of EGFR than ST6Gal-I-low cells. The EGFR inhibitor, erlotinib, neutralized ST6Gal-I- dependent differences in EGFR activation, mesenchymal marker expression, and invasiveness in Suit2 and S2-LM7AA, but not S2-013, lines. Collectively, these results advance our understanding of ST6Gal-I's tumor-promoting function by highlighting a role for ST6Gal-I in EMT, which may be mediated, at least in part, by alpha 2-6-sialylated EGFR.	[Britain, Colleen M.; Bhalerao, Nikita; Silva, Austin D.; Chakraborty, Asmi; Edwards, Yvonne J. K.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Crowley, Michael R.; Crossman, David K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Edwards, Yvonne J. K.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Edwards, YJK; Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.; Edwards, YJK (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	yedwards@uab.edu; bellis@uab.edu		Bellis, Susan/0000-0002-5071-527X; Edwards, Yvonne/0000-0001-8505-3168; Chakraborty, Asmi/0000-0002-6528-8602; Buchsbaum, Donald/0000-0003-2797-5847	National Institutes of Health [U01 CA233581]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were funded by the National Institutes of Health grant U01 CA233581 (S. L. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; BRESALIER RS, 1990, CANCER RES, V50, P1299; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Chakraborty A, 2018, J BIOL CHEM, V293, P984, DOI 10.1074/jbc.M117.808584; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hasehira K, 2012, MOL CELL PROTEOMICS, V11, P1913, DOI 10.1074/mcp.M112.020586; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Irani MA, 2017, PROTEINS, V85, P1529, DOI 10.1002/prot.25314; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jones RB, 2018, J BIOL CHEM, V293, P5659, DOI 10.1074/jbc.RA117.001194; KIARIS H, 1995, INT J ONCOL, V7, P413; Kim JY, 2018, ONCOL RES TREAT, V41, P603, DOI 10.1159/000493554; Kirby MK, 2016, MOL ONCOL, V10, P1169, DOI 10.1016/j.molonc.2016.05.004; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Mathew MP, 2016, ONCOTARGET, V7, P66491, DOI 10.18632/oncotarget.11582; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Oliveira-Cunha Melissa, 2011, Cancers (Basel), V3, P1513, DOI 10.3390/cancers3021513; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rodrigues E, 2018, CANCERS, V10, DOI 10.3390/cancers10060207; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Voon DCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070427; Whitson KB, 2005, BIOCHEMISTRY-US, V44, P14920, DOI 10.1021/bi050751j; Wichert B, 2018, GLYCOBIOLOGY, V28, P898, DOI 10.1093/glycob/cwy065; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yen HY, 2015, P NATL ACAD SCI USA, V112, P6955, DOI 10.1073/pnas.1507329112; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	53	15	15	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100034	10.1074/jbc.RA120.014126	http://dx.doi.org/10.1074/jbc.RA120.014126			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33148698	Green Published, gold			2022-12-26	WOS:000672866400018
J	Kaushik, A; Rahisuddin, R; Saini, N; Singh, RP; Kaur, R; Koul, S; Kumaran, S				Kaushik, Abhishek; Rahisuddin, R.; Saini, Neha; Singh, Ravi P.; Kaur, Rajveer; Koul, Sukirte; Kumaran, S.			Molecular mechanism of selective substrate engagement and inhibitor disengagement of cysteine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; PROTEIN-PROTEIN INTERACTIONS; ACTIVE-SITE; CONFORMATIONAL SELECTION; SALMONELLA-TYPHIMURIUM; SERINE SULFHYDRYLASE; CRYSTAL-STRUCTURES; COMPLEX; HEXOKINASE; CATALYSIS	O-acetyl serine sulfhydrylase (OASS), referred to as cysteine synthase (CS), synthesizes cysteine from O-acetyl serine (OAS) and sulfur in bacteria and plants. The inherent challenge for CS is to overcome 4 to 6 log-folds stronger affinity for its natural inhibitor, serine acetyltransferase (SAT), as compared with its affinity for substrate, OAS. Our recent study showed that CS employs a novel competitive-allosteric mechanism to selectively recruit its substrate in the presence of natural inhibitor. In this study, we trace the molecular features that control selective substrate recruitment. To generalize our findings, we used CS from three different bacteria (Haemophilus, Salmonella, and Mycobacterium) as our model systems and analyzed structural and substrate-binding features of wild-type CS and its similar to 13 mutants. Results show that CS uses a noncatalytic residue, M120, located 20 A away from the reaction center, to discriminate in favor of substrate. M120A and background mutants display significantly reduced substrate binding, catalytic efficiency, and inhibitor binding. Results shows that M120 favors the substrate binding by selectively enhancing the affinity for the substrate and disengaging the inhibitor by 20 to 286 and 5- to 3-folds, respectively. Together, M120 confers a net discriminative force in favor of substrate by 100- to 858-folds.	[Kaushik, Abhishek; Rahisuddin, R.; Saini, Neha; Singh, Ravi P.; Kaur, Rajveer; Koul, Sukirte; Kumaran, S.] CSIR, Inst Microbial Technol IMTECH, GN Ramachandran Prot Ctr, Sect 39-A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumaran, S (corresponding author), CSIR, Inst Microbial Technol IMTECH, GN Ramachandran Prot Ctr, Sect 39-A, Chandigarh, India.	skumaran@imtech.res.in		Singh, Ravi Pratap/0000-0002-5465-323X	CSIR India; Department of Biotechnology, India; CSIR	CSIR India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by CSIR India, in part by Department of Biotechnology, India. A. K., R. P. S., and N. S. received CSIR SRF fellowships, and R. R. was a DBT-SRF fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Banerjee K, 2017, J PHYS CHEM LETT, V8, P1552, DOI 10.1021/acs.jpclett.7b00441; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Brunner K, 2016, J MED CHEM, V59, P6848, DOI 10.1021/acs.jmedchem.6b00674; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; De Luca L, 2011, CHEMMEDCHEM, V6, P1184, DOI 10.1002/cmdc.201100071; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Franko N, 2018, J ENZYM INHIB MED CH, V33, P1343, DOI 10.1080/14756366.2018.1504040; Fry DC, 2012, CURR PHARM DESIGN, V18, P4679; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Joshi P, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1572-4; Kaur H, 2011, BIOCHIMIE, V93, P175, DOI 10.1016/j.biochi.2010.09.008; Kaushik A, 2017, BIOCHEMISTRY-US, V56, P2385, DOI 10.1021/acs.biochem.6b01204; Kiss-Szeman AJ, 2019, CURR PROTEIN PEPT SC, V20, P1089, DOI 10.2174/1389203720666190925103339; KOSHLAND DE, 1963, SCIENCE, V142, P1533, DOI 10.1126/science.142.3599.1533; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagpal I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030305; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Po P, 2017, J MOL BIOL, V429, P1873, DOI 10.1016/j.jmb.2017.04.019; Poyraz O, 2013, J MED CHEM, V56, P6457, DOI 10.1021/jm400710k; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Salsi E, 2010, J MED CHEM, V53, P345, DOI 10.1021/jm901325e; Sartori P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.188101; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AK, 2017, BIOCHEMISTRY-US, V56, P5011, DOI 10.1021/acs.biochem.7b00500; Singh AK, 2014, BIOCHEMISTRY-US, V53, P7870, DOI 10.1021/bi501263u; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Tawfik DS, 2014, CURR OPIN CHEM BIOL, V21, P73, DOI 10.1016/j.cbpa.2014.05.008; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wang T, 2012, J BIOL CHEM, V287, P4360, DOI 10.1074/jbc.M111.288423; Wu S, 2014, CHEM REV, V114, P2759, DOI 10.1021/cr3005179	50	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100041	10.1074/jbc.RA120.014490	http://dx.doi.org/10.1074/jbc.RA120.014490			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33162395	Green Published, gold			2022-12-26	WOS:000672866400025
J	Zheng, FX; Li, N; Xu, Y; Zhou, YP; Li, YP				Zheng, Fuxiang; Li, Ni; Xu, Yi; Zhou, Yuanping; Li, Yi-Ping			Adaptive mutations promote hepatitis C virus assembly by accelerating core translocation to the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CELL-CULTURE SYSTEMS; APOLIPOPROTEIN-E; COMPENSATORY MUTATIONS; RNA REPLICATION; GENOTYPES 1-6; NS2; NS5A; PARTICLES; P7	The envelopment of hepatitis C virus (HCV) is believed to occur primarily in the endoplasmic reticulum (ER)-associated membrane, and the translocation of viral Core protein from lipid droplets (LDs) to the ER is essential for the envelopment of viral particles. However, the factors involved are not completely understood. Herein, we identified eight adaptive mutations that enhanced virus spread and infectivity of genotype 1a clone TNcc in hepatoma Huh7 cells through long-term culture adaptation and reverse genetic study. Of eight mutations, I853V in NS2 and C2865F in NS5B were found to be minimal mutation sets that enabled an increase in virus production without apparently affecting RNA replication, thus suggesting its roles in the post-replication stage of the HCV life cycle. Using a protease K protection and confocal microscopy analysis, we demonstrated that C2865F and the combination of I853V/C2865F enhanced virus envelopment by facilitating Core translocation from the LDs to the ER. Buoyant density analysis revealed that I853V/C2865F contributed to the release of virion with a density of similar to 1.10 g/ml. Moreover, we demonstrated that NS5B directly interacted with NS2 at the protease domain and that mutations I853V, C2865F, and I853V/C2865F enhanced the interaction. In addition, C2865F also enhanced the interaction between NS5B and Core. In conclusion, this study demonstrated that adaptive mutations in NS2 and NS5B promoted HCV envelopment by accelerating Core translocation from the LDs to the ER and reinforced the interaction between NS2 and NS5B. The findings facilitate our understanding of the assembly of HCV morphogenesis.	[Zheng, Fuxiang; Li, Ni; Li, Yi-Ping] Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Inst Human Virol, Guangzhou, Peoples R China; [Zheng, Fuxiang; Li, Ni; Li, Yi-Ping] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Peoples R China; [Xu, Yi] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Pediat, Guangzhou, Peoples R China; [Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Peoples R China; [Li, Yi-Ping] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai, Peoples R China; [Zheng, Fuxiang] Sun Yat Sen Univ, Sch Med, Affiliated Hosp 7, Ctr Infect & Immun Studies CIIS,MOE Key Lab Trop, Shenzhen 518107, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University	Li, YP (corresponding author), Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Inst Human Virol, Guangzhou, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai, Peoples R China.	lyiping@mail.sysu.edu.cn		Zhou, Yuanping/0000-0002-2493-396X	National Natural Science Foundation of China, China [81971938, 31470263, 81772923]; Innovation Research Team for Basic and Clinical Studies on Chronic Liver Diseases of 2018 High-Level Health Teams of Zhuhai, China	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Innovation Research Team for Basic and Clinical Studies on Chronic Liver Diseases of 2018 High-Level Health Teams of Zhuhai, China	This work was supported by the National Natural Science Foundation of China, China (No. 81971938 and 31470263 for Y.-P. L.; 81772923 for Y. Z.) and the Innovation Research Team for Basic and Clinical Studies on Chronic Liver Diseases of 2018 High-Level Health Teams of Zhuhai, China (for Y.-P. L.).	Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boson B, 2017, GASTROENTEROLOGY, V152, P895, DOI 10.1053/j.gastro.2016.11.047; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boyer A, 2018, GASTROENTEROLOGY, V155, P1923, DOI 10.1053/j.gastro.2018.08.027; Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268; Chen MX, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02950; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Date T, 2012, J VIROL, V86, P10805, DOI 10.1128/JVI.07235-11; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Duan XB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0140-z; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gouklani H, 2013, J VIRAL HEPATITIS, V20, pe66, DOI 10.1111/jvh.12004; Gouklani H, 2012, J VIROL, V86, P5080, DOI 10.1128/JVI.07089-11; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Haddad JG, 2017, J VIROL, V91, DOI 10.1128/JVI.00048-17; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Humes D, 2018, VIROLOGY, V522, P177, DOI 10.1016/j.virol.2018.05.020; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Li YP, 2015, J VIROL, V89, P811, DOI 10.1128/JVI.02877-14; Li YP, 2014, GASTROENTEROLOGY, V146, P812, DOI 10.1053/j.gastro.2013.11.009; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lu J, 2014, J VIROL, V88, P1484, DOI 10.1128/JVI.02929-13; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Pham LV, 2018, GASTROENTEROLOGY, V154, P2194, DOI 10.1053/j.gastro.2018.02.017; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Pietschmann T, 2019, TRENDS MICROBIOL, V27, P379, DOI 10.1016/j.tim.2019.01.001; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Ramirez S, 2014, HEPATOLOGY, V59, P395, DOI 10.1002/hep.26660; Roder AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007163; Roder AE, 2019, METHODS MOL BIOL, V1911, P209, DOI 10.1007/978-1-4939-8976-8_14; Roingeard P, 2004, BIOL CELL, V96, P103, DOI 10.1016/j.biolcel.2003.11.006; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Scheel TKH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003228; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Spearman CW, 2019, LANCET, V394, P1451, DOI 10.1016/S0140-6736(19)32320-7; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Uchida M, 2002, HEPATOL RES, V22, P297, DOI 10.1016/S1386-6346(02)00005-0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yan Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02399-16; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhang XW, 2016, BIOCHEM BIOPH RES CO, V479, P683, DOI 10.1016/j.bbrc.2016.09.152; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	80	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100018	10.1074/jbc.RA120.016010	http://dx.doi.org/10.1074/jbc.RA120.016010			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33144326	Green Published, gold			2022-12-26	WOS:000672866400004
J	Amberg, A; Saunders, DN				Amberg, Amanda; Saunders, Darren N.			Cancer in the news: Bias and quality in media reporting of cancer research	PLOS ONE			English	Article							POPULAR PRESS; ACCURACY; COVERAGE; WOMEN; HYPE	Cancer research in the news is often associated with sensationalised and inaccurate reporting, which may give rise to false hopes and expectations. The role of study selection for cancer-related news stories is an important but less commonly acknowledged issue, as the outcomes of primary research are generally less reliable than those of meta-analyses and systematic reviews. Few studies have investigated the quality of research that makes the news and no previous analyses of the proportions of primary and secondary research in the news have been found in the literature. We analysed distribution of study types, research sources, reporting quality, gender bias, and national bias in online news reports by four major news outlets in USA, UK and Australia over six-months. We measured significant variation in reporting quality and observed biases in many aspects of cancer research reporting, including the types of study selected for coverage, the spectrum of cancer types, gender of scientists, and geographical source of research represented. We discuss the implications of these findings for guiding accurate, contextual reporting of cancer research, which is critical in helping the public understand complex science, appreciate the outcomes of publicly-funded research, maintain trust, and assist informed decision-making. The striking gender bias observed may compromise high-quality coverage of research by limiting diversity of opinion, reinforces stereotypes and skews public visibility and recognition towards male scientists. Our findings provide useful guidelines for scientists and journalists alike to consider in providing the most informative and accurate reporting of research.	[Amberg, Amanda; Saunders, Darren N.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Saunders, DN (corresponding author), Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia.	d.saunders@unsw.edu.au						Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2014, REG ANESTH PAIN MED; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Borup M, 2006, TECHNOL ANAL STRATEG, V18, P285, DOI 10.1080/09537320600777002; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Brechman JM, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2011.01550.x; Caulfield T, 2004, TRENDS BIOTECHNOL, V22, P337, DOI 10.1016/j.tibtech.2004.03.014; Caulfield T, 2018, PERSPECT BIOL MED, V61, P560, DOI 10.1353/pbm.2018.0065; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Dumas-Mallet E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172650; Earp BD, 2016, HLTH WATCH, V101, P4; Entwistle V., 1992, PUBLIC UNDERST SCI, V1, P367, DOI DOI 10.1088/0963-6625/1/4/002; Gonon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044275; Granado A, 2011, JOURNALISM, V12, P794, DOI 10.1177/1464884911412702; Haneef Romana, 2017, Res Integr Peer Rev, V2, P9, DOI 10.1186/s41073-017-0033-z; Heim D, 2014, INT J CANCER, V135, P2362, DOI 10.1002/ijc.28882; Helmer M, 2017, ELIFE, V6, DOI 10.7554/eLife.21718; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jia S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148434; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Knobloch-Westerwick S, 2013, SCI COMMUN, V35, P603, DOI 10.1177/1075547012472684; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; Lee CJ, 2014, J HEALTH COMMUN, V19, P1330, DOI 10.1080/10810730.2014.894598; Lewison G, 2008, BRIT J CANCER, V99, P569, DOI 10.1038/sj.bjc.6604531; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; MOYER A, 1995, HEALTH COMMUN, V7, P147, DOI 10.1207/s15327027hc0702_4; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Prasad V, 2013, J CLIN EPIDEMIOL, V66, P361, DOI 10.1016/j.jclinepi.2012.11.005; Putnam KE, 2015, HARVARD BUS REV, V93, P22; Rohrig B, 2009, DTSCH ARZTEBL INT, V106, P262, DOI 10.3238/arztebl.2009.0262; Ross K, 2011, MEDIA CULT SOC, V33, P1148, DOI 10.1177/0163443711418272; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Schoenfeld JD, 2013, AM J CLIN NUTR, V97, P127, DOI 10.3945/ajcn.112.047142; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; SINGER E, 1990, J COMMUN, V40, P102, DOI 10.1111/j.1460-2466.1990.tb02284.x; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Taylor JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127848; Wagner CS, 2017, NATURE, V550, P32, DOI 10.1038/550032a; Welfare A.I.o.H.a, 2017, CANC IN AUSTR; Wilson A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000323; Wilson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004831	44	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242133	10.1371/journal.pone.0242133	http://dx.doi.org/10.1371/journal.pone.0242133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166352	gold, Green Published, Green Submitted			2022-12-26	WOS:000592382600001
J	Capizzi, J; Leahy, J; Wheelock, H; Garcia, J; Strnad, L; Sikka, M; Englander, H; Thomas, A; Korthuis, PT; Menza, TW				Capizzi, Jeffrey; Leahy, Judith; Wheelock, Haven; Garcia, Jonathan; Strnad, Luke; Sikka, Monica; Englander, Honora; Thomas, Ann; Korthuis, P. Todd; Menza, Timothy William			Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; UNITED-STATES; METHAMPHETAMINE; INCREASES; EPIDEMICS	Background Injection drug use has far-reaching social, economic, and health consequences. Serious bacterial infections, including skin/soft tissue infections, osteomyelitis, bacteremia, and endocarditis, are particularly morbid and mortal consequences of injection drug use. Methods We conducted a population-based retrospective cohort analysis of hospitalizations among patients with a diagnosis code for substance use and a serious bacterial infection during the same hospital admission using Oregon Hospital Discharge Data. We examined trends in hospitalizations and costs of hospitalizations attributable to injection drug use-related serious bacterial infections from January 1, 2008 through December 31, 2018. Results From 2008 to 2018, Oregon hospital discharge data included 4,084,743 hospitalizations among 2,090,359 patients. During the study period, hospitalizations for injection drug use-related serious bacterial infection increased from 980 to 6,265 per year, or from 0.26% to 1.68% of all hospitalizations (P0.001). The number of unique patients with an injection drug use-related serious bacterial infection increased from 839 to 5,055, or from 2.52% to 8.46% of all patients (P0.001). While hospitalizations for all injection drug use-related serious bacterial infections increased over the study period, bacteremia/sepsis hospitalizations rose most rapidly with an 18-fold increase. Opioid use diagnoses accounted for the largest percentage of hospitalizations for injection drug use-related serious bacterial infections, but hospitalizations for amphetamine-type stimulant-related serious bacterial infections rose most rapidly with a 15-fold increase. People living with HIV and HCV experienced increases in hospitalizations for injection drug use-related serious bacterial infection during the study period. Overall, the total cost of hospitalizations for injection drug use-related serious bacterial infections increased from $16,305,129 in 2008 to $150,879,237 in 2018 (P0.001). Conclusions In Oregon, hospitalizations for injection drug use-related serious bacterial infections increased dramatically and exacted a substantial cost on the health care system from 2008 to 2018. This increase in hospitalizations represents an opportunity to initiate substance use disorder treatment and harm reduction services to improve outcomes for people who inject drugs.	[Capizzi, Jeffrey; Leahy, Judith; Thomas, Ann; Korthuis, P. Todd; Menza, Timothy William] Oregon Hlth Author, Publ Hlth Div, Portland, OR 97232 USA; [Wheelock, Haven] OutsideIn, Portland, OR USA; [Garcia, Jonathan] Oregon State Univ, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA; [Strnad, Luke; Sikka, Monica; Englander, Honora; Korthuis, P. Todd; Menza, Timothy William] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	Oregon State University; Oregon Health & Science University	Menza, TW (corresponding author), Oregon Hlth Author, Publ Hlth Div, Portland, OR 97232 USA.; Menza, TW (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.	TIMOTHY.W.MENZA@dhsoha.state.or.us		Menza, Timothy/0000-0003-4154-7718; Korthuis, Philip/0000-0001-5556-3597	NIH National Institute on Drug Abuse [UH3DA044831, U01TR002631, UG1DA015815]	NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by grants from the NIH National Institute on Drug Abuse (UH3DA044831, U01TR002631, UG1DA015815) to PTK. The URL for the National Institute on Drug Abuse is drugabuse.gov. The funder had no role in study design, implementation, analysis, or manuscript review.	Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; [Anonymous], 3330190005 OAR; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2019, HIV INCREASES 2019 P; [Anonymous], RUR FRONT DAT; [Anonymous], 2015, COMMUNITY OUTBREAK H; Barocas JA, 2020, CLIN INFECT DIS PUBL, DOI [10.1093/cid/ciaa1346, DOI 10.1093/CID/CIAA134632901815]; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Bottner R, 2020, J ADDICT MED, V14, P178, DOI 10.1097/ADM.0000000000000545; Collins D, 2019, J GEN INTERN MED, DOI 10.1007/s11606-019-05311-0; Ellis MS, 2018, DRUG ALCOHOL DEPEN, V193, P14, DOI 10.1016/j.drugalcdep.2018.08.029; Englander H, 2019, J GEN INTERN MED, V34, P2796, DOI 10.1007/s11606-019-05251-9; Englander H, 2019, J ADDICT MED, V13, P85, DOI 10.1097/ADM.0000000000000487; Englander H, 2017, J HOSP MED, V12, P339, DOI 10.12788/jhm.2736; Furukawa NW, CLIN INFECT DIS, DOI 10.1093/cid/ciaa507/5829012; Gbinigie OA, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1205-0; Gray ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3408-y; Jackson KA, 2018, MMWR-MORBID MORTAL W, V67, P625, DOI 10.15585/mmwr.mm6722a2; Keeshin SW, 2016, AM J MED SCI, V352, P609, DOI 10.1016/j.amjms.2016.10.002; Kidd SE, 2019, MMWR-MORBID MORTAL W, V68, P144, DOI 10.15585/mmwr.mm6806a4; Kropenske V, 1994, PROTECTING CHILDREN, DOI DOI 10.1037/E300212004-001; Kuo YF, 2018, J AM GERIATR SOC, V66, P945, DOI 10.1111/jgs.15332; Larochelle MR, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.06.039; Leahy J, 2019, CD SUMMARY SEX DRUGS; Lopez A. M., 2019, COUSE METHAMPHETAMIN; Marks LR, 2019, CLIN INFECT DIS, V68, P1935, DOI 10.1093/cid/ciy924; National Institute on Drug Abuse, 2020, OR OP INV DEATHS REL; OHA Public Health Division, 2018, HIV INF OR, P6; Oregon Health Authority, HOSP REP PROGR OFF H; Oregon Health Authority, PRESCR OV DAT OR OP; Oregon Workers' Compensation Division, MED FEE SCHED MED ST; Paquette CE, 2018, INT J DRUG POLICY, V57, P104, DOI 10.1016/j.drugpo.2018.04.004; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Price CN, 2020, J INFECT DIS, V222, pS494, DOI 10.1093/infdis/jiaa025; Robles F., 2018, NEW YORK TIMES; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Schranz A, 2018, ANN INTERN MED, DOI [10.7326/M18-2124, DOI 10.7326/M18-2124]; Serota DP, 2020, CLIN INFECT DIS, V70, P968, DOI 10.1093/cid/ciz804; Springer SA, 2018, ANN INTERN MED, V169, P335, DOI 10.7326/M18-1203; Suzuki J, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy194; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tookes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129360; Velez CM, 2017, J GEN INTERN MED, V32, P296, DOI 10.1007/s11606-016-3919-4; Wakeman SE, 2017, J GEN INTERN MED, V32, P909, DOI 10.1007/s11606-017-4077-z; Weinstein ZM, 2020, DRUG ALCOHOL DEPEN, V213, DOI 10.1016/j.drugalcdep.2020.108081; Winkelman TNA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3758; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	47	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242165	10.1371/journal.pone.0242165	http://dx.doi.org/10.1371/journal.pone.0242165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166363	gold, Green Published			2022-12-26	WOS:000592382600066
J	Ghaznavi, C; Sakamoto, H; Nomura, S; Kubota, A; Yoneoka, D; Shibuya, K; Ueda, P				Ghaznavi, Cyrus; Sakamoto, Haruka; Nomura, Shuhei; Kubota, Anna; Yoneoka, Daisuke; Shibuya, Kenji; Ueda, Peter			The herbivore's dilemma: Trends in and factors associated with heterosexual relationship status and interest in romantic relationships among young adults in Japan-Analysis of national surveys, 1987-2015	PLOS ONE			English	Article							MATE PREFERENCES; HEALTH; RESOURCES	Background It has been suggested that an increasing proportion of young adults in Japan have lost interest in romantic relationships, a phenomenon termed "herbivorization". We assessed trends in heterosexual relationship status and self-reported interest in heterosexual romantic relationships in nationally representative data. Methods We used data from seven rounds of the National Fertility Survey (1987-2015) and included adults aged 18-39 years (18-34 years in the 1987 survey; sample size 11,683-17,675). Current heterosexual relationship status (married; unmarried but in a relationship; single) was estimated by sex, age group and survey year, with singles further categorized into those reporting interest vs. no interest in heterosexual romantic relationships. Information about same-sex relationships were not available. Results Between 1992 and 2015, the age-standardized proportion of 18-39-year-old Japanese adults who were single had increased steadily, from 27.4 to 40.7% among women and from 40.3 to 50.8% among men. This increase was largely driven by decreases in the proportion of married women aged 25-39 years and men aged 30-39 years, while those in a relationship had increased only slightly for women and remained stable for men. By 2015, the proportion of single women was 30.2% in those aged 30-34 years and 24.4% in those aged 35-39 years. The corresponding numbers for men were 39.3% and 32.4%. Around half of the singles (21.4% of all women and 25.1% of all men aged 18-39 years) reported that they had no interest in heterosexual romantic relationships. Single women and men who reported no interest in romantic relationships had lower income and educational levels and were less likely to have regular employment compared to those who reported such an interest. Conclusions In this analysis of heterosexual relationships in nationally representative data from Japan, singlehood among young adults had steadily increased over the last three decades. In 2015 around one in four women and one in three men in their thirties were unmarried and not in a heterosexual relationship. Half of the singles reported no interest in romantic relationships and these women and men had lower income and educational levels and were less likely to have regular employment.	[Ghaznavi, Cyrus; Sakamoto, Haruka; Nomura, Shuhei; Kubota, Anna; Yoneoka, Daisuke; Shibuya, Kenji; Ueda, Peter] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Ghaznavi, Cyrus] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Sakamoto, Haruka] Tokyo Womens Med Univ, Dept Trop Med & Int Affairs, Tokyo, Japan; [Yoneoka, Daisuke] St Lukes Int Univ, Grad Sch Publ Hlth, Div Biostat & Bioinformat, Tokyo, Japan; [Ueda, Peter] Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden	University of Tokyo; Washington University (WUSTL); Tokyo Women's Medical University; St. Luke's International Hospital; Karolinska Institutet	Ueda, P (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.; Ueda, P (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden.	peter.ueda@gmail.com	Nomura, Shuhei/HCH-5356-2022; Yoneoka, Daisuke/A-9336-2016	Ghaznavi, Cyrus/0000-0002-5942-1948; sakamoto, haruka/0000-0001-9003-7402; Yoneoka, Daisuke/0000-0002-3525-5092; Nomura, Shuhei/0000-0002-2963-7297	Ministry of Education, Culture, Sports, Science and Technology of Japan [16H02643]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	SK: Grants-in-Aid for Scientific Research (KAKEN) from Ministry of Education, Culture, Sports, Science and Technology of Japan (16H02643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August K. J., 2018, ENCY MENTAL HLTH, VSecond, P46, DOI [10.1016/B978-0-12-397045-9.00074-4, DOI 10.1016/B978-0-12-397045-9.00074-4]; Baer, 2015, BUSINESS INSIDER; Buunk BP, 2002, PERS RELATIONSHIP, V9, P271, DOI 10.1111/1475-6811.00018; Cabinet Office: Government of Japan, 2018, 2018 DECL BIRTH WHIT; Cabinet Office: Government of Japan, 2016, WAK NO SEIK NI KANS; Cabinet Office: Government of Japan, 2014, SURV MARR FAM FORM; Cabinet Office: Government of Japan, 2019, SEIK JOUK NI KANS CH; Charlebois Justin, 2013, CULTURE SOC MASCULIN, V5, P89, DOI [10.3149/CSM.0501.89, DOI 10.3149/CSM.0501.89]; Fales MR, 2016, PERS INDIV DIFFER, V88, P78, DOI 10.1016/j.paid.2015.08.041; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Fukasawa M, 2009, SOUSHOKU DANSHI SEDA; Fukuda S, 2009, SHIFTING EC FDN MARR; Genda Y, 2007, SHIGOTO TO SEKKUSU N; Ghaznavi C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6677-5; Gribble JN, 1999, J SEX RES, V36, P16, DOI 10.1080/00224499909551963; Haydon AA, 2014, ARCH SEX BEHAV, V43, P221, DOI 10.1007/s10508-013-0164-3; Hitsch GJ, 2010, QME-QUANT MARK ECON, V8, P393, DOI 10.1007/s11129-010-9088-6; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Jalovaara M, 2012, POP STUD-J DEMOG, V66, P69, DOI 10.1080/00324728.2011.641720; Jeong S, 2019, CNN; Kim JH, 2017, ARCH SEX BEHAV, V46, P2403, DOI 10.1007/s10508-017-0968-7; Kitamura K, 2011, SEKKUSU GIRAINA WAKA; Korea Institute for Health and Social Affairs, 2018, 2018 NYEON JEONG CHU; Lim, 2009, NPR; Loving T.J., 2013, OXFORD HDB CLOSE REL, P617, DOI [10.1093/oxfordhb/9780195398694.013.0028, DOI 10.1093/OXFORDHB/9780195398694.013.0028]; May G, 2015, TELEGRAPH; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Ministry of Health Labour and Welfare; Japan, 2009, 6 LONG SURV AD 21 CE; Ministry of Health Labour and Welfare; Japan, NAT FERT SURV; Ministry of Internal Affairs and Communications, POP CENS; Morioka M, 2009, SAIGO NO KOI WA SOU; Morioka Masahiro., 2013, REV LIFE STUDIES, V4, P1; National Institute of Population and Social Security Research, 2017, MARR CHILDB JAP TOD; National Institute of Population and Social Security Research, 2017, POP PROJ JAP 2017 20; Neill M, 2009, CNN; NORC, GEN SOC SURV GSS; OECD, 2018, OECD FAM DAT MARR DI; Perelli-Harris B, 2016, SOC FORCES, V95, P251, DOI 10.1093/sf/sow054; Powdthavee N., 2008, J SOCIO-ECON, V37, P1459, DOI [DOI 10.1016/j.socec.2007.04.004, 10.1016/j.socec.2007.04.004, DOI 10.1016/J.SOCEC.2007.04.004]; Rissel C, 2014, SEX HEALTH, V11, P416, DOI 10.1071/SH14105; Shimizu T, 2019, ANN ONCOL, V30, DOI 10.1093/annonc/mdz343.104; Sweeney MM, 2004, J MARRIAGE FAM, V66, P1015, DOI 10.1111/j.0022-2445.2004.00073.x; Tamagawa M, 2018, J GLBT FAM STUD, V14, P488, DOI 10.1080/1550428X.2017.1338172; Uecker JE, 2012, J HEALTH SOC BEHAV, V53, P67, DOI 10.1177/0022146511419206; Ushikubo Megumi., 2015, RENAI SHINAI WAKAMON; Yamaoka K, 2008, SOC SCI MED, V66, P885, DOI 10.1016/j.socscimed.2007.10.024	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241571	10.1371/journal.pone.0241571	http://dx.doi.org/10.1371/journal.pone.0241571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166316	Green Published, gold			2022-12-26	WOS:000592382600022
J	Small, AM; Huffman, JE; Klarin, D; Lynch, JA; Assimes, T; DuVall, S; Sun, YV; Shere, L; Natarajan, P; Gaziano, M; Rader, DJ; Wilson, PWF; Tsao, PS; Chang, KM; Cho, K; O'Donnell, CJ; Casas, JP; Damrauer, SM				Small, Aeron M.; Huffman, Jennifer E.; Klarin, Derek; Lynch, Julie A.; Assimes, Themistocles; DuVall, Scott; Sun, Yan, V; Shere, Labiba; Natarajan, Pradeep; Gaziano, Michael; Rader, Daniel J.; Wilson, Peter W. F.; Tsao, Philip S.; Chang, Kyong-Mi; Cho, Kelly; O'Donnell, Christopher J.; Casas, Juan P.; Damrauer, Scott M.		VA Million Vet Program	PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; RISK; ASSOCIATION; CHOLESTEROL; EVOLOCUMAB; VARIANTS	Background Therapeutic inhibition of PCSK9 protects against coronary artery disease (CAD) and ischemic stroke (IS). The impact on other diseases remains less well characterized. Methods We created a genetic risk score (GRS) for PCSK9 using four single nucleotide polymorphisms (SNPs) at or near the PCSK9 locus known to impact lower LDL-Cholesterol (LDL-C): rs11583680, rs11591147, rs2479409, and rs11206510. We then used our GRS to calculate weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on several pre-specified phenotypes including CAD, IS, peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), type 2 diabetes, dementia, chronic obstructive pulmonary disease, and cancer. Finally, we used our weighted GRS to perform a phenome-wide association study. Results Genetic and electronic health record data that passed quality control was available in 312,097 individuals, (227,490 White participants, 58,907 Black participants, and 25,700 Hispanic participants). PCSK9 mediated reduction in LDL-C was associated with a reduced risk of CAD and AAA in trans-ethnic meta-analysis (CAD OR 0.83 [95% CI 0.80-0.87], p = 6.0 x 10(-21); AAA OR 0.76 [95% CI 0.68-0.86], p = 2.9 x 10(-06)). Significant protective effects were noted for PAD in White individuals (OR 0.83 [95% CI 0.71-0.97], p = 2.3 x 10(-04)) but not in other genetic ancestries. Genetically reduced PCSK9 function associated with a reduced risk of dementia in trans-ethnic meta-analysis (OR 0.86 [95% CI 0.78-0.93], p = 5.0 x 10(-04)). Conclusions Genetically reduced PCSK9 function results in a reduction in risk of several important extra-coronary atherosclerotic phenotypes in addition to known effects on CAD and IS, including PAD and AAA. We also highlight a novel reduction in risk of dementia, supporting a well-recognized vascular component to cognitive impairment and an opportunity for therapeutic repositioning.	[Small, Aeron M.; Chang, Kyong-Mi; Damrauer, Scott M.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA; [Small, Aeron M.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Huffman, Jennifer E.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Klarin, Derek; Natarajan, Pradeep; Gaziano, Michael; Cho, Kelly; O'Donnell, Christopher J.; Casas, Juan P.] Boston VA Healthcare Syst, Boston, MA USA; [Klarin, Derek; Natarajan, Pradeep] Massachusetts Gen Hosp, Ctr Genom Med, Harvard Med Sch, Boston, MA USA; [Klarin, Derek] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Klarin, Derek] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Lynch, Julie A.; DuVall, Scott] Salt Lake City Hlth Care Syst, Dept Vet Affairs, Salt Lake City, UT USA; [Lynch, Julie A.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA USA; [Lynch, Julie A.] Edith Nourse Rogers Mem VA Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Assimes, Themistocles; Tsao, Philip S.] VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA; [Assimes, Themistocles; Tsao, Philip S.] Stanford Univ, Sch Med, Stanford, CA USA; [DuVall, Scott] Vet Affairs Informat & Comp Infrastruct, Decatur, GA USA; [Sun, Yan, V; Wilson, Peter W. F.] Atlanta VA Hlth Care Syst, Decatur, GA USA; [Sun, Yan, V] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA USA; [Sun, Yan, V] Emory Univ, Dept Biomed Informat, Sch Med, Atlanta, GA USA; [Shere, Labiba] VA Palo Alto Hlth Care Syst, Palo Alto Epidemiol Res & Informat Ctr Genom, Boston, MA USA; [Natarajan, Pradeep] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA USA; [Gaziano, Michael] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Boston, MA USA; [Rader, Daniel J.; Chang, Kyong-Mi] Univ Penn, Perlman Sch Med, Dept Med, Philadelphia, PA USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [O'Donnell, Christopher J.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Cardiovasc Med Div, Boston, MA USA; [Damrauer, Scott M.] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; University of Massachusetts System; University of Massachusetts Boston; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Emory University; Rollins School Public Health; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Damrauer, SM (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA.; Damrauer, SM (corresponding author), Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA.	scott.damrauer@va.gov	Natarajan, Pradeep/H-9764-2019; Assimes, Themistocles Leonard/D-9696-2015	Natarajan, Pradeep/0000-0001-8402-7435; Assimes, Themistocles Leonard/0000-0003-2349-0009; DuVall, Scott/0000-0002-4898-3865; Klarin, Derek/0000-0002-4636-5780	Department of Veterans Affairs (VA) Office of Research and Development [MVP000, I01-01BX03340, I01-BX003362, I01-CX001025]; VA Clinical Sciences Research and Development Career Development Award [IK2-CX001780]	Department of Veterans Affairs (VA) Office of Research and Development(US Department of Veterans Affairs); VA Clinical Sciences Research and Development Career Development Award	This work was supported by funding from the Department of Veterans Affairs (VA) Office of Research and Development for the Million Veteran Program Grant #MVP000 and three additional awards (I01-01BX03340 [Cho/Wilson], I01-BX003362 [Tsao/Chang], and I01-CX001025 [Wilson]). Dr. Damrauer is supported by the VA Clinical Sciences Research and Development Career Development Award [IK2-CX001780].	Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Folsom AR, 2009, ATHEROSCLEROSIS, V202, P211, DOI 10.1016/j.atherosclerosis.2008.03.009; Harrison SC, 2018, JAMA CARDIOL, V3, P26, DOI 10.1001/jamacardio.2017.4293; Hopewell JC, 2018, EUR HEART J, V39, P354, DOI 10.1093/eurheartj/ehx373; JC C., 2006, N ENGL J MED, V23; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; McGuinness B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub3; Sabatine MS, 2017, LANCET DIABETES ENDO, V5, P941, DOI 10.1016/S2213-8587(17)30313-3; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Schmidt AF, 2017, LANCET DIABETES ENDO, V5, P97, DOI 10.1016/S2213-8587(16)30396-5	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0239752	10.1371/journal.pone.0239752	http://dx.doi.org/10.1371/journal.pone.0239752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166319	gold, Green Published			2022-12-26	WOS:000592382600088
J	Teng, HY; Yuan, YD; Zhang, TS; Chang, XL; Wang, DS				Teng, Haiyuan; Yuan, Yongda; Zhang, Tianshu; Chang, Xiaoli; Wang, Dongsheng			Evaluation of the sublethal effect of tetrachlorantraniliprole on Spodoptera exigua and its potential toxicity to two non-target organisms	PLOS ONE			English	Article							LEPIDOPTERA-NOCTUIDAE; BIOLOGICAL-CONTROL; SEED TREATMENTS; INSECTICIDES; PESTICIDES; CHLORANTRANILIPROLE; EARTHWORM; LETHAL; CYANTRANILIPROLE; REPRODUCTION	Tetrachlorantraniliprole (TCAP) is a novel anthranilic diamide insecticide that specifically targets the ryanodine receptors of lepidopteran insect species with excellent insecticidal activity. Previous studies have reported the sublethal effects of multiple diamides on several lepidopteran species, whereas the sublethal and non-target effects of TCAP remain largely unknown. We assessed the sublethal effects of TCAP on Spodoptera exigua. We also investigated the effects of TCAP on non-target Harmonia axyridis and Eisenia fetida, S. exigua was more sensitive to TCAP than to chlorantraniliprole, as the LC50 (10.371 mu g L-1 at 72 h) of TCAP was relatively lower. Compared with those of the control, sublethal concentrations of TCAP (LC10 and LC30) not only prolonged the duration of the larval and pupal stages as well as the mean generation time but also reduced certain population parameters. On the other hand, TCAP exposure, even at the highest concentration, did not induce toxic effects in H. axyridis ladybugs (1(st) instar larvae and adults) or E. fetida earthworms. Taken together, our results suggest that TCAP can be used as a novel and promising component of the integrated pest management (IPM) program against S. exigua due to its robust target effects and negligible non-target risks.	[Teng, Haiyuan; Yuan, Yongda; Zhang, Tianshu; Chang, Xiaoli; Wang, Dongsheng] Shanghai Acad Agr Sci, Inst Ecoenvironm & Plant Protect, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Wang, DS (corresponding author), Shanghai Acad Agr Sci, Inst Ecoenvironm & Plant Protect, Shanghai, Peoples R China.	zb3@saas.sh.cn		Wang, Dongsheng/0000-0002-6388-3352; teng, haiyuan/0000-0001-5487-1870	SAAS Program for Excellent Research Team [SPERT2017(A-03)]; Growth of Youth Talents Program of Shanghai Municipal Agricultural Commission (Shanghai Agricultural Youth (2015)) [1-24]; promotion project of Developing Agriculture through Science and Technology of the Shanghai Agricultural Committee (Hu nong ke tui zi (2018)) [4-14]	SAAS Program for Excellent Research Team; Growth of Youth Talents Program of Shanghai Municipal Agricultural Commission (Shanghai Agricultural Youth (2015)); promotion project of Developing Agriculture through Science and Technology of the Shanghai Agricultural Committee (Hu nong ke tui zi (2018))	The authors are grateful for the financial support provided by SAAS Program for Excellent Research Team (SPERT2017(A-03)), the Growth of Youth Talents Program of Shanghai Municipal Agricultural Commission (Shanghai Agricultural Youth (2015) No. 1-24) and the promotion project of Developing Agriculture through Science and Technology of the Shanghai Agricultural Committee (Hu nong ke tui zi (2018)No.4-14).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Ahmad M, 2018, CROP PROT, V107, P79, DOI 10.1016/j.cropro.2017.12.028; [Anonymous], SPSS STAT SOFTW VERS; Ban LF, 2017, MODERN AGROCHEMICALS, V16, P47; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Barbosa PRR, 2017, J ECON ENTOMOL, V110, P2039, DOI 10.1093/jee/tox217; Bezchlebova J, 2007, ECOTOX ENVIRON SAFE, V67, P206, DOI 10.1016/j.ecoenv.2006.12.015; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Chen Xuewei, 2016, Ecotoxicology, V25, P1841; Chi, 2015, TWOSEX MSCHART A COM, P197; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; Cycon M, 2013, J ENVIRON MANAGE, V131, P55, DOI 10.1016/j.jenvman.2013.09.041; Datta S, 2016, ENVIRON SCI POLLUT R, V23, P8227, DOI 10.1007/s11356-016-6375-0; de Castro AA, 2013, CHEMOSPHERE, V93, P1043, DOI 10.1016/j.chemosphere.2013.05.075; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dong JF, 2017, PESTIC BIOCHEM PHYS, V136, P58, DOI 10.1016/j.pestbp.2016.08.003; Guedes RNC, 2008, PEST MANAG SCI, V64, P1314, DOI 10.1002/ps.1634; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; Hannig GT, 2009, PEST MANAG SCI, V65, P969, DOI 10.1002/ps.1781; He FL, 2018, ECOTOX ENVIRON SAFE, V164, P665, DOI 10.1016/j.ecoenv.2018.08.076; IRAC, 020 IRAC; Jia BT, 2009, PEST MANAG SCI, V65, P996, DOI 10.1002/ps.1785; Kim KY, 2017, ORAL DIS, V23, P91, DOI 10.1111/odi.12579; Kinney CA, 2012, SCI TOTAL ENVIRON, V433, P507, DOI 10.1016/j.scitotenv.2012.06.097; Lai TC, 2011, J PEST SCI, V84, P381, DOI 10.1007/s10340-011-0366-1; Lanka SK, 2013, J ECON ENTOMOL, V106, P181, DOI 10.1603/EC12282; LeOra Software, 2003, POL US GUID PROB LOG; Liu YB, 1997, P ROY SOC B-BIOL SCI, V264, P605, DOI 10.1098/rspb.1997.0086; Lu Y, 2017, MED SCI MONITOR, V23, P1800, DOI 10.12659/MSM.902754; Mali Gajanan Vishnu, 2019, Nature Environment and Pollution Technology, V18, P1387; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Metcalf RL, 1992, DESTRUCTIVE USEFUL I, V490; Moscardini VF, 2014, BIOCONTROL, V59, P503, DOI 10.1007/s10526-014-9588-5; OECD, 2004, OECD GUIDELINE TESTI, P222; OECD (Organisation for Economic Co-operation and Development), 1984, GUID TEST CHEM 207 E; Pelosi C, 2014, AGRON SUSTAIN DEV, V34, P199, DOI 10.1007/s13593-013-0151-z; Ricupero M, 2020, CHEMOSPHERE, V247, DOI 10.1016/j.chemosphere.2019.125728; Saber M, 2018, EXP APPL ACAROL, V75, P55, DOI 10.1007/s10493-018-0226-2; Sang Song, 2014, Journal of South China Agricultural University, V35, P64; Selin-Rani S, 2016, PESTIC BIOCHEM PHYS, V126, P92, DOI 10.1016/j.pestbp.2015.08.003; Sohrabi F, 2013, CROP PROT, V45, P98, DOI 10.1016/j.cropro.2012.11.024; Song PP, 2018, ECOTOX ENVIRON SAFE, V166, P237, DOI 10.1016/j.ecoenv.2018.09.092; Tuan SJ, 2016, J ECON ENTOMOL, V109, P13, DOI 10.1093/jee/tov265; Uwizeyimana H, 2017, ENVIRON TOXICOL PHAR, V55, P20, DOI 10.1016/j.etap.2017.08.001; Vasantha-Srinivasan P, 2018, ENVIRON SCI POLLUT R, V25, P10371, DOI 10.1007/s11356-017-9236-6; Wang L, 2016, SUBLETHAL EFFECT TET; Wang XG, 2018, PESTIC BIOCHEM PHYS, V146, P71, DOI 10.1016/j.pestbp.2018.02.008; Wang YH, 2012, CHEMOSPHERE, V88, P484, DOI 10.1016/j.chemosphere.2012.02.086; Wang YH, 2012, ECOTOX ENVIRON SAFE, V79, P122, DOI 10.1016/j.ecoenv.2011.12.016; Xiao D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128936; Xiao K, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-11; Xu CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156555; Yu Hui-Ling, 2015, Acta Entomologica Sinica, V58, P634	56	6	6	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242052	10.1371/journal.pone.0242052	http://dx.doi.org/10.1371/journal.pone.0242052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166345	Green Published, gold			2022-12-26	WOS:000592382600006
J	Dionizio, EA; Pimenta, FM; Lima, LB; Costa, MH				Dionizio, Emily Ane; Pimenta, Fernando Martins; Lima, Lucas Barbosa; Costa, Marcos Heil			Carbon stocks and dynamics of different land uses on the Cerrado agricultural frontier	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; GRASSLAND MANAGEMENT; CLAYEY OXISOL; CONVERSION; EMISSIONS; IMPACTS; STORAGE; MATTER; REGION	The largest and most dynamic agricultural frontier in Brazil is known as MATOPIBA, an area that covers part of the Cerrado biome. Within this region, Western Bahia stands out as a large producer of soy and cotton. There are no studies that quantify carbon stocks for different land uses and land cover types in Western Bahia, which hinders comprehension of the role of agricultural expansion in carbon dynamics and the development of sustainable agriculture policies. Here, we evaluate how the land use changes in this region have affected the carbon balance in the aboveground biomass (AGB), belowground biomass (BGB), and soil reservoirs. We collected soil samples for areas with different land uses and land cover types to estimate soil carbon stocks (SCS) and combined remote sensing results and modeling techniques to develop a historical reconstruction of spatial patterns of SCS, AGB, and BGB during the period 1990-2018. The replacement of areas from the forest formations class with pasture and rainfed agriculture reduced the 100 cm depth SCS (SCS100) by 37.3% (p = 0.031) and 30.3% (p = 0.053), respectively. By contrast, the conversion of pasture and rainfed agriculture to irrigated agriculture increased SCS100 by 34% (p = 0.034) and 26.5% (p = 0.022), respectively. Spatial changes in historical carbon stocks are strongly associated with land use changes that occurred between 1990 and 2018. We estimated a non-significant loss of 61.9 Tg-C (p = 0.726) from the total carbon stocks (calculated as the sum of AGB, BGB, and SCS) of which 80% of the losses came from soil stocks, 11% from BGB, and 8% from AGB. These findings reveal the need to monitor carbon stocks in sandy soils to reduce the uncertainties of estimates and support the development of effective sustainable agriculture policies. The best alternatives for reducing carbon losses in the Cerrado are to maintain natural forest cover and to recover soils through sustainable soil management, especially in pasturelands where soil carbon stocks are lowest.	[Dionizio, Emily Ane; Pimenta, Fernando Martins; Lima, Lucas Barbosa; Costa, Marcos Heil] Fed Univ Vicosa UFV, Dept Agr Engn, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Dionizio, EA (corresponding author), Fed Univ Vicosa UFV, Dept Agr Engn, Vicosa, MG, Brazil.	emilyy.ane@gmail.com	Pimenta, Fernando Martins/B-3819-2014	Pimenta, Fernando Martins/0000-0002-7589-5721; Dionizio da Silva, Emily Ane/0000-0002-1925-1809	PRODEAGRO [011/2016, 045/2019]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]	PRODEAGRO; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by PRODEAGRO grants 011/2016 and 045/2019. Emily Silva was also partially funded through Coordenacao de Aperfeicoamento de Pessoal de LNivel Superior-Brasil (CAPES)-Finance Code 001.	AIBA, 2017, AN AGR OEST BAH SAFR, P53; [Anonymous], 2013, JHL, V16, pD46; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Batistella Mateus, 2009, Biota Neotrop., V9, P61; Batistella M, 2002, MONITORAMENTO EXPANS; Batlle-Bayer L, 2010, AGR ECOSYST ENVIRON, V137, P47, DOI 10.1016/j.agee.2010.02.003; Bernoux M, 2002, SOIL SCI SOC AM J, V66, P888, DOI 10.2136/sssaj2002.0888; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Blum WEH, 2018, GEOECOL ESSAYS, P1; Bonfatti BR, 2016, GEODERMA, V261, P204, DOI 10.1016/j.geoderma.2015.07.016; Brannstrom C, 2005, GEOFORUM, V36, P257, DOI 10.1016/j.geoforum.2004.06.002; Brannstrom C, 2008, LAND USE POLICY, V25, P579, DOI 10.1016/j.landusepol.2007.11.008; Bustamante MMC, 2012, BRAZ J BIOL, V72, P655, DOI 10.1590/S1519-69842012000400005; Bustamante M. M. C., 2006, Carbon sequestration in soils of Latin America, P285; Calvin KV, 2016, ENERG ECON, V56, P615, DOI 10.1016/j.eneco.2015.03.020; Campos R, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10050156; Cardozo FM, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016141-7939; Chenu C, 2019, SOIL TILL RES, V188, P41, DOI 10.1016/j.still.2018.04.011; Conant RT, 2017, ECOL APPL, V27, P662, DOI 10.1002/eap.1473; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Corbeels M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21450; da Silva JE, 2004, AGR ECOSYST ENVIRON, V103, P357, DOI 10.1016/j.agee.2003.12.007; de Castro ER, 2012, AGR ECON-BLACKWELL, V43, P293, DOI 10.1111/j.1574-0862.2012.00583.x; de Moraes Sa JC, 2015, LAND DEGRAD DEV, V26, P531, DOI 10.1002/ldr.2218; de Oliveira CP, 2019, CIENC FLOREST, V29, P255, DOI 10.5902/1980509827065; de Oliveira SN, 2017, REG ENVIRON CHANGE, V17, P411, DOI 10.1007/s10113-016-0960-0; Deng L, 2016, GLOB ECOL CONSERV, V5, P127, DOI 10.1016/j.gecco.2015.12.004; Dionizio EA, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9010024; Donagema GK, 2011, EMBRAPA SOLOS, P1517; Durigan MR, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030379; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Faleiro FG, 2008, SAVANAS DESAFIOS EST; FAO and ITPS, 2015, INT TECHN PAN SOILS; FAOSTAT, 2017, US; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Fontana A, 2015, SOLOS FRAGEIS CARACT; Fujisaki K, 2018, AGR ECOSYST ENVIRON, V259, P147, DOI 10.1016/j.agee.2017.12.008; Gamble JD, 2017, SOIL SCI SOC AM J, V81, P1557, DOI 10.2136/sssaj2017.04.0138; Gaspar M.T.P, 2012, REV BRAS GEOCIENC, V42, P154, DOI [10.5327/Z0375-75362012000500013, DOI 10.5327/Z0375-75362012000500013]; Gomes LC, 2019, GEODERMA, V340, P337, DOI 10.1016/j.geoderma.2019.01.007; Hairiah K, 2001, CARBON STOCKS TROPIC, V60; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; Hounkpatin OKL, 2018, CATENA, V166, P298, DOI 10.1016/j.catena.2018.04.013; IBGE, 1992, MAN TECN VEG BRAS; Jantalia CP, 2007, SOIL TILL RES, V95, P97, DOI 10.1016/j.still.2006.11.005; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lal R, 2001, LAND DEGRAD DEV, V12, P519, DOI 10.1002/ldr.472; Lardy LC, 2002, AGR ECOSYST ENVIRON, V92, P147, DOI 10.1016/S0167-8809(01)00303-6; Leite CC, 2011, J LAND USE SCI, V6, P33, DOI 10.1080/1747423X.2010.501157; Leite LFC, 2010, SOIL ORGANIC CARBON; Leite LFC, 2010, AUST J SOIL RES, V48, P258, DOI 10.1071/SR09122; MarchAo RL, 2009, SOIL TILLAGE RES; Minasny B, 2017, GEODERMA, V292, P59, DOI 10.1016/j.geoderma.2017.01.002; Mitchard ETA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/049001; Moreira VS, 2018, EARTH INTERACT, V22, DOI 10.1175/EI-D-16-0033.1; Noojipady P, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5986; Olson KR, 2020, EURASIAN SOIL SCI+, V53, P436, DOI 10.1134/S1064229320040122; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Pimenta FM, REMOTE SENS UNPUB; Pousa R, 2019, WATER-SUI, V11, DOI 10.3390/w11050933; Ribeiro JF, 2008, PRINCIPAIS FITOFISIO, P153; Sano E., 2011, GEOCIENCIAS, V30, P479; de Araujo MLS, 2019, LAND USE POLICY, V80, P57, DOI 10.1016/j.landusepol.2018.09.040; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Spera SA, 2016, GLOBAL CHANGE BIOL, V22, P3405, DOI 10.1111/gcb.13298; Toth G, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6415-3; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wantzen KM, 2012, AGR ECOSYST ENVIRON, V151, P70, DOI 10.1016/j.agee.2012.01.030; Zdruli P, 2017, ANTHROP POL ECON SOC, V15, P13, DOI 10.1007/978-3-319-45035-3_2; Zhang YZ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11232744; Zilio M, 2014, CRESCIMENTO PARTICAO	73	14	14	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241637	10.1371/journal.pone.0241637	http://dx.doi.org/10.1371/journal.pone.0241637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156847	Green Published, gold			2022-12-26	WOS:000591376400010
J	Poh, WH; Lin, JQ; Colley, B; Muller, N; Goh, BC; Schleheck, D; El Sahili, A; Marquardt, A; Liang, Y; Kjelleberg, S; Lescar, J; Rice, SA; Klebensberger, J				Poh, Wee-Han; Lin, Jianqing; Colley, Brendan; Mueller, Nicolai; Goh, Boon Chong; Schleheck, David; El Sahili, Abbas; Marquardt, Andreas; Liang, Yang; Kjelleberg, Staffan; Lescar, Julien; Rice, Scott A.; Klebensberger, Janosch			The SiaABC threonine phosphorylation pathway controls biofilm formation in response to carbon availability in Pseudomonas aeruginosa	PLOS ONE			English	Article							C-DI-GMP; BACTERIAL BIOFILMS; SIGNAL-TRANSDUCTION; PROTEIN SECRETION; ESCHERICHIA-COLI; CELL-AGGREGATION; STRESS-RESPONSE; VIRULENCE; PHOSPHATASES; INFECTIONS	The critical role of bacterial biofilms in chronic human infections calls for novel anti-biofilm strategies targeting the regulation of biofilm development. However, the regulation of biofilm development is very complex and can include multiple, highly interconnected signal transduction/response pathways, which are incompletely understood. We demonstrated previously that in the opportunistic, human pathogen P. aeruginosa, the PP2C-like protein phosphatase SiaA and the di-guanylate cyclase SiaD control the formation of macroscopic cellular aggregates, a type of suspended biofilms, in response to surfactant stress. In this study, we demonstrate that the SiaABC proteins represent a signal response pathway that functions through a partner switch mechanism to control biofilm formation. We also demonstrate that SiaABCD functionality is dependent on carbon substrate availability for a variety of substrates, and that upon carbon starvation, SiaB mutants show impaired dispersal, in particular with the primary fermentation product ethanol. This suggests that carbon availability is at least one of the key environmental cues integrated by the SiaABCD system. Further, our biochemical, physiological and crystallographic data reveals that the phosphatase SiaA and its kinase counterpart SiaB balance the phosphorylation status of their target protein SiaC at threonine 68 (T68). Crystallographic analysis of the SiaA-PP2C domain shows that SiaA is present as a dimer. Dynamic modelling of SiaA with SiaC suggested that SiaA interacts strongly with phosphorylated SiaC and dissociates rapidly upon dephosphorylation of SiaC. Further, we show that the known phosphatase inhibitor fumonisin inhibits SiaA mediated phosphatase activity in vitro. In conclusion, the present work improves our understanding of how P. aeuruginosa integrates specific environmental conditions, such as carbon availability and surfactant stress, to regulate cellular aggregation and biofilm formation. With the biochemical and structural characterization of SiaA, initial data on the catalytic inhibition of SiaA, and the interaction between SiaA and SiaC, our study identifies promising targets for the development of biofilm-interference drugs to combat infections of this aggressive opportunistic pathogen.	[Poh, Wee-Han; Liang, Yang; Kjelleberg, Staffan; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Lin, Jianqing; Goh, Boon Chong; El Sahili, Abbas; Lescar, Julien] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Lin, Jianqing] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore, Singapore; [Colley, Brendan; Kjelleberg, Staffan] Univ New South Wales, Ctr Marine Sci & Innovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Mueller, Nicolai; Schleheck, David; Marquardt, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Chem, Constance, Germany; [Mueller, Nicolai; Schleheck, David; Marquardt, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Biol, Constance, Germany; [Goh, Boon Chong] Singapore MIT Alliance Res & Technol, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore; [El Sahili, Abbas; Liang, Yang; Kjelleberg, Staffan; Lescar, Julien; Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Rice, Scott A.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Klebensberger, Janosch] Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany; [Lin, Jianqing] Agcy Sci Technol & Res, Infect Dis Horizontal Technol Ctr, Singapore, Singapore; [Lin, Jianqing] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Colley, Brendan] Bio Mol Syst, Sydney, NSW, Australia; [Liang, Yang] Southern Univ Sci & Technol SUSTec, Sch Med, Shenzhen, Guangdong, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of New South Wales Sydney; University of Konstanz; University of Konstanz; Singapore-MIT Alliance for Research & Technology Centre (SMART); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Technology Sydney; University of Stuttgart; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Rice, SA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.; Lescar, J (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore.; Lescar, J; Rice, SA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Rice, SA (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia.; Klebensberger, J (corresponding author), Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany.	janosch.klebensberger@itb.uni-stuttgart.de; rscott@ntu.edu.sg; julien@ntu.edu.sg	Goh, Boon Chong/L-2516-2016; rice, scott/A-6084-2019	Goh, Boon Chong/0000-0002-0292-0922; rice, scott/0000-0002-9486-2343; LIN, JIANQING/0000-0003-4336-9003; El Sahili, Abbas/0000-0003-3973-686X; Klebensberger, Janosch/0000-0003-2740-3769	Federal Ministry of Education and Research in Germany [FKZ: 01DP17004]; Ministry of Trade and Industry in Singapore [SGP-PROG3-023. 2017]; Singapore Centre for Environmental Life Sciences Engineering; National Research Foundation Singapore; Ministry of Education; Nanyang Technological University; National University of Singapore, under its Research Centre of Excellence Programme; Ministry of Education [RG154/14]	Federal Ministry of Education and Research in Germany; Ministry of Trade and Industry in Singapore; Singapore Centre for Environmental Life Sciences Engineering; National Research Foundation Singapore(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University(Nanyang Technological University); National University of Singapore, under its Research Centre of Excellence Programme(National University of Singapore); Ministry of Education	The work of Janosch Klebensberger, Wee Han Poh, Julien Lescar, Jianqing Lin, Scott A. Rice were partially supported by a joint mobility grant funded by the Federal Ministry of Education and Research in Germany (FKZ: 01DP17004) and the Ministry of Trade and Industry in Singapore (SGP-PROG3-023. 2017). We acknowledge financial support from the Singapore Centre for Environmental Life Sciences Engineering, whose research is supported by the National Research Foundation Singapore, Ministry of Education, Nanyang Technological University and National University of Singapore, under its Research Centre of Excellence Programme as well as funding from the Ministry of Education (AcRF tier 1 grant RG154/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Baena I, 2019, ENVIRON MICROBIOL, V21, P3379, DOI 10.1111/1462-2920.14624; BAGHAL AF, 2013, FEMS MICROBIOL LETT, V343, P77, DOI DOI 10.1111/1574-6968.12132; Baker EH, 2006, P NUTR SOC, V65, P227, DOI 10.1079/PNS2006499; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Barker M, 2006, EUR RESPIR J, V27, P929, DOI 10.1183/09031936.06.00085105; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bradshaw N, 2017, ELIFE, V6, DOI 10.7554/eLife.26111; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Burrichter A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02792; Chen AI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004480; Chen GK, 2020, EMBO J, V39, DOI 10.15252/embj.2019103412; Chew SC, 2018, MBIO, V9, DOI 10.1128/mBio.00585-18; Chua SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10052; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Colley B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00179; Corona F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34741-9; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Debnath S, 2018, J BIOL CHEM, V293, P7993, DOI 10.1074/jbc.RA117.001213; Denger K, 2014, NATURE, V507, P114, DOI 10.1038/nature12947; Dworkin J, 2015, CURR OPIN MICROBIOL, V24, P47, DOI 10.1016/j.mib.2015.01.005; Fazzeli H, 2012, J RES MED SCI, V17, P332; Flemming HC, 2019, NAT REV MICROBIOL, V17, P247, DOI 10.1038/s41579-019-0158-9; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Fukuda H, 1996, BIOCHEM BIOPH RES CO, V220, P160, DOI 10.1006/bbrc.1996.0374; Gilbert P, 2002, ADV MICROB PHYSIOL, V46, P203, DOI 10.1016/S0065-2911(02)46005-5; Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; He K, 2014, TRENDS MICROBIOL, V22, P389, DOI 10.1016/j.tim.2014.04.004; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jagmann N, 2015, APPL MICROBIOL BIOT, V99, P8285, DOI 10.1007/s00253-015-6726-7; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Jones CJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003984; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Klebensberger J, 2006, ARCH MICROBIOL, V185, P417, DOI 10.1007/s00203-006-0111-y; Klebensberger J, 2009, ENVIRON MICROBIOL, V11, P3073, DOI 10.1111/j.1462-2920.2009.02012.x; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; LaBauve AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003889; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Laventie BJ, 2019, CELL HOST MICROBE, V25, P140, DOI 10.1016/j.chom.2018.11.008; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Letoffe S, 2014, MBIO, V5, DOI 10.1128/mBio.00944-13; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Liu QY, 2018, ENVIRON MICROBIOL, V20, P3927, DOI 10.1111/1462-2920.14332; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; MEYER TS, 1965, BIOCHIM BIOPHYS ACTA, V107, P144, DOI 10.1016/0304-4165(65)90403-4; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Moradali MF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00039; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nguyen M, 2016, ISME J, V10, P2978, DOI 10.1038/ismej.2016.76; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pawar V, 2015, ANTIMICROB AGENTS CH, V59, P4974, DOI 10.1128/AAC.00194-15; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pestrak MJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006842; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; Poh W-H, 2019, 674879V1 BIORXIV; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Ravichandran A, 2009, PROTEOMICS, V9, P2764, DOI 10.1002/pmic.200800655; Romero M, 2018, NUCLEIC ACIDS RES, V46, P6823, DOI 10.1093/nar/gky324; Romling U, 2005, ENVIRON MICROBIOL, V7, P1029, DOI 10.1111/j.1462-2920.2005.00780.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07; Schleheck D, 2000, APPL ENVIRON MICROB, V66, P1911, DOI 10.1128/AEM.66.5.1911-1916.2000; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Schmidt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056905; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tanoue K, 2013, BIOCHEMISTRY-US, V52, P5830, DOI 10.1021/bi4005649; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Valentini M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006354; Venkataraman A, 2014, ISME J, V8, P1210, DOI 10.1038/ismej.2013.232; Whiteson KL, 2014, ISME J, V8, P1247, DOI 10.1038/ismej.2013.229; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	113	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241019	10.1371/journal.pone.0241019	http://dx.doi.org/10.1371/journal.pone.0241019			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156827	Green Published, gold			2022-12-26	WOS:000591376400019
J	Gummadi, S; Kadiyala, MDM; Rao, KPC; Athanasiadis, I; Mulwa, R; Kilavi, M; Legesse, G; Amede, T				Gummadi, Sridhar; Kadiyala, M. D. M.; Rao, K. P. C.; Athanasiadis, Ioannis; Mulwa, Richard; Kilavi, Mary; Legesse, Gizachew; Amede, Tilahun			Simulating adaptation strategies to offset potential impacts of climate variability and change on maize yields in Embu County, Kenya	PLOS ONE			English	Article							MINIMUM TEMPERATURE TRENDS; CROP; MAXIMUM; AFRICA; EVAPOTRANSPIRATION; AGRICULTURE; SCENARIOS; SYSTEMS; EASTERN; MODELS	In this study, we assessed the possible impacts of climate variability and change on growth and performance of maize using multi-climate, multi-crop model approaches built on Agricultural Model Intercomparison and Improvement Project (AgMIP) protocols in five different agro-ecological zones (AEZs) of Embu County in Kenya and under different management systems. Adaptation strategies were developed that are locally relevant by identifying a set of technologies that help to offset potential impacts of climate change on maize yields. Impacts and adaptation options were evaluated using projections by 20 Coupled Model Intercomparison Project-Phase 5 (CMIP5) climate models under two representative concentration pathways (RCPs) 4.5 and 8.5. Two widely used crop simulation models, Agricultural Production Systems Simulator (APSIM) and Decision Support System for Agrotechnology Transfer (DSSAT) was used to simulate the potential impacts of climate change on maize. Results showed that 20 CMIP5 models are consistent in their projections of increased surface temperatures with different magnitude. Projections by HadGEM2-CC, HadGEM2-ES, and MIROC-ESM tend to be higher than the rest of 17 CMIP5 climate models under both emission scenarios. The projected increase in minimum temperature (Tmin) which ranged between 2.7 and 5.8 degrees C is higher than the increase in maximum temperature (Tmax) that varied between 2.2 and 4.8 degrees C by end century under RCP 8.5. Future projections in rainfall are less certain with high variability projections by GFDL-ESM2G, MIROC5, and NorESM1-M suggest 8 to 25% decline in rainfall, while CanESM2, IPSL-CM5A-MR and BNU-ESM suggested more than 85% increase in rainfall under RCP 8.5 by end of 21(st) century. Impacts of current and future climatic conditions on maize yields varied depending on the AEZs, soil type, crop management and climate change scenario. Impacts are largely negative in the low potential AEZs such as Lower Midlands (LM4 and LM5) compared with the high potential AEZs Upper Midlands (UM2 and UM3). However, impacts of climate change are largely positive across all AEZs and management conditions when CO2 fertilization is included. Using the differential impacts of climate change, a strategy to adapt maize cultivation to climate change in all the five AEZs was identified by consolidating those practices that contributed to increased yields under climate change. We consider this approach as more appropriate to identify operational adaptation strategies using readily available technologies that contribute positively under both current and future climatic conditions. This approach when adopted in strategic manner will also contribute to further strengthen the development of adaptation strategies at national and local levels. The methods and tools validated and applied in this assessment allowed estimating possible impacts of climate change and adaptation strategies which can provide valuable insights and guidance for adaptation planning.	[Gummadi, Sridhar; Rao, K. P. C.; Legesse, Gizachew; Amede, Tilahun] Int Crops Res Inst Semi Arid Trop, Addis Ababa, Ethiopia; [Kadiyala, M. D. M.] Acharya NG Ranga Agr Univ ANGRAU, Guntur, Andhra Pradesh, India; [Athanasiadis, Ioannis] Wageningen Univ, Gelderland, Netherlands; [Mulwa, Richard] Univ Nairobi, Ctr Adv Studies Environm Law & Policy CASELAP, Nairobi, Kenya; [Kilavi, Mary] Kenya Meteorol Dept, Nairobi, Kenya	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Acharya N. G. Ranga Agricultural University; Wageningen University & Research; University of Nairobi	Gummadi, S (corresponding author), Int Crops Res Inst Semi Arid Trop, Addis Ababa, Ethiopia.	sridhar.gummadi@irri.org	Athanasiadis, Ioannis N/F-6301-2010; Kadiyala, Dakshina Murthy/ADW-4340-2022	Athanasiadis, Ioannis N/0000-0003-2764-0078; Kadiyala, Dakshina Murthy/0000-0001-5468-5760; Legesse, Gizachew/0000-0003-4028-2455; Gummadi, Sridhar/0000-0001-9590-6806	CGIAR; Department of International Development; United States Department of Agriculture; International Crops Research Institute for the Semi-Arid Tropics; AgMIP project	CGIAR(CGIAR); Department of International Development; United States Department of Agriculture(United States Department of Agriculture (USDA)); International Crops Research Institute for the Semi-Arid Tropics; AgMIP project	This work was implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors. The Agricultural Model Intercomparison and Improvement Project (AgMIP) - The future of food and farming in Sub-Saharan Africa was funded by the Department of International Development, United States Department of Agriculture and implemented by Columbia University and International Crops Research Institute for the Semi-Arid Tropics. AgMIP project provided support in the form of salary for authors KPCR and SG during the period 2013-2015. AgMIP global team leaders developed the protocols for data collection and analysis, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgMIP, 2012, HDB METH PROC VERS 4; Ahmad A., 2015, HDB CLIMATE CHANGE A, P219, DOI DOI 10.1142/9781783265640_0019; Araya A, 2015, AGR FOREST METEOROL, V214, P252, DOI 10.1016/j.agrformet.2015.08.259; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Challinor AJ, 2013, AGR FOREST METEOROL, V170, P2, DOI 10.1016/j.agrformet.2012.09.007; Cline W.R, 2007, GLOBAL WARMING AGR; Cohen J. M., 1987, Drought and hunger in Africa: denying famine a future, P269; COHEN SJ, 1990, B AM METEOROL SOC, V71, P520, DOI 10.1175/1520-0477(1990)071<0520:BTGWIC>2.0.CO;2; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Dominguez-Faus R, 2013, ENVIRON SCI TECHNOL, V47, P6030, DOI 10.1021/es400435n; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Elshamy ME, 2008, HYDROL EARTH SYST SC, V5, P1407; Engelbrecht F, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085004; FAO, 2000, WORLD SOIL RESOURCES, V90; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; GATES WL, 1985, CLIMATIC CHANGE, V7, P267, DOI 10.1007/BF00144171; Hastenrath S, 2007, J CLIMATE, V20, P4628, DOI 10.1175/JCLI4238.1; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hoogenboom G, 2000, AGR FOREST METEOROL, V103, P137, DOI 10.1016/S0168-1923(00)00108-8; Hoogenboom G., 2015, DECIS SUPPORT SYST; Hutchinson CF, 1996, J ARID ENVIRON, V33, P519, DOI 10.1006/jare.1996.0087; IPCC: Intergovernmental Panel on Climate Change, 2014, CLIMATE CHANGE 2014; Jaetzold R., 2007, FARM MANAGEMENT HDB, VII, P573; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; KIM JW, 1984, MON WEATHER REV, V112, P2069, DOI 10.1175/1520-0493(1984)112<2069:TSPOCI>2.0.CO;2; King AD, 2020, NAT CLIM CHANGE, V10, P177, DOI 10.1038/s41558-020-0718-z; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; LAMB PJ, 1987, B AM METEOROL SOC, V68, P1116, DOI 10.1175/1520-0477(1987)068<1116:OTDORC>2.0.CO;2; Liebmann B, 2014, J CLIMATE, V27, P8630, DOI 10.1175/JCLI-D-13-00714.1; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; Mavromatis T, 2011, THEOR APPL CLIMATOL, V104, P13, DOI 10.1007/s00704-010-0320-9; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mote P., 2009, WASHINGTON CLIMATE C; Mulwa R, 2016, CLIM RES, V67, P87, DOI 10.3354/cr01357; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Olesen JE, 2012, FOOD ADDIT CONTAM A, V29, P1527, DOI 10.1080/19440049.2012.712060; Omamo S. W., 2006, 150 IFPRI, DOI [10.2499/9780896291584RR150, DOI 10.2499/9780896291584RR150]; Omoyo NN., 2015, AGR FOOD SECUR, V4, P1, DOI [10.1186/s40066-015-0028-2, DOI 10.1186/S40066-015-0028-2]; Otieno VO, 2013, CLIM DYNAM, V41, P2099, DOI 10.1007/s00382-013-1694-z; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Petherick A, 2012, NAT CLIM CHANGE, V2, P228, DOI 10.1038/nclimate1472; Recha CW, 2008, ASIAN J APPL SCI, P128; Robinson PJ, 1989, STRATEGIES DEV CLIMA, P73; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Rowell DP, 2015, J CLIMATE, V28, P9768, DOI 10.1175/JCLI-D-15-0140.1; Ruane AC, 2015, HDB CLIMATE CHANGE A, P45, DOI [10.1142/9781783265640_0003, DOI 10.1142/9781783265640_0003]; Sacks WJ, 2011, AGR FOREST METEOROL, V151, P882, DOI 10.1016/j.agrformet.2011.02.010; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Sharafati A, 2020, THEOR APPL CLIMATOL, V139, P389, DOI 10.1007/s00704-019-02979-6; Shisanya CA., 1990, J E AFRICA RESOURCE, V20, P127; Sombroek W. G., 1982, Exploratory soil map and agro-climatic zone map of Kenya, 1980, scale 1:1,000,000.; Tabari H, 2011, AGR FOREST METEOROL, V151, P128, DOI 10.1016/j.agrformet.2010.09.009; Taylor K.E., 2009, SUMMARY CMIP5 EXPT D; Thornton PK, 2011, PHILOS T R SOC A, V369, P117, DOI 10.1098/rsta.2010.0246; Tokatlidis IS, 2013, AGRON SUSTAIN DEV, V33, P63, DOI 10.1007/s13593-012-0108-7; Trzaska S., 2014, REV DOWNSCALING METH, DOI DOI 10.4236/OJOG.2016.613098; Turner NC, 2013, AGR SYST, V121, P53, DOI 10.1016/j.agsy.2013.06.002; UNDP (United Nations Development Programme), 2006, HUMAN DEV REPORT 200; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wilby RL, 2009, INT J CLIMATOL, V29, P1193, DOI 10.1002/joc.1839; Wilby RL, 2004, GUIDELINES USE CLIMA, P27; Yang XL, 2014, HOLOCENE, V24, P1657, DOI 10.1177/0959683614551222; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60; Zhang X, 2004, RCLIMDEX USER MANUAL, P22	73	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241147	10.1371/journal.pone.0241147	http://dx.doi.org/10.1371/journal.pone.0241147			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151967	Green Published, gold			2022-12-26	WOS:000591376200082
J	Yao, TY; Sweeney, E; Nagorski, J; Shulman, JM; Allen, GI				Yao, Tianyi; Sweeney, Elizabeth; Nagorski, John; Shulman, Joshua M.; Allen, Genevera I.			Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score	PLOS ONE			English	Article							RUSH MEMORY; RELIGIOUS ORDERS; EPSILON-4 ALLELE; AD PATHOLOGY; RESERVE; DEMENTIA; NEUROPATHOLOGY; IMPAIRMENT; DIAGNOSIS; RISK	Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understand and study CR, we develop the Alzheimer's Disease Cognitive Resilience Score (AD-CR Score), which we define as the difference between the observed and expected cognition given the observed level of AD pathology. Unlike other definitions of CR, our AD-CR Score is a fully non-parametric, stand-alone, individual-level quantification of CR that is derived independently of other factors or proxy variables. Using data from two ongoing, longitudinal cohort studies of aging, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), we validate our AD-CR Score by showing strong associations with known factors related to CR such as baseline and longitudinal cognition, non AD-related pathology, education, personality, APOE, parkinsonism, depression, and life activities. Even though the proposed AD-CR Score cannot be directly calculated during an individual's lifetime because it uses postmortem pathology, we also develop a machine learning framework that achieves promising results in terms of predicting whether an individual will have an extremely high or low AD-CR Score using only measures available during the lifetime. Given this, our AD-CR Score can be used for further investigations into mechanisms of CR, and potentially for subject stratification prior to clinical trials of personalized therapies.	[Yao, Tianyi; Nagorski, John; Allen, Genevera I.] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Sweeney, Elizabeth] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shulman, Joshua M.; Allen, Genevera I.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Allen, Genevera I.] Rice Univ, Dept Elect & Comp Engn, POB 1892, Houston, TX 77251 USA; [Yao, Tianyi; Allen, Genevera I.] Rice Univ, Dept Comp Sci, Houston, TX USA	Rice University; Cornell University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Rice University	Yao, TY (corresponding author), Rice Univ, Dept Stat, Houston, TX 77251 USA.	tianyi.yao@rice.edu			NSF [DMS-1264058, DMS-1554821, NeuroNex-1707400]; Rice Academy; NIH [5T32CA09652010]; NIH/NIA [R01AG053960, R01AG050631, R01AG057339, U01AG046161, U01AG061357]; Huffington Foundation; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NIA [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]; Illinois Department of Public Health; Translational Genomics Research Institute	NSF(National Science Foundation (NSF)); Rice Academy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Huffington Foundation; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Translational Genomics Research Institute	T.Y. and G.I.A. acknowledge support from NSF DMS-1264058, NSF DMS-1554821, and NSF NeuroNex-1707400. E.S. acknowledges support from Rice Academy Postdoctoral Fellowship. J.N. was supported in this work by the NIH Training Award in Biostatistics for Cancer Research Award 5T32CA09652010. J.M.S. was additionally supported by NIH/NIA grants (R01AG053960, R01AG050631, R01AG057339, U01AG046161, U01AG061357), Huffington Foundation, Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, and a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, NEUROBIOL AGING, V18, pS1; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 1997, NEUROLOGY, V49, P1580, DOI 10.1212/WNL.49.6.1580; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Boyle PA, 2010, NEUROEPIDEMIOLOGY, V34, P43, DOI 10.1159/000256662; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Geerlings MI, 1999, PSYCHOL MED, V29, P1219, DOI 10.1017/S0033291799008867; Gu C, 2013, SPRINGER SER STAT, V297, P1, DOI 10.1007/978-1-4614-5369-7; Hensley K, 2011, J ALZHEIMERS DIS, V24, P767, DOI 10.3233/JAD-2011-101995; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Lawton MP., 1970, NURS RES, V19, P278, DOI [10.1212/01.WNL.0000287431.88658.8b, DOI 10.1097/00006199-197005000-00029]; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388; Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Reed BR, 2010, BRAIN, V133, P2196, DOI 10.1093/brain/awq154; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Schmalensee R, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.1.103; Schneider JA, 2005, STROKE, V36, P954, DOI 10.1161/01.STR.0000160747.27470.2a; Schneider JA, 2003, NEUROLOGY, V60, P1082, DOI 10.1212/01.WNL.0000055863.87435.B2; Schneider JA, 2007, ANN NEUROL, V62, P59, DOI 10.1002/ana.21142; Serra L, 2015, NEUROBIOL AGING, V36, P592, DOI 10.1016/j.neurobiolaging.2014.10.010; Stekhoven D.J, 2013, MISSFOREST NONPARAME; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Vance DE, 2006, ACT ADAPT AGING, V30, P61, DOI 10.1300/J016v30n03_04; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Wilson RS, 2007, PSYCHOSOM MED, V69, P47, DOI 10.1097/01.psy.0000250264.25017.21; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Wilson RS, 2003, AM J EPIDEMIOL, V158, P827, DOI 10.1093/aje/kwg224; Yu L, 2015, NEUROPSYCHOLOGY, V29, P335, DOI 10.1037/neu0000159; Zahodne LB, 2015, NEUROPSYCHOLOGIA, V77, P260, DOI 10.1016/j.neuropsychologia.2015.09.009	55	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241707	10.1371/journal.pone.0241707	http://dx.doi.org/10.1371/journal.pone.0241707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33152028	Green Published, gold			2022-12-26	WOS:000591376200107
J	Valenzuela, MV; Domenech, M; Mateos-Martinez, P; Gonzalez-Camacho, F; de la Campa, AG; Garcia, MT				Valenzuela, Myriam V.; Domenech, Mirian; Mateos-Martinez, Patricia; Gonzalez-Camacho, Fernando; de la Campa, Adela G.; Teresa Garcia, Maria			Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; TOPOLOGY-REACTING GENE; BIOFILM FORMATION; ANTIMICROBIAL RESISTANCE; SEROTYPE REPLACEMENT; VITRO; LEVOFLOXACIN; MOXIFLOXACIN; MANAGEMENT; CIPROFLOXACIN	The DNA topoisomerase complement of Streptococcus pneumoniae is constituted by two type II enzymes (topoisomerase IV and gyrase), and a single type I enzyme (topoisomerase I). These enzymes maintain the DNA topology, which is essential for replication and transcription. While fluoroquinolones target the type II enzymes, seconeolitsine, a new antimicrobial agent, targets topoisomerase I. We compared for the first time the in vitro effect of inhibition of topoisomerase I by seconeolitsine and of the type II topoisomerases by the fluoroquinolones levofloxacin and moxifloxacin. We used three isogenic non-encapsulated strains and five non-vaccine serotypes isolates belonging to two circulating pneumococcal clones, ST63(8) (2 strains) and ST156(9V) (3 strains). Each group contained strains with diverse susceptibility to fluoroquinolones. Minimal inhibitory concentrations, killing curves and postantibiotic effects were determined. Seconeolitsine demonstrated the fastest and highest bactericidal activity against planktonic bacteria and biofilms. When fluoroquinolone-susceptible planktonic bacteria were considered, seconeolitsine induced postantibiotic effects (1.00-1.87 h) similar than levofloxacin (1.00-2.22 h), but longer than moxifloxacin (0.39-1.71 h). The same effect was observed in sessile bacteria forming biofilms. Seconeolitsine induced postantibiotic effects (0.84-2.31 h) that were similar to those of levofloxacin (0.99-3.32 h) but longer than those of moxifloxacin (0.89-1.91 h). The greatest effect was observed in the viability and adherence of bacteria in the postantibiotic phase. Seconeolitsine greatly reduced the thickness of the biofilms formed in comparison with fluoroquinolones: 2.91 +/- 0.43 mu m (seconeolitsine), 7.18 +/- 0.58 mu m (levofloxacin), 17.08 +/- 1.02 mu m (moxifloxacin). When fluoroquinolone-resistant bacteria were considered, postantibiotic effects induced by levofloxacin and moxifloxacin, but not by seconeolitsine, were shorter, decreasing up to 5-fold (levofloxacin) or 2-fold (moxifloxacin) in planktonic cells, and up to 1.7 (levofloxacin) or 1.4-fold (moxifloxacin) during biofilm formation. Therefore, topoisomerase I inhibitors could be an alternative for the treatment of pneumococcal diseases, including those caused by fluoroquinolone-resistant isolates.	[Valenzuela, Myriam V.; Mateos-Martinez, Patricia; Teresa Garcia, Maria] Univ Complutense, Dept Genet, Unidad Microbiol Fisiol & Microbiol, Madrid, Spain; [Domenech, Mirian; Gonzalez-Camacho, Fernando] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Neumococos, Madrid, Spain; [de la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Genet Bacteriana, Madrid, Spain; [de la Campa, Adela G.] CSIC, Madrid, Spain	Complutense University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC)	Garcia, MT (corresponding author), Univ Complutense, Dept Genet, Unidad Microbiol Fisiol & Microbiol, Madrid, Spain.; de la Campa, AG (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Genet Bacteriana, Madrid, Spain.; de la Campa, AG (corresponding author), CSIC, Madrid, Spain.	agcampa@isciii.es; mariat16@ucm.es	González-Camacho, Fernando/P-1610-2014; Domenech, Mirian/G-2561-2018; de la Campa, Adela/K-1654-2014	Domenech, Mirian/0000-0002-0942-8180; Gonzalez-Camacho, Fernando/0000-0003-3175-9004; Mateos-Martinez, Patricia/0000-0001-9293-9100; de la Campa, Adela/0000-0002-3598-2548	Plan Nacional de I+D+I of the Ministry of Economy and Competitiveness [BIO2017-82951-R]	Plan Nacional de I+D+I of the Ministry of Economy and Competitiveness	This study was supported by grant BIO2017-82951-R from Plan Nacional de I+D+I of the Ministry of Economy and Competitiveness (to AGC).	Adam HJ, 2009, INT J ANTIMICROB AG, V34, P82, DOI 10.1016/j.ijantimicag.2009.02.002; Albertson TE, 2010, INT J CLIN PRACT, V64, P378, DOI 10.1111/j.1742-1241.2009.02239.x; [Anonymous], 2017, M100S27 CLIN LAB STA; Appelbaum PC, 2000, CLIN INFECT DIS, V31, pS29, DOI 10.1086/314057; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; Balsalobre L, 2011, ANTIMICROB AGENTS CH, V55, P1097, DOI 10.1128/AAC.00783-10; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boswell FJ, 1999, J ANTIMICROB CHEMOTH, V43, P43, DOI 10.1093/jac/43.suppl_2.43; Chang B, 2015, J CLIN MICROBIOL, V53, P3318, DOI 10.1128/JCM.01222-15; Chao YS, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00194; Cheng BK, 2007, J ANTIMICROB CHEMOTH, V59, P640, DOI 10.1093/jac/dkl556; Cremades R, 2011, J ANTIMICROB CHEMOTH, V66, P2281, DOI 10.1093/jac/dkr281; Crook DW, 2004, PNEUMOCCOCUS, P136; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; de los Rios A, 2004, FEMS MICROBIOL ECOL, V50, P143, DOI 10.1016/j.femsec.2004.06.010; del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016; Domenech A, 2014, ANTIMICROB AGENTS CH, V58, P2393, DOI 10.1128/AAC.02669-13; Domenech M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01992-16; Dorman Charles J, 2016, Biophys Rev, V8, P89, DOI 10.1007/s12551-016-0238-2; editorial Journal, 2014, NETW SECUR, V7, P1; Eisenstein BI, 2004, EXPERT OPIN INV DRUG, V13, P1159, DOI 10.1517/13543784.13.9.1159; Eliopoulos GM, 1999, DRUGS, V58, P23, DOI 10.2165/00003495-199958002-00005; Ferrandiz MJ, 2016, NUCLEIC ACIDS RES, V44, P7292, DOI 10.1093/nar/gkw602; Ferrandiz MJ, 2010, NUCLEIC ACIDS RES, V38, P3570, DOI 10.1093/nar/gkq106; Fliegauf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059925; Garcia MT, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00737-19; Garcia MT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01659; Garcia Y, 1998, Rev Esp Quimioter, V11, P157; Hamilos DL, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0657-x; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hoshi S, 2008, ANTIMICROB AGENTS CH, V52, P2970, DOI 10.1128/AAC.01466-07; Ip M, 2007, ANTIMICROB AGENTS CH, V51, P2192, DOI 10.1128/AAC.00139-07; Janoir C, 1996, ANTIMICROB AGENTS CH, V40, P2760, DOI 10.1128/AAC.40.12.2760; Jones RN, 2000, CLIN INFECT DIS, V31, pS16, DOI 10.1086/314054; Keller LE, 2016, MBIO, V7, DOI 10.1128/mBio.01792-15; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lister PD, 2001, J ANTIMICROB CHEMOTH, V47, P811, DOI 10.1093/jac/47.6.811; Lu CY, 2016, PEDIATR NEONATOL, V57, P363, DOI 10.1016/j.pedneo.2015.08.012; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Mulholland K, 2012, LANCET, V379, P1387, DOI 10.1016/S0140-6736(12)60588-1; Munoz R, 1996, ANTIMICROB AGENTS CH, V40, P2252, DOI 10.1128/AAC.40.10.2252; Murrah KA, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu011; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; ODENHOLTTORNQVIST I, 1993, J ANTIMICROB CHEMOTH, V31, P881, DOI 10.1093/jac/31.6.881; Olsen KM, 2006, ANTIMICROB AGENTS CH, V50, P210, DOI 10.1128/AAC.50.1.210-219.2006; Pankuch GA, 2006, ANTIMICROB AGENTS CH, V50, P3956, DOI 10.1128/AAC.00724-06; Peng LC, 2015, INT J CLIN EXP PATHO, V8, P5217; Riedel S, 2007, EUR J CLIN MICROBIOL, V26, P485, DOI 10.1007/s10096-007-0321-5; Roveta S, 2007, INT J ANTIMICROB AG, V30, P415, DOI 10.1016/j.ijantimicag.2007.06.029; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Shi CX, 2018, J VET SCI, V19, P808, DOI 10.4142/jvs.2018.19.6.808; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Spangler SK, 2000, ANTIMICROB AGENTS CH, V44, P186, DOI 10.1128/AAC.44.1.186-189.2000; Spangler SK, 1998, ANTIMICROB AGENTS CH, V42, P1253, DOI 10.1128/AAC.42.5.1253; Garcia MT, 2011, J BIOL CHEM, V286, P6402, DOI 10.1074/jbc.M110.148148; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; Tse-Dinh YC, 2009, NUCLEIC ACIDS RES, V37, P731, DOI 10.1093/nar/gkn936; Vandevelde NM, 2014, ANTIMICROB AGENTS CH, V58, P1348, DOI 10.1128/AAC.01858-13; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Yan R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051116; YANG Y, 2016, EVID BASED COMPL ALT, DOI DOI 10.1155/2016/8163150	66	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241780	10.1371/journal.pone.0241780	http://dx.doi.org/10.1371/journal.pone.0241780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141832	Green Published, gold, Green Accepted			2022-12-26	WOS:000588376700026
J	Bueno, MM; Leles, PSD; Abreu, JFG; dos Santos, JJS; de Carvalho, DF				Bueno, Mateus Marques; dos Santos Leles, Paulo Sergio; Goncalves Abreu, Joao Felicio; Santana dos Santos, Jaqueline Jesus; de Carvalho, Daniel Fonseca			Water requirement and growth indicators of forest tree species seedlings produced with automated irrigation management	PLOS ONE			English	Article							SCHIZOLOBIUM-PARAHYBA; DEFICIT IRRIGATION; RESTORATION; SUBSTRATE; LETTUCE	The lack of information regarding the water requirement of tree species results in water waste in the seedlings production in nurseries. Water requirement, the growth plant factors and water efficiencies for height and diameter were determined for Schizolobium parahyba (Vell.) Blake, Cytharexylum myrianthum Cham. and Ceiba speciosa Ravenna seedlings, under automated irrigation management and greenhouse conditions, located at 22(o)45'53" S and 43(o)41'50" W. We used sewage sludge biosolids as substrate in the seedling phase (280 cm(-3) tube), and sandy soil material in the initial pot growth phase (18 dm(-3) pot). In the seedlings phase, four water replacement levels were applied to the substrate, by drip irrigation, corresponding to average replacement ranging from 40 (V1) to 100% (V4) of the species water requirement. Seedlings developed properly and 80 days after emergence, S. parahyba, C. myrianthum and C. speciosa seedlings received, respectively, 2.40, 1.08 and 0.85 L per plant, for V4. After growth phase (230 DAE), the total water volumes were, respectively, 70.0, 50.3 and 52.7 L per plant. Under adequate water supply, there were rapid recovery and growth of the species, even for the seedlings which showed different height and diameter in the tube phase. The growth plant factors values found were below 0.5 for all species indicating low sensitivity to growth, both in height and in diameter, in response to water deficit. Water efficiency indicators point to distinct trends between the two phases, and C. speciosa has higher values of water efficiencies for height (80.7 and 17.0 cm L-1) and diameter (2.1 and 0.5 mm L-1) in both phases.	[Bueno, Mateus Marques] Fed Inst Educ Sci & Technol Minas Gerais IFMG, Dept Agron, Sao Joao Evangelista, MG, Brazil; [dos Santos Leles, Paulo Sergio] Fed Rural Univ Rio de Janeiro UFRRJ, Forest Inst, Dept Forestry, Rio De Janeiro, Brazil; [Goncalves Abreu, Joao Felicio; Santana dos Santos, Jaqueline Jesus; de Carvalho, Daniel Fonseca] Fed Rural Univ Rio de Janeiro UFRRJ, Inst Technol, Dept Engn, Rio De Janeiro, Brazil	Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG)	Bueno, MM (corresponding author), Fed Inst Educ Sci & Technol Minas Gerais IFMG, Dept Agron, Sao Joao Evangelista, MG, Brazil.	mateusjuruaia@gmail.com		Bueno, Mateus/0000-0002-9585-6869	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/202.909/2018]; Coordination for the Improvement of Higher Level Personnel (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/, grant number E-26/202.909/2018) (DFC).; We thank the Coordination for the Improvement of Higher Level Personnel (CAPES)-Finance Code 001, and the Federal Rural University of Rio de Janeiro, specifically the PPGACS, GPASSA and LAPER.	Alonso JM, 2018, CERNE, V24, P420, DOI 10.1590/01047760201824042568; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Artur AG, 2007, PESQUI AGROPECU BRAS, V42, P843, DOI 10.1590/S0100-204X2007000600011; Campoe OC, 2014, FOREST ECOL MANAG, V313, P233, DOI 10.1016/j.foreco.2013.11.016; Caron BO, 2010, CIENC FLOREST, V20, P683, DOI 10.5902/198050982427; Carvalho P.E.R., 2014, ESPECIES ARBOREAS BR, V5th; Contin DR, 2014, TREES-STRUCT FUNCT, V28, P1705, DOI 10.1007/s00468-014-1079-x; dos Santos JFC, 2019, SCI TOTAL ENVIRON, V650, P809, DOI 10.1016/j.scitotenv.2018.09.016; de Carvalho DF, 2016, CIENC RURAL, V46, P1145, DOI 10.1590/0103-8478cr20150363; Dias G.C.O., 2013, REV BRASILEIRA FRUTI, V35, P40; Doorenbos J., 1979, YIELD RESPONSE WATER; Duarte D. M., 2016, Floresta, V46, P405, DOI 10.5380/rf.v46i3.39529; Dumroese RK, 2005, CAN J FOREST RES, V35, P2961, DOI 10.1139/X05-226; Garg NK, 2014, AGR WATER MANAGE, V137, P68, DOI 10.1016/j.agwat.2014.02.008; Ghazoul J, 2017, ANNU REV ENV RESOUR, V42, P161, DOI 10.1146/annurev-environ-102016-060736; Gomes DP, 2017, ACTA SCI-AGRON, V39, P201, DOI 10.4025/actasciagron.v39i2.32547; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Keifer JF, 2019, REV BRAS ENG AGR AMB, V23, P733, DOI 10.1590/1807-1929/agriambi.v23n10p733-740; Klippel VH, 2015, REV ARVORE, V39, P69, DOI 10.1590/0100-67622015000100007; de Morais VTM, 2019, ECOL INDIC, V98, P854, DOI 10.1016/j.ecolind.2018.12.004; de Abreu AHM, 2017, CIENC FLOREST, V27, P1179, DOI 10.5902/1980509830300; Medici LO, 2010, SCI AGR, V67, P727, DOI 10.1590/S0103-90162010000600016; Memoriam In, 2018, ALI REP, V40, P1, DOI DOI 10.1109/LED.2018.2880303; Bezerra ACM, 2019, SCI AGR, V76, P179, DOI [10.1590/1678-992X-2017-0163, 10.1590/1678-992x-2017-0163]; Monteiro EB, 2016, REV BRAS ENG AGR AMB, V20, P709, DOI 10.1590/1807-1929/agriambi.v20n8p709-715; Panigrahi P, 2012, AGR WATER MANAGE, V104, P79, DOI 10.1016/j.agwat.2011.11.018; Pertassek T., 2015, HYPROP FIT SOFTW, P66; de Abreu RCR, 2014, ACTA OECOL, V54, P57, DOI 10.1016/j.actao.2013.03.013; Sansevero JBB, 2018, RESTOR ECOL, V26, P997, DOI 10.1111/rec.12662; Schindler U, 1980, PLANT CONSTRUCTION F, P1; Schwartz G, 2017, FOREST ECOL MANAG, V390, P166, DOI 10.1016/j.foreco.2017.01.031; Souza Junior CN, 2016, SEMENTES MUDAS GUIA; Souza MTP, 2020, FOREST ECOLOGY MANAG, V462; Valenca DD, 2018, SCI AGR, V75, P52, DOI [10.1590/1678-992x-2016-0331, 10.1590/1678-992X-2016-0331]	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0238677	10.1371/journal.pone.0238677	http://dx.doi.org/10.1371/journal.pone.0238677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137134	Green Submitted, Green Published, gold			2022-12-26	WOS:000588375500016
J	Tehrani, ZR; Saadat, S; Saleh, E; Ouyang, X; Constantine, N; DeVico, AL; Harris, AD; Lewis, GK; Kottilil, S; Sajadi, MM				Tehrani, Zahra Rikhtegaran; Saadat, Saman; Saleh, Ebtehal; Ouyang, Xin; Constantine, Niel; DeVico, Anthony L.; Harris, Anthony D.; Lewis, George K.; Kottilil, Shyam; Sajadi, Mohammad M.			Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays	PLOS ONE			English	Article							ANTIBODIES	There is an urgent need for an accurate antibody test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have developed 3 ELISA methods, trimer spike IgA, trimer spike IgG, and nucleocapsid IgG, for detecting anti-SARS-CoV-2 antibodies. We evaluated their performance along with four commercial ELISAs, EDI (TM) Novel Coronavirus COVID-19 ELISA IgG and IgM, Euroimmun Anti-SARS-CoV-2 ELISA IgG and IgA, and one lateral flow assay, DPP (R) COVID-19 IgM/IgG System (Chembio). Both sensitivity and specificity were evaluated and the probable causes of false-positive reactions were determined. The assays were evaluated using 300 pre-epidemic samples and 100 PCR-confirmed COVID-19 samples. The sensitivities and specificities of the assays were as follows: 90%/100% (in-house trimer spike IgA), 90%/99.3% (in-house trimer spike IgG), 89%/98.3% (in-house nucleocapsid IgG), 73.7%/100% (EDI nucleocapsid IgM), 84.5%/95.1% (EDI nucleocapsid IgG), 95%/93.7% (Euroimmun S1 IgA), 82.8%/99.7% (Euroimmun S1 IgG), 82.0%/91.7% (Chembio nucleocapsid IgM), 92%/93.3% (Chembio nucleocapsid IgG). The presumed causes of false positive results from pre-epidemic samples in commercial and in-house assays were mixed. In some cases, assays lacked reproducibility. In other cases, reactivity was abrogated by competitive inhibition (spiking the sample with the same antigen that was used for coating ELISAs prior to performing the assay), suggesting positive reaction could be attributed to the presence of antibodies against these antigens. In other cases, reactivity was consistently detected but not abrogated by the spiking, suggesting positive reaction was not attributed to the presence of antibodies against these antigens. Overall, there was wide variability in assay performance using our samples, with in-house tests exhibiting the highest combined sensitivity and specificity. The causes of "false positivity" in pre-epidemic samples may be due to plasma antibodies apparently reacting with the corresponding antigen, or spurious reactivity may be directed against non-specific components in the assay system. Identification of these targets will be essential to improving assay performance.	[Tehrani, Zahra Rikhtegaran; Saadat, Saman; Ouyang, Xin; Kottilil, Shyam; Sajadi, Mohammad M.] Univ Maryland, Inst Human Virol, Div Clin Care & Res, Baltimore, MD 21201 USA; [Tehrani, Zahra Rikhtegaran; Saadat, Saman; DeVico, Anthony L.; Lewis, George K.; Sajadi, Mohammad M.] Univ Maryland, Inst Human Virol, Div Vaccine Res, Sch Med, Baltimore, MD 21201 USA; [Saleh, Ebtehal; Constantine, Niel] Univ Maryland, Sch Med, Div Epidemiol & Prevent, Inst Human Virol, Baltimore, MD 21201 USA; [Harris, Anthony D.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med Baltimore, Baltimore, MD 21201 USA; [Sajadi, Mohammad M.] Baltimore VA Med Ctr, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Sajadi, MM (corresponding author), Univ Maryland, Inst Human Virol, Div Clin Care & Res, Baltimore, MD 21201 USA.; Sajadi, MM (corresponding author), Univ Maryland, Inst Human Virol, Div Vaccine Res, Sch Med, Baltimore, MD 21201 USA.; Sajadi, MM (corresponding author), Baltimore VA Med Ctr, Dept Med, Baltimore, MD 21201 USA.	msajadi@ihv.umaryland.edu	Kottilil, Shyam/ABF-7605-2021	Saadat, Saman/0000-0001-9851-7638; , Mohammad/0000-0001-7798-3605	National Institute of Allergy and Infectious Diseases [R01AI147870-01A1]; U.S. Department of Veterans Affairs Merit Award [IBX004525-01A2, IBX005469A]; Centers for Disease Control and Prevention (US) [U01CK000556-02-01]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Centers for Disease Control and Prevention (US)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Author MMS was supported by National Institute of Allergy and Infectious Diseases R01AI147870-01A1 and by the U.S. Department of Veterans Affairs Merit Award IBX004525-01A2 and IBX005469A. Author AH was supported by Centers for Disease Control and Prevention (US) U01CK000556-02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TEST SCREEN OUTBR RE; Babiker A, 2020, AM J CLIN PATHOL, V153, P706, DOI [10.1093/AJCP/AQAA052, 10.1093/ajcp/aqaa052]; Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468; Binley JM, 2000, J INFECT DIS, V182, P945, DOI 10.1086/315774; C.Morishima, 2020, medRxiv, DOI 10.1101/2020.04.20.20071423; CDC, 2020, INTERIM GUIDELINES C; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Food and Drug Administration (US), 2020, FDA CLEARANCE K19200; Grzelak L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3103; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Lassauniere R., 2020, EVALUATION 9 COMMERC, DOI DOI 10.1101/2020.04.09.20056325V1; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lou B, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00763-2020; Nicol T, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104511; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489; Salazar Eric, 2020, bioRxiv, DOI 10.1101/2020.06.08.138990; Schilling Paul, 2020, ESTIMATING CLIN AGRE; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Woo PCY, 2004, CLIN DIAGN LAB IMMUN, V11, P665, DOI 10.1128/CDLI.11.4.665-668.2004; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zeng WH, 2020, BIOCHEM BIOPH RES CO, V527, P618, DOI 10.1016/j.bbrc.2020.04.136	24	42	42	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0237828	10.1371/journal.pone.0237828	http://dx.doi.org/10.1371/journal.pone.0237828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137138	Green Published, gold			2022-12-26	WOS:000588375500013
J	Abdullah, A; Akhand, SS; Paez, JSP; Brown, W; Pan, L; Libring, S; Badamy, M; Dykuizen, E; Solorio, L; Tao, WA; Wendt, MK				Abdullah, Ammara; Akhand, Saeed Salehin; Paez, Juan Sebastian Paez; Brown, Wells; Pan, Li; Libring, Sarah; Badamy, Michael; Dykuizen, Emily; Solorio, Luis; Tao, W. Andy; Wendt, Michael K.			Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CELL MIGRATION; ACTIVATION; EXPRESSION; FAMILY; COMBINATION; BEVACIZUMAB; INHIBITION; ERLOTINIB; OUTGROWTH	Human epidermal growth factor receptor 2 (HER2)-amplified breast cancers are treated using targeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor recurrence of metastatic disease. Herein, we conducted gene expression analyses of HER2 kinase inhibitor-resistant cell lines as compared to their drug-sensitive counterparts. These data demonstrate the induction of epithelial-mesenchymal transition (EMT), which included enhanced expression of fibroblast growth factor receptor 1 (FGFR1) and axonal guidance molecules known as neuropilins (NRPs). Immunoprecipitation of FGFR1 coupled with mass spectroscopy indicated that FGFR1 forms a physical complex with NRPs, which is enhanced upon induction of EMT. Confocal imaging revealed that FGFR1 and NRP1 predominantly interact throughout the cytoplasm. Along these lines, short hairpin RNA-mediated depletion of NRP1, but not the use of NRP1-blocking antibodies, inhibited FGFR signaling and reduced tumor cell growth in vitro and in vivo. Our results further indicate that NRP1 upregulation during EMT is mediated via binding of the chromatin reader protein, bromodomain containing 4 (BRD4) in the NRP1 proximal promoter region. Pharmacological inhibition of BRD4 decreased NRP1 expression and ablated FGF-mediated tumor cell growth. Overall, our studies indicate that NRPs facilitate aberrant growth factor signaling during EMT-associated drug resistance and metastasis. Pharmacological combination of epigenetic modulators with FGFR-targeted kinase inhibitors may provide improved outcomes for breast cancer patients with drug-resistant metastatic disease.	[Abdullah, Ammara; Akhand, Saeed Salehin; Paez, Juan Sebastian Paez; Brown, Wells; Pan, Li; Badamy, Michael; Dykuizen, Emily; Tao, W. Andy; Wendt, Michael K.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Libring, Sarah; Solorio, Luis] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Dykuizen, Emily; Solorio, Luis; Tao, W. Andy; Wendt, Michael K.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wendt, MK (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.; Wendt, MK (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	mwendt@purdue.edu		dykhuizen, emily/0000-0003-3072-1469; Libring, Sarah/0000-0001-8336-5862	American Cancer Society Research Scholar Grant [RSG-CSM-130259]; National Cancer Institute [R01CA207751]; METavivor Translational Research Award; Purdue Center for Cancer Research via its NIH NCI [P30CA023168]; NIH-funded Indiana Clinical and Translational Sciences Institute	American Cancer Society Research Scholar Grant(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); METavivor Translational Research Award; Purdue Center for Cancer Research via its NIH NCI; NIH-funded Indiana Clinical and Translational Sciences Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an American Cancer Society Research Scholar Grant (RSG-CSM-130259), the National Cancer Institute (R01CA207751), and a METavivor Translational Research Award, to M. K.W. We also acknowledge the support of the Purdue Center for Cancer Research via its NIH NCI grant (P30CA023168). We thank Genentech for supplying the antiNRP1 antibody YW107.4. We also acknowledge the personnel for the use of the facilities within the Bindley Bioscience Center, a core facility of the NIH-funded Indiana Clinical and Translational Sciences Institute.	Ali R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1034-7; Azuma K, 2014, ONCOTARGET, V5, P5908, DOI 10.18632/oncotarget.1866; Azuma K, 2011, BIOCHEM BIOPH RES CO, V407, P219, DOI 10.1016/j.bbrc.2011.03.002; Benedetti R, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810116; Brown WS, 2016, ONCOTARGET, V7, P83424, DOI 10.18632/oncotarget.13117; Brown WS, 2016, MOL CANCER THER, V15, P2096, DOI 10.1158/1535-7163.MCT-16-0136; Bumbaca D, 2012, BRIT J PHARMACOL, V166, P368, DOI 10.1111/j.1476-5381.2011.01777.x; Cagnoni G, 2014, ONCOGENE, V33, P4795, DOI 10.1038/onc.2013.474; Chen CX, 2016, MOL MED REP, V13, P188, DOI 10.3892/mmr.2015.4556; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chua V, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809081; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Dickler MN, 2008, CLIN CANCER RES, V14, P7878, DOI 10.1158/1078-0432.CCR-08-0141; Dickler MN, 2009, BREAST CANCER RES TR, V115, P115, DOI 10.1007/s10549-008-0055-9; Elsheikh SE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1665; Er EE, 2018, NAT CELL BIOL, V20, P966, DOI 10.1038/s41556-018-0138-8; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Hanker AB, 2017, CLIN CANCER RES, V23, P4323, DOI 10.1158/1078-0432.CCR-16-2287; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Issitt T, 2019, ISCIENCE, V11, P205, DOI 10.1016/j.isci.2018.12.005; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Kachel P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1135-y; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lee TW, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0443-3; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Patnaik A, 2014, CANCER CHEMOTH PHARM, V73, P951, DOI 10.1007/s00280-014-2426-8; Qian X, 2014, ONCOGENE, V33, P3411, DOI 10.1038/onc.2013.310; Rastelli F, 2010, TUMORI J, V96, P875, DOI 10.1177/548.6505; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rizzolio S, 2018, J CLIN INVEST, V128, P3976, DOI 10.1172/JCI99257; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shinde A, 2018, MOL CANCER RES, V16, P1579, DOI 10.1158/1541-7786.MCR-18-0151; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Smith IE, 2007, J CLIN ONCOL, V25, P3816, DOI 10.1200/JCO.2006.09.6578; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Sutton LM, 2010, AM J CLIN PATHOL, V134, P782, DOI 10.1309/AJCPRMD3ARUO5WPN; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vivekanandhan S, 2019, SEMIN CANCER BIOL, V54, P72, DOI 10.1016/j.semcancer.2018.01.014; Weekes CD, 2014, INVEST NEW DRUG, V32, P653, DOI 10.1007/s10637-014-0071-z; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wendt MK, 2015, NEOPLASIA, V17, P124, DOI 10.1016/j.neo.2014.11.009; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; WENDT MK, 2014, BREAST CANCER RES, V16; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Zhang L, 2013, CANCER RES, V73, P3316, DOI 10.1158/0008-5472.CAN-12-3015; Zhao MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12713	56	9	9	4	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					322	333		10.1038/s41388-020-01530-6	http://dx.doi.org/10.1038/s41388-020-01530-6		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33128042	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000585769600002
J	Deviaene, M; Weigel, KM; Wood, RC; Luabeya, AKK; Jones-Engel, L; Hatherill, M; Cangelosi, GA				Deviaene, Meagan; Weigel, Kris M.; Wood, Rachel C.; Luabeya, Angelique K. K.; Jones-Engel, Lisa; Hatherill, Mark; Cangelosi, Gerard A.			Sample adequacy controls for infectious disease diagnosis by oral swabbing	PLOS ONE			English	Article							REAL-TIME PCR; DNA	Oral swabs are emerging as a non-invasive sample type for diagnosing infectious diseases including Ebola, tuberculosis (TB), and COVID-19. To assure proper sample collection, sample adequacy controls (SACs) are needed that detect substances indicative of samples collected within the oral cavity. This study evaluated two candidate SACs for this purpose. One detected representative oral microbiota (Streptococcus species DNA) and the other, human cells (human mitochondrial DNA, mtDNA). Quantitative PCR (qPCR) assays for the two target cell types were applied to buccal swabs (representing samples collected within the oral cavity) and hand swabs (representing improperly collected samples) obtained from 51 healthy U.S. volunteers. Quantification cycle (Cq) cutoffs that maximized Youden's index were established for each assay. The streptococcal target at a Cq cutoff of <= 34.9 had 99.0% sensitivity and specificity for oral swab samples, whereas human mtDNA perfectly distinguished between hand and mouth swabs with a Cq cutoff of 31.3. The human mtDNA test was then applied to buccal, tongue, and gum swabs that had previously been collected from TB patients and controls in South Africa, along with "air swabs" collected as negative controls (total N = 292 swabs from 71 subjects). Of these swabs, 287/292 (98%) exhibited the expected Cq values. In a paired analysis the three oral sites yielded indistinguishable amounts of human mtDNA, however PurFlock(TM) swabs collected slightly more human mtDNA than did OmniSwabs(TM) (p = 0.012). The results indicate that quantification of human mtDNA cannot distinguish swabs collected from different sites within the mouth. However, it can reliably distinguish oral swabs from swabs that were not used orally, which makes it a useful SAC for oral swab-based diagnosis.	[Deviaene, Meagan; Weigel, Kris M.; Wood, Rachel C.; Jones-Engel, Lisa; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Luabeya, Angelique K. K.; Hatherill, Mark] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, South African TB Vaccine Initiat SATVI, Cape Town, South Africa; [Luabeya, Angelique K. K.; Hatherill, Mark] Univ Cape Town, Div Immunol, Cape Town, South Africa	University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town	Cangelosi, GA (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gcang@uw.edu		Cangelosi, Jerry/0000-0003-0006-6520; Weigel, Kris/0000-0003-3199-2148	Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation [OPP1191195]; NIH [R01AI139254]	Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Grand Challenges Explorations grant (OPP1191195) from the Bill & Melinda Gates Foundation, and by NIH grant R01AI139254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; [Anonymous], 2017, B WORLD HEALTH ORGAN, V95, P639; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Aschar M, 2016, VET PARASITOL, V225, P108, DOI 10.1016/j.vetpar.2016.06.005; Banoo S, 2006, NAT REV MICROBIO, V4, P21; Brukner I, 2020, J INFECT PUBLIC HEAL, V13, P991, DOI 10.1016/j.jiph.2020.01.307; Caldwell JM, 2007, ENVIRON SCI TECHNOL, V41, P3277, DOI 10.1021/es062912s; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Engel GA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.31; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Hang D, 2014, CANCER EPIDEM BIOMAR, V23, P2101, DOI 10.1158/1055-9965.EPI-14-0084; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kim AE, 2020, SEATTLE FLU STUDY SW; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Luabeya AK, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01847-18; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mesman AW, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4385-y; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Nicol MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47302-5; Picard FJ, 2004, J CLIN MICROBIOL, V42, P3686, DOI 10.1128/jcm.42.8.3686-3695.2004; Pugnale P, 2006, J VIROL METHODS, V133, P195, DOI 10.1016/j.jviromet.2005.11.007; Sepulveda D, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-183; SMFM Consult Series #39, 2016, AM J OBSTET GYNECOL, V214, pB9; Sociedade Brasileira de Diabetes (SBD), 2015, SBD, V1, P72, DOI DOI 10.1016/J.CELS.2015.01.001; Tu Y.-P., 2020, N ENGL J MED; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Wilbur AK, 2012, AM J PRIMATOL, V74, P676, DOI 10.1002/ajp.22022	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241542	10.1371/journal.pone.0241542	http://dx.doi.org/10.1371/journal.pone.0241542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125422	Green Published, gold, Green Submitted			2022-12-26	WOS:000588368900045
J	Curado, EMF; Curado, MR				Curado, Evaldo M. F.; Curado, Marco R.			A discrete-time-evolution model to forecast progress of Covid-19 outbreak	PLOS ONE			English	Article								Here we present a discrete-time-evolution model with one day interval to forecast the propagation of Covid-19. The proposed model can be easily implemented with daily updated data sets of the pandemic publicly available by distinct online sources. It has only two adjustable parameters and it predicts the evolution of the total number of infected people in a country for the next 14 days if parameters do not change during the analyzed period. The model incorporates the main aspects of the disease such as the fact that there are asymptomatic and symptomatic phases (both capable of propagating the virus), and that these phases take almost two weeks before the infected person status evolves to the next (asymptomatic becomes symptomatic or symptomatic becomes either recovered or dead). A striking advantage of the model for its implementation by the health sector is that it gives directly the number of total infected people in each day (in thousands, tens of thousands or hundred of thousands). Here, the model is tested with data from Brazil, UK and South Korea, presenting low error rates on the prediction of the evolution of the disease in all analyzed countries. We hope this model may be a useful tool to estimate the propagation of the disease.	[Curado, Evaldo M. F.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil; [Curado, Evaldo M. F.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil; [Curado, Marco R.] AbbVie Deutschland GmbH & Co KG, Data & Stat Sci DSS, Ludwigshafen, Germany	Centro Brasileiro de Pesquisas Fisicas; AbbVie	Curado, EMF (corresponding author), Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil.; Curado, EMF (corresponding author), Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil.	evaldo@cbpf.br	Curado, E./N-1808-2013		CNPq; FAPERJ; CAPES; AbbVie Deutschland GmbH Co. KG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); AbbVie Deutschland GmbH Co. KG(AbbVie)	This study received financial support from CNPq, FAPERJ and CAPES [EMFC]. AbbVie Deutschland GmbH & Co. KG provided support in the form of salary for the author [MRC] and reviewed the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2011, CLIN INFECT DIS S5, V52, pS397; Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006; Brauer F., 2010, MATH MODELS POPULATI; Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Keeling, 2008, MODELING INFECT DIS; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kouadio K, 2016, VACCINE, V34, P5175, DOI 10.1016/j.vaccine.2016.05.070; Mandal M, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109889; Ota Miyo, 2020, Nat Rev Immunol, V20, P351, DOI 10.1038/s41577-020-0316-3; Paules CI, 2017, ANN INTERN MED, V167, P805, DOI 10.7326/M17-2496; Tsallis C, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00217; United Nations (UN), 2020, SHARED RESPONSIBILIT; WHO, 2020, COVID 19 PUBLIC HLTH	15	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241472	10.1371/journal.pone.0241472	http://dx.doi.org/10.1371/journal.pone.0241472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119708	gold, Green Published, Green Submitted			2022-12-26	WOS:000600013600058
J	Quareshy, M; Shanmugam, M; Townsend, E; Jameson, E; Bugg, TDH; Cameron, AD; Chen, Y				Quareshy, Mussa; Shanmugam, Muralidharan; Townsend, Eleanor; Jameson, Eleanor; Bugg, Timothy D. H.; Cameron, Alexander D.; Chen, Yin			Structural basis of carnitine monooxygenase CntA substrate specificity, inhibition, and intersubunit electron transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMETHYLAMINE N-OXIDE; RIESKE-TYPE OXYGENASE; GUT MICROBIOME; CHOLINE MONOOXYGENASE; O-2 ACTIVATION; NITRIC-OXIDE; IRON; METABOLISM; HEALTH; VISUALIZATION	Microbial metabolism of carnitine to trimethylamine (TMA) in the gut can accelerate atherosclerosis and heart disease, and these TMA-producing enzymes are therefore important drug targets. Here, we report the first structures of the carnitine oxygenase CntA, an enzyme of the Rieske oxygenase family. CntA exists in a head-to-tail alpha(3) trimeric structure. The two functional domains (the Rieske and the catalytic mononuclear iron domains) are located >40 angstrom apart in the same monomer but adjacent in two neighboring monomers. Structural determination of CntA and subsequent electron paramagnetic resonance measurements uncover the molecular basis of the so-called bridging glutamate (E205) residue in intersubunit electron transfer. The structures of the substrate-bound CntA help to define the substrate pocket. Importantly, a tyrosine residue (Y203) is essential for ligand recognition through a pi-cation interaction with the quaternary ammonium group. This interaction between an aromatic residue and quaternary amine substrates allows us to delineate a subgroup of Rieske oxygenases (group V) from the prototype ring-hydroxylating Rieske oxygenases involved in bioremediation of aromatic pollutants in the environment. Furthermore, we report the discovery of the first known CntA inhibitors and solve the structure of CntA in complex with the inhibitor, demonstrating the pivotal role of Y203 through a p-p stacking interaction with the inhibitor. Our study provides the structural and molecular basis for future discovery of drugs targeting this TMA-producing enzyme in human gut.	[Quareshy, Mussa; Townsend, Eleanor; Jameson, Eleanor; Cameron, Alexander D.; Chen, Yin] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Shanmugam, Muralidharan] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Shanmugam, Muralidharan] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England	University of Warwick; University of Warwick; University of Manchester; University of Manchester	Quareshy, M; Chen, Y (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	mussaquareshy@gmail.com; y.chen.25@warwick.ac.uk	Jameson, Eleanor/V-7945-2019	Jameson, Eleanor/0000-0001-6427-3794; Bugg, Timothy/0000-0003-3964-4498; Shanmugam, Muralidharan/0000-0003-3818-1401; Townsend, Eleanor/0000-0002-1531-1747; Quareshy, Mussa/0000-0001-8115-9803; Chen, Yin/0000-0002-0367-4276	Leverhulme Trust [RPG-2016-307]	Leverhulme Trust(Leverhulme Trust)	This work was supported by a Leverhulme Trust research grant (RPG-2016-307).	Barry SM, 2013, ACS CATAL, V3, P2362, DOI 10.1021/cs400087p; BATIE CJ, 1987, J BIOL CHEM, V262, P1510; Berg G, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00875-0; Bodea S, 2016, CELL CHEM BIOL, V23, P1206, DOI 10.1016/j.chembiol.2016.07.020; Bollenbach M, 2020, ACS MED CHEM LETT, V11, P1980, DOI 10.1021/acsmedchemlett.0c00005; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; BURNET M, 1995, PLANT PHYSIOL, V108, P581, DOI 10.1104/pp.108.2.581; BURNET M, 1995, PLANT PHYSIOL, V108, P42; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; D'Ordine RL, 2009, J MOL BIOL, V392, P481, DOI 10.1016/j.jmb.2009.07.022; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; DeRose VJ, 1996, BIOCHEMISTRY-US, V35, P11085, DOI 10.1021/bi960749f; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ertekin E, 2017, ENVIRON SCI TECHNOL, V51, P175, DOI 10.1021/acs.est.6b03705; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fennema D, 2016, DRUG METAB DISPOS, V44, P1839, DOI 10.1124/dmd.116.070615; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Hedison TM, 2019, CHEM COMMUN, V55, P5863, DOI 10.1039/c9cc01026b; Hemminga MA., 2007, ESR SPECTROSCOPY MEM; Jameson E, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000080; Jameson E, 2016, ENVIRON MICROBIOL, V18, P2886, DOI 10.1111/1462-2920.13059; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Kalnins G, 2015, J BIOL CHEM, V290, P21732, DOI 10.1074/jbc.M115.670471; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Karuppiah V, 2017, ACS CATAL, V7, P6268, DOI 10.1021/acscatal.7b01924; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JK, 2005, J BIOL CHEM, V280, P36719, DOI 10.1074/jbc.M505334200; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Massmig M, 2020, J BIOL CHEM, V295, P13065, DOI 10.1074/jbc.RA120.014266; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Neibergall MB, 2007, BIOCHEMISTRY-US, V46, P8004, DOI 10.1021/bi700120j; Orman M, 2019, J AM CHEM SOC, V141, P33, DOI 10.1021/jacs.8b04883; Pavel E G, 1994, Chem Biol, V1, P173, DOI 10.1016/1074-5521(94)90007-8; Perry C, 2018, NAT PROD REP, V35, P622, DOI 10.1039/c8np00004b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto A, 2006, BIOCHEMISTRY-US, V45, P9032, DOI 10.1021/bi060216z; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; Roberts AB, 2018, NAT MED, V24, P1407, DOI 10.1038/s41591-018-0128-1; Rogers MS, 2019, BIOCHEMISTRY-US, V58, P5305, DOI 10.1021/acs.biochem.9b00292; ROSCHE B, 1995, BBA-PROTEIN STRUCT M, V1252, P177, DOI 10.1016/0167-4838(95)00151-J; Schmidt AC, 2020, DRUG DISCOV TODAY, V25, P1710, DOI 10.1016/j.drudis.2020.06.026; Shao YH, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00377-18; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Tang WHW, 2019, NAT REV CARDIOL, V16, P137, DOI 10.1038/s41569-018-0108-7; Tang WHW, 2017, CIRCULATION, V135, P1008, DOI 10.1161/CIRCULATIONAHA.116.024251; Tars K, 2014, J MED CHEM, V57, P2213, DOI 10.1021/jm401603e; Wackett LP, 2002, ENZYME MICROB TECH, V31, P577, DOI 10.1016/S0141-0229(02)00129-1; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wolfe MD, 2003, J BIOL CHEM, V278, P829, DOI 10.1074/jbc.M209604200; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200; Zeisel SH, 2017, ANNU REV NUTR, V37, P157, DOI 10.1146/annurev-nutr-071816-064732; Zhu W, 2018, J THROMB HAEMOST, V16, P1857, DOI 10.1111/jth.14234; Zhu YJ, 2014, P NATL ACAD SCI USA, V111, P4268, DOI 10.1073/pnas.1316569111	67	4	4	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100038	10.1074/jbc.RA120.016019	http://dx.doi.org/10.1074/jbc.RA120.016019			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33158989	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400022
J	Hayano, J; Yamamoto, H; Nonaka, I; Komazawa, M; Itao, K; Ueda, N; Tanaka, H; Yuda, E				Hayano, Junichiro; Yamamoto, Hiroaki; Nonaka, Izumi; Komazawa, Makoto; Itao, Kenichi; Ueda, Norihiro; Tanaka, Haruhito; Yuda, Emi			Quantitative detection of sleep apnea with wearable watch device	PLOS ONE			English	Article							PULSE-RATE VARIABILITY; HEART-RATE; DIAGNOSIS; EPIDEMIOLOGY; POPULATION; SURROGATE; MORTALITY; HYPOPNEA; PRESSURE	The spread of wearable watch devices with photoplethysmography (PPG) sensors has made it possible to use continuous pulse wave data during daily life. We examined if PPG pulse wave data can be used to detect sleep apnea, a common but underdiagnosed health problem associated with impaired quality of life and increased cardiovascular risk. In 41 patients undergoing diagnostic polysomnography (PSG) for sleep apnea, PPG was recorded simultaneously with a wearable watch device. The pulse interval data were analyzed by an automated algorithm called auto-correlated wave detection with adaptive threshold (ACAT) which was developed for electrocardiogram (ECG) to detect the cyclic variation of heart rate (CVHR), a characteristic heart rate pattern accompanying sleep apnea episodes. The median (IQR) apnea-hypopnea index (AHI) was 17.2 (4.4-28.4) and 22 (54%) subjects had AHI >= 15. The hourly frequency of CVHR (Fcv) detected by the ACAT algorithm closely correlated with AHI (r = 0.81), while none of the time-domain, frequency-domain, or non-linear indices of pulse interval variability showed significant correlation. The Fcv was greater in subjects with AHI >= 15 (19.6 +/- 12.3 /h) than in those with AHI <15 (6.4 +/- 4.6 /h), and was able to discriminate them with 82% sensitivity, 89% specificity, and 85% accuracy. The classification performance was comparable to that obtained when the ACAT algorithm was applied to ECG R-R intervals during the PSG. The analysis of wearable watch PPG by the ACAT algorithm could be used for the quantitative screening of sleep apnea.	[Hayano, Junichiro; Ueda, Norihiro] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Yamamoto, Hiroaki; Nonaka, Izumi; Tanaka, Haruhito] Gifu Mates Sleep Clin, Gifu, Japan; [Komazawa, Makoto; Itao, Kenichi] WINFrontier Co Ltd, Tokyo, Japan; [Yuda, Emi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan	Nagoya City University; Tohoku University	Hayano, J (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan.	hayano@acm.org		Hayano, Junichiro/0000-0002-5340-6325; Yuda, Emi/0000-0002-1865-7735	WINFrontier Co., Ltd.	WINFrontier Co., Ltd.	This study is partly funded by WINFrontier Co., Ltd. This company participated in the study design and supported the data collection, but did not have any additional role in the data analysis, decision to publish, or preparation of the manuscript. The company also provided support in the form of salaries for two of the authors (M.K. and K.I.). The specific roles of these authors are articulated in the `author contributions' section.	Adler A, 2016, VALIDATION EMPATICA, P1; [Anonymous], 2017, CIRC, V136, pe196; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Berry RB, 2020, AASM MANUAL SCORING; Cassar A, 2007, J AM COLL CARDIOL, V50, P1310, DOI 10.1016/j.jacc.2007.06.028; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Constant I, 1999, CLIN SCI, V97, P391, DOI 10.1042/CS19990062; Cooksey JA, 2016, CHEST, V149, P1074, DOI 10.1378/chest.15-1076; Corino VDA, 2017, PHYSIOL MEAS, V38, P787, DOI 10.1088/1361-6579/aa5dd7; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; GUILLEMINAULT C, 1984, LANCET, V1, P126; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hayano J, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-62; Hayano J, 2017, EUROPACE, V19, P1392, DOI 10.1093/europace/euw222; Hayano J, 2013, SLEEP BREATH, V17, P243, DOI 10.1007/s11325-012-0681-7; Hayano J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P64, DOI 10.1161/CIRCEP.110.958009; Khandoker AH, 2011, MED ENG PHYS, V33, P204, DOI 10.1016/j.medengphy.2010.09.020; Kundel V, 2017, SLEEP MED CLIN, V12, P137, DOI 10.1016/j.jsmc.2016.10.006; Lu Sheng, 2008, J Clin Monit Comput, V22, P23, DOI 10.1007/s10877-007-9103-y; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Nakano H, 2004, RESP MED, V98, P421, DOI 10.1016/j.rmed.2003.11.009; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Rapalis A, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aac24a; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Shiomi T, 2002, PSYCHIAT CLIN NEUROS, V56, P333, DOI 10.1046/j.1440-1819.2002.01004.x; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Wong JS, 2012, J CLIN MONIT COMPUT, V26, P107, DOI 10.1007/s10877-012-9340-6; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071; Yuda E, 2020, J PHYSIOL ANTHROPOL, V39, DOI 10.1186/s40101-020-00233-x; Yuda E, 2020, J PHYSIOL ANTHROPOL, V39, DOI 10.1186/s40101-020-0214-1	33	9	9	9	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0237279	10.1371/journal.pone.0237279	http://dx.doi.org/10.1371/journal.pone.0237279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166293	Green Submitted, gold, Green Published			2022-12-26	WOS:000592382600041
J	Shum, LC; Hollenberg, AM; Baldwin, AL; Kalicharan, BH; Maqsoodi, N; Rubery, PT; Mesfin, A; Eliseev, RA				Shum, Laura C.; Hollenberg, Alex M.; Baldwin, Avionna L.; Kalicharan, Brianna H.; Maqsoodi, Noorullah; Rubery, Paul T.; Mesfin, Addisu; Eliseev, Roman A.			Role of oxidative metabolism in osseointegration during spinal fusion	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; TERM-FOLLOW-UP; INTERBODY FUSION; MITOCHONDRIAL; DIFFERENTIATION; PSEUDOARTHROSIS; OUTCOMES; SURGERY; COMPLICATIONS	Spinal fusion is a commonly performed orthopedic surgery. Autologous bone graft obtained from the iliac crest is frequently employed to perform spinal fusion. Osteogenic bone marrow stromal (a.k.a. mesenchymal stem) cells (BMSCs) are believed to be responsible for new bone formation and development of the bridging bone during spinal fusion, as these cells are located in both the graft and at the site of fusion. Our previous work revealed the importance of mitochondrial oxidative metabolism in osteogenic differentiation of BMSCs. Our objective here was to determine the impact of BMSC oxidative metabolism on osseointegration of the graft during spinal fusion. The first part of the study was focused on correlating oxidative metabolism in bone graft BMSCs to radiographic outcomes of spinal fusion in human patients. The second part of the study was focused on mechanistically proving the role of BMSC oxidative metabolism in osseointegration during spinal fusion using a genetic mouse model. Patients' iliac crest-derived graft BMSCs were identified by surface markers. Mitochondrial oxidative function was detected in BMSCs with the potentiometric probe, CMXRos. Spinal fusion radiographic outcomes, determined by the Lenke grade, were correlated to CMXRos signal in BMSCs. A genetic model of high oxidative metabolism, cyclophilin D knockout (CypD KO), was used to perform spinal fusion in mice. Graft osseointegration in mice was assessed with micro-computed tomography. Our study revealed that higher CMXRos signal in patients' BMSCs correlated with a higher Lenke grade. Mice with higher oxidative metabolism (CypD KO) had greater mineralization of the spinal fusion bridge, as compared to the control mice. We therefore conclude that higher oxidative metabolism in BMSCs correlates with better spinal fusion outcomes in both human patients and in a mouse model. Altogether, our study suggests that promoting oxidative metabolism in osteogenic cells could improve spinal fusion outcomes for patients.	[Shum, Laura C.; Hollenberg, Alex M.; Baldwin, Avionna L.; Kalicharan, Brianna H.; Maqsoodi, Noorullah; Rubery, Paul T.; Mesfin, Addisu; Eliseev, Roman A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester	Eliseev, RA (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.	roman_eliseev@urmc.rochester.edu			Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; NIH/NIAMS [R01 AR072601]; J. Robert Gladden Society; NIH/NCATS [TL1-TR000096]	Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); J. Robert Gladden Society; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this project was provided by a grant from the Orthopaedic Research and Education Foundation with additional funding provided by Musculoskeletal Transplant Foundation, NIH/NIAMS R01 AR072601 grant to RAE, grant from J. Robert Gladden Society to AM, and NIH/NCATS TL1-TR000096 grant to LCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliuskevicius M, 2020, J ORTHOP RES, V38, P545, DOI 10.1002/jor.24498; [Anonymous], 2007, TYPOGRAPHY PAPERS, V7, P61; Barba M, 2014, SCI WORLD J, DOI 10.1155/2014/406159; Berjano P, 2015, EUR SPINE J, V24, pS369, DOI 10.1007/s00586-015-3929-7; Berman D, 2017, INT J SPINE SURG, V11, DOI 10.14444/4029; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Bolland MJ, 2007, OSTEOPOROSIS INT, V18, P479, DOI 10.1007/s00198-006-0259-y; Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Castillo Elena C, 2019, Cell Physiol Biochem, V53, P465, DOI 10.33594/000000151; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Daffner SD, 2015, SPINE J, V15, P1402, DOI 10.1016/j.spinee.2015.02.041; Dede O, 2015, SPINE J, V15, P977, DOI 10.1016/j.spinee.2013.05.039; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Dimar JR, 2009, SPINE J, V9, P880, DOI 10.1016/j.spinee.2009.03.013; Dranka BP, 2012, J NEUROCHEM, V122, P941, DOI 10.1111/j.1471-4159.2012.07836.x; EGRISE D, 1992, BONE, V13, P355, DOI 10.1016/8756-3282(92)90451-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer CR, 2014, J AM ACAD ORTHOP SUR, V22, P503, DOI 10.5435/JAAOS-22-08-503; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gutierrez-Aguilar M, 2015, BBA-GEN SUBJECTS, V1850, P2041, DOI 10.1016/j.bbagen.2014.11.009; Hall JF, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1424-2; Heller JG, 2001, SPINE, V26, P1330, DOI 10.1097/00007632-200106150-00013; Hofler RC, 2018, WORLD NEUROSURG, V120, pE194, DOI 10.1016/j.wneu.2018.08.026; Ito M, 2011, J BONE MINER METAB, V29, P131, DOI 10.1007/s00774-010-0258-0; Iunes EA, 2020, J NEUROSURG-SPINE, V33, P717, DOI 10.3171/2020.4.SPINE20357; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim YJ, 2006, SPINE, V31, P2329, DOI 10.1097/01.brs.0000238968.82799.d9; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; La Colla A, 2013, J ENDOCRINOL, V216, P331, DOI 10.1530/JOE-12-0486; Lara-Almunia M, 2015, INT J SPINE SURG, V9, DOI 10.14444/2022; Lau D, 2014, J NEUROSURG-SPINE, V21, P547, DOI 10.3171/2014.6.SPINE13762; LENKE LG, 1992, J SPINAL DISORD, V5, P433, DOI 10.1097/00002517-199212000-00008; Leven D, 2016, ASIAN SPINE J, V10, P776, DOI 10.4184/asj.2016.10.4.776; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Makino T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082430; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manzur M, 2019, SPINE J, V19, P1294, DOI 10.1016/j.spinee.2019.03.001; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Martin BI, 2019, SPINE, V44, P369, DOI 10.1097/BRS.0000000000002822; Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059; Menon V, 2014, JOVE-J VIS EXP, DOI 10.3791/52241; Mesfin A, 2015, J NEUROSURG-SPINE, V22, P367, DOI 10.3171/2014.10.SPINE14365; Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730; Meyers AJ, 2021, GLOB SPINE J, V11, P697, DOI 10.1177/2192568220921833; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205; Nguyen LH, 2012, ADV EXP MED BIOL, V760, P188; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Oh JY, 2019, FREE RADICAL BIO MED, V130, P328, DOI 10.1016/j.freeradbiomed.2018.11.003; Phan K, 2018, WORLD NEUROSURG, V110, pE998, DOI 10.1016/j.wneu.2017.11.157; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Robbins MA, 2017, GLOB SPINE J, V7, P801, DOI 10.1177/2192568217701102; Rodgers WB, 2012, INT J SPINE SURG, V6, P24, DOI 10.1016/j.ijsp.2011.10.001; Russo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07536-7; Sandhu HS, 1998, ORTHOP CLIN N AM, V29, P621, DOI 10.1016/S0030-5898(05)70035-3; Shares BH, 2020, BONE, V137, DOI 10.1016/j.bone.2020.115391; Shares BH, 2018, J BIOL CHEM, V293, P16019, DOI 10.1074/jbc.RA118.004102; Shum LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155709; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Suljic Enra Mehmedika, 2018, Med Arch, V72, P262, DOI 10.5455/medarh.2018.72.262-266; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; TSUJI T, 1990, MECH AGEING DEV, V51, P121, DOI 10.1016/0047-6374(90)90094-V; Vaccaro Alexander R, 2002, Spine J, V2, P206, DOI 10.1016/S1529-9430(02)00180-8; Wada E, 2001, SPINE, V26, P1443, DOI 10.1097/00007632-200107010-00011; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu YC, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00080	74	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241998	10.1371/journal.pone.0241998	http://dx.doi.org/10.1371/journal.pone.0241998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166330	gold, Green Published			2022-12-26	WOS:000592382600069
J	Wang, LJ; Moore, DC; Huang, JH; Wang, YH; Zhao, H; Yue, JDH; Jackson, CL; Quesenberry, PJ; Cao, WB; Yang, WT				Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; Wang, Yuhong; Zhao, Hu; D-H Yue, Jerry; Jackson, Cynthia L.; Quesenberry, Peter J.; Cao, Weibiao; Yang, Wentian			SHP2 regulates the development of intestinal epithelium by modifying OSTERIX+ crypt stem cell self-renewal and proliferation	FASEB JOURNAL			English	Article						Crypt stem cell; LGR5; OLFM4; Osteoblast; OSTERIX; SHP2; SOX9	CRE-MEDIATED RECOMBINATION; TYROSINE PHOSPHATASE SHP2; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; SOX9 EXPRESSION; GENE; INFLAMMATION; ACTIVATION; PATHWAY; GROWTH	The protein tyrosine phosphatase SHP2, encoded by PTPN11, is ubiquitously expressed and essential for the development and/or maintenance of multiple tissues and organs. SHP2 is involved in gastrointestinal (GI) epithelium development and homeostasis, but the underlying mechanisms remain elusive. While studying SHP2's role in skeletal development, we made osteoblast-specific SHP2 deficient mice using Osterix (Osx)-Cre as a driver to excise Ptpn11 floxed alleles. Phenotypic characterization of these SHP2 mutants unexpectedly revealed a critical role of SHP2 in GI biology. Mice lacking SHP2 in Osx(+) cells developed a fatal GI pathology with dramatic villus hypoplasia. OSTERIX, an OB-specific zinc finger-containing transcription factor is for the first time found to be expressed in GI crypt cells, and SHP2 expression in the crypt Osx+ cells is critical for self-renewal and proliferation. Further, immunostaining revealed the colocalization of OSTERIX with OLFM4 and LGR5, two bona fide GI stem cell markers, at the crypt cells. Furthermore, OSTERIX expression is found to be associated with GI malignancies. Knockdown of SHP2 expression had no apparent influence on the relative numbers of enterocytes, goblet cells or Paneth cells. Given SHP2's key regulatory role in OB differentiation, our studies suggest that OSTERIX and SHP2 are indispensable for gut homeostasis, analogous to SOX9's dual role as a master regulator of cartilage and an important regulator of crypt stem cell biology. Our findings also provide a foundation for new avenues of inquiry into GI stem cell biology and of OSTERIX's therapeutic and diagnostic potential.	[Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; D-H Yue, Jerry; Yang, Wentian] Brown Univ, Alpert Med Sch, Dept Orthoped, Hoppin St,Coro 402E, Providence, RI 02903 USA; [Wang, Lijun; Moore, Douglas C.; Huang, Jiahui; D-H Yue, Jerry; Jackson, Cynthia L.; Quesenberry, Peter J.; Cao, Weibiao; Yang, Wentian] Rhode Isl Hosp, Hoppin St,Coro 402E, Providence, RI 02903 USA; [Wang, Yuhong; Zhao, Hu] Texas A&M Coll Dent, Dept Comprehens Dent, Dallas, TX USA; [Jackson, Cynthia L.; Cao, Weibiao] Brown Univ, Alpert Med Sch, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Quesenberry, Peter J.] Brown Univ, Alpert Med Sch, Dept Hematol & Oncol, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthoped, Hoppin St,Coro 402E, Providence, RI 02903 USA.; Yang, WT (corresponding author), Rhode Isl Hosp, Hoppin St,Coro 402E, Providence, RI 02903 USA.	wyang@lifespan.org	Wang, Yu/GZL-9655-2022		HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1AR066746]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [8P20GM103468, 1P20 GM119943]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: RO1AR066746; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: #8P20GM103468; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: 1P20 GM119943	Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2013, CELL, V152, P1198, DOI 10.1016/j.cell.2013.02.030; Coulombe G, 2016, J CELL PHYSIOL, V231, P2529, DOI 10.1002/jcp.25407; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Dai QS, 2015, ONCOL LETT, V10, P1870, DOI 10.3892/ol.2015.3448; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Fan YY, 2019, METHODS MOL BIOL, V1576, P171, DOI 10.1007/7651_2016_8; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Felber K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144982; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Gagne-Sansfacon J, 2019, J PATHOL, V247, P135, DOI 10.1002/path.5177; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heuberger J, 2014, P NATL ACAD SCI USA, V111, P3472, DOI 10.1073/pnas.1309342111; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jourdan F, 2003, VIRCHOWS ARCH, V443, P115, DOI 10.1007/s00428-003-0833-z; Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lowery JW, 2018, PHYSIOL REV, V98, P2431, DOI 10.1152/physrev.00028.2017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Narumi Y, 2009, J CLIN IMMUNOL, V29, P303, DOI 10.1007/s10875-008-9272-6; Neel B. G., 2009, HDB CELL SIGNALING, P771; O'Rourke Kevin P, 2016, Bio Protoc, V6; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Powell AE, 2014, AM J PHYSIOL-GASTR L, V307, pG16, DOI 10.1152/ajpgi.00358.2013; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Qu S, 2019, J CELL MOL MED, V23, P1116, DOI 10.1111/jcmm.14012; Quante M, 2008, PHYSIOLOGY, V23, P350, DOI 10.1152/physiol.00031.2008; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Roberts DJ, 2000, DEV DYNAM, V219, P109, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Sukhotnik I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110675; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; Wang LJ, 2018, FASEB J, V32, P875, DOI 10.1096/fj.201700672RR; Xiao P, 2019, J EXP MED, V216, P337, DOI 10.1084/jem.20181198; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yao B, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1269-3; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107; Zuo CL, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0013-z	72	2	2	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001091R	http://dx.doi.org/10.1096/fj.202001091R		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33165997				2022-12-26	WOS:000590824300001
J	Glaeser, SS; Edwards, KL; Wielebnowski, N; Brown, JL				Glaeser, Sharon S.; Edwards, Katie L.; Wielebnowski, Nadja; Brown, Janine L.			Effects of physiological changes and social life events on adrenal glucocorticoid activity in female zoo-housed Asian elephants (Elephas maximus)	PLOS ONE			English	Article							SALIVARY CORTISOL SECRETION; RANGING AFRICAN ELEPHANTS; ADRENOCORTICAL ACTIVITY; COMPARATIVE ENDOCRINOLOGY; BEHAVIORAL REACTIONS; OVARIAN CYCLICITY; STRESS RESPONSES; CIRCADIAN-RHYTHM; ESTROUS-CYCLE; PREGNANCY	Ensuring good health and welfare is an increasingly important consideration for conservation of endangered species and includes breeding of individuals managed under human care. Understanding how factors in the captive environment affect individual animal wellbeing can be aided by long-term monitoring of biological functioning. This study involved longitudinal assessments (4 to 28 years) of reproductive and adrenal hormones in zoo-housed female Asian elephants (Elephas maximus) (age range 4 to similar to 71 years) to elucidate patterns in adrenal glucocorticoid (GC) activity in association with reproductive and demographic factors, and examine individual response to major social changes. Concentrations of serum and urinary cortisol covaried more consistently with physiological changes (ovarian cycle phase, puberty, pregnancy, lactational anestrus, and age) than with social life events (births, deaths, and facility transfers). Cortisol fluctuated across the ovarian cycle with mean concentrations being higher in the follicular than in the luteal phase, and concentrations were highest in lactational anestrous compared to all other reproductive states. The elephants in this study exhibited substantial individuality in adrenal GC response to major social change, reinforcing the need to assess welfare on an individual basis and to consider factors influencing the impact of perceived stressors, such as social relationships, social support, temperament, and life history. Outcomes from this study deepen our understanding of Asian elephant physiology and highlight the importance of taking intrinsic patterns of hormone secretion into account when evaluating the impact of external factors. Finally, a better understanding of the impact of social change and resiliency in response to real and perceived stressors allows us to improve social management to enhance welfare in both captive settings and free-ranging environments.	[Glaeser, Sharon S.; Wielebnowski, Nadja] Oregon Zoo, Portland, OR 97221 USA; [Edwards, Katie L.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Edwards, Katie L.] Chester Zoo, North England Zool Soc, Upton By Chester, England	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Glaeser, SS (corresponding author), Oregon Zoo, Portland, OR 97221 USA.	Sharon.Glaeser@oregonzoo.org	; Edwards, Katie/K-5559-2015	Glaeser, Sharon/0000-0002-7268-6780; Edwards, Katie/0000-0001-6736-1183	Oregon Zoo; Oregon Zoo Foundation; Smithsonian Conservation Biology Institute; North of England Zoological Society; Chester Zoo	Oregon Zoo; Oregon Zoo Foundation; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); North of England Zoological Society; Chester Zoo	This work was supported by the Oregon Zoo (https://www.oregonzoo.org), Oregon Zoo Foundation (https://www.oregonzoo.org/about/about-oregon-zoo-foundation), and discretionary funds from the Smithsonian Conservation Biology Institute (https://www.si.edu/unit/conservation-biology-institute).Employers provided financial support in the form of author salaries as follows: Oregon Zoo Foundation (SSG), Oregon Zoo (NW), Smithsonian Conservation Biology Institute (JLB, KLE), North of England Zoological Society, Chester Zoo (KLE). The Oregon Zoo had a role in collection of biological samples; otherwise, funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J DESERT RES, V31, P442; Atkinson HC, 1997, ENDOCRINOLOGY, V138, P3842, DOI 10.1210/en.138.9.3842; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonaparte-Saller M, 2018, APPL ANIM BEHAV SCI, V199, P45, DOI 10.1016/j.applanim.2017.10.011; BORG KE, 1991, J ANIM SCI, V69, P3230; Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Brown JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217326; Brown JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145673; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 2010, ZOO BIOL, V29, P274, DOI 10.1002/zoo.20268; Brown JL, 1997, ZOO BIOL, V16, P149, DOI 10.1002/(SICI)1098-2361(1997)16:2<149::AID-ZOO5>3.0.CO;2-A; Brown JL, 1999, BIOL REPROD, V61, P1294, DOI 10.1095/biolreprod61.5.1294; Brown JL, 1995, ZOO BIOL, V14, P533, DOI 10.1002/zoo.1430140606; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 1995, ZOO BIOL, V14, P555, DOI 10.1002/zoo.1430140608; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Brown JL, 2004, ZOO BIOL, V23, P45, DOI 10.1002/zoo.10116; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Burks KD, 2004, ZOO BIOL, V23, P109, DOI 10.1002/zoo.10132; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Buwalda B, 2012, HORM BEHAV, V61, P218, DOI 10.1016/j.yhbeh.2011.12.012; Carlstead K, 2019, APPL ANIM BEHAV SCI, V211, P103, DOI 10.1016/j.applanim.2018.11.003; Casares M, 2016, ZOO BIOL, V35, P65, DOI 10.1002/zoo.21262; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Chave E, 2019, GEN COMP ENDOCR, V276, P1, DOI 10.1016/j.ygcen.2019.02.005; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; COLBORN DR, 1991, J ANIM SCI, V69, P2556; Cole J, 2018, J APPL ANIM WELF SCI, V21, P49, DOI 10.1080/10888705.2018.1513839; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dag O, 2018, R J, V10, P175; Dayton A, 2016, HYPERTENSION, V68, P1139, DOI 10.1161/HYPERTENSIONAHA.116.08207; de Silva S, 2017, BEHAV ECOL, V28, P243, DOI 10.1093/beheco/arw153; de Silva S, 2012, INT J PRIMATOL, V33, P1125, DOI 10.1007/s10764-011-9564-1; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Edwards KL, 2020, GEN COMP ENDOCR, V289, DOI 10.1016/j.ygcen.2019.113376; Edwards KL, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coy077; Edwards KL, 2016, GEN COMP ENDOCR, V225, P104, DOI 10.1016/j.ygcen.2015.09.011; Edwards KL, 2015, GEN COMP ENDOCR, V214, P186, DOI 10.1016/j.ygcen.2014.07.026; Edwards PD, 2018, GEN COMP ENDOCR, V259, P122, DOI 10.1016/j.ygcen.2017.11.012; Fanson B, 2014, HORMLONG LONGITUDINA; Fanson KV, 2014, ENDOCR CONNECT, V3, P57, DOI 10.1530/EC-14-0025; Fanson KV, 2013, EUR J WILDLIFE RES, V59, P655, DOI 10.1007/s10344-013-0718-7; Fernando P, 2003, PLOS BIOL, V1, P110, DOI 10.1371/journal.pbio.0000006; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Ganswindt A, 2010, WILDLIFE BIOL, V16, P323, DOI 10.2981/09-081; Garai Marion E., 2006, Zeitschrift des Koelner Zoo, V49, P85; Glaeser SS, 2012, THERIOGENOLOGY, V78, P285, DOI 10.1016/j.theriogenology.2012.01.014; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; Grand AP, 2012, APPL ANIM BEHAV SCI, V142, P69, DOI 10.1016/j.applanim.2012.09.002; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; Hambrecht S, 2020, ZOO BIOL, V39, P186, DOI 10.1002/zoo.21537; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Hovland AL, 2017, APPL ANIM BEHAV SCI, V197, P75, DOI 10.1016/j.applanim.2017.08.009; HOWLAND BE, 1985, J ANDROL, V6, P89; Kaewmanee S, 2011, THAI J VET MED, V41, P91; Kajaysri J, 2014, J VET MED SCI, V76, P363, DOI 10.1292/jvms.13-0103; Kersey DC, 2011, GEN COMP ENDOCR, V173, P364, DOI 10.1016/j.ygcen.2011.06.013; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kumar V, 2019, INDIAN J EXP BIOL, V57, P307; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; Lee B, 2019, AZA REGIONAL STUDBOO; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; LIPTRAP RM, 1968, J ENDOCRINOL, V42, P33, DOI 10.1677/joe.0.0420033; LIPTRAP RM, 1978, J ENDOCRINOL, V76, P75, DOI 10.1677/joe.0.0760075; Pesantez-Pacheco JL, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060295; MacDougall-Shackleton SA, 2019, INTEGR ORGANISM BIOL, V1, DOI 10.1093/iob/obz017; McCormick SD, 2017, BIOSCIENCE, V67, P429, DOI 10.1093/biosci/bix026; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Menargues A, 2012, J APPL ANIM WELF SCI, V15, P383, DOI 10.1080/10888705.2012.709157; Marcilla AM, 2012, GEN COMP ENDOCR, V176, P259, DOI 10.1016/j.ygcen.2012.02.001; Meyer JM, 2004, GEN COMP ENDOCR, V138, P263, DOI 10.1016/j.ygcen.2004.06.010; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Moberg GP., 2000, BIOL RESPONSE STRESS; MONFORT SL, 1990, J REPROD FERTIL, V88, P271; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Mumby HS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov030; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Norkaew T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204965; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; Pinter-Wollman N, 2009, BIOL CONSERV, V142, P1116, DOI 10.1016/j.biocon.2009.01.027; Pinto A, 2020, J ZOO AQUAR RES, V8, P45, DOI 10.19227/jzar.v8i1.406; Plotnik JM, 2014, PEERJ, V2, DOI 10.7717/peerj.278; Pokharel SS, 2019, WILDLIFE RES, V46, P679, DOI 10.1071/WR18163; Prado-Oviedo NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154750; Proctor CM, 2015, J ZOO AQUAR RES, V3, P1; Proctor CM, 2010, ZOO BIOL, V29, P168, DOI 10.1002/zoo.20292; R Core Team, 2020, R LANG ENV STAT COMP, DOI 11/44679/index.htm; Ralph CR, 2016, J ANIM SCI, V94, P457, DOI 10.2527/jas.2015-9645; Rasbash J, 2005, MLWIN V 2 02; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Schiml PA, 1999, BEHAV NEUROSCI, V113, P166; Schmid J, 2001, ANIM WELFARE, V10, P357; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Sharma N, 2020, PRIMATES, V61, P129, DOI 10.1007/s10329-019-00739-8; Sharma R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17042-5; Shepherdson DJ, 2004, ANIM WELFARE, V13, pS105; Sosa C, 2013, BIOL RHYTHM RES, V44, P445, DOI 10.1080/09291016.2012.704793; Stocker M, 2016, HORM BEHAV, V78, P194, DOI 10.1016/j.yhbeh.2015.11.009; Tetsuka M, 2007, ANIM SCI J, V78, P112, DOI 10.1111/j.1740-0929.2007.00414.x; Thitaram C, 2018, THERIOGENOLOGY, V109, P42, DOI 10.1016/j.theriogenology.2017.12.009; Turner AI, 2010, ENDOCRINOLOGY, V151, P4324, DOI 10.1210/en.2010-0234; Viijoen JJ, 2008, S AFR J WILDL RES, V38, P146; Viljoen Jozua J., 2008, Koedoe, V50, P18; Wielebnowski N, 2003, J AM VET MED ASSOC, V223, P973, DOI 10.2460/javma.2003.223.973; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016	116	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241910	10.1371/journal.pone.0241910	http://dx.doi.org/10.1371/journal.pone.0241910			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156856	gold, Green Published			2022-12-26	WOS:000591376400044
J	Sharma, T; Langlois, C; Morassut, RE; Meyre, D				Sharma, Tanmay; Langlois, Christine; Morassut, Rita E.; Meyre, David			Effect of living arrangement on anthropometric traits in first-year university students from Canada: The GENEiUS study	PLOS ONE			English	Article							FRESHMAN WEIGHT-GAIN; PHYSICAL-ACTIVITY; OBESITY; ADJUSTMENT; OVERWEIGHT; ADIPOSITY; ADULTHOOD; EPIDEMIC; COLLEGE; RISK	Background The transition to university often involves a change in living arrangement for many first-year students. While weight gain during first year of university has been well documented, Canadian literature on the impact of living arrangement within this context is limited. The objective of this investigation was to explore the effect of living arrangement on anthropometric traits in first-year university students from Ontario, Canada. Methods 244 first-year undergraduate students were followed longitudinally with data collected early in the academic year and towards the end of the year. Anthropometric parameters including weight, waist and hip circumference, body mass index (BMI), and waist-to-hip ratio (WHR) were examined. The Wilcoxon signed-rank test was used for pairwise comparison of traits from the beginning to end the year in the absence of adjustments. Additionally, linear regression models with covariate adjustments were used to investigate effect of the type of living arrangement (i.e. on-campus, off-campus, or family home) on the aforementioned traits. Results In the overall sample, a significant weight increase of 1.55kg (95% CI: 1.24-1.86) was observed over the school year (p<0.001), which was also accompanied by significant gains in BMI, and waist and hip circumferences (p<0.001). At baseline, no significant differences were found between people living on-campus, off-campus, and at home with family. Stratified analysis of change by type of living arrangement indicated significant gains across all traits among students living on-campus (p<0.05), and significant gains in weight and BMI among students living at home with family. Additionally, a comparison between living arrangements revealed that students living on campus experienced significantly larger gains in weight and BMI compared to students living off-campus (p<0.05). Conclusion Our findings indicate that living arrangement is associated with different weight gain trajectories in first-year university students.	[Sharma, Tanmay; Langlois, Christine; Morassut, Rita E.; Meyre, David] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca		Morassut, Rita/0000-0001-5617-4366	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DM holds a Canada Research Chair in Genetics of Obesity. TS is supported by the Canadian Institutes of Health Research Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; [Anonymous], 2018, NEUROSURG FOCUS, V45; [Anonymous], 2009, COMMUNICATION TECHNO, V09, P88; Association ACH, 2018, NAT COLL HLTH ASS UN; Baum CL, 2017, DEMOGRAPHY, V54, P311, DOI 10.1007/s13524-016-0530-6; Brown DMY, 2014, J AM COLL HEALTH, V62, P234, DOI 10.1080/07448481.2014.887572; Buote VM, 2007, J ADOLESCENT RES, V22, P665, DOI 10.1177/0743558407306344; Canada S, 2016, BOD MASS IND OV OB S; Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Dhillon J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040816; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fryar CD, 2016, NATL HLTH STAT REPOR, P1; Guo G, 2015, SOC SCI RES, V52, P193, DOI 10.1016/j.ssresearch.2015.01.002; Guo SS, 1999, AM J CLIN NUTR, V70, p145S; Hilbrecht M., 2014, World Leisure Journal, V56, P151, DOI 10.1080/16078055.2014.903723; Hirko KA, 2015, AM J EPIDEMIOL, V182, P441, DOI 10.1093/aje/kwv084; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Leischner K, 2018, HEALTHFULNESS ENTREE, P28; Leon AC, 2007, STAT MED, V26, P1712, DOI 10.1002/sim.2795; Levitsky DA, 2004, INT J OBESITY, V28, P1435, DOI 10.1038/sj.ijo.0802776; Li Y, 2016, J HEALTH SOC BEHAV, V57, P297, DOI 10.1177/0022146516661594; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendoza JA, 2011, J PHYS ACT HEALTH, V8, P488, DOI 10.1123/jpah.8.4.488; Mihalopoulos NL, 2008, J AM COLL HEALTH, V56, P531, DOI 10.3200/JACH.56.5.531-534; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Morassut RE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019365; Nelson MC, 2009, AM J PREV MED, V36, P523, DOI 10.1016/j.amepre.2009.01.030; Organization WHO, 2011, WAIST CIRCUMFERENCE; Pliner P, 2008, PHYSIOL BEHAV, V93, P76, DOI 10.1016/j.physbeh.2007.07.017; Provencher V, 2009, PHYSIOL BEHAV, V96, P135, DOI 10.1016/j.physbeh.2008.09.011; Racette SB, 2005, J AM COLL HEALTH, V53, P245, DOI 10.3200/JACH.53.6.245-251; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; Ryan DH, 2017, CURR OBES REP, V6, P187, DOI 10.1007/s13679-017-0262-y; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Urhonen Terhi, 2016, Prev Med Rep, V4, P490, DOI 10.1016/j.pmedr.2016.09.001; Vadeboncoeur Claudia, 2015, BMC Obes, V2, P22, DOI 10.1186/s40608-015-0051-7; van Woerden I, 2020, APPETITE, V144, DOI 10.1016/j.appet.2019.104482; Vella-Zarb RA, 2010, HEALTH EDUC J, V69, P321, DOI 10.1177/0017896910369416; Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392; Wengreen HJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-32; Yakusheva O, 2011, ECON HUM BIOL, V9, P119, DOI 10.1016/j.ehb.2010.12.002; Zheng Y, 2017, JAMA-J AM MED ASSOC, V318, P255, DOI 10.1001/jama.2017.7092	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241744	10.1371/journal.pone.0241744	http://dx.doi.org/10.1371/journal.pone.0241744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156864	gold, Green Published			2022-12-26	WOS:000591376400033
J	Tran, PN; Sheng, JS; Randolph, AL; Baron, CA; Thiebaud, N; Ren, M; Wu, M; Johannesen, L; Volpe, DA; Patel, D; Blinova, K; Strauss, DG; Wu, WW				Tran, Phu N.; Sheng, Jiansong; Randolph, Aaron L.; Baron, Claudia Alvarez; Thiebaud, Nicolas; Ren, Ming; Wu, Min; Johannesen, Lars; Volpe, Donna A.; Patel, Dakshesh; Blinova, Ksenia; Strauss, David G.; Wu, Wendy W.			Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block	PLOS ONE			English	Article							MU-OPIOID-RECEPTOR; CELL-DERIVED CARDIOMYOCYTES; ANESTHETIC-LIKE INHIBITION; CARDIAC REPOLARIZATION; INTERVAL PROLONGATION; IN-VITRO; METHADONE; NALOXONE; AGONIST; BINDING	Buprenorphine is a mu-opioid receptor (MOR) partial agonist used to manage pain and addiction. QT(C) prolongation that crosses the 10 msec threshold of regulatory concern was observed at a supratherapeutic dose in two thorough QT studies for the transdermal buprenorphine product BUTRANS(R). Because QT(C) prolongation can be associated with Torsades de Pointes (TdP), a rare but potentially fatal ventricular arrhythmia, these results have led to further investigation of the electrophysiological effects of buprenorphine. Drug-induced QT(C) prolongation and TdP are most commonly caused by acute inhibition of hERG current (I-hERG) that contribute to the repolarizing phase of the ventricular action potentials (APs). Concomitant inhibition of inward late Na+ (I-NaL) and/or L-type Ca2+ (I-CaL) current can offer some protection against proarrhythmia. Therefore, we characterized the effects of buprenorphine and its major metabolite norbuprenorphine on cardiac hERG, Ca2+, and Na+ ion channels, as well as cardiac APs. For comparison, methadone, a MOR agonist associated with QT(C) prolongation and high TdP risk, and naltrexone and naloxone, two opioid receptor antagonists, were also studied. Whole cell recordings were performed at 37 degrees C on cells stably expressing hERG, Ca(V)1.2, and Na(V)1.5 proteins. Microelectrode array (MEA) recordings were made on human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The results showed that buprenorphine, norbuprenorphine, naltrexone, and naloxone had no effect on I-hERG, I-CaL, I-NaL, and peak Na+ current (I-NaP) at clinically relevant concentrations. In contrast, methadone inhibited I-hERG, I-CaL, and I-NaL. Experiments on iPSC-CMs showed a lack of effect for buprenorphine, norbuprenorphine, naltrexone, and naloxone, and delayed repolarization for methadone at clinically relevant concentrations. The mechanism of QT(C) prolongation is opioid moiety-specific. This remains undefined for buprenorphine, while for methadone it involves direct hERG channel block. There is no evidence that buprenorphine use is associated with TdP. Whether this lack of TdP risk can be generalized to other drugs with QT(C) prolongation not mediated by acute hERG channel block warrants further study.	[Tran, Phu N.; Sheng, Jiansong; Randolph, Aaron L.; Baron, Claudia Alvarez; Thiebaud, Nicolas; Ren, Ming; Wu, Min; Volpe, Donna A.; Strauss, David G.; Wu, Wendy W.] US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Tran, Phu N.; Wu, Min] US FDA, Div Immunol & Hematol Devices, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Sheng, Jiansong] CiPALab, Gaithersburg, MD USA; [Thiebaud, Nicolas] Vertex Pharmaceut Europe Ltd, Abingdon, Oxon, England; [Johannesen, Lars] US FDA, Div Cardiol & Nephrol, Off Cardiol Hematol Endocrinol & Nephrol, Off New Drugs,Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Patel, Dakshesh; Blinova, Ksenia] US FDA, Div Biomed Phys, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Patel, Dakshesh] Harvard Med Sch, Cardiovasc Res Ctr, Massachusetts Gen Hosp, Boston, MA 02115 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Vertex Pharmaceuticals; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Harvard Medical School; Massachusetts General Hospital	Wu, WW (corresponding author), US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	wendy.wu@fda.hhs.gov	Strauss, David G/A-9211-2012	Patel, Dakshesh/0000-0002-6507-9771; Volpe, Donna/0000-0002-8286-9679	United States Food and Drug Administration (FDA); Department of Energy; FDA	United States Food and Drug Administration (FDA); Department of Energy(United States Department of Energy (DOE)); FDA(United States Department of Health & Human Services)	This work was supported by internal funding from the United States Food and Drug Administration (FDA) and appointment to the Research Participation Programs at the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the Department of Energy and FDA.	Abi-Gerges N, 2011, BRIT J PHARMACOL, V164, P419, DOI 10.1111/j.1476-5381.2011.01378.x; Alexandrou AJ, 2006, BRIT J PHARMACOL, V147, P905, DOI 10.1038/sj.bjp.0706678; ASALI LA, 1984, EUR J CLIN PHARMACOL, V27, P459, DOI 10.1007/BF00549595; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Blinova K, 2018, CELL REP, V24, P3582, DOI 10.1016/j.celrep.2018.08.079; Blinova K, 2017, TOXICOL SCI, V155, P234, DOI 10.1093/toxsci/kfw200; BOACHIEANSAH G, 1989, BRIT J PHARMACOL, V97, P801, DOI 10.1111/j.1476-5381.1989.tb12019.x; Bourgonje VJA, 2013, CIRC-ARRHYTHMIA ELEC, V6, P371, DOI 10.1161/CIRCEP.113.000322; BRASCH H, 1986, BRIT J PHARMACOL, V88, P733, DOI 10.1111/j.1476-5381.1986.tb16245.x; Brimecombe Jessica C., 2009, Journal of Pharmacological and Toxicological Methods, V59, P29, DOI 10.1016/j.vascn.2008.10.004; Brown SM, 2011, ANESTHESIOLOGY, V115, P1251, DOI 10.1097/ALN.0b013e318238fea0; Cassel JA, 2005, EUR J PHARMACOL, V520, P29, DOI 10.1016/j.ejphar.2005.08.008; CERBAI E, 1989, EUR J PHARMACOL, V162, P491, DOI 10.1016/0014-2999(89)90340-3; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Darpo B, 2016, CLIN THER, V38, P315, DOI 10.1016/j.clinthera.2015.12.004; Eap CB, 2007, CLIN PHARMACOL THER, V81, P719, DOI 10.1038/sj.clpt.6100120; Florian J, 2012, CLIN PHARMACOL THER, V91, P666, DOI 10.1038/clpt.2011.273; Frame LH, 1985, CIRCULATION, V72, pIII; FRANCOCERECEDA A, 1987, CIRC RES, V60, P393, DOI 10.1161/01.RES.60.3.393; Gintant G, 2011, PHARMACOL THERAPEUT, V129, P109, DOI 10.1016/j.pharmthera.2010.08.008; Goineau S, 2013, REGUL TOXICOL PHARM, V67, P499, DOI 10.1016/j.yrtph.2013.10.001; Guo JQ, 2005, HEART RHYTHM, V2, P860, DOI 10.1016/j.hrthm.2005.04.029; Harris SC, 2017, POSTGRAD MED, V129, P69, DOI 10.1080/00325481.2017.1270156; Huang P, 2001, J PHARMACOL EXP THER, V297, P688; Hung CF, 1998, LIFE SCI, V63, P1205, DOI 10.1016/S0024-3205(98)00383-X; Isbister GK, 2017, BRIT J CLIN PHARMACO, V83, P2274, DOI 10.1111/bcp.13326; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Katchman AN, 2002, J PHARMACOL EXP THER, V303, P688, DOI 10.1124/jpet.102.038240; Kauthale RR, 2015, J APPL TOXICOL, V35, P799, DOI 10.1002/jat.3074; Khanna IK, 2015, J PAIN RES, V8, DOI 10.2147/JPR.S85951; Khroyan TV, 2015, BRIT J PHARMACOL, V172, P668, DOI 10.1111/bph.12796; Kirsch Glenn E., 2004, Journal of Pharmacological and Toxicological Methods, V50, P93, DOI 10.1016/j.vascn.2004.06.003; Kuryshev YA, 2010, J CARDIOVASC PHARM, V56, P420, DOI 10.1097/FJC.0b013e3181f1d21b; LEDDA F, 1984, EUR J PHARMACOL, V102, P443, DOI 10.1016/0014-2999(84)90565-X; Leffler A, 2012, ANESTHESIOLOGY, V116, P1335, DOI 10.1097/ALN.0b013e3182557917; Li G, 2009, BIOORG MED CHEM LETT, V19, P1825, DOI 10.1016/j.bmcl.2008.12.093; MANTELLI L, 1987, GEN PHARMACOL-VASC S, V18, P309, DOI 10.1016/0306-3623(87)90017-6; MANTELLI L, 1986, ARCH INT PHARMACOD T, V282, P298; Martell BA, 2005, AM J CARDIOL, V95, P915, DOI 10.1016/j.amjcard.2004.11.055; MESTEK A, 1995, J NEUROSCI, V15, P2396, DOI 10.1523/JNEUROSCI.15-03-02396.1995; MUSHA T, 1989, J PHARMACOL EXP THER, V250, P1087; Niciu MJ, 2013, CNS DRUGS, V27, P777, DOI 10.1007/s40263-013-0096-4; OLDROYD KG, 1993, CARDIOVASC RES, V27, P296, DOI 10.1093/cvr/27.2.296; Peng XM, 2007, J MED CHEM, V50, P2254, DOI 10.1021/jm061327z; Pollard CE, 2017, TOXICOL SCI, V159, P94, DOI 10.1093/toxsci/kfx125; RAYNOR K, 1995, J PHARMACOL EXP THER, V272, P423; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Schocken D, 2018, J PHARMACOL TOX MET, V90, P39, DOI 10.1016/j.vascn.2017.11.002; Schulze V, 2014, BRIT J PHARMACOL, V171, P427, DOI 10.1111/bph.12465; Shah RR, 2006, PHARMACOGENOMICS, V7, P889, DOI 10.2217/14622416.7.6.889; SHIMIZU W, 1995, J AM COLL CARDIOL, V26, P1299, DOI 10.1016/0735-1097(95)00313-4; Sobanski P, 2014, HEART VESSELS, V29, P855, DOI 10.1007/s00380-013-0456-5; Stockbridge N, 2013, DRUG SAFETY, V36, P167, DOI 10.1007/s40264-013-0016-z; TITELER M, 1989, EUR J PHARMACOL, V167, P221, DOI 10.1016/0014-2999(89)90582-7; Toll L, 1998, NIDA Res Monogr, V178, P440; TRAYNOR JR, 1995, MOL PHARMACOL, V47, P848; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS133; Tschirhart JN, 2019, MOL PHARMACOL, V95, P386, DOI 10.1124/mol.118.114751; Volpe DA, 2011, REGUL TOXICOL PHARM, V59, P385, DOI 10.1016/j.yrtph.2010.12.007; Walker BD, 1999, BRIT J PHARMACOL, V128, P444, DOI 10.1038/sj.bjp.0702774; Wang DX, 2007, J PHARMACOL EXP THER, V321, P544, DOI 10.1124/jpet.106.118810; Wedam EF, 2007, ARCH INTERN MED, V167, P2469, DOI 10.1001/archinte.167.22.2469; Wei XH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01056-0; WEITZELL R, 1984, N-S ARCH PHARMACOL, V328, P186, DOI 10.1007/BF00512070; Wentland MP, 2009, BIOORG MED CHEM LETT, V19, P203, DOI 10.1016/j.bmcl.2008.10.134; Wu M, 2019, J PHARMACOL TOX MET, V100, DOI 10.1016/j.vascn.2019.106605; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x; Yao Jian-An, 2005, Journal of Pharmacological and Toxicological Methods, V52, P146, DOI 10.1016/j.vascn.2005.04.008; Zaveri N, 2001, EUR J PHARMACOL, V428, P29, DOI 10.1016/S0014-2999(01)01282-1; Zhabyeyev P, 2019, CHANNELS, V13, P520, DOI 10.1080/19336950.2019.1697127; Zhabyeyev P, 2019, J MOL CELL CARDIOL, V132, P98, DOI 10.1016/j.yjmcc.2019.05.008; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zunkler BJ, 2010, CARDIOVASC TOXICOL, V10, P161, DOI 10.1007/s12012-010-9074-y	74	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241362	10.1371/journal.pone.0241362	http://dx.doi.org/10.1371/journal.pone.0241362			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33157550	Green Published, gold			2022-12-26	WOS:000591376400001
J	Choi, J; Kim, SH; Han, S; Lee, D; Shim, JH; Lim, YS; Lee, HC; Chung, YH; Lee, YS; Lee, SG; Kim, KH; Kim, KM				Choi, Jonggi; Kim, So-Hyun; Han, Seungbong; Lee, Danbi; Shim, Ju Hyun; Lim, Young-Suk; Lee, Han Chu; Chung, Young-Hwa; Lee, Yung Sang; Lee, Sung-Gyu; Kim, Ki-Hun; Kim, Kang Mo			A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma	PLOS ONE			English	Article							SCORE; HEPATECTOMY; MORTALITY; FAILURE; COMPLICATIONS; DISEASE; DEATH	Background & aim Hepatic resection is a treatment option for patients with hepatocellular carcinoma (HCC). However, factors associated with candidacy for resection and predictive of liver-related morbidity after resection for HCC remain unclear. This study aimed to assess candidacy for liver resection in patients with HCC and to design a model predictive of liver-related morbidity after resection. Methods A retrospective analysis of 1,565 patients who underwent liver resection for HCC between January 2016 and December 2017 was performed. The primary outcome was liver-related morbidity, including post-hepatectomy biochemical dysfunction (PHBD), ascites, hepatic encephalopathy, rescue liver transplantation, and death from any cause within 90 days. PHBD was defined as international normalized ratio (INR) > 1.5 or hyperbilirubinemia (> 2.9 mg/dL) on postoperative day >= 5. Results The 1,565 patients included 1,258 (80.4%) males and 307 (19.6%) females with a mean age of 58.3 years. Of these patients, 646 (41.3%) and 919 (58.7%) patients underwent major and minor liver resection, respectively. Liver-related morbidity was observed in 133 (8.5%) patients, including 77 and 56 patients who underwent major and minor resection, respectively. A total of 83 (5.3%) patients developed PHBD. Multivariate analysis identified cut-off values of the platelet count, serum albumin concentration, and ICG R15 value for predicting liver-related morbidity after resection. A model predicting postoperative liver-related morbidity was developed, which included seven factors: male sex, age >= 55 years, ICG R15 value >= 15%, major resection, platelet count < 150,000/mm(3), serum albumin concentration < 3.5 g/dL, and INR > 1.1. Conclusion Hepatic resection for HCC was safe with 90-day liver-related morbidity and mortality rates of 8.5% and 0.8%, respectively. The developed point-based scoring system with seven factors could allow the prediction of the risk of liver-related morbidity after resection for HCC.	[Choi, Jonggi; Kim, So-Hyun; Lee, Danbi; Shim, Ju Hyun; Lim, Young-Suk; Lee, Han Chu; Chung, Young-Hwa; Lee, Yung Sang; Kim, Kang Mo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Asan Liver Ctr, Seoul, South Korea; [Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam Si, South Korea; [Lee, Sung-Gyu; Kim, Ki-Hun] Univ Ulsan, Coll Med, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; Gachon University; University of Ulsan	Kim, KM (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Asan Liver Ctr, Seoul, South Korea.; Kim, KH (corresponding author), Univ Ulsan, Coll Med, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Asan Med Ctr, Seoul, South Korea.	khkim620@amc.seoul.kr; kimkm70@amc.seoul.kr	Choi, Jonggi/L-1521-2019					Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Child C G, 1964, Major Probl Clin Surg, V1, P1; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Cucchetti A, 2006, LIVER TRANSPLANT, V12, P966, DOI 10.1002/lt.20761; De Gasperi A, 2016, WORLD J HEPATOL, V8, P355, DOI 10.4254/wjh.v8.i7.355; Dinant S, 2007, J NUCL MED, V48, P685, DOI 10.2967/jnumed.106.038430; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Han HS, 2015, J HEPATOL, V63, P643, DOI 10.1016/j.jhep.2015.04.005; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hyder O, 2013, J AM COLL SURGEONS, V216, P1049, DOI 10.1016/j.jamcollsurg.2013.01.004; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Madoff DC, 2003, RADIOLOGY, V227, P251, DOI 10.1148/radiol.2271012010; Mai RY, 2019, CANCER MANAG RES, V11, P8799, DOI 10.2147/CMAR.S213432; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Rahbari NN, 2011, ANN SURG ONCOL, V18, P3640, DOI 10.1245/s10434-011-1829-6; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Reissfelder C, 2011, BRIT J SURG, V98, P836, DOI 10.1002/bjs.7459; Ross SW, 2016, SURGERY, V159, P777, DOI 10.1016/j.surg.2015.08.021; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Serenari M, 2020, J HEPATOL, V73, P855, DOI 10.1016/j.jhep.2020.04.032; Sposito C, 2016, BRIT J SURG, V103, P871, DOI 10.1002/bjs.10137; STRASBERG SM, 2000, HPB, V2, P333, DOI DOI 10.1080/136518202760378489; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Teh SH, 2007, GASTROENTEROLOGY, V132, P1261, DOI 10.1053/j.gastro.2007.01.040; van Buuren S, 2011, J STAT SOFTW, V45, P1; Yoon YI, 2017, ANN SURG, V265, P856, DOI 10.1097/SLA.0000000000002072; Zhang ZQ, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1500-9; Zhang ZH, 2019, CANCER RES TREAT, V51, P65, DOI 10.4143/crt.2018.038	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241808	10.1371/journal.pone.0241808	http://dx.doi.org/10.1371/journal.pone.0241808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152023	Green Published, gold			2022-12-26	WOS:000591376200025
J	Maurer, MN; Roebers, CM				Maurer, Michelle N.; Roebers, Claudia M.			Is the fine motor-executive functions link stronger for new compared to repeated fine motor tasks?	PLOS ONE			English	Article							SKILLS; PERFORMANCE; PRINCIPLES; CONTRIBUTE	Although the motor-executive function (EF) link is actively being investigated, there remain open questions surrounding why some studies found associations between specific motor and specific EF tasks, while others did not. Furthermore, it is also yet unknown which factors impact the magnitude of the motor-EF link. Findings from neuroimaging studies have proposed that neural activity in networks that are important for motor and cognitive tasks is especially strong when a task is new. In the present behavioral study, we systematically investigated the impact that task novelty had on the motor-EF link. In our study, n = 124 kindergarten children aged five to six administered in a within-subject design three fine motor tasks of the Movement Assessment Battery for Children-2 (Posting Coins, Threading Beads, and Drawing Trail) twice in succession (new vs. repeated), and three EF tasks (adapted versions of a Flanker, a N-back, and the Advanced Dimensional Chance Card Sort task). Results not only replicated the fine motor-EF link, but also showed a significantly stronger association between EF and the new task compared to the repeated Drawing Trail task. However, for the time-based task of Posting Coins and Threading Beads, motor-EF associations did not differ between the new task and the repeated task. Future investigations of more than two repetitions will provide further insights into the assumption that the motor-EF link is mainly driven by the EF processes triggered when a task is new, demands attention, and requires fast and flexible adaptation.	[Maurer, Michelle N.; Roebers, Claudia M.] Univ Bern, Inst Psychol, Dept Dev Psychol, Bern, Switzerland	University of Bern	Maurer, MN (corresponding author), Univ Bern, Inst Psychol, Dept Dev Psychol, Bern, Switzerland.	michelle.maurer@psy.unibe.ch		Maurer, Michelle N./0000-0003-4014-8619				ACKERMAN PL, 1988, J EXP PSYCHOL GEN, V117, P288, DOI 10.1037/0096-3445.117.3.288; Becker DR, 2014, EARLY CHILD RES Q, V29, P411, DOI 10.1016/j.ecresq.2014.04.014; Cameron CE, 2012, CHILD DEV, V83, P1229, DOI 10.1111/j.1467-8624.2012.01768.x; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Duran CAK, 2018, EARLY CHILD RES Q, V42, P21, DOI 10.1016/j.ecresq.2017.08.005; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FISK AD, 1983, J EXP PSYCHOL LEARN, V9, P177, DOI 10.1037/0278-7393.9.2.177; Fitts PM., 1967, HUM PERFORM; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Jager K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01473; Lee I. A., 2013, CALCULATION TEST DIF; Lee K, 2013, CHILD DEV, V84, P1933, DOI 10.1111/cdev.12096; Lee K, 2011, J EDUC PSYCHOL, V103, P269, DOI 10.1037/a0023068; Livesey D, 2006, HUM MOVEMENT SCI, V25, P50, DOI 10.1016/j.humov.2005.10.008; McClelland MM, 2018, EARLY CHILD RES Q, V46, P142, DOI 10.1016/j.ecresq.2018.03.014; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Oberer N, 2017, HUM MOVEMENT SCI, V52, P170, DOI 10.1016/j.humov.2017.02.002; Petermann F., 2011, MOVEMENT ASSESSMENT; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Roebers CM, 2009, DEVELOPMENTAL SCI, V12, P175, DOI 10.1111/j.1467-7687.2008.00755.x; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Stockel T, 2016, PSYCHOL RES-PSYCH FO, V80, P543, DOI 10.1007/s00426-015-0662-0; van der Fels IMJ, 2015, J SCI MED SPORT, V18, P697, DOI 10.1016/j.jsams.2014.09.007; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P226, DOI 10.1037/a0025361; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Zhang L, 2018, EARLY EDUC DEV, V29, P1061, DOI 10.1080/10409289.2018.1510204	32	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241308	10.1371/journal.pone.0241308	http://dx.doi.org/10.1371/journal.pone.0241308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151994	Green Published, gold			2022-12-26	WOS:000591376200114
J	Single, RM; Meyer, D; Nunes, K; Francisco, RS; Hunemeier, T; Maiers, M; Hurley, CK; Bedoya, G; Gallo, C; Hurtado, AM; Llop, E; Petzl-Erler, ML; Poletti, G; Rothhammer, F; Tsuneto, L; Klitz, W; Ruiz-Linares, A				Single, Richard M.; Meyer, Diogo; Nunes, Kelly; Francisco, Rodrigo Santos; Hunemeier, Tabita; Maiers, Martin; Hurley, Carolyn K.; Bedoya, Gabriel; Gallo, Carla; Hurtado, Ana Magdalena; Llop, Elena; Petzl-Erler, Maria Luiza; Poletti, Giovanni; Rothhammer, Francisco; Tsuneto, Luiza; Klitz, William; Ruiz-Linares, Andres			Demographic history and selection at HLA loci in Native Americans	PLOS ONE			English	Article							STATISTICAL EVALUATION; HAPLOTYPE FREQUENCIES; BALANCING SELECTION; B ALLELES; POPULATIONS; AMERINDIANS; PERSPECTIVE; EVOLUTION; ANCESTRY; MODELS	The American continent was the last to be occupied by modern humans, and native populations bear the marks of recent expansions, bottlenecks, natural selection, and population substructure. Here we investigate how this demographic history has shaped genetic variation at the strongly selected HLA loci. In order to disentangle the relative contributions of selection and demography process, we assembled a dataset with genome-wide microsatellites and HLA-A, -B, -C, and -DRB1 typing data for a set of 424 Native American individuals. We find that demographic history explains a sizeable fraction of HLA variation, both within and among populations. A striking feature of HLA variation in the Americas is the existence of alleles which are present in the continent but either absent or very rare elsewhere in the world. We show that this feature is consistent with demographic history (i.e., the combination of changes in population size associated with bottlenecks and subsequent population expansions). However, signatures of selection at HLA loci are still visible, with significant evidence selection at deeper timescales for most loci and populations, as well as population differentiation at HLA loci exceeding that seen at neutral markers.	[Single, Richard M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Meyer, Diogo; Nunes, Kelly; Francisco, Rodrigo Santos; Hunemeier, Tabita] Univ Sao Paulo, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Maiers, Martin] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Hurley, Carolyn K.] Georgetown Univ, CW Bill Young Marrow Donor Recruitment & Res Prog, Washington, DC USA; [Bedoya, Gabriel] Univ Antioquia Medellin, Inst Biol, Medellin, Colombia; [Gallo, Carla] Univ Peruana Cayetano Heredia, Labs Invest & Desarrollo, Lima, Peru; [Hurtado, Ana Magdalena] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Llop, Elena; Rothhammer, Francisco] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago, Chile; [Petzl-Erler, Maria Luiza] Univ Fed Parana, Dept Genet, Curitiba, Parana, Brazil; [Poletti, Giovanni] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru; [Rothhammer, Francisco] Tarapaca Univ, Inst Alta Invest, Arica, Chile; [Tsuneto, Luiza] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil; [Klitz, William] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ruiz-Linares, Andres] Fudan Univ, Key Lab Contemporary Anthropol, Sch Life Sci & Human Phenome Inst, Minist Educ, Shanghai, Peoples R China; [Ruiz-Linares, Andres] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci & Human Phenome Inst, Shanghai, Peoples R China; [Ruiz-Linares, Andres] D Aix Marseille Univ, ADES, EFS, CNRS, Marseille, France	University of Vermont; Universidade de Sao Paulo; Center for International Blood & Marrow Transplant Research; Georgetown University; Universidad de Antioquia; Universidad Peruana Cayetano Heredia; Arizona State University; Arizona State University-Tempe; Universidad de Chile; Universidade Federal do Parana; Universidad Peruana Cayetano Heredia; Universidad de Tarapaca; Universidade Estadual de Maringa; University of California System; University of California Berkeley; Fudan University; Fudan University; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Single, RM (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.	Richard.Single@uvm.edu	Nunes, Kelly/AAU-6879-2021; Petzl-Erler, Maria Luiza/H-8221-2012; Ruiz-Linares, Andres/AAR-1104-2021	Nunes, Kelly/0000-0003-0864-2414; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Ruiz-Linares, Andres/0000-0001-8372-1011; Meyer, Diogo/0000-0002-7155-5674; Maiers, Martin/0000-0002-0198-2064; Bedoya, Gbriel/0000-0001-7281-3981; Hunemeier, Tabita/0000-0002-3156-2079	Sao Paulo Research Foundation [12/18010-0]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support for this work was provided by the Sao Paulo Research Foundation, www.fapesp.br, grant 12/18010-0 (DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Amos W, 2010, P R SOC B, V277, P131, DOI 10.1098/rspb.2009.1473; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; BLACK FL, 1981, AM J HUM GENET, V33, P894; Brandt DYC, 2018, G3-GENES GENOM GENET, V8, P2805, DOI 10.1534/g3.118.200367; Buhler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014643; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Flegontov P, 2019, NATURE, V570, P236, DOI 10.1038/s41586-019-1251-y; Garrigan D, 2003, EVOLUTION, V57, P1707; Gnecchi-Ruscone GA, 2019, MOL BIOL EVOL, V36, P1254, DOI 10.1093/molbev/msz066; Goncalves VF, 2013, P NATL ACAD SCI USA, V110, P6465, DOI 10.1073/pnas.1217905110; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harris DN, 2018, P NATL ACAD SCI USA, V115, pE6526, DOI 10.1073/pnas.1720798115; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; Lancaster Alex, 2003, Pac Symp Biocomput, P514; Lewis CM, 2005, AM J PHYS ANTHROPOL, V127, P351, DOI 10.1002/ajpa.20102; Lewontin RC, 1973, GENETICS; Lindo J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4921; Lindo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13175; Malaspinas AS, 2014, CURR BIOL, V24, pR1035, DOI 10.1016/j.cub.2014.09.078; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Parham P, 1997, TISSUE ANTIGENS, V50, P219, DOI 10.1111/j.1399-0039.1997.tb02866.x; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pinotti T, 2019, CURR BIOL, V29, P149, DOI 10.1016/j.cub.2018.11.029; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rivet P, 1957, ORIGINES HOMME AM; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Single RM, 2007, TISSUE ANTIGENS, V69, P185, DOI 10.1111/j.1399-0039.2006.00767.x; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Strauss A, 2015, AM J PHYS ANTHROPOL, V157, P202, DOI 10.1002/ajpa.22703; TAJIMA F, 1989, GENETICS, V123, P585; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tu B, 2007, TISSUE ANTIGENS, V69, P73, DOI 10.1111/j.1399-0039.2006.00728.x; Vina MAF, 2012, PHILOS T R SOC B, V367, P820, DOI 10.1098/rstb.2011.0320; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WATTERSON GA, 1978, GENETICS, V88, P405	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241282	10.1371/journal.pone.0241282	http://dx.doi.org/10.1371/journal.pone.0241282			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147239	Green Published, gold			2022-12-26	WOS:000589609300005
J	Ssemata, AS; Opoka, RO; Ssenkusu, JM; Nakasujja, N; John, CC; Bangirana, P				Ssemata, Andrew S.; Opoka, Robert O.; Ssenkusu, John M.; Nakasujja, Noeline; John, Chandy C.; Bangirana, Paul			Neurodevelopmental performance among pre-schoolers treated for severe anaemia at lira regional referral hospital, Uganda	PLOS ONE			English	Article							SEVERE MALARIAL ANEMIA; INTERMITTENT TREATMENT; SYSTEMATIC ANALYSIS; COGNITIVE FUNCTION; CHILD-DEVELOPMENT; CEREBRAL MALARIA; LOW-INCOME; BRAIN; INFANTS; PREVALENCE	Background Severe anaemia is a common clinical problem among young children in sub-Saharan Africa. However, the effect of severe anaemia on neurodevelopment of these children is not well described. Therefore, we assessed the neurodevelopmental performance of preschool children diagnosed with severe anaemia in Northern Uganda. Methods We conducted a prospective cohort study among children < 5 years of age 14 days post discharge after an episode of severe anaemia (Hb < 5.0 g/dl; n = 171; mean Hb = 3.9g/dl) at Lira Regional Referral Hospital, Uganda. Neurodevelopmental outcomes (cognitive, language and motor) were assessed using Bayley Scales of Infant and Toddler Development, 3(rd) edition (Bayley-III). Age-adjusted z-scores for each domain were calculated using scores from healthy community control children (n = 88) recruited from the same environment for each age category. Multiple linear regression was used to compare z-scores in the cognitive, language and motor scales between the two groups after adjusting for weight-for-age z-score, socioeconomic status, mother's education, and father's employment on all the scales. Results The prevalence of neurodevelopmental impairment was 2.3% (95% CI: 0.8-6.1) for cognition, 1.7% (95%: 0.6-5.3) for language and 3.5% (95% CI: 1.6-7.6) for motor scales and 4.6% (95% CI: 2.3-9.1) for deficits in >= 1 area of neurodevelopment. Significant differences were observed between the two groups with the SA group performing worse on cognition [adjusted mean score, (Standard error, SE), P-value] [-0.20, (0.01) vs. 0.00, (0.01), P = 0.02]; language [-0.25, (0.01) vs. 0.00, (0.01), P 0.001]; and motor [-0.17, (0.01) vs. 0.00, (0.01), P = 0.05] scales. Conclusion In children < 5 years of age, severe anaemia was associated with neurocognitive (cognition, language and motor) deficits in the immediate period post treatment. Further research is needed to identify risk factors and determine the long-term effects of poor neurodevelopment in young children with severe anaemia.	[Ssemata, Andrew S.; Nakasujja, Noeline; Bangirana, Paul] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Opoka, Robert O.] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Ssenkusu, John M.] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [John, Chandy C.] Ryan White Ctr Pediat Infect Dis & Global Hlth, Sch Med, Indianapolis, IN USA	Makerere University; Makerere University; Makerere University	Ssemata, AS (corresponding author), Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda.	andrewssemata@yahoo.co.uk	Nakasujja, Noeline/GSI-4189-2022; John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411	National Institutes of Health [D43TW010132]; Fogarty International Centre [D43 NS078280]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by funding from grant number D43TW010132 from National Institutes of Health and a Fogarty International Centre grant number D43 NS078280, awarded to CCJ. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; [Anonymous], 2018, J CANC RES THER, V14, pS622; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1266-x; Bojang KA, 1997, T ROY SOC TROP MED H, V91, P557, DOI 10.1016/S0035-9203(97)90025-0; Calis JCJ, 2016, MALAWI MED J, V28, P99; Crais ER, 2010, PRACT RESOUR MENT, P47, DOI 10.1016/B978-0-12-374177-6.10003-0; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; Dhabangi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209476; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Georgieff MK, 2011, NUTR REV, V69, pS43, DOI 10.1111/j.1753-4887.2011.00432.x; Hare Gregory M T, 2004, Curr Opin Anaesthesiol, V17, P363, DOI 10.1097/00001503-200410000-00003; Hohm E, 2007, EUR CHILD ADOLES PSY, V16, P149, DOI 10.1007/s00787-006-0567-y; HOLM S, 1979, SCAND J STAT, V6, P65; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Legason Ismail Dragon, 2017, BMC Hematol, V17, P10, DOI 10.1186/s12878-017-0081-0; Lozoff B, 2006, SEMINARS PEDIAT NEUR; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Ministry of Health Uganda, 2012, UG CLIN GUID; Muhoozi GKM, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30270; Noubiap JJ, 2017, NEUROLOGY, V89, P1516, DOI 10.1212/WNL.0000000000004537; Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770; Opoka RO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210982; Opoka RO, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3382-5; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Ruisenor-Escudero H, 2019, CHILD NEUROPSYCHOL, V25, P466, DOI 10.1080/09297049.2018.1497588; Sabanathan S, 2015, ARCH DIS CHILD, V100, P482, DOI 10.1136/archdischild-2014-308114; Santos Juliana Nunes, 2009, Rev. paul. pediatr., V27, P67; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Singla DR, 2015, LANCET GLOB HEALTH, V3, pE458, DOI 10.1016/S2214-109X(15)00099-6; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wachs TD, 2014, ANN NY ACAD SCI, V1308, P89, DOI 10.1111/nyas.12314; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Warner-Rogers J, 2013, CLIN NEUROPSYCHOLOGY, P317; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; WHO, 2006, WHO CHILD GROWTH STA; Zonnenberg IA, 2016, NEONATOLOGY, V109, P282, DOI 10.1159/000443320	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240694	10.1371/journal.pone.0240694	http://dx.doi.org/10.1371/journal.pone.0240694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147287	Green Published, Green Accepted, gold			2022-12-26	WOS:000589609300055
J	Mohammed, HT; Payson, LA; Alarakhia, M				Mohammed, Heba Tallah; Payson, Lori-Anne; Alarakhia, Mohamed			The impact of integrating electronic referral within a musculoskeletal model of care on wait time to receive orthopedic care in Ontario	PLOS ONE			English	Article							QUALITY-OF-LIFE	An MSK model of care for hip and knee patients integrated with an electronic referral solution (eReferral) has been deployed within four subregions across Ontario. Referrals are sent from primary care offices to a central intake (CI), where the referral forms are reviewed and forwarded, if appropriate, to a rapid access clinic (RAC) where patients are assessed by an advanced practice clinician (APC). The pragmatic design of eReferral allows for a seamless flow of electronic orthopedic referrals from primary care to CI. It also enables CI to process and transcribe faxed referrals into the eReferral system for a smooth flow of data electronically to the RACs. In general, wait time is the time interval between receiving the patient's referral at CI or the surgeon's office until receiving the orthopedic surgeon's first consultation. Wait time is further broken down into wait 1 a and wait 1 b. Wait 1 a is the time between the receipt of the referral at CI until the date of the first initial assessment at the RAC. This study aimed at: a) assessing the processing time of orthopedic referrals at central intakes (CI) to be forwarded to the RAC, b) assessing the wait time (wait 1 a) of orthopedic referrals processed through the eReferral system to receive an initial assessment at the RACs. c) comparing the ability of the RACs to meet the target wait time for assessment (four weeks) by the method of referral (eReferrals vs. fax). d) evaluating patients' satisfaction with the length of time they waited to receive care at the RACs with eReferral. We used Ocean eReferral database to access MSK hip and knee referral data processed through the system. Patients whose referrals were initiated electronically through the system and opted to receive email notification of their referral status had the opportunity to take an online satisfaction survey embedded in the booked appointment notification message. There were 1,723 patients initially referred electronically for hip, and knee pain consults, while 13,780 referrals started as paper-based and transcribed into the system to be forwarded later electronically by CI to a RAC. Higher mean processing time at CI by 21.76 days for paper-based referral was detected as opposed to referrals received electronically (p<0.001). RACs took significantly less time to book appointments for referrals initiated electronically with a shorter average wait 1a of 21.42 days for eReferrals compared to paper-based referrals (p<0.001). RACs timeframe to book an appointment was significantly shorter for eReferrals versus fax referrals. A total of 393 patients completed the patient satisfaction survey with a response rate of 16%. Overall, 87.7% were satisfied with their experience with the eReferral process, and 81% agreed that they had waited a reasonable time to receive the needed care. eReferral can elicit faster processing of referrals and shorter wait time for patients, which improved patient satisfaction with the referral process.	[Mohammed, Heba Tallah; Payson, Lori-Anne; Alarakhia, Mohamed] eHlth Ctr Excellence, Kitchener, ON, Canada; [Payson, Lori-Anne; Alarakhia, Mohamed] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	McMaster University	Mohammed, HT (corresponding author), eHlth Ctr Excellence, Kitchener, ON, Canada.	heba.mohammed@ehealthce.ca						Aiken Alice B, 2009, Healthc Q, V12, P80; [Anonymous], 2004, CLIN GOVERNANCE INT, DOI DOI 10.1108/14777270410566661; [Anonymous], 2014, 11 IFIP WG 5 1 INT C, V442; [Anonymous], 2007, SPINE J S, V7, p1S; Barua, 2014, WAITING YOUR TURN WA; Cancer Care Ontario, 2018, ACCESS CARE MSK RAPI; Cannaby S, 2005, COST BENEFIT ELECT P; Desmeules F, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-107; Fyie K, 2014, J EVAL CLIN PRACT, V20, P66, DOI 10.1111/jep.12080; Heywood J W, 2005, J R Army Med Corps, V151, P152; Idowu Adebayo Peter, 2014, International Journal of Computer Science & Information Technology, V6, P59, DOI 10.5121/ijcsit.2014.6405; Kreitz Tyler M, 2016, J Patient Exp, V3, P39, DOI 10.1177/2374373516652253; Liddy Clare, 2018, Healthc Policy, V13, P59, DOI 10.12927/hcpol.2018.25397; MacKay C, 2009, J EVAL CLIN PRACT, V15, P178, DOI 10.1111/j.1365-2753.2008.00979.x; Ministry of Health, 2019, ONT HLTH TEAM DIG HL ONT HLTH TEAM DIG HL; Mohammed HT, 2020, QUAL MANAG HEALTH CA, V29, P20, DOI 10.1097/QMH.0000000000000235; Napier C, 2013, PHYSIOTHER CAN, V65, P358, DOI 10.3138/ptc.2012-53; Paquette -Warren J, 2006, INT J INTEGR CARE, V6, DOI [10.5334/ijic.164, DOI 10.5334/IJIC.164]; Rabey M, 2009, CLIN GOV, V14, P15, DOI DOI 10.1108/14777270910933424; Razmjou H, 2013, PHYSIOTHER CAN, V65, P46, DOI 10.3138/ptc.2011-56; Reginster JY, 2002, RHEUMATOLOGY, V41, P3, DOI 10.1093/rheumatology/41.suppl_1.3; Roux CH, 2005, ANN RHEUM DIS, V64, P606, DOI 10.1136/ard.2004.020784; Tuzun EH, 2007, BEST PRACT RES CL RH, V21, P567, DOI 10.1016/j.berh.2007.03.001; Lorenzo IV, 2007, GAC SANIT, V21, P114, DOI 10.1157/13101037; Whyte J., 2011, ENG PROJ ORGAN J, V1, P159, DOI DOI 10.1080/21573727.2011.597743	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241624	10.1371/journal.pone.0241624	http://dx.doi.org/10.1371/journal.pone.0241624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141866	gold, Green Published			2022-12-26	WOS:000588376700027
J	Beko, K; Kreizinger, Z; Yvon, C; Saller, O; Catania, S; Feberwee, A; Gyuranecz, M				Beko, Katinka; Kreizinger, Zsuzsa; Yvon, Cecile; Saller, Orsolya; Catania, Salvatore; Feberwee, Anneke; Gyuranecz, Miklos			Development of molecular assays for the rapid and cost-effective determination of fluoroquinolone, macrolide and lincosamide susceptibility of Mycoplasma synoviae isolates	PLOS ONE			English	Article							RESISTANCE; MUTATIONS	Mycoplasma synoviae infection occurs worldwide, leading to considerable economic losses in the chicken and turkey industry due to infectious synovitis, respiratory diseases and eggshell apex abnormalities. Control programs against M. synoviae infection are based on eradication, vaccination and medication with antimicrobial agents. Prudent use of antibiotics can be improved greatly by the determination of antibiotic susceptibility prior to the treatment. However, the conventional broth or agar microdilution is very labor-intensive and time-consuming method. Thus, there is an increasing need for rapid antimicrobial susceptibility tests in order to guide antibiotic therapy more effectively. The aim of this study was to develop mismatch amplification mutation assays (MAMAs) to detect resistance-associated mutations in M. synoviae. M. synoviae strains with previously determined minimal inhibitory concentrations (MICs) and whole genomes (n = 92) were used for target selection and assay specification. For the evaluation of the developed assays, 20 clinical samples and an additional 20 M. synoviae isolates derived from these specimens were also included in this study. MIC values of these 20 isolates were determined by broth microdilution method. Five MAMAs were designed to identify elevated MICs of fluoroquinolones, while three MAMAs were developed to detect decreased susceptibility to macrolides and lincomycin. The sensitivity of the MAMA tests varied between 10(2)-10(4) template copy number/reaction depending on the assay. Clinical samples showed identical genotype calls with the M. synoviae isolates derived from the corresponding specimens in each case. Supporting the results of conventional in vitro sensitivity tests, our approach provides a feasible tool for diagnostics. Rapidity, robustness and cost-effectiveness are powerful advantages of the developed assays. Supporting prudent antibiotic usage instead of empirical treatment, the use of this method can reduce significantly the economic impact of M. synoviae in the poultry industry and decrease bacterial resistance-related public health concerns.	[Beko, Katinka; Kreizinger, Zsuzsa; Yvon, Cecile; Saller, Orsolya; Gyuranecz, Miklos] Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Catania, Salvatore] Inst Zooprofilatt Sperimentale Venezie, Verona, Italy; [Feberwee, Anneke] GD Anim Hlth Serv, Deventer, Netherlands; [Gyuranecz, Miklos] Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Veterinary Medicine Budapest	Gyuranecz, M (corresponding author), Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.; Gyuranecz, M (corresponding author), Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary.	m.gyuranecz@gmail.com		Catania, Salvatore/0000-0003-3258-172X; Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet program of the Hungarian Academy of Sciences [LP2012-22]; National Research, Development and Innovation Office, Hungary [119594, 129751, 124019]; Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences; Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Innovation and Technology [UNKP-19-4-ATE-1]	Lendulet program of the Hungarian Academy of Sciences; National Research, Development and Innovation Office, Hungary; Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Innovation and Technology	MG was supported by the Lendulet program (LP2012-22) of the Hungarian Academy of Sciences (https://mta.hu/), the K_16 (119594) and KKP19 (129751) grants of the National Research, Development and Innovation Office, Hungary (https://nkfih.gov.hu/), the Bolyai Ja ' nos Research Fellowship of the Hungarian Academy of Sciences, and the Bolyai+ Fellowship (U ' NKP-19-4-ATE-1) of the New National Excellence Program of the Ministry of Innovation and Technology (https://www.kormany.hu/en/ministry-for-innovation-andtechnology).ZK was supported by the FK_17 (124019) grant of the National Research, Development and Innovation Office, Hungary, and the Bolyai Ja ' nos Research Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar AM, 2016, J INFECT DEV COUNTR, V10, P807, DOI 10.3855/jidc.7850; Beko K, 2020, VET MICROBIOL, V248, DOI 10.1016/j.vetmic.2020.108818; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Catania S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224903; Chernova OA, 2016, ACTA NATURAE, V8, P24, DOI 10.32607/20758251-2016-8-2-24-34; Felde O, 2020, VET MICROBIOL, V245, DOI 10.1016/j.vetmic.2020.108697; FREY ML, 1968, AM J VET RES, V29, P2163; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Hilderbrand D., 1985, Clinica Veterinaria, V108, P89; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kreizinger Z, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1266-2; Lauerman LH, 1995, AVIAN DIS, V39, P804, DOI 10.2307/1592417; Le Carrou JM, 2006, VET RES, V37, P145, DOI 10.1051/vetres:2005046; Lysnyansky I, 2013, ANTIMICROB AGENTS CH, V57, P3072, DOI 10.1128/AAC.00203-13; Lysnyansky I, 2015, MICROB DRUG RESIST, V21, P581, DOI 10.1089/mdr.2014.0290; NOEL-FERGUSON N., 2013, DIS POULTRY, P900; Piddock LJV, 1999, DRUGS, V58, P11, DOI 10.2165/00003495-199958002-00003; Raviv Z, 2009, AVIAN DIS, V53, P103, DOI 10.1637/8469-091508-Reg.1; Staroscik A., 2004, CALCULATOR DETERMINI; Sulyok KM, 2018, VET MICROBIOL, V213, P47, DOI 10.1016/j.vetmic.2017.11.026; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x	21	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241647	10.1371/journal.pone.0241647	http://dx.doi.org/10.1371/journal.pone.0241647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125410	Green Published, gold, Green Accepted			2022-12-26	WOS:000588368900033
J	Lira, KHDD; Passos, TS; Ramalho, HMM; Rodrigues, KDDR; Vieira, ED; Cordeiro, AMTD; Maciel, BLL; Damasceno, KSFDC; de Sousa, FC; de Assis, CF				Dias da Silva Lira, Keith Hellen; Passos, Thais Souza; Maia Ramalho, Heryka Myrna; da Silva Ribeiro Rodrigues, Karla Danielly; Vieira, Erica de Andrade; Tribuzy de Magalhaes Cordeiro, Angela Maria; Lima Maciel, Bruna Leal; da Silva Chaves Damasceno, Karla Suzanne Florentino; de Sousa Junior, Francisco Caninde; de Assis, Cristiane Fernandes			Whey protein isolate-gelatin nanoparticles enable the water-dispersibility and potentialize the antioxidant activity of quinoa oil (Chenopodium quinoa)	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; STABILITY EVALUATION; LIPID OXIDATION; FATTY-ACID; FISH-OIL; NANOEMULSIONS; NANOENCAPSULATION; HOMOGENIZATION; ENCAPSULATION; CAROTENOIDS	The quinoa oil presents benefits to health, but its low water dispersibility in the aqueous matrix and instability of bioactive compounds is challenging for food application. This study performed the physicochemical and chemical characterization of quinoa oil and evaluated its water dispersibility and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging activity after nanoencapsulation in porcine gelatin and combination with whey protein isolate by emulsification O/W technique. Thus, three formulations were obtained: 1) OG-containing quinoa oil and porcine gelatin in aqueous phase 2; 2) OWG1-containing quinoa oil, whey protein isolate, and porcine gelatin in aqueous phase 2; and 3) OWG2-containing quinoa oil and whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2. The oil characterization showed that quinoa oil presented the predominance of linoleic acid (53.4%), and concentration of alpha and gamma-tocopherol, respectively, of 8.56 and 6.28 mg.100g(-1). All formulations presented a smooth surface without depression or cracking, an average diameter between 165.77 and 529.70 nm. Fourier transform infrared spectroscopy indicated chemical interaction between the encapsulating agents and the oil in all formulations, being more intensified in OWG1 and OWG2. Based on this, these formulations showed higher dispersibility in aqueous solution [68% (3.48) and 71% (2.97)]. This resulted in higher antioxidant activity for OWG1 and OWG2, showing the amounts that reduces antioxidant activity by 50% equal to 5.30 (0.19) mg/mL and 5.54 (0.27) mg/mL, respectively, compared to quinoa oil [13.36 (0.28) mg/mL] (p < 0.05). Thus, quinoa oil nanoencapsulation proved to be an efficient alternative to enable water-dispersibility and enhance antioxidant activity, increasing its potential for application in the food industry.	[Dias da Silva Lira, Keith Hellen; da Silva Ribeiro Rodrigues, Karla Danielly; Lima Maciel, Bruna Leal; da Silva Chaves Damasceno, Karla Suzanne Florentino; de Sousa Junior, Francisco Caninde; de Assis, Cristiane Fernandes] Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Nutr Postgrad Program, Natal, RN, Brazil; [Passos, Thais Souza; da Silva Ribeiro Rodrigues, Karla Danielly; Lima Maciel, Bruna Leal; da Silva Chaves Damasceno, Karla Suzanne Florentino] Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Dept Nutr, Natal, RN, Brazil; [Maia Ramalho, Heryka Myrna] Univ Potiguar, Hlth Sci, Biotechnol Postgrad Program, Natal, RN, Brazil; [Vieira, Erica de Andrade; Tribuzy de Magalhaes Cordeiro, Angela Maria] Univ Fed Paraiba, Technol Ctr, Food Sci & Technol Postgrad Program, Joao Pessoa, Paraiba, Brazil; [de Sousa Junior, Francisco Caninde; de Assis, Cristiane Fernandes] Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Dept Pharm, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Potiguar; Universidade Federal da Paraiba; Universidade Federal do Rio Grande do Norte	de Assis, CF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Nutr Postgrad Program, Natal, RN, Brazil.; de Assis, CF (corresponding author), Univ Fed Rio Grande do Norte, Ctr Hlth Sci, Dept Pharm, Natal, RN, Brazil.	cristianeassis@hotmail.com	Assis, Cristiane Fernandes de/AAY-9213-2021	Assis, Cristiane Fernandes de/0000-0001-7595-5395; DE MAGALHAES CORDEIRO, ANGELA MARIA TRIBUZY/0000-0002-9475-0202; DE ANDRADE VIEIRA, ERICA/0000-0001-6984-4736	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -Finance Code 001. The authors want to thank by Plantus LTDA (Ni ' sia Floresta, Brazil) for providing the quinoa oil utilized to conduct this research. There was no additional external funding received for this study.	Abolle A, 2009, BIOMASS BIOENERG, V33, P1653, DOI 10.1016/j.biombioe.2009.08.008; Acosta E, 2009, CURR OPIN COLLOID IN, V14, P3, DOI 10.1016/j.cocis.2008.01.002; Alcantara MA, 2019, POWDER TECHNOL, V354, P877, DOI 10.1016/j.powtec.2019.06.026; Almeida K., 2013, REV VERDE AGROECOL D, V8, P218; American Oil Chemists' Society (AOCS), 2005, NOSTRANDS ENCY CHEM, DOI [10.1002/0471740039.vec0152, DOI 10.1002/0471740039.VEC0152]; Anarjan N, 2013, MOLECULES, V18, P768, DOI 10.3390/molecules18010768; Ando H, 2002, FOOD SCI TECHNOL RES, V8, P80, DOI 10.3136/fstr.8.80; [Anonymous], 2018, CANCER DISCOV, V8, P9; [Anonymous], 2019, J NUCL MED, V60, p7n; [Anonymous], 2016, CANC DISCOV; Aquino JD, 2012, J BRAZIL CHEM SOC, V23, P212, DOI 10.1590/S0103-50532012000200004; Bhattacharjee S, 2016, J CONTROL RELEASE, V235, P337, DOI 10.1016/j.jconrel.2016.06.017; Cebi N, 2016, FOOD CHEM, V190, P1109, DOI 10.1016/j.foodchem.2015.06.065; Chen YS, 2019, FOOD CHEM, V286, P592, DOI 10.1016/j.foodchem.2019.02.016; Comunian TA, 2020, FOOD CHEM, V326, DOI 10.1016/j.foodchem.2020.126995; Das S, 2019, INT J BIOL MACROMOL, V133, P294, DOI 10.1016/j.ijbiomac.2019.04.070; Medeiros AKDC, 2019, FOOD CHEM, V270, P562, DOI 10.1016/j.foodchem.2018.07.099; Dias MI, 2015, FOOD FUNCT, V6, P1035, DOI 10.1039/c4fo01175a; Eastman JE, 1982, COLD WATER SOLUBLE G, V438,088, P465; Fan YT, 2018, FOOD CHEM, V265, P200, DOI 10.1016/j.foodchem.2018.05.098; Fischer S, 2017, IND CROP PROD, V107, P558, DOI 10.1016/j.indcrop.2017.04.035; Ghadermazi R, 2019, INT J BIOL MACROMOL, V131, P368, DOI 10.1016/j.ijbiomac.2019.03.026; Gonzalez A, 2016, POWDER TECHNOL, V301, P868, DOI 10.1016/j.powtec.2016.07.026; Grilo E. C., 2015, Revista do Instituto Adolfo Lutz, V74, P216; Hartman L, 1973, Lab Pract, V22, P475; Jafari SM, 2008, FOOD RES INT, V41, P172, DOI 10.1016/j.foodres.2007.11.002; Jugreet BS, 2020, TRENDS FOOD SCI TECH, V101, P89, DOI 10.1016/j.tifs.2020.04.025; Karim AA, 2008, TRENDS FOOD SCI TECH, V19, P644, DOI 10.1016/j.tifs.2008.08.001; Lima J. R., 1997, Alimentos e Nutricao, V8, P65; Lima RP, 2017, IND CROP PROD, V97, P536, DOI 10.1016/j.indcrop.2016.12.052; Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008; Ng SC, 2007, FOOD CHEM, V101, P185, DOI 10.1016/j.foodchem.2006.01.016; NIERENBERG DW, 1992, AM J CLIN NUTR, V56, P417, DOI 10.1093/ajcn/56.2.417; Nowak V, 2016, FOOD CHEM, V193, P47, DOI 10.1016/j.foodchem.2015.02.111; Park SJ, 2019, J FOOD ENG, V259, P12, DOI 10.1016/j.jfoodeng.2019.04.011; Pellegrini M, 2018, IND CROP PROD, V111, P38, DOI 10.1016/j.indcrop.2017.10.006; Pezato R, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-45; Rakmai J, 2018, IND CROP PROD, V111, P219, DOI 10.1016/j.indcrop.2017.10.027; Repo-Carrasco R, 2003, FOOD REV INT, V19, P179, DOI 10.1081/FRI-120018884; Rezaei A, 2019, FOOD HYDROCOLLOID, V88, P146, DOI 10.1016/j.foodhyd.2018.10.003; Rostami H, 2018, FOOD BIOSCI, V26, P126, DOI 10.1016/j.fbio.2018.10.010; Rufino M.S.M., 2007, METODOLOGIA CIENT FI, P36; Ryan E, 2007, PLANT FOOD HUM NUTR, V62, P85, DOI 10.1007/s11130-007-0046-8; Shetta A, 2019, INT J BIOL MACROMOL, V126, P731, DOI 10.1016/j.ijbiomac.2018.12.161; Silverstein R, 2005, SPECTROMETRIC IDENTI, V7, P550; Stan C, 2019, I C CONTR SYS COMP S, P210, DOI 10.1109/CSCS.2019.00042; Taherian AR, 2011, FOOD HYDROCOLLOID, V25, P868, DOI 10.1016/j.foodhyd.2010.08.007; Taktak W, 2019, MAT SCI ENG C-MATER, V104, DOI 10.1016/j.msec.2019.109867; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Toledo AMN de, 2015, ENCAPSULACAO OLEO ES; Yuan Y, 2008, FOOD RES INT, V41, P61, DOI 10.1016/j.foodres.2007.09.006; Zhang RJ, 2020, COLLOID SURFACE B, V194, DOI 10.1016/j.colsurfb.2020.111202	53	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240889	10.1371/journal.pone.0240889	http://dx.doi.org/10.1371/journal.pone.0240889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125402	Green Published, gold			2022-12-26	WOS:000588368900054
J	Galvin, JE; Tolea, MI; Rosenfeld, A; Chrisphonte, S				Galvin, James E.; Tolea, Magdalena, I; Rosenfeld, Amie; Chrisphonte, Stephanie			The Quick Physical Activity Rating (QPAR) scale: A brief assessment of physical activity in older adults with and without cognitive impairment	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; ELDERLY PASE; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; GO TEST; DISEASE; DEMENTIA; FRAILTY; RELIABILITY; VALIDITY	Introduction Alzheimer's disease and related dementias (ADRD) currently affect over 5.7 million Americans and over 35 million people worldwide. At the same time, over 31 million older adults are physically inactive with impaired physical performance interfering with activities of daily living. Low physical activity is a risk factor for ADRD. We examined the utility of a new measure, the Quick Physical Activities Rating (QPAR) as an informant-rated instrument to quantify the dosage of physical activities in healthy controls, MCI and ADRD compared with Gold Standard assessments of objective measures of physical performance, fitness, and functionality. Methods This study analyzed 390 consecutive patient-caregiver dyads who underwent a comprehensive evaluation including the Clinical Dementia Rating (CDR), mood, neuropsychological testing, caregiver ratings of patient behavior and function, and a comprehensive physical performance and gait assessment. The QPAR was completed prior to the office visit and was not considered in the clinical evaluation, physical performance assessment, staging or diagnosis of the patient. Psychometric properties including item variability and distribution, floor and ceiling effects, strength of association, known-groups performance, and internal consistency were determined. Results The patients had a mean age of 75.3 +/- 9.2 years, 15.7 +/- 2.8 years of education and were 46.9% female. The patients had a mean CDR-SB of 4.8 +/- 4.7 and a mean MoCA score of 18.6 +/- 7.1 and covered a range of healthy controls (CDR 0 = 54), MCI or very mild dementia (CDR 0.5 = 161), mild dementia (CDR 1 = 92), moderate dementia (CDR 2 = 64), and severe dementia (CDR 3 = 29). The mean QPAR score was 20.2 +/- 18.9 (range 0-132) covering a wide range of physical activity. The QPAR internal consistency (Cronbach alpha) was very good at 0.747. The QPAR was correlated with measures of physical performance (dexterity, grip strength, gait, mobility), physical functionality rating scales, measures of activities of daily living and comorbidities, the UPDRS, and frailty ratings (all p < .001). The QPAR report of physical activities was able to discriminate between individuals with impaired physical functionality (32.2 +/- 23.9 vs 15.2 +/- 13.8, p < .001), falls risk (28.4 +/- 21.6 vs. 14.5 +/- 13.2, p < .001), and the presence of frailty (28.1 +/- 22.7 vs. 11.8 +/- 9.4, p < .001). The QPAR showed strong psychometric properties and excellent data quality, and worked equally well across different patient ages, sexes, informant relationships, and in individuals with and without cognitive impairment. Discussion The QPAR is a brief detection tool that captures informant reports of physical activities and differentiates individuals with normal physical functionality from those individuals with impaired physical functionality. The QPAR correlated with Gold Standard assessments of strength and sarcopenia, activities of daily living, gait and mobility, fitness, health related quality of life, frailty, global physical performance, and provided good discrimination between states of physical functionality, falls risk, and frailty. The QPAR performed well in comparison to standardized scales of objective physical performance, but in a brief fashion that could facilitate its use in clinical care and research.	[Galvin, James E.; Tolea, Magdalena, I; Rosenfeld, Amie; Chrisphonte, Stephanie] Univ Miami, Miller Sch Med, Dept Neurol, Comprehens Ctr Brain Hlth, Miami, FL 33136 USA	University of Miami	Galvin, JE (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Comprehens Ctr Brain Hlth, Miami, FL 33136 USA.	Jeg200@miami.edu	Galvin, James/AAM-7492-2021		National Institute on Aging [R01 AG040211-A1, R01 NS101483-01A]; Harry T. Mangurian Foundation; Leo and Anne Albert Charitable Trust	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harry T. Mangurian Foundation; Leo and Anne Albert Charitable Trust	This study was supported by grants from the National Institute on Aging of JEG (R01 AG040211-A1 and R01 NS101483-01A), the Harry T. Mangurian Foundation, and the Leo and Anne Albert Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K, 2012, J AM GERIATR SOC, V60, P2333, DOI 10.1111/j.1532-5415.2012.04240.x; Ahmad S, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0324-8; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alqarni AM, 2018, CLIN INTERV AGING, V13, P419, DOI 10.2147/CIA.S157007; Alzheimer's Association, 2019 ALZH DIS FACTS; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], **NON-TRADITIONAL**; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Berryman N, 2013, EXP GERONTOL, V48, P1402, DOI 10.1016/j.exger.2013.08.017; Boyle PA, 2010, J AM GERIATR SOC, V58, P248, DOI 10.1111/j.1532-5415.2009.02671.x; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Brigola Allan Gustavo, 2015, Dement. neuropsychol., V9, P110, DOI 10.1590/1980-57642015DN92000005; Brinkley TE, 2018, J GERONTOL A-BIOL, V73, P1229, DOI 10.1093/gerona/gly041; Buchman AS, 2014, J GERONTOL A-BIOL, V69, P1536, DOI 10.1093/gerona/glu117; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Dorsman KA, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00104; Egerton Thorlene, 2014, BMC Res Notes, V7, P542, DOI 10.1186/1756-0500-7-542; Elovainio M, 2009, J EPIDEMIOL COMMUN H, V63, P468, DOI 10.1136/jech.2008.081505; Falck RS, 2016, BRIT J SPORT MED, V50, P464, DOI 10.1136/bjsports-2014-094413; Fowles JR, 2017, APPL PHYSIOL NUTR ME, V42, P677, DOI 10.1139/apnm-2016-0412; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2011, PATIENT EDUC COUNS, V83, P278, DOI 10.1016/j.pec.2010.04.032; Galvin JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235534; Galvin JE, 2018, CURR GERIATR REP, V7, P19, DOI 10.1007/s13670-018-0236-2; Galvin JE, 2017, NEUROLOGY, V89, P2049, DOI 10.1212/WNL.0000000000004614; Galvin JE, 2017, J AM GERIATR SOC, V65, P2128, DOI 10.1111/jgs.14997; Galvin James E, 2015, Alzheimers Dement (Amst), V1, P249; Galvin JE, 2014, NEURODEGENER DIS MAN, V4, P455, DOI [10.2217/nmt.14.47, 10.2217/NMT.14.47]; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gray SL, 2013, J GERONTOL A-BIOL, V68, P1083, DOI 10.1093/gerona/glt013; Groll DL, 2006, AM J PHYS MED REHAB, V85, P574, DOI 10.1097/01.phm.0000223220.91914.61; Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Houck J, 2020, J GERIATR PHYS THER, V43, P142, DOI 10.1519/JPT.0000000000000220; Ismail N, 2015, ASIA-PAC J PUBLIC HE, V27, p62S, DOI 10.1177/1010539515590179; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Kivipelto M, 2020, ALZHEIMERS DEMENT, V16, P1078, DOI 10.1002/alz.12123; Lusardi MM, 2017, J GERIATR PHYS THER, V40, P1, DOI 10.1519/JPT.0000000000000099; McGough EL, 2011, PHYS THER, V91, P1210, DOI 10.2522/ptj.20100372.ar; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Messick S., 1995, ED MEASUREMENT ISSUE, V14, P5, DOI [10.1111/j.17453992.1995.tb00881.x, DOI 10.1111/J.1745-3992.1995.TB00881.X]; Messick S. L., 1989, ED MEASUREMENT, V3rd, P13, DOI DOI 10.7203/RELIEVE.22.1.8248; Miller DK, 2008, J GERONTOL A-BIOL, V63, P487, DOI 10.1093/gerona/63.5.487; Miller DK, 2009, J GERONTOL A-BIOL, V64, P388, DOI 10.1093/gerona/gln033; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Center for Health Statistics, HLTH US 2012 SPEC FE; Neumann PJ, 2000, MED DECIS MAKING, V20, P413, DOI 10.1177/0272989X0002000405; Nordin E, 2006, PHYS THER, V86, P646, DOI 10.1093/ptj/86.5.646; Olney NT, 2017, NEUROL CLIN, V35, P339, DOI [10.1016/j.ncl.2017.01.008, 10.1016/j.nc1.2017.01.008]; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pA1; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sattler MC, 2020, SPORTS MED, V50, P1271, DOI 10.1007/s40279-020-01268-x; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Skrobot OA, 2017, ALZHEIMERS DEMENT, V13, P624, DOI 10.1016/j.jalz.2016.10.007; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tappen RM, 2010, CLIN NEUROPSYCHOL, V24, P646, DOI 10.1080/13854040903482855; Taylor-Piliae RE, 2010, J PHYS ACT HEALTH, V7, P87, DOI 10.1123/jpah.7.1.87; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Tinetti ME, 2016, JAMA CARDIOL, V1, P9, DOI 10.1001/jamacardio.2015.0248; Tolea MI, 2018, CLIN INTERV AGING, V13, P1111, DOI 10.2147/CIA.S164113; Tolea MI, 2016, ALZ DIS ASSOC DIS, V30, P230, DOI 10.1097/WAD.0000000000000136; Tolea MI, 2016, ALZ DIS ASSOC DIS, V30, P60, DOI 10.1097/WAD.0000000000000091; Tolea MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122878; Tolea MI, 2015, CLIN INTERV AGING, V10, P663, DOI 10.2147/CIA.S76275; Vieweg J, 2020, EXP AGING RES, V46, P273, DOI 10.1080/0361073X.2020.1766299; Washburn RA, 1999, J SPORT MED PHYS FIT, V39, P336; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; Wilkins CH, 2013, J AM GERIATR SOC, V61, P1055, DOI 10.1111/jgs.12255; Zahodne LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073645; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	79	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241641	10.1371/journal.pone.0241641	http://dx.doi.org/10.1371/journal.pone.0241641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125429	Green Published, gold			2022-12-26	WOS:000588368900013
J	Kirino, H; Yoshimoto, K; Shinya, R				Kirino, Haru; Yoshimoto, Kohki; Shinya, Ryoji			Thaumatin-like proteins and a cysteine protease inhibitor secreted by the pine wood nematode Bursaphelenchus xylophilus induce cell death in Nicotiana benthamiana	PLOS ONE			English	Article							WILT DISEASE; MOLECULAR-CLONING; 1ST REPORT; EXPRESSION; WHEAT; INTERFERENCE; PATHOGENESIS; ARABIDOPSIS; MECHANISMS; EFFECTORS	Pine wilt disease (PWD) is an infectious disease of pines that typically kills affected trees. The causal pathogen of PWD is the pine wood nematode (PWN), Bursaphelenchus xylophilus. Understanding of the disease has advanced in recent years through the use of a highly sensitive proteomics procedure and whole genome sequence analysis; in combination, these approaches have enabled identification of proteins secreted by PWNs. However, the roles of these proteins during the onset of parasitism have not yet been elucidated. In this study, we used a leaf-disk assay based on transient overexpression in Nicotiana benthamiana to allow functional screening of 10 candidate pathogenic proteins secreted by PWNs. These proteins were selected based on previous secretome and RNA-seq analyses. We found that five molecules induced significant cell death in tobacco plants relative to a GFP-only control. Three of these proteins (Bx-TH1, Bx-TH2, and Bx-CPI) may have a role in molecular mimicry and likely make important contributions to inducing hypersensitive responses in host plants.	[Kirino, Haru; Yoshimoto, Kohki; Shinya, Ryoji] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan; [Shinya, Ryoji] JST PRESTO, Kawasaki, Kanagawa, Japan	Meiji University; Japan Science & Technology Agency (JST)	Shinya, R (corresponding author), Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan.; Shinya, R (corresponding author), JST PRESTO, Kawasaki, Kanagawa, Japan.	shinya@meiji.ac.jp		Shinya, Ryoji/0000-0002-2450-3054	JST, PRESTO, Japan [JPMJPR17Q5]; JSPS, Japan [JP19K15853]	JST, PRESTO, Japan; JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by grants from JST, PRESTO Grant Number JPMJPR17Q5 (to R. S.), Japan, and JSPS, Grant-in-Aid for Early-Career Scientists JP19K15853 (to R.S.), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; [Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/journal.pone.0083963; [Anonymous], 2008, PINE WILT DISEASE; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; Atamian HS, 2013, MOL PLANT MICROBE IN, V26, P67, DOI 10.1094/MPMI-06-12-0144-FI; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Chen WP, 1999, THEOR APPL GENET, V99, P755, DOI 10.1007/s001220051294; Ding X, 2000, INT J PARASITOL, V30, P77, DOI 10.1016/S0020-7519(99)00165-4; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Espada M, 2016, MOL PLANT PATHOL, V17, P286, DOI 10.1111/mpp.12280; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fukuda K., 1997, J RES, V2, P171, DOI [10.1007/BF02348216, DOI 10.1007/BF02348216]; Futai K, 2003, PINE WILT IS EPIDEMI; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Futamura N, 2006, TREE PHYSIOL, V26, P51, DOI 10.1093/treephys/26.1.51; Garavaglia BS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-51; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Guo YF, 2011, PLANT PHYSIOL, V157, P476, DOI 10.1104/pp.111.180554; Han H, 2008, PLANT DIS, V92, P1251, DOI 10.1094/PDIS-92-8-1251A; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Jayaraj J, 2004, BIOL PLANTARUM, V48, P425, DOI 10.1023/B:BIOP.0000041097.03177.2d; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kettles GJ, 2017, NEW PHYTOL, V213, P338, DOI 10.1111/nph.14215; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kuroda M, 2001, BIOSCI BIOTECH BIOCH, V65, P22, DOI 10.1271/bbb.65.22; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27438; Lin SF, 2011, EXP PARASITOL, V127, P440, DOI 10.1016/j.exppara.2010.10.013; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meng FL, 2017, PHYSIOL MOL PLANT P, V100, P178, DOI 10.1016/j.pmpp.2017.10.002; Meng FL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030982; Meng FL, 2019, PHYTOPATHOLOGY, V109, P1949, DOI 10.1094/PHYTO-03-19-0082-R; Mitchum MG, 2012, ANNU REV PHYTOPATHOL, V50, P175, DOI 10.1146/annurev-phyto-081211-173008; Morimoto K., 1972, Journal of the Japanese Forestry Society, V54, P177; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; MYERS RF, 1988, J NEMATOL, V20, P236; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; ODANI K, 1985, Journal of the Japanese Forestry Society, V67, P366; Park JE, 2008, MOL CELLS, V26, P81; Pernas M, 1999, MOL PLANT MICROBE IN, V12, P624, DOI 10.1094/MPMI.1999.12.7.624; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Santos CS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-599; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Shinya R, 2013, J BIOSCI BIOENG, V116, P1, DOI 10.1016/j.jbiosc.2013.01.003; Vicente CSL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123839; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299; Wang Jian, 2014, STUDIES SCI SCI, V32, P305; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Xue Q, 2019, BIOL OPEN, V8, DOI 10.1242/bio.042655; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhang Q, 2006, BIOSCI BIOTECH BIOCH, V70, P2727, DOI 10.1271/bbb.60330; Zhao Y, 1996, PLANT PHYSIOL, V111, P1299, DOI 10.1104/pp.111.4.1299	62	6	6	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241613	10.1371/journal.pone.0241613	http://dx.doi.org/10.1371/journal.pone.0241613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125444	gold, Green Published			2022-12-26	WOS:000588368900024
J	Tecer, D; Gogus, F; Kalkanci, A; Erdogan, M; Hasanreisoglu, M; Ergin, C; Karakan, T; Kozan, R; Coban, S; Diker, KS				Tecer, Duygu; Gogus, Feride; Kalkanci, Ayse; Erdogan, Merve; Hasanreisoglu, Murat; Ergin, Cagri; Karakan, Tarkan; Kozan, Ramazan; Coban, Seda; Diker, Kadir Serdar			Succinivibrionaceae is dominant family in fecal microbiota of Behcet's Syndrome patients with uveitis	PLOS ONE			English	Article							TURKISH PATIENTS; MEFV GENE; DISEASE; ASSOCIATION; PATHOGENESIS; SIGNATURE	Behcet's Syndrome (BS) is a multisystem vasculitis with various clinical manifestations. Pathogenesis is unclear, but studies have shown genetic factors, innate immunity and autoinflammation to have an important role in the disease course. Diversity in the microbial community of gut microbiota may significantly contribute to the activation of the innate immune system. The clinical features of BS present themselves in clusters and each cluster may be a consequence of different disease mechanisms. For this reason we aimed to investigate the gut microbiota of BS patients with uveitis. In addition to healthy controls, we have aimed to compare the gut microbiota of BS with that of Familial Mediterranean Fever (FMF) and Crohn's Disease (CD) as both diseases have innate and autoinflammatory features in their pathogenesis. Seven patients with BS, 12 patients with FMF, 9 patients with CD and 16 healthy controls (HC) were included in the study. Total genomic DNAs were isolated from fecal samples of the patients. Partial 16S rRNA gene was sequenced using the PGM Ion Torrent (Thermo Fisher Scientific, Waltham, MA, USA) for microbiota analysis. Statistical analysis showed that significant differences were detected on the microbial community of four groups. Succinivibrionaceae is dominant and the signature family, whereas Bacteroides was absent in BS patients.	[Tecer, Duygu; Gogus, Feride] Gazi Univ, Dept Phys Med & Rehabil, Div Rheumatol, Fac Med, Ankara, Turkey; [Kalkanci, Ayse; Erdogan, Merve] Gazi Univ, Dept Med Microbiol, Fac Med, Ankara, Turkey; [Hasanreisoglu, Murat] Gazi Univ, Dept Ophthalmol, Fac Med, Ankara, Turkey; [Ergin, Cagri] Pamukkale Univ, Dept Med Microbiol, Fac Med, Denizli, Turkey; [Karakan, Tarkan] Gazi Univ, Dept Internal Med, Div Gastroenterol, Fac Med, Ankara, Turkey; [Kozan, Ramazan] Gazi Univ, Dept Gen Surg, Fac Med, Ankara, Turkey; [Coban, Seda] Gazi Univ, Fac Med, Ankara, Turkey; [Diker, Kadir Serdar] Adnan Menderes Univ, Fac Vet Med, Dept Microbiol, Aydin, Turkey	Gazi University; Gazi University; Gazi University; Pamukkale University; Gazi University; Gazi University; Gazi University; Adnan Menderes University	Kalkanci, A (corresponding author), Gazi Univ, Dept Med Microbiol, Fac Med, Ankara, Turkey.	aysekalkanci@email.com	Hasanreisoglu, Murat/K-3887-2012; Ergin, Çağrı/L-3988-2017; Kozan, Ramazan/A-2266-2019; Tecer, Duygu/AAH-9697-2019; Karakan, Tarkan/A-9875-2016	Hasanreisoglu, Murat/0000-0001-9885-5653; Ergin, Çağrı/0000-0001-7783-8723; Kozan, Ramazan/0000-0002-3835-8759; Tecer, Duygu/0000-0002-8816-6181; Karakan, Tarkan/0000-0003-1561-8789	Turkish League Against Rheumatism	Turkish League Against Rheumatism	This project was supported and funded with a grant of Turkish League Against Rheumatism. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoc N, 2018, BEST PRACT RES CL RH, V32, P261, DOI 10.1016/j.berh.2018.08.010; [Anonymous], 2019, CIRCULATION, V2019; Bag S, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00834-17; Bettiol A, 2020, RHEUMATOLOGY, V59, P101, DOI 10.1093/rheumatology/kez626; Bettiol A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02830; Bitik B, 2016, CLIN EXP RHEUMATOL, V34, pS82; Blum HE, 2017, ADV MED SCI-POLAND, V62, P414, DOI 10.1016/j.advms.2017.04.005; Celenligil-Nazliel H, 1999, J PERIODONTOL, V70, P1449, DOI 10.1902/jop.1999.70.12.1449; Coit P, 2016, CLIN IMMUNOL, V169, P28, DOI 10.1016/j.clim.2016.06.002; Consolandi C, 2015, AUTOIMMUN REV, V14, P269, DOI 10.1016/j.autrev.2014.11.009; Criteria for diagnosis of Behcet's disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-6736(90)92643-V; Direskeneli H, 2006, RHEUMATOLOGY, V45, P1461, DOI 10.1093/rheumatology/kel329; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freysdottir J, 2006, ORAL DIS, V12, P271, DOI 10.1111/j.1601-0825.2005.01185.x; Giza M, 2018, CLIN EXP IMMUNOL, V191, P11, DOI 10.1111/cei.13049; Gogus F, 2005, CLIN EXP RHEUMATOL, V23, pS81; Gul A, 2015, SEMIN IMMUNOPATHOL, V37, P413, DOI 10.1007/s00281-015-0502-8; Hatemi G, 2004, ANN RHEUM DIS, V63, P1450, DOI 10.1136/ard.2003.017467; Hedayatfar Alireza, 2013, J Ophthalmic Vis Res, V8, P291; Hussein MA, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/9518065; Imirzalioglu N, 2005, SCAND J RHEUMATOL, V34, P56, DOI 10.1080/03009740510017931; Inanc N, 2005, J RHEUMATOL, V32, P287; Leite AZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01107; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Maeda Y, 2017, J CLIN MED, V6, DOI 10.3390/jcm6060060; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; MEGE JL, 1993, J RHEUMATOL, V20, P1544; Miura T, 2005, ORAL MICROBIOL IMMUN, V20, P167, DOI 10.1111/j.1399-302X.2005.00207.x; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Mumcu G, 2009, CLIN EXP RHEUMATOL, V27, pS32; Naser SA, 2012, WORLD J GASTROENTERO, V18, P412, DOI 10.3748/wjg.v18.i5.412; Oezguen N, 2019, CLIN EXP RHEUMATOL, V37, P58; Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003; Seoudi N, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27150; Seyahi E, 2019, INTERN EMERG MED, V14, P677, DOI 10.1007/s11739-019-02046-y; Sheridan PO, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000043; Shimizu J, 2019, CLIN RHEUMATOL, V38, P1437, DOI 10.1007/s10067-018-04419-8; Shimizu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153746; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; SOYLU M, 1992, ACTA OPHTHALMOL, V70, P786; Suwa A, 2019, MOD RHEUMATOL, V29, P357, DOI 10.1080/14397595.2018.1457424; Takeuchi M, 2017, NAT GENET, V49, P438, DOI 10.1038/ng.3786; Talotta R, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6836498; Tasliyurt T, 2013, GENE, V530, P100, DOI 10.1016/j.gene.2013.08.026; Tong BN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00665; Tunc R, 2002, J RHEUMATOL, V29, P2393; Valenti S, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0162-4; Wen CP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1271-6; Yacoub R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184789; Ye Z, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0520-6	50	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241691	10.1371/journal.pone.0241691	http://dx.doi.org/10.1371/journal.pone.0241691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125440	Green Published, gold			2022-12-26	WOS:000588368900022
J	Nakashima, D; Onuma, T; Tanabe, K; Kito, Y; Uematsu, K; Mizutani, D; Enomoto, Y; Tsujimoto, M; Doi, T; Matsushima-Nishiwaki, R; Tokuda, H; Ogura, S; Iwama, T; Kozawa, O; Iida, H				Nakashima, Daiki; Onuma, Takashi; Tanabe, Kumiko; Kito, Yuko; Uematsu, Kodai; Mizutani, Daisuke; Enomoto, Yukiko; Tsujimoto, Masanori; Doi, Tomoaki; Matsushima-Nishiwaki, Rie; Tokuda, Haruhiko; Ogura, Shinji; Iwama, Toru; Kozawa, Osamu; Iida, Hiroki			Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; HSP27 PHOSPHORYLATION; CD40 LIGAND; MAP KINASE; FACTOR-I; DISEASE; MECHANISMS; CHEMOKINE; RELEASE	CXCL12, also known as stromal cell-derived factor-1, is a chemokine classified into CXC families, which exerts its function by binding to specific receptors called CXCR4 and CXCR7. Human platelets express CXCR4 and CXCR7 on the plasma membrane. It has been reported that CXCL12 potentiates to induce platelet aggregation in cooperation with agonists including collagen. However, the precise roles and mechanisms of CXCL12 in human platelet activation are not fully elucidated. In the present study, we investigated the effect of simultaneous stimulation with low doses of collagen and CXCL12 on the activation of human platelets. The simultaneous stimulation with collagen and CXCL12 induced the secretion of platelet-derived growth factor (PDGF)-AB and the release of soluble CD40 ligand (sCD40L) from human platelets in addition to their aggregation, despite the fact that the simultaneous stimulation with thrombin receptor-activating peptide (TRAP) or adenosine diphosphate (ADP), and CXCL12 had little effects on the platelet aggregation. The agonist of Glycoprotein (GP) convulxin and CXCL12 also induced platelet aggregation synergistically. The monoclonal antibody against CXCR4 but not CXCR7 suppressed the platelet aggregation induced by simultaneous stimulation with collagen and CXCL12. The phosphorylation of p38 mitogen-activated protein kinase (MAPK), but not p44/p42 MAPK, was induced by the simultaneous stimulation. In addition, the simultaneous stimulation with collagen and CXCL12 induced the phosphorylation of HSP27 and the subsequent release of phosphorylated-HSP27 from human platelets. SB203580, a specific inhibitor of p38 MAPK, attenuated the platelet aggregation, the phosphorylation of p38 MAPK and HSP27, the PDGF-AB secretion, the sCD40L release and the phosphorylated-HSP27 release induced by the simultaneous stimulation with collagen and CXCL12. These results strongly suggest that collagen and CXCL12 in low doses synergistically act to induce PDGF-AB secretion, sCD40L release and phosphorylated-HSP27 release from activated human platelets via p38 MAPK activation.	[Nakashima, Daiki; Onuma, Takashi; Tanabe, Kumiko; Kito, Yuko; Iida, Hiroki] Gifu Univ, Dept Anesthesiol & Pain Med, Grad Sch Med, Gifu, Japan; [Nakashima, Daiki; Uematsu, Kodai; Mizutani, Daisuke; Matsushima-Nishiwaki, Rie; Tokuda, Haruhiko; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan; [Uematsu, Kodai; Mizutani, Daisuke; Enomoto, Yukiko; Tsujimoto, Masanori] Gifu Univ, Dept Neurosurg, Grad Sch Med, Gifu, Japan; [Doi, Tomoaki; Ogura, Shinji] Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, Gifu, Japan; [Iwama, Toru] Natl Ctr Geriatr & Gerontol, Med Genome Ctr Biobank, Dept Clin Lab, Obu, Aichi, Japan	Gifu University; Gifu University; Gifu University; Gifu University; National Center for Geriatrics & Gerontology	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okkasugai@yahoo.co.jp		Iwama, Toru/0000-0002-9426-284X	National Center for Geriatrics and Gerontology, Japan [28-9, 19-21]	National Center for Geriatrics and Gerontology, Japan	This study was supported in part by the Research Funding for Longevity Sciences (28-9 and 19-21) from National Center for Geriatrics and Gerontology, Japan, https://www.ncgg.go.jp/english/index.html Funding acquisition: OK, HT The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Aoki T, 1998, THROMB HAEMOSTASIS, V79, P1184; Arrigo AP, 2014, CANCERS, V6, P333, DOI 10.3390/cancers6010333; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Camnitz W, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-23; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Derakhshan R, 2012, INFLAMMATION, V35, P900, DOI 10.1007/s10753-011-9391-8; Enomoto Y, 2010, ATHEROSCLEROSIS, V209, P415, DOI 10.1016/j.atherosclerosis.2009.10.024; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gao JH, 2019, CLIN CHIM ACTA, V495, P538, DOI 10.1016/j.cca.2019.05.022; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Hla T, 2012, J EXP MED, V209, P2137, DOI 10.1084/jem.20122284; Janssens R, 2018, CYTOKINE GROWTH F R, V44, P51, DOI 10.1016/j.cytogfr.2018.10.004; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; Kageyama Y, 2013, INT J MOL MED, V32, P813, DOI 10.3892/ijmm.2013.1455; Karim ZA, 2016, BBA-MOL CELL RES, V1863, P314, DOI 10.1016/j.bbamcr.2015.11.028; Kato H, 2008, ARCH BIOCHEM BIOPHYS, V475, P80, DOI 10.1016/j.abb.2008.04.023; Kato H, 2010, THROMB RES, V126, P39, DOI 10.1016/j.thromres.2009.12.003; KATO K, 1994, J BIOL CHEM, V269, P11274; Kato K, 1996, J NEUROCHEM, V66, P946; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Mehta NN, 2014, EUR HEART J, V35, P2115, DOI 10.1093/eurheartj/eht481; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Niedergang F, 2000, BIOCHEM BIOPH RES CO, V273, P246, DOI 10.1006/bbrc.2000.2940; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Schutt RC, 2012, STROKE, V43, P3382, DOI 10.1161/STROKEAHA.112.660878; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Sjaarda J, 2018, J AM COLL CARDIOL, V72, P300, DOI 10.1016/j.jacc.2018.04.067; Tokuda H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128977; Walsh TG, 2015, CELL SIGNAL, V27, P37, DOI 10.1016/j.cellsig.2014.09.021; Wang J, 2014, DEVELOPMENT, V141, P4199, DOI 10.1242/dev.101071	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241139	10.1371/journal.pone.0241139	http://dx.doi.org/10.1371/journal.pone.0241139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119719	gold, Green Published			2022-12-26	WOS:000600013600023
J	Lau, YC; Perera, RAPM; Fang, VJ; Luk, LH; Chu, DKW; Wu, P; Barr, IG; Peiris, JSM; Cowling, BJ				Lau, Yiu Chung; Perera, Ranawaka A. P. M.; Fang, Vicky J.; Luk, Long Hei; Chu, Daniel K. W.; Wu, Peng; Barr, Ian G.; Peiris, J. S. Malik; Cowling, Benjamin J.			Variation by lineage in serum antibody responses to influenza B virus infections	PLOS ONE			English	Article							CHILDREN; VACCINE	Two lineages of influenza B virus currently co-circulate and have distinct antigenicity, termed Victoria and Yamagata after the B/Victoria/2/87 and B/Yamagata/16/88 strains, respectively. We analyzed antibody titer dynamics following PCR-confirmed influenza B virus infection in a longitudinal community-based cohort study conducted in Hong Kong from 2009-2014 to assess patterns in changes in antibody titers to B/Victoria and B/Yamagata viruses following infections with each lineage. Among 62 PCR-confirmed cases, almost half had undetectable hemagglutination inhibition (HAI) antibody titers to the lineage of infection both pre-infection and post-infection. Among those infected with influenza B/Victoria who showed an HAI titer response after infection, we found strong rises to the lineage of infection, positive but smaller cross-lineage HAI titer boosts, a small dependence of HAI titer boosts on pre-infection titers, and a shorter half-life of HAI titers in adults. Our study is limited by the low HAI sensitivity for non-ether-treated IBV antigen and the incapacity of performing other assays with higher sensitivity, as well as the mismatch between the B/Yamagata lineage circulating strain and the assay strain in one of the study seasons.	[Lau, Yiu Chung; Perera, Ranawaka A. P. M.; Fang, Vicky J.; Luk, Long Hei; Chu, Daniel K. W.; Wu, Peng; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China; [Barr, Ian G.] WHO Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Barr, Ian G.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China	University of Hong Kong; World Health Organization; University of Melbourne; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China.	bcowling@hku.hk	Perera, Dr. Ranawaka A.P.M Perera/N-8263-2015	Perera, Dr. Ranawaka A.P.M Perera/0000-0003-3936-1535; Lau, Yiu-Chung/0000-0001-6618-9094	Food and Health Bureau of the Hong Kong SAR Government [CHP-CE-03, 11100882, 13120602]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N]	Food and Health Bureau of the Hong Kong SAR Government; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This study was funded by the Food and Health Bureau of the Hong Kong SAR Government to the Centre for Health Protection (grant nos. CHP-CE-03, 11100882 and 13120602), and the Research Grants Council of the Hong Kong Special Administrative Region, China (project no. T11-705/14N). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	[Anonymous], 2017, J ONCOL PRACT, V13, pe353; Caini S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222381; Cowling BJ, 2014, CLIN INFECT DIS, V59, P517, DOI 10.1093/cid/ciu356; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Freeman G, 2016, EPIDEMIOL INFECT, V144, P2306, DOI 10.1017/S0950268816000583; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Jacobson RM, 2015, HUM VACC IMMUNOTHER, V11, P961, DOI 10.1080/21645515.2015.1011990; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Liu Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08165-y; PYHALA R, 1985, J HYG-CAMBRIDGE, V94, P341, DOI 10.1017/S002217240006157X; R Core Team, 2018, R LANG ENV STAT COMP; Skowronski DM, 2017, J INFECT DIS, V216, P697, DOI 10.1093/infdis/jix393; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Stan Development Team, RSTAN R INT STAN R P; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Trombetta CM, 2018, INFLUENZA OTHER RESP, V12, P675, DOI 10.1111/irv.12591; Yang J, 2018, EMERG INFECT DIS, V24, P1536, DOI 10.3201/eid2408.180063; Zhao XH, 2018, AM J EPIDEMIOL, V187, P135, DOI 10.1093/aje/kwx201	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241693	10.1371/journal.pone.0241693	http://dx.doi.org/10.1371/journal.pone.0241693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166348	Green Published, gold			2022-12-26	WOS:000592382600021
J	Zhang, CN; Liu, QZ				Zhang, Chao-nan; Liu, Qi-zhi			Phasmarhabditis zhejiangensis sp. nov. (Nematoda: Rhabditidae), a new rhabditid nematode from Zhejiang, China	PLOS ONE			English	Article							SLUG-PARASITIC NEMATODE; N. SP; DEROCERAS-RETICULATUM; FIELD EXPERIMENTS; INVASIVE SLUGS; HERMAPHRODITA; HETERORHABDITIS; BIOCONTROL; AGENT	A new nematode species of the genus Phasmarhabditis was isolated from the body surface of a slug (Philomycus bilineatus Benson, PB). Morphological and molecular analyses confirmed this nematode as a new species. The nematode was named Phasmarhabditis zhejiangensis sp. nov. (Nematoda: Rhabditidae) and is dioecious. In males, the open bursa with genital papillae is characterized by the formula 1-1-1-2-1-3, and the spicule length is 58 mu m. In female, the vulva is located approximately in the middle of the body. The nematode belongs to papillosa group because of its tail shape pointed with filiform tip. The phasmids are rod-shaped. The posterior anus is slightly swollen. P. zhejiangensis was further characterized by internal transcribed spacer (ITS), 18S rDNA and 28S rDNA sequences. After the sequencing results were compared with sequences available from the National Center for Biotechnology Information (NCBI), the maximum similarities of ITS, 18S and 28S sequences were 89.81%, 96.22% and 95.28%, respectively. Phylogenetic analyses placed Phasmarhabditis zhejiangensis sp. nov. in the genus Phasmarhabditis.	[Zhang, Chao-nan; Liu, Qi-zhi] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China	China Agricultural University	Liu, QZ (corresponding author), China Agr Univ, Coll Plant Protect, Beijing, Peoples R China.	lqzzyx163@163.com			earmarked fund for China Agriculture Research System [CARS-28-18]	earmarked fund for China Agriculture Research System	This work was financially supported by the earmarked fund for China Agriculture Research System (Project No. CARS-28-18).	[Anonymous], 2007, PHILOS CHRISTI, V9, P29; Askary TH, 2010, NEMATODES BIOCONTROL, DOI [10.1007/978-90-481-3333-8-13, DOI 10.1007/978-90-481-3333-8-13]; Azzam Karima M., 2003, Journal of the Egyptian German Society of Zoology, V42, P79; BRENNER S, 1974, GENETICS, V77, P71; De Ley IT, 2014, NEMATOLOGY, V16, P1129, DOI 10.1163/15685411-00002838; Ester A, 2003, CROP PROT, V22, P689, DOI 10.1016/S0261-2194(03)00003-6; Ester A, 2000, POTATO RES, V43, P253, DOI 10.1007/BF02358084; Glen DM, 2000, BIOL CONTROL, V17, P73, DOI 10.1006/bcon.1999.0778; Hooper DJ, 1999, NEMATOLOGY, V1, P173, DOI 10.1163/156854199508144; Huang RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144386; Iglesias J, 2001, ANN APPL BIOL, V139, P285, DOI 10.1111/j.1744-7348.2001.tb00141.x; Iglesias J, 2001, BIOCONTROL SCI TECHN, V11, P93, DOI 10.1080/09583150020029772; Ivanova ES, 2017, RUSS J NEMATOL, V25, P129; Ivanvoa ES, 2019, NEMATOLOGY, V0, P1; Kozlowski J, 2019, POTATO RES, V62, P239, DOI 10.1007/s11540-018-9409-9; Li XY, 2012, ZOOTAXA, P25, DOI 10.11646/zootaxa.3569.1.2; Nash MA, 2007, PEST MANAG SCI, V63, P851, DOI 10.1002/ps.1411; Nermut J, 2019, BIOCONTROL, V64, P697, DOI 10.1007/s10526-019-09967-9; Nermut J, 2017, NEMATOLOGY, V19, P93, DOI 10.1163/15685411-00003034; Nermut J, 2016, ZOOTAXA, V4179, P530, DOI 10.11646/zootaxa.4179.3.8; Nermut J, 2016, NEMATOLOGY, V18, P1095, DOI 10.1163/15685411-00003017; NGUYEN KB, 1995, J NEMATOL, V27, P206; Pieterse A, 2017, NEMATOLOGY, V19, P1035, DOI 10.1163/15685411-00003105; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; Port C.M., 1986, Agricultural Zoology Reviews, V1, P255; Port C. M., 1986, AGR ZOOLOGY REV, V1, P253; Ross JL, 2018, ZOOTAXA, V4420, P391, DOI 10.11646/zootaxa.4420.3.5; San-Blas E, 2013, BIOL CONTROL, V66, P102, DOI 10.1016/j.biocontrol.2013.04.002; Seinhorst J. W., 1959, Nematologica, V4, P67; Tandingan De Ley I, 2016, NEMATOLOGY, V18, P175, DOI 10.1163/15685411-00002952; Vernava MN, 2004, ANN APPL BIOL, V145, P279, DOI 10.1111/j.1744-7348.2004.tb00384.x; WILSON MJ, 1993, BIOCONTROL SCI TECHN, V3, P503, DOI 10.1080/09583159309355306; WILSON MJ, 1995, BIOCONTROL SCI TECHN, V5, P233, DOI 10.1080/09583159550039954; WILSON MJ, 1994, ANN APPL BIOL, V125, P377, DOI 10.1111/j.1744-7348.1994.tb04978.x	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241413	10.1371/journal.pone.0241413	http://dx.doi.org/10.1371/journal.pone.0241413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166297	Green Published, gold			2022-12-26	WOS:000592382600028
J	Limbu, DK; Piryani, RM; Sunny, AK				Limbu, Dil K.; Piryani, Rano M.; Sunny, Avinash K.			Healthcare workers' knowledge, attitude and practices during the COVID-19 pandemic response in a tertiary care hospital of Nepal	PLOS ONE			English	Article								Background COVID-19 is an ongoing pandemic, for which appropriate infection prevention and control measures need to be adopted. Healthcare workers' adherence to prevention and control measures is affected by their knowledge, attitudes, and practices (KAP) towards COVID-19. In this study, we assessed the KAP among healthcare workers towards the COVID-19 during the ongoing pandemic. Method A self-developed piloted KAP questionnaire was administered to the recruited healthcare workers involved in the COVID-19 response at the Universal College of Medical Sciences Teaching Hospital (UCMSTH), in Bhairahawa, Nepal. The knowledge questionnaire consisted of questions regarding the clinical characteristics, prevention, and management of COVID-19. Assessment on attitudes and practices towards COVID-19 included questions on behaviour and change in practices made towards COVID-19 response. Knowledge scores were calculated and compared by demographic characteristics and their attitude and practices towards COVID-19. Data were analysed using bivariate statistics. Results A total of 103 healthcare workers participated in the study. The mean age of the participants was 28.24 +/- 6.11 years (range: 20-56); 60.2% were females; 61.2% were unmarried; 60.2% had a medical degree, and 39.8% were the nursing staff. The mean knowledge score was 10.59 +/- 1.12 (range: 7-13), and it did not vary significantly when adjusted for demographic characteristics. The attitude was positive for 53.4% of the participants with a mean knowledge score of 10.35 +/- 1.19 and negative for 46.6% participants with a mean knowledge score of 10.88 +/- 0.98 (p = 0.02). The practice was good (>= 3 score) for 81.5% participants with a mean knowledge score of 10.73 +/- 1.12 and poor for 18.5% participants with a mean knowledge score of 10.46 +/- 1.13 (p = 0.24). The attitude of the participants improved with increasing age (29.55 +/- 7.17, p = 0.02). Conclusion There is comparably better knowledge regarding COVID-19 among healthcare workers. Appropriate practice correlates with better knowledge and positive attitude towards COVID-19 infection is seen with increasing age. Hence, training on protection and protective measures for having a positive attitude among healthcare workers is necessary against the fight with COVID-19 infection.	[Limbu, Dil K.] Univ Coll Med Sci, Dept Gen Practice & Emergency Med, Bhairahawa, Nepal; [Piryani, Rano M.] Univ Coll Med Sci, Dept Internal Med, Bhairahawa, Nepal; [Sunny, Avinash K.] Golden Community, Res Div, Lalitpur, Nepal		Sunny, AK (corresponding author), Golden Community, Res Div, Lalitpur, Nepal.	avinashkayastha@gmail.com	Piryani, Rano Mal/ABF-8765-2020	Piryani, Rano Mal/0000-0003-2574-7226; Kayastha, Avinash/0000-0002-9965-181X				Ghebreyesus TA, 2020, WORLD PSYCHIATRY, V19, P129, DOI 10.1002/wps.20768; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Jiang LL, 2018, J HOSP INFECT, V98, P404, DOI 10.1016/j.jhin.2017.10.020; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; Ministry of Health and Population Nepal, 2020, 173 MIN JUST, P1; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Pradhan TR., 2020, KATHMANDU POST; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; WHO, 2020, INTERVENTIONTRIGGERA, P18; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; World Health Organization, 152 WHO; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012	14	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0242126	10.1371/journal.pone.0242126	http://dx.doi.org/10.1371/journal.pone.0242126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156873	Green Submitted, gold, Green Published			2022-12-26	WOS:000591376400047
J	Bonmati-Carrion, MA; Padilla, J; Arguelles-Prieto, R; Osterholm, AM; Reynolds, JR; Madrid, JA; Rol, MA				Bonmati-Carrion, Maria Angeles; Padilla, Javier; Arguelles-Prieto, Raquel; Osterholm, Anna M.; Reynolds, John R.; Madrid, Juan Antonio; Rol, Maria Angeles			Electrochromic selective filtering of chronodisruptive visible wavelengths	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MELATONIN SUPPRESSION; ACTION SPECTRUM; PUPIL RESPONSE; SHIFT WORK; LIGHT; MELANOPSIN; CONE; COLOR; SIGNALS	We present evidence of pupil response modification, as well as differential theoretical melatonin suppression through selective and dynamic electrochromic filtering of visible light in the 400-500 nm range to minimize chronodisruptive nocturnal blue light exposure. A lower activation of intrinsically photosensitive retinal ganglion cells (ipRGCs), the first step for light to reach a human's internal clock, is related to melatonin secretion therefore avoiding detrimental effects of excessive blue light exposure. Pupillary Light Reflex and Color Naming were experimentally assessed under light filtered by two different coloration states (transmissive and absorptive) of these novel dynamic filters, plus an uncoated test device, in 16 volunteers. Also, different commercial light sources at illuminances ranging from 1 to 1000 lux were differentially filtered and compared in terms of theoretical melatonin suppression. Representative parameters of the pupil responses reflected lower pupil constriction when the electrochromic filters (ECFs) were switched on (absorptive state, blue light is absorbed by the filter) compared to uncoated filters (control sample), but failed to do so under transmissive state (blue light passes through the filter) indicating less activation of ipRGCs under absorptive state (although no significant differences between states was found). Out of eight colors tested, just one showed significant differences in naming between both filter states. Thus, the ECF would have some protecting effect on ipRGC activation with very limited changes in color perception. While there are some limitations of the theoretical model used, the absorptive state yielded significantly lower theoretical melatonin suppression in all those light sources containing blue wavelengths across the illuminance range tested. This would open the way for further research on biological applications of electrochromic devices.	[Bonmati-Carrion, Maria Angeles; Arguelles-Prieto, Raquel; Madrid, Juan Antonio; Rol, Maria Angeles] Univ Murcia, Dept Physiol, Chronobiol Lab, IMIB Arrixaca, Murcia, Spain; [Bonmati-Carrion, Maria Angeles; Arguelles-Prieto, Raquel; Madrid, Juan Antonio; Rol, Maria Angeles] Ciber Fragilidad & Envejecimiento Saludable, Madrid, Spain; [Padilla, Javier] Tech Univ Cartagena UPCT, Dept Appl Phys & Naval Technol, ETSII, Cartagena, Spain; [Osterholm, Anna M.; Reynolds, John R.] Georgia Inst Technol, Sch Mat Sci & Engn, Sch Chem & Biochem, Atlanta, GA 30332 USA	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Universidad Politecnica de Cartagena; University System of Georgia; Georgia Institute of Technology	Bonmati-Carrion, MA (corresponding author), Univ Murcia, Dept Physiol, Chronobiol Lab, IMIB Arrixaca, Murcia, Spain.; Bonmati-Carrion, MA (corresponding author), Ciber Fragilidad & Envejecimiento Saludable, Madrid, Spain.	mabonmati@um.es	ROL, ANGELES/ABH-6431-2020	ROL, ANGELES/0000-0002-9343-3918; Padilla, Javier/0000-0002-9974-7774; Bonmati-Carrion, Maria-Angeles/0000-0002-9050-6448	Ministry of Economy and Competitiveness (FEDER); Instituto de Salud Carlos III through a CIBERFES grant (FEDER) [CB16/10/00239]; Fundacion Seneca (FEDER) [19899/GERM/15]; Ministry of Science, Innovation and Universities (FEDER) [RTI2018-093528-B-I00, 825546]; Fundacion Seneca [20401/SF/17, 20529/PDC/18, 20985/PI/18]; Ministry of Education, Culture and Sports [FPU13/01421]; Ministry of Economy and Competitiveness [ENE2016-79282-C5-5-R]; Air Force Office of Scientific Research [FA9550-18-1-0184]	Ministry of Economy and Competitiveness (FEDER); Instituto de Salud Carlos III through a CIBERFES grant (FEDER); Fundacion Seneca (FEDER); Ministry of Science, Innovation and Universities (FEDER); Fundacion Seneca(Fundacion Seneca); Ministry of Education, Culture and Sports; Ministry of Economy and Competitiveness; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Ministry of Economy and Competitiveness, the Instituto de Salud Carlos III through a CIBERFES grant (CB16/10/00239) awarded to JAM, the Fundacion Seneca through grant 19899/GERM/15 awarded to JAM, and the Ministry of Science, Innovation and Universities through grant RTI2018-093528-B-I00 awarded to MAR and Call H2020-sc1-BHC-2018-2020 (Grant agreement 825546, Diabrail-Latam) awarded to MAR (all of them co-financed by FEDER). Research fellowship granted to MAB-C (20401/SF/17) by the Fundacion Seneca and to RA-P (FPU13/01421) by Ministry of Education, Culture and Sports. JP acknowledges funding from Fundacion Seneca (grants 20529/PDC/18 and 20985/PI/18) and Ministry of Economy and Competitiveness through grant ENE2016-79282-C5-5-R. AMO and JRR gratefully acknowledge the financial support from the Air Force Office of Scientific Research (FA9550-18-1-0184).	Adhikari P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161175; Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Akacem Lameese D., 2016, Neurobiology of Sleep and Circadian Rhythms, V1, P27, DOI 10.1016/j.nbscr.2016.11.002; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Bonmati-Carrion MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162476; Bonmati-Carrion MA, 2014, INT J MOL SCI, V15, P23448, DOI 10.3390/ijms151223448; [Anonymous], 2000, JOINT PUB, pvii; Barrionuevo PA, 2014, INVEST OPHTH VIS SCI, V55, P719, DOI 10.1167/iovs.13-13252; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bonmati-Carrion MA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01019; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; Brainard GC, 2001, J NEUROSCI, V21, P6405; Cao DC, 2015, J VISION, V15, DOI 10.1167/15.1.27; Cao KL, 2016, MACROMOLECULES, V49, P8498, DOI 10.1021/acs.macromol.6b01763; CIE, 2019, US EQ DAYL D65 ILL T; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; Dyer AL, 2011, ACS APPL MATER INTER, V3, P1787, DOI 10.1021/am200040p; Erren TC, 2013, NATURWISSENSCHAFTEN, V100, P291, DOI 10.1007/s00114-013-1026-5; Erren TC, 2010, DTSCH ARZTEBL INT, V107, P657, DOI 10.3238/arztebl.2010.0657; Erren TC, 2009, MED HYPOTHESES, V73, P537, DOI 10.1016/j.mehy.2009.06.003; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Garaulet M, 2010, ADV DRUG DELIVER REV, V62, P967, DOI 10.1016/j.addr.2010.05.005; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Joyce DS, 2016, J VISION, V16, DOI 10.1167/16.8.5; Kayumov L, 2005, BLOCKING LOW WAVELEN; Kayumov L, 2007, EUR J CANCER PREV, V16, P357, DOI 10.1097/01.cej.0000215622.59122.d4; Kelbsch C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00129; Knutsson A, 2000, Rev Environ Health, V15, P359; Lee SI, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13942; Logvinenko AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135029; Lowenstein O, 1942, ARCH OPHTHALMOL-CHIC, V27, P969; Martinez-Nicolas A, 2011, CHRONOBIOL INT, V28, P617, DOI 10.3109/07420528.2011.593278; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Nagare R, 2019, J BIOL RHYTHM, V34, P195, DOI 10.1177/0748730419830013; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102827; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Rahman SA, 2013, CHRONOBIOL INT, V30, P951, DOI 10.3109/07420528.2013.789894; Rea MS, 2012, LIGHTING RES TECHNOL, V44, P386, DOI 10.1177/1477153511430474; Rea Mark S, 2010, J Circadian Rhythms, V8, P2, DOI 10.1186/1740-3391-8-2; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303; Reynolds J. R., 2019, CONJUGATED POLYM, V4th; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Spitschan M, 2019, OPHTHAL PHYSL OPT, V39, P459, DOI 10.1111/opo.12648; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Stehle JH, 2003, J NEUROENDOCRINOL, V15, P383, DOI 10.1046/j.1365-2826.2003.01001.x; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tsujimura S, 2006, CURR EYE RES, V31, P401, DOI 10.1080/02713680600681327; Woelders T, 2018, P NATL ACAD SCI USA, V115, P792, DOI 10.1073/pnas.1716281115; Wright HR, 2001, CHRONOBIOL INT, V18, P801, DOI 10.1081/CBI-100107515; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	57	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241900	10.1371/journal.pone.0241900	http://dx.doi.org/10.1371/journal.pone.0241900			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152042	gold, Green Published			2022-12-26	WOS:000591376200054
J	Deligianni, X; Hirschmann, A; Place, N; Bieri, O; Santini, F				Deligianni, Xeni; Hirschmann, Anna; Place, Nicolas; Bieri, Oliver; Santini, Francesco			Dynamic MRI of plantar flexion: A comprehensive repeatability study of electrical stimulation-gated muscle contraction standardized on evoked force	PLOS ONE			English	Article							PHASE-CONTRAST MRI; SKELETAL-MUSCLE; ISOMETRIC CONTRACTION; TENDON COMPLEX; IN-VIVO; STRAIN; MOTION; RECRUITMENT; TISSUE; TENSOR	Quantification of skeletal muscle contraction in Magnetic Resonance Imaging (MRI) is a non-invasive method for studying muscle motion and deformation. The aim of this study was to evaluate the repeatability of quantitative measures such as strain, based on single slice dynamic MRI synchronized with neuromuscular electrical stimulation (NMES) and standardized to a similar relative force level across various individuals. Unilateral electrical stimulation of the triceps surae muscles was applied in eight volunteers during single-slice, three-directional phase contrast MRI acquisition at a 3T MRI scanner. To assess repeatability, the same process was executed on two different days by standardizing the stimulation aiming at evoking a fixed percentage of their maximal voluntary force in the same position. Except from the force, the effect of using the current as reference was evaluated on day two as a secondary acquisition. Finally, the presence of fatigue induced by NMES was assessed (on day one) by examining the difference between consecutive measurements. Strain maps were derived from the acquired slice at every time point; distribution of strain in the muscle and peak strain over the muscle of interest were evaluated for repeatability. It was found that fatigue did not have an appreciable effect on the results. The stimulation settings based on evoked force produced more repeatable results with respect to using the current as the only reference, with an intraclass correlation coefficient between different days of 0.95 for the former versus 0.88 for the latter. In conclusion, for repeatable strain imaging it is advisable to record the force output of the evoked contraction and use that for the standardization of the NMES setup rather than the current.	[Deligianni, Xeni; Bieri, Oliver; Santini, Francesco] Univ Hosp Basel, Dept Radiol, Div Radiol Phys, Basel, Switzerland; [Deligianni, Xeni; Bieri, Oliver; Santini, Francesco] Univ Basel, Dept Biomed Engn, Allschwil, Switzerland; [Hirschmann, Anna] Univ Hosp Basel, Dept Radiol, Basel, Switzerland; [Place, Nicolas] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland	University of Basel; University of Basel; University of Basel; University of Lausanne	Deligianni, X (corresponding author), Univ Hosp Basel, Dept Radiol, Div Radiol Phys, Basel, Switzerland.; Deligianni, X (corresponding author), Univ Basel, Dept Biomed Engn, Allschwil, Switzerland.	xeni.deligianni@unibas.ch	Place, Nicolas/B-3416-2018	Place, Nicolas/0000-0001-9044-0621; Santini, Francesco/0000-0001-6984-4816	172876 Swiss National Science Foundation	172876 Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	FS grant Nr. 172876 Swiss National Science Foundation http://www.snf.ch/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa DS, 2003, J MAGN RESON IMAGING, V18, P734, DOI 10.1002/jmri.10422; AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Babault N, 2007, J STRENGTH COND RES, V21, P431; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Behnam AJ, 2011, J BIOMECH, V44, P193, DOI 10.1016/j.jbiomech.2010.08.029; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Borotikar B, 2017, ANN PHYS REHABIL MED, V60, pe28; Deligianni X, 2020, MAGN RESON MATER PHY, V33, P393, DOI 10.1007/s10334-019-00787-7; Deligianni X, 2017, MAGN RESON MED, V77, P664, DOI 10.1002/mrm.26154; DRACE JE, 1994, RADIOLOGY, V191, P835, DOI 10.1148/radiology.191.3.8184075; DRACE JE, 1994, J MAGN RESON IMAGING, V4, P157, DOI 10.1002/jmri.1880040211; DRACE JE, 1994, RADIOLOGY, V193, P423, DOI 10.1148/radiology.193.2.7972757; Englund EK, 2011, AM J PHYSIOL-REG I, V300, pR1079, DOI 10.1152/ajpregu.00474.2010; Finni T, 2003, J APPL PHYSIOL, V95, P829, DOI 10.1152/japplphysiol.00775.2002; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gondin J, 2014, NMR BIOMED, V27, P870, DOI 10.1002/nbm.3122; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hosseini MS, 2017, IEEE T IMAGE PROCESS, V26, P4596, DOI 10.1109/TIP.2017.2713950; Hosseini MS, 2017, ARXIV170908321; Jensen ER, 2015, J BIOMECH, V48, P95, DOI 10.1016/j.jbiomech.2014.10.035; Kamen G, 2004, J GERONTOL A-BIOL, V59, P1334, DOI 10.1093/gerona/59.12.1334; Lee HD, 2006, J APPL PHYSIOL, V100, P2004, DOI 10.1152/japplphysiol.01085.2005; Maffiuletti NA, 2018, ARCH PHYS MED REHAB, V99, P806, DOI 10.1016/j.apmr.2017.10.028; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Malis V, 2020, MAGN RESON MED, V84, P142, DOI 10.1002/mrm.28100; Mazzoli V, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3791; Moerman KM, 2012, MED PHYS, V39, P1793, DOI 10.1118/1.3685579; Pusterla O, 2018, J MAGN RESON IMAGING, V48, P48, DOI 10.1002/jmri.25928; RStudio Team, 2018, RSTUDIO INT DEV R; Selesnick IW, 1998, IEEE T CIRCUITS-II, V45, P53, DOI 10.1109/82.659456; Selesnick IW, 1998, IEEE T SIGNAL PROCES, V46, P1688, DOI 10.1109/78.678493; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinha S, 2004, J MAGN RESON IMAGING, V20, P1008, DOI 10.1002/jmri.20210; Sinha S, 2012, J MAGN RESON IMAGING, V36, P498, DOI 10.1002/jmri.23617; Sinha U, 2015, MAGN RESON MED, V73, P1852, DOI 10.1002/mrm.25312; Thummalapenta S, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P162, DOI 10.1109/ICSE.2013.6606562; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhong XD, 2008, J BIOMECH, V41, P532, DOI 10.1016/j.jbiomech.2007.10.026; Zhou HH, 2007, J MAGN RESON IMAGING, V25, P175, DOI 10.1002/jmri.20783; 2019, CAN J KIDNEY HLTH DI, V6, P1	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241832	10.1371/journal.pone.0241832	http://dx.doi.org/10.1371/journal.pone.0241832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152035	gold, Green Published			2022-12-26	WOS:000591376200099
J	Richards, P; Mokuwa, GA; Vandi, A; Mayhew, SH; Hodges, MH				Richards, Paul; Mokuwa, Gelejimah Alfred; Vandi, Ahmed; Mayhew, Susannah Harding; Hodges, Mary Hamer		Ebola Gbalo Res Team	Re-analysing Ebola spread in Sierra Leone: The importance of local social dynamics	PLOS ONE			English	Article							VIRUS DISEASE	Background The 2013-15 Ebola epidemic in West Africa was the largest so far recorded, and mainly affected three adjacent countries, Guinea, Liberia and Sierra Leone. The worst affected country (in terms of confirmed cases) was Sierra Leone. The present paper looks at the epidemic in Sierra Leone. The epidemic in this country was a concatenation of local outbreaks. These local outbreaks are not well characterized through analysis using standard numerical techniques. In part, this reflects difficulties in record collection at the height of the epidemic. This paper offers a different approach, based on application of field-based techniques of social investigation that provide a richer understanding of the epidemic. Methods In a post-epidemic study (2016-18) of two districts (Bo and Moyamba) we use ethnographic data to reconstruct local infection pathways from evidence provided by affected communities, cross-referenced to records of the epidemic retained by the National Ebola Response Commission, now lodged in the Ebola Museum and Archive at Njala University. Our study documents and discusses local social and contextual factors largely missing from previously published studies. Results Our major finding is that the epidemic in Sierra Leone was a series of local outbreaks, some of which were better contained than others. In those that were not well contained, a number of contingent factors helps explain loss of control. Several numerical studies have drawn attention to the importance of local heterogeneities in the Sierra Leone Ebola epidemic. Our qualitative study throws specific light on a number of elements that explain these heterogeneities: the role of externalities, health system deficiencies, cultural considerations and local coping capacities. Conclusions Social issues and local contingencies explain the spread of Ebola in Sierra Leone and are key to understanding heterogeneities in epidemiological data. Integrating ethnographic research into epidemic-response is critical to properly understand the patterns of spread and the opportunities to intervene. This conclusion has significant implications for future interdisciplinary research and interpretation of standard numerical data, and consequently for control of epidemic outbreaks.	[Richards, Paul] Njala Univ, Sch Environm Sci, Mokonde, Sierra Leone; [Mokuwa, Gelejimah Alfred] Eastern Polytech, Dept Agr & Forestry, Kenema, Sierra Leone; [Vandi, Ahmed] Sch Community Hlth Sci, Kowama, Bo, Sierra Leone; [Mayhew, Susannah Harding] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	Njala University; University of London; London School of Hygiene & Tropical Medicine	Richards, P (corresponding author), Njala Univ, Sch Environm Sci, Mokonde, Sierra Leone.	paul.richards1945@gmail.com		Richards, Paul/0000-0001-5813-0228; Mayhew, Susannah/0000-0002-2433-3809	MRC [MR/N015754/1]; UK Medical Research Council [MR/N015754/1]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC Grant: MR/N015754/1 SHM, UK Medical Research Council Grant: MR/N015754/1, PR, UK Medical Research Council Grant: MR/N015754/1 Grant title: Building resilient health systems: lessons from international, national and local emergency responses to the Ebola epidemic in Sierra Leone. The funder played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; Babawo LS, 2019, LANCET, V393, P2647, DOI 10.1016/S0140-6736(19)31211-5; DiGiacomo SM, 1999, MED ANTHROPOL Q, V13, P436, DOI 10.1525/maq.1999.13.4.436; Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Garske T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0308; Krauer F, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004867; Manguvo A., 2015, PAN AFRICAN MED J, V22, P1; Mokuwa EY, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007666; Nichter M., 2008, GLOBAL HLTH WHY CULT; Parker M, 2019, MED ANTHROPOL, V38, P440, DOI 10.1080/01459740.2019.1609472; Richards P, 2016, EBOL PEOPLES SCI HEL; Richards P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224511; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Wong JY, 2016, EPIDEMIOL INFECT, V144, P1473, DOI 10.1017/S0950268815003003	15	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0234823	10.1371/journal.pone.0234823	http://dx.doi.org/10.1371/journal.pone.0234823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151945	Green Published, Green Accepted, gold			2022-12-26	WOS:000591376200053
J	Sarker, BK; Rahman, M; Rahman, T; Rahman, T; Khalil, JJ; Hasan, M; Rahman, F; Ahmed, A; Mitra, DK; Mridha, MK; Rahman, A				Sarker, Bidhan Krishna; Rahman, Musfikur; Rahman, Tanjina; Rahman, Tawhidur; Khalil, Jubaida Jahan; Hasan, Mehedi; Rahman, Fariya; Ahmed, Anisuddin; Mitra, Dipak Kumar; Mridha, Malay Kanti; Rahman, Anisur			Status of the WHO recommended timing and frequency of antenatal care visits in Northern Bangladesh	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; MATERNAL MORTALITY; TRENDS; DETERMINANTS	Objective There is dearth of information on the timeliness of antenatal care (ANC) uptake. This study aimed to determine the timely ANC uptake by a medically trained provider (MTP) as per the World Health Organization (WHO) recommendations and the country guideline. Methods Cross-sectional survey was done with 2,731 women having livebirth outcome in last one year in Dinajpur, Nilphamari and Rajshahi districts, Bangladesh from August-November,2016. Results About 82%(2,232) women received at least one ANC from a MTP. Overall, 78%(2,142) women received 4 or more ANCs by any provider and 43%(1168) from a MTP. Only 14%(378) women received their first ANC at the 1(st) trimester by a MTP. As per 4 schedule visits by the WHO FANC model and the country guideline 8%(203) and 20%(543) women respectively received the first 2 timely ANC by a MTP; where only 1%(32) and 3%(72) received the first 3 visits timely and 0.6%(17) and 1%(29) received all the four timely visits. Factors significantly associated with the first two timely visits are: 10 or above years of schooling of women [adj. OR 2.13 (CI: 1.05, 4.30)] and their husbands [adj. OR 2.40 (CI: 1.31, 4.38)], women's employment [adj. OR 2.32 (CI: 1.43, 3.76)], urban residential status [adj. OR 3.49 (CI: 2.46, 4.95)] and exposure to mass media [adj. OR 1.58 (CI: 1.07, 2.34)] at 95% confidence interval. According to the 2016 WHO ANC model, only 1.5%(40) women could comply with the first two ANC contacts timely by a MTP and no one could comply with all the timely 8 contacts. Conclusion Despite high coverage of ANC utilization, timely ANC visit is low as per both the WHO recommendations and the country guideline. For better understanding, further studies on the timeliness of ANC coverage are required to design feasible intervention for improving maternal and child health.	[Sarker, Bidhan Krishna; Rahman, Musfikur; Rahman, Tanjina; Rahman, Tawhidur; Khalil, Jubaida Jahan; Hasan, Mehedi; Rahman, Fariya; Ahmed, Anisuddin; Rahman, Anisur] Icddrb, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Mitra, Dipak Kumar] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Mridha, Malay Kanti] BRAC Univ, James P Grant Sch Publ Hlth, Ctr Excellence Noncommunicable Dis, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); North South University (NSU); Bangladesh Rural Advancement Committee BRAC; BRAC University	Sarker, BK (corresponding author), Icddrb, Maternal & Child Hlth Div, Dhaka, Bangladesh.	bidhan@icddrb.org	Mridha, Malay Kanti/AAJ-5539-2020; Rahman, Tanjina/HHZ-2026-2022; Mitra, Dipak/W-9569-2018	Mridha, Malay Kanti/0000-0001-9226-457X; Hasan, M. Tasdik/0000-0002-3256-093X; Sarker, Bidhan Krishna/0000-0003-1479-158X; Mitra, Dipak/0000-0001-8680-4146	Bill and Melinda Gates Foundation; BMGF [OPP1146943]; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); BMGF; Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This study funded by Bill and Melinda Gates Foundation. The awarded BMGF grant number is OPP1146943. BKS received the funding. URL of funder website is https://www.gatesfoundation.org.The sponsors had no role in the study design, data collection and analysis, decision to publish and preparing manuscript.; icddr,b acknowledges with gratitude the commitment of Bill & Melinda Gates Foundation to its research efforts. We are grateful to our study participants for their spontaneous participation and sincere commitment to fulfill the research endeavor. icddr,b is also grateful to the Government of Bangladesh, Canada, Sweden and the UK for providing core/ unrestricted support.	Ali S., 2018, J PREG NEONATAL MED, V2; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2012, KIDNEY INT, V2, ps1; Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; Association of Paediatric Anaesthetists of Great Britain and Ireland, 2012, PAEDIAT ANAESTH S1, V22, pS1; Azimi MW, 2019, NAGOYA J MED SCI, V81, P121, DOI 10.18999/nagjms.81.1.121; Bangladesh Bureau of Statistics (BBS) UNICEF Bangladesh, 2019, BANGL MULT IND CLUST; Bangladesh Bureau of Statistics Statistics and Informatics Division Ministry of Planning, 2015, POP HOUS CENS 2011; Bangladesh Bureau of Statistics Statistics and Informatics Division Ministry of Planning, 2013, POP HOUS CENS COMM R; Banik BK., 2016, S E ASIA J PUBLIC HL, V6, P23, DOI [10.3329/seajph.v6i2.31832, DOI 10.3329/SEAJPH.V6I2.31832]; BBS, 2015, BANGL POP HOUS CENS; BBS, 2014, BANGL POP HOUS CENS; BBS, 2013, DISTR STAT 2011 KHAG; Beeckman K, 2013, EUR J PUBLIC HEALTH, V23, P366, DOI 10.1093/eurpub/cks123; Beeckman K, 2013, EUR J PUBLIC HEALTH, V23, P67, DOI 10.1093/eurpub/cks020; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bobo FT, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0602-2; Bostoen K, 2006, INT J EPIDEMIOL, V35, P751, DOI 10.1093/ije/dyl019; Chaka EE, STUDIES, V13, P20; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Debiec KE, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.001; Debiec KE, 2010, IMPR BIRTH OUTC M CH, V203, p122e1, DOI 10.1016/j.ajog.2010.03.001; Farah S, 2015, BANGL MED J, V44, P67; Gupta R, 2017, J NEONATAL BIOL, V6, P263, DOI [DOI 10.4172/2167-0897.1000263, 10.4172/2167-0897.1000263]; Gupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101893; Halim A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1866-2; Hollowell J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-13; Human Resource management (HRM) Ministry of Health and Family Welfare (MOHFW), 2014, HRH DAT SHEET 2014; IIPS ICF, 2017, IND NAT FAM HLTH SUR; Jo Y, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4696-7; Kadapatti MG, 2012, ANTENATAL CARE OCCUR, V2; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1467, DOI 10.1177/1010539513485786; Keya K, 2013, BARRIER DISTANCE TRA; Mannan M. A., 2013, Bangladesh Development Studies, V36, P25; Ministry of Health and Family Welfare (MOHFW), 2018, HLTH POP NUTR ETOOLK; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Mohammad K, 2018, BANGLADESH J SCI RES, V30, P23, DOI [10.3329/bjsr.v30i1-2.36117, DOI 10.3329/BJSR.V30I1-2.36117]; Moinuddin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189365; Moller AB, 2017, UN HLHT FAM WELF CTR, V5, pe977, DOI 10.1016/S2214-109X(17)30325-X; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Mridha MK, 2009, J HEALTH POPUL NUTR, V27, P124; Myatt M., 2012, SHORT GUIDE UNDERTAK; National Institute of Population Research and Training, 2012, BANGL MAT MORT HLTH; National Institute of Population Research and Training Associates for Community and Population Research ICF International, 2016, BANGL HLTH FAC SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates ORC Macro, 2004, BANGL DEM HLTH SURV; National Institute of Population ResearchTraining International Centre for Diarrhoeal Disease Research Bangladesh MEASURE Evaluation, 2017, BANGL MAT MORT HLTH; National Institute of Population Studies (NIPS) [Pakistan] and ICF, 2019, PAK DEM HLTH SURV 20; NIPORT ICF, 2019, BANGL DEM HLTH SURV; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Phommachanh S, 2019, GLOB IND FRAM SUST D, V19, P255, DOI 10.1186/s12884-019-2345-0; Phommachanh S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2345-0; Ponna Satyendra Nath, 2017, J Family Med Prim Care, V6, P231, DOI 10.4103/2249-4863.220024; Rahman A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001462; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Siddique AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205149; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; StataCorp, 2013, STATA STAT SOFTW REL; Tesfaye G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208729; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; THE WORLD BANK, 2019, LOW MIDDL INC 2019; Tuncalp O, 2017, BJOG-INT J OBSTET GY, V124, P860, DOI 10.1111/1471-0528.14599; UNDP Bangladesh, 2020, COV 19 REAL CHECK BA; UNFPA-Afghanistan, 2015, SOC EC SURV CHILD MO; United Nations, 2015, GLOBAL STRATEGY WOME; United Nations International Children's Emergency Fund (unicef), 2016, ANT CAR 2016; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Walton LM, 2012, J HLTH ETHICS    FAL; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2015, BANGLADESH HLTH SYST; WHO, 2016, WORLD HLTH STAT 2016; WHO. UNICEF UNFPA World Bank Group Division atUNP, 2015, TRENDS MAT MORT 1990; World Mission Prayer League (LAMB Hospital), 2017, LAMB ANN REP 2017	78	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241185	10.1371/journal.pone.0241185	http://dx.doi.org/10.1371/journal.pone.0241185			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151964	Green Published, gold			2022-12-26	WOS:000591376200037
J	Ekanem, PE; Nyaga, ACK; Imbusi, EA; Ekanem, R; Mebrahte, B; Gebreslasie, A; Peter, N				Ekanem, Peter Etim; Nyaga, Anne Caroline Kendi; Imbusi, Elizabeth Akitsa; Ekanem, Regina; Mebrahte, Berhanu; Gebreslasie, Adhanom; Peter, Nissi			Neuroimaging patterns of anatomical features in pediatric cerebral palsy patients at Ayder hospital, Mekelle, Ethiopia	PLOS ONE			English	Article							RADIATION-EXPOSURE; RISK; ASSOCIATIONS; POPULATION; OUTCOMES; CANCER; MRI	Background Neuroradiological studies have greatly improved the knowledge and diagnoses of cerebral palsy with its underlying pathology, types and accompanying changes in brain morphology. However, there is no published study on cerebral palsy neuroimaging patterns in Ethiopia. Methods Retrospective chart and neuroimaging reviews were conducted among pediatric patients, who attended Ayder Comprehensive Specialized Hospital between January 2016 and August 2019, fulfilling the study criteria. The magnetic resonance images and computed tomography scans reviewed by a neuroradiologist and/or pediatric neurologist were included. Data was collected using a structured checklist and analyzed using SPSS statistical software version 22. Results were represented using tables, graphs and images. Results The median age at neuroimaging was 2 years. There were more males (54.5%) than females (45.5%) with a male: female ratio of 1.2:1. Majority of the patients had magnetic resonance (81.8%) as opposed to computed tomography scans (18.2%). Most of the patients (69.7%) had been born at term with spastic quadriplegia (33.3%) found to be the leading type of cerebral palsy. 30.3% of the patients had normal neuroimaging studies whereas 69.7% had neuroimaging abnormalities. Anomalies included pathologies of the white matter (18.2%), basal ganglia (15.2%), cortex and lobes (27.3%), corpus callosum (6.1%), lateral ventricles (12.1%), cysts (18.2%) and cerebellum (3%), respectively. Other findings were seen in 45.5% of the patients. Conclusion Severe forms of cerebral palsy (spastic quadriplegia) were most common with majorly cortical and subcortical brain involvement.	[Ekanem, Peter Etim; Mebrahte, Berhanu; Gebreslasie, Adhanom] Mekelle Univ, Coll Hlth Sci, Dept Anat, Mekelle, Ethiopia; [Nyaga, Anne Caroline Kendi; Imbusi, Elizabeth Akitsa] Mekelle Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Mekelle, Ethiopia; [Ekanem, Regina; Peter, Nissi] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Peter, Nissi] Houston Community Coll, Southwest Campus Honors Program, Stafford, TX USA	Mekelle University; Mekelle University; Mekelle University	Ekanem, PE (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Anat, Mekelle, Ethiopia.	etimkpan@gmail.com			Mekelle University [ERC 1360/2019]	Mekelle University	Author: ACKN Grant number: ERC 1360/2019 Funder: Mekelle University URL: www.mu.edu.et The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2017, J PEDIATR-US, V187, P58, DOI 10.1016/j.jpeds.2017.04.059; [Anonymous], 2013, J AFRICAIN IMAGERIE; [Anonymous], 2017, CELL ADHES MIGR, V21, P1, DOI DOI 10.1177/2331216517737230; [Anonymous], 2002, NOR EPIDEMIOL, V12, P43; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bearden DR, 2016, PEDIATR NEUROL, V59, P23, DOI 10.1016/j.pediatrneurol.2016.03.002; Boyd RN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-57; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; Donald KA, 2015, J CHILD NEUROL, V30, P963, DOI 10.1177/0883073814549245; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Korzeniewski SJ, 2008, J CHILD NEUROL, V23, P216, DOI 10.1177/0883073807307983; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Medscape (Neurology), 2018, CER PALS WORK; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; National Guideline Alliance (UK, 2017, CER PALS 25S ASS MAN; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sharma N, 2017, INT J ANATOMY RADIOL, V6, pRO31; Stanley F, 2000, CLIN DEV MED; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; Volpe J.J., 2008, NEUROLOGY NEWBORN; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Wu YW, 2006, PEDIATRICS, V118, P690, DOI 10.1542/peds.2006-0278; Yin R, 2000, J PAEDIATR CHILD H, V36, P139, DOI 10.1046/j.1440-1754.2000.00484.x; YOKOCHI K, 1991, ACTA PAEDIATR SCAND, V80, P818, DOI 10.1111/j.1651-2227.1991.tb11955.x	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241436	10.1371/journal.pone.0241436	http://dx.doi.org/10.1371/journal.pone.0241436			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147254	gold, Green Published			2022-12-26	WOS:000589609300073
J	Abdullah, N; Al Marzooq, F; Mohamad, S; Abd Rahman, N; Rani, KGA; Ngo, HC; Samaranayake, LP				Abdullah, Nizam; Al Marzooq, Farah; Mohamad, Suharni; Abd Rahman, Normastura; Rani, Koippallil Gopalakrishnan Aghila; Hien Chi Ngo; Samaranayake, Lakshman Perera			The antibacterial efficacy of silver diamine fluoride (SDF) is not modulated by potassium iodide (KI) supplements: A study on in-situ plaque biofilms using viability real-time PCR with propidium monoazide	PLOS ONE			English	Article							GLASS-IONOMER CEMENT; STREPTOCOCCUS-MUTANS; PRIMARY TEETH; CARIES; VIVO; INHIBITION; BACTERIA	Silver diamine fluoride (SDF) is commonly used to arrest caries lesions, especially in early childhood caries. Recently, it was suggested that SDF can be combined with potassium iodide (KI) to minimize the discoloration of demineralized dentine associated with SDF application. However, the antibacterial efficacy of SDF alone or combined with KI on in-situ biofilm is unknown. Hence, we compared the anti-plaque biofilm efficacy of two different commercially available SDF solutions, with or without KI, using an in-situ biofilm, analysed using viability real-time PCR with propidium monoazide (PMA). Appliance-borne in-situ biofilm samples (n = 90) were grown for a period of 6 h in five healthy subjects who repeated the experiment on three separate occasions, using a validated, novel, intraoral device. The relative anti-biofilm efficacy of two SDF formulations; 38.0% Topamine (SDFT) and 31.3%, Riva Star (SDF(R)), KI alone, and KI in combination with SDF(R) (SDFR+KI) was compared. The experiments were performed by applying an optimized volume of the agents onto the biofilm for 1min, mimicking the standard clinical procedure. Afterwards the viability of the residual biofilm bacteria was quantified using viability real-time PCR with PMA, then the percentage of viable from total bacteria was calculated. Both SDF formulations (SDFT and SDF(R)) exhibited potent antibacterial activities against the in-situ biofilm; however, there was non-significant difference in their efficacy. KI alone did not demonstrate any antibacterial effect, and there was non-significant difference in the antibacterial efficacy of SDF alone compared to SDF with KI, (SDFT v SDFR/KI). Thus, we conclude that the antibacterial efficacy of SDF against plaque biofilms is not modulated by KI supplements. Viability real-time PCR with PMA was successfully used to analyze the viability of naturally grown oral biofilm; thus, the same method can be used to test the antimicrobial effect of other agents on oral biofilms in future research.	[Abdullah, Nizam; Rani, Koippallil Gopalakrishnan Aghila; Hien Chi Ngo; Samaranayake, Lakshman Perera] Univ Sharjah, Coll Dent Med, Sharjah, U Arab Emirates; [Abdullah, Nizam; Mohamad, Suharni; Abd Rahman, Normastura] Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Al Marzooq, Farah] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Al Ain, U Arab Emirates; [Hien Chi Ngo] Univ Western Australia, UWA Dent Sch, Nedlands, WA, Australia; [Samaranayake, Lakshman Perera] Univ Hong Kong, Fac Dent, Hong Kong, Peoples R China	University of Sharjah; Universiti Sains Malaysia; United Arab Emirates University; University of Western Australia; University of Hong Kong	Mohamad, S (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.	suharni@usm.my	/K-4947-2018	/0000-0002-9122-336X; Al-Marzooq, Farah/0000-0001-5711-6264	University of Sharjah, UAE [170110022]	University of Sharjah, UAE	This study was funded by the University of Sharjah, UAE. (Seed Grant number 170110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah N, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2019.1647757; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Auschill T M, 2004, Clin Oral Investig, V8, P97; Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x; Besinis A, 2014, NANOTOXICOLOGY, V8, P745, DOI 10.3109/17435390.2013.825343; Chu CH, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0960-2; Crystal YO, 2019, J AM DENT ASSOC, V150, P140, DOI 10.1016/j.adaj.2018.10.016; de Almeida Leopoldina de F. D, 2011, Acta odontol. latinoam., V24, P127; Ersin NK, 2006, CARIES RES, V40, P172, DOI 10.1159/000091120; Frencken JE, 2007, CARIES RES, V41, P102, DOI 10.1159/000098042; Fung MHT, 2018, J DENT RES, V97, P171, DOI 10.1177/0022034517728496; Garg S, 2019, OPER DENT, V44, P221, DOI 10.2341/17-266-S; Hamama HH, 2015, AUST DENT J, V60, P80, DOI 10.1111/adj.12276; HIEN NGO, 2001, TOOTH SURFACE TREATM, Patent No. US20010864250; Jefferson KK, 2006, METH MOL B, V341, P119; Karched M, 2019, J ORAL SCI, V61, P19, DOI 10.2334/josnusd.17-0366; Knight GM, 2009, QUINTESSENCE INT, V40, P155; Knight GM, 2006, AUST DENT J, V51, P42, DOI 10.1111/j.1834-7819.2006.tb00399.x; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Lee Y., 2012, SOL CELLS, V22, P2; Lee Y., 2012, SOL CELL, V22, P2; Liu BY, 2012, AUST DENT J, V57, P65, DOI 10.1111/j.1834-7819.2011.01641.x; Llodra JC, 2005, J DENT RES, V84, P721, DOI 10.1177/154405910508400807; Mei ML, 2014, J DENT, V42, P395, DOI 10.1016/j.jdent.2013.12.007; Mei ML, 2013, MED ORAL PATOL ORAL, V18, pE824, DOI 10.4317/medoral.18831; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Palmer Robert J Jr, 2010, Compend Contin Educ Dent, V31, P104; Peng JJY, 2012, J DENT, V40, P531, DOI 10.1016/j.jdent.2012.03.009; Targino AGR, 2014, J MATER SCI-MATER M, V25, P2041, DOI 10.1007/s10856-014-5221-5; Roberts A, 2020, AUST DENT J, V65, P109, DOI 10.1111/adj.12743; Rosenblatt A, 2009, J DENT RES, V88, P116, DOI 10.1177/0022034508329406; Shao YY, 2016, J DAIRY SCI, V99, P9570, DOI 10.3168/jds.2016-11597; Skeie MS, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0478-6; U.S Food & Drug Administration, DIAMM SILV FLUOR DEN; Vinson LA, 2018, J DENT CHILD, V85, P120; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Yasunaga A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-157; Zhang W, 2013, CARIES RES, V47, P284, DOI 10.1159/000346620; Zhao I.S., 2017, INT DENT J, P21; Zhao IS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020340	42	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241519	10.1371/journal.pone.0241519	http://dx.doi.org/10.1371/journal.pone.0241519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141868	gold, Green Published			2022-12-26	WOS:000588376700010
J	Abou Mrad, Z; Saliba, N; Abou Merhi, D; Rahi, A; Nabulsi, M				Abou Mrad, Zaki; Saliba, Nicole; Abou Merhi, Dima; Rahi, Amal; Nabulsi, Mona			Sustaining compliance with hand hygiene when resources are low: A quality improvement report	PLOS ONE			English	Article							HOSPITALS; PROGRAM; SUCCESS	Background Sustainability of hand hygiene is challenging in low resource settings. Adding ownership and goal setting to the WHO-5 multimodal intervention may help sustain high compliance. Aim To increase and sustain compliance of nursing and medical staff with hand hygiene in a tertiary referral center with limited resources. Methods A quality improvement initiative was conducted over two years (2016-2018). After determining baseline compliance rates, the WHO-5 multimodal intervention was implemented with staff education and training, system change, hospital reminders, direct observation and feedback, and hospital safety climate. Additionally, the medical staff was responsible for continuous surveillance of compliance (ownership) until rates above 90% were achieved and sustained (goal setting). Results Of 2987 observations collected between August 2016 and April 2018, 1630 (54.5%) were before, and 1357 (45.5%) were after patient encounters. The average overall compliance with hand hygiene was sustained at 94% for nursing and medical staff. Two instances of drops below 90% were associated with incidence of nosocomial Rotavirus infections. There were no similar infections during intervention periods with compliance rates above the set goal. Analysis using p-charts revealed significant improvement in compliance rates from baseline (chi(2) (1) = 7.94, p = 0.005). Conclusion Adding ownership and goal setting to the WHO-5 multimodal intervention may help achieve, and sustain high rates of compliance with hand hygiene. Involving health care workers in quality improvement initiatives is feasible, durable, reliable, and cheap, especially in settings with limited financial resources.	[Abou Mrad, Zaki] Amer Univ Beirut, Fac Arts & Sci, Med Res Volunteer Program MRVP, Beirut, Lebanon; [Saliba, Nicole; Abou Merhi, Dima; Rahi, Amal; Nabulsi, Mona] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon	American University of Beirut; American University of Beirut	Nabulsi, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon.	mn04@aub.edu.lb	; Nabulsi, Mona/A-8002-2016	Abou Mrad, Zaki/0000-0001-6387-8396; Nabulsi, Mona/0000-0001-7415-6436				Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; [Anonymous], 2010, EUR J CARDIOTHORA S1, V38, pS1; Beyersmann J, 2009, INFECT CONT HOSP EP, V30, P273, DOI 10.1086/596020; Carey RG, 2003, BASIC ADV SPC METHOD; Crews JD, 2013, INFECT CONT HOSP EP, V34, P751, DOI 10.1086/671002; Ghee L, 2017, AM SURGEON, V83, pE468; Harbarth S, 2002, PEDIATR INFECT DIS J, V21, P489, DOI 10.1097/00006454-200206000-00002; Harris BD, 2011, HEALTH AFFAIR, V30, P1751, DOI 10.1377/hlthaff.2010.1282; Homa Karen, 2011, Qual Manag Health Care, V20, P116, DOI 10.1097/QMH.0b013e318213ae83; Hussain AS, 2020, ARCH DIS CHILD, DOI 10.1136/archdischild-2019-318779; Johnson L, 2014, AM J INFECT CONTROL, V42, P1146, DOI 10.1016/j.ajic.2014.07.003; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Lacey G, 2020, AM J INFECT CONTROL, V48, P162, DOI 10.1016/j.ajic.2019.06.015; Linam WM, 2016, AM J INFECT CONTROL, V44, P544, DOI 10.1016/j.ajic.2015.12.019; Linam WM, 2011, PEDIATRICS, V128, pE689, DOI 10.1542/peds.2010-3587; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; McLean Heather S, 2017, Hosp Pediatr, V7, P189, DOI 10.1542/hpeds.2016-0110; Mestre G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047200; Ogrinc Greg, 2016, BMJ Qual Saf, V25, P986, DOI 10.1136/bmjqs-2015-004411; Pimentel MPT, 2019, J PATIENT SAF, V15, pE44, DOI 10.1097/PTS.0000000000000282; Rees S, 2013, J NURS CARE QUAL, V28, P312, DOI 10.1097/NCQ.0b013e3182902404; Rosenbluth G, 2016, AM J MED QUAL, V31, P577, DOI 10.1177/1062860615596567; Sharma S, 2019, INDIAN J CRIT CARE M, V23, P224, DOI 10.5005/jp-journals-10071-23165; Smiddy Maura P, 2019, J Infect Prev, V20, P164, DOI 10.1177/1757177419833165; Squires JE, 2014, INFECT CONT HOSP EP, V35, P1511, DOI 10.1086/678597; The European Collaborative Study, 2003, PEDIATRICS, V111, pe52; World Health Organization, 2009, WHO GUID HAND HYG HL; Zoutman DE, 2017, INT J HEALTH CARE Q, V30, P16, DOI 10.1108/IJHCQA-12-2015-0144	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241706	10.1371/journal.pone.0241706	http://dx.doi.org/10.1371/journal.pone.0241706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141855	gold, Green Published			2022-12-26	WOS:000588376700045
J	Pinchoff, J; Mills, CW; Balk, D				Pinchoff, Jessie; Mills, Carrie W.; Balk, Deborah			Urbanization and health: The effects of the built environment on chronic disease risk factors among women in Tanzania	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INFLAMMATION	Sub-Saharan Africa is experiencing rapid urban growth. Cities enable greater access to health services and improved water and sanitation infrastructure, leading to some improvements in health. However, urban settings may also be associated with more sedentary, stressful lifestyles and consumption of less nutritious food. C-reactive protein (CRP) is a measure of chronic inflammation predictive of cardiovascular disease, and high body mass index (BMI), a ratio of weight to height, indicates overweight or obesity and is associated with an increased risk of many chronic diseases. To explore the association between urbanicity and these two markers, we overlaid data from the 2010 Tanzania Demographic and Health Survey (DHS) with a satellite-derived measure of built environment. Linear regression models were constructed for the outcomes of BMI and CRP, by 1) administratively defined urban/rural categorization from the DHS, 2) satellite derived built environment, and 3) built environment stratified by urban/rural. A total of 2,212 women were included; 23% had elevated CRP, 21% were overweight or obese. A third (33%) lived in a highly built up area and 29% lived in an area classified as urban. A strong positive association between both CRP and BMI and built environment was detected; log CRP increased 0.43 in the highest built up areas compared to not built up (p<0.05); log BMI increased 0.02 in the most built up areas compared to not built up (p<0.05). However, comparing urban to rural category was only significant in unadjusted models. Models stratified by urban/rural category highlight that the variation in CRP and BMI by built environment is mainly driven by rural areas; within urban areas there is less variation. Our findings highlight the potential negative effects of urbanicity on chronic disease markers, with potentially more change detected for those transitioning from rural to urban lifestyles. Satellite-derived urbanicity measures are reproducible and provide more nuanced understanding of effects of built environment on health.	[Pinchoff, Jessie] Populat Council, Dept Poverty Gender & Youth, 1230 York Ave, New York, NY 10021 USA; [Mills, Carrie W.; Balk, Deborah] CUNY, Inst Demog Res, New York, NY 10021 USA	Population Council; City University of New York (CUNY) System	Pinchoff, J (corresponding author), Populat Council, Dept Poverty Gender & Youth, 1230 York Ave, New York, NY 10021 USA.	jpinchoff@popcouncil.org		Pinchoff, Jessie/0000-0003-3155-595X; Balk, Deborah/0000-0002-9028-7898	CUNY Institute for Demographic Research	CUNY Institute for Demographic Research	Co-author Carrie Mills received funding from the CUNY Institute for Demographic Research as a Demography Fellow. Otherwise, the authors received no specific funding for this work.	[Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2003, CITIES TRANSFORMED D; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Bingenheimer JB, 2007, INT FAM PLAN PERSPEC, V33, P83, DOI 10.1363/3308307; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Burgert C. R., 2013, DHS SPATIAL ANAL REP; Chirinos DA, 2019, ANN BEHAV MED, V53, P827, DOI 10.1093/abm/kay092; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Corker J, 2017, POPUL SPACE PLACE, V23, DOI 10.1002/psp.2009; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Djikstra L, 2018, 16 C IAOS; Dorelien A, 2013, POPUL DEV REV, V39, P413, DOI 10.1111/j.1728-4457.2013.00610.x; Duthe G, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0084-2; Egger G, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110301; Gamil S, 2015, PLASMA LEVELS CREACT; Grace K, 2019, POPUL DEV REV, V45, P197, DOI 10.1111/padr.12222; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Henderson JV, DEMOGRAPHIC HLTH OUT, P2019; Holmes LM, 2012, HEALTH PLACE, V18, P683, DOI 10.1016/j.healthplace.2011.11.006; Johnson TV, 2013, MOL DIAGN THER, V17, P147, DOI 10.1007/s40291-013-0026-7; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Juma K., 2019, NONCOMMUNICABLE DIS; Kohler IV, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-4; Magnus MC, 2017, EPIDEMIOLOGY, V28, P880, DOI [10.1097/EDE.0000000000000712, 10.1097/ede.0000000000000712]; Mbanya J. C., 2014, Current Diabetes Reports, V14, P501, DOI 10.1007/s11892-014-0501-5; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Montgomery MR, 2009, POPULATION B, V64; National Bureau of Statistics (NBS) [Tanzania] and ICF Macro, 2011, MICR RES 2010 TANZ D; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pesaresi M, 1990, GHS BUILT UP GRID DE; Pesaresi M, 2000, GHS BUILT UP GRID DE; Pesaresi M, 2014, GHS BUILT UP GRID DE; Pesaresi M, 1975, GHS BUILT UP GRID DE; Pesaresi M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040299; Popkin BM, 2019, NATURE, V569, P200, DOI 10.1038/d41586-019-01182-x; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Rutstein SO, 2006, GUIDE DHS STAT; Shayo GA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-365; Shishehbor MH, 2003, CLEV CLIN J MED, V70, P634, DOI 10.3949/ccjm.70.7.634; Shrivastava AK, 2015, EGYPT HEART J, V67, P89, DOI 10.1016/j.ehj.2014.11.005; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Team F, 2019, GHSL DAT PACK 2019; Tebekaw Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1126; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Thompson AL, 2014, HEALTH PLACE, V28, P177, DOI 10.1016/j.healthplace.2014.05.003; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1	47	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241810	10.1371/journal.pone.0241810	http://dx.doi.org/10.1371/journal.pone.0241810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141863	Green Published, gold			2022-12-26	WOS:000588376700016
J	Chou, JY; O'Driscoll, K; Sandercock, DA; D'Eath, RB				Chou, Jen-Yun; O'Driscoll, Keelin; Sandercock, Dale A.; D'Eath, Rick B.			Can increased dietary fibre level and a single enrichment device reduce the risk of tail biting in undocked growing-finishing pigs in fully slatted systems?	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; DOCKED PIGS; BEHAVIOR; WOOD; OBJECTS; STRAW	This study evaluated the effectiveness of combined dietary and enrichment strategies to manage tail biting in pigs with intact tails in a conventional fully-slatted floor housing system. A 2 x 2 x 2 factorial design was used. Pigs had either a high fibre (weaner 5.3% and finisher 11.6% of crude fibre) or standard fibre diet (weaner 3.7% and finisher 5.9% of crude fibre). In the weaner stage, pigs had either a spruce wooden post (supplied in a wall-mounted dispenser) or a rubber floor toy as a enrichment device, and in the finisher stage, they had either the same or alternate enrichment item. Six hundred and seventy-two pigs were assigned to 48 pens of 14 pigs and followed from weaning until slaughter. Individual tail lesion scores and pen level behaviours were directly recorded every 2 weeks. Twenty-six pens had tail biting outbreaks and 161 injured pigs needed removal for treatment. Pigs fed with the high fibre diet performed more tail biting (p < 0.05) and tended to have a worse tail damage scores than those fed the standard fibre diet (p = 0.08). Pigs which had the floor toy as weaners and wood as finishers tended to have fewer tail lesions in the finisher stage than their counterparts (p = 0.06). Pigs receiving the floor toy as enrichment interacted with the enrichment more frequently overall (p < 0.001) and performed fewer harmful behaviours in the weaner stage (p < 0.05). Overall, higher fibre in the diet in a relatively barren environment did not help reduce tail biting or tail lesions. Altering the fibre level in the pigs' diet and providing a single enrichment device to undocked pigs on fully slatted floors resulted in a high level of tail biting and a large proportion of pigs with partial tail amputation.	[Chou, Jen-Yun; O'Driscoll, Keelin] TEAGASC, Pig Dev Dept, Fermoy, Cork, Ireland; [Chou, Jen-Yun; Sandercock, Dale A.; D'Eath, Rick B.] Scotlands Rural Coll, Anim & Vet Sci Res Grp, Easter Bush, Midlothian, Scotland; [Chou, Jen-Yun] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland	Teagasc; Scotland's Rural College; University of Edinburgh	Chou, JY (corresponding author), TEAGASC, Pig Dev Dept, Fermoy, Cork, Ireland.; Chou, JY (corresponding author), Scotlands Rural Coll, Anim & Vet Sci Res Grp, Easter Bush, Midlothian, Scotland.; Chou, JY (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	jenyun.chou@gmail.com	Chou, Jen-Yun/AAB-6425-2020; Sandercock, Dale Andrew/D-2492-2013	Chou, Jen-Yun/0000-0001-7537-2528; Sandercock, Dale Andrew/0000-0002-1519-9206; D'Eath, Rick/0000-0002-1801-254X	Teagasc Walsh Fellowship; Department of Agriculture, Food and the Marine in Ireland; Scotland's Rural College (SRUC); Rural & Environmental Science & Analytical Services Division of the Scottish Government	Teagasc Walsh Fellowship; Department of Agriculture, Food and the Marine in Ireland; Scotland's Rural College (SRUC); Rural & Environmental Science & Analytical Services Division of the Scottish Government	This project was co-funded by the Teagasc Walsh Fellowship, the Department of Agriculture, Food and the Marine in Ireland, and Scotland's Rural College (SRUC). SRUC also receives funding from the Rural & Environmental Science & Analytical Services Division of the Scottish Government.	[Anonymous], 2009, FRANKFURTER ALLG, V116, P1, DOI DOI 10.1016/j.applanim.2008.08.001; Barbari M., 2017, Agronomy Research, V15, P313; Bolhuis JE, 2008, ANIMAL, V2, P1028, DOI 10.1017/S175173110800222X; Bracke M. B. M., 2018, Advances in pig welfare: a volume in herd and flock welfare, P167; Brunberg EI, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00057; Chou JY, 2020, APPL ANIM BEHAV SCI, V224, DOI 10.1016/j.applanim.2020.104944; Chou JY, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080582; Chou JY, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040139; Chou JY, 2018, LIVEST SCI, V213, P19, DOI 10.1016/j.livsci.2018.04.004; D'Eath RB, 2016, ANIMAL, V10, P687, DOI 10.1017/S1751731115002098; D'Eath RB, 2014, ANIMAL, V8, P1479, DOI 10.1017/S1751731114001359; De Briyne N, 2018, PORCINE HEALTH MANAG, V4, DOI 10.1186/s40813-018-0103-8; de Leeuw JA, 2008, P NUTR SOC, V67, P334, DOI 10.1017/S002966510800863X; Docking CM, 2008, APPL ANIM BEHAV SCI, V110, P244, DOI 10.1016/j.applanim.2007.05.004; Donaldson TM, 2002, APPL ANIM BEHAV SCI, V79, P221, DOI 10.1016/S0168-1591(02)00138-7; Edwards S, 2014, DILEMMAS IN ANIMAL WELFARE, P6, DOI 10.1079/9781780642161.0006; EFSA, 2007, EFSA J, V611, P1, DOI 10.2903/j.efsa.2007.611; EFSA, 2005, WELF WEAN REAR PIGS, V268, P1; European Commission, 2001, OFFICIAL J EUROP UNI, pL 316/36; FRASER D, 1991, APPL ANIM BEHAV SCI, V30, P307, DOI 10.1016/0168-1591(91)90135-K; Haigh A, 2019, PORCINE HEALTH MANAG, V5, DOI 10.1186/s40813-019-0135-8; Horback KM, 2016, APPL ANIM BEHAV SCI, V184, P7, DOI 10.1016/j.applanim.2016.09.002; Kallabis KE, 2012, ARCH TIERZUCHT, V55, P272, DOI 10.5194/aab-55-272-2012; Kallio PA, 2018, ANIM WELFARE, V27, P21, DOI 10.7120/09627286.27.1.021; Lahrmann HP, 2017, ANIMAL, V11, P1825, DOI 10.1017/S1751731117000490; McIntyre J, 2002, P BR SOC ANIM SCI, V2002, P34, DOI [10.1017/S1752756200006906, DOI 10.1017/S1752756200006906]; Moinard C, 2003, APPL ANIM BEHAV SCI, V81, P333, DOI 10.1016/S0168-1591(02)00276-9; Naya A, 2019, LIVEST SCI, V223, P133, DOI 10.1016/j.livsci.2019.03.010; NEWBERRY RC, 1988, BEHAV PROCESS, V17, P205, DOI 10.1016/0376-6357(88)90004-6; NOBLET J, 1993, J ANIM SCI, V71, P3389, DOI 10.2527/1993.71123389x; Oliviero C, 2009, RES VET SCI, V86, P314, DOI 10.1016/j.rvsc.2008.07.007; Sandercock DA, 2016, J COMP PATHOL, V155, P40, DOI 10.1016/j.jcpa.2016.05.003; Schroder-Petersen DL, 2001, VET J, V162, P196, DOI 10.1053/tvjl.2001.0605; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Telkanranta H, 2014, APPL ANIM BEHAV SCI, V161, P51, DOI 10.1016/j.applanim.2014.09.007; Valros A., 2018, Advances in pig welfare: a volume in herd and flock welfare, P137; Valros A, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00405; Van De Weerd HA, 2006, APPL ANIM BEHAV SCI, V99, P230, DOI 10.1016/j.applanim.2005.10.014; van Staaveren N, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090677; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005	40	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241619	10.1371/journal.pone.0241619	http://dx.doi.org/10.1371/journal.pone.0241619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125443	Green Published, gold			2022-12-26	WOS:000588368900049
J	Wong, W; Kim, A; Monaghan, JR; Seifert, AW; Maden, M; Crane, JD				Wong, Wesley; Kim, Austin; Monaghan, James R.; Seifert, Ashley W.; Maden, Malcolm; Crane, Justin D.			Spiny mice (Acomys) exhibit attenuated hallmarks of aging and rapid cell turnover after UV exposure in the skin epidermis	PLOS ONE			English	Article							RADIATION-INDUCED INFLAMMATION; KERATINOCYTE PROLIFERATION; RODENT; HYPERSENSITIVITY; DIFFERENTIATION; DETERMINANT; ACTIVATION; RESISTANCE; STRESS; ARREST	The study of long-lived and regenerative animal models has revealed diverse protective responses to stressors such as aging and tissue injury. Spiny mice (Acomys) are a unique mammalian model of skin wound regeneration, but their response to other types of physiological skin damage has not been investigated. In this study, we examine how spiny mouse skin responds to acute UVB damage or chronological aging compared to non-regenerative C57Bl/6 mice (M. musculus). We find that, compared to M. musculus, the skin epidermis in A. cahirinus experiences a similar UVB-induced increase in basal cell proliferation but exhibits increased epidermal turnover. Notably, A. cahirinus uniquely form a suprabasal layer co-expressing Keratin 14 and Keratin 10 after UVB exposure concomitant with reduced epidermal inflammatory signaling and reduced markers of DNA damage. In the context of aging, old M. musculus animals exhibit typical hallmarks including epidermal thinning, increased inflammatory signaling and senescence. However, these age-related changes are absent in old A. cahirinus skin. Overall, we find that A. cahirinus have evolved novel responses to skin damage that reveals new aspects of its regenerative phenotype.	[Wong, Wesley; Kim, Austin; Monaghan, James R.; Crane, Justin D.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Seifert, Ashley W.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Maden, Malcolm] Univ Florida, UF Genet Inst & Dept Biol, Gainesville, FL USA	Northeastern University; University of Kentucky; State University System of Florida; University of Florida	Crane, JD (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	j.crane@northeastern.edu		Seifert, Ashley/0000-0001-6576-3664; Wong, Wesley/0000-0003-3333-6689; Crane, Justin/0000-0002-5380-5676	Northeastern University Provost's Office	Northeastern University Provost's Office	This work was supported by startup funding from the Northeastern University Provost's Office (toJ. D. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HDB BIOL AGING; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Brant JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142931; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Freije A, 2014, CELL REP, V9, P1349, DOI 10.1016/j.celrep.2014.10.012; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gawriluk T. R., 2019, BIORXIV, DOI [10.1101/723783, DOI 10.1101/723783]; Gawriluk TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11164; Hadi F, 2018, BIORXIV, DOI [10.1101/404574, DOI 10.1101/404574]; Joven A, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167700; Kench JA, 1999, CLIN IMMUNOL, V92, P300, DOI 10.1006/clim.1999.4754; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kowalczyk A, 2020, ELIFE, V9, DOI 10.7554/eLife.51089; Liu N, 2019, NATURE, V568, P344, DOI 10.1038/s41586-019-1085-7; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Maden M, 2018, BURNS, V44, P1509, DOI 10.1016/j.burns.2018.05.018; Maden M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27178-7; Mikkelsen SA, 2018, J BIOL CHEM, V293, P3880, DOI 10.1074/jbc.RA117.000941; Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110; Ota T, 2014, ACTA HISTOCHEM CYTOC, V47, P175, DOI 10.1267/ahc.14027; Ouhtit A, 2000, AM J PATHOL, V156, P201, DOI 10.1016/S0002-9440(10)64720-7; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Qiang L, 2017, AUTOPHAGY, V13, P2086, DOI 10.1080/15548627.2017.1380757; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Robia SL, 2018, J BIOL CHEM, V293, P3890, DOI 10.1074/jbc.H118.002088; Saxena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12398-w; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Seluanov A, 2018, NAT REV CANCER, V18, P433, DOI 10.1038/s41568-018-0004-9; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Streeter KA, 2020, J COMP NEUROL, V528, P1535, DOI 10.1002/cne.24836; Tian X, 2015, P NATL ACAD SCI USA, V112, P1053, DOI 10.1073/pnas.1418203112; TREVITHICK JR, 1992, ARCH BIOCHEM BIOPHYS, V296, P575, DOI 10.1016/0003-9861(92)90613-2; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Wang AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15901-9; Wang M, 1999, P NATL ACAD SCI USA, V96, P6885, DOI 10.1073/pnas.96.12.6885; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong W, 2019, J BIOL CHEM, V294, P20024, DOI 10.1074/jbc.RA119.010740; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	48	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241617	10.1371/journal.pone.0241617	http://dx.doi.org/10.1371/journal.pone.0241617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125436	Green Published, Green Submitted, gold			2022-12-26	WOS:000588368900051
J	Park, J; Hwang, Y; Nam, JH; Oh, DJ; Kim, KB; Song, HJ; Kim, SH; Kang, SH; Jung, MK; Lim, YJ				Park, Junseok; Hwang, Youngbae; Nam, Ji Hyung; Oh, Dong Jun; Kim, Ki Bae; Song, Hyun Joo; Kim, Su Hwan; Kang, Sun Hyung; Jung, Min Kyu; Jeong Lim, Yun			Artificial intelligence that determines the clinical significance of capsule endoscopy images can increase the efficiency of reading	PLOS ONE			English	Article								Artificial intelligence (AI), which has demonstrated outstanding achievements in image recognition, can be useful for the tedious capsule endoscopy (CE) reading. We aimed to develop a practical AI-based method that can identify various types of lesions and tried to evaluate the effectiveness of the method under clinical settings. A total of 203,244 CE images were collected from multiple centers selected considering the regional distribution. The AI based on the Inception-Resnet-V2 model was trained with images that were classified into two categories according to their clinical significance. The performance of AI was evaluated with a comparative test involving two groups of reviewers with different experiences. The AI summarized 67,008 (31.89%) images with a probability of more than 0.8 for containing lesions in 210,100 frames of 20 selected CE videos. Using the AI-assisted reading model, reviewers in both the groups exhibited increased lesion detection rates compared to those achieved using the conventional reading model (experts; 34.3%-73.0%; p = 0.029, trainees; 24.7%-53.1%; p = 0.029). The improved result for trainees was comparable to that for the experts (p = 0.057). Further, the AI-assisted reading model significantly shortened the reading time for trainees (1621.0-746.8 min; p = 0.029). Thus, we have developed an AI-assisted reading model that can detect various lesions and can successfully summarize CE images according to clinical significance. The assistance rendered by AI can increase the lesion detection rates of reviewers. Especially, trainees could improve their efficiency of reading as a result of reduced reading time using the AI-assisted model.	[Park, Junseok] Soonchunhyang Univ, Coll Med, Inst Digest Res, Dept Internal Med,Digest Dis Ctr, Seoul, South Korea; [Hwang, Youngbae] Chungbuk Natl Univ, Dept Elect Engn, Cheongju, South Korea; [Nam, Ji Hyung; Oh, Dong Jun; Jeong Lim, Yun] Dongguk Univ, Coll Med, Ilsan Hosp, Div Gastroenterol,Dept Internal Med, Goyang, South Korea; [Kim, Ki Bae] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Song, Hyun Joo] Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea; [Kim, Su Hwan] Seoul Metropolitan Govt Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kang, Sun Hyung] Chungnam Natl Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Daejeon, South Korea; [Jung, Min Kyu] Kyungpook Natl Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Daegu, South Korea	Soonchunhyang University; Chungbuk National University; Dongguk University; NHIS Ilsan Hospital; Chungbuk National University; Jeju National University; Seoul National University (SNU); Seoul National University Hospital; Chungnam National University; Kyungpook National University; Kyungpook National University Hospital	Lim, YJ (corresponding author), Dongguk Univ, Coll Med, Ilsan Hosp, Div Gastroenterol,Dept Internal Med, Goyang, South Korea.	drlimyj@gmail.com	Song, hyunjoo/GWC-1292-2022; KIM, SUHWAN/GSE-0120-2022	Oh, Dong jun/0000-0002-3876-2153; Jung, Min Kyu/0000-0001-8749-408X; Kang, Sun Hyung/0000-0002-1913-4346	Korean Health Technology R&D project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI19C0665]	Korean Health Technology R&D project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D project through the Korean Health Industry Development Institute (KHIDI, https://www.khidi.or.kr/eps), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI19C0665). The corresponding author, Dr. LYJ, received the fund. The funders did not play a direct role in writing this article, but this study could be constructed on the fund.	Ahn JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211579; Aoki T, 2019, GASTROINTEST ENDOSC, V89, P357, DOI 10.1016/j.gie.2018.10.027; Bianco S, 2018, IEEE ACCESS, V6, P64270, DOI 10.1109/ACCESS.2018.2877890; Deng J., 2009, 2009 IEEE C COMP VIS; Ding Z, 2019, GASTROENTEROLOGY, V157, P1044, DOI 10.1053/j.gastro.2019.06.025; He JY, 2018, IEEE T IMAGE PROCESS, V27, P2379, DOI 10.1109/TIP.2018.2801119; He K., 2017, P IEEE INT C COMP VI, P2961; Khan Asifullah, 2019, ABS190106032 CORR; Kim SH, 2020, KOREAN J INTERN MED, V35, P889, DOI 10.3904/kjim.2019.312; Ko YC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233079; Koulaouzidis A, 2013, WORLD J GASTROENTERO, V19, P3726, DOI 10.3748/wjg.v19.i24.3726; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Leenhardt R, 2019, GASTROINTEST ENDOSC, V89, P189, DOI 10.1016/j.gie.2018.06.036; Lim YJ, 2015, CLIN ENDOSC, V48, P399, DOI 10.5946/ce.2015.48.5.399; Liu W, 2016, **DROPPED REF**, DOI DOI 10.1007/978-3-319-46448-0_2; Park J, 2019, CLIN ENDOSC, V52, P328, DOI 10.5946/ce.2018.172; Redmon J., 2016, P 2016 IEEE C COMP V; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Wang A, 2013, GASTROINTEST ENDOSC, V78, P805, DOI 10.1016/j.gie.2013.06.026; Westerhof J, 2012, WORLD J GASTROENTERO, V18, P1502, DOI 10.3748/wjg.v18.i13.1502	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241474	10.1371/journal.pone.0241474	http://dx.doi.org/10.1371/journal.pone.0241474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119718	gold, Green Published			2022-12-26	WOS:000600013600067
J	Liang, R; Wang, G; Zhang, D; Ye, G; Li, MX; Shi, YJ; Shi, JL; Chen, HC; Peng, GQ				Liang, Rui; Wang, Gang; Zhang, Ding; Ye, Gang; Li, Mengxia; Shi, Yuejun; Shi, Jiale; Chen, Huanchun; Peng, Guiqing			Structural comparisons of host and African swine fever virus dUTPases reveal new clues for inhibitor development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; NUCLEOSIDE ANALOGS; ELECTROSTATICS; REPLICATION; MECHANISM; BINDING; URACIL	African swine fever, caused by the African swine fever virus (ASFV), is among the most significant swine diseases. There are currently no effective treatments against ASFV. ASFV contains a gene encoding a dUTPase (E165R), which is required for viral replication in swine macrophages, making it an attractive target for inhibitor development. However, the full structural details of the ASFV dUTPase and those of the comparable swine enzyme are not available, limiting further insights. Herein, we determine the crystal structures of ASFV dUTPase and swine dUTPase in both their ligand-free and ligand-bound forms. We observe that the swine enzyme employs a classical dUTPase architecture made up of three-subunit active sites, whereas the ASFV enzyme employs a novel two-subunit active site. We then performed a comparative analysis of all dUTPase structures uploaded in the Protein Data Bank (PDB), which showed classical and non-classical types were mainly determined by the C-terminal beta-strand orientation, and the difference was mainly related to the four amino acids behind motif IV. Thus, our study not only explains the reason for the structural diversity of dUTPase but also reveals how to predict dUTPase type, which may have implications for the dUTPase family. Finally, we tested two dUTPase inhibitors developed for the Plasmodium falciparum dUTPase against the swine and ASFV enzymes. One of these compounds inhibited the ASFV dUTPase at low micromolar concentrations (K-d = 15.6 mu M) and with some selectivity (similar to 2x) over swine dUTPase. In conclusion, our study expands our understanding of the dUTPase family and may aid in the development of specific ASFV inhibitors.	[Liang, Rui; Wang, Gang; Zhang, Ding; Ye, Gang; Li, Mengxia; Shi, Yuejun; Shi, Jiale; Chen, Huanchun; Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Liang, Rui; Wang, Gang; Zhang, Ding; Ye, Gang; Li, Mengxia; Shi, Yuejun; Shi, Jiale; Chen, Huanchun; Peng, Guiqing] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Hubei, Peoples R China; [Shi, Yuejun] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Peng, GQ (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Peng, GQ (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Hubei, Peoples R China.	penggq@mail.hzau.edu.cn	Ye, Gang/ADQ-1652-2022; Ye, Gang/HHC-0194-2022	Ye, Gang/0000-0001-6034-2174; Mengxia, Li/0000-0003-4115-9037; Liang, Rui/0000-0003-2259-0112; Zhang, Ding/0000-0002-5520-7629	National Key R&D Program of China [:2018YFC0840402]; National Natural Science Foundation of China [31941005]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program of China [No:2018YFC0840402]; and the National Natural Science Foundation of China [grant number 31941005].	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alejo A, 2018, J VIROL, V92, DOI 10.1128/JVI.01293-18; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baragana B, 2011, BIOORGAN MED CHEM, V19, P2378, DOI 10.1016/j.bmc.2011.02.012; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Doi T, 2019, INVEST NEW DRUG, V37, P507, DOI 10.1007/s10637-018-0697-3; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galindo I, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050103; Gonzalez A, 2001, ACTA CRYSTALLOGR D, V57, P767, DOI 10.1107/S0907444901004255; Hagenkort A, 2017, ONCOTARGET, V8, P23713, DOI 10.18632/oncotarget.15785; Hampton SE, 2011, CHEMMEDCHEM, V6, P1816, DOI 10.1002/cmdc.201100255; Karger A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090864; Kerepesi C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01768; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li CY, 2019, MBIO, V10, DOI 10.1128/mBio.02483-19; Li G., 2020, J VIROL, V94; Liu S, 2019, CELL HOST MICROBE, V26, P836, DOI 10.1016/j.chom.2019.11.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miao FM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01004; Miyahara S, 2012, J MED CHEM, V55, P5483, DOI 10.1021/jm300416h; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagy GN, 2016, J AM CHEM SOC, V138, P15035, DOI 10.1021/jacs.6b09012; Nguyen C, 2006, J MED CHEM, V49, P4183, DOI 10.1021/jm060126s; Oliveros M, 1999, J VIROL, V73, P8934, DOI 10.1128/JVI.73.11.8934-8943.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Perez-Moreno G, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3025-2; Persson T, 1996, BIOORGAN MED CHEM, V4, P553, DOI 10.1016/0968-0896(96)00044-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reis AL, 2017, J VIROL, V91, DOI 10.1128/JVI.02338-16; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Szilagyi A, 2012, J MOL BIOL, V415, P221, DOI 10.1016/j.jmb.2011.10.045; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Wang N, 2019, SCIENCE, V366, P640, DOI 10.1126/science.aaz1439; Yano W, 2018, MOL CANCER THER, V17, P1683, DOI 10.1158/1535-7163.MCT-17-0911; Yu Q, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02684; Zeng Z, 2018, J VIROL, V92, DOI 10.1128/JVI.00692-18; Zhang R, 2017, J VIROL, V91, DOI [10.1128/JVI.01148-17, 10.1128/jvi.01148-17]; Zhou XT, 2018, TRANSBOUND EMERG DIS, V65, P1482, DOI 10.1111/tbed.12989	48	7	9	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100015	10.1074/jbc.RA120.014005	http://dx.doi.org/10.1074/jbc.RA120.014005			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33139328	gold, Green Published			2022-12-26	WOS:000672866400001
J	Wu, LL; Zhao, GQ; Xu, SY; Kuang, JQ; Ming, J; Wu, GM; Wang, T; Wang, B; Zhu, P; Pei, DQ; Liu, J				Wu, Linlin; Zhao, Guoqing; Xu, Shuyang; Kuang, Junqi; Ming, Jin; Wu, Guangmin; Wang, Tao; Wang, Bo; Zhu, Ping; Pei, Duanqing; Liu, Jing			The nuclear factor CECR2 promotes somatic cell reprogramming by reorganizing the chromatin structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; INDUCTION; COMPLEX; SALL4; TET1	Somatic cells can be reprogrammed into pluripotent stem cells with a minimal set of defined factors, Oct3/4, Sox2, Klf4, and c-Myc, also known as OKSM, although this reprogramming is somewhat inefficient. Recent work has identified other nuclear factors, including SALL4, that can synergize with the OSK factors to improve reprogramming dynamics, but the specific role of each of these factors remains poorly understood. In this study, we sought to learn more about the role of SALL4. We observed that SALL4 was the most significant factor in promoting OKS-induced reprogramming. To look for molecules downstream of SALL4, we screened a set of putative targets to determine whether they could promote OKS-induced reprogramming. We identified CECR2, a multidomain nuclear factor and histone acetyl-lysine reader, as a SALL4 effector. Mechanistically, we determined that SALL4 activates Cecr2 expression by directly binding to its promotor region. CECR2 in turn promotes reprogramming by forming a chromatin remodeling complex; this complex contained the SWI/SNF family member SMARCA1 and was dependent on CECR2's DTT domain. In combination, our findings suggest that CECR2 is a novel reprogramming factor and works through a protein network to overcome epigenetic barriers during reprogramming.	[Wu, Linlin] Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China; [Wu, Linlin; Zhao, Guoqing; Xu, Shuyang; Kuang, Junqi; Ming, Jin; Wang, Tao; Wang, Bo; Pei, Duanqing; Liu, Jing] Chinese Acad & Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Wu, Linlin; Zhao, Guoqing; Xu, Shuyang; Kuang, Junqi; Ming, Jin; Wang, Tao; Wang, Bo; Pei, Duanqing; Liu, Jing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Stem Cell & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Zhao, Guoqing] Guangzhou Med Univ, Guangzhou Inst Biomed & Hlth, Chinese Acad Sci, Joint Sch Life Sci, Guangzhou, Peoples R China; [Zhao, Guoqing; Wu, Guangmin; Wang, Tao; Wang, Bo; Pei, Duanqing; Liu, Jing] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China; [Kuang, Junqi; Ming, Jin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Ping] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Pei, DQ; Liu, J (corresponding author), Chinese Acad & Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou, Peoples R China.; Pei, DQ; Liu, J (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Stem Cell & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China.; Pei, DQ; Liu, J (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China.	pei_duanqing@gibh.ac.cn; Liu_Jing@gibh.ac.cn		pei, duan qing/0000-0002-5222-014X	National Key Research and Development Program of China [2017YFA0504100, 2016YFA0101800, 2018YFE0204800]; National Natural Science Foundation of China [32022019, 32000502, 31421004, 31530038, 31830060, 31970681, 21907095]; "Frontier Science Research Program" of the Chinese Academy of Sciences [QYZDJ-SSW-SMC009]; Science and Technology Planning Project of Guangdong Province [2017B030314056, 2019A1515011024]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104003]; Science and Technology Program of Guangzhou, China [201804010004]; Fountain-Valley Life Sciences Fund of University of Chinese Academy of Sciences Education Foundation	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Frontier Science Research Program" of the Chinese Academy of Sciences; Science and Technology Planning Project of Guangdong Province; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Science and Technology Program of Guangzhou, China; Fountain-Valley Life Sciences Fund of University of Chinese Academy of Sciences Education Foundation	This work was supported by grants from The National Key Research and Development Program of China (2017YFA0504100, 2016YFA0101800, 2018YFE0204800); National Natural Science Foundation of China (32022019, 32000502, 31421004, 31530038, 31830060, 31970681, 21907095); "Frontier Science Research Program" of the Chinese Academy of Sciences, Grant No: QYZDJ-SSW-SMC009; Science and Technology Planning Project of Guangdong Province No. 2017B030314056, 2019A1515011024; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104003). Science and Technology Program of Guangzhou, China (201804010004). The research is partly supported by Fountain-Valley Life Sciences Fund of University of Chinese Academy of Sciences Education Foundation.	Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Habib O, 2014, MOL CELLS, V37, P31, DOI 10.14348/molcells.2014.2212; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Hutchins Andrew Paul, 2014, Cell Regen, V3, P1, DOI 10.1186/2045-9769-3-1; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KC, 2013, BIOMEDICINES, V1, P49, DOI 10.3390/biomedicines1010049; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatetsu H, 2016, GENE, V584, P111, DOI 10.1016/j.gene.2016.02.019; Thompson PJ, 2012, J MOL BIOL, V415, P793, DOI 10.1016/j.jmb.2011.11.041; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wang B, 2019, CELL REP, V27, P3473, DOI 10.1016/j.celrep.2019.05.068; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6042; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	31	0	0	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100022	10.1074/jbc.RA120.014598	http://dx.doi.org/10.1074/jbc.RA120.014598			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33144328	Green Published, gold			2022-12-26	WOS:000672866400007
J	Kim, HY; Lee, DS				Kim, Hee Youn; Lee, Dong Sup			A role for phosphodiesterase type 5 inhibitors in remodelling the urinary bladder after radiation exposure	PLOS ONE			English	Article							RANDOMIZED-TRIAL; RAT MODEL; PROSTATE; ANGIOGENESIS; RADIOTHERAPY; VARDENAFIL; VEGF(164); CHANNELS	Minimizing the toxicity of radiotherapy is challenging. We investigated the effects of a phosphodiesterase type-5 inhibitor (PDE5I) on the urinary bladder after pelvic radiotherapy. Eight rats were assigned to each group (group 1: control; group 2: radiation; group 3: radiation plus PDE5I). Radiation dose was 10 Gy/one fraction. Udenafil (20 mg/kg, daily for 4 weeks) was administered in group 3. Cystometry was performed 4 weeks after treatment, followed by real-time PCR for PDE5, vascular endothelial growth factor (VEGF), and endothelial nitric oxide synthase (eNOS) mRNA, western blotting for PDE5, cyclic GMP-dependent protein kinase (PRKG), VEGF(164), Akt, eNOS and NADPH oxidase (NOX)-2 proteins, and immunohistochemistry for eNOS. The expression of both VEGF mRNA and eNOS mRNA was higher in group 3 than in group 2. VEGF and eNOS protein expression improved with PDE5I treatment. Akt protein phosphorylation was higher in group 3 than in group 2, but NOX-2 protein expression was lower in group 3 than in group 2. Immunohistochemistry showed that the mean density of arterioles expressing eNOS was higher in group 3 than in group 2. Cystometry revealed that the intercontraction interval was remarkably longer in group 3 than in group 2 but that the maximal voiding pressure was higher in group 2 than in group 3. Daily treatment with a PDE5I after radiotherapy may prevent bladder storage dysfunction, potentially due to its effects on vasodilation and angiogenesis and through minimizing tissue oxidative damage by means of the VEGF/Akt/eNOS pathway.	[Kim, Hee Youn; Lee, Dong Sup] Catholic Univ Korea, Dept Urol, St Vincents Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea	Lee, DS (corresponding author), Catholic Univ Korea, Dept Urol, St Vincents Hosp, Coll Med, Seoul, South Korea.	LDS@catholic.ac.kr		Lee, Dong Sup/0000-0003-0862-3205	Dong-a ST Co., Ltd. (Seoul, Republic of Korea)	Dong-a ST Co., Ltd. (Seoul, Republic of Korea)	Initials of the authors who received each award: DSL Grant numbers awarded to each author: none The full name of each funder: Dong-a ST Co., Ltd. (Seoul, Republic of Korea) URL of each funder website: http://www.donga-st.com/Main.da Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript?: NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PODTATRANSKE NOVINY, V47, P5; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Cheppudira BP, 2008, AM J PHYSIOL-RENAL, V295, pF826, DOI 10.1152/ajprenal.90305.2008; Fowler JF, 2005, ACTA ONCOL, V44, P265, DOI 10.1080/02841860410002824; Huh JS, 2018, INT J IMPOT RES, V30, P122, DOI 10.1038/s41443-017-0010-6; Khan MA, 2001, WORLD J UROL, V19, P220, DOI 10.1007/s003450000162; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimura M, 2012, J SEX MED, V9, P1535, DOI 10.1111/j.1743-6109.2012.02716.x; Lai HH, 2017, BJU INT, V120, P576, DOI 10.1111/bju.13924; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Liberman D, 2014, TRANSL ANDROL UROL, V3, P186, DOI 10.3978/j.issn.2223-4683.2014.04.01; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattot V, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013925.19218.7B; Morelli A, 2004, ENDOCRINOLOGY, V145, P2253, DOI 10.1210/en.2003-1699; Nomiya M, 2013, J UROLOGY, V189, P754, DOI 10.1016/j.juro.2012.07.141; Pascoe C, 2019, BJU INT, V123, P585, DOI 10.1111/bju.14516; Pollack A, 2013, J CLIN ONCOL, V31, P3860, DOI 10.1200/JCO.2013.51.1972; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Sahara M, 2010, ARTERIOSCL THROM VAS, V30, P1315, DOI 10.1161/ATVBAHA.109.201327; Salloum FN, 2006, J MOL CELL CARDIOL, V40, P405, DOI 10.1016/j.yjmcc.2005.10.002; Sokolakis I, 2019, INT J IMPOT RES, V31, P162, DOI 10.1038/s41443-018-0064-0; The Reproductive Health Report, 2011, EUR J CONTRACEP REPR, V16, p[sup1, S1], DOI 10.3109/13625187.2011.607690; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Yamashita S, 2017, METHODS MOL BIOL, V1560, P147, DOI 10.1007/978-1-4939-6788-9_10; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242006	10.1371/journal.pone.0242006	http://dx.doi.org/10.1371/journal.pone.0242006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166368	gold, Green Published			2022-12-26	WOS:000592382600070
J	Ohshima, Y; Higashide, T; Sakaguchi, K; Sasaki, M; Udagawa, S; Ohkubo, S; Yoneda, T; Sugiyama, K				Ohshima, Yoshimi; Higashide, Tomomi; Sakaguchi, Kimikazu; Sasaki, Makoto; Udagawa, Sachiko; Ohkubo, Shinji; Yoneda, Takashi; Sugiyama, Kazuhisa			The association of primary aldosteronism with glaucoma-related fundus abnormalities	PLOS ONE			English	Article							NERVE-FIBER LAYER; COTTON-WOOL SPOTS; OPEN-ANGLE GLAUCOMA; OPTIC DISK; DEFECTS; HYPERTENSION; PREVALENCE; PROGRESSION; APPEARANCE; INFERIOR	Purpose To elucidate glaucoma-related fundus abnormalities in patients with primary aldosteronism (PA). Methods The study compared 272 eyes from 137 PA patients and 352 eyes from 177 control subjects selected randomly from 1173 participants of a public glaucoma screening. The presence of glaucomatous optic disc appearance (rim thinning and cup enlargement) and retinal nerve fiber layer defects (RNFLDs) was determined independently from fundus photographs. The results were compared between the PA and control groups. Results There were 9 patients (6.6%) with glaucomatous optic disc abnormalities in the PA group and 10 cases (5.6%) identified in the control group (p = 0.92). RNFLDs were detected more frequently in the PA group (55 eyes, 20.2%) than in the control group (26 eyes, 7.4%; p<0.001). The two types of RNFLDs were classified as either having their central ends at the disc margin (D) or away from the disc margin and around the retinal vessels (V). Type D and V RNFLDs were detected in 35 (12.9%) and 26 (9.6%) eyes in the PA group and in 25 (7.1%) and 4 (1.1%) eyes in the control group, respectively. Both types of RNFLDs were more frequent in the PA group than in the control group (Type D and V, p = 0.03, <0.001, respectively). Conclusion Although the prevalence of glaucomatous optic disc appearance did not differ between the two groups, RNFLDs were more frequent in PA patients than in the control group. Moreover, RNFLDs with their central ends located around retinal vessels were characteristic of PA patients.	[Ohshima, Yoshimi; Higashide, Tomomi; Sakaguchi, Kimikazu; Sasaki, Makoto; Udagawa, Sachiko; Ohkubo, Shinji; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ohkubo, Shinji] Ohkubo Eye Clin, Kanazawa, Ishikawa, Japan; [Yoneda, Takashi] Kanazawa Univ, Dept Cardiovasc & Internal Med, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Higashide, T (corresponding author), Kanazawa Univ, Dept Ophthalmol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp						Alencar Luciana M, 2007, Semin Ophthalmol, V22, P103, DOI 10.1080/08820530701420058; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Bhargava M, 2012, J HUM HYPERTENS, V26, P71, DOI 10.1038/jhh.2011.37; Born-Frontsberg E, 2009, J CLIN ENDOCR METAB, V94, P1125, DOI 10.1210/jc.2008-2116; Chaum E, 2001, J NEURO-OPHTHALMOL, V21, P276, DOI 10.1097/00041327-200112000-00010; CHIHARA E, 1991, GRAEF ARCH CLIN EXP, V229, P13, DOI 10.1007/BF00172255; Cho HK, 2012, AM J OPHTHALMOL, V154, P958, DOI 10.1016/j.ajo.2012.05.025; Flammer J, 1999, J GLAUCOMA, V8, P212; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Fraser-Bell S, 2017, CLIN EXP OPHTHALMOL, V45, P45, DOI 10.1111/ceo.12905; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Grosso A, 2005, BRIT J OPHTHALMOL, V89, P1646, DOI 10.1136/bjo.2005.072546; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P197, DOI 10.1159/000309999; Hayreh SS, 2000, AM J OPHTHALMOL, V130, P91, DOI 10.1016/S0002-9394(00)00387-1; HOYT WF, 1973, INVEST OPHTH VISUAL, V12, P814; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P577, DOI 10.1136/bjo.56.8.577; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeon SJ, 2016, INVEST OPHTH VIS SCI, V57, P4008, DOI 10.1167/iovs.16-19525; Jie R, 2015, INVEST OPHTH VIS SCI, V56, P5118, DOI 10.1167/iovs.15-16682; Jonas JB, 1996, SURV OPHTHALMOL, V40, P369, DOI 10.1016/S0039-6257(96)80065-8; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P285, DOI 10.1136/bjo.78.4.285; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Kiyota N, 2019, INVEST OPHTH VIS SCI, V60, P2650, DOI 10.1167/iovs.19-27230; Koh JW, 2010, JPN J OPHTHALMOL, V54, P296, DOI 10.1007/s10384-010-0830-0; Kotowski Jacek, 2014, Surv Ophthalmol, V59, P458, DOI 10.1016/j.survophthal.2013.04.007; Lee J, 2012, EYE, V26, P1473, DOI 10.1038/eye.2012.204; Leung CKS, 2010, OPHTHALMOLOGY, V117, P2337, DOI 10.1016/j.ophtha.2010.04.002; Mallick Jyotiranjan, 2016, J Ophthalmic Vis Res, V11, P204, DOI 10.4103/2008-322X.183914; McLeod D, 2005, BRIT J OPHTHALMOL, V89, P229, DOI 10.1136/bjo.2004.058347; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Nitta E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.240; Ohkubo S, 2007, J GLAUCOMA, V16, P531, DOI 10.1097/IJG.0b013e31804a5e97; Ono A, 2018, JPN J OPHTHALMOL, V62, P499, DOI 10.1007/s10384-018-0595-4; Park HYL, 2012, AM J OPHTHALMOL, V154, P466, DOI 10.1016/j.ajo.2012.03.028; Prejbisz A, 2017, HORM METAB RES, V49, P969, DOI 10.1055/s-0043-122887; Rayner B, 2008, J CLIN PATHOL, V61, P825, DOI 10.1136/jcp.2007.053264; Satoh F, 2011, REV ENDOCR METAB DIS, V12, P11, DOI 10.1007/s11154-011-9161-9; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Suzuki J, 2004, JPN J OPHTHALMOL, V48, P340, DOI 10.1007/s10384-004-0072-0; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813; van Dijk EHC, 2016, GRAEF ARCH CLIN EXP, V254, P2033, DOI 10.1007/s00417-016-3417-8; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; ZEITER JH, 1994, GRAEF ARCH CLIN EXP, V232, P205, DOI 10.1007/BF00184006; Zhang L, 2012, ARCH OPHTHALMOL-CHIC, V130, P913, DOI 10.1001/archophthalmol.2011.1567	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0242090	10.1371/journal.pone.0242090	http://dx.doi.org/10.1371/journal.pone.0242090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156869	Green Published, gold			2022-12-26	WOS:000591376400015
J	Feyisa, JW; Hebo, SH; Negash, FG; Sidamo, NB; Gergiso, KT; Shimbre, MS; Chekol, BM				Feyisa, Jira Wakoya; Hebo, Sultan Hussen; Negash, Firdawek Getahun; Sidamo, Negussie Boti; Gergiso, Kabtamu Tolosie; Shimbre, Mulugeta Shegaze; Chekol, Bitew Mekonnen			Sub-fecundity and associated factors among mothers with natural planned conception attending antenatal care service in Arba Minch Health Facilities	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; CURRENT DURATION APPROACH; TIME-TO-PREGNANCY; ALCOHOL-CONSUMPTION; CAFFEINE INTAKE; INFERTILITY; COUPLES; FECUNDABILITY; PREVALENCE; WOMEN	Background Fecundity is a physiological ability to have children. The inability to get the desired child which was commonly caused by the prolonged time to conceive due to unwanted non-conception period increased from time to time. As a result, many couples are developing psychological, social, and economic problems and unstable life. However, information on fecundity status is limited in Ethiopia context. Therefore, this study aimed to assess the proportion of sub-fecundity and associated factors in Ethiopia context. Methods A health institution based cross-sectional study was conducted in Arba Minch health facilities from March 25 to April 25, 2020. By using a systematic sampling method, 539 mothers were selected for the study. Structured questionnaire was used for data collection. A binary logistic regression model was used to identify factors associated with the sub-fecundity. Variables with p-value <0.25 in the bi-variable logistic regression analysis were interred and checked for association in a multivariable logistic regression model. The level of statistical significance was declared at p-value <0.05. Result The proportion of sub-fecundity was 17.8% with 95%CI (14.8%-21.3%). Mothers' age >= 30 (AOR = 2.54, 95%CI; 1.18-5.48), partners' age >= 35 (AOR = 2.20, 95%CI; 1.01-4.75), coffee consumption of >= 4 cups/day (AOR = 2.93, 95%CI; 1.14-7.53), menses irregularity (AOR = 3.79 95%CI; 2.01-7.14) and coital frequency of 1day/week (AOR = 3.65, 95%CI; 1.47-9.05) were significantly associated with the sub-fecundity. Conclusion This study found that a substantial proportion of mothers were sub-fecund. Factors that contributed to the sub-fecundity were pre-pregnancy; mothers' age, partners' age, coffee drinking of >= 4 cups/day, coital frequency of 1day/week, and menses irregularity. Thus, efforts to prevent sub-fecundity should focus on awareness creation as to plan to conceive at early age, reducing coffee consumption, increasing days of coital frequency per week, and investigating and treating mothers with irregular menses.	[Feyisa, Jira Wakoya] Mettu Univ, Dept Publ Hlth, Fac Med & Hlth Sci, Mettu, Ethiopia; [Hebo, Sultan Hussen; Negash, Firdawek Getahun; Sidamo, Negussie Boti; Shimbre, Mulugeta Shegaze] Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Gergiso, Kabtamu Tolosie] Arba Minch Univ, Dept Stat, Coll Nat Sci, Arba Minch, Ethiopia; [Chekol, Bitew Mekonnen] Arba Minch Univ, Sch Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Hebo, SH (corresponding author), Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	Sultanhussn@gmail.com	Boti, Negussie/X-7354-2019	Boti, Negussie/0000-0001-8949-573X; Shimbre, Mulugeta Shegaze/0000-0001-5633-1309; Wakoya Feyisa, Jira/0000-0002-9774-2398	Arba Minch University	Arba Minch University	We would like to acknowledge the AMHFs administrator, health professionals and data collectors who contributed to this work. We would like to thank all the participants for their participation and information they provided us. We would like to extend our gratitude to Arba Minch University for all support and opportunity provided for us to conduct this study.	Axmon A, 2006, HUM REPROD, V21, P1279, DOI 10.1093/humrep/dei469; Bello B, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0224-y; Bolumar F, 1997, AM J EPIDEMIOL, V145, P324, DOI 10.1093/oxfordjournals.aje.a009109; Bradley D, 2019, HUM FERTIL, DOI 10.1080/14647273.2019.1613680; Bretveld R, 2006, SCAND J WORK ENV HEA, V32, P359, DOI 10.5271/sjweh.1031; Cabrera-Leon A, 2015, HUM REPROD, V30, P2677, DOI 10.1093/humrep/dev226; DiMarco CS., 2000, FERTIL STERIL, V74, P425, DOI [10.1016/s0015-0282(00)00647-6, DOI 10.1016/S0015-0282(00)00647-6, 10.1016/S0015-0282(00)00647-6]; E M, 2013, OBG MANAGEMENT, V25, P39; Eisenberg ML, 2016, HUM REPROD, V31, P2369, DOI 10.1093/humrep/dew200; FLORACK EIM, 1994, PREV MED, V23, P175, DOI 10.1006/pmed.1994.1024; Frank O, 2019, DEMOGRAPHY FERTILITY; Gemmill A, 2018, HUM REPROD, V33, P1158, DOI 10.1093/humrep/dey065; Geraldine barrett kW, 2002, WHAT IS PLANN PREGN, V55, P545, DOI [10.1016/s0277-9536(01)00187-3, DOI 10.1016/S0277-9536(01)00187-3]; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; Greil L A, 2004, HELP SEEKING PATTERN, V22, P305; Habbema JDF, 2004, HUM REPROD, V19, P1497, DOI 10.1093/humrep/deh303; Hassan MAM, 2004, FERTIL STERIL, V81, P384, DOI 10.1016/j.fertnstert.2003.06.027; Horbst Viola, 2016, Reprod Biomed Soc Online, V2, P108, DOI 10.1016/j.rbms.2016.07.003; Issa Y, 2010, HUM REPROD, V25, P2132, DOI 10.1093/humrep/deq133; Jensen TK, 1998, BRIT MED J, V317, P505, DOI 10.1136/bmj.317.7157.505; Kaandorp SP, 2014, HUM REPROD, V29, P1146, DOI 10.1093/humrep/deu052; Kassa EM, 2018, AFR J REPROD HEALTH, V22, P33, DOI 10.29063/ajrh2018/v22i3.4; Kupka MS, 2016, HUM REPROD, V31, P233, DOI 10.1093/humrep/dev319; Leridon H, 2007, CR BIOL, V330, P339, DOI 10.1016/j.crvi.2007.02.013; Loy SL, 2018, HUM REPROD, V33, P2141, DOI 10.1093/humrep/dey300; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Mutsaerts MAQ, 2012, HUM REPROD, V27, P583, DOI 10.1093/humrep/der429; Nohr EA, 2009, HUM REPROD, V24, P226, DOI 10.1093/humrep/den357; Polis CB, 2017, HUM REPROD, V32, P1064, DOI 10.1093/humrep/dex025; Regassa N., 2007, STUD TRIBES TRIBALS, V5, P103; Rothman KJ, 2013, FERTIL STERIL, V99, P1958, DOI 10.1016/j.fertnstert.2013.02.040; Roupa Z., 2009, HLTH SCI J, V3, P80; Sapra KJ, 2014, HUM REPROD, V29, P2553, DOI 10.1093/humrep/deu216; Sapra KJ, 2016, NICOTINE TOB RES, V18, P2154, DOI 10.1093/ntr/ntw132; Shrestha A, 2011, HUM REPROD, V26, P259, DOI 10.1093/humrep/deq316; Sozou PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046544; Stanford JB, 2002, OBSTET GYNECOL, V100, P1333, DOI 10.1016/S0029-7844(02)02382-7; Strassmann BI, 1998, AM J PHYS ANTHROPOL, V105, P167, DOI 10.1002/(SICI)1096-8644(199802)105:2<167::AID-AJPA5>3.0.CO;2-S; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; Tuntiseranee P, 1998, HUM REPROD, V13, P471, DOI 10.1093/humrep/13.2.471; Van Geloven N, 2013, HUM REPROD, V28, P658, DOI 10.1093/humrep/des428; Wesselink AK, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.09.002; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241995	10.1371/journal.pone.0241995	http://dx.doi.org/10.1371/journal.pone.0241995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152037	Green Published, gold			2022-12-26	WOS:000591376200049
J	Song, HF; Cao, XR; Ye, H; He, L; Li, GY; Wan, TJ; Wang, D; Liu, YQ; Huang, ZH; Li, BX; Wen, L; Su, Y; Jiang, C; Feng, QS				Song, Hongfei; Cao, Xiaoren; Ye, Hua; He, Li; Li, Guiyu; Wan, Tingjun; Wang, Dong; Liu, Yuqiao; Huang, Zonghai; Li, Baixue; Wen, Li; Su, Yue; Jiang, Cen; Feng, Quansheng			Pattern of COVID-19 in Sichuan province, China: A descriptive epidemiological analysis	PLOS ONE			English	Article								This study described the epidemiology of 487 confirmed coronavirus disease 2019 (COVID-19) cases in Sichuan province of China, and aimed to provide epidemiological evidence to support public health decision making. Epidemiological information of 487 COVID-19 cases were collected from the official websites of 21 districts (including 18 cities, 3 autonomous prefecture) health commissions within Sichuan between 21(st) of January 2020 to 17(th) of April 2020. We focus on the single-day diagnosis, demographics (gender and age), regional distribution, incubation period and symptoms. The number of single-day confirmed COVID-19 cases reach a peak on January 29 (33 cases), and then decreased. Chengdu (121 cases), Dazhou (39 cases) Nanchong (37 cases) and Ganzi Tibetan Autonomous Prefecture (78 cases) contributed 275 cases (56.5% of the total cases) of Sichuan province. The median age of patients was 44.0 years old and 52.6% were male. The history of living in or visiting Hubei, close contact, imported and unknown were 170 cases (34.9%), 136 cases (27.9%), 21 cases (4.3%) and 160 cases (32.9%) respectively. The interval from the onset of initial symptoms to laboratory diagnosis was 4.0 days in local cases, while that of imported cases was 4.5 days. The most common symptoms of illness onset were fever (71.9%) and cough (35.9%). The growth rate of COVID-19 in Sichuan has significantly decreased. New infected cases have shifted from the living in or visiting Wuhan and close contact to imported. It is necessary to closely monitor the physical condition of imported cases.	[Song, Hongfei; Li, Guiyu; Wan, Tingjun; Wang, Dong; Li, Baixue; Wen, Li; Su, Yue; Jiang, Cen; Feng, Quansheng] Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Sichuan, Peoples R China; [Cao, Xiaoren] Second Peoples Hosp Yaan City, Doctor Dept Rehabil Med, Yaan City, Sichuan, Peoples R China; [Ye, Hua; He, Li; Huang, Zonghai] Chengdu Univ Tradit Chinese Med, Sch Med Informat Engn, Chengdu, Sichuan, Peoples R China; [Liu, Yuqiao] Chengdu Univ Tradit Chinese Med, Sch Clin Med, Chengdu, Sichuan, Peoples R China	Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Jiang, C; Feng, QS (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Sichuan, Peoples R China.	jiangcen517@163.com; fengqs118@163.com			National Major Project of Science and Technology [2017ZX10205501]; Industrial Cluster Collaborative Innovation Project of Chengdu Technology Bureau [2016-XT00-00033-GX]; Study on the Biological Mechanism of "different treatment of the same Disease" in typical Syndromes of chronic Hepatitis B based on the differentiation of T Cell subsets mediated by H2b acetylation/HMGB1-PTEN Pathway [81803976]; Sichuan Science and Technology Innovation (Miaozi Project) cultivation Project (2019) [2019049]	National Major Project of Science and Technology; Industrial Cluster Collaborative Innovation Project of Chengdu Technology Bureau; Study on the Biological Mechanism of "different treatment of the same Disease" in typical Syndromes of chronic Hepatitis B based on the differentiation of T Cell subsets mediated by H2b acetylation/HMGB1-PTEN Pathway; Sichuan Science and Technology Innovation (Miaozi Project) cultivation Project (2019)	This work was supported by the National Major Project of Science and Technology (No. 2017ZX10205501), Industrial Cluster Collaborative Innovation Project of Chengdu Technology Bureau (2016-XT00-00033-GX), Study on the Biological Mechanism of "different treatment of the same Disease" in typical Syndromes of chronic Hepatitis B based on the differentiation of T Cell subsets mediated by H2b acetylation/HMGB1-PTEN Pathway (81803976) and Sichuan Science and Technology Innovation (Miaozi Project) cultivation Project in 2019049 (2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received a salary from any of our funders.	C-CF T, 2020, CIRC-CARDIOVASC QUAL, V13, P1, DOI DOI 10.1002/eco.2160; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gao HS, 2021, J FINANC QUANT ANAL, V56, P1908, DOI 10.1017/S0022109020000605; Han CQ, 2020, AM J GASTROENTEROL, V115, P916, DOI 10.14309/ajg.0000000000000664; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Meng YF, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008520; National Health Commission of the People's Republic of China, 2020, COVID 19S DIAGN TREA, V7th; Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275; Qian J, 2020, CLIN INFECT DIS, V71, P2488, DOI 10.1093/cid/ciaa683; Sichuan Provincial Bureau of Statistics, 2019, POP STAT B SICH PROV; Sichuan Provincial Health Commission, 2020, LAT SIT COVID 19 EP; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; WHO Europe, 2020, 2019 NCOV OUTBR IS E; Zhou YW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233328; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	15	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241470	10.1371/journal.pone.0241470	http://dx.doi.org/10.1371/journal.pone.0241470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152043	Green Published, gold			2022-12-26	WOS:000591376200045
J	Braun, DC; Jain, S; Epstein, E; Greenwald, BH; Herold, B; Gray, M				Braun, Derek C.; Jain, Samir; Epstein, Eric; Greenwald, Brian H.; Herold, Brienna; Gray, Margaret			Deaf intermarriage has limited effect on the prevalence of recessive deafness and no effect on underlying allelic frequency	PLOS ONE			English	Article							UNITED-STATES; GJB2 MUTATIONS; GENE; CONNEXIN-26; POPULATION; FITNESS; FOUNDER	The idea that deaf intermarriage increases the prevalence of deafness was forcefully pushed in the late 19th century by Alexander Graham Bell, in proceedings published by the National Academy of Science. Bell's hypothesis was not supported by a 19th century study by Edward Allen Fay, which was funded by Bell's own organization, the Volta Bureau. The Fay study showed through an analysis of 4,471 deaf marriages that the chances of having deaf children did not increase significantly when both parents were deaf. In light of an apparent increase in non-complementary pairings when a modern dataset of Gallaudet alumni was compared with the 19th century Fay dataset, Bell's argument has been resurrected. This hypothesis is that residential schools for the deaf, which concentrate signing deaf individuals together, have promoted assortative mating, which in turn has increased the prevalence of recessive deafness and also the commonest underlying deafness allele. Because this hypothesis persists, even though it contradicts classical models of assortative mating, it is critically important that it be thoroughly investigated. In this study, we used an established forward-time genetics simulator with parameters and measurements collected from the published literature. Compared to mathematical equations, simulations allowed for more complex modeling, operated without assumptions of parametricity, and captured ending distributions and variances. Our simulation results affirm predictions from classical equations and show that intense assortative mating only modestly increases the prevalence of deafness, with this effect mostly completed by the third generation. More importantly, our data show that even intense assortative mating does not affect the frequency of the underlying alleles under reported conditions. These results are not locus-specific and are generalizable to other forms of recessive deafness. We explain the higher rate of non-complementary pairings measured in the contemporary Gallaudet alumni sample as compared to the Fay dataset.	[Braun, Derek C.; Jain, Samir; Epstein, Eric; Herold, Brienna; Gray, Margaret] Gallaudet Univ, Dept Sci Technol & Math, Washington, DC 20002 USA; [Greenwald, Brian H.] Gallaudet Univ, Dept Hist Philosophy Relig & Sociol, Washington, DC USA		Braun, DC (corresponding author), Gallaudet Univ, Dept Sci Technol & Math, Washington, DC 20002 USA.	derek.braun@gallaudet.edu		Braun, Derek/0000-0003-4922-5588; , Brian/0000-0001-7889-6423				Arnos KS, 2008, AM J HUM GENET, V83, P200, DOI 10.1016/j.ajhg.2008.07.001; Bell Alexander Graham, 1884, MEMOIR FORMATION DEA; Blanton SH, 2010, ANN HUM GENET, V74, P27, DOI 10.1111/j.1469-1809.2009.00553.x; Burke TB, 2016, MONOGR HUM GENET, V20, P1, DOI 10.1159/000442334; Conover WJ, 1979, LA7677MS; CROW JF, 1968, EUGEN QUART, V15, P85, DOI 10.1080/19485565.1968.9987760; Fay E.A., 1898, MARRIAGES DEAF AM; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Greenwald BH, 2016, OUR OWN HANDS ESSAYS, P149; Greenwald BH, 2015, J GILDED AGE PROGR E, V14, P28, DOI 10.1017/S1537781414000528; HU DN, 1987, J MED GENET, V24, P589, DOI 10.1136/jmg.24.10.589; LIU XZ, 1994, AM J MED GENET, V53, P192, DOI 10.1002/ajmg.1320530214; Mahdieh N, 2009, INT J AUDIOL, V48, P363, DOI 10.1080/14992020802607449; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; Nance WE, 2004, AM J HUM GENET, V74, P1081, DOI 10.1086/420979; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Peng B, 2008, BIOINFORMATICS, V24, P1408, DOI 10.1093/bioinformatics/btn179; RUBEN RJ, 1991, ANN NY ACAD SCI, V630, P6, DOI 10.1111/j.1749-6632.1991.tb19571.x; Schein J.D., 1974, DEAF POPULATION US; Schimmenti LA, 2008, GENET MED, V10, P517, DOI [10.1097/GIM.0b013e31817708fa, 10.1097GIM.0b013e31817708fa]; Scully J.L., 2019, RUSSIAS CRISPR DEAF; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; Wright S, 1921, GENETICS, V6, P144; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yang T, 2019, ADV EXP MED BIOL, V1130, P73, DOI 10.1007/978-981-13-6123-4_5	32	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241609	10.1371/journal.pone.0241609	http://dx.doi.org/10.1371/journal.pone.0241609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147256	Green Published, gold			2022-12-26	WOS:000589609300038
J	Buckwalter, W; Peterson, A				Buckwalter, Wesley; Peterson, Andrew			Public attitudes toward allocating scarce resources in the COVID-19 pandemic	PLOS ONE			English	Article							HEALTH-CARE; DISASTERS	The general public is subject to triage policies that allocate scarce lifesaving resources during the COVID-19 pandemic, one of the worst public health emergencies in the past 100 years. However, public attitudes toward ethical principles underlying triage policies used during this pandemic are not well understood. Three experiments (preregistered; online samples; N = 1,868; U.S. residents) assessed attitudes toward ethical principles underlying triage policies. The experiments evaluated assessments of utilitarian, egalitarian, prioritizing the worst-off, and social usefulness principles in conditions arising during the COVID-19 pandemic, involving resource scarcity, resource reallocation, and bias in resource allocation toward at-risk groups, such as the elderly or people of color. We found that participants agreed with allocation motivated by utilitarian principles and prioritizing the worst-off during initial distribution of resources and disagreed with allocation motivated by egalitarian and social usefulness principles. At reallocation, participants agreed with giving priority to those patients who received the resources first. Lastly, support for utilitarian allocation varied when saving the greatest number of lives resulted in disadvantage for at-risk or historically marginalized groups. Specifically, participants expressed higher levels of agreement with policies that shifted away from maximizing benefits to one that assigned the same priority to members of different groups if this mitigated disadvantage for people of color. Understanding these attitudes can contribute to developing triage policies, increase trust in health systems, and assist physicians in achieving their goals of patient care during the COVID-19 pandemic.	[Buckwalter, Wesley] Univ Manchester, Dept Philosophy, Manchester, Lancs, England; [Peterson, Andrew] George Mason Univ, Inst Philosophy & Publ Policy, Dept Philosophy, Fairfax, VA 22030 USA	University of Manchester; George Mason University	Peterson, A (corresponding author), George Mason Univ, Inst Philosophy & Publ Policy, Dept Philosophy, Fairfax, VA 22030 USA.	apeter31@gmu.edu			Greenwall Foundation Faculty Scholars Program	Greenwall Foundation Faculty Scholars Program	AP is supported by the Greenwall Foundation Faculty Scholars Program.	[Anonymous], 2015, VENT ALL GUID; [Anonymous], 2020, BMJ-BRIT MED J, V369, pm2170, DOI 10.1136/bmj.m2170; [Anonymous], 2012, COMMITTEE GUIDANCE E; Arora C, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0152-y; Biddison ELD, 2019, CHEST, V155, P848, DOI 10.1016/j.chest.2018.09.025; Biddison ELD, 2018, CHEST, V153, P187, DOI 10.1016/j.chest.2017.08.001; Birrell I, 2020, DOCTORS CHOOSING WHO; British Medical Association B, 2020, COVID 19 ETH ISS; Cameron J, 2021, J MED ETHICS, V47, P722, DOI 10.1136/medethics-2020-106330; Chang HJ, 2004, AM J PUBLIC HEALTH, V94, P562, DOI 10.2105/AJPH.94.4.562; Christian MD, 2014, CHEST, V146, pE61S, DOI 10.1378/chest.14-0736; Manchanda EC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2011359; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Daugherty Biddison Elizabeth L, 2014, Ann Am Thorac Soc, V11, P777, DOI 10.1513/AnnalsATS.201310-379OC; Emanuel EJ, 2003, ANN INTERN MED, V139, P589, DOI 10.7326/0003-4819-139-7-200310070-00011; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Faryon J, 2020, LOS ANGELES TIMES; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Group UoTJCfBPIW, 2005, STAND GUARD THEE ETH; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Huang K, 2020, VEIL OF IGNORANCE RE; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Lanoix R., 2002, TOPICS EMERGENCY MED, V24, P60; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Mello MM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2011997; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Pew, 2020, HLTH CONC COVID 19 M; Pilkington Ed, 2020, GUARDIAN; PILL J, 1971, SOCIO ECON PLAN SCI, V5, P57, DOI 10.1016/0038-0121(71)90041-3; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Rodriguez-Arias D, 2020, BIOETHICS, V34, P509, DOI 10.1111/bioe.12707; Savulescu J, 2020, BIOETHICS, V34, P620, DOI 10.1111/bioe.12771; Savulescu J, 2020, BRIT J ANAESTH, V125, P10, DOI 10.1016/j.bja.2020.04.011; Schmidt H., 2020, NEW YORK TIMES; Schultz CH, 1996, NEW ENGL J MED, V334, P438, DOI 10.1056/NEJM199602153340706; SINGER P, 1995, J MED ETHICS, V21, P144, DOI 10.1136/jme.21.3.144; TAUREK JM, 1977, PHILOS PUBLIC AFF, V6, P293; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Vergano M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02891-w; Werner RM, 2020, NEW ENGL J MED, V383, P903, DOI 10.1056/NEJMp2014811; White DB, 2020, MODEL HOSP POLICY AL; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046	42	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240651	10.1371/journal.pone.0240651	http://dx.doi.org/10.1371/journal.pone.0240651			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147213	Green Published, gold			2022-12-26	WOS:000589609300051
J	Neves, PDMD; Souza, RA; Torres, FM; Reis, FA; Pinheiro, RB; Dias, CB; Yu, L; Woronik, V; Furukawa, LS; Cavalcante, LB; Araujo, SD; Wanderley, DC; Malheiros, DM; Jorge, LB				Miranda de Menezes Neves, Precil Diego; Souza, Rafael A.; Torres, Fabio M.; Reis, Fabio A.; Pinheiro, Rafaela B.; Dias, Cristiane B.; Yu, Luis; Woronik, Viktoria; Furukawa, Luzia S.; Cavalcante, Livia B.; Araujo, Stanley de Almeida; Wanderley, David Campos; Malheiros, Denise M.; Jorge, Lecticia B.			Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; IMMUNOGLOBULIN-A NEPHROPATHY; MESANGIAL C4D DEPOSITION; KIDNEY-DISEASE; COMPLEMENT; GLOMERULOPATHY; HYPERTENSION; PROGRESSION; MUTATION	Introduction IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide. According to the Oxford Classification, changes in the kidney vascular compartment are not related with worse outcomes. This paper aims to assess the impact of thrombotic microangiopathy (TMA) in the outcomes of Brazilian patients with IgAN. Materials and methods Analysis of clinical data and kidney biopsy findings from patients with IgAN to assess the impact of TMA on renal outcomes. Results The majority of the 118 patients included were females (54.3%); mean age of 33 years (25;43); hypertension and hematuria were observed in 67.8% and 89.8%, respectively. Median creatinine: 1.45mg/dL; eGFR: 48.8ml/min/1.73m(2); 24-hour proteinuria: 2.01g; low serum C3: 12.5%. Regarding to Oxford Classification: M1: 76.3%; E1: 35.6%; S1: 70.3%; T1/T2: 38.3%; C1/C2: 28.8%. Average follow-up: 65 months. Histologic evidence of TMA were detected in 21 (17.8%) patients and those ones presented more frequently hypertension (100% vs. 61%, p <0.0001), hematuria (100% vs 87.6%, p = 0.0001), worse creatinine levels (3.8 vs. 1.38 mg/dL, p = 0.0001), eGFR (18 vs. 60 ml/min/1.73m(2)), p = 0.0001), low serum C3 (28.5% vs. 10.4%, p = 0.003), lower hemoglobin levels (10.6 vs. 12.7g/dL, p0.001) and platelet counts (207,000 vs. 267,000, p = 0.001). Biopsy findings of individuals with TMA revealed only greater proportions of E1 (68% vs. 32%, p = 0.002). Individuals with TMA were followed for less time (7 vs. 65 months, p<0.0001) since they progressed more frequently to chronic kidney disease (CKD) requiring kidney replacement therapy (KRT) (71.4% vs. 21,6%, p<0.0001). Male sex, T1/T2, and TMA were independently associated with progression to CKD-KRT. Conclusions In this study patients with TMA had worse clinical manifestations and outcomes. In terms of histologic evidence, E1 distinguished patients with TMA from other patients. Further studies are necessary to analyze the impact of vascular lesions on IgAN prognosis.	[Miranda de Menezes Neves, Precil Diego; Souza, Rafael A.; Torres, Fabio M.; Reis, Fabio A.; Dias, Cristiane B.; Yu, Luis; Woronik, Viktoria; Furukawa, Luzia S.; Jorge, Lecticia B.] Univ Sao Paulo, Sch Med, Nephrol Div, Sao Paulo, SP, Brazil; [Pinheiro, Rafaela B.; Cavalcante, Livia B.; Malheiros, Denise M.] Univ Sao Paulo, Sch Med, Pathol Div, Sao Paulo, SP, Brazil; [Araujo, Stanley de Almeida; Wanderley, David Campos] Nephropathol Inst, Belo Horizonte, MG, Brazil; [Araujo, Stanley de Almeida; Wanderley, David Campos] Univ Fed Minas Gerais, Pathol Div, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Neves, PDMD (corresponding author), Univ Sao Paulo, Sch Med, Nephrol Div, Sao Paulo, SP, Brazil.	precilmed61@yahoo.com.br	; Neves, Precil/L-9063-2015	Yu, Luis/0000-0001-9102-0063; Neves, Precil/0000-0003-1089-6763; Reis, Fabio/0000-0003-0100-1622				[Anonymous], 2009, KIDNEY INT, V76, P546, DOI DOI 10.1038/ki.2009.168; Barbour S, 2018, CURR OPIN NEPHROL HY, V27, P214, DOI 10.1097/MNH.0000000000000405; Bettoni S, 2017, J IMMUNOL, V199, P1021, DOI 10.4049/jimmunol.1601121; Brocklebank V, 2018, CLIN J AM SOC NEPHRO, V13, P300, DOI 10.2215/CJN.00620117; Buob D, 2016, KIDNEY INT, V90, P1321, DOI 10.1016/j.kint.2016.07.021; Cai QQ, 2019, AM J KIDNEY DIS, V74, P629, DOI 10.1053/j.ajkd.2019.03.416; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cavero T, 2019, KIDNEY INT, V96, P995, DOI 10.1016/j.kint.2019.05.014; Chang A, 2006, CLIN NEPHROL, V66, P397; Chua JS, 2019, MODERN PATHOL, V32, P1147, DOI 10.1038/s41379-019-0259-z; COPPO R, 1993, CONTRIB NEPHROL, V104, P162; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Drachenberg CB, 2019, KIDNEY INT REP, V4, P1555, DOI 10.1016/j.ekir.2019.07.015; El Karoui K, 2019, HAEMATOLOGICA, V104, P2501, DOI 10.3324/haematol.2019.216903; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Endo M, 1998, NEPHROL DIAL TRANSPL, V13, P1984, DOI 10.1093/ndt/13.8.1984; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; Fujita E, 2015, J NIPPON MED SCH, V82, P30, DOI 10.1272/jnms.82.27; Gallan AJ, 2020, SEMIN DIAGN PATHOL, V37, P121, DOI 10.1053/j.semdp.2020.01.002; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Fabiano RCG, 2017, PEDIATR NEPHROL, V32, P1211, DOI 10.1007/s00467-017-3610-y; Goodship THJ, 2017, KIDNEY INT, V91, P539, DOI 10.1016/j.kint.2016.10.005; Gordon CE, 2017, AM J KIDNEY DIS, V70, P715, DOI 10.1053/j.ajkd.2017.05.017; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Haas M, 2018, KIDNEY DIS-BASEL, V4, P165; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li C, 2019, J RHEUMATOL, V46, P1478, DOI 10.3899/jrheum.180773; Maixnerova D, 2016, J NEPHROL, V29, P535, DOI 10.1007/s40620-016-0299-0; Manenti L, 2013, NEPHROL DIAL TRANSPL, V28, P2246, DOI 10.1093/ndt/gft220; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Morita S, 1999, INTERNAL MED, V38, P495, DOI 10.2169/internalmedicine.38.495; Moriyama T, 2019, CLIN EXP NEPHROL, V23, P1089, DOI 10.1007/s10157-019-01735-4; Nakamura H, 2018, NEPHRON, V138, P324, DOI 10.1159/000485194; Nasri H, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.10234; Radhakrishnan J, 2015, CLIN J AM SOC NEPHRO, V10, P1287, DOI 10.2215/CJN.01010115; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Sahin OZ, 2014, INT J CLIN EXP PATHO, V7, P3299; Schmitt R, 2011, EUR J PEDIATR, V170, P107, DOI 10.1007/s00431-010-1279-3; Segarra A, 2018, CLIN J AM SOC NEPHRO, V13, P258, DOI 10.2215/CJN.02530317; Sevillano AM, 2015, NEFROLOGIA, V35, P42, DOI 10.3265/Nefrologia.pre2014.Oct.12735; Soares MF, 2019, HISTOPATHOLOGY, V74, P629, DOI 10.1111/his.13768; Soares MF, 2017, CURR OPIN NEPHROL HY, V26, P165, DOI 10.1097/MNH.0000000000000312; Timmermans SAMEG, 2017, KIDNEY INT, V91, P1420, DOI 10.1016/j.kint.2016.12.009; Trimarchi H., 2019, NEPHROL DIAL TRANSPL; Trimarchi H, 2019, KIDNEY INT, V95, P750, DOI 10.1016/j.kint.2019.01.007; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; WANG MX, 1993, AM J KIDNEY DIS, V22, P378, DOI 10.1016/S0272-6386(12)70139-7; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904	53	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0233199	10.1371/journal.pone.0233199	http://dx.doi.org/10.1371/journal.pone.0233199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147224	Green Submitted, gold, Green Published			2022-12-26	WOS:000589609300041
J	Hindenes, LB; Haberg, AK; Johnsen, LH; Mathiesen, EB; Robben, D; Vangberg, TR				Hindenes, Lars B.; Haberg, Asta K.; Johnsen, Liv Hege; Mathiesen, Ellisiv B.; Robben, David; Vangberg, Torgil R.			Variations in the Circle of Willis in a large population sample using 3D TOF angiography: The Tromso Study	PLOS ONE			English	Article							ANTERIOR COMMUNICATING ARTERY; CEREBRAL-BLOOD-FLOW; MR-ANGIOGRAPHY; CONFIGURATION; CIRCULATION; VARIANTS; VOLUME; RISK; AGE	The main arteries that supply blood to the brain originate from the Circle of Willis (CoW). The CoW exhibits considerable anatomical variations which may have clinical importance, but the variability is insufficiently characterised in the general population. We assessed the anatomical variability of CoW variants in a community-dwelling sample (N = 1,864, 874 men, mean age = 65.4, range 40-87 years), and independent and conditional frequencies of the CoW's artery segments. CoW segments were classified as present or missing/hypoplastic (w/1mm diameter threshold) on 3T time-of-flight magnetic resonance angiography images. We also examined whether age and sex were associated with CoW variants. We identified 47 unique CoW variants, of which five variants constituted 68.5% of the sample. The complete variant was found in 11.9% of the subjects, and the most common variant (27.8%) was missing both posterior communicating arteries. Conditional frequencies showed patterns of interdependence across most missing segments in the CoW. CoW variants were associated with mean-split age (P = .0147), and there was a trend showing more missing segments with increasing age. We found no association with sex (P = .0526). Our population study demonstrated age as associated with CoW variants, suggesting reduced collateral capacity with older age.	[Hindenes, Lars B.; Johnsen, Liv Hege; Mathiesen, Ellisiv B.; Vangberg, Torgil R.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Hindenes, Lars B.; Vangberg, Torgil R.] Univ Hosp North Norway, PET Ctr, Tromso, Norway; [Haberg, Asta K.] St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Haberg, Asta K.] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Mathiesen, Ellisiv B.] Univ Hosp North Norway, Dept Neurol, Tromso, Norway; [Robben, David] Katholieke Univ Leuven, Dept Elect Engn, ESAT PSI, Leuven, Belgium; [Robben, David] Icometrix, Leuven, Belgium	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; KU Leuven	Hindenes, LB (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.; Hindenes, LB (corresponding author), Univ Hosp North Norway, PET Ctr, Tromso, Norway.	lars.b.hindenes@uit.no	; Vangberg, Torgil/B-8075-2008	Haberg, Asta Kristine/0000-0002-9007-1202; Robben, David/0000-0002-2266-8867; Vangberg, Torgil/0000-0003-4808-5464; Mathiesen, Ellisiv B/0000-0001-8887-6100; Bakke Hindenes, Lars/0000-0003-0597-0906	Helse Nord project grant [HNF1369-17, SFP127116]	Helse Nord project grant	This work was supported by a Helse Nord project grant (HNF1369-17) to LBH and (SFP127116) for collecting the MR data. Icometrix provided salary for DR. Helse Nord and Icometrix had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; Chuang YM, 2011, EUR NEUROL, V66, P136, DOI 10.1159/000329274; De Silva KRD, 2009, ANN INDIAN ACAD NEUR, V12, P157, DOI 10.4103/0972-2327.56314; Dimmick SJ, 2009, RADIOGRAPHICS, V29, P1027, DOI 10.1148/rg.294085730; Eftekhar B, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-22; El-Barhoun EN, 2009, J MED IMAG RADIAT ON, V53, P248, DOI 10.1111/j.1754-9485.2009.02056.x; Forgo B, 2018, TWIN RES HUM GENET, V21, P384, DOI 10.1017/thg.2018.50; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P8, DOI DOI 10.1088/1475-7516/2015/09/008; Gunnal SA, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/687281; Hashemi Seyed Mahmood Ramak, 2013, Surg Neurol Int, V4, P65, DOI 10.4103/2152-7806.112185; Hoksbergen AWJ, 2003, CEREBROVASC DIS, V16, P191, DOI 10.1159/000071115; Horikoshi T, 2002, J NEUROSURG, V96, P697, DOI 10.3171/jns.2002.96.4.0697; Kapoor K, 2008, ANAT SCI INT, V83, P96, DOI [10.1111/j.1447-073X.2007.00216.x, 10.1111/j.1447-073x.2007.00216.x]; Klimek-Piotrowska W, 2016, ANAT SCI INT, V91, P325, DOI 10.1007/s12565-015-0301-2; Krabbe-Hartkamp MJ, 1998, RADIOLOGY, V207, P103, DOI 10.1148/radiology.207.1.9530305; Li Q, 2011, J CLIN NEUROSCI, V18, P379, DOI 10.1016/j.jocn.2010.07.137; Liebeskind DS, 2018, J CEREBR BLOOD F MET, V38, P1449, DOI 10.1177/0271678X17711625; Ozaki T, 1977, Nihon Geka Hokan, V46, P3; Papantchev V, 2013, EUR J CARDIO-THORAC, V44, P743, DOI 10.1093/ejcts/ezt103; RIGGS HE, 1963, ARCH NEUROL-CHICAGO, V8, P8, DOI 10.1001/archneur.1963.00460010024002; Ryan DJ, 2015, INT J STROKE, V10, P547, DOI 10.1111/ijs.12042; Saba L, 2017, EUR J RADIOL, V89, P111, DOI 10.1016/j.ejrad.2017.01.031; Saba L, 2015, J NEUROIMAGING, V25, P226, DOI 10.1111/jon.12103; Tanaka H, 2006, AM J NEURORADIOL, V27, P1770; Tarulli E, 2014, AM J NEURORADIOL, V35, P1551, DOI 10.3174/ajnr.A3991; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; van Seeters T, 2015, NEURORADIOLOGY, V57, P1247, DOI 10.1007/s00234-015-1589-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolf JJHB, 2016, J CEREBR BLOOD F MET, V36, P1570, DOI 10.1177/0271678X15626155; Wright SN, 2013, NEUROIMAGE, V82, P170, DOI 10.1016/j.neuroimage.2013.05.089; Zaninovich OA, 2017, WORLD NEUROSURG, V106, P953, DOI [10.1016/J.WNEU.2017.07.084, 10.1016/j.wneu.2017.07.084]	32	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241373	10.1371/journal.pone.0241373	http://dx.doi.org/10.1371/journal.pone.0241373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141840	gold, Green Published, Green Submitted			2022-12-26	WOS:000588376700013
J	Grisaru-Granovsky, S; Nag, JK; Zakar, L; Rudina, T; Gupta, CL; Maoz, M; Kozlova, D; Bar-Shavit, R				Grisaru-Granovsky, Sorina; Nag, Jeetendra Kumar; Zakar, Liat; Rudina, Tatyana; Gupta, Chhedi Lal; Maoz, Myriam; Kozlova, Daria; Bar-Shavit, Rachel			PAR(1&2) driven placenta EVT invasion act via LRP5/6 as coreceptors	FASEB JOURNAL			English	Article						beta&#8208; catenin; extravilous trophoblasts; G&#8208; protein copupled receptors; placenta; protease&#8208; activated receptors	PROTEASE-ACTIVATED RECEPTOR-2; EXTRAVILLOUS TROPHOBLAST INVASION; SIGNALING PATHWAY; WNT; EXPRESSION; CELL; DIFFERENTIATION; PREECLAMPSIA; ASSOCIATION; RECURRENT	While the involvement of protease-activated receptors (PARs) in the physiological regulation of human placenta development, as in tumor biology, is recognized, the molecular pathway is unknown. We evaluated the impact of PAR(1) and PAR(2) function in cytotrophoblast (CTB) proliferation and invasion in a system of extravillous trophoblast (EVT) organ culture and in human cell-lines. Activation of PAR(1)- and PAR(2)-induced EVT invasion and proliferation, while the shRNA silencing of low-density lipoprotein receptor-related protein 5/6 (LRP5/6) inhibited these processes. PAR(1) and PAR(2) effectively induce beta-catenin stabilization in a manner similar to that shown for the canonical beta-catenin stabilization pathway yet independent of Wnts. Immunoprecipitation analyses and protein-protein docking demonstrated the co-association between either PAR(1) or PAR(2) with LRP5/6 forming an axis of PAR-LRP5/6-Axin. Noticeably, in PAR(1)-PAR(2) heterodimers a dominant role is assigned to PAR(2) over PAR(1) as shown by inhibition of PAR(1)-induced beta-catenin levels, and Dvl nuclear localization. This inhibition takes place either by shRNA silenced hPar2 or in the presence of a TrPAR(2) devoid its cytoplasmic tail. Indeed, TrPAR(2) cannot form the PAR(1)-PAR(2) complex, obstructing thereby the flow of signals downstream. Elucidation of the mechanism of PAR-induced invasion contributes to therapeutic options highlighting key partners in the process.	[Grisaru-Granovsky, Sorina; Zakar, Liat; Kozlova, Daria] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Nag, Jeetendra Kumar; Rudina, Tatyana; Maoz, Myriam; Bar-Shavit, Rachel] Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, POB 12000, IL-91120 Jerusalem, Israel; [Gupta, Chhedi Lal] Agr Res Org, Inst Soil Water & Environm Sci, Volcani Res Ctr, Rishon Leziyyon, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Bar-Shavit, R (corresponding author), Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, POB 12000, IL-91120 Jerusalem, Israel.	Rachelbar@ekmd.huji.ac.il	Gupta, Chhedi Lal/ABH-9176-2020	Gupta, Chhedi Lal/0000-0001-9389-299X	Israel Science Foundation (ISF) [1420/16]	Israel Science Foundation (ISF)(Israel Science Foundation)	Israel Science Foundation (ISF), Grant/Award Number: 1420/16	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Aplin JD, 2000, J REPROD FERTIL, P57; Bao SH, 2013, CLIN EXP IMMUNOL, V172, P437, DOI 10.1111/cei.12066; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Bose P, 2006, PLACENTA, V27, P869, DOI 10.1016/j.placenta.2005.09.007; Bose P, 2004, AM J OBSTET GYNECOL, V191, P2125, DOI 10.1016/j.ajog.2004.05.014; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grisaru-Granovsky S, 2007, AM J MED GENET A, V143A, P2557, DOI 10.1002/ajmg.a.31985; Grisaru-Granovsky S, 2015, EUR J OBSTET GYN R B, V185, P13, DOI 10.1016/j.ejogrb.2014.11.021; Grisaru-Granovsky S, 2009, J CELL PHYSIOL, V218, P512, DOI 10.1002/jcp.21625; Gu Y, 2012, PLACENTA, V33, P803, DOI 10.1016/j.placenta.2012.06.020; Gupta CL, 2016, BIOTECHNOL APPL BIOC, V63, P441, DOI 10.1002/bab.1377; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jaber M, 2014, CELL MOL LIFE SCI, V71, P2517, DOI 10.1007/s00018-013-1498-7; Kancharla A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9853; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Lee CQE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162305; Lim KH, 1997, AM J PATHOL, V151, P1809; Nag JK, 2017, ONCOTARGET, V8, P38650, DOI 10.18632/oncotarget.16246; Nicola C, 2005, J CLIN ENDOCR METAB, V90, P4736, DOI 10.1210/jc.2005-0413; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; O'Brien PJ, 2003, AM J PATHOL, V163, P1245, DOI 10.1016/S0002-9440(10)63484-0; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Sato Y, 2003, DEVELOPMENT, V130, P5519, DOI 10.1242/dev.00729; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shi XL, 2004, MOL CANCER RES, V2, P395; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Taylor J, 2014, MOL REPROD DEV, V81, P42, DOI 10.1002/mrd.22279; Turm H, 2010, J BIOL CHEM, V285, P15137, DOI 10.1074/jbc.M109.072843; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westwood M, 2017, PLACENTA, V60, P1, DOI 10.1016/j.placenta.2017.09.009; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Windsperger K, 2017, HUM REPROD, V32, P1208, DOI 10.1093/humrep/dex058; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang X, 2004, CLIN CANCER RES, V10, P8451, DOI 10.1158/1078-0432.CCR-04-0546; Zhang Z, 2013, REPROD SCI, V20, P981, DOI 10.1177/1933719112472740; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	57	3	3	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15701	15717		10.1096/fj.202000306R	http://dx.doi.org/10.1096/fj.202000306R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33136328				2022-12-26	WOS:000586612200001
J	Peng, AQ; Hu, JJ; Wang, Q; Jiang, WQ; Liu, W; Zhang, ZW; Huang, C; Chen, YC				Peng, Anquan; Hu, Junjiao; Wang, Qin; Jiang, Wenqi; Liu, Wei; Zhang, Zhiwen; Huang, Chao; Chen, Yichao			Modulation of hearing function following the downgrading or upgrading of endolymphatic hydrops in Meniere's disease patients with endolymphatic duct blockage	PLOS ONE			English	Article							DOSE GADODIAMIDE UTILITY; INNER-EAR; MRI EVIDENCE; GLYCEROL; VISUALIZATION; GADOLINIUM; SYMPTOMS	The present study was to investigate the dynamics of endolymphatic hydrops (EH) and hearing function, and explore whether the hearing loss is caused by EH alone and whether the hearing function can be modulated by changes in the EH. The extent of EH visualized by gadolinium (Gd)-enhanced inner ear magnetic resonance imaging, hearing thresholds and the summating potential/action potential ratio (-SP/AP ratio) of electrocochleography (ECochG) were recorded prior to and following surgery in 22 patients with intractable Meniere's disease (MD) who underwent endolymphatic duct blockage (EDB). The difference value of the hearing threshold and -SP/AP ratio was significantly positively correlated with the difference value of the endolymph to vestibule-volume ratio (EVVR) and grading of cochlear hydrops between prior to and following surgery. Among patients with a decreased EVVR, the average hearing threshold and -SP/AP ratio was significantly decreased following surgery, as compared to that prior to surgery. Six out of seven patients with a hearing improvement (>= 10-dB decline) and 4/5 patients with a negative conversion of EcochG showed downgrading of their hydrops in the cochlea and/or vestibule. By contrast, among patients with an increased EVVR, the average hearing threshold and -SP/AP ratio tended to increase following EDB, as compared with that prior to surgery. One out of two patients with a hearing deterioration (>= 10-dB elevation) showed upgrading of her hydrops in both cochlea and vestibule. The present results showed the downgrading of cochlear and/or vestibular hydrops accompanied by the downregulation of the hearing threshold and -SP/AP ratio of EcochG, as well as the upgrading of cochlear and/or vestibular hydrops that tended to upregulate the hearing threshold and -SP/AP ratio of EcochG; this suggested that hearing loss is likely to be caused by hydrops and that the impaired hearing function be modulated by changes in the hydrops.	[Peng, Anquan; Wang, Qin; Jiang, Wenqi; Liu, Wei; Zhang, Zhiwen; Huang, Chao; Chen, Yichao] Cent South Univ, Xiangya Hosp 2, Dept Otolaryngol, Changsha, Hunan, Peoples R China; [Hu, Junjiao] Cent South Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Huang, C; Chen, YC (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Otolaryngol, Changsha, Hunan, Peoples R China.	huangchaofan@csu.edu.cn; 2204120818@csu.edu.cn	jiang, wen/GYI-9662-2022		National Natural Science Foundation of china [81570928]	National Natural Science Foundation of china(National Natural Science Foundation of China (NSFC))	We were funded by National Natural Science Foundation of china(Grant No.81570928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN F, 1965, ANN OTO RHINOL LARYN, V74, P915, DOI 10.1177/000348946507400402; Arenberg I K, 1974, Rev Laryngol Otol Rhinol (Bord), V95, P709; Basel T, 2013, EAR HEARING, V34, P370, DOI 10.1097/AUD.0b013e31826d0c08; COHEN J, 1985, ARCH OTO-RHINO-LARYN, V241, P285, DOI 10.1007/BF00453702; Crane BT, 2009, OTOL NEUROTOL, V30, P619, DOI 10.1097/MAO.0b013e3181a66d2b; Cruz M., 2014, MED TODAY, V15, P18; DUVALL AJ, 1987, ACTA OTO-LARYNGOL, V103, P241, DOI 10.3109/00016488709107790; Foster CA, 2013, OTOL NEUROTOL, V34, P1210, DOI 10.1097/MAO.0b013e31829e83df; Fukushima M, 2013, ACTA OTO-LARYNGOL, V133, P1292, DOI 10.3109/00016489.2013.831480; Gibson WPR, 2010, OTOLARYNG CLIN N AM, V43, P1019, DOI 10.1016/j.otc.2010.05.013; Gluth MB, 2020, OTOL NEUROTOL, V41, P242, DOI 10.1097/MAO.0000000000002502; Gurkov R, 2013, EUR ARCH OTO-RHINO-L, V270, P1231, DOI 10.1007/s00405-012-2087-3; Gurkov R, 2011, EUR ARCH OTO-RHINO-L, V268, P1743, DOI 10.1007/s00405-011-1573-3; HARRISON RV, 1985, J SPEECH HEAR DISORD, V50, P213, DOI 10.1044/jshd.5002.213; Higashi-Shingai K, 2019, AURIS NASUS LARYNX, V46, P335, DOI 10.1016/j.anl.2018.10.011; Iida T, 2013, ACTA OTO-LARYNGOL, V133, P434, DOI 10.3109/00016489.2012.753640; Ito T, 2019, ACTA OTO-LARYNGOL, V139, P739, DOI 10.1080/00016489.2019.1630757; Ito T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00046; Jablonka-Strom A, 2013, EUR ARCH OTO-RHINO-L, V270, P1751, DOI 10.1007/s00405-012-2246-6; Jerin C, 2018, OTOL NEUROTOL, V39, pe123, DOI 10.1097/MAO.0000000000001681; Kitahara M, 1976, 5 EXTR M BAR SOC KYO, P17; Klockhoff I., 1967, ACTA OTOLARYNG STO S, V224, P449, DOI 10.3109/00016486709123623; LINDSAY JR, 1946, LARYNGOSCOPE, V56, P325; Lingam RK, 2018, CLIN RADIOL, V73, P35, DOI 10.1016/j.crad.2017.09.002; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; MAGLIULO G, 1991, J OTOLARYNGOL, V20, P188; MAGLIULO G, 1993, ANN OTO RHINOL LARYN, V102, P596, DOI 10.1177/000348949310200805; MCCABE BF, 1961, ANN OTO RHINOL LARYN, V70, P541, DOI 10.1177/000348946107000218; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; Naganawa S, 2006, EUR RADIOL, V16, P733, DOI 10.1007/s00330-005-0046-8; Naganawa S, 2014, MAGN RESON MED SCI, V13, P133, DOI 10.2463/mrms.2013-0061; Naganawa S, 2013, MAGN RESON MED SCI, V12, P63, DOI 10.2463/mrms.2012-0027; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213, DOI 10.2463/mrms.11.213; Naganawa S, 2010, MAGN RESON MED SCI, V9, P237, DOI 10.2463/mrms.9.237; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P5, DOI 10.1080/00016480902729827; Pyykko I, 2010, OTOLARYNG CLIN N AM, V43, P1059, DOI 10.1016/j.otc.2010.06.001; RAUCH SD, 1989, ANN OTO RHINOL LARYN, V98, P873, DOI 10.1177/000348948909801108; Saliba I., 2016, OPER TECHN OTOLARYNG, V27, P221, DOI [10.1016/j.otot.2016.10.008, DOI 10.1016/J.OTOT.2016.10.008]; SCHUKNECHT HF, 1983, ANN OTO RHINOL LARYN, V92, P1; Seo YJ, 2013, AURIS NASUS LARYNX, V40, P167, DOI 10.1016/j.anl.2012.07.009; Sepahdari AR, 2016, AM J NEURORADIOL, V37, P151, DOI 10.3174/ajnr.A4462; Shi SM, 2019, ANN OTO RHINOL LARYN, V128, P286, DOI 10.1177/0003489418819551; Takeda T, 2020, AURIS NASUS LARYNX, V47, P25, DOI 10.1016/j.anl.2019.09.005; TONNDORF J, 1976, ARCH OTO-RHINO-LARYN, V212, P293, DOI 10.1007/BF00453677; TONNDORF J., 1957, ANN OTOL RHINOL AND LARYNGOL, V66, P766; Wesseler A, 2019, OTOL NEUROTOL, V40, pE225, DOI 10.1097/MAO.0000000000002082; Wu QR, 2016, LARYNGOSCOPE, V126, P974, DOI 10.1002/lary.25576; Yoshioka M, 2009, OTOL NEUROTOL, V30, P645, DOI 10.1097/MAO.0b013e31819bda66	49	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240315	10.1371/journal.pone.0240315	http://dx.doi.org/10.1371/journal.pone.0240315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125386	Green Published, gold			2022-12-26	WOS:000588368900003
J	Hashimoto, Y; Tanaka, H				Hashimoto, Yoshitami; Tanaka, Hirofumi			Ongoing replication forks delay the nuclear envelope breakdown upon mitotic entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; XENOPUS CUT5; REPLISOME; ATR; MITOSIS; STRESS; KINASE; CHK1; WEE1; TERMINATION	DNA replication is a major contributor to genomic instability, and protection against DNA replication perturbation is essential for normal cell division. Certain types of replication stress agents, such as aphidicolin and hydroxyurea, have been shown to cause reversible replication fork stalling, wherein replisome complexes are stably maintained with competence to restart in the S phase of the cell cycle. If these stalled forks persist into the M phase without a replication restart, replisomes are disassembled in a p97-dependent pathway and under-replicated DNA is subjected to mitotic DNA repair synthesis. Here, using Xenopus egg extracts, we investigated the consequences that arise when stalled forks are released simultaneously with the induction of mitosis. Ara-cytidine-50 triphosphate-induced stalled forks were able to restart with the addition of excess dCTP during early mitosis before the nuclear envelope breakdown (NEB). However, stalled forks could no longer restart efficiently after the NEB. Although replisome complexes were finally disassembled in a p97dependent manner during mitotic progression whether or not fork stalling was relieved, the timing of the NEB was delayed with the ongoing forks, rather than the stalled forks, and the delay was dependent on Wee1/Myt1 kinase activities. Thus, ongoing DNA replication was found to be directly linked to the regulation of Wee1/Myt1 kinases to modulate cyclin-dependent kinase activities because of which DNA replication and mitosis occur in a mutually exclusive and sequential manner.	[Hashimoto, Yoshitami; Tanaka, Hirofumi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Hashimoto, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo, Japan.	hashimo@toyaku.ac.jp		Hashimoto, Yoshitami/0000-0002-8496-7846	JSPS KAKENHI from the Ministry of Education, Cultures, Sports, Science and Technology (MEXT) in Japan [JP19K06617, 15K06855]	JSPS KAKENHI from the Ministry of Education, Cultures, Sports, Science and Technology (MEXT) in Japan	This work was supported by JSPS KAKENHI grants to Y. H. (JP19K06617 and 15K06855) from the Ministry of Education, Cultures, Sports, Science and Technology (MEXT) in Japan.	Achuthankutty D, 2019, J CELL BIOL, V218, P3943, DOI 10.1083/jcb.201905064; Bass TE, 2019, J CELL BIOL, V218, P1235, DOI 10.1083/jcb.201810058; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Champion L, 2017, TRENDS CELL BIOL, V27, P26, DOI 10.1016/j.tcb.2016.07.004; Crncec A, 2019, FEBS LETT, V593, P2868, DOI 10.1002/1873-3468.13635; Deng L, 2019, MOL CELL, V73, P915, DOI 10.1016/j.molcel.2018.12.021; Dewar JM, 2017, GENE DEV, V31, P275, DOI 10.1101/gad.291799.116; Duda H, 2016, DEV CELL, V39, P740, DOI 10.1016/j.devcel.2016.11.017; Elbaek CR, 2020, MUTAT RES-FUND MOL M, V819, DOI 10.1016/j.mrfmmm.2020.111694; Fragkos M, 2017, CELL CYCLE, V16, P613, DOI 10.1080/15384101.2017.1288322; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hashimoto Y, 2018, BIOCHEM BIOPH RES CO, V506, P108, DOI 10.1016/j.bbrc.2018.10.064; Hashimoto Y, 2012, NAT STRUCT MOL BIOL, V19, P17, DOI 10.1038/nsmb.2177; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hegarat N, 2016, BIOESSAYS, V38, P627, DOI 10.1002/bies.201600057; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Jain R, 2018, CURR OPIN STRUC BIOL, V53, P77, DOI 10.1016/j.sbi.2018.06.003; Kinoshita K, 2017, CURR OPIN CELL BIOL, V46, P46, DOI 10.1016/j.ceb.2017.01.006; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lanz MC, 2019, EMBO J, V38, DOI 10.15252/embj.2019101801; Lawrence Katherine S, 2015, Trends Cell Mol Biol, V10, P141; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Lemmens B, 2019, J CELL BIOL, V218, P3892, DOI 10.1083/jcb.201909032; Lemmens B, 2018, MOL CELL, V71, P117, DOI 10.1016/j.molcel.2018.05.026; Li HL, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700208; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Moiseeva TN, 2018, DNA REPAIR, V72, P99, DOI 10.1016/j.dnarep.2018.09.003; Moreno SP, 2020, BIOCHEM SOC T, V48, P823, DOI 10.1042/BST20190363; Moreno SP, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900390; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Ode KL, 2011, GENES CELLS, V16, P380, DOI 10.1111/j.1365-2443.2011.01501.x; Ovejero S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020225; Pfander B, 2017, FEBS LETT, V591, P2048, DOI 10.1002/1873-3468.12727; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Singh B, 2019, CURR GENET, V65, P79, DOI 10.1007/s00294-018-0860-6; Sonneville R, 2019, ELIFE, V8, DOI 10.7554/eLife.48686; Sonneville R, 2017, NAT CELL BIOL, V19, P468, DOI 10.1038/ncb3500; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Zegerman P, 2015, CHROMOSOMA, V124, P309, DOI 10.1007/s00412-014-0500-y; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	53	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100033	10.1074/jbc.RA120.015142	http://dx.doi.org/10.1074/jbc.RA120.015142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33148697	Green Published, gold			2022-12-26	WOS:000672866400017
J	Alderman, G; Keegan, R; Semple, S; Toohey, K				Alderman, Georgina; Keegan, Richard; Semple, Stuart; Toohey, Kellie			Physical activity for people living with cancer: Knowledge, attitudes, and practices of general practitioners in Australia	PLOS ONE			English	Article							ACTIVITY PROMOTION; BREAST-CANCER; EXERCISE; ONCOLOGISTS; SURVIVORS; BARRIERS; RECOMMENDATION; INTERVENTIONS; CHEMOTHERAPY; BEHAVIOR	Background Healthcare professionals' (Oncologists, doctors, and nurses) physical activity (PA) recommendations impact patients living with cancer PA levels. General practitioners (GPs) monitor the overall health of patients living with cancer throughout their treatment journey. This is the first study to explore GP's knowledge, attitudes and practices of PA for patients living with cancer. Methods GPs who see patients living with cancer regularly (n = 111) completed a survey based on The Theory of Planned Behaviour (TPB). Participants (GP's) reported knowledge, attitudes, perceived behaviour control and subjective norms of PA within the cancer population. GP recommendation and referral rates of PA were reported. Principal component analysis was conducted to establish a set of survey items aligned to TPB constructs (attitude, subjective norms, perceived control), and multiple regression analyses characterised associations between these predictor variables and (a) recommendation; and (b) referral-of PA to cancer patients. Results GPs (n = 111) recommended PA to 41-60% of their patients and referred 1-20% to PA programs. Multiple regression models significantly predicted the percent of patients recommended PA, p < .0005 adj. R-2 = 0.40 and referred PA, p < .0005, adj. R-2 = 0.21. GP attitudes and perceived behavioural control and GP's own activity levels were significant predictors of whether patients were recommended and referred for PA, p<0.05. Conclusion GPs reported positive attitudes and perceptions towards promoting PA for their patients living with cancer. Despite having a positive correlation between PA recommendations and referral rates, a gap was evident between GP's PA beliefs and their individual referral practices. More GP's willing to promote and refer their patients for PA, would improve the physical and mental health outcomes of the cancer population.	[Alderman, Georgina; Keegan, Richard; Semple, Stuart; Toohey, Kellie] Univ Canberra, Fac Hlth, Discipline Sport & Exercise Sci, Canberra, ACT, Australia; [Alderman, Georgina; Keegan, Richard; Semple, Stuart; Toohey, Kellie] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Alderman, Georgina; Semple, Stuart; Toohey, Kellie] Univ Canberra, Prehabil Act Canc Exercise & Survivorship PACES R, Canberra, ACT, Australia; [Keegan, Richard; Semple, Stuart; Toohey, Kellie] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia	University of Canberra; University of Canberra; University of Canberra; University of Canberra	Toohey, K (corresponding author), Univ Canberra, Fac Hlth, Discipline Sport & Exercise Sci, Canberra, ACT, Australia.; Toohey, K (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia.; Toohey, K (corresponding author), Univ Canberra, Prehabil Act Canc Exercise & Survivorship PACES R, Canberra, ACT, Australia.; Toohey, K (corresponding author), Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia.	kellie.toohey@canberra.edu.au		Toohey, Kellie/0000-0002-1776-6200				ABC, 2019, PODC 21 11, V21, P11; AJZEN I, 1992, J LEISURE RES, V24, P207, DOI 10.1080/00222216.1992.11969889; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; Armonk, 2016, VERS 25 0 ED; Baumann FT, 2018, BREAST CANCER RES TR, V170, P1, DOI 10.1007/s10549-018-4725-y; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown WJ, 2012, DEV EVIDENCE BASED P; Buffart LM, 2009, BRIT J SPORT MED, V43, P1149, DOI 10.1136/bjsm.2008.049577; Cantwell M, 2017, EUROPEAN J CANC CARE; CheckMarket, CALC REPR SAMPL SIZ; Cormie P, 2018, MED J AUSTRALIA, V209, P184, DOI 10.5694/mja18.00199; Daley AJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-46; Dalla Via J, 2018, OSTEOPOROSIS INT, V29, P287, DOI 10.1007/s00198-017-4237-3; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Doyle C, 2006, CA-CANCER J CLIN, V56, P323, DOI 10.3322/canjclin.56.6.323; Duregon F, 2018, CRIT REV ONCOL HEMAT, V121, P90, DOI 10.1016/j.critrevonc.2017.11.002; Fie S, 2011, HLTH ED J, V72, P102; Fisher A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006853; Gill DP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-20; Hagger SJHCMSNZCPMOCMS, 2017, PSYCHO-ONCOLOGY, P26, DOI [10.1002/pon.4111, DOI 10.1002/PON.411126935994]; Hardcastle SJ, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12679; Hardcastle SJ, 2018, SUPPORT CARE CANCER, V26, P3711, DOI 10.1007/s00520-018-4230-1; Hardcastle SJ, 2018, SUPPORT CARE CANCER, V26, P1289, DOI 10.1007/s00520-017-3952-9; Hardcastle SJ, 2017, PSYCHO-ONCOLOGY, V26, P1099, DOI 10.1002/pon.4288; Haussmann A, 2018, SUPPORT CARE CANCER, V26, P4087, DOI 10.1007/s00520-018-4279-x; Silva EH, 2019, J CANCER SURVIV, V13, P97, DOI 10.1007/s11764-018-0730-8; Hilfiker R, 2018, BRIT J SPORT MED, V52, P651, DOI 10.1136/bjsports-2016-096422; Irwin ML, 2009, BRIT J SPORT MED, V43, P32, DOI 10.1136/bjsm.2008.053843; Jones LW, 2005, SUPPORT CARE CANCER, V13, P929, DOI 10.1007/s00520-005-0805-8; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Jones LW, 2002, CANCER PRACT, V10, P66, DOI 10.1046/j.1523-5394.2002.102004.x; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Karvinen KH, 2012, CANCER NURS, V35, pE41, DOI 10.1097/NCC.0b013e31822d9081; Karvinen Kristina H, 2010, J Support Oncol, V8, P35; Keogh JWL, 2017, ONCOL NURS FORUM, V44, P235, DOI 10.1188/17.ONF.235-245; Limited AMA, 2017, GEN PRACT FACTS 2017; Maxwell-Smith C, 2017, PSYCHO-ONCOLOGY, V26, P808, DOI 10.1002/pon.4234; McGowan EL, 2013, ONCOL NURS FORUM, V40, P44, DOI 10.1188/13.ONF.44-52; McTiernan A, 2019, MED SCI SPORT EXER, V51, P1252, DOI 10.1249/MSS.0000000000001937; Nadler M, 2017, SUPPORT CARE CANCER, V25, P2297, DOI 10.1007/s00520-017-3640-9; NSW CC, FOLL MED CAR CANC TR; Organisation WH, CANC 2018; Park JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1250-9; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Randles RH, 2001, AM STAT, V55, P96, DOI 10.1198/000313001750358554; Rieger P, 2003, ROLE ONCOLOGY NURSE, V6th; Ross R., 2019, DETERMINE PROVIDER L; Garcia RS, 2016, INTERACT CARDIOV TH, V23, P486, DOI 10.1093/icvts/ivw152; Sheill G, 2018, IRISH J MED SCI, V187, P337, DOI 10.1007/s11845-017-1677-x; Sheill G, 2018, PHYSIOTHER THEOR PR, V34, P534, DOI 10.1080/09593985.2017.1422821; Smaradottir A, 2017, J NATL COMPR CANC NE, V15, P588, DOI 10.6004/jnccn.2017.0061; Spellman C, 2014, HEALTH EDUC J, V73, P566, DOI 10.1177/0017896913508395; Statistics aBo, 2019, NAT HLTH SURV 1 RES; Tsang S, 2017, SAUDI J ANAESTH, V11, pS80, DOI 10.4103/sja.SJA_203_17; Ungar N, 2019, REST NOT REST HLTH C; van der Leeden M, 2018, DISABIL REHABIL, V40, P486, DOI 10.1080/09638288.2016.1260647; Zimmer P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1820954; 2013, SURVEILLANCE, V40, P44	61	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241668	10.1371/journal.pone.0241668	http://dx.doi.org/10.1371/journal.pone.0241668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166304	gold, Green Published			2022-12-26	WOS:000592382600045
J	da Silva, MF; Goncalves, MC; Brito, MD; Medeiros, CN; Harakava, R; Landell, MGD; Pinto, LR				da Silva, Marcel Fernando; Goncalves, Marcos Cesar; Brito, Michael dos Santos; Medeiros, Cibele Nataliane; Harakava, Ricardo; de Andrade Landell, Marcos Guimaraes; Pinto, Luciana Rossini			Sugarcane mosaic virus mediated changes in cytosine methylation pattern and differentially transcribed fragments in resistance-contrasting sugarcane genotypes	PLOS ONE			English	Article							CDNA-AFLP ANALYSIS; DNA METHYLATION; GENE-EXPRESSION; PLANT DEFENSE; PROTEIN; RESPONSES; SEQUENCE; POLYMORPHISMS; MECHANISMS; INFECTION	Sugarcane mosaic virus (SCMV) is the causal agent of sugarcane mosaic disease (SMD) in Brazil; it is mainly controlled by using resistant cultivars. Studies on the changes in sugarcane transcriptome provided the first insights about the molecular basis underlying the genetic resistance to SMD; nonetheless, epigenetic modifications such as cytosine methylation is also informative, considering its roles in gene expression regulation. In our previous study, differentially transcribed fragments (DTFs) were obtained using cDNA-amplified fragment length polymorphism by comparing mock- and SCMV-inoculated plants from two sugarcane cultivars with contrasting responses to SMD. In this study, the identification of unexplored DTFs was continued while the same leaf samples were used to evaluate SCMV-mediated changes in the cytosine methylation pattern by using methylation-sensitive amplification polymorphism. This analysis revealed minor changes in cytosine methylation in response to SCMV infection, but distinct changes between the cultivars with contrasting responses to SMD, with higher hypomethylation events 24 and 72 h post-inoculation in the resistant cultivar. The differentially methylated fragments (DMFs) aligned with transcripts, putative promoters, and genomic regions, with a preponderant distribution within CpG islands. The transcripts found were associated with plant immunity and other stress responses, epigenetic changes, and transposable elements. The DTFs aligned with transcripts assigned to stress responses, epigenetic changes, photosynthesis, lipid transport, and oxidoreductases, in which the transcriptional start site is located in proximity with CpG islands and tandem repeats. Real-time quantitative polymerase chain reaction results revealed significant upregulation in the resistant cultivar of aspartyl protease and VQ protein, respectively, selected from DMF and DTF alignments, suggesting their roles in genetic resistance to SMD and supporting the influence of cytosine methylation in gene expression. Thus, we identified new candidate genes for further validation and showed that the changes in cytosine methylation may regulate important mechanisms underlying the genetic resistance to SMD.	[da Silva, Marcel Fernando] Univ Estadual Paulista, Fac Ciencias Agr & Vet FCAV, Biol Aplicada Agr, Jaboticabal, SP, Brazil; [Goncalves, Marcos Cesar; Harakava, Ricardo] Inst Biol, Crop Protect Res Ctr, Sao Paulo, Brazil; [Brito, Michael dos Santos] Univ Fed Sao Paulo, Dept Ciencia & Tecnol, Inst Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil; [da Silva, Marcel Fernando; Medeiros, Cibele Nataliane; de Andrade Landell, Marcos Guimaraes; Pinto, Luciana Rossini] Inst Agron, Ctr Cana, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Agronomico de Campinas (IAC)	Pinto, LR (corresponding author), Inst Agron, Ctr Cana, Ribeirao Preto, SP, Brazil.	lrossini@iac.sp.gov.br	da Silva, Luciana Rossini Pinto Machado/AAT-6921-2021; Harakava, Ricardo/GYU-7506-2022; Gonçalves, Marcos/C-8679-2013; Harakava, Ricardo/C-4471-2012	da Silva, Luciana Rossini Pinto Machado/0000-0002-7369-7609; Gonçalves, Marcos/0000-0002-9923-7459; Harakava, Ricardo/0000-0003-1431-2665; Landell, Marcos Guimaraes de Andrade/0000-0001-8574-1489; da Silva, Marcel/0000-0002-7664-8423	CNPq [424050/2016-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15060-6]; FAPESP [08/56146-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES [001]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LRP (CNPq grant 424050/2016-1); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant: 2012/15060-6); MGAL (FAPESP grant: 08/56146-5); MFS (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES -Finance Code 001). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid G, 2017, ENVIRON EXP BOT, V142, P34, DOI 10.1016/j.envexpbot.2017.08.004; Alonso C, 2016, MOL ECOL RESOUR, V16, P80, DOI 10.1111/1755-0998.12426; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2009, RURAL, V69, P213, DOI DOI 10.1526/003601104323087589; Ashikawa I, 2001, PLANT J, V26, P617, DOI 10.1046/j.1365-313x.2001.01062.x; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Camelo-Garcia VM, 2016, ARCH VIROL, V161, P1335, DOI 10.1007/s00705-016-2772-4; Carr JP, 2019, PLANT SCI, V279, P87, DOI 10.1016/j.plantsci.2018.04.011; Casteel CL, 2015, PLANT PHYSIOL, V169, P209, DOI 10.1104/pp.15.00332; Chen S, 2017, PLANT CELL REP, V36, P297, DOI 10.1007/s00299-016-2080-1; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Dechorgnat J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042491; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Ding B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00675; Dong M, 2017, TROP PLANT BIOL, V10, P45, DOI 10.1007/s12042-016-9183-2; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dutta A, 2017, PLANT J, V91, P1015, DOI 10.1111/tpj.13623; Espinas NA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01201; Everaert C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01617-3; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Francischini JHMB, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029585; Garsmeur O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05051-5; Goncalves Marcos C., 2007, Fitopatologia Brasileira, V32, P32, DOI 10.1590/S0100-41582007000100004; Goncalves MC, 2012, FUNCT PLANT SCI BIOT, V6, P108; Grativol C, 2014, PLANT J, V79, P162, DOI 10.1111/tpj.12539; Guo HM, 2014, FUNCT INTEGR GENOMIC, V14, P127, DOI 10.1007/s10142-013-0347-y; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hoang NV, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00182; Hou YX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0674-3; Iwasaki M, 2014, P NATL ACAD SCI USA, V111, P8547, DOI 10.1073/pnas.1402275111; Jing YJ, 2015, PLANT PHYSIOL, V169, P371, DOI 10.1104/pp.15.00788; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kebede AF, 2015, FEBS J, V282, P1658, DOI 10.1111/febs.13047; Kumar G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149934; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lei C.P., 2006, ASIA PACIFIC J MOL B, V14, P47; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Mattiello L, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0694-z; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Medeiros CN, 2014, ADV MICROBIOL, V4, P511, DOI DOI 10.4236/aim.2014.49057; Ming R, 2006, PL BRED RE, V27, P15; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Arraes FBM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0597-z; Muller K, 2009, BIOL CHEM, V390, P245, DOI 10.1515/BC.2009.029; Nayak SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110856; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; Niederhuth CE, 2014, MOL PLANT, V7, P472, DOI 10.1093/mp/sst165; Nuskern L, 2018, MICROB ECOL, V75, P790, DOI 10.1007/s00248-017-1064-1; OHara I.M., 2016, SUGARCANE BASED BIOF; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramirez-Parra E, 2007, CELL CYCLE CONTROL P, P144, DOI [10.1242/dev.010108, DOI 10.1242/DEV.010108]; Ramirez-Prado JS, 2018, TRENDS PLANT SCI, V23, P833, DOI 10.1016/j.tplants.2018.06.004; Rigas S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00145; Rubio B, 2019, NEW PHYTOL, V221, P2026, DOI 10.1111/nph.15507; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schaker PDC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162237; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Sforca DA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00553; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Souza GM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz129; Steele JFC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221226; Suzuki N, 2002, PLANT J, V32, P165, DOI 10.1046/j.1365-313X.2002.01412.x; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; The DNA methyltransferase family, 2018, NAT REV GENET, V19, P81; To TK, 2015, PLANT PHYSIOL, V168, P1219, DOI 10.1104/pp.15.00543; Uchiyama A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00584; Veluchamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3091; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; VICENTINI R, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0134909; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; West PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105267; Wu ZF, 2019, PLANT CELL PHYSIOL, V60, P1471, DOI 10.1093/pcp/pcz051; Xiao D, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.34; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Xu YF, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25006; Yang ZN, 1997, PHYTOPATHOLOGY, V87, P932, DOI 10.1094/PHYTO.1997.87.9.932; Yuan X, 2019, PHYTOPATHOL RES, V1, DOI 10.1186/s42483-018-0008-0; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004; Zhai YS, 2015, BIOCHEM BIOPH RES CO, V466, P312, DOI 10.1016/j.bbrc.2015.09.015; Zhang HM, 2018, NAT REV MOL CELL BIO, V19, P489, DOI 10.1038/s41580-018-0016-z; Zhang JS, 2018, NAT GENET, V50, P1565, DOI 10.1038/s41588-018-0237-2	97	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241493	10.1371/journal.pone.0241493	http://dx.doi.org/10.1371/journal.pone.0241493			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166323	Green Published, gold			2022-12-26	WOS:000592382600023
J	Maiga, Y; Diallo, S; Konipo, FDN; Sangho, O; Sangare, M; Diallo, SH; Mahamadou, S; Pereon, Y; Giumelli, B; Coulibaly, A; Daou, M; Traore, Z; Sylla, DS; Albakaye, M; Guinto, CO; Ouologem, M; Sissoko, AS; Traore, HA; Coulibaly, SP; Damier, P; Attal, N; Nizard, J				Maiga, Youssoufa; Diallo, Salimata; Konipo, Fatoumata Dite Nene; Sangho, Oumar; Sangare, Modibo; Diallo, Seybou H.; Mahamadou, Saliou; Pereon, Yann; Giumelli, Bernard; Coulibaly, Awa; Daou, Mariam; Traore, Zoumana; Sylla, Djeneba Sow; Albakaye, Mohamed; Guinto, Cheick Oumar; Ouologem, Madani; Sissoko, Adama S.; Traore, Hamar A.; Coulibaly, Souleymane Papa; Damier, Philippe; Attal, Nadine; Nizard, Julien			Diabetic polyneuropathy with/out neuropathic pain in Mali: A cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PERIPHERAL NEUROPATHY; PREVALENCE; TYPE-1; COMPLICATIONS; EPIDEMIOLOGY; DIAGNOSIS; MELLITUS; CARE; INTERVENTIONS	Introduction Diabetic polyneuropathy (DPN) with or without neuropathic pain is a frequent complication of diabetes. This work aimed to determine the prevalence of diabetic polyneuropathy, to describe its epidemiological aspects, and to analyze the therapeutic itinerary of patients with DPN. Methods This was a cross-sectional, descriptive study performed synchronously over six months at two major follow-up sites for patients with diabetes in Mali. DPN was diagnosed based on the Michigan Neuropathy Screening Instrument (MNSI). The neuropathic nature of the pain and the quality of life of patients were evaluated by the DN4 and the ED-5D scale, respectively. We used three (3) different questionnaires to collect data from patients (one at inclusion and another during the follow-up consultation) and from the caregivers of patients with DPN. Results We included 252 patients with diabetes, and DPN was found to have a healthcare facility-based prevalence of 69.8% (176/252). The sex ratio was approximately three females for every male patient. The patients were mostly 31 to 60 years of age, 83% had type 2 diabetes, and 86.9% had neuropathic pain Approximately half of the patients (48.3%) had autonomic neuropathy and they reported moderate to intense pain, which was mainly described as a burning sensation. The patients exhibited impaired exteroceptive and proprioceptive sensations in 51.7% of cases. The patients smoked tobacco in 3.4% of cases, while 36.6% of the patients were obese and had dyslipidemia. The caregivers clearly indicated that appropriate medications were not readily accessible or available for their patients with DPN. Conclusion The healthcare facility-based prevalence of DPN with or without neuropathic pain was high in our cohort. These inexpensive and easy-to-use tools (MNSI, DN4) can be used to adequately diagnose DPN in the African context. In Mali, screening and early treatment of patients at risk of DPN should allow for a reduction of the burden of the disease, while caregivers need to be adequately trained to manage DPN.	[Maiga, Youssoufa; Konipo, Fatoumata Dite Nene; Sangho, Oumar; Sangare, Modibo; Diallo, Seybou H.; Sylla, Djeneba Sow; Guinto, Cheick Oumar; Sissoko, Adama S.; Traore, Hamar A.; Coulibaly, Souleymane Papa] Univ Tech Sci & Technol, Fac Med, Bamako, Mali; [Maiga, Youssoufa; Diallo, Salimata; Diallo, Seybou H.; Coulibaly, Awa; Daou, Mariam; Albakaye, Mohamed] Gabriel Toure Teaching Hosp, Dept Neurol, Bamako, Mali; [Maiga, Youssoufa; Nizard, Julien] Univ Nantes, Fac Med Nantes, Lab Therapeut EA3826, Nantes, France; [Mahamadou, Saliou] Gabriel Toure UHC, Dept Diabetol, Bamako, Mali; [Pereon, Yann] UHC Nantes, Reference Ctr Neuromuscular Dis Atlantique Occita, Hotel Dieu, Nantes, France; [Giumelli, Bernard; Ouologem, Madani] Univ Nantes, Fac Dent Surg, Nantes, France; [Traore, Zoumana] Hosp Mali, Dept Neurol, Bamako, Mali; [Sylla, Djeneba Sow] Ctr Combating Diabet Mali CCD, Bamako, Mali; [Damier, Philippe; Nizard, Julien] Univ Nantes, Fac Med, Nantes, France; [Attal, Nadine] CHU Ambroise Pare, CET, INSERM, U98, F-92100 Boulogne, France; [Nizard, Julien] Nantes UHC, Lab Therapeut, Fed Pain Palliat Care & Support, Nantes, France	Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Maiga, Y (corresponding author), Univ Tech Sci & Technol, Fac Med, Bamako, Mali.; Maiga, Y (corresponding author), Gabriel Toure Teaching Hosp, Dept Neurol, Bamako, Mali.; Maiga, Y (corresponding author), Univ Nantes, Fac Med Nantes, Lab Therapeut EA3826, Nantes, France.	youssoufamaiga@hotmail.com	Sangare, Modibo/GPK-1366-2022	Sangho, Oumar/0000-0003-2856-0395				Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Abdul M, 2014, INT J ADV RES; Agnaniet H, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1052-x; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Allen MD, 2016, J APPL PHYSIOL, V121, P1, DOI 10.1152/japplphysiol.00733.2015; Amara F, 2019, CURR DIABETES REV, V15, P340, DOI 10.2174/1573399815666190226150402; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Andersen ST, 2018, DIABETES CARE, V41, P1068, DOI 10.2337/dc17-2062; Ang L, 2014, CURR DIABETES REP, V14, P1, DOI 10.1007/s11892-014-0528-7; [Anonymous], 1988, DIABETES CARE, P592; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2019, DIABETES CARE, V42, pS124, DOI DOI 10.2337/DC19-S011; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2003, CAHIERS, V1, P11; Aspray TJ, 2001, ADV EXP MED BIOL, V498, P21; Azevedo M, 2008, INT J DIABETES DEV C, V28, P101, DOI 10.4103/0973-3930.45268; Bai JW, 2017, J DIABETES COMPLICAT, V31, P1318, DOI 10.1016/j.jdiacomp.2017.05.002; Barrett AM, 2007, PAIN MED, V8, pS50, DOI 10.1111/j.1526-4637.2006.00179.x; Bouchenaki H, 2019, THERAPIE, V74, P633, DOI 10.1016/j.therap.2019.04.003; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bouhassira D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074195; Boulton Andrew J M, 2014, Handb Clin Neurol, V126, P97, DOI 10.1016/B978-0-444-53480-4.00008-4; Boulton AJM, 2013, DIABETES-METAB RES, V29, P327, DOI 10.1002/dmrr.2397; Bytwerk RL, 2015, HOLOCAUST GENOCIDE S, V29, P212, DOI 10.1093/hgs/dcv024; Chahbi Z, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.158.14687; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; Degu H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211449; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Ekwunife Obinna Ikechukwu, 2016, BMC Res Notes, V9, P24, DOI 10.1186/s13104-015-1832-2; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Feng Y, 2017, QUAL LIFE RES, V26, P2067, DOI 10.1007/s11136-017-1541-5; Gilron I, 2015, MAYO CLIN PROC, V90, P532, DOI 10.1016/j.mayocp.2015.01.018; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Greig Marni, 2014, Handb Clin Neurol, V126, P559, DOI 10.1016/B978-0-444-53480-4.00037-0; Gylfadottir SS, 2020, PAIN, V161, P574, DOI 10.1097/j.pain.0000000000001744; Gylfadottir SS, 2019, J DIABETES INVEST, V10, P1148, DOI 10.1111/jdi.13105; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Jacovides A, 2014, J INT MED RES, V42, P1018, DOI 10.1177/0300060514525759; Kengne AP, 2017, INT J EPIDEMIOL, V46, P1421, DOI 10.1093/ije/dyx078; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Malik RA, 2001, ACTA NEUROPATHOL, V101, P367; Mercer T, 2019, DIABET METAB SYND OB, V12, P2261, DOI 10.2147/DMSO.S207427; Mwendwa F M, 2005, East Afr Med J, V82, pS163; Nukada Hitoshi, 2014, Handb Clin Neurol, V126, P469, DOI 10.1016/B978-0-444-53480-4.00023-0; Okoro EO, 2002, J DIABETES COMPLICAT, V16, P159, DOI 10.1016/S1056-8727(01)00145-3; Olmez N, 2015, NEUROSCIENCE MED, V6, P98; Osei K, 2003, J CARDIOVASC RISK, V10, P85, DOI 10.1097/00043798-200304000-00003; PIRART J, 1977, DIABETES METAB, V3, P245; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Shakeel M, 2015, DIABETES METAB SYND, V9, P373, DOI 10.1016/j.dsx.2014.04.029; Shillo P, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1150-5; TaSKapilioGLu  Oz., 2018, NORO PSIKIYATR ARS, V55, ps15; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Traore D, 2014, Mali Med, V29, P15; Truini A, 2018, PAIN, V159, P2658, DOI 10.1097/j.pain.0000000000001378; Tuei Vivian C, 2010, Diabetes Metab Res Rev, V26, P433, DOI 10.1002/dmrr.1106; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhang X., 2002, TRADITIONAL MED STRA; Ziegler D, 1992, J Diabetes Complications, V6, P49, DOI 10.1016/1056-8727(92)90049-Q	67	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241387	10.1371/journal.pone.0241387	http://dx.doi.org/10.1371/journal.pone.0241387			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166296	Green Published, gold			2022-12-26	WOS:000592382600056
J	Yea, JH; Kim, I; Sym, G; Park, JK; Lee, AY; Cho, BC; Bae, TS; Kim, BJ; Jo, CH				Yea, Ji-Hye; Kim, InJa; Sym, Gayoung; Park, Jin-Kyung; Lee, Ah-Young; Cho, Byeong Chan; Bae, Tae Soo; Kim, Byoung Jae; Jo, Chris Hyunchul			Regeneration of a full-thickness defect in rotator cuff tendon with umbilical cord-derived mesenchymal stem cells in a rat model	PLOS ONE			English	Article							PLATELET-RICH PLASMA; NATURAL-HISTORY; REPAIR; DEGENERATION; INJURY; EXPRESSION; TEAR; EPIDEMIOLOGY; PROGRESSION; FATE	Although rotator cuff disease is a common cause of shoulder pain, there is still no treatment method that could halt or reveres its development and progression. The purpose of this study was to investigate the efficacy of umbilical cord-derived mesenchymal stem cells (UC MSCs) on the regeneration of a full-thickness rotator cuff defect (FTD) in a rat model. We injected either UC MSCs or saline to the FTD and investigated macroscopic, histological and biomechanical results and cell trafficking. Treatment with UC MSCs improved macroscopic appearance in terms of tendon thickness at two weeks, and inflammation, defect size, swelling/redness and connection surrounding tissue and slidability at four weeks compared to the saline group. Histologically, UC MSCs induced the tendon matrix formation recovering collagen organization, nuclear aspect ratio and orientation angle of fibroblast as well as suppressing cartilage-related glycosaminoglycan compared to saline group at four weeks. The UC MSCs group also improved ultimate failure load by 25.0% and 19.0% and ultimate stress by 27.3% and 26.8% at two and four weeks compared to saline group. UC MSCs labeled with PKH26 exhibited 5.3% survival at four weeks compared to three hours after injection. This study demonstrated that UC MSCs regenerated the FTD with tendon tissue similar properties to the normal tendon in terms of macroscopic, histological and biomechanical characteristics in a rat model.	[Yea, Ji-Hye; Jo, Chris Hyunchul] Seoul Natl Univ, Dept Translat Med, Coll Med, Seoul, South Korea; [Yea, Ji-Hye; Kim, InJa; Sym, Gayoung; Park, Jin-Kyung; Lee, Ah-Young; Jo, Chris Hyunchul] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Cho, Byeong Chan; Bae, Tae Soo] Jungwon Univ, Dept Biomed Engn, Coll Sci & Engn, Chungcheongbuk Do, South Korea; [Kim, Byoung Jae] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Jungwon University; Seoul National University (SNU); Seoul National University Hospital	Jo, CH (corresponding author), Seoul Natl Univ, Dept Translat Med, Coll Med, Seoul, South Korea.; Jo, CH (corresponding author), Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthoped Surg, Coll Med, Seoul, South Korea.	chrisjo@snu.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation of Korea [NRF-2015M3A9E6028412]; Basic Science Research Program of the National Research Foundation of Korea [NRF-2017R1A2B2010995]	Bio & Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea)	C.H.J.; This research was supported by a grant (NRF-2015M3A9E6028412) of the Bio & Medical Technology Development Program and a grant (NRF-2017R1A2B2010995) of the Basic Science Research Program of the National Research Foundation of Korea.	Abat F, 2017, J Exp Orthop, V4, P18, DOI 10.1186/s40634-017-0092-6; Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Abraham AC, 2017, TECH SHOULDER ELBOW, V18, P84, DOI 10.1097/BTE.0000000000000124; Aina R, 2001, RADIOLOGY, V221, P455, DOI 10.1148/radiol.2212000830; Fernandez-Sarmiento JA, 2013, J BONE JOINT SURG AM, V95A, P246, DOI 10.2106/JBJS.K.01659; [Anonymous], 2011, DRUG SAFETY UPDATE, V4, pH1; Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Beck J, 2012, AM J SPORT MED, V40, P2037, DOI 10.1177/0363546512453300; Beeravolu N, 2016, STEM CELL RES, V16, P696, DOI 10.1016/j.scr.2016.04.010; Berkan O, 2009, THORAC CARDIOV SURG, V57, P91, DOI 10.1055/s-2008-1039107; Bianco ST, 2019, ANN NY ACAD SCI, V1442, P35, DOI 10.1111/nyas.13918; Carpenter JE, 1998, J SHOULDER ELB SURG, V7, P599, DOI 10.1016/S1058-2746(98)90007-6; Chen HS, 2015, CELL TRANSPLANT, V24, P509, DOI 10.3727/096368915X686968; Chen L, 2014, CELL PHYSIOL BIOCHEM, V34, P2153, DOI 10.1159/000369659; Choi HR, 2002, J ORTHOP RES, V20, P927, DOI 10.1016/S0736-0266(02)00016-5; Conconi MT, 2006, INT J MOL MED, V18, P1089; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; De Miguel MP, 2012, CURR MOL MED, V12, P574; Degen RM, 2016, ARTHROSCOPY, V32, P2435, DOI 10.1016/j.arthro.2016.04.019; EC, 2014, OFFICIAL J EUROPEA L, V13, P1, DOI DOI 10.1186/1475-2891-13-1; El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]; Galatz LM, 2006, J BONE JOINT SURG AM, V88A, P2027, DOI 10.2106/JBJS.E.00899; Galatz LM, 2009, J SHOULDER ELB SURG, V18, P669, DOI 10.1016/j.jse.2009.02.016; Gimbel JA, 2004, J BIOMECH, V37, P739, DOI 10.1016/j.jbiomech.2003.09.019; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Hashimoto T, 2003, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01/blo.0000092974.12414.22; Hebert-Davies J, 2017, J BONE JOINT SURG AM, V99, P832, DOI 10.2106/JBJS.16.00030; Hermans J, 2013, JAMA-J AM MED ASSOC, V310, P837, DOI 10.1001/jama.2013.276187; Hsieh CF, 2016, NANOMEDICINE-UK, V11, P1153, DOI 10.2217/nnm.16.34; Jo CH, 2008, CELL TISSUE RES, V334, P423, DOI 10.1007/s00441-008-0696-3; Jo CH, 2017, KNEE SURG SPORT TR A, V25, P2100, DOI 10.1007/s00167-016-4376-7; Kang ES, 2012, J KOREAN MED SCI, V27, P586, DOI 10.3346/jkms.2012.27.6.586; Karasuyama Masaki, 2020, Clin Shoulder Elb, V23, P86, DOI 10.5397/cise.2020.00031; Killian ML, 2013, J ORTHOP RES, V31, P1240, DOI 10.1002/jor.22345; Kraus TM, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0999-6; Kwon DR, 2018, CELL TRANSPLANT, V27, P1613, DOI 10.1177/0963689718799040; Kwon DR, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7146384; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; Lee SY, 2017, AM J SPORT MED, V45, P1429, DOI 10.1177/0363546517689874; Li MR, 2017, INT WOUND J, V14, P64, DOI 10.1111/iwj.12551; Li SY, 2007, CANCER LETT, V251, P220, DOI 10.1016/j.canlet.2006.11.024; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Merolla G, 2011, MLTJ-MUSCLE LIGAMENT, V1, P12; Narayanan G, 2018, ACS BIOMATER SCI ENG, V4, P751, DOI 10.1021/acsbiomaterials.7b00631; Norelli JB, 2018, J TISSUE ENG, V9, DOI 10.1177/2041731418811183; Park GY, 2015, STEM CELL TRANSL MED, V4, P1344, DOI 10.5966/sctm.2015-0040; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schneider M, 2018, ADV DRUG DELIVER REV, V129, P352, DOI 10.1016/j.addr.2017.12.016; Stoll C, 2011, BIOMATERIALS, V32, P4806, DOI 10.1016/j.biomaterials.2011.03.026; Tashjian RZ, 2012, CLIN SPORT MED, V31, P589, DOI 10.1016/j.csm.2012.07.001; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Uthoff H, 2003, J IMMUNOL, V171, P3485, DOI 10.4049/jimmunol.171.7.3485; vanderWindt DAWM, 1996, BRIT J GEN PRACT, V46, P519; Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086; Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041; Yea JH, 2020, ACTA BIOMATER, V114, P104, DOI 10.1016/j.actbio.2020.07.020; Yuksel S, 2016, CONNECT TISSUE RES, V57, P360, DOI 10.1080/03008207.2016.1189909; Zhang BY, 2017, CURR STEM CELL RES T, V12, P447, DOI 10.2174/1574888X12666170502102423; Zhao S, 2014, INT J NANOMED, V9, P2373, DOI 10.2147/IJN.S59536	61	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0235239	10.1371/journal.pone.0235239	http://dx.doi.org/10.1371/journal.pone.0235239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166292	Green Submitted, gold, Green Published			2022-12-26	WOS:000592382600080
J	Gupta, V; Sudhakaran, IP; Islam, Z; Vaikath, NN; Hmila, I; Lukacsovich, T; Kolatkar, PR; El-Agnaf, OMA				Gupta, Vijay; Sudhakaran, Indulekha P.; Islam, Zeyaul; Vaikath, Nishant N.; Hmila, Issam; Lukacsovich, Tamas; Kolatkar, Prasanna R.; El-Agnaf, Omar M. A.			Expression, purification and characterization of alpha-synuclein fibrillar specific scFv from inclusion bodies	PLOS ONE			English	Article							PROTEIN-PROTEIN; BODY PROTEINS; SOLUBILIZATION; ANTIBODIES; QUALITY; SERVER; SYSTEM; HDOCK	Aggregation of alpha-synuclein (alpha-syn) has been implicated in multiple neurodegenerative disorders including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), collectively grouped as synucleinopathies. Recently, recombinant antibody fragments (Fab, scFvs and diabodies) against alpha-syn have emerged as an alternative to the traditional full-length antibody in immunotherapeutic approaches owing to their advantages including smaller size and higher stability, specificity and affinity. However, most of the recombinant antibody fragments tend to be expressed as inclusion bodies (IBs) making its purification extremely challenging. In the current study, a single-chain variable fragment (scFv-F) antibody, targeting the pathogenic alpha-syn fibrils, was engineered and expressed in E. coli. Majority of the expressed scFv-F accumulated in insoluble aggregates as IBs. A variety of mild and harsh solubilizing conditions were tested to solubilize IBs containing scFv-F to obtain the active protein. To preserve secondary structure and bioactivity, a mild solubilizing protocol involving 100 mM Tris, pH 12.5 with 2 M urea was chosen to dissolve IBs. Slow on-column refolding method was employed to subsequently remove urea and obtain active scFv-F. A three-dimensional (3D) model was built using homology modeling and subjected to molecular docking with the known alpha-syn structure. Structural alignment was performed to delineate the potential binding pocket. The scFv-F thus purified demonstrated high specificity towards alpha-syn fibrils compared to monomers. Molecular modeling studies suggest that scFv-F shares the same structural topology with other known scFvs. We present evidence through structural docking and alignment that scFv-F binds to alpha-syn C-terminal region. In conclusion, mild solubilization followed by slow on-column refolding can be utilized as a generalized and efficient method for hard to purify disease relevant insoluble proteins and/or antibody molecules from IBs.	[Gupta, Vijay; Sudhakaran, Indulekha P.; Vaikath, Nishant N.; Hmila, Issam; El-Agnaf, Omar M. A.] Hamad Bin Khalifa Univ HBKU, Qatar Fdn, Neurol Disorder Res Ctr, Qatar Biomed Res Inst QBRI, Doha, Qatar; [Islam, Zeyaul; Kolatkar, Prasanna R.] Hamad Bin Khalifa Univ HBKU, Qatar Fdn, Ctr Diabet, Qatar Biomed Res Inst QBRI, Doha, Qatar; [Lukacsovich, Tamas] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); University of Zurich	El-Agnaf, OMA (corresponding author), Hamad Bin Khalifa Univ HBKU, Qatar Fdn, Neurol Disorder Res Ctr, Qatar Biomed Res Inst QBRI, Doha, Qatar.	oelagnaf@hbku.edu.qa	Islam, Zeyaul/AAZ-5625-2020; Vaikath, Nishant/ABG-8351-2021	Islam, Zeyaul/0000-0002-5444-3910; Gupta, Dr. Vijay/0000-0002-3613-6378	Qatar Biomedical Research Institute [SF 2017-007]	Qatar Biomedical Research Institute(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	Dr. El-Agnaf's laboratory is funded by Qatar Biomedical Research Institute under the Start-up Fund SF 2017-007. The funding agency had no role in the study design, data collection and analysis of the manuscript.	[Anonymous], 2015, INDIAN J TRADIT KNOW, V14, P24; Ardah MT, 2015, NEUROBIOL DIS, V74, P89, DOI 10.1016/j.nbd.2014.11.007; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Chia KY, 2018, CNS NEUROL DISORD-DR, V17, P671, DOI 10.2174/1871527317666180315161626; Datta I, 2013, SUSTAIN CHEM PROCESS, V1, P2, DOI [10.1186/2043-7129-1-2, DOI 10.1186/2043-7129-1-2]; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; El-Agnaf O, 2017, NEUROBIOL DIS, V104, P85, DOI 10.1016/j.nbd.2017.05.002; Freskgard PO, 2017, NEUROPHARMACOLOGY, V120, P38, DOI 10.1016/j.neuropharm.2016.03.014; Gupta V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65035-8; Huang L, 2013, INT J MOL SCI, V14, P19109, DOI 10.3390/ijms140919109; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Manoutcharian K, 2017, CURR NEUROPHARMACOL, V15, P779, DOI 10.2174/1570159X01666160930121647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Razeghifard MR, 2004, PROTEIN EXPRES PURIF, V37, P180, DOI 10.1016/j.pep.2004.05.007; de Groot NS, 2006, FEBS LETT, V580, P6471, DOI 10.1016/j.febslet.2006.10.071; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Singh A, 2015, METHODS MOL BIOL, V1258, P283, DOI 10.1007/978-1-4939-2205-5_15; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Singh SM, 2012, PROTEIN EXPRES PURIF, V81, P75, DOI 10.1016/j.pep.2011.09.004; Skrlj N, 2013, APPL BIOCHEM BIOTECH, V169, P159, DOI 10.1007/s12010-012-9962-7; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Vaikath NN, 2019, J NEUROCHEM, V150, P612, DOI 10.1111/jnc.14713; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Vinogradov AA, 2003, ANAL BIOCHEM, V320, P234, DOI 10.1016/S0003-2697(03)00384-1; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Zella SMA, 2019, NEUROL THER, V8, P29, DOI 10.1007/s40120-018-0122-z	32	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241773	10.1371/journal.pone.0241773	http://dx.doi.org/10.1371/journal.pone.0241773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156828	gold, Green Published, Green Submitted			2022-12-26	WOS:000591376400023
J	Lye, TJY; Ng, KR; Tan, AWE; Syn, N; Woo, SM; Lim, EKW; Eng, AKH; Chan, WH; Tan, JTH; Lim, CH				Lye, Tiffany Jian Ying; Ng, Kiat Rui; Tan, Alexander Wei En; Syn, Nicholas; Woo, Shi Min; Lim, Eugene Kee Wee; Eng, Alvin Kim Hock; Chan, Weng Hoong; Tan, Jeremy Tian Hui; Lim, Chin Hong			Small hiatal hernia and postprandial reflux after vertical sleeve gastrectomy: A multiethnic Asian cohort	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; OBESE-PATIENTS; REPAIR; DISEASE; ESOPHAGEAL; EXPERIENCE; MANAGEMENT; SYMPTOMS	Background Laparoscopic vertical sleeve gastrectomy (LSG) is a popular bariatric procedure performed in Asia, as obesity continues to be on the rise in our population. A major problem faced is the development of de novo gastroesophageal reflux disease (GERD) after LSG, which can be chronic and debilitating. In this study, we aim to assess the relationship between the presence of small hiatal hernia (HH) and the development of postoperative GERD, as well as to explore the correlation between GERD symptoms after LSG and timing of meals. In doing so, we hope to gain a better understanding about the type of reflux that occurs after LSG and take a step closer towards effectively managing this difficult to treat condition. Methods We retrospectively reviewed data collected from patients who underwent LSG in our hospital from Dec 2008 to Dec 2016. All patients underwent preoperative upper GI endoscopy, during which the identification of hiatal hernia takes place. Patients' information and reflux symptoms are recorded using standardized questionnaires, which are administered preoperatively, and again during postoperative follow up visits. Results Of the 255 patients, 125 patients (74%) developed de novo GERD within 6 months post-sleeve gastrectomy. The rate of de novo GERD was 57.1% in the group with HH, and 76.4% in the group without HH. Adjusted analysis showed no significant association between HH and GERD (RR = 0.682; 95% CI 0.419 to 1.111; P = 0.125). 88% of the patients who developed postoperative GERD reported postprandial symptoms occurring only after meals, and the remaining 12% of patients reported no correlation between the timing of GERD symptoms and meals. Conclusion There is no direct correlation between the presence of small hiatal hernia and GERD symptoms after LSG. Hence, the presence of a small sliding hiatal hernia should not be exclusion for sleeve gastrectomy. Electing not to perform concomitant hiatal hernia repair also does not appear to result in higher rates of postoperative or de novo GERD.	[Lye, Tiffany Jian Ying; Lim, Eugene Kee Wee; Eng, Alvin Kim Hock; Chan, Weng Hoong; Tan, Jeremy Tian Hui; Lim, Chin Hong] Singapore Gen Hosp, Div Surg, Dept Upper Gastrointestinal & Bariatr Surg, Singapore, Singapore; [Ng, Kiat Rui; Tan, Alexander Wei En] Univ Sheffield, Sheffield Med Sch, Sheffield, S Yorkshire, England; [Syn, Nicholas; Woo, Shi Min] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	Singapore General Hospital; University of Sheffield; National University of Singapore	Lye, TJY (corresponding author), Singapore Gen Hosp, Div Surg, Dept Upper Gastrointestinal & Bariatr Surg, Singapore, Singapore.	tiffany.lye.j.y@singhealth.com.sg		Woo, Shi Min/0000-0002-2290-9034; , Tiffany/0000-0002-0926-3136				Althuwaini S, 2018, OBES SURG, V28, P916, DOI 10.1007/s11695-017-2971-4; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boyce HW, 2000, GASTROINTEST ENDOSC, V51, P586, DOI 10.1016/S0016-5107(00)70295-1; Carter PR, 2011, SURG OBES RELAT DIS, V7, P569, DOI 10.1016/j.soard.2011.01.040; Chang CG, 2016, JSLS-J SOC LAPAROEND, V20, DOI 10.4293/JSLS.2015.00104; Chiu SR, 2011, SURG OBES RELAT DIS, V7, P510, DOI 10.1016/j.soard.2010.09.011; Daes J, 2012, OBES SURG, V22, P1874, DOI 10.1007/s11695-012-0746-5; EDMUNDOWICZ SA, 1991, AM J PHYSIOL, V260, pG512, DOI 10.1152/ajpgi.1991.260.3.G512; El Chaar M, 2016, OBES SURG, V26, P68, DOI 10.1007/s11695-015-1739-y; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Gagner M, 2016, SURG OBES RELAT DIS, V12, P750, DOI 10.1016/j.soard.2016.01.022; Gordon C, 2004, ALIMENT PHARM THER, V20, P719, DOI 10.1111/j.1365-2036.2004.02149.x; Koh YX, 2016, SINGAP MED J, V57, P669, DOI 10.11622/smedj.2016018; Kohn GP, 2013, SURG ENDOSC, V27, P4409, DOI 10.1007/s00464-013-3173-3; Lim CH, 2020, OBES SURG, V30, P4751, DOI 10.1007/s11695-020-04913-6; Mahawar K, 2015, OBES SURG, V25, P159, DOI 10.1007/s11695-014-1470-0; Samakar K, 2016, OBES SURG, V26, P61, DOI 10.1007/s11695-015-1737-0; Santonicola A, 2014, SURG OBES RELAT DIS, V10, P250, DOI 10.1016/j.soard.2013.09.006; Sarkhosh K, 2013, CAN J SURG, V56, P347, DOI 10.1503/cjs.033511; Sheppard CE, 2015, OBES SURG, V25, P763, DOI 10.1007/s11695-014-1480-y; Snyder B, 2016, SURG OBES RELAT DIS, V12, P1681, DOI 10.1016/j.soard.2016.09.004; Soricelli E, 2013, SURG OBES RELAT DIS, V9, P356, DOI 10.1016/j.soard.2012.06.003; Soricelli E, 2010, OBES SURG, V20, P1149, DOI 10.1007/s11695-009-0056-8; Suter M, 2004, OBES SURG, V14, P959, DOI 10.1381/0960892041719581; Weitzendorfer M, 2017, EUR SURG, V49, P210, DOI 10.1007/s10353-017-0492-y; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241847	10.1371/journal.pone.0241847	http://dx.doi.org/10.1371/journal.pone.0241847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156875	gold, Green Published			2022-12-26	WOS:000591376400025
J	Chen, CM; Sun, LW; Tseng, C; Chen, YC; Wang, GC				Chen, Chien-Min; Sun, Li-Wei; Tseng, Chun; Chen, Ying-Chieh; Wang, Guan-Chyuan			Surgical outcomes of full endoscopic spinal surgery for lumbar disc herniation over a 10-year period: A retrospective study	PLOS ONE			English	Article							RISK-FACTORS; INTERVERTEBRAL DISC; CLINICAL-OUTCOMES; DISKECTOMY; COMPLICATIONS; PREVALENCE; DISEASE; FUSION	Objective Full endoscopic lumbar discectomy (FELD) for lumbar disc herniation (LDH) has become popular in recent years. Previous studies have proven the efficacy, but few have discussed the possible risk factors of poor outcome. In this study, we reviewed patients who underwent FELD at Changhua Christian Hospital in the past 10 years and sought to identify factors associated with poor surgical outcomes and re-operations. Methods We retrospectively reviewed records from mid-2009 to mid-2018. Patients had undergone FELD and follow-up for >= 1 year were included. Factors included in the outcome evaluations were age, sex, surgical time, body mass index, surgical methods, disc herniation type, extension of herniation, degree of canal compromised, disc degenerative grade, smoking and alcohol use, surgical lumbar level, symptom duration, Oswestry low back disability index, and visual analog scale score. We had evolved from inside-out methods to outside-in methods after 2016, thus, we included this factor in the analysis. The primary outcomes of interest were poor/fair MacNab score and re-operation. Results From mid-2009 to mid-2018, 521 patients met our criteria and were analyzed. The median follow-up was 1685 days (range, 523-3923 days). Thirty-one (6.0%) patients had poor surgical outcomes (fair/poor MacNab score) and 45 (8.6%) patients required re-operation. Prolapsed herniated disc (P < 0.001), higher disc degenerative grade (P = 0.047), higher lumbar level (P = 0.026), longer preoperative symptoms (P < 0.001), and surgery before 2017 (outside-in technique, P = 0.020) were significant factors associated with poor outcomes in univariate analyses. In multivariate analyses, prolapsed herniated disc (P < 0.001), higher disc degenerative grade (P = 0.030), and higher lumbar level (P = 0.046) were statistically significant. The most common adverse symptom was numbness. Factors possibly associated with higher re-operation rate were older age (P = 0.045), alcohol use (P = 0.073) and higher lumbar level (P = 0.069). Only alcohol use showed statistically significant re-operation rates in multivariate analyses (P = 0.035). Conclusions For treating LDH by FELD, we concluded that prolapsed disc, higher disc degenerative grade, higher lumbar level, and longer preoperative symptom duration were possibly associated with unsatisfactory surgical outcomes (poor/fair MacNab score). The outside-in technique might be superior to the inside-out technique. Older age and alcohol use might be associated with a higher re-operation rate.	[Chen, Chien-Min; Sun, Li-Wei; Chen, Ying-Chieh] Changhua Christian Hosp, Dept Surg, Div Neurosurg, Changhua, Taiwan; [Chen, Chien-Min] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, Chien-Min] Dayeh Univ, Coll Nursing & Hlth Sci, Changhua, Taiwan; [Tseng, Chun] China Med Univ, Beigang Hosp, Dept Orthopaed Surg, Yunlin Cty, Taiwan; [Wang, Guan-Chyuan] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Neurosurg, Hualien, Taiwan	Changhua Christian Hospital; Kaohsiung Medical University; Da Yeh University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Wang, GC (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Neurosurg, Hualien, Taiwan.	b9402097@gmail.com		Wang, Guan-Chyuan/0000-0003-2815-7846				[Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2019, FUEL CELL B, V2019, P9, DOI [10.1016/S1464-2859(19)30422-5., DOI 10.1016/S1464-2859(19)30422-5, DOI 10.1016/S0306-3747(19)30119-8]; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; Birkenmaier C, 2013, PAIN PHYSICIAN, V16, P335; Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016; Dewing CB, 2008, SPINE, V33, P33, DOI 10.1097/BRS.0b013e31815e3a42; Djurasovic M, 2012, EUR SPINE J, V21, P1616, DOI 10.1007/s00586-012-2244-9; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fotakopoulos George, 2018, J Clin Med Res, V10, P486, DOI 10.14740/jocmr3121w; Gu X, 2013, CLIN ANAT, V26, P728, DOI 10.1002/ca.22286; Hohenberger C, 2020, J NEUROL SURG PART A, V81, P290, DOI 10.1055/s-0039-1697024; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; HURME M, 1987, SPINE, V12, P933, DOI 10.1097/00007632-198711000-00016; Jiang XJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013417; Jones JC, 2019, J NEUROSURG-SPINE, V31, P389, DOI 10.3171/2019.3.SPINE18419; JSH, 2004, HYPERTENS RES S29, V29, pS1; Lewandrowski KU, 2019, INT J SPINE SURG, V13, P399, DOI 10.14444/6055; MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P891, DOI 10.2106/00004623-197153050-00004; Mattei TA, 2017, NEUROSURG REV, V40, P67, DOI 10.1007/s10143-016-0751-6; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a; McGrath LB, 2019, J NEUROSURG-SPINE, V30, P491, DOI 10.3171/2018.9.SPINE18689; Mikosch P, 2014, WIEN MED WOCHENSCHR, V164, P15, DOI 10.1007/s10354-013-0258-5; Miwa S, 2015, J SPINAL DISORD TECH, V28, pE265, DOI 10.1097/BSD.0b013e31828215b3; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rasmussen C, 1998, Eur Spine J, V7, P24, DOI 10.1007/s005860050022; Rasmussen C, 1998, Ugeskr Laeger, V160, P5189; Ruetten S, 2008, SPINE, V33, P931, DOI 10.1097/BRS.0b013e31816c8af7; S3-Leitlinie, 2017, SOMNOLOGIE, V20, pS97 S180; Schoenfeld AJ, 2015, CLIN ORTHOP RELAT R, V473, P1963, DOI 10.1007/s11999-014-3505-1; Shin BJ, 2014, ASIAN SPINE J, V8, P211, DOI 10.4184/asj.2014.8.2.211; Shrestha D, 2015, Kathmandu Univ Med J (KUMJ), V13, P333; Shriver MF, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15281; Sigmundsson FG, 2012, ACTA ORTHOP, V83, P536, DOI 10.3109/17453674.2012.733915; Silverplats K, 2010, EUR SPINE J, V19, P1459, DOI 10.1007/s00586-010-1433-7; Soliman HM, 2015, SPINE J, V15, P2282, DOI 10.1016/j.spinee.2015.07.009; Wang HW, 2015, J NEUROSURG-SPINE, V23, P320, DOI 10.3171/2014.10.SPINE1442; Wang HW, 2013, ACTA NEUROCHIR, V155, P1931, DOI 10.1007/s00701-013-1828-4; Yang Hu, 2018, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V32, P933, DOI 10.7507/1002-1892.201711039; Yeung AT, 2002, SPINE, V27, P722, DOI 10.1097/00007632-200204010-00009; Yin S, 2018, PAIN PHYSICIAN, V21, P337; Zhou CL, 2018, PAIN PHYSICIAN, V21, pE105	42	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241494	10.1371/journal.pone.0241494	http://dx.doi.org/10.1371/journal.pone.0241494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152001	gold, Green Published			2022-12-26	WOS:000591376200017
J	Haga, H; Sato, H; Koseki, A; Saito, T; Okumoto, K; Hoshikawa, K; Katsumi, T; Mizuno, K; Nishina, T; Ueno, Y				Haga, Hiroaki; Sato, Hidenori; Koseki, Ayumi; Saito, Takafumi; Okumoto, Kazuo; Hoshikawa, Kyoko; Katsumi, Tomohiro; Mizuno, Kei; Nishina, Taketo; Ueno, Yoshiyuki			A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus	PLOS ONE			English	Article							REPLICATION; RESISTANCE	In recent years, the development of diagnostics using artificial intelligence (AI) has been remarkable. AI algorithms can go beyond human reasoning and build diagnostic models from a number of complex combinations. Using next-generation sequencing technology, we identified hepatitis C virus (HCV) variants resistant to directing-acting antivirals (DAA) by whole genome sequencing of full-length HCV genomes, and applied these variants to various machine-learning algorithms to evaluate a preliminary predictive model. HCV genomic RNA was extracted from serum from 173 patients (109 with subsequent sustained virological response [SVR] and 64 without) before DAA treatment. HCV genomes from the 109 SVR and 64 non-SVR patients were randomly divided into a training data set (57 SVR and 29 non-SVR) and a validation-data set (52 SVR and 35 non-SVR). The training data set was subject to nine machine-learning algorithms selected to identify the optimized combination of functional variants in relation to SVR status following DAA therapy. Subsequently, the prediction model was tested by the validation-data set. The most accurate learning method was the support vector machine (SVM) algorithm (validation accuracy, 0.95; kappa statistic, 0.90; F-value, 0.94). The second-most accurate learning algorithm was Multi-layer perceptron. Unfortunately, Decision Tree, and Naive Bayes algorithms could not be fitted with our data set due to low accuracy (< 0.8). Conclusively, with an accuracy rate of 95.4% in the generalization performance evaluation, SVM was identified as the best algorithm. Analytical methods based on genomic analysis and the construction of a predictive model by machine-learning may be applicable to the selection of the optimal treatment for other viral infections and cancer.	[Haga, Hiroaki; Koseki, Ayumi; Saito, Takafumi; Okumoto, Kazuo; Hoshikawa, Kyoko; Katsumi, Tomohiro; Mizuno, Kei; Nishina, Taketo; Ueno, Yoshiyuki] Yamagata Univ, Dept Gastroenterol, Fac Med, Yamagata, Japan; [Sato, Hidenori] Yamagata Univ, Inst Promot Med Sci Res, Genome Informat Unit, Yamagata, Japan; [Saito, Takafumi] Yamagata Univ, Sch Nursing, Fac Med, Yamagata, Japan	Yamagata University; Yamagata University; Yamagata University	Haga, H (corresponding author), Yamagata Univ, Dept Gastroenterol, Fac Med, Yamagata, Japan.	hihaga@med.id.yamagata-u.ac.jp		Ueno, Yoshiyuki/0000-0001-5623-4250	Japan Agency for Medical Research and Development (AMED) [JP20fk0210072s0401, JP20fk0210058s2102, JP20fk0210047s0702]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This research was supported by Japan Agency for Medical Research and Development (AMED) under Grant Number JP20fk0210072s0401, JP20fk0210058s2102 and JP20fk0210047s0702.	[Anonymous], 2017, J AHIMA, V88, P76; [Anonymous], 2015, NATURE, V521, P436, DOI [10.1038/, DOI 10.1038/NATURE14539, 10.1038/nature14539]; Bull RA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2575-8; Diviney S, 2008, J VIROL, V82, P9008, DOI 10.1128/JVI.02326-07; Grobler JA, 2003, J BIOL CHEM, V278, P16741, DOI 10.1074/jbc.M212602200; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; KATO N, 1991, FEBS LETT, V280, P325, DOI 10.1016/0014-5793(91)80322-T; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MCPHEE F, 2012, J HEPATOL S2, V56, pS473; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Takehara T, 2019, J GASTROENTEROL, V54, P87, DOI 10.1007/s00535-018-1503-x; Toyoda H, 2018, J GASTROENTEROL, V53, P1276, DOI 10.1007/s00535-018-1473-z; Ueda Y, 2019, J GASTROENTEROL, V54, P660, DOI 10.1007/s00535-019-01561-1; Uemura H, 2018, HEPATOL RES, V48, P233, DOI 10.1111/hepr.12980; Wang HL, 2017, J GASTROEN HEPATOL, V32, P45, DOI 10.1111/jgh.13587	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0242028	10.1371/journal.pone.0242028	http://dx.doi.org/10.1371/journal.pone.0242028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152046	gold, Green Published			2022-12-26	WOS:000591376200076
J	Huang, JX; Qi, ZH				Huang, Jinxi; Qi, Zhenhui			MiR-21 mediates the protection of kaempferol against hypoxia/reoxygenation-induced cardiomyocyte injury via promoting Notch1/PTEN/AKT signaling pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; MICRORNA-21; APOPTOSIS; OXIDE; PROLIFERATION; PHOSPHATASE; EXPRESSION	Kaempferol, a natural flavonoid compound, possesses potent myocardial protective property in ischemia/reperfusion (I/R), but the underlying mechanism is not well understood. The present study was aimed to explore whether miR-21 contributes to the cardioprotective effect of kaempferol on hypoxia/reoxygenation (H/R)-induced H9c2 cell injury via regulating Notch/phosphatase and tensin homologue (PTEN)/Akt signaling pathway. Results revealed that kaempferol obviously attenuates H/R-induced the damages of H9c2 cells as evidence by the up-regulation of cell viability, the down-regulation of lactate dehydrogenase (LDH) activity, the reduction of apoptosis rate and pro-apoptotic protein (Bax) expression, and the increases of anti-apoptotic protein (Bcl-2) expression. In addition, kaempferol enhanced miR-21 level in H9c2 cells exposed to H/R, and inhibition of miR-21 induced by transfection with miR-21 inhibitor significantly blocked the protection of kaempferol against H/R-induced H9c2 cell injury. Furthermore, kaempferol eliminated H/R-induced oxidative stress and inflammatory response as illustrated by the decreases in reactive oxygen species generation and malondialdehyde content, the increases in antioxidant enzyme superoxide dismutase and glutathione peroxidase activities, the decreases in pro-inflammatory cytokines interleukin (IL)-1 beta, IL-8 and tumor necrosis factor-alpha levels, and an increase in anti-inflammatory cytokine IL-10 level, while these effects of kaempferol were all reversed by miR-21 inhibitor. Moreover, results elicited that kaempferol remarkably blocks H/R-induced the down-regulation of Notch1 expression, the up-regulation of PTEN expression, and the reduction of P-Akt/Akt, indicating that kaempferol promotes Notch1/PTEN/AKT signaling pathway, and knockdown of Notch1/PTEN/AKT signaling pathway induced by Notch1 siRNA also abolished the protection of kaempferol against H/R-induced the damage of H9c2 cells. Notably, miR-21 inhibitor alleviated the promotion of kaempferol on Notch/PTEN/Akt signaling pathways in H9c2 cells exposed to H/R. Taken together, these above findings suggested thatmiR-21 mediates the protection of kaempferol against H/R-induced H9c2 cell injuryvia promoting Notch/PTEN/Akt signaling pathway.	[Huang, Jinxi; Qi, Zhenhui] Shanxi Prov Peoples Hosp, Dept Cardiol, Taiyuan, Shanxi, Peoples R China	Shanxi People's Hospital	Huang, JX (corresponding author), Shanxi Prov Peoples Hosp, Dept Cardiol, Taiyuan, Shanxi, Peoples R China.	huangjinx01001@qq.com						[Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2015, BMJ, V2015, ph1887; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Cao J, 2015, MOL MED REP, V11, P2889, DOI 10.3892/mmr.2014.3107; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Cividini F, 2016, J BIOL CHEM, V291, P26515, DOI 10.1074/jbc.M116.754481; Colpaert RMW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070737; Ding J, 2019, ADV EXP MED BIOL, V1193, P107, DOI 10.1007/978-981-13-6260-6_6; Donato M, 2017, CURR OPIN CARDIOL, V32, P784, DOI 10.1097/HCO.0000000000000447; Fan ZX, 2015, SAUDI MED J, V36, P787, DOI 10.15537/smj.2015.7.11089; Fang HC, 2019, J CELL PHYSIOL, V234, P3634, DOI 10.1002/jcp.27133; Gan RH, 2018, CELL CYCLE, V17, P216, DOI 10.1080/15384101.2017.1395534; Gu GL, 2015, CARDIOVASC THER, V33, P109, DOI 10.1111/1755-5922.12118; Guo Z, 2015, EUR J PHARMACOL, V761, P245, DOI 10.1016/j.ejphar.2015.05.056; Hales EC, 2014, CELL SIGNAL, V26, P149, DOI 10.1016/j.cellsig.2013.09.021; Han Q, 2016, DNA CELL BIOL, V35, P192, DOI 10.1089/dna.2015.3003; Hu SQ, 2018, AM J TRANSL RES, V10, P3677; Huang H, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7973098; Jia YX, 2006, CLIN EXP PHARMACOL P, V33, P1202, DOI 10.1111/j.1440-1681.2006.04498.x; Jin H, 2018, MOL THER, V26, P1040, DOI 10.1016/j.ymthe.2018.01.011; Kan CL, 2019, EXP THER MED, V17, P3129, DOI 10.3892/etm.2019.7286; Khalilzadeh B, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2980-6; Kim EN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216610; Kim K, 2015, MOL CELL BIOCHEM, V407, P143, DOI 10.1007/s11010-015-2464-5; Kreutzer FP, 2020, J PHYSIOL-LONDON, V598, P2995, DOI 10.1113/JP278131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Lu Yan-Zhen, 2016, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V32, P351, DOI 10.13459/j.cnki.cjap.2016.04.017; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Mo JS, 2013, P NATL ACAD SCI USA, V110, P6865, DOI 10.1073/pnas.1209078110; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Ong SB, 2018, EXPERT OPIN THER TAR, V22, P247, DOI 10.1080/14728222.2018.1439015; Pan YQ, 2018, EUR REV MED PHARMACO, V22, P7928, DOI 10.26355/eurrev_201811_16420; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0373-x; Qiao SG, 2015, ANESTHESIOLOGY, V123, P786, DOI 10.1097/ALN.0000000000000807; Rasaratnam B, 2004, CLIN SCI, V107, P425, DOI 10.1042/CS20040157; Ren J, 2019, EXP THER MED, V18, P2759, DOI 10.3892/etm.2019.7886; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sinning C, 2017, BIOMARK MED, V11, P1031, DOI 10.2217/bmm-2017-0110; Suchal K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7580731; Thind GS, 2015, FUTUR CARDIOL, V11, P61, DOI [10.2217/FCA.14.76, 10.2217/fca.14.76]; Toldo S, 2014, CIRC-CARDIOVASC GENE, V7, P311, DOI 10.1161/CIRCGENETICS.113.000381; Wang DS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4639081; Xiong Y, 2014, LIFE SCI, V106, P19, DOI 10.1016/j.lfs.2014.04.017; Xu HX, 2019, MOL MED REP, V20, P719, DOI 10.3892/mmr.2019.10266; Xu XL, 2014, PHYSIOL GENOMICS, V46, P789, DOI 10.1152/physiolgenomics.00020.2014; Yan TX, 2019, PHYTOTHER RES, V33, P1065, DOI 10.1002/ptr.6300; Yang Q, 2014, MOL MED REP, V9, P2213, DOI 10.3892/mmr.2014.2068; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yu LM, 2015, APOPTOSIS, V20, P796, DOI 10.1007/s10495-015-1122-4; Yuan JX, 2017, CELL PHYSIOL BIOCHEM, V42, P2207, DOI 10.1159/000479995; Zhang BF, 2019, INT IMMUNOPHARMACOL, V73, P98, DOI 10.1016/j.intimp.2019.04.060; Zhang X, 2017, BIOMED PHARMACOTHER, V91, P1042, DOI 10.1016/j.biopha.2017.05.033; Zhao Z, 2019, J CELL PHYSIOL, V234, P10726, DOI 10.1002/jcp.27745; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; 2019, HUM REPROD, V34	59	10	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241007	10.1371/journal.pone.0241007	http://dx.doi.org/10.1371/journal.pone.0241007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151961	gold, Green Published			2022-12-26	WOS:000591376200006
J	Randon, M; Le Pape, O; Ernande, B; Mahe, K; Volckaert, FAM; Petit, EJ; Lassalle, G; Le Berre, T; Reveillac, E				Randon, Marine; Le Pape, Olivier; Ernande, Bruno; Mahe, Kelig; Volckaert, Filip A. M.; Petit, Eric J.; Lassalle, Gilles; Le Berre, Thomas; Reveillac, Elodie			Complementarity and discriminatory power of genotype and otolith shape in describing the fine-scale population structure of an exploited fish, the common sole of the Eastern English Channel	PLOS ONE			English	Article							ATLANTIC COD; STOCK DISCRIMINATION; EMPIRICAL-EVALUATION; NORTHEAST ATLANTIC; SPATIAL STRUCTURE; FOURIER-ANALYSIS; MARINE FISHES; LARVAL DRIFT; GENE FLOW; R-PACKAGE	Marine organisms show population structure at a relatively fine spatial scale, even in open habitats. The tools commonly used to assess subtle patterns of connectivity have diverse levels of resolution and can complement each other to inform on population structure. We assessed and compared the discriminatory power of genetic markers and otolith shape to reveal the population structure on evolutionary and ecological time scales of the common sole (Solea solea), living in the Eastern English Channel (EEC) stock off France and the UK. First, we genotyped fish with Single Nucleotide Polymorphisms to assess population structure at an evolutionary scale. Then, we tested for spatial segregation of the subunits using otolith shape as an integrative tracer of life history. Finally, a supervised machine learning framework was applied to genotypes and otolith phenotypes to probabilistically assign adults to subunits and assess the discriminatory power of each approach. Low but significant genetic differentiation was found among subunits. Moreover, otolith shape appeared to vary spatially, suggesting spatial population structure at fine spatial scale. However, results of the supervised discriminant analyses failed to discriminate among subunits, especially for otolith shape. We suggest that the degree of population segregation may not be strong enough to allow for robust fish assignments. Finally, this study revealed a weak yet existing metapopulation structure of common sole at the fine spatial scale of the EEC based on genotypes and otolith shape, with one subunit being more isolated. Our study argues for the use of complementary tracers to investigate marine population structure.	[Randon, Marine; Le Pape, Olivier; Petit, Eric J.; Lassalle, Gilles; Le Berre, Thomas; Reveillac, Elodie] INRAE, ESE, Ecol & Sante Ecosyst, Inst Agro Agrocampus Ouest, Rennes, France; [Randon, Marine] Simon Fraser Univ, Stat & Actuarial Sci Dept, Burnaby, BC, Canada; [Ernande, Bruno; Mahe, Kelig] Ifremer, Lab Fisheries, Sclerochronol Ctr, Boulogne Sur Mer, France; [Ernande, Bruno] IIASA, Evolut & Ecol Program, Schlosspl, Laxenburg, Austria; [Volckaert, Filip A. M.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Reveillac, Elodie] La Rochelle Univ, CNRS, UMR 7266, LIENSs,Littoral Environm & Soc, La Rochelle, France	INRAE; Institut Agro; Simon Fraser University; Ifremer; International Institute for Applied Systems Analysis (IIASA); KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Randon, M (corresponding author), INRAE, ESE, Ecol & Sante Ecosyst, Inst Agro Agrocampus Ouest, Rennes, France.; Randon, M (corresponding author), Simon Fraser Univ, Stat & Actuarial Sci Dept, Burnaby, BC, Canada.	marine_randon@sfu.ca	Petit, Eric J/C-1091-2011; Randon, Marine/AAG-5286-2021; Gonse, Marine/GRO-2323-2022; Ernande, Bruno/C-1182-2008	Petit, Eric J/0000-0001-5058-5826; Randon, Marine/0000-0002-5378-8482; Ernande, Bruno/0000-0002-0727-5774; mahe, kelig/0000-0002-6506-211X; Le Pape, Olivier/0000-0002-7233-7951	"France Filiere Peche", the French Ministry of Fisheries "Direction des Peches Maritimes et de l'Aquaculture"; European Marine Biological Resource Centre (EMBRC) Belgium - Research Foundation - Flanders [I001219N]	"France Filiere Peche", the French Ministry of Fisheries "Direction des Peches Maritimes et de l'Aquaculture"; European Marine Biological Resource Centre (EMBRC) Belgium - Research Foundation - Flanders	This research was part of the SMAC (Sole de Manche Est Amelioration des Connaissances pour une meilleure gestion du stock) research program, supported by the fisheries organization "France Filiere Peche", the French Ministry of Fisheries "Direction des Peches Maritimes et de l'Aquaculture". This study was carried out with support of the European Marine Biological Resource Centre (EMBRC) Belgium funded by the Research Foundation - Flanders (project I001219N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P167, DOI 10.1016/j.fishres.2007.09.021; Allaya H, 2016, CAH BIOL MAR, V57, P195; [Anonymous], 2019, LANCET DIGITAL HLTH; Archarnbault B, 2016, FISH RES, V181, P198, DOI 10.1016/j.fishres.2016.03.023; Bourillet JF, 2003, J QUATERNARY SCI, V18, P261, DOI 10.1002/jqs.757; Cadrin SX, 2010, ICES J MAR SCI, V67, P1617, DOI 10.1093/icesjms/fsq046; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cadrin SX, 2013, STOCK IDENTIFICATION; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Cardinale M, 2004, CAN J FISH AQUAT SCI, V61, P158, DOI 10.1139/F03-151; CASTONGUAY M, 1991, CAN J FISH AQUAT SCI, V48, P296, DOI 10.1139/f91-041; Chen KY, 2018, METHODS ECOL EVOL, V9, P439, DOI 10.1111/2041-210X.12897; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Colura RL, 1995, BEL BAR LIB, P617; Cooke GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150991; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruz VP, 2017, MOL ECOL RESOUR, V17, P550, DOI 10.1111/1755-0998.12564; Cuveliers EL, 2012, MAR BIOL, V159, P1239, DOI 10.1007/s00227-012-1905-x; D'Aloia CC, 2020, MOL ECOL, V29, P2189, DOI 10.1111/mec.15405; DaCosta JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106713; de Mendiburu F., 2020, R PACKAGE VERSION, DOI DOI 10.1890/08-1823.1; Delerue-Ricard S, 2019, CONNECTIVITY LARVAL; Delerue-Ricard S, 2019, HYDROBIOLOGIA, V845, P95, DOI 10.1007/s10750-018-3736-3; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Diopere E, 2017, ICES J MAR SCI; Du Pontavice H, 2018, FISH RES, V207, P28, DOI 10.1016/j.fishres.2018.05.009; FRIEDLAND KD, 1994, CAN J FISH AQUAT SCI, V51, P91, DOI 10.1139/f94-011; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Fu CH, 2004, N AM J FISH MANAGE, V24, P775, DOI 10.1577/M03-134.1; Goethel DR, 2017, CAN J FISH AQUAT SCI, V74, P1878, DOI 10.1139/cjfas-2016-0290; Gohin F., 2010, ATLAS TEMPERATURE CO, P53; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hawkins SJ, 2016, FISH RES, V179, P333, DOI 10.1016/j.fishres.2016.01.015; Hess JE, 2011, MOL ECOL RESOUR, V11, P137, DOI 10.1111/j.1755-0998.2010.02958.x; Holsinger KE, 1996, GENETICS, V142, P629; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hussy K, 2008, J EXP MAR BIOL ECOL, V364, P35, DOI 10.1016/j.jembe.2008.06.026; Hussy K, 2016, FISH RES, V174, P210, DOI 10.1016/j.fishres.2015.10.010; ICES, 2017, 2017ACOM34 ICES CM, P673; ICES, 2019, ICES WGNSSK REP SOL; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; Kelley JL, 2016, NAT REV GENET, V17, P523, DOI 10.1038/nrg.2016.66; Kerr LA, 2017, ICES J MAR SCI, V74, P1708, DOI 10.1093/icesjms/fsw188; Kritzer J.P., 2010, MARINE METAPOPULATIO; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Le Bris A, 2018, ICES J MAR SCI, V75, P135, DOI 10.1093/icesjms/fsx098; Le Pape O, 2016, J SEA RES, V107, P43, DOI 10.1016/j.seares.2015.06.001; Lecomte J-B, 2020, CAN J FISH AQUAT SCI; Mahe K, 2016, CAN J FISH AQUAT SCI, V73, P1363, DOI 10.1139/cjfas-2015-0332; Martin J, 2015, CAN J FISH AQUAT SCI, V72, P991, DOI 10.1139/cjfas-2014-0510; Merigot B, 2007, MAR BIOL, V151, P997, DOI 10.1007/s00227-006-0549-0; Milano I, 2014, MOL ECOL, V23, P118, DOI 10.1111/mec.12568; Mille T, 2016, MAR ECOL PROG SER, V555, P167, DOI 10.3354/meps11784; Moreira C, 2018, FISH RES, V197, P113, DOI 10.1016/j.fishres.2017.08.012; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Mullins RB, 2018, ICES J MAR SCI, V75, P2145, DOI 10.1093/icesjms/fsy102; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ostman O, 2017, FISH FISH, V18, P324, DOI 10.1111/faf.12182; Palaiokostas C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1383-x; Perrier C, 2011, CAN J FISH AQUAT SCI, V68, P977, DOI [10.1139/F2011-040, 10.1139/f2011-040]; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Puritz JB, 2014, PEERJ, V2, DOI 10.7717/peerj.431; Quemere E, 2016, J BIOGEOGR, V43, P498, DOI 10.1111/jbi.12632; Randon M, 2018, J SEA RES, V142, P91, DOI 10.1016/j.seares.2018.09.012; Reis-Santos P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28701-6; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Riou P, 2001, AQUAT LIVING RESOUR, V14, P125, DOI 10.1016/S0990-7440(01)01110-X; Ripley B., 2022, PACKAGE MASS; Rivera-Colon AG, 2021, MOL ECOL RESOUR, V21, P363, DOI 10.1111/1755-0998.13163; Rochette S, 2013, ECOL APPL, V23, P1659, DOI 10.1890/12-0336.1; Rochette S, 2012, FISH OCEANOGR, V21, P229, DOI 10.1111/j.1365-2419.2012.00621.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Savina M, 2016, J SEA RES, V111, P1, DOI 10.1016/j.seares.2015.11.010; Secor DH, 2015, MIGRATION ECOLOGY OF MARINE FISHES, P1; Sley A, 2016, CAH BIOL MAR, V57, P309; Smedbol RK, 2002, FISH RES, V55, P161; Smith SJ, 2010, CAN J FISH AQUAT SCI, V67, P1533, DOI 10.1139/F10-078; Smolinski S, 2020, CAN J FISH AQUAT SCI, V77, P674, DOI 10.1139/cjfas-2019-0251; Stuckas H, 2017, MOL ECOL, V26, P2765, DOI 10.1111/mec.14075; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; Tanner SE, 2016, FISH RES, V173, P206, DOI 10.1016/j.fishres.2015.07.019; Tracey SR, 2006, FISH RES, V77, P138, DOI 10.1016/j.fishres.2005.10.013; Tuset VM, 2003, J APPL ICHTHYOL, V19, P88, DOI 10.1046/j.1439-0426.2003.00344.x; Vasconcelos J, 2018, FISH B-NOAA, V116, P81, DOI 10.7755/FB.116.1.9; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vignon M, 2015, MAR ECOL PROG SER, V534, P163, DOI 10.3354/meps11376; Vignon M, 2010, MAR ECOL PROG SER, V411, P231, DOI 10.3354/meps08651; Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zhang C, 2016, FISHERIES SCI, V82, P251, DOI 10.1007/s12562-016-0968-x	98	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241429	10.1371/journal.pone.0241429	http://dx.doi.org/10.1371/journal.pone.0241429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151981	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000591376200113
J	Macartney-Coxson, D; Cameron, AM; Clapham, J; Benton, MC				Macartney-Coxson, Donia; Cameron, Alanna M.; Clapham, Jane; Benton, Miles C.			DNA methylation in blood-Potential to provide new insights into cell biology	PLOS ONE			English	Article							WIDE ASSOCIATION; EPIGENETICS	Epigenetics plays a fundamental role in cellular development and differentiation; epigenetic mechanisms, such as DNA methylation, are involved in gene regulation and the exquisite nuance of expression changes seen in the journey from pluripotency to final differentiation. Thus, DNA methylation as a marker of cell identify has the potential to reveal new insights into cell biology. We mined publicly available DNA methylation data with a machine-learning approach to identify differentially methylated loci between different white blood cell types. We then interrogated the DNA methylation and mRNA expression of candidate loci in CD4(+), CD8(+), CD14(+), CD19(+) and CD56(+) fractions from 12 additional, independent healthy individuals (6 male, 6 female). 'Classic' immune cell markers such as CD8 and CD19 showed expected methylation/expression associations fitting with established dogma that hypermethylation is associated with the repression of gene expression. We also observed large differential methylation at loci which are not established immune cell markers; some of these loci showed inverse correlations between methylation and mRNA expression (such as PARK2, DCP2). Furthermore, we validated these observations further in publicly available DNA methylation and RNA sequencing datasets. Our results highlight the value of mining publicly available data, the utility of DNA methylation as a discriminatory marker and the potential value of DNA methylation to provide additional insights into cell biology and developmental processes.	[Macartney-Coxson, Donia; Clapham, Jane; Benton, Miles C.] Inst Environm Sci & Res ESR, Human Genom, Wellington, New Zealand; [Cameron, Alanna M.] Malaghan Inst Med Res, Wellington, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; Malaghan Institute; Victoria University Wellington	Macartney-Coxson, D; Benton, MC (corresponding author), Inst Environm Sci & Res ESR, Human Genom, Wellington, New Zealand.	Donia.Macartney-Coxson@esr.cri.nz; miles.benton84@gmail.com		Macartney-Coxson, Donia/0000-0002-1051-537X; Benton, Miles/0000-0003-3442-965X	Wellington Medical Research Foundation [2015/255]	Wellington Medical Research Foundation	The study was supported in part by funding provided by the Wellington Medical Research Foundation (https://researchforlife.org.nz/) grant number 2015/255 awarded to MB. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Abraham G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-88; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, MR INT J ENG TECHNOL, V9, P39, DOI DOI 10.1007/s12520-016-0414-0; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Bacalini MG, 2015, AGING-US, V7, P97, DOI 10.18632/aging.100718; Benton MC, 2017, AGING-US, V9, P753, DOI 10.18632/aging.101187; Blasius AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002915; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cypris O, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0617-1; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Decamps C, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-019-3307-2; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Dosenovic P, 2015, IMMUNOL CELL BIOL, V93, P136, DOI 10.1038/icb.2014.82; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Feinberg AP, 2018, NEW ENGL J MED, V378, P1323, DOI [10.1056/nejmra1402513, 10.1056/NEJMra1402513]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang B, 2014, EPIGENOMICS-UK, V6, P73, DOI 10.2217/epi.13.72; Kim S, 2016, EPIGENOMICS-UK, V8, P1185, DOI 10.2217/epi-2016-0037; Kobak D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13056-x; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Linderman GC, 2019, NAT METHODS, V16, P243, DOI 10.1038/s41592-018-0308-4; Lowe R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-359; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Martin EM, 2018, ANNU REV PUBL HEALTH, V39, P309, DOI 10.1146/annurev-publhealth-040617-014629; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Minskaia E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02540; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mooijman D, 2016, NAT BIOTECHNOL, V34, P852, DOI 10.1038/nbt.3598; Moris N, 2016, NAT REV GENET, V17, P693, DOI 10.1038/nrg.2016.98; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Salas LA, 2018, GENOME RES, V28, P1285, DOI 10.1101/gr.233213.117; Salas LA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1448-7; Shayevitch R, 2018, RNA, V24, P1351, DOI 10.1261/rna.064865.117; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Waldmann Patrik, 2013, Frontiers in Genetics, V4, P270, DOI 10.3389/fgene.2013.00270; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; Xu WL, 2019, EBIOMEDICINE, V39, P44, DOI 10.1016/j.ebiom.2018.11.053; Yi H, 2015, GENETICS, V199, P205, DOI 10.1534/genetics.114.167817; Zhou B, 2020, METHODS MOL BIOL, V2117, P159, DOI 10.1007/978-1-0716-0301-7_8; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241367	10.1371/journal.pone.0241367	http://dx.doi.org/10.1371/journal.pone.0241367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147241	gold, Green Published			2022-12-26	WOS:000589609300011
J	Eguchi, K; Mikami, D; Sun, H; Tsumita, T; Takahashi, K; Mukai, K; Yuyama, K; Igarashi, Y				Eguchi, Koichi; Mikami, Daisuke; Sun, Hui; Tsumita, Takuya; Takahashi, Kaori; Mukai, Katsuyuki; Yuyama, Kohei; Igarashi, Yasuyuki			Blood-brain barrier permeability analysis of plant ceramides	PLOS ONE			English	Article							AMYLOID-BETA; HEALTH; DIFFERENTIATION; SPHINGOLIPIDS; METABOLISM; CLEARANCE; EXOSOMES; UNIT	Ceramides, a type of sphingolipid, are cell membrane components and lipid mediators that modulate a variety of cell functions. In plants, ceramides are mostly present in a glucosylated glucosylceramide (GlcCer) form. We previously showed that oral administration of konjac-derived GlcCer to a mouse model of Alzheimer's disease reduced brain amyloid-beta and amyloid plaques. Dietary plant GlcCer compounds are absorbed as ceramides, but it is unclear whether they can cross the blood-brain barrier (BBB). Herein, we evaluated the BBB permeability of synthetic plant-type ceramides (4, 8-sphingadienine, d18:2) using mouse and BBB cell culture models, and found that they could permeate the BBB both in vivo and in vitro. In addition, administrated ceramides were partially metabolized to other sphingolipid species, namely sphingomyelin (SM) and GlcCer, while crossing the BBB. Thus, plant ceramides can cross the BBB, suggesting that ceramides and their metabolites might affect brain functions.	[Eguchi, Koichi; Takahashi, Kaori; Mukai, Katsuyuki] Daicel Corp, Innovat & Business Dev Headquarters, Tokyo, Japan; [Mikami, Daisuke; Sun, Hui; Mukai, Katsuyuki; Yuyama, Kohei; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Sapporo, Hokkaido, Japan; [Tsumita, Takuya] Hokkaido Univ, Dept Vasc Biol & Mol Pathol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Daicel Corporation; Hokkaido University; Hokkaido University	Yuyama, K (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Sapporo, Hokkaido, Japan.	kyuyama@pharm.hokudai.ac.jp			Daicel Corporation [8607011, PCS8617001]; Hokkaido University	Daicel Corporation; Hokkaido University	Daicel Corporation provided support in the research materials and the form of salaries for authors KE, KT, KM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This work was supported by Industry Creation Departments Funding (8607011, PCS8617001) provided by Daicel Corporation to the Lipid Biofunction Section of Hokkaido University, and by a contract from Hokkaido University to Dr. Y. Igarashi. Other competing interests are nothing.	Aida J, 2011, J BIOCHEM, V150, P303, DOI 10.1093/jb/mvr058; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; CARTER HE, 1956, J BIOL CHEM, V221, P879; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ishikawa J, 2009, J DERMATOL SCI, V56, P216, DOI 10.1016/j.jdermsci.2009.09.002; Janiurek MM, 2019, ELIFE, V8, DOI 10.7554/eLife.49405; KARLSSON KA, 1970, LIPIDS, V5, P878, DOI 10.1007/BF02531119; KAWAHARA K, 1991, FEBS LETT, V292, P107, DOI 10.1016/0014-5793(91)80845-T; KOBAYASHI T, 1981, J BIOL CHEM, V256, P7768; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; LEESE HJ, 1973, J BIOL CHEM, V248, P8170; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V187, P113, DOI 10.1016/0005-2760(69)90138-6; NOJIRI H, 1984, BLOOD, V64, P534; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; SCHMELZ EM, 1994, J NUTR, V124, P702, DOI 10.1093/jn/124.5.702; Shibuya K, 2019, ACS OMEGA, V4, P16943, DOI 10.1021/acsomega.9b02307; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; Wada-Isoe K, 2009, NEUROEPIDEMIOLOGY, V32, P101, DOI 10.1159/000177035; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Yamaguchi S, 2020, J CONTROL RELEASE, V321, P744, DOI 10.1016/j.jconrel.2020.03.001; Yano M, 2020, J NAT MED-TOKYO, V74, P448, DOI 10.1007/s11418-020-01388-8; Yano M, 2020, J NAT MED-TOKYO, V74, P212, DOI 10.1007/s11418-019-01368-7; Yuyama K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53394-w; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	38	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241640	10.1371/journal.pone.0241640	http://dx.doi.org/10.1371/journal.pone.0241640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137152	gold, Green Published			2022-12-26	WOS:000588375500010
J	Han, SS; Wen, KK; Vyas, YM				Han, Seong-Su; Wen, Kuo-Kuang; Vyas, Yatin M.			Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes	ONCOGENE			English	Article							KAPPA-B; CANCER; WASP; CELLS; TRANSFORMATION; HALLMARKS; LYMPHOMA; INVASION; GENES; CDC42	Immunodeficiency is associated with cancer risk. Accordingly, hematolymphoid cancers develop in Wiskott-Aldrich syndrome (WAS), an X-linked primary immunodeficiency disorder (PID) resulting from the deficiency of WAS-protein (WASp) expressed predominantly in the hematolymphoid cell lineages. Despite the correlation between WASp deficiency and hematolymphoid cancers, the molecular mechanism underlying the oncogenic role of WASp is incompletely understood. Employing the WASp-sufficient and WASp-deficient cell-pair model of human T and B lymphocytes, we show that WASp deficiency differentially influences hyperactivation versus inhibition of both CDC42:ERK1/2 and NF-kappa B:AP-1 pro-oncogenic signaling pathways in nonmalignant versus malignant T and B lymphocytes. Furthermore, WASp deficiency induces a cell-type specific up/down-modulation of the DNA-binding activities of NF-kappa B, AP-1, and multiple other transcription factors with known roles in oncogenesis. We propose that WASp functions as a putative "tumor-suppressor" protein in normal T and B cells, and "oncoprotein" in a subset of established T and B cell malignancies that are not associated with the NPM-ALK fusion.	[Han, Seong-Su; Wen, Kuo-Kuang; Vyas, Yatin M.] Carver Coll Med, Div Pediat Hematol Oncol, Iowa City, IA 52242 USA; [Han, Seong-Su; Wen, Kuo-Kuang; Vyas, Yatin M.] Stead Family Univ Iowa, Childrens Hosp, Iowa City, IA 52242 USA		Vyas, YM (corresponding author), Carver Coll Med, Div Pediat Hematol Oncol, Iowa City, IA 52242 USA.; Vyas, YM (corresponding author), Stead Family Univ Iowa, Childrens Hosp, Iowa City, IA 52242 USA.	yatin-vyas@uiowa.edu		Han, Seong-Su/0000-0001-9824-6751; Vyas, Yatin/0000-0002-4595-0267	NIH [R21AI138051, R01AI146380]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the NIH grant R21AI138051 and R01AI146380 (to YMV).	Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Castellano G, 2010, CELL CYCLE, V9, P557, DOI 10.4161/cc.9.3.10554; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheminant M, 2019, J ALLERGY CLIN IMMUN, V143, P2311, DOI 10.1016/j.jaci.2019.01.046; Davuluri G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110627; Escoll M, 2017, ONCOGENE, V36, P3515, DOI 10.1038/onc.2016.518; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FARBER E, 1995, CANCER RES, V55, P3759; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo-Sastre A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.127275; Hou JX, 2017, AM J TRANSL RES, V9, P403; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawanishi S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081808; Keszei M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468954; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Li H, 2019, CANCER RES, V79, P2167, DOI 10.1158/0008-5472.CAN-18-1253; Liu CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001704; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maldonado MD, 2018, CANCER RES, V78, P3101, DOI 10.1158/0008-5472.CAN-18-0619; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Menotti M, 2019, NAT MED, V25, P130, DOI 10.1038/s41591-018-0262-9; Morris HT, 2018, J PATHOL, V245, P337, DOI 10.1002/path.5086; Murga-Zamalloa CA, 2017, ONCOGENE, V36, P2085, DOI 10.1038/onc.2016.366; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Rey-Suarez I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14335-8; Sadhukhan S, 2014, J IMMUNOL, V193, P150, DOI 10.4049/jimmunol.1302923; Sarkar K, 2018, J ALLERGY CLIN IMMUN, V142, P219, DOI 10.1016/j.jaci.2017.11.023; Sarkar K, 2015, BLOOD, V126, P1670, DOI 10.1182/blood-2015-05-646182; Sarkar K, 2014, BLOOD, V124, P3409, DOI 10.1182/blood-2014-07-587642; Schrank BR, 2018, NATURE, V559, P61, DOI 10.1038/s41586-018-0237-5; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Tong L, 2014, BIOSCIENCE REP, V34, P283, DOI 10.1042/BSR20140021; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Li-Hui, 2018, Cell Physiol Biochem, V51, P2647, DOI 10.1159/000495956; Wang Wenmeng, 2017, Critical Reviews in Oncogenesis, V22, P1, DOI 10.1615/CritRevOncog.2017021314; Wen KK, 2020, J ALLERGY CLIN IMMUN, V145, P324, DOI 10.1016/j.jaci.2019.09.026	44	3	3	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					345	354		10.1038/s41388-020-01533-3	http://dx.doi.org/10.1038/s41388-020-01533-3		NOV 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33139832	Green Accepted			2022-12-26	WOS:000584356100001
J	Hundertpfund, J; Meyer, JE; Ovari, A				Hundertpfund, Julia; Meyer, Jens Eduard; Ovari, Attila			Patient-reported long-term benefit with an active transcutaneous bone-conduction device	PLOS ONE			English	Article							HEARING IMPLANT; BONEBRIDGE IMPLANTATION; AUDIOLOGICAL OUTCOMES; SUBJECTIVE BENEFIT; SAFETY; SPEECH	Purpose To evaluate the long-term benefits in hearing-related quality of life, patient satisfaction and wearing time of patients rehabilitated with an active transcutaneous bone-conduction device. Adverse events and audiological outcomes are reported as secondary outcomes. Methods This retrospective, mono-centric cohort analysis involves 16 adults with conductive or mixed hearing loss with a mean device experience of 51.25 months. Patient-reported outcome measures were assessed using the short version of the Speech, Spatial and Qualities of Hearing Scale (SSQ12-B) and the German version of the Audio Processor Satisfaction Questionnaire (APSQ). Audiological outcomes as well as incidence of adverse events were obtained from patients ' charts. Results The hearing-related quality of life improved significantly within all subscales of the SSQ12-B scoring a mean overall of 2.95 points. Patient satisfaction measured with the APSQ scored 8.8 points on average. Wearing times differed considerably and patients with lower levels of education seemed to use their device longer compared to patients with academic education. Eight minor adverse events were documented, all of which resolved during follow-up. The mean gain in word recognition score at the last follow-up measured at 65 dB was 75.9%, while speech reception threshold was lowered by 35.1 dB. Conclusion Even after several years, patients report significant benefits in hearing-related quality of life and device satisfaction. In combination with a low rate of minor adverse events and significantly improved audiological outcomes, the device is considered as a comfortable and effective option in hearing rehabilitation.	[Hundertpfund, Julia; Meyer, Jens Eduard; Ovari, Attila] Semmelweis Univ, Asklepios Med Sch, Hamburg, Germany; [Meyer, Jens Eduard; Ovari, Attila] Asklepios Klin St Georg, Dept Otorhinolaryngol Head & Neck Surg, Plast Surg, Hamburg, Germany; [Ovari, Attila] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg Otto Koern, Rostock, Germany	Semmelweis University; Asklepios Klinik St. Georg; University of Rostock	Ovari, A (corresponding author), Semmelweis Univ, Asklepios Med Sch, Hamburg, Germany.; Ovari, A (corresponding author), Asklepios Klin St Georg, Dept Otorhinolaryngol Head & Neck Surg, Plast Surg, Hamburg, Germany.; Ovari, A (corresponding author), Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg Otto Koern, Rostock, Germany.	atiova@gmail.com		Ovari, Attila/0000-0003-4610-6890				[Anonymous], **NON-TRADITIONAL**; Archbold Sue M, 2009, Cochlear Implants Int, V10, P25, DOI 10.1179/cim.2009.10.1.25; Barbara M, 2013, ACTA OTO-LARYNGOL, V133, P1058, DOI 10.3109/00016489.2013.799293; Baumgartner WD, 2016, OTOL NEUROTOL, V37, P713, DOI 10.1097/MAO.0000000000001038; Bianchin G, 2015, ORL J OTO-RHINO-LARY, V77, P17, DOI 10.1159/000371425; Billinger-Finke M, 2020, INT J AUDIOL, V59, P392, DOI 10.1080/14992027.2019.1697830; Brkic FF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101614; Eberhard KE, 2016, OTOL NEUROTOL, V37, P267, DOI 10.1097/MAO.0000000000000969; Zernotti ME, 2016, ACTA OTO-LARYNGOL, V136, P556, DOI 10.3109/00016489.2016.1143119; Fan XM, 2019, OTOL NEUROTOL, V40, P998, DOI 10.1097/MAO.0000000000002370; Gerdes T, 2016, OTOL NEUROTOL, V37, P685, DOI 10.1097/MAO.0000000000001010; Ihler F, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516669330; Ihler F, 2014, OTOL NEUROTOL, V35, P211, DOI 10.1097/MAO.0000000000000208; Kiringoda R, 2013, OTOL NEUROTOL, V34, P790, DOI 10.1097/MAO.0b013e318291c651; Korkmaz MH, 2016, EUR ARCH OTO-RHINO-L, V273, P3723, DOI 10.1007/s00405-016-4046-x; Laske RD, 2015, OTOL NEUROTOL, V36, P1151, DOI 10.1097/MAO.0000000000000791; Manrique M, 2014, OTOL NEUROTOL, V35, P216, DOI 10.1097/MAO.0000000000000253; Noble W, 2013, INT J AUDIOL, V52, P409, DOI 10.3109/14992027.2013.781278; R Core Team, 2013, R LANG ENV STAT COMP; Rader T, 2018, OTOL NEUROTOL, V39, P874, DOI 10.1097/MAO.0000000000001834; Rahne T, 2015, EUR ARCH OTO-RHINO-L, V272, P3263, DOI 10.1007/s00405-014-3403-x; Reinfeldt S, 2015, MED DEVICES-EVID RES, V8, P79, DOI 10.2147/MDER.S39691; Rigato C, 2016, OTOL NEUROTOL, V37, P1381, DOI 10.1097/MAO.0000000000001183; Riss D, 2014, LARYNGOSCOPE, V124, P2802, DOI 10.1002/lary.24832; Schmerber S, 2017, EUR ARCH OTO-RHINO-L, V274, P1835, DOI 10.1007/s00405-016-4228-6; Schwab B, 2020, EUR ARCH OTO-RHINO-L, V277, P423, DOI 10.1007/s00405-019-05727-8; Siegert R, 2013, OTOL NEUROTOL, V34, P927, DOI 10.1097/MAO.0b013e31828682e5; Skarzynski PH, 2019, AUDIOL NEURO-OTOL, V24, P90, DOI 10.1159/000499363; Sprinzl G, 2013, OTOL NEUROTOL, V34, P1076, DOI 10.1097/MAO.0b013e31828bb541; Weiss R, 2017, EUR ARCH OTO-RHINO-L, V274, P2107, DOI 10.1007/s00405-016-4434-2; Weldring T, 2013, HEALTH SERV INSIGHTS, V6, P61, DOI 10.4137/HSI.S11093; Wimmer W, 2019, AURIS NASUS LARYNX, V46, P681, DOI 10.1016/j.anl.2018.12.012; Winn S, 2006, AM ANN DEAF, V151, P434, DOI 10.1353/aad.2006.0048; Wiseman Kathryn B, 2018, Cochlear Implants Int, V19, P131, DOI 10.1080/14670100.2017.1418161; Yang J, 2018, ACTA OTO-LARYNGOL, V138, P877, DOI 10.1080/00016489.2018.1469789; Zernotti ME, 2019, INT J PEDIATR OTORHI, V119, P54, DOI 10.1016/j.ijporl.2019.01.016	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241247	10.1371/journal.pone.0241247	http://dx.doi.org/10.1371/journal.pone.0241247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137128	gold, Green Published			2022-12-26	WOS:000588375500007
J	Cypryanska, M; Nezlek, JB				Cypryanska, Marzena; Nezlek, John B.			Anxiety as a mediator of relationships between perceptions of the threat of COVID-19 and coping behaviors during the onset of the pandemic in Poland	PLOS ONE			English	Article							FEAR APPEALS	At the beginning of the COVID-19 pandemic (10-14 March, 2020) we conducted a survey (n = 1028) of a nationally representative sample (age, sex, and locale) in Poland. Respondents indicated how strong they thought the threat was to themselves, to Poland, and the world. They also described their emotional reactions to the pandemic, which we used to calculate three scores: Anxiety, Hopelessness, and Panic. Respondents also indicated how often they engaged in various coping behaviors and how much they supported different types of economic sacrifice. We used these responses to calculate measures that we labelled as Spread Prevention (e.g., social distancing), Self-preservation (food stockpiling), and Economic Sacrifice (e.g., fighting COVID-19 regardless of the cost). Multiple regression analyses found that perceived threat to self was the most reliable predictor (positive) of emotional reactions and of coping behaviors, and that Anxiety was the most reliable predictor (positive) of Spread prevention and Economic sacrifice. Panic predicted (positively) Self-preservation. A series of mediation analyses found that Anxiety mediated relationships between threat and coping behaviors, and that Panic mediated the relationship between perceived threats and Self-preservation. In addition, we found that scores on all measures, except Panic, increased following the announcement of the first COVID-19 related fatality in Poland, which occurred on the third (middle) day of the study. The mediational relationships we found did not vary as a function of whether the data were collected before or after this announcement. The present results suggest that emotional reactions to perceived threats can serve an instrumental function by providing the motivation to engage in coping behaviors. Such a mechanism complements much research on stress that has focused on how coping mediates threat-emotion relationships.	[Cypryanska, Marzena] SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Nezlek, John B.] SWPS Univ Social Sci & Humanities, Inst Psychol, Poznan, Poland; [Nezlek, John B.] Coll William & Mary, Dept Psychol Sci, Williamsburg, VA USA	SWPS University of Social Sciences & Humanities; SWPS University of Social Sciences & Humanities; William & Mary	Cypryanska, M (corresponding author), SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland.	mcypryanska@swps.edu.pl	Cypryańska, Marzena/AAI-3811-2021	Cypryańska, Marzena/0000-0001-9234-5628; Nezlek, John/0000-0003-4963-3637				Barrett LF, 1998, J PERS SOC PSYCHOL, V74, P967, DOI 10.1037/0022-3514.74.4.967; Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bridgman A., 2020, HARVARD KENNEDY SCH, V1, P1, DOI [DOI 10.37016/MR-2020-028, 10.37016/mr-2020-028]; Capraro V., PSYARXIV PREPR, P2020, DOI [10.31234/osf.io/wtcqy, DOI 10.31234/OSF.IO/WTCQY]; Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5; Costello AB, 2005, PRACT ASSESSMENT RES, V10; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Harper C.A., 2020, INT J MENT HEALTH AD, P1, DOI DOI 10.1007/s11469-020-00281-5; Heffner J, 2020, EMOTIONAL RESPONSES, DOI [10.1016/j.paid.2020.110420, DOI 10.1016/J.PAID.2020.110420]; IZARD CE, 1993, J PERS SOC PSYCHOL, V64, P847, DOI 10.1037/0022-3514.64.5.847; Karademas EC, 2013, J HEALTH PSYCHOL, V18, P419, DOI 10.1177/1359105312436765; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS, 1999, STRESS EMOTION; Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169; Maloney EK, 2011, SOC PERSONAL PSYCHOL, V5, P206, DOI 10.1111/j.1751-9004.2011.00341.x; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schwarzer R., 2012, OXFORD HDB HLTH PSYC, P591; Searle K, 2010, INT J CLIM CHANG STR, V2, P362, DOI 10.1108/17568691011089891; Stanton AL, 2012, OXFORD HDB STRESS HL, DOI [10.1093/oxfordhb/9780195375343.013.0018, DOI 10.1093/OXFORDHB/9780195375343.013.0018]; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Ussishkin D., 2002, PANIC ORIGINS INSIGH, P5, DOI [10.1103/PhysRevLett.89.287001, DOI 10.1103/PHYSREVLETT.89.287001]; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	29	32	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241464	10.1371/journal.pone.0241464	http://dx.doi.org/10.1371/journal.pone.0241464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125435	Green Published, gold			2022-12-26	WOS:000588368900047
J	Simelane, MS; Chemhaka, GB; Zwane, E				Simelane, Maswati S.; Chemhaka, Garikayi B.; Zwane, Eugene			A multilevel analysis of individual, household and community level factors on stunting among children aged 6-59 months in Eswatini: A secondary analysis of the Eswatini 2010 and 2014 Multiple Indicator Cluster Surveys	PLOS ONE			English	Article								Introduction Child stunting is a significant public health problem in Eswatini. It is associated with a range of child health outcomes, including morbidity, physical and cognitive growth. Objective To determine the individual, household, and community-level factors associated with child stunting in Eswatini in 2010 and 2014. Methods Using the Eswatini Multiple Indicator Cluster Surveys conducted in 2010 and 2014, a secondary analysis was done of the children surveyed, aged 6-59 months. A total of 1,891 were surveyed in 2010, and 1,963 children in 2014. Univariate, bivariable analysis and multivariable multilevel logistic regression were used to establish the factors associated with stunting. Results The study found that stunting decreased significantly between 2010 and 2014, from 31.4% to 25.5% (p<0.001). In both 2010 and 2014, lower odds of stunting were observed among female children, in children born to women with tertiary education compared to those born to women with no formal education. Lower odds of stunting were observed among children from rich households compared to poorest households. In both 2010 and 2014, increased odds of stunting were observed among children aged 12-23, 24-35 and 36-47 months compared to children aged 6-11 months. At the household level, higher odds of stunting were observed among children from households with two and more children under five years of age compared to those with only one child and in 2010, among children from households with a pit latrine and no toilet facility compared to households with a flush toilet. At the community level, in 2010, higher odds of stunting were observed among children from the Shiselweni compared to those from the Lubombo region. Conclusion The findings highlight the individual, household, and community-level factors significantly associated with stunting and the changes between the two surveys.	[Simelane, Maswati S.; Chemhaka, Garikayi B.; Zwane, Eugene] Univ Eswatini, Fac Social Sci, Dept Stat & Demog, Kwaluseni, Eswatini		Simelane, MS (corresponding author), Univ Eswatini, Fac Social Sci, Dept Stat & Demog, Kwaluseni, Eswatini.	smasimelane@uniswa.sz		Chemhaka, Garikayi/0000-0001-8863-9826; Simelane, Maswati/0000-0002-4931-9026				Adekanmbi VT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-361; Adekanmbi VT, 2013, MATERN CHILD NUTR, V9, P244, DOI 10.1111/j.1740-8709.2011.00361.x; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; [Anonymous], 2016, ANT CAR; Buisman LR, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100384; Central Statistical Office, 2017, 2017 POP HOUS CENS P; Central Statistical Office UNICEF, 2011, ESW MULT IND CLUST S; Central Statistical Office UNICEF, 2016, ESW MULT IND CLUST S; Central Statistics Office, 2011, POV DEC SLOW EC GROW; Central Statitsics Office, 2018, SWAZ HOUS INC EXPR S; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Condo JU, 2015, TROP MED INT HEALTH, V20, P17, DOI 10.1111/tmi.12406; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; Darteh EKM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-504; Desa U, 2016, TRANSF OUR WORLD 203; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Eswatini Government, 2014, JOINT FAO WHO 2 INT; Eswatini Ministry of Agriculture, 2016, CASH TRANSF INT MOD; Eswatini Ministry of Education and Training, 2015, SWAZ ED ALL REV REP; Cruz LMG, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050491; Gebru KF, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1545-0; Haile D, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0587-9; Kismul H, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4621-0; Kunene S, 2015, LIVED POVERTY CAN IN; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mejia-Guevara I, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002757; Menezes Risia Cristina Egito de, 2011, Rev. Saúde Pública, V45, P1079, DOI 10.1590/S0034-89102011000600010; Mzumara B, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0260-9; Nshimyiryo A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6504-z; Ntenda PAM, 2018, PEDIATR NEONATOL, V59, P380, DOI 10.1016/j.pedneo.2017.11.019; Nyiraneza L, 2019, J MANAGEMENT STRATEG, V10, P34; Ramos CV, 2015, J PEDIAT-BRAZIL, V91, P175, DOI 10.1016/j.jped.2014.07.005; Raykov T, 2011, STRUCT EQU MODELING, V18, P73, DOI 10.1080/10705511.2011.534319; Rose Elizabeth S, 2015, BMC Nutr, V1; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Titaley CR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051106; Tsawe M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0162-2; UNDP, 2018, HUMAN DEV INDICES IN; UNICEF, 2017, UNICEF ANN REP 2017; UNICEF, DEM HLTH INF MORT; UNICEF, 2017, UNICEF ANN REP MBAB; UNICEF, 2017, SWAZ HUM SIT REP; United Nation Population Fund (UNFPA), 2019, REN COMM 3 ZER; Urke HB, 2011, NUTR RES, V31, P741, DOI 10.1016/j.nutres.2011.09.007; Wamani H., 2007, BMC Pediatrics, V7; Wasting-Stunting Technical Interest Group (WaSt TIG), 2018, CHILD WAST STUNT TIM; WHO, 2017, GLOB NUTR MON FRAM O; Wit JM, 2017, HORM RES PAEDIAT, V88, P79, DOI 10.1159/000456007; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241548	10.1371/journal.pone.0241548	http://dx.doi.org/10.1371/journal.pone.0241548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125409	Green Published, gold			2022-12-26	WOS:000588368900071
J	Wang, Y; Xu, G; Huang, YW				Wang, Yang; Xu, Guang; Huang, Yue-Wern			Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speaking	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; AIR; DROPLETS; SIZE; AEROSOLS	Particle size is an essential factor when considering the fate and transport of virus-containing droplets expelled by human, because it determines the deposition pattern in the human respiratory system and the evolution of droplets by evaporation and gravitational settling. However, the evolution of virus-containing droplets and the size-dependent viral load have not been studied in detail. The lack of this information leads to uncertainties in understanding the airborne transmission of respiratory diseases, such as the COVID-19. In this study, through a set of differential equations describing the evolution of respiratory droplets and by using the SARS-CoV-2 virus as an example, we investigated the distribution of airborne virus in human expelled particles from coughing and speaking. More specifically, by calculating the vertical distances traveled by the respiratory droplets, we examined the number of viruses that can remain airborne and the size of particles carrying these airborne viruses after different elapsed times. From a single cough, a person with a high viral load in respiratory fluid (2.35 x 10(9) copies per ml) may generate as many as 1.23 x 10(5) copies of viruses that can remain airborne after 10 seconds, compared to 386 copies of a normal patient (7.00 x 10(6) copies per ml). Masking, however, can effectively block around 94% of the viruses that may otherwise remain airborne after 10 seconds. Our study found that no clear size boundary exists between particles that can settle and can remain airborne. The results from this study challenge the conventional understanding of disease transmission routes through airborne and droplet mechanisms. We suggest that a complete understanding of the respiratory droplet evolution is essential and needed to identify the transmission mechanisms of respiratory diseases.	[Wang, Yang] Missouri Univ Sci & Technol, Dept Civil Architectural & Environm Engn, Rolla, MO 65409 USA; [Xu, Guang] Missouri Univ Sci & Technol, Dept Min & Nucl Engn, Rolla, MO 65409 USA; [Huang, Yue-Wern] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO 65409 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology	Wang, Y (corresponding author), Missouri Univ Sci & Technol, Dept Civil Architectural & Environm Engn, Rolla, MO 65409 USA.	yangwang@mst.edu	Wang, Yang/K-3936-2017	Wang, Yang/0000-0002-0543-0443; Huang, Yue-Wern/0000-0003-1957-6459; Xu, Guang/0000-0001-8328-6670	U.S. National Science Foundation [2034198]	U.S. National Science Foundation(National Science Foundation (NSF))	YW, GX, and YH are supported by the U.S. National Science Foundation (nsf.gov) grant 2034198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KK, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110089; Allen JG, 2020, INDOOR AIR, V30, P557, DOI 10.1111/ina.12697; Alonso C, 2017, J VET DIAGN INVEST, V29, P298, DOI 10.1177/1040638717700221; Arslan M, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140709; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Asadi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227699; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Bao L, 2020, J INFECT DIS; Centers for Disease Control and Prevention (CDC), 2020, INT INF PREV CONTR R; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; CHEN CC, 1992, AM J INFECT CONTROL, V20, P177, DOI 10.1016/S0196-6553(05)80143-9; Chen LD, 2020, INT J HYG ENVIR HEAL, V229, DOI 10.1016/j.ijheh.2020.113568; Chen WZ, 2020, BUILD ENVIRON, V176, DOI 10.1016/j.buildenv.2020.106859; Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P1258, DOI 10.1017/ice.2020.282; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Faridi S, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138401; Fears AC, 2020, EMERG INFECT DIS, V26, P2168, DOI 10.3201/eid2609.201806; Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Hadei M, 2020, AEROSOL AIR QUAL RES, V20, P911, DOI 10.4209/aaqr.2020.04.0158; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Howard JR, 2020, SUNY Series Afr Amer, P1; Inan B, 2020, MATH METHOD APPL SCI, V43, P2588, DOI 10.1002/mma.6067; Jiang J, 2020, TRANSMISSION VIA AER; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032; Lednicky JA, 2020, AEROSOL AIR QUAL RES, V20, P1167, DOI [10.4209/aaqr.2020.05.0202, 10.4209/aaqr.2020.02.0202]; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Liu L, 2017, INDOOR AIR, V27, P179, DOI 10.1111/ina.12297; Lu D, 2020, PHYSICA A, V537, DOI 10.1016/j.physa.2019.122634; Milton DK, 2020, J PEDIAT INF DIS SOC, V9, P413, DOI 10.1093/jpids/piaa079; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska L, 2018, ENVIRON INT, V116, P286, DOI 10.1016/j.envint.2018.04.018; Nishimura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080244; Pan MH, 2019, AEROSOL SCI TECH, V53, P583, DOI 10.1080/02786826.2019.1581917; Podgorski A, 2006, CHEM ENG SCI, V61, P6804, DOI 10.1016/j.ces.2006.07.022; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; RANZ WE, 1952, CHEM ENG PROG, V48, P141; Razzini K, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140540; Rengasamy S, 2011, ANN OCCUP HYG, V55, P253, DOI 10.1093/annhyg/meq096; Savory Eric, 2014, BMC Res Notes, V7, P563, DOI 10.1186/1756-0500-7-563; Schunemann H.J., 2020, LANCET; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wallace M, 2017, OPEN FORUM INFECT DI; Welham S.J., 2014, STAT METHODS BIOL DE; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610; Yao MS, 2020, SCI TOTAL ENVIRON, V731, DOI 10.1016/j.scitotenv.2020.139178; Zayas G, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-11; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zuo ZL, 2014, APPL ENVIRON MICROB, V80, P2796, DOI 10.1128/AEM.00056-14	58	36	35	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241539	10.1371/journal.pone.0241539	http://dx.doi.org/10.1371/journal.pone.0241539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125421	gold, Green Published			2022-12-26	WOS:000588368900052
J	Zivanovic, M; Markovic, MV				Zivanovic, Marko; Markovic, Masa Vukcevic			Latent structure of secondary traumatic stress, its precursors, and effects on people working with refugees	PLOS ONE			English	Article							IRAQI ASYLUM SEEKERS; QUALITY-OF-LIFE; CONFIRMATORY FACTOR-ANALYSES; MANCHESTER SHORT ASSESSMENT; MENTAL-HEALTH; DIMENSIONAL STRUCTURE; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; SYMPTOMS; IMPACT	The study aims to examine the latent structure of secondary traumatic stress (STS), its precursors, and the psychological effects of it on the population of service providers working with refugees passing through the Balkan route. A total of 270 service providers (57% female) of different professional backgrounds working directly with refugees took part in the study. Participants were assessed for STS using the Secondary Traumatic Stress Scale, the extent of secondary exposure to trauma (i.e., clients' traumatic experiences from the countries of origin and travel that were communicated to them directly), depression, anxiety, and quality of life. Comparisons of several confirmatory factor analyses following prominent PTSD conceptualizations showed that the model with three relatively distinct but highly correlated factors-intrusion, avoidance, and the blend of negative alterations in cognitions, mood, and reactivity (NACMR), had the best fit. STS has been shown to be positively correlated both with the amount of different traumatic experiences that were communicated to them as well as with the specific content of those experiences. Path analysis showed that the amount of secondary exposure to the clients' traumatic experiences during travel, but not in the country of origin, had exclusive relationships with all three factors of STS. NACMR demonstrated direct effects on anxiety and depression symptoms, while intrusions exhibited a direct effect on anxiety-related symptomatology only. The avoidance factor did not have any independent direct effects on anxiety or depression. Finally, the effects of STS factors on quality of life were fully mediated by an increase of depression-related symptomatology. Results provide evidence on the latent structure of the STS which partially deviates from the prominent models of PTSD thus questioning the isomorphism of two constructs on the empirical level. Additionally, findings provide insights on the cascade of events that make professionals working with traumatized people especially vulnerable to STS and broader psychological distress.	[Zivanovic, Marko; Markovic, Masa Vukcevic] Univ Belgrade, Inst Psychol, Dept Psychol, Belgrade, Serbia; [Zivanovic, Marko; Markovic, Masa Vukcevic] Psychosocial Innovat Network, Belgrade, Serbia	University of Belgrade	Zivanovic, M (corresponding author), Univ Belgrade, Inst Psychol, Dept Psychol, Belgrade, Serbia.; Zivanovic, M (corresponding author), Psychosocial Innovat Network, Belgrade, Serbia.	marko.zivanovic@f.bg.ac.rs	Marković, Maša Vukčević/ABG-3303-2020; Živanović, Marko/T-1259-2019	Živanović, Marko/0000-0001-7048-5187	International Refugee Committee (IRC); UNHCR Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia [179018]	International Refugee Committee (IRC); UNHCR Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The study was funded by International Refugee Committee (IRC) and UNHCR Serbia. Both authors are supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (project number 179018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsulure-Smith AM, 2018, J TRAUMA STRESS, V31, P202, DOI 10.1002/jts.22279; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2016, STROKE, V47, pe262; [Anonymous], 2019, FRONTIERS PLANT SCI; Armour C, 2015, J PSYCHIATR RES, V61, P106, DOI 10.1016/j.jpsychires.2014.10.012; Badger K, 2008, HEALTH SOC WORK, V33, P63, DOI 10.1093/hsw/33.1.63; Ben-Porat A, 2011, CLIN SUPERV, V30, P95, DOI 10.1080/07325223.2011.566089; Bjorkman T, 2005, NORD J PSYCHIAT, V59, P302, DOI 10.1080/08039480500213733; Bjornestad AG, 2014, J NERV MENT DIS, V202, P864, DOI 10.1097/NMD.0000000000000213; Bogic M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0064-9; Bride BE, 2004, RES SOCIAL WORK PRAC, V14, P27, DOI 10.1177/1049731503254106; Bride BE, 2007, SOC WORK, V52, P63, DOI 10.1093/sw/52.1.63; Bride BE, 2007, J EVID-INFORM SOC WO, V4, P69, DOI 10.1300/J394v04n03_05; Cantekin D, 2017, J SOC CLIN PSYCHOL, V36, P835; Carswell Kenneth, 2011, Int J Soc Psychiatry, V57, P107, DOI 10.1177/0020764008105699; Christodoulou-Fella M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1908712; Cunningham M, 2003, SOC WORK, V48, P451, DOI 10.1093/sw/48.4.451; Devilly GJ, 2009, AUST NZ J PSYCHIAT, V43, P373, DOI 10.1080/00048670902721079; Dominguez-Gomez E, 2009, J EMERG NURS, V35, P199, DOI 10.1016/j.jen.2008.05.003; Eklund Mona, 2006, Scand J Occup Ther, V13, P23, DOI 10.1080/11038120500239578; Elhai JD, 2011, J ANXIETY DISORD, V25, P340, DOI 10.1016/j.janxdis.2010.10.007; Elwood LS, 2011, CLIN PSYCHOL REV, V31, P25, DOI 10.1016/j.cpr.2010.09.004; FIGLEY CR, 1988, COUNS PSYCHOL, V16, P635, DOI 10.1177/0011000088164005; Figley CR, 1995, BRUNNER MAZEL PSYCHO, V23; Gerritsen AAM, 2006, SOC PSYCH PSYCH EPID, V41, P18, DOI 10.1007/s00127-005-0003-5; Gob A, 2016, SECONDARY TRAUMATIC; Hallas P, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-288; Hensel JM, 2015, J TRAUMA STRESS, V28, P83, DOI 10.1002/jts.21998; Holmgren Helle, 2003, INTERVENTION, V1, P22; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Insurance Institute for Highway Safety, 2010, STATUS REP, V45; Jacobs I, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00191; Keller AS, 2003, LANCET, V362, P1721, DOI 10.1016/S0140-6736(03)14846-5; Kellogg MB, 2018, J PEDIATR NURS, V43, P97, DOI 10.1016/j.pedn.2018.08.016; Kindermann D, 2017, PSYCHOPATHOLOGY, V50, P262, DOI 10.1159/000477670; Kneevi G, 1996, MERENJE PSIHOLOGIJI, V2, P35; Laban CJ, 2005, J NERV MENT DIS, V193, P825, DOI 10.1097/01.nmd.0000188977.44657.1d; Laban CJ, 2004, J NERV MENT DIS, V192, P843, DOI 10.1097/01.nmd.0000146739.26187.15; Laban CJ, 2008, SOC PSYCH PSYCH EPID, V43, P507, DOI 10.1007/s00127-008-0333-1; Mairean C, 2016, SOC SCI J, V53, P14, DOI 10.1016/j.soscij.2015.11.007; Makadia R, 2017, CLIN PSYCHOL PSYCHOT, V24, P1059, DOI 10.1002/cpp.2068; Mirsaleh Y.R., 2014, IRAN J PSYCHIAT CLIN, V20, P134; Mordeno IG, 2017, ASIAN J PSYCHIATR, V25, P154, DOI 10.1016/j.ajp.2016.10.024; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Raghavan S, 2013, PSYCHOL TRAUMA-US, V5, P377, DOI 10.1037/a0028118; rejoinder Buc's, 2007, EARLY MEDIEV EUR, V15, P441; Renner W, 2006, SOC BEHAV PERSONAL, V34, P1101, DOI 10.2224/sbp.2006.34.9.1101; Silove, 2004, MEASURING TRAUMA MEA; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Steel Z, 1999, J TRAUMA STRESS, V12, P421, DOI 10.1023/A:1024710902534; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Ting L, 2005, J HUM BEHAV SOC ENVI, V11, P177, DOI 10.1300/J137v11n03_09; Tsai J, 2015, J CLIN PSYCHIAT, V76, P546, DOI 10.4088/JCP.14m09091; UNHCR, GLOB TRENDS FORC DIS; Vukcevic M, 2016, PSIHOLOGIJA, V49, P277, DOI 10.2298/PSI1603277V; Vukevi M, 2014, STUDY MENTAL HLTH AS; Vukevi M., 2014, MENTAL HLTH ASYLUM S; Vukevi Markovi M., 2017, REFUGEES MENTAL HLTH; Vukevic M.M., 2019, FORCED MIGRATION SOC, P511, DOI [10.4324/9780429432415, DOI 10.4324/9780429432415]; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Watson D, 2009, ANNU REV CLIN PSYCHO, V5, P221, DOI 10.1146/annurev.clinpsy.032408.153510; Weitkamp K, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.21875; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	65	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241545	10.1371/journal.pone.0241545	http://dx.doi.org/10.1371/journal.pone.0241545			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125384	Green Published, gold			2022-12-26	WOS:000588368900041
J	Shindo, Y; Tadaka, E				Shindo, Yuka; Tadaka, Etsuko			Development of the life change adaptation scale for family caregivers of individuals with acquired brain injury	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH; CARE; BURDEN; STROKE	Aim Life changes due to the sudden onset of acquired brain injury (ABI) are drastic personal and social changes that require adaptation and are also an important indicator of the quality of life of family caregivers. However, there are no instruments for evaluating life change adaptation among family caregivers of individuals with acquired brain injury. This study aimed to develop the Life Change Adaptation Scale (LCAS) for family caregivers of individuals with ABI and examine its reliability and validity. Methods A cross-sectional study was conducted using a self-reported questionnaire. A total of 1622 family caregivers of individuals with ABI who belonged to 82 associations for families of individuals with ABI were selected as eligible participants. The construct validity was evaluated using a confirmatory factor analysis. Internal consistency was calculated using Cronbach's alpha. The K6 was also administered to assess the criterion-related validity of the LCAS. Results In total, 339 valid responses were received. The confirmatory factor analysis identified eight items from two domains, "Changes in the appraisal of caregiving resources" and "Changes in the health belief as a caregiver" (goodness of fit index = 0.963, adjusted goodness of fit index = 0.926, comparative fit index = 0.986, root mean square error of approximation = 0.043.) Cronbach's alpha was 0.84. The LCAS was negatively correlated with the K6 (r = -0.504; P< 0.001). Conclusions The LCAS is a brief, easy-to-administer instrument that is reliable and valid for family caregivers of individuals with ABI. This study contributes to the assessment and identification by family caregivers of individuals with ABI who require aid in adapting to life changes. Further research should be undertaken to verify the predictive value in a longitudinal study and to attempt to apply the LCAS to assess a broader range of subjects in a wider range of settings.	[Shindo, Yuka; Tadaka, Etsuko] Yokohama City Univ, Grad Sch Med, Dept Community Hlth Nursing, Yokohama, Kanagawa, Japan	Yokohama City University	Shindo, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Community Hlth Nursing, Yokohama, Kanagawa, Japan.	t206705c@yokohama-cu.ac.jp		Shindo(Iwata), Yuka/0000-0002-1911-3588				[Anonymous], 2009, KRITIKA, V10, P1; [Anonymous], 2015, MED LETT DRUGS THER, V57, P43; [Anonymous], 2016, EBIOMEDICINE, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4418; Atchley R., 1999, CONTINUITY ADAPTATIO; ATCHLEY RC, 1989, GERONTOLOGIST, V29, P183, DOI 10.1093/geront/29.2.183; Bakas T, 1999, NURS RES, V48, P250, DOI 10.1097/00006199-199909000-00005; Bakas T, 2006, NURS RES, V55, P346, DOI 10.1097/00006199-200609000-00007; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; Denham AMJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216682; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Fortune N., 1999, DEFINITION INCIDENCE; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Greyson B, 1982, J NEAR DEATH STUD; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Hodson T, 2020, SCAND J OCCUP THER, V27, P184, DOI 10.1080/11038128.2019.1633401; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson CO, 2019, LANCET NEUROL, V18, P439, DOI 10.1016/S1474-4422(19)30034-1; Kolb PJ, 2008, DEV THEORIES LIFE CY, P285; Kosciulek J. F., 1994, REHABILITATION COUNS, V37, P245; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Hayas CL, 2015, REHABIL PSYCHOL, V60, P295, DOI 10.1037/rep0000040; Hayas CL, 2014, REHABIL PSYCHOL, V59, P193, DOI 10.1037/a0035622; MacIsaac Laura, 2010, Can J Neurosci Nurs, V32, P39; Muthucumarana MW, 2018, TOP STROKE REHABIL, V25, P397, DOI 10.1080/10749357.2018.1481353; Negarandeh Reza, 2015, Int J Community Based Nurs Midwifery, V3, P283; Ovbiagele B, 2011, NEUROTHERAPEUTICS, V8, P319, DOI 10.1007/s13311-011-0053-1; Parag V, 2008, CEREBROVASC DIS, V25, P548, DOI 10.1159/000131673; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Prescrire Editorial Staff, 2017, PRESCRIRE INT, V26, P154; Roy-O'Reilly M, 2018, ENDOCRINOLOGY, V159, P3120, DOI 10.1210/en.2018-00465; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Smart J., 2008, DISABILITY SOC INDIV; Smeets SM, 2012, ARCH PHYS MED REHAB, V93, P834, DOI 10.1016/j.apmr.2011.10.029; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Vogler J, 2014, BRAIN INJURY, V28, P1381, DOI 10.3109/02699052.2014.919536; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Watanabe S, 2009, JPN J REHABIL MED, V46, P118, DOI [10.2490/jjrmc.46.118, DOI 10.2490/JJRMC.46.118]; Wongvatunyu S, 2008, J FAM NURS, V14, P314, DOI 10.1177/1074840708321473	44	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241386	10.1371/journal.pone.0241386	http://dx.doi.org/10.1371/journal.pone.0241386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119723	gold, Green Published			2022-12-26	WOS:000600013600108
J	Yoshida, A; Choi, J; Jin, HR; Li, Y; Bajpai, S; Qie, S; Diehl, JA				Yoshida, Akihiro; Choi, Jaewoo; Jin, Hong Ri; Li, Yan; Bajpai, Sagar; Qie, Shuo; Diehl, J. Alan			Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3	ONCOGENE			English	Article							D1; PHOSPHORYLATION; OVEREXPRESSION; EXPRESSION; TARGETS; PHASE; UBIQUITINATION; ACCUMULATION; PROTEOLYSIS; PROGRESSION	Overexpression of D-type cyclins in human cancer frequently occurs as a result of protein stabilization, emphasizing the importance of identification of the machinery that regulates their ubiqutin-dependent degradation. Cyclin D3 is overexpressed in similar to 50% of Burkitt's lymphoma correlating with a mutation of Thr-283. However, the E3 ligase that regulates phosphorylated cyclin D3 and whether a stabilized, phosphorylation deficient mutant of cyclin D3, has oncogenic activity are undefined. We describe the identification of SCF-Fbxl8 as the E3 ligase for Thr-283 phosphorylated cyclin D3. SCF-Fbxl8 poly-ubiquitylates p-Thr-283 cyclin D3 targeting it to the proteasome. Functional investigation demonstrates that Fbxl8 antagonizes cell cycle progression, hematopoietic cell proliferation, and oncogene-induced transformation through degradation of cyclin D3, which is abolished by expression of cyclin D3T283A, a non-phosphorylatable mutant. Clinically, the expression of cyclin D3 is inversely correlated with the expression of Fbxl8 in lymphomas from human patients implicating Fbxl8 functions as a tumor suppressor. Highlights Fbxl8 suppresses cell division, cell proliferation, and tumorigenesis through phosphorylation-dependent degradation of cyclin D3. Fbxl8 suppresses oncogene-induced transformation of hematopoietic cells and lymphoma cell proliferation through cyclin D3 degradation.	[Yoshida, Akihiro; Bajpai, Sagar; Qie, Shuo; Diehl, J. Alan] Case Western Reserve Univ, Case Comprehens Canc Ctr, Dept Biochem, Cleveland, OH 44106 USA; [Yoshida, Akihiro; Jin, Hong Ri; Li, Yan; Bajpai, Sagar] Med Univ South Carolina, Hollings Canc Ctr, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Yoshida, Akihiro; Qie, Shuo; Diehl, J. Alan] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Choi, Jaewoo] Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	Case Western Reserve University; Medical University of South Carolina; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine	Diehl, JA (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Dept Biochem, Cleveland, OH 44106 USA.; Diehl, JA (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	jad283@case.edu	Qie, Shuo/O-4382-2015	Qie, Shuo/0000-0002-3481-3582; , J. Alan/0000-0001-9854-5049	National Institutes of Health [R01CA093237, P01CA098101]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Louis M. Staudt for providing Gumbus cell line. This work was supported by grants from National Institutes of Health: R01CA093237, P01CA098101 (JAD).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bu YW, 2018, NAT CELL BIOL, V20, P104, DOI 10.1038/s41556-017-0006-y; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Chen BB, 2012, ONCOGENE, V31, P2566, DOI 10.1038/onc.2011.432; Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911; de Leeuw R, 2018, CLIN CANCER RES, V24, P4201, DOI 10.1158/1078-0432.CCR-18-0410; DELMER A, 1995, BLOOD, V85, P2870, DOI 10.1182/blood.V85.10.2870.bloodjournal85102870; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dong H, 2020, CANCER MED-US, V9, P1790, DOI 10.1002/cam4.2829; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Nagasawa S, 2001, J SURG ONCOL, V78, P208, DOI 10.1002/jso.1152; Ott MM, 1997, BLOOD, V90, P3154, DOI 10.1182/blood.V90.8.3154; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Sawai CM, 2012, CANCER CELL, V22, P452, DOI 10.1016/j.ccr.2012.09.016; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Yoshida A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax6352; Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931	31	6	6	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					292	306		10.1038/s41388-020-01532-4	http://dx.doi.org/10.1038/s41388-020-01532-4		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33122824	hybrid, Green Published			2022-12-26	WOS:000582827800001
J	Jimbo, K; Okuno, T; Ohgaki, R; Nishikubo, K; Kitamura, Y; Sakurai, Y; Quan, LL; Shoji, H; Kanai, Y; Shimizu, T; Yokomizo, T				Jimbo, Keisuke; Okuno, Toshiaki; Ohgaki, Ryuichi; Nishikubo, Kou; Kitamura, Yuri; Sakurai, Yumiko; Quan, Lili; Shoji, Hiromichi; Kanai, Yoshikatsu; Shimizu, Toshiaki; Yokomizo, Takehiko			A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy	PLOS ONE			English	Article							PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; NONSPECIFIC MULTIPLE ULCERS; SMALL-INTESTINE; IDENTIFICATION; EXPRESSION; INHIBITION; METABOLISM; DIAGNOSIS; CLONING	Chronic enteropathy associated with SLCO2A1 gene (CEAS) is caused by loss-of-function mutations in SLCO2A1, which encodes a prostaglandin (PG) transporter. In this study, we report a sibling case of CEAS with a novel pathogenic variant of the SLCO2A1 gene. Compound heterozygous variants in SLCO2A1 were identified in an 8-year-old boy and 12-year-old girl, and multiple chronic nonspecific ulcers were observed in the patients using capsule endoscopy. The splice site mutation (c.940 + 1G>A) of the paternal allele was previously reported to be pathogenic, whereas the missense variant (c.1688T>C) of the maternal allele was novel and had not yet been reported. The affected residue (p.Leu563Pro) is located in the 11th transmembrane domain (helix 11) of SLCO2A1. Because SLCO2A1 mediates the uptake and clearance of PGs, the urinary PG metabolites were measured by liquid chromatography coupled to tandem mass spectrometry. The urinary tetranor-prostaglandin E metabolite levels in the patients were significantly higher than those in unaffected individuals. We established cell lines with doxycycline-inducible expression of wild type SLCO2A1 (WT-SLCO2A1) and the L563P mutant. Immunofluorescence staining showed that WT-SLCO2A1 and the L563P mutant were dominantly expressed on the plasma membranes of these cells. Cells expressing WT-SLCO2A1 exhibited time- and dose-dependent uptake of PGE(2), while the mutant did not show any uptake activity. Residue L563 is very close to the putative substrate-binding site in SLCO2A1, R561 in helix 11. However, in a molecular model of SLCO2A1, the side chain of L563 projected outside of helix 11, indicating that L563 is likely not directly involved in substrate binding. Instead, the substitution of Pro may twist the helix and impair the transporter function. In summary, we identified a novel pathogenic variant of SLCO2A1 that caused loss-of-function and induced CEAS.	[Jimbo, Keisuke; Kitamura, Yuri; Sakurai, Yumiko; Shoji, Hiromichi; Shimizu, Toshiaki] Juntendo Univ, Dept Pediat, Grad Sch Med, Tokyo, Japan; [Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Grad Sch Med, Tokyo, Japan; [Ohgaki, Ryuichi; Nishikubo, Kou; Quan, Lili; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Biosyst Pharmacol, Osaka, Japan; [Kanai, Yoshikatsu] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Osaka, Japan	Juntendo University; Juntendo University; Osaka University; Osaka University	Okuno, T (corresponding author), Juntendo Univ, Dept Biochem, Grad Sch Med, Tokyo, Japan.	tokuno@juntendo.ac.jp	Shoji, Hiromichi/ABB-5653-2021	Shoji, Hiromichi/0000-0003-2532-8910; Jimbo, Keisuke/0000-0001-6317-4305; Ohgaki, Ryuichi/0000-0002-6894-7239; Nishikubo, Kou/0000-0002-8314-0708	MEXT/JSPS KAKENHI [16K08596, 19K07357, 15H05904, 15H05897, 18H02627, 19KK0199]; Mishima Kaiun Memorial Foundation; Ono Medical Research Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Ono Medical Research Foundation	This work was supported by MEXT/JSPS KAKENHI grants (16K08596, 19K07357 (to TO), and 15H05904, 15H05897, 18H02627, and 19KK0199 (to TY)); the Mishima Kaiun Memorial Foundation (to TO) and the Ono Medical Research Foundation (to TY).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGGARD E, 1971, EUR J PHARMACOL, V14, P66, DOI 10.1016/0014-2999(71)90123-3; Banu SK, 2003, P NATL ACAD SCI USA, V100, P11747, DOI 10.1073/pnas.1833330100; Busch J, 2012, J INVEST DERMATOL, V132, P2473, DOI 10.1038/jid.2012.146; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Diggle CP, 2012, HUM MUTAT, V33, P1175, DOI 10.1002/humu.22111; HAMBERG M, 1972, BIOCHEM BIOPH RES CO, V49, P720, DOI 10.1016/0006-291X(72)90470-6; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Hosoe N, 2017, J CROHNS COLITIS, V11, P1277, DOI 10.1093/ecco-jcc/jjx068; Hou YF, 2018, BONE, V106, P96, DOI 10.1016/j.bone.2017.09.015; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; LEE SC, 1975, J BIOL CHEM, V250, P548; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Matsumoto T, 2004, J CLIN PATHOL, V57, P1145, DOI 10.1136/jcp.2003.015735; Matsumoto T, 2006, DIGEST DIS SCI, V51, P1357, DOI 10.1007/s10620-006-9080-x; Matsuno Y, 2019, WORLD J GASTROENTERO, V25, P1753, DOI 10.3748/wjg.v25.i14.1753; Nagamori S, 2016, P NATL ACAD SCI USA, V113, P775, DOI 10.1073/pnas.1519959113; Nakanishi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123895; Nakata R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61775-9; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Ohgaki R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00427-16; Ohgaki R, 2016, J PHARMACOL EXP THER, V358, P94, DOI 10.1124/jpet.116.232025; Schuster Victor L, 2015, Trans Am Clin Climatol Assoc, V126, P248; Schuster VL, 2002, PROSTAG OTH LIPID M, V68-9, P633, DOI 10.1016/S0090-6980(02)00061-8; Schuster VL, 1998, ANNU REV PHYSIOL, V60, P221, DOI 10.1146/annurev.physiol.60.1.221; Seifert W, 2012, HUM MUTAT, V33, P660, DOI 10.1002/humu.22042; Shoji H, 2018, ACTA PAEDIATR, V107, P95, DOI 10.1111/apa.14068; Tsuge K, 2019, INT IMMUNOL, V31, P597, DOI 10.1093/intimm/dxz021; Umeno J, 2018, J GASTROENTEROL, V53, P907, DOI 10.1007/s00535-017-1426-y; Umeno J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005581; Zhang Z, 2013, J CLIN ENDOCR METAB, V98, pE923, DOI 10.1210/jc.2012-3568; Zhang ZL, 2012, AM J HUM GENET, V90, P125, DOI 10.1016/j.ajhg.2011.11.019	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241869	10.1371/journal.pone.0241869	http://dx.doi.org/10.1371/journal.pone.0241869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166338	gold, Green Published			2022-12-26	WOS:000592382600085
J	Hu, YJ; Yang, Z; Wang, SL; Sun, DX; Zhong, MM; Wen, MD; Song, J; Zhang, YH				Hu, Yajie; Yang, Zhen; Wang, Shenglan; Sun, Danxiong; Zhong, Mingmei; Wen, Mudong; Song, Jie; Zhang, Yunhui			Comprehensive analysis of differential expression profiles via transcriptome sequencing in SH-SY5Y cells infected with CV-A16	PLOS ONE			English	Article							MOUTH-DISEASE; OXIDATIVE STRESS; CA16 INFECTIONS; HAND; FOOT; EPIDEMIOLOGY; VACCINE; EV71; MODEL	Coxsackievirus A16 (CV-A16) is one of the viruses that is most frequently associated with hand-foot-and-mouth disease (HFMD). Previous studies have shown that CV-A16 infections are mostly self-limiting, but in recent years, it has been gradually found that CV-A16 infections can also induce neurological complications and eventually cause death in children with HFMD. Moreover, no curative drugs or preventative vaccines have been developed for CV-A16 infection. Therefore, it is particularly important to investigate the mechanism of CV-A16 infection-induced neuropathy. In the current study, transcriptome sequencing technology was used to identify changes in the transcriptome of SH-SY5Y cells infected with CV-A16, which might hide the mechanism of CV-A16-induced neuropathology. The transcriptome profiling showed that 82,406,974, 108,652,260 and 97,753,565 clean reads were obtained in the Control, CV-A16-12 h and CV-A16-24 h groups, respectively. And it was further detected that a total of 136 and 161 differentially expressed genes in CV-A16-12 h and CV-A16-24 h groups, respectively, when compared with Control group. Then, to explore the mechanism of CV-A16 infection, we focused on the common differentially expressed genes at different time points of CV-A16 infection and found that there were 34 differentially expressed genes based on which clustering analysis and functional category enrichment analysis were performed. The results indicated that changes in oxidation levels were particularly evident in the GO term analysis, while only the "Gonadotropin-releasing hormone receptor pathway" was enriched in the KEGG pathway analysis, which might be closely related to the neurotoxicity caused by CV-A16 infection. Meanwhile, the ID2 closely related to nervous system has been demonstrated to be increased during CV-A16 infection. Additionally, the data on differentially expressed non-protein-coding genes of different types within the transcriptome sequencing results were analyzed, and it was speculated that these dysregulated non-protein-coding genes played a pivotal role in CV-A16 infection. Ultimately, qRT-PCR was utilized to validate the transcriptome sequencing findings, and the results of qRT-PCR were in agreement with the transcriptome sequencing data. In conclusion, transcriptome profiling was carried out to analyze response of SH-SY5Y cells to CV-A16 infection. And our findings provide important information to elucidate the possible molecular mechanisms which were linked to the neuropathogenesis of CV-A16 infection.	[Hu, Yajie; Yang, Zhen; Wang, Shenglan; Sun, Danxiong; Zhong, Mingmei; Wen, Mudong; Zhang, Yunhui] First Peoples Hosp Yunnan Prov, Dept Resp Med, Kunming, Yunnan, Peoples R China; [Hu, Yajie; Yang, Zhen; Wang, Shenglan; Sun, Danxiong; Zhong, Mingmei; Wen, Mudong; Zhang, Yunhui] Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Yunnan, Peoples R China; [Song, Jie] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College	Zhang, YH (corresponding author), First Peoples Hosp Yunnan Prov, Dept Resp Med, Kunming, Yunnan, Peoples R China.; Zhang, YH (corresponding author), Kunming Univ Sci & Technol, Affiliated Hosp, Kunming, Yunnan, Peoples R China.; Song, J (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China.	songjiekm@163.com; zhangyh123kh@163.com			Yunnan Applied Basic Research Projects [2019FB018, 2018ZF006]; First People's Hospital of Yunnan Province [KHBS-2020-013]; National Natural Sciences Foundations of China [31700153]; Fundamental Research Funds for the Central Universities and PUMC Youth Fund [and PUMC Youth Fund (3332019004]; Medical Reserve Talents of Yunnan Province Health and Family Planning [H-2017034]; Top young talents of Yunnan province ten thousand talents plan	Yunnan Applied Basic Research Projects; First People's Hospital of Yunnan Province; National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities and PUMC Youth Fund; Medical Reserve Talents of Yunnan Province Health and Family Planning; Top young talents of Yunnan province ten thousand talents plan	This study is supported by Yunnan Applied Basic Research Projects (2019FB018 and 2018ZF006), Doctoral Research Fund of the First People's Hospital of Yunnan Province (KHBS-2020-013), National Natural Sciences Foundations of China (31700153), Fundamental Research Funds for the Central Universities and PUMC Youth Fund (3332019004), Medical Reserve Talents of Yunnan Province Health and Family Planning (H-2017034) and Top young talents of Yunnan province ten thousand talents plan (Jie Song). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2017, VIROL SIN, V32, P207, DOI 10.1007/s12250-017-3968-9; [Anonymous], 2017, CR CONSUMER REPORTS, V6, P4, DOI DOI 10.3390/computers6010004; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Aswathyraj S, 2016, MED MICROBIOL IMMUN, V205, P397, DOI 10.1007/s00430-016-0465-y; Brown DM, 2018, MBIO, V9, DOI 10.1128/mBio.01954-18; Camini FC, 2017, VIRUS RES, V236, P1, DOI 10.1016/j.virusres.2017.04.017; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Esposito S, 2018, EUR J CLIN MICROBIOL, V37, P391, DOI 10.1007/s10096-018-3206-x; Guerra AM, 2019, HAND FOOT MOUTH DIS; Hu YJ, 2017, VIRUS RES, V228, P90, DOI 10.1016/j.virusres.2016.11.024; Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Lee Kyung Yeon, 2016, Korean J Pediatr, V59, P395; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Liu MM, 2017, MICROBES INFECT, V19, P580, DOI 10.1016/j.micinf.2017.08.008; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Moraes F, 2016, BIOCHEM MOL BIOL EDU, V44, P215, DOI 10.1002/bmb.20952; Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279; Peng LJ, 2017, INT J INFECT DIS, V65, P37, DOI 10.1016/j.ijid.2017.09.020; Sakai T, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00217; Sharma N, 2016, REV MED VIROL, V26, P356, DOI 10.1002/rmv.1893; Shipley MM, 2017, J VIROL, V91, DOI 10.1128/JVI.00958-17; Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6; Song J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0157-3; Song J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177657; Soung A, 2018, TRENDS MOL MED, V24, P950, DOI 10.1016/j.molmed.2018.09.001; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Yu WM, 2016, BIOMED REP, V4, P761, DOI 10.3892/br.2016.663	33	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241174	10.1371/journal.pone.0241174	http://dx.doi.org/10.1371/journal.pone.0241174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156879	Green Published, gold			2022-12-26	WOS:000591376400017
J	Kim, SY; Choi, SW				Kim, So-Young; Choi, Seong-Woo			Double burden of malnutrition and obesity in children and adolescents from North Korean refugee families	PLOS ONE			English	Article							GROWTH; RISK; OVERWEIGHT; NUTRITION	This study assessed the nutritional status of children and adolescents from North Korean refugee (NKR) families who have settled and are living in South Korea (SK). Among the 547 individuals who participated in the study, 526 were ultimately included after excluding 21 with missing height or weight data. Their nutritional status was estimated using the 2017 Korean National Growth Charts for children and adolescents. Stunting, underweight, wasting, and obesity were defined as a height-for-age z-score < -2.0, weight-for-age z-score < -2.0, weight-for-height z-score < -2.0, and body mass index z-score > 2.0, respectively. The overall prevalence of stunting, underweight, wasting, and obesity was 7.0%, 6.8%, 5.3%, and 9.1%, respectively. Meanwhile, the prevalence of stunting, underweight, wasting, and obesity was 5.4%, 7.0%, 7.6%, and 10.3% for individuals settled in SK for <5 years and 6.1%, 6.1%, 0.0%, and 13.3% for those living in SK for >= 5 years, respectively. Therefore, children and adolescents from NKR families experience the double burden of malnutrition and obesity.	[Kim, So-Young; Choi, Seong-Woo] Chosun Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea	Chosun University	Choi, SW (corresponding author), Chosun Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea.	jcsw74@hanmail.net		Choi, Seong-Woo/0000-0002-6150-3934	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A3B03031660]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2017R1D1A3B03031660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek Hye-Jeong, 2007, [Studies on Korean Youth, 한국청소년연구], V18, P183; Choi SK, 2010, NUTR RES PRACT, V4, P136, DOI 10.4162/nrp.2010.4.2.136; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Gadd M, 2005, EUR J CARDIOV PREV R, V12, P535, DOI 10.1097/00149831-200512000-00004; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; INSOOK LEE, 2011, Child Health Nursing Research, V17, P256; Kim Jae Hyun, 2018, Korean J Pediatr, V61, P135, DOI 10.3345/kjp.2018.61.5.135; Korea Hana Foundation, 2019, SETTL SURV N KOR REF; Korean Foundation, 2020, CURR STAT DEP KOR LA; Lee Kiyoung, 2015, [The Journal of Northeast Asia Research, 동북아연구], V30, P93; Lee SK, 2015, ANN HUM BIOL, V42, P581, DOI 10.3109/03014460.2014.993704; Lee SooKyung, 2012, Korean Journal of Community Nutrition, V17, P407; McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004; Pak S, 2004, ECON HUM BIOL, V2, P511, DOI 10.1016/j.ehb.2004.09.001; Pak S, 2010, ECON HUM BIOL, V8, P385, DOI 10.1016/j.ehb.2010.05.006; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Sawaya AL, 2003, NUTR REV, V61, P168, DOI 10.1301/nr.2003.may.168-175; T&D, 2005, TECHNOL DISABIL, V17, P55; Wells JC, 2020, LANCET, V395, P75, DOI 10.1016/S0140-6736(19)32472-9; WHO, 2006, WHO CHILD GROWTH STA; Yoo GH, 2004, J KOREAN HOME MANAGE, V22, P185	22	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241963	10.1371/journal.pone.0241963	http://dx.doi.org/10.1371/journal.pone.0241963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156888	gold, Green Published			2022-12-26	WOS:000591376400002
J	Amponsah, AK; Bam, V; Stolt, M; Korhonen, J; Axelin, A				Kusi Amponsah, Abigail; Bam, Victoria; Stolt, Minna; Korhonen, Joonas; Axelin, Anna			Evaluating the content validity of two versions of an instrument used in measuring pediatric pain knowledge and attitudes in the Ghanaian context	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; CHILDREN; CONSEQUENCES; ADOLESCENTS; PREVALENCE	In this article, we compared the content validity of two instruments used in measuring pediatric pain knowledge and attitudes. This was considered necessary due to the universal differences in culture, semantics and healthcare resources in different parts of the globe. Thirteen (13) pediatric experts in Ghana assessed the content validity of two instruments: the 42-item Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) and the 41-item Pediatric Healthcare Providers' Knowledge and Attitudes Survey Regarding Pain (PHPKASRP). The relevance and clarity of each item on these instruments were rated on a four-point likert scaled options from 1 (not relevant/ not clear) to 4 (very relevant/ very clear). The item-level content validity index (I-CVI) was calculated by dividing the number of experts who rated an item with 3 or 4 by the total number of experts. The average scale-level content validity index (S-CVI/Ave) was also estimated by summing up the I-CVIs of all items and dividing them by the total number of items. The I-CVIs on the PNKAS ranged from 0.62 to 1.00 for the relevance component and 0.69 to 1.00 for the clarity component. The I-CVIs on the PHPKASRP ranged from 0.62 to 1.00 for both the relevance and clarity components. The S-CVI/Ave were 0.87 and 0.89 for the relevance and clarity aspects on the PNKAS respectively. The S-CVI/Ave for the PHPKASRP instrument were 0.86 and 0.89 for the relevance and clarity aspects correspondingly. At the end of the validation process, 5 items were revised on both instruments whilst 37 and 36 items were maintained on the PNKAS and PHPKASRP instruments respectively. The PNKAS and PHPKASRP have an acceptable level of content validity in the Ghanaian context and recommended for educational and research purposes. Other forms of validity and reliability of these instruments should also be examined in future studies.	[Kusi Amponsah, Abigail; Stolt, Minna; Korhonen, Joonas; Axelin, Anna] Univ Turku, Fac Med, Dept Nursing Sci, Turku, Finland; [Kusi Amponsah, Abigail; Bam, Victoria] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana	University of Turku; Kwame Nkrumah University Science & Technology	Amponsah, AK (corresponding author), Univ Turku, Fac Med, Dept Nursing Sci, Turku, Finland.; Amponsah, AK (corresponding author), Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana.	abkuam@utu.fi	Stolt, Minna/D-1153-2014; Amponsah, Abigail Kusi/AAJ-4569-2021	Stolt, Minna/0000-0002-1845-9800; Amponsah, Abigail Kusi/0000-0002-4591-4215; Axelin, Anna/0000-0003-2743-3589; Korhonen, Joonas/0000-0002-5324-1727				[Anonymous], 2018, LANCET ONCOL, V19, pe581; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Beck CT, 2012, NURSING RES GENERATI; Belay ED, 1999, NEW ENGL J MED, V340, P1377, DOI 10.1056/NEJM199905063401801; Carretero-Dios H, 2009, SPAN J PSYCHOL, V12, P773, DOI 10.1017/S1138741600002146; Catania Gianluca, 2006, Assist Inferm Ric, V25, P149; Chiwaridzo Matthew, 2017, Arch Physiother, V7, P3, DOI 10.1186/s40945-017-0031-y; Clark Richard F., 1995, Journal of Emergency Medicine, V13, P797, DOI 10.1016/0736-4679(95)02002-0; Delgado-Rico E, 2012, INT J CLIN HLTH PSYC, V12, P449; Ferrell B., 2014, VASA OCT VASA OCT, P3, DOI [10.1089/jpm.2007.9828, DOI 10.1089/JPM.2007.9828]; Forgeron PA, 2010, PAIN RES MANAG, V15, P27, DOI 10.1155/2010/820407; Friedrichsdorf SJ, 2016, OTOLARYNG HEAD NECK, V154, P804, DOI 10.1177/0194599816636100; Gadallah M.A.E.-A., 2017, J NURS ED PRACT, V7, P101, DOI [10.5430/jnep.v7n6p100, DOI 10.5430/JNEP.V7N6P100]; Galozzi P, 2019, REUMATISMO, V71, P132, DOI 10.4081/reumatismo.2019.1229; Gan TJ, 2017, J PAIN RES, V10, P2287, DOI 10.2147/JPR.S144066; Habecker S., 2016, J PAN AFR STUD, V9, P253; Holle D, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-485; Hovde Kari Raaum, 2012, Pediatr Nurs, V38, P264; LYNN MR, 1986, NURS RES, V35, P382; Manworren R C, 2001, Pediatr Nurs, V27, P151; Manworren R C, 2000, Pediatr Nurs, V26, P610; Mathews L, 2011, INDIAN J PALLIAT CAR, V17, P70, DOI 10.4103/0973-1075.76247; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Nuseir K, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/8432973; Ojeda B, 2014, FAM SYST HEALTH, V32, P399, DOI 10.1037/fsh0000069; Ozcetin M, 2011, HONG KONG J PAEDIATR, V16, P247; Peirce D, 2016, J CLIN NURS, V25, P1566, DOI 10.1111/jocn.13130; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035; Rieman Mary T, 2007, Pediatr Nurs, V33, P303; Rios R, 2011, HEALTH PSYCHOL, V30, P58, DOI 10.1037/a0022025; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V153, P1067, DOI 10.1177/0194599815608366; Rubio DM, 2003, SOC WORK RES, V27, P94, DOI 10.1093/swr/27.2.94; Shave K, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1300-y; Shrotryia VK, 2019, SAGE OPEN, V9, DOI 10.1177/2158244018821751; Sinatra R, 2010, PAIN MED, V11, P1859, DOI 10.1111/j.1526-4637.2010.00983.x; Sireci S. G., 1998, ED ASSESS, V5, P299, DOI [10.1207/s15326977-a0504_2, DOI 10.1207/S15326977EA0504_2]; Sullivan Gail M, 2011, J Grad Med Educ, V3, P119, DOI 10.4300/JGME-D-11-00075.1; Tafas CA, 2002, CANCER NURS, V25, P8, DOI 10.1097/00002820-200202000-00003; TILDEN VP, 1990, NURS RES, V39, P172; Twycross Alison, 2013, Pain Manag Nurs, V14, pe47, DOI 10.1016/j.pmn.2011.03.001; Wynd CA, 2002, APPL NURS RES, V15, P184, DOI 10.1053/apnr.2002.34243; Zamanzadeh V., 2014, NURS PRACT TODAY, V1, P163; Zamanzadeh Vahid, 2015, J Caring Sci, V4, P165, DOI 10.15171/jcs.2015.017	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241983	10.1371/journal.pone.0241983	http://dx.doi.org/10.1371/journal.pone.0241983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156874	Green Published, gold			2022-12-26	WOS:000591376400035
J	Wilkop, TE; Wang, MM; Heringer, A; Singh, J; Zakharov, F; Krishnan, VV; Drakakaki, G				Wilkop, Thomas E.; Wang, Minmin; Heringer, Angelo; Singh, Jaideep; Zakharov, Florence; Krishnan, Viswanathan V.; Drakakaki, Georgia			NMR spectroscopy analysis reveals differential metabolic responses in arabidopsis roots and leaves treated with a cytokinesis inhibitor	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENE-EXPRESSION; SINGLE-CELL; PLANT; THALIANA; AUXIN; STATE; BETA-1,3-GLUCANASE; BIOSYNTHESIS; DYNAMICS	In plant cytokinesis, de novo formation of a cell plate evolving into the new cell wall partitions the cytoplasm of the dividing cell. In our earlier chemical genomics studies, we identified and characterized the small molecule endosidin-7, that specifically inhibits callose deposition at the cell plate, arresting late-stage cytokinesis in arabidopsis. Endosidin-7 has emerged as a very valuable tool for dissecting this essential plant process. To gain insights regarding its mode of action and the effects of cytokinesis inhibition on the overall plant response, we investigated the effect of endosidin-7 through a nuclear magnetic resonance spectroscopy (NMR) metabolomics approach. In this case study, metabolomics profiles of arabidopsis leaf and root tissues were analyzed at different growth stages and endosidin-7 exposure levels. The results show leaf and root-specific metabolic profile changes and the effects of endosidin-7 treatment on these metabolomes. Statistical analyses indicated that the effect of endosidin-7 treatment was more significant than the developmental impact. The endosidin-7 induced metabolic profiles suggest compensations for cytokinesis inhibition in central metabolism pathways. This study further shows that long-term treatment of endosidin-7 profoundly changes, likely via alteration of hormonal regulation, the primary metabolism of arabidopsis seedlings. Hormonal pathway-changes are likely reflecting the plant's responses, compensating for the arrested cell division, which in turn are leading to global metabolite modulation. The presented NMR spectral data are made available through the Metabolomics Workbench, providing a reference resource for the scientific community.	[Wilkop, Thomas E.] Univ Kentucky, Light Microscopy Core Dept Physiol, Lexington, KY USA; [Wilkop, Thomas E.; Wang, Minmin; Heringer, Angelo; Zakharov, Florence; Drakakaki, Georgia] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Singh, Jaideep; Krishnan, Viswanathan V.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Krishnan, Viswanathan V.] Univ Calif, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA	University of Kentucky; University of California System; University of California Davis; California State University System; California State University Fresno	Drakakaki, G (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Krishnan, VV (corresponding author), Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA.; Krishnan, VV (corresponding author), Univ Calif, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA.	krish@csufresno.edu; gdrakakaki@ucdavis.edu	; Heringer, Angelo/M-8275-2014	Singh, Jaideep/0000-0003-4422-392X; Heringer, Angelo/0000-0002-2723-7353; Wang, Minmin/0000-0001-9545-7895	U.S. National Science Foundation [MCB-1818219]; U.S. Department of Agriculture [CA-D-PLS-2132-H]; U.S. National Institutes of Health [SC3-GM125546]	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the U.S. National Science Foundation MCB-1818219 award to G.D., and U.S. Department of Agriculture award CA-D-PLS-2132-H to G.D and in part by the U.S. National Institutes of Health grant SC3-GM125546 to V.V.K.	Abramoff RZ, 2015, NEW PHYTOL, V205, P1054, DOI 10.1111/nph.13111; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2016, PLANT SIGNAL BEHAV, DOI DOI 10.4161/15592324.2014.984520; [Anonymous], 2019, J ELECTROCHEM SOC, V166, pF3202; Augustijn D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163258; Augustijn D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209695; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Bourguignon J, 1999, BOOK SOIL P, P111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt S, 2002, J EXP BOT, V53, P2315, DOI 10.1093/jxb/erf093; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Choudhury SR, 2010, PLANT CELL REP, V29, P813, DOI 10.1007/s00299-010-0866-0; Davis DJ, 2020, J CELL SCI, V133, DOI 10.1242/jcs.249599; Deborde C, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1488-3; Deborde C, 2017, PROG NUCL MAG RES SP, V102, P61, DOI 10.1016/j.pnmrs.2017.05.001; Deborde Catherine, 2014, Methods Mol Biol, V1083, P3, DOI 10.1007/978-1-62703-661-0_1; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Dick-Perez M, 2012, MAGN RESON CHEM, V50, P539, DOI 10.1002/mrc.3836; Doxey AC, 2007, MOL BIOL EVOL, V24, P1045, DOI 10.1093/molbev/msm024; Drakakaki G, 2015, PLANT SCI, V236, P177, DOI 10.1016/j.plantsci.2015.03.018; Drakakaki G, 2011, P NATL ACAD SCI USA, V108, P17850, DOI 10.1073/pnas.1108581108; Emwas AH, 2019, METABOLITES, V9, DOI 10.3390/metabo9070123; Fontaine JX, 2010, CR CHIM, V13, P453, DOI 10.1016/j.crci.2009.08.003; Ghatak A, 2016, J PROTEOMICS, V143, P122, DOI 10.1016/j.jprot.2016.02.032; Gowda GAN, 2017, ANAL CHEM, V89, P490, DOI 10.1021/acs.analchem.6b04420; Gromova M, 2010, PHYSIOL PLANTARUM, V140, P111, DOI 10.1111/j.1399-3054.2010.01387.x; Hartig K, 2006, PLANT BIOLOGY, V8, P389, DOI 10.1055/s-2006-923797; Hendrawati O, 2006, PLANT SCI, V170, P1118, DOI 10.1016/j.plantsci.2006.01.017; Hennig L, 2007, TRENDS PLANT SCI, V12, P287, DOI 10.1016/j.tplants.2007.05.002; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Izquierdo-Garcia JL, 2011, PROG NUCL MAG RES SP, V59, P263, DOI 10.1016/j.pnmrs.2011.02.001; Jiang ZF, 2020, J INTEGR AGR, V19, P953, DOI 10.1016/S2095-3119(19)62676-6; Johnson SR, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00022; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Keunen E, 2016, ENVIRON EXP BOT, V124, P64, DOI 10.1016/j.envexpbot.2015.11.015; Khan IH, 2009, CYTOM PART B-CLIN CY, V76B, P159, DOI 10.1002/cyto.b.20452; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026214; Kim SW, 2007, BIOTECHNOL BIOPROC E, V12, P653, DOI 10.1007/BF02931082; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Krishnan VV, 2014, CYTOM PART B-CLIN CY, V86, P426, DOI 10.1002/cyto.b.21147; Krueger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017806; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; KULL U, 1978, PLANT CELL PHYSIOL, V19, P801, DOI 10.1093/oxfordjournals.pcp.a075654; Lane AN, 2017, ARCH BIOCHEM BIOPHYS, V628, P123, DOI 10.1016/j.abb.2017.02.009; Levy A, 2007, PLANT J, V49, P669, DOI 10.1111/j.1365-313X.2006.02986.x; Lipka E, 2015, WIRES DEV BIOL, V4, P391, DOI 10.1002/wdev.186; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mahmud I, 2015, J AGR FOOD CHEM, V63, P8083, DOI 10.1021/acs.jafc.5b02108; Markley JL, 2017, CURR OPIN BIOTECH, V43, P34, DOI 10.1016/j.copbio.2016.08.001; Marti G, 2013, PLANT CELL ENVIRON, V36, P621, DOI 10.1111/pce.12002; McMichael CM, 2013, NEW PHYTOL, V197, P1039, DOI 10.1111/nph.12122; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Misra BB, 2014, TRENDS PLANT SCI, V19, P637, DOI 10.1016/j.tplants.2014.05.005; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Nziengui H, 2018, PLANT PHYSIOL, V178, P1370, DOI 10.1104/pp.18.00126; Orr DJ, 2014, METHODS MOL BIOL, V1056, P225, DOI 10.1007/978-1-62703-592-7_21; Park E, 2014, PLANT PHYSIOL, V165, P1019, DOI 10.1104/pp.114.241497; Petit-Paly G, 1999, J PLANT PHYSIOL, V155, P9, DOI 10.1016/S0176-1617(99)80134-5; Philosoph-Hadas S, 2005, VITAM HORM, V72, P31, DOI 10.1016/S0083-6729(05)72002-1; Phyo P, 2017, BIOMACROMOLECULES, V18, P2937, DOI 10.1021/acs.biomac.7b00888; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prokopova J, 2010, PLANT PHYSIOL BIOCH, V48, P716, DOI 10.1016/j.plaphy.2010.04.003; R Core Team, 2013, R LANG ENV STAT COMP; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; Schad M, 2005, ELECTROPHORESIS, V26, P2729, DOI 10.1002/elps.200410399; Schaller GE, 2014, CURR OPIN PLANT BIOL, V21, P7, DOI 10.1016/j.pbi.2014.05.015; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Smertenko A, 2017, TRENDS CELL BIOL, V27, P885, DOI 10.1016/j.tcb.2017.08.008; Sreenivasulu N, 2004, PLANT J, V37, P539, DOI 10.1046/j.1365-313X.2003.01981.x; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P369, DOI 10.1104/pp.98.1.369; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Thi THD, 2009, PLANT PHYSIOL BIOCH, V47, P146, DOI 10.1016/j.plaphy.2008.10.001; THOMAS BR, 1994, PLANT PHYSIOL, V106, P1235, DOI 10.1104/pp.106.4.1235; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Tsukaya H, 2015, NEW NEGATIVES PLANT, V1-2, P53; Ullah N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4321-2; Van Norman JM, 2009, WIRES SYST BIOL MED, V1, P372, DOI 10.1002/wsbm.25; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Wang L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00163; Wang T, 2013, P NATL ACAD SCI USA, V110, P16444, DOI 10.1073/pnas.1316290110; Wang XY, 2016, PLANT PHYSIOL BIOCH, V107, P273, DOI 10.1016/j.plaphy.2016.06.016; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wolfender JL, 2019, ANAL CHEM, V91, P704, DOI 10.1021/acs.analchem.8b05112; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Yuan YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146460; Zarei A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35115; Zeng JB, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1404-4; Zhao Yunde, 2014, Arabidopsis Book, V12, pe0173, DOI 10.1199/tab.0173; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	115	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241627	10.1371/journal.pone.0241627	http://dx.doi.org/10.1371/journal.pone.0241627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156865	gold, Green Published			2022-12-26	WOS:000591376400057
J	Ceballos, GA; Hernandez, LF; Paredes, D; Betancourt, LR; Abdulreda, MH				Ceballos, Gerardo A.; Hernandez, Luis F.; Paredes, Daniel; Betancourt, Luis R.; Abdulreda, Midhat H.			A machine learning approach to predict pancreatic islet grafts rejection versus tolerance	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS; IMMUNE	The application of artificial intelligence (AI) and machine learning (ML) in biomedical research promises to unlock new information from the vast amounts of data being generated through the delivery of healthcare and the expanding high-throughput research applications. Such information can aid medical diagnoses and reveal various unique patterns of biochemical and immune features that can serve as early disease biomarkers. In this report, we demonstrate the feasibility of using an AI/ML approach in a relatively small dataset to discriminate among three categories of samples obtained from mice that either rejected or tolerated their pancreatic islet allografts following transplant in the anterior chamber of the eye, and from naive controls. We created a locked software based on a support vector machine (SVM) technique for pattern recognition in electropherograms (EPGs) generated by micellar electrokinetic chromatography and laser induced fluorescence detection (MEKC-LIFD). Predictions were made based only on the aligned EPGs obtained in microliter-size aqueous humor samples representative of the immediate local microenvironment of the islet allografts. The analysis identified discriminative peaks in the EPGs of the three sample categories. Our classifier software was tested with targeted and untargeted peaks. Working with the patterns of untargeted peaks (i.e., based on the whole pattern of EPGs), it was able to achieve a 21 out of 22 positive classification score with a corresponding 95.45% prediction accuracy among the three sample categories, and 100% accuracy between the rejecting and tolerant recipients. These findings demonstrate the feasibility of AI/ML approaches to classify small numbers of samples and they warrant further studies to identify the analytes/biochemicals corresponding to discriminative features as potential biomarkers of islet allograft immune rejection and tolerance.	[Ceballos, Gerardo A.; Paredes, Daniel; Betancourt, Luis R.] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA; [Hernandez, Luis F.; Betancourt, Luis R.; Abdulreda, Midhat H.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Abdulreda, Midhat H.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Abdulreda, Midhat H.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Abdulreda, Midhat H.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Ceballos, Gerardo A.] Univ Los Andes, Fac Engn, Ctr Biomed Engn & Telemed, Merida, Venezuela; [Betancourt, Luis R.] Univ Los Andes, Sch Med, Fac Med, Dept Morphol Sci, Merida, Venezuela	University of Denver; University of Miami; University of Miami; University of Miami; University of Miami; University of Los Andes Venezuela; University of Los Andes Venezuela	Ceballos, GA (corresponding author), Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA.; Abdulreda, MH (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.; Abdulreda, MH (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.; Abdulreda, MH (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.; Abdulreda, MH (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA.	gerardoacv@gmail.com; mabdulreda@miami.edu		Betancourt, Luis/0000-0002-0791-6113; Abdulreda, Midhat/0000-0002-0146-5876	Diabetes Research Institute Foundation (DRIF); National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [R56AI130330]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UC4DK116241/K01DK097194]; Fulbright Program [PS00256278, PS00289153]	Diabetes Research Institute Foundation (DRIF); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fulbright Program	This research was supported through funds from the Diabetes Research Institute Foundation (DRIF) to MHA; and the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) - R56AI130330 (to MHA), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - UC4DK116241/K01DK097194 (to MHA), the Fulbright Program - PS00256278 (to LRB) and PS00289153 to (GAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulreda MH, 2019, DIABETOLOGIA, V62, P1237, DOI 10.1007/s00125-019-4879-0; Abdulreda MH, 2019, DIABETOLOGIA, V62, P811, DOI 10.1007/s00125-019-4814-4; Abdulreda MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50466; Abdulreda MH, 2011, P NATL ACAD SCI USA, V108, P12863, DOI 10.1073/pnas.1105002108; Alcazar O, 2020, J PROTEOMICS, V223, DOI 10.1016/j.jprot.2020.103826; Alcazar O, 2019, METABOLITES, V9, DOI 10.3390/metabo9100207; Atkinson MA, 2019, LANCET DIABETES ENDO, V7, P52, DOI 10.1016/S2213-8587(18)30112-8; Betancourt L, 2018, J CHROMATOGR B, V1081, P55, DOI 10.1016/j.jchromb.2018.02.015; Betancourt L, 2012, J CHROMATOGR B, V880, P58, DOI 10.1016/j.jchromb.2011.11.016; Ceballos GA, 2008, ELECTROPHORESIS, V29, P2828, DOI 10.1002/elps.200700831; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; HERNANDEZ L, 1993, J CHROMATOGR A, V652, P399, DOI 10.1016/0021-9673(93)83259-U; Jacobsen LM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00070; Kanzelmeyer NK, 2019, TRANSPL INT, V32, P28, DOI 10.1111/tri.13363; Khosravi-Maharlooei M, 2015, EUR J ENDOCRINOL, V173, pR165, DOI 10.1530/EJE-15-0094; Lablanche S, 2018, LANCET DIABETES ENDO, V6, P527, DOI 10.1016/S2213-8587(18)30078-0; Lake BM, 2015, SCIENCE, V350, P1332, DOI 10.1126/science.aab3050; Lernmark A, 2013, NAT REV ENDOCRINOL, V9, P92, DOI 10.1038/nrendo.2012.237; Liang HY, 2019, NAT MED, V25, P433, DOI 10.1038/s41591-018-0335-9; Luis Hernandez JE, 1991, J CHROMATOGR A, V559, P13; Miska J, 2014, J EXP MED, V211, P441, DOI 10.1084/jem.20130785; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Shapiro AMJ, 2017, NAT REV ENDOCRINOL, V13, P268, DOI 10.1038/nrendo.2016.178; Skyler JS, 2015, DIABETES CARE, V38, P997, DOI 10.2337/dc15-0349; Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Takahashi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179790	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241925	10.1371/journal.pone.0241925	http://dx.doi.org/10.1371/journal.pone.0241925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152016	gold, Green Published			2022-12-26	WOS:000591376200029
J	Li, C; Zhang, HB; Singh, VP; Fan, JJ; Wei, XW; Yang, JT; Wei, XC				Li, Ci; Zhang, Hongbo; Singh, Vijay P.; Fan, Jingjing; Wei, Xiaowei; Yang, Jiantao; Wei, Xingchen			Investigating variations of precipitation concentration in the transitional zone between Qinling Mountains and Loess Plateau in China: Implications for regional impacts of AO and WPSH	PLOS ONE			English	Article							EXTREME PRECIPITATION; ARCTIC OSCILLATION; RIVER-BASIN; SPATIAL-DISTRIBUTION; CONCENTRATION INDEX; VARIABILITY; TEMPERATURE; DROUGHT; PATTERNS; SHAANXI	Changes in precipitation patterns greatly impact regional drought/flood risk management and utilization of water resources. The main purpose of this paper was to investigate spatio-temporal variability of precipitation concentration in the transitional zone between Qinling Mountains (QDM), Guanzhong Plain (GZP) and the Loess Plateau (LPNS) in China, using monthly-scale precipitation concentration index (PCI) and daily-scale concentration index (CI) from daily rainfall records. The Mann-Kendall method was employed to illustrate the change in trend of PCI and CI, the Kriging interpolation method was adopted to measure spatial distribution, and the Wavelet transforms were used to explore their spatio-temporal correlation with the Arctic Oscillation (AO) & Western Pacific Subtropical High (WPSH) for revealing the potential attribution of precipitation concentration variation. Also, the regional implication of CI was investigated in the zone to provide local knowledge of the index application. Results showed that annual precipitation demonstrated a north-south increasing layered spatial distribution in the zone, representing a generally decreasing trend. The CI change generally exhibited a more significant decreasing trend than did PCI in LPNS and GZP due to AO slowly increasing over time, with a spatially weak layered or radial north-south decay, and an insignificant increasing trend in QDM impacted by the enhancing WPSH, with an obvious layered or radial spatial distribution. The spatiotemporal pattern of PCI variation represented similar characteristics in attribution with CI, but an inverse spatial distribution due to the phase difference (positive and negative effects) of AO and WPSH influencing seasonal precipitation. Regional analysis of CI showed that the CI value with over 0.62 indicated that approximately 80% of precipitation was contributed by 25% of the rainiest days in this zone. Fortunately, the area with this high CI has been getting smaller, implying a positive trend toward regional flash flood and debris flow control.	[Li, Ci; Zhang, Hongbo; Wei, Xiaowei; Yang, Jiantao; Wei, Xingchen] Changan Univ, Sch Water & Environm, Xian, Peoples R China; [Zhang, Hongbo] Changan Univ, Key Lab Subsurface Hydrol & Ecol Effect Arid Reg, Minist Educ, Xian, Peoples R China; [Singh, Vijay P.] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX USA; [Singh, Vijay P.] Texas A&M Univ, Zachry Dept Civil & Environm Engn, College Stn, TX USA; [Singh, Vijay P.] UAE Univ, Natl Water Ctr, Al Ain, U Arab Emirates; [Fan, Jingjing] Hebei Univ Engn, Sch Water Conservancy & Hydroelect Power, Handan, Peoples R China	Chang'an University; Chang'an University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United Arab Emirates University; Hebei University of Engineering	Zhang, HB (corresponding author), Changan Univ, Sch Water & Environm, Xian, Peoples R China.; Zhang, HB (corresponding author), Changan Univ, Key Lab Subsurface Hydrol & Ecol Effect Arid Reg, Minist Educ, Xian, Peoples R China.	hbzhang@chd.edu.cn	Zhang, Hongbo/E-7708-2016	Zhang, Hongbo/0000-0002-3866-7711	National Natural Science Foundation of China [51979005, 51809005]; Natural Science Foundation of Hebei Province, China [E2019402432]; Natural Science Basic Research Program of Shaanxi Province, China [2020JM250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province, China(Natural Science Foundation of Hebei Province); Natural Science Basic Research Program of Shaanxi Province, China	The work described in this paper was supported financially by the National Natural Science Foundation of China (51979005, 51809005) (http://www.nsfc.gov.cn/), received by HZ; Natural Science Foundation of Hebei Province, China (E2019402432) (https://kjt.hebei.gov.cn/jjb/), received by JF; and Natural Science Basic Research Program of Shaanxi Province, China (2020JM250) (http://kjt.shaanxi.gov.cn/), received by HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Apaydin H, 2006, J HYDROL, V328, P726, DOI 10.1016/j.jhydrol.2006.01.019; Brunetti M, 2006, INT J CLIMATOL, V26, P345, DOI 10.1002/joc.1251; Chang JX, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-016-2638-9; Chen YN, 2014, QUATERN INT, V336, P35, DOI 10.1016/j.quaint.2013.12.057; Cooley A, 2017, CLIMATE, V5, DOI 10.3390/cli5010010; Coscarelli R, 2012, J HYDROL, V416, P145, DOI 10.1016/j.jhydrol.2011.11.047; Deng SL, 2017, J HYDROL-REG STUD, V9, P183, DOI 10.1016/j.ejrh.2016.12.079; Diaz-Sandoval R, 2011, ANN GEOPHYS-GERMANY, V29, P1113, DOI 10.5194/angeo-29-1113-2011; Dogan M, 2015, THEOR APPL CLIMATOL, V121, P23, DOI 10.1007/s00704-014-1209-9; Du SQ, 2015, WATER-SUI, V7, P1808, DOI 10.3390/w7051808; Gabriels D., 2006, SOIL EROSION EUROPE, DOI [10.1002/0470859202.ch48, DOI 10.1002/0470859202.CH48]; Givati A, 2013, ATMOS RES, V132, P114, DOI 10.1016/j.atmosres.2013.05.001; Gong XH, 2020, AGR WATER MANAGE, V239, DOI 10.1016/j.agwat.2020.106264; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; He YF, 2018, GEOMAT NAT HAZ RISK, V9, P70, DOI 10.1080/19475705.2017.1407369; Huang J, 2015, STOCH ENV RES RISK A, V29, P1403, DOI 10.1007/s00477-015-1051-3; Huang J, 2014, THEOR APPL CLIMATOL, V118, P581, DOI 10.1007/s00704-013-1087-6; Huang SZ, 2017, J HYDROL, V547, P184, DOI 10.1016/j.jhydrol.2017.01.041; Jiang RG, 2017, THEOR APPL CLIMATOL, V130, P831, DOI 10.1007/s00704-016-1910-y; Kendall MG, 1990, SCI FORUM, V5th, DOI [10.2307/1907752, DOI 10.2307/1907752]; Li BF, 2016, ATMOS RES, V167, P275, DOI 10.1016/j.atmosres.2015.08.017; LI C, 2019, WATER SUI, V0011, DOI DOI 10.3390/W11112407; Li C, 2017, THEOR APPL CLIMATOL, V129, P397, DOI 10.1007/s00704-016-1783-0; Li P., 2019, ECOL INDIC, V98, P462, DOI [10.1016/j.ecolind.2018.11.037, DOI 10.1016/j.ecolind.2018.11.037]; Li Q, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5583-8; Liu RF, 2012, J CHENGDU U INFORM T, V27, P306; Liu SY, 2017, J HYDROL, V548, P184, DOI 10.1016/j.jhydrol.2017.03.012; Liu WL, 2013, QUATERN INT, V313, P118, DOI 10.1016/j.quaint.2013.06.033; [刘友存 Liu Youcun], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P1564; Liu ZY, 2018, ATMOS RES, V200, P117, DOI 10.1016/j.atmosres.2017.10.012; LU YJ, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11050881; Ma SM, 2015, J CLIMATE, V28, P6960, DOI 10.1175/JCLI-D-15-0011.1; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Mao R, 2011, CLIM RES, V50, P187, DOI 10.3354/cr01041; Martin-Vide J, 2004, INT J CLIMATOL, V24, P959, DOI 10.1002/joc.1030; Mathbout S, 2020, INT J CLIMATOL, V40, P1435, DOI 10.1002/joc.6278; Meseguer-Ruiz O, 2019, INT J CLIMATOL, V39, P4595, DOI 10.1002/joc.6089; Nery J. T., 2017, Atmospheric and Climate Sciences, V7, P176, DOI 10.4236/acs.2017.72013; OLIVER JE, 1980, PROF GEOGR, V32, P300, DOI 10.1111/j.0033-0124.1980.00300.x; Pagano L, 2010, LANDSLIDES, V7, P273, DOI 10.1007/s10346-010-0216-x; Qu JX, 2017, THEOR APPL CLIMATOL, V130, P487, DOI 10.1007/s00704-016-1900-0; Shi WL, 2013, J HYDROL, V495, P197, DOI 10.1016/j.jhydrol.2013.05.002; Song XY, 2015, ATMOS RES, V157, P137, DOI 10.1016/j.atmosres.2015.01.022; Sun WY, 2016, ATMOS RES, V168, P33, DOI 10.1016/j.atmosres.2015.09.001; Teixeira JC, 2014, NAT HAZARD EARTH SYS, V14, P2009, DOI 10.5194/nhess-14-2009-2014; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1998, Q J ROY METEOR SOC, V124, P1985, DOI 10.1256/smsqj.55009; Vu TM, 2018, INT J CLIMATOL, V38, P2067, DOI 10.1002/joc.5317; Vyshkvarkova E, 2018, ATMOS RES, V203, P36, DOI 10.1016/j.atmosres.2017.12.003; Wang SJ, 2013, QUATERN INT, V311, P97, DOI 10.1016/j.quaint.2013.07.008; Wei XW, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072410; Wen SH, 2019, J CHENGDU U INFORM T, V34, P403; Wu H, 2017, INT J CLIMATOL, V37, P2582, DOI 10.1002/joc.4866; WU LZ, 2019, WATER SUI, V0011, DOI [DOI 10.3390/w11061159, DOI 10.3390/W11061159]; Xu M, 2018, ATMOS RES, V203, P141, DOI 10.1016/j.atmosres.2017.12.007; Yang RW, 2017, J CLIMATE, V30, P3325, DOI 10.1175/JCLI-D-16-0434.1; Yang T, 2020, ATMOS RES, V241, DOI 10.1016/j.atmosres.2020.104954; Zamani R, 2018, STOCH ENV RES RISK A, V32, P1085, DOI 10.1007/s00477-017-1447-3; Zeng W, 2018, METEOROL ATMOS PHYS, V130, P191, DOI 10.1007/s00703-017-0509-x; Zhai LX, 2009, NAT HAZARDS, V49, P1, DOI 10.1007/s11069-008-9274-y; Zhang KX, 2019, INT J CLIMATOL, V39, P4648, DOI 10.1002/joc.6092; Zhang KX, 2017, THEOR APPL CLIMATOL, V130, P523, DOI 10.1007/s00704-016-1887-6; Zhang Q, 2006, J HYDROL, V324, P255, DOI 10.1016/j.jhydrol.2005.09.023; Zhang Q, 2009, STOCH ENV RES RISK A, V23, P377, DOI 10.1007/s00477-008-0225-7; [赵强 Zhao Qiang], 2013, [中国农业气象, Chinese Journal of Agrometeorology], V34, P278; Zhou TJ, 2009, J CLIMATE, V22, P2199, DOI 10.1175/2008JCLI2527.1; Zolina O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042468	68	8	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0238709	10.1371/journal.pone.0238709	http://dx.doi.org/10.1371/journal.pone.0238709			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151946	gold, Green Published			2022-12-26	WOS:000591376200108
J	Milne, RJ; Cotfas, LA; Delcea, C; Craciun, L; Molanescu, AG				Milne, R. John; Cotfas, Liviu-Adrian; Delcea, Camelia; Craciun, Liliana; Molanescu, Anca-Gabriela			Adapting the reverse pyramid airplane boarding method for social distancing in times of COVID-19	PLOS ONE			English	Article							LINEAR-PROGRAMMING APPROACH; MODEL; PASSENGERS; OPTIMIZATION	Social distancing resulting from the new coronavirus (SARS-CoV2) has disrupted the airplane boarding process. Social distancing norms reduce airplane capacity by keeping the middle seats unoccupied, while an imposed aisle social distance between boarding passengers slows the boarding. Recent literature suggests the Reverse Pyramid boarding method is a promising way to reduce health risk and keep boarding times low when 10 apron buses (essentially 10 boarding groups) are used to transport passengers from the airport terminal to a two-door airplane. We adapt the Reverse Pyramid method for social distancing when an airplane is boarded using a jet bridge that connects the terminal the airplane's front door. We vary the number of boarding groups from two to six and use stochastic simulation and agent-based modelling to show the resulting impact on four performance evaluation metrics. Increasing the number of boarding groups from two to six reduces boarding time only up to four groups but continues to reduce infection risk up to six groups. If the passengers carry fewer luggage aboard the airplane, health risks (as well as boarding times) decrease. One adaptation of the Reverse Pyramid (RP) method (RP-Spread) provides slightly faster boarding times than the other (RP-Steep), when luggage volumes are high, while RP-Steep results in less risk to window seat passengers from later-boarding passengers walking by their row. Increasing the minimum aisle social distance from 1 m to 2 m increases boarding times but results in lower health risks to passengers walking down the aisle and to the previously seated passengers they pass.	[Milne, R. John] Clarkson Univ, David D Reh Sch Business, Potsdam, NY USA; [Cotfas, Liviu-Adrian; Delcea, Camelia] Bucharest Univ Econ Studies, Dept Econ Informat & Cybernet, Bucharest, Romania; [Craciun, Liliana; Molanescu, Anca-Gabriela] Bucharest Univ Econ Studies, Dept Econ & Econ Policies, Bucharest, Romania	Clarkson University; Bucharest University of Economic Studies; Bucharest University of Economic Studies	Delcea, C (corresponding author), Bucharest Univ Econ Studies, Dept Econ Informat & Cybernet, Bucharest, Romania.	camelia.delcea@csie.ase.ro	Milne, R. John/R-8923-2019; Cotfas, Liviu-Adrian/D-2317-2009; Delcea, Camelia/C-4343-2011	Cotfas, Liviu-Adrian/0000-0002-4192-183X; Delcea, Camelia/0000-0003-3589-1969				Alitalia, 2020, ALITALIA; Alizadeh R, 2011, SAFETY SCI, V49, P315, DOI 10.1016/j.ssci.2010.09.006; [Anonymous], DELTA NEWS HUB; [Anonymous], 2020, SYMMETRY BASEL, DOI DOI 10.3390/SYM12071087; [Anonymous], 2020, FUTURE TRAVEL EXPERI; [Anonymous], 2019, SYMMETRY BASEL, DOI DOI 10.3390/SYM11101221; Ash L., 2020, SIMPLE FLYING; Audenaert J., 2009, P 21 BEN C ART INT E, P3; Bachmat E, 2009, OPER RES, V57, P499, DOI 10.1287/opre.1080.0630; Badham J, 2015, REV INTRO AGENT BASE; Baker P, 2020, PUBLIC GLOBAL HLTH, DOI [DOI 10.1101/2020.07.02.20143826, 10.1101/2020.07.02.20143826]; Bazargan M, 2007, EUR J OPER RES, V183, P394, DOI 10.1016/j.ejor.2006.09.071; Bidanda R., 2017, P 24 INT C PROD RES, P1; Business Traveller, 2020, BUS TRAVEL; Clark G, 2018, ECON HIST REV, V71, P55, DOI 10.1111/ehr.12528; Cotfas LA, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11081044; Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570; DELCEA C, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10103619; Delcea C, 2019, IEEE ACCESS, V7, P134372, DOI 10.1109/ACCESS.2019.2941532; Delcea C, 2018, LECT NOTES ARTIF INT, V11055, P329, DOI 10.1007/978-3-319-98443-8_30; Delcea C, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061879; Delta, 2020, DELTA NEWS HUB; Derjany P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235891; EASA, 2020, COVID 19 AV HLTH SAF; Ferrari P, 2005, TRANSPORT RES REC, P44, DOI 10.3141/1915-06; Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806; Harrington J, OUTHWEST CHANGES BOA; Hutter L, 2018, OMEGA, DOI 10.1016/j.omega.2018.09.002; Iacus SM, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104791; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Islam T, 2020, ARXIV200606403; Jaehn F, 2015, EUR J OPER RES, V244, P339, DOI 10.1016/j.ejor.2014.12.008; Kierzkowski A, 2017, PROCEDIA ENGINEER, V187, P348, DOI 10.1016/j.proeng.2017.04.385; Kuo CC, 2015, APPL MANAG SCI, V17, P53, DOI 10.1108/S0276-897620140000017003; Lahijani MS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229690; Milne RJ, 2020, IEEE ACCESS, V8, P151650, DOI 10.1109/ACCESS.2020.3015736; Milne RJ, 2020, IEEE ACCESS, V8, P18019, DOI 10.1109/ACCESS.2020.2968410; Milne RJ, 2019, J AIR TRANSP MANAG, V80, DOI 10.1016/j.jairtraman.2019.101705; Milne RJ, 2018, AEROSPACE-BASEL, V5, DOI 10.3390/aerospace5030080; Milne RJ, 2016, J AIR TRANSP MANAG, V54, P104, DOI 10.1016/j.jairtraman.2016.03.022; Milne RJ, 2014, J AIR TRANSP MANAG, V34, P93, DOI 10.1016/j.jairtraman.2013.08.006; Milne RJ, 2020, J REV UNPUB; Notomista G, 2016, J AIR TRANSP MANAG, V53, P140, DOI 10.1016/j.jairtraman.2016.02.012; Nyquist DC, 2008, J AIR TRANSP MANAG, V14, P197, DOI 10.1016/j.jairtraman.2008.04.004; Ponsiglione C, 2015, ADV INTELL SYST, V377, P309, DOI 10.1007/978-3-319-19704-3_26; Qiang SJ, 2014, J AIR TRANSP MANAG, V40, P42, DOI 10.1016/j.jairtraman.2014.05.007; Ren XH, 2020, J AIR TRANSP MANAG, V84, DOI 10.1016/j.jairtraman.2019.101761; Salari M, 2020, J AIR TRANSP MANAG, V89, DOI 10.1016/j.jairtraman.2020.101915; Schultz M., 2017, SAE TECH PAP, DOI [10.4271/2017-01-2113, DOI 10.4271/2017-01-2113]; Schultz M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135329; Schultz M, 2018, TRANSPORT RES C-EMER, V90, P334, DOI 10.1016/j.trc.2018.03.016; Schultz M, 2018, AEROSPACE, V5, DOI 10.3390/aerospace5010008; Schultz M, 2018, AEROSPACE, V5, DOI 10.3390/aerospace5010027; Schultz M, 2018, TRANSPORT RES C-EMER, V86, P467, DOI 10.1016/j.trc.2017.11.002; Schultz M, 2017, TRANSPORT RES C-EMER, V85, P131, DOI 10.1016/j.trc.2017.09.014; Soolaki M, 2012, APPL MATH MODEL, V36, P4060, DOI 10.1016/j.apm.2011.11.030; Steffen JH, 2008, AM J PHYS, V76, P1114, DOI 10.1119/1.2982636; Steffen JH, 2008, J AIR TRANSP MANAG, V14, P146, DOI 10.1016/j.jairtraman.2008.03.003; Steffen JH, 2012, J AIR TRANSP MANAG, V18, P64, DOI 10.1016/j.jairtraman.2011.10.003; Steiner A., 2009, P SWISS TRANSP RES C, P1; Tang TQ, 2018, TRANSPORT RES C-EMER, V93, P115, DOI 10.1016/j.trc.2018.05.029; Taylor Stephanie., 2020, APEX AIRLINE PASSENG; thelocal.it, 2020, ITALY BANS HAND LUGG; thelocal.it, 2020, ITALY LIFTS BAN HAND; Thiessen T, FORBES; Topham G., 2020, GUARDIAN; van den Briel MHL, 2005, INTERFACES, V35, P191, DOI 10.1287/inte.1050.0135; Van Landeghem H, 2002, EUR J OPER RES, V142, P294, DOI 10.1016/S0377-2217(01)00294-6; Walton John., 2020, WILL EMPTY MIDDLE SE; Wilensky U., 2015, INTRO AGENT BASED MO; Wilensky U., 1999, NETLOGO; Wittmann J, 2019, J AIR TRANSP MANAG, V76, P31, DOI 10.1016/j.jairtraman.2019.02.002; WTTC-World Travel and Tourism Council, 2020, LEAD GLOB PROT NEW N	73	15	15	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0242131	10.1371/journal.pone.0242131	http://dx.doi.org/10.1371/journal.pone.0242131			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147603	Green Published, gold			2022-12-26	WOS:000589609300003
J	Sikombe, K; Mody, A; Kadota, J; Pry, JJ; Simbeza, S; Eshun-Wilson, I; Situmbeko, SR; Bukankala, C; Beres, L; Mukamba, N; Mwanza, MW; Bolton-Moore, C; Holmes, CB; Geng, EH; Sikazwe, I				Sikombe, Kombatende; Mody, Aaloke; Kadota, Jillian; Pry, Jesse Jake; Simbeza, Sandra; Eshun-Wilson, Ingrid; Situmbeko, Sitali Richard; Bukankala, Chama; Beres, Laura; Mukamba, Njekwa; Mwanza, Mwanza Wa; Bolton-Moore, Carolyn; Holmes, Charles B.; Geng, Elvin H.; Sikazwe, Izukanji			Understanding patient transfers across multiple clinics in Zambia among HIV infected adults	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; CARE; AFRICA; RETENTION; OUTCOMES; LOST; PROGRAMS; REASONS; SERVICE	Many patients in HIV care in Africa considered lost to follow up (LTFU) at one facility are reportedly accessing care in another. The success of these unofficial transfers as measured by time to re-entry at the new-facility, prevalence of treatment interruptions, speed of ART-initiation, and overall continuity of care is not well characterized but may reveal opportunities for improvement. We traced a random sample of LTFU HIV-infected patients in Zambia. Among those found alive and reported in care at a new-facility, we reviewed records at the receiving facility to verify transfer; and when verified, documented the transfer experience. We used Kaplan-Meier methods to examine incidence of ART-initiation after transfer to new clinic. We assessed demographic and clinical characteristics, official and cross-provincial transfer for associations with HIV treatment re-engagement using Poisson regression models and associations between official-transfer and same-day ART initiation at the new-facility. Among 350 LTFU-patients, 178 (51%) were successfully verified through chart review at the new-facility. 132 (74.2%) were female, 72 (40.4%) aged 25-35, and 51% were ever recorded as previously being on ART. 110 patients (61.8%) were registered under new ART-IDs and 97 (54.5%) received a new HIV test. 54% of those previously on ART-initiated on the same-day. Using the same ART-ID was associated with same-day initiation compared to those receiving a new ART-ID (p = 0.07). 80% (n = 91) of those ever on ART had evidence of medication initiation at new clinic. Among these, initiation reached 66% (95% CI: 56-75) by 30 days, 77.5% (95% CI: 68-86) by 90 days after new-facility presentation. Many patients use new identifiers at new facilities, indicative of inefficiencies. Re-entry into new facilities among the unofficial-transfer population is often delayed and timely treatment initiation is inconsistent, suggesting interruptions in treatment. Health systems innovations to ensure smooth and safe transfers are needed to maintain quality HIV care.	[Sikombe, Kombatende; Pry, Jesse Jake; Simbeza, Sandra; Situmbeko, Sitali Richard; Bukankala, Chama; Mukamba, Njekwa; Mwanza, Mwanza Wa; Bolton-Moore, Carolyn; Holmes, Charles B.; Sikazwe, Izukanji] Ctr Infect Dis Res Zambia, Res Dept, Lusaka, Zambia; [Sikombe, Kombatende] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Mody, Aaloke; Pry, Jesse Jake; Eshun-Wilson, Ingrid; Geng, Elvin H.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Kadota, Jillian] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Kadota, Jillian] Univ Calif San Francisco, Ctr TB, San Francisco, CA 94143 USA; [Beres, Laura; Holmes, Charles B.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Bolton-Moore, Carolyn] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Holmes, Charles B.] Georgetown Univ, Ctr Global Hlth & Qual, Washington, DC USA	University of London; London School of Hygiene & Tropical Medicine; Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Georgetown University	Sikombe, K (corresponding author), Ctr Infect Dis Res Zambia, Res Dept, Lusaka, Zambia.; Sikombe, K (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England.	Kombatendes.sikombe@cidz.org	Sikombe, Kombatende/AAW-5080-2021; Pry, Jake Michael/V-7245-2019	Sikombe, Kombatende/0000-0002-8187-8661; Pry, Jake Michael/0000-0001-6312-4420; Bolton Moore, Carolyn/0000-0001-9103-7746; Beres, Laura/0000-0002-4731-7828	Bill and Melinda Gates Foundation [OPP1105071]; National Institutes for Allergy and Infectious Diseases [P30 AI027763, K24 AI134413]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was made possible by funding support from the Bill and Melinda Gates Foundation [grant number OPP1105071] and National Institutes for Allergy and Infectious Diseases [P30 AI027763 and K24 AI134413 to Elvin H. Geng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camlin CS, 2014, POPUL SPACE PLACE, V20, P528, DOI 10.1002/psp.1794; Clouse K, 2017, INT HEALTH, V9, P203, DOI 10.1093/inthealth/ihx024; Clouse K, 2017, JAIDS-J ACQ IMM DEF, V74, P383, DOI 10.1097/qai.0000000000001284; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gill MJ, 2016, AIDS CARE, V28, P1073, DOI 10.1080/09540121.2016.1139042; Hickey MD, 2016, AIDS CARE, V28, P1386, DOI 10.1080/09540121.2016.1179253; Holmes CB, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002489; Kinfu Y, 2009, B WORLD HEALTH ORGAN, V87, P225, DOI 10.2471/BLT.08.051599; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Labonte R, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0093-4; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; Lv Z., 2008, PLOS ONE, V3, pe3933; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mwamba C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001007; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Sikazwe I, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002811; Stime KJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3154-2; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; Vincenty Thaddeus, 1975, SURVEY REV; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Bank, 2018, ROL DIG ID HEALTHC E; World Health Organization (WHO), 2015, GUID START ANT THER, P78; Zanolini A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002636	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241477	10.1371/journal.pone.0241477	http://dx.doi.org/10.1371/journal.pone.0241477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147250	Green Published, gold			2022-12-26	WOS:000589609300076
J	Tillman, FD; Anderson, JR; Unema, JA; Chapin, TP				Tillman, Fred D.; Anderson, Jessica R.; Unema, Joel A.; Chapin, Thomas P.			Assessing uranium and select trace elements associated with breccia pipe uranium deposits in the Colorado River and main tributaries in Grand Canyon, USA	PLOS ONE			English	Article							SEDIMENT QUALITY GUIDELINES; WATERS; METALS; ARIZONA	Assessing chemical loading from streams in remote, difficult-to-access watersheds is challenging. The Grand Canyon area in northern Arizona, an international tourist destination and sacred place for many Native Americans, is characterized by broad plateaus divided by canyons as much as two-thousand meters deep and hosts some of the highest-grade uranium deposits in the U.S. From 2015-2018 major surface waters in Grand Canyon were monitored for select elements associated with breccia-pipe uranium deposits in the area, including uranium, arsenic, cadmium, and lead. Dissolved constituents in the Colorado River were monitored upstream (Lees Ferry), in the middle (Phantom Ranch), and downstream (Diamond Creek) of uranium mining areas. Concentrations of uranium, arsenic, cadmium, and lead at these main-stem sites varied little during the study period and were all well below human health and aquatic life benchmark criteria (30, 10, 5, and 15 mu g/L maximum contaminant levels and 15, 150, 0.8, and 3.1 mu g/L aquatic life criteria, respectively). Additionally, dissolved and sediment-bound constituents were monitored during a wide range of streamflow conditions at Little Colorado River, Kanab Creek, and Havasu Creek tributaries, whose watersheds have experienced different levels of uranium mining activities over time. Samples from the tributary sites contained <= 3.8 mu g/L of dissolved cadmium and lead, and <= 17 mu g/L of dissolved uranium. Dissolved arsenic also was mostly below human and aquatic life criteria at Little Colorado River and Kanab Creek; however, 63% of water samples from Havasu Creek were above the maximum contaminant level for arsenic. Arsenic in suspended sediment was greater than sediment quality guidelines in 9%, 35%, and 35% of samples from Little Colorado River, Kanab Creek, and Havasu Creek, respectively. At the concentrations observed during this study, tributaries contributed on average only about 0.12 mu g/L of arsenic and 0.03 mu g/L of uranium to the main-stem river. This study demonstrates how chemical loading from mined watersheds may be reliably assessed across a wide range of flow conditions in challenging locations.	[Tillman, Fred D.] US Geol Survey, Arizona Water Sci Ctr, Tucson, AZ 85721 USA; [Anderson, Jessica R.; Unema, Joel A.] US Geol Survey, Arizona Water Sci Ctr, Flagstaff, AZ 86001 USA; [Chapin, Thomas P.] US Geol Survey, Geol Geophys & Geochem Sci Ctr, Box 25046, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Tillman, FD (corresponding author), US Geol Survey, Arizona Water Sci Ctr, Tucson, AZ 85721 USA.	ftillman@usgs.gov		Chapin, Thomas/0000-0001-6587-0734; Tillman, Fred/0000-0002-2922-402X	USGS Toxic Substances Hydrology Program; Department of the Interior's Glen Canyon Dam Adaptive Management Program	USGS Toxic Substances Hydrology Program(United States Geological Survey); Department of the Interior's Glen Canyon Dam Adaptive Management Program	This study was supported by the USGS Toxic Substances Hydrology Program and Department of the Interior's Glen Canyon Dam Adaptive Management Program.	[Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Beisner KR, 2020, HYDROGEOL J, V28, P1615, DOI 10.1007/s10040-020-02192-0; Beisner KR, 2017, HYDROGEOL J, V25, P539, DOI 10.1007/s10040-016-1494-8; Beisner KR, 2017, 20175086 US GEOL SUR, P58, DOI [10.3133/sir20175068, DOI 10.3133/SIR20175068]; Bern CR, 2019, ENVIRON POLLUT, V248, P90, DOI 10.1016/j.envpol.2019.01.122; Billingsley GH, 1983, US GEOL SURV MISC FI, P10; Brugge D, 2002, AM J PUBLIC HEALTH, V92, P1410, DOI 10.2105/AJPH.92.9.1410; Canadian Council of Ministers of the Environment, 2011, CAN ENV QUAL GUID; Cenci RM, 2004, SCI TOTAL ENVIRON, V332, P167, DOI 10.1016/j.scitotenv.2004.01.018; Chenoweth WL, 1986, 86510 US GEOL SURV, P125, DOI [10.3133/ofr86510, DOI 10.3133/0FR86510]; Cohen Michael., 2011, MUNICIPAL DELIVERIES; Dahlkamp F. J., 2009, URANIUM DEPOSITS WOR; EPA (United States Environmental Protection Agency), 2019, NAT REC WAT QUAL CRI; Faires LM, 1993, 92634 US GEOL SURV; Fisk GG, 1994, 94356 US GEOL SURV, P468, DOI [10.3133/ofr94356, DOI 10.3133/0FR94356]; Foust RD, 1985, SEASONAL TRENDS CHEM, P11617413; Garbarino JR, 2006, US GEOL SURV TECHN B, P88; Helsel D. R., 2002, 4A3 USGS, V4, pA3; Helsel D. R., 2012, STAT CENSORED ENV DA; Helsel DR, 2005, ENVIRON SCI TECHNOL, V39, p419A, DOI 10.1021/es053368a; Hem JD, 1989, US GEOLOGICAL SURVEY, V2254, P264; Hopkins RT, 1984, 84291 US GEOL SURV, P84, DOI [10.3133/ofr84291, DOI 10.3133/0FR84291]; Hore-Lacy I, 2016, WOODHEAD PUBLISHING, V93, P488; HUNTOON PW, 1981, GROUND WATER, V19, P20, DOI 10.1111/j.1745-6584.1981.tb03433.x; LANGMUIR D, 1978, GEOCHIM COSMOCHIM AC, V42, P547, DOI 10.1016/0016-7037(78)90001-7; Lee L., 2017, PACKAGE NADA NONDETE; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Monroe SA, 2005, 20045146 US GEOL SUR, P59, DOI 10.3133/sir20045146; Namiesnik J, 2010, CHEM SPEC BIOAVAILAB, V22, P1, DOI 10.3184/095422910X12632119406391; National Park Service, 1996, NPSNRWRDNRTR96842V, V2; National Research Council, 1999, ARS DRINK WAT, DOI [10.17226/6444, DOI 10.17226/6444]; Organisation for Economic Co-operation and Development, 2014, 7062 NEA ORG EC COOP, P144; Otton JK, 2010, 20105025 US GEOL SUR, P353, DOI [10.3133/sir20105025, DOI 10.3133/SIR20105025]; R Core Team, 2021, R LANGUAGE ENV STAT; Raoult FM, 1887, MODERN THEORY SOLUTI, P125; Roberts LC, 2004, ENVIRON SCI TECHNOL, V38, P307, DOI 10.1021/es0343205; STEWART BD, 1988, J RADIOAN NUCL CH AR, V123, P121, DOI 10.1007/BF02036385; Taggart JE, 2002, 02223 US GEOL SURV; Taylor HE, 1996, 96614 US GEOL SURV, P176, DOI [10.3133/ofr96614, DOI 10.3133/0FR96614]; Thompson PA, 2005, ENVIRON MONIT ASSESS, V110, P71, DOI 10.1007/s10661-005-6291-0; UNESCO, 2021, WORLD HER LIST; US Department of the Interior, 2012, REC DEC NORTH AR WIT; US Environmental Protection Agency, 2007, EPA600R07140, P124; US Environmental Protection Agency, 2019, DRINK WAT CONT; US Environmental Protection Agency, 2006, 402R5009 EPA, P26; US Environmental Protection Agency, 1999, 402R99004B EPA, P341; US Geological Survey, 2019, SED DISCH DAT; US Geological Survey, US GEOL SURV TECH ME, pA1; Van Gosen BS, 2016, 20161160 US GEOL SUR, P9, DOI [10.3133/ofr20161160, DOI 10.3133/0FR20161160]; Wenrich JK, 1994, 93619 US GEOL SURV, P66, DOI [10.3133/ofr93619, DOI 10.3133/0FR93619]; Wirt L, 1994, 944192 US GEOL SURV, P26, DOI [10.3133/wri944192, DOI 10.3133/WRI944192]; Wolf RE, 2015, 20151010 US GEOL SUR, P34, DOI [10.3133/ofr20151010, DOI 10.3133/0FR20151010]	54	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241502	10.1371/journal.pone.0241502	http://dx.doi.org/10.1371/journal.pone.0241502			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147289	gold, Green Published			2022-12-26	WOS:000589609300047
J	Luo, C; Li, YR; Chen, AF; Tang, YL				Luo, Chen; Li, Yuru; Chen, Anfan; Tang, Yulong			What triggers online help-seeking retransmission during the COVID-19 period? Empirical evidence from Chinese social media	PLOS ONE			English	Article							HEALTH INFORMATION; SELF-DISCLOSURE; SOURCE CREDIBILITY; SUPPORT; CANCER; COMMUNICATION; SATISFACTION; RETWEET; NETWORK; PERCEPTIONS	The past nine months witnessed COVID-19's fast-spreading at the global level. Limited by medical resources shortage and uneven facilities distribution, online help-seeking becomes an essential approach to cope with public health emergencies for many ordinaries. This study explores the driving forces behind the retransmission of online help-seeking posts. We built an analytical framework that emphasized content characteristics, including information completeness, proximity, support seeking type, disease severity, and emotion of help-seeking messages. A quantitative content analysis was conducted with a probability sample consisting of 727 posts. The results illustrate the importance of individual information completeness, high proximity, instrumental support seeking. This study also demonstrates slight inconformity with the severity principle but stresses the power of anger in help-seeking messages dissemination. As one of the first online help-seeking diffusion analyses in the COVID-19 period, our research provides a reference for constructing compelling and effective help-seeking posts during a particular period. It also reveals further possibilities for harnessing social media's power to promote reciprocal and cooperative actions as a response to this deepening global concern.	[Luo, Chen] Tsinghua Univ, Sch Journalism & Commun, Beijing, Peoples R China; [Luo, Chen] Univ Calif Davis, Dept Commun, Davis, CA 95616 USA; [Li, Yuru] Univ Bremen, Ctr Media Commun & Informat Res, Bremen, Germany; [Chen, Anfan] Univ Sci & Technol China, Sch Humanity & Social Sci, Hefei, Anhui, Peoples R China; [Tang, Yulong] Commun Univ China, Inst Commun Studies, Beijing, Peoples R China	Tsinghua University; University of California System; University of California Davis; University of Bremen; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Communication University of China	Li, YR (corresponding author), Univ Bremen, Ctr Media Commun & Informat Res, Bremen, Germany.; Chen, AF (corresponding author), Univ Sci & Technol China, Sch Humanity & Social Sci, Hefei, Anhui, Peoples R China.	yuru.li@foxmail.com; caftsinghuaedu@gmail.com	Chen, Anfan/AAR-4988-2021; Luo, Chen/AAW-9043-2020; Luo, Chen/GQO-9299-2022	Luo, Chen/0000-0002-9736-0533; 	Science Popularization and Risk Communication of Transgenic Biotechnologies Project [2016ZX08015002]; China Scholarship [201906210115]; USTC [DA2110251001, YD2110002015]	Science Popularization and Risk Communication of Transgenic Biotechnologies Project; China Scholarship; USTC	This study is supported by the Science Popularization and Risk Communication of Transgenic Biotechnologies Project (Grant code: 2016ZX08015002) to CL and AC, China Scholarship (Grant code: 201906210115) to CL, the 25th department funding of USTC (Grant code: DA2110251001) to AC, 2019 New Humanities Funding of USTC (Grant code: YD2110002015) to AC. The funders had no role in the study design, data collection, analysis, decision to publish, or manuscript preparation.	Altman I, 1973, SOCIAL PENETRATION D; American Association for Public Opinion Research, MARG SAMPL ERR CRED; Andalibi N, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P1485, DOI 10.1145/2998181.2998243; ANDRINGA E, 1996, POETICS, V23, P431, DOI 10.1016/0304-422X(95)00009-9; [Anonymous], 2020, CHINA DAILY; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Barros JM, 2020, J MED INTERNET RES, V22, DOI 10.2196/13680; Bates BR, 2006, MED INFORM INTERNET, V31, P45, DOI 10.1080/14639230600552601; Batson CD, 2005, BASIC APPL SOC PSYCH, V27, P15, DOI 10.1207/s15324834basp2701_2; Berger C. R., 1987, INTERPERSONAL PROCES, P39; Biddison LD, 2014, CHEST, V146, pE145S, DOI 10.1378/chest.14-0742; Boehmer J., 2015, International Journal of Sport Communication, V8, P212, DOI 10.1123/IJSC.2015-0011; Braithwaite DO, 1999, HEALTH COMMUN, V11, P123, DOI 10.1207/s15327027hc1102_2; Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258; Bucy EP, 2003, JOURNALISM MASS COMM, V80, P247, DOI 10.1177/107769900308000202; Cao XX, 2015, INT J NONPROFIT VOLU, V20, P12, DOI 10.1002/nvsm.1514; Capraro V., 2019, DUAL PROCESS APPROAC, DOI DOI 10.31234/OSF.IO/432YW; Capraro V, 2020, PRIMING REASONING IN; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Capraro V, 2019, J EXP SOC PSYCHOL, V83, P142, DOI 10.1016/j.jesp.2019.04.006; China Internet Network Information Centre (CNNIC), 2019, STAT REP INT DEV CHI; Cole S, 2013, PSYCHOL SCI, V24, P34, DOI 10.1177/0956797612446953; Coulson NS, 2007, PATIENT EDUC COUNS, V68, P173, DOI 10.1016/j.pec.2007.06.002; Coulson NS, 2005, CYBERPSYCHOL BEHAV, V8, P580, DOI 10.1089/cpb.2005.8.580; Coursaris CK, 2009, COMPUT HUM BEHAV, V25, P911, DOI 10.1016/j.chb.2009.03.006; CUTRONA CE, 1992, COMMUN RES, V19, P154, DOI 10.1177/009365092019002002; Dillard JP, 2006, J COMMUN, V56, pS123, DOI 10.1111/j.1460-2466.2006.00286.x; DOVIDIO JF, 1984, ADV EXP SOC PSYCHOL, V17, P361, DOI 10.1016/S0065-2601(08)60123-9; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Federici RA., 2014, INT ED STUDIES, V7, P21, DOI [DOI 10.5539/IES.V7N1P21, 10.5539/ies.v7n1p21]; Filho PCL, 2020, ASSESSING QUALITY RE, DOI [10.1101/2020.05.30.20117614, DOI 10.1101/2020.05.30.20117614]; Fogg BJ, 1999, P SIGCHI C HUM FACT, DOI DOI 10.1145/302979.303001; Fogg BJ., 2000, P CHI 00 HUM FACT CO, P287, DOI DOI 10.1145/633292.633460; Freeman KS, 2004, TECH COMMUN-STC, V51, P239; Fu K. -W., 2020, J RISK RES, P1, DOI [10.1080/13669877.2020.1756380, DOI 10.1080/13669877.2020.1756380]; Ha S., 2011, ICIS 2011 P; Hilligoss B, 2008, INFORM PROCESS MANAG, V44, P1467, DOI 10.1016/j.ipm.2007.10.001; House JS, 1981, WORK STRESS SOCIAL S; Hu Y., 2020, ARXIV200509174; Huang CM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19087; Huang HY, 2016, COMPUT HUM BEHAV, V57, P122, DOI 10.1016/j.chb.2015.12.030; Huang YLL, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P969, DOI 10.1145/2675133.2675202; Indian M, 2014, PERS INDIV DIFFER, V59, P102, DOI 10.1016/j.paid.2013.11.016; Jin YH, 2020, PLA MED J, V45, P1; Ko HC, 2013, CYBERPSYCH BEH SOC N, V16, P194, DOI 10.1089/cyber.2012.0297; Kwon KH, 2017, MASS COMMUN SOC, V20, P869, DOI 10.1080/15205436.2017.1369545; Lazarus R.S., 1991, EMOTION ADAPTATION; Lee JY, 2013, HEALTH COMMUN, V28, P509, DOI 10.1080/10410236.2012.700391; Lee M, 2015, PSYCHOLOGIA, V58, P189; Li LF, 2020, IEEE T COMPUT SOC SY, V7, P556, DOI 10.1109/TCSS.2020.2980007; Li SY, 2015, COMMUN Q, V63, P586, DOI 10.1080/01463373.2015.1078389; Liu G, 2014, LECT NOTES COMPUT SC, V8485, P781, DOI 10.1007/978-3-319-08010-9_84; Liu XC, 2017, HEALTH COMMUN, V32, P1252, DOI 10.1080/10410236.2016.1217454; Liu ZM, 2012, INTERNET RES, V22, P443, DOI 10.1108/10662241211250980; Loewenstein G, 2007, REV GEN PSYCHOL, V11, P112, DOI 10.1037/1089-2680.11.2.112; Lu J, 2013, ASIAN PERSPECT-SEOUL, V37, P305, DOI 10.1353/apr.2013.0012; Luker KA, 1996, J ADV NURS, V23, P487, DOI 10.1111/j.1365-2648.1996.tb00010.x; Malecki CK, 2003, SCHOOL PSYCHOL QUART, V18, P231, DOI 10.1521/scpq.18.3.231.22576; Motro D, 2018, J BUS ETHICS, V152, P133, DOI 10.1007/s10551-016-3337-x; Mukherjee S, 2011, TOXICOL ENVIRON CHEM, V93, P575, DOI 10.1080/02772248.2010.532217; Mukkamala A, 2018, 26 EUR C INF SYST EC; Munoz-Laboy M, 2014, AM J MENS HEALTH, V8, P226, DOI 10.1177/1557988313508303; Myrick JG, 2016, HEALTH COMMUN, V31, P596, DOI 10.1080/10410236.2014.981664; Newman M.W., 2011, P ACM 2011 C COMPUTE, P341, DOI [DOI 10.1145/1958824.1958876, 10.1145/1958824.1958876]; Pan WJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00978; Pan WJ, 2018, J LANG SOC PSYCHOL, V37, P3, DOI 10.1177/0261927X17706983; Pan WJ, 2017, J HEALTH COMMUN, V22, P45, DOI 10.1080/10810730.2016.1250845; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Rabjohn N, 2008, P 41 ANN HAWAII INT; Rains SA, 2007, COMMUN RES, V34, P100, DOI 10.1177/0093650206296084; Rains SA, 2015, COMMUN MONOGR, V82, P403, DOI 10.1080/03637751.2015.1019530; Recuero R., 2011, P 5 INT AAAI C WEBL, P305; Rini C, 2006, PERS RELATIONSHIP, V13, P207, DOI 10.1111/j.1475-6811.2006.00114.x; Rui JR, 2013, CYBERPSYCH BEH SOC N, V16, P669, DOI 10.1089/cyber.2012.0350; Sbaffi L, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7579; Shakespeare-Finch J, 2011, J PERS ASSESS, V93, P483, DOI 10.1080/00223891.2011.594124; Shen CH, 2020, J MED INTERNET RES, V22, DOI 10.2196/19421; Sina Weibo Data Center, 2019, WEIB US REP 2018; Stacks D.W., 1996, INTEGRATED APPROACH; STOKES JP, 1983, AM J COMMUN PSYCHOL, V11, P141, DOI 10.1007/BF00894363; Strohminger N, 2011, COGNITION, V119, P295, DOI 10.1016/j.cognition.2010.12.012; Stvilia B, 2009, J AM SOC INF SCI TEC, V60, P1781, DOI 10.1002/asi.21115; Sundar SS, 1999, JOURNALISM MASS COMM, V76, P373, DOI 10.1177/107769909907600213; Trepte S, 2015, MEDIA PSYCHOL, V18, P74, DOI 10.1080/15213269.2013.838904; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van der Molen B, 2000, EUR J CANCER CARE, V9, P48; Vitak J, 2013, NEW MEDIA SOC, V15, P243, DOI 10.1177/1461444812451566; Wang B, 2020, DEV NOVEL CORONAVIRU; Wang XH, 2019, COMPUT HUM BEHAV, V93, P149, DOI 10.1016/j.chb.2018.12.024; Wilson DK, 1999, ANN BEHAV MED, V21, P235, DOI 10.1007/BF02884840; Wingate VS, 2020, J LANG SOC PSYCHOL, V39, P397, DOI 10.1177/0261927X20911989; World Health Organization, COR DIS COVID 19 PAN; World Health Organization, 2018, MAN EP KEY FACTS MAJ; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xu K, 2020, GLOBAL TIMES; Yang QH, 2018, J HEALTH COMMUN, V23, P1026, DOI 10.1080/10810730.2018.1540671; Zhang JW, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.105751; Zhang L, 2014, COMPUT HUM BEHAV, V31, P242, DOI 10.1016/j.chb.2013.10.031; Zhuang J, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010304	102	14	14	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241465	10.1371/journal.pone.0241465	http://dx.doi.org/10.1371/journal.pone.0241465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141860	Green Submitted, gold, Green Published			2022-12-26	WOS:000588376700032
J	Jiang, WB; Pilkington, EH; Kelly, HG; Tan, HX; Juno, JA; Wheatley, AK; Kent, SJ				Jiang, Wenbo; Pilkington, Emily H.; Kelly, Hannah G.; Tan, Hyon-Xhi; Juno, Jennifer A.; Wheatley, Adam K.; Kent, Stephen J.			Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem	PLOS ONE			English	Article							IMMUNE-RESPONSES; INFLUENZA; DELIVERY	Influenza virus infection is a global public health threat. Current seasonal influenza vaccines are efficacious only when vaccine strains are matched with circulating strains. There is a critical need for developing "universal" vaccines that protect against all influenza viruses. HA stem is a promising target for developing broad-spectrum influenza vaccines due to its relatively conserved feature. However, HA stem is weakly immunogenic when administered alone in a soluble form. Several approaches have been employed to improve the immunogenicity of HA stem, including conjugation of HA stem with a highly immunogenic carrier protein or displaying HA stem on a nanoparticle scaffold. Converting a weakly immunologic protein into a multimer through aggregation can significantly enhance its immunogenicity, with some multimeric protein aggregates previously shown to be more immunogenic than their soluble counterparts in animal models. Here, we show that a chemically coupling a peptide derived from the head domain of PR8 HA (P35) with the poorly immunogenic HA stem protein results in aggregation of the HA stem which significantly increases stem-specific B cell responses following vaccination. Importantly, vaccination with this conjugate in the absence of adjuvant still induced robust B cell responses against stem in vivo. Improving HA stem immunogenicity by aggregation provides an alternative avenue to conjugation with exotic carrier proteins or nanoparticle formulation.	[Jiang, Wenbo; Pilkington, Emily H.; Kelly, Hannah G.; Tan, Hyon-Xhi; Juno, Jennifer A.; Wheatley, Adam K.; Kent, Stephen J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Clin & Infect Dis Dept, Cent Clin Sch, Carlton, Vic, Australia; [Kent, Stephen J.] Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne	Kent, SJ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Clin & Infect Dis Dept, Cent Clin Sch, Carlton, Vic, Australia.; Kent, SJ (corresponding author), Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic, Australia.	skent@unimelb.edu.au	Juno, Jennifer/AAK-9930-2021	Juno, Jennifer/0000-0002-9072-1017; Kent, Stephen/0000-0002-8539-4891; Tan, Hyon Xhi/0000-0003-1064-3934	NHMRC [APP1149990, GNT112909]; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship; NHMRC fellowships	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship; NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NHMRC grants APP1149990 and GNT112909. WJ is supported by a Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. JAJ, AKW and SJK are supported by NHMRC fellowships.	[Anonymous], 2006, GENET MED S1, V8, p1S; [Anonymous], 2019, CIRCULATION, V2019; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Centers for Disease Control and Prevention, ADJ VACC EFF EST INF; Chen JR, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-0626-6; Cox Manon M J, 2015, Ther Adv Vaccines, V3, P97, DOI 10.1177/2051013615595595; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; David M., 2013, FIELDS VIROLOGY; Ghimire TR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0972-0; Grenfell RFQ, 2015, CLIN VACCINE IMMUNOL, V22, P336, DOI 10.1128/CVI.00714-14; He P, 2015, HUM VACC IMMUNOTHER, V11, P477, DOI 10.1080/21645515.2014.1004026; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; HogenEsch H, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0089-x; Ilyinskii PO, 2008, VACCINE, V26, P3223, DOI 10.1016/j.vaccine.2008.03.078; Irvine DJ, 2020, CURR OPIN IMMUNOL, V65, P1, DOI 10.1016/j.coi.2020.01.007; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Jiang WB, 2019, J IMMUNOL METHODS, V467, P48, DOI 10.1016/j.jim.2019.02.008; Jones JC, 2011, VACCINE, V29, P7696, DOI 10.1016/j.vaccine.2011.07.133; Kelly HG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136653; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; McCluskie MJ, 2016, IMMUNOPHARM IMMUNOT, V38, P184, DOI 10.3109/08923973.2016.1165246; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Morefield GL, 2004, VACCINE, V22, P1973, DOI 10.1016/j.vaccine.2003.10.040; Moyer TJ, 2020, NAT MED, V26, P430, DOI 10.1038/s41591-020-0753-3; Moyer TJ, 2016, J CLIN INVEST, V126, P799, DOI 10.1172/JCI81083; Nachbagauer R, 2020, ANNU REV MED, V71, P315, DOI 10.1146/annurev-med-120617-041310; Ostrowsky J, 2020, CURR OPIN VIROL, V40, P28, DOI 10.1016/j.coviro.2020.02.003; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Rappuoli R, 2019, P NATL ACAD SCI USA, V116, P14, DOI 10.1073/pnas.1819612116; rei X. O, 2010, REV HIST IDEIAS, V31, P53; Robert G, 2013, TXB INFLUENZA, VSecond; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Saenz R, 2010, VACCINE, V28, P7556, DOI 10.1016/j.vaccine.2010.08.054; Snapper CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00598; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Vogel OA, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00135; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Yang LPH, 2013, DRUGS, V73, P1357, DOI 10.1007/s40265-013-0103-6; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241649	10.1371/journal.pone.0241649	http://dx.doi.org/10.1371/journal.pone.0241649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137148	Green Published, gold			2022-12-26	WOS:000588375500022
J	Abe, R; Takagi, H; Fujimoto, K; Sugiura, K				Abe, Reiko; Takagi, Hiroko; Fujimoto, Kyoko; Sugiura, Katsuaki			Evaluation of the antimicrobial use in pigs in Japan using dosage-based indicators	PLOS ONE			English	Article							THERAPEUTIC-USE; DRUG USAGE; QUANTIFICATION; TRENDS	The use of antimicrobial agents in food-producing animals may lead to the emergence and spread of antimicrobial resistance in bacteria of animal origin. The use of antimicrobial agents in pigs in 2018 in Japan was evaluated in terms of the weight of active ingredient and number of defined daily doses (DDD), using annual sales data of veterinary antimicrobials sold for use in pigs. In addition, the use of antimicrobial agents in the Japanese pig sector in 2008 to 2017 was evaluated to determine whether or not there were any differences in temporal change pattern by use of different metrics. In 2018, 447 metric tons of active ingredient, corresponding to 77,379 x 10(6) kg-days (Japanese DDD) and 34,903 x 10(6) kg-days (European DDD) were sold. The proportion of the sales amount of sulfonamides, trimethoprim and lincosamides to the total sales amount was significantly different depending on the metric used. For most antimicrobial classes, the number of Japanese DDDs was greater than the number of European DDDs. These results indicate that the DDD-based metric, which is more reflective of the selective pressure of antimicrobials, is recommended for use in monitoring the antimicrobial use in pigs in Japan. The differences in the number of Japanese DDDs and European DDDs appear to confirm the need for Japanese DDDs.	[Abe, Reiko; Takagi, Hiroko; Fujimoto, Kyoko; Sugiura, Katsuaki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan	University of Tokyo	Sugiura, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan.	aksugiur@mail.ecc.u-tokyo.ac.jp		Sugiura, Katsuaki/0000-0002-8807-7584	Ministry of Agriculture, Forestry and Fisheries of Japan [JPJ008617.17935699]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	KS JPJ008617.17935699 Ministry of Agriculture, Forestry and Fisheries of Japan https://www.maff.go.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACTING-network, DESCR EX MON SYST CO; Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Bosman AL, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00220; Brault SA, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00330; Chauvin C, 2008, J VET PHARMACOL THER, V31, P301, DOI 10.1111/j.1365-2885.2008.00960.x; Collineau L, 2017, ZOONOSES PUBLIC HLTH, V64, P165, DOI 10.1111/zph.12298; EMA, PRINC ASS DEF DAIL D; EMA, DEF DAIL DOS AN DDDV; European Medicine Agency (EMA), SAL VET ANT AG 30 EU; European Medicines Agency (EMA), DEF DAIL DPS AN DDDV; Filippitzi ME, 2014, VLAAMS DIERGEN TIJDS, V83, P215; French Agency for Food Environmental and Occupational Health and Safety, SAL SURV VET MED PRO; Gonzalez SM, 2010, PREV VET MED, V95, P50, DOI 10.1016/j.prevetmed.2010.03.004; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Hosoi Y, 2014, REV SCI TECH OIE, V33, P1007, DOI 10.20506/rst.33.3.2337; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Kasabova S, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00116; Matsuda M, 2017, J ANIMAL HYG, V42, P191; Mills HL, 2018, VET REC, V182, P379, DOI 10.1136/vr.104701; Ministry of Agriculture, 2018, SAL AM MED QUASI MED; Netherlands Veterinary Institute (SDa), US ANT AGR LIV NETH; O'Neill J., REV ANTIMICROBIAL RE; Sanders P, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00540; Staten Serum Institute, DANMAP 2017 US ANT A; Takagi H., 2020, NIPPON JUISHIKAI ZAS, V73, P352; Takagi H, 2019, JAP J ANIM HYG, V45, P155; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; WHO Collaborating Centre for Drug Statistics Methodology, 2012, ATCVET	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241644	10.1371/journal.pone.0241644	http://dx.doi.org/10.1371/journal.pone.0241644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125427	gold, Green Published			2022-12-26	WOS:000588368900007
J	Lou, E; Teoh, D; Brown, K; Blaes, A; Holtan, SG; Jewett, P; Parsons, H; Mburu, EW; Thomaier, L; Hui, JYC; Nelson, HH; Vogel, RI				Lou, Emil; Teoh, Deanna; Brown, Katherine; Blaes, Anne; Holtan, Shernan G.; Jewett, Patricia; Parsons, Helen; Mburu, E. Waruiru; Thomaier, Lauren; Jane Yuet Ching Hui; Nelson, Heather H.; Vogel, Rachel, I			Perspectives of cancer patients and their health during the COVID-19 pandemic	PLOS ONE			English	Article								Introduction The immunosuppressive nature of some cancers and many cancer-directed treatments may increase the risk of infection with and severe sequelae from Coronavirus Disease 2019 (COVID-19). The objective of this study was to compare concerns about COVID-19 among individuals undergoing cancer treatment to those with a history of cancer not currently receiving therapy and to those without a cancer history. Methods We conducted a cross-sectional anonymous online survey study of adults currently residing in the United States. Participants were recruited over a one-week period (April 3-11, 2020) using promoted advertisements on Facebook and Twitter. Groups were compared using chi-squared tests, Fisher's exact tests, and t-tests. Results 543 respondents from 47 states provided information on their cancer history and were included in analyses. Participants receiving active treatment reported greater concern about infection from the SARS-CoV-2 coronavirus (p<0.001), higher levels of family distress caused by the COVID-19 pandemic (p = 0.004), and greater concern that the general public does not adequately understand the seriousness of COVID-19 (p = 0.04). Those with metastatic disease were more likely to indicate that COVID-19 had negatively affected their cancer care compared to patients with non-metastatic cancer (50.8% vs. 31.0%; p = 0.02). The most commonly reported treatment modifications included chemotherapy delays. Conclusions Patients undergoing active treatment for cancer were most concerned about the short-term effects of the COVID-19 pandemic on the logistics as well as potential efficacy of ongoing cancer treatment, longer term effects, and overarching societal concerns that the population at large is not as concerned about the public health implications of SARS-CoV-2 infection.	[Lou, Emil; Blaes, Anne; Holtan, Shernan G.; Jewett, Patricia] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Lou, Emil; Teoh, Deanna; Blaes, Anne; Holtan, Shernan G.; Parsons, Helen; Jane Yuet Ching Hui; Nelson, Heather H.; Vogel, Rachel, I] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Teoh, Deanna; Brown, Katherine; Thomaier, Lauren; Vogel, Rachel, I] Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN USA; [Parsons, Helen] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Mburu, E. Waruiru; Nelson, Heather H.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jane Yuet Ching Hui] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lou, E (corresponding author), Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA.; Lou, E (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	lou@umn.edu	Holtan, Shernan G./AAA-2456-2022	Hui, Jane Yuet Ching/0000-0002-2628-0720; Nelson, Heather/0000-0003-1901-9513; Vogel, Rachel/0000-0003-0149-8464	National Institutes of Health's National Center for Advancing Translational Sciences [UL1TR002494]; National Cancer Institute P30 Cancer Center Support Grant [CA77598]	National Institutes of Health's National Center for Advancing Translational Sciences; National Cancer Institute P30 Cancer Center Support Grant	This research was supported in part by the National Institutes of Health's National Center for Advancing Translational Sciences, grant UL1TR002494 as well as the National Cancer Institute P30 Cancer Center Support Grant, grant CA77598. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health's National Center for Advancing Translational Sciences or the National Cancer Institute.	ACS, 2020, COVID 19 PAND IMP CA; Al-Quteimat OM, 2020, AM J CLIN ONCOL-CANC, V43, P452, DOI 10.1097/COC.0000000000000712; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; Chabner BA, 2020, ONCOLOGIST, V25, P455, DOI 10.1634/theoncologist.2020-0313; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Marron JM, 2020, J CLIN ONCOL, V38, P2201, DOI 10.1200/JCO.20.00960; Schattner E, 2015, FORBES MAGAZINE; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; UK Coronavirus Canc, 2020, LANCET ONCOL, V21, P622, DOI 10.1016/S1470-2045(20)30230-8; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296	11	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241741	10.1371/journal.pone.0241741	http://dx.doi.org/10.1371/journal.pone.0241741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125442	Green Submitted, Green Published, gold			2022-12-26	WOS:000588368900043
J	Kuan, MTY; Voss, C; Lopez, J; Hemphill, NM; Harris, KC				Kuan, Mimi T. Y.; Voss, Christine; Lopez, Jimmy; Hemphill, Nicole M.; Harris, Kevin C.			Children with congenital heart disease exhibit seasonal variation in physical activity	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; GENERAL-POPULATION; PREVALENCE; VALIDITY	Objective We sought to identify seasonal variation in physical activity that different physical activity measurement tools can capture in children with congenital heart disease. Methods Data were collected as part of a prospective cohort study at BC Children's Hospital, Vancouver, Canada. Daily step counts of children aged 9-16 years with moderate-to-severe CHD were assessed continuously for 1-year via a commercial activity tracker (Fitbit Charge 2((TM))). Physical activity levels were also assessed conventionally at one time-point via accelerometers (ActiGraph) and physical activity questionnaires. Results 156 children (mean age 12.7 +/- 2.4 years; 42% female) participated in the study. Fitbit data (n = 96) over a 1-year period clearly illustrated seasonal peaks (late spring and autumn) and dips (winter and summer school holidays) in physical activity levels, with group mean values being below 12,000 steps per day throughout the year. According to conventional accelerometry data (n = 142), 26% met guidelines, which tended to differ according to season of measurement (spring: 39%, summer: 11%, fall: 20%, winter: 39%; p-value = 0.053). Questionnaire data (n = 134) identified that the most widely reported activities were walking (81%) and running (78%) with walking being the highest in summer and fall and running in winter and spring. Furthermore, regardless of overall activity levels the children exhibit similar seasonal variation. Conclusions We demonstrated that physical activity level changes across seasons in children with CHD. It is important to be aware of these fluctuations when assessing and interpreting physical activity levels. Season specific counselling for physical activity may be beneficial in a clinical setting.	[Kuan, Mimi T. Y.; Voss, Christine; Lopez, Jimmy; Hemphill, Nicole M.; Harris, Kevin C.] BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada; [Kuan, Mimi T. Y.; Voss, Christine; Harris, Kevin C.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia	Harris, KC (corresponding author), BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada.; Harris, KC (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.	kharris2@cw.bc.ca	Voss, Christine/E-7425-2010	Voss, Christine/0000-0003-3811-2465; Harris, Kevin/0000-0001-9651-0926; Kuan, Mimi/0000-0002-4751-6579	Heart and Stroke Foundation of Canada [G-17-0018284]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was funded by Heart and Stroke Foundation of Canada (G-17-0018284; PI Harris). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, INDIAN J HEMATOL BLO, V33, pS113; [Anonymous], 2014, J AM ACAD PSYCHIAT S, V30, pS3; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Bouma BJ, 2017, CIRC RES, V120, P908, DOI 10.1161/CIRCRESAHA.116.309302; Carson V, 2010, PEDIATR EXERC SCI, V22, P81, DOI 10.1123/pes.22.1.81; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Colley RC, 2017, HEALTH REP, V28, P8; Colley RC, 2012, MED SCI SPORT EXER, V44, P977, DOI 10.1249/MSS.0b013e31823f23b1; Cook HD, 2013, ED STUD BOD TAK PHYS; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dollman J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010169; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough SJ, 2016, MED SCI SPORT EXER, V48, P245, DOI 10.1249/MSS.0000000000000771; Goodman A, 2012, J PHYS ACT HEALTH, V9, P1105, DOI 10.1123/jpah.9.8.1105; Khairy P, 2010, J AM COLL CARDIOL, V56, P1149, DOI 10.1016/j.jacc.2010.03.085; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Longmuir PE, 2013, CIRCULATION, V127, P2147, DOI 10.1161/CIR.0b013e318293688f; Lopez JR, 2020, CAN J CARDIOL, V36, P1474, DOI 10.1016/j.cjca.2019.12.019; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396; Palve KS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000594; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Voss C, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004665; Voss C, 2017, CAN J CARDIOL, V33, P799, DOI 10.1016/j.cjca.2016.11.024; Voss C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175806; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Wilk P, 2018, SSM-POPUL HLTH, V4, P76, DOI 10.1016/j.ssmph.2017.11.004	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241187	10.1371/journal.pone.0241187	http://dx.doi.org/10.1371/journal.pone.0241187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151936	Green Published, gold			2022-12-26	WOS:000591376200034
J	McAtee, KJ; Thorne, KM; Whitcraft, CR				McAtee, Kaelin J.; Thorne, Karen M.; Whitcraft, Christine R.			Short-term impact of sediment addition on plants and invertebrates in a southern California salt marsh	PLOS ONE			English	Article							SEA-LEVEL RISE; MACROFAUNAL COMMUNITIES; SPARTINA-ALTERNIFLORA; ECOSYSTEM SERVICES; DREDGED MATERIAL; RESTORATION; ELEVATION; RESPONSES; ENHANCEMENT; STABILITY	The implementation and monitoring of management strategies is integral to protect coastal marshes from increased inundation and submergence under sea-level rise. Sediment addition is one such strategy in which sediment is added to marshes to raise relative elevations, decrease tidal inundation, and enhance ecosystem processes. This study looked at the plant and invertebrate community responses over 12 months following a sediment addition project on a salt marsh located in an urbanized estuary in southern California, USA. This salt marsh is experiencing local subsidence, is sediment-limited from landscape modifications, has resident protected species, and is at-risk of submergence from sea-level rise. Abiotic measurements, invertebrate cores, and plant parameters were analyzed before and after sediment application in a before-after-control-impact (BACI) design. Immediately following the sediment application, plant cover and invertebrate abundance decreased significantly, with smothering of existing vegetation communities without regrowth, presumably creating resulting harsh abiotic conditions. At six months after the sediment application treatment, Salicornia bigelovii minimally colonized the sediment application area, and Spartina foliosa spread vegetatively from the edges of the marsh; however, at 12 months following sediment application overall plant recovery was still minimal. Community composition of infaunal invertebrates shifted from a dominance of marsh-associated groups like oligochaetes and polychaetes to more terrestrial and more mobile dispersers like insect larvae. In contrast to other studies, such as those with high organic deposition, that showed vegetation and invertebrate community recovery within one year of sediment application, our results indicated a much slower recovery following a sediment addition of 32 cm which resulted in a supratidal elevation with an average of 1.62 m (NAVD88) at our sampling locations. Our results indicate that the site did not recover after one year and that recovery may take longer which illustrates the importance of long-term monitoring to fully understand restoration trajectories and inform adaptive management. Testing and monitoring sea-level rise adaptation strategies like sediment addition for salt marshes is important to prevent the loss of important coastal ecosystems.	[McAtee, Kaelin J.; Whitcraft, Christine R.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Thorne, Karen M.] US Geol Survey USGS, Western Ecol Res Ctr, Davis, CA USA	California State University System; California State University Long Beach; United States Department of the Interior; United States Geological Survey	Whitcraft, CR (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	christine.whitcraft@csulb.edu			California Department of Fish and Wildlife; California State Coastal Conservancy [14-029-01]; U.S. Fish & Wildlife Service (2015 Cooperative Recovery Initiative Grant); U.S. Army Corps of Engineers; CSULB; CSU COAST	California Department of Fish and Wildlife; California State Coastal Conservancy; U.S. Fish & Wildlife Service (2015 Cooperative Recovery Initiative Grant); U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army); CSULB; CSU COAST	The project described in this publication was supported by grants and funding from the California Department of Fish and Wildlife (https://nrm.dfg.ca.gov/FileHandler.ashx?DocumentID=141828&inline, CRW), California State Coastal Conservancy (ProjectNo.14-029-01, CRW, https://scc.ca.gov/webmaster/ftp/pdf/sccbb/2014/1410/20141002Board11_Seal_Beach_Sediment_ Augmentation.pdf), U.S. Fish & Wildlife Service (2015 Cooperative Recovery Initiative Grant, no direct support to authors), U.S. Army Corps of Engineers (in-kind, Ecosystem Management & Restoration Research Program), and in-kind contributions from Orange County Parks for the Sediment and Application Contract (http://www.ocparks.com/). In addition, this publication was supported by grants to CW from CSULB (Small Faculty Grant) and through a CSU COAST award to KJM (2016-17 Graduate Student Research Program Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizad K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205176; [Anonymous], 1991, GEOTECHNIK 1, V14, P1; Bawden GW, 2001, NATURE, V412, P812, DOI 10.1038/35090558; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; Blair Emily M., 2013, Bulletin Southern California Academy of Sciences, V112, P161; Bolam S, 2003, CEDA DREDGING DAYS; Bolam SG, 2005, MAR POLLUT BULL, V50, P40, DOI 10.1016/j.marpolbul.2004.08.006; Bortolus A, 2002, ECOLOGY, V83, P733, DOI 10.1890/0012-9658(2002)083[0733:PPAIIT]2.0.CO;2; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Boyer KE, 2000, ESTUARIES, V23, P711, DOI 10.2307/1352897; Boyer KE, 1998, ECOL APPL, V8, P692, DOI 10.1890/1051-0761(1998)008[0692:EONAOT]2.0.CO;2; Buffington KJ, 2016, REMOTE SENS ENVIRON, V186, P616, DOI 10.1016/j.rse.2016.09.020; Cahoon D.R., 1987, SPRAY DISPOSAL DREDG; Cahoon DR, 2019, ESTUAR COAST, V42, P1, DOI 10.1007/s12237-018-0448-x; Cahoon DR, 1998, VULNERABILITY COAST; Cornu CE, 2002, RESTOR ECOL, V10, P474, DOI 10.1046/j.1526-100X.2002.01035.x; Costanza R, 1998, ECOL ECON, V25, P1, DOI 10.1016/S0921-8009(98)00007-X; Croft AL, 2006, ESTUARIES COASTS, V29, P737, DOI 10.1007/BF02786525; DELAUNE RD, 1990, J COASTAL RES, V6, P181; Doughty CL, 2019, GLOBAL CHANGE BIOL, V25, P78, DOI 10.1111/gcb.14429; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Fagherazzi S., 2004, The ecogeomorphology of tidal marshes; Ford MA, 1999, ECOL ENG, V12, P189, DOI 10.1016/S0925-8574(98)00061-5; Freeman CM, 2017, THIN LAYER SED UNPUB; Husbands J., 2012, CLIMATE SOCIAL STRES; Janousek CN, 2005, FUNCTIONAL DIVERSITY; Johnston KK, 2012, BALLONA WETLANDS ECO; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; La Peyre MK, 2009, ESTUAR COAST, V32, P390, DOI 10.1007/s12237-008-9126-8; Levin LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P661; Levin LA, 1998, ESTUARIES, V21, P129, DOI 10.2307/1352552; Levin LA, 2002, ECOL APPL, V12, P1785, DOI 10.1890/1051-0761(2002)012[1785:NAMSOH]2.0.CO;2; Levin LA, 2005, CALIF SEAGRANT RES F; MASSEY BW, 1984, J FIELD ORNITHOL, V55, P67; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Neira C, 2005, MAR ECOL PROG SER, V292, P111, DOI 10.3354/meps292111; Nomann BE, 1998, J EXP MAR BIOL ECOL, V225, P53, DOI 10.1016/S0022-0981(97)00209-8; Raposa K.K., 2020, GUIDANCE THIN LAYER; Ray G. L, 2007, ERDC EL TECHNICAL NO; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Rosencranz JA, 2016, ESTUAR COAST, V39, P1035, DOI 10.1007/s12237-015-0056-y; Scarton F, 2015, J COAST CONSERV, V19, P321, DOI 10.1007/s11852-015-0394-8; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Schrift AM, 2008, WETLANDS, V28, P1071, DOI 10.1672/07-78.1; Schwarz CJ, 2015, COURSE NOTES BEGINNI; Slocum MG, 2005, ESTUARIES, V28, P519, DOI 10.1007/BF02696063; Spencer T, 2016, GLOBAL PLANET CHANGE, V139, P15, DOI 10.1016/j.gloplacha.2015.12.018; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Stagg CL, 2010, RESTOR ECOL, V18, P10, DOI 10.1111/j.1526-100X.2010.00718.x; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Streever W. J., 2000, Wetlands Ecology and Management, V8, P295, DOI 10.1023/A:1008483203083; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Takekawa J.Y., 2013, EVALUATION SUBTERRAN; Takekawa JY, 2010, WETL ECOL MANAG, V18, P297, DOI 10.1007/s11273-009-9170-6; Talley TS, 1999, ESTUAR COAST SHELF S, V49, P713, DOI 10.1006/ecss.1999.0553; Thorne K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao3270; Thorne KM, 2019, ECOL ENG, V136, P197, DOI 10.1016/j.ecoleng.2019.05.011; Tong CF, 2013, ECOL ENG, V51, P151, DOI 10.1016/j.ecoleng.2012.12.010; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Whitcraft CR, 2007, ECOLOGY, V88, P904, DOI 10.1890/05-2074; Widdows J, 2006, MAR ECOL PROG SER, V319, P27, DOI 10.3354/meps319027; Wigand Cathleen, 2017, Estuaries Coast, V40, P682, DOI 10.1007/s12237-015-0003-y; Wilbur P, 1993, EDP0132 USACE WAT EX; Zedler J.B., 2001, HDB RESTORING TIDAL; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 1992, ECOLOGY TIJUANA ESTU, DOI [10.1177/00220345920710071001, DOI 10.1177/00220345920710071001]	72	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0240597	10.1371/journal.pone.0240597	http://dx.doi.org/10.1371/journal.pone.0240597			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151998	gold, Green Published			2022-12-26	WOS:000591376200065
J	Memarpour, M; Baghdadabadi, NA; Rafiee, A; Vossoughi, M				Memarpour, Mahtab; Afzali Baghdadabadi, Neda; Rafiee, Azade; Vossoughi, Mehrdad			Ion release and recharge from a fissure sealant containing amorphous calcium phosphate	PLOS ONE			English	Article							CARIES-INHIBITION; SMART MATERIALS; COMPOSITES; NANOCOMPOSITE; NANOPARTICLES; PIT	To assess- the release of calcium and phosphate ions from a fissure sealant containing amorphous calcium phosphate (ACP), and to determine the re-release capacity of these ions when charged with a solution containing casein phosphopeptide-amorphous calcium phosphate (CPP-ACP). Nine blocks of ACP resin-based sealant were prepared and immersed in three solutions at different pH (4.0, 5.5, 7.0), and calcium and phosphate ion release was measured with ion chromatography at 1, 3, 5, 7, 14, 21 and 28 days after immersion. Sixty days after immersion, each block was charged with CPP-ACP solution in three 7-day cycles to investigate the re-release of these ions, which was measured on days 1, 3, and 7. No difference was observed in initial calcium ion release at pH 4.0 and pH 5.5. At both values, ion release was significantly higher than at pH 7.0 (p0.001). Initial phosphate release was significantly different among the three pH values (p0.001). After re-charging the specimens, calcium ion re-release was greater than phosphate ion release. Initial ion release from ACP resin-based sealant was greatest at the lowest pH. Ion release decreased with time. As the number of recharge cycles increased, ion re-release also improved. Phosphate ion re-release required more recharge cycles than calcium ion re-release.	[Memarpour, Mahtab; Afzali Baghdadabadi, Neda; Rafiee, Azade] Shiraz Univ Med Sci, Oral & Dent Dis Res Ctr, Dept Pediat Dent, Sch Dent, Shiraz, Iran; [Vossoughi, Mehrdad] Shiraz Univ Med Sci, Oral & Dent Dis Res Ctr, Dept Dent Publ Hlth, Sch Dent, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science	Baghdadabadi, NA (corresponding author), Shiraz Univ Med Sci, Oral & Dent Dis Res Ctr, Dept Pediat Dent, Sch Dent, Shiraz, Iran.	nedaafzali1@gmail.com	Memarpour, Mahtab/P-8751-2018; Vossoughi, Mehrdad/H-2390-2016; Rafiee, Azade/P-6738-2015	Memarpour, Mahtab/0000-0003-1910-5913; Vossoughi, Mehrdad/0000-0003-2844-8141; Rafiee, Azade/0000-0003-3837-3147	Vice-Chancellery of Research of Shiraz University of Medical Science, Shiraz, Iran [99-17795]; Vice-Chancellory of Research of Shiraz University of Medical Science, Shiraz, Iran	Vice-Chancellery of Research of Shiraz University of Medical Science, Shiraz, Iran; Vice-Chancellory of Research of Shiraz University of Medical Science, Shiraz, Iran	The authors wish to thank the Vice-Chancellery of Research of Shiraz University of Medical Science, Shiraz, Iran, for supporting this research (grant #99-17795 awarded to N.A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Vice-Chancellory of Research of Shiraz University of Medical Science, Shiraz, Iran, for supporting this research. The authors thank the Center for Improvement, Shiraz Dental School, for the statistical analysis, and K. Shashok (AuthorAID in the Eastern Mediterranean) for help with the English in the article.	Ahovuo-Saloranta A, COCHRANE DATABASE SY; Zraikat H, 2011, DENT MATER, V27, P235, DOI 10.1016/j.dental.2010.10.008; Badami V, 2014, SCI WORLD J, DOI 10.1155/2014/986912; Barszczewska-Rybarek IM, 2009, DENT MATER, V25, P1082, DOI 10.1016/j.dental.2009.01.106; Bayrak S., 2010, EUR J DENT, V4, P245, DOI [DOI 10.1016/J.AJ0D0.2005.11.011, 10.1055/s-0039-1697835, DOI 10.1055/S-0039-1697835]; Bourbia M, 2013, J DENT RES, V92, P989, DOI 10.1177/0022034513504436; Braga RR, 2019, DENT MATER, V35, P3, DOI 10.1016/j.dental.2018.08.288; Burbank BD, 2017, AM J DENT, V30, P59; Choudhary Prashant, 2012, Indian J Dent Res, V23, P157, DOI 10.4103/0970-9290.100419; Elliott S, 1994, BEST PRACTICE IN ABORIGINAL AND TORRES STRAIT ISLANDER EDUCATION, P34; Floyd CJE, 2006, DENT MATER, V22, P1143, DOI 10.1016/j.dental.2005.10.009; Hr Poureslami, 2016, J Dent Biomater, V3, P214; Khudanov BO, 2018, ORAL HLTH PREV DENT, V16, P195, DOI 10.3290/j.ohpd.a39823; Kishor Amit, 2013, J Indian Soc Pedod Prev Dent, V31, P159, DOI 10.4103/0970-4388.117966; Kumar VLN, 2008, AUST DENT J, V53, P34, DOI 10.1111/j.1834-7819.2007.00006.x; McCabe JF, 2011, AUST DENT J, V56, P3, DOI 10.1111/j.1834-7819.2010.01291.x; McCabe JF, 2009, DENT MATER J, V28, P37; Melo MAS, 2013, DENT MATER, V29, P231, DOI 10.1016/j.dental.2012.10.010; POGGIO C., 2016, J CLIN EXP DENT, V8, P284; Polk DE, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0480-z; Rodrigues MC, 2018, DENT MATER, V34, P746, DOI 10.1016/j.dental.2018.01.026; Rodrigues MC, 2015, J BIOMED MATER RES B, V103, P1670, DOI 10.1002/jbm.b.33327; Ryu IS, 2018, RSC ADV, V8, P23481, DOI 10.1039/c8ra02919a; Sen Tunc E, 2012, AUST DENT J, V57, P79, DOI 10.1111/j.1834-7819.2011.01639.x; Sharma Ena, 2012, J Indian Soc Periodontol, V16, P504, DOI 10.4103/0972-124X.106885; Silva KG, 2010, ACTA ODONTOL SCAND, V68, P11, DOI 10.3109/00016350903260264; Skrtic D, 2007, J BIOMATER APPL, V21, P375, DOI 10.1177/0885328206064823; Skrtic D, 2003, J RES NATL INST STAN, V108, P167, DOI 10.6028/jres.108.017; Skrtic D, 1996, DENT MATER, V12, P295, DOI 10.1016/S0109-5641(96)80037-6; Smallridge J, 2018, PEDIAT DENT, P155; Unal M, 2015, J CLIN PEDIATR DENT, V39, P113, DOI 10.17796/jcpd.39.2.h247471176596757; Utneja Shivani, 2018, J Conserv Dent, V21, P681, DOI 10.4103/JCD.JCD_31_18; Uysal T, 2010, AUST DENT J, V55, P285, DOI 10.1111/j.1834-7819.2010.01236.x; Walsh LJ., 2009, INT DENT SA, V4, P34; Xu HHK, 2010, J DENT RES, V89, P19, DOI 10.1177/0022034509351969; Xu HHK, 2011, DENT MATER, V27, P762, DOI 10.1016/j.dental.2011.03.016; Xu HHK, 2010, J BIOMED MATER RES B, V92B, P332, DOI 10.1002/jbm.b.31519; Xu HHK, 2009, DENT MATER, V25, P535, DOI 10.1016/j.dental.2008.10.009; Zalizniak I, 2013, J DENT, V41, P449, DOI 10.1016/j.jdent.2013.02.003; Zawaideh Feda I, 2016, Int J Clin Pediatr Dent, V9, P10, DOI 10.5005/jp-journals-10005-1325; Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36476; Zhang L, 2016, DENT MATER, V32, P285, DOI 10.1016/j.dental.2015.11.015; Zhang L, 2015, J DENT, V43, P1587, DOI 10.1016/j.jdent.2015.06.009; Zhao J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-40	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241272	10.1371/journal.pone.0241272	http://dx.doi.org/10.1371/journal.pone.0241272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151995	gold, Green Published			2022-12-26	WOS:000591376200094
J	Vazquez, NM; Mariani, F; Torres, PS; Moreno, S; Galvan, EM				Vazquez, Nicolas M.; Mariani, Florencia; Torres, Pablo S.; Moreno, Silvia; Galvan, Estela M.			Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum beta-lactamase-producing uropathogenic Escherichia coli isolates by 1,8-cineole	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; ESSENTIAL OILS; MECHANISMS; BACTERIA; CARVACROL; STRAINS	Escherichia coli is the most frequent agent of urinary tract infections in humans. The emergence of uropathogenic multidrug-resistant (MDR) E. coli strains that produce extended spectrum beta-lactamases (ESBL) has created additional problems in providing adequate treatment of urinary tract infections. We have previously reported the antimicrobial activity of 1,8-cineole, one of the main components of Rosmarinus officinalis volatile oil, against Gram negative bacteria during planktonic growth. Here, we evaluated the antibiofilm activity of 1,8-cineole against pre-formed mature biofilms of MDR ESBL-producing uropathogenic E. coli clinical strains by carrying out different technical approaches such as counting of viable cells, determination of biofilm biomass by crystal violet staining, and live/dead stain for confocal microscopy and flow cytometric analyses. The plant compound showed a concentration- and time-dependent antibiofilm activity over pre-formed biofilms. After a 1 h treatment with 1% (v/v) 1,8-cineole, a significant decrease in viable biofilm cell numbers (3-log reduction) was observed. Biofilms of antibiotic-sensitive and MDR ESBL-producing E. coli isolates were sensitive to 1,8-cineole exposure. The phytochemical treatment diminished the biofilm biomass by 48-65% for all four E. coli strain tested. Noteworthy, a significant cell death in the remaining biofilm was confirmed by confocal laser scanning microscopy after live/dead staining. In addition, the majority of the biofilm-detached cells after 1,8-cineole treatment were dead, as shown by flow cytometric assessment of live/dead-stained bacteria. Moreover, phytochemical-treated biofilms did not fully recover growth after 24 h in fresh medium. Altogether, our results support the efficacy of 1,8-cineole as a potential antimicrobial agent for the treatment of E. coli biofilm-associated infections.	[Vazquez, Nicolas M.; Moreno, Silvia] Univ Maimonides, Lab Farmacol Bioact Vegetales, Dept Invest Bioquim & Farmacet, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Vazquez, Nicolas M.; Mariani, Florencia; Galvan, Estela M.] Univ Maimonides, Lab Patogenesis Bacteriana, Dept Invest Bioquim & Farmacet, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Vazquez, Nicolas M.; Mariani, Florencia; Torres, Pablo S.; Moreno, Silvia; Galvan, Estela M.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Torres, Pablo S.] Inst Ciencia & Tecnol Dr Cesar Milstein Fdn Pablo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Moreno, S (corresponding author), Univ Maimonides, Lab Farmacol Bioact Vegetales, Dept Invest Bioquim & Farmacet, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina.; Galvan, EM (corresponding author), Univ Maimonides, Lab Patogenesis Bacteriana, Dept Invest Bioquim & Farmacet, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina.; Moreno, S; Galvan, EM (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	moreno.silvia@maimonides.edu; galvan.estela@maimonides.edu			National Research Council of Argentina (CONICET) [PIP 11220130100426CO]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 2017-0183]; Fundacion Cientifica Felipe Fiorellino, Universidad Maimonides, Argentina	National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Fundacion Cientifica Felipe Fiorellino, Universidad Maimonides, Argentina	This work was supported by grant number PIP 11220130100426CO from the National Research Council of Argentina (CONICET) to EMG; grant number PICT 2017-0183 from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, to EMG; and intramural funding from Fundacion Cientifica Felipe Fiorellino, Universidad Maimonides, Argentina, to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2016, INFECT DIS CLIN N AM, V30, P347, DOI 10.1016/j.idc.2016.02.003; Amalaradjou MAR, 2010, J UROLOGY, V184, P358, DOI 10.1016/j.juro.2010.03.006; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Azeredo J, 2017, CRIT REV MICROBIOL, V43, P313, DOI 10.1080/1040841X.2016.1208146; Borges A, 2016, MOLECULES, V21, DOI 10.3390/molecules21070877; Clinical and Laboratory Standards Institute (CLSI), 2022, PERFORMANCE STANDARD, V32nd; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunn SJ, 2019, CURR OPIN MICROBIOL, V51, P51, DOI 10.1016/j.mib.2019.06.004; Ferrieres L, 2007, FEMS IMMUNOL MED MIC, V51, P212, DOI 10.1111/j.1574-695X.2007.00296.x; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Galdiero E, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11070322; Galvan EM, 2016, BIOFOULING, V32, P1067, DOI 10.1080/08927014.2016.1231300; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Hendry ER, 2009, J ANTIMICROB CHEMOTH, V64, P1219, DOI 10.1093/jac/dkp362; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jiang Y, 2011, ENVIRON TOXICOL PHAR, V32, P63, DOI 10.1016/j.etap.2011.03.011; Juarez GE, 2018, BIOFOULING, V34, P287, DOI 10.1080/08927014.2018.1434876; Karigoudar RM, 2019, J LAB PHYS, V11, P17, DOI 10.4103/JLP.JLP_98_18; Knowles JR, 2005, APPL ENVIRON MICROB, V71, P797, DOI 10.1128/AEM.71.2.797-803.2005; Kwiatkowski P, 2019, MOLECULES, V24, DOI 10.3390/molecules24173105; Lagha R, 2019, MOLECULES, V24, DOI 10.3390/molecules24061161; Lee JH, 2017, J APPL MICROBIOL, V123, P1420, DOI 10.1111/jam.13602; Lil L. Z., 2014, J CLIN EXP MED, V7, P1721; Maheshwari M, 2019, BIOFOULING, V35, P1026, DOI 10.1080/08927014.2019.1688305; Mann CM, 1998, J APPL MICROBIOL, V84, P538, DOI 10.1046/j.1365-2672.1998.00379.x; Martinez A., 2018, THESIS; Mazzariol A, 2017, J CHEMOTHERAPY, V29, P2, DOI [10.1080/1120009x.2017.1380395, 10.1080/1120009X.2017.1380395]; Mittal S, 2015, PATHOG GLOB HEALTH, V109, P26, DOI 10.1179/2047773215Y.0000000001; Musken M, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01635-18; Mulyaningsih S, 2010, PHYTOMEDICINE, V17, P1061, DOI 10.1016/j.phymed.2010.06.018; Naves P, 2008, J APPL MICROBIOL, V105, P585, DOI 10.1111/j.1365-2672.2008.03791.x; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Ojeda-Sana AM, 2013, FOOD CONTROL, V31, P189, DOI 10.1016/j.foodcont.2012.09.022; Robertson J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00801; Rumbaugh KP, 2020, NAT REV MICROBIOL, V18, P571, DOI 10.1038/s41579-020-0385-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schurmann M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02325; Skarp KP, 2019, INT J ANTIMICROB AG, V53, P74, DOI 10.1016/j.ijantimicag.2018.09.011; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Tariq S, 2019, MICROB PATHOGENESIS, V134, DOI 10.1016/j.micpath.2019.103580; Terlizzi ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01566; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Vorregaard M., 2008, COMSTAT2 MODERN 3D I; Zhou SX, 2019, TOXINS, V11, DOI 10.3390/toxins11100598; 2019, LANCET DIGITAL HLTH, V1	46	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241978	10.1371/journal.pone.0241978	http://dx.doi.org/10.1371/journal.pone.0241978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152054	Green Published, gold			2022-12-26	WOS:000591376200043
J	Minh, NNQ; Toi, PV; Qui, LM; Tinh, LBB; Ngoc, NT; Kim, LTN; Uyen, NH; Hang, VTT; B'Krong, NTTC; Tham, NT; Khoa, TD; Khuong, HD; Vi, PQ; Phuc, NNH; Vien, LTM; Pouplin, T; Khanh, DV; Phuong, PN; Lam, PK; Wertheim, HFL; Campbell, JI; Baker, S; Parry, CM; Bryant, JE; Schultsz, C; Hung, NT; de Jong, MD; van Doorn, HR				Ngo Ngoc Quang Minh; Pham Van Toi; Le Minh Qui; Le Binh Bao Tinh; Nguyen Thi Ngoc; Le Thi Ngoc Kim; Nguyen Hanh Uyen; Vu Thi Ty Hang; Nguyen Thi Thuy Chinh B'Krong; Nguyen Thi Tham; Thai Dang Khoa; Huynh Duy Khuong; Pham Quynh Vi; Nguyen Ngoc Hong Phuc; Le Thi Minh Vien; Pouplin, Thomas; Doan Van Khanh; Pham Nguyen Phuong; Phung Khanh Lam; Wertheim, Heiman F. L.; Campbell, James, I; Baker, Stephen; Parry, Christopher M.; Bryant, Juliet E.; Schultsz, Constance; Nguyen Thanh Hung; de Jong, Menno D.; van Doorn, H. Rogier			Antibiotic use and prescription and its effects on Enterobacteriaceae in the gut in children with mild respiratory infections in Ho Chi Minh City, Vietnam. A prospective observational outpatient study	PLOS ONE			English	Article							TIME PCR ASSAY; STREPTOCOCCUS-PNEUMONIAE; BORDETELLA-PERTUSSIS; TRACT INFECTIONS; VIRULENCE FACTOR; RESISTANCE; AMPLIFICATION; PHARYNGITIS; MANAGEMENT; DIAGNOSIS	Background and objectives Treatment guidelines do not recommend antibiotic use for acute respiratory infections (ARI), except for streptococcal pharyngitis/tonsillitis and pneumonia. However, antibiotics are prescribed frequently for children with ARI, often in absence of evidence for bacterial infection. The objectives of this study were 1) to assess the appropriateness of antibiotic prescriptions for mild ARI in paediatric outpatients in relation to available guidelines and detected pathogens, 2) to assess antibiotic use on presentation using questionnaires and detection in urine 3) to assess the carriage rates and proportions of resistant intestinal Enterobacteriaceae before, during and after consultation. Materials and methods Patients were prospectively enrolled in Children's Hospital 1, Ho Chi Minh City, Vietnam and diagnoses, prescribed therapy and outcome were recorded on first visit and on follow-up after 7 days. Respiratory bacterial and viral pathogens were detected using molecular assays. Antibiotic use before presentation was assessed using questionnaires and urine HPLC. The impact of antibiotic usage on intestinal Enterobacteriaceae was assessed with semi-quantitative culture on agar with and without antibiotics on presentation and after 7 and 28 days. Results A total of 563 patients were enrolled between February 2009 and February 2010. Antibiotics were prescribed for all except 2 of 563 patients. The majority were 2(nd) and 3(rd) generation oral cephalosporins and amoxicillin with or without clavulanic acid. Respiratory viruses were detected in respiratory specimens of 72.5% of patients. Antibiotic use was considered inappropriate in 90.1% and 67.5%, based on guidelines and detected pathogens, respectively. On presentation parents reported antibiotic use for 22% of patients, 41% of parents did not know and 37% denied antibiotic use. Among these three groups, six commonly used antibiotics were detected with HPLC in patients' urine in 49%, 40% and 14%, respectively. Temporary selection of 3(rd) generation cephalosporin resistant intestinal Enterobacteriaceae during antibiotic use was observed, with co-selection of resistance to aminoglycosides and fluoroquinolones. Conclusions We report overuse and overprescription of antibiotics for uncomplicated ARI with selection of resistant intestinal Enterobacteriaceae, posing a risk for community transmission and persistence in a setting of a highly granular healthcare system and unrestricted access to antibiotics through private pharmacies. Registration This study was registered at the International Standard Randomised Controlled Trials Number registry under number ISRCTN32862422: http://www.isrctn.com/ISRCTN32862422	[Ngo Ngoc Quang Minh; Pham Van Toi; Nguyen Hanh Uyen; Vu Thi Ty Hang; Nguyen Thi Thuy Chinh B'Krong; Nguyen Thi Tham; Thai Dang Khoa; Huynh Duy Khuong; Pham Quynh Vi; Nguyen Ngoc Hong Phuc; Le Thi Minh Vien; Pouplin, Thomas; Doan Van Khanh; Pham Nguyen Phuong; Phung Khanh Lam; Wertheim, Heiman F. L.; Campbell, James, I; Baker, Stephen; Bryant, Juliet E.; Schultsz, Constance; de Jong, Menno D.; van Doorn, H. Rogier] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Ngo Ngoc Quang Minh; Le Minh Qui; Le Binh Bao Tinh; Nguyen Thi Ngoc; Le Thi Ngoc Kim; Nguyen Thanh Hung] Childrens Hosp 1, Ho Chi Minh City 1, Vietnam; [Wertheim, Heiman F. L.; van Doorn, H. Rogier] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Old Rd Campus, Oxford, England; [Parry, Christopher M.] Univ Liverpool Liverpool Sch Trop Med, Clin Sci, Pembroke PI, Liverpool, Merseyside, England; [Parry, Christopher M.] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Schultsz, Constance] Univ Amsterdam, Amsterdam Univ Med Ctr, Inst Global Hlth & Dev, Dept Global Hlth Amsterdam, Amsterdam, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Dept Med Microbiol, Med Ctr, Amsterdam, Netherlands; [Doan Van Khanh] Tan Tao Univ, Fac Med, Long An, Vietnam; [Wertheim, Heiman F. L.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, Nijmegen, Netherlands; [Bryant, Juliet E.] Merieux Fdn, Lyon, France	University of Oxford; University of Oxford; Liverpool School of Tropical Medicine; Nagasaki University; University of Amsterdam; University of Amsterdam; Radboud University Nijmegen	van Doorn, HR (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.; van Doorn, HR (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Old Rd Campus, Oxford, England.	rvandoorn@oucru.org	van Doorn, H. Rogier/H-3080-2019; Wertheim, Heiman/F-3338-2016	van Doorn, H. Rogier/0000-0002-9807-1821; Wertheim, Heiman/0000-0002-5003-5565; Baker, Stephen/0000-0003-1308-5755; Doan, Khanh/0000-0002-7251-3599; BKRONG NGUYEN, CHINH/0000-0003-4588-0016; Lam, Phung/0000-0001-7968-473X	Wellcome Trust of Great Britain [089276/Z/09/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the Wellcome Trust of Great Britain [077078/Z/05/Z and 089276/Z/09/Z]. The funders had no role in in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; [Anonymous], 2009, OFFICIAL J EUROPEAN, V59, pL342; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Banfil, 2004, ANN T NORD RHEOL SOC, V12, p2004x; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Center for Disease Dynamics Economics & Policy., 2015, STATE WORLDS ANTIBIO; Chonmaitree T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180630; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; European Centre for Disease Prevention and Control, 2009, BACT CHALL TIM REAC; Global Antibiotic Resistance Partnership, 2010, GARP VIETN SIT AN AN; Heddema ER, 2006, CLIN MICROBIOL INFEC, V12, P571, DOI 10.1111/j.1469-0691.2006.01417.x; Jansen RR, 2011, J CLIN VIROL, V51, P179, DOI 10.1016/j.jcv.2011.04.010; Johansson M, 2011, TROP MED INT HEALTH, V16, P737, DOI 10.1111/j.1365-3156.2011.02753.x; Kabra SK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004874.pub3; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kosters K, 2002, J CLIN MICROBIOL, V40, P1719, DOI 10.1128/JCM.40.5.1719-1722.2002; Larsson M, 2000, TROP MED INT HEALTH, V5, P711, DOI 10.1046/j.1365-3156.2000.00630.x; Lim C, 2016, ELIFE, V5, DOI 10.7554/eLife.18082; Lindbaek M, 2006, BRIT J GEN PRACT, V56, P164; Lingard H, 2008, SCAND J PRIM HEALTH, V26, P211, DOI 10.1080/02813430802214470; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; Molenkamp R, 2007, J VIROL METHODS, V141, P205, DOI 10.1016/j.jviromet.2006.12.007; Murad C, 2019, INT J INFECT DIS, V86, P73, DOI 10.1016/j.ijid.2019.06.024; National Institute for Health and Care Excellence, 2008, RESP TRACT INF SELF; Neeleman C, 2004, J CLIN MICROBIOL, V42, P4355, DOI 10.1128/JCM.42.9.4355-4357.2004; Nilsson AI, 2006, P NATL ACAD SCI USA, V103, P6976, DOI 10.1073/pnas.0602171103; O'Neill J, 2014, ANTIMICROBIAL RESIST; Toi PV, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4699; Reischl U, 2001, J CLIN MICROBIOL, V39, P1963, DOI 10.1128/JCM.39.5.1963-1966.2001; Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Song YK, 2017, ARCH DIS CHILD, V102, P660, DOI 10.1136/archdischild-2016-310981; Spinks A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub4; Spurling GKP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub3; Suguitan Jr AL, 2011, PLOS ONE, V6; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; United States Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organization, 2014, ANT RES GLOB REP SUR	51	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241760	10.1371/journal.pone.0241760	http://dx.doi.org/10.1371/journal.pone.0241760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147269	Green Published, gold, Green Accepted			2022-12-26	WOS:000589609300014
J	Kato, M; Onoyama, I; Kawakami, M; Yoshida, S; Kawamura, K; Kodama, K; Hori, E; Cui, L; Matsumura, Y; Yagi, H; Asanoma, K; Yahata, H; Itakura, A; Takeda, S; Kato, K				Kato, Masaya; Onoyama, Ichiro; Kawakami, Minoru; Yoshida, Sachiko; Kawamura, Keiko; Kodama, Keisuke; Hori, Emiko; Cui, Lin; Matsumura, Yumiko; Yagi, Hiroshi; Asanoma, Kazuo; Yahata, Hideaki; Itakura, Atsuo; Takeda, Satoru; Kato, Kiyoko			Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia	PLOS ONE			English	Article							GLOBAL CANCER; DNA; APOBEC3B; 5-METHYLCYTOSINE; MUTAGENESIS; EXPRESSION; P53	Around the world, cervical cancer is one of the most common neoplastic diseases among women, and the prognosis of patients in an advanced stage remains poor. To reduce the mortality rate of cervical cancer, early diagnosis and treatment are essential. DNA methylation is an important aspect of gene regulation, and aberrant DNA methylation contributes to carcinogenesis and cancer progression in various cancers. Although 5-methylcytosine (5mC) has been analyzed intensively, the function of 5-hydroxymethylcytosine (5hmC) has not been clarified. The purpose of our study was to identify the molecular biomarkers for early diagnosis of cervical tumors due to epigenetic alterations. To assess the clinical relevance of DNA methylation, we used immunohistochemistry (IHC) to characterize the level of 5hmC in 102 archived human cervical intraepithelial neoplasia (CIN) samples and cervical cancer specimens. The level of 5hmC was significantly decreased between CIN2 and CIN3. The progression of cervical tumors is caused by a reduction of TP53 and RB1 because of HPV infection. We observed that Tp53 and Rb1 were knocked down in mouse embryonic fibroblasts (MEF), a model of normal cells. The level of 5hmC was reduced in Tp53-knockdown cells, and the expression levels of DNA methyltransferase 1 (DNMT1) and ten-eleven translocation methylcytosine dioxygenase 1 (TET1) were induced. In contrast, there was no significant change in Rb1-knockdown cells. Mechanistically, we focused on apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) 3B (A3B) as a cause of 5hmC reduction after TP53 knockdown. In the human cell line HHUA with a wild-type TP53 gene, A3B was induced in TP53-knockdown cells, and A3B knockdown recovered 5hmC levels in TP53-knockdown cells. These data indicate that TP53 suppression leads to 5hmC reduction in part through A3B induction. Moreover, IHC showed that expression levels of A3B in CIN3 were significantly higher than those in both normal epithelium and in CIN2. In conclusion, 5hmC levels are decreased between CIN2 and CIN3 through the TP53-A3B pathway. Since A3B could impair genome stability, 5hmC loss might increase the chances of accumulating mutations and of progressing from CIN3 to cervical cancer. Thus, these epigenetic changes could predict whether CINs are progressing to cancer or disappearing.	[Kato, Masaya; Onoyama, Ichiro; Kawakami, Minoru; Yoshida, Sachiko; Kawamura, Keiko; Kodama, Keisuke; Hori, Emiko; Cui, Lin; Matsumura, Yumiko; Yagi, Hiroshi; Asanoma, Kazuo; Yahata, Hideaki; Kato, Kiyoko] Kyushu Univ, Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Japan; [Kato, Masaya; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Sch Med Sci, Dept Obstet & Gynecol, Tokyo, Japan	Kyushu University; Juntendo University	Onoyama, I (corresponding author), Kyushu Univ, Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Japan.	ichiro@med.kyushu-u.ac.jp		Kato, Masaya/0000-0003-2692-2014; kodama, keisuke/0000-0001-7031-6359	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP20K09646, JP19H03800]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grants JP20K09646 (IO) and JP19H03800 (KK).	[Anonymous], 2008, ARQ CIENC SAUDE, V15, P163; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Ebisch RMF, 2016, BJOG-INT J OBSTET GY, V123, P59, DOI 10.1111/1471-0528.13530; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kafer GR, 2016, CELL REP, V14, P1283, DOI 10.1016/j.celrep.2016.01.035; Kato M, 2020, INT J CANCER, V147, P1987, DOI 10.1002/ijc.32965; Kessler TA, 2017, SEMIN ONCOL NURS, V33, P172, DOI 10.1016/j.soncn.2017.02.005; Kitade S, 2016, CANCER SCI, V107, P1399, DOI 10.1111/cas.13026; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Levine AJ, 2012, ONCOTARGET, V3, P1503; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Martin-Hirsch PPL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001421.pub3; Menendez D, 2017, MOL CANCER RES, V15, P735, DOI 10.1158/1541-7786.MCR-17-0019; Mori S, 2017, J VIROL, V91, DOI 10.1128/JVI.02413-16; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Periyasamy M, 2017, NUCLEIC ACIDS RES, V45, P11056, DOI 10.1093/nar/gkx721; Pfeifer GP, 2014, CELL TISSUE RES, V356, P631, DOI 10.1007/s00441-014-1896-7; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Su PH, 2019, CANCER LETT, V450, P53, DOI 10.1016/j.canlet.2019.01.033; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tomkova M, 2016, ELIFE, V5, DOI 10.7554/eLife.17082; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Tovy A, 2017, GENE DEV, V31, P959, DOI 10.1101/gad.299198.117; Vasanthakumar A, 2015, CANCER GENET-NY, V208, P167, DOI 10.1016/j.cancergen.2015.02.009; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang LY, 2016, JPN J CLIN ONCOL, V46, P427, DOI 10.1093/jjco/hyw002; 2018, NURSING PRACTICE RES, V15, P11	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241482	10.1371/journal.pone.0241482	http://dx.doi.org/10.1371/journal.pone.0241482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141854	gold, Green Published			2022-12-26	WOS:000588376700002
J	Manalo, JM; Liu, H; Ding, DL; Hicks, J; Sun, H; Salvi, R; Kellems, RE; Pereira, FA; Xia, Y				Manalo, Jeanne M.; Liu, Hong; Ding, Dalian; Hicks, John; Sun, Hong; Salvi, Richard; Kellems, Rodney E.; Pereira, Fred A.; Xia, Yang			Adenosine A2B receptor: A pathogenic factor and a therapeutic target for sensorineural hearing loss	FASEB JOURNAL			English	Article						ADA&#8208; deficiency; adenosine deaminase deficiency; aging; myelination; myelin protein zero	SICKLE-CELL-DISEASE; ELEVATED ADENOSINE; MITOCHONDRIAL-DNA; PERIPHERAL-NERVES; SCIATIC-NERVE; MICE; CONTRIBUTES; HYPOXIA; ATP; DEGENERATION	Over 466 million people worldwide are diagnosed with hearing loss (HL). About 90% of HL cases are sensorineural HL (SNHL) with treatments limited to hearing aids and cochlear implants with no FDA-approved drugs. Intriguingly, ADA-deficient patients have been reported to have bilateral SNHL, however, its underlying cellular and molecular basis remain unknown. We report that Ada(-/-) mice, phenocopying ADA-deficient humans, displayed SNHL. Ada(-/-) mice cochlea with elevated adenosine caused substantial nerve fiber demyelination and mild hair cell loss. ADA enzyme therapy in these mice normalized cochlear adenosine levels, attenuated SNHL, and prevented demyelination. Additionally, ADA enzyme therapy rescued SNHL by restoring nerve fiber structure in Ada(-/-) mice post two-week drug withdrawal. Moreover, elevated cochlear adenosine in untreated mice was associated with enhanced Adora2b gene expression. Preclinically, ADORA2B-specific antagonist treatment in Ada(-/-) mice significantly improved HL, nerve fiber density, and myelin compaction. We also provided genetic evidence that ADORA2B is detrimental for age-related SNHL by impairing cochlear myelination in WT aged mice. Overall, understanding purinergic molecular signaling in SNHL in Ada(-/-) mice allows us to further discover that ADORA2B is also a pathogenic factor underlying aged-related SNHL by impairing cochlear myelination and lowering cochlear adenosine levels or blocking ADORA2B signaling are effective therapies for SNHL.	[Manalo, Jeanne M.; Liu, Hong; Kellems, Rodney E.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin,MSB 6-202, Houston, TX 77030 USA; [Manalo, Jeanne M.; Liu, Hong; Kellems, Rodney E.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Ding, Dalian; Salvi, Richard] Univ Buffalo State Univ New York, Dept Commun Disorders & Sci, Buffalo, NY USA; [Hicks, John] Texas Childrens Hosp, Dept Pathol, Houston, TX USA; [Sun, Hong] Cent South Univ, Xiangya Hosp, Otolaryngol Head & Neck Surg, Changsha, Peoples R China; [Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Baylor College of Medicine; Central South University; Baylor College of Medicine	Xia, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin,MSB 6-202, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu		Manalo, Jeanne/0000-0001-7289-8102	McGovern Scholar Funds; Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School	McGovern Scholar Funds; Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School	We thank Dr Yoshihiro Komatsu and his lab for lending us the cryostat machine and the confocal microscope. This work was supported by McGovern Scholar Funds (YX) and the Bob and Hazel Casey Endowment (REK) of the University of Texas McGovern Medical School.	Abo-Salem OM, 2004, J PHARMACOL EXP THER, V308, P358, DOI 10.1124/jpet.103.056036; Adebiyi MG, 2019, BLOOD ADV, V3, P1347, DOI 10.1182/bloodadvances.2018030619; Albuquerque W, 2004, J PEDIATR-US, V144, P278, DOI 10.1016/j.jpeds.2003.10.055; Arlinger S, 2003, INT J AUDIOL, V42, pS17; BAUMGOLD J, 1992, BIOCHEM PHARMACOL, V43, P889, DOI 10.1016/0006-2952(92)90257-J; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Blundon JA, 2017, SCIENCE, V356, P1352, DOI 10.1126/science.aaf4612; Bruder ED, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-3; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10762; da Silva JT, 2015, GROWTH FACTORS, V33, P8, DOI 10.3109/08977194.2014.953630; Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586; Ding DL, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P189, DOI 10.1201/9781420038736.ch13; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ford MS, 1997, HEARING RES, V105, P130, DOI 10.1016/S0378-5955(96)00204-3; Gratton MA, 1996, HEARING RES, V94, P116, DOI 10.1016/0378-5955(96)00011-1; Hayallah AM, 2002, J MED CHEM, V45, P1500, DOI 10.1021/jm011049y; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; Iriyama T, 2015, CIRCULATION, V131, P730, DOI 10.1161/CIRCULATIONAHA.114.013740; Johnson KR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44450; Kamil K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00087; Kobayashi R, 2005, PHARMACOLOGY, V74, P143, DOI 10.1159/000084547; Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352; Liu H, 2016, CIRCULATION, V134, P405, DOI 10.1161/CIRCULATIONAHA.116.021311; Liu H, 2015, J APPL PHYSIOL, V119, P1173, DOI 10.1152/japplphysiol.00350.2015; Long P, 2018, DEV NEUROBIOL, V78, P80, DOI 10.1002/dneu.22538; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Melcangi RC, 2000, PROG NEUROBIOL, V60, P291, DOI 10.1016/S0301-0082(99)00028-3; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MIKAELIAN DO, 1979, LARYNGOSCOPE, V89, P1; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Quarles RH., 2006, BASIC NEUROCHEM MOL, V7, P51; Rangaraju S, 2009, AGING CELL, V8, P178, DOI 10.1111/j.1474-9726.2009.00460.x; Reed JC, 2011, APOPTOSIS PHYSL PATH, P182; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Seidman MD, 2002, OTOLARYNG HEAD NECK, V127, P138, DOI 10.1067/mhn.2002.127627; Shen H., 2018, IET CONTROL THEORY A, V12, P1; Shin SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215316; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Tanaka C, 1996, BRAIN DEV-JPN, V18, P304, DOI 10.1016/0387-7604(96)00014-9; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023; Vlajkovic SM, 2007, CELL TISSUE RES, V328, P461, DOI 10.1007/s00441-006-0374-2; Vlajkovic SM, 2009, CURR NEUROPHARMACOL, V7, P246, DOI 10.2174/157015909789152155; Wan GQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14487; Whitmore KV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00314; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29637; Xu XB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00416; Zhang WR, 2013, CIRC RES, V112, P1466, DOI 10.1161/CIRCRESAHA.111.300166; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	62	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15771	15787		10.1096/fj.202000939R	http://dx.doi.org/10.1096/fj.202000939R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131093	Bronze			2022-12-26	WOS:000586604700001
J	Cao, L; Jin, XJ; Zhang, YX; Zhang, MC; Wang, YH				Cao, Liang; Jin, Xijun; Zhang, Yuxian; Zhang, Mingcong; Wang, Yanhong			Transcriptomic and metabolomic profiling of melatonin treated soybean (Glycine max L.) under drought stress during grain filling period through regulation of secondary metabolite biosynthesis pathways	PLOS ONE			English	Article							EXOGENOUS MELATONIN; FLAVONOID BIOSYNTHESIS; FUNCTIONAL ROLES; WATER-STRESS; TOLERANCE; PHOTOSYNTHESIS; PERFORMANCE; SENESCENCE; EXPRESSION; RESISTANCE	There is a growing need to enhance the productivity of soybean (Glycine max L.) under severe drought conditions in order to improve global food security status. Melatonin, a ubiquitous hormone, could alleviate drought stress in various plants. Earlier, we demonstrated that exogenous melatonin treatment could enhance the tolerance of drought-treated soybean. However, the underlying mechanisms by which this hormone exerts drought resistance is still unclear. The present study used transcriptomic and metabolomic techniques to determine some critical genes and pathways regulating melatonin response to drought conditions. Results showed that exogenous melatonin treatment could increase relative water content and decrease electrolyte leakage in the leaves and increase seed yield under drought stress. Transcriptomic analysis showed that there were 852 core differentially expressed genes (DEGs) that were regulated by drought stress and melatonin in soybean leaves. The most enriched drought-responsive genes are mainly involved in the 'biosynthesis of secondary metabolites'. Metabolomic profiling under drought stress showed higher accumulation levels of secondary metabolites related to drought tolerance after exogenous melatonin treatment. Also, we highlighted the vital role of the pathways including phenylpropanoid, flavonoid, isoflavonoid, and steroid biosynthesis pathways for improvement of drought tolerance in soybean by exogenous melatonin treatment. In all, findings from this study give detailed molecular basis for the application of melatonin as a drought-resistant agent in soybean cultivation.	[Cao, Liang; Jin, Xijun; Zhang, Yuxian; Zhang, Mingcong; Wang, Yanhong] Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University	Zhang, YX (corresponding author), Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Heilongjiang, Peoples R China.	zyx_lxy@126.com			China Agriculture Research System [CARS-04-01A]; National Natural Science Foundation [31801303]; Natural Science Foundation of Heilongjiang Province of China [C2017049]; Start-up Project of Heilongjiang Bayi Agricultural University [XBD-2017-03]; Heilongjiang Bayi Agricultural University Postgraduate Innovative Research Project [YJSCX2019-Z01]	China Agriculture Research System; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Start-up Project of Heilongjiang Bayi Agricultural University; Heilongjiang Bayi Agricultural University Postgraduate Innovative Research Project	This study was funded by the China Agriculture Research System (CARS-04-01A), the National Natural Science Foundation (No. 31801303), Natural Science Foundation of Heilongjiang Province of China (C2017049), the Start-up Project of Heilongjiang Bayi Agricultural University (XBD-2017-03) and the Heilongjiang Bayi Agricultural University Postgraduate Innovative Research Project (YJSCX2019-Z01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Muriefah S. S., 2015, International Journal of Agriculture and Crop Sciences (IJACS), V8, P94; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Akpinar BA, 2013, SCI WORLD J, DOI 10.1155/2013/361921; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; Bettaieb I, 2011, ACTA PHYSIOL PLANT, V33, P1103, DOI 10.1007/s11738-010-0638-z; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campos CN, 2019, AGR WATER MANAGE, V211, P37, DOI 10.1016/j.agwat.2018.09.025; Cao L, 2019, PHOTOSYNTHETICA, V57, P812, DOI 10.32615/ps.2019.100; Cui GB, 2017, PLANT PHYSIOL BIOCH, V118, P138, DOI 10.1016/j.plaphy.2017.06.014; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; El Naqa I, 2017, PHYS MED BIOL, V62, pR179, DOI 10.1088/1361-6560/aa7c55; Fawzia AE, SITOSTEROL AMELIORAT; Gamel Rasha Eid, 2017, International Journal of Botany, V13, P1, DOI 10.3923/ijb.2017.1.14; Guidi L, 2008, TREE PHYSIOL, V28, P873, DOI 10.1093/treephys/28.6.873; Gupta M, 2017, PLANT CELL REP, V36, P637, DOI 10.1007/s00299-016-2064-1; Hardeland R., 2019, MELATONIN RES, V2, P10, DOI DOI 10.32794/MR11250029; Hu WH, 2013, SCI HORTIC-AMSTERDAM, V150, P232, DOI 10.1016/j.scienta.2012.11.012; Huang B, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00677; Ithal N, 2004, PLANT SCI, V166, P1505, DOI 10.1016/j.plantsci.2004.02.002; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Khan WA, 2018, BIOCHEM BIOPH RES CO, V506, P755, DOI 10.1016/j.bbrc.2018.04.112; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim J, 2016, MOL PLANT, V9, P813, DOI 10.1016/j.molp.2016.04.017; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lei YT, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1250-4; Li C, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12523; Li C, 2015, J EXP BOT, V66, P669, DOI 10.1093/jxb/eru476; Li Z, 2019, PLANTA, V250, P2033, DOI 10.1007/s00425-019-03277-1; Liang D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00426; Liu JL, 2015, PLANT GROWTH REGUL, V77, P317, DOI 10.1007/s10725-015-0066-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DY, 2014, PLANT PHYSIOL BIOCH, V80, P60, DOI 10.1016/j.plaphy.2014.03.024; Ma Y, 2012, MOL PLANT, V5, P1176, DOI 10.1093/mp/sss085; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Meena KK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00172; Meng JF, 2014, J PINEAL RES, V57, P200, DOI 10.1111/jpi.12159; Naghizadeh M, 2019, PHYSIOL MOL BIOL PLA, V25, P881, DOI 10.1007/s12298-019-00674-4; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Posmyk MM, 2008, J PINEAL RES, V45, P24, DOI 10.1111/j.1600-079X.2007.00552.x; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Sharma A, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8070190; Szafranska K, 2013, BIOL PLANTARUM, V57, P91, DOI 10.1007/s10535-012-0253-5; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wei ZW, 2019, PLANT PHYSIOL BIOCH, V139, P630, DOI 10.1016/j.plaphy.2019.04.026; Xu CS, 2018, PLANT CELL REP, V37, P1611, DOI 10.1007/s00299-018-2332-3; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Ye J, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2045-y; Yin LH, 2013, J PINEAL RES, V54, P426, DOI 10.1111/jpi.12038; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x	58	11	11	14	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0239701	10.1371/journal.pone.0239701	http://dx.doi.org/10.1371/journal.pone.0239701			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125378	Green Published, gold			2022-12-26	WOS:000588368900055
J	Chen, C; Song, JL; Xu, XL; Zhou, LM; Wang, YH; Chen, H				Chen, Chen; Song, Jinglin; Xu, Xiaolan; Zhou, Leming; Wang, Yonghong; Chen, Hong			Analysis of influencing factors of economic burden and medical service utilization of diabetic patients in China	PLOS ONE			English	Article								Background This study analyzed factors that affect the financial burden and utilization of medical services of patients with diabetes in a city of China. Methods We randomly sampled 10% of the information on the front page of diabetic inpatient medical records in the city from January 2014 to September 2019. Total cost of hospitalization, length of hospitalization and the number of hospitalization were analyzed. Descriptive statistical analysis and multiple linear regression analysis were adopted. Results Understanding the current financial burden of diabetic patients and the use of medical services, the results show that the direct economic burden of diabetic patients per hospitalization was approximately 8,000 Yuan, and the indirect economic burden was approximately 2,000 Yuan. Age, medical payment methods, admission channels, and medical institution grades are all important factors affecting medical expenses and medical service utilization of diabetic patients. In addition, the inequality of medical service utilization of patients is increased due to different types of medical insurance. Conclusions To reduce the economic burden on patients and society, governments should strengthen supervision, the advancement of diagnosis and treatment systems, the service conditions of primary medical institutions, the management of medical services, and the use of medical resources. To create a more impartial medical and health environment where the value of medical staff are truly reflected, financial investments should be attained to improve medical technologies and labor costs.	[Chen, Chen; Song, Jinglin] Southwestern Univ Finance & Econ, Sch Publ Adm, Dept Publ Econ Syst & Policy, Chengdu, Sichuan, Peoples R China; [Xu, Xiaolan; Zhou, Leming] Chongqing Hlth Informat Ctr, Dept Stat & Dev Res, Chongqing, Peoples R China; [Wang, Yonghong] Chongqing Qianjiang Cent Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Chen, Hong] Univ Chinese Acad Sci, Chongqing Inst Translat Med, Chongqing, Peoples R China	Southwestern University of Finance & Economics - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, H (corresponding author), Univ Chinese Acad Sci, Chongqing Inst Translat Med, Chongqing, Peoples R China.	chenh54012@126.com			Chongqing Science and Technology Bureau of Science and Health Joint Medical Research Project Funding:An Empirical Study of Health Economic on Non-Communicable Disease Prevention and Management in Chongqing [2019ZDXM006]	Chongqing Science and Technology Bureau of Science and Health Joint Medical Research Project Funding:An Empirical Study of Health Economic on Non-Communicable Disease Prevention and Management in Chongqing	This study was supported by Chongqing Science and Technology Bureau of Science and Health Joint Medical Research Project Funding:An Empirical Study of Health Economic on Non-Communicable Disease Prevention and Management in Chongqing(2019ZDXM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; [Anonymous], 2014, CHIN J DIABETES; [Anonymous], 2019, LETTERATURA CAVALLER, V1, P29; Arredondo A, 2011, VALUE HEALTH, V14, pS85, DOI 10.1016/j.jval.2011.05.022; [李舍予 Li Sheyu], 2013, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V13, P1180; Geng S, 2011, MED SOC, V24, P55, DOI [10.3870/YXYSH.2011.12.019, DOI 10.3870/YXYSH.2011.12.019]; International Diabetes Federation, INT DIAB FED IDF DIA; Liu K, 2002, CENTRAL S FOREST INV, V21, P36, DOI 10.3969/j.issn.1003-0743.2002.07.016; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Ning Hang, 2012, STUDY HOSP EXPENSES; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; van der Linden MW, 2009, VALUE HEALTH, V12, P909, DOI 10.1111/j.1524-4733.2009.00506.x; Van Doorslaer E, 2008, HEALTH POLICY, V86, P97, DOI 10.1016/j.healthpol.2007.09.018; Wang, 2012, CHIN J PREV CONTROL, V20, P681; Wang T, 2013, HLTH EC RESOUR, V2, P52; Yang GH, 2005, DEATH CAUSES THEIR R; [杨菊 Yang Ju], 2013, [中国全科医学, Chinese General Practice], V16, P82; Yang Yuting, 2015, SHANGHAI CHIN J HOSP, V31, P271; Yu R, 2012, CHINESE J PREVENTION, V20, P274; [袁庆 Yuan Qing], 2008, [中国卫生统计, Chinese Journal of Health Statistics], V25, P360; Zhu HP, 2008, SOC SCI CHINA, V29, P50, DOI 10.1080/02529200801920806; 吴彬, 2013, [中国卫生统计, Chinese Journal of Health Statistics], V30, P747	22	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0239844	10.1371/journal.pone.0239844	http://dx.doi.org/10.1371/journal.pone.0239844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33126237	Green Published, gold			2022-12-26	WOS:000588368900020
J	Nishihara, H; Gastfriend, BD; Soldati, S; Perriot, S; Mathias, A; Sano, Y; Shimizu, F; Gosselet, F; Kanda, T; Palecek, SP; Du Pasquier, R; Shusta, EV; Engelhardt, B				Nishihara, Hideaki; Gastfriend, Benjamin D.; Soldati, Sasha; Perriot, Sylvain; Mathias, Amandine; Sano, Yasuteru; Shimizu, Fumitaka; Gosselet, Fabien; Kanda, Takashi; Palecek, Sean P.; Du Pasquier, Renaud; Shusta, Eric V.; Engelhardt, Britta			Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions	FASEB JOURNAL			English	Article						blood&#8208; brain barrier; human induced pluripotent stem cells; T&#8208; cell migration; adhesion molecules; VCAM&#8208; 1	MICROVASCULAR ENDOTHELIAL-CELLS; IN-VITRO; RETINOIC ACID; DIFFERENTIATION; TRAFFICKING; PROMOTES; DISEASE; ESTABLISHMENT; PERMEABILITY; ACTIVATION	Human induced pluripotent stem cell (hiPSC)-derived blood-brain barrier (BBB) models established to date lack expression of key adhesion molecules involved in immune cell migration across the BBB in vivo. Here, we introduce the extended endothelial cell culture method (EECM), which differentiates hiPSC-derived endothelial progenitor cells to brain microvascular endothelial cell (BMEC)-like cells with good barrier properties and mature tight junctions. Importantly, EECM-BMEC-like cells exhibited constitutive cell surface expression of ICAM-1, ICAM-2, and E-selectin. Pro-inflammatory cytokine stimulation increased the cell surface expression of ICAM-1 and induced cell surface expression of P-selectin and VCAM-1. Co-culture of EECM-BMEC-like cells with hiPSC-derived smooth muscle-like cells or their conditioned medium further increased the induction of VCAM-1. Functional expression of endothelial ICAM-1 and VCAM-1 was confirmed by T-cell interaction with EECM-BMEC-like cells. Taken together, we introduce the first hiPSC-derived BBB model that displays an adhesion molecule phenotype that is suitable for the study of immune cell interactions.	[Nishihara, Hideaki; Soldati, Sasha; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland; [Gastfriend, Benjamin D.; Palecek, Sean P.; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [Perriot, Sylvain; Mathias, Amandine; Du Pasquier, Renaud] Lausanne Univ Hosp, Neurosci Res Ctr, Lab Neuroimmunol, Lausanne, Switzerland; [Perriot, Sylvain; Mathias, Amandine; Du Pasquier, Renaud] Univ Lausanne, Lausanne, Switzerland; [Sano, Yasuteru; Shimizu, Fumitaka; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi, Japan; [Gosselet, Fabien] Univ Artois, Blood Brain Barrier Lab, Lens, France; [Shusta, Eric V.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA	University of Bern; University of Wisconsin System; University of Wisconsin Madison; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Yamaguchi University; Universite d'Artois; University of Wisconsin System; University of Wisconsin Madison	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.; Shusta, EV (corresponding author), Univ Wisconsin, Dept Neurol Surg, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	eshusta@wisc.edu; bengel@tki.unibe.ch	Gosselet, Fabien/U-8427-2019; Nishihara, Hideaki/AAJ-7563-2021	Gosselet, Fabien/0000-0002-0481-5026; Nishihara, Hideaki/0000-0002-2990-835X; Perriot, Sylvain/0000-0002-0337-3262	BangerterRhyner Foundation; Swiss MS Society; ECTRIMS Postdoctoral Research Exchange Fellowship; Uehara Memorial Foundation; JSPS Overseas Research Fellowships; National Institutes of Health [NS103844]; National Science Foundation Graduate Research Fellowship program [1747503]; National Institutes of Health Biotechnology Training Program [T32 GM008349]; Bern Center for Precision Medicine;  [SNF 320030-179531]	BangerterRhyner Foundation; Swiss MS Society; ECTRIMS Postdoctoral Research Exchange Fellowship; Uehara Memorial Foundation(Uehara Memorial Foundation); JSPS Overseas Research Fellowships; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Institutes of Health Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bern Center for Precision Medicine; 	This study was funded by the BangerterRhyner Foundation and the Bern Center for Precision Medicine to BE, the Swiss MS Society to BE and RDP, an ECTRIMS Postdoctoral Research Exchange Fellowship, the Uehara Memorial Foundation, and JSPS Overseas Research Fellowships to HN, and National Institutes of Health Grant NS103844 to EVS and SPP. RDP was also supported by a SNF 320030-179531. BDG was supported by the National Science Foundation Graduate Research Fellowship program under grant number 1747503 and the National Institutes of Health Biotechnology Training Program grant T32 GM008349.	Abadier M, 2015, EUR J IMMUNOL, V45, P1043, DOI 10.1002/eji.201445125; Alter A, 2003, J IMMUNOL, V170, P4497, DOI 10.4049/jimmunol.170.9.4497; Alvarez JI, 2015, NEUROBIOL DIS, V74, P14, DOI 10.1016/j.nbd.2014.09.016; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Bao XP, 2016, METHODS MOL BIOL, V1481, P183, DOI 10.1007/978-1-4939-6393-5_17; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Bonney S, 2016, J NEUROSCI, V36, P7786, DOI 10.1523/JNEUROSCI.3952-15.2016; Boyer-Di Ponio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084179; Canfield SG, 2017, J NEUROCHEM, V140, P874, DOI 10.1111/jnc.13923; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cayrol R, 2011, METHODS MOL BIOL, V686, P275, DOI 10.1007/978-1-60761-938-3_13; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Clark PA, 2016, MOL PHARMACEUT, V13, P3341, DOI 10.1021/acs.molpharmaceut.6b00441; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; DIAS MC, 2019, SCI REP UK, V9; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Engen SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104306; Halaidych OV, 2018, STEM CELL REP, V10, P1642, DOI 10.1016/j.stemcr.2018.03.012; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Herich S, 2019, BRAIN, V142, P3411, DOI 10.1093/brain/awz301; Hirase T, 1997, J CELL SCI, V110, P1603; Hollmann EK, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0059-0; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Larochelle C, 2012, BRAIN, V135, P2906, DOI 10.1093/brain/aws212; Lecuyer MA, 2017, P NATL ACAD SCI USA, V114, pE524, DOI 10.1073/pnas.1614336114; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Linville RM, 2019, BIOMATERIALS, V190, P24, DOI 10.1016/j.biomaterials.2018.10.023; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Luo JY, 1999, BLOOD, V93, P3785, DOI 10.1182/blood.V93.11.3785.411a44_3785_3791; Lyck R, 2017, J CEREBR BLOOD F MET, V37, P2894, DOI 10.1177/0271678X16678639; Malin D, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.CCR-13-1255; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Mossu A, 2019, J CEREBR BLOOD F MET, V39, P395, DOI 10.1177/0271678X18820584; Neal EH, 2019, STEM CELL REP, V12, P1380, DOI 10.1016/j.stemcr.2019.05.008; Nishihara H, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-019-0165-2; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Perriot S, 2018, STEM CELL REP, V11, P1199, DOI 10.1016/j.stemcr.2018.09.015; Pinheiro MAL, 2016, ELIFE, V5, DOI 10.7554/eLife.13149; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Praca C, 2019, STEM CELL REP, V13, P599, DOI 10.1016/j.stemcr.2019.08.002; Qian TC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701679; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Shimizu F, 2011, J CELL PHYSIOL, V226, P255, DOI 10.1002/jcp.22337; Stebbins MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7375; Stebbins MJ, 2016, METHODS, V101, P93, DOI 10.1016/j.ymeth.2015.10.016; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Vatine GD, 2019, CELL STEM CELL, V24, P995, DOI 10.1016/j.stem.2019.05.011; Vatine GD, 2017, CELL STEM CELL, V20, P831, DOI 10.1016/j.stem.2017.04.002; Vazao H, 2017, P NATL ACAD SCI USA, V114, pE3022, DOI 10.1073/pnas.1617451114; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wimmer I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00711; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	73	21	21	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16693	16715		10.1096/fj.202001507RR	http://dx.doi.org/10.1096/fj.202001507RR		OCT 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33124083	hybrid, Green Published			2022-12-26	WOS:000589710000001
J	Porsch, EA; Yagupsky, P; St Geme, JW				Porsch, Eric A.; Yagupsky, Pablo; St Geme, Joseph W., III			Kingella negevensis shares multiple putative virulence factors with Kingella kingae	PLOS ONE			English	Article							OSTEOARTICULAR INFECTIONS; EMERGING PATHOGEN; IV PILI; IDENTIFICATION; EXPRESSION; ADHERENCE; CARRIAGE; LOCUS	Kingella negevensis is a newly described gram-negative bacterium in the Neisseriaceae family and is closely related to Kingella kingae, an important cause of pediatric osteoarticular infections and other invasive diseases. Like K. kingae, K. negevensis can be isolated from the oropharynx of young children, although at a much lower rate. Due to the potential for misidentification as K. kingae, the burden of disease due to K. negevensis is currently unknown. Similarly, there is little known about virulence factors present in K. negevensis and how they compare to virulence factors in K. kingae. Using a variety of approaches, we show that K. negevensis produces many of the same putative virulence factors that are present in K. kingae, including a polysaccharide capsule, a secreted exopolysaccharide, a Knh-like trimeric autotransporter, and type IV pili, suggesting that K. negevensis may have significant pathogenic potential.	[Porsch, Eric A.; St Geme, Joseph W., III] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Yagupsky, Pablo] Soroka Univ, Med Ctr, Clin Microbiol Lab, Beer Sheva, Israel; [St Geme, Joseph W., III] Univ Penn, Perlman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ben Gurion University; Soroka Medical Center; University of Pennsylvania	St Geme, JW (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; St Geme, JW (corresponding author), Univ Penn, Perlman Sch Med, Philadelphia, PA 19104 USA.	stgemeiiij@email.chop.edu		St. Geme, Joseph/0000-0002-6787-9510	National Institute of Allergy and Infectious Diseases [1R01AI121015]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy [DE-SC0015662]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) under award 1R01AI121015 to J.W.S and by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy (https://www.energy.gov/science/bes/basic-energy-sciences) grant (DE-SC0015662) to Parastoo Azadi at the Complex Carbohydrate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; Cherkaoui A, 2009, J MED MICROBIOL, V58, P65, DOI 10.1099/jmm.0.47707-0; Chometon S, 2007, PEDIATR INFECT DIS J, V26, P377, DOI 10.1097/01.inf.0000259954.88139.f4; Dubnov-Raz G, 2010, PEDIATR INFECT DIS J, V29, P639, DOI 10.1097/INF.0b013e3181d57a6c; Edgar RJ, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00126; El Houmami N, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00571-17; El Houmami N, 2017, J CLIN MICROBIOL, V55, P3113, DOI [10.1128/JCM.00736-17, 10.1128/jcm.00736-17]; El Houmami N, 2017, INT J SYST EVOL MICR, V67, P2370, DOI 10.1099/ijsem.0.001957; Ilharreborde B, 2009, J CLIN MICROBIOL, V47, P1837, DOI 10.1128/JCM.00144-09; Kehl-Fie TE, 2008, J BACTERIOL, V190, P7157, DOI 10.1128/JB.00884-08; Kehl-Fie TE, 2007, J BACTERIOL, V189, P430, DOI 10.1128/JB.01319-06; Kehl-Fie TE, 2010, INFECT IMMUN, V78, P1692, DOI 10.1128/IAI.00908-09; Kehl-Fie TE, 2009, J BACTERIOL, V191, P4976, DOI 10.1128/JB.00123-09; Lehours P, 2011, J CLIN MICROBIOL, V49, P1245, DOI 10.1128/JCM.01657-10; Opota O, 2017, MICROBES INFECT, V19, P546, DOI 10.1016/j.micinf.2017.08.001; Pendela VS, 2020, AM J TROP MED HYG, V103, P672, DOI 10.4269/ajtmh.20-0202; Porsch EA, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00060-17, 10.1128/msphere.00060-17]; Porsch EA, 2013, J BACTERIOL, V195, P886, DOI 10.1128/JB.02186-12; Porsch EA, 2012, MBIO, V3, DOI 10.1128/mBio.00372-12; Starr KF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005944; Starr KF, 2016, INFECT IMMUN, V84, P1775, DOI 10.1128/IAI.00128-16; Starr KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075409; Yagupsky P., 2018, New Microbes and New Infections, V26, P59, DOI 10.1016/j.nmni.2018.08.011; Yagupsky P, 2015, CLIN MICROBIOL REV, V28, P54, DOI 10.1128/CMR.00028-14; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867; Yang QL, 2001, METH MOLEC MED, V66, P41, DOI 10.1385/1-59259-148-5:41	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241511	10.1371/journal.pone.0241511	http://dx.doi.org/10.1371/journal.pone.0241511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125432	Green Published, gold			2022-12-26	WOS:000588368900065
J	Carvalho, V; Prabudiansyah, I; Kovacik, L; Chami, M; Kieffer, R; van der Valk, R; de Lange, N; Engel, A; Aubin-Tam, ME				Carvalho, Vanessa; Prabudiansyah, Irfan; Kovacik, Lubomir; Chami, Mohamed; Kieffer, Roland; van der Valk, Ramon; de Lange, Nick; Engel, Andreas; Aubin-Tam, Marie-Eve			The cytoplasmic domain of the AAA plus protease FtsH is tilted with respect to the membrane to facilitate substrate entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI FTSH; CRYO-EM STRUCTURE; TRANSMEMBRANE HELICES; PROVIDES INSIGHTS; INNER MEMBRANE; PREDICTION; TOPOLOGY; VISUALIZATION; REFINEMENT	AAA+ proteases are degradation machines that use ATP hydrolysis to unfold protein substrates and translocate them through a central pore toward a degradation chamber. FtsH, a bacterial membrane-anchored AAA+ protease, plays a vital role in membrane protein quality control. How substrates reach the FtsH central pore is an open key question that is not resolved by the available atomic structures of cytoplasmic and periplasmic domains. In this work, we used both negative stain TEM and cryo-EM to determine 3D maps of the full-length Aquifex aeolicus FtsH protease. Unexpectedly, we observed that detergent solubilization induces the formation of fully active FtsH dodecamers, which consist of two FtsH hexamers in a single detergent micelle. The striking tilted conformation of the cytosolic domain in the FtsH dodecamer visualized by negative stain TEM suggests a lateral substrate entrance between the membrane and cytosolic domain. Such a substrate path was then resolved in the cryo-EM structure of the FtsH hexamer. By mapping the available structural information and structure predictions for the transmembrane helices to the amino acid sequence we identified a linker of similar to 20 residues between the second transmembrane helix and the cytosolic domain. This unique polypeptide appears to be highly flexible and turned out to be essential for proper functioning of FtsH as its deletion fully eliminated the proteolytic activity of FtsH.	[Carvalho, Vanessa; Prabudiansyah, Irfan; Kieffer, Roland; van der Valk, Ramon; de Lange, Nick; Aubin-Tam, Marie-Eve] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands; [Kovacik, Lubomir; Chami, Mohamed; Engel, Andreas] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, BioEM Lab, Biozentrum,C CINA, Basel, Switzerland	Delft University of Technology; University of Basel	Aubin-Tam, ME (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.; Engel, A (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt, BioEM Lab, Biozentrum,C CINA, Basel, Switzerland.	andreas.engel@unibas.ch; m.e.aubin-tam@tudelft.nl			Netherlands Organization for Scientific Research VIDI Grant [723-016-007]; Swiss Commission for Technology and Innovation [CTI 18272.1]	Netherlands Organization for Scientific Research VIDI Grant; Swiss Commission for Technology and Innovation	The work was supported by the Netherlands Organization for Scientific Research VIDI Grant 723-016-007 (I. P., R. K., and M. -E. A. -T.) and by the Swiss Commission for Technology and Innovation, Grant CTI 18272.1 (L. K. and M. C.). Cryo-EM calculations were performed at sciCORE (http://scicore.unibas.ch/) scientific computing center at University of Basel.	Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Akiyama Y, 2002, P NATL ACAD SCI USA, V99, P8066, DOI 10.1073/pnas.122616899; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Bittner LM, 2017, BIOL CHEM, V398, P625, DOI 10.1515/hsz-2016-0302; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Botelho SC, 2013, J BIOL CHEM, V288, P4792, DOI 10.1074/jbc.M112.430892; Botos I, 2019, CURR RES STRUCT BIOL, V1, P13, DOI 10.1016/j.crstbi.2019.10.001; Breyton C, 2019, BBA-BIOMEMBRANES, V1861, P939, DOI 10.1016/j.bbamem.2019.02.003; Bruckner RC, 2003, BIOCHEMISTRY-US, V42, P10843, DOI 10.1021/bi034516h; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chaptal V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41751; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cooley RB, 2016, ELIFE, V5, DOI 10.7554/eLife.21848; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Hari SB, 2016, BIOCHEMISTRY-US, V55, P5649, DOI 10.1021/acs.biochem.6b00920; Hinz A, 2011, J BACTERIOL, V193, P4790, DOI 10.1128/JB.05133-11; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kereiche S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33631; Kim SH, 2008, J SYNCHROTRON RADIAT, V15, P208, DOI 10.1107/S090904950706846X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lee S, 2011, J BIOL CHEM, V286, P4404, DOI 10.1074/jbc.M110.158741; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Ludtke SJ, 2016, METHOD ENZYMOL, V579, P159, DOI 10.1016/bs.mie.2016.05.001; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Richard I, 2005, J MED GENET, V42, P529, DOI 10.1136/jmg.2004.028118; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rose A, 2009, NUCLEIC ACIDS RES, V37, pW575, DOI 10.1093/nar/gkp418; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rotanova TV, 2019, FEBS OPEN BIO, V9, P1536, DOI 10.1002/2211-5463.12691; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; Scharfenberg F, 2015, J MOL BIOL, V427, P910, DOI 10.1016/j.jmb.2014.12.024; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Steele TE, 2019, MITOCHONDRION, V49, P121, DOI 10.1016/j.mito.2019.07.012; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Suno R, 2012, FEBS LETT, V586, P3117, DOI 10.1016/j.febslet.2012.07.069; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vostrukhina M, 2015, ACTA CRYSTALLOGR D, V71, P1307, DOI 10.1107/S1399004715005945; Woessner J, 2012, HDB PROTEOLYTIC ENZY; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100029	10.1074/jbc.RA120.014739	http://dx.doi.org/10.1074/jbc.RA120.014739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33154162	Green Published, Green Accepted, gold			2022-12-26	WOS:000672866400013
J	Chen, XC; Zhao, C; Xu, YT; Huang, KL; Wang, YL; Wang, XY; Zhou, XG; Pang, WJ; Yang, GS; Yu, TY				Chen, Xiaochang; Zhao, Chen; Xu, Yanting; Huang, Kuilong; Wang, Yulong; Wang, Xiaoyu; Zhou, Xiaoge; Pang, Weijun; Yang, Gongshe; Yu, Taiyong			Adipose-specific BMP and activin membrane-bound inhibitor (BAMBI) deletion promotes adipogenesis by accelerating ROS production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; OXIDATIVE STRESS; STEM-CELL; BETA; OBESITY; INSIGHTS	With the improvement of people's living standards, the number of obese patients has also grown rapidly. It is reported that the level of oxidative stress in obese patients has significantly increased, mainly caused by the increase in reactive oxygen species (ROS) levels in adipose tissue. Studies have shown that the use of siRNA to interfere with bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) expression could promote adipocyte differentiation, and under hypoxic conditions, BAMBI could act as a regulator of HIF1a to regulate the polarity damage of epithelial cells. In view of these results, we speculated that BAMBI may regulate adipogenesis by regulating the level of ROS. In this study, we generated adipose-specific BAMBI knockout mice (BAMBI AKO) and found that compared with control mice, BAMBI AKO mice showed obesity when fed with high-fat diet, accompanied by insulin resistance, glucose intolerance, hypercholesterolemia, and increased inflammation in adipose tissue. Interestingly, adipose-specific deficiency of BAMBI could cause an increase in the expression level of Nox4, thereby promoting ROS production in cytoplasm and mitochondria and the DNA-binding activity of C/EBP beta and ultimately promoting adipogenesis. Consistently, our findings indicated that BAMBI may be a reactive oxygen regulator to affect adipogenesis, thereby controlling obesity and metabolic syndrome.	[Chen, Xiaochang; Zhao, Chen; Xu, Yanting; Huang, Kuilong; Wang, Yulong; Wang, Xiaoyu; Zhou, Xiaoge; Pang, Weijun; Yang, Gongshe; Yu, Taiyong] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yu, TY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China.	yutaiyong310@nwsuaf.edu.cn		Wang, Xiaoyu/0000-0002-0861-0204; Yu, Taiyong/0000-0001-6951-9968	Key R&D Program of Shaanxi [2018ZDCXL-NY-02-05]; National Science and Technology Major Project of China [2016ZX08006003]; National Key R&D Program of China [2017YFD0502003]	Key R&D Program of Shaanxi; National Science and Technology Major Project of China; National Key R&D Program of China	This work was supported by Key R&D Program of Shaanxi (2017ZDXM-NY-077), National Science and Technology Major Project of China (2016ZX08006003), Key R&D Program of Shaanxi (2018ZDCXL-NY-02-05), and National Key R&D Program of China (2017YFD0502003).	Abuyassin B, 2015, E MEDITERR HEALTH J, V21, P420, DOI 10.26719/2015.21.420; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Ayer J, 2015, EUR HEART J, V36, P1371, DOI 10.1093/eurheartj/ehv089; Bai L, 2017, THERIOGENOLOGY, V100, P24, DOI 10.1016/j.theriogenology.2017.05.022; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim YM, 2014, CELL SIGNAL, V26, P784, DOI 10.1016/j.cellsig.2013.12.005; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; Lee CH, 2019, J DIABETES INVEST, V10, P29, DOI 10.1111/jdi.12918; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Mai Y, 2014, BIOCHEM CELL BIOL, V92, P172, DOI 10.1139/bcb-2014-0011; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Raykhel I, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210906; Reilly JJ, 2018, LANCET, V391, P1773, DOI 10.1016/S0140-6736(18)30794-3; Rhee YH, 2016, J PHYSIOL BIOCHEM, V72, P145, DOI 10.1007/s13105-015-0463-3; Seo MJ, 2016, PHYTOTHER RES, V30, P1802, DOI 10.1002/ptr.5683; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sun SW, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0988-z; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Villar AV, 2013, BBA-MOL BASIS DIS, V1832, P323, DOI 10.1016/j.bbadis.2012.11.007; Wang J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040372; Wang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120629; Wang X, 2016, MOL BIOL REP, V43, P607, DOI 10.1007/s11033-016-4022-y; Wang X, 2015, FREE RADICAL BIO MED, V89, P99, DOI 10.1016/j.freeradbiomed.2015.07.012; Yao XP, 2019, BIOCHEM BIOPH RES CO, V509, P125, DOI 10.1016/j.bbrc.2018.12.082; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zhang QL, 2015, INT J MOL SCI, V16, P17734, DOI 10.3390/ijms160817734	35	7	8	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100037	10.1074/jbc.RA120.014793	http://dx.doi.org/10.1074/jbc.RA120.014793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33158991	Green Published, gold			2022-12-26	WOS:000672866400021
J	Hipfner, JM; Prill, MM; Studholme, KR; Domalik, AD; Tucker, S; Jardine, C; Maftei, M; Wright, KG; Beck, JN; Bradley, RW; Carle, RD; Good, TP; Hatch, SA; Hodum, PJ; Ito, M; Pearson, SF; Rojek, NA; Slater, L; Watanuki, Y; Will, AP; Bindoff, AD; Crossin, GT; Drever, MC; Burg, TM				Hipfner, J. Mark; Prill, Marie M.; Studholme, Katharine R.; Domalik, Alice D.; Tucker, Strahan; Jardine, Catherine; Maftei, Mark; Wright, Kenneth G.; Beck, Jessie N.; Bradley, Russell W.; Carle, Ryan D.; Good, Thomas P.; Hatch, Scott A.; Hodum, Peter J.; Ito, Motohiro; Pearson, Scott F.; Rojek, Nora A.; Slater, Leslie; Watanuki, Yutaka; Will, Alexis P.; Bindoff, Aidan D.; Crossin, Glenn T.; Drever, Mark C.; Burg, Theresa M.			Geolocator tagging links distributions in the non-breeding season to population genetic structure in a sentinel North Pacific seabird	PLOS ONE			English	Article							AUKLET CERORHINCA-MONOCERATA; MITOCHONDRIAL-DNA VARIATION; LANCE AMMODYTES-HEXAPTERUS; CORDILLERAN ICE-SHEET; MURRES URIA-AALGE; RHINOCEROS AUKLET; AETHIA-PYGMAEA; FORAGE FISH; MARBLED MURRELETS; SEASCAPE GENETICS	We tested the hypothesis that segregation in wintering areas is associated with population differentiation in a sentinel North Pacific seabird, the rhinoceros auklet (Cerorhinca monocerata). We collected tissue samples for genetic analyses on five breeding colonies in the western Pacific Ocean (Japan) and on 13 colonies in the eastern Pacific Ocean (California to Alaska), and deployed light-level geolocator tags on 12 eastern Pacific colonies to delineate wintering areas. Geolocator tags were deployed previously on one colony in Japan. There was strong genetic differentiation between populations in the eastern vs. western Pacific Ocean, likely due to two factors. First, glaciation over the North Pacific in the late Pleistocene might have forced a southward range shift that historically isolated the eastern and western populations. And second, deep-ocean habitat along the northern continental shelf appears to act as a barrier to movement; abundant on both sides of the North Pacific, the rhinoceros auklet is virtually absent as a breeder in the Aleutian Islands and Bering Sea, and no tagged birds crossed the North Pacific in the non-breeding season. While genetic differentiation was strongest between the eastern vs. western Pacific, there was also extensive differentiation within both regional groups. In pairwise comparisons among the eastern Pacific colonies, the standardized measure of genetic differentiation (F-ST) was negatively correlated with the extent of spatial overlap in wintering areas. That result supports the hypothesis that segregation in the non-breeding season is linked to genetic structure. Philopatry and a neritic foraging habit probably also contribute to the structuring. Widely distributed, vulnerable to anthropogenic stressors, and exhibiting extensive genetic structure, the rhinoceros auklet is fully indicative of the scope of the conservation challenges posed by seabirds.	[Hipfner, J. Mark; Domalik, Alice D.; Maftei, Mark; Wright, Kenneth G.; Drever, Mark C.] Environm & Climate Change Canada, Wildlife Res Div, Delta, BC, Canada; [Prill, Marie M.; Burg, Theresa M.] Univ Lethbridge, Dept Biol, Lethbridge, AB, Canada; [Studholme, Katharine R.; Crossin, Glenn T.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Domalik, Alice D.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Tucker, Strahan] Fisheries & Oceans Canada, Nanaimo, BC, Canada; [Jardine, Catherine] Birds Canada, Delta, BC, Canada; [Beck, Jessie N.; Carle, Ryan D.] Oikonos Ecosyst Knowledge, Santa Cruz, CA USA; [Bradley, Russell W.] Point Blue Conservat Sci, Petaluma, CA USA; [Good, Thomas P.] NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Washington, DC USA; [Hatch, Scott A.] Inst Seabird Res & Conservat, Anchorage, AK USA; [Hodum, Peter J.] Univ Puget Sound, Dept Biol, Washington, DC USA; [Ito, Motohiro] Toyo Univ, Dept Appl Biosci, Bunky Ku, Tokyo, Japan; [Pearson, Scott F.] Washington Dept Fish & Wildlife, Washington, DC USA; [Rojek, Nora A.; Slater, Leslie] US Fish & Wildlife Serv, Homer, AK USA; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Will, Alexis P.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Bindoff, Aidan D.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia; [Maftei, Mark] Raincoast Educ Soc, Tofino, BC, Canada; [Bradley, Russell W.] Calif State Univ Channel Isl, Camarillo, CA USA	Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; University of Lethbridge; Dalhousie University; Simon Fraser University; Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA; Toyo University; Washington Department of Fish & Wildlife (WDFW); United States Department of the Interior; US Fish & Wildlife Service; Hokkaido University; University of Alaska System; University of Alaska Fairbanks; University of Tasmania; California State University System; California State University Channel Islands	Hipfner, JM (corresponding author), Environm & Climate Change Canada, Wildlife Res Div, Delta, BC, Canada.	mark.hipfner@canada.ca		Crossin, Glenn/0000-0003-1080-1189; Bindoff, Aidan/0000-0002-0943-2702; Pearson, Scott/0000-0003-4960-3956; Carle, Ryan/0000-0002-8213-4306; Drever, Mark/0000-0001-5303-9230	Environment and Climate Change Canada; Natural Sciences and Engineering Research Council of Canada; North Pacific Research Board; United States Fish and Wildlife Service; Alaska Maritime National Wildlife Refuge; Farallon Islands National Wildlife Refuge; Washington State Department of Fish and Wildlife; Japan Society for the Promotion of Science [16H06739, 17K15308]	Environment and Climate Change Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); North Pacific Research Board; United States Fish and Wildlife Service(US Fish & Wildlife Service); Alaska Maritime National Wildlife Refuge; Farallon Islands National Wildlife Refuge; Washington State Department of Fish and Wildlife; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Primary funding was provided by Environment and Climate Change Canada (J.M.H.), the Natural Sciences and Engineering Research Council of Canada (Discovery Grants to G.T.C. and T.M.B.), the North Pacific Research Board (Graduate Student Research Awards to K.R.S. (2014) and A.P.W. (2015)) the United States Fish and Wildlife Service, the Alaska Maritime National Wildlife Refuge (N.R. and L.S.), the Farallon Islands National Wildlife Refuge (R.W.B.), the Washington State Department of Fish and Wildlife (S.F.P.), and a Japan Society for the Promotion of Science Grant-in Aid for Scientific Research (16H06739 and 17K15308 to M.I.). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2014, MAR BIOL, V161, P275, DOI 10.1007/s00227-013-2333-2; Addison B, 2008, BEHAV ECOL SOCIOBIOL, V63, P135, DOI 10.1007/s00265-008-0643-z; AINLEY DG, 1974, CONDOR, V76, P432, DOI 10.2307/1365816; Albertson GR, 2017, CONSERV GENET, V18, P33, DOI 10.1007/s10592-016-0880-z; Alvarez-Varas R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223587; [Anonymous], 2013, SEAB COL DAT; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertram DF, 2002, CAN J ZOOL, V80, P2190, DOI 10.1139/Z02-211; BERTRAM DF, 1993, CAN J FISH AQUAT SCI, V50, P1908, DOI 10.1139/f93-213; Bicknell AWJ, 2012, MOL ECOL, V21, P2863, DOI 10.1111/j.1365-294X.2012.05558.x; Bindoff AD, 2018, METHODS ECOL EVOL, V9, P1190, DOI 10.1111/2041-210X.12953; Birt Tim P., 2011, Marine Ornithology, V39, P45; Borstad G, 2011, MAR ECOL PROG SER, V424, P285, DOI 10.3354/meps08950; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Burg TM, 2004, MOL ECOL, V13, P2345, DOI 10.1111/j.1365-294X.2004.02232.x; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carr MH, 2003, ECOL APPL, V13, pS90; Clucas GV, 2018, MOL ECOL, V27, P4680, DOI 10.1111/mec.14896; Congdon BC, 2000, EVOLUTION, V54, P974; Coulson JC, 2016, WATERBIRDS, V39, P229; Cronin MA, 1996, J MAMMAL, V77, P546, DOI 10.2307/1382828; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Cummins PF, 2007, PROG OCEANOGR, V75, P253, DOI 10.1016/j.pocean.2007.08.006; Dawson DA, 2005, MOL ECOL NOTES, V5, P289, DOI 10.1111/j.1471-8286.2005.00906.x; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dias MP, 2019, BIOL CONSERV, V237, P525, DOI 10.1016/j.biocon.2019.06.033; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fayet AL, 2017, CURR BIOL, V27, P3871, DOI 10.1016/j.cub.2017.11.009; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Friesen VL, 2015, J ORNITHOL, V156, pS27, DOI 10.1007/s10336-015-1235-0; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gaston A.J., 1998, THE AUKS; Gaston AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171726; Gibson D. D., 2007, BIRDS ALEUTIAN ISLAN; Goetze E, 2005, EVOLUTION, V59, P2378; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Good TP, 2014, MAR POLLUT BULL, V86, P367, DOI 10.1016/j.marpolbul.2014.06.042; Hamel Nathalie J., 2009, Marine Ornithology, V37, P41; Hasegawa O, 2005, MOL ECOL NOTES, V5, P637, DOI 10.1111/j.1471-8286.2005.01028.x; Hastings KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176840; Hatch S.A., 1983, Murrelet, V64, P39, DOI 10.2307/3534688; HATCH SA, 1990, CAN J ZOOL, V68, P1664, DOI 10.1139/z90-247; Hays GC, 2019, TRENDS ECOL EVOL, V34, P459, DOI 10.1016/j.tree.2019.01.009; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Henkel LA, 2014, MAR POLLUT BULL, V79, P155, DOI 10.1016/j.marpolbul.2013.12.023; Hipfner JM, 2011, SCI TOTAL ENVIRON, V409, P1328, DOI 10.1016/j.scitotenv.2010.12.022; Hipfner JM, 2019, MAR ORNITHOL, V47, P225; Hipfner JM, 2018, ENVIRON POLLUT, V239, P215, DOI 10.1016/j.envpol.2018.04.009; Hipfner JM, 2008, J AVIAN BIOL, V39, P611, DOI 10.1111/j.1600-048X.2008.04355.x; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Jahnke M, 2018, EVOL APPL, V11, P645, DOI 10.1111/eva.12589; Johns ME, 2020, ECOL APPL, V30, DOI 10.1002/eap.2068; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kidd MG, 1998, EVOLUTION, V52, P1158, DOI 10.1111/j.1558-5646.1998.tb01842.x; Lack D., 1968, pvii; Lal MM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3410-y; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LeValley R., 1982, American Birds, V36, P1011; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; MCCHESNEY GJ, 1995, COLON WATERBIRD, V18, P79, DOI 10.2307/1521401; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Melvin EF, 1999, CONSERV BIOL, V13, P1386, DOI 10.1046/j.1523-1739.1999.98426.x; Menounos B, 2017, SCIENCE, V358, P781, DOI 10.1126/science.aan3001; Mertens LEA, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00268; Miller A, 2014, ENVIRON POLLUT, V195, P48, DOI 10.1016/j.envpol.2014.08.009; MOEN SM, 1991, AUK, V108, P755; Morris-Pocock JA, 2008, MOL ECOL, V17, P4859, DOI 10.1111/j.1365-294X.2008.03977.x; Morris-Pocock JA, 2010, MOL PHYLOGENET EVOL, V54, P883, DOI 10.1016/j.ympev.2009.11.013; Morrison KW, 2011, AUK, V128, P707, DOI 10.1525/auk.2011.10198; Munro KJ, 2017, EMU, V117, P4, DOI 10.1080/01584197.2016.1271988; NELSON J W, 1987, Murrelet, V68, P1, DOI 10.2307/3535044; Nettleship D., 1996, HDB BIRDS WORLD, V3, P678; Nicastro KR, 2008, MAR ECOL PROG SER, V368, P189, DOI 10.3354/meps07607; Nielsen MM, 2016, J PHYCOL, V52, P523, DOI 10.1111/jpy.12428; Niizuma Y, 2002, CAN J ZOOL, V80, P1549, DOI 10.1139/Z02-158; Oka N, 2000, MAR POLLUT BULL, V40, P340, DOI 10.1016/S0025-326X(99)00223-4; OSBORNE TO, 1973, CONDOR, V75, P463, DOI 10.2307/1366570; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearce RL, 2002, CONDOR, V104, P84, DOI 10.1650/0010-5422(2002)104[0084:MDSHGF]2.0.CO;2; Pearson SF, 2013, CONDOR, V115, P356, DOI 10.1525/cond.2013.110207; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Prill MM, 2019, THESIS; Pritchard JK, 2000, GENETICS, V155, P945; Pshenichnikova OS, 2017, J AVIAN BIOL, V48, P1047, DOI 10.1111/jav.01124; Pshenichnikova OS, 2015, MAR BIOL, V162, P1329, DOI 10.1007/s00227-015-2672-2; Quillfeldt P, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1008-x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rayner MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1330; Reid BN, 2019, MOL ECOL, V28, P3358, DOI 10.1111/mec.15165; Rexer-Huber K, 2019, MOL ECOL, V28, P4552, DOI 10.1111/mec.15248; Robinson CLK, 2013, PROG OCEANOGR, V115, P119, DOI 10.1016/j.pocean.2013.05.029; Rodway MS, 2018, SEABIRD COLONIES BRI; Roura A, 2019, PROG OCEANOGR, V170, P11, DOI 10.1016/j.pocean.2018.10.005; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sa-Pinto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050330; Sauve D, 2019, MAR ORNITHOL, V47, P199; Schacter CR, 2018, AUK, V135, P706, DOI 10.1642/AUK-17-235.1; Scott J.M., 1974, Western Birds, V5, P13; Selkoe KA, 2016, MAR ECOL PROG SER, V554, P1, DOI 10.3354/meps11792; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Shoji A, 2019, ENVIRON TOXICOL CHEM, V38, P106, DOI 10.1002/etc.4286; Smith JL, 2005, TECHNICAL REPORT; Smith NA, 2015, J AVIAN BIOL, V46, P125, DOI 10.1111/jav.00487; Steinfartz S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-297; Studholme KR, 2019, MAR ECOL PROG SER, V619, P169, DOI 10.3354/meps12965; Takahashi A, 2015, MAR ECOL PROG SER, V525, P229, DOI 10.3354/meps11179; Taylor MA, 2014, EARTH PLANET SC LETT, V403, P89, DOI 10.1016/j.epsl.2014.06.026; Taylor SA, 2012, MAR ECOL PROG SER, V451, P285, DOI 10.3354/meps09694; Tesson SVM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114984; Thanou E, 2017, MOL ECOL, V26, P2796, DOI 10.1111/mec.13996; Thayer JA, 2008, CAN J FISH AQUAT SCI, V65, P1610, DOI 10.1139/F08-076; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Tigano A, 2017, ECOL EVOL, V7, P2370, DOI 10.1002/ece3.2819; Tigano A, 2015, J HERED, V106, P238, DOI 10.1093/jhered/esv016; Tranquilla LM, 2015, CAN J ZOOL, V93, P447, DOI 10.1139/cjz-2014-0315; Ushakova MV, 2007, ZOOL ZH, V86, P955; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez-Carrillo C, 2014, ANIM CONSERV, V17, P244, DOI 10.1111/acv.12089; Wallace SJ, 2015, J BIOGEOGR, V42, P390, DOI 10.1111/jbi.12404; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warzybok P, 2018, J MARINE SYST, V185, P25, DOI 10.1016/j.jmarsys.2018.04.009; Watanuki Y, 2012, MAR ECOL PROG SER, V454, P183, DOI 10.3354/meps09627; WILSON UW, 1986, CONDOR, V88, P143, DOI 10.2307/1368909; Wood AR, 2007, MAR ECOL PROG SER, V349, P159, DOI 10.3354/meps07110; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright D, 2015, DIVERS DISTRIB, V21, P698, DOI 10.1111/ddi.12302	138	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0240056	10.1371/journal.pone.0240056	http://dx.doi.org/10.1371/journal.pone.0240056			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166314	Green Accepted, gold, Green Published			2022-12-26	WOS:000592382600058
J	Ouanes, S; Becetti, I; Ghuloum, S; Hammoudeh, S; Shehata, M; Ghabrash, H; Yehya, A; Al-Lawati, H; Al-Fakhri, N; Iram, H; Ajmal, N; Eltorki, Y; Al-Amin, H				Ouanes, Sami; Becetti, Imen; Ghuloum, Suhaila; Hammoudeh, Samer; Shehata, Mena; Ghabrash, Hany; Yehya, Areej; Al-Lawati, Hawra; Al-Fakhri, Nora; Iram, Huma; Ajmal, Nighat; Eltorki, Yassin; Al-Amin, Hassen			Patterns of prescription of antipsychotics in Qatar	PLOS ONE			English	Article							META-REGRESSION; SCHIZOPHRENIA; POLYPHARMACY; CLOZAPINE; MONOTHERAPY; PREVALENCE; GUIDELINES; INPATIENTS	Objective Even though all guidelines recommend generally against antipsychotic polypharmacy, antipsychotic polypharmacy appears to be a very common practice across the globe. This study aimed to examine the prescription patterns of antipsychotics in Qatar, in comparison with the international guidelines, and to scrutinize the sociodemographic and clinical features associated with antipsychotic polypharmacy. Methods All the medical records of all the inpatients and outpatients treated by antipsychotics at the Department of Psychiatry-Hamad Medical Corporation (HMC) in Doha, Qatar (between October 2012 and April 2014) were retrospectively analyzed. We retrieved the available sociodemographic data, psychiatric features, and details on the medication history. Results Our sample consisted of 537 individuals on antipsychotics (2/3 were male; mean age 33.8 +/- 10.2 years), prescribed for a psychotic disorder in 57%, a mood disorder in 9.3%, and various other diagnoses in 33.7%. About 55.9% received one antipsychotic, 29.6% received two antipsychotics, and 14.5% received more than two antipsychotics. Polypharmacy was associated with younger age (p = 0.025), being single (p<0.001), the diagnosis of a psychotic disorder (p<0.001), and previous admissions to psychiatry (p<0.001). Conclusions Antipsychotic polypharmacy appears to be quite common in Qatar, as it is the case in many other countries, in contrast with most international recommendations. Studies are needed to explore the reasons behind this disparity.	[Ouanes, Sami; Ghuloum, Suhaila; Shehata, Mena; Ghabrash, Hany; Iram, Huma; Ajmal, Nighat] Hamad Med Corp, Dept Psychiat, Doha, Qatar; [Becetti, Imen; Al-Lawati, Hawra; Al-Fakhri, Nora] Weill Cornell Med Coll, Med Educ, Doha, Qatar; [Hammoudeh, Samer; Yehya, Areej] Weill Cornell Med Coll, Res Dept, Doha, Qatar; [Eltorki, Yassin] Hamad Med Corp, Pharm Dept, Psychiat Hosp, Doha, Qatar; [Al-Amin, Hassen] Weill Cornell Med Coll, Psychiat Dept, Doha, Qatar	Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Al-Amin, H (corresponding author), Weill Cornell Med Coll, Psychiat Dept, Doha, Qatar.	haa2019@qatar-med.cornell.edu	Al-Amin, Hassen/ABC-3650-2020	Al-Amin, Hassen/0000-0001-6358-1541; Hammoudeh, Samer/0000-0003-0805-8111; Ouanes, Sami/0000-0003-0867-060X	Qatar National Research Fund (QNRF) [UREP 16-012-3-003]	Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF))	The study was funded by a Qatar National Research Fund (QNRF) grant: UREP 16-012-3-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhadhari S, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S78788; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Freudenreich O, 2002, ACTA PSYCHIAT SCAND, V106, P323, DOI 10.1034/j.1600-0447.2002.01331.x; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Galling B, 2017, WORLD PSYCHIATRY, V16, P77, DOI 10.1002/wps.20387; Howes OD, 2012, BRIT J PSYCHIAT, V201, P481, DOI 10.1192/bjp.bp.111.105833; Hui CLM, 2019, INT REV PSYCHIATR, V31, P441, DOI 10.1080/09540261.2019.1613965; Ismail D, 2019, ASIAN J PSYCHIATR, V39, P93, DOI 10.1016/j.ajp.2018.12.011; Joukamaa M, 2006, BRIT J PSYCHIAT, V188, P122, DOI 10.1192/bjp.188.2.122; Kaneko K, 2018, YONAGO ACTA MED, V61, P91, DOI 10.33160/yam.2018.06.001; Kim HY, 2014, CLIN PSYCHOPHARM NEU, V12, P128, DOI 10.9758/cpn.2014.12.2.128; Lally J, 2019, IRISH J PSYCHOL MED, V36, P279, DOI 10.1017/ipm.2018.47; Larrayadieu A, 2011, AGE AGEING, V40, P368, DOI 10.1093/ageing/afr032; Man LSL, 2018, ASIAN J PSYCHIATR, V33, P113, DOI 10.1016/j.ajp.2018.03.012; Matsui K, 2019, SCHIZOPHR RES, V209, P50, DOI 10.1016/j.schres.2019.05.030; O'Sullivan ED, 2018, J ROY COLL PHYS EDIN, V48, P225, DOI 10.4997/JRCPE.2018.306; Remington G, 2017, CAN J PSYCHIAT, V62, P604, DOI 10.1177/0706743717720448; Stahl SM, 2004, CURR MED CHEM, V11, P313, DOI 10.2174/0929867043456070; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P93, DOI 10.4088/JCP.v63n0201; Stringer Gary, 2015, VARIORUM EDITION POE, V3, P140; Stroup TS, 2014, PSYCHIAT SERV, V65, P186, DOI 10.1176/appi.ps.201300180; Tang Y, 2017, PSYCHIAT SERV, V68, P579, DOI 10.1176/appi.ps.201600041; Tiihonen J, 2019, JAMA PSYCHIAT, V76, P499, DOI 10.1001/jamapsychiatry.2018.4320; Tungaraza TE, 2017, THER ADV PSYCHOPHARM, V7, P103, DOI 10.1177/2045125316683151; Wilkinson S, 2018, NEW ZEAL MED J, V131, P61; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Xue QJ, 2014, INT CLIN PSYCHOPHARM, V29, P288, DOI 10.1097/YIC.0000000000000024; Yang SY, 2018, PSYCHIAT CLIN NEUROS, V72, P572, DOI 10.1111/pcn.12676; Yazici Esra, 2017, Clin Pract Epidemiol Ment Health, V13, P92, DOI 10.2174/1745017901713010092; Yoshimura R, 2006, PSYCHIAT CLIN NEUROS, V60, P778, DOI 10.1111/j.1440-1819.2006.01601.x; Young SL, 2015, J PSYCHOPHARMACOL, V29, P353, DOI 10.1177/0269881114562090	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241986	10.1371/journal.pone.0241986	http://dx.doi.org/10.1371/journal.pone.0241986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7JZ	33166337	gold, Green Published			2022-12-26	WOS:000592382600049
J	Sonavane, M; Hayat, F; Makarov, M; Migaud, ME; Gassman, NR				Sonavane, Manoj; Hayat, Faisal; Makarov, Mikhail; Migaud, Marie E.; Gassman, Natalie R.			Dihydronicotinamide riboside promotes cell-specific cytotoxicity by tipping the balance between metabolic regulation and oxidative stress	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DAMAGE; NICOTINAMIDE RIBOSIDE; NAD(+) METABOLISM; REDOX STATE; MOUSE MODEL; REPAIR; BIOSYNTHESIS; HOMEOSTASIS; ACTIVATION; PELLAGRA	Nicotinamide adenine dinucleotide (NAD(+)), the essential cofactor derived from vitamin B3, is both a coenzyme in redox enzymatic processes and substrate in non-redox events; processes that are intimately implicated in all essential bioenergetics. A decrease in intracellular NAD(+) levels is known to cause multiple metabolic complications and age-related disorders. One NAD(+) precursor is dihydronicotinamide riboside (NRH), which increases NAD(+) levels more potently in both cultured cells and mice than current supplementation strategies with nicotinamide riboside (NR), nicotinamide mononucleotide (NMN) or vitamin B3 (nicotinamide and niacin). However, the consequences of extreme boosts in NAD(+) levels are not fully understood. Here, we demonstrate the cell-specific effects of acute NRH exposure in mammalian cells. Hepatocellular carcinoma (HepG3) cells show dose-dependent cytotoxicity when supplemented with 100-1000 mu M NRH. Cytotoxicity was not observed in human embryonic kidney (HEK293T) cells over the same dose range of NRH. PUMA and BAX mediate the cell-specific cytotoxicity of NRH in HepG3. When supplementing HepG3 with 100 mu M NRH, a significant increase in ROS was observed concurrent with changes in the NAD(P)H and GSH/GSSG pools. NRH altered mitochondrial membrane potential, increased mitochondrial superoxide formation, and induced mitochondrial DNA damage in those cells. NRH also caused metabolic dysregulation, altering mitochondrial respiration. Altogether, we demonstrated the detrimental consequences of an extreme boost of the total NAD (NAD(+) + NADH) pool through NRH supplementation in HepG3. The cell-specific effects are likely mediated through the different metabolic fate of NRH in these cells, which warrants further study in other systemic models.	[Sonavane, Manoj; Gassman, Natalie R.] Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, Mobile, AL 36688 USA; [Sonavane, Manoj; Hayat, Faisal; Makarov, Mikhail; Migaud, Marie E.; Gassman, Natalie R.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Hayat, Faisal; Makarov, Mikhail; Migaud, Marie E.] Univ S Alabama, Dept Pharmacol, Coll Med, Mobile, AL USA	University of South Alabama; University of South Alabama; University of South Alabama	Gassman, NR (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, Mobile, AL 36688 USA.; Gassman, NR (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA.	nrgassman@health.southalabama.edu	HAYAT, FAISAL/GPX-4505-2022	HAYAT, FAISAL/0000-0001-5493-0199; Gassman, Natalie/0000-0002-8488-2332	National Institutes of Health, National Center for Complementary and Integrative Health [R21AT009908]; Elysium Health	National Institutes of Health, National Center for Complementary and Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elysium Health	MS, FH, MEM, and NRG are supported by R21AT009908 from National Institutes of Health, National Center for Complementary and Integrative Health (http://www.nccih.nih.gov/).MEM is partially supported by Elysium Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OFF J EUR UNION; Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Ciccarese F, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00117; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giroud-Gerbetant J, 2019, MOL METAB, V30, P192, DOI 10.1016/j.molmet.2019.09.013; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Guan Y, 2017, J AM SOC NEPHROL, V28, P2337, DOI 10.1681/ASN.2016040385; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Holton NW, 2017, JOVE-J VIS EXP, DOI 10.3791/56265; Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Kulikova V, 2019, METABOLITES, V9, DOI 10.3390/metabo9120293; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Makarov MV, 2019, ORG BIOMOL CHEM, V17, P8716, DOI 10.1039/c9ob01981b; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Megarity CF, 2014, FEBS LETT, V588, P1666, DOI 10.1016/j.febslet.2014.02.063; Migaud M, 2014, INVENTORSMETHODS PRE; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Moreno-Sanchez R, 2018, BBA-BIOENERGETICS, V1859, P1138, DOI 10.1016/j.bbabio.2018.07.008; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Rajakumar K, 2000, SOUTH MED J, V93, P272, DOI 10.1097/00007611-200003000-00005; Riches Z, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21921; Shats I, 2020, CELL METAB, V31, P564, DOI 10.1016/j.cmet.2020.02.001; Smith Kelly R, 2019, Chem Res Toxicol, V32, P1722, DOI 10.1021/acs.chemrestox.9b00230; Song SB, 2017, MOL CELLS, V40, P503, DOI 10.14348/molcells.2017.0081; Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Tummala KS, 2014, CANCER CELL, V26, P826, DOI 10.1016/j.ccell.2014.10.002; Williams AC, 2007, MED HYPOTHESES, V69, P618, DOI 10.1016/j.mehy.2007.01.029; Xiao W., 2017, ANTIOXIDANTS REDOX S, V28, P251; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Yaku K, 2018, AGEING RES REV, V47, P1, DOI 10.1016/j.arr.2018.05.006; Yang Y, 2020, NAT METAB, V2, P364, DOI 10.1038/s42255-020-0194-9; Yang Y, 2019, J BIOL CHEM, V294, P9295, DOI 10.1074/jbc.RA118.005772; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112; Ziegler M, 2020, NAT METAB, V2, P291, DOI 10.1038/s42255-020-0197-6	56	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242174	10.1371/journal.pone.0242174	http://dx.doi.org/10.1371/journal.pone.0242174			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166357	gold, Green Published			2022-12-26	WOS:000592382600005
J	Lee, DE; Ryoo, HW; Moon, S; Park, JH; Shin, SD				Lee, Dong Eun; Ryoo, Hyun Wook; Moon, Sungbae; Park, Jeong Ho; Shin, Sang Do			Effect of citywide enhancement of the chain of survival on good neurologic outcomes after out-of-hospital cardiac arrest from 2008 to 2017	PLOS ONE			English	Article							HEART-ASSOCIATION GUIDELINES; ADVANCED AIRWAY MANAGEMENT; CARDIOPULMONARY-RESUSCITATION; CARE; UPDATE; TRENDS; RATES	Improving outcomes after out-of-hospital cardiac arrests (OHCAs) requires an integrated approach by strengthening the chain of survival and emergency care systems. This study aimed to identify the change in outcomes over a decade and effect of citywide intervention on good neurologic outcomes after OHCAs in Daegu. This is a before- and after-intervention study to examine the association between the citywide intervention to improve the chain of survival and outcomes after OHCA. The primary outcome was a good neurologic outcome, defined as a cerebral performance category score of 1 or 2. After dividing into 3 phases according to the citywide intervention, the trends in outcomes after OHCA by primary electrocardiogram rhythm were assessed. Logistic regression analysis was used to analyze the association between the phases and outcomes. Overall, 6203 patients with OHCA were eligible. For 10 years (2008-2017), the rate of survival to discharge and the good neurologic outcomes increased from 2.6% to 8.7% and from 1.5% to 6.6%, respectively. Especially for patients with an initial shockable rhythm, these changes in outcomes were more pronounced (survival to discharge: 23.3% in 2008 to 55.0% in 2017, good neurologic outcomes: 13.3% to 46.0%). Compared with phase 1, the adjusted odds ratio (AOR) and 95% confidence intervals (CI) for good neurologic outcomes was 1.20 (95% CI: 0.78-1.85) for phase 2 and 1.64 (1.09-2.46) for phase 3. For patients with an initial shockable rhythm, the AOR for good neurologic outcomes was 3.76 (1.88-7.52) for phase 2 and 5.51 (2.77-10.98) for phase 3. Citywide improvement was observed in the good neurologic outcomes after OHCAs of medical origin, and the citywide intervention was significantly associated with better outcomes, particularly in those with initial shockable rhythm.	[Lee, Dong Eun] Kyungpook Natl Univ, Dept Emergency Med, Chilgok Hosp, Sch Med, Daegu, South Korea; [Ryoo, Hyun Wook; Moon, Sungbae] Kyungpook Natl Univ, Dept Emergency Med, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea; [Park, Jeong Ho; Shin, Sang Do] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU)	Ryoo, HW (corresponding author), Kyungpook Natl Univ, Dept Emergency Med, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea.	ryoo@knu.ac.kr		Lee, Dong Eun/0000-0002-2057-5261; Ryoo, Hyun Wook/0000-0002-1361-9887				[Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Cho H, 2014, CLIN EXP EMERG MED, V1, P94, DOI 10.15441/ceem.14.021; Ewy GA, 2015, RESUSCITATION, V96, P180, DOI 10.1016/j.resuscitation.2015.08.011; Grasner JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10035; Homma Y, 2019, AM J EMERG MED, V37, P241, DOI 10.1016/j.ajem.2018.05.037; Jabre P, 2018, JAMA-J AM MED ASSOC, V319, P779, DOI 10.1001/jama.2018.0156; Jeong S, 2016, AM J EMERG MED, V34, P2101, DOI 10.1016/j.ajem.2016.07.025; Kim KH, 2020, PREHOSP EMERG CARE, V24, P485, DOI 10.1080/10903127.2019.1668989; Kim S, 2020, CLIN EXP EMERG MED, V7, P21, DOI 10.15441/ceem.19.002; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Kronick SL, 2015, CIRCULATION, V132, pS397, DOI 10.1161/CIR.0000000000000258; Lascarrou JB, 2019, NEW ENGL J MED, V381, P2327, DOI 10.1056/NEJMoa1906661; Lee DE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e134; Lee YJ, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e328; Moon S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211804; Myat A, 2018, LANCET, V391, P970, DOI 10.1016/S0140-6736(18)30472-0; Nadarajan GD, 2018, RESUSCITATION, V132, P85, DOI 10.1016/j.resuscitation.2018.08.022; Okubo M, 2017, RESUSCITATION, V115, P120, DOI 10.1016/j.resuscitation.2017.03.036; Park JH, 2019, EMERG MED AUSTRALAS, V31, P1073, DOI 10.1111/1742-6723.13326; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Song KJ, 2016, CLIN EXP EMERG MED, V3, pS10, DOI 10.15441/ceem.16.129; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Yukawa T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0440-7; 2019, HUM REPROD, V0034, pE141	29	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241804	10.1371/journal.pone.0241804	http://dx.doi.org/10.1371/journal.pone.0241804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156868	gold, Green Published			2022-12-26	WOS:000591376400024
J	Abe, K; Fujita, M; Hayashi, M; Takahashi, A; Ohira, H				Abe, Kazumichi; Fujita, Masashi; Hayashi, Manabu; Takahashi, Atsushi; Ohira, Hiromasa			Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis	PLOS ONE			English	Article							REGULATORY T-CELLS; VITAMIN-D STATUS; IFN-GAMMA; LIVER FIBROSIS; D DEFICIENCY; DIAGNOSIS; CLASSIFICATION; PATHOGENESIS; EXPRESSION; GUIDELINES	25-Hydroxyvitamin D [25(OH)D] has been reported to be associated with several chronic liver diseases. The relationship between 25(OH)D and autoimmune hepatitis (AIH) pathogenesis is incompletely understood. We investigated the association of serum total and free 25(OH)D levels with necroinflammatory activity and cytokine levels in 66 patients with AIH diagnosed in our hospital. The median age at AIH diagnosis was 57 years, and the male:female ratio was 7:59. The median serum total 25(OH)D level in therapy-naive patients with AIH was 14.2 ng/mL (interquartile range [IQR], 11.4-17.9 ng/mL). Of the 66 patients with AIH, 36 had serum total 25(OH)D levels of < 15 ng/mL and were considered to have vitamin D deficiency, and 30 had serum total 25(OH)D levels of >= 15 ng/mL. Patients with acute-onset AIH had significantly lower serum total 25(OH)D levels than those with chronic-onset AIH. In particular, serum total 25(OH)D levels were significantly lower in patients with severe forms of AIH. Furthermore, the serum total 25(OH)D level was positively correlated with the serum albumin level and prothrombin time and negatively correlated with the serum total bilirubin level and necroinflammatory activity in AIH. Multivariate logistic regression analysis showed that the serum total 25(OH)D level was an independent factor for severe necroinflammatory activity. Interestingly, AIH patients with serum total 25(OH)D levels of < 15 ng/mL had higher levels of inflammatory cytokines such as interferon-gamma and interleukin-33. Free 25(OH)D levels were correlated with total 25(OH)D levels, and the percentage of free 25(OH)D was significantly associated with necroinflammatory activity. In conclusion, 25(OH)D deficiency may play an important role in predicting AIH severity via inflammatory cytokine production.	[Abe, Kazumichi; Fujita, Masashi; Hayashi, Manabu; Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan	Fukushima Medical University	Abe, K (corresponding author), Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan.	k-abe@fmu.ac.jp		Abe, Kazumichi/0000-0001-5359-9465	AbbVie Inc.	AbbVie Inc.(AbbVie)	This study was supported in part by AbbVie Inc. There was no additional external funding received for this study.	Abe K, 2019, HEPATOL COMMUN, V3, P670, DOI 10.1002/hep4.1326; Abramovitch S, 2015, AM J PHYSIOL-GASTR L, V308, pG112, DOI 10.1152/ajpgi.00132.2013; Almerighi C, 2009, CYTOKINE, V45, P190, DOI 10.1016/j.cyto.2008.12.009; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Beyazit Y, 2015, DIGEST DIS SCI, V60, P1106, DOI 10.1007/s10620-015-3526-y; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; Bikle DD, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00317; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Czaja AJ, 2000, DIGEST DIS SCI, V45, P1028, DOI 10.1023/A:1005506031717; da Silva RR, 2014, CYTOKINE, V65, P143, DOI 10.1016/j.cyto.2013.11.012; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Ebadi M, 2019, ALIMENT PHARM THER, V49, P173, DOI 10.1111/apt.15029; Efe C, 2014, DIGEST DIS SCI, V59, P3035, DOI 10.1007/s10620-014-3267-3; Solari NEF, 2010, CLIN IMMUNOL, V137, P396, DOI 10.1016/j.clim.2010.08.013; Finkelmeier F, 2014, ALIMENT PHARM THER, V39, P1204, DOI 10.1111/apt.12731; Finkelmeier F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132119; Gorham JD, 2001, J IMMUNOL, V166, P6413, DOI 10.4049/jimmunol.166.10.6413; Goules A, 2006, J AUTOIMMUN, V26, P165, DOI 10.1016/j.jaut.2006.02.002; Griesenauer B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00475; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hu XD, 2010, ACTA PHARMACOL SIN, V31, P703, DOI 10.1038/aps.2010.53; JOHNSON PJ, 1993, HEPATOLOGY, V18, P998, DOI 10.1002/hep.1840180435; Kamijo A, 2011, HEPATOL RES, V41, P350, DOI 10.1111/j.1872-034X.2011.00773.x; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Krawitt EL, 1996, NEW ENGL J MED, V334, P897, DOI 10.1056/NEJM199604043341406; Kubota Takuo, 2006, Clin Pediatr Endocrinol, V15, P23, DOI 10.1297/cpe.15.23; LEMIRE JM, 1992, J CELL BIOCHEM, V49, P26, DOI 10.1002/jcb.240490106; Lohse AW, 2015, J HEPATOL, V63, P971, DOI 10.1016/j.jhep.2015.06.030; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Luong Khanh Vinh Quoc, 2013, J Clin Med Res, V5, P407, DOI 10.4021/jocmr1505w; Ma L, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7964654; Malmstroem S, 2017, J AOAC INT, V100, P1323, DOI 10.5740/jaoacint.17-0085; Miroliaee A, 2010, HEPATOL INT, V4, P634, DOI 10.1007/s12072-010-9194-2; MULLER K, 1991, IMMUNOL LETT, V28, P115, DOI 10.1016/0165-2478(91)90108-M; Nagayama K, 2001, AM J GASTROENTEROL, V96, P2211, DOI 10.1016/S0002-9270(01)02522-9; Ohira H, 2015, INTERNAL MED, V54, P1323, DOI 10.2169/internalmedicine.54.4125; Onji M, 2014, HEPATOL RES, V44, P368, DOI 10.1111/hepr.12300; Reiter FP, 2015, BIOCHEM BIOPH RES CO, V459, P227, DOI 10.1016/j.bbrc.2015.02.074; Robinson RT, 2009, J IMMUNOL, V182, P3278, DOI 10.4049/jimmunol.0803417; Sahay Manisha, 2012, Indian J Endocrinol Metab, V16, P164, DOI 10.4103/2230-8210.93732; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Smyk DS, 2013, CLIN RES HEPATOL GAS, V37, P535, DOI 10.1016/j.clinre.2013.05.016; Stokes CS, 2014, EUR J CLIN INVEST, V44, P176, DOI 10.1111/eci.12205; Stokes CS, 2013, LIVER INT, V33, P338, DOI 10.1111/liv.12106; Sun XM, 2014, NUTRIENTS, V6, P221, DOI 10.3390/nu6010221; Takahashi A, 2017, J GASTROENTEROL, V52, P631, DOI 10.1007/s00535-016-1267-0; Tsutsui A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/913793; Vergani D, 2007, SEMIN LIVER DIS, V27, P140, DOI 10.1055/s-2007-979467; Zhao Y, 2011, LIVER INT, V31, P721, DOI 10.1111/j.1478-3231.2011.02487.x; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0239481	10.1371/journal.pone.0239481	http://dx.doi.org/10.1371/journal.pone.0239481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151930	Green Published, gold			2022-12-26	WOS:000591376200057
J	Al-Ghouti, MA; Khan, M; Nasser, MS; Al Saad, K; Heng, OONE				Al-Ghouti, Mohammad A.; Khan, Mariam; Nasser, Mustafa S.; Al Saad, Khalid; Ee Heng, O. O. N.			Application of geopolymers synthesized from incinerated municipal solid waste ashes for the removal of cationic dye from water	PLOS ONE			English	Article							LOW-COST ADSORBENTS; COAL FLY-ASH; METHYLENE-BLUE; AQUEOUS-SOLUTION; HEAVY-METALS; EXPERIMENTAL-DESIGN; BOTTOM ASH; ADSORPTION; METAKAOLIN; KINETICS	In this study, municipal solid waste bottom ash (MSW-BA) and fly ash (MSW-FA) were used as a source of aluminosilicate to prepare geopolymer (GEO) adsorbents (GEO-MSWBA and GEO-MSWFA) for the removal of methylene blue (MB) from water. The effects of temperature, pH, and initial concentration on the MB adsorption onto GEO-MSWBA and GEO-MSWFA were evaluated. The adsorption isotherms parameters and thermodynamics were also determined. Detailed physical and chemical characterizations of the prepared adsorbents were carried out to further understand their impact on MB adsorption. The results from the scanning electron microscopy revealed a uniform granule-sphere like structure on both prepared geopolymers, which would facilitate the MB adsorption onto the adsorbents. The X-ray diffraction allowed observation of the microstructural transformations that occur after the alkaline activation. The surface areas of the GEO-MSWBA and the GEO-MSWFA were recorded as 32.78 m(2)/g and 4.5 m(2)/g, respectively. From the Fourier transform infrared, a stretching vibration of the aluminosilicate tetrahedral was observed, which indicated the success of geopolymerization. The prepared geopolymers showed a high capability of MB adsorption from an aqueous solution. The adsorption process was best suited and explained using the Langmuir isotherm model with a maximum adsorption capacity of 666.7 mg/g for the GEO-MSWBA (at 25 degrees C) and 769.2 mg/g for the GEO-MSWFA (at 35 degrees C). The positive value of the enthalpy (Delta H-o) for the GEO-MSWBA suggested the reaction favored endothermic reaction while the negative value of entropy (Delta S-o) indicated a solid/liquid random interaction. On the other hand, the negative Delta H-o value for the GEO-MSWFA indicated the reaction followed an exothermic reaction causing energy to be released, the positive Delta S-o value indicated a good affinity at the solid-liquid surface. The overall negative value for Gibbs free energy (Delta G(o)) for both adsorbents suggested the adsorption was spontaneous and feasible. It was also inferred that n- pi interaction, direct and indirect hydrogen bond, and electrostatic interaction between the MB and the prepared geopolymers facilitated the adsorption process. The current study shows that the GEO-MSWBA and the GEO-MSWFA have a great potential of removing MB as a cationic dye from water without performing any sort of laborious pretreatments.	[Al-Ghouti, Mohammad A.; Khan, Mariam] Qatar Univ, Dept Biol & Environm Sci, Coll Arts & Sci, Doha, Qatar; [Nasser, Mustafa S.] Qatar Univ, Coll Engn, Gas Proc Ctr, Doha, Qatar; [Al Saad, Khalid] Qatar Univ, Dept Chem & Earth Sci, Coll Arts & Sci, Doha, Qatar; [Ee Heng, O. O. N.] Domest Solid Waste Management Ctr DSWMC, Doha, Qatar	Qatar University; Qatar University; Qatar University	Al-Ghouti, MA (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Coll Arts & Sci, Doha, Qatar.	mohammad.alghouti@qu.edu.qa		Al-Ghouti, Mohammad/0000-0002-9943-1091	Qatar University [QUCG-CAS-2018/2019-2]; Qatar National Library	Qatar University(Qatar National Research Fund (QNRF)); Qatar National Library(Qatar National Research Fund (QNRF))	This study was funded by a grant from Qatar University (grant #QUCG-CAS-2018/2019-2). The publication of this article was funded by the Qatar National Library. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams A., 1997, People and Computers XII. Proceedings of HCI '97, P1; AHARONI C, 1977, J CHEM SOC FARAD T 1, V73, P456, DOI 10.1039/f19777300456; Al-Ghouti MA, 2019, ENVIRON TECHNOL INNO, V16, DOI 10.1016/j.eti.2019.100488; Al-Ghouti MA, 2018, J ENVIRON MANAGE, V207, P405, DOI 10.1016/j.jenvman.2017.11.062; Asfaram A, 2015, DALTON T, V44, P14707, DOI 10.1039/c5dt01504a; Ayawei N, 2017, J CHEM-NY, V2017, DOI 10.1155/2017/3039817; Barbosa TR, 2018, CERAM INT, V44, P416, DOI 10.1016/j.ceramint.2017.09.193; Calimli MH, 2020, J MOL LIQ, V309, DOI 10.1016/j.molliq.2020.113171; Chindaprasirt P, 2009, WASTE MANAGE, V29, P539, DOI 10.1016/j.wasman.2008.06.023; Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001; Dil EA, 2016, RSC ADV, V6, P54149, DOI 10.1039/c6ra11292g; Dogan M, 2007, DYES PIGMENTS, V75, P701, DOI 10.1016/j.dyepig.2006.07.023; Duan P, 2016, CERAM INT, V42, P13507, DOI 10.1016/j.ceramint.2016.05.143; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; El Alouani M., 2019, CHEM DATA COLLECT, V23, DOI [10.1016/j.cdc.2019.100265, DOI 10.1016/J.CDC.2019.100265]; El Alouani M, 2019, J CHEM-NY, V2019, DOI 10.1155/2019/4212901; Falah M, 2016, J HAZARD MATER, V318, P772, DOI 10.1016/j.jhazmat.2016.06.016; Ge YY, 2017, CHEM ENG J, V311, P126, DOI 10.1016/j.cej.2016.11.079; Goretta KC, 2007, J MATER SCI, V42, P3066, DOI 10.1007/s10853-006-0561-2; Guo XL, 2017, CONSTR BUILD MATER, V151, P394, DOI 10.1016/j.conbuildmat.2017.05.199; Guo XL, 2010, CEMENT CONCRETE COMP, V32, P142, DOI 10.1016/j.cemconcomp.2009.11.003; Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017; Han RP, 2009, CHEM ENG J, V145, P496, DOI 10.1016/j.cej.2008.05.003; He TS, 2019, CONSTR BUILD MATER, V198, P537, DOI 10.1016/j.conbuildmat.2018.11.287; Hea Jian, 2012, STRENGTH MICROSTRUCT, P80; Huang T, 2020, WASTE MANAGE, V103, P361, DOI 10.1016/j.wasman.2019.12.048; Janos P, 2003, WATER RES, V37, P4938, DOI 10.1016/j.watres.2003.08.011; Jin MT, 2016, J NON-CRYST SOLIDS, V450, P116, DOI 10.1016/j.jnoncrysol.2016.07.036; Kaewmee P, 2020, J CLEAN PROD, V272, DOI 10.1016/j.jclepro.2020.122617; Kan LL, 2020, J CLEAN PROD, V254, DOI 10.1016/j.jclepro.2020.120168; Kara I, 2018, APPL CLAY SCI, V161, P184, DOI 10.1016/j.clay.2018.04.027; Khadka SD, 2020, TRANSP GEOTECH, V23, DOI 10.1016/j.trgeo.2020.100327; Khan MI, 2015, RSC ADV, V5, P61410, DOI 10.1039/c5ra08255b; Khraisheh MAM, 2005, WATER RES, V39, P922, DOI 10.1016/j.watres.2004.12.008; Kumar KV, 2005, J COLLOID INTERF SCI, V284, P14, DOI 10.1016/j.jcis.2004.09.063; Lancellotti I, 2010, WASTE MANAGE, V30, P673, DOI 10.1016/j.wasman.2009.09.032; Lau CK, 2019, CONSTR BUILD MATER, V222, P731, DOI 10.1016/j.conbuildmat.2019.06.198; Lecomte I, 2006, J EUR CERAM SOC, V26, P3789, DOI 10.1016/j.jeurceramsoc.2005.12.021; Lee NK, 2017, MICROPOR MESOPOR MAT, V242, P238, DOI 10.1016/j.micromeso.2017.01.030; Lee WKW, 2002, COLLOID SURFACE A, V211, P115, DOI 10.1016/S0927-7757(02)00239-X; Lertcumfu N, 2020, COLLOID SURFACE A, V602, DOI 10.1016/j.colsurfa.2020.125080; Li CX, 2015, J IND ENG CHEM, V23, P344, DOI 10.1016/j.jiec.2014.08.038; Li YC, 2019, WASTE MANAGE, V83, P202, DOI 10.1016/j.wasman.2018.11.019; Lin LD, 2016, INT J MINER PROCESS, V148, P32, DOI 10.1016/j.minpro.2016.01.010; Liu K., 2019, PETROPHYSICAL CHARAC, P3, DOI DOI 10.1016/B978-0-12-816698-7.00001-2; Liu Y, 2016, FUEL, V185, P181, DOI 10.1016/j.fuel.2016.07.116; Lopez Guzman F.J., 2014, STUDY GEOPOLYMER ADS; Luo ZY, 2020, COMPOS PART B-ENG, V198, DOI 10.1016/j.compositesb.2020.108185; Maleki A, 2020, ARAB J CHEM, V13, P3017, DOI 10.1016/j.arabjc.2018.08.011; Maleki A, 2019, J CLEAN PROD, V215, P1233, DOI 10.1016/j.jclepro.2019.01.084; Mantasha I, 2020, INORG CHIM ACTA, V511, DOI 10.1016/j.ica.2020.119787; Mazaheri H, 2017, PHYS CHEM CHEM PHYS, V19, P11299, DOI 10.1039/c6cp08437k; Ngulube T, 2017, J ENVIRON MANAGE, V191, P35, DOI 10.1016/j.jenvman.2016.12.031; Novais RM, 2018, J CLEAN PROD, V178, P258, DOI 10.1016/j.jclepro.2018.01.033; Ozbay N, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/234904; Pacheco-Torgal F, 2012, CONSTR BUILD MATER, V36, P1053, DOI 10.1016/j.conbuildmat.2012.07.003; Phoo-ngernkham T, 2014, MATER DESIGN, V55, P58, DOI 10.1016/j.matdes.2013.09.049; Preethi RK, 2020, CONSTR BUILD MATER, V257, DOI 10.1016/j.conbuildmat.2020.119563; Qiu RF, 2018, J CLEAN PROD, V172, P1918, DOI 10.1016/j.jclepro.2017.11.236; Rasaki SA, 2019, J CLEAN PROD, V213, P42, DOI 10.1016/j.jclepro.2018.12.145; Rida K, 2013, APPL CLAY SCI, V83-84, P99, DOI 10.1016/j.clay.2013.08.015; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Sahu S, 2020, J MOL LIQ, V315, DOI 10.1016/j.molliq.2020.113743; Shamsuddin RM, 2014, APPL CLAY SCI, V87, P52, DOI 10.1016/j.clay.2013.11.023; Shao NN, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2019.121736; Sharifpour E, 2018, ULTRASON SONOCHEM, V40, P373, DOI 10.1016/j.ultsonch.2017.07.030; Shirani M, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2054-2; Singh KP, 2011, J HAZARD MATER, V186, P1462, DOI 10.1016/j.jhazmat.2010.12.032; Siyal AA, 2018, J ENVIRON MANAGE, V224, P327, DOI 10.1016/j.jenvman.2018.07.046; Sun Z, 2010, J CHEM TECHNOL BIOT, V85, P845, DOI 10.1002/jctb.2377; Tang Q, 2015, MATER DESIGN, V88, P1244, DOI 10.1016/j.matdes.2015.09.126; Vadi M, 2013, ASIAN J CHEM, V25, P5467, DOI 10.14233/ajchem.2013.14786; Wang R, 2020, CONSTR BUILD MATER, V240, DOI 10.1016/j.conbuildmat.2019.117935; Wang SB, 2006, J HAZARD MATER, V136, P946, DOI 10.1016/j.jhazmat.2006.01.038; Wang SW, 2009, APPL CLAY SCI, V43, P164, DOI 10.1016/j.clay.2008.07.028; Wang YG, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118852; Wongsa A, 2017, J CLEAN PROD, V148, P49, DOI 10.1016/j.jclepro.2017.01.147; Woolard CD, 2002, APPL GEOCHEM, V17, P1159, DOI 10.1016/S0883-2927(02)00057-4; Yagub MT, 2014, ADV COLLOID INTERFAC, V209, P172, DOI 10.1016/j.cis.2014.04.002; Yang JB, 2014, J IND ENG CHEM, V20, P480, DOI 10.1016/j.jiec.2013.05.005; Yao T, 2015, J HAZARD MATER, V292, P90, DOI 10.1016/j.jhazmat.2015.03.014; Zhang YS, 2008, ACI MATER J, V105, P156; Zheng L, 2010, CHEMOSPHERE, V79, P665, DOI 10.1016/j.chemosphere.2010.02.018; Zhou CY, 2013, J POROUS MAT, V20, P587, DOI 10.1007/s10934-012-9631-9	84	5	5	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0239095	10.1371/journal.pone.0239095	http://dx.doi.org/10.1371/journal.pone.0239095			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151952	Green Published, gold			2022-12-26	WOS:000591376200072
J	Bakalov, V; Reyes-Uribe, L; Deshpande, R; Maloy, AL; Shapiro, SD; Angus, DC; Chang, CCH; Le Moyec, L; Wendell, SG; Kaynar, AM				Bakalov, Veli; Reyes-Uribe, Laura; Deshpande, Rahul; Maloy, Abigail L.; Shapiro, Steven D.; Angus, Derek C.; Chang, Chung-Chou H.; Le Moyec, Laurence; Wendell, Stacy Gelhaus; Kaynar, Ata Murat			Dichloroacetate-induced metabolic reprogramming improves lifespan in a Drosophila model of surviving sepsis	PLOS ONE			English	Article							PYRUVATE-KINASE M2; CHAIN FATTY-ACIDS; DEHYDROGENASE; MORTALITY; INFLAMMATION; IL-1-BETA; LACTATE; POLARIZATION; MACROPHAGES; PNEUMONIA	Sepsis is the leading cause of death in hospitalized patients and beyond the hospital stay and these long-term sequelae are due in part to unresolved inflammation. Metabolic shift from oxidative phosphorylation to aerobic glycolysis links metabolism to inflammation and such a shift is commonly observed in sepsis under normoxic conditions. By shifting the metabolic state from aerobic glycolysis to oxidative phosphorylation, we hypothesized it would reverse unresolved inflammation and subsequently improve outcome. We propose a shift from aerobic glycolysis to oxidative phosphorylation as a sepsis therapy by targeting the pathways involved in the conversion of pyruvate into acetyl-CoA via pyruvate dehydrogenase (PDH). Chemical manipulation of PDH using dichloroacetic acid (DCA) will promote oxidative phosphorylation over glycolysis and decrease inflammation. We tested our hypothesis in a Drosophila melanogaster model of surviving sepsis infected with Staphylococcus aureus. Drosophila were divided into 3 groups: unmanipulated, sham and sepsis survivors, all treated with linezolid; each group was either treated or not with DCA for one week following sepsis. We followed lifespan, measured gene expression of Toll, defensin, cecropin A, and drosomycin, and levels of lactate, pyruvate, acetyl-CoA as well as TCA metabolites. In our model, metabolic effects of sepsis are modified by DCA with normalized lactate, TCA metabolites, and was associated with improved lifespan of sepsis survivors, yet had no lifespan effects on unmanipulated and sham flies. While Drosomycin and cecropin A expression increased in sepsis survivors, DCA treatment decreased both and selectively increased defensin.	[Bakalov, Veli; Reyes-Uribe, Laura; Maloy, Abigail L.; Angus, Derek C.; Chang, Chung-Chou H.; Kaynar, Ata Murat] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Bakalov, Veli] Allegheny Hlth Network, Med Inst, Pittsburgh, PA USA; [Deshpande, Rahul; Wendell, Stacy Gelhaus] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Shapiro, Steven D.; Chang, Chung-Chou H.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Le Moyec, Laurence] Univ Paris Saclay, Univ Evry Val Essonne, Evry, France; [Le Moyec, Laurence] CNRS, UMR7245, Unite MCAM, Museum Natl Hist Nat, Paris, France; [Kaynar, Ata Murat] Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaynar, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA.; Kaynar, AM (corresponding author), Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA USA.	kaynar@pitt.edu	Kaynar, Ata Murat/ABI-6877-2020; Bakalov, Veli/GQB-5348-2022; Reyes-Uribe, Laura/AAQ-8483-2021	Kaynar, Ata Murat/0000-0001-8847-0450; Gelhaus Wendell, Stacy/0000-0001-9083-6933; Reyes Uribe, Laura/0000-0001-6091-6705	NIH [HL126711]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Kaynar received research grant support from NIH (HL126711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Kaynar received salary support from NIH (HL126711).	Abdelmalak M, 2013, MOL GENET METAB, V109, P139, DOI 10.1016/j.ymgme.2013.03.019; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; [Anonymous], 1999, AM J PHYSIOL-CELL PH, V277, pC1; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Borges RC, 2015, INTENS CARE MED, V41, P1433, DOI 10.1007/s00134-015-3914-y; Broderick KE, 2006, FASEB J, V20, P1865, DOI 10.1096/fj.06-5780com; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Cambiaghi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09619-x; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chowdhury M, 2019, DEV COMP IMMUNOL, V95, P50, DOI 10.1016/j.dci.2019.01.017; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dolezal T, 2019, INSECT BIOCHEM MOLEC, V109, P31, DOI 10.1016/j.ibmb.2019.04.005; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Guo HH, 2016, J IMMUNOL, V196, P2300, DOI 10.4049/jimmunol.1500130; Guo K, 2011, J CHROMATOGR A, V1218, P3689, DOI 10.1016/j.chroma.2011.04.024; Han J, 2015, ANAL CHIM ACTA, V854, P86, DOI 10.1016/j.aca.2014.11.015; Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Heigenhauser GJF, 1999, ADV EXP MED BIOL, V474, P205; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Hu YT, 2017, SCI REP-UK, V7, DOI 10.1038/srep41255; Kaynar Ata Murat, 2016, Intensive Care Med Exp, V4, P4, DOI 10.1186/s40635-016-0075-4; Krejcova G, 2019, ELIFE, V8, DOI 10.7554/eLife.50414; Lack JB, 2016, MOL BIOL EVOL, V33, P3308, DOI 10.1093/molbev/msw195; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Linder A, 2014, CRIT CARE MED, V42, P2211, DOI 10.1097/CCM.0000000000000503; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mayr FB, 2017, JAMA-J AM MED ASSOC, V317, P530, DOI 10.1001/jama.2016.20468; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Mukherjee K, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-25; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nuzzo E, 2015, ANN AM THORAC SOC, V12, P1662, DOI 10.1513/AnnalsATS.201505-267BC; o A, 2013, DTSCH ARZTEBL, V110, pA; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pandey A, 2014, AGE, V36, P1139, DOI 10.1007/s11357-014-9628-1; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Shankar-Hari M, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0544-7; Shapiro NI, 2005, ANN EMERG MED, V45, P524, DOI 10.1016/j.annemergmed.2004.12.006; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sung EJ, 2017, P NATL ACAD SCI USA, V114, P13786, DOI 10.1073/pnas.1712453115; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Wang HB, 2019, J BIOL CHEM, V294, P5466, DOI 10.1074/jbc.RA118.005200; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Yamamoto-Hino M, 2015, P NATL ACAD SCI USA, V112, P5809, DOI 10.1073/pnas.1424514112; Yamane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098032; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	66	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241122	10.1371/journal.pone.0241122	http://dx.doi.org/10.1371/journal.pone.0241122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151963	gold, Green Published			2022-12-26	WOS:000591376200010
J	Lee, HS; Jung, JI; Kim, KH; Park, SJ; Kim, EJ				Lee, Hyun Sook; Jung, Jae In; Kim, Kyeong-Hee; Park, Sang Jae; Kim, Eun Ji			Toxicodendron vernicifluum Stokes extract inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice	PLOS ONE			English	Article							COLORECTAL-CANCER; MEDICINAL-PLANTS; MIGRATION; ADHESION; FISETIN; DETOXIFICATION; PERSPECTIVE; PROGRESSION; PREVENTION; EXPRESSION	Toxicodendron vernicifluum Stokes has long been used as a food supplement and traditional herbal medicine in East Asia. We applied a new extraction method to produce Toxicodendron vernicifluum Stokes extract (TVSE), that doesn't contain urushiol (an allergenic toxin) but dose have higher levels of some flavonoids such as fustin and fisetin. This study was conducted to investigate the anticancer effects of TVSE in an in vivo system. Fifty BALB/c mice were acclimated for one week and then injected with 4T1 murine mammary carcinoma cells in mammary fat pads. After 7 days, the mice were randomly divided into 5 groups, and orally administered with 0, 50, 100, 200 or 400 mg of TVSE/kg body weight (BW)/day for 20 days. TVSE reduced tumor volume and weight dose-dependently. The expression of Ki67 was significantly reduced and the number of TUNEL-positive apoptotic cells was significantly increased in the TVSE-treated group over 100 mg/kg BW/day. While tumor nodules were not found in the liver, but only in lungs, the number of tumor nodules was reduced in a dose-dependent manner in the TVSE treated groups compared to the control group. In breast tumors, expression of platelet endothelial cell adhesion molecule (PECAM-1) and vascular endothelial growth factor (VEGF) was reduced by TVSE treatment. TVSE treatment significantly suppressed mRNA expression in tumors of matrix metalloproteinase (MMP)-2, tissue inhibitor of metalloproteinase (TIMP)-1, urokinase-type plasminogen activator (uPA), intercellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 while increasing plasminogen activator inhibitor (PAI)-1. These results suggest that TVSE is potentially beneficial for the suppression of breast cancer growth and its-associated lung metastasis.	[Lee, Hyun Sook] Dongseo Univ, Dept Food Sci & Nutr, Busan, South Korea; [Jung, Jae In; Kim, Eun Ji] Hallym Univ, Reg Strateg Ind Innovat Ctr, Chunchon, South Korea; [Kim, Kyeong-Hee; Park, Sang Jae] Medience Co Ltd, Chunchon, South Korea	Dongseo University; Hallym University	Kim, EJ (corresponding author), Hallym Univ, Reg Strateg Ind Innovat Ctr, Chunchon, South Korea.	myej4@hallym.ac.kr						Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheon SH, 2011, FORSCH KOMPLEMENTMED, V18, P77, DOI 10.1159/000327306; Choi HS, 2007, FOOD SCI BIOTECHNOL, V16, P935; Chu JE, 2014, NEOPLASIA, V16, P180, DOI 10.1593/neo.132076; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; Degryse B, 2011, CURR PHARM DESIGN, V17, P1872, DOI 10.2174/138161211796718161; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Gligorov J, 2008, BREAST CANCER RES TR, V112, P53, DOI 10.1007/s10549-008-0232-x; Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]; Grynkiewicz G, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00697; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; HAN-SEOK CHOI，, 2012, [Korean Journal of Food Science and Technology, 한국식품과학회지], V44, P173; Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948; Jin LT, 2018, CANCER BIOL THER, V19, P858, DOI 10.1080/15384047.2018.1456599; Young Yoon Hee, 2020, [KOREA INTERNATIONAL COMMERCIAL REVIEW, 국제상학], V35, P45, DOI 10.18104/kaic.2020.35.2.45; Jung CH, 2007, J ETHNOPHARMACOL, V110, P490, DOI 10.1016/j.jep.2006.10.013; Jung CH, 2006, BIOL PHARM BULL, V29, P1603, DOI 10.1248/bpb.29.1603; Kang SH, 2016, AM J CHINESE MED, V44, P1719, DOI 10.1142/S0192415X16500968; Kashyap D, 2018, LIFE SCI, V194, P75, DOI 10.1016/j.lfs.2017.12.005; Kim JH, 2006, INT J MOL MED, V18, P201; Kim YS, 2012, BMB REP, V45, P623, DOI 10.5483/BMBRep.2012.45.11.233; Kobayashi S, 2000, CHEM LETT, P1214, DOI 10.1246/cl.2000.1214; Lall RK, 2016, MOL NUTR FOOD RES, V60, P1396, DOI 10.1002/mnfr.201600025; Lee HS, 2020, NUTR RES PRACT, V14, P463, DOI 10.4162/nrp.2020.14.5.463; Lee JD, 2009, INT IMMUNOPHARMACOL, V9, P268, DOI 10.1016/j.intimp.2008.11.005; Lee KW, 2018, ONCOL REP, V39, P1141, DOI 10.3892/or.2018.6179; Lee Sang-Hun, 2009, [Journal of Korean Medicine, 대한한의학회지], V30, P112; Lee SH, 2009, INTEGR CANCER THER, V8, P148, DOI 10.1177/1534735409336438; Lee S, 2011, ONCOLOGY-BASEL, V81, P312, DOI 10.1159/000334695; Lee SO, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2310-x; Li G, 2015, MOL MED REP, V12, P2203, DOI 10.3892/mmr.2015.3586; Li W, 2019, MOLECULES, V24, DOI 10.3390/molecules24224062; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; MacDonald IC, 2002, BIOESSAYS, V24, P885, DOI 10.1002/bies.10156; Medeiros B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092272; Melincovici CS, 2018, ROM J MORPHOL EMBRYO, V59, P455; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Park BC, 2007, EXP MOL MED, V39, P316, DOI 10.1038/emm.2007.35; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Qamar H, 2019, CURR DRUG TARGETS, V20, P1227, DOI 10.2174/1389450120666190429120314; Salerno S, 2010, CURR MED CHEM, V17, P4270, DOI 10.2174/092986710793361252; Saravanakumar K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040127; Sauter BV, 2000, P NATL ACAD SCI USA, V97, P4802, DOI 10.1073/pnas.090065597; SCHLAPPACK OK, 1988, KLIN WOCHENSCHR, V66, P790, DOI 10.1007/BF01726581; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Suruga K, 2019, FOOD NUTR RES, V63, DOI 10.29219/fnr.v63.3601; Syed DN, 2013, ANTI-CANCER AGENT ME, V13, P995, DOI 10.2174/18715206113139990129; Tarhini AA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-19; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Wang TY, 2018, ASIAN J PHARM SCI, V13, P12, DOI 10.1016/j.ajps.2017.08.004; Wertheim KY, 2017, B MATH BIOL, V79, P693, DOI 10.1007/s11538-017-0248-7; Wu Q, 2017, ONCOTARGET, V8, P27990, DOI 10.18632/oncotarget.15856; Xiao X, 2013, HUM REPROD UPDATE, V19, P167, DOI 10.1093/humupd/dms049; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Ye F, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1863-9	63	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241805	10.1371/journal.pone.0241805	http://dx.doi.org/10.1371/journal.pone.0241805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152052	Green Published, gold			2022-12-26	WOS:000591376200028
J	Nieto, O; Brooks, RA; Landrian, A; Cabral, A; Fehrenbacher, AE				Nieto, Omar; Brooks, Ronald A.; Landrian, Amanda; Cabral, Alejandra; Fehrenbacher, Anne E.			PrEP discontinuation among Latino/a and Black MSM and transgender women: A need for PrEP support services	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; ADHERENCE; HEALTH; MEN; ACCEPTABILITY; FACILITATORS; BARRIERS; CARE	Purpose Disparities persist in HIV infection among Black and Latino men who have sex with men (BLMSM) and Black and Latina transgender women (BLTW). Increasing uptake and subsequent consistent use of pre-exposure prophylaxis (PrEP), an effective biomedical strategy for preventing HIV acquisition, can dramatically reduce HIV incidence in these populations. The purpose of this study was to explore reasons for PrEP discontinuation among BLMSM and BLTW living in Los Angeles County to inform the development of support services for these populations to remain persistent with their PrEP regimen. Methods In-depth, semi-structured interviews were conducted with 15 BLMSM and 7 BLTW who reported either temporary or indefinite PrEP discontinuation. A thematic analysis approach was used to analyze qualitative data. Results Four themes emerged related to reasons for PrEP discontinuation, including: (1) lower perceived HIV risk related to changes in sexual behavior; (2) structural or logistical barriers (e.g., lapse or loss of health insurance, cost, difficulty navigating complex medical systems); (3) anticipated and experienced medication side effects, with a sub-theme of interactions between PrEP and feminizing hormone medications; and (4) challenges with medication adherence. Conclusions PrEP is an important prevention tool for BLMSM and BLTW, particularly during periods of heightened HIV risk. However, both individual (e.g., inability to adhere to medication, changes in HIV sexual risk behaviors) and structural/logistical (e.g., loss of insurance, navigating complex medical systems) factors can cause temporary or indefinite PrEP discontinuation. Additional support services, beyond those offered by medical providers, are needed to help BLMSM and BLTW PrEP users overcome barriers to discontinuation and assist them to remain persistent with their PrEP regimen. We describe potential options for support services such as PrEP case management, expanded PrEP navigation services, or text messaging services.	[Nieto, Omar; Brooks, Ronald A.; Landrian, Amanda; Cabral, Alejandra] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90024 USA; [Brooks, Ronald A.; Fehrenbacher, Anne E.] Univ Calif Los Angeles, Ctr HIV Identificat Prevent & Treatment Serv CHIP, Los Angeles, CA 90024 USA; [Landrian, Amanda; Cabral, Alejandra] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Fehrenbacher, Anne E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Brooks, RA (corresponding author), Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90024 USA.; Brooks, RA (corresponding author), Univ Calif Los Angeles, Ctr HIV Identificat Prevent & Treatment Serv CHIP, Los Angeles, CA 90024 USA.	rabrooks@mednet.ucla.edu			California Community Foundation [BA-17-136260]; National Institute of Mental Health [R21MH107339, T32MH109205]; UCLA Center for HIV Identification, Prevention, and Treatment (CHIPTS) [P30MH058107]	California Community Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCLA Center for HIV Identification, Prevention, and Treatment (CHIPTS)	RAB received funding from the California Community Foundation under Grant #BA-17-136260 (URL: https://www.calfund.org/); the National Institute of Mental Health under Grant #R21MH107339 and T32MH109205 (URL: https://www.nimh.nih.gov/); and the UCLA Center for HIV Identification, Prevention, and Treatment (CHIPTS) under Grant #P30MH058107 (URL: http://chipts.ucla.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CLIN INFECT DIS S5, V52, pS397; [Anonymous], 2020, WHAT IS END HIV EP P; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks RA, 2019, J URBAN HLTH; Brooks RA, 2019, TRANSGENDER HEALTH, V4, P188, DOI 10.1089/trgh.2019.0014; Brooks RA, 2019, AIDS BEHAV, V23, P1964, DOI 10.1007/s10461-019-02397-9; CDC, 2019, HIV SURVEILLANCE REP; Centers for Disease Control and Prevention, 2019, HIV TRANSG PEOPL; Centers for Disease Control and Prevention, 2017, HIV GAY BIS MEN FACT; Cunningham WE, 2008, J NATL MED ASSOC, V100, P840, DOI 10.1016/S0027-9684(15)31379-1; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Doblecki-Lewis S, 2019, J INT ASS PROVID AID, V18, DOI 10.1177/2325958219848848; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; FDA, 2019, FDA APPR 2 DRUG PREV; Fuchs JD, 2018, AIDS PATIENT CARE ST, V32, P104, DOI 10.1089/apc.2017.0255; Garofalo R, 2016, AIDS BEHAV, V20, P1049, DOI 10.1007/s10461-015-1192-x; Gerke DR, 2020, HEALTH PROMOT PRACT, V21, P716, DOI 10.1177/1524839920936242; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hevey MA, 2018, AIDS EDUC PREV, V30, P393, DOI 10.1521/aeap.2018.30.5.393; Hiransuthikul A, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25338; HIV Prevention Trials Network, 2020, HPTN 083 STUD DEM SU; Hojilla JC, 2018, AIDS BEHAV, V22, P1096, DOI 10.1007/s10461-017-2009-x; Holloway IW, 2017, JAIDS-J ACQ IMM DEF, V74, P15, DOI 10.1097/QAI.0000000000001164; Katz MH, 2001, EFFECT CASE MANAGEME, V9; Kay ES, 2020, AM J PUBLIC HEALTH, V110, P61, DOI 10.2105/AJPH.2019.305389; Landovitz RJ, 2017, JAIDS-J ACQ IMM DEF, V76, P501, DOI [10.1097/QAI.0000000000001538, 10.1097/qai.0000000000001538]; Liu A, 2019, C RETR OPP INF CROI; Liu AY, 2019, CLIN INFECT DIS, V68, P2010, DOI 10.1093/cid/ciy810; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Mayer KH, 2020, ADV THER, V37, P1778, DOI 10.1007/s12325-020-01295-0; Mitchell JT, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10456; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Morgan E, 2018, AIDS BEHAV, V22, P3645, DOI 10.1007/s10461-018-2125-2; Pathela P, 2020, JAIDS-J ACQ IMM DEF, V83, P357, DOI 10.1097/QAI.0000000000002274; Rael CT, 2018, AIDS BEHAV, V22, P3627, DOI 10.1007/s10461-018-2102-9; Rao DW, 2019, SEX TRANSM DIS, V46, P221, DOI 10.1097/OLQ.0000000000000965; Reback CJ, 2019, J COMMUN HEALTH, V44, P1193, DOI 10.1007/s10900-019-00705-x; Sevelius JM, 2016, GLOB PUBLIC HEALTH, V11, P1060, DOI 10.1080/17441692.2016.1154085; Sherman EM, 2020, AIDS RES THER, V17, DOI 10.1186/s12981-020-00275-2; Spinelli MA, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz101; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; U.S. Food & Drug Administration, 2012, PRESS ANN APPR 1 DRU; Wheeler DP, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25223; Whitfield THF, 2018, AIDS BEHAV, V22, P3566, DOI 10.1007/s10461-018-2045-1; Wood S, 2019, AIDS BEHAV, V23, P2719, DOI 10.1007/s10461-019-02502-y	50	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241340	10.1371/journal.pone.0241340	http://dx.doi.org/10.1371/journal.pone.0241340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151997	Green Published, gold			2022-12-26	WOS:000591376200036
J	Girolamini, L; Mazzotta, M; Lizzadro, J; Pascale, MR; Dormi, A; Salaris, S; Cristino, S				Girolamini, Luna; Mazzotta, Marta; Lizzadro, Jessica; Pascale, Maria Rosaria; Dormi, Ada; Salaris, Silvano; Cristino, Sandra			Sit bath systems: A new source of Legionella infection	PLOS ONE			English	Article							PRESSURE ULCERS; IDENTIFICATION; TEMPERATURE; RESISTANCE; BIOFILM; IMPACT; GROWTH; SCHEME	Sit Bath Systems (SBSs) are the most common hygiene method for patients who are not self-sufficient. Therefore, the water quality of SBSs in the nosocomial environment plays a fundamental role in controlling infections for both patients and health-care workers. A long-term study on Legionella and Pseudomonas aeruginosa (P. aeruginosa) contamination was performed in SBSs (n = 20) of six Health Care Facilities (HCFs). A total of 254 water samples were analyzed following ISO procedures. The samples were positive for P. aeruginosa (46.85%) and Legionella (53.54%), respectively, both over the directive limits. Legionella isolates were identified as: Legionella pneumophila (L. pneumophila) serogroups 1, 3, and 6 and Legionella non-pneumophila species (L. anisa, L. londiniensis, L. rubrilucens, and L. nagelii). Moreover, the contamination found was studied with respect to median temperature measured (42 degrees C), from which two groups (A and B) could be distinguished. P. aeruginosa was found in both groups (100% of SBSs), while a higher percentage of Legionella positive samples was found in group A (75% of SBSs), compared to group B (50% of SBSs), showing how Legionella control could be carried out by using temperatures above 42 degrees C. An analysis of SBS water pipelines, maintenance, and disinfection treatments indicates SBSs as a new source of infection risk for both patients and health-care workers.	[Girolamini, Luna; Mazzotta, Marta; Lizzadro, Jessica; Pascale, Maria Rosaria; Salaris, Silvano; Cristino, Sandra] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, BO, Italy; [Dormi, Ada] Univ Bologna, Dept Med & Surg Sci, Bologna, BO, Italy	University of Bologna; University of Bologna	Cristino, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, BO, Italy.	sandra.cristino@unibo.it		CRISTINO, SANDRA/0000-0002-5084-2615	University of Bologna, Italy [RFO 2018]	University of Bologna, Italy	This work was supported by a research grant RFO 2018 from University of Bologna, Italy.	Abu Khweek A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00038; [Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2018, 14885 EN; [Anonymous], 2007, STUDIA BOBOLANUM, V1, P57; Bartram J, 2007, EMERG INFECT DIS, V14, p1006a; Caselli E, 2019, INFECT DRUG RESIST, V12, P501, DOI 10.2147/IDR.S194670; Chaoui L, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/3236526; Dana AN, 2015, J SPINAL CORD MED, V38, P147, DOI 10.1179/2045772314Y.0000000234; Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053; Falkinham JO, 2015, PATHOGENS, V4, P373, DOI 10.3390/pathogens4020373; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Fry NK, 2007, CLIN MICROBIOL INFEC, V13, P1119, DOI 10.1111/j.1469-0691.2007.01808.x; Gamage SD, 2016, INFECT DIS CLIN N AM, V30, P689, DOI 10.1016/j.idc.2016.04.004; Garcia MR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01259; Hayes-Phillips D, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010027; Hse SE, 2012, MANAGING RISKS HOT W, P1; International Labour Office (ILO) G, 2010, LIST OCC DIS ID REC; ISO, 2017, 117312017 ISO; Italian Health Ministry, 2015, APPR C STAT REG SED; Italian Health Ministry, ATT REL EP INF; Kampf G, 2018, J HOSP INFECT, V100, pE1, DOI 10.1016/j.jhin.2018.05.019; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaye KS, 2016, INFECT PREVENTION 1; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; KROPINSKI AMB, 1987, J BACTERIOL, V169, P1960, DOI 10.1128/jb.169.5.1960-1966.1987; Lee K, 2017, J MICROBIOL BIOTECHN, V27, P1053, DOI 10.4014/jmb.1611.11056; Legislative Decree n. 31 02.02.2001, 2001, OFFICIAL J ITALIAN R; Mentasti M, 2012, EUR J CLIN MICROBIOL, V31, P2017, DOI 10.1007/s10096-011-1535-0; Moore MR, 2006, APPL ENVIRON MICROB, V72, P378, DOI 10.1128/AEM.72.1.378-383.2006; Peng JH, 2017, J PROTEOMICS, V152, P75, DOI 10.1016/j.jprot.2016.10.005; Perrin Y, 2019, INT J HYG ENVIR HEAL, V222, P687, DOI 10.1016/j.ijheh.2019.04.010; Principe L, 2017, ENVIRON RES, V152, P485, DOI 10.1016/j.envres.2016.09.018; Ratcliff RM, 1998, J CLIN MICROBIOL, V36, P1560, DOI 10.1128/JCM.36.6.1560-1567.1998; Rhoads WJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0134-1; Rota Maria Cristina, 2019, NOT I SUPER SANITA, P32; Squier, 2000, Curr Infect Dis Rep, V2, P490, DOI 10.1007/s11908-000-0049-1; Sydnor ERM, 2012, INFECT CONT HOSP EP, V33, P235, DOI 10.1086/664047; Tedeschi S, 2017, CLIN MICROBIOL INFEC, V23, P943, DOI 10.1016/j.cmi.2017.04.015; Treepong P, 2018, CLIN MICROBIOL INFEC, V24, P258, DOI 10.1016/j.cmi.2017.06.018; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; UNI, 2008, 162662008 UNI EN ISO; UNI, 2006, 194582006 UNI EN ISO; WAUTERS G, 1995, J CLIN MICROBIOL, V33, P845, DOI 10.1128/JCM.33.4.845-849.1995; Weber DJ, 2013, INFECT CONT HOSP EP, V34, P449, DOI 10.1086/670223; Zotti CM, 2017, REPORT ITALIANO PPS2, P1	46	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241756	10.1371/journal.pone.0241756	http://dx.doi.org/10.1371/journal.pone.0241756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147266	gold, Green Published			2022-12-26	WOS:000589609300070
J	Lin, SF; Fan, YC; Chou, CC; Pan, WH; Bai, CH				Lin, Sheng-Feng; Fan, Yen-Chun; Chou, Chia-Chi; Pan, Wen-Harn; Bai, Chyi-Huey			Body composition patterns among normal glycemic, pre-diabetic, diabetic health Chinese adults in community: NAHSIT 2013-2016	PLOS ONE			English	Article							OPPOSITE ASSOCIATIONS; INSULIN-RESISTANCE; ABDOMINAL OBESITY; WAIST CIRCUMFERENCE; DIETARY PATTERNS; MUSCLE MASS; PREVALENCE; NUTRITION; MELLITUS; TRUNK	Background Central obesity is known to be associated with diabetes. Increasing lower extremity circumference was hypothesized in association with lower risk of diabetes. Objective This study determined which anthropometric patterns correlates the best with pre-diabetic and diabetic status among healthy adults. Design Cross-sectional study with nationwide population sampling of participants was designed. Participants In total, 1,358 ethnic Chinese adult participants were recruited from the Nutrition and Health Survey in Taiwan 2013-2016; the whole-body composition was measured through dual-energy X-ray absorptiometry. Main outcome measures Fat and lean mass in whole and specific parts of body among heathy Asian adults with normal glycemic, pre-diabetic, and diabetic states were measured, separately. Statistical analyses performed The generalized linear model was used to investigate the association between body composition (lean and fat mass) and hyperglycemic status. The reduced rank regression (RRR) was used to confirm the correlation between glycemic status and predicting factors (body composition parameters). Results Trunk fat positively correlated with the fasting glucose level (r = 0.327, P < 0.001) and HbA1c (r = 0.329, P < 0.001), whereas limb fat negatively correlated with the fasting glucose level (r = -0.325, P < 0.001) and HbA1c (rho = -0.342, P < 0.001), respectively. In RRR analyses, fasting glucose and HbA1c exhibited a high positive association on fat amount per lean mass of the trunk (factor loading = 0.5319 and 0.5599, respectively) and of android area (0.6422 and 0.6104) and a high negative association fat amount per lean mass of the legs (-0.3863 and -0.3083) and gynoid area (-0.3414 and -0.3725). Conclusions For healthy community participants, increasing trunk fat had a greater risk of hyperglycemic status. Increasing lower extremity mass may confer lower risk of diabetes.	[Lin, Sheng-Feng; Fan, Yen-Chun; Bai, Chyi-Huey] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Lin, Sheng-Feng] Far Eastern Mem Hosp, Div Hospitalist, Dept Internal Med, New Taipei, Taiwan; [Lin, Sheng-Feng] Far Eastern Mem Hosp, Dept Neurol, New Taipei, Taiwan; [Chou, Chia-Chi] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Chou, Chia-Chi] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chou, Chia-Chi] Chang Gung Mem Hosp, Dept Internal Med, Keelung, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan	Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Taipei Medical University	Bai, CH (corresponding author), Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan.; Bai, CH (corresponding author), Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan.	baich@tmu.edu.tw	Pan, Wen-Harn/F-9972-2010; Fan, Yen-Chun/AAG-7183-2021	Pan, Wen-Harn/0000-0001-9136-0658; Bai, Chyi-Huey/0000-0002-4658-1088	Health Promotion Administration, Ministry of Health and Welfare [MOHW108-HPA-H-114-134703, MOHW109-HPA-H-114-144702]; Ministry of Science and Technology, Taiwan [MOST 107-2314-B-038-072-MY3]	Health Promotion Administration, Ministry of Health and Welfare; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the Health Promotion Administration, Ministry of Health and Welfare (MOHW108-HPA-H-114-134703, MOHW109-HPA-H-114-144702), as well as funded by Ministry of Science and Technology, Taiwan in the form of a grant awarded to CHB (MOST 107-2314-B-038-072-MY3). The Health Promotion Administration, Ministry of Health and Welfare, Taiwan is the governmental entity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; [Anonymous], 2011, Prescrire Int, V20, P238; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268; Chang HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169577; Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Chen HD, 1997, DIABETES RES CLIN PR, V38, P199, DOI 10.1016/S0168-8227(97)00104-6; Chuang SY, 2019, J AM MED DIR ASSOC, V20, P544, DOI 10.1016/j.jamda.2018.10.017; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Julian Valerie, 2017, J Clin Med Res, V9, P917, DOI 10.14740/jocmr3142w; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kawakami R, 2015, J EPIDEMIOL, V25, P656, DOI 10.2188/jea.JE20140256; Kim KS, 2014, GERIATR GERONTOL INT, V14, P115, DOI 10.1111/ggi.12189; Kim K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21168-5; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Lee JSW, 2010, DIABETIC MED, V27, P1366, DOI 10.1111/j.1464-5491.2010.03118.x; Lim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212963; Lo YL, 2017, J AM GERIATR SOC, V65, P2009, DOI 10.1111/jgs.14972; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Pan WH, 2008, OBES REV, V9, P22, DOI 10.1111/j.1467-789X.2007.00434.x; Pinnick KE, 2014, DIABETES, V63, P3785, DOI 10.2337/db14-0385; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Rankin KC, 2019, J SPINAL CORD MED, V42, P508, DOI 10.1080/10790268.2018.1438879; Shih YH, 2019, ASIA PAC J CLIN NUTR, V28, P371, DOI 10.6133/apjcn.201906_28(2).0020; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Tatsukawa Y, 2018, EUR J CLIN NUTR, V72, P374, DOI 10.1038/s41430-017-0077-7; Thomas EL, 2012, NUTR RES REV, V25, P150, DOI 10.1017/S0954422412000054; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; Tu SH, 2011, ASIA PAC J CLIN NUTR, V20, P225; Weikert C, 2016, CURR OPIN CLIN NUTR, V19, P341, DOI 10.1097/MCO.0000000000000308; Wu HY, 2010, J CLIN ENDOCR METAB, V95, P4389, DOI 10.1210/jc.2010-0181; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241121	10.1371/journal.pone.0241121	http://dx.doi.org/10.1371/journal.pone.0241121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147251	Green Published, gold			2022-12-26	WOS:000589609300001
J	Gaullier, G; Roberts, G; Muthurajan, UM; Bowerman, S; Rudolph, J; Mahadevan, J; Jha, A; Rae, PS; Luger, K				Gaullier, Guillaume; Roberts, Genevieve; Muthurajan, Uma M.; Bowerman, Samuel; Rudolph, Johannes; Mahadevan, Jyothi; Jha, Asmita; Rae, Purushka S.; Luger, Karolin			Bridging of nucleosome-proximal DNA double-strand breaks by PARP2 enhances its interaction with HPF1	PLOS ONE			English	Article							ADP-RIBOSYLATION; STRUCTURAL BASIS; CRYO-EM; DAMAGE; POLY(ADP-RIBOSYL)ATION; ACTIVATION; MECHANISM; BINDING; APLF; IDENTIFICATION	Poly(ADP-ribose) Polymerase 2 (PARP2) is one of three DNA-dependent PARPs involved in the detection of DNA damage. Upon binding to DNA double-strand breaks, PARP2 uses nicotinamide adenine dinucleotide to synthesize poly(ADP-ribose) (PAR) onto itself and other proteins, including histones. PAR chains in turn promote the DNA damage response by recruiting downstream repair factors. These early steps of DNA damage signaling are relevant for understanding how genome integrity is maintained and how their failure leads to genome instability or cancer. There is no structural information on DNA double-strand break detection in the context of chromatin. Here we present a cryo-EM structure of two nucleosomes bridged by human PARP2 and confirm that PARP2 bridges DNA ends in the context of nucleosomes bearing short linker DNA. We demonstrate that the conformation of PARP2 bound to damaged chromatin provides a binding platform for the regulatory protein Histone PARylation Factor 1 (HPF1), and that the resulting HPF1 center dot PARP2 center dot nucleosome complex is enzymatically active. Our results contribute to a structural view of the early steps of the DNA damage response in chromatin.	[Gaullier, Guillaume; Roberts, Genevieve; Muthurajan, Uma M.; Bowerman, Samuel; Rudolph, Johannes; Mahadevan, Jyothi; Jha, Asmita; Rae, Purushka S.; Luger, Karolin] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA; [Gaullier, Guillaume; Muthurajan, Uma M.; Bowerman, Samuel; Rudolph, Johannes; Luger, Karolin] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Gaullier, Guillaume] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Uppsala University	Luger, K (corresponding author), Univ Colorado, Dept Biochem, Boulder, CO 80309 USA.; Luger, K (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	karolin.luger@colorado.edu	Gaullier, Guillaume/ABG-6974-2020; Mahadevan, Jyothi/AAC-8711-2021	Gaullier, Guillaume/0000-0003-3405-6021; Mahadevan, Jyothi/0000-0002-4776-840X; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Jha, Asmita/0000-0002-2612-551X	 [R01 CA218255-01];  [T32 GM008759 20POST35211059]	; 	R01 CA218255-01 Howard Hughes Medical Institute T32 GM008759 20POST35211059.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Aleksandrov R, 2018, MOL CELL, V69, P1046, DOI 10.1016/j.molcel.2018.02.016; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Andres SN, 2019, J BIOL CHEM, V294, P3312, DOI 10.1074/jbc.RA118.006759; Arimura Y, 2018, NUCLEIC ACIDS RES, V46, P10007, DOI 10.1093/nar/gky661; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bilokapic S, 2020, NATURE, V585, P609, DOI 10.1038/s41586-020-2725-7; Bilokapic S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25429-1; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Burnley T, 2017, ACTA CRYSTALLOGR D, V73, P469, DOI 10.1107/S2059798317007859; Carrassa L, 2017, CANCER TREAT REV, V60, P139, DOI 10.1016/j.ctrv.2017.08.013; Case D. A., 2018, AMBER 2019; Chen Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05588-5; D'Imprima E, 2019, ELIFE, V8, DOI 10.7554/eLife.42747; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dawicki-McKenna JM, 2015, MOL CELL, V60, P755, DOI 10.1016/j.molcel.2015.10.013; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eustermann S, 2015, MOL CELL, V60, P742, DOI 10.1016/j.molcel.2015.10.032; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Gagne JP, 2015, DNA REPAIR, V30, P68, DOI 10.1016/j.dnarep.2015.02.004; Gatchalian J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01598-x; Gibbs-Seymour I, 2016, MOL CELL, V62, P432, DOI 10.1016/j.molcel.2016.03.008; Glaeser RM, 2018, CURR OPIN COLLOID IN, V34, P1, DOI 10.1016/j.cocis.2017.12.009; Glaeser Robert M, 2017, Biophys Rep, V3, P1, DOI 10.1007/s41048-016-0026-3; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Graham TGW, 2018, NAT STRUCT MOL BIOL, V25, P877, DOI 10.1038/s41594-018-0120-y; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; HULETSKY A, 1985, EUR J BIOCHEM, V146, P277, DOI 10.1111/j.1432-1033.1985.tb08650.x; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karch KR, 2017, MOL BIOSYST, V13, P2660, DOI 10.1039/c7mb00498b; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Langelier MF, 2014, NUCLEIC ACIDS RES, V42, P7762, DOI 10.1093/nar/gku474; Lehmann LC, 2017, MOL CELL, V68, P847, DOI 10.1016/j.molcel.2017.10.017; Leidecker O, 2016, NAT CHEM BIOL, V12, P998, DOI 10.1038/nchembio.2180; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Liszczak G, 2018, NAT CHEM BIOL, V14, P837, DOI 10.1038/s41589-018-0097-1; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Macke TJ, 1997, AM CHEM SOC, P379, DOI 10.1021/bk-1998-0682.ch024; Mahadevan J, 2019, BIOPHYS J, V116, P2224, DOI 10.1016/j.bpj.2019.04.032; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marabelli C, 2019, CELL REP, V27, P387, DOI 10.1016/j.celrep.2019.03.061; Martiniano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10326; Morrison EA, 2018, ELIFE, V7, DOI 10.7554/eLife.31481; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Muthurajan U, 2016, METHOD ENZYMOL, V573, P3, DOI 10.1016/bs.mie.2016.01.002; Obaji E, 2018, NUCLEIC ACIDS RES, V46, P12154, DOI 10.1093/nar/gky927; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Papeo G, 2015, J MED CHEM, V58, P6875, DOI 10.1021/acs.jmedchem.5b00680; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricks TK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00222; Rudolph J, 2018, ELIFE, V7, DOI 10.7554/eLife.37818; Rulten SL, 2008, MOL CELL BIOL, V28, P4620, DOI 10.1128/MCB.02243-07; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seifert FU, 2016, EMBO J, V35, P759, DOI 10.15252/embj.201592934; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Singh HR, 2017, MOL CELL, V68, P860, DOI 10.1016/j.molcel.2017.11.019; Sinha NK, 2018, SCIENCE, V359, P329, DOI 10.1126/science.aaq0921; Suskiewicz MJ, 2020, NATURE, V579, P598, DOI 10.1038/s41586-020-2013-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang JL, 2018, NAT STRUCT MOL BIOL, V25, P482, DOI 10.1038/s41594-018-0065-1; Wilkinson OJ, 2019, ELIFE, V8, DOI 10.7554/eLife.42129; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; YOSHIHARA K, 1977, BIOCHEM BIOPH RES CO, V78, P1281, DOI 10.1016/0006-291X(77)91431-0; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou KD, 2019, NAT STRUCT MOL BIOL, V26, P3, DOI 10.1038/s41594-018-0166-x	80	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240932	10.1371/journal.pone.0240932	http://dx.doi.org/10.1371/journal.pone.0240932			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141820	Green Published, Green Submitted, gold			2022-12-26	WOS:000588376700049
J	He, D; Wang, D; Lu, P; Yang, N; Xue, ZG; Zhu, XM; Zhang, P; Fan, GP				He, Di; Wang, Di; Lu, Ping; Yang, Nan; Xue, Zhigang; Zhu, Xianmin; Zhang, Peng; Fan, Guoping			Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations	ONCOGENE			English	Article							NF-KAPPA-B; ETS TRANSCRIPTION FACTOR; NONCODING RNA; NECROSIS-FACTOR; CANCER; EXPRESSION; METASTASIS; PROGRESSION; INDUCTION; ACTIVATOR	Lung adenocarcinoma (LUAD) harboring EGFR mutations prevails in Asian population. However, the inter-patient and intra-tumor heterogeneity has not been addressed at single-cell resolution. Here we performed single-cell RNA sequencing (scRNA-seq) of total 125,674 cells from seven stage-I/II LUAD samples harboring EGFR mutations and five tumor-adjacent lung tissues. We identified diverse cell types within the tumor microenvironment (TME) in which myeloid cells and T cells were the most abundant stromal cell types in tumors and adjacent lung tissues. Within tumors, accompanied by an increase in CD1C(+) dendritic cells, the tumor-associated macrophages (TAMs) showed pro-tumoral functions without signature gene expression of defined M1 or M2 polarization. Tumor-infiltrating T cells mainly displayed exhausted and regulatory T-cell features. The adenocarcinoma cells can be categorized into different subtypes based on their gene expression signatures in distinct pathways such as hypoxia, glycolysis, cell metabolism, translation initiation, cell cycle, and antigen presentation. By performing pseudotime trajectory, we found that ELF3 was among the most upregulated genes in more advanced tumor cells. In response to secretion of inflammatory cytokines (e.g., IL1B) from immune infiltrates, ELF3 in tumor cells was upregulated to trigger the activation of PI3K/Akt/NF-kappa B pathway and elevated expression of proliferation and anti-apoptosis genes such as BCL2L1 and CCND1. Taken together, our study revealed substantial heterogeneity within early-stage LUAD harboring EGFR mutations, implicating complex interactions among tumor cells, stromal cells and immune infiltrates in the TME.	[He, Di; Zhu, Xianmin; Fan, Guoping] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China; [He, Di; Wang, Di; Zhu, Xianmin; Zhang, Peng] Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, Shanghai 200433, Peoples R China; [Lu, Ping; Xue, Zhigang] Tongji Univ, Tongji Hosp, Translat Ctr Stem Cell Res, Dept Regenerat Med,Sch Med, Shanghai 200065, Peoples R China; [Yang, Nan] Zhangjiang High Tech Pk Ltd, PharmaLegacy Labs Shanghai Co, Bldg 7,388 Jialilue Rd, Shanghai 201203, Peoples R China; [Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	ShanghaiTech University; Tongji University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, XM; Fan, GP (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Zhu, XM; Zhang, P (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, Shanghai 200433, Peoples R China.; Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	xianminzhu@hotmail.com; zhangpeng1121@aliyun.com; gfan@mednet.ucla.edu	Zhu, Xianmin/M-6437-2017	Zhu, Xianmin/0000-0003-1405-9700; Fan, Guoping/0000-0001-5235-6410; Lu, Ping/0000-0002-0127-3911	National Program on Key Basic Research Project (973 Program) [2015CB964702, 2015CB964601]; National Natural Science Foundation of China [81570521, 81470244, 81622001, 81430026, 91642108, 31871288]; Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality [18140903900, 15140903900]; Fundamental Research Funds for the Central Universities	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Wei Jiang at Genergy Bio-technology (Shanghai) Co., Ltd and Minghui Li at Sinotech Genomics (Shenzhen) Co., Ltd for their contribution in library construction, sequencing and data analysis. The work was supported by National Program on Key Basic Research Project (973 Program 2015CB964702, 2015CB964601); National Natural Science Foundation of China (81570521, 81470244, 81622001, 81430026, 91642108, 31871288); Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality (18140903900, 15140903900); Fundamental Research Funds for the Central Universities (Xianmin Zhu and Peng Zhang).	Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; AlHossiny M, 2016, CANCER RES, V76, P3376, DOI 10.1158/0008-5472.CAN-15-2654; Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Apostolopoulos V, 2015, CELL MOL LIFE SCI, V72, P4475, DOI 10.1007/s00018-015-2014-z; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Bouillez A, 2017, ONCOGENE, V36, P4037, DOI 10.1038/onc.2017.47; Campbell MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079114; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chen HM, 2019, ONCOL REP, V41, P570, DOI 10.3892/or.2018.6807; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Chittezhath M, 2014, IMMUNITY, V41, P815, DOI 10.1016/j.immuni.2014.09.014; Cortot AB, 2014, EUR RESPIR REV, V23, P356, DOI 10.1183/09059180.00004614; Dong PX, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00471; Enfield KSS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13295-y; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Goossens P, 2019, CELL METAB, V29, P1376, DOI 10.1016/j.cmet.2019.02.016; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lanitis E, 2017, ANN ONCOL, V28, P18, DOI 10.1093/annonc/mdx238; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Longoni N, 2013, CANCER RES, V73, P4533, DOI 10.1158/0008-5472.CAN-12-4537; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Milette S, 2019, J PATHOL, V247, P589, DOI 10.1002/path.5241; Min JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135817; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukhtar RA, 2012, ANN SURG ONCOL, V19, P3979, DOI 10.1245/s10434-012-2415-2; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Oliver JR, 2012, LAB INVEST, V92, P320, DOI 10.1038/labinvest.2011.186; Oliver JR, 2011, LAB INVEST, V91, P1514, DOI 10.1038/labinvest.2011.100; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Ozes ON, 1999, NATURE, V401, P82; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Pocha K, 2020, CLIN CANCER RES, V26, P2231, DOI 10.1158/1078-0432.CCR-19-2184; Psallidas I, 2013, ONCOGENE, V32, P528, DOI 10.1038/onc.2012.57; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Seow WJ, 2017, HUM MOL GENET, V26, P454, DOI 10.1093/hmg/ddw414; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2019, CANCERS, V216, P1; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wang H, 2018, INT J BIOCHEM CELL B, V94, P98, DOI 10.1016/j.biocel.2017.12.002; Wang JL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.206; Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zhang L, 2019, ARTIF CELL NANOMED B, V47, P2516, DOI 10.1080/21691401.2019.1626409; Zhang YM, 2014, INFLAMMATION, V37, P1240, DOI 10.1007/s10753-014-9851-z; Zhang Z, 2019, NUCLEIC ACIDS RES, V47, pD8, DOI 10.1093/nar/gky993; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng LB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0399-y; Zheng PM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0465-5	77	52	53	4	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					355	368		10.1038/s41388-020-01528-0	http://dx.doi.org/10.1038/s41388-020-01528-0		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33144684	Green Published, hybrid			2022-12-26	WOS:000585016500001
J	Doi, S; Kawamura, M; Oyama, K; Akamatsu, T; Mizobuchi, M; Oyama, Y; Masuda, T; Kamemura, N				Doi, Sayaka; Kawamura, Mina; Oyama, Keisuke; Akamatsu, Tetsuya; Mizobuchi, Mizuki; Oyama, Yasuo; Masuda, Toshiya; Kamemura, Norio			Bioactivity of alginetin, a caramelization product of pectin: Cytometric analysis of rat thymic lymphocytes using fluorescent probes	PLOS ONE			English	Article							CA2+	Alginetin is the major product formed from pentoses and hexurionic acids. Alginetin is producted by cooking process of food including pection, a naturally-occurring polysacharride found in many plants. However, the biological interaction and toxicity of alginetin are not known at all. The aim of the present study was to investigate the cellular actions of alginetin on rat thymic lymphocytes. The effects of alginetin on the cell were examined using flow cytometry with fluorescent probes. Alginetin increased cellular content of non-protein thiols ([NPT](i)) and elevated intracellular Zn2+ levels ([Zn2+](i)). Chelation of intracellular Zn2+ reduced the effect of alginetin on [NPT](i), and chelation of external Zn2+ almost completely diminished alginetin-induced elevation of [Zn2+](i), indicating that alginetin treatment increased Zn2+ influx. Increased [NPT](i) and [Zn2+](i) levels in response to alginetin were positively correlated. Alginetin protected cells against oxidative stress induced by hydrogen peroxide and Ca2+ overload by calcium ionophore. It is considered that the increases in [NPT](i) and [Zn2+](i) are responsible for the cytoprotective activity of alginetin because NPT attenuates oxidative stress and Zn2+ competes with Ca2+. Alginetin may be produced during manufacturing of jam, which may provide additional health benefits of jam.	[Doi, Sayaka; Masuda, Toshiya] Osaka City Univ, Fac Human Life Sci, Osaka, Osaka, Japan; [Kawamura, Mina; Akamatsu, Tetsuya; Oyama, Yasuo] Tokushima Univ, Fac Biosci & Bioind, Tokushima, Japan; [Oyama, Keisuke] Sakai City Med Ctr, Surg Div, Sakai, Osaka, Japan; [Mizobuchi, Mizuki; Kamemura, Norio] Tokushima Bunri Univ, Fac Life Sci, Dept Food Nutr Sci, Tokushima, Japan	Osaka Metropolitan University; Tokushima University; Tokushima Bunri University	Kamemura, N (corresponding author), Tokushima Bunri Univ, Fac Life Sci, Dept Food Nutr Sci, Tokushima, Japan.	kamemura.norio@tks.bunri-u.ac.jp		Masuda, Toshiya/0000-0001-6691-9464	Japan Society for the Promotion of Science (Tokyo, Japan) [C26340039, 18K14408]	Japan Society for the Promotion of Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Japan Society for the Promotion of Science (Tokyo, Japan) supports this study with Grant-in-Aids for Scientific Research (C26340039, 18K14408).	[Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Aso K, 1953, TOHOKU J AGR RES, V3, P359; Baba Shahid P., 2018, Current Opinion in Toxicology, V7, P133, DOI 10.1016/j.cotox.2018.03.005; Chikahisa L, 1996, JPN J PHARMACOL, V71, P299, DOI 10.1254/jjp.71.299; DEUEL H, 1958, ADV ENZYMOL REL S BI, V20, P341; Gamal-Eldeen AM, 2007, Z NATURFORSCH C, V62, P331; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Ha KN, 2006, INVEST OPHTH VIS SCI, V47, P2709, DOI 10.1167/iovs.05-1322; Kinazaki A, 2011, J PHYSIOL SCI, V61, P403, DOI 10.1007/s12576-011-0160-0; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Okazaki E, 1996, JPN J PHARMACOL, V71, P273, DOI 10.1254/jjp.71.273; Omar SI, 2016, CURR ALZHEIMER RES, V13, P777, DOI 10.2174/1567205013666160310144100; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Ren HT, 2018, J SURG RES, V222, P39, DOI 10.1016/j.jss.2017.09.041; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sakanashi Y, 2009, TOXICOL IN VITRO, V23, P338, DOI 10.1016/j.tiv.2008.12.006	16	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241290	10.1371/journal.pone.0241290	http://dx.doi.org/10.1371/journal.pone.0241290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137129	Green Published, gold			2022-12-26	WOS:000588375500019
J	Gunasekaran, T; Olivier, B; Griffith, L; Sanders, R				Gunasekaran, Tamilselvam; Olivier, Bari; Griffith, Lucas; Sanders, Robert			Comparison of heart rate obtained from shorter duration Holter recordings to 24-hour mean heart rate in dogs with atrial fibrillation	PLOS ONE			English	Article							THERAPY	The objective of this study was to evaluate the accuracy of short duration electrocardiographic (ECG) recordings extracted from ambulatory continuous ECG (Holter) to assess 24-hour mean heart rate in dogs with atrial fibrillation. In this retrospective study, Holter recordings obtained from 20 dogs with atrial fibrillation were selected for analysis. Ten out of 20 dogs were receiving drugs to control heart rate at the time of Holter evaluation. From the Holter recordings, heart rate averages were calculated for various sample durations (five-minutes, 30 minutes, one-hour, two-hours, and three-hours) for each dog. Percentage of these shorter duration ECG obtained HR averages that fell within +/- 10%, +/- 15% and +/- 20% of 24-hour mean heart rate was determined for each sample duration and for each dog. Seventy five percent of heart rate averages obtained from three-hour ECG recordings fell within +/- 10% of 24-hour mean HR. All the heart rate averages obtained from two-hour ECG recordings fell within +/- 20% of 24-hour mean heart rate. Based on the results of this study it can be concluded that the duration of the ECG recording affects the prediction accuracy for 24-hour Holter mean HR. Only two and three hours of Holter recordings provided all heart rate averages within +/- 20% of 24-hour mean heart rate. No significant differences were noted in the prediction accuracy of shorter duration ECG recordings based on rate control therapy status. Further prospective studies are needed to assess the accuracy of HR obtained at home using various ECG recording devices to predict 24-hour mean heart rate in dogs with atrial fibrillation.	[Gunasekaran, Tamilselvam; Olivier, Bari; Sanders, Robert] Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Griffith, Lucas] Iowa State Univ, US DOE, Ames Lab, Ames, IA USA	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Sanders, R (corresponding author), Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	ras@msu.edu		Gunasekaran, Tamilselvam/0000-0002-1861-9122; Griffith, Lucas/0000-0001-9439-2321				Bright JM, 2008, J VET INTERN MED, V22, P114, DOI 10.1111/j.1939-1676.2007.0015.x; Bright Janice M, 2005, J Vet Cardiol, V7, P85, DOI 10.1016/j.jvc.2005.07.003; Brundel Bianca J J M, 2005, J Vet Cardiol, V7, P121, DOI 10.1016/j.jvc.2005.07.001; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Galli A, 2016, ARRHYTH ELECTROPHYSI, V5, P136, DOI 10.15420/AER.2016.17.2; Gelzer AR, 2015, J SMALL ANIM PRACT, V56, P456, DOI 10.1111/jsap.12363; Gelzer ARM, 2009, J VET INTERN MED, V23, P499, DOI 10.1111/j.1939-1676.2009.0301.x; Gelzer ARM, 2004, VET CLIN N AM-SMALL, V34, P1127, DOI 10.1016/j.cvsm.2004.05.001; Glaus TM, 2003, J AM ANIM HOSP ASSOC, V39, P237, DOI 10.5326/0390237; Menaut Pierre, 2005, J Vet Cardiol, V7, P75, DOI 10.1016/j.jvc.2005.07.002; Moise N Sydney, 2005, J Vet Cardiol, V7, P143, DOI 10.1016/j.jvc.2005.09.004; Pariaut R, 2017, VET CLIN N AM-SMALL, V47, P977, DOI 10.1016/j.cvsm.2017.04.002; Pedro B, 2018, J VET INTERN MED, V32, P86, DOI 10.1111/jvim.14896; Sanders RA, 2018, JAVMA-J AM VET MED A, V252, P966, DOI 10.2460/javma.252.8.966; Saunders AB, 2006, J VET INTERN MED, V20, P921, DOI 10.1892/0891-6640(2006)20[921:OATIDW]2.0.CO;2; Uechi M, 2002, J VET MED SCI, V64, P1023, DOI 10.1292/jvms.64.1023; Vezzosi T, 2019, VET REC, V184, DOI 10.1136/vr.104917	17	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241620	10.1371/journal.pone.0241620	http://dx.doi.org/10.1371/journal.pone.0241620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137157	gold, Green Submitted, Green Published			2022-12-26	WOS:000588375500029
J	Liu, SQ; Wang, LY; Guo, C				Liu, Siqi; Wang, Luyao; Guo, Chao			Heavy metal pollution and ecological risk assessment in brownfield soil from Xi'an, China: An integrated analysis of man-land interrelations	PLOS ONE			English	Article							URBAN SOILS; URBANIZATION; CITY; INDUSTRIALIZATION; GROUNDWATER; EMISSIONS	The core of urbanization is land use change, resulting in the urban sprawl and urban population explosion. The problem of land resources shortage and ecological environment destruction has become increasingly prominent. Land use change and human activities can directly lead to urban soil pollution. This study analyzed the concentration of Cd, Cr, Cu, Ni, Pb, Zn, Hg and As in the original site of Xi'an chlor-alkali chemical plant, which was know as a brownfield. The results showed the concentrations of Hg, Pb and Zn in research areas were obviously higher than soil background value. Through pollution index (PI) method and Geo-accumulation Index (I-geo) method, totally 26 sample points in different areas (A, B, C, D) were classified into different pollution degrees. The CPI results indicated 9 sample points were heavily polluted, accounting for 34.6% of the total. Among them, 6 out of 9 were located in area A. 12 samples points were not polluted. The average I-geo values of single heavy metal were arranged in the order of Hg (1.83) > Zn (1.26) > Pb (0.33). The pollution of Hg was relatively serious and extensive, especially in area A. It was mainly because of the historical pollution produced by chemical plant. The pollution of Pb in each point was quite different. Mainly influenced by automobile related activities, I-geo(Pb) in sample point 15 and 16 were all beyond 4.00. The average potential ecological risk (PER) of each area was in the order of A (1428) > B (297) > D (249) > C (163). The ecological risk was mainly determined by previous industrial production and present human activity at the same time. People and land are interdependent and interactive. The understanding on the mechanism of man-land interralations, regarding to urban land use and ecological environment, will promote urban sustainability.	[Liu, Siqi; Wang, Luyao; Guo, Chao] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Peoples R China; [Liu, Siqi; Wang, Luyao; Guo, Chao] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Peoples R China; [Liu, Siqi; Wang, Luyao; Guo, Chao] Minist Nat Resources, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Peoples R China; [Liu, Siqi; Wang, Luyao; Guo, Chao] Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Peoples R China	Ministry of Natural Resources of the People's Republic of China	Liu, SQ (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Peoples R China.; Liu, SQ (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Peoples R China.; Liu, SQ (corresponding author), Minist Nat Resources, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Peoples R China.; Liu, SQ (corresponding author), Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Peoples R China.	liusq0609@163.com		Liu, Siqi/0000-0003-2775-4606				[Anonymous], 2015, J TRANSNATL L POLY, V25, P121; Burakov AE, 2018, ECOTOX ENVIRON SAFE, V148, P702, DOI 10.1016/j.ecoenv.2017.11.034; Chen TB, 2005, CHEMOSPHERE, V60, P542, DOI 10.1016/j.chemosphere.2004.12.072; [方创琳 Fang Chuanglin], 2019, [地理研究, Geographical Research], V38, P13; Gasiorek M, 2017, CHEMOSPHERE, V179, P148, DOI 10.1016/j.chemosphere.2017.03.106; Gmochowska W, 2019, GEOCHEMISTRY-GERMANY, V79, P434, DOI 10.1016/j.chemer.2019.07.002; Green TL, 2018, LAND USE POLICY, V73, P299, DOI 10.1016/j.landusepol.2018.01.008; Guan B.R., 1979, ENV SCI, V4, P67; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; [和莉莉 HE Lili], 2008, [土壤通报, Journal of Soil Science], V39, P1210; Huang GX, 2018, SCI TOTAL ENVIRON, V635, P913, DOI 10.1016/j.scitotenv.2018.04.210; Jiang Jing-kun, 2005, Huan Jing Ke Xue, V26, P34; Kuang B, 2020, HABITAT INT, V100, DOI 10.1016/j.habitatint.2019.102103; Li K, 2015, RENEW SUST ENERG REV, V52, P1107, DOI 10.1016/j.rser.2015.07.185; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Long HL, 2018, LAND USE POLICY, V74, P111, DOI 10.1016/j.landusepol.2017.03.021; Lu XH, 2018, HABITAT INT, V77, P90, DOI 10.1016/j.habitatint.2017.10.007; Lv JS, 2013, J HAZARD MATER, V261, P387, DOI 10.1016/j.jhazmat.2013.07.065; Martinat S, 2016, J CLEAN PROD, V118, P78, DOI 10.1016/j.jclepro.2016.01.029; Megremi I, 2019, SCI TOTAL ENVIRON, V651, P656, DOI 10.1016/j.scitotenv.2018.09.186; Messerli B, 2000, QUATERNARY SCI REV, V19, P459, DOI 10.1016/S0277-3791(99)00075-X; Ministry of Ecology and Environmental of P.R. China Ministry of Natural Resources of P.R. China, 2014, COMM SOIL CONT STAT COMM SOIL CONT STAT; Morton-Bermea O, 2009, J GEOCHEM EXPLOR, V101, P218, DOI 10.1016/j.gexplo.2008.07.002; Rasmussen PE, 2001, SCI TOTAL ENVIRON, V267, P125, DOI 10.1016/S0048-9697(00)00775-0; Ren WX, 2014, LAND USE POLICY, V38, P138, DOI 10.1016/j.landusepol.2013.11.005; Streets DG, 2005, ATMOS ENVIRON, V39, P7789, DOI 10.1016/j.atmosenv.2005.08.029; United States Environmental Protection Agency, 2020, DOES EPAS BROWNF LAN; Wang J, 2018, LAND USE POLICY, V75, P375, DOI 10.1016/j.landusepol.2018.04.011; Wang Y., 2011, THESIS; Wei ZY, 2011, PROCEDIA ENVIRON SCI, V10, P1946, DOI 10.1016/j.proenv.2011.09.305; Xiao Q, 2015, ECOTOX ENVIRON SAFE, V120, P377, DOI 10.1016/j.ecoenv.2015.06.019; [薛志斌 Xue Zhibin], 2018, [中国水土保持科学, Science of Soil and Water Conservation], V16, P119; Yang PG, 2020, CATENA, V190, DOI 10.1016/j.catena.2020.104554; [姚士谋 Yao Shimou], 2014, [地理科学, Scientia Geographica Sinica], V34, P641; Zhang XL, 2020, CITIES, V102, DOI 10.1016/j.cities.2020.102724	35	1	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241398	10.1371/journal.pone.0241398	http://dx.doi.org/10.1371/journal.pone.0241398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YA	33137143	Green Published, gold			2022-12-26	WOS:000588375500045
J	Marques-Sanchez, P; Sanchez, EQ; Liebana-Presa, C; Fernandez-Martinez, E; Garcia-Rodriguez, I; Benitez-Andrades, JA				Marques-Sanchez, Pilar; Quiroga Sanchez, Enedina; Liebana-Presa, Cristina; Fernandez-Martinez, Elena; Garcia-Rodriguez, Isaias; Alberto Benitez-Andrades, Jose			The consumption of alcohol by adolescent schoolchildren: Differences in the triadic relationship pattern between rural and urban environments	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; TRANSITIVITY; DRINKING; TOBACCO	Objective Excessive alcohol consumption in adolescents is one of the most significant public health problems currently facing society. Social and geographical contexts contribute to the development of alcohol-related behavior in adolescents. The aim of this research is to analyze the social pattern related to alcohol consumption in adolescents based on their geographical environment. Methodology We designed a descriptive cross-sectional study based on social network analysis. We recruited 196 high school students between 16 and 18 years of age to participate in the study. The methodology applied was social network analysis by means of transitivity and homophily social triads. The data were analyzed using STATA statistical software. Results and conclusions A total of 58.48% of rural adolescents consumed alcohol compared to 49.52% of urban adolescents. These results demonstrate that adolescents who live in rural areas exhibit a greater risk of drinking alcohol than those who live in urban areas. The presence of transitive triads increases the probability of sharing sociodemographic attributes in such a way that it may be considered one of the causes of homophily, contributing to adolescents taking greater risks, such as consuming alcohol.	[Marques-Sanchez, Pilar; Quiroga Sanchez, Enedina; Liebana-Presa, Cristina; Fernandez-Martinez, Elena] Univ Leon, Fac Hlth Sci, SALBIS Res Grp, Ponferrada, Spain; [Garcia-Rodriguez, Isaias] Univ Leon, Escuela Ingenierias Ind & Informat, SECOMUCI Res Grp, Leon, Spain; [Alberto Benitez-Andrades, Jose] Univ Leon, Dept Elect Syst & Automat Engn, SALBIS Res Grp, Leon, Spain	Universidad de Leon; Universidad de Leon; Universidad de Leon	Sanchez, EQ (corresponding author), Univ Leon, Fac Hlth Sci, SALBIS Res Grp, Ponferrada, Spain.	equis@unileon.es	Benítez Andrades, José Alberto/M-1195-2017; Liebana-Presa, Cristina/O-1771-2017; QUIROGA SÁNCHEZ, ENEDINA/ABE-9443-2021; Fernández-Martínez, Elena/I-8357-2017; García, Isaías/Y-9131-2019	Benítez Andrades, José Alberto/0000-0002-4450-349X; Liebana-Presa, Cristina/0000-0003-1272-3014; Fernández-Martínez, Elena/0000-0002-8582-6631; García, Isaías/0000-0001-5209-8773				Alshamsi A, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0044-2; [Anonymous], 2009, SOCIAL NETWORK ANAL; [Anonymous], 2009, AN PROSP; Arias N, 2017, ADM PUBLICAS COMO SO, P314; Barr PB, 2018, SOC SCI MED, V209, P51, DOI 10.1016/j.socscimed.2018.05.027; BERNARD HR, 1980, SOC NETWORKS, V2, P191, DOI 10.1016/0378-8733(79)90014-5; BISHOP JM, 1979, PAC SOCIOL REV, V22, P185; BLAU PM, 1982, AM SOCIOL REV, V47, P45, DOI 10.2307/2095041; Borgatti SP., 2002, UCINET WINDOWS SOFTW, DOI 10.1111/j.1439-0310.2009.01613.x; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cronk CE, 1997, AM J PUBLIC HEALTH, V87, P760, DOI 10.2105/AJPH.87.5.760; DAVIS JA, 1970, AM SOCIOL REV, V35, P843, DOI 10.2307/2093295; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; Donath C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-84; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erskine-Shaw M, 2017, DRUG ALCOHOL DEPEN, V179, P341, DOI 10.1016/j.drugalcdep.2017.07.032; Heider F, 1958, PSYCHOL INTERPERSONA, P59, DOI 10.1037/10628-000; Institute on Drug Abuse N, I DRUG ABUSE N ALCOH; Instituto Nacional de Estadistica, I NACL ESTADISTICA; Kelly C, 2015, LAND USE POLICY, V46, P11, DOI 10.1016/j.landusepol.2015.01.026; Kiuru N, 2007, J YOUTH ADOLESCENCE, V36, P995, DOI 10.1007/s10964-006-9118-6; Knecht AB, 2011, J RES ADOLESCENCE, V21, P475, DOI 10.1111/j.1532-7795.2010.00685.x; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Komro KA, 2007, ADDICTION, V102, P1597, DOI 10.1111/j.1360-0443.2007.01941.x; Laespada MT, 2004, FACTORES RIESGO PROT; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Louch H, 2000, SOC NETWORKS, V22, P45, DOI 10.1016/S0378-8733(00)00015-0; Lourenco Eduardo, 2014, COLONIALISMO COMO NO, P277; Lozares Carlos., 1996, PAPERS, V48, P103, DOI DOI 10.5565/REV/PAPERS/V48N0.1814; McCabe SE, 2006, J AM COLL HEALTH, V54, P269, DOI 10.3200/JACH.54.5.269-278; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Ministerio de Sanidad C y BS, 2011, C MIN EUR OMS STOCKH; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Obradors-Rial N, 2014, GAC SANIT, V28, P381, DOI 10.1016/j.gaceta.2014.04.004; Pearson M, 2005, CANC DRUG DISC DEV, P1; Pegg KJ, 2018, CYBERPSYCH BEH SOC N, V21, P50, DOI 10.1089/cyber.2016.0665; Sotos JR, 2015, J ADV NURS, V71, P581, DOI 10.1111/jan.12548; Robinson J. M., 1995, J STRENGTH COND RES, V9, P216; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders W., 1992, SCH SCI MATH, V92, P136; Savolainen I, 2020, ALCOHOL ALCOHOLISM, V55, P86, DOI 10.1093/alcalc/agz088; Simmel G., 1950, SOCIOLOGY G SIMMEL; Smith PK, 2008, J CHILD PSYCHOL PSYC, V49, P376, DOI 10.1111/j.1469-7610.2007.01846.x; Sudhinaraset M, 2016, ALCOHOL RES-CURR REV, V38, P35; Teunissen HA, 2016, J ADOLESCENCE, V53, P45, DOI 10.1016/j.adolescence.2016.08.017; Valente TW, 2003, AM J PUBLIC HEALTH, V93, P1837, DOI 10.2105/AJPH.93.11.1837; Valladolid GR, 1998, REV CLIN ESP, V198, P11; Wasserman S., 1994, SOCIAL NETWORK ANAL; WHO, 2019, WORLD HLTH STAT 2019	50	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241135	10.1371/journal.pone.0241135	http://dx.doi.org/10.1371/journal.pone.0241135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YA	33137141	Green Published, gold			2022-12-26	WOS:000588375500021
J	Kanagasabai, U; Singh, A; Shiraishi, RW; Ly, V; Hy, C; Sanith, S; Srun, S; Sansam, S; SopHeap, ST; Liu, YL; Jones, G; Ijeoma, UC; Bock, N; Benech, I; Selenic, D; Drammah, B; Gadde, R; Mili, FD				Kanagasabai, Udhayashankar; Singh, Adarshpal; Shiraishi, Ray W.; Ly, Vanthy; Hy, Chhaily; Sanith, Sou; Srun, Sok; Sansam, Sim; SopHeap, S. Teak; Liu, Yuliang; Jones, Gerald; Ijeoma, Ugonna C.; Bock, Naomi; Benech, Irene; Selenic, Dejana; Drammah, Bakary; Gadde, Renuka; Mili, Fatima D.			Improving injection safety practices of Cambodian healthcare workers through training	PLOS ONE			English	Article							POSTEXPOSURE PROPHYLAXIS; INFECTIONS	Background This study evaluated the impact of a safe injection safety training on healthcare worker (HCW) practice and knowledge following an HIV outbreak in Roka commune, Cambodia. Methods Surveys were conducted at baseline (September 2016) and seven months after a training intervention (March 2018) using the World Health Organization standardized injection practices assessment tool. HCWs were sampled at 15 purposively government health facilities in two provinces. HCWs were observed during injection practices and interviewed by trained experts from Becton-Dickinson and the Ministry of Health Cambodia. The Rao-Scott chi square test was used test for differences between baseline and follow-up. Results We completed 115 observations of practice at baseline and 206 at post-training follow-up. The proportion of patients whose identification was confirmed by HCWs prior to procedure being performed increased from 40.4% to 98% (p <0.0001). The proportion of HCWs who practiced correct hand hygiene increased from 22.0% to 80.6% (p = 0.056) [therapeutic observations] and 17.2% to 63.4% (p = 0.0012) [diagnostic observations]. Immediate disposal of sharps by HCWs decreased from 96.5% to 92.5% (p = 0.0030). Conclusions We found significant improvements in the practice of patient identity confirmation and hand hygiene but not in the immediate disposal of sharps in the post-training intervention. However, findings are not representative of all HCWs in the country. Further pre-service and in-service training and monitoring are necessary to ensure sustained behavior change.	[Kanagasabai, Udhayashankar] CDC, Epidem Intelligence Serv, DGHT, Atlanta, GA 30333 USA; [Singh, Adarshpal; Gadde, Renuka] Becton Dickinson & Co, Franklifn Lakes, NJ USA; [Shiraishi, Ray W.; Liu, Yuliang; Ijeoma, Ugonna C.; Bock, Naomi; Benech, Irene; Selenic, Dejana; Drammah, Bakary; Mili, Fatima D.] CDC, Div Global HIV AIDS & TB, Atlanta, GA 30333 USA; [Ly, Vanthy; Hy, Chhaily] US Ctr Dis Control & Prevent, Phnom Penh, Cambodia; [Sanith, Sou; Srun, Sok; Sansam, Sim] Minist Hlth, Phnom Pehn, Cambodia; [SopHeap, S. Teak] Pursat Prov Hlth Dept, Pursat, Cambodia; [Jones, Gerald] CDC, Div Hlth Informat & Surveillance Epidemiol & Lab, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Becton Dickinson; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kanagasabai, U (corresponding author), CDC, Epidem Intelligence Serv, DGHT, Atlanta, GA 30333 USA.	nqy2@cdc.gov	Kanagasabai, Udhayashankar/AID-9549-2022	Kanagasabai, Udhayashankar/0000-0003-1694-9344; Shiraishi, Ray/0000-0001-7640-0666	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S Centers for Disease Control and Prevention (CDC) [5U2GGH00814]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S Centers for Disease Control and Prevention (CDC)	This publication has been supported [in part] by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S Centers for Disease Control and Prevention (CDC) under the terms as part of Cooperative Agreement number [5U2GGH00814]. The commercial funder provided support in the form of salaries for authors [RG and AS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2013, FLORA FOLIUMII, V8, P8; [Anonymous], 2012, ALRIV, V3, P125; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Centers for Disease Control and Prevention, 2012, PROT PAT PREV HARM F; degli Atti MLC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-466; Diprose P, 2000, BRIT J ANAESTH, V84, P767, DOI 10.1093/oxfordjournals.bja.a013591; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Fan CX, 2012, INT HEALTH, V4, P295, DOI 10.1016/j.inhe.2012.08.002; Frcgp JDH, 2000, HAWTHORNE EFFECTS RE, P65; Girou E., 2002, BMJ-BRIT MED J, V325, P1; Gyawali S, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-3; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hauri AM, 2004, GLOBAL BURDEN DIS AT, P7; Hutin Y, 2005, B ETIN WHO, V81, P491; Ijeoma C. Ugonna, 2018, MORB MORTAL WKLY REP, V67, P135, DOI [10.15585/mmwr.mm6704a6, DOI 10.15585/MMWR.MM6704A6]; Kermode M, 2004, INT J INFECT DIS, V8, P325, DOI 10.1016/j.ijid.2004.03.005; Kosal S, 2015, CAMBODIA DEMOGRAPHIC; Logez S, 2004, AM J INFECT CONTROL, V32, P31, DOI 10.1016/j.ajic.2003.06.006; Mantel C, 2007, TROP MED INT HEALTH, V12, P422, DOI 10.1111/j.1365-3156.2006.01802.x; Marra AR, 2010, POSITIVE DEVIANCE NE; Maury E, 2000, AM J RESP CRIT CARE, V162, P324, DOI 10.1164/ajrccm.162.1.9908118; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Morar MM, 2016, TRANSFUSION, V56, P3121, DOI 10.1111/trf.13816; Pandit NB, 2008, SINGAP MED J, V49, P936; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Rouet F, 2018, CLIN INFECT DIS, V66, P1733, DOI 10.1093/cid/cix1071; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Solomon J, 2006, J IN SERVICE ED, V25, P307; Turner F, 2017, TEACH DEV, V21, P175, DOI 10.1080/13664530.2016.1205508; Varghese GM, 2003, POSTGRAD MED J, V79, P324, DOI 10.1136/pmj.79.932.324; Vun MC, 2016, MMWR-MORBID MORTAL W, V65, P142, DOI 10.15585/mmwr.mm6506a2; Wilburn SQ, 2013, PREVENTING NEEDLESTI, V3525; World Health Organization, 2008, REV INJ SAF ASS TOOL; Yan Youwang, 2006, Indian J Med Sci, V60, P407; Zakar MZ, PRACTICES TRANSMISSI; Zaragoza M, 1999, AM J INFECT CONTROL, V27, P258, DOI 10.1053/ic.1999.v27.a97622	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241176	10.1371/journal.pone.0241176	http://dx.doi.org/10.1371/journal.pone.0241176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33126238	Green Submitted, Green Published, gold			2022-12-26	WOS:000588368900021
J	D'Almeida, OC; Violante, IR; Quendera, B; Moreno, C; Gomes, L; Castelo-Branco, M				D'Almeida, Otilia C.; Violante, Ines R.; Quendera, Bruno; Moreno, Carolina; Gomes, Leonor; Castelo-Branco, Miguel			The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes	PLOS ONE			English	Article							METABOLITE CONCENTRATIONS; INHIBITION BALANCE; GLUCOSE-METABOLISM; HUMAN BRAIN; MELLITUS; LEVEL; NEUROTRANSMITTER; QUANTIFICATION; QUANTITATION; EXCITATION	Glucose metabolism is pivotal for energy and neurotransmitter synthesis and homeostasis, particularly in Glutamate and GABA systems. In turn, the stringent control of inhibitory/excitatory tonus is known to be relevant in neuropsychiatric conditions. Glutamatergic neurotransmission dominates excitatory synaptic functions and is involved in plasticity and excitotoxicity. GABAergic neurochemistry underlies inhibition and predicts impaired psychophysical function in diabetes. It has also been associated with cognitive decline in people with diabetes. Still, the relation between metabolic homeostasis and neurotransmission remains elusive. Two 3T proton MR spectroscopy studies were independently conducted in the occipital cortex to provide insight into inhibitory/excitatory homeostasis (GABA/Glutamate) and to evaluate the impact of chronic metabolic control on the levels and regulation (as assessed by regression slopes) of the two main neurotransmitters of the CNS in type 2 diabetes (T2DM) and type 1 diabetes (T1DM). Compared to controls, participants with T2DM showed significantly lower Glutamate, and also GABA. Nevertheless, higher levels of GABA/Glx (Glutamate+Glutamine), and lower levels of Glutamate were associated with poor metabolic control in participants with T2DM. Importantly, the relationship between GABA/Glx and HbA(1c) found in T2DM supports a relationship between inhibitory/excitatory balance and metabolic control. Interestingly, this neurometabolic profile was undetected in T1DM. In this condition we found strong evidence for alterations in MRS surrogate measures of neuroinflammation (myo-Inositol), positively related to chronic metabolic control. Our results suggest a role for Glutamate as a global marker of T2DM and a sensitive marker of glycemic status. GABA/Glx may provide a signature of cortical metabolic state in poorly controlled patients as assessed by HbA(1c) levels, which indicate long-term blood Glucose control. These findings are consistent with an interplay between abnormal neurotransmission and metabolic control in particular in type 2 diabetes thereby revealing dissimilar contributions to the pathophysiology of neural dysfunction in both types of diabetes.	[D'Almeida, Otilia C.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Coimbra, Portugal; [D'Almeida, Otilia C.; Quendera, Bruno; Castelo-Branco, Miguel] Univ Coimbra, Coimbra Inst Biomed Imaging & Translat Res, Inst Nucl Sci Appl Hlth ICNAS, CiBIT, Coimbra, Portugal; [Violante, Ines R.] Univ Surrey, Sch Psychol, Fac Hlth & Med Sci, Guildford, Surrey, England; [Moreno, Carolina; Gomes, Leonor] Coimbra Univ & Hosp Ctr CHUC, Dept Endocrinol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; University of Surrey; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	D'Almeida, OC; Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Coimbra, Portugal.; D'Almeida, OC; Castelo-Branco, M (corresponding author), Univ Coimbra, Coimbra Inst Biomed Imaging & Translat Res, Inst Nucl Sci Appl Hlth ICNAS, CiBIT, Coimbra, Portugal.	oalmeida@fmed.uc.pt; mcbranco@fmed.uc.pt	d'Almeida, Otília C./AAM-4929-2020; Castelo-Branco, Miguel/F-3866-2019	d'Almeida, Otília C./0000-0003-4849-0507; Castelo-Branco, Miguel/0000-0003-4364-6373	European Society for the Study of Diabetes, EASD-SANOFI, INFARMED [FIS-2015-01_DIA_20150630-173, FCT-UID/4950/2020]; COMPETE, FEDER-, Portuguese Foundation for Science and Technology, BIGDATIMAGE [CENTRO-01-0145-FEDER-000016]; Centro 2020 FEDER, COMPETE, PAC -MEDPERSYST [POCI-01-0145-FEDER-016428]	European Society for the Study of Diabetes, EASD-SANOFI, INFARMED; COMPETE, FEDER-, Portuguese Foundation for Science and Technology, BIGDATIMAGE; Centro 2020 FEDER, COMPETE, PAC -MEDPERSYST	This work was supported by the following grants to MCB: European Society for the Study of Diabetes, EASD-SANOFI, INFARMED, FIS-2015-01_DIA_20150630-173, FCT-UID/4950/2020, COMPETE, FEDER-, Portuguese Foundation for Science and Technology, BIGDATIMAGE, CENTRO-01-0145-FEDER-000016, Centro 2020 FEDER, COMPETE, PAC -MEDPERSYST, POCI-01-0145-FEDER-016428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Andersson JD, 2019, NEUROSCI LETT, V691, P35, DOI 10.1016/j.neulet.2018.08.010; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barbagallo M, 2014, WORLD J DIABETES, V5, P889, DOI 10.4239/wjd.v5.i6.889; Benwell CSY, 2020, NEUROBIOL AGING, V85, P83, DOI 10.1016/j.neurobiolaging.2019.10.004; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Brundel M, 2014, EUR NEUROPSYCHOPHARM, V24, P1967, DOI 10.1016/j.euroneuro.2014.01.023; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; d'Almeida OC, 2018, GRAEF ARCH CLIN EXP, V256, P2341, DOI 10.1007/s00417-018-4153-z; Duarte J.M.N, 2016, DIABETES METAB DISOR, V3, P1, DOI [10.24966/DMD-201X/100011, DOI 10.24966/DMD-201X/100011]; Duarte JV, 2015, J CEREBR BLOOD F MET, V35, P1671, DOI 10.1038/jcbfm.2015.106; Duncan NW, 2014, NEUROSCI BIOBEHAV R, V47, P36, DOI 10.1016/j.neubiorev.2014.07.016; Durst CR, 2015, MAGN RESON IMAGING, V33, P611, DOI 10.1016/j.mri.2015.02.015; Dyke K, 2017, NEUROIMAGE, V152, P360, DOI 10.1016/j.neuroimage.2017.03.011; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Ende G, 2015, NEUROPSYCHOL REV, V25, P315, DOI 10.1007/s11065-015-9295-8; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Fisher SK, 2002, INOSITOL HIGHER INOS, P736, DOI [10.1046/j.1471-4159.2002.01041.x, DOI 10.1046/J.1471-4159.2002.01041.X]; Foss-Feig JH, 2017, BIOL PSYCHIAT, V81, P848, DOI 10.1016/j.biopsych.2017.03.005; Fried PJ, 2019, CLIN NEUROPHYSIOL, V130, P1502, DOI 10.1016/j.clinph.2019.04.721; Fried PJ, 2017, J ALZHEIMERS DIS, V55, P89, DOI 10.3233/JAD-160505; Hajek T, 2015, BIOL PSYCHIAT, V77, P295, DOI 10.1016/j.biopsych.2013.11.007; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Heikkila O, 2009, DIABETOLOGIA, V52, P534, DOI 10.1007/s00125-008-1242-2; Hertz L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00042; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Jensen JE, 2005, NMR BIOMED, V18, P570, DOI 10.1002/nbm.994; KREIS R, 1992, RADIOLOGY, V184, P123, DOI 10.1148/radiology.184.1.1319074; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Makimattila S, 2004, J CEREBR BLOOD F MET, V24, P1393, DOI 10.1097/01.WCB.0000143700.15489.B2; Mangia S, 2013, J CEREBR BLOOD F MET, V33, P754, DOI 10.1038/jcbfm.2013.13; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McCall AL, 2004, EUR J PHARMACOL, V490, P147, DOI 10.1016/j.ejphar.2004.02.052; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mikkelsen M, 2018, BRAIN RES, V1701, P204, DOI 10.1016/j.brainres.2018.09.021; Minati L, 2010, J MED PHYS, V35, P154, DOI 10.4103/0971-6203.62128; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Petrou M, 2012, ACAD RADIOL, V19, P607, DOI 10.1016/j.acra.2012.02.004; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rackayova V, 2017, ANAL BIOCHEM, V529, P144, DOI 10.1016/j.ab.2016.11.007; Ribeiro MJ, 2015, CORTEX, V64, P194, DOI 10.1016/j.cortex.2014.10.019; Sahin I, 2008, J DIABETES COMPLICAT, V22, P254, DOI 10.1016/j.jdiacomp.2007.03.007; Sanches M, 2017, METAB BRAIN DIS, V32, P913, DOI 10.1007/s11011-017-9986-3; Seaquist ER, 2015, PSYCHOSOM MED, V77, P616, DOI 10.1097/PSY.0000000000000207; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sinha Sanjeev, 2014, BMC Res Notes, V7, P41, DOI 10.1186/1756-0500-7-41; Skyler J.S., 2004, CLIN DIABETES, V22, P162, DOI [10.2337/diaclin.22.4.162, DOI 10.2337/DIACLIN.22.4.162]; van Bussel FCG, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004803; Violante IR, 2013, BRAIN, V136, P918, DOI 10.1093/brain/aws368; Waagepetersen HS, 1999, J NEUROCHEM, V73, P1335, DOI 10.1046/j.1471-4159.1999.0731335.x; Wiegers EC, 2019, DIABETOLOGIA, V62, P1065, DOI 10.1007/s00125-019-4862-9; Yasen AL, 2017, NEUROSCI LETT, V643, P121, DOI 10.1016/j.neulet.2017.02.039; Zhao X, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180660; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	57	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240907	10.1371/journal.pone.0240907	http://dx.doi.org/10.1371/journal.pone.0240907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33120406	Green Published, gold			2022-12-26	WOS:000600013600085
J	Gao, ZL; van der Velden, YU; Fan, MH; van der Linden, CA; Vink, M; Herrera-Carrillo, E; Berkhout, B				Gao, Zongliang; van der Velden, Yme Ubeles; Fan, Minghui; van der Linden, Cynthia Alyssa; Vink, Monique; Herrera-Carrillo, Elena; Berkhout, Ben			Engineered miniature H1 promoters with dedicated RNA polymerase II or III activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; TRANSCRIPTION; INTERFERENCE; MULTIPLE	RNA polymerase III (Pol III) promoters, such as 7SK, U6, and H1, are widely used for the expression of small noncoding RNAs, including short hairpin RNAs for RNAi experiments and guide RNAs for CRISPR-mediated genome editing. We previously reported dual RNA polymerase activity (Pol II/III) for the human H1 promoter and demonstrated that this promiscuous RNA polymerase use can be exploited for the simultaneous expression of both a noncoding RNA and an mRNA. However, this combination is not a desired feature in other experimental and therapeutic settings. To overcome this limitation of the H1 promoter, we engineered a miniature H1/7SK hybrid promoter with minimal Pol II activity, thereby boosting Pol III activity to a level that is higher than that of either parental promoter. In parallel, we also engineered small Pol II-specific H1 promoter variants and explored their use as general Pol II promoters for protein expression. The newly engineered promoter variants form an attractive alternative to the commonly used H1 promoter in terms of not only activity and small promoter size but also concerning safety by exclusive expression of the desired therapeutic transcript (either pol II or pol III but not both).	[Gao, Zongliang; van der Velden, Yme Ubeles; Fan, Minghui; van der Linden, Cynthia Alyssa; Vink, Monique; Herrera-Carrillo, Elena; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Amsterdam UMC, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands; [Gao, Zongliang] Aarhus Univ, Dept Biomed, Aarhus, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University	Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam UMC, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands.	b.berkhout@amsterdamumc.nl	Bak, Rasmu/GLT-3180-2022; 范, 明惠/GYK-2093-2022	Bak, Rasmu/0000-0002-8257-8986; 范, 明惠/0000-0002-2236-5479; Herrera Carrillo, Elena/0000-0001-9986-8552	National Institutes of Health [1R01AI145045IH]; AIDS Fonds grant [HIV-P-37102]; King Baudouin Foundation; China Scholarship Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fonds grant; King Baudouin Foundation; China Scholarship Council(China Scholarship Council)	This research was supported by National Institutes of Health (RO1 grant: 1R01AI145045IH to B. B., E. H.-C.), AIDS Fonds grant (HIV-P-37102 to E. H.-C.) and King Baudouin Foundation (to B. B.). Z. G. and M. F. are supported by a scholarship from the China Scholarship Council.	BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Dergai O, 2019, TRENDS GENET, V35, P457, DOI 10.1016/j.tig.2019.04.001; Domitrovich AM, 2003, NUCLEIC ACIDS RES, V31, P2344, DOI 10.1093/nar/gkg331; Even DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148918; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Gao ZL, 2019, MOL THER-NUCL ACIDS, V14, P32, DOI 10.1016/j.omtn.2018.10.016; Gao ZL, 2018, MOL THER-NUCL ACIDS, V12, P135, DOI 10.1016/j.omtn.2018.05.001; Gao ZL, 2018, MOL THER-NUCL ACIDS, V10, P36, DOI 10.1016/j.omtn.2017.11.006; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903; Herzog RW, 2004, SEMIN THROMB HEMOST, V30, P215, DOI 10.1055/s-2004-825635; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Ni W, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue2-fulltext-10; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Zaldumbide A, 2008, GENE THER, V15, P239, DOI 10.1038/sj.gt.3303082	21	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100026	10.1074/jbc.RA120.015386	http://dx.doi.org/10.1074/jbc.RA120.015386			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33154168	Green Published, gold			2022-12-26	WOS:000672866400011
J	Sheweita, SA; Meftah, AA; Sheweita, MS; Balbaa, ME				Sheweita, Salah A.; Meftah, Amal A.; Sheweita, Mohamed S.; Balbaa, Mahmoud E.			Erectile dysfunction drugs altered the activities of antioxidant enzymes, oxidative stress and the protein expressions of some cytochrome P-450 isozymes involved in the steroidogenesis of steroid hormones	PLOS ONE			English	Article							SILDENAFIL CITRATE; SUPEROXIDE-DISMUTASE; IMPACT; RATS; PURIFICATION; INFERTILITY; THERAPY; MARKERS; BLOOD; LIVER	Objectives Infertility is a global health problem with about 15 percent of couples involved. About half of the cases of infertility are related to male-related factors. A major cause of infertility in men is oxidative stress, which refers to an imbalance between levels of reactive oxygen species (ROS) and antioxidants. Erectile dysfunction drugs (EDD), known as phosphodiesterase inhibitors (PDEIs), have been used for the treatment of ED. It has been shown that oxidative stress plays an important role in the progression of erectile dysfunction. Oxidative stress can be alleviated or decreased by non-antioxidants and antioxidant enzymes. The present study was undertaken to determine if these compounds could have a role in the incidence of infertility, especially after long-term use. Therefore, the present study aims to investigate the effect of EDD on the activities of antioxidant enzymes, free radical levels as well as the protein expression of different cytochrome P-450 isozymes involved in the steroidogenesis of different hormones. In addition, the activity of both 17 beta-hydroxysteroid dehydrogenase and 17-ketosteroid reductase were assayed. The architectures of both livers and testes cells were investigated under the influence of EDD. Methods A daily dose of Sildenafil (1.48 mg/kg), Tadalafil (0.285 mg/kg) and Vardenafil (0.285 mg/kg) were administered orally to male rabbits for 12 week. Western immunoblotting, ELISA, spectrophotometric and histopathological techniques were used in this study. Results The present study showed that Sildenafil, Vardenafil, and Tadalafil treatments significantly decreased the levels of glutathione and free radicals in both livers and testes of rabbits. Also, Vardenafil and Sildenafil induced the activity of superoxide dismutase and catalase whereas, glutathione S-transferase, glutathione reductase, and glutathione peroxidase activities inhibited in livers of rabbits. The protein expression of cytochrome P-450 isozymes (CYP 11A1, 21A2, and 19C) which are involved in the steroidogenesis was markedly changed in both livers and testes of rabbits after their treatments for 12 weeks. After the treatment of rabbits with these medication, the protein expression of CYP11A1 was slightly down-regulated in both livers and testes except Sildenafil up-regulated such protein expression. In addition, the protein expressions of CYP11A1 and CYP 19C in both livers and testes were down-regulated after treatment of rabbits with Sildenafil, Vardenafil, and Tadalafil for 12 weeks. Also, these drugs inhibited the activity of both 17 beta-hydroxysteroid dehydrogenase and 17-ketosteroid reductase in testes of rabbits. Moreover, Sildenafil, Vardenafil, and Tadalafil-treated rabbits showed a decrease in spermatocytes and the number of sperms in the testes. Conclusions It is concluded that ED drugs induced the activities of both SOD and catalase which consequently decreased MDA level. Decrement in MDA levels and oxidative stress could therefore sustain the erection for a long period of time. On the other hand, it is not advised to use these drugs for a long-term since the protein expressions of CYP isozymes involved in steroidogenesis as well as the numbers of spermatocytes in testes were decreased.	[Sheweita, Salah A.] King Khalid Univ, Fac Med, Dept Clin Biochem, Abha, Saudi Arabia; [Sheweita, Salah A.; Meftah, Amal A.] Alexandria Univ, Dept Biotechnol, Alexandria, Egypt; [Sheweita, Mohamed S.] Alexandria Univ, Alexandria Main Hosp, Dept Urol, Alexandria, Egypt; [Balbaa, Mahmoud E.] Alexandria Univ, Fac Sci, Dept Biochem, Alexandria, Egypt	King Khalid University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Sheweita, SA (corresponding author), King Khalid Univ, Fac Med, Dept Clin Biochem, Abha, Saudi Arabia.; Sheweita, SA (corresponding author), Alexandria Univ, Dept Biotechnol, Alexandria, Egypt.	ssheweita@yahoo.com	Sheweita, Salah A/AFU-1622-2022	Sheweita, Salah A/0000-0001-8113-4403				Ameli M, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13068; Andersson S, 1996, J CLIN ENDOCR METAB, V81, P130, DOI 10.1210/jc.81.1.130; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Azzouni F, 2011, J SEX MED, V8, P2894, DOI 10.1111/j.1743-6109.2011.02382.x; Behr-Roussel D, 2008, AM J HYPERTENS, V21, P1258, DOI 10.1038/ajh.2008.273; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; BOGOVICH K, 1980, J BIOL CHEM, V255, P5552; Castela A, 2015, J DIABETES, V7, P393, DOI 10.1111/1753-0407.12181; Chakraborty P., 2009, J CANC MOL, V4, P183; Chandra AK, 2013, INDIAN J EXP BIOL, V51, P37; CHIU DTY, 1976, BIOCHIM BIOPHYS ACTA, V445, P558, DOI 10.1016/0005-2744(76)90110-8; De Young L, 2004, J ANDROL, V25, P830; Deng W, 2010, METHODS MOL BIOL, V610, P213, DOI 10.1007/978-1-60327-029-8_13; Drury R, 1980, HISTOLOGICAL TECHNIQ, V5th; Dutta S, 2019, ARAB J UROL, V17, P87, DOI 10.1080/2090598X.2019.1599624; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P257, DOI 10.1271/bbb.110568; Fernandes MAS, 2008, MOL CELL BIOCHEM, V309, P77, DOI 10.1007/s11010-007-9645-9; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Gul S, 2010, J CLIN NEUROSCI, V17, P1038, DOI 10.1016/j.jocn.2010.02.001; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; Hirata H, 2009, J UROLOGY, V182, P2518, DOI 10.1016/j.juro.2009.07.009; Jannini EA, 2012, J SEX MED, V9, P26, DOI 10.1111/j.1743-6109.2011.02611.x; Jarvi K, 2008, J UROLOGY, V179, P1060, DOI 10.1016/j.juro.2007.10.077; Katryna B, 1980, BIOL CHEM, P255; Kelso GF, 2012, CHEM BIOL, V19, P1237, DOI 10.1016/j.chembiol.2012.08.005; Kim Ji Hoon, 2013, Korean J Thorac Cardiovasc Surg, V46, P14, DOI 10.5090/kjtcs.2013.46.1.14; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1981, J BIOL CHEM, V256, P8110; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Meseguer Marcos, 2007, Drug Metab Lett, V1, P121, DOI 10.2174/187231207780363633; Milara J, 2010, EUR J PHARM SCI, V39, P363, DOI 10.1016/j.ejps.2010.01.005; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Morano S, 2007, EUR UROL, V52, P1768, DOI 10.1016/j.eururo.2007.04.042; Noss MB, 1999, DRUG TODAY, V35, P211, DOI 10.1358/dot.1999.35.3.533850; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Pentyala S., 2011, INT J MED MED SCI, V3, P22; Mesquita JFP, 2012, CLINICS, V67, P181, DOI 10.6061/clinics/2012(02)15; Perk H, 2008, J CLIN PHARM THER, V33, P635, DOI 10.1111/j.1365-2710.2008.00962.x; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; SANTNER SJ, 1981, CLIN CHEM, V27, P1892; Sheweita SA, 2017, ENVIRON TOXICOL, V32, P2212, DOI 10.1002/tox.22436; Sheweita SA, 2005, CURR DRUG METAB, V6, P495, DOI 10.2174/138920005774330594; Sheweita S, 2015, TOXICOL REP, V2, P933, DOI 10.1016/j.toxrep.2015.06.002; Sheweita SA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4970906; Shukla N, 2009, BJU INT, V103, P1522, DOI 10.1111/j.1464-410X.2009.08415.x; Smits RM, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007411.pub4; STOCCO DM, 1991, ENDOCRINOLOGY, V128, P1918, DOI 10.1210/endo-128-4-1918; SUOJANEN JN, 1980, BIOCHIM BIOPHYS ACTA, V630, P485, DOI 10.1016/0304-4165(80)90003-3; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P333, DOI 10.1016/0003-9861(59)90259-0; Terai T, 2007, CHEM BIOL, V14, P877, DOI 10.1016/j.chembiol.2007.08.002; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uzun H, 2008, WORLD J SURG, V32, P2107, DOI 10.1007/s00268-008-9661-2; Vicari E, 2010, J SEX MED, V7, P1247, DOI 10.1111/j.1743-6109.2009.01420.x; Zablocka A, 2008, POSTEP HIG MED DOSW, V62, P118	58	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241509	10.1371/journal.pone.0241509	http://dx.doi.org/10.1371/journal.pone.0241509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166302	Green Published, gold			2022-12-26	WOS:000592382600081
J	Adams, AJ; Pessier, A; Cranston, P; Grasso, RL				Adams, Andrea J.; Pessier, Allan; Cranston, Peggy; Grasso, Robert L.			Chytridiomycosis-induced mortality in a threatened anuran	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; EMERGING INFECTIOUS-DISEASE; NORTH-AMERICAN BULLFROG; RANA-DRAYTONII; SIERRA-NEVADA; LEGGED FROG; POPULATION DECLINES; AMPHIBIAN DECLINES; CALIFORNIA; PATHOGEN	Effectively planning conservation introductions involves assessing the suitability of both donor and recipient populations, including the landscape of disease risk. Chytridiomycosis, caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), has caused extensive amphibian declines globally and may hamper reintroduction attempts. To determine Bd dynamics in potential source populations for conservation translocations of the threatened California red-legged frog (Rana draytonii) to Yosemite National Park, we conducted Bd sampling in two populations in the foothills of the Sierra Nevada Mountains, California, U.S.A. At one of two sites, we observed lethally high Bd loads in early post-metamorphic life stages and confirmed one chytridiomycosis-induced mortality, the first such report for this species. These results informed source population site selection for subsequent R. draytonii conservation translocations. Conservation efforts aimed at establishing new populations of R. draytonii in a landscape where Bd is ubiquitous can benefit from an improved understanding of risk through disease monitoring and ex situ infection studies.	[Adams, Andrea J.; Grasso, Robert L.] Yosemite Natl Pk, El Portal, CA 95389 USA; [Adams, Andrea J.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Pessier, Allan] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Cranston, Peggy] US Bur Land Management, Mother Lode Field Off, Fair Oaks, CA USA	University of California System; University of California Santa Barbara; Washington State University	Adams, AJ (corresponding author), Yosemite Natl Pk, El Portal, CA 95389 USA.; Adams, AJ (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	andreajoyadams@gmail.com	Adams, Andrea/AAH-3580-2021	Adams, Andrea/0000-0001-5609-6150	Dorrance Family Foundation via the Park's nonprofit partner, Yosemite Conservancy	Dorrance Family Foundation via the Park's nonprofit partner, Yosemite Conservancy	Robert L. Grasso, Aquatic Ecologist at Yosemite National Park, received generous funding for this work from The Dorrance Family Foundation (http://dorrancefamilyfoundation.org/) via the Park's nonprofit partner, Yosemite Conservancy (https://yosemite.org/). Funders did not play a role in the design of the study, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abu Bakar A, 2016, OECOLOGIA, V181, P997, DOI 10.1007/s00442-016-3607-4; Adams AJ, TREAT NOT TREA UNPUB; Adams AJ, 2017, ECOL EVOL, V7, P10216, DOI 10.1002/ece3.3468; Adams AJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1740; Adams AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135389; Adams Michael J., 2007, V2, P679; Alvarez Jeff A., 2013, Herpetological Review, V44, P126; American River Conservancy, 1999, FIN REP HAB ACQ REST; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], **NON-TRADITIONAL**; Barry SJ, 2013, HERPETOL CONSERV BIO, V8, P456; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; Brannelly LA, 2016, ANIM CONSERV, V19, P153, DOI 10.1111/acv.12230; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Byrne AQ, 2019, P NATL ACAD SCI USA, V116, P20382, DOI 10.1073/pnas.1908289116; Collins J.P., 2009, EXTINCTION OUR TIMES; Davidson C, 2002, CONSERV BIOL, V16, P1588, DOI 10.1046/j.1523-1739.2002.01030.x; Drost C, 1994, DECLINE FROG SPECIES; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fellers GM, 2011, HERPETOL CONSERV BIO, V6, P383; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Flynn LM, 2017, NORTHWEST SCI, V91, P244, DOI 10.3955/046.091.0305; Flynn LM, 2017, NW SCI, V91, P13; Fuller TE, 2011, RESTOR ECOL, V19, P204, DOI 10.1111/j.1526-100X.2010.00708.x; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Green DE, 2001, J HERPETOL, V35, P92, DOI 10.2307/1566028; IUCN, 2013, GUID REINTR OTH CONS; Jani A. J, 2017, P ROYAL SOC BIOL SCI, V284, P1857; Jennings M. R., 1994, AMPHIBIAN REPTILE SP; JENNINGS MR, 1985, HERPETOLOGICA, V41, P94; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Joseph MB, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2499; Kahle D, 2013, GGMAP PACKAGE SPATIA; Kamoroff C, 2020, BIOL INVASIONS, V22, P617, DOI 10.1007/s10530-019-02116-4; Karlstrom EL, 1962, TOAD GENUS BUFO SIER; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Knapp RA, 2000, CONSERV BIOL, V14, P428, DOI 10.1046/j.1523-1739.2000.99099.x; Knapp RA, 2016, P NATL ACAD SCI USA, V113, P11889, DOI 10.1073/pnas.1600983113; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kupferberg SJ, 1997, ECOLOGY, V78, P1736; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; Lawrence DJ, 2011, CONSERV LETT, V4, P364, DOI 10.1111/j.1755-263X.2011.00185.x; McFadden Michael, 2010, P77; Miaud C, 2016, BIOL INVASIONS, V18, P2299, DOI 10.1007/s10530-016-1161-y; MOYLE PB, 1973, COPEIA, P18; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Padgett-Flohr GE., 2009, THESIS; Padgett-Flohr GE, 2008, HERPETOL CONSERV BIO, V3, P182; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Peralta-Garcia A, 2018, DIS AQUAT ORGAN, V127, P193, DOI 10.3354/dao03202; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Petrovan SO, 2019, BIOL CONSERV, V236, P252, DOI 10.1016/j.biocon.2019.05.023; Piovia-Scott J, 2015, ISME J, V9, P1570, DOI 10.1038/ismej.2014.241; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; RCore Team, 2020, R LANG ENV STAT COMP; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2014, BIOL CONSERV, V172, P128, DOI 10.1016/j.biocon.2014.02.026; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Russell RE, 2019, BIOL CONSERV, V236, P296, DOI 10.1016/j.biocon.2019.05.017; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Savage AE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3115; Savage AE, 2015, EVOL APPL, V8, P560, DOI 10.1111/eva.12264; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Storer T. I., 1925, University of California Publications in Zoology, V27, P1; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tatarian Patricia, 2010, Herpetological Review, V41, P325; *US FISH WILDL SER, 2002, REC PLAN CAL RED LEG; Waddle AW, 2019, ECOHEALTH, V16, P701, DOI 10.1007/s10393-019-01446-y; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Yuan ZY, 2016, SYST BIOL, V65, P824, DOI 10.1093/sysbio/syw055	80	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241119	10.1371/journal.pone.0241119	http://dx.doi.org/10.1371/journal.pone.0241119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156870	Green Published, gold			2022-12-26	WOS:000591376400011
J	Dorji, T; Tshering, T; Wangdi, K				Dorji, Thinley; Tshering, Tandin; Wangdi, Kinley			Assessment of knowledge, attitude and practice on tuberculosis among teacher trainees of Samtse College of Education, Bhutan	PLOS ONE			English	Article							AWARENESS; STUDENTS; OUTBREAK; COUGH; RISK	Background Tuberculosis (TB) is a major public health problem in Bhutan despite the implementation of directly observed treatment short-course since 1997. This study aimed to assess the knowledge, attitude and practice on TB among the teacher trainees of Samtse College of Education. Methodology A cross-sectional study was conducted among the teacher trainees of Samtse College of Education. A standardized pretested questionnaire was distributed and self-administered. The participants were selected randomly using randomization. The data was entered in Epi-data 4.4.2.1 and analysed using STATA version 13. A score of 1 point for a correct answer and 0 for wrong/don't know answer was given. The knowledge, attitude and practice score were divided into good and poor based on 50% cut off. Logistic regression was used for the analysis to identify the significant covariates. Results A total of 420 trainees responded to the survey questionnaire. The average knowledge score on TB was 10.7 (Range = 0-21). Two hundred and forty respondents (58.6%) had low knowledge (mean score 7.8 +/- 2.5) on TB. Cough, chest pain and weight loss were correctly reported as the symptoms of TB by 306 (72.9%), 187(44.5%) and 187 (44.5%) participants. Eighty-nine-point five percent (376) of participants reported coughing as the main route of TB transmission and 85% (357) of the participants said that it could be prevented by covering the mouth while coughing. In multivariable analysis; the trainees in the junior years of college had good knowledge of TB compared with the senior years (adjusted odds ratio [AOR] 2.02; 95% confidence interval [CI] 1.18-3.5; p-value 0.011). Respondents previously treated for TB were more likely to have good knowledge on TB compared to those who never had TB in the past (AOR 2.39; 95% CI 1.07-5.31; p-value 0.033). The majority (93%) of respondents had a good attitude towards TB cases. Female trainees were 2.4 (95% CI 1.02-5.62; p-value 0.045) times more likely than male trainees to have a positive attitude towards TB. Eighty-eight percent of the respondents reported that they would visit the hospital if they had TB symptoms. The mean score for the practice on TB was 1.33 +/- 0.59 (Range:0-2). Conclusion In this study, the majority of the trainees had poor knowledge on TB, especially among the trainees in senior years of college and those who had never suffered from TB. The attitude towards TB was good especially among the female trainees. However, the overall practice was poor among the participants. Therefore, the Ministry of Health should collaborate with relevant stakeholders especially the Ministry of Education to incorporate topics on TB in the syllabus of students and colleges to create awareness on it.	[Dorji, Thinley] Kanglung Hosp, Trashigang, Bhutan; [Tshering, Tandin] Samtse Coll Educ, Samtse, Bhutan; [Wangdi, Kinley] Australian Natl Univ, Dept Global Hlth, Res Sch Populat Hlth, Coll Hlth & Med, Canberra, ACT, Australia	Australian National University	Dorji, T (corresponding author), Kanglung Hosp, Trashigang, Bhutan.	thinleydorji2005@gmail.com		Dorji, Thinley/0000-0001-8664-3178; Wangdi, Dr Kinley/0000-0002-8857-2665				[Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2015, ILLAPA, V12, P13; [Anonymous], 2019, DIABETES PREVALENCE; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2019, PREVALENCE HIV TOTAL; ARIANO E, 1994, EPIDEMIOL INFECT, V113, P83, DOI 10.1017/S0950268800051499; Bati J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-734; Bruce MG, 2001, JAMA-J AM MED ASSOC, V286, P688, DOI 10.1001/jama.286.6.688; Cardoso MA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3974651; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Choi Yun, 2018, Osong Public Health Res Perspect, V9, P269, DOI 10.24171/j.phrp.2018.9.5.09; Correspondent, 2011, ASIANSENTINEL   0216; Datiko DG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224196; Dendup T, 2013, PUBLIC HEALTH ACTION, V3, P11, DOI 10.5588/pha.12.0091; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Esmael A, 2013, AM J TROP MED HYG, V88, P785, DOI 10.4269/ajtmh.12-0312; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Khalid FA, 2013, SUDAN J MED SCI, V8, P5; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Laygoi M, 2011, SAARC J TUBERCULOSIS, V8, P36; Luba TR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3688-x; Ministry of Health, 2020, ANN HLTH B THIMPH; Moonan PK, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001135; Onyeonoro UU, 2014, J INFECT DIS IMMUN, V6, P1, DOI [10.5897/jidi2011.0020, DOI 10.5897/JIDI2011.0020]; Organization WH, 2020, US HIGH BURD COUNTR; Patterson B, 2019, TUBERCULOSIS, V117, P31, DOI 10.1016/j.tube.2019.05.003; Rana M, 2015, BMC PUBLIC HEALTH, V15, P1; Rifat M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008273; Rosen MJ, 2006, CHEST, V129, p197S, DOI 10.1378/chest.129.1_suppl.197S; Sharma N, 2007, ASIA-PAC J PUBLIC HE, V19, P10, DOI 10.1177/10105395070190020301; Stein-Zamir C, 2006, EUR RESPIR J, V28, P986, DOI 10.1183/09031936.06.00002506; Tolossa D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-804; Wangchuk LZ, 2013, INT J TUBERC LUNG D, V17, P468, DOI 10.5588/ijtld.12.0668; Wangdi Kinley, 2012, BMC Res Notes, V5, P311, DOI 10.1186/1756-0500-5-311; WHO, 2017, GLOB TUB REP 2017; Wolde Deneke, 2017, Int J Bacteriol, V2017, P9840670, DOI 10.1155/2017/9840670; Wondawek TM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7886-7; World Bank, SEC INT SERV PER 1 M; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, TUB FACTSH 2019; World Health Organization, 2007, NAT TUB CONTR PROGR; World Health Organization (WHO) Stop TB Partnership, 2008, ADVOCACY COMMUNICATI; Zafar NA, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0014-y; Zhao Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003454; 2008, EFSA J, V6	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241923	10.1371/journal.pone.0241923	http://dx.doi.org/10.1371/journal.pone.0241923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156845	gold, Green Published			2022-12-26	WOS:000591376400027
J	Hussain, I; Majeed, A; Saeed, H; Hashmi, FK; Imran, I; Akbar, M; Chaudhry, MO; Rasool, MF				Hussain, Iltaf; Majeed, Abdul; Saeed, Hamid; Hashmi, Furqan K.; Imran, Imran; Akbar, Muqarrab; Chaudhry, Muhammad O.; Rasool, Muhammad Fawad			A national study to assess pharmacists' preparedness against COVID-19 during its rapid rise period in Pakistan	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES	To evaluate the pharmacist's preparedness against the COVID-19 during its rapid rise period in Pakistan, an online cross-sectional study was carried out from March 30 to May 22, 2020 among the pharmacists using a pre-validated self-administered questionnaire. A total of 1149 participants completed the survey, amongst which 430(37.9%) were working as retail pharmacists, 216 (18.8%) as community pharmacists, and 213(18.5%) as hospital pharmacists. The mean COVID-19 knowledge score of the participants was 6.77 +/- 0.5, which indicated that 84% of them had good knowledge about COVID-19. The multiple linear regression model revealed that attitude was significantly associated with gender (p = 0.001), marital status (p<0.0001) and resident (p = 0.013). The mean practice score was 2.85 +/- 0.4, showing that 94% of the participants were following adequate preventive practices against this infection. The results from this study suggest that Pharmacists demonstrated good knowledge, positive attitudes, and acceptable practices regarding COVID-19.	[Hussain, Iltaf; Majeed, Abdul; Rasool, Muhammad Fawad] Bahauddin Zakariya Univ, Dept Pharm Practice, Fac Pharm, Multan, Pakistan; [Saeed, Hamid; Hashmi, Furqan K.] Univ Punjab, Univ Coll Pharm, Allama Iqbal Campus, Lahore, Pakistan; [Imran, Imran] Bahauddin Zakariya Univ, Dept Pharmacol, Fac Pharm, Multan, Pakistan; [Akbar, Muqarrab] Bahauddin Zakariya Univ, Dept Polit Sci, Multan, Pakistan; [Chaudhry, Muhammad O.] Bahauddin Zakariya Univ, Sch Econ, Multan, Pakistan	Bahauddin Zakariya University; University of Punjab; Bahauddin Zakariya University; Bahauddin Zakariya University; Bahauddin Zakariya University	Rasool, MF (corresponding author), Bahauddin Zakariya Univ, Dept Pharm Practice, Fac Pharm, Multan, Pakistan.	fawadrasool@bzu.edu.pk	Chaudhry, Omer Muhammad/L-4380-2016; Rasool, Muhammad Fawad/I-6610-2013; Hussain, Iltaf/AAY-5508-2020; Imran, Imran/AAL-5734-2020; Hussain, Iltaf/GNM-9382-2022	Rasool, Muhammad Fawad/0000-0002-8607-8583; Hussain, Iltaf/0000-0003-0556-0181; Imran, Imran/0000-0003-1337-8574; Hussain, Iltaf/0000-0002-2989-8809				Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; Alzoubi H, 2020, FRONT PUBLIC HEALTH, V8, P253, DOI [10.3389/fpubh.2020.00253, DOI 10.3389/FPUBH.2020.00253]; Atif M, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00240-4; Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015; CDC, 2020, CPR COVID 19; Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008; Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798; Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814; Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848; Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Tachfouti N, 2012, PAN AFR MED J, V12; Ung COL, 2020, RES SOC ADMIN PHARM, V16, P583, DOI 10.1016/j.sapharm.2020.02.003; WHO, 2020, COR DIS COVID 19 PAN; Zegarra-Valdivia J, 2020, PREPRINT; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	17	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241467	10.1371/journal.pone.0241467	http://dx.doi.org/10.1371/journal.pone.0241467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151984	Green Published, gold			2022-12-26	WOS:000591376200040
J	Traverson, M; Stewart, CE; Papich, MG				Traverson, Marine; Stewart, Connor E.; Papich, Mark G.			Evaluation of bioabsorbable calcium sulfate hemihydrate beads for local delivery of carboplatin	PLOS ONE			English	Article							PHASE-I EVALUATION; CELL CARCINOMA; VITRO; PLATINUM; ELUTION; GENTAMICIN; EXCISION; RELEASE; FLUID; LINES	The objectives of this study were to evaluate a novel kit of resorbable calcium sulfate beads marketed specifically for use in veterinary medicine and generally used for local delivery of antimicrobials as carboplatin-delivery system. The study characterized the elution of carboplatin in vitro, and investigated whether the initial dose and formulation of carboplatin, or the bead size significantly influences carboplatin elution in vitro. Calcium sulfate hemihydrate beads of 3- and 5-mm diameter were prepared. Five doses and two formulations of carboplatin (20, 50, 100, and 500 mg carboplatin per kit in powder formulation; 20 mg in liquid formulation) were tested in triplicates for each diameter beads. Beads were placed in 37 degrees C phosphate buffered saline for 72 hours. Carboplatin concentrations in the eluent were measured by high-performance liquid chromatography at 11 time points with a modified United States Pharmacopeia assay. Concentrations of carboplatin in the eluent proportionally increased with the initial dose and peaked between 13 and 52 hours, ranging from 42.1% to 79.3% of the incorporated load. Higher peak concentrations, percentages released, and elution rates were observed with the liquid formulation and with higher carboplatin doses. There was no significant difference in maximum carboplatin concentrations between 3- and 5-mm diameter beads, but 5-mm diameter beads had slower elution rates. The novel kit can be used for preparation of carboplatin-impregnated resorbable calcium sulfate beads at variable doses, sizes and formulations. Further study is warranted to define the in vivo requirements and effective carboplatin dose, spatial diffusion and desired duration of elution.	[Traverson, Marine] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Stewart, Connor E.] North Carolina State Univ, Coll Sci, Dept Biol Sci, Raleigh, NC USA; [Papich, Mark G.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Traverson, M (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.	matraver@ncsu.edu		Papich, Mark/0000-0002-7591-7898; Stewart, Connor/0000-0003-1115-2272	North Carolina state University	North Carolina state University	The study was funded by North Carolina state University as part of Dr. Marine Traverson start-up funds. The authors thank Kerrier for providing the calcium sulfate hemihydrate kits used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Health-System Pharmacists, 2006, AM J HEALTH-SYST PH, V63, P1172, DOI DOI 10.2146/AJHP050529; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Bailey DB, 2009, AM J VET RES, V70, P770, DOI 10.2460/ajvr.70.6.770; Bergman NS, 2016, JAVMA-J AM VET MED A, V248, P1148, DOI 10.2460/javma.248.10.1148; Convention USP, 2019, 43NF38 USP; Dorbandt DM, 2018, VET OPHTHALMOL, V21, P419, DOI 10.1111/vop.12501; Galvao JFD, 2012, AM J VET RES, V73, P1262, DOI 10.2460/ajvr.73.8.1262; GAVER RC, 1988, CANCER CHEMOTH PHARM, V21, P197; Hess TA, 2018, JAVMA-J AM VET MED A, V252, P448, DOI 10.2460/javma.252.4.448; Hewes CA, 2006, JAVMA-J AM VET MED A, V229, P1617, DOI 10.2460/javma.229.10.1617; Holmes KE, 2015, VET COMP ONCOL, V13, P166, DOI 10.1111/vco.12031; Johnson JG, 2016, J ZOO WILDLIFE MED, V47, P931, DOI 10.1638/2015-0230.; KNAPP DW, 1995, AM J VET RES, V56, P801; Maxwell EA, 2020, VET SURG, V49, P748, DOI 10.1111/vsu.13372; Maxwell EA, 2018, VET SURG, V47, P219, DOI 10.1111/vsu.12709; Boothe DM, 2006, VET CLIN N AM-SMALL, V36, P1129, DOI 10.1016/j.cvsm.2006.07.003; PAGE RL, 1993, J VET INTERN MED, V7, P235, DOI 10.1111/j.1939-1676.1993.tb01013.x; Phillips H, 2018, AM J VET RES, V79, P592, DOI 10.2460/ajvr.79.6.592; Polovich M., 2005, CHEMOTHERAPY BIOTHER; Risselada M, 2016, AM J VET RES, V77, P1381, DOI 10.2460/ajvr.77.12.1381; Roberts R, 2014, J BIOMED MATER RES B, V102, P667, DOI 10.1002/jbm.b.33045; Sanicola Shawn M, 2005, J Foot Ankle Surg, V44, P121, DOI 10.1053/j.jfas.2005.01.006; Santschi EM, 2003, VET SURG, V32, P128, DOI 10.1053/jvet.2003.50010; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Tulipan RJ, 2017, AM J VET RES, V78, P618, DOI 10.2460/ajvr.78.5.618; Tulipan RJ, 2016, AM J VET RES, V77, P1252, DOI 10.2460/ajvr.77.11.1252; U.S. Department of Health and Human Services PHS Centers for Disease Control and Prevention National Institute for Occupational Safety and Health, 2004, NIOSH AL PREV OCC EX; Wichelhaus TA, 2001, J ANTIMICROB CHEMOTH, V48, P117, DOI 10.1093/jac/48.1.117; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Ye FB, 2012, J PHARMACEUT BIOMED, V71, P27, DOI 10.1016/j.jpba.2012.07.024	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241718	10.1371/journal.pone.0241718	http://dx.doi.org/10.1371/journal.pone.0241718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151989	gold, Green Published			2022-12-26	WOS:000591376200067
J	Cross, I; Garcia, E; Rodriguez, ME; Arias-Perez, A; Portela-Bens, S; Merlo, MA; Rebordinos, L				Cross, Ismael; Garcia, Emilio; Rodriguez, Maria E.; Arias-Perez, Alberto; Portela-Bens, Silvia; Merlo, Manuel A.; Rebordinos, Laureana			The genomic structure of the highly-conserved dmrt1 gene in Solea senegalensis (Kaup, 1868) shows an unexpected intragenic duplication	PLOS ONE			English	Article							SEX DETERMINATION; DIFFERENTIAL EXPRESSION; DIMORPHIC EXPRESSION; GONADAL DEVELOPMENT; EVOLUTION; CHROMOSOME; INSIGHTS; MEDAKA; IDENTIFICATION; LOCALIZATION	Knowing the factors responsible for sex determination in a species has significant theoretical and practical implications; the dmrt1 gene (Doublesex and Mab-3 (DM)-related Transcription factor 1) plays this role in diverse animal species. Solea senegalensis is a commercially important flat fish in which females grow 30% faster than males. It has 2n = 42 chromosomes and an XX / XY chromosome system for sex determination, without heteromorph chromosomes but with sex proto-chromosome. In the present study, we are providing the genomic structure and nucleotide sequence of dmrt1 gene obtained from cDNA from male and female adult gonads. A cDNA of 2027 containing an open-reading frame (ORF) of 1206 bp and encoding a 402 aa protein it is described for dmrt1 gene of S. senegalensis. Multiple mRNA isoforms indicating a high variable system of alternative splicing in the expression of dmrt1 of the sole in gonads were studied. None isoforms could be related to sex of individuals. The genomic structure of the dmrt1 of S. senegalensis showed a gene of 31400 bp composed of 7 exons and 6 introns. It contains an unexpected duplication of more than 10399 bp, involving part of the exon I, exons II and III and a SINE element found in the sequence that it is proposed as responsible for the duplication. A mature miRNA of 21 bp in length was localized at 336 bp from exon V. Protein-protein interacting networks of the dmrt1 gene showed matches with dmrt1 protein from Cynoglossus semilaevis and a protein interaction network with 11 nodes (dmrt1 plus 10 other proteins). The phylogenetic relationship of the dmrt1 gene in S. senegalensis is consistent with the evolutionary position of its species. The molecular characterization of this gene will enhance its functional analysis and the understanding of sex differentiation in Solea senegalensis and other flatfish.	[Cross, Ismael; Garcia, Emilio; Rodriguez, Maria E.; Arias-Perez, Alberto; Portela-Bens, Silvia; Merlo, Manuel A.; Rebordinos, Laureana] Univ Cadiz, CASEM, Area Genet, Cadiz, Spain	Universidad de Cadiz	Rebordinos, L (corresponding author), Univ Cadiz, CASEM, Area Genet, Cadiz, Spain.	laureana.rebordinos@uca.es	Arias-Pérez, Alberto/G-7109-2011; Torres, Manuel Alejandro Merlo/K-1203-2014; Garcia, Emilio/AAD-6120-2021; Rodríguez, María Esther/K-7672-2017; Portela Bens, Silvia/K-2209-2014; Cross, Ismael/K-1674-2014; REBORDINOS, LAUREANA/K-1327-2014	Arias-Pérez, Alberto/0000-0001-8967-4519; Torres, Manuel Alejandro Merlo/0000-0002-5049-5481; Rodríguez, María Esther/0000-0002-4475-2170; Portela Bens, Silvia/0000-0001-5269-2182; Cross, Ismael/0000-0002-2291-5629; REBORDINOS, LAUREANA/0000-0001-6255-9449	Spanish Ministerio de Ciencia e Innovacion (MICINN-FEDER) [RTI2018-096847-B-C21]; ELIXIR-CZ project [LM2015047]	Spanish Ministerio de Ciencia e Innovacion (MICINN-FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ELIXIR-CZ project	This research was funded by the Spanish Ministerio de Ciencia e Innovacion (MICINN-FEDER project RTI2018-096847-B-C21).; Computational resources for Repeat Explorer were provided by the ELIXIR-CZ project (LM2015047), part of the international ELIXIR infrastructure.	Adolfi MC, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/1477-7827-13-2; Merlo MA, 2017, GENOME, V60, P441, DOI 10.1139/gen-2016-0143; Aoyama S, 2003, CYTOGENET GENOME RES, V101, P295, DOI 10.1159/000074352; ARIASPEREZ A, 2018, OBM GENETICS, V2, P1; Berbejillo J, 2013, FISH PHYSIOL BIOCHEM, V39, P91, DOI 10.1007/s10695-012-9666-5; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brykov VA, 2014, RUSS J MAR BIOL+, V40, P407, DOI 10.1134/S1063074014060145; Campos C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-525; Cheng HH, 2006, CELL RES, V16, P389, DOI 10.1038/sj.cr.7310050; Cioffi MB, 2010, HEREDITY, V105, P554, DOI 10.1038/hdy.2010.18; Deng Si-Ping, 2012, Acta Hydrobiologica Sinica, V36, P610; Ejima Y, 2003, HUM MOL GENET, V12, P1321, DOI 10.1093/hmg/ddg138; El-Mogharbel N, 2007, GENOMICS, V89, P10, DOI 10.1016/j.ygeno.2006.07.017; Rodriguez ME, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205111; Fernandino JI, 2008, SEX DEV, V2, P316, DOI 10.1159/000195681; Gao X, 2009, P NATL ACAD SCI USA, V106, P20818, DOI 10.1073/pnas.0911093106; Garcia E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53673-6; Garcia-Angulo A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5216-6; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Huang X, 2005, BIOL REPROD, V73, P1017, DOI 10.1095/biolreprod.105.041871; Molina-Luzon MJ, 2015, J APPL GENET, V56, P77, DOI 10.1007/s13353-014-0233-x; Jia YY, 2019, FISH PHYSIOL BIOCHEM, V45, P245, DOI 10.1007/s10695-018-0558-1; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Leng XQ, 2016, J FISH BIOL, V88, P567, DOI 10.1111/jfb.12852; Li XY, 2018, SCI CHINA LIFE SCI, V61, P1503, DOI 10.1007/s11427-018-9415-7; Li XY, 2014, MOL PHYLOGENET EVOL, V78, P96, DOI 10.1016/j.ympev.2014.05.005; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Martinez P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00340; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Murdock C, 2003, CYTOGENET GENOME RES, V101, P302, DOI 10.1159/000074353; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pardo BG, 2001, HEREDITY, V86, P531, DOI 10.1046/j.1365-2540.2001.00802.x; Peng T, 2009, BIOCHEM BIOPH RES CO, V383, P163, DOI 10.1016/j.bbrc.2009.03.162; Picard MAL, 2015, CR BIOL, V338, P451, DOI 10.1016/j.crvi.2015.04.010; Portela-Bens S, 2017, CHROMOSOMA, V126, P261, DOI 10.1007/s00412-016-0589-2; Raghuveer K, 2009, J MOL ENDOCRINOL, V42, P437, DOI 10.1677/JME-09-0011; Trukhina AV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/587460; Ubeda-Manzanaro M, 2014, GENE, V535, P255, DOI 10.1016/j.gene.2013.11.021; Vega L., 2002, Boletin Instituto Espanol de Oceanografia, V18, P245; Vinas J, 2013, GONADAL SEX DIFFEREN; Volff JN, 2002, CYTOGENET GENOME RES, V99, P170, DOI 10.1159/000071590; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; Webster KA, 2017, DEV BIOL, V422, P33, DOI 10.1016/j.ydbio.2016.12.008; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Yan NN, 2019, COMP BIOCHEM PHYS B, V234, P68, DOI 10.1016/j.cbpb.2019.05.005; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zafar Imran, 2019, Biotechnology Reports, V24, pe00398, DOI 10.1016/j.btre.2019.e00398; Zhang XJ, 2018, GENE, V658, P36, DOI 10.1016/j.gene.2018.03.014; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zheng Y, 2014, FISH PHYSIOL BIOCHEM, V40, P1141, DOI 10.1007/s10695-014-9911-1	53	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241518	10.1371/journal.pone.0241518	http://dx.doi.org/10.1371/journal.pone.0241518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137109	Green Published, gold			2022-12-26	WOS:000588375500015
J	Katongole, P; Sande, OJ; Yusuf, M; Joloba, M; Reynolds, SJ; Niyonzima, N				Katongole, Paul; Sande, Obondo J.; Yusuf, Mulumba; Joloba, Moses; Reynolds, Steven J.; Niyonzima, Nixon			Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2015 and 2019 at the Uganda Cancer Institute	PLOS ONE			English	Article								Background Prostate cancer is the second most common cancer among men in Uganda, with over 2086 incident cases in 2018. This study's objective was to report the clinical characteristics and primary management of men diagnosed with prostate cancer at the Uganda Cancer Institute from 1(st) January 2015 to 31(st) December 2019. Methods Records from all men diagnosed with Prostate cancer at the Uganda Cancer Institute from 1(st) January 2015 to 31(st) December 2019 were reviewed. Clinical characteristics and primary treatment were recorded. Risk categorization was done using the European Society for Medical Oncology prostate cancer risk group classification. Results A total of 874 medical records for men diagnosed with prostate cancer was retrieved. The median age was 70 years (interquartile range 64-77). In this study, 501 (57.32%) patients had localized disease. Among patients with localized disease, 2 (0.23%) were classified as low-risk, 5 (0.53%) as intermediate-risk, and 494 (56.52%) as high-risk. Three hundred seventy-three (373) patients had metastatic disease at diagnosis. Among patients with distant metastases, the most common site of metastases was bone 143 (16.36%), followed by spinal cord 54 (6.18%), abdomen 22 (2.52%), and lungs 14 (1.60%). Regarding the primary treatment options majority of the patients were on chemotherapy 384(43.94%) followed by hormonal therapy 336 (38.44%) and radiotherapy 127 (14.53%). Conclusion The majority of the patients diagnosed with prostate cancer at the Uganda Cancer Institute presented with advanced disease. The primary treatments were mostly chemotherapy, hormonal therapy, and radiotherapy. There is a need to improve prostate cancer screening in regional health care facilities and the communities to enhance early detection and management of prostate cancer.	[Katongole, Paul] Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Katongole, Paul] Makerere Univ, Dept Med Biochem, Coll Hlth Sci, Kampala, Uganda; [Sande, Obondo J.; Joloba, Moses] Makerere Univ, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda; [Yusuf, Mulumba; Niyonzima, Nixon] Uganda Canc Inst, Kampala, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Makerere University; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Katongole, P (corresponding author), Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda.; Katongole, P (corresponding author), Makerere Univ, Dept Med Biochem, Coll Hlth Sci, Kampala, Uganda.	paul.katongole@gmail.com		Sande, Obondo/0000-0002-2301-5980; KATONGOLE, PAUL/0000-0003-4952-801X	African Development bank under Uganda Cancer Institute; Office of the Director, National Institutes of Health (OD) [D43TW010132]; National Institute of Dental & Craniofacial Research (NIDCR); National Institute of Neurological Disorders and Stroke (NINDS); National Heart, Lung, And Blood Institute (NHLBI); Fogarty International Center (FIC); National Institute on Minority Health and Health Disparities (NIMHD); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)	African Development bank under Uganda Cancer Institute; Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, And Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PK receives funding from the African Development bank under Uganda Cancer Institute to support PK's doctoral work and also receives support from a training grant, D43TW010132 supported by Office of the Director, National Institutes of Health (OD), National Institute of Dental & Craniofacial Research (NIDCR), National Institute of Neurological Disorders and Stroke (NINDS), National Heart, Lung, And Blood Institute (NHLBI), Fogarty International Center (FIC), National Institute on Minority Health and Health Disparities (NIMHD). Funded in part (SJR) by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the authors' responsibility and do not necessarily represent the supporting offices' official views.	Adeloye D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153496; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cassell A, 2019, WORLD J ONCOL, V10, P162, DOI 10.14740/wjon1221; Farashi S, 2019, NAT REV CANCER, V19, P46, DOI 10.1038/s41568-018-0087-3; McGinley KF, 2016, NAT REV UROL, V13, P99, DOI 10.1038/nrurol.2015.298; Okuku Fred, 2016, J Glob Oncol, V2, P181, DOI 10.1200/JGO.2015.001040; Parker C, 2015, ANN ONCOL, V26, pV69, DOI 10.1093/annonc/mdv222; Peprah E, 2015, PUBLIC HEALTH GENOM, V18, P40, DOI 10.1159/000367962; Pernar CH, 2018, COLD SPRING HARB PER; Shenoy D, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0137-7; Sundi D, 2015, UROLOGY, V85, P155, DOI 10.1016/j.urology.2014.08.014; Taitt HE, 2018, AM J MENS HEALTH, V12, P1807, DOI 10.1177/1557988318798279	12	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0236458	10.1371/journal.pone.0236458	http://dx.doi.org/10.1371/journal.pone.0236458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125383	Green Submitted, gold, Green Published			2022-12-26	WOS:000588368900016
J	Bakhshaliyev, K; Gunes, MH				Bakhshaliyev, Khalid; Gunes, Mehmet Hadi			Generation of 2-mode scale-free graphs for link-level internet topology modeling	PLOS ONE			English	Article							POWER LAWS; DISTRIBUTIONS	Comprehensive analysis that aims to understand the topology of real-world networks and the development of algorithms that replicate their characteristics has been significant research issues. Although the accuracy of newly developed network protocols or algorithms does not depend on the underlying topology, the performance generally depends on the topology. As a result, network practitioners have concentrated on generating representative synthetic topologies and utilize them to investigate the performance of their design in simulation or emulation environments. Network generators typically represent the Internet topology as a graph composed of point-to-point links. In this study, we discuss the implications of multi-access links on the synthetic network generation and modeling of the networks as bi-partite graphs to represent both subnetworks and routers. We then analyze the characteristics of sampled Internet topology data sets from backbone Autonomous Systems (AS) and observe that in addition to the commonly recognized power-law node degree distribution, the subnetwork size and the router interface distributions often exhibit power-law characteristics. We introduce a SubNetwork Generator (SubNetG) topology generation approach that incorporates the observed measurements to produce bipartite network topologies. In particular, generated topologies capture the 2-mode relation between the layer-2 (i.e., the subnetwork and interface distributions) and the layer-3 (i.e., the degree distribution) that is missing from the current network generators that produce 1-mode graphs. The SubNetG source code and experimental data is available at https://github.com/netml/sonet.	[Bakhshaliyev, Khalid] Univ Nevada, Dept Comp Sci & Engn, Reno, NV 89557 USA; [Gunes, Mehmet Hadi] Stevens Inst Technol, Sch Syst & Enterprises, Hoboken, NJ 07030 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Stevens Institute of Technology	Gunes, MH (corresponding author), Stevens Inst Technol, Sch Syst & Enterprises, Hoboken, NJ 07030 USA.	mgunes@stevens.edu		Gunes, Mehmet Hadi/0000-0002-3351-7685	National Science Foundation [CNS-1321164]	National Science Foundation(National Science Foundation (NSF))	K.B. and M.G. were supported by the National Science Foundation, under grant CNS-1321164 https://www.nsf.gov/awardsearch/showAward?AWD_ID=1321164 Sponsor did not play any role in study design, data collection, analysis, or publication preparation.	Akgun MB, 2013, I S MOD ANAL SIM COM, P399, DOI 10.1109/MASCOTS.2013.60; Aksoy A., 2019, ASIAR ANAL SUBNETWOR; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bakhshaliyev K., 2019, ACM T MODELING PERFO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Canbaz MA, 2018, SPRINGER PR COMPLEX, P243, DOI 10.1007/978-3-319-73198-8_21; Cheng LC, 2008, 2008 22ND INTERNATIONAL WORKSHOPS ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOLS 1-3, P526, DOI 10.1109/WAINA.2008.66; Cheverez-Gonzalez D, 2009, IFAC P VOL 1 IFAC WO, V24, P125, DOI DOI 10.3182/20090924-3-IT-4005.00020; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dimitropoulos X, 2009, ACM T MODEL COMPUT S, V19, DOI 10.1145/1596519.1596522; Doar MB, 1996, IEEE GLOBECOM 1996 - GLOBAL INTERNET'96, CONFERENCE RECORD, P86, DOI 10.1109/GLOCOM.1996.586131; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Giudicianni C, 2018, WATER-SUI, V10, DOI 10.3390/w10040444; Govindan R., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), P1371, DOI 10.1109/INFCOM.2000.832534; Gunes M., 2007, ACM SIGCOMM INT MEAS; Gunes MH, 2007, COMPUT NETW, V51, P4153, DOI 10.1016/j.comnet.2007.05.001; Gunes MH, 2009, IEEE ACM T NETWORK, V17, P1738, DOI 10.1109/TNET.2009.2014227; Gunes MH, 2007, 2007 IEEE GLOBAL INTERNET SYMPOSIUM, P19, DOI 10.1109/GI.2007.4301425; Hale SA, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P833, DOI 10.1145/2556288.2557203; Hidaka N, 2008, FOURTH INTERNATIONAL CONFERENCE ON AUTONOMIC AND AUTONOMOUS SYSTEMS (ICAS 2008), P169, DOI 10.1109/ICAS.2008.7; Kardes H., 2012, 2012 4 INT C COMM SY, P1, DOI [10.1109/COMSNETS.2012.6151326, DOI 10.1109/C0MSNETS.2012.6151326]; Kardes H., 2011, CHELEBY SUBNET LEVEL; Kardes H, 2015, COMPUT NETW, V81, P178, DOI 10.1016/j.comnet.2015.02.012; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Komurov K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006017; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Krioukov D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036106; Labovitz C, 2001, IEEE INFOCOM SER, P537, DOI 10.1109/INFCOM.2001.916775; Lappas T., 2010, 2010 17 IEEE WORKSH, P1, DOI [10.1109/LANMAN.2010.5507153, DOI 10.1109/LANMAN.2010.5507153]; Latapy M, 2008, IEEE INFOCOM SER, P2333; Luckie M, 2008, IMC'08: PROCEEDINGS OF THE 2008 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P311; Mahadevan P, 2006, ACM SIGCOMM COMP COM, V36, P135, DOI 10.1145/1151659.1159930; Mahadevan P, 2007, ACM SIGCOMM COMP COM, V37, P325, DOI 10.1145/1282427.1282417; Medina A, 2000, ACM SIGCOMM COMP COM, V30, P18, DOI 10.1145/505680.505683; Medina A., 2001, BRITE UNIVERSAL TOPO; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pastor-Satorras R., 2004, EVOLUTION STRUCTURE, DOI [10.1017/CBO9780511610905, DOI 10.1017/CB09780511610905]; Quoitin B., 2010, TECH REP; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Thomas M., 1994, COLL COMPUT; Tozal M. E., 2010, P 10 ACM SIGCOMM C I, P356, DOI [10.1145/1879141.1879188, DOI 10.1145/1879141.1879188]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winick J., 2002, CSETR45602 U MICH	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0240100	10.1371/journal.pone.0240100	http://dx.doi.org/10.1371/journal.pone.0240100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166286	gold, Green Published			2022-12-26	WOS:000592382600078
J	de Winter, D; Salaets, T; Gie, A; Deprest, J; Levtchenko, E; Toelen, J				de Winter, Derek; Salaets, Thomas; Gie, Andre; Deprest, Jan; Levtchenko, Elena; Toelen, Jaan			Glomerular developmental delay and proteinuria in the preterm neonatal rabbit	PLOS ONE			English	Article							INCREASED BLOOD-PRESSURE; GESTATIONAL-AGE; RISK-FACTORS; BIRTH; PREMATURITY; MATURATION; NUMBER	Recent advances in neonatal care have improved the survival rate of those born premature. But prenatal conditions, premature birth and clinical interventions can lead to transient and permanent problems in these fragile patients. Premature birth (<36 gestational weeks) occurs during critical renal development and maturation. Some consequences have been observed but the exact pathophysiology is still not entirely known. This experimental animal study aims to investigate the effect of premature birth on postnatal nephrogenesis in premature neonatal rabbits compared to term rabbits of the same corrected age. We analyzed renal morphology, glomerular maturity and functional parameters (proteinuria and protein/creatinine ratio) in three cohorts of rabbit pups: preterm (G28), preterm at day 7 of life (G28+7) and term at day 4 of life (G31+4). We found no significant differences in kidney volume and weight, and relative kidney volume between the cohorts. Nephrogenic zone width increased significantly over time when comparing G31 + 4 to G28. The renal corpuscle surface area, in the inner cortex and outer cortex, tended to decrease significantly after birth in both preterm and term groups. With regard to glomerular maturity, we found that the kidneys in the preterm cohorts were still in an immature state (presence of vesicles and capillary loop stage). Importantly, significant differences in proteinuria and protein/creatinine ratio were found. G28 + 7 showed increased proteinuria (p = 0.019) and an increased protein/creatinine ratio (p = 0.023) in comparison to G31 +4. In conclusion, these results suggest that the preterm rabbit kidney tends to linger in the immature glomerular stages and shows signs of a reduced renal functionality compared to the kidney born at term, which could in time lead to short- and long-term health consequences.	[de Winter, Derek] Amsterdam UMC, Fac Med, Amsterdam, Netherlands; [Salaets, Thomas; Gie, Andre; Deprest, Jan; Levtchenko, Elena; Toelen, Jaan] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Salaets, Thomas; Levtchenko, Elena; Toelen, Jaan] Univ Hosp Leuven, Dept Paediat, Div Woman & Child, Leuven, Belgium; [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Woman & Child, Leuven, Belgium; [Deprest, Jan] UCL, Inst Womens Hlth, London, England	University of Amsterdam; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of London; University College London	de Winter, D (corresponding author), Amsterdam UMC, Fac Med, Amsterdam, Netherlands.	derekdwinter@gmail.com	de Winter, Derek/AAL-6880-2021	de Winter, Derek/0000-0002-4820-143X; Toelen, Jaan/0000-0001-9339-5408; Salaets, Thomas/0000-0002-0971-5147	Erasmus+ Programme of the European Union [2013-0040]; Research Foundation - Flanders (FWO Flanders) [1.801207, G0C4419N]; Research Foundation Flanders (FWO Flanders) [1801110N]; Katholieke Universiteit Leuven (C2 grant) [C24/18/101]	Erasmus+ Programme of the European Union; Research Foundation - Flanders (FWO Flanders)(FWO); Research Foundation Flanders (FWO Flanders)(FWO); Katholieke Universiteit Leuven (C2 grant)	AG is funded with support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040). JD is funded by The Research Foundation - Flanders (FWO Flanders) as clinical researcher (1.801207). EL is funded by The Research Foundation Flanders (FWO Flanders) as clinical investigator (1801110N). This study was supported by The Research Foundation - Flanders (FWO Flanders) (grant G0C4419N) and Katholieke Universiteit Leuven (C2 grant: C24/18/101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Allegaert K, 2014, NEONATOLOGY, V105, P344, DOI 10.1159/000360648; [Anonymous], 2014, NUCL ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Black MJ, 2012, BASIC NEPHROLOGY ACU, P61; Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80; Callaway DA, 2018, PEDIATR RES, V83, P702, DOI 10.1038/pr.2017.290; Charlton JR, 2020, PEDIATR RES, V87, P1185, DOI 10.1038/s41390-019-0684-1; Charlton JR, 2021, PEDIATR NEPHROL, V36, P797, DOI 10.1007/s00467-020-04534-2; Cooper R, 2009, INT J EPIDEMIOL, V38, P235, DOI 10.1093/ije/dyn154; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; dos Santos AM, 2006, EARLY HUM DEV, V82, P709, DOI 10.1016/j.earlhumdev.2006.01.013; Gubhaju L, 2009, AM J PHYSIOL-RENAL, V297, pF1668, DOI 10.1152/ajprenal.00163.2009; Guignard JP, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e49; Huang HP, 2007, NEPHROLOGY, V12, P572, DOI 10.1111/j.1440-1797.2007.00882.x; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Keijzer-Veen MG, 2010, PEDIATR NEPHROL, V25, P509, DOI 10.1007/s00467-009-1373-9; Kistner A, 2002, PEDIATR RES, V51, P675, DOI 10.1203/01.PDR.0000017482.64723.C4; Kistner A, 2000, PEDIATR NEPHROL, V15, P215, DOI 10.1007/s004670000473; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Naruse K, 2000, KIDNEY INT, V57, P1836, DOI 10.1046/j.1523-1755.2000.00033.x; PESCE MA, 1973, CLIN CHEM, V19, P1265; Puelles VG, 2015, CURR OPIN NEPHROL HY, V24, P224, DOI 10.1097/MNH.0000000000000121; Raju TNK, 2017, J PEDIATR-US, V181, P309, DOI 10.1016/j.jpeds.2016.10.015; Salaets T, 2017, CURR PHARM DESIGN, V23, P5887, DOI 10.2174/1381612823666170926123550; Siewert-Delle A, 1998, AM J HYPERTENS, V11, P946, DOI 10.1016/S0895-7061(98)00090-9; Stelloh C, 2012, TRANSL RES, V159, P80, DOI 10.1016/j.trsl.2011.10.004; Sutherland MR, 2011, J AM SOC NEPHROL, V22, P1365, DOI 10.1681/ASN.2010121266; THONY HC, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02191509; TSUKAHARA H, 1994, NEPHRON, V68, P212, DOI 10.1159/000188259; van der Merwe J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39922-8; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241384	10.1371/journal.pone.0241384	http://dx.doi.org/10.1371/journal.pone.0241384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166318	Green Published, gold			2022-12-26	WOS:000592382600042
J	Dutt, NR; Veals, AM; Koprowski, JL				Dutt, Neil R.; Veals, Amanda M.; Koprowski, John L.			Resource selection of a montane endemic: Sex-specific differences in white-bellied voles (Microtus longicaudus leucophaeus)	PLOS ONE			English	Article							SMALL MAMMALS; HABITAT USE; MEADOW VOLE; HOME RANGES; OLD-GROWTH; SPACE USE; PENNSYLVANICUS; FRAGMENTATION; SEGREGATION; SQUIRRELS	Resources that an individual selects contrasted against what is available can provide valuable information regarding species-specific behavior and ecological relationships. Small mammals represent excellent study organisms to assess such relationships. Isolated populations that exist on the edge of a species' distribution often exhibit behavioral adaptations to the extremes experienced by a species and can provide meaningful insight into the resource requirements of the species. We deployed radio transmitters in a peripheral population of the long-tailed vole (Microtus longicaudus) during the mating season. We developed models of resource selection at multiple scales (within home range and patch). We found voles generally selected areas close to water and roads and consisting of high understory vegetation primarily composed of grasses. Resource selection varied between sexes suggesting different resource needs during the breeding season. The differential resource needs of voles might be a result of the energetic requirements for reproduction and are representative of a promiscuous or polygynous mating system.	[Dutt, Neil R.; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Veals, Amanda M.] Texas A&M Univ Kingsville, Kingsville, TX USA; [Koprowski, John L.] Univ Wyoming, Haub Sch Environm & Nat Resources, Laramie, WY 82071 USA	University of Arizona; Texas A&M University System; Texas A&M University Kingsville; University of Wyoming	Dutt, NR (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	neildutt89@gmail.com		Dutt, Neil/0000-0003-0767-2590; Koprowski, John/0000-0003-1406-9853; Veals Dutt, Amanda/0000-0001-5129-3462	University of Arizona; T&E Incorporated's Grants for Conservation Research	University of Arizona; T&E Incorporated's Grants for Conservation Research	NRD-Funding was provided by University of Arizona (http://www.arizona.edu/) and T&E Incorporated's Grants for Conservation Research (www.tandeinc.com).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anich PS, 2013, AM MIDL NAT, V170, P274, DOI 10.1674/0003-0031-170.2.274; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2012, AR STAT WILDL ACT PL; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Batzli G. O., 1985, BIOL NEW WORLD MICRO, V8, P779; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; beda A., 2015, PLOS ONE, V10, P1; BORELL ADREY E., 1934, JOUR MAMMALOGY, V15, P12, DOI 10.2307/1373895; Bos DG, 2003, ECOGRAPHY, V26, P810; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; Carey AB, 2001, J WILDLIFE MANAGE, V65, P1014, DOI 10.2307/3803050; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148121; CHEW RM, 1951, ECOL MONOGR, V21, P215, DOI 10.2307/1943558; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; CLUTTONBROCK TH, 1987, J ZOOL, V211, P275, DOI 10.1111/j.1469-7998.1987.tb01534.x; Collins RJ, 1997, LANDSCAPE ECOL, V12, P63, DOI 10.1007/BF02698208; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Cudworth NL, 2011, J WILDLIFE MANAGE, V75, P1668, DOI 10.1002/jwmg.194; Cudworth NL, 2010, J MAMMAL, V91, P1235, DOI 10.1644/09-MAMM-A-426.1; DIFFENDORFER JE, 1995, ECOLOGY, V76, P827, DOI 10.2307/1939348; Doumas SL, 2013, RESTOR ECOL, V21, P133, DOI 10.1111/j.1526-100X.2012.00864.x; Edelman AJ, 2006, CAN J ZOOL, V84, P404, DOI 10.1139/z06-009; ESRI, 2019, ARCGIS PRO VER 2 4 1; Findley JS, 1975, MAMMALS NEW MEXICO; Foley AM, 2015, J MAMMAL, V96, P279, DOI 10.1093/jmammal/gyv004; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Hale SL, 2018, RESTOR ECOL, V26, P439, DOI 10.1111/rec.12684; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hardie DC, 2010, ENVIRON REV, V18, P1, DOI 10.1139/A09-014; HOFFMEISTER D. F., 1956, AMER MIDLAND NAT, V55, P257, DOI 10.2307/2422591; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; Hoset KS, 2008, BEHAV ECOL, V19, P139, DOI 10.1093/beheco/arm112; Ji SN, 2017, TRANSPORT RES D-TR E, V50, P223, DOI 10.1016/j.trd.2016.11.006; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Lee EJ, 2016, FOLIA ZOOL, V65, P101, DOI 10.25225/fozo.v65.i2.a5.2016; Leonard KM, 2010, SOUTHWEST NAT, V55, P217, DOI 10.1894/MRD-01.1; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Manly B.F.J., 2002, RESOURCE SELECTION A; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; McManus JJ, 1983, J MAMMAL, V64, P337; Olsen B. R., 2018, ECOSPHERE, V9, P1; Pita R, 2011, ACTA OECOL, V37, P124, DOI 10.1016/j.actao.2011.01.006; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Development Core Team, 2016, R LANG ENV STAT COMP; Ribble DO, 2002, J MAMMAL, V83, P260, DOI 10.1644/1545-1542(2002)083<0260:ACOHRO>2.0.CO;2; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Scheller RM, 2002, ECOL APPL, V12, P1329, DOI 10.1890/1051-0761(2002)012[1329:USPADI]2.0.CO;2; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Shoemaker KT, 2018, ECOL EVOL, V8, P3556, DOI 10.1002/ece3.3936; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; SMOLEN M J, 1987, Mammalian Species, P1, DOI 10.2307/3503956; Spaeth PA, 2009, J MAMMAL, V90, P571, DOI 10.1644/08-MAMM-A-204R2.1; Spicer RB, 1985, STATUS WHITE BELLIED, P1; Stokke S, 2002, AFR J ECOL, V40, P360, DOI 10.1046/j.1365-2028.2002.00395.x; Strickler GS, 1959, USE DENSIOMETER ESTI; THOMPSON DQ, 1965, AM MIDL NAT, V74, P76, DOI 10.2307/2423121; Tisell HB, 2019, CAN J ZOOL, V97, P1101, DOI 10.1139/cjz-2018-0338; U.S. Department of Agriculture (USDA) Forest Service, 2017, FRYE FIR AER PHOT DI; VANHORNE B, 1982, CAN J ZOOL, V60, P1690; Wang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053904; Warshall P, 1996, GRAHAM CONSERV BIOL, V10, P1479; WEBSTER AB, 1981, OIKOS, V37, P80, DOI 10.2307/3544076; WEBSTER AB, 1980, CAN J ZOOL, V58, P997, DOI 10.1139/z80-139; Wolff J.O., 1985, Special Publication American Society of Mammalogists, P340; Wood DJA, 2007, J WILDLIFE MANAGE, V71, P2357, DOI 10.2193/2006-511; Wszola LS, 2019, ECOL MODEL, V392, P268, DOI 10.1016/j.ecolmodel.2018.10.017	74	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242104	10.1371/journal.pone.0242104	http://dx.doi.org/10.1371/journal.pone.0242104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166355	Green Published, gold			2022-12-26	WOS:000592382600030
J	Nishikawa, M; Honda, M; Kimura, R; Kobayashi, A; Yamaguchi, Y; Hori, S; Kobayashi, H; Waragai, M; Kawamura, H; Nakayama, Y; Todate, Y; Takano, Y; Yamaguchi, H; Hamada, K; Iketani, S; Seto, I; Izumi, Y; Seto, K				Nishikawa, Mao; Honda, Michitaka; Kimura, Ryosuke; Kobayashi, Ayaka; Yamaguchi, Yuji; Hori, Soshi; Kobayashi, Hiroshi; Waragai, Mitsuru; Kawamura, Hidetaka; Nakayama, Yujiro; Todate, Yukitoshi; Takano, Yoshinao; Yamaguchi, Hisashi; Hamada, Koichi; Iketani, Susumu; Seto, Ichiro; Izumi, Yuichi; Seto, Kanichi			The bacterial association with oral cavity and intra-abdominal abscess after gastrectomy	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HELICOBACTER-PYLORI; PERIODONTAL-DISEASE; RISK-FACTOR; PREVENTION; MICROBIOTA; ATROPHY; CANCER	Background Perioperative oral management has been reported to be effective for preventing postoperative infectious complications. In addition, severe periodontal disease was identified as the significant risk factor for complications after gastrointestinal surgery. We investigated the bacteriological association between the periodontal pocket, stomach mucosa and drainage fluid to determine whether oral bacteria directly cause intra-abdominal infection after gastrectomy. Methods Patients who were scheduled to undergo surgery for gastric cancer were prospectively enrolled. We evaluated the similarity of bacterial strains in periodontal pocket, stomach mucosa and fluid from drainage tube. Gingival crevicular fluid and dental plaque were collected from the periodontal pocket and cultured to detect bacteria. Specimens from the resected stomach were collected and used for bacterial culturing. Drainage fluid from the abdominal cavity was also cultured. Results All of 52 patients were enrolled. In the periodontal pocket, alpha-Streptococcus spp., Neisseria sp., and Prevotella sp. were mainly detected. Bacterial cultures in the stomach mucosa were positive in 26 cases. In 20 cases (76.9%), the detected strains were the same as those in the periodontal pocket. Six patients had the postoperative intra-abdominal infection after gastrectomy, and the same bacterial strains was detected in both of drainage fluid and periodontal pocket in two patients with severe periodontal disease. Conclusions We found the bacteriological association that same strain detected in periodontal pocket, stomach and in intra-abdominal drainage fluid after gastrectomy in patients with periodontal disease.	[Nishikawa, Mao; Kimura, Ryosuke; Kobayashi, Ayaka; Yamaguchi, Yuji; Iketani, Susumu; Seto, Ichiro; Izumi, Yuichi; Seto, Kanichi] Southern TOHOKU Gen Hosp, Dept Oral & Maxillofacial Surg, Koriyama, Fukushima, Japan; [Honda, Michitaka; Hori, Soshi; Kobayashi, Hiroshi; Kawamura, Hidetaka; Nakayama, Yujiro; Todate, Yukitoshi; Yamaguchi, Hisashi; Hamada, Koichi] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima, Fukushima, Japan; [Honda, Michitaka; Hori, Soshi; Kobayashi, Hiroshi; Waragai, Mitsuru; Kawamura, Hidetaka; Nakayama, Yujiro; Todate, Yukitoshi; Takano, Yoshinao] Southern TOHOKU Gen Hosp, Dept Surg, Koriyama, Fukushima, Japan	Fukushima Medical University	Honda, M (corresponding author), Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima, Fukushima, Japan.; Honda, M (corresponding author), Southern TOHOKU Gen Hosp, Dept Surg, Koriyama, Fukushima, Japan.	mhonda@fukushimamed.com	Honda, Michitaka/GRX-6955-2022					[Anonymous], 1998, OFITSIYNYY VISNYK UK, V3, P108; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bauerfeind P, 1997, GUT, V40, P25, DOI 10.1136/gut.40.1.25; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; CORREA P, 1992, CANCER RES, V52, P6735; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Eissele R, 1997, GASTROENTEROLOGY, V112, P707, DOI 10.1053/gast.1997.v112.pm9041231; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Ishimaru M, 2018, BRIT J SURG, V105, P1688, DOI 10.1002/bjs.10915; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; Niikura N, 2020, ONCOLOGIST, V25, pE223, DOI 10.1634/theoncologist.2019-0382; Nishikawa M, 2019, INT J CLIN ONCOL, V24, P1558, DOI 10.1007/s10147-019-01513-y; Periodontology JSo, 2016, CLIN PRACT GUID PER; Sato K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07196-7; Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205; Shiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30997; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; vonTroilLinden B, 1995, J DENT RES, V74, P1789, DOI 10.1177/00220345950740111201; Williams C, 2006, ALIMENT PHARM THER, V23, P3, DOI 10.1111/j.1365-2036.2006.02707.x; Wren SM, 2010, J AM COLL SURGEONS, V210, P491, DOI 10.1016/j.jamcollsurg.2010.01.009; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242091	10.1371/journal.pone.0242091	http://dx.doi.org/10.1371/journal.pone.0242091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166362	Green Published, gold			2022-12-26	WOS:000592382600018
J	Rodriguez-Nogueira, O; Balaguer, JM; Lopez, AN; Merino, JR; Botella-Rico, JM; Del Rio-Medina, S; Poyato, AMR				Rodriguez-Nogueira, Oscar; Morera Balaguer, Jaume; Nogueira Lopez, Abel; Roldan Merino, Juan; Botella-Rico, Jose-Martin; Del Rio-Medina, Sonia; Moreno Poyato, Antonio R.			The psychometric properties of the person-centered therapeutic relationship in physiotherapy scale	PLOS ONE			English	Article							PATIENT-CENTEREDNESS; FIT INDEXES; CARE; REHABILITATION; ALLIANCE; QUALITY; SATISFACTION; PERCEPTIONS; CRITERIA; ELEMENTS	Objective To determine the psychometric properties of the Person-Centered Therapeutic Relationship in Physiotherapy Scale (PCTR-PT) in order to find the most appropriate fit for the tool. Methods Patients who had received treatment at the physiotherapy service of nine hospitals in Spain were invited to complete the 31 items of the PCTR-PT scale. To select the most appropriate items of the PCTR-PT, an exploratory factorial analysis (EFA) was performed using the maximum likelihood and oblique rotation (promin) methods. Factor validity, goodness-of-fit and psychometric properties were analyzed by confirmatory factor analysis (CFA). Convergent (CFA) and discriminant validity were calculated. Internal consistency was verified using the Cronbach's alpha coefficient. The intraclass correlation coefficient (ICC) was used to examine temporal stability. Results 366 patients over 18 years old who had received, at least, 15 physiotherapy treatment sessions completed the questionnaire. The results of the exploratory factor analysis revealed a tool with 15 items in four factors [Relational Bond (N items = 4); Individualized Partnership (N items = 4); Professional Empowerment (N items = 3) and Therapeutic Communication (N items = 4)], explaining 78.4% of the variance of the total variables of this tool. The confirmatory factor analysis further confirmed the four-structure model. Reliability of the tool was approved by Cronbach's alpha in all four dimensions, as all were above .70, ranging from .84 (Individualized Partnership) to .91 (Professional Empowerment). = 0.94. Test-retest was performed with two-week intervals, indicating an appropriate stability for the scale (ICC = 0.900). Conclusion The Person-Centered Therapeutic Relationship in Physiotherapy Scale (PCTR-PT) is a useful, valid and applicable instrument to evaluate the person-centered therapeutic relationship during physiotherapy interventions. It would be interesting to investigate the predictive capacity (sensitivity and specificity) of the PCTR-PT scale.	[Rodriguez-Nogueira, Oscar] Univ Leon, Dept Nursing & Physiotherapy, SALBIS Res Grp, Campus Ponferrada, Leon, Spain; [Morera Balaguer, Jaume; Botella-Rico, Jose-Martin; Del Rio-Medina, Sonia] Univ Cardenal Herrera CEU, Phys Therapy Dept, CEU Univ, Alicante, Spain; [Nogueira Lopez, Abel] European Univ Atlantic, Santander, Spain; [Nogueira Lopez, Abel] Int Ibero Amer Univ, Campeche, Campeche, Mexico; [Nogueira Lopez, Abel] Int Univ Cuanza, Dept Sport, Cuito, Angola; [Roldan Merino, Juan] Univ Barcelona, Sch Nursing, Campus Docent, St Joan De Deu Fundacio Privada, Barcelona, Spain; [Roldan Merino, Juan] Res Grp GIES Grp Invest Enfermeriia Educ & Soc, Barcelona, Spain; [Moreno Poyato, Antonio R.] Res Grp GEIMAC, Grp Studies Invarianza Instruments Measurement &, Barcelona, Spain; Univ Barcelona, Escola Infermeria, Fac Med & Ciencies Salut, Dept Infermeria Salut Publ Salut Mental & Materno, Campus Bellvitge,Pavello Govern, Barcelona, Spain	Universidad de Leon; Universidad CEU Cardenal Herrera; University of Barcelona; University of Barcelona	Balaguer, JM (corresponding author), Univ Cardenal Herrera CEU, Phys Therapy Dept, CEU Univ, Alicante, Spain.	jmorera.el@uchceu.es	Moreno-Poyato, Antonio R./O-3975-2019; Rodríguez, Oscar/AAF-8023-2021; Nogueira López, Abel/GVT-4093-2022; Roldan-Merino, Juan/H-9063-2019	Moreno-Poyato, Antonio R./0000-0002-5700-4315; Rodríguez, Oscar/0000-0002-4203-5784; Nogueira López, Abel/0000-0001-6761-2907; Roldan-Merino, Juan/0000-0002-7895-6083; Morera Balaguer, Jaume/0000-0001-8733-4406	CEU Cardenal Herrera University; San Pablo University-Santander Foundation (FUSP)	CEU Cardenal Herrera University; San Pablo University-Santander Foundation (FUSP)	Authors JMB, ORN, are recipients of a grant from CEU Cardenal Herrera University (www.uchceu.es) and the San Pablo University-Santander Foundation (FUSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecillas D. X. A., 2016, REV POLIT CNICA, V37, P68; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; BARKHAM M, 1993, BRIT J MED PSYCHOL, V66, P157, DOI 10.1111/j.2044-8341.1993.tb01738.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bordin ES., 1979, PSYCHOTHERAPY THEORY, V16, DOI [10.1037/h0085885, DOI 10.1037/H0085885]; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd, DOI [10.1680/geot.8.B.012, DOI 10.1680/GEOT.8.B.012]; Byrne AL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229923; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Castro EM, 2016, PATIENT EDUC COUNS, V99, P1923, DOI 10.1016/j.pec.2016.07.026; Constand MK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-271; DeVellis RF., 2016, SCALE DEV THEORY APP, V4th; Diaz De Rada V., 2001, REV INT SOCIOL, V59, P133, DOI [10.3989/ris.2001.i29.759, DOI 10.3989/RIS.2001.I29.759]; Eklund JH, 2019, PATIENT EDUC COUNS, V102, P3, DOI 10.1016/j.pec.2018.08.029; Ekman N, 2020, INT J NURS STUD, V109, DOI 10.1016/j.ijnurstu.2020.103634; Del Bano-Aledo ME, 2014, PHYSIOTHERAPY, V100, P73, DOI 10.1016/j.physio.2013.05.001; Farrell AM, 2010, J BUS RES, V63, P324, DOI 10.1016/j.jbusres.2009.05.003; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Hair J.F., 2010, MULTIVARIATE DATA AN, V7; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Institute of Medicine, 2001, SHAP FUT CROSS QUAL, DOI 10.17226/10027; Jaju A, 1999, AM MARK ASS, V10, P127; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lorenzo-Seva U, 1999, MULTIVAR BEHAV RES, V34, P347, DOI 10.1207/S15327906MBR3403_3; Luborsky L, 1996, J Psychother Pract Res, V5, P260; Maroco J. P., 2014, STRUCTURAL EQUATIONS, V2; McGuire-Snieckus R, 2007, PSYCHOL MED, V37, P85, DOI 10.1017/S0033291706009299; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Medina-Mirapeix F, 2013, ARCH PHYS MED REHAB, V94, P2248, DOI 10.1016/j.apmr.2013.04.018; Medina-Mirapeix F, 2013, CLIN REHABIL, V27, P555, DOI 10.1177/0269215512468142; Miciak M, 2019, PHYSIOTHER THEOR PR, V35, P40, DOI 10.1080/09593985.2018.1434707; Miciak Maxi, 2018, Arch Physiother, V8, P3, DOI 10.1186/s40945-018-0044-1; Morera-Balaguer J, 2021, PHYSIOTHER THEOR PR, V37, P17, DOI 10.1080/09593985.2019.1603258; Morera-Balaguer J, 2018, BRAZ J PHYS THER, V22, P484, DOI 10.1016/j.bjpt.2018.04.003; Morgan S, 2012, J HOLIST NURS, V30, P6, DOI 10.1177/0898010111412189; Nolte E, 2020, EUR OBS HEALTH SYST, P1; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Keeffe M, 2016, PHYS THER, V96, P609, DOI 10.2522/ptj.20150240; Olsson LE, 2013, J CLIN NURS, V22, P456, DOI 10.1111/jocn.12039; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Ramos A, 2018, REV PSICOL DEPORTE, V27, P87; Rathert C, 2015, HEALTH EXPECT, V18, P199, DOI 10.1111/hex.12020; Ree E, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3798-y; Nogueira OR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228916; Santana MJ, 2018, HEALTH EXPECT, V21, P429, DOI 10.1111/hex.12640; Scholl I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107828; Sidani S, 2014, J INTERPROF CARE, V28, P134, DOI 10.3109/13561820.2013.862519; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wagner EH, 2005, J ALTERN COMPLEM MED, V11, pS7, DOI 10.1089/acm.2005.11.s-7; WHO, 2018, INT PRIM HLTH CAR BA; Wijma AJ, 2017, PHYSIOTHER THEOR PR, V33, P825, DOI 10.1080/09593985.2017.1357151; Yun D, 2019, INT J NURS STUD, V93, P74, DOI 10.1016/j.ijnurstu.2019.02.012; Zimmermann L, 2014, PATIENT EDUC COUNS, V96, P98, DOI 10.1016/j.pec.2014.04.015	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241010	10.1371/journal.pone.0241010	http://dx.doi.org/10.1371/journal.pone.0241010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156867	Green Published, gold			2022-12-26	WOS:000591376400016
J	Brunk, E; Becker, MW; Bix, L				Brunk, Eric; Becker, Mark W.; Bix, Laura			Empirical evaluation of the presence of a label containing standard drinks on pour accuracy among US college students	PLOS ONE			English	Article							KNOWLEDGE; ABILITY; GLASS; SHAPE	Purpose Alcohol concentration has traditionally been labeled in the form of alcohol by volume (ABV). This format can cause difficulty in evaluating accuracy of a pour because it doesn't directly connect with recommendations related to "standard drinks," the approach used by the US CDC and others organizations which intend to facilitate responsible drinking behaviors. Strategies which more directly connect guidelines related to healthy drinking behaviors to alcohol labeling are needed. Objective Assess how a label identifying the number of standard drinks per container impacts the ability of undergraduate students to accurately pour a standard drink. Design This study employed a 3 x 2 x 2 experimental design. Undergraduates were asked to pour a standard drink from mock products from three alcohol categories (beer, wine and liquor); products were presented in two types of label (traditional ABV vs. standard drinks/container) at two concentrations of alcohol content (high and low). Results We calculated standardized pour errors (pour errors in standard drink units). Analysis of these standardized pour errors suggested that 1) people tended to underpour beverages of low concentration across product categories and overpour those high in concentration. 2) When the standard drink label was present, pour accuracy was improved, when compared with pours from containers affixed with ABV labels in low alcohol concentrations across all product categories (beer, wine and liquor). 3) For treatments that comprised high concentrations of alcohol, the standard drink label significantly increased accuracy only for beer. However, it is worth noting that beer with an ABV label was the condition with the most dramatic overpours, and these problematic overpours were dramatically reduced by the addition of a standard drink label. Conclusions Our work empirically supports the notion that Undergraduate students are better able to accurately assess and pour a standard drink of alcohol from bottles incorporating a label which includes standard drinks/container vs. those with traditional ABV labeling. That said, the effect is quite different for each alcohol category: beer, wine, and liquor and depends on whether the product is high or low in concentration of alcohol for its category; as such, policy makers should consider alcohol categories and concentrations from a public health perspective when recommending changes to labeling.	[Brunk, Eric; Bix, Laura] Michigan State Univ, Packaging HUB, Healthcare Universal Design & Biomech Lab, E Lansing, MI 48824 USA; [Becker, Mark W.] Michigan State Univ, Cognit & Cognit Neurosci Grp, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Bix, L (corresponding author), Michigan State Univ, Packaging HUB, Healthcare Universal Design & Biomech Lab, E Lansing, MI 48824 USA.	bixlaura@msu.edu		Bix, Laura/0000-0002-5779-7474	College of Agriculture and Natural Resources; USDA Hatch Act Program NIFA [MICL 00263]	College of Agriculture and Natural Resources; USDA Hatch Act Program NIFA	The study presented herein was funded internally partially through proceeds developed by a conference our laboratory holds every other year, and partially through a grant from the College of Agriculture and Natural Resources that intends to enable Undergraduate Students to engage in research projects, provided to Eric Brunk. As mentioned above, a portion of this money remained upon completion of his UG Degree and, as such, was carried forward to support his MS work. A portion of Dr. Bix's salary is covered through the USDA Hatch Act Program within NIFA under project #MICL 00263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, WHAT IS STANDARD DRI; [Anonymous], 2018, FED REG, V83; [Anonymous], 2020, DRINK LEV DEF; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Center for Science in the Public Interest Consumer Federation of America National Consumers League, 2019, RESP TTB NOT 176 83; De Visser RO, 2012, DRUG ALCOHOL REV, V31, P206, DOI 10.1111/j.1465-3362.2011.00371.x; Devos-Comby Loraine, 2008, Curr Drug Abuse Rev, V1, P162; Epley N, 2006, PSYCHOL SCI, V17, P311, DOI 10.1111/j.1467-9280.2006.01704.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Hasking P, 2005, J DRUG EDUC, V35, P95, DOI 10.2190/9Y34-F5XR-AQV5-KEL8; Hobin E, 2018, ALCOHOL ALCOHOLISM, V53, P3, DOI 10.1093/alcalc/agx052; IBM Corporation, 2017, IBM SPSS STAT WINDOW; Jones SC, 2009, DRUG ALCOHOL REV, V28, P230, DOI 10.1111/j.1465-3362.2008.00020.x; Kanny D., 2011, MMWR SUPPLEMENTS S3, V62, P77; Kerr WC, 2009, DRUG ALCOHOL REV, V28, P360, DOI 10.1111/j.1465-3362.2009.00056.x; Loxey W, 2004, PREVENTION SUBSTANCE; MARTIN CS, 1991, J DRUG EDUC, V21, P149, DOI 10.2190/0T17-GTXP-NW2P-ELN6; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Osiowy M, 2015, ADDICT RES THEORY, V23, P163, DOI 10.3109/16066359.2014.955480; Stockwell T, 1990, Drug Alcohol Rev, V9, P81, DOI 10.1080/09595239000185111; STOCKWELL T, 1991, AUST J PUBLIC HEALTH, V15, P56; Stockwell T., 1991, HEALTH PROMOT INT, V6, P207, DOI [https://doi.org/10.1093/heapro/6.3.207, DOI 10.1093/HEAPRO/6.3.207]; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Walker D, 2014, SUBST USE MISUSE, V49, P295, DOI 10.3109/10826084.2013.832327; Wansink B, 2005, BRIT MED J, V331, P1512, DOI 10.1136/bmj.331.7531.1512; Wettlaufer A, 2018, SUBST USE MISUSE, V53, P585, DOI 10.1080/10826084.2017.1349798; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x; White AM, 2005, ALCOHOL CLIN EXP RES, V29, P631, DOI 10.1097/01.ALC.0000158836.77407.E6	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241583	10.1371/journal.pone.0241583	http://dx.doi.org/10.1371/journal.pone.0241583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PT	33151959	Green Published, gold			2022-12-26	WOS:000591376200035
J	Di Carlo, P; Chiacchiaretta, P; Sinjari, B; Aruffo, E; Stuppia, L; De Laurenzi, V; Di Tomo, P; Pelusi, L; Potenza, F; Veronese, A; Vecchiet, J; Falasca, K; Ucciferri, C				Di Carlo, Piero; Chiacchiaretta, Piero; Sinjari, Bruna; Aruffo, Eleonora; Stuppia, Liborio; De Laurenzi, Vincenzo; Di Tomo, Pamela; Pelusi, Letizia; Potenza, Francesca; Veronese, Angelo; Vecchiet, Jacopo; Falasca, Katia; Ucciferri, Claudio			Air and surface measurements of SARS-CoV-2 inside a bus during normal operation	PLOS ONE			English	Article								Transmission pathways of SARS-CoV-2 are aerosol, droplet and touching infected material. The diffusion of the virus contagion among people is easier in indoor location, but direct detection of SARS-CoV-2 in air or on surfaces is quite sparse, especially regarding public transport, while it would be important to know how and if it is safe to use them. To answer these questions we analysed the air and the surfaces most usually touched by passengers inside a city bus during normal operation, in order to understand the possible spreading of the virus and the effectiveness of the protective measures. The measurements were carried out across the last week of the lockdown and the first week when, gradually, all the travel restrictions were removed. The air and surface samples were analysed with the RT-PCR for the detection of SARS-CoV-2 virus. After two weeks of measurements and more than 1100 passenger travelling on the bus the virus was never detected both on surfaces and on air, suggesting that the precautions adopted on public transportation are effective in reducing the COVID-19 spreading.	[Di Carlo, Piero; Aruffo, Eleonora; Stuppia, Liborio] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Di Carlo, Piero; Aruffo, Eleonora; Stuppia, Liborio; De Laurenzi, Vincenzo; Di Tomo, Pamela; Pelusi, Letizia; Potenza, Francesca; Veronese, Angelo] Univ G dAnnunzio, Ctr Adv Studies & Technol CAST, Chieti, Italy; [Chiacchiaretta, Piero] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Sinjari, Bruna; De Laurenzi, Vincenzo] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Vecchiet, Jacopo; Falasca, Katia; Ucciferri, Claudio] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Vecchiet, Jacopo; Falasca, Katia; Ucciferri, Claudio] SS Annunziata Hosp, Clin Infect Dis, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Di Carlo, P (corresponding author), Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.; Di Carlo, P (corresponding author), Univ G dAnnunzio, Ctr Adv Studies & Technol CAST, Chieti, Italy.	piero.dicarlo@unich.it	Di Carlo, Piero/Q-4450-2016; Sinjari, Bruna/AAG-5781-2019; Chiacchiaretta, Piero/J-3972-2016	Di Carlo, Piero/0000-0003-4971-4509; Sinjari, Bruna/0000-0002-4444-3343; Chiacchiaretta, Piero/0000-0003-1089-9809; ARUFFO, ELEONORA/0000-0002-9164-7293; DI TOMO, PAMELA/0000-0003-1995-3306; UCCIFERRI, Claudio/0000-0002-5866-3849	DISPUTER research funds	DISPUTER research funds	This work was partially supported by DISPUTER research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Buonanno G., 2020, Environ Int, V141, P105794, DOI [DOI 10.1016/j.envint.2020.105794, 10.1016/j.envint.2020.105794]; Centers for Disease Control and Prevention, 2019, COR DIS 2019 COVID 1; Cheng SO, 2020, INT J SURG, V76, P71; Di Carlo P, 2020, NORMAL BREATHING REL; DPCM-Decree of the President of the Council of Ministers, 2020, GUID PUBL TRANSP; European Centre for Disease Prevention and Control (ECDC), 2020, ANTIMICROBIAL RESIST; Faridi S, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138401; Hadei M, 2020, AEROSOL AIR QUAL RES, V20, P911, DOI 10.4209/aaqr.2020.04.0158; IHM-Italian Health Ministry, REP COR IT 2020; ISS-Istituto Superiore di Sanita, 2020, EP PUBL HLTH; MIT- Minister of infrastructure and transport of the Italian Government, 2020, PROT SEC WORK PLAC T; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6	18	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0235943	10.1371/journal.pone.0235943	http://dx.doi.org/10.1371/journal.pone.0235943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151953	gold, Green Submitted, Green Published			2022-12-26	WOS:000591376200085
J	Golassa, L; Messele, A; Amambua-Ngwa, A; Swedberg, G				Golassa, Lemu; Messele, Alebachew; Amambua-Ngwa, Alfred; Swedberg, Gote			High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; HISTIDINE-RICH PROTEIN-2; PLASMODIUM-FALCIPARUM; MALARIA PARASITES	Deletions in Plasmodium falciparum histidine rich protein 2(pfhrp2) gene threaten the usefulness of the most widely used HRP2-based malaria rapid diagnostic tests (mRDTs) that cross react with its structural homologue, PfHRP3. Parasites with deleted pfhrp2/3 genes remain undetected and untreated due to 'false-negative' RDT results. As Ethiopia recently launched malaria elimination by 2030 in certain selected areas, the availability of RDTs and the scale of their use have rapidly increased in recent years. Thus, it is important to explore the presence and prevalence of deletion in the target genes, pfhrp2 and pfhrp3. From a total of 189 febrile patients visited Adama Malaria Diagnostic centre, sixty-four microscopically-and polymerase chain reaction (PCR)-confirmed P. falciparum clinical isolates were used to determine the frequency of pfhrp2/3 gene deletions. Established PCR assays were applied to DNA extracted from blood spotted onto filter papers to amplify across pfhrp2/3 exons and flanking regions. However, analysis of deletions in pfhrp2, pfhrp3 and flanking genomic regions was successful for 50 of the samples. The pfhrp2 gene deletion was fixed in the population with all 50(100%) isolates presenting a deletion variant. This deletion extended downstream towards the Pf3D7 0831900 (MAL7PI.230) gene in 11/50 (22%) cases. In contrast, only 2/50 (4%) of samples had deletions for the Pf3D7 0831700 (MALPI.228) gene, upstream of pfhrp2. Similarly, the pfhrp3 gene was deleted in all isolates (100%), while 40% of the isolates had an extension of the deletion to the downstream flanking region that codes for Pf3D7 13272400 (MAL13PI.485).The pfhrp3 deletion also extended upstream to Pf3D7 081372100 (MAL13PI.475) region in 49/50 (95%) of the isolates, exhibiting complete absence of the locus. Although all samples showed deletions of pfhrp2 exon regions, amplification of an intron region was successful in five cases. Two different repeat motifs in the intron regions were observed in the samples tested. Pfhrp2/3 gene deletions are fixed in Ethiopia and this will likely reduce the effectiveness of PfHRP2-based mRDTs. It will be important to determine the sensitivity PfHRP 2/3-based RDTs in these populations and conduct a countrywide survey to determine the extent of these deletions and its effect on routine RDT-based malaria diagnosis.	[Golassa, Lemu; Messele, Alebachew] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Amambua-Ngwa, Alfred] London Sch Hyg & Trop Med, MRC Unit Gambia, Banjul, Gambia; [Swedberg, Gote] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Addis Ababa University; University of London; London School of Hygiene & Tropical Medicine; Uppsala University	Golassa, L (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	lgolassa@gmail.com	Swedberg, Gote/AAD-8258-2022; Amambua-Ngwa, Alfred/AHD-7882-2022; Golassa, Lemu/AAJ-2204-2021; Amambua-Ngwa, Alfred/HGU-8062-2022	Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Kebede, Alebachew Messele/0000-0002-5244-4020	DELTAS Africa Initiative [DELGEME] [107740/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [DELGEME] [107740/Z/15/Z]; UK government	DELTAS Africa Initiative [DELGEME]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [DELGEME](Wellcome Trust); UK government	This work was supported through the DELTAS Africa Initiative [DELGEME grant 107740/Z/15/Z]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DELGEME grant 107740/Z/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababa A, 2015, FEDERAL DEMOCRATIC R; Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Berhane A, 2018, EMERG INFECT DIS, V24, P462, DOI 10.3201/eid2403.171723; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Cheng Q, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-283; Endeshaw T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-118; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gatton ML, 2017, J INFECT DIS, V215, P1156, DOI 10.1093/infdis/jix094; Hayward RE, 2000, EXP PARASITOL, V96, P139, DOI 10.1006/expr.2000.4557; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plucinski MM, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00875-19; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Taffese HS, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0487-3; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Watson OJ, 2017, ELIFE, V6, DOI [10.7554/eLife.25008, 10.7554/elife.25008]; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WHO, 2016, WORLD MAL REP 2016; World Health Organization, MAL RAP DIAGN TEST P; World Health Organization, WORLD MAL REP 2015; 2017, EUR UROL S, V16	30	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241807	10.1371/journal.pone.0241807	http://dx.doi.org/10.1371/journal.pone.0241807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152025	Green Published, gold			2022-12-26	WOS:000591376200027
J	Jerbi, M; Labidi, S; Sahraoui, ALH; Chaar, H; Ben Jeddi, F				Jerbi, Maroua; Labidi, Sonia; Lounes-Hadj Sahraoui, Anissa; Chaar, Hatem; Ben Jeddi, Faysal			Higher temperatures and lower annual rainfall do not restrict, directly or indirectly, the mycorrhizal colonization of barley (Hordeum vulgare L.) under rainfed conditions	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL; ROOT COLONIZATION; SEASONAL-VARIATION; SOIL AGGREGATION; CLIMATIC FACTORS; ATMOSPHERIC CO2; PLS-SEM; FUNGI; NITROGEN; IMPACT	Whereas the role of arbuscular mycorrhizal fungi (AMF) in plant growth improvement has been well described in agroecosystems, little is known about the effect of environmental factors on AMF root colonization status of barley, the fourth most important cereal crop all over the world. In order to understand the influence of environmental factors, such as climatic and soil physico-chemical properties, on the spontaneous mycorrhizal ability of barley (Hordeum vulgare L.), a field investigation was conducted in 31 different sites in sub-humid, upper and middle semi-arid areas of Northern Tunisia. Mycorrhizal root colonization of H. vulgare varied considerably among sites. Principal component analysis showed that barley mycorrhization is influenced by both climatic and edaphic factors. A partial least square structural equation modelling (PLS-SEM) revealed that 39% (R-2) of the total variation in AMF mycorrhizal rate of barley roots was mainly explained by chemical soil properties and climatic characteristics. Whereas barley root mycorrhizal rates were inversely correlated with soil organic nitrogen (ON), available phosphorus amounts (P), altitude (Z), average annual rainfall (AAR), they were directly correlated with soil pH and temperature. Our results indicated that AMF root colonization of barley was strongly related to climatic characteristics than chemical soil properties. The current study highlights the importance of the PLS-SEM to understand the interactions between climate, soil properties and AMF symbiosis of barley in field conditions.	[Jerbi, Maroua; Labidi, Sonia; Ben Jeddi, Faysal] Univ Carthage, Inst Natl Agron Tunisie, Lab Sci Horticoles LR13AGR01, Tunis, Mahrajene, Tunisia; [Lounes-Hadj Sahraoui, Anissa] Univ Littoral Cote dOpale, CNRS, Unite Chim Environm & Interact Vivant UCEIV, SFR Condorcet,FR 3417, Calais, France; [Chaar, Hatem] Univ Carthage, Inst Natl Agron Tunisie, Lab Grandes Cultures LR16INRAT02, Tunis, Mahrajene, Tunisia	Universite de Carthage; Centre National de la Recherche Scientifique (CNRS); Universite du Littoral-Cote-d'Opale; Universite de Carthage	Sahraoui, ALH (corresponding author), Univ Littoral Cote dOpale, CNRS, Unite Chim Environm & Interact Vivant UCEIV, SFR Condorcet,FR 3417, Calais, France.	lounes@univ-littoral.fr		Lounes-Hadj Sahraoui, Anissa/0000-0001-8478-0128; LABIDI, SONIA/0000-0002-9046-9835	Tunisian Ministry of Higher Education and Scientific Research; European Union; French Region of Hauts-de-France	Tunisian Ministry of Higher Education and Scientific Research; European Union(European Commission); French Region of Hauts-de-France	This study was supported by the Tunisian Ministry of Higher Education and Scientific Research. This work has also been carried out in the framework of the Alibiotech project which is financed by the European Union, the French State and the French Region of Hauts-de-France. We thank Safa Bousbih for creating the sampling map using Qgis software.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Auge RM, 2015, MYCORRHIZA, V25, P13, DOI 10.1007/s00572-014-0585-4; Bencherif K., 2019, MICROORGANISMS SALIN, VVolume 56, P265, DOI [10.1007/978-3-030-18975-4_11, DOI 10.1007/978-3-030-18975-4_11]; Bohrer KE, 2004, MYCORRHIZA, V14, P329, DOI 10.1007/s00572-004-0292-7; Bothmer R, 2003, DIVERSITY BARLEY HOR, V7, P300; Bruce RC, 1982, BULLETIN, VQB82004; Carrenho Rosilaine, 2007, Acta Bot. Bras., V21, P723, DOI 10.1590/S0102-33062007000300018; Ceccarelli S, 2007, EXP AGR, V43, P411, DOI 10.1017/S0014479707005327; Chin WW, 1998, QUANT METH SER, P295; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; Cole CV, 1954, 939 USDA AGR; Correa A, 2015, MYCORRHIZA, V25, P499, DOI 10.1007/s00572-015-0627-6; Coughlan AP, 2000, CAN J FOREST RES, V30, P1543, DOI 10.1139/cjfr-30-10-1543; Cregger MA, 2012, APPL ENVIRON MICROB, V78, P8587, DOI 10.1128/AEM.02050-12; de Oliveira AN, 2010, BRAZ ARCH BIOL TECHN, V53, P653, DOI 10.1590/S1516-89132010000300021; DGPA (Direction Generale de la Production Agricole), 2015, RAPP ACT 2015 DIR GE; DGPA (Direction Generale de la Production Agricole), 2018, RAPP ACT 2018 DIR GE; Driver JD, 2005, SOIL BIOL BIOCHEM, V37, P101, DOI 10.1016/j.soilbio.2004.06.011; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Farooq M., 2012, PLANT RESPONSES DROU, P1, DOI [10.1007/978-3-642-32653-0_1, DOI 10.1007/978-3-642-32653-0_1]; Fitter AH, 2000, NEW PHYTOL, V147, P179, DOI 10.1046/j.1469-8137.2000.00680.x; Frater PN, 2018, PLANT SOIL, V425, P493, DOI 10.1007/s11104-018-3597-6; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Global Modeling and Assimilation Office (GMAO), 2015, MERRA 2 TAVG1 2D SLV, DOI DOI 10.5067/VJAFPLI1CSIV; Grace EJ, 2008, THESIS; Guo HJ, 2012, AFR J MICROBIOL RES, V6, P5745, DOI 10.5897/AJMR11.1560; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Hair JF, 2014, PRIMER PARTIAL LEAST, P374; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hammer EC, 2011, SOIL BIOL BIOCHEM, V43, P2332, DOI 10.1016/j.soilbio.2011.07.004; Hattori R., 2014, International Journal of Agricultural Policy and Research, V2, P41; Hawkes CV, 2011, GLOBAL CHANGE BIOL, V17, P1637, DOI 10.1111/j.1365-2486.2010.02327.x; He F, 2016, EUR J SOIL SCI, V67, P847, DOI 10.1111/ejss.12381; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; HETRICK BAD, 1984, MYCOLOGIA, V76, P953, DOI 10.2307/3793155; Hodge A, 2010, FUNGAL ECOL, V3, P267, DOI 10.1016/j.funeco.2010.02.002; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; HOLFORD ICR, 1985, AUST J SOIL RES, V23, P417, DOI 10.1071/SR9850417; Jacobsen SE, 2012, FIELD CROP RES, V128, P34, DOI 10.1016/j.fcr.2011.12.001; Jalonen R, 2013, AGROFOREST SYST, V87, P319, DOI 10.1007/s10457-012-9553-1; Jansa J, 2019, CHEM BIOL TECHNOL AG, V6, DOI 10.1186/s40538-019-0147-2; Jones C, 2011, NEUROPSYCHOPHARMACOL, P1; JONES JB, 1987, J PLANT NUTR, V10, P1675, DOI 10.1080/01904168709363706; Klironomos JN, 2002, MYCORRHIZA, V12, P181, DOI 10.1007/s00572-002-0169-6; Kotilinek M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06938-x; Labidi S, 2015, MYCORRHIZA, V25, P297, DOI 10.1007/s00572-014-0609-0; Labidi S, 2011, PHYTOCHEMISTRY, V72, P2335, DOI 10.1016/j.phytochem.2011.08.016; Leifheit EF, 2014, PLANT SOIL, V374, P523, DOI 10.1007/s11104-013-1899-2; Lenoir I, 2016, PHYTOCHEMISTRY, V123, P4, DOI 10.1016/j.phytochem.2016.01.002; Lugo MA, 2003, MYCOLOGIA, V95, P407, DOI 10.2307/3761882; Lumini E, 2011, ECOL APPL, V21, P1696, DOI 10.1890/10-1542.1; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Morton JB, 2001, MYCOLOGIA, V93, P181, DOI 10.2307/3761615; Mustafa G, 2016, MYCORRHIZA, V26, P685, DOI 10.1007/s00572-016-0698-z; Mustafa G, 2017, FUNCT PLANT BIOL, V44, P443, DOI 10.1071/FP16206; Naanaa W., 1988, METHODES ANAL PHYS C, P118; Ouzounidou G, 2015, BRAZ J BOT, V38, P487, DOI 10.1007/s40415-015-0166-6; Pauwels J.M., 1992, PUBLICATIONS AGRICOL, VN28, P265; Petard, 1993, METHODES ANAL, V5, P7; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Posada RH, 2008, J APPL MICROBIOL, V104, P132, DOI 10.1111/j.1365-2672.2007.03533.x; Pregitzer KS, 2005, ECOL STU AN, V181, P277; Querejeta JI, 2009, ECOLOGY, V90, P649, DOI 10.1890/07-1696.1; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Ruotsalainen AL, 2004, ARCT ANTARCT ALP RES, V36, P239, DOI 10.1657/1523-0430(2004)036[0239:RFCAAA]2.0.CO;2; Sarstedt M, 2015, PROCEEDINGS OF THE 2009 ACADEMY OF MARKETING SCIENCE (AMS) ANNUAL CONFERENCE, P8; Sivakumar N., 2013, Annals of Microbiology, V63, P151, DOI 10.1007/s13213-012-0455-2; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Soudzilovskaia NA, 2015, GLOBAL ECOL BIOGEOGR, V24, P371, DOI 10.1111/geb.12272; Staddon PL, 2004, GLOBAL CHANGE BIOL, V10, P1909, DOI 10.1111/j.1365-2486.2004.00861.x; Staddon PL, 2003, GLOBAL CHANGE BIOL, V9, P186, DOI 10.1046/j.1365-2486.2003.00593.x; Stocker T. F., 2013, CAMBRIDGE, P1535, DOI DOI 10.1017/CB09781107415324; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; USDA (United States Department of Agriculture). Word Agricultural Production. Office of global analysis. Foreign Agricultural Service, 2019, CIRC SER WAP, VWAP 11-19, P33; WANG GM, 1993, NEW PHYTOL, V124, P465, DOI 10.1111/j.1469-8137.1993.tb03837.x; Wang YY, 2018, J PHYTOPATHOL, V166, P67, DOI 10.1111/jph.12662; Wenzel A, 2015, METABOLOMICS, V11, P454, DOI 10.1007/s11306-014-0708-0; Wilson H, 2016, PEERJ, V4, DOI 10.7717/peerj.2083; Witzenberger A., 1989, Gesunde Pflanzen, V41, P384; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; Zhang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23488; Zubek S, 2009, ARCT ANTARCT ALP RES, V41, P272, DOI 10.1657/1938-4246-41.2.272	91	4	4	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241794	10.1371/journal.pone.0241794	http://dx.doi.org/10.1371/journal.pone.0241794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33152013	gold, Green Published			2022-12-26	WOS:000591376200105
J	Chang, SH; Zhou, D; Eliasy, A; Li, YC; Elsheikh, A				Chang, Shao-Hsuan; Zhou, Dong; Eliasy, Ashkan; Li, Yi-Chen; Elsheikh, Ahmed			Experimental evaluation of stiffening effect induced by UVA/Riboflavin corneal cross-linking using intact porcine eye globes	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BIOMECHANICAL CHANGES; COLLAGEN; ULTRAVIOLET; RIBOFLAVIN; RIBOFLAVIN/ULTRAVIOLET; VISUALIZATION; ORIENTATION; KERATOCONUS; STRAIN	UVA/riboflavin corneal cross-linking (CXL) is a common used approach to treat progressive keratoconus. This study aims to investigate the alteration of corneal stiffness following CXL by mimicking the inflation of the eye under the in vivo loading conditions. Seven paired porcine eye globes were involved in the inflation test to examine the corneal behaviour. Cornea-only model was constructed using the finite element method, without considering the deformation contribution from sclera and limbus. Inverse analysis was conducted to calibrate the non-linear material behaviours in order to reproduce the inflation test. The corneal stress and strain values were then extracted from the finite element models and tangent modulus was calculated under stress level at 0.03 MPa. UVA/riboflavin cross-linked corneas displayed a significant increase in the material stiffness. At the IOP of 27.25 mmHg, the average displacements of corneal apex were 307 +/- 65 mu m and 437 +/- 63 mu m (p = 0.02) in CXL and PBS corneas, respectively. Comparisons performed on tangent modulus ratios at a stress of 0.03 MPa, the tangent modulus measured in the corneas treated with the CXL was 2.48 +/- 0.69, with a 43 +/- 24% increase comparing to its PBS control. The data supported that corneal material properties can be well-described using this inflation methods following CXL. The inflation test is valuable for investigating the mechanical response of the intact human cornea within physiological IOP ranges, providing benchmarks against which the numerical developments can be translated to clinic.	[Chang, Shao-Hsuan; Zhou, Dong; Eliasy, Ashkan; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Chang, Shao-Hsuan; Li, Yi-Chen] Feng Chia Univ, Dept Chem Engn, Taichung, Taiwan	University of Liverpool; Feng Chia University	Chang, SH (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.; Chang, SH; Li, YC (corresponding author), Feng Chia Univ, Dept Chem Engn, Taichung, Taiwan.	changshao1311@gmail.com; yicli@fcu.edu.tw	Eliasy, Ashkan/AAF-4941-2019	Eliasy, Ashkan/0000-0002-4473-1900; Elsheikh, Ahmed/0000-0001-7456-1749	Tawian Ministry of Science and Technology [MOST 109-2221-E-035 -036 -MY3, MOST 109-2221-E-035 -007 -MY3]	Tawian Ministry of Science and Technology	This work was supported by grants from the Tawian Ministry of Science and Technology (MOST 109-2221-E-035 -036 -MY3 and MOST 109-2221-E-035 -007 -MY3).	Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9; Akhtar S, 2013, MOL VIS, V19, P1526; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2013, BENEFITS Q, V29, P64; Bell JS, 2018, ACTA BIOMATER, V65, P216, DOI 10.1016/j.actbio.2017.11.015; Chai D, 2011, INVEST OPHTH VIS SCI, V52, P4231, DOI 10.1167/iovs.10-7105; Chang SH, 2018, J REFRACT SURG, V34, P264, DOI 10.3928/1081597X-20180220-01; Elsheikh A, 2005, J R SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Girard G, 2011, MICROBIOL-SGM, V157, P398, DOI 10.1099/mic.0.043075-0; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Godefrooij DA, 2017, AM J OPHTHALMOL, V175, P169, DOI 10.1016/j.ajo.2016.12.015; Hayes S, 2007, ANAT REC, V290, P1542, DOI 10.1002/ar.20613; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Ivekovic S, 2008, EVOL COMPUT, V16, P509, DOI 10.1162/evco.2008.16.4.509; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Koster S, 2007, LANGMUIR, V23, P357, DOI 10.1021/la062473a; Kohgo H, 2006, J COMPUT ASSIST TOMO, V30, P111, DOI 10.1097/01.rct.0000188652.12270.98; Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0; MARTIN RB, 1993, J BIOMECH, V26, P1047, DOI 10.1016/S0021-9290(05)80004-1; Matteoli S, 2016, J APPL BIOMATER FUNC, V14, pE163, DOI 10.5301/jabfm.5000262; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Roy AS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002934; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Shin TJ, 1997, J BIOMECH, V30, P497, DOI 10.1016/S0021-9290(97)84433-8; Smolek MK, 1998, J CATARACT REFR SURG, V24, P1079, DOI 10.1016/S0886-3350(98)80101-6; Spoerl E, 1999, J REFRACT SURG, V15, P711; Srodka W, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952189; Wang XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136999; Whitford C, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0052-8; Whitford C, 2015, J MECH BEHAV BIOMED, V42, P76, DOI 10.1016/j.jmbbm.2014.11.006; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015; WOO SLY, 1972, EXP EYE RES, V14, P29, DOI 10.1016/0014-4835(72)90139-X; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	40	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240724	10.1371/journal.pone.0240724	http://dx.doi.org/10.1371/journal.pone.0240724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147249	Green Published, gold			2022-12-26	WOS:000589609300060
J	Kato, S; Shimizu, K; Igarashi, A				Kato, Sayaka; Shimizu, Kimiya; Igarashi, Akihito			Assessment of low-vault cases with an implantable collamer lens	PLOS ONE			English	Article							PHAKIC INTRAOCULAR-LENS; IN-SITU KERATOMILEUSIS; LOW-TO-MODERATE; ROTATIONAL STABILITY; VISUAL OUTCOMES; FOLLOW-UP	This study aimed to examine clinical results in low-vault eyes after implementation of a Hole implantable collamer lens (KS-AquaPORT (TM), STAAR Surgical Company) in terms of visual outcomes and complications over a one-year follow-up period. This was a retrospective cohort study of subjects who underwent Hole implantable collamer lens surgery at Sanno Hospital, exhibited low vault, and were followed up for 1 year. Patients were included if they met the following criteria: 20 <= age <= 55 years; stable refraction >= 6 months; -1.0 to -20.0 diopters of myopia; endothelial cell density >= 1800 cells/mm(2); and no history of ocular surgery, progressive corneal degeneration, cataract, glaucoma, or uveitis. Main outcome measurements were the safety and efficacy indices, predictability, and vault. Values were indicated as the mean +/- standard deviation. Subjects included 16 patients (age: 38 +/- 8 years; 6 males; 25 eyes). Toric lenses were utilized for 10 eyes. Implantable collamer lens size was 12.1, 12.6, and 13.2 mm for 18, 6, and 1 eye(s), respectively. One year postoperatively, the safety index was 1.07; for 22 eyes with a target refraction of that of emmetropic eyes, the efficacy index was 0.90; and 96% of eyes were within +/- 0.50 diopters of attempted versus achieved spherical equivalent correction. Postoperative vault was 142 +/- 60 mu m. One year postoperatively, no additional surgery was required for rotation of toric implantable collamer lens, and no advanced cataracts, increased intraocular pressure, or decreased endothelial cells were observed. In conclusion, Hole implantable collamer lens yielded satisfactory visual outcomes and no postoperative complications for low-vault eyes, suggesting its suitability for such cases.	[Kato, Sayaka; Shimizu, Kimiya; Igarashi, Akihito] Sanno Hosp, Eye Ctr, Tokyo, Japan		Kato, S (corresponding author), Sanno Hosp, Eye Ctr, Tokyo, Japan.	sayaka331010843@yahoo.co.jp						Alfonso JF, 2011, J CATARACT REFR SURG, V37, P873, DOI 10.1016/j.jcrs.2010.11.040; Atchison DA, 2008, J VISION, V8, DOI 10.1167/8.4.29; Baikoff G, 2006, J CATARACT REFR SURG, V32, P1827, DOI 10.1016/j.jcrs.2006.08.025; Dougherty PJ, 2017, CLIN OPHTHALMOL, V11, P273, DOI 10.2147/OPTH.S120427; Ganesh S, 2017, CLIN OPHTHALMOL, V11, P1253, DOI 10.2147/OPTH.S127101; Goukon H, 2017, BRIT J OPHTHALMOL, V101, P1461, DOI 10.1136/bjophthalmol-2016-309363; Igarashi A, 2019, J CATARACT REFR SURG, V45, P1099, DOI 10.1016/j.jcrs.2019.02.020; Igarashi A, 2014, AM J OPHTHALMOL, V157, P532, DOI 10.1016/j.ajo.2013.11.006; Igarashi A, 2009, AM J OPHTHALMOL, V148, P164, DOI 10.1016/j.ajo.2009.02.001; Fernandez-Vigo JI, 2017, AM J OPHTHALMOL, V181, P37, DOI 10.1016/j.ajo.2017.06.018; Kamiya K, 2018, BRIT J OPHTHALMOL, V102, P177, DOI 10.1136/bjophthalmol-2017-310164; Kamiya K, 2012, AM J OPHTHALMOL, V153, P1178, DOI 10.1016/j.ajo.2011.12.005; Kamiya K, 2009, ARCH OPHTHALMOL-CHIC, V127, P845, DOI 10.1001/archophthalmol.2009.67; Kobashi H, 2014, J CATARACT REFR SURG, V40, P2019, DOI 10.1016/j.jcrs.2014.03.028; Kojima T, 2010, J REFRACT SURG, V26, P327, DOI 10.3928/1081597X-20090617-11; Lee H, 2018, J REFRACT SURG, V34, P489, DOI 10.3928/1081597X-20180521-01; Pjano Melisa Ahmedbegovic, 2017, Med Arch, V71, P93, DOI 10.5455/medarh.2017.71.93-96; Rodriguez-Una I, 2017, J REFRACT SURG, V33, P244, DOI 10.3928/1081597X-20170110-01; Sanders DR, 2008, J REFRACT SURG, V24, P566, DOI 10.3928/1081597X-20080601-04; Schmidinger G, 2010, OPHTHALMOLOGY, V117, P1506, DOI 10.1016/j.ophtha.2009.12.013; Sheng XL, 2012, INT J OPHTHALMOL-CHI, V5, P459, DOI 10.3980/j.issn.2222-3959.2012.04.10; Shimizu K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003270; Shimizu K, 2012, BRIT J OPHTHALMOL, V96, P409, DOI 10.1136/bjophthalmol-2011-300148; Yan ZP, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8678352	24	3	4	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241814	10.1371/journal.pone.0241814	http://dx.doi.org/10.1371/journal.pone.0241814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147267	Green Published, gold			2022-12-26	WOS:000589609300058
J	Wan, HB; Selvaggio, G; Pearlstein, RA				Wan, Hongbin; Selvaggio, Gianluca; Pearlstein, Robert A.			Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia	PLOS ONE			English	Article							LONG-QT-SYNDROME; CARDIAC-ARRHYTHMIA; DRUGS; KINETICS; INSIGHTS; DISSOCIATION; HYDROXYCHLOROQUINE; PROARRHYTHMIA; PROLONGATION; MECHANISMS	The human ether-a-go-go-related voltage-gated cardiac ion channel (commonly known as hERG) conducts the rapid outward repolarizing potassium current in cardiomyocytes (I-Kr). Inadvertent blockade of this channel by drug-like molecules represents a key challenge in pharmaceutical R&D due to frequent overlap between the structure-activity relationships of hERG and many primary targets. Building on our previous work, together with recent cryo-EM structures of hERG, we set about to better understand the energetic and structural basis of promiscuous blocker-hERG binding in the context of Biodynamics theory. We propose a two-step blocker binding process consisting of: The initial capture step: diffusion of a single fully solvated blocker copy into a large cavity lined by the intra-cellular cyclic nucleotide binding homology domain (CNBHD). Occupation of this cavity is a necessary but insufficient condition for ion current disruption. The IKr disruption step: translocation of the captured blocker along the channel axis, such that: The head group, consisting of a quasi-rod-shaped moiety, projects into the open pore, accompanied by partial de-solvation of the binding interface. One tail moiety packs along a kink between the S6 helix and proximal C-linker helix adjacent to the intra-cellular entrance of the pore, likewise accompanied by mutual de-solvation of the binding interface (noting that the association barrier is comprised largely of the total head + tail group de-solvation cost). Blockers containing a highly planar moiety that projects into a putative constriction zone within the closed channel become trapped upon closing, as do blockers terminating prior to this region. A single captured blocker copy may conceivably associate and dissociate to/from the pore many times before exiting the CNBHD cavity. Lastly, we highlight possible flaws in the current hERG safety index (SI), and propose an alternate in vivo-relevant strategy factoring in: Benefit/risk. The predicted arrhythmogenic fractional hERG occupancy (based on action potential (AP) simulations of the undiseased human ventricular cardiomyocyte). Alteration of the safety threshold due to underlying disease. Risk of exposure escalation toward the predicted arrhythmic limit due to patient-to-patient pharmacokinetic (PK) variability, drug-drug interactions, overdose, and use for off-label indications in which the hERG safety parameters may differ from their on-label counterparts.	[Wan, Hongbin; Selvaggio, Gianluca; Pearlstein, Robert A.] Novartis Inst BioMed Res, Comp Aided Drug Discovery, Global Discovery Chem, Cambridge, MA 02139 USA	Novartis	Pearlstein, RA (corresponding author), Novartis Inst BioMed Res, Comp Aided Drug Discovery, Global Discovery Chem, Cambridge, MA 02139 USA.	robert.pearlstein@novartis.com	WAN, HONGBIN/AAH-9691-2020	WAN, HONGBIN/0000-0002-4875-531X; Selvaggio, Gianluca/0000-0001-8911-7288; Pearlstein, Robert/0000-0002-4313-8136				Akhavan A, IDENTIFICATION CYCLI, DOI [10.1242/jcs.02423, DOI 10.1242/JCS.02423]; Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018; [Anonymous], 2018, BMJ, V362, pk3210; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; BARBER MJ, 1992, J CLIN INVEST, V90, P368, DOI 10.1172/JCI115871; Capel RA, 2015, HEART RHYTHM, V12, P2186, DOI 10.1016/j.hrthm.2015.05.027; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; Chang KC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00917; Cheung AK, 2018, J MED CHEM, V61, P11021, DOI 10.1021/acs.jmedchem.8b01291; Colatsky T, 2016, J PHARMACOL TOX MET, V81, P15, DOI 10.1016/j.vascn.2016.06.002; Concordia Pharmaceuticals, 2017, PLAQ HYDR SULF TABL; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dickson CJ, 2020, J CHEM INF MODEL, V60, P192, DOI 10.1021/acs.jcim.9b00773; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Giudicessi JR, 2020, HEART RHYTHM, V17, P1487, DOI 10.1016/j.hrthm.2020.04.045; Giudicessi JR, 2020, MAYO CLIN P MAYO CLI; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; Juhasz B, 2011, J CELL MOL MED, V15, P1973, DOI 10.1111/j.1582-4934.2010.01153.x; Kalyaanamoorthy S, 2018, MED RES REV, V38, P525, DOI 10.1002/med.21445; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kerr SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47436-6; Kirsch Glenn E., 2004, Journal of Pharmacological and Toxicological Methods, V50, P93, DOI 10.1016/j.vascn.2004.06.003; Liang SI, 2018, CELL REP, V22, P2593, DOI 10.1016/j.celrep.2018.02.031; Lim HS, 2009, ANTIMICROB AGENTS CH, V53, P1468, DOI 10.1128/AAC.00339-08; Mercuro Nicholas J, 2020, JAMA Cardiol, V5, P1036, DOI 10.1001/jamacardio.2020.1834; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Nagatomo T, POSTER P3 6 COMP HER; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pearlstein RA, 2016, CURR TOP MED CHEM, V16, P1792, DOI 10.2174/1568026616666160315142156; Pearlstein RA, 2013, PROTEINS, V81, P1509, DOI 10.1002/prot.24276; Pearlstein RA, 2010, PROTEINS, V78, P2571, DOI 10.1002/prot.22767; Tran QT, 2013, PROTEINS, V81, P291, DOI 10.1002/prot.24185; Recanatini M, 2008, CHEMMEDCHEM, V3, P523, DOI 10.1002/cmdc.200700264; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Selvaggio G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202376; Stork D, 2007, BRIT J PHARMACOL, V151, P1368, DOI 10.1038/sj.bjp.0707356; Szendrei L, 2002, BIOCHEM PHARMACOL, V63, P543, DOI 10.1016/S0006-2952(01)00913-3; Tosaki A, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00616; Traebert M, 2004, EUR J PHARMACOL, V484, P41, DOI 10.1016/j.ejphar.2003.11.003; Tran QT, 2014, PROTEINS, V82, P2998, DOI 10.1002/prot.24659; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vasseur L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133181; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Windisch A, 2011, BRIT J PHARMACOL, V162, P1542, DOI 10.1111/j.1476-5381.2010.01159.x; Windley MJ, 2018, MOL PHARMACOL, V94, P760, DOI 10.1124/mol.117.111534; Wisniowska B, 2009, TOXICOL MECH METHOD, V19, P278, DOI 10.1080/15376510902777194; Yang ZJ, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.115.003560; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; Yu Z, 2015, BRIT J PHARMACOL, V172, P940, DOI 10.1111/bph.12967	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0234946	10.1371/journal.pone.0234946	http://dx.doi.org/10.1371/journal.pone.0234946			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147278	gold, Green Published, Green Submitted			2022-12-26	WOS:000589609300081
J	Ramos-Romero, S; Santocildes, G; Pinol-Pinol, D; Roses, C; Pages, T; Hereu, M; Amezqueta, S; Torrella, JR; Torres, JL; Viscor, G				Ramos-Romero, Sara; Santocildes, Garoa; Pinol-Pinol, David; Roses, Carles; Pages, Teresa; Hereu, Merce; Amezqueta, Susana; Ramon Torrella, Joan; Lluis Torres, Josep; Viscor, Gines			Implication of gut microbiota in the physiology of rats intermittently exposed to cold and hypobaric hypoxia	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BACTERIAL DYSBIOSIS; ENERGY-BALANCE; MECHANISMS; OBESITY; HOMEOSTASIS; RECOVERY; EXERCISE; DIET	This study examines the influence of intermittent exposure to cold, hypobaric hypoxia, and their combination, in gut microbiota and their metabolites in vivo, and explores their effects on the physiology of the host. Sprague-Dawley rats were exposed to cold (4 degrees C), hypobaric hypoxia (462 torr), or both simultaneously, 4 h/day for 21 days. Biometrical and hematological parameters were monitored. Gut bacterial subgroups were evaluated by qPCR and short-chain fatty acids were determined by gas chromatography in caecum and feces. Cold increased brown adipose tissue, Clostridiales subpopulation and the concentration of butyric and isovaleric acids in caecum. Hypobaric hypoxia increased hemoglobin, red and white cell counts and Enterobacteriales, and reduced body and adipose tissues weights and Lactobacilliales. Cold plus hypobaric hypoxia counteracted the hypoxia-induced weight loss as well as the increase in white blood cells, while reducing the Bacteroidetes:Firmicutes ratio and normalizing the populations of Enterobacteriales and Lactobacilliales. In conclusion, intermittent cold and hypobaric hypoxia exposures by themselves modified some of the main physiological variables in vivo, while their combination kept the rats nearer to their basal status. The reduction of the Bacteroidetes:Firmicutes ratio and balanced populations of Enterobacteriales and Lactobacilliales in the gut may contribute to this effect.	[Ramos-Romero, Sara; Roses, Carles; Hereu, Merce; Lluis Torres, Josep] Inst Adv Chem Catalonia IQAC CSIC, Dept Biol Chem, Barcelona, Spain; [Ramos-Romero, Sara; Santocildes, Garoa; Pinol-Pinol, David; Pages, Teresa; Ramon Torrella, Joan; Viscor, Gines] Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Physiol Sect, Barcelona, Spain; [Amezqueta, Susana] Univ Barcelona, Dept Engn Quim & Quim Analit, Barcelona, Spain; [Amezqueta, Susana] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Barcelona; University of Barcelona; University of Barcelona	Ramos-Romero, S (corresponding author), Inst Adv Chem Catalonia IQAC CSIC, Dept Biol Chem, Barcelona, Spain.; Ramos-Romero, S (corresponding author), Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Physiol Sect, Barcelona, Spain.	sara.ramos@iqac.csic.es	Santocildes, Garoa/GYD-3847-2022; Viscor, Ginés/A-9519-2008; Torres, Josep Lluís/N-7256-2013; Pages, Teresa/G-4244-2011; Torrella, Joan Ramon/D-4919-2014; Ramos-Romero, Sara/K-8301-2017	Santocildes, Garoa/0000-0002-3728-2588; Viscor, Ginés/0000-0003-4942-2346; Torres, Josep Lluís/0000-0002-5072-8265; Pages, Teresa/0000-0002-4969-1522; Torrella, Joan Ramon/0000-0001-6314-6523; Pinol Pinol, David/0000-0002-2511-1271; Ramos-Romero, Sara/0000-0002-9293-4454; Roses Pol, Carles/0000-0003-0060-9353	Spanish Ministry of Economy, Industry and Competitiveness [DEP2013-48334-C2-1-P, AGL2017-83599-R, BES2014-068592]; University of Barcelona	Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); University of Barcelona	This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (DEP2013-48334-C2-1-P, AGL2017-83599-R and graduate fellowship BES2014-068592 to M.H.) and the University of Barcelona (graduate fellowship APIF 2016-2017 to G.S.).	Adak A, 2014, INDIAN J EXP BIOL, V52, P1098; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Burcelin R, 2016, TRENDS ENDOCRIN MET, V27, P67, DOI 10.1016/j.tem.2015.12.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dore J, 2015, CURR OPIN BIOTECH, V32, P195, DOI 10.1016/j.copbio.2015.01.002; Farre N, 2018, CHEST, V154, P754, DOI 10.1016/j.chest.2018.03.001; Hankenson FC, 2018, COMPARATIVE MED, V68, P425, DOI 10.30802/AALAS-CM-18-000049; Hereu M, 2018, J FUNCT FOODS, V50, P120, DOI 10.1016/j.jff.2018.09.018; Karl JP, 2018, AM J PHYSIOL-GASTR L, V315, pG1003, DOI 10.1152/ajpgi.00253.2018; Kayser B, 2013, OBES REV, V14, P579, DOI 10.1111/obr.12034; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Li BG, 2019, CELL REP, V26, P2720, DOI 10.1016/j.celrep.2019.02.015; Li LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09028; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Maier E, 2015, NUTRIENTS, V7, P45, DOI 10.3390/nu7010045; Moreno-Indias I, 2016, SLEEP, V39, P1891, DOI 10.5665/sleep.6176; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405; Quintero P, 2010, MED HYPOTHESES, V74, P901, DOI 10.1016/j.mehy.2009.10.022; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rizo-Roca D, 2017, J APPL PHYSIOL, V122, P580, DOI 10.1152/japplphysiol.00501.2016; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serebrovskaya TV, 2002, HIGH ALT MED BIOL, V3, P205, DOI 10.1089/15270290260131939; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Urdampilleta A, 2012, J PHYSIOL BIOCHEM, V68, P289, DOI 10.1007/s13105-011-0115-1; Viscor G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00814; Xing JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04453-9; Xu CL, 2014, WORLD J GASTROENTERO, V20, P4662, DOI 10.3748/wjg.v20.i16.4662; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75	33	9	9	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240686	10.1371/journal.pone.0240686	http://dx.doi.org/10.1371/journal.pone.0240686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33142314	Green Published, gold			2022-12-26	WOS:000588376700018
J	Tam, KM; Walker, N; Moreno, J				Tam, Ka-Ming; Walker, Nicholas; Moreno, Juana			Effect of mitigation measures on the spreading of COVID-19 in hard-hit states in the US	PLOS ONE			English	Article								State government-mandated social distancing measures have helped to slow the growth of the COVID-19 pandemic in the United States. Many of the current predictive models of the development of COVID-19, especially after mitigation efforts, partially rely on extrapolations from data collected in other countries. Since most states enacted stay-at-home orders towards the end of March, the resulting effects of social distancing should be reflected in the death and infection counts by the end of April. Using the data available through April 25(th), we investigate the change in the infection rate due to the mitigation efforts and project death and infection counts through September 2020 for some of the most heavily impacted states: New York, New Jersey, Michigan, Massachusetts, Illinois, and Louisiana. We find that with the current mitigation efforts, five of those six states have reduced their base reproduction number to a value less than one, stopping the exponential growth of the pandemic. We also project different scenarios after the mitigation is relaxed.	[Tam, Ka-Ming; Walker, Nicholas; Moreno, Juana] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; [Tam, Ka-Ming; Moreno, Juana] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Tam, KM (corresponding author), Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA.; Tam, KM (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.	kmtam@lsu.edu	; Moreno, Juana/D-5882-2012	Tam, Ka-Ming/0000-0002-2273-000X; Walker, Nicholas/0000-0001-6939-953X; Moreno, Juana/0000-0002-7601-9934	National Science Foundation EPSCoR CIMM project [OIA-1541079]	National Science Foundation EPSCoR CIMM project	This work is funded by the National Science Foundation EPSCoR CIMM project under award OIA-1541079. This work used the high performance computational resources provided by the Louisiana Optical Network Initiative and HPC@LSUcomputing.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acioli P. H., ARXIV200311449; Amaro J. E., ARXIV200313747; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Baker R., ARXIV200308285; Bastos SB, ARXIV200314288; Bin M., ARXIV200309930; Biswas K., ARXIV200307063; Brugnano L., ARXIV200309875; Calafiore G.C., ARXIV200314391; Crokidakis C., ARXIV200312150; Dell'Anna L., ARXIV200313571; Gaeta G, ARXIV200314098; Gaeta G., ARXIV200314102; Giordano G., ARXIV200309861; Huppert A, 2013, CLIN MICROBIOL INFEC, V19, P999, DOI 10.1111/1469-0691.12308; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu, ARXIV200300122; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Marchant R., ARXIV200404734; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Notari A., ARXIV200312417; Pedersen M, 2020, QUANTIFYING UNDETECT, DOI [10.13140/RG.2.2.11753.85600, DOI 10.13140/RG.2.2.11753.85600]; Piccolomini E. L., ARXIV200309909; Radulescu A., ARXIV200311150; Roques L., ARXIV200310720; Sameni R., 2020, ARXIV200311371; Schulz RA, ARXIV200313932; Simha A, ARXIV200311920; Sonnino G., ARXIV200313540; Tam K.-M., ARXIV200402859; te Vrugt M., ARXIV200313967; Teles P., ARXIV200310047; World Health Organization, 30 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang J., ARXIV200306419; Zhang Y., ARXIV200313901; Zlati V., ARXIV200308479; Zullo F., ARXIV200311363	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240877	10.1371/journal.pone.0240877	http://dx.doi.org/10.1371/journal.pone.0240877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141823	gold, Green Published, Green Submitted			2022-12-26	WOS:000588376700024
J	Amoras, EDG; Gomes, STM; Queiroz, MAF; de Araujo, MSM; de Araujo, MTF; Conde, SRSD; Ishak, R; Vallinoto, ACR				Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas Queiroz, Maria Alice; Moura de Araujo, Mauro Sergio; Ferreira de Araujo, Marialva Tereza; Souza da Silva Conde, Simone Regina; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos			Intrahepatic interleukin 10 expression modulates fibrinogenesis during chronic HCV infection	PLOS ONE			English	Article							CD4(+) T-CELLS; CYTOKINE PRODUCTION; HELPER TYPE-1; IN-VITRO; HEPATITIS; LIVER	Introduction Liver fibrosis is a result of continuous damage to the liver combined with accumulation of the extracellular matrix and is characteristic of most chronic liver diseases such as hepatitis C virus (HCV) infection. Methods This study evaluated interleukin 10 (IL10) expression in the liver and plasma of 45 HCV patients and its association with the pathogenesis and progression of liver fibrosis. The expression of transforming growth factor beta (TGFB1) was also assessed. Patients were divided into three groups according to the METAVIR classification (F0-F1, F2 and F3-F4); there was also a control group (n = 8). Results In the control group, high intrahepatic IL10 mRNA expression showed a positive association with F0-F1 fibrosis, no inflammation, low concentrations of liver enzymes and a high viral load; conversely, low intrahepatic IL10 mRNA expression showed a negative association with fibrosis progression. Intrahepatic TGFB1 mRNA expression was greater in the HCV group than in the control group, and regarding different disease phases, its expression increased as fibrosis evolved to more severe forms. Conclusion Intrahepatic IL10 mRNA expression decreases with persistent fibrosis, probably due to the production of TGF-beta 1, a potent antimitotic and fibrogenic cytokine. IL10 restricts and decreases the immune response and limits the fibrogenic response; however, a decrease in IL10 favors persistent inflammatory infiltrate, resulting in severe fibrosis.	[Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas Queiroz, Maria Alice; Moura de Araujo, Mauro Sergio; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos] Fed Univ Para, Biol Sci Inst, Virol Lab, Belem, Para, Brazil; [Ferreira de Araujo, Marialva Tereza; Souza da Silva Conde, Simone Regina] Univ Fed Para, Sch Med, Hlth Sci Inst, Belem, Para, Brazil; [Souza da Silva Conde, Simone Regina] Joao Barros Barreto Univ Hosp, Hepatol Outpatient Clin, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Vallinoto, ACR (corresponding author), Fed Univ Para, Biol Sci Inst, Virol Lab, Belem, Para, Brazil.	vallinoto@ufpa.br	Gomes, Samara Tatielle Monteiro/GVT-9626-2022; Queiroz, Maria Alice/GON-7881-2022; Vallinoto, Antonio Carlos/AAL-9501-2020	Vallinoto, Antonio Carlos/0000-0003-1135-6507; /0000-0001-7079-4844	National Council for Scientific and Technological Development (CNPq) [480128/2013-8]; Federal University of Para [PROPESP/PAPQ/2018]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Para	The study was funded by the National Council for Scientific and Technological Development (CNPq No. 480128/2013-8) and the Federal University of Para (PROPESP/PAPQ/2018).	Aroucha DCBL, 2013, CYTOKINE, V62, P421, DOI 10.1016/j.cyto.2013.03.024; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chusri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22487; Cobalt Development Institute, 2016, COBALT NEWS, V16, P3; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; de Souza-Cruz S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0610-6; Delpuech O, 2001, EUR CYTOKINE NETW, V12, P69; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Amoras EDG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121754; Gramenzi A, 2005, J VIRAL HEPATITIS, V12, P525, DOI 10.1111/j.1365-2893.2005.00634.x; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Larrubia JR, 2009, REV ESP ENFERM DIG, V101, P343, DOI 10.4321/s1130-01082009000500006; Louis H, 2003, ACTA GASTRO-ENT BELG, V66, P7; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Niesen E, 2015, J INFECT DIS, V211, P821, DOI 10.1093/infdis/jiu541; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Persico M, 2006, J HEPATOL, V45, P779, DOI 10.1016/j.jhep.2006.07.026; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Wan S, 1997, AM HEART J, V133, P335, DOI 10.1016/S0002-8703(97)70229-1; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Zhang LJ, 2006, WORLD J GASTROENTERO, V12, P1681, DOI 10.3748/wjg.v12.i11.1681	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241199	10.1371/journal.pone.0241199	http://dx.doi.org/10.1371/journal.pone.0241199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125400	gold, Green Published			2022-12-26	WOS:000588368900067
J	van Dijk, MP; Beek, PJ; van Soest, AJK				van Dijk, Marit P.; Beek, Peter J.; van Soest, A. J. Knoek			Predicting dive start performance from kinematic variables at water entry in (sub-)elite swimmers	PLOS ONE			English	Article							UNDERWATER PHASE; SWIMMING START; PARAMETERS; VELOCITY; FRONT; BLOCK	The dive start is an important component of competitive swimming, especially at shorter race distances. Previous research has suggested that start performance depends on kinematic variables pertaining to the swimmer at water entry, notably the distance from the block, the horizontal velocity of the centre of mass and the angle between body and water surface. However, the combined and relative contributions of these variables to start performance remain to be determined. The aim of the present study was therefore to develop a model to predict start performance (time from take-off to reaching the 15-m line) from a set of kinematic variables that collectively define the swimmer's entry state. To obtain an appropriate database for this purpose, fifteen well-trained, (sub-)elite swimmers performed dive starts under different instructions intended to induce substantial variation in entry state. Kinematic data were extracted from video recordings of these starts, optimised and analysed statistically. A mixed effects analysis of the relation between entry state and start performance was conducted, which revealed a significant and robust dependence of start performance on entry state (chi 2(3) = 88, p < .001), explaining 86.1% of the variance. Start time was reduced by 0.6 s (p < .001) when the horizontal displacement at water entry was 1 m further, by 0.3 s (p < .001) when the horizontal velocity of the centre of mass was 1 m/s higher, and by 0.5 s (p < .01) when the entry angle was 1 radian flatter. The robustness of the analysis was confirmed by a similar mixed effects analysis of the relation between entry state and time to the 5-m line. In conclusion, dive start performance can be predicted to a considerable extent from the swimmer's state at water entry. The implications of those findings for studying and improving block phase kinetics are discussed.	[van Dijk, Marit P.; Beek, Peter J.; van Soest, A. J. Knoek] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [van Dijk, Marit P.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Delft, Netherlands	Vrije Universiteit Amsterdam; Delft University of Technology	van Dijk, MP (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; van Dijk, MP (corresponding author), Delft Univ Technol, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Delft, Netherlands.	maritvdijk@gmail.com		van Dijk, Marit/0000-0002-4900-8084; Beek, Peter/0000-0002-0917-8548				Alley LE, 1952, RES QUART, V23, P253, DOI 10.1080/10671188.1952.10624867; Barlow H, 2014, HUM MOVEMENT SCI, V34, P178, DOI 10.1016/j.humov.2014.02.002; Barto K, 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beretic I, 2013, J SPORT SCI MED, V12, P639; Blanksby Brian, 2002, Sports Biomech, V1, P11, DOI 10.1080/14763140208522784; Brady TW, 2014, LINEAR MIXED MODELS; Casius LJR, 2004, J APPL BIOMECH, V20, P421, DOI 10.1123/jab.20.4.421; Cossor J., 2001, 19 INT S BIOM SPORTS, P70; Elipot M, 2009, J BIOMECH, V42, P1367, DOI 10.1016/j.jbiomech.2009.03.032; Elipot M, 2010, P 11 BIOM MED SWIMM, VXI, P72; Faber H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204575; Fischer S, 2016, SPORT BIOMECH, V15, P397, DOI 10.1080/14763141.2016.1171893; Fox J., 2018, R COMPANION APPL REG, VThird; Garcia-Ramos A, 2015, EUR J SPORT SCI, V15, P687, DOI 10.1080/17461391.2015.1063699; Holthe MJ, 2001, 19 S INT SOC BIOM SP, P31; Honda KE, 2010, 11 INT S BIOM MED SW, P94; Houel N, 2013, J APPL BIOMECH, V29, P49, DOI 10.1123/jab.29.1.49; Hubert M., 2006, PORTUGUESE J SPORT S, V6, P44; Ikeda Y, 2016, J APPL BIOMECH, V32, P462, DOI 10.1123/jab.2015-0303; Lyttle A, 2005, 13 INT S BIOM MED SW; Maechler M., 2019, MATRIX SPARSE DENSE; Marinho DA, 2020, J SPORT SCI MED, V19, P397; R Core Team, 2021, R LANGUAGE ENV STAT; Ruschel C, 2007, P 25 ISBS S OUR PRET, P385; Seifert L, 2010, J STRENGTH COND RES, V24, P507, DOI 10.1519/JSC.0b013e3181c06a0e; Silveira RP, 2018, EUR J SPORT SCI, V18, P1317, DOI 10.1080/17461391.2018.1486460; Slawson SE, 2013, J SPORT SCI, V31, P468, DOI 10.1080/02640414.2012.736631; Takeda T, 2017, J SPORT SCI, V35, P565, DOI 10.1080/02640414.2016.1180417; Taladriz S, 2016, J BIOMECH, V49, P1789, DOI 10.1016/j.jbiomech.2016.04.012; Tor E, 2015, THESIS, P72; Tor E., 2014, BIOM MED SWIMM C CAN; Tor E, 2015, J APPL BIOMECH, V31, P8, DOI [10.1123/jab.2014-0081, 10.1123/JAB.2014-0081]; Tor E, 2015, J APPL BIOMECH, V31, P62, DOI [10.1123/jab.2014-0155, 10.1123/JAB.2014-0155]; Tor E, 2015, J SPORT SCI, V33, P1313, DOI 10.1080/02640414.2014.990486; Tor E, 2014, INT J SPORT PHYSIOL, V9, P633, DOI [10.1123/IJSPP.2013-0205, 10.1123/ijspp.2013-0205]; Van Hooren B, 2017, J STRENGTH COND RES, V31, P2011, DOI 10.1519/JSC.0000000000001913; Vantorre J, 2014, J SPORT SCI MED, V13, P223; Veiga S, 2014, SPORT BIOMECH, V13, P285, DOI 10.1080/14763141.2014.910265; Vilas-Boas JP, 2000, P 18 INT S BIOM SPOR, P113; Welcher RL, 2008, SPORT BIOMECH, V7, P100, DOI 10.1080/14763140701683247; West DJ, 2011, J STRENGTH COND RES, V25, P950, DOI 10.1519/JSC.0b013e3181c8656f; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO	43	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241345	10.1371/journal.pone.0241345	http://dx.doi.org/10.1371/journal.pone.0241345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125412	Green Published, gold			2022-12-26	WOS:000588368900044
J	Wiarda, JE; Boggiatto, PM; Bayles, DO; Waters, WR; Thacker, TC; Palmer, MV				Wiarda, Jayne E.; Boggiatto, Paola M.; Bayles, Darrell O.; Waters, W. Ray; Thacker, Tyler C.; Palmer, Mitchell, V			Severity of bovine tuberculosis is associated with innate immune-biased transcriptional signatures of whole blood in early weeks after experimental Mycobacterium bovis infection	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; GAMMA-INTERFERON; CATTLE; SEQUENCE; RESPONSES	Mycobacterium bovis, the causative agent of bovine tuberculosis, is a pathogen that impacts both animal and human health. Consequently, there is a need to improve understanding of disease dynamics, identification of infected animals, and characterization of the basis of immune protection. This study assessed the transcriptional changes occurring in cattle during the early weeks following a M. bovis infection. RNA-seq analysis of whole blood-cell transcriptomes revealed two distinct transcriptional clusters of infected cattle at both 4- and 10-weeks post-infection that correlated with disease severity. Cattle exhibiting more severe disease were transcriptionally divergent from uninfected animals. At 4-weeks post-infection, 25 genes had commonly increased expression in infected cattle compared to uninfected cattle regardless of disease severity. Ten weeks post-infection, differential gene expression was only observed when severely-affected cattle were compared to uninfected cattle. This indicates a transcriptional divergence based on clinical status following infection. In cattle with more severe disease, biological processes and cell type enrichment analyses revealed overrepresentation of innate immune-related processes and cell types in infected animals. Collectively, our findings demonstrate two distinct transcriptional profiles occur in cattle following M. bovis infection, which correlate to clinical status.	[Wiarda, Jayne E.; Boggiatto, Paola M.; Bayles, Darrell O.; Waters, W. Ray; Thacker, Tyler C.; Palmer, Mitchell, V] ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Wiarda, Jayne E.] Iowa State Univ, Immunobiol Grad Program, Ames, IA USA; [Wiarda, Jayne E.] ARS, Oak Ridge Inst Sci & Educ, Participat Program, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Iowa State University; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Boggiatto, PM (corresponding author), ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	paola.boggiatto@usda.gov	; Thacker, Tyler/P-4271-2018	Wiarda, Jayne/0000-0002-9538-2720; Thacker, Tyler/0000-0001-6779-7649	United States Department of Agriculture, Agricultural Research Service Project, CRIS [5030-32000-222]	United States Department of Agriculture, Agricultural Research Service Project, CRIS	Research was funded by intramural funds from the United States Department of Agriculture, Agricultural Research Service Project, CRIS #5030-32000-222.	Andrews S., 2018, FASTQC QUALITY CONTR; [Anonymous], 2007, MARKET WATCH ENERGY, V6, P10; [Anonymous], 2011, DIABETOLOGIA PRAKTYC, V12, pA28; [Anonymous], MYCOBACTERIUM BOVIS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16; Blanco FC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/258353; Cashion AK, 2011, RES NURS HEALTH, V34, P408, DOI 10.1002/nur.20448; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Dean GS, 2005, INFECT IMMUN, V73, P6467, DOI 10.1128/IAI.73.10.6467-6471.2005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doherty TM, 2004, J CLIN INVEST, V114, P1699, DOI 10.1172/JCI200423867; Francisco TI, 2014, JAVMA-J AM VET MED A, V244, P805, DOI 10.2460/javma.244.7.805; Garber J, 2011, GUIDE CARE USE LAB C; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gideon HP, 2016, J IMMUNOL, V197, P4817, DOI 10.4049/jimmunol.1601138; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Killick KE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-611; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Livingstone P., 2018, Bovine tuberculosis, P225, DOI 10.1079/9781786391520.0225; MacHugh DE, 2009, TRANSBOUND EMERG DIS, V56, P204, DOI 10.1111/j.1865-1682.2009.01082.x; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLoughlin KE, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00396; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Noss EH, 2000, CELL IMMUNOL, V201, P63, DOI 10.1006/cimm.2000.1633; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Palmer MV, 2015, J COMP PATHOL, V153, P150, DOI 10.1016/j.jcpa.2015.06.004; Palmer MV, 2019, VET PATHOL, V56, P544, DOI 10.1177/0300985819833454; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Rhodes SG, 2000, INFECT IMMUN, V68, P5393, DOI 10.1128/IAI.68.9.5393-5400.2000; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schwochow D, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-33; Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460; Shukla SK, 2017, MICROB PATHOGENESIS, V113, P480, DOI 10.1016/j.micpath.2017.11.030; Societies FoAS, 2010, GUIDE CARE USE AGR A; Soreq L, 2015, GENOM DATA, V3, P57, DOI 10.1016/j.gdata.2014.11.009; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Thom ML, 2006, VET IMMUNOL IMMUNOP, V114, P25, DOI 10.1016/j.vetimm.2006.07.001; Tsao K, 2014, INFECT GENET EVOL, V28, P137, DOI 10.1016/j.meegid.2014.09.025; Villarreal-Ramos B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18575-5; Vordermeier HM, 2016, ANNU REV ANIM BIOSCI, V4, P87, DOI 10.1146/annurev-animal-021815-111311; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2010, CLIN VACCINE IMMUNOL, V17, P247, DOI 10.1128/CVI.00442-09; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Weckle A, 2015, JOVE-J VIS EXP, DOI 10.3791/52227; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0239938	10.1371/journal.pone.0239938	http://dx.doi.org/10.1371/journal.pone.0239938			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166313	gold, Green Published			2022-12-26	WOS:000592382600036
J	Alves, KCG; Guimaraes, RA; de Souza, MR; Neto, OLD				Alves, Kelly Cristina Gomes; Guimaraes, Rafael Alves; de Souza, Marta Rovery; de Morais Neto, Otaliba Libanio			Performance of family health teams for tackling chronic diseases in a state of the Amazon	PLOS ONE			English	Article							PRINCIPAL-COMPONENTS-ANALYSIS; IMPROVING PRIMARY-CARE; NONCOMMUNICABLE DISEASES; PHYSICAL-ACTIVITY; BRAZIL; UNITS; STRATEGY; PROGRAM	The most common cause of death worldwide is noncommunicable diseases. A cross-sectional study was conducted to evaluate the adequacy of the work process among family health teams and compare differences in regional adequacy in the state of Tocantins, in the Amazonian Region, Brazil. Categorical principal components analysis was used, and scores of each principal component extracted in the analysis were compared among health regions in Tocantins. A post hoc analysis was performed to compare the heath region pairs. The adequacy of family health teams' work process was evaluated with respect to the Strategic Action Plan to Tackle NCDs. The results showed that the family health teams performed actions according to the Strategic Action Plan to Tackle NCDs. However, overall, the adequacy percentages of these actions according to the axes of the Plan are very uneven in Tocantins, with large variations among health regions. The family health teams in the Bico do Papagaio (Region 1), Medio Norte Araguaia (Region 2), Cantao (Region 4) and Capim Dourado (Region 5) regions have adequacy percentages >= 50% with the Strategic Action Plan to Tackle NCDs, whereas all other regions have percentages <50%. Health teams perform surveillance actions, health promotion, and comprehensive care for NCDs in accordance with the guidelines of the Strategic Action Plan to Tackle NCDs. The challenge of NCDs in primary care requires a care model that is tailored to users' needs and has the power to reduce premature mortality and its determinants.	[Alves, Kelly Cristina Gomes] Fed Univ Tocantins, Dept Med, Palmas, Tocantins, Brazil; [Guimaraes, Rafael Alves; de Souza, Marta Rovery; de Morais Neto, Otaliba Libanio] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil	Universidade Federal do Tocantins (UFT); Universidade Federal de Goias	Alves, KCG (corresponding author), Fed Univ Tocantins, Dept Med, Palmas, Tocantins, Brazil.	kellygomesalves@gmail.com						[Anonymous], 2018, PROPOSED AMENDMENTS, VIII, P5; [Anonymous], 2017, INDIAN J HEMATOL BLO, V33, pS113; [Anonymous], 2007, AM J RHINOL, V21, P164; [Anonymous], 2018, FORENSIC SCI INT GEN, V34, pe18; de Sa GBAR, 2016, CIENC SAUDE COLETIVA, V21, P1849, DOI 10.1590/1413-81232015216.09562016; Barreto SM, 2005, EPIDEMIOL SERV SAUDE, V14, P41; Cavalcante DDB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198428; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bousquat A, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00037316, 10.1590/0102-311x00037316]; Brazil. Ministry of Health, 2017, PROGR IMPR ACC QUAL; Buja A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020626; Castor Mei L, 2008, Infect Dis Obstet Gynecol, V2008, P727505, DOI 10.1155/2008/727505; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Debelak R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148143; Departamento de AtencAo Basica, 2018, HIST COB ESTR SAUD F; de Mello LDF, 2017, J AMBUL CARE MANAG, V40, pS71, DOI 10.1097/JAC.0000000000000188; Fonseca Sobrinho Délcio da, 2014, Saúde debate, V38, P83, DOI 10.5935/0103-1104.2014S007; Garnelo Luiza, 2014, Saúde debate, V38, P158, DOI 10.5935/0103-1104.2014S012; Alves KCG, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4737-2; Grove A., 2014, GLOB J HLTH SCI, V7, P210, DOI DOI 10.5539/GJHS.V7N2P210; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hartz Z, 2005, AVALIACAO SAUDE MODE; Hartz ZMdA., 1999, CIENCIA SAUDE COLETI, V4, P341; Hoque DME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183667; JORESKOG KG, 1994, PSYCHOMETRIKA, V59, P381, DOI 10.1007/BF02296131; Kadu MK, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0219-0; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Kruk ME, 2015, AM J PUBLIC HEALTH, V105, P431, DOI 10.2105/AJPH.2014.302392; Nguyen LH, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006907; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Malta DC, 2017, SAO PAULO MED J, V135, P213, DOI 10.1590/1516-3180.2016.0330050117; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002; Malta DC, 2016, EPIDEMIOL SERV SAUDE, V25, P373, DOI [10.5123/S167-49742016000200016, 10.5123/S1679-49742016000200016, 10.5123/s1679-49742016000200016]; Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P3, DOI 10.1590/1980-5497201500060002; Malta DC, 2016, CIENC SAUDE COLETIVA, V21, P327, DOI 10.1590/1413-81232015212.23602015; Malta DC, 2014, CIENC SAUDE COLETIVA, V19, P4301, DOI 10.1590/1413-812320141911.07732014; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; Neves RG, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00072317, 10.1590/0102-311X00072317]; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pelone F, 2013, INT J QUAL HEALTH C, V25, P381, DOI 10.1093/intqhc/mzt020; Pinto Hêider Aurélio, 2014, Saúde debate, V38, P358, DOI 10.5935/0103-1104.2014S027; Ramos LR, 2014, REV SAUDE PUBL, V48, P837, DOI 10.1590/S0034-8910.2014048005249; Rzewuska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171813; Savalei V, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01515; Schiotz ML, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2724-z; Schmittdiel JA, 2006, ANN FAM MED, V4, P117, DOI 10.1370/afm.520; Silva LS, 2013, REV PANAM SALUD PUBL, V34, P343; Neto JJS, 2016, CIENC SAUDE COLETIVA, V21, P2709, DOI 10.1590/1413-81232015219.16432016; Tocantins, 2017, IND SOC EST TOC 2017; Tomasi Elaine, 2015, Rev. Bras. Saude Mater. Infant., V15, P171, DOI 10.1590/S1519-38292015000200003; Tosto G, 2015, J NEUROL, V262, P2548, DOI 10.1007/s00415-015-7886-1; Tran US, 2009, EDUC PSYCHOL MEAS, V69, P50, DOI 10.1177/0013164408318761; Tsai AC, 2005, AM J MANAG CARE, V11, P478; [United Nations General Assembly. United Nations General Assembly], 2012, 66 SESS AG IT 117; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Winters R, 2010, OCHSNER J, V10, P213; Word Health Organization, 2003, 5 M WHO TECHN ADV GR, P1; World Health Organization, 2010, 63 WORLD HLTH ASS; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2000, 53 WORLD HLTH ASS; World Health Organization, 2019, WORLD HLTH STAT MON; Young H, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5217-z; 2014, ALZHEIMERS DEMENTIA, V10, P2	66	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241765	10.1371/journal.pone.0241765	http://dx.doi.org/10.1371/journal.pone.0241765			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156831	gold, Green Published			2022-12-26	WOS:000591376400003
J	Lavaniegos, BE				Lavaniegos, Bertha E.			Hyperiid amphipods from the Gulf of Ulloa and offshore region, Baja California: The possible role of the gelatinous zooplankton as a transport vector into the coastal shelf waters	PLOS ONE			English	Article							WEST-COAST; SOUTHERN CALIFORNIA; PELAGIC AMPHIPODS; BRITISH-COLUMBIA; PACIFIC-OCEAN; VARIABILITY; ASSOCIATIONS; SEA; ECOLOGY; DIET	Hyperiid amphipod species from the Gulf of Ulloa, Baja California, and the adjacent region (from the shelf break to 200 km offshore) were analyzed to evaluate diversity and abundances. This productive area supports small-scale commercial fisheries, including sand bass (Paralabrax nebulifer), California spiny lobster (Panulirus interruptus), abalones, clams, and others. Strong coastal upwelling events were observed during summer seasons of the period 2002-2008 between Punta Eugenia and Punta Abreojos. The upwelling plumes at Punta Abreojos are transported southward in slope waters bordering the coastal shelf of the Gulf of Ulloa, contributing to the separation of coastal and oceanic regions, and explain differences in amphipod diversity and abundances between both regions. In the offshore region, the most abundant species were Vibilia armata, Lestrigonus schizogeneios, Primno brevidens, and Eupronoe minuta, similar to previous findings in northern regions of Baja California and southern California. However, abundances of these species were lower (10-30 individuals/1000 m(3)), only reaching 20-50% of abundance levels reported off northern Baja California. In the coastal shelf of the Gulf of Ulloa, amphipods were virtually absent during 2002, 2003 and 2006. However, during 2004 and 2005, abundances of P. brevidens increased (54 and 20 ind/1000 m(3), respectively). Moreover, during the late summer of 2007, abundances of L. schizogeneios, P. brevidens, Lycaea nasuta, Lycaea pulex, and Simorhynchotus antennarius increased considerably (261, 39, 31, 68, 416 ind/1000 m(3), respectively), indicating occasional utilization of the coastal shelf by pelagic amphipods. Changes in gelatinous populations (medusae, siphonophores, ctenophores, doliolids, and salps) paralleled changes in hyperiid populations, with highest abundances in 2005-2008 in the coastal shelf. Significant correlations of 17 amphipod species with gelatinous taxa, which are often used as host organisms by hyperiid amphipods, suggest that gelatinous presence enhanced hyperiid abundance and promoted the progression of hyperiid amphipods onto the coastal shelf during parts of the 2002-2008 period.	[Lavaniegos, Bertha E.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Lavaniegos, BE (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico.	berlav@cicese.mx			Consejo Nacional de Ciencia y Tecnologia [129611, 23804, 23947]; CICESE project Variability of zooplankton in function of climatic changes of diverse scale	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CICESE project Variability of zooplankton in function of climatic changes of diverse scale	This study was supported by the Consejo Nacional de Ciencia y Tecnologia, grants 129611, 23804, 23947, and the CICESE project Variability of zooplankton in function of climatic changes of diverse scale. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auel H, 2009, PROG OCEANOGR, V83, P237, DOI 10.1016/j.pocean.2009.07.040; Avolio ML, 2019, NEW PHYTOL, V223, P1106, DOI 10.1111/nph.15789; Bertram DF, 2009, MAR ECOL PROG SER, V393, P199, DOI 10.3354/meps08223; Boltovskoy D., 1999, S ATLANTIC ZOOPLANKT; BOWMAN THOMAS E., 1963, CHESAPEAKE SCI, V4, P141, DOI 10.2307/1350747; BOWMAN THOMAS E., 1960, PROC U S NATL MUS, V112, P343; Brusca G. J., 1970, Bull Sth Calif Acad Sci, V69, P179; BRUSCA GJ, 1967, PAC SCI, V21, P449; Burridge AK, 2017, PROG OCEANOGR, V158, P224, DOI 10.1016/j.pocean.2016.08.003; CAHOON LB, 1986, CRUSTACEANA, V51, P94; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Dalpadado P, 2008, DEEP-SEA RES PT II, V55, P2266, DOI 10.1016/j.dsr2.2008.05.016; De Silva-Davila R, 2002, J PLANKTON RES, V24, P1057, DOI 10.1093/plankt/24.10.1057; Dorman JG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046245; Elder LE, 2015, J PLANKTON RES, V37, P897, DOI 10.1093/plankt/fbv066; Etnoyer Peter, 2004, Oceanography, V17, P90; FELIX F, 2007, REV BIOL MAR OCEANOG, V42, P77; Fleming NEC, 2014, MAR ECOL PROG SER, V510, P229, DOI 10.3354/meps10896; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Gasca R, 2004, HYDROBIOLOGIA, V530, P529, DOI 10.1007/s10750-004-2657-5; Gasca R, 2007, MAR BIOL, V151, P233, DOI 10.1007/s00227-006-0478-y; Gasca R, 2015, J MAR BIOL ASSOC UK, V95, P503, DOI 10.1017/S0025315414001416; Gonzalez-Rodriguez E, 2012, OCEAN SCI, V8, P703, DOI 10.5194/os-8-703-2012; Gorbatenko KM, 2017, OCEANOLOGY+, V57, P278, DOI 10.1134/S0001437016060023; Gorley C.K., 2006, GETTING STARTED PRIM; HARBISON GR, 1977, DEEP-SEA RES, V24, P465, DOI 10.1016/0146-6291(77)90484-2; Haro-Garay MJ, 2003, CRUSTACEANA, V76, P1291, DOI 10.1163/156854003323009821; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; HOOGENBOOM J, 1985, CRUSTACEANA, V49, P233, DOI 10.1163/156854085X00558; Cota-Nieto JJ, 2018, REG STUD MAR SCI, V18, P68, DOI 10.1016/j.rsma.2017.12.014; Kuhn CE, 2014, MAR MAMMAL SCI, V30, P1297, DOI 10.1111/mms.12110; Laval P., 1980, Oceanography and Marine Biology an Annual Review, V18, P11; Laval P, 1972, ANN I OCEANOGRAPHIQU, V48, P49; Lavaniegos BE, 2017, J MARINE SYST, V165, P13, DOI 10.1016/j.jmarsys.2016.09.001; Lavaniegos BE, 2014, J MARINE SYST, V132, P1, DOI 10.1016/j.jmarsys.2013.12.012; Lavaniegos BE, 2012, PROG OCEANOGR, V97, P164, DOI 10.1016/j.pocean.2011.11.008; Lavaniegos BE, 2009, MAR ECOL PROG SER, V394, P137, DOI 10.3354/meps08285; Espinosa-Leal LL, 2016, CAL COOP OCEAN FISH, V57, P132; Lilly LE, 2018, DEEP-SEA RES PT I, V140, P36, DOI 10.1016/j.dsr.2018.07.015; LONGHURS.AR, 1967, DEEP-SEA RES, V14, P393, DOI 10.1016/0011-7471(67)90047-2; LORZ HV, 1975, J FISH RES BOARD CAN, V32, P1442, DOI 10.1139/f75-165; Lyon B., 2005, US CLIVAR VARIATIONS, V3, P1; MADIN LP, 1977, DEEP-SEA RES, V24, P449, DOI 10.1016/0146-6291(77)90483-0; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McFarlane G, 2010, CAL COOP OCEAN FISH, V51, P169; McPhaden MJ, 2004, B AM METEOROL SOC, V85, P677, DOI 10.1175/BAMS-85-5-677; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Navarrete AH, 2008, REV CHIL HIST NAT, V81, P305; Nomura H, 2003, LA MER, V41, P69; Pares-Escobar F, 2018, PROG OCEANOGR, V160, P53, DOI 10.1016/j.pocean.2017.11.009; Pinchuk AI, 2013, ICES J MAR SCI, V70, P1244, DOI 10.1093/icesjms/fst031; Ramirez-Rodriguez M, 2012, MAR POLICY, V36, P108, DOI 10.1016/j.marpol.2011.04.003; Riascos JM, 2012, J FISH BIOL, V81, P1686, DOI 10.1111/j.1095-8649.2012.03427.x; Samelson RM, 2017, J PHYS OCEANOGR, V47, P3037, DOI 10.1175/JPO-D-17-0077.1; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Seminoff JA, 2014, ENDANGER SPECIES RES, V24, P207, DOI 10.3354/esr00601; Singh A, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006862; Soto-Mardones L, 2004, DEEP-SEA RES PT II, V51, P785, DOI 10.1016/j.dsr2.2004.05.024; Suntsov AV, 2008, MAR ECOL PROG SER, V373, P81, DOI 10.3354/meps07678; Torres HS, 2015, DEEP-SEA RES PT I, V98, P31, DOI 10.1016/j.dsr.2014.12.003; Valle-Rodriguez J, 2017, ADV SPACE RES, V59, P2313, DOI 10.1016/j.asr.2017.01.050; Van Noord JE, 2013, J FISH BIOL, V83, P326, DOI 10.1111/jfb.12173; Van Noord JE, 2016, FISH B-NOAA, V114, P274, DOI 10.7755/FB.114.3.2; Venrick E., 2003, CALCOFI REP, V44, P28; Vinogradov M. E., 1996, HYPERIID AMPHIPODS A; Wingfield DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027874; Yamaji I., 1979, ILLUSTRATION MARINE; Zaitsev O, 2014, CIENC MAR, V40, P89, DOI [10.7773/cm.v40i2.2393, 10.7773/cm.v40i2.2314]; ZEIDLER W, 2004, ZOOTAXA 0714, P1; Zheng F, 2012, DYNAM ATMOS OCEANS, V57, P45, DOI 10.1016/j.dynatmoce.2012.06.002	71	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0233071	10.1371/journal.pone.0233071	http://dx.doi.org/10.1371/journal.pone.0233071			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151968	Green Submitted, Green Published, gold			2022-12-26	WOS:000591376200019
J	Leger, T; Jacquier, A; Barral, PA; Castelli, M; Finance, J; Lagier, JC; Million, M; Parola, P; Brouqui, P; Raoult, D; Bartoli, A; Gaubert, JY; Habert, P				Leger, Thomas; Jacquier, Alexis; Barral, Pierre-Antoine; Castelli, Maxime; Finance, Julie; Lagier, Jean-Christophe; Million, Matthieu; Parola, Philippe; Brouqui, Philippe; Raoult, Didier; Bartoli, Axel; Gaubert, Jean-Yves; Habert, Paul			Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score	PLOS ONE			English	Article								Objectives The purpose is to assess the ability of low-dose CT (LDCT) to determine lung involvement in SARS-CoV-2 pneumonia and to describe a COVID19-LDCT severity score. Materials and methods Patients with SARS-CoV-2 infection confirmed by RT-PCR were retrospectively analysed. Clinical data, the National Early Warning Score (NEWS) and imaging features were recorded. Lung features included ground-glass opacities (GGO), areas of consolidation and crazy paving patterns. The COVID19-LDCT score was calculated by summing the score of each segment from 0 (no involvement) to 10 (severe impairment). Univariate analysis was performed to explore predictive factor of high COVID19-LDCT score. The nonparametric Mann-Whitney test was used to compare groups and a Spearman correlation used with p<0.05 for significance. Results Eighty patients with positive RT-PCR were analysed. The mean age was 55 years +/- 16, with 42 males (53%). The most frequent symptoms were fever (60/80, 75%) and cough (59/80, 74%), the mean NEWS was 1.7 +/- 2.3. All LDCT could be analysed and 23/80 (28%) were normal. The major imaging finding was GGOs in 56 cases (67%). The COVID19-LDCT score (mean value = 19 +/- 29) was correlated with NEWS (r = 0.48, p<0.0001). No symptoms were risk factor to have pulmonary involvement. Univariate analysis shown that dyspnea, high respiratory rate, hypertension and diabetes are associated to a COVID19-LDCT score superior to 50. Conclusions COVID19-LDCT score did correlate with NEWS. It was significantly different in the clinical low-risk and high-risk groups. Further work is needed to validate the COVID19-LDCT score against patient prognosis.	[Leger, Thomas; Jacquier, Alexis; Barral, Pierre-Antoine; Castelli, Maxime; Bartoli, Axel; Gaubert, Jean-Yves; Habert, Paul] La Timone Hosp, AP HM, Dept Radiol, Marseille, France; [Jacquier, Alexis; Bartoli, Axel] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, AP HM, UMR 7339,CNRS,Ctr Explorat Metab Resonance Magnet, Marseille, France; [Finance, Julie; Lagier, Jean-Christophe; Million, Matthieu; Parola, Philippe; Brouqui, Philippe; Raoult, Didier] IHU Mediterranee Infect, Marseille, France; [Lagier, Jean-Christophe; Million, Matthieu; Brouqui, Philippe; Raoult, Didier] Aix Marseille Univ, MEPHI, AP HM, IRD, Marseille, France; [Parola, Philippe] Aix Marseille Univ, VITROME, SSA, AP HM,IRD, Marseille, France; [Gaubert, Jean-Yves; Habert, Paul] Aix Marseille Univ, LIIE, Marseille, France; [Gaubert, Jean-Yves; Habert, Paul] Aix Marseille Univ, CERIMED, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Habert, P (corresponding author), La Timone Hosp, AP HM, Dept Radiol, Marseille, France.; Habert, P (corresponding author), Aix Marseille Univ, LIIE, Marseille, France.; Habert, P (corresponding author), Aix Marseille Univ, CERIMED, Marseille, France.	Paul.habert@ap-hm.fr	Zixuan, Huang/ABI-3557-2020; Parola, Philippe/AAY-4346-2021; Lagier, Jean-Christophe/AAY-3837-2021; RAOULT, Didier/A-8434-2008; Million, Matthieu/F-7693-2011	Parola, Philippe/0000-0002-1061-1927; Lagier, Jean-Christophe/0000-0003-0771-8245; RAOULT, Didier/0000-0002-0633-5974; Million, Matthieu/0000-0002-5556-6947; julie, Finance/0000-0003-4577-8708				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Amrane S, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101632; Chen ZH, 2020, KOREAN J RADIOL, V21, P623, DOI 10.3348/kjr.2020.0195; Cheng ZH, 2020, AM J ROENTGENOL, V215, P121, DOI 10.2214/AJR.20.22959; Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230; Debray MP, 2016, EUR RADIOL, V26, P3138, DOI 10.1007/s00330-015-4126-0; Dziedzic R, 2018, J THORAC DIS, V10, pE234, DOI 10.21037/jtd.2018.03.30; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kang Z, 2020, EUR RADIOL, V30, P4356, DOI 10.1007/s00330-020-06809-6; Lagier JC, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101624; Lei PG, 2020, J INFECTION, V80, pE30, DOI 10.1016/j.jinf.2020.03.020; Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672; Martini K, 2020, DIAGN INTERV IMAG, V101, P269, DOI 10.1016/j.diii.2020.01.012; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Nakada T, 2019, THORAC CANCER, V10, P1945, DOI 10.1111/1759-7714.13173; Ooi GC, 2004, RADIOLOGY, V230, P836, DOI 10.1148/radiol.2303030853; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Taqi A H, 2019, J Biomed Phys Eng, V9, P127; Wang YZ, 2020, NEURORADIOLOGY, V62, P1141, DOI 10.1007/s00234-020-02455-3; Xiong Y, 2020, INVEST RADIOL, V55, P332, DOI 10.1097/RLI.0000000000000674; Yang WJ, 2020, RADIOLOGY, V295, pE3, DOI 10.1148/radiol.2020200702; Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0; Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241407	10.1371/journal.pone.0241407	http://dx.doi.org/10.1371/journal.pone.0241407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141845	gold, Green Published			2022-12-26	WOS:000588376700023
J	Mardu, F; Negash, H; Legese, H; Berhe, B; Tesfay, K; Haileslasie, H; Tesfanchal, B; Gebremichail, G; Belay, G; Gebremedhin, H				Mardu, Fitsum; Negash, Hadush; Legese, Haftom; Berhe, Brhane; Tesfay, Kebede; Haileslasie, Hagos; Tesfanchal, Brhane; Gebremichail, Gebremedhin; Belay, Getachew; Gebremedhin, Haftay			Assessment of knowledge, practice, and status of food handlers toward Salmonella, Shigella, and intestinal parasites: A cross-sectional study in Tigrai prison centers, Ethiopia	PLOS ONE			English	Article							PREVALENCE	Background Unsafe food becomes a global public health and economic threat to humans. The health status, personal hygiene, knowledge, and practice of food handlers have crucial impact on food contamination. Hence, this study is aimed at assessing the knowledge, practice, and prevalence of Salmonella, Shigella, and intestinal parasites among food handlers in Eastern Tigrai prison centers, Northern Ethiopia. Methods An institutional-based cross-sectional study was carried out from April to September 2019 among food handlers in Eastern Tigrai prison centers, Northern Ethiopia. A structured questionnaire was used to collect the demographic characteristics, the knowledge, and the practice of the study participants. Direct wet mount and formol-ether concentration techniques were applied to identify intestinal parasites. Culture and biochemical tests were used to isolate the Salmonella and the Shigella species. Additionally, antimicrobial susceptibility tests to selected antibiotics were performed using Kirby-Baur disk diffusion method. We used SPSS version 23 software for statistical analysis. Results Thirty-seven (62.7%, 37/59) of the participants had harbored one or more intestinal parasites. The protozoan Entamoeba histolytica/dispar was detected among 23.7% (14/59) of the study participants who provided stool specimen. Besides, 6.8% (4/59) of the samples were positive for either Salmonella or Shigella species. The Salmonella isolates (n = 2) were sensitive to Gentamicin, Ciprofloxacin, Ceftriaxone, and Clarithromycin but resistant to Amoxicillin, Ampicillin, and Amoxicillin/clavulanic acid. Similarly, the two Shigella isolates were susceptible to Gentamicin, Ciprofloxacin, and Ceftriaxone but showed resistance to Amoxicillin, Tetracycline, and Chloramphenicol. Further, 60.6% (40/66) of the participants had good level of knowledge, and 51.5% (34/66) had good level of practice on foodborne diseases and on food safety. Conclusions We conclude that foodborne pathogens are significant health problems in the study areas. Regular health education and training programs among the food handlers are demanded to tackle foodborne diseases at the prison centers.	[Mardu, Fitsum; Berhe, Brhane; Tesfay, Kebede] Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Unit Med Parasitol, Adigrat, Ethiopia; [Negash, Hadush; Legese, Haftom] Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Unit Med Microbiol, Adigrat, Ethiopia; [Haileslasie, Hagos; Gebremichail, Gebremedhin] Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Unit Hematol & Immunohematol, Adigrat, Ethiopia; [Tesfanchal, Brhane; Belay, Getachew] Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Unit Clin Chem, Adigrat, Ethiopia; [Gebremedhin, Haftay] Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Mardu, F (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Unit Med Parasitol, Adigrat, Ethiopia.	fmardu25@gmail.com			Adigrat University College of Medicine and Health Sciences, Adigrat, Ethiopia [AGU/CMHS/035/10]	Adigrat University College of Medicine and Health Sciences, Adigrat, Ethiopia	FM received fund from Adigrat University College of Medicine and Health Sciences, Adigrat, Ethiopia (Grant number AGU/CMHS/035/10) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Dayem M, 2014, J MICROBIOL IMMUNOL, V47, P377, DOI 10.1016/j.jmii.2013.06.001; Akabanda F, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3986-9; Alum A, 2010, INT J INFECT DIS, V14, pE732, DOI 10.1016/j.ijid.2009.11.036; [Anonymous], 2019, FUEL CELLS B, V2019, P8, DOI [10.1016/s1464-2859(19)30107-5, DOI 10.1016/S1464-2859(19)30107-5]; [Anonymous], MIBR ZON; [Anonymous], 2013, JHL, V16, pD46; Bhattacharya S, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_452_18; Centers for Disease Control and Prevention (CDC), TRANSM PAR DIS FOOD; Centers for Diseases control and Prevention (CDC), DPD LAB ID PAR PUBL; Chekol FA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4047-0; CLSI, 2016, M100S CLSI; Dekker JP, 2015, CLIN LAB MED, V35, P225, DOI 10.1016/j.cll.2015.02.002; Eshetu L, 2019, RES REP TROP MED, V10, P25, DOI 10.2147/RRTM.S186723; Food Safety, 2019, COLDFOODSTORAGECHART; Gaafar MR, 2011, INT J INFECT DIS, V15, pE541, DOI 10.1016/j.ijid.2011.04.004; Galgamuwa L.S., 2016, INTERMT J SCI, V2, P304, DOI DOI 10.18203/issn.2454-2156.IntJSciRep20164307; Getie M, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0566-7; Gezehegn D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4831-5; Ibrahim RA, 2018, AFR J LAB MED, V7, DOI 10.4102/ajlm.v7i2.770; Kebede E, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4182-7; Kheirandish F, 2014, REV INST MED TROP SP, V56, P111, DOI 10.1590/S0036-46652014000200004; Kubde S.R., 2016, INT J COMMUNITY MED, V3, P251; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mama M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2035-8; Mama M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2790-x; Marami Dadi, 2018, BMC Res Notes, V11, P74, DOI 10.1186/s13104-018-3189-9; Mengist A, 2018, INT J INFECT DIS, V75, P74, DOI 10.1016/j.ijid.2018.08.008; Motazedian MH, 2015, IRAN J PARASITOL, V10, P652; Nasrolahei M, 2017, J INFECT PUBLIC HEAL, V10, P171, DOI 10.1016/j.jiph.2016.03.006; Rediet Habahwi, 2014, ADV FOOD SCI TEC SEP, V2, P260; Research program on Agriculture for Nutrition and Health, 2019, NEW 6 MILL DON INV T; Sharif L., 2013, Food and Nutrition Sciences, V4, P245, DOI 10.4236/fns.2013.43033; Tessema AG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-571; Word Bank, 2018, FOOD BORN ILLN COST; World health organization, 2015, WHO GLOB FOODB INF N; World Health Organization, 10 FACTS FOOD SAF; World Health Organization, 2015, WHOS 1 EV GLOB EST F; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; World Health Organization (WHO), 1989, SAF FOOD HANDL TRAIN	39	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241145	10.1371/journal.pone.0241145	http://dx.doi.org/10.1371/journal.pone.0241145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141859	gold, Green Published			2022-12-26	WOS:000588376700033
J	Schonherr, SG; Wendt, S; Ranft, D; Schock, B; Lubbert, C				Schoenherr, Sebastian G.; Wendt, Sebastian; Ranft, Donald; Schock, Bettina; Luebbert, Christoph			Assessing the impact of institution-specific guidelines for antimicrobials on doctors' prescribing behavior at a German tertiary-care center and the additional benefits of providing a mobile application	PLOS ONE			English	Article							ANTIBIOTIC PRESCRIPTION; STEWARDSHIP PROGRAM; HEALTH	Objective To assess usage patterns, perceived usability, and effects of institution-specific guidelines (ISGs) for antimicrobials on clinicians' prescribing behavior and the additional benefits of the mobile application (app), a single-center survey among medical doctors was performed. Methods The study was carried out in a 1451-bed tertiary-care academic medical center in Leipzig, Germany. To ensure optimal empirical antibiotic therapies, appropriate diagnostics, and targeted antimicrobial prophylaxis, ISGs were provided as printed pocket guides (since 2014), a PDF version on ward computers, and a mobile app (since 2017). For the survey, we used an electronically structured cross-sectional questionnaire with 31 items, ordinal Likert scales, and percent bars, allowing for quantitative comparisons. Results Of the 914 doctors contacted by email, 282 (31%) responded, and 254 (28%) surveys were eligible. ISGs were reported to be the most commonly used source of information for antimicrobial prescribing among the respondents. Ninety-four percent used ISGs at least once and 55% at least weekly. On average, participants reported using them in 38% of antibiotic prescriptions and to adhere to consulted recommendations in 87% of cases. Young clinicians (<= 30 years) reported significantly higher use of the ISGs than their older colleagues (47% vs. 35% of antibiotic prescriptions, p = 0.004). Ninety-six percent of users found ISGs to be user-friendly, and nearly 100% recommended ISGs to other colleagues. Forty-five percent regarded the app as the most user-friendly way to access ISGs, and app users were significantly more likely to use ISGs regularly (p = 0.024). Eighty-four percent reported behavioral changes regarding at least one aspect of antimicrobial therapy (e.g. duration, application mode, prescription frequency), while 54% reported changes regarding the choice of specific substance groups. Conclusions ISGs are used regularly and appear to have a relevant impact on clinicians' prescribing habits. A mobile app may be the most effective way to provide ISGs, although multiple platforms seem to add value. While the majority of participants reported perceived effects on their prescribing behavior, this study does not allow any conclusions to be drawn about the extent of the effects of ISGs on antibiotic use and patient outcomes.	[Schoenherr, Sebastian G.; Wendt, Sebastian; Luebbert, Christoph] Leipzig Univ Hosp, Dept Med 2, Div Infect Dis & Trop Med, Leipzig, Germany; [Wendt, Sebastian] Leipzig Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, Leipzig, Germany; [Wendt, Sebastian; Ranft, Donald; Schock, Bettina; Luebbert, Christoph] Leipzig Univ Hosp, Interdisciplinary Ctr Infect Dis, Leipzig, Germany; [Ranft, Donald] Leipzig Univ Hosp, Hosp Pharm, Leipzig, Germany; [Schock, Bettina] Leipzig Univ Hosp, Inst Hyg Hosp Epidemiol & Environm Med, Leipzig, Germany; [Luebbert, Christoph] Hosp St Georg, Dept Infect Dis Trop Med Nephrol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University	Lubbert, C (corresponding author), Leipzig Univ Hosp, Dept Med 2, Div Infect Dis & Trop Med, Leipzig, Germany.; Lubbert, C (corresponding author), Leipzig Univ Hosp, Interdisciplinary Ctr Infect Dis, Leipzig, Germany.; Lubbert, C (corresponding author), Hosp St Georg, Dept Infect Dis Trop Med Nephrol & Rheumatol, Leipzig, Germany.	christoph.luebbert@medizin.uni-leipzig.de		Wendt, Sebastian/0000-0002-6775-3686	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2019, COR EL HOSP ANT STEW; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Charani E, 2017, J ANTIMICROB CHEMOTH, V72, P1825, DOI 10.1093/jac/dkx040; Davey P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub4; Fralick M, 2017, INT J MED EDUC, V8, P416, DOI 10.5116/ijme.5a11.8422; Hearn P, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0172-5; Hoff Brian M, 2018, J Pathol Inform, V9, P10, DOI 10.4103/jpi.jpi_77_17; Jenkins TC, 2020, INFECT CONT HOSP EP, V41, P212, DOI 10.1017/ice.2019.331; Leiner DJ, 2019, SOSCI SURVEY 2019 VE; Lubbert C, 2017, APP ANTIBIOTIKAANTII; Lubbert C, 2014, DEUT MED WOCHENSCHR, V139, P2578, DOI 10.1055/s-0034-1387220; Panesar P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154202; Standiford HC, 2012, INFECT CONT HOSP EP, V33, P338, DOI 10.1086/664909; Tuon FF, 2017, BRAZ J INFECT DIS, V21, P660, DOI 10.1016/j.bjid.2017.08.002; Yoon CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211157; Young HL, 2018, INFECT CONT HOSP EP, V39, P986, DOI 10.1017/ice.2018.135	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241642	10.1371/journal.pone.0241642	http://dx.doi.org/10.1371/journal.pone.0241642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141858	Green Published, gold			2022-12-26	WOS:000588376700007
J	Gao, HB; Antony, R; Srinivasan, R; Wu, PL; Wang, XJ; Li, YF				Gao, Hongbo; Antony, Ryan; Srinivasan, Rekha; Wu, Penglong; Wang, Xuejun; Li, Yifan			UCHL1 regulates oxidative activity in skeletal muscle	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; CHAPERONIN HSP60; FIBER TYPES; PROTEINS; EXERCISE; EXPRESSION	Ubiquitin C-terminal Hydrolase L1 (UCHL1) is a deubiquitinating enzyme that was originally identified in neurons. Our recent study showed that UCHL1 was expressed in C2C12 myoblast cells and mouse skeletal muscle. Here we report that in mouse skeletal muscle, UCHL1 is primarily expressed in oxidative muscle fibers. Skeletal muscle specific gene knockout (smKO) of UCHL1 in mice reduced oxidative activity in skeletal muscle measured by SDH staining. The in situ muscle contraction test revealed that gastrocnemius muscle from UCHL1 smKO mice was more prone to fatigue in response to the repetitive stimulation. This data suggests that UCHL1 plays a role in maintenance of muscle oxidative metabolism. Moreover, UCHL1 smKO caused a significant reduction in key proteins that are involved in mitochondrial oxidative phosphorylation in soleus muscles, suggesting that UCHL1 may be involved in regulation of mitochondrial content and function. Immunostaining showed the co-localization of UCHL1 and mitochondrial marker VDAC in skeletal muscle. Mitochondrial fractionation assay revealed that, although UCHL1 was primarily present in the cytosolic fraction, a low level of UCHL1 protein was present in mitochondrial fraction. The level of phosphorylation of AMPK alpha, a master regulator of mitochondrial biogenesis, were unchanged in UCHL1 smKO muscle. On the other hand, immunoprecipitation from soleus muscle sample indicated the interaction between UCHL1 and HSP60, a chaperon protein that is involved in mitochondrial protein transport. There was a trend of downregulation of HSP60 in UCHL1 smKO muscle. Overall, our data suggests UCHL1 is a novel regulator of mitochondrial function and oxidative activity in skeletal muscle.	[Gao, Hongbo; Antony, Ryan; Srinivasan, Rekha; Wu, Penglong; Wang, Xuejun; Li, Yifan] Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	University of South Dakota	Li, YF (corresponding author), Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	yifan.li@usd.edu		Antony, Ryan/0000-0002-1286-7731	National Institutes of Health [R03AG051926, R01HL147105, R01HL072166, R01HL131667]; USD BBS graduate program; USD CBBRe pilot grant; USD SSOM faculty research grant; USD Graduate Research and Creative Scholarship Grant; USD-N3 Student Travel Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USD BBS graduate program; USD CBBRe pilot grant; USD SSOM faculty research grant; USD Graduate Research and Creative Scholarship Grant; USD-N3 Student Travel Award	This study is supported by National Institutes of Health grants, R03AG051926, R01HL147105 (to YL), R01HL072166, and R01HL131667 (to XW), the USD BBS graduate program, a USD CBBRe pilot grant, and a USD SSOM faculty research grant (to YL). USD Graduate Research and Creative Scholarship Grant and USD-N3 Student Travel Award (to HG). There was no additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, LANCET GLOB HEALTH, V6, pE593, DOI 10.1016/S2214-109X(18)30239-0; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Fromm S, 2016, J EXP BOT, V67, P3079, DOI 10.1093/jxb/erw165; Gao HB, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116699; Gao HB, 2017, BIOCHEM BIOPH RES CO, V492, P96, DOI 10.1016/j.bbrc.2017.08.027; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kumar A, 2015, JOVE-J VIS EXP, DOI 10.3791/52793; LARSSON L, 1993, ACTA PHYSIOL SCAND, V147, P227, DOI 10.1111/j.1748-1716.1993.tb09493.x; Lavie J, 2018, CELL REP, V23, P2852, DOI 10.1016/j.celrep.2018.05.013; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Meng QL, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00035; Miljkovic N, 2015, ANN REHABIL MED-ARM, V39, P155, DOI 10.5535/arm.2015.39.2.155; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Powis RA, 2014, NEUROPATH APPL NEURO, V40, P873, DOI 10.1111/nan.12168; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Satta A, 1997, EUR RESPIR J, V10, P2853, DOI 10.1183/09031936.97.10122853; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sullivan MJ, 1997, MED SCI SPORT EXER, V29, P860, DOI 10.1097/00005768-199707000-00004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vasu VT, 2009, FREE RADICAL RES, V43, P106, DOI 10.1080/10715760802616676; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630	34	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241716	10.1371/journal.pone.0241716	http://dx.doi.org/10.1371/journal.pone.0241716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137160	gold, Green Published			2022-12-26	WOS:000588375500014
J	Au, HW; Tsang, MW; Chen, YW; So, PK; Wong, KY; Leung, YC				Au, Ho-Wah; Tsang, Man-Wah; Chen, Yu Wai; So, Pui-Kin; Wong, Kwok-Yin; Leung, Yun-Chung			BADAN-conjugated beta-lactamases as biosensors for beta-lactam antibiotic detection	PLOS ONE			English	Article							CLOXACILLIN; RESIDUES; ASSAY; MILK	beta-Lactam antibiotic detection has significant implications in food safety control, environmental monitoring and pharmacokinetics study. Here, we report the development of two BADAN-conjugated beta-lactamases, E166Cb and E166Cb/N170Q, as sensitive biosensors for beta-lactam antibiotic detection. These biosensors were constructed by coupling an environment-sensitive BADAN probe onto location 166 at the active site of the PenP beta-lactamase E166C and E166C/N170Q mutants. They gave fluorescence turn-on signals in response to beta-lactam antibiotics. Molecular dynamics simulation of E166Cb suggested that the turn-on signal might be attributed to a polarity change of the microenvironment of BADAN and the removal of the fluorescence quenching effect on BADAN exerted by a nearby Tyr-105 upon the antibiotic binding. In the detection of four beta-lactams (penicillin G, penicillin V, cefotaxime and moxalactam), both E166Cb and E166Cb/N170Q delivered signal outputs in an antibiotic-concentration dependent manner with a dynamic range spanning from 10 nM to 1 mu M. Compared to E166Cb, E166Cb/N170Q generally exhibited more stable signals owing to its higher deficiency in hydrolyzing the antibiotic analyte. The overall biosensor performance of E166Cb and E166Cb/N170Q was comparable to that of their respective fluorescein-modified counterparts, E166Cf and E166Cf/N170Q. But comparatively, the BADAN-conjugated enzymes showed a higher sensitivity, displayed a faster response in detecting moxalactam and a more stable fluorescence signals towards penicillin G. This study illustrates the potential of BADAN-conjugated beta-lactamases as biosensing devices for beta-lactam antibiotics.	[Au, Ho-Wah; Tsang, Man-Wah; Chen, Yu Wai; So, Pui-Kin; Wong, Kwok-Yin; Leung, Yun-Chung] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chem Biol & Drug Discovery, Hung Hom,Kowloon, Hong Kong, Peoples R China; [Leung, Yun-Chung] Hong Kong Polytech Univ, Lo Ka Chung Res Ctr Nat Anticanc Drug Dev, Hung Hom, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Wong, KY; Leung, YC (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chem Biol & Drug Discovery, Hung Hom,Kowloon, Hong Kong, Peoples R China.; Leung, YC (corresponding author), Hong Kong Polytech Univ, Lo Ka Chung Res Ctr Nat Anticanc Drug Dev, Hung Hom, Kowloon, Hong Kong, Peoples R China.	kwok-yin.wong@polyu.edu.hk; thomas.yun-chung.leung@polyu.edu.hk	Tsang, Emily Man Wah/A-5746-2015	Tsang, Emily Man Wah/0000-0002-1637-2015	RGC GRF grant from Research Grants Council, University Grants Committee (Hong Kong) [151019/14M, 151069/17M]; RGC grants from Research Grants Council, University Grants Committee (Hong Kong) [C5031-14E, G-YBB3, G-YB RX, BBX4, BBX8]	RGC GRF grant from Research Grants Council, University Grants Committee (Hong Kong); RGC grants from Research Grants Council, University Grants Committee (Hong Kong)	This work was supported by the RGC GRF grant (151019/14M and 151069/17M) and RGC grants (C5031-14E, G-YBB3, G-YB RX, BBX4 and BBX8) from Research Grants Council, University Grants Committee (Hong Kong). For the following, the recipients are Kwok-Yin Wong and Yun-Chung Leung: 151019/14M, 151069/17M, BBX4, BBX8 For the following, the recipient is YunChung Leung: C5031-14E, G-YBB3, G-YB RX.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahmed S, 2017, TALANTA, V166, P176, DOI 10.1016/j.talanta.2017.01.057; Andresen M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051424; Andresen M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4307987; Aslam B, 2018, INFECT DRUG RESIST, V11, P1645, DOI 10.2147/IDR.S173867; Au HW, 2019, ACS OMEGA, V4, P20493, DOI 10.1021/acsomega.9b02211; Blumenthal KG, 2019, LANCET, V393, P183, DOI 10.1016/S0140-6736(18)32218-9; Bush K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00047-19; Chan PH, 2004, J AM CHEM SOC, V126, P4074, DOI 10.1021/ja038409m; CHARM SE, 1982, J ASSOC OFF ANA CHEM, V65, P1186; Chen CCH, 1999, PROTEIN ENG, V12, P573, DOI 10.1093/protein/12.7.573; Chen J, 2019, J AGR FOOD CHEM, V67, P7569, DOI 10.1021/acs.jafc.9b01334; Cheong WL, 2014, BIOSCIENCE REP, V34, P523, DOI 10.1042/BSR20140057; Das S, 2014, J FOOD SCI TECH MYS, V51, P1161, DOI 10.1007/s13197-011-0609-4; Docquier JD, 2018, DRUG RESIST UPDATE, V36, P13, DOI 10.1016/j.drup.2017.11.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fonin AV, 2015, J MOL STRUCT, V1090, P107, DOI 10.1016/j.molstruc.2015.01.038; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huth SP, 2002, J AOAC INT, V85, P355; Kim C, 2018, J ENVIRON MANAGE, V217, P629, DOI 10.1016/j.jenvman.2018.04.006; Kjeldgaard J, 2012, MBIO, V3, DOI 10.1128/mBio.00190-12; Korsrud GO, 1998, J AOAC INT, V81, P21; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Pospisil P, 2014, J PHYS CHEM B, V118, P10085, DOI 10.1021/jp504625d; Romano A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0594-9; Suhren G, 1998, J AOAC INT, V81, P978; Tsang MW, 2015, BIOTECHNOL J, V10, P126, DOI 10.1002/biot.201400140; Tsang MW, 2011, ANAL CHEM, V83, P1996, DOI 10.1021/ac102595r; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; van Duin D, 2016, CLIN INFECT DIS, V63, P234, DOI 10.1093/cid/ciw243; Ventola C Lee, 2015, P T, V40, P277; Verhoven SM, 2018, CLIN CHIM ACTA, V482, P60, DOI 10.1016/j.cca.2018.03.021; WHO, 2017, WHO GUID ETH ISS PUB; Wong WT, 2011, J BIOL CHEM, V286, P31771, DOI 10.1074/jbc.M110.198895	36	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241594	10.1371/journal.pone.0241594	http://dx.doi.org/10.1371/journal.pone.0241594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125437	gold, Green Published			2022-12-26	WOS:000588368900057
J	Chaniad, P; Trakunran, K; Geater, SL; Keeratichananont, W; Thongsuksai, P; Raungrut, P				Chaniad, Pichitpon; Trakunran, Keson; Geater, Sarayut Lucien; Keeratichananont, Warangkana; Thongsuksai, Paramee; Raungrut, Pritsana			Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MICRORNAS; EXPRESSION; BIOMARKERS; INVASION; IDENTIFICATION; METAANALYSIS; METASTASIS; PROGNOSIS; RESOURCE	Tumor-promoting cytokines are a cause of tumor progression; therefore, identifying key regulatory microRNAs (miRNAs) for controlling their production is important. The aim of this study is to identify promising miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer (NSCLC). We identified circulating miRNAs from 16 published miRNA profiles. The selected miRNAs were validated in the serum of 32 NSCLC patients and compared with 33 patients with other lung diseases and 23 healthy persons using quantitative real-time PCR. The cytokine concentration was investigated using the enzyme-linked immunoassay in the same sample set, with clinical validation of the miRNAs. The correlation between miRNA expression and cytokine concentration was evaluated by Spearman's rank correlation. For consistent direction, one up-regulated miRNA (miR-145) was found in four studies, and seven miRNAs were reported in three studies. One miRNA (miR-20a) and four miRNAs (miR-25-3p, miR-223, let-7f, and miR-20b) were reported in six and five studies. However, their expression was inconsistent. In the clinical validation, serum miR-145 was significantly down-regulated, whereas serum miR-20a was significantly up-regulated in NSCLC, compared with controls. Regarding serum cytokine, all cytokines [vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and transforming growth factor beta (TGF-beta)], except tumor necrosis factor-alpha (TNF-alpha), had a higher level in NSCLC patients than controls. In addition, we found a moderate correlation between the TGF-beta concentration and miR-20a (r = -0.537, p = 0.002) and miR-223 (r = 0.428, p = 0.015) and a weak correlation between the VEGF concentration with miR-20a (r = 0.376, p = 0.037) and miR-223 (r = -0.355, p = 0.046). MiR-145 and miR-20a are potential biomarkers for NSCLC. In addition, the regulation of tumor-promoting cytokine, through miR-20a and miR-223, might be a new therapeutic approach for lung cancer.	[Chaniad, Pichitpon; Trakunran, Keson; Raungrut, Pritsana] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand; [Geater, Sarayut Lucien; Keeratichananont, Warangkana] Prince Songkla Univ, Fac Med, Div Resp & Resp Crit Care Med, Hat Yai, Thailand; [Thongsuksai, Paramee] Prince Songkla Univ, Fac Med, Dept Pathol Dept, Hat Yai, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Raungrut, P (corresponding author), Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand.	rpritsan@medicine.psu.ac.th			Prince of Songkla University [MED590692S]; Research Center for Cancer Control in Thailand [MEDRC59036]; Faculty of Medicine, Prince of Songkla University [REC60350042]	Prince of Songkla University; Research Center for Cancer Control in Thailand; Faculty of Medicine, Prince of Songkla University	This study is funded by a grant from the Prince of Songkla University [grant number MED590692S], the Research Center for Cancer Control in Thailand [grant number MEDRC59036], and the Faculty of Medicine, Prince of Songkla University [grant number REC60350042]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiso T, 2018, ONCOL LETT, V16, P6643, DOI 10.3892/ol.2018.9464; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2018, INT J CYBER SECURITY, V7, P21, DOI [10.17781/p002318, DOI 10.17781/P002318]; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berenstein R, 2016, MOL CARCINOGEN, V55, P1927, DOI 10.1002/mc.22440; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campayo M, 2013, EUR RESPIR J, V41, P1172, DOI 10.1183/09031936.00048712; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chen YK, 2016, ONCOL REP, V36, P3379, DOI 10.3892/or.2016.5144; Cheng DT, 2016, ONCOTARGET, V7, P45199, DOI 10.18632/oncotarget.9900; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Correia ACP, 2016, J CELL SCI, V129, P569, DOI 10.1242/jcs.176248; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fan L, 2012, ACTA BIOCH BIOPH SIN, V44, P407, DOI 10.1093/abbs/gms019; Fan LH, 2016, TUMOR BIOL, V37, P7777, DOI 10.1007/s13277-015-4608-3; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao XJ, 2016, ONCOTARGET, V7, P59664, DOI 10.18632/oncotarget.11198; Geng Q, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0149-3; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Halvorsen AR, 2016, ONCOTARGET, V7, P37250, DOI 10.18632/oncotarget.9363; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Howlader N, 2019, NIH, V1; Hua Z, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0628-5; Huang Y, 2018, INT J CLIN EXP PATHO, V11, P5715; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Krupke DM, 2017, CANCER RES, V77, pE67, DOI 10.1158/0008-5472.CAN-17-0584; Leidinger P, 2016, ONCOTARGET, V7, P4611, DOI 10.18632/oncotarget.6566; Liang HC, 2015, TUMOR BIOL, V36, P5305, DOI 10.1007/s13277-015-3191-y; Liu XX, 2018, CELL PHYSIOL BIOCHEM, V46, P1439, DOI 10.1159/000489185; Luengo-Gil G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194638; Marrugal A, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/2138627; Nadal E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12464; Nakamura K, 2017, J EPIDEMIOL, V27, pS49, DOI 10.1016/j.je.2016.12.010; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pellatt AJ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1566-8; Rani S, 2013, CANCER BIOL THER, V14, P1104, DOI 10.4161/cbt.26370; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Roth C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038248; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Song XY, 2013, ASIAN PAC J CANCER P, V14, P4765, DOI 10.7314/APJCP.2013.14.8.4765; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trakunram Keson, 2019, Asian Pac J Cancer Prev, V20, P1641, DOI 10.31557/APJCP.2019.20.6.1641; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Wozniak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125026; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang RR, 2017, BIOMED REP, V6, P429, DOI 10.3892/br.2017.862; Yang Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0710-z; Yu YB, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-017-0499-2	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241593	10.1371/journal.pone.0241593	http://dx.doi.org/10.1371/journal.pone.0241593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125430	gold, Green Published			2022-12-26	WOS:000588368900059
J	Zhou, YH; Qiu, Q; Luo, KW; Liao, QH; Li, Y; Cui, P; Liang, L; Cheng, YB; Wang, LL; Wang, K; Tan, LV; van Doorn, HR; Yu, HJ				Zhou, Yonghong; Qiu, Qi; Luo, Kaiwei; Liao, Qiaohong; Li, Yu; Cui, Peng; Liang, Lu; Cheng, Yibing; Wang, Lili; Wang, Kai; Tan, Le Van; van Doorn, H. Rogier; Yu, Hongjie			Molecular strategy for the direct detection and identification of human enteroviruses in clinical specimens associated with hand, foot and mouth disease	PLOS ONE			English	Article							COXSACKIEVIRUS A6; PICORNAVIRUS; DIAGNOSIS; OUTBREAK; CHINA	Background Diseases caused by human enteroviruses (EVs) are a major global public health problem. Thus, the effective diagnosis of all human EVs infections and the monitoring of epidemiological and ecological dynamic changes are urgently needed. Methods Based on two comprehensive virological surveillance systems of hand, foot and mouth disease (HFMD), real-time PCR and nested RT-PCR (RT-snPCR) methods based on the enteroviral VP1, VP4-VP2 and VP4 regions were designed to directly detect all human EVs serotypes in clinical specimens. Results The results showed that the proposed serotyping strategy exhibit very high diagnostic efficiency (Study 1: 99.9%; Study 2: 89.5%), and the variance between the study was due to inclusion of the specific Coxsackie virus A6 (CVA6) real-time RT-PCR and VP4 RT-snPCR in Study 1 but not Study 2. Furthermore, only throat swabs were collected and analyzed in Study 2, whereas in Study 1, if a specific EV serotype was not identified in the primary stool sample, other sample types (rectal swab and throat swab) were further tested where available. During the study period from 2013 to 2018, CVA6 became one of the main HFMD causative agents, whereas the level of enterovirus A71 (EV-A71) declined in 2017. Conclusion The findings of this study demonstrate the appropriate application of PCR methods and the combination of biological sample types that are useful for etiological studies and propose a molecular strategy for the direct detection of human EVs in clinical specimens associated with HFMD.	[Zhou, Yonghong; Qiu, Qi; Liao, Qiaohong; Cui, Peng; Wang, Lili; Wang, Kai; Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China; [Luo, Kaiwei] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Liao, Qiaohong; Li, Yu] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Liang, Lu] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China; [Cheng, Yibing] Hosp Affiliated Zhengzhou Univ, Henan Childrens Hosp, Zhengzhou, Peoples R China; [Tan, Le Van; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [van Doorn, H. Rogier] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	Fudan University; Chinese Center for Disease Control & Prevention; Sichuan University; University of Oxford; University of Oxford	Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.	yhj@fudan.edu.cn	Yu, Hongjie/GZK-5351-2022; wang, lili/HDL-7210-2022; van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821; Zhou, Yonghong/0000-0002-1242-1764; Le Van, Tan/0000-0002-1791-3901	National Science and Technology Major Projects of China [2018ZX10713001-007, 2017ZX10103009-005]; National Natural Science Fund for Distinguished Young Scholars of China [81525023]; National Natural Science Foundation of China [81473031]; Program of Shanghai Academic/Technology Research Leader [18XD1400300]; United States National Institutes of Health [U19AI51915]; Li Ka Shing Oxford Global Health Programme [B9RST00-B900.57]; Chinese Preventive Medicine Association [20101801]; Hunan Provincial Natural Science Foundation [2019JJ80115]; Scientific Research Project of Hunan Provincial Health Commission [B2019039]	National Science and Technology Major Projects of China; National Natural Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic/Technology Research Leader; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Li Ka Shing Oxford Global Health Programme; Chinese Preventive Medicine Association; Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province); Scientific Research Project of Hunan Provincial Health Commission	This work was supported by funding from the National Science and Technology Major Projects of China (No. 2018ZX10713001-007), National Science and Technology Major Projects of China (No. 2017ZX10103009-005), National Natural Science Fund for Distinguished Young Scholars of China (No. 81525023), the National Natural Science Foundation of China (No. 81473031), the Program of Shanghai Academic/Technology Research Leader (No. 18XD1400300), the United States National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19AI51915), the Li Ka Shing Oxford Global Health Programme (No. B9RST00-B900.57), the Chinese Preventive Medicine Association (No: 20101801), the Hunan Provincial Natural Science Foundation (2019JJ80115) and the Scientific Research Project of Hunan Provincial Health Commission (B2019039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi OM, 2018, PATHOG GLOB HEALTH, V112, P421, DOI 10.1080/20477724.2018.1548117; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], **NON-TRADITIONAL**; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chen JF, 2014, INT J INFECT DIS, V28, P17, DOI 10.1016/j.ijid.2014.07.024; Consenso GESIDA y PNS, 2011, ENFERM INFEC MICR CL, V29, P165, DOI [10.1016/j.eimc.2010.12.004, DOI 10.1016/J.EIMC.2010.12.004]; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Cui P, 2019, Zhonghua Er Ke Za Zhi, V57, P445, DOI 10.3760/cma.j.issn.0578-1310.2019.06.009; Gu HY, 2014, PEDIATR INFECT DIS J, V33, P1302, DOI 10.1097/INF.0000000000000467; Harvala H, 2018, J CLIN VIROL, V101, P11, DOI 10.1016/j.jcv.2018.01.008; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Li JL, 2014, J INFECTION, V69, P299, DOI 10.1016/j.jinf.2014.04.001; Li XW, 2018, WORLD J PEDIATR, V14, P437, DOI 10.1007/s12519-018-0189-8; Li Y, 2018, EMERG INFECT DIS, V24, P1902, DOI 10.3201/eid2410.171953; McIntyre Mary G., 2012, Morbidity and Mortality Weekly Report, V61, P213; Muehlenbachs A, 2015, J PATHOL, V235, P217, DOI 10.1002/path.4438; B'Krong NTTC, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0980-0; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Ooi MH, 2007, J CLIN MICROBIOL, V45, P1858, DOI 10.1128/JCM.01394-06; Sapia EY, 2020, ARCH ARGENT PEDIATR, V118, pE199, DOI 10.5546/aap.2020.e199; Sinclair C, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.12.20745; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Song Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05618-0; Stehouwer CDA, 2018, DIABETES, V67, P1729, DOI 10.2337/dbi17-0044; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Wang XM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198552; Yang BY, 2017, EUROSURVEILLANCE, V22, P38, DOI 10.2807/1560-7917.ES.2017.22.50.16-00824; Yu HJ, 2019, LANCET CHILD ADOLESC, V3, P373, DOI 10.1016/S2352-4642(19)30065-3; Zhang L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-298	33	1	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241614	10.1371/journal.pone.0241614	http://dx.doi.org/10.1371/journal.pone.0241614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166321	gold, Green Published			2022-12-26	WOS:000592382600062
J	Malinova, V; Pinter, A; Dragaescu, C; Rohde, V; Trenkwalder, C; Sixel-Doring, F; von Eckardstein, KL				Malinova, Vesna; Pinter, Anabel; Dragaescu, Cristina; Rohde, Veit; Trenkwalder, Claudia; Sixel-Doering, Friederike; von Eckardstein, Kajetan L.			The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; NUCLEUS; MACROSTIMULATION; MICROSTIMULATION	Objective Intraoperative microelectrode recording (MER) and test-stimulation are regarded as the gold standard for proper placement of subthalamic (STN) deep brain stimulation (DBS) electrodes in Parkinson's disease (PD), requiring the patient to be awake during the procedure. In accordance with good clinical practice, most attending neurologists will request the clinically most efficacious trajectory for definite lead placement. However, the necessity of microelectrode-test-stimulation is disputed, as it may limit the access to DBS therapy, excluding those not willing or incapable of undergoing awake surgery. Methods We retrospectively analyzed the MERs and microelectrode-test-stimulation results with regard to the decision on definite lead placement and clinical outcome in a cohort of 67 PD-patients with STN-DBS. All patients received bilateral quadripolar ring electrodes. To ascertain overall procedural efficacy, we calculated the surgical index (SI) by comparing preoperative motor improvement induced by levodopa to that induced by stimulation 7 to 18 months after surgery, measured as the relative difference between ON and OFF-states on the Unified Parkinson's Disease Rating Scale motor part (UPDRS-3). Additionally, a side-specific surgical index (SSSI) was calculated using the unilateral assessable items of the UPDRS-3. The SSSI where microelectrode-test-stimulation overruled MER were compared to those where the result of microelectrode-test-stimulation was congruent to MER results. Results A total of 134 electrodes were analyzed. For final lead placement, the central trajectory was chosen in 54% of patient hemispheres. The mean SI was 0.99 (+/- 0.24). SSSI averaged 1.04 (+/- 0.45). In 37 lead placements, microelectrode-test-stimulation overruled MER in the final trajectory selection, in 27 of these lead placements adverse effects during microelectrode-test-stimulation were decisive. Neither the number of test electrodes used nor the STN-signal length had an impact on the SSSI. The SSSI did not differ between lead placements with MER/microelectrode-test-stimulation congruency and those where the results of microelectrode-test-stimulation initiated lead placement in a trajectory with shorter STN signal. Conclusion Intraoperative testing is mandatory to ensure an optimal motor outcome of STN DBS in PD-patients when using quadripolar ring electrodes. However, we also demonstrated that neither the length of the STN-signal on MER nor the number of test electrodes influenced the motor outcome.	[Malinova, Vesna; Rohde, Veit; Trenkwalder, Claudia; von Eckardstein, Kajetan L.] Gottingen Univ Med Ctr, Dept Neurosurg, Gottingen, Germany; [Pinter, Anabel] Gottingen Univ Med Ctr, Dept Neurol, Gottingen, Germany; [Dragaescu, Cristina; Trenkwalder, Claudia; Sixel-Doering, Friederike] Paracelsus Elena Clin, Kassel, Germany; [von Eckardstein, Kajetan L.] Westpfalz Klinikum Kaiserslautern, Dept Neurosurg, Kaiserslautern, Germany	Westpfalz-Klinikum GmbH	Malinova, V (corresponding author), Gottingen Univ Med Ctr, Dept Neurosurg, Gottingen, Germany.	vesna.malinova@gmail.com	Trenkwalder, Claudia/AHD-1232-2022; Trenkwalder, Claudia/ABD-6559-2021	Trenkwalder, Claudia/0000-0001-6407-1199; 				Benabid AL, 2011, YOUMANS NEUROLOGICAL, P944; Bjerknes S, 2018, MOV DISORD CLIN PRAC, V5, P296, DOI 10.1002/mdc3.12621; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960; Harries AM, 2012, J NEUROSURG, V116, P107, DOI 10.3171/2011.7.JNS11319; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kocabicak E, 2019, TURK NEUROSURG, V29, P677, DOI 10.5137/1019-5149.JTN.23307-18.3; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lozano CS, 2019, J NEUROSURG, V130, P1847, DOI 10.3171/2018.2.JNS172186; Mehanna R, 2017, NEUROMODULATION, V20, P456, DOI 10.1111/ner.12553; Pollak P, 2002, MOVEMENT DISORD, V17, pS155, DOI 10.1002/mds.10158; Reck C, 2012, J NEUROL SURG PART A, V73, P377, DOI 10.1055/s-0032-1326957; Rezai AR, 2006, MOVEMENT DISORD, V21, pS197, DOI 10.1002/mds.20956; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; ten Brinke TR, 2018, BRAIN STIMUL, V11, P949, DOI 10.1016/j.brs.2018.04.008; Tsai ST, 2019, PARKINSONS DIS-US, V2019, DOI 10.1155/2019/5676345; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Zeiler FA, 2013, CAN J NEUROL SCI, V40, P572, DOI 10.1017/S0317167100014682; Zuchner, 2006, NEUROSURGERY, V59, pE1138, DOI [DOI 10.1227/01.NEU.0000245603.77075.55, 10.1227/01.NEU.0000245603.77075.55]	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241752	10.1371/journal.pone.0241752	http://dx.doi.org/10.1371/journal.pone.0241752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156830	gold, Green Published			2022-12-26	WOS:000591376400048
J	Poppenberg, KE; Li, L; Waqas, M; Paliwal, N; Jiang, KY; Jarvis, JN; Sun, YJ; Snyder, KV; Levy, EI; Siddiqui, AH; Kolega, J; Meng, H; Tutino, VM				Poppenberg, Kerry E.; Li, Lu; Waqas, Muhammad; Paliwal, Nikhil; Jiang, Kaiyu; Jarvis, James N.; Sun, Yijun; Snyder, Kenneth V.; Levy, Elad I.; Siddiqui, Adnan H.; Kolega, John; Meng, Hui; Tutino, Vincent M.			Whole blood transcriptome biomarkers of unruptured intracranial aneurysm	PLOS ONE			English	Article							COST-EFFECTIVENESS; SUBARACHNOID HEMORRHAGE; EXPRESSION; POLYMORPHISMS; INFLAMMATION; POPULATION; CELLS; RISK	Background The rupture of an intracranial aneurysm (IA) causes devastating subarachnoid hemorrhages, yet most IAs remain undiscovered until they rupture. Recently, we found an IA RNA expression signature of circulating neutrophils, and used transcriptome data to build predictive models for unruptured IAs. In this study, we evaluate the feasibility of using whole blood transcriptomes to predict the presence of unruptured IAs. Methods We subjected RNA from peripheral whole blood of 67 patients (34 with unruptured IA, 33 without IA) to next-generation RNA sequencing. Model genes were identified using the least absolute shrinkage and selection operator (LASSO) in a random training cohort (n = 47). These genes were used to train a Gaussian Support Vector Machine (gSVM) model to distinguish patients with IA. The model was applied to an independent testing cohort (n = 20) to evaluate performance by receiver operating characteristic (ROC) curve. Gene ontology and pathway analyses investigated the underlying biology of the model genes. Results We identified 18 genes that could distinguish IA patients in a training cohort with 85% accuracy. This SVM model also had 85% accuracy in the testing cohort, with an area under the ROC curve of 0.91. Bioinformatics reflected activation and recruitment of leukocytes, activation of macrophages, and inflammatory response, suggesting that the biomarker captures important processes in IA pathogenesis. Conclusions Circulating whole blood transcriptomes can detect the presence of unruptured IAs. Pending additional testing in larger cohorts, this could serve as a foundation to develop a simple blood-based test to facilitate screening and early detection of IAs.	[Poppenberg, Kerry E.; Paliwal, Nikhil; Snyder, Kenneth V.; Levy, Elad I.; Siddiqui, Adnan H.; Kolega, John; Meng, Hui; Tutino, Vincent M.] Canon Stroke & Vasc Res Ctr, Buffalo, NY 14203 USA; [Poppenberg, Kerry E.; Paliwal, Nikhil; Meng, Hui; Tutino, Vincent M.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Poppenberg, Kerry E.; Waqas, Muhammad; Snyder, Kenneth V.; Levy, Elad I.; Siddiqui, Adnan H.; Meng, Hui; Tutino, Vincent M.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Li, Lu] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY USA; [Jiang, Kaiyu; Jarvis, James N.; Sun, Yijun] SUNY Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY USA; [Jarvis, James N.] SUNY Buffalo, Dept Pediat, Buffalo, NY USA; [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY USA; [Snyder, Kenneth V.; Levy, Elad I.; Siddiqui, Adnan H.] SUNY Buffalo, Dept Radiol, Buffalo, NY USA; [Snyder, Kenneth V.] SUNY Buffalo, Dept Neurol, Buffalo, NY USA; [Kolega, John; Tutino, Vincent M.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Tutino, VM (corresponding author), Canon Stroke & Vasc Res Ctr, Buffalo, NY 14203 USA.; Tutino, VM (corresponding author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.; Tutino, VM (corresponding author), SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA.; Tutino, VM (corresponding author), SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA.	vincentt@buffalo.edu		Poppenberg, Kerry/0000-0002-1748-887X	Neurovascular Diagnostics, Inc. in the form of a National Science Foundation [1746694]; Brain Aneurysm Foundation; New York State Center for Advanced Technology in Big Data and Health Sciences; Cummings Foundation	Neurovascular Diagnostics, Inc. in the form of a National Science Foundation; Brain Aneurysm Foundation; New York State Center for Advanced Technology in Big Data and Health Sciences; Cummings Foundation	This study was supported by Neurovascular Diagnostics, Inc. in the form of a National Science Foundation (https://www.nsf.gov/) grant awarded to VMT (1746694), The Brain Aneurysm Foundation (https://bafound.org/) in the form of funding awarded to VMT, The New York State Center for Advanced Technology in Big Data and Health Sciences (http://www.buffalo.edu/bioinformatics/resources/funding-incentives/ubcat.html) in the form of funding awarded to VMT, and The Cummings Foundation (https://jameshcummings.com/) in the form of funding awarded to AHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, INVEST OPHTHALMOL VI, V38, pS1; ANZAI N, 1995, BLOOD, V86, P917; Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bor ASE, 2010, NEUROLOGY, V74, P1671, DOI 10.1212/WNL.0b013e3181e04297; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Chen SH, 2004, CYTOKINE GROWTH F R, V15, P379, DOI 10.1016/j.cytogfr.2004.06.002; Chu Y, MYELOPEROXIDASE IS I, P1524; Chyatte D, 1999, NEUROSURGERY, V45, P1137, DOI 10.1097/00006123-199911000-00024; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Greving JP, 2009, NEUROLOGY, V73, P258, DOI 10.1212/01.wnl.0b013e3181a2a4ea; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Hopmans EM, 2016, EUR STROKE J, V1, P320, DOI 10.1177/2396987316674862; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Juvela S, 2004, STROKE, V35, P372, DOI 10.1161/01.STR.0000115299.02909.68; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Liao B, 2020, J ATHEROSCLER THROMB, V27, P545, DOI 10.5551/jat.51102; Morgan L, 2006, J NEUROL NEUROSUR PS, V77, P915, DOI 10.1136/jnnp.2005.081976; Nakagawa D, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010051; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nowicki KW, 2018, J NEUROINTERV SURG, V10, P93, DOI 10.1136/neurintsurg-2016-012911; Olafsson E, 1997, NEUROLOGY, V48, P1191, DOI 10.1212/WNL.48.5.1191; Pawlowska E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041245; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Serra Raffaele, 2014, Br J Neurosurg; Sun H, 2008, NEUROSCI LETT, V440, P1, DOI 10.1016/j.neulet.2008.04.077; Teng LF, 2017, ONCOTARGET, V8, P107125, DOI 10.18632/oncotarget.22349; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Turkmani AH, 2015, NEUROIMMUNOL NEUROIN, V2, P2015; Tutino VM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1749-3; Tutino VM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191407; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang GZ, 2011, J NEUROL SCI, V306, P94, DOI 10.1016/j.jns.2011.03.036; Zhang HF, 2013, INFLAMMATION, V36, P1195, DOI 10.1007/s10753-013-9655-6	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0241838	10.1371/journal.pone.0241838	http://dx.doi.org/10.1371/journal.pone.0241838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156839	Green Published, gold			2022-12-26	WOS:000591376400008
J	Bolgan, M; Pereira, BP; Crucianelli, A; Mylonas, CC; Pousao-Ferreira, P; Parmentier, E; Fonseca, PJ; Amorim, MCP				Bolgan, Marta; Pereira, Beatriz P.; Crucianelli, Aurora; Mylonas, Constantinos C.; Pousao-Ferreira, Pedro; Parmentier, Eric; Fonseca, Paulo J.; Amorim, M. Clara P.			Vocal repertoire and consistency of call features in the meagre Argyrosomous regius (Asso, 1801)	PLOS ONE			English	Article							SOUND PRODUCTION; PASSIVE ACOUSTICS; SPARUS-AURATA; FISH; TEMPERATURE; COMMUNICATION; BIOACOUSTICS; ENHANCEMENT; AQUACULTURE; SCIAENIDAE	Passive Acoustic Monitoring (PAM) is a non-intrusive and cost-effective method capable of providing high-resolution, long-term information on the status and health of vocal populations and communities. To successfully monitor the same species over wide geographical and temporal scales, it is necessary to characterise the range of sound variability, as well as the consistency of sound features between populations. The meagre (Argyrosomus regius, Asso 1801) is an interesting case study because recent investigations suggest a wider vocal repertoire than previously described. In this study, meagre vocalizations were recorded and analysed from a variety of settings, ranging from rearing facilities to wild populations to provide a comprehensive characterisation of its vocal repertoire, while investigating the consistency of spawning sound features between populations. All sounds presented a similar acoustic structure in their basic unit (i.e. the pulse), while an important variability was found in the number of pulses; the meagre can emit sounds made of one single pulse or many pulses (up to more than 100). High level of overlap in the Principal Component Analysis made difficult to differentiate sound type clusters. Despite this, two sound types were identifiable: knocks (sounds from 1 to 3 pulses) and long grunts (sounds with more than 29 pulses). Discriminant Analysis carried out on PCA residuals showed that knock had the highest proportion of correct placement (92% of the observations correctly placed) followed by long grunts (80%). All other previously described sound types (intermediate grunt, short grunt and disturbance sounds) could not be separated and presented low levels of correct placement, suggesting that care should be taken when defining these as independent sound types. Finally, acoustic features consistency was found in meagre grunts emitted by different populations during spawning nights; statistical differences could be explained by recording settings and fish conditions. The results of this study provide important information for fostering PAM programs of wild meagre populations, while contributing to the discussion around the definition of fish sound types in vocal fish communities. Studies of this kind, which evaluate both variability and consistency of sound features, are of fundamental importance for maximising PAM efforts in the wild, at both the specific and the community level.	[Bolgan, Marta; Pereira, Beatriz P.; Amorim, M. Clara P.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Bolgan, Marta; Pereira, Beatriz P.; Amorim, M. Clara P.] Univ Lisbon, Dept Anim Biol, Fac Sci, Lisbon, Portugal; [Bolgan, Marta; Crucianelli, Aurora; Parmentier, Eric] Univ Liege, Lab Funct & Evolutionary Morphol, Dept Biol Ecol & Evolut, FOCUS,AFFISH RC,Inst Chim B6c, Liege, Belgium; [Mylonas, Constantinos C.] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece; [Pousao-Ferreira, Pedro] Inst Portugues Mar & Atmosfera, Olhao, Portugal; [Fonseca, Paulo J.] Univ Lisbon, Dept Anim Biol, Fac Sci, Lisbon, Portugal; [Fonseca, Paulo J.] Univ Lisbon, CE3c Ctr Ecol Evolut & Environm Changes, Fac Sci, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa; University of Liege; Hellenic Centre for Marine Research; Instituto Portugues do Mar e da Atmosfera; Universidade de Lisboa; Universidade de Lisboa	Bolgan, M (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.; Bolgan, M (corresponding author), Univ Lisbon, Dept Anim Biol, Fac Sci, Lisbon, Portugal.; Bolgan, M (corresponding author), Univ Liege, Lab Funct & Evolutionary Morphol, Dept Biol Ecol & Evolut, FOCUS,AFFISH RC,Inst Chim B6c, Liege, Belgium.	marta.bolgan@gmail.com	Fonseca, Paulo J/K-1537-2012; Parmentier, Eric/P-9733-2018; Bolgan, Marta/AAV-8435-2021; Amorim, M. Clara P./K-1889-2012; Pousao-Ferreira, Pedro/H-3689-2014	Fonseca, Paulo J/0000-0002-2663-9385; Bolgan, Marta/0000-0002-4286-577X; Amorim, M. Clara P./0000-0002-2453-6999; Pousao-Ferreira, Pedro/0000-0001-6746-764X; Crucianelli, Aurora/0000-0002-5232-9153	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-BMA/30517/2017, PTDC/BIA-BMA/29662/2017, UID/MAR/04292/2019, UID/BIA/00329/2019]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	this study was funded by Fundacao para a Ciencia e a Tecnologia, Portugal (project PTDC/BIA-BMA/30517/2017 and project PTDC/BIA-BMA/29662/2017 and the strategic projects UID/MAR/04292/2019 granted to MARE and UID/BIA/00329/2019 granted to Centre for Ecology, Evolution and Environmental Changes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbers SA, 2012, J FISH BIOL, V81, P1859, DOI 10.1111/j.1095-8649.2012.03399.x; Aalbers SA, 2008, T AM FISH SOC, V137, P542, DOI 10.1577/T04-058.1; Amorim Maria Clara P., 2006, P71; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; Bertucci F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33326; Bolgan M, 2020, AQUACULTURE, V524, DOI 10.1016/j.aquaculture.2020.735243; Bolgan M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28771-6; Buxton RT, 2018, CONSERV BIOL, V32, P1174, DOI 10.1111/cobi.13119; Carrico R, 2019, PEERJ, V7, DOI 10.7717/peerj.7772; Ceballos G., 2010, J COSMOL, V8, P1821; Chao LN, 1978, FAO SPECIES IDENTIFI; CONNAUGHTON MA, 1995, ENVIRON BIOL FISH, V42, P233, DOI 10.1007/BF00004916; Connaughton MA, 1997, J EXP BIOL, V200, P2449; Cuvier G., 1830, HIST NATURELLE POISS, V5; Desidera E, 2019, MAR ECOL PROG SER, V608, P183, DOI 10.3354/meps12812; Desjonqueres C, 2020, FRESHWATER BIOL, V65, P7, DOI 10.1111/fwb.13356; Dufosse L, 1874, ANN SCI NAT, V20, P117; Fine ML, 2008, T AM FISH SOC, V137, P627, DOI 10.1577/T04-134.1; Fine ML, 2015, ANIM SIG COMM, V4, P77, DOI 10.1007/978-3-7091-1846-7_3; Fish M. P., 1970, SOUNDS W N ATLANTIC; Fonseca PJ, 2008, BIOACOUSTICS, V18, P17, DOI 10.1080/09524622.2008.9753588; Fonseca PJ, 2011, Patent Application, Patent No. [PT 105, 933, 105]; Fowler J., 1990, PRACTICAL STAT FIELD; Gannon DP, 2008, T AM FISH SOC, V137, P638, DOI 10.1577/T04-142.1; Gottesman BL, 2020, FRESHWATER BIOL, V65, P117, DOI 10.1111/fwb.13096; Haffray P, 2012, AQUAT LIVING RESOUR, V25, P173, DOI 10.1051/alr/2012016; Harris SA, 2016, METHODS ECOL EVOL, V7, P713, DOI 10.1111/2041-210X.12527; HILL GL, 1987, COPEIA, P708; Kever L, 2015, J FISH BIOL, V87, P502, DOI 10.1111/jfb.12730; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Ladich F, 2018, FISH FISH, V19, P598, DOI 10.1111/faf.12277; Lagardere JP, 2006, J FISH BIOL, V69, P1697, DOI 10.1111/j.1095-8649.2006.01237.x; Lindseth AV, 2018, FISHES-BASEL, V3, DOI 10.3390/fishes3030036; Lobel PS, 2010, REPRODUCTION AND SEXUALITY IN MARINE FISHES: PATTERNS AND PROCESSES, P307; Locascio JV, 2011, FISH B-NOAA, V109, P327; Luczkovich JJ, 2008, T AM FISH SOC, V137, P576, DOI 10.1577/T05-290.1; Luczkovich Joseph J., 1999, Bioacoustics, V10, P143; Metcalfe JD, 2011, J FISH BIOL, V78, P393, DOI 10.1111/j.1095-8649.2010.02900.x; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; Monczak A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209914; Monczak A, 2017, MAR ECOL PROG SER, V581, P1, DOI 10.3354/meps12322; Montie EW, 2016, J FISH BIOL, V88, P1776, DOI 10.1111/jfb.12938; Montie EW, 2017, PEERJ, V5, DOI 10.7717/peerj.2944; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; Mylonas CC, 2017, AQUACULTURE, V472, P21, DOI 10.1016/j.aquaculture.2016.04.021; Mylonas CC, 2016, AQUACULTURE, V464, P323, DOI 10.1016/j.aquaculture.2016.07.006; Parmentier E, 2018, ANIM CONSERV, V21, P211, DOI 10.1111/acv.12362; Parmentier E, 2016, SPRINGER HANDB AUDIT, V53, P19, DOI 10.1007/978-3-319-27721-9_2; Parmentier E, 2014, AQUACULTURE, V432, P204, DOI 10.1016/j.aquaculture.2014.05.017; Parsons MJG, 2013, ACOUST AUST, V41, P196; Pereira BP, 2020, PEERJ, V8, DOI 10.7717/peerj.8559; Picciulin M, 2020, AQUAT CONSERV, V30, P1299, DOI 10.1002/aqc.3340; Pousao-Ferreira P, 1999, AQUAC RES, V30, P751, DOI 10.1046/j.1365-2109.1999.00394.x; Quemener L, 2002, AQUAT LIVING RESOUR, V15, P293, DOI 10.1016/S0990-7440(02)01187-7; Ramcharttar J, 2006, T AM FISH SOC, V135, P1409, DOI 10.1577/T05-207.1; Ripple WJ, 2020, BIOSCIENCE, V70, P8, DOI 10.1093/biosci/biz088; Roe D., 2019, 24 IIED; Rossi T, 2017, LANDSCAPE ECOL, V32, P239, DOI 10.1007/s10980-016-0439-x; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; Rountree RA, 2019, FISHERIES, V44, P137, DOI 10.1002/fsh.10190; Rowell TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03383-8; Ruppe L, 2015, P NATL ACAD SCI USA, V112, P6092, DOI 10.1073/pnas.1424667112; Smith H. M., 1905, Science, Vxxii, P376; Staaterman E, 2013, CORAL REEFS, V32, P553, DOI 10.1007/s00338-012-1007-8; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Tricas TC, 2014, MAR ECOL PROG SER, V511, P1, DOI 10.3354/meps10930; Vieira M, 2019, FISHES-BASEL, V4, DOI 10.3390/fishes4020028	68	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241792	10.1371/journal.pone.0241792	http://dx.doi.org/10.1371/journal.pone.0241792			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151979	Green Published, gold			2022-12-26	WOS:000591376200090
J	Yamamoto, A; Morioki, H; Nakae, T; Miyake, Y; Harada, T; Noda, S; Mitsuoka, S; Matsumoto, K; Tomimatsu, M; Kanemoto, S; Tanaka, S; Maeda, M; Conway, SJ; Imaizumi, K; Fujio, Y; Obana, M				Yamamoto, Ayaha; Morioki, Hitomi; Nakae, Takafumi; Miyake, Yoshiaki; Harada, Takeo; Noda, Shunsuke; Mitsuoka, Sayuri; Matsumoto, Kotaro; Tomimatsu, Masashi; Kanemoto, Soshi; Tanaka, Shota; Maeda, Makiko; Conway, Simon J.; Imaizumi, Kazunori; Fujio, Yasushi; Obana, Masanori			Transcription factor old astrocyte specifically induced substance is a novel regulator of kidney fibrosis	FASEB JOURNAL			English	Article						chronic kidney disease; fibrosis; myofibroblast; transcription regulation	RENAL FIBROBLAST ACTIVATION; EXPRESSION; OASIS; MYOFIBROBLASTS; OASIS/CREB3L1; METASTASIS; TRANSDUCER; MECHANISMS; INHIBITION; MIGRATION	Prevention of kidney fibrosis is an essential requisite for effective therapy in preventing chronic kidney disease (CKD). Here, we identify Old astrocyte specifically induced substance (OASIS)/cAMP responsive element-binding protein 3-like 1 (CREB3l1), a CREB/ATF family transcription factor, as a candidate profibrotic gene that drives the final common pathological step along the fibrotic pathway in CKD. Although microarray data from diseased patient kidneys and fibrotic mouse model kidneys both exhibit OASIS/Creb3l1 upregulation, the pathophysiological roles of OASIS in CKD remains unknown. Immunohistochemistry revealed that OASIS protein was overexpressed in human fibrotic kidney compared with normal kidney. Moreover, OASIS was upregulated in murine fibrotic kidneys, following unilateral ureteral obstruction (UUO), resulting in an increase in the number of OASIS-expressing pathological myofibroblasts. In vitro assays revealed exogenous TGF-beta 1 increased OASIS expression coincident with fibroblast-to-myofibroblast transition and OASIS contributed to TGF-beta 1-mediated myofibroblast migration and increased proliferation. Significantly, in vivo kidney fibrosis induced via UUO or ischemia/reperfusion injury was ameliorated by systemic genetic knockout of OASIS, accompanied by reduced myofibroblast proliferation. Microarrays revealed that the transmembrane glycoprotein Bone marrow stromal antigen 2 (Bst2) expression was reduced in OASIS knockout myofibroblasts. Interestingly, a systemic anti-Bst2 blocking antibody approach attenuated kidney fibrosis in normal mice but not in OASIS knockout mice after UUO, signifying Bst2 functions downstream of OASIS. Finally, myofibroblast-restricted OASIS conditional knockouts resulted in resistance to kidney fibrosis. Taken together, OASIS in myofibroblasts promotes kidney fibrosis, at least in part, via increased Bst2 expression. Thus, we have identified and demonstrated that OASIS signaling is a novel regulator of kidney fibrosis.	[Yamamoto, Ayaha; Morioki, Hitomi; Nakae, Takafumi; Miyake, Yoshiaki; Harada, Takeo; Noda, Shunsuke; Mitsuoka, Sayuri; Matsumoto, Kotaro; Tomimatsu, Masashi; Tanaka, Shota; Fujio, Yasushi; Obana, Masanori] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan; [Kanemoto, Soshi] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido, Japan; [Maeda, Makiko; Fujio, Yasushi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmacol & Therapeut, Suita, Osaka, Japan; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Fujio, Yasushi; Obana, Masanori] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan; [Obana, Masanori] Osaka Univ, Inst Radiat Sci, Radioisotope Res Ctr, Suita, Osaka, Japan	Osaka University; Asahikawa Medical College; Osaka University; Indiana University System; Indiana University Bloomington; Hiroshima University; Osaka University; Osaka University	Obana, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.; Obana, M (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan.	obana@phs.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930	MEXT \ Japan Society for the Promotion of Science (JSPS) [18K15027, 18H02603, 18K19545]; HHS <INF>\</INF> National Institutes of Health (NIH) [R01 HL148165]; Takeda Science Foundation; Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED) [JP20am0101084]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HHS <INF>\</INF> National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18K15027, 18H02603 and 18K19545; HHS | National Institutes of Health (NIH), Grant/Award Number: R01 HL148165; Takeda Science Foundation; Japanese Association of Dialysis Physicians (JAPD); Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20am010104	Abulizi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00902-5; [Anonymous], 2014, PLOS ONE; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bego MG, 2012, J VIROL, V86, P3513, DOI 10.1128/JVI.06971-11; Carthy JM, 2015, J CELL PHYSIOL, V230, P3084, DOI 10.1002/jcp.25049; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Cui M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16455; Deng H, 2019, SCI REP, V9, P1; Di J, 2014, CELL PHYSIOL BIOCHEM, V34, P1063, DOI 10.1159/000366321; Eddy AA, 2013, NAT MED, V19, P964, DOI 10.1038/nm.3299; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng YX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01052-y; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; GOTO T, 1994, BLOOD, V84, P1922; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Gu GP, 2012, J CELL BIOCHEM, V113, P1013, DOI 10.1002/jcb.23433; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Imaeda A, 2019, BIOCHEM BIOPH RES CO, V510, P149, DOI 10.1016/j.bbrc.2019.01.070; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kanemoto S, 2015, J CELL SCI, V128, P4353, DOI 10.1242/jcs.176057; Kanno Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05967; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Lindahl K, 2018, BONE, V114, P268, DOI 10.1016/j.bone.2018.06.019; Liu WY, 2018, BIOTECHNOL LETT, V40, P1015, DOI 10.1007/s10529-018-2562-z; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mellor P, 2013, MOL CELL BIOL, V33, P4985, DOI 10.1128/MCB.00959-13; Moll S, 2014, EXPERT OPIN DRUG DIS, V9, P1471, DOI 10.1517/17460441.2014.956075; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Rose M, 2014, EPIGENETICS-US, V9, P1626, DOI 10.4161/15592294.2014.988052; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Suchanski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184970; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Vellanki RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054060; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Wang HJ, 2017, J PHARMACOL SCI, V133, P203, DOI 10.1016/j.jphs.2016.12.005; Ward AK, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0672-x; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25272	54	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001820R	http://dx.doi.org/10.1096/fj.202001820R		NOV 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150680	Green Published, hybrid			2022-12-26	WOS:000589711000001
J	Altamiranda-Saavedra, M; Osorio-Olvera, L; Yanez-Arenas, C; Marin-Ortiz, JC; Parra-Henao, G				Altamiranda-Saavedra, Mariano; Osorio-Olvera, Luis; Yanez-Arenas, Carlos; Carlos Marin-Ortiz, Juan; Parra-Henao, Gabriel			Geographic abundance patterns explained by niche centrality hypothesis in two Chagas disease vectors in Latin America	PLOS ONE			English	Article							ECOLOGICAL NICHE; POPULATION ABUNDANCE; HABITAT SUITABILITY; RHODNIUS-PALLESCENS; TRIATOMA-INFESTANS; TRYPANOSOMA-CRUZI; CLIMATE-CHANGE; RISK-FACTORS; LAND-USE; MODELS	Ecoepidemiological scenarios for Chagas disease transmission are complex, so vector control measures to decrease human-vector contact and prevent infection transmission are difficult to implement in all geographic contexts. This study assessed the geographic abundance patterns of two vector species of Chagas disease: Triatoma maculata (Erichson, 1848) and Rhodnius pallescens (Barber, 1932) in Latin America. We modeled their potential distribution using the maximum entropy algorithm implemented in Maxent and calculated distances to their niche centroid by fitting a minimum-volume ellipsoid. In addition, to determine which method would accurately explain geographic abundance patterns, we compared the correlation between population abundance and the distance to the ecological niche centroid (DNC) and between population abundance and Maxent environmental suitability. The potential distribution estimated for T. maculata showed that environmental suitability covers a large area, from Panama to Northern Brazil. R. pallescens showed a more restricted potential distribution, with environmental suitability covering mostly the coastal zone of Costa Rica and some areas in Nicaragua, Honduras, Belize and the Yucatan Peninsula in Mexico, northern Colombia, Acre, and Rondonia states in Brazil, as well as a small region of the western Brazilian Amazon. We found a negative slope in the relationship between population abundance and the DNC in both species. R. pallecens has a more extensive potential latitudinal range than previously reported, and the distribution model for T. maculata corroborates previous studies. In addition, population abundance increases according to the niche centroid proximity, indicating that population abundance is limited by the set of scenopoetic variables at coarser scales (non-interactive variables) used to determine the ecological niche. These findings might be used by public health agencies in Latin America to implement actions and support programs for disease prevention and vector control, identifying areas in which to expand entomological surveillance and maintain chemical control, in order to decrease human-vector contact.	[Altamiranda-Saavedra, Mariano; Parra-Henao, Gabriel] Univ Cooperat Colombia, Ctr Invest Salud Trop CIST, Santa Marta, Colombia; [Altamiranda-Saavedra, Mariano] Politecn Colombiano Jaime Isaza Cadavid, Medellin, Antioquia, Colombia; [Osorio-Olvera, Luis] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Yanez-Arenas, Carlos] Univ Nacl Autonoma Mexico, Lab Ecol Geog, Unidad Conservac Biodiversidad, UMDI Sisal,Fac Ciencias, Mexico City, DF, Mexico; [Carlos Marin-Ortiz, Juan] Univ Nacl Colombia, Fac Ciencias Agr, Dept Ciencias Agr, Medellin, Colombia; [Parra-Henao, Gabriel] Natl Hlth Inst, Bogota, Colombia	Universidad Cooperativa de Colombia; University of Kansas; Universidad Nacional Autonoma de Mexico; Universidad Nacional de Colombia	Altamiranda-Saavedra, M (corresponding author), Univ Cooperat Colombia, Ctr Invest Salud Trop CIST, Santa Marta, Colombia.; Altamiranda-Saavedra, M (corresponding author), Politecn Colombiano Jaime Isaza Cadavid, Medellin, Antioquia, Colombia.	maltamiranda2@gmail.com	Parra-Henao, Gabriel/Q-1535-2016; Yanez, Carlos/GNW-3861-2022	Parra-Henao, Gabriel/0000-0003-4535-6521; Marin-Ortiz, Juan Carlos/0000-0002-1334-4721; Altamiranda-Saavedra, Mariano/0000-0003-1453-3214; Osorio-Olvera, Luis/0000-0003-0701-5398	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Administrative Science, Technology, and Innovation Department, Colciencias) [80740-504-2019]; Universidad Cooperativa de Colombia (Cooperative University of Colombia); Consejo Nacional de Ciencia y Tecnologia (National Science and Technology Council) (CONACyT) [740751, CVU: 368747]; PAPIIT [IN116018]; Posgrado en Ciencias Biologicas (Graduate Program in Biological Sciences), UNAM	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Administrative Science, Technology, and Innovation Department, Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Cooperativa de Colombia (Cooperative University of Colombia); Consejo Nacional de Ciencia y Tecnologia (National Science and Technology Council) (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Posgrado en Ciencias Biologicas (Graduate Program in Biological Sciences), UNAM	This work was derived from MAS postdoctoral fellowship number 80740-504-2019 by Departamento Administrativo de Ciencia, Tecnologi ' a e Innovacio ' n (Administrative Science, Technology, and Innovation Department, Colciencias) and the Universidad Cooperativa de Colombia (Cooperative University of Colombia). LOO acknowledges the partial support from Consejo Nacional de Ciencia y Tecnologia (National Science and Technology Council) (CONACyT; postdoctoral fellowship number 740751; CVU: 368747), PAPIIT IN116018, and Posgrado en Ciencias Biologicas (Graduate Program in Biological Sciences), UNAM.	Abad-Franch F, 2005, TROP MED INT HEALTH, V10, P1258, DOI 10.1111/j.1365-3156.2005.01511.x; Abrahan L, 2016, J VECTOR ECOL, V41, P90, DOI 10.1111/jvec.12198; Osorio-Olvera LA, 2016, REV MEX BIODIVERS, V87, P1080, DOI 10.1016/j.rmb.2016.07.001; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2014, POPULAR KHETI, V2, P170; [Anonymous], 2012, PSYCHE CAMBRIDGE; Arboleda S, 2009, INFECT GENET EVOL, V9, P441, DOI 10.1016/j.meegid.2008.12.006; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Boyce MS, 2001, J WILDLIFE MANAGE, V65, P498, DOI 10.2307/3803103; Braz AG, 2020, ECOGRAPHY, V43, P1560, DOI 10.1111/ecog.04898; Briceno-Leon R, 2009, CAD SAUDE PUBLICA, V25, pS71, DOI 10.1590/S0102-311X2009001300007; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Cantillo-Barraza O, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1100-2; Carmona-Castro O, 2018, MED VET ENTOMOL, V32, P84, DOI 10.1111/mve.12269; Carvalho BM, 2017, B ENTOMOL RES, V107, P419, DOI 10.1017/S0007485316001097; Castillo-Neyra R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003433; Ceccarelli S, 2015, J MED ENTOMOL, V52, P1333, DOI 10.1093/jme/tjv119; Chavy A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007629; Ciss M, 2019, BMC ECOL, V19, DOI 10.1186/s12898-019-0261-9; Cobos ME, 2019, ECOL INFORM, V53, DOI 10.1016/j.ecoinf.2019.100983; Cobos ME, 2019, PEERJ, V7, DOI 10.7717/peerj.6281; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Conners EE, 2016, ACTA TROP, V156, P68, DOI 10.1016/j.actatropica.2016.01.002; Dallas T, 2017, ECOL LETT, V20, P1526, DOI 10.1111/ele.12860; Dallas TA, 2018, GLOBAL ECOL BIOGEOGR, V27, P1448, DOI 10.1111/geb.12820; De La Vega GJ, 2018, MED VET ENTOMOL, V32, P1, DOI 10.1111/mve.12262; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Erazo D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1240-4; Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174; Etherington TR, 2019, PEERJ, V7, DOI 10.7717/peerj.6678; Feng X, 2019, ECOL EVOL, V9, P10365, DOI 10.1002/ece3.5555; Quintana MG, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/652803; Girdhar A, 2018, IET IMAGE PROCESS, V12, P1, DOI 10.1049/iet-ipr.2017.0162; Gomez-Palacio A, 2015, INFECT GENET EVOL, V36, P15, DOI 10.1016/j.meegid.2015.08.035; Gorla David E, 2002, Ecol. austral, V12, P117; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001884; Gottdenker NL, 2011, AM J TROP MED HYG, V84, P70, DOI 10.4269/ajtmh.2011.10-0041; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Jaramilloi N, 2000, RES REV PARASITOL, V60, P3; Rincon-Galvis HJ, 2020, J MED ENTOMOL, V57, P173, DOI 10.1093/jme/tjz162; Johnson CA, 2016, FUNCT ECOL, V30, P1122, DOI 10.1111/1365-2435.12583; Johnston A, 2015, ECOL APPL, V25, P1749, DOI 10.1890/14-1826.1; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Lazzari CR, 2013, MEM I OSWALDO CRUZ, V108, P34, DOI 10.1590/0074-0276130409; Luitgards-Moura José Francisco, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P131, DOI 10.1590/S0036-46652005000300003; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Martinez-Gutierrez PG, 2018, DIVERS DISTRIB, V24, P103, DOI 10.1111/ddi.12662; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Martins-Melo FR, 2014, ACTA TROP, V130, P167, DOI 10.1016/j.actatropica.2013.10.002; Medina-Torres I, 2010, AM J TROP MED HYG, V82, P49, DOI 10.4269/ajtmh.2010.08-0624; Moncayo A, 2017, AMERICAN TRYPANOSOMIASIS CHAGAS DISEASE: ONE HUNDRED YEARS OF RESEARCH, 2ND EDITION, P59, DOI 10.1016/B978-0-12-801029-7.00004-6; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Monsalve Y, 2016, J VECTOR ECOL, V41, P72, DOI 10.1111/jvec.12196; Moo-Llanes DA, 2020, ACTA TROP, V211, DOI 10.1016/j.actatropica.2020.105607; NESTEL D, 1995, ENVIRON ENTOMOL, V24, P506, DOI 10.1093/ee/24.3.506; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osorio-Olvera L, 2020, METHODS ECOL EVOL, V11, P1199, DOI 10.1111/2041-210X.13452; Osorio-Olvera L, 2020, ECOL LETT, V23, P555, DOI 10.1111/ele.13453; Osorio-Olvera L, 2019, ECOGRAPHY, V42, P1415, DOI 10.1111/ecog.04442; Otalora-Luna F, 2015, REV CHIL HIST NAT, V88, DOI [10.1186/S40693-014-0032-0, 10.1186/s40693-014-0032-0]; Pan American Health Organization, 2018, CHAG DIS AM REV CURR; Parra-Henao Gabriel, 2016, J Trop Med, V2016, P1439090, DOI 10.1155/2016/1439090; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2017, INT J PARASITOL, V47, P667, DOI 10.1016/j.ijpara.2017.04.007; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Raghavan RK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37205-2; RCore Team, 2020, R LANG ENV STAT COMP; Salazar A, 2015, GLOBAL PLANET CHANGE, V128, P103, DOI 10.1016/j.gloplacha.2015.02.009; Sanchez-Martin MJ, 2006, TROP MED INT HEALTH, V11, P1585, DOI 10.1111/j.1365-3156.2006.01717.x; Sanmartino M, 2000, Rev Panam Salud Publica, V7, P173; Santini L, 2019, ECOGRAPHY, V42, P696, DOI 10.1111/ecog.04027; SCHWEIGMANN N, 1988, MED VET ENTOMOL, V2, P401, DOI 10.1111/j.1365-2915.1988.tb00215.x; Simons RRL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225250; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; SoberuEn J., 2018, RETHINKING ECOLOGY, V3, P13, DOI [10.1111/ele.12860, DOI 10.3897/RETHINKINGECOLOGY.3.24827]; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; THOMAS MB, 1992, OECOLOGIA, V89, P78, DOI 10.1007/BF00319018; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Peterson AT, 2020, BIODIVERS INFORM, V15, P1; Urbano P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0813-6; Urena-Aranda CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131452; Van Aelst S, 2009, WIRES COMPUT STAT, V1, DOI 10.1002/wics.19; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Venables WN., 2002, MODERN APPL STAT S 4; Verberk W., 2011, NAT ED KNOWL, V3, P38; Von Hoermann C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196839; WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Yanez-Arenas C, 2020, BIODIVERS INFORM, V15, P92; Yanez-Arenas C, 2014, ECOL MODEL, V294, P36, DOI 10.1016/j.ecolmodel.2014.09.014; Yanez-Arenas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100957; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P75, DOI 10.1590/S0074-02762006000100014; Zhu H, 2014, ECOL ENTOMOL, V39, P453, DOI 10.1111/een.12120; 2015, DRUG SAFETY UPDATE, V8, P1	102	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241710	10.1371/journal.pone.0241710	http://dx.doi.org/10.1371/journal.pone.0241710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147272	Green Published, gold			2022-12-26	WOS:000589609300074
J	Begum, SZ; Nizam, NSM; Muhamad, A; Saiman, MI; Crouse, KA; Rahman, MBA				Begum, Sharifa Zaithun; Nizam, Nurul Shairah Mohd; Muhamad, Azira; Saiman, Mohd Izham; Crouse, Karen Anne; Rahman, Mohd Basyaruddin Abdul			Imidazole-rich copper peptides as catalysts in xenobiotic degradation	PLOS ONE			English	Article							WASTE-WATER; PHARMACEUTICALS; OXIDATION; LACCASE; REACTOR; AIR	Laccases, oxidative copper-enzymes found in fungi and bacteria were used as the basis in the design of nona- and tetrapeptides. Laccases are known to be excellent catalysts for the degradation of phenolic xenobiotic waste. However, since solvent extraction of laccases is environmentally-unfriendly and yields obtained are low, they are less preferred compared to synthetic catalysts. The histidine rich peptides were designed based on the active site of laccase extracted from Trametes versicolor through RCSB Protein Data Bank, LOMETS and PyMol software. The peptides were synthesized using Fmoc-solid phase peptide synthesis (SPPS) with 30-40% yield. These peptides were purified and characterized using LC-MS (purities >75%), FTIR and NMR spectroscopy. Synthesized copper(II)-peptides were crystallized and then analyzed spectroscopically. Their structures were elucidated using 1D and 2D NMR. Standards (o,m,p-cresol, 2,4-dichlorophenol) catalysed using laccase from Trametes versicolor (0.66 U/mg) were screened under different temperatures and stirring rate conditions. After optimizing the degradation of the standards with the best reaction conditions reported herein, medications with phenolic and aromatic structures such as ibuprofen, paracetamol (acetaminophen), salbutamol, erythromycin and insulin were screened using laccase (positive control), apo-peptides and copper-peptides. Their activities evaluated using GC-MS, were compared with those of peptide and copper-peptide catalysts. The tetrapeptide was found to have the higher degradation activity towards salbutamol (96.8%) compared with laccase at 42.8%. Ibuprofen (35.1%), salbutamol (52.9%) and erythromycin (49.7%) were reported to have the highest degradation activities using Cu-tetrapeptide as catalyst when compared with the other medications. Consequently, o-cresol (84%) was oxidized by Tp-Cu while the apo-peptides failed to oxidize the cresols. Copper(II)-peptides were observed to have higher catalytic activity compared to their parent peptides and the enzyme laccase for xenobiotic degradation.	[Begum, Sharifa Zaithun; Rahman, Mohd Basyaruddin Abdul] Univ Putra Malaysia, Fac Sci, Integrated Chem BioPhys Res, Serdang, Selangor, Malaysia; [Begum, Sharifa Zaithun; Nizam, Nurul Shairah Mohd] Univ Putra Malaysia, Fac Sci, Nanomol Lab, Serdang, Selangor, Malaysia; [Muhamad, Azira] Natl Inst Biotechnol Malaysia, Malaysia Genome Inst, Struct & Biophys Facil, Jalan Bangi, Bangi, Selangor, Malaysia; [Saiman, Mohd Izham; Crouse, Karen Anne; Rahman, Mohd Basyaruddin Abdul] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Putra Malaysia	Rahman, MBA (corresponding author), Univ Putra Malaysia, Fac Sci, Integrated Chem BioPhys Res, Serdang, Selangor, Malaysia.; Rahman, MBA (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang, Selangor, Malaysia.	basya@upm.edu.my		Abdul Rahman, Mohd Basyaruddin/0000-0002-5665-2564; Begum, Sharifa/0000-0003-4491-3365; Muhamad, Azira/0000-0002-7204-8789	Ministry of Higher Education [FRGS/01-01-15-1702FR (5524807)]; Research Management Centre, Universiti Putra Malaysia, Malaysia (RMC-UPM) [GP-IPS/2018/9664100]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Research Management Centre, Universiti Putra Malaysia, Malaysia (RMC-UPM)	This research was funded by FRGS/01-01-15-1702FR (5524807) from the Ministry of Higher Education grant and Graduate Putra Grant (GP-IPS/2018/9664100) from the Research Management Centre, Universiti Putra Malaysia, Malaysia (RMC-UPM) to MBAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; Arjmand F, 2013, SPECTROCHIM ACTA A, V108, P151, DOI 10.1016/j.saa.2013.01.059; Barnes CAS, 2002, ANAL CHEM, V74, P26, DOI 10.1021/ac0108562; Barton B, 2005, ORG PROCESS RES DEV, V9, P70, DOI 10.1021/op049844j; D'Annibale A, 1999, PROCESS BIOCHEM, V34, P697, DOI 10.1016/S0032-9592(98)00144-7; Duran N, 2000, APPL CATAL B-ENVIRON, V28, P83, DOI 10.1016/S0926-3373(00)00168-5; Eshelman MR, 2014, TETRAHEDRON, V70, P7651, DOI 10.1016/j.tet.2014.07.083; Gonzalez P, 2017, INORG CHEM, V56, P14870, DOI 10.1021/acs.inorgchem.7b01996; Hashim A. H., 2014, THESIS; Hautphenne C, 2016, ENVIRON TECHNOL INNO, V5, P250, DOI 10.1016/j.eti.2016.04.001; Huber MM, 2005, ENVIRON SCI TECHNOL, V39, P4290, DOI 10.1021/es048396s; Jackson E, 2016, PROCESS BIOCHEM, V51, P1248, DOI 10.1016/j.procbio.2016.06.001; Jones SM, 2015, CELL MOL LIFE SCI, V72, P869, DOI 10.1007/s00018-014-1826-6; Langenhoff A. A. M., 2009, Land Contamination & Reclamation, V17, P619, DOI 10.2462/09670513.962; Langenhoff A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/325806; Llorens-Blanch G, 2015, ENVIRON SCI-PROC IMP, V17, P429, DOI [10.1039/c4em00579a, 10.1039/C4EM00579A]; Ming LJ, 2010, J CHIN CHEM SOC-TAIP, V57, P285, DOI 10.1002/jccs.201000043; Ngoc Han Tran, 2010, Journal of Water and Environmental Technology, V8, P125, DOI 10.2965/jwet.2010.125; Oller I, 2011, SCI TOTAL ENVIRON, V409, P4141, DOI 10.1016/j.scitotenv.2010.08.061; Patneedi C. B., 2015, Rasayan Journal of Chemistry, V8, P67; Rodarte-Morales AI, 2012, BIODEGRADATION, V23, P145, DOI 10.1007/s10532-011-9494-9; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Shoshan MS, 2013, JOVE-J VIS EXP, DOI 10.3791/50747; Szakacs Z., 2015, ANTHROPIC AWARENESS, P257, DOI DOI 10.1016/B978-0-12-419963-7.00007-9; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; Touahar IE, 2014, SCI TOTAL ENVIRON, V481, P90, DOI 10.1016/j.scitotenv.2014.01.132; Wen XH, 2009, CHEMOSPHERE, V75, P1003, DOI 10.1016/j.chemosphere.2009.01.052; Zaithun BS, 2018, RSC ADV, V8, P34004, DOI 10.1039/c8ra06814c	28	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0238147	10.1371/journal.pone.0238147	http://dx.doi.org/10.1371/journal.pone.0238147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147237	Green Accepted, gold, Green Published			2022-12-26	WOS:000589609300086
J	da Silva, CA; Monteiro, MLGD; Araujo, LS; Urzedo, MG; Rocha, LB; dos Reis, MA; Machado, JR				da Silva, Crislaine Aparecida; Goncalves dos Reis Monteiro, Maria Luiza; Araujo, Liliane Silvano; Urzedo, Monise Gini; Rocha, Lenaldo Branco; dos Reis, Marlene Antonia; Machado, Juliana Reis			In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease	PLOS ONE			English	Article							FOOT PROCESS EFFACEMENT; PARIETAL EPITHELIAL-CELLS; PUROMYCIN AMINONUCLEOSIDE; APOPTOSIS; EXPRESSION; PATHOLOGY; PROTEIN; BETA	Podocyte injury in focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) results from the imbalance between adaptive responses that maintain homeostasis and cellular dysfunction that can culminate in cell death. Therefore, an in situ analysis was performed to detect morphological changes related to cell death and autophagy in renal biopsies from adult patients with podocytopathies. Forty-nine renal biopsies from patients with FSGS (n = 22) and MCD (n = 27) were selected. In situ expression of Wilms Tumor 1 protein (WT1), light chain microtubule 1-associated protein (LC3) and caspase-3 protein were evaluated by immunohistochemistry. The foot process effacement and morphological alterations related to podocyte cell death and autophagy were analyzed with transmission electronic microscopy. Reduction in the density of WT1-labeled podocytes was observed for FSGS and MCD cases as compared to controls. Foot process width (FPW) in control group was lower than in cases of podocytopathies. In FSGS group, FPW was significantly higher than in MCD group and correlated with proteinuria. A density of LC3-labeled podocytes and the number of autophagosomes in podocytes/ pedicels were higher in the MCD group than in the FSGS group. The number of autophagosomes correlated positively with the estimated glomerular filtration rate in cases of MCD. The density of caspase-3-labeled podocytes in FSGS and MCD was higher than control group, and a higher number of podocytes with an evidence of necrosis was detected in FSGS cases than in MCD and control cases. Podocytes from patients diagnosed with FSGS showed more morphological and functional alterations resulting from a larger number of lesions and reduced cell adaptation.	[da Silva, Crislaine Aparecida; Goncalves dos Reis Monteiro, Maria Luiza; Araujo, Liliane Silvano; Urzedo, Monise Gini; Rocha, Lenaldo Branco; dos Reis, Marlene Antonia; Machado, Juliana Reis] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Dept Pathol Genet & Evolut, Discipline Gen Pathol, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro	Machado, JR (corresponding author), Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Dept Pathol Genet & Evolut, Discipline Gen Pathol, Uberaba, MG, Brazil.	juliana.patologiageral@gmail.com	Machado, Juliana/AAY-1978-2020; Rocha, Lenaldo Branco/D-2382-2011	Machado, Juliana/0000-0002-8673-7788; Rocha, Lenaldo Branco/0000-0002-4345-6994	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU)	The authors appreciate the financial support of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU).	[Anonymous], 2014, Obesity (Silver Spring), V22 Suppl 2, pS40, DOI 10.1002/oby.20822; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], OFFICIAL J EUROPEA L, VL16, P3; [Anonymous], 2019, CIRCULATION, V2019; Braun F, 2016, SEMIN NEPHROL, V36, P208, DOI 10.1016/j.semnephrol.2016.03.008; Buscher AK, 2012, EUR J PEDIATR, V171, P1151, DOI 10.1007/s00431-011-1668-2; Cui JH, 2012, J NEPHROL, V25, P255, DOI 10.5301/JN.2011.8451; Pereira LHD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217569; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Giannico G, 2009, CLIN J AM SOC NEPHRO, V4, P1747, DOI 10.2215/CJN.01510209; GUNDERSEN HJG, 1980, CELL TISSUE RES, V205, P147; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Inokuchi S, 1996, KIDNEY INT, V50, P1278, DOI 10.1038/ki.1996.439; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Lasagni L, 2013, CURR MOL MED, V13, P13, DOI 10.2174/156652413804486250; Lennon R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00160; Liang SK, 2016, INT UROL NEPHROL, V48, P2109, DOI 10.1007/s11255-016-1398-5; Liapis H, 2013, AM J PATHOL, V183, P1364, DOI 10.1016/j.ajpath.2013.06.033; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Mohr S, 1998, P NATL ACAD SCI USA, V95, P5045, DOI 10.1073/pnas.95.9.5045; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012; Neufeld MJ, 2015, ENDEAVOUR, V39, P147, DOI 10.1016/j.endeavour.2015.05.006; Ogawa-Akiyama A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228337; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Sanwal V, 2001, EXP MOL PATHOL, V70, P54, DOI 10.1006/exmp.2000.2345; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shankland SJ, 2013, CURR OPIN NEPHROL HY, V22, P302, DOI 10.1097/MNH.0b013e32835fefd4; Shirato I, 2002, MICROSC RES TECHNIQ, V57, P241, DOI 10.1002/jemt.10082; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tashiro K, 1998, NEPHRON, V79, P21, DOI 10.1159/000044986; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Venkatareddy M, 2014, J AM SOC NEPHROL, V25, P1118, DOI 10.1681/ASN.2013080859; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zeng CH, 2014, J PATHOL, V234, P203, DOI 10.1002/path.4382	41	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241745	10.1371/journal.pone.0241745	http://dx.doi.org/10.1371/journal.pone.0241745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147279	gold, Green Published			2022-12-26	WOS:000589609300042
J	Ceballos, F; Hernandez, MA; Olivet, F; Paz, C				Ceballos, Francisco; Hernandez, Manuel Alejandro; Olivet, Francisco; Paz, Cynthia			Assessing the use of cell phones to monitor health and nutrition interventions: Evidence from rural Guatemala	PLOS ONE			English	Article							SMS; INFORMATION; BEHAVIOR; TOOL	In-person (face-to-face) data collection methods offer many advantages but can also be time-consuming and expensive, particularly in areas of difficult access. We take advantage of the increasing mobile phone penetration rate in rural areas to evaluate the feasibility of using cell phones to monitor the provision of key health and nutrition interventions linked to the first 1,000 days of life, a critical period of growth and development. We examine response rates to calendarized text messages (SMS) and phone calls sent to 1,542 households over a period of four months. These households have children under two years old and pregnant women and are located across randomly selected communities in Quiche, Guatemala. We find that the overall (valid) response rate to phone calls is over 5 times higher than to text messages (75.8% versus 14.4%). We also test whether simple SMS reminders improve the timely reception of health services but do not find any effects in this regard. Language, education, and age appear to be major barriers to respond to text messages as opposed to phone calls, and the rate of response is not correlated with a household's geographic location (accessibility). Moreover, response veracity is high, with an 84-91% match between household responses and administrative records. The costs per monitored intervention are around 1.12 US dollars using text messages and 85 cents making phone calls, with the costs per effective answer showing a starker contrast, at 7.76 and 1.12 US dollars, respectively. Our findings indicate that mobile phone calls can be an effective, low-cost tool to collect reliable information remotely and in real time. In the current context, where in-person contact with households is not possible due to the COVID-19 crisis, phone calls can be a valuable instrument for collecting information, monitoring development interventions, or implementing brief surveys.	[Ceballos, Francisco; Hernandez, Manuel Alejandro; Paz, Cynthia] Int Food Policy Res Inst IFPRI, Markets Trade & Inst Div, Washington, DC 20005 USA; [Olivet, Francisco] Univ Mariano Galvez, Escuela Ingn Agron, Guatemala City, Guatemala	CGIAR; International Food Policy Research Institute (IFPRI)	Hernandez, MA (corresponding author), Int Food Policy Res Inst IFPRI, Markets Trade & Inst Div, Washington, DC 20005 USA.	m.a.hernandez@cgiar.org		Hernandez, Manuel/0000-0003-4754-8471	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The study was funded by the United States Agency for International Development (USAID). The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents and conclusions of the study are the responsibility of the authors and do not necessarily reflect the views of the International Food Policy Research Institute (IFPRI), USAID, or the United States Government.	Aker JC, 2011, AGR ECON-BLACKWELL, V42, P631, DOI 10.1111/j.1574-0862.2011.00545.x; Angeles G, 2014, ENCUESTA MONITOREO E; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2013, CANC DISCOV, V3, pOF14; [Anonymous], 2008, LANCET; Barton J, 2019, DEV TELECOMS TRENDS; Chaparro C, 2012, INSEGURIDAD ALIMENTA; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Gobierno de Guatemala, 2012, PLAN PACT HAMBR CER; GSMA, 2020, MOB EC 2020; IFPRI, 2016, GLOBAL NUTR REPORT 2; International Food Policy Research Institute-IFPRI, 2016, INF FIN EV IMP PLAN; International Food Policy Research Institute-IFPRI, 2018, EST FACT INC TEL CEL; International Telecommunication Union-ITU, 2019, WORLD TEL ICT IND DA; Johansen Bendt, 2010, Chiropr Osteopat, V18, P10, DOI 10.1186/1746-1340-18-10; Kannisto KA, 2014, J MED INTERNET RES, V16, P100, DOI 10.2196/jmir.3442; Li Y, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2906; Ministerio de Salud Publica y Asistencia Social-MSPAS Instituto Nacional de Estadistica-INE ICF International, 2017, ENCUESTA NACL SALUD; Nakasone E, 2014, ANNU REV RESOUR ECON, V6, P533, DOI 10.1146/annurev-resource-100913-012714; Orr JA, 2015, HEALTH PSYCHOL REV, V9, P397, DOI 10.1080/17437199.2015.1022847; Pattnaik A, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-5066-1; Poorman E, 2015, MATERN CHILD HLTH J, V19, P969, DOI 10.1007/s10995-014-1595-8; Secretaria de Seguridad Alimentaria y Nutricional-SESAN, 2016, ESTR NACL PREV DESN; SUN Movement, 2011, SCAL NUTR FRAM ACT; United States Department of Health and Human Services-USDHHS, 2014, US HLTH TEXT MESS IM; Whitford HM, 2012, J AM MED INFORM ASSN, V19, P744, DOI 10.1136/amiajnl-2011-000785; World Bank, 2020, WORLD DEV IND	27	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240526	10.1371/journal.pone.0240526	http://dx.doi.org/10.1371/journal.pone.0240526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141833	gold, Green Published			2022-12-26	WOS:000588376700035
J	Delancey, CD; Islam, K				Delancey, Clayton D.; Islam, Kamal			Analysis of microhabitat characteristics at roost sites of Cerulean Warblers	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; RADIO-TRANSMITTERS; SETOPHAGA-CERULEA; HABITAT SELECTION; BEHAVIOR; SONGBIRD; FOREST; SURVIVAL	Little information exists on songbird roosting habits and the types of habitats that songbirds select. To better understand a species' habitat requirements, all aspects of its biology should be studied. The Cerulean Warbler (Setophaga cerulea, Wilson) is a Nearctic-Neotropical migrant that is a species of conservation concern across its range. It is one of the fastest declining species of wood-warbler (Parulidae) in North America. Since 2007, a breeding population of Cerulean Warblers has been monitored in southern Indiana, as part of the Hardwood Ecosystem Experiment. The Hardwood Ecosystem Experiment is a 100 yr project that studies the effects of different forest management practices on plant and animal communities. During the 2017 breeding season, 10 male Cerulean Warblers were tracked to roost locations. Roost sites selected by male Cerulean Warbler were characterized with less basal area, higher canopy cover, greater grapevine (Vitis spp., L.) presence, less shrubs, steeper slopes, and less white oak (Quercus alba, L.) abundance. With this new knowledge we can incorporate additional features of habitat in the formulation of a management plan for this declining species.	[Delancey, Clayton D.; Islam, Kamal] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	Ball State University	Islam, K (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	kislam@bsu.edu		Delancey, Clayton/0000-0002-7736-7308	Indiana Department of Natural Resources [240117]; Indiana Academy of Science [257377]; Amos W. Butler Audubon Society [257336]; Association of Field Ornithologists [257348]; Robert Cooper Audubon Society [257343]; Ball State University ASPiRE Research Grant [I605-16]	Indiana Department of Natural Resources; Indiana Academy of Science; Amos W. Butler Audubon Society; Association of Field Ornithologists; Robert Cooper Audubon Society; Ball State University ASPiRE Research Grant	KI 240117 Indiana Department of Natural Resources https://www.in.gov/dnr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDD 257377 Indiana Academy of Science The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDD 257336 Amos W. Butler Audubon Society https://www.amosbutleraudubon.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDD 257348 Association of Field Ornithologists https://www.afonet.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDD 257343 Robert Cooper Audubon Society http://cooperaudubon.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDD I605-16 Ball State University ASPiRE Research Grant https://www.bsu.edu/about/administrativeoffices/sponsored-projectsadministration/aspire The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2003, BIOSCIENCE, V53, P927, DOI 10.1641/0006-3568(2003)053[0927:WHATWO]2.0.CO;2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bakermans MH, 2015, NORTHEAST NAT, V22, P690, DOI 10.1656/045.022.0405; Barg JJ, 2006, WILSON J ORNITHOL, V118, P316, DOI 10.1676/05-027.1; Barnes KW, 2016, J WILDLIFE MANAGE, V80, P101, DOI 10.1002/jwmg.995; BEERS TW, 1966, J FOREST, V64, P691; BirdLife International, 2020, SPEC FACTSH SET CER; BIRKHEAD TR, 1987, BEHAVIOUR, V101, P101, DOI 10.1163/156853987X00396; Boves TJ, 2013, AUK, V130, P46, DOI 10.1525/auk.2012.12104; Brown DR, 2008, WILSON J ORNITHOL, V120, P455, DOI 10.1676/07-084.1; Buehler DA, 2020, BIRDS WORLD, DOI [10.2173/bow.cerwar.01, DOI 10.2173/BOW.CERWAR.01]; Buehler DA, 2008, J WILDLIFE MANAGE, V72, P646, DOI 10.2193/2006-339; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Carpenter JP, 2018, J FIELD ORNITHOL, V89, P47, DOI 10.1111/jofo.12245; Delancey CD, 2019, PEERJ, V7, DOI 10.7717/peerj.7358; Environmental Systems Research Institute [ESRI], 2015, ARCGIS DESKT 10 2; Evans ML, 2009, J FIELD ORNITHOL, V80, P146, DOI 10.1111/j.1557-9263.2009.00216.x; Hamel PB, 2004, AUK, V121, P7, DOI 10.1642/0004-8038(2004)121[0007:HWCLMA]2.0.CO;2; Holmes RT, 2007, IBIS, V149, P2, DOI 10.1111/j.1474-919X.2007.00685.x; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Homoya M.A., 1985, Proceedings of the Indiana Academy of Science, V94, P245; Indiana Department of Natural Resources, 1984, IND FOR SOILS HDB; Indiana General Assembly, 2007, IND GEN ASS TITL 312; Janousek WM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-399; Jirinec V, 2016, AUK, V133, P1, DOI 10.1642/AUK-15-76.1; Jirinec V, 2011, BIRD CONSERV INT, V21, P353, DOI 10.1017/S0959270910000614; Kalb R. A., 2013, HARDWOOD ECOSYSTEM E, P36; Liao WB, 2008, BIRD CONSERV INT, V18, P260, DOI 10.1017/S0959270908000257; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; MacNeil M. M., 2010, THESIS; Martin TE, 1995, ECOLOGY MANAGEMENT N; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; McGowan A, 2006, ANIM BEHAV, V72, P1035, DOI 10.1016/j.anbehav.2006.02.020; Merola-Zwartjes M, 1998, AUK, V115, P780, DOI 10.2307/4089429; Morrissey RC, 2009, FOREST ECOL MANAG, V257, P1839, DOI 10.1016/j.foreco.2009.02.004; Nemes CE, 2017, FOREST ECOL MANAG, V387, P52, DOI 10.1016/j.foreco.2016.11.008; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Peterson SM, 2015, CONDOR, V117, P386, DOI 10.1650/CONDOR-14-124.1; Powell R. A, 2000, ANIMAL HOME RANGES T; Pyle P, 1997, IDENTIFICATION GUIDE; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rasband W., 2006, IMAGEJ; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Roth KL, 2008, WILSON J ORNITHOL, V120, P105, DOI 10.1676/06-181.1; Roth KL, 2007, AM MIDL NAT, V157, P345, DOI 10.1674/0003-0031(2007)157[345:DCWDCE]2.0.CO;2; Ruhl PJ, 2018, WILSON J ORNITHOL, V130, P397, DOI 10.1676/16-222.1; SAMUEL MD, 1985, J WILDLIFE MANAGE, V49, P513, DOI 10.2307/3801564; Sauer JR, 2012, N AM BREEDING BIRD S; Slager DL, 2015, WILSON J ORNITHOL, V127, P109, DOI 10.1676/14-038.1; Smith JAM, 2008, J AVIAN BIOL, V39, P460, DOI 10.1111/j.2008.0908-8857.04227.x; Streby HM, 2015, CONDOR, V117, P249, DOI 10.1650/CONDOR-14-182.1; Townsend JM, 2009, CONDOR, V111, P565, DOI 10.1525/cond.2009.090062; United States Fish and Wildlife Service [USFWS], 2006, CER WARBL DENDR CER; Van Kley J., 1995, FIELD GUIDE ECOLOGIC; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Wagner JR, 2014, NORTHEAST NAT, V21, P515, DOI 10.1656/045.021.0403; WARKENTIN IG, 1995, WILSON BULL, V107, P374; Weakland CA, 2005, AUK, V122, P497, DOI 10.1642/0004-8038(2005)122[0497:CWDCMA]2.0.CO;2	59	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241501	10.1371/journal.pone.0241501	http://dx.doi.org/10.1371/journal.pone.0241501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141873	gold, Green Published			2022-12-26	WOS:000588376700029
J	Jocsak, I; Malgwi, I; Rabnecz, G; Szego, A; Varga-Visi, E; Vegvari, G; Ponya, Z				Jocsak, Ildiko; Malgwi, Isaac; Rabnecz, Gyula; Szego, Anita; Varga-Visi, Eva; Vegvari, Gyorgy; Ponya, Zsolt			Effect of cadmium stress on certain physiological parameters, antioxidative enzyme activities and biophoton emission of leaves in barley (Hordeum vulgare L.) seedlings	PLOS ONE			English	Article							PHOTON-EMISSION; ASCORBATE; PEROXIDASE; PLANTS	Biophoton emission is a well-known phenomenon in living organisms, including plant species; however, the underlying mechanisms are not yet well elucidated. Nevertheless, non-invasive stress detection is of high importance when in plant production and plant research. Therefore, the aim of our work was to investigate, whether biophoton emission is suitable for the detection of cadmium stress in the early phase of stress evolution and to identify certain stress-related events that occur rapidly upon cadmium exposure of barley seedlings parallel to biophoton emission measurements. Changes of biophoton emission, chlorophyll content estimation index, ascorbate level, the activity of ascorbate- and guaiacol peroxidase enzymes and lipid oxidation were measured during seven days of cadmium treatment in barley (Hordeum vulgare L.) seedlings. The results indicate that the antioxidant enzyme system responded the most rapidly to the stress caused by cadmium and the lipid oxidation-related emission of photons was detected in cadmium-treated samples as early as one day after cadmium exposure. Furthermore, a concentration-dependent increase in biophoton emission signals indicating an increased rate of antioxidative enzymes and lipid oxidation was also possible to determine. Our work shows evidence that biophoton emission is suitable to identify the initial phase of cadmium stress effectively and non-invasively.	[Jocsak, Ildiko; Ponya, Zsolt] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Plant Sci, Kaposvar Campus, Kaposvar, Hungary; [Malgwi, Isaac] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Nutr & Prod Dev Sci, Kaposvar Campus, Kaposvar, Hungary; [Rabnecz, Gyula] PraxisLab Ltd, Budapest, Hungary; [Szego, Anita] Szent Istvan Univ, Inst Hort Plant Biol, Dept Plant Biol & Plant Biochem, Budapest, Hungary; [Varga-Visi, Eva; Vegvari, Gyorgy] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Physiol Biochem & Anim Hlth, Kaposvar Campus, Kaposvar, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Vegvari, G (corresponding author), Szent Istvan Univ, Fac Agr & Environm Sci, Inst Physiol Biochem & Anim Hlth, Kaposvar Campus, Kaposvar, Hungary.	gyorgy.vegvari@szie.hu	Malgwi, Isaac/CAH-2837-2022; Jócsák, Ildikó/ABI-5634-2020; Varga-Visi, Eva/G-9859-2018	Malgwi, Isaac/0000-0003-0231-6992; Varga-Visi, Eva/0000-0001-8613-0620	EU [EFOP-3.6.3-VEKOP-16-2017-00005, GINOP-2.2.1-152016-00021, GINOP-2.3.4-15-2016-00005]; European Structural and Investment Funds; European Union; European Regional Development Fund; Hungarian State	EU(European Commission); European Structural and Investment Funds; European Union(European Commission); European Regional Development Fund(European Commission); Hungarian State	This work was supported by the "EFOP-3.6.3-VEKOP-16-2017-00005, GINOP-2.2.1-152016-00021 and GINOP-2.3.4-15-2016-00005" projects, co-funded from EU sources and European Structural and Investment Funds and co-financed by the European Union and the European Regional Development Fund and the Hungarian State. Praxis Ltd. provided support in the form of salary for author GR, but did not have any role in funding this research, also did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, EUROPEAN BIOPHYSICS, V44, pS208; Birtic S, 2011, PLANT J, V67, P1103, DOI 10.1111/j.1365-313X.2011.04646.x; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; Dominguez R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100429; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; Hasan M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10031189; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hegedus A, 2001, PLANT SCI, V160, P1085, DOI 10.1016/S0168-9452(01)00330-2; Hennecke M, MEASUREMENT BIOPHOTO; HIDEG E, 1991, PHOTOCHEM PHOTOBIOL, V53, P137, DOI 10.1111/j.1751-1097.1991.tb08479.x; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Iida T, 2002, FOOD CHEM, V77, P471, DOI 10.1016/S0308-8146(01)00385-5; Jocsak I, 2019, THEOR EXP PLANT PHYS, V31, P359, DOI 10.1007/s40626-019-00152-y; Kamal AM, 2016, MOL BIOL REP, V43, P73, DOI 10.1007/s11033-015-3940-4; Kobayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105700; Kovaik J, ALGAL RES, V24, P354, DOI 10.1016/j.algal.2017.04.026; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Oros CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198962; Oszlanyi R, 2020, INT J BIOL MACROMOL, V161, P864, DOI 10.1016/j.ijbiomac.2020.06.050; Pereira CS, 2005, PROTOPLASMA, V226, P223, DOI 10.1007/s00709-005-0120-8; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Prasad A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06331-8; Prasad MNV, 2013, HEAVY METAL STRESS P; Shahid M, 2017, J HAZARD MATER, V325, P36, DOI 10.1016/j.jhazmat.2016.11.063; SZLLSI R, 2002, ACTA BIOL SZEG, V46, P125; Toth SZ, 2009, PLANT PHYSIOL, V149, P1568, DOI 10.1104/pp.108.132621	28	7	7	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0240470	10.1371/journal.pone.0240470	http://dx.doi.org/10.1371/journal.pone.0240470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141841	gold, Green Published			2022-12-26	WOS:000588376700003
J	Larson-Casey, JL; He, C; Che, PL; Wang, MM; Cai, GQ; Kim, YI; El Hamdaoui, M; Grytz, R; Ding, Q; Carter, AB				Larson-Casey, Jennifer L.; He, Chao; Che, Pulin; Wang, Meimei; Cai, Guoqiang; Kim, Young-Il; El Hamdaoui, Mustapha; Grytz, Rafael; Ding, Qiang; Carter, A. Brent			Technical advance: The use of tree shrews as a model of pulmonary fibrosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ALTERNATIVE ACTIVATION; MACROPHAGES; MYOFIBROBLASTS; PREVALENCE; APOPTOSIS; BIOLOGY; MICE	Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with a high morbidity and mortality. Some of the mechanisms of fibrosis development have been described using rodent models; however, the relevance of findings in these animal models is difficult to assess. New innovative models are needed that closely mimic IPF disease pathology. Methods To overcome this unmet need of investigating IPF with a relevant model, we utilized tree shrews, which are genetically, anatomically, and metabolically similar to primates and humans. Using human antibodies and primers, we investigated the role of macrophage phenotypic switching in normal and IPF subjects and bleomycin-injured tree shrews. Results Bronchoalveolar lavage (BAL) cells from tree shrews expressed human markers, and there was recruitment of monocyte-derived macrophages (MDMs) to the lung in IPF subjects and bleomycin-injured tree shrews. MDMs were polarized to a profibrotic phenotype in IPF and in bleomycin-injured tree shrews. Resident alveolar macrophages (RAMs) expressed proinflammatory markers regardless of bleomycin exposure. Tree shrews developed bleomycin-induced pulmonary fibrosis with architectural distortion in parenchyma and widespread collagen deposition. Conclusion The profibrotic polarization of macrophages has been demonstrated to be present in IPF subjects and in fibrotic mice. Although the lung macrophages have long been considered to be homogeneous, recent evidence indicates that these cells are heterogeneous during multiple chronic lung diseases. Here, we show new data that indicate a critical and essential role for macrophage-fibroblast crosstalk promoting fibroblast differentiation and collagen production. in the development and progression of fibrosis. The current data strongly suggest development of therapeutics that attenuate of the profibrotic activation of MDMs may mitigate macrophage-fibroblast interaction. These observations demonstrate that tree shrews are an ideal animal model to investigate the pathogenesis of IPF as they are genetically, anatomically, and metabolically closer to humans than the more commonly used rodent models.	[Larson-Casey, Jennifer L.; He, Chao; Kim, Young-Il; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Che, Pulin; Wang, Meimei; Cai, Guoqiang; Ding, Qiang] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [El Hamdaoui, Mustapha; Grytz, Rafael] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL USA; [Carter, A. Brent] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.; Carter, AB (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA.	bcarter1@uab.edu		WANG, MEIMEI/0000-0003-2116-5958; Larson-Casey, Jennifer L./0000-0001-7238-7986; Carter, A. Brent/0000-0001-6002-4715; Grytz, Rafael/0000-0001-9539-4070	National Institutes of Health [2R01 ES015981-13]; Department of Veterans Affairs [1 I01 CX001715-01]; Parker B. Francis Foundation; American Lung Association [RG-507440]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Parker B. Francis Foundation; American Lung Association	ABC: 2R01 ES015981-13, National Institutes of Health; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ABC: 1 I01 CX001715-01, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JLLC: Parker B. Francis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JLLC: RG-507440, American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldivia S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166644; Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE; Burman A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99543; Collard Harold R, 2012, J Med Econ, V15, P829, DOI 10.3111/13696998.2012.680553; Duan X. C., 2015, AM J PHYSIOL-HEART C, V308, pH603; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Eapen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13888-x; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Grytz R, 2017, J ELASTICITY, V129, P171, DOI 10.1007/s10659-016-9603-4; Gu L, 2017, FASEB J; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; He C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126551; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Ni RJ, 2018, NEUROSCI BULL, V34, P405, DOI 10.1007/s12264-018-0212-z; Petruzziello F, 2012, J PROTEOME RES, V11, P886, DOI 10.1021/pr200709j; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111; Ye LH, 2016, ONCOL LETT, V11, P2091, DOI 10.3892/ol.2016.4156; Zhang L, 2019, EMERG MICROBES INFEC, V8, P232, DOI 10.1080/22221751.2018.1559707; Zhang XH, 2013, GENE, V522, P147, DOI 10.1016/j.gene.2013.03.113; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	41	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241323	10.1371/journal.pone.0241323	http://dx.doi.org/10.1371/journal.pone.0241323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141839	Green Published, gold			2022-12-26	WOS:000588376700008
J	Sala, C; Giampieri, E; Vitali, S; Garagnani, P; Remondini, D; Bazzani, A; Franceschi, C; Castellani, GC				Sala, Claudia; Giampieri, Enrico; Vitali, Silvia; Garagnani, Paolo; Remondini, Daniel; Bazzani, Armando; Franceschi, Claudio; Castellani, Gastone C.			Gut microbiota ecology: Biodiversity estimated from hybrid neutral-niche model increases with health status and aging	PLOS ONE			English	Article							RELATIVE SPECIES ABUNDANCE; DIVERSITY	In this work we propose an index to estimate the gut microbiota biodiversity using a modeling approach with the aim of describing its relationship with health and aging. The gut microbiota, a complex ecosystem that links nutrition and metabolism, has a pervasive effect on all body organs and systems, undergoes profound changes with age and life-style, and substantially contributes to the pathogenesis of age-related diseases. For these reasons, the gut microbiota is a suitable candidate for assessing and quantifying healthy aging, i.e. the capability of individuals to reach an advanced age, avoiding or postponing major age-related diseases. The importance of the gut microbiota in health and aging has been proven to be related not only to its taxonomic composition, but also to its ecological properties, namely its biodiversity. Following an ecological approach, here we intended to characterize the relationship between the gut microbiota biodiversity and healthy aging through the development a parsimonious model of gut microbiota from which biodiversity can be estimated. We analysed publicly available metagenomic data relative to subjects of different ages, countries, nutritional habits and health status and we showed that a hybrid niche-neutral model well describes the observed patterns of bacterial relative abundance. Moreover, starting from such ecological modeling, we derived an estimate of the gut microbiota biodiversity that is consistent with classical indices, while having a higher statistical power. This allowed us to unveil an increase of the gut microbiota biodiversity during aging and to provide a good predictor of health status in old age, dependent on life-style and aging disorders.	[Sala, Claudia; Remondini, Daniel; Bazzani, Armando] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Giampieri, Enrico; Garagnani, Paolo; Castellani, Gastone C.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Vitali, Silvia] BCAM Basque Ctr Appl Math, Bilbao, Spain; [Franceschi, Claudio] Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod, Russia; [Castellani, Gastone C.] Galvani Interdept Ctr, Bologna, Italy	University of Bologna; University of Bologna; Basque Center for Applied Mathematics (BCAM); Lobachevsky State University of Nizhni Novgorod	Sala, C (corresponding author), Univ Bologna, Dept Phys & Astron, Bologna, Italy.	claudia.sala3@unibo.it	Sala, Claudia/AAC-2293-2022; Giampieri, Enrico/AAC-7354-2022; Vitali, SIlvia/AAE-9295-2021	Sala, Claudia/0000-0002-4889-1047; Giampieri, Enrico/0000-0003-2269-2338; Bazzani, Armando/0000-0002-9633-0017; Garagnani, Paolo/0000-0002-4161-3626	Interomics CNR Flagship Initiative [PB05]; European Union's Seventh Framework Programme [305280]; European Union's H2020 Programme (ITN grant) [721815]; Ministry of Education and Science of the Russian Federation [075-15-2019-871]	Interomics CNR Flagship Initiative; European Union's Seventh Framework Programme(European Commission); European Union's H2020 Programme (ITN grant); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	GC and DR were supported by the Interomics CNR Flagship Initiative PB05 (https://www.interomics.eu/), by the European Union's Seventh Framework Programme (grant agreement 305280 MIMOmics, http://www.mimomics.eu/) and by the European Union's H2020 Programme (ITN grant agreement 721815 ImforFUTURE, https://imforfuture.eu/).CF was supported by the grant of the Ministry of Education and Science of the Russian Federation Agreement No. 075-15-2019-871 (http://government.ru/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An R, 2018, GUT, V67, P2213, DOI 10.1136/gutjnl-2017-315542; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2016, CURR BIOL CB, V26, pR1258; [Anonymous], 2018, VOX             0919; [Anonymous], 2018, LANCET ONCOL, V19, pe581; Azaele S, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035003; Bazzani A, 2016, THEOR BIOL FORUM, V109, P37, DOI 10.19272/201611402003; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Biagi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112023; Bian GR, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00327-17, 10.1128/msphere.00327-17]; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Garcia-Pena C, 2017, ARCH MED RES, V48, P681, DOI 10.1016/j.arcmed.2017.11.005; Gordon A, 2010, FASTX TOOLKIT FASTQ; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hubbell Stephen P., 2001, V32, pi; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jackson M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0262-7; Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Kreft JU, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02299; Lan YM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-2; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042; MAHONEY F I, 1965, Md State Med J, V14, P61; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Marin JM, 2012, STAT COMPUT, V22, P1167, DOI 10.1007/s11222-011-9288-2; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Patil A, 2010, J STAT SOFTW, V35, P1; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Python Software Foundation, PYTH LANG REF VERS 3; Quercia S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00587; Raftery AE, 1999, SOCIOL METHOD RES, V27, P411, DOI 10.1177/0049124199027003005; Sala C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0858-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tang JF, 2013, J THEOR BIOL, V317, P212, DOI 10.1016/j.jtbi.2012.10.019; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Waskom M, 2014, SEABORN STAT DATA VI; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilmanski T, 2020, BIORXIV; Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2	61	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0237207	10.1371/journal.pone.0237207	http://dx.doi.org/10.1371/journal.pone.0237207			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125392	gold, Green Published, Green Accepted			2022-12-26	WOS:000588368900053
J	Olyaee, MH; Khanteymoori, A; Khalifeh, K				Olyaee, Mohammad Hossein; Khanteymoori, Alireza; Khalifeh, Khosrow			A chaotic viewpoint-based approach to solve haplotype assembly using hypergraph model	PLOS ONE			English	Article							SINGLE INDIVIDUAL HAPLOTYPE; MINING FREQUENT PATTERNS; GENOME SEQUENCE; GAME REPRESENTATION; WHITE PATIENTS; ALGORITHM; RECONSTRUCTION; GENERATION; BLACK	Decreasing the cost of high-throughput DNA sequencing technologies, provides a huge amount of data that enables researchers to determine haplotypes for diploid and polyploid organisms. Although various methods have been developed to reconstruct haplotypes in diploid form, their accuracy is still a challenging task. Also, most of the current methods cannot be applied to polyploid form. In this paper, an iterative method is proposed, which employs hypergraph to reconstruct haplotype. The proposed method by utilizing chaotic viewpoint can enhance the obtained haplotypes. For this purpose, a haplotype set was randomly generated as an initial estimate, and its consistency with the input fragments was described by constructing a weighted hypergraph. Partitioning the hypergraph specifies those positions in the haplotype set that need to be corrected. This procedure is repeated until no further improvement could be achieved. Each element of the finalized haplotype set is mapped to a line by chaos game representation, and a coordinate series is defined based on the position of mapped points. Then, some positions with low qualities can be assessed by applying a local projection. Experimental results on both simulated and real datasets demonstrate that this method outperforms most other approaches, and is promising to perform the haplotype assembly.	[Olyaee, Mohammad Hossein] Univ Gonabad, Dept Comp Engn, Fac Engn, Gonabad, Iran; [Khanteymoori, Alireza] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany; [Khalifeh, Khosrow] Univ Zanjan, Dept Biol, Fac Sci, Zanjan, Iran; [Khalifeh, Khosrow] Univ Zanjan, Res Inst Modern Biol Tech, Dept Biotechnol, Zanjan, Iran	University of Freiburg; University Zanjan; University Zanjan	Khanteymoori, A (corresponding author), Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany.	khanteymoori@gmail.com	olyaee, Mohammad hossein/AAG-9595-2019	Khanteymoori, Alireza/0000-0001-6811-9196				Anitas EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181385; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2016, AUTOMATICA, V64, P94; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Barnsley M.F., 2014, FRACTALS EVERYWHERE, DOI DOI 10.1016/C2013-0-10335-2; Bracciali A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1170-y; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Cai CX, 2016, IEEE J-STSP, V10, P647, DOI 10.1109/JSTSP.2016.2547860; Chen X, 2014, J THEOR BIOL, V358, P85, DOI 10.1016/j.jtbi.2014.05.034; Chen ZX, 2008, J COMPUT BIOL, V15, P535, DOI 10.1089/cmb.2008.0003; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Edge P, 2017, GENOME RES, V27, P801, DOI 10.1101/gr.213462.116; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Ge L, 2019, J MATH BIOL, V78, P441, DOI 10.1007/s00285-018-1279-x; Genovese LM, 2008, IEEE ACM T COMPUT BI, V5, P492, DOI 10.1109/TCBB.2008.67; Geraci F, 2010, BIOINFORMATICS, V26, P2217, DOI 10.1093/bioinformatics/btq411; Glusman G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0073-7; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Han JW, 2004, DATA MIN KNOWL DISC, V8, P53, DOI 10.1023/B:DAMI.0000005258.31418.83; Han JW, 2000, SIGMOD RECORD, V29, P1; Hashemi A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4551-y; Hoang T, 2016, GENOMICS, V108, P134, DOI 10.1016/j.ygeno.2016.08.002; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Kuleshov V, 2014, BIOINFORMATICS, V30, pI379, DOI 10.1093/bioinformatics/btu484; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Loggetto Sandra Regina, 2013, Rev. Bras. Hematol. Hemoter., V35, P155, DOI 10.5581/1516-8484.20130048; Mazrouee S, 2020, IEEE ACM T COMPUT BI, V17, P264, DOI 10.1109/TCBB.2018.2858803; Mazrouee S, 2014, BIOINFORMATICS, V30, pI371, DOI 10.1093/bioinformatics/btu442; McLaren Gordon D, 2009, Hematology Am Soc Hematol Educ Program, P195, DOI 10.1182/asheducation-2009.1.195; Olyaee MH, 2016, J THEOR BIOL, V404, P375, DOI 10.1016/j.jtbi.2016.06.018; Olyaee MH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46844-y; Olyaee MH, 2018, COMPUT BIOL CHEM, V72, P1, DOI 10.1016/j.compbiolchem.2017.12.005; Panconesi A, 2004, FAST HARE FAST HEURI, P266; Patterson M, 2015, J COMPUT BIOL, V22, P498, DOI 10.1089/cmb.2014.0157; Puljiz Z, 2016, IEEE ACM T COMPUT BI, V13, P518, DOI 10.1109/TCBB.2015.2462367; Rhee JK, 2016, GENES GENOM, V38, P1, DOI 10.1007/s13258-015-0342-x; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Rohlfs EM, 2011, CLIN CHEM, V57, P841, DOI 10.1373/clinchem.2010.159285; RUANO G, 1990, P NATL ACAD SCI USA, V87, P6296, DOI 10.1073/pnas.87.16.6296; RUANO G, 1989, NUCLEIC ACIDS RES, V17, P8392, DOI 10.1093/nar/17.20.8392; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Tininini L, 2010, IEEE ACM T COMPUT BI, V7, P511, DOI 10.1109/TCBB.2008.130; Varner RV, 1998, PSYCHIAT QUART, V69, P117, DOI 10.1023/A:1024762503100; Wang RS, 2005, BIOINFORMATICS, V21, P2456, DOI 10.1093/bioinformatics/bti352; Wang TC, 2012, J BIOMED INFORM, V45, P922, DOI 10.1016/j.jbi.2012.03.004; Wang Y, 2007, COMPUT BIOL CHEM, V31, P148, DOI 10.1016/j.compbiolchem.2007.02.001; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie MZ, 2016, BIOINFORMATICS, V32, P3735, DOI 10.1093/bioinformatics/btw537; Yan KY, 2019, IEEE ACCESS, V7, P108906, DOI 10.1109/ACCESS.2019.2930359; Zhao YY, 2005, COMPUT BIOL CHEM, V29, P281, DOI 10.1016/j.compbiolchem.2005.05.001	55	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241291	10.1371/journal.pone.0241291	http://dx.doi.org/10.1371/journal.pone.0241291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33120403	gold, Green Published, Green Submitted			2022-12-26	WOS:000600013600090
J	Rowley, OC; Courtney, RL; Browning, SA; Seymour, JE				Rowley, Olivia C.; Courtney, Robert L.; Browning, Sally A.; Seymour, Jamie E.			Bay watch: Using unmanned aerial vehicles (UAV's) to survey the box jellyfish Chironex fleckeri	PLOS ONE			English	Article							DRONE; BEHAVIOR; ECOLOGY; SHARK	Biological investigations on free ranging marine species are regarded as challenging throughout the scientific community. This is particularly true for 'logistically difficult species' where their cryptic natures, low abundance, patchy distributions and difficult and/or dangerous sampling environments, make traditional surveys near impossible. What results is a lack of ecological knowledge on such marine species. However, advances in UAV technology holds potential for overcoming these logistical difficulties and filling this knowledge gap. Our research focused on one such logistically difficult species, the Australian box Jellyfish (Chironex fleckeri), and we investigated the capacity of consumer grade UAV technology to detect this, highly venomous, target species in the inshore waters of Northern Queensland Australia. At two sites in the Weipa area, we utilized video analysis, visual count comparisons with a netted animal tally, and evaluated the role of associated environmental conditions, such as wind speed, water visibility and cloud cover on jellyfish detection rates. In total fifteen, 70 meter transects were completed between two sites, with 107 individuals captured. Drone success varied between the two sites with a significant difference between field and post-field (laboratory) counts. Animal size and cloud cover also had significant effects on detection rates with an increase in cloud cover and animal size enhancing detection probability. This study provides evidence to suggest drone surveys overcome obstacles that traditional surveys can't, with respect to species deemed logistically difficult and open scope for further ecological investigations on such species.	[Rowley, Olivia C.; Courtney, Robert L.; Browning, Sally A.; Seymour, Jamie E.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Rowley, Olivia C.] James Cook Univ, Div Trop Hlth & Med, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia	James Cook University; James Cook University	Rowley, OC (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.; Rowley, OC (corresponding author), James Cook Univ, Div Trop Hlth & Med, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.	olivia.rowley@my.jcu.edu.au		Rowley, Olivia/0000-0002-0809-342X	Queensland Lions Foundation	Queensland Lions Foundation	Queensland Lions Foundation. Award recipient Olivia Rowley. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznar F, 2017, OCEAN ENG, V134, P24, DOI 10.1016/j.oceaneng.2017.02.009; Benavides MT, 2020, J UNMANNED VEH SYST, V8, P44, DOI 10.1139/juvs-2019-0002; Bevan E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194460; Bevan Elizabeth, 2015, Marine Turtle Newsletter, P19; Bordehore C, 2016, OCEAN COAST MANAGE, V131, P45, DOI 10.1016/j.ocecoaman.2016.08.008; Burnett JD, 2019, MAR MAMMAL SCI, V35, P108, DOI 10.1111/mms.12527; Butcher PA, 2019, WILDLIFE RES, V46, P701, DOI 10.1071/WR18119; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Colefax AP, 2019, OCEAN COAST MANAGE, V174, P108, DOI 10.1016/j.ocecoaman.2019.03.008; Currie BJ, 2005, MED J AUSTRALIA, V183, P631, DOI 10.5694/j.1326-5377.2005.tb00062.x; Ferguson MC, 2018, J UNMANNED VEH SYST, V6, P128, DOI 10.1139/juvs-2018-0002; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Hensel E, 2018, LAT AM J AQUAT RES, V46, P1025, DOI 10.3856/vol46-issue5-fulltext-15; Hodgson JC, 2018, METHODS ECOL EVOL, V9, P1160, DOI 10.1111/2041-210X.12974; Joyce KE, 2019, MAR FRESHWATER RES, V70, P952, DOI 10.1071/MF17380; Kelaher BP, 2020, MAR FRESHWATER RES, V71, P68, DOI 10.1071/MF18375; Kiszka JJ, 2016, MAR ECOL PROG SER, V560, P237, DOI 10.3354/meps11945; Lyons MB, 2019, METHODS ECOL EVOL, V10, P1024, DOI 10.1111/2041-210X.13194; Pimm SL, 2015, TRENDS ECOL EVOL, V30, P685, DOI 10.1016/j.tree.2015.08.008; Pitt K.A., 2009, JELLYFISH BLOOMS CAU; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Purcell JE, 2009, HYDROBIOLOGIA, V616, P23, DOI 10.1007/s10750-008-9585-8; Raoult V, 2018, FISH RES, V207, P160, DOI 10.1016/j.fishres.2018.06.010; Schaub J, 2018, MAR ECOL PROG SER, V591, P29, DOI 10.3354/meps12414; Schofield G, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108214; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Torres LG, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00319; Weir JS, 2018, AQUAT MAMM, V44, P603, DOI 10.1578/AM.44.6.2018.603; Xiao F, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1527	31	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241410	10.1371/journal.pone.0241410	http://dx.doi.org/10.1371/journal.pone.0241410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119724	gold, Green Accepted, Green Published			2022-12-26	WOS:000600013600029
J	Aliaj, K; Feeney, GM; Sundaralingam, B; Hermans, T; Foreman, KB; Bachus, KN; Henninger, HB				Aliaj, Klevis; Feeney, Gentry M.; Sundaralingam, Balakumar; Hermans, Tucker; Foreman, K. Bo; Bachus, Kent N.; Henninger, Heath B.			Replicating dynamic humerus motion using an industrial robot	PLOS ONE			English	Article							SOFT-TISSUE ARTIFACT; HUMAN MOVEMENT ANALYSIS; GLENOHUMERAL JOINT; KNEE KINEMATICS; ROTATIONS; SHOULDER; LIGAMENT; OPTIMIZATION; FRACTURE; SYSTEMS	Transhumeral percutaneous osseointegrated prostheses provide upper-extremity amputees with increased range of motion, more natural movement patterns, and enhanced proprioception. However, direct skeletal attachment of the endoprosthesis elevates the risk of bone fracture, which could necessitate revision surgery or result in loss of the residual limb. Bone fracture loads are direction dependent, strain rate dependent, and load rate dependent. Furthermore, in vivo, bone experiences multiaxial loading. Yet, mechanical characterization of the bone-implant interface is still performed with simple uni- or bi-axial loading scenarios that do not replicate the dynamic multiaxial loading environment inherent in human motion. The objective of this investigation was to reproduce the dynamic multiaxial loading conditions that the humerus experiences in vivo by robotically replicating humeral kinematics of advanced activities of daily living typical of an active amputee population. Specifically, 115 jumping jack, 105 jogging, 15 jug lift, and 15 internal rotation trials-previously recorded via skin-marker motion capture-were replicated on an industrial robot and the resulting humeral trajectories were verified using an optical tracking system. To achieve this goal, a computational pipeline that accepts a motion capture trajectory as input and outputs a motion program for an industrial robot was implemented, validated, and made accessible via public code repositories. The industrial manipulator utilized in this study was able to robotically replicate over 95% of the aforementioned trials to within the characteristic error present in skin-marker derived motion capture datasets. This investigation demonstrates the ability to robotically replicate human motion that recapitulates the inertial forces and moments of high-speed, multiaxial activities for biomechanical and orthopaedic investigations. It also establishes a library of robotically replicated motions that can be utilized in future studies to characterize the interaction of prosthetic devices with the skeletal system, and introduces a computational pipeline for expanding this motion library.	[Aliaj, Klevis; Feeney, Gentry M.; Foreman, K. Bo; Bachus, Kent N.; Henninger, Heath B.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Aliaj, Klevis; Feeney, Gentry M.; Bachus, Kent N.; Henninger, Heath B.] Univ Utah, Dept Bimed Engn, Salt Lake City, UT 84112 USA; [Sundaralingam, Balakumar; Hermans, Tucker] Univ Utah, Sch Comp, Salt Lake City, UT USA; [Hermans, Tucker; Foreman, K. Bo; Henninger, Heath B.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Foreman, K. Bo] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT USA; [Foreman, K. Bo; Bachus, Kent N.] US Dept Vet Affairs, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Henninger, HB (corresponding author), Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA.; Henninger, HB (corresponding author), Univ Utah, Dept Bimed Engn, Salt Lake City, UT 84112 USA.; Henninger, HB (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.	heath.henninger@utah.edu	Sundaralingam, Balakumar/AAC-8731-2021	Henninger, Heath/0000-0002-3635-1289; Aliaj, Klevis/0000-0001-7324-6931; Hermans, Tucker/0000-0003-2496-2768	US Army Medical Research and Materiel Command [W81XWH-15-C-0058]; United States Department of Veterans Affairs Rehabilitation Research and Development Service [I01RX001246]; NIH NIAMS [R01 AR067196]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); United States Department of Veterans Affairs Rehabilitation Research and Development Service; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	KB received a grant from US Army Medical Research and Materiel Command (W81XWH-15-C-0058) and the United States Department of Veterans Affairs Rehabilitation Research and Development Service (I01RX001246). HH received a grant from the NIH NIAMS (R01 AR067196). The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adharapurapu RR, 2006, MAT SCI ENG C-BIO S, V26, P1325, DOI 10.1016/j.msec.2005.08.008; An YH, 1999, MECH TESTING BONE BO; [Anonymous], 2016, THE TOTAL AUDIENCE R; Aristidou A, 2018, COMPUTER GRAPHICS FO; Barre A, 2017, J BIOMECH, V62, P21, DOI 10.1016/j.jbiomech.2017.04.036; Bates NA, 2015, ANN BIOMED ENG, V43, P2456, DOI 10.1007/s10439-015-1285-8; Baxter JR, 2016, J ORTHOP RES, V34, P1663, DOI 10.1002/jor.23169; Bey MJ, 2008, J BIOMECH, V41, P711, DOI 10.1016/j.jbiomech.2007.09.029; Biscani F, 2019, ESA PAGMO2 2 10, V2.10; Blache Y, 2017, J BIOMECH, V62, P39, DOI 10.1016/j.jbiomech.2016.10.019; Boguszewski DV, 2011, J ORTHOP RES, V29, P641, DOI 10.1002/jor.21298; Buss S. R., 2004, IEEE J ROBOT AUTOM, V17, P1; Camomilla V, 2017, J BIOMECH, V62, P1, DOI 10.1016/j.jbiomech.2017.09.001; Colbrunn RW, 2019, J ORTHOP RES, V37, P2601, DOI 10.1002/jor.24439; Condurache D, 2002, ACTA MECH, V153, P147, DOI 10.1007/BF01177449; Craig JJ, 2009, INTRO ROBOTICS MECH, V3/E; Dal Maso F, 2014, CLIN BIOMECH, V29, P1048, DOI 10.1016/j.clinbiomech.2014.08.006; Darcy SP, 2006, J BIOMECH, V39, P2371, DOI 10.1016/j.jbiomech.2005.08.009; Debski RE, 1999, J SHOULDER ELB SURG, V8, P324, DOI 10.1016/S1058-2746(99)90154-4; Debski RE, 2004, J APPL BIOMECH, V20, P450, DOI 10.1123/jab.20.4.450; Diebel J, 2006, REPRESENTING ATTITUD, DOI [10.1016/j.amjsurg.2005.10.041, DOI 10.1016/J.AMJSURG.2005.10.041]; Drew AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189418; Edwards S, 2019, CHALLENGE TRANSITION; Edwards S, 2012, IEEE INT C ROB AUT E; Eggert DW, 1997, MACH VISION APPL, V9, P272, DOI 10.1007/s001380050048; El Daou H, 2019, MED ENG PHYS, V63, P57, DOI 10.1016/j.medengphy.2018.10.006; Frangiamore SJ, 2018, J SHOULDER ELB SURG, V27, P2068, DOI 10.1016/j.jse.2018.05.020; Gill PE, 2005, SIAM REV, V47, P99, DOI 10.1137/S0036144504446096; Giphart JE, 2013, J BONE JOINT SURG AM, V95A, P238, DOI 10.2106/JBJS.J.01875; Goldsmith MT, 2015, J BIOMECH, V48, P4093, DOI 10.1016/j.jbiomech.2015.10.009; Hamming D, 2012, J BIOMECH, V45, P1161, DOI 10.1016/j.jbiomech.2012.02.003; Hansen U, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838032; Herfat ST, 2012, ANN BIOMED ENG, V40, P1545, DOI 10.1007/s10439-011-0500-5; HOGAN N, 1984, J NEUROSCI, V4, P2745; Hoorn GAv, 2018, NEW EXPT FANUC ROBOT; Huyghe B, 2011, THESIS; Huynh DQ, 2009, J MATH IMAGING VIS, V35, P155, DOI 10.1007/s10851-009-0161-2; Johnson M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-8; Kanamori A, 2000, ARTHROSCOPY, V16, P633, DOI 10.1053/jars.2000.7682; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; Keyak JH, 2001, J ORTHOPAED RES, V19, P539, DOI 10.1016/S0736-0266(00)00046-2; Kretzer JP, 2010, J BIOMECH, V43, P1092, DOI 10.1016/j.jbiomech.2009.12.016; Kshettry VR, 2017, J NEUROSURG, V127, P829, DOI 10.3171/2016.7.JNS16293; Kulin RM, 2011, ACTA BIOMATER, V7, P724, DOI 10.1016/j.actbio.2010.09.027; Ludewig PM, 2009, J BONE JOINT SURG AM, V91A, P378, DOI 10.2106/JBJS.G.01483; Markley FL, 2007, J GUID CONTROL DYNAM, V30, P1193, DOI 10.2514/1.28949; Marquardt B, 2006, AM J SPORT MED, V34, P1756, DOI 10.1177/0363546506289702; McMahon I, 2016, IMPROVING ROS IND MO; Moore SA, 2008, J ORTHOP RES, V26, P1598, DOI 10.1002/jor.20685; Nesbitt Rebecca J, 2016, Am J Biomed Eng, V6, P12; Ng KCG, 2019, AM J SPORT MED, V47, P420, DOI 10.1177/0363546518815159; Noble LD, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000851; OHAVER TC, 1981, ANAL CHEM, V53, P1876, DOI 10.1021/ac00235a036; Otto S.A., 2019, NORMALIZE RMSE; PERES A, 1980, AM J PHYS, V48, P70, DOI 10.1119/1.12267; Quigley M., 2009, ICRA WORKSH OP SOURC, V3, P5; Richter H, 2015, APPL MATH MODEL, V39, P559, DOI 10.1016/j.apm.2014.06.006; Sharkey NA, 1998, CLIN BIOMECH, V13, P420, DOI 10.1016/S0268-0033(98)00003-5; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; Spencer AJM, 2004, CONTINUUM MECH COURI; Spivey W, 2019, 15 ANN INJ BIOM S; Stenlund P, 2019, ANN BIOMED ENG, V47, P1369, DOI 10.1007/s10439-019-02244-x; Taylor CE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237179; Thesleff A, 2018, ANN BIOMED ENG, V46, P377, DOI 10.1007/s10439-017-1976-4; van Arkel RJ, 2016, J BIOMECH, V49, P4154, DOI 10.1016/j.jbiomech.2016.10.036; WRIGHT TM, 1976, MED BIOL ENG, V14, P671, DOI 10.1007/BF02477046; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yu B, 1999, J APPL BIOMECH, V15, P318, DOI 10.1123/jab.15.3.318	70	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242005	10.1371/journal.pone.0242005	http://dx.doi.org/10.1371/journal.pone.0242005			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166328	Green Published, gold			2022-12-26	WOS:000592382600072
J	Wakabayashi, Y; Uchiyama, M; Daisaki, H; Matsumoto, M; Sakamoto, M; Kashikura, K				Wakabayashi, Yasuharu; Uchiyama, Mayuki; Daisaki, Hiromitsu; Matsumoto, Makoto; Sakamoto, Masafumi; Kashikura, Kenichi			Investigation of the new non-invasive semi-quantitative method of I-123-IMP pediatric cerebral perfusion SPECT	PLOS ONE			English	Article							BLOOD-FLOW; SURFACE-AREA; QUANTIFICATION; CHILDREN; FORMULA; WEIGHT; HEIGHT	In pediatric cases requiring quantification of cerebral blood flow (CBF) using I-123-N-isopropyl-p-iodoamphetamine (I-123-IMP) single-photon emission computed tomography (SPECT), arterial blood sampling is sometimes impossible due to issues such as movement, crying, or body motion. If arterial blood sampling fails, quantitative diagnostic assessment becomes impossible despite radiation exposure. We devised a new easy non-invasive microsphere (e-NIMS) method using whole-body scan data. This method can be used in conjunction with autoradiography (ARG) and can provide supportive data for invasive CBF quantification. In this study, we examined the usefulness of e-NIMS for pediatric cerebral perfusion semi-quantitative SPECT and compared it with the invasive ARG. The e-NIMS estimates cardiac output (CO) using whole-body acquisition data after I-123-IMP injection and the body surface area from calculation formula. A whole-body scan was performed 5 minutes after the I-123-IMP injection and CO was estimated by region of interest (ROI) counts measured for the whole body, lungs, and brain using the whole-body anterior image. The mean CBF (mCBF) was compared with that acquired via ARG in 115 pediatric patients with suspected cerebrovascular disorders (age 0-15 years). Although the mCBF estimated by the e-NIMS indicated a slight deviation in the extremely low- or high-mCBF cases when compared with the values acquired using the invasive ARG, there was a good correlation between the two methods (r = 0.799; p < 0.001). There were no significant differences in the mCBF values based on physical features, such as patients' height, weight, and age. Our findings suggest that I-123-IMP brain perfusion SPECT with e-NIMS is the simplest semi-quantitative method that can provide supportive data for invasive CBF quantification. This method may be useful, especially in pediatric brain perfusion SPECT, when blood sampling or identifying pulmonary arteries for CO estimation using the graph plot method is difficult.	[Wakabayashi, Yasuharu; Matsumoto, Makoto] Saitama Prefectural Childrens Med Ctr, Div Radiol Technol, Saitama, Saitama, Japan; [Wakabayashi, Yasuharu; Daisaki, Hiromitsu; Kashikura, Kenichi] Gunma Prefectural Coll Hlth Sci, Grad Sch Radiol Technol, Maebashi, Gumma, Japan; [Uchiyama, Mayuki] Tokyo Jikeikai Med Univ, Div Radiol, Minato Ku, Tokyo, Japan; [Sakamoto, Masafumi] Saitama Prefectural Resp & Cardiovasc Ctr, Div Radiol Technol, Kumagaya, Saitama, Japan		Wakabayashi, Y (corresponding author), Saitama Prefectural Childrens Med Ctr, Div Radiol Technol, Saitama, Saitama, Japan.; Wakabayashi, Y (corresponding author), Gunma Prefectural Coll Hlth Sci, Grad Sch Radiol Technol, Maebashi, Gumma, Japan.	yasuwaka0604@gmail.com	Daisaki, Hiromitsu/ABD-5831-2021	Daisaki, Hiromitsu/0000-0001-5778-2363				Abe RTS, 2012, CLIN NUCL MED, V37, P258, DOI 10.1097/RLU.0b013e31823928a7; Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; CHIRON C, 1992, J NUCL MED, V33, P696; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; FUJIMOTO S, 1968, Japanese Journal of Hygiene, V23, P437; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; IEEE, 1985, ACM SIGPLAN NOTICES, V22; IIDA H, 1994, J NUCL MED, V35, P2019; Iida H, 1994, Eur J Nucl Med, V21, P1072; Iida H, 2010, J NUCL MED, V51, P1624, DOI 10.2967/jnumed.110.078352; Iida Hidehiro, 1995, Kaku Igaku, V32, P263; Itoh H, 1992, Kaku Igaku, V29, P1193; Kameyama M, 2018, ANN NUCL MED, V32, P620, DOI 10.1007/s12149-018-1282-8; Kaminaga T, 2001, ANN NUCL MED, V15, P61, DOI 10.1007/BF03012134; Kim KM, 2006, NEUROIMAGE, V33, P1126, DOI 10.1016/j.neuroimage.2006.06.064; Knoll P, 2012, Z MED PHYS, V22, P58, DOI 10.1016/j.zemedi.2011.04.007; Koizumi K, 2014, ANN NUCL MED, V28, P498, DOI 10.1007/s12149-014-0826-9; KUHL DE, 1982, J NUCL MED, V23, P196; Liu Feng, 2018, EURO J PED NEURO, V4, P582; Massin M, 1997, PEDIATR CARDIOL, V18, P297, DOI 10.1007/s002469900178; Miyazaki Yoshiharu, 1996, Kaku Igaku, V33, P285; Nagamachi Shigeki, 2003, Kaku Igaku, V40, P155; Ofuji A, 2016, ANN NUCL MED, V30, P242, DOI 10.1007/s12149-015-1053-8; Okamoto K, 2002, CLIN NUCL MED, V27, P191, DOI 10.1097/00003072-200203000-00009; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Subcommittee for Standardization of Radionuclide Imaging Medical and Pharmaceutical Committee, 1988, RADIOISOTOPES, V37, P627, DOI DOI 10.3769/RADIOISOTOPES.37.11_627; SUGA K, 1992, NUCL MED COMMUN, V13, P33, DOI 10.1097/00006231-199201000-00006; Takeuchi R, 2002, EUR J NUCL MED MOL I, V29, P331, DOI 10.1007/s00259-001-0715-z; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; YONEKURA Y, 1990, Kaku Igaku, V27, P1311; Yonekura Yoshiharu, 1997, Kaku Igaku, V34, P901	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241987	10.1371/journal.pone.0241987	http://dx.doi.org/10.1371/journal.pone.0241987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166343	Green Published, gold			2022-12-26	WOS:000592382600047
J	Wang, XT; Li, XL; Li, J; Zhai, LD; Liu, DQ; Abdurahman, A; Zhang, YF; Yokota, H; Zhang, P				Wang, Xuetong; Li, Xinle; Li, Jie; Zhai, Lidong; Liu, Daquan; Abdurahman, Abdusami; Zhang, Yifan; Yokota, Hiroki; Zhang, Ping			Mechanical loading stimulates bone angiogenesis through enhancing type H vessel formation and downregulating exosomal miR-214-3p from bone marrow-derived mesenchymal stem cells	FASEB JOURNAL			English	Article						knee loading; MiRNA; osteoporosis; type H vessels; vessel remodeling	OSTEOPOROTIC FRACTURE; FEMORAL-HEAD; OSTEONECROSIS; DIFFERENTIATION; OSTEOGENESIS; REGENERATION; MICRORNAS; MODEL	Exosomes are important transporters of miRNAs, which play varying roles in the healing of the bone fracture. Angiogenesis is one of such critical events in bone healing, and we previously reported the stimulatory effect of mechanical loading in vessel remodeling. Focusing on type H vessels and exosomal miR-214-3p, this study examined the mechanism of loading-driven angiogenesis. MiRNA sequencing and qRT-PCR revealed that miR-214-3p was increased in the exosomes of the bone-losing ovariectomized (OVX) mice, while it was significantly decreased by knee loading. Furthermore, compared to the OVX group, exosomes, derived from the loading group, promoted the angiogenesis of endothelial cells. In contrast, exosomes, which were transfected with miR-214-3p, decreased the angiogenic potential. Notably, knee loading significantly improved the microvascular volume, type H vessel formation, and bone mineral density and contents, as well as BV/TV, Tb.Th, Tb.N, and Tb.Sp. In cell cultures, the overexpression of miR-214-3p in endothelial cells reduced the tube formation and cell migration. Collectively, this study demonstrates that knee loading promotes angiogenesis by enhancing the formation of type H vessels and downregulating exosomal miR-214-3p.	[Wang, Xuetong; Li, Xinle; Li, Jie; Zhai, Lidong; Liu, Daquan; Abdurahman, Abdusami; Zhang, Yifan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Tianjin Medical University	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin, Peoples R China.	pizhang@tmu.edu.cn			National Natural Science Foundation of China [81772405, 81572100, 81601863, 31871212]; Natural Science Foundation of Tianjin [18JCQNJC82200]; NIH [AR052144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Natural Science Foundation of China, Grant/Award Number: 81772405, 81572100, 81601863 and 31871212; Natural Science Foundation of Tianjin, Grant/Award Number: 18JCQNJC82200; NIH, Grant/Award Number: AR052144	Behera Jyotirmaya, 2018, Oncoscience, V5, P181, DOI 10.18632/oncoscience.421; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Ding JN, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9742765; Filipowska J, 2017, ANGIOGENESIS, V20, P291, DOI 10.1007/s10456-017-9541-1; Fishman A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1495-0; Fu R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14076-3; Hatori K, 2015, OSTEOPOROSIS INT, V26, P303, DOI 10.1007/s00198-014-2857-4; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Huang JH, 2020, NEUROSCIENCE, V424, P133, DOI 10.1016/j.neuroscience.2019.10.043; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Huang L, 2018, BIOMATERIALS, V182, P58, DOI 10.1016/j.biomaterials.2018.07.046; Ji G, 2019, BONE JOINT J, V101B, P108, DOI 10.1302/0301-620X.101B7.BJJ-2018-1473.R1; Jing D, 2016, J BONE MINER RES, V31, P1713, DOI 10.1002/jbmr.2837; Kusumbe AP, 2015, NAT PROTOC, V10, P1904, DOI 10.1038/nprot.2015.125; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2159-z; Li WD, 2018, STEM CELLS, V36, P1863, DOI 10.1002/stem.2904; Li XL, 2019, FASEB J, V33, P8913, DOI 10.1096/fj.201802711R; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05488-6; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Liu M, 2018, J DENT RES, V97, P859, DOI 10.1177/0022034518764411; Liu XL, 2017, INT J BIOL SCI, V13, P232, DOI 10.7150/ijbs.16951; Lombardo G, 2018, ONCOGENE, V37, P1175, DOI 10.1038/s41388-017-0034-x; Ma T, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3290372; Peng Y, 2020, THERANOSTICS, V10, P426, DOI 10.7150/thno.34126; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Qi YX, 2018, ADV EXP MED BIOL, V1097, P69, DOI 10.1007/978-3-319-96445-4_4; Qin YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050712; Ren H, 2019, BONE, V120, P371, DOI 10.1016/j.bone.2018.11.013; Santos TS, 2015, J CELL BIOCHEM, V116, P2896, DOI 10.1002/jcb.25237; Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006; Shang S, 2019, CANCER MED-US, V8, P7728, DOI 10.1002/cam4.2633; Sundh D, 2018, J BONE MINER RES, V33, P1242, DOI 10.1002/jbmr.3431; Teng JW, 2018, EUR REV MED PHARMACO, V22, P17, DOI 10.26355/eurrev_201801_14095; Tian GE, 2019, WORLD J STEM CELLS, V11, P1104, DOI 10.4252/wjsc.v11.i12.1104; Tian XT, 2018, EXP THER MED, V16, P595, DOI 10.3892/etm.2018.6252; van der Eerden BCJ, 2014, ARCH BIOCHEM BIOPHYS, V561, P46, DOI 10.1016/j.abb.2014.04.016; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Wang B, 2019, J CELL PHYSIOL, V234, P10602, DOI 10.1002/jcp.27735; Wang CD, 2017, EXP CELL RES, V352, P346, DOI 10.1016/j.yexcr.2017.02.021; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wei FY, 2016, EUR CELLS MATER, V31, P341, DOI 10.22203/eCM.v031a22; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xie Y, 2017, J CELL MOL MED, V21, P1033, DOI 10.1111/jcmm.13039; Yamasaki Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0613-3; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Zhang P, 2007, J BONE MINER RES, V22, P1979, DOI 10.1359/JBMR.070803; Zhang P, 2012, J BONE MINER METAB, V30, P31, DOI 10.1007/s00774-011-0292-6; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhang P, 2009, EXERC SPORT SCI REV, V37, P52, DOI 10.1097/JES.0b013e31819121c6; Zheng WW, 2020, FASEB J, V34, P3399, DOI 10.1096/fj.201902117R; Zheng WW, 2019, FASEB J, V33, P4077, DOI 10.1096/fj.201801851R; Zhou LG, 2019, EUR REV MED PHARMACO, V23, P449, DOI 10.26355/eurrev_201901_16854	55	21	25	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001080RR	http://dx.doi.org/10.1096/fj.202001080RR		NOV 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33161580	Green Accepted			2022-12-26	WOS:000590916700001
J	Felestrino, EB; Sanchez, AB; Caneschi, WL; Lemes, CGD; Assis, RDB; Cordeiro, IF; Fonseca, NP; Villa, MM; Vieira, IT; Kamino, LHY; do Carmo, FF; da Silva, AM; Thomas, AM; Patane, JSL; Ferreira, FC; de Freitas, LG; Varani, AD; Ferro, JA; Silva, RS; Almeida, NF; Garcia, CCM; Setubal, JC; Moreira, LM				Felestrino, Erica Barbosa; Sanchez, Angelica Bianchini; Caneschi, Washington Luiz; Lemes, Camila Gracyelle de Carvalho; Assis, Renata de Almeida Barbosa; Cordeiro, Isabella Ferreira; Fonseca, Natasha Peixoto; Villa, Morghana Marina; Vieira, Izadora Tabuso; Kamino, Luciana Hiromi Yoshino; do Carmo, Flavio Fonseca; da Silva, Aline Maria; Thomas, Andrew Maltez; Patane, Jose Salvatore Leister; Ferreira, Fernanda Carla; de Freitas, Leandro Grassi; Varani, Alessandro de Mello; Ferro, Jesus Aparecido; Silva, Robson Soares; Almeida, Nalvo Franco; Garcia, Camila Carriao Machado; Setubal, Joao Carlos; Moreira, Leandro Marcio			Complete genome sequence and analysis of Alcaligenes faecalis strain Mc250, a new potential plant bioinoculant	PLOS ONE			English	Article							BACTERIUM; FILAMENT; ZD02; SITE; N2O; NO	Here we present and analyze the complete genome of Alcaligenes faecalis strain Mc250 (Mc250), a bacterium isolated from the roots of Mimosa calodendron, an endemic plant growing in ferruginous rupestrian grasslands in Minas Gerais State, Brazil. The genome has 4,159,911 bp and 3,719 predicted protein-coding genes, in a single chromosome. Comparison of the Mc250 genome with 36 other Alcaligenes faecalis genomes revealed that there is considerable gene content variation among these strains, with the core genome representing only 39% of the protein-coding gene repertoire of Mc250. Mc250 encodes a complete denitrification pathway, a network of pathways associated with phenolic compounds degradation, and genes associated with HCN and siderophores synthesis; we also found a repertoire of genes associated with metal internalization and metabolism, sulfate/sulfonate and cysteine metabolism, oxidative stress and DNA repair. These findings reveal the genomic basis for the adaptation of this bacterium to the harsh environmental conditions from where it was isolated. Gene clusters associated with ectoine, terpene, resorcinol, and emulsan biosynthesis that can confer some competitive advantage were also found. Experimental results showed that Mc250 was able to reduce (similar to 60%) the virulence phenotype of the plant pathogen Xanthomonas citri subsp. citri when co-inoculated in Citrus sinensis, and was able to eradicate 98% of juveniles and stabilize the hatching rate of eggs to 4% in two species of agricultural nematodes. These results reveal biotechnological potential for the Mc250 strain and warrant its further investigation as a biocontrol and plant growth-promoting bacterium.	[Felestrino, Erica Barbosa; Sanchez, Angelica Bianchini; Caneschi, Washington Luiz; Lemes, Camila Gracyelle de Carvalho; Assis, Renata de Almeida Barbosa; Cordeiro, Isabella Ferreira; Fonseca, Natasha Peixoto; Garcia, Camila Carriao Machado; Moreira, Leandro Marcio] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Villa, Morghana Marina; Vieira, Izadora Tabuso; Garcia, Camila Carriao Machado; Moreira, Leandro Marcio] Univ Fed Ouro Preto UFOP, Inst Ciencias Exatas & Biol ICEB, Dept Ciencias Biol DECBI, Ouro Preto, MG, Brazil; [Kamino, Luciana Hiromi Yoshino; do Carmo, Flavio Fonseca] Inst Pristino, Belo Horizonte, MG, Brazil; [da Silva, Aline Maria; Thomas, Andrew Maltez; Patane, Jose Salvatore Leister; Setubal, Joao Carlos] Univ Sao Paulo, Inst Quim IQ, Dept Bioquim DBQ, Sao Paulo, SP, Brazil; [Ferreira, Fernanda Carla; de Freitas, Leandro Grassi] Univ Fed Vicosa UFV, Inst Biotecnol Aplicada Agr BIOAGRO, Vicosa, MG, Brazil; [Varani, Alessandro de Mello; Ferro, Jesus Aparecido] Univ Estadual Paulista UNESP, Dept Tecnol, Fac Ciencias Agr & Vet Jaboticabal FCAV, Sao Paulo, SP, Brazil; [Silva, Robson Soares; Almeida, Nalvo Franco] Univ Fed Mato Grosso do Sul, Fac Comp FACOM, Campo Grande, MS, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade de Sao Paulo; Universidade Federal de Vicosa; Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul	Moreira, LM (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil.; Moreira, LM (corresponding author), Univ Fed Ouro Preto UFOP, Inst Ciencias Exatas & Biol ICEB, Dept Ciencias Biol DECBI, Ouro Preto, MG, Brazil.; Setubal, JC (corresponding author), Univ Sao Paulo, Inst Quim IQ, Dept Bioquim DBQ, Sao Paulo, SP, Brazil.	setubal@iq.usp.br; lmmorei@gmail.com	Setubal, Joao Carlos/C-7305-2012; Assis, Renata/HGD-9366-2022; da Silva, Aline Maria/C-3649-2012; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; de Almeida B. Assis, Renata/GLV-4566-2022; Fonseca, Natasha/AAB-5437-2019; Ferro, Jesus Aparecido A/C-8251-2013	Setubal, Joao Carlos/0000-0001-9174-2816; da Silva, Aline Maria/0000-0001-9249-4922; Fonseca, Natasha/0000-0002-0542-8159; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Sanchez, Angelica Bianchini/0000-0001-7107-7193; Thomas, Andrew Maltez/0000-0001-5789-3354	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) [001, CFP 51/2013, 3385/2013]; National Council of Technological and Scientific Development (CNPq) [481226/2013-3]; Minas Gerais Research Foundation FAPEMIG [APQ-02387-14, APQ-02357-17]; CNPq; Fundect-MS [TO 141/2016, TO 007/2015]; PROPP-UFMS; PROPPI-UFOP	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundect-MS(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); PROPP-UFMS; PROPPI-UFOP	This study was financed in part by the Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) - Finance Code 001 (the BIGA Project, CFP 51/2013, process 3385/2013), National Council of Technological and Scientific Development (CNPq Process 481226/2013-3), and Minas Gerais Research Foundation FAPEMIG (process APQ-02387-14 and process APQ-02357-17). LMM, AMV, JAF, JCS, NFA, LGF and AMDS were funded in part by research fellowship from CNPq. NFA was funded in part by grants from Fundect-MS (TO 141/2016 and TO 007/2015) by a research fellowship from PROPP-UFMS. LMM was funded in part by a research fellowship from PROPPI-UFOP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2008, PLANT SIGNAL BEHAV, V3, P423, DOI 10.4161/psb.3.6.5472; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarenga DO, 2018, METHODS MOL BIOL, V1704, P213, DOI 10.1007/978-1-4939-7463-4_7; ANDERSON IC, 1993, APPL ENVIRON MICROB, V59, P3525, DOI 10.1128/AEM.59.11.3525-3533.1993; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; [Anonymous], 2014, PEERJ, V2, pe447; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Basharat Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21919-4; Bharali P, 2011, INT BIODETER BIODEGR, V65, P682, DOI 10.1016/j.ibiod.2011.04.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boos W, 1998, METHOD ENZYMOL, V292, P40; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chen SY, 2000, J NEMATOL, V32, P117; Cianciotto NP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00014-17; Conrads T, 2002, J AM CHEM SOC, V124, P11276, DOI 10.1021/ja027684q; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dumitru Speranta, 2009, REV EUROPEENNE MIGRA, V1, P119; Duran RE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00528; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Quiroz-Castaneda RE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/570243; Felestrino EB, 2017, J SOIL SCI PLANT NUT, V17, P1102, DOI 10.4067/S0718-95162017000400019; Finkemeier Iris, 2009, F1000 Biol Rep, V1, P47, DOI 10.3410/B1-47; Guo SQ, 2018, FEBS J, V285, P1812, DOI 10.1111/febs.14441; Hajam IA, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.172; Ju SY, 2016, APPL ENVIRON MICROB, V82, P2112, DOI 10.1128/AEM.03444-15; Ju SY, 2016, J BIOTECHNOL, V218, P73, DOI 10.1016/j.jbiotec.2015.12.001; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kaliaperumal S, 2006, EYE, V20, P968, DOI 10.1038/sj.eye.6702080; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kesik M, 2006, J APPL MICROBIOL, V101, P655, DOI 10.1111/j.1365-2672.2006.02927.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Machado ACZ, 2015, TROP PLANT PATHOL, V40, P102, DOI 10.1007/s40858-015-0013-0; Martin-Mora D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20283-7; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; MURPHY MEP, 1995, BIOCHEMISTRY-US, V34, P12107, DOI 10.1021/bi00038a003; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Phung LT, 2012, J BACTERIOL, V194, P5153, DOI 10.1128/JB.01185-12; Regar RK, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00067-16; Ribeiro SP, 2017, PLANT SPEC BIOL, V32, P147, DOI 10.1111/1442-1984.12136; Schaefer C.E., 2015, GEOSSISTEMAS FERRUGI, P77; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; SIMMONS DG, 1981, AVIAN DIS, V25, P610, DOI 10.2307/1589991; Song WS, 2017, J MOL BIOL, V429, P847, DOI 10.1016/j.jmb.2017.02.001; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Vasconcelos J. M., 2016, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V11, P49; Yang H-C, NOVEL PATHWAY ARSENI; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon IH, 2009, ENVIRON GEOCHEM HLTH, V31, P109, DOI 10.1007/s10653-008-9170-0; Zeng QW, 2017, J MICROBIOL BIOTECHN, V27, P844, DOI 10.4014/jmb.1611.11057; Zhang J, 2010, MOL PLANT, V3, P783, DOI 10.1093/mp/ssq035; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	60	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241546	10.1371/journal.pone.0241546	http://dx.doi.org/10.1371/journal.pone.0241546			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151992	gold, Green Published			2022-12-26	WOS:000591376200081
J	Guan, BL; Tang, XF				Guan, Binglei; Tang, Xianfeng			Multisensor decentralized nonlinear fusion using adaptive cubature information filter	PLOS ONE			English	Article								In nonlinear multisensor system, abrupt state changes and unknown variance of measurement noise are very common, which challenges the majority of the previously developed models for precisely known multisensor fusion techniques. In terms of this issue, an adaptive cubature information filter (CIF) is proposed by embedding strong tracking filter (STF) and variational Bayesian (VB) method, and it is extended to multi-sensor fusion under the decentralized fusion framework with feedback. Specifically, the new algorithms use an equivalent description of STF, which avoid the problem of solving Jacobian matrix during determining strong trace fading factor and solve the interdependent problem of combination of STF and VB. Meanwhile, A simple and efficient method for evaluating global fading factor is developed by introducing a parameter variable named fading vector. The analysis shows that compared with the traditional information filter, this filter can effectively reduce the data transmission from the local sensor to the fusion center and decrease the computational burden of the fusion center. Therefore, it can quickly return to the normal error range and has higher estimation accuracy in response to abrupt state changes. Finally, the performance of the developed algorithms is evaluated through a target tracking problem.	[Guan, Binglei] Shanghai Maritime Univ, Logist Engn Coll, Shanghai, Peoples R China; [Guan, Binglei] Ningbo Univ Technol, Sch Elect & Informat Engn, Ningbo, Peoples R China; [Tang, Xianfeng] Zhejiang Univ, Informat Technol Ctr, Hangzhou, Peoples R China	Shanghai Maritime University; Ningbo University of Technology; Zhejiang University	Guan, BL (corresponding author), Shanghai Maritime Univ, Logist Engn Coll, Shanghai, Peoples R China.; Guan, BL (corresponding author), Ningbo Univ Technol, Sch Elect & Informat Engn, Ningbo, Peoples R China.	deliabing@nbut.edu.cn		guan, binglei/0000-0003-4264-2346	National Natural Science Foundation of China [61403218, 61503336, 61602141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is all supported by the National Natural Science Foundation of China (Nos.61403218 to BLG, 61503336 and 61602141 to XFT). There was no additional external funding received for this study.	Arasaratnam I., 2013, SENSOR FUSION SQUARE, V4, P11; Arasaratnam I, 2009, IEEE T AUTOMAT CONTR, V54, P1254, DOI 10.1109/TAC.2009.2019800; Bai SZ, 2015, ACSR ADV COMPUT, V13, P1623; Beaudeau JP, 2015, IEEE T SIGNAL PROCES, V63, P5033, DOI 10.1109/TSP.2015.2448530; Chandra KPB, 2013, IEEE SENS J, V13, P750, DOI 10.1109/JSEN.2012.2226441; Ge Q., 2014, IFAC P VOLUMES, V47, P5945, DOI 10.3182/20140824-6-za-1003.00558; Ge QB, 2014, SIGNAL PROCESS, V94, P434, DOI 10.1016/j.sigpro.2013.06.015; Han Chongzhao, 2010, MULTISOURCE INFORM F, VSecond; Julier S, 2000, IEEE T AUTOMAT CONTR, V45, P477, DOI 10.1109/9.847726; LI Y, 2017, SENSORS BASEL, V17, DOI DOI 10.3390/S17102222; Li ZT, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051093; Liggins M. E., 2008, HDB MULTISENSOR DATA, V2nd; Sarkka S, 2009, IEEE T AUTOMAT CONTR, V54, P596, DOI 10.1109/TAC.2008.2008348; Wang Jianjun, 2014, 2014 INT C MULT FUS, P1; Yin X, 2020, IEEE T AUTOMAT CONTR, V65, P376, DOI 10.1109/TAC.2019.2914257; Zhang Q., 2019, AIMS ELECT ELECT ENG, V3, P382, DOI [10.3934/ElectrEng.2019.4.382, DOI 10.3934/ELECTRENG.2019.4.382]; Zhang XC, 2014, CIRC SYST SIGNAL PR, V33, P1799, DOI 10.1007/s00034-013-9730-0; Zhou D. H., 2000, MODEM FAULT DIAGNOSE	18	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241517	10.1371/journal.pone.0241517	http://dx.doi.org/10.1371/journal.pone.0241517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151987	Green Published, gold			2022-12-26	WOS:000591376200013
J	Liu, RS; Wang, DM				Liu, Ruosha; Wang, Dongmei			Soil C, N, P and K stoichiometry affected by vegetation restoration patterns in the alpine region of the Loess Plateau, Northwest China	PLOS ONE			English	Article							CNP STOICHIOMETRY; ECOLOGICAL STOICHIOMETRY; GLOBAL ANALYSIS; ORGANIC-CARBON; LAND-USE; CUNNINGHAMIA-LANCEOLATA; NUTRIENT LIMITATION; NITROGEN; AFFORESTATION; PHOSPHORUS	The Grain-for-Green project is an important ecological restoration measure to address the degradation of alpine ecosystems in China, which has an important impact on the ecological stoichiometry of soil carbon (C), nitrogen (N), phosphorus (P) and potassium (K). However, soil stoichiometry changes under different vegetation restoration patterns and at different soil depths remain poorly understood in the alpine region of the Loess Plateau. To clarify these soil stoichiometry changes, a 0-60 cm soil profile was sampled from two typical vegetation restoration patterns: grassland (GL) and forestland (FL), including Picea crassifolia (PC), Larix principis-rupprechtii (LR), Populus cathayana (PR) and Betula platyphylla (BP). The control was a wheat field (WF). In all soil layers, the soil organic carbon (SOC), total nitrogen (TN), soil available nitrogen and potassium (AN and AK, respectively) and C:P, C:K, N:P and N:K ratios of FL were higher than those of GL and WF. The TN content and N:P and N:K ratios of GL were higher than those of WF in each soil layer. Additionally, the soil nutrients (except TK) of all vegetation types and stoichiometry of PR and GL (except the N:P ratio of GL) were greater at 0-20 cm than at 20-60 cm. Moreover, the SOC and TN showed the strongest correlation with the soil stoichiometry (except P:K ratio); thus, C and N had the greatest effect on the soil stoichiometry. Furthermore, soil fertility was limited by N. Our results indicated that different vegetation restoration patterns and soil depths had significant effects on the soil nutrients and stoichiometry in the alpine region of the Loess Plateau. The recovery of farmland to forestland promoted better improvements of soil nutrients, and PR had the most significant positive effect on soil surface nutrients.	[Liu, Ruosha; Wang, Dongmei] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University	Wang, DM (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China.	dmwang_bjfu@126.com			National Key Research and Development Plan Projects of China [2017YFC0504604]	National Key Research and Development Plan Projects of China	YES-This work has received financial support from the National Key Research and Development Plan Projects of China (Grant No. 2017YFC0504604).	[Anonymous], 2012, REGEN MED S3, V7, pS14; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Bai XJ, 2019, CATENA, V183, DOI 10.1016/j.catena.2019.104186; Barreto PAB, 2011, AGROFOREST SYST, V81, P213, DOI 10.1007/s10457-010-9300-4; Berger TW, 2002, FOREST ECOL MANAG, V159, P3, DOI 10.1016/S0378-1127(01)00705-8; Bing HJ, 2016, J SOIL SEDIMENT, V16, P405, DOI 10.1007/s11368-015-1200-9; Brady N, 2002, AGR ECOSYST ENVIRON, V95, P393, DOI DOI 10.1016/S0167-8809(02)00230-X; Brown MA, 2014, ENERGY RES SOC SCI, V4, P64, DOI 10.1016/j.erss.2014.08.008; Cannell MGR, 1999, FORESTRY, V72, P237, DOI 10.1093/forestry/72.3.237; Cao Y, 2018, J SOIL SEDIMENT, V18, P1478, DOI 10.1007/s11368-017-1884-0; Cao Y, 2017, ECOL ENG, V105, P125, DOI 10.1016/j.ecoleng.2017.04.024; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Conrad MK, 2011, ECOL ENG, V37, P1149, DOI 10.1016/j.ecoleng.2011.02.010; Deng J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151446; Eaton J, 2008, CLIMATIC CHANGE, V91, P317, DOI 10.1007/s10584-008-9412-2; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Filley TR, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000564; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Fu BJ, 2017, ANNU REV EARTH PL SC, V45, P223, DOI 10.1146/annurev-earth-063016-020552; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Hagedorn F, 2010, BIOGEOCHEMISTRY, V97, P1, DOI 10.1007/s10533-009-9386-9; Hogan EJ, 2010, NEW PHYTOL, V186, P911, DOI 10.1111/j.1469-8137.2010.03222.x; Hong JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109052; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jiao F, 2011, CATENA, V86, P110, DOI 10.1016/j.catena.2011.03.001; Li CZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159075; Liu HN, 2006, PROGRESS ON POST-GENOME TECHNOLOGIES, P159; Liu Kai, 2018, Journal of Beijing Forestry University, V40, P89; Liu X, 2017, CATENA, V150, P146, DOI 10.1016/j.catena.2016.11.020; Mooshammer M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4694; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Niu D, 2009, J ENVIRON SCI-CHINA, V21, P801, DOI 10.1016/S1001-0742(08)62344-X; Osman N, 2011, ECOL ENG, V37, P139, DOI 10.1016/j.ecoleng.2010.08.002; Pang DB, 2018, FORESTS, V9, DOI 10.3390/f9020056; Ren CJ, 2016, FOREST ECOL MANAG, V376, P59, DOI 10.1016/j.foreco.2016.06.004; Robbins CJ, 2019, FRESHWATER BIOL, V64, P2247, DOI 10.1111/fwb.13410; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Shi J, 2010, LANDSCAPE URBAN PLAN, V98, P75, DOI 10.1016/j.landurbplan.2010.07.011; Sterner RW, 2002, PRINCENTON U PRESS, V408, P578; Sun JN, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-018-8012-3; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tian LM, 2018, SCI TOTAL ENVIRON, V622, P192, DOI 10.1016/j.scitotenv.2017.11.331; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; [谢锦 Xie Jin], 2016, [生态学报, Acta Ecologica Sinica], V36, P4363; Xu HW, 2019, FORESTS, V10, DOI 10.3390/f10010027; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029; Yao FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116391; Yuan ZY, 2012, P ROY SOC B-BIOL SCI, V279, P3796, DOI 10.1098/rspb.2012.0955; Zeng QC, 2017, ECOL ENG, V109, P92, DOI 10.1016/j.ecoleng.2017.10.003; Zeng QC, 2016, CATENA, V147, P481, DOI 10.1016/j.catena.2016.07.047; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang JH, 2018, FUNCT ECOL, V32, P50, DOI 10.1111/1365-2435.12979; Zhang QF, 2019, FOREST ECOL MANAG, V448, P256, DOI 10.1016/j.foreco.2019.06.021; Zhang W, 2019, GEODERMA, V337, P280, DOI 10.1016/j.geoderma.2018.09.042; [张笑培 Zhang Xiaopei], 2011, [西北林学院学报, Journal of Northwest Forestry College], V26, P22; Zhang XM, 2017, ARID LAND RES MANAG, V31, P335, DOI 10.1080/15324982.2017.1300613; Zhang YN, 2013, ECOL ENG, V52, P308, DOI 10.1016/j.ecoleng.2012.10.002; Zhang Y, 2019, J SOIL SEDIMENT, V19, P1820, DOI 10.1007/s11368-018-2173-2; Zhao FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10195; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhao FZ, 2013, SOIL SCI, V178, P550, DOI 10.1097/SS.0000000000000018; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou Y, 2018, BIOGEOCHEMISTRY, V140, P341, DOI 10.1007/s10533-018-0495-1; 2012, J ENDOUROL, V26	66	2	4	32	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0241859	10.1371/journal.pone.0241859	http://dx.doi.org/10.1371/journal.pone.0241859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151996	Green Published, gold			2022-12-26	WOS:000591376200041
J	Jia, P; Caspari, G; Betts, A; Mohamadi, B; Balz, T; Cong, DX; Shen, H; Meng, Q				Jia, Peter; Caspari, Gino; Betts, Alison; Mohamadi, Bahaa; Balz, Timo; Cong, Dexin; Shen, Hui; Meng, Qi			Seasonal movements of Bronze Age transhumant pastoralists in western Xinjiang	PLOS ONE			English	Article							ALTAI MOUNTAINS; POPULATIONS; ADUNQIAOLU; REVEALS; RECORD	The paper explores seasonal movements of Bronze Age mobile pastoralists in the western Tianshan mountainous region of Xinjiang, China. Fieldwork by a team from the Institute of Archaeology of the Chinese Academy of Social Science (CASS) and the University of Sydney, Australia have identified cyclical land use practices associated with the Andronovo cultural complex. Their pattern of seasonal movements has been reconstructed through ethnographic studies and analysis of modern snow and grass cover. Using this detailed combination of data, the study defines requirements for seasonal pastures-winter, summer and spring/autumn-and shows a clear correlation between modern land use and seasonal patterns of movement in the Bronze Age.	[Jia, Peter; Caspari, Gino; Betts, Alison; Meng, Qi] Univ Sydney, Dept Archaeol, Sydney, NSW, Australia; [Jia, Peter] Henan Univ, Sch Culture & Hist, Kaifeng, Peoples R China; [Caspari, Gino] Univ Bern, Inst Archaeol Sci, Bern, Switzerland; [Mohamadi, Bahaa; Balz, Timo] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Peoples R China; [Cong, Dexin] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Shen, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China	University of Sydney; Henan University; University of Bern; Wuhan University; Chinese Academy of Social Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Caspari, G (corresponding author), Univ Sydney, Dept Archaeol, Sydney, NSW, Australia.; Caspari, G (corresponding author), Univ Bern, Inst Archaeol Sci, Bern, Switzerland.	gino.caspari@sydney.edu.au	Caspari, Gino/GNP-1139-2022; Mohamadi, Bahaa/AAF-9701-2019	Betts, Alison/0000-0002-3664-6001; Mohamadi, Bahaa/0000-0003-2685-8948	Swiss National Science Foundation [P400PG_190982]; Australian Research Council [DP150100121]; China Studies Centre; University of Sydney; Centre for Classical and Near Eastern Studies, University of Sydney	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Australian Research Council(Australian Research Council); China Studies Centre; University of Sydney(University of Sydney); Centre for Classical and Near Eastern Studies, University of Sydney	G.C. was supported by a Postdoctoral Mobility Fellowship of the Swiss National Science Foundation (P400PG_190982) http://www.snf.ch/ P.J. and A.B. are funded by the Australian Research Council (DP150100121) https://www.arc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fieldwork in the Bortala Valley is a collaboration between the Institute of Archaeology, Chinese Academy of Social Sciences (Beijing), University of Sydney and Monash University. We are thankful for the additional support from the China Studies Centre and the University of Sydney, and the Centre for Classical and Near Eastern Studies, University of Sydney.	Abuduresule Y, 2019, CULTURES ANCIENT XIN, P19; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; [Anonymous], **DATA OBJECT**, DOI DOI 10.5067/MODIS/MOD10A2.006; Arnold ER, 2006, BRIT ARCHAEOLOGICAL; Begzsuren S, 2004, J ARID ENVIRON, V59, P785, DOI 10.1016/j.jaridenv.2004.02.001; Benecke N., 2003, PREHISTORIC STEPPE A, P69; Betts A, 2019, ARCHAEOL RES ASIA, V17, P204, DOI 10.1016/j.ara.2018.04.001; Bourgeois J, 2017, ARCHAEOL RES ASIA, V10, P17, DOI 10.1016/j.ara.2017.02.003; Caspari G, 2017, ARCHAEOL RES ASIA, V10, P48, DOI 10.1016/j.ara.2017.04.001; Caspari G, 2020, ASIAN PERSPECT, V59, P421; Caspari G, 2020, ARCHAEOL RES ASIA, V23, DOI 10.1016/j.ara.2019.100157; Caspari G, 2018, ARCHAEOL RES ASIA, V15, P82, DOI 10.1016/j.ara.2017.11.001; Caspari G, 2017, J ARCHAEOL SCI-REP, V14, P12, DOI 10.1016/j.jasrep.2017.05.036; CHANG C, 1993, AM ANTHROPOL, V95, P687, DOI 10.1525/aa.1993.95.3.02a00080; Chen X., 2017, NOMADIC HERDERS ALTA, P142; Cong D, 2019, CULTURES ANCIENT XIN, P52; Conte TJ, 2015, J POLIT ECOL, V22, P79, DOI 10.2458/v22i1.21079; Copernicus, 2018, SENTINEL 2 2016 2018; Cribb R., 1991, NOMADS ARCHAEOLOGY; Currie A, 2016, STUD HIST PHILOS SCI, V55, P84, DOI 10.1016/j.shpsa.2015.08.010; Edelberg L, 1966, FOLK, V9, P374; Fitzhugh W., 2009, CURRENT ARCHAEOLOGIC, P183; Frachetti M. D., 2008, ARCHAEOLOGY MOBILITY, P366; Frachetti MD, 2008, PASTORALIST LANDSCAPES AND SOCIAL INTERACTION IN BRONZE AGE EURASIA, P1; Gao SZ, 2015, AM J PHYS ANTHROPOL, V157, P71, DOI 10.1002/ajpa.22690; Gould R.A., 1980, LIVING ARCHAEOLOGY; Gryaznov M., 1984, GROSSKURGAN ARZAN TU; Guan B., 2018, W REG STUD, V3, P137; HALL DK, 1995, REMOTE SENS ENVIRON, V54, P127, DOI 10.1016/0034-4257(95)00137-P; Hawkes C, 1954, AM ANTHROPOL, V56, P155, DOI 10.1525/aa.1954.56.2.02a00020; Jacobson-Tepfer Esther, 2015, HUNTER STAG MOTHER A; Jia PW, 2017, ANTIQUITY, V91, P621, DOI 10.15184/aqy.2017.67; Jia PW, 2018, ARCHAEOL RES ASIA, V15, P70, DOI 10.1016/j.ara.2017.10.005; Khazanov Anatoly M., 1984, NOMADS OUTSIDE WORLD; Kolh P, 2010, EUR J CARDIO-THORAC, V38, pS1, DOI 10.1016/j.ejcts.2010.08.019; Koryakova L, 2007, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9780511618451; Kovalev A., 2015, EARLIEST EUROPEANS H; Kuzmina E., 2007, ORIGINS INDO IRANIAN; Kuzmina EE, 2008, ENCOUNTERS ASIA, P1; Li CX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0237-5; Li CX, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-15; MODIS, 2018, MOD10A2 MYD10A2 SNOW; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Paruelo JM, 2000, APPL VEG SCI, V3, P189, DOI 10.2307/1478997; Rhew IC, 2011, ANN EPIDEMIOL, V21, P946, DOI 10.1016/j.annepidem.2011.09.001; Rhodes TE, 1996, PALAEOGEOGR PALAEOCL, V120, P105, DOI 10.1016/0031-0182(95)00037-2; Riggs GA, 2016, MODIS SNOW PRODUCTS; Rouse J.W., 1972, MONITORING VERNAL AD; Sadykov T, 2020, J FIELD ARCHAEOL, V45, P556, DOI 10.1080/00934690.2020.1821152; [邵孔兰 Shao Konglan], 2019, [第四纪研究, Quaternary Sciences], V39, P37; Stenning Derrick, 1957, J ROYAL ANTHR I GREA, V87, P57, DOI DOI 10.2307/2843971; Tudryn A, 2010, J PALEOLIMNOL, V44, P109, DOI 10.1007/s10933-009-9391-y; Wagner M, 2011, P NATL ACAD SCI USA, V108, P15733, DOI 10.1073/pnas.1105273108; Wilkin S, 2020, NAT ECOL EVOL, V4, P346, DOI 10.1038/s41559-020-1120-y; Wright J., 2012, ASIAN PERSPECT, V51, P139; Wylie A., 1985, ADV ARCHAEOL METH TH, V8, P63, DOI DOI 10.1016/B978-0-12-003108-5.50008-7; XIA. Xinjiang Institute of Archaeology and Relics, 2017, XINJIANG RELICS, V2, P19; Xu H, 2019, GEOLOGY, V47, P255, DOI 10.1130/G45686.1; Yu J, 2018, W REGIONS STUDIES, V1, P132	59	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240739	10.1371/journal.pone.0240739	http://dx.doi.org/10.1371/journal.pone.0240739			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147229	gold, Green Published			2022-12-26	WOS:000589609300080
J	Na, HY; Moon, JH; Choi, JY; Yu, HW; Jeong, WJ; Kim, YK; Choe, JY; Park, SY				Na, Hee Young; Moon, Jae Hoon; Choi, June Young; Yu, Hyeong Won; Jeong, Woo-Jin; Kim, Yeo Koon; Choe, Ji-Young; Park, So Yeon			Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses	PLOS ONE			English	Article							ASSOCIATION MANAGEMENT GUIDELINES; BETHESDA SYSTEM; PATTERN APPROACH; ADULT PATIENTS; NEOPLASM; NODULES; LESIONS; BIOPSY; CANCER; FEATURES	Cytologic diagnosis of thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma (FACHAC) is challenging due to cytomorphologic features that overlap with other follicular-patterned lesions. This study was designed to analyze diagnostic categories (DCs) of preoperative fine needle aspiration cytology (FNAC) of histologically proven thyroid FACHACs to evaluate under- or misdiagnoses in FNAC and elucidate potential causes for such phenomena. A total of 104 thyroid nodules with preoperative FNAC which were diagnosed as FACHAC in resection specimens were included in this study. Of these, 66 cases had also undergone thyroid core needle biopsy (CNB); FNAC and CNB DCs were compared in these cases. Various cytologic and histologic parameters were compared between the nodules with different FNAC DCs. After a review of FNAC slides, DCs were re-assigned in 20 (19.2%) out of the 104 cases. Of the 66 cases with CNB diagnoses which were mostly classified as lower DCs in FNAC, 31 (47.0%) were diagnosed as suspicious for a follicular neoplasm in CNB. Cases which were underdiagnosed in FNACs were associated with lower cellularity, predominant macrofollicular pattern, absence of microfollicles arranged in trabecular pattern, and absence of transgressing vessels in cytology smears. High cellularity, microfollicles arranged in trabecular pattern, nucleolar prominence, and large cell dysplasia were more frequently found in malignancy than in benign neoplasm. In conclusion, thyroid FACHACs seem to be under- and misdiagnosed in preoperative FNAC. Innate characteristics of the nodules were associated with under-diagnosis as well as the quality of the FNAC specimens. Certain cytomorphologic features can be helpful in differentiating malignancy among FACHACs.	[Na, Hee Young; Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Bundang Hosp, Seoul, South Korea; [Moon, Jae Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul, South Korea; [Choi, June Young; Yu, Hyeong Won] Seoul Natl Univ, Coll Med, Dept Surg, Bundang Hosp, Seoul, South Korea; [Jeong, Woo-Jin] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bundang Hosp, Seoul, South Korea; [Kim, Yeo Koon] Seoul Natl Univ, Coll Med, Dept Radiol, Bundang Hosp, Seoul, South Korea; [Choe, Ji-Young] Hallym Univ, Dept Pathol, Sacred Heart Hosp, Anyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Hallym University	Park, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Bundang Hosp, Seoul, South Korea.	sypmd@snu.ac.kr		Na, Hee Young/0000-0002-2464-0665; Park, So Yeon/0000-0002-0299-7268				Anderson TJT, 2014, RADIOLOGY, V272, P777, DOI 10.1148/radiol.14132134; Aschebrook-Kilfoy B, 2013, THYROID, V23, P1015, DOI 10.1089/thy.2012.0356; Baloch ZW, 2002, AM J CLIN PATHOL, V117, P143; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.10043; Bommanahalli BP, 2010, J CYTOL, V27, P127, DOI 10.4103/0970-9371.73295; Bongiovanni M, 2020, THYROID, V30, P72, DOI 10.1089/thy.2018.0607; Bongiovanni M, 2012, ACTA CYTOL, V56, P333, DOI 10.1159/000339959; CARAWAY NP, 1993, DIAGN CYTOPATHOL, V9, P345, DOI 10.1002/dc.2840090320; Choe JY, 2018, CLIN ENDOCRINOL, V88, P96, DOI 10.1111/cen.13397; Cibas ES, 2017, THYROID, V27, P1341, DOI 10.1089/thy.2017.0500; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Dal Maso L, 2011, ANN ONCOL, V22, P957, DOI 10.1093/annonc/mdq467; Deveci M Salih, 2006, Cytojournal, V3, P9, DOI 10.1186/1742-6413-3-9; Elliott DD, 2006, CANCER CYTOPATHOL, V108, P102, DOI 10.1002/cncr.21716; Faquin WC, 2009, HEAD NECK PATHOL, V3, P82, DOI 10.1007/s12105-009-0104-7; GaleraDavidson H, 1997, DIAGN CYTOPATHOL, V17, P422, DOI 10.1002/(SICI)1097-0339(199712)17:6<422::AID-DC9>3.0.CO;2-A; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Giorgadze T, 2004, DIAGN CYTOPATHOL, V31, P307, DOI 10.1002/dc.20132; Greaves TS, 2000, CANCER CYTOPATHOL, V90, P335, DOI 10.1002/1097-0142(20001225)90:6<335::AID-CNCR3>3.3.CO;2-C; Gupta S, 2019, CYTOPATHOLOGY; Hahn SY, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130007; Han K, 2018, J PATHOL TRANSL MED, V52, P110, DOI 10.4132/jptm.2018.01.17; Haugen BR, 2017, CANCER-AM CANCER SOC, V123, P372, DOI 10.1002/cncr.30360; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Jung CK, 2015, J PATHOL TRANSL MED, V49, P288, DOI 10.4132/jptm.2015.06.04; Kim M, 2018, J PATHOL TRANSL MED, V52, P171, DOI 10.4132/jptm.2018.04.03; Kim M, 2017, J PATHOL TRANSL MED, V51, P410, DOI 10.4132/jptm.2017.04.05; Kini S R, 1985, Diagn Cytopathol, V1, P123, DOI 10.1002/dc.2840010208; KINI SR, 2008, THYROID CYTOPATHOLOG; Lloyd RV, 2017, WHO CLASSIFICATION T, V4th; Lubitz CC, 2010, THYROID, V20, P25, DOI 10.1089/thy.2009.0208; Maruta J, 2011, DIAGN CYTOPATHOL, V39, P28, DOI 10.1002/dc.21321; Min HS, 2014, APMIS, V122, P993, DOI 10.1111/apm.12244; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Na DG, 2012, THYROID, V22, P468, DOI 10.1089/thy.2011.0185; Nasrollah N, 2013, ENDOCRINE, V43, P659, DOI 10.1007/s12020-012-9811-z; Nayar R, 2001, SEMIN DIAGN PATHOL, V18, P81, DOI 10.1053/sdia.2001.23741; Nikiforov YE, 2019, CANCER CYTOPATHOL, V127, P225, DOI 10.1002/cncy.22112; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Nikiforova MN, 2018, CANCER-AM CANCER SOC, V124, P1682, DOI 10.1002/cncr.31245; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; Puxeddu E, 2009, THYROID, V19, P1145, DOI 10.1089/thy.2009.1601; Renshaw AA, 2003, DIAGN CYTOPATHOL, V29, P183, DOI 10.1002/dc.10376; Renshaw AA, 2002, CANCER CYTOPATHOL, V96, P261, DOI 10.1002/cncr.10797; Savala R, 2018, DIAGN CYTOPATHOL, V46, P244, DOI 10.1002/dc.23880; Somma J, 2010, ACTA CYTOL, V54, P123, DOI 10.1159/000324996; Wang HH, 2006, DIAGN CYTOPATHOL, V34, P67, DOI 10.1002/dc.20400; Wu HHJ, 2012, DIAGN CYTOPATHOL, V40, P399, DOI 10.1002/dc.21754; Yang GCH, 2003, CANCER CYTOPATHOL, V99, P69, DOI 10.1002/cncr.10957; Yoo C, 2013, KOREAN J PATHOL, V47, P61, DOI 10.4132/KoreanJPathol.2013.47.1.61; Yoon RG, 2014, THYROID, V24, P1612, DOI 10.1089/thy.2014.0140; Zacks JF, 1998, DIAGN CYTOPATHOL, V18, P87, DOI 10.1002/(SICI)1097-0339(199802)18:2<87::AID-DC1>3.0.CO;2-Q	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241597	10.1371/journal.pone.0241597	http://dx.doi.org/10.1371/journal.pone.0241597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147258	Green Published, gold			2022-12-26	WOS:000589609300078
J	Nagaraj, NK; Magimairaj, BM				Nagaraj, Naveen K.; Magimairaj, Beula M.			Auditory processing in children: Role of working memory and lexical ability in auditory closure	PLOS ONE			English	Article							BOTTOM-UP CUES; LANGUAGE IMPAIRMENT; PERCEPTUAL RESTORATION; INTERRUPTED SPEECH; WORD RECOGNITION; YOUNG-CHILDREN; INTELLIGIBILITY; ATTENTION; HEARING; PREVALENCE	We examined the relationship between cognitive-linguistic mechanisms and auditory closure ability in children. Sixty-seven school-age children recognized isolated words and keywords in sentences that were interrupted at a rate of 2.5 Hz and 5 Hz. In essence, children were given only 50% of speech information and asked to repeat the complete word or sentence. Children's working memory capacity (WMC), attention, lexical knowledge, and retrieval from long-term memory (LTM) abilities were also measured to model their role in auditory closure ability. Overall, recognition of monosyllabic words and lexically easy multisyllabic words was significantly better at 2.5 Hz interruption rate than 5 Hz. Recognition of lexically hard multisyllabic words and keywords in sentences was better at 5 Hz relative to 2.5 Hz. Based on the best fit generalized "logistic" linear mixed effects models, there was a significant interaction between WMC and lexical difficulty of words. WMC was positively related only to recognition of lexically easy words. Lexical knowledge was found to be crucial for recognition of words and sentences, regardless of interruption rate. In addition, LTM retrieval ability was significantly associated with sentence recognition. These results suggest that lexical knowledge and the ability to retrieve information from LTM is crucial for children's speech recognition in adverse listening situations. Study findings make a compelling case for the assessment and intervention of lexical knowledge and retrieval abilities in children with listening difficulties.	[Nagaraj, Naveen K.; Magimairaj, Beula M.] Utah State Univ, Dept Commun Disorders & Deaf Educ, Cognit Hearing Sci Lab, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Magimairaj, BM (corresponding author), Utah State Univ, Dept Commun Disorders & Deaf Educ, Cognit Hearing Sci Lab, Logan, UT 84322 USA.	beula.m@usu.edu		, Beula/0000-0002-7834-4335	University Research Council Grant from the University of Central Arkansas	University Research Council Grant from the University of Central Arkansas	This work was supported by a University Research Council Grant from the University of Central Arkansas to the second author. The funders did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS1; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], BKB SINTM SPEECH IN; Archibald LMD, 2007, J MEM LANG, V57, P177, DOI 10.1016/j.jml.2006.11.004; Bashford JA, 1996, PERCEPT PSYCHOPHYS, V58, P342, DOI 10.3758/BF03206810; BASHFORD JA, 1987, PERCEPT PSYCHOPHYS, V42, P431, DOI 10.3758/BF03209750; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benard MR, 2014, J ACOUST SOC AM, V135, pEL88, DOI 10.1121/1.4862879; Benard MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058149; Besser J, 2013, TRENDS AMPLIF, V17, P75, DOI 10.1177/1084713813495459; Bishop DVM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035851; Bologna WJ, 2019, J ACOUST SOC AM, V145, pEL173, DOI 10.1121/1.5091664; Braden J. P., 2003, WJ 3 CLIN USE INTERP, P377, DOI [10.1016/B978-012628982-4/50013-1, DOI 10.1016/B978-012628982-4/50013-1]; Bradley JS, 2008, J ACOUST SOC AM, V123, P2078, DOI 10.1121/1.2839285; Briscoe J, 2009, INT J LANG COMM DIS, V44, P236, DOI 10.1080/13682820802028760; Camos V, 2011, DEV PSYCHOL, V47, P898, DOI 10.1037/a0023193; CHARLESLUCE J, 1990, J CHILD LANG, V17, P205, DOI 10.1017/S0305000900013180; Chermak GD, 2013, HDB CENTRAL AUDITORY, VII; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Clarke J, 2016, J ACOUST SOC AM, V139, P395, DOI 10.1121/1.4939962; Cooke M, 2006, J ACOUST SOC AM, V119, P1562, DOI 10.1121/1.2166600; Dawes P, 2009, INT J LANG COMM DIS, V44, P440, DOI 10.1080/13682820902929073; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Eisenberg LS, 2000, J ACOUST SOC AM, V107, P2704, DOI 10.1121/1.428656; Eisenberg LS, 2002, EAR HEARING, V23, P450, DOI 10.1097/00003446-200210000-00007; ELLIOTT LL, 1990, J LEARN DISABIL, V23, P248, DOI 10.1177/002221949002300408; ELMAN JL, 1988, J MEM LANG, V27, P143, DOI 10.1016/0749-596X(88)90071-X; Finneran DA, 2009, J SPEECH LANG HEAR R, V52, P915, DOI 10.1044/1092-4388(2009/07-0053); Fort M, 2012, INT J BEHAV DEV, V36, P457, DOI 10.1177/0165025412447752; Hammill D, CREVT3 COMPREHENSIVE; Hind SE, 2011, INT J AUDIOL, V50, P708, DOI 10.3109/14992027.2011.582049; Hox JJ, 2010, MULTILEVEL ANAL TECH; Im-Bolter N, 2006, CHILD DEV, V77, P1822, DOI 10.1111/j.1467-8624.2006.00976.x; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kirk KI, 2004, LEXICAL NEIGHBORHOOD; Krull V, 2010, EAR HEARING, V31, P102, DOI 10.1097/AUD.0b013e3181b7892f; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Lewis D, 2017, EAR HEARING, V38, pE180, DOI 10.1097/AUD.0000000000000395; Li N, 2007, J ACOUST SOC AM, V122, P1165, DOI 10.1121/1.2749454; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Magimairaj BM, 2020, AM J AUDIOL, V29, P710, DOI 10.1044/2020_AJA-20-00018; Magimairaj BM, 2018, J COMMUN DISORD, V76, P60, DOI 10.1016/j.jcomdis.2018.09.001; Magimairaj BM, 2018, J SPEECH LANG HEAR R, V61, P1294, DOI 10.1044/2018_JSLHR-H-17-0312; Magimairaj BM, 2012, ACTA PSYCHOL, V140, P196, DOI 10.1016/j.actpsy.2012.05.004; Mattys SL, 2014, PSYCHON B REV, V21, P748, DOI 10.3758/s13423-013-0544-7; Meronen A, 2013, J SPEECH LANG HEAR R, V56, P211, DOI 10.1044/1092-4388(2012/11-0270); MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; Montgomery JW, 2008, INT J LANG COMM DIS, V43, P499, DOI 10.1080/13682820701736638; Montgomery JW, 1998, J SPEECH LANG HEAR R, V41, P1432, DOI 10.1044/jslhr.4106.1432; Montgomery JW, 1999, J SPEECH LANG HEAR R, V42, P735, DOI 10.1044/jslhr.4203.735; Montgomery JW, 1995, APPL PSYCHOLINGUIST, V16, P355, DOI 10.1017/S0142716400065991; Moore DR, 2018, J AM ACAD AUDIOL, V29, P364, DOI 10.3766/jaaa.16130; Nagaraj NK, 2017, J ACOUST SOC AM, V142, P3756, DOI 10.1121/1.5018429; Nagaraj NK, 2015, J ACOUST SOC AM, V138, pEL145, DOI 10.1121/1.4927635; Newman RS, 2004, APPL PSYCHOLINGUIST, V25, P481, DOI 10.1017/s0142716404001237; NITTROUER S, 1990, J ACOUST SOC AM, V87, P2705, DOI 10.1121/1.399061; Picard M, 2001, AUDIOLOGY, V40, P221; Samuel AG, 2001, PSYCHOL SCI, V12, P348, DOI 10.1111/1467-9280.00364; Shafiro V, 2011, J ACOUST SOC AM, V130, P2076, DOI 10.1121/1.3631629; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Snowling MJ, 2018, PSYCHOL SCI, V29, P1270, DOI 10.1177/0956797618763090; Srinivasan S, 2005, SPEECH COMMUN, V45, P63, DOI 10.1016/j.specom.2004.09.002; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; VERSCHUURE J, 1983, PERCEPT PSYCHOPHYS, V33, P232, DOI 10.3758/BF03202859; Walker EA, 2019, J SPEECH LANG HEAR R, V62, P2519, DOI 10.1044/2019_JSLHR-H-18-0407; WALLEY AC, 1988, COGNITIVE DEV, V3, P137, DOI 10.1016/0885-2014(88)90016-0; Wang X, 2010, J ACOUST SOC AM, V128, P2100, DOI 10.1121/1.3483733; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; Winstone N, 2012, INFANT CHILD DEV, V21, P287, DOI 10.1002/icd.749; Ziegler JC, 2005, P NATL ACAD SCI USA, V102, P14110, DOI 10.1073/pnas.0504446102; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	72	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240534	10.1371/journal.pone.0240534	http://dx.doi.org/10.1371/journal.pone.0240534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OR6WM	33147602	Green Published, gold			2022-12-26	WOS:000589609300045
J	Kameda, M; Otsuka, M; Chiba, H; Kuronuma, K; Hasegawa, T; Takahashi, H				Kameda, Masami; Otsuka, Mitsuo; Chiba, Hirofumi; Kuronuma, Koji; Hasegawa, Takehiro; Takahashi, Hiroki			CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; SYSTEMIC-SCLEROSIS; CHEMOKINES; EXPRESSION; DIAGNOSIS; FIBROSIS; CXCR3	Introduction Interstitial lung disease (ILD) is a heterogeneous group of diseases characterized by varying degrees of lung inflammation and/or fibrosis. We investigated biomarkers to infer whether patients with collagen vascular diseases associated ILD (CVD-ILD) and interstitial pneumonia with autoimmune features (IPAF) benefit from immunosuppressive therapy. Materials and methods We retrospectively investigated patients with CVD-ILD, IPAF, and idiopathic pulmonary fibrosis (IPF) between June 2013 and May 2017 at our department. First, we assessed differences in serum and bronchoalveolar lavage fluid (BALF) levels of cytokines between groups. Second, we assessed the associations of patient's clinical variables with serum and BALF levels of those cytokines that were different between groups. Finally, we assessed the associations of diagnosis and response to immunosuppressive therapy with serum levels of those cytokines that were different between groups. Results We included 102 patients (51 with IPF, 35 with IPAF, and 16 with CVD-ILD). Serum and BALF levels of CXCL9, CXCL10, and CXCL11 were significantly elevated in patients with IPAF or CVD-ILD compared with those in patients with IPF. BALF levels of CXCL9 and CXCL10 were correlated with the percentages of lymphocytes and macrophages in BALF. Serum levels of CXCL9 and CXCL10 were correlated with BALF levels. Serum levels of CXCL9, CXCL10, and CXCL11 were correlated C-reactive protein, percent predicted forced vital capacity, alveolar-arterial oxygen difference, and the percentages of lymphocytes and macrophages in BALF. Serum levels of CXCL9, CXCL10, and CXCL11 showed moderate accuracy to distinguish patients with CVD-ILD from those with IPAF and IPF. Pre-treatment serum levels of CXCL9 and CXCL11 showed strong positive correlations with the annual forced vital capacity changes in patients with IPAF and CVD-ILD treated with immunosuppressive drugs. Conclusions Serum CXCL9, CXCL10, and CXCL11 are potential biomarkers for autoimmune inflammation and predictors of the immunosuppressive therapy responses in ILD with background autoimmunity.	[Kameda, Masami; Chiba, Hirofumi; Kuronuma, Koji; Takahashi, Hiroki] Sapporo Med Univ, Dept Resp Med & Allergol, Sch Med, Sapporo, Hokkaido, Japan; [Otsuka, Mitsuo] Sapporo Kosei Gen Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan; [Hasegawa, Takehiro] Sysmex Corp, Kobe, Hyogo, Japan; [Takahashi, Hiroki] Sapporo Med Univ, Dept Rheumatol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Kosei General Hospital; Sysmex Corporation; Sapporo Medical University	Kuronuma, K (corresponding author), Sapporo Med Univ, Dept Resp Med & Allergol, Sch Med, Sapporo, Hokkaido, Japan.	kuronumak@sapmed.ac.jp		Hasegawa, Takehiro/0000-0002-4635-4942	Sysmex Corp.	Sysmex Corp.	MK, MO, and HT received funding from Sysmex Corp. TH is an employee of Sysmex Corp. T.H. contributed to the measurement of cytokines. The funder provided support in the form of salaries for TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon Segovia D., 1987, MIXED CONNECTIVE TIS, V33; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Antonelli A, 2008, RHEUMATOLOGY, V47, P45, DOI 10.1093/rheumatology/kem313; Brito Y, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0701-5; Chen J, 2015, ARTHRITIS RHEUMATOL, V67, P28, DOI 10.1002/art.38904; Chiba H, 2018, RESPIR INVESTIG, V56, P384, DOI 10.1016/j.resinv.2018.06.001; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258; Graney BA, 2019, ANN AM THORAC SOC, V16, P525, DOI 10.1513/AnnalsATS.201808-565CME; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Honda T, 2010, AM J MED SCI, V339, P41, DOI 10.1097/MAJ.0b013e3181c14aaa; Kong KO, 2009, CLIN EXP IMMUNOL, V156, P134, DOI 10.1111/j.1365-2249.2009.03880.x; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Nielepkowicz-Gozdzinska A, 2015, ARCH IMMUNOL THER EX, V63, P465, DOI 10.1007/s00005-015-0356-8; Oda K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01685-5; Oldham JM, 2016, EUR RESPIR J, V47, P1767, DOI 10.1183/13993003.01565-2015; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pilkington C, 2014, ARTHRITIS RHEUMATOL, V66, pS70, DOI 10.1002/art.38463; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richards TJ, 2009, ARTHRITIS RHEUM-US, V60, P2183, DOI 10.1002/art.24631; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Wilfong EM, 2018, ARTHRITIS RHEUMATOL, V70, P1901, DOI 10.1002/art.40679	26	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241719	10.1371/journal.pone.0241719	http://dx.doi.org/10.1371/journal.pone.0241719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137121	gold, Green Published			2022-12-26	WOS:000588375500012
J	Kuiper, JWP; Baade, T; Kremer, M; Kranaster, R; Irmisch, L; Schuchmann, M; Zander, J; Marx, A; Hauck, CR				Kuiper, Johannes W. P.; Baade, Timo; Kremer, Marcel; Kranaster, Ramon; Irmisch, Linda; Schuchmann, Marcus; Zander, Johannes; Marx, Andreas; Hauck, Christof R.			Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification	PLOS ONE			English	Article							CORONAVIRUS; SPECIMENS	SARS-CoV-2 is spreading globally with unprecedented consequences for modern societies. The early detection of infected individuals is a pre-requisite to contain the virus. Currently, purification of RNA from patient samples followed by RT-PCR is the gold standard to assess the presence of this single-strand RNA virus. However, these procedures are time consuming, require continuous supply of specialized reagents, and are prohibitively expensive in resource-poor settings. Here, we report an improved nucleic-acid-based approach to detect SARS-CoV-2 with the ability to detect as little as five viral genome equivalents. The approach delivers results without the need to purify RNA, reduces handling steps, minimizes costs, and allows evaluation by non-specialized equipment. The use of unprocessed swap samples is enabled by employing a heat-stable RNA- and DNA-dependent DNA polymerase, which performs the double task of stringent reverse transcription of RNA at elevated temperatures as well as PCR amplification of a SARS-CoV-2 specific target gene. As results are obtained within 2 hours and can be read-out by a hand-held LED-screen, this novel protocol will be of particular importance for large-scale virus surveillance in economically constrained settings.	[Kuiper, Johannes W. P.; Baade, Timo; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany; [Baade, Timo; Marx, Andreas; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Kremer, Marcel; Zander, Johannes] Lab Dr Brunner, Constance, Germany; [Kranaster, Ramon; Marx, Andreas] MyPOLS Biotec GmbH, Constance, Germany; [Irmisch, Linda; Schuchmann, Marcus] Klinikum Konstanz, Constance, Germany; [Marx, Andreas] Univ Konstanz, Lehrstuhl Organ Chem Zellulare Chem, Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Hauck, CR (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany.; Hauck, CR (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany.	christof.hauck@uni-konstanz.de			Konstanz Research School Chemical Biology (KoRS-CB); German Research Foundation (DFG) [SPP 1784]	Konstanz Research School Chemical Biology (KoRS-CB); German Research Foundation (DFG)(German Research Foundation (DFG))	TB acknowledges support from the Konstanz Research School Chemical Biology (KoRS-CB) and AM support by the German Research Foundation (DFG) within SPP 1784. RK acknowledges support by MyPOLS Biotech GmbH, which provided support in the form of salary for RK. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Blatter N, 2013, ANGEW CHEM INT EDIT, V52, P11935, DOI 10.1002/anie.201306655; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Cloud JL, 2002, J CLIN MICROBIOL, V40, P3838, DOI 10.1128/JCM.40.10.3838-3840.2002; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; DENBOON JA, 1995, VIROLOGY, V213, P364, DOI 10.1006/viro.1995.0009; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Lo IL, 2020, INT J BIOL SCI, V16, P1698, DOI 10.7150/ijbs.45357; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Nedialkova DD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000772; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Sauter KBM, 2006, ANGEW CHEM INT EDIT, V45, P7633, DOI 10.1002/anie.200602772; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8	22	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241740	10.1371/journal.pone.0241740	http://dx.doi.org/10.1371/journal.pone.0241740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137168	Green Submitted, gold, Green Published			2022-12-26	WOS:000588375500030
J	Schermer, B; Fabretti, F; Damagnez, M; Di Cristanziano, V; Heger, E; Arjune, S; Tanner, NA; Imhof, T; Koch, M; Ladha, A; Joung, J; Gootenberg, JS; Abudayyeh, OO; Burst, V; Zhang, F; Klein, F; Benzing, T; Muller, RU				Schermer, Bernhard; Fabretti, Francesca; Damagnez, Maximilian; Di Cristanziano, Veronica; Heger, Eva; Arjune, Sita; Tanner, Nathan A.; Imhof, Thomas; Koch, Manuel; Ladha, Alim; Joung, Julia; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Burst, Volker; Zhang, Feng; Klein, Florian; Benzing, Thomas; Mueller, Roman-Ulrich			Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION	Background Rapid and extensive testing of large parts of the population and specific subgroups is crucial for proper management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and decision-making in times of a pandemic outbreak. However, point-of-care (POC) testing in places such as emergency units, outpatient clinics, airport security points or the entrance of any public building is a major challenge. The need for thermal cycling and nucleic acid isolation hampers the use of standard PCR-based methods for this purpose. Methods To avoid these obstacles, we tested PCR-independent methods for the detection of SARS-CoV-2 RNA from primary material (nasopharyngeal swabs) including reverse transcription loop-mediated isothermal amplification (RT-LAMP) and specific high-sensitivity enzymatic reporter unlocking (SHERLOCK). Results Whilst specificity of standard RT-LAMP assays appears to be satisfactory, sensitivity does not reach the current gold-standard quantitative real-time polymerase chain reaction (qPCR) assays yet. We describe a novel multiplexed RT-LAMP approach and validate its sensitivity on primary samples. This approach allows for fast and reliable identification of infected individuals. Primer optimization and multiplexing helps to increase sensitivity significantly. In addition, we directly compare and combine our novel RT-LAMP assays with SHERLOCK. Conclusion In summary, this approach reveals one-step multiplexed RT-LAMP assays as a prime-option for the development of easy and cheap POC test kits.	[Schermer, Bernhard; Fabretti, Francesca; Arjune, Sita; Burst, Volker; Benzing, Thomas; Mueller, Roman-Ulrich] Univ Cologne, Fac Med, Dept Internal Med 2, Cologne, Germany; [Schermer, Bernhard; Fabretti, Francesca; Arjune, Sita; Imhof, Thomas; Koch, Manuel; Burst, Volker; Klein, Florian; Benzing, Thomas; Mueller, Roman-Ulrich] Univ Hosp Cologne, Cologne, Germany; [Schermer, Bernhard; Fabretti, Francesca; Arjune, Sita; Imhof, Thomas; Koch, Manuel; Klein, Florian; Benzing, Thomas; Mueller, Roman-Ulrich] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Cologne, Germany; [Schermer, Bernhard; Fabretti, Francesca; Arjune, Sita; Benzing, Thomas; Mueller, Roman-Ulrich] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Damagnez, Maximilian; Di Cristanziano, Veronica; Heger, Eva; Klein, Florian] Univ Cologne, Fac Med, Inst Virol, Cologne, Germany; [Damagnez, Maximilian; Di Cristanziano, Veronica; Heger, Eva; Klein, Florian] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Tanner, Nathan A.] New England Biolabs Inc, Ipswich, MA USA; [Imhof, Thomas; Koch, Manuel] Univ Cologne, Ctr Biochem, Inst Dent Res & Oral Musculoskeletal Biol, Cologne, Germany; [Ladha, Alim; Joung, Julia; Zhang, Feng] Howard Hughes Med Inst, Cambridge, MA USA; [Ladha, Alim; Joung, Julia; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ladha, Alim; Joung, Julia; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ladha, Alim; Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] Massachusetts Consortium Pathogen Readiness, Boston, MA USA; [Burst, Volker] Fac Med, Emergency Dept, Cologne, Germany; [Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; New England Biolabs; University of Cologne; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Cologne; Massachusetts Institute of Technology (MIT); German Center for Infection Research; University of Cologne	Schermer, B (corresponding author), Univ Cologne, Fac Med, Dept Internal Med 2, Cologne, Germany.; Schermer, B (corresponding author), Univ Hosp Cologne, Cologne, Germany.; Schermer, B (corresponding author), Univ Cologne, Fac Med, Ctr Mol Med Cologne, Cologne, Germany.; Schermer, B (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	bernhard.schermer@uk-koeln.de	Gootenberg, Jonathan/AAY-8174-2021; Joung, Julia/HCH-8944-2022; Koch, Manuel/AAG-9914-2021; Müller, Roman-Ulrich/AAK-3493-2021; Arjune, Sita/HCI-1336-2022; Arjune, Sita/ABG-9488-2021; Schermer, Bernhard/E-9972-2014	Gootenberg, Jonathan/0000-0003-2757-2175; Koch, Manuel/0000-0002-2962-7814; Müller, Roman-Ulrich/0000-0001-6910-0745; Arjune, Sita/0000-0002-6121-4614; Damagnez, Maximilian/0000-0002-2745-7719; Schermer, Bernhard/0000-0002-5194-9000				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Anahtar M.N., 2020, CLIN ASSESSMENT VALI, DOI [10.1101/2020.05.12.20095638, DOI 10.1101/2020.05.12.20095638]; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Baek YH, 2020, EMERG MICROBES INFEC, V9, P998, DOI 10.1080/22221751.2020.1756698; Ben-Assa N., 2020, SARS COV 2 SPOT VIRU, DOI [10.1101/2020.04.22.20072389, DOI 10.1101/2020.04.22.20072389]; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Ganguli A, 2020, P NATL ACAD SCI USA, V117, P22727, DOI 10.1073/pnas.2014739117; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huang WE, 2020, MICROB BIOTECHNOL, V13, P950, DOI 10.1111/1751-7915.13586; Jefferson T., 2020, VIRAL CULTURES COVID, DOI [10.1101/2020.08.04.20167932, DOI 10.1101/2020.08.04.20167932]; Joung Julia, 2020, medRxiv, DOI 10.1101/2020.05.04.20091231; Kellner M. J., 2020, SCALABLE RAPID HIGHL, DOI 10.1101/2020.06.23.166397; Kellner MJ, 2019, NAT PROTOC, V14, P2986, DOI 10.1038/s41596-019-0210-2; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Lu RF, 2020, VIROL SIN, V35, P344, DOI 10.1007/s12250-020-00218-1; Lubke N, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104579; National Centre for Infectious Diseases and the Chapter of Infectious Disease Physicians Academy of Medicine Singapore., 2020, POS STAT; Park GS, 2020, J MOL DIAGN, V22, P729, DOI 10.1016/j.jmoldx.2020.03.006; Pastorino B, 2020, BIORXIV, DOI [DOI 10.1101/2020.04.11.036855, 10.1101/2020.04.11.036855]; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Yan C, 2020, CLIN MICROBIOL INFEC, V26, P773, DOI 10.1016/j.cmi.2020.04.001; Zhang R, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1101-x; Zhang Yinhua, 2020, Biotechniques, V69, P178, DOI 10.2144/btn-2020-0078	28	33	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0238612	10.1371/journal.pone.0238612	http://dx.doi.org/10.1371/journal.pone.0238612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137122	gold, Green Published, Green Submitted			2022-12-26	WOS:000588375500036
J	Zafarullah, M; Palczewski, G; Rivera, SM; Hessl, DR; Tassone, F				Zafarullah, Marwa; Palczewski, Grzegorz; Rivera, Susan M.; Hessl, David R.; Tassone, Flora			Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)	FASEB JOURNAL			English	Article						fatty acids; fragile X-associated tremor/ataxia syndrome; FMR1; molecular biomarkers; metabolomic	MITOCHONDRIAL DYSFUNCTION; KYNURENINE PATHWAY; EXPANDED ALLELES; ALZHEIMERS; CERAMIDE; NEURODEGENERATION; BRAIN; LACTOSYLCERAMIDE; IDENTIFICATION; APOPTOSIS	Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder associated with the FMR1 premutation. It is currently unknown when, and if, individual premutation carriers will develop FXTAS. Thus, with the aim of identifying biomarkers for early diagnosis, development, and progression of FXTAS, we performed global metabolomic profiling of premutation carriers (PM) who, as part of an ongoing longitudinal study, emerged into two distinct categories: those who developed symptoms of FXTAS (converters, CON) at subsequent visits and those who did not (non-converters, NCON) and we compared to age-matched healthy controls (HC). We assessed CGG repeat allele size by Southern Blot and PCR analysis. Metabolomic profile was obtained by ultra-performance liquid chromatography, accurate mass spectrometer, and an Orbitrap mass analyzer. In this study we found 47 metabolites were significantly dysregulated between HC and the premutation groups (PM). Importantly, we identified 24 metabolites that showed significant changes in expression in the CON as compared to the NCON both at V1 and V2, and 70 metabolites in CON as compared to NCON but only at V2. These findings suggest the potential role of the identified metabolites as biomarkers for early diagnosis and for FXTAS disease progression, respectively. Interestingly, the majority of the identified metabolites were lipids, followed by amino acids. To our knowledge, this the first report of longitudinal metabolic profiling and identification of unique biomarkers of FXTAS. The lipid metabolism and specifically the sub pathways involved in mitochondrial bioenergetics, as observed in other neurodegenerative disorders, are significantly altered in FXTAS.	[Zafarullah, Marwa; Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Palczewski, Grzegorz] Metabolon, Morrisville, NC USA; [Rivera, Susan M.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Rivera, Susan M.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Rivera, Susan M.; Hessl, David R.; Tassone, Flora] Univ Calif Davis, MIND Inst, Med Ctr, 2825 50th St,Room 2460, Sacramento, CA 95817 USA; [Hessl, David R.] Univ Calif Davis, Dept Psychiat & Behav Sci, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; Metabolon; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tassone, F (corresponding author), Univ Calif Davis, MIND Inst, Med Ctr, 2825 50th St,Room 2460, Sacramento, CA 95817 USA.	ftassone@ucdavis.edu		Zafarullah, Marwa/0000-0003-1856-0535	HHS | National Institutes of Health (NIH) [RO1NS110100-11, RO1MH078041]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: RO1NS110100-11 and RO1MH078041	Adachi Y, 2018, INT J GERONTOL, V12, P290, DOI 10.1016/j.ijge.2018.03.003; Bacalman S, 2006, J CLIN PSYCHIAT, V67, P87, DOI 10.4088/JCP.v67n0112; Basavarajappa BS, 2017, J NEUROCHEM, V142, P624, DOI 10.1111/jnc.14098; BLESA J, 2015, FRONT NEUROANAT, V0009; Cenini G, 2020, OXIDATIVE MED CELLUL, V2020, P1; Checa A, 2015, MULT SCLER J, V21, P1271, DOI 10.1177/1352458514561908; CHENG D, 2011, PLOS ONE, V6; Corso G, 2017, DEMENT GER COGN D EX, V7, P143, DOI 10.1159/000466688; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Eker A, 2016, NOROPSIKIYATRI ARS, V53, P92, DOI 10.5152/npa.2015.10011; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Figura M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191670; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Giulivi C, 2016, BIOCHEM J, V473, P3871, DOI 10.1042/BCJ20160585; Giulivi C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00071; Gong YG, 2015, J PHARMACEUT BIOMED, V115, P174, DOI 10.1016/j.jpba.2015.07.007; Graham SF, 2016, J PROTEOME RES, V15, P1592, DOI 10.1021/acs.jproteome.6b00049; Greco CM, 2008, ARCH NEUROL, V65; Gu QQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34662-7; Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00564; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hagerman RJ, 2016, NAT REV NEUROL, V12, P403, DOI 10.1038/nrneurol.2016.82; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; Heemels MT, 2016, NATURE, V539, P179, DOI 10.1038/539179a; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kong HE, 2019, HUM MOL GENET, V28, P980, DOI 10.1093/hmg/ddy410; Lahiri DK, 2010, EXP GERONTOL, V45, P291, DOI 10.1016/j.exger.2010.01.001; Lin CN, 2019, ANN CLIN TRANSL NEUR, V6, P537, DOI 10.1002/acn3.726; Maddison DC, 2015, SEMIN CELL DEV BIOL, V40, P134, DOI 10.1016/j.semcdb.2015.03.002; Majlath Z, 2015, TARGET BROADLY PATHO, P193; Makrecka-Kuka M, 2017, SCI REP, V7, P1; Mashhadi Akbar Boojar M., 2018, EGYPT J BASIC APPL S, V5, P237, DOI [10.1016/j.ejbas.2018.10.003, DOI 10.1016/J.EJBAS.2018.10.003]; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Napoli E, 2019, MOL NEUROBIOL, V56, P3702, DOI 10.1007/s12035-018-1330-3; Napoli E, 2016, FASEB J, V30, P3334, DOI 10.1096/fj.201600315R; Novgorodov SA, 2016, J LIPID RES, V57, P546, DOI 10.1194/jlr.M060061; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Peng B, 2015, PROTEIN CELL, V6, P628, DOI 10.1007/s13238-015-0185-x; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Schulz H, 2004, ENCY BIOL CHEM, V1, P90; Shamim A., 2018, CLIN NUTR EXP, V20, P1, DOI [10.1016/j.yclnex.2018.05.001, DOI 10.1016/J.YCLNEX.2018.05.001]; Shao YP, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0304-2; Shelton AL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00379; Skene DJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43030; Socha E, 2019, AMINO ACIDS, V51, P367, DOI 10.1007/s00726-019-02705-6; Song G, 2016, MOL MED, V22, P548, DOI 10.2119/molmed.2016.00122; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401; Van Assche R, 2015, METABOLOMICS, V11, P477, DOI 10.1007/s11306-014-0711-5; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wood PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191815; Xu Q, 2006, FUTURE LIPIDOL, V1, P441, DOI 10.2217/17460875.1.4.441; Yadav RS, 2014, MOL NEUROBIOL, V50, P168, DOI 10.1007/s12035-014-8661-5; Zafarullah M, 2019, METHODS MOL BIOL, V1942, P173, DOI 10.1007/978-1-4939-9080-1_15; Zhao HY, 2018, J CHROMATOGR B, V1081, P105, DOI 10.1016/j.jchromb.2018.01.025	65	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16676	16692		10.1096/fj.202001880R	http://dx.doi.org/10.1096/fj.202001880R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33131090	Green Published, hybrid			2022-12-26	WOS:000586602600001
J	Kawaji, T; Shizuta, S; Aizawa, T; Yamagami, S; Takeji, Y; Yoshikawa, Y; Kato, M; Yokomatsu, T; Miki, S; Ono, K; Kimura, T				Kawaji, Tetsuma; Shizuta, Satoshi; Aizawa, Takanori; Yamagami, Shintaro; Takeji, Yasuaki; Yoshikawa, Yusuke; Kato, Masashi; Yokomatsu, Takafumi; Miki, Shinji; Ono, Koh; Kimura, Takeshi			Renal function and outcomes in atrial fibrillation patients after catheter ablation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; THERAPEUTIC RANGE; WARFARIN; RISK; THROMBIN	Background Atrial fibrillation (AF) and renal failure coexist and interact. However, scarce data about association between renal function and clinical outcomes in patients undergoing catheter ablation for AF are available. We sought to evaluate long-term renal function and clinical outcomes after AF ablation. Methods We enrolled 791 non-dialysis patients undergoing catheter ablation for AF, and evaluated the incidence of worsening renal function (WRF) after the procedure, defined as >30% decline in estimate glomerular filtration rate. Results Mean follow-up duration was 5.1 +/- 2.5 years. Five hundreds and twenty-six patients (66.5%) were free from recurrent atrial arrhythmias without any antiarrhythmic drugs at the time of final follow-up. Cumulative incidence of WRF was 13.2% at 5-year after procedure, which was significantly higher in patients with recurrent AF compared to those without (21.6% versus 8.7%, P<0.001). In the multivariable analysis, recurrent AF was an independent risk factor for WRF (adjusted hazard ratio [HR] 1.89, 95% confidence interval 1.27-2.81, P = 0.002), along with congestive heart failure, diabetes, and eGFR <60 ml/min/1.73m(2) at baseline. Patients with WRF had significantly higher 5-year incidences of all-cause death, cardiovascular death, heart failure hospitalization, ischemic stroke, and major bleeding compared to those without WRF. After adjustment of baseline differences in the multivariate Cox model, the excessive risks of WRF for all-cause death and heart failure hospitalization remained significant (adjusted HR 3.46, P = 0.002; adjusted HR 3.67, P<0.001). Conclusions In AF patients undergoing catheter ablation for AF, arrhythmia recurrence was associated with WRF during follow-up, which was a strong predictor of adverse clinical outcomes.	[Kawaji, Tetsuma; Kato, Masashi; Yokomatsu, Takafumi; Miki, Shinji] Ryorei Mem Kyoto Hosp, Dept Cardiol, Kyoto, Japan; [Kawaji, Tetsuma; Shizuta, Satoshi; Aizawa, Takanori; Yamagami, Shintaro; Takeji, Yasuaki; Yoshikawa, Yusuke; Ono, Koh; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Shizuta, Satoshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Shizuta, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.; Shizuta, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan.	shizuta@kuhp.kyoto-u.ac.jp	Yoshikawa, Yusuke/AAV-6436-2021; Shizuta, Satoshi/AAL-5546-2021	Yoshikawa, Yusuke/0000-0001-8082-2036; 				Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Berger M, 2020, BIOSTATISTICS, V21, P449, DOI 10.1093/biostatistics/kxy069; Bohm M, 2015, J AM COLL CARDIOL, V65, P2481, DOI 10.1016/j.jacc.2015.03.577; Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44; Brodsky SV, 2010, NEPHRON CLIN PRACT, V115, pC142, DOI 10.1159/000312877; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Chao TF, 2012, HEART RHYTHM, V9, P1755, DOI 10.1016/j.hrthm.2012.06.039; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Fordyce CB, 2016, CIRCULATION, V134, P37, DOI 10.1161/CIRCULATIONAHA.116.021890; Kawaji T, 2017, INT J CARDIOL, V249, P204, DOI 10.1016/j.ijcard.2017.09.023; Kornej J, 2015, HEART, V101, P126, DOI 10.1136/heartjnl-2014-306013; Lawson CA, 2018, INT J CARDIOL, V267, P120, DOI 10.1016/j.ijcard.2018.04.090; Lee IO, 2012, J PHARMACOL EXP THER, V343, P253, DOI 10.1124/jpet.112.194837; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nogami A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1994; Park JW, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013204; Pokorney SD, 2015, AM HEART J, V170, P141, DOI 10.1016/j.ahj.2015.03.017; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; Sparkenbaugh EM, 2014, BLOOD, V123, P1747, DOI 10.1182/blood-2013-08-523936; Takahashi Y, 2011, CIRCULATION, V124, P2380, DOI 10.1161/CIRCULATIONAHA.111.047266; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Wattad M, 2015, AM J CARDIOL, V115, P932, DOI 10.1016/j.amjcard.2015.01.019; Xu DZ, 2015, AM J CARDIOL, V115, P328, DOI 10.1016/j.amjcard.2014.10.041; Yao XX, 2017, J AM COLL CARDIOL, V70, P2621, DOI 10.1016/j.jacc.2017.09.1087	27	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241449	10.1371/journal.pone.0241449	http://dx.doi.org/10.1371/journal.pone.0241449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166317	Green Published, gold			2022-12-26	WOS:000592382600038
J	Goldstein, A; Rivlin, I; Goldstein, A; Pertzov, Y; Hassin, RR				Goldstein, Ariel; Rivlin, Ido; Goldstein, Alon; Pertzov, Yoni; Hassin, Ran R.			Predictions from masked motion with and without obstacles	PLOS ONE			English	Article							REPRESENTATIONAL MOMENTUM; UNCONSCIOUS PERCEPTION; CONSCIOUS PERCEPTION; SUBLIMINAL STIMULI; FINAL POSITION; EYE-MOVEMENTS; AWARENESS; ATTENTION; ACTIVATION; INTEGRATION	Predicting the future is essential for organisms like Homo sapiens, who live in a dynamic and ever-changing world. Previous research has established that conscious stimuli can lead to non-conscious predictions. Here we examine whether masked stimuli can also induce such predictions. We use masked movement-with and without obstacles-to examine predictions from masked stimuli. In six experiments a moving object was masked using continuous flash suppression (CFS). A few hundred milliseconds after the object had disappeared, a conscious probe appeared in a location that was either consistent with the masked stimulus or not. In Experiments 1-3 the movement was linear, and reaction times (RTs) indicated predictions that were based on direction and speed of movement. In Experiment 4, the masked moving object collided with an obstacle and then disappeared. Predictions in this case should reflect deflection, and indeed reaction times revealed predictions on the deflection route. In Experiments 5 and 6 we introduce an innovative way of using eye-tracking during continuous flash suppression (CFS) and report physiological evidence-in the forms of eye-movements-for masked stimuli induced predictions. We thus conclude that humans can use dynamic masked stimuli to generate active predictions about the future, and use these predictions to guide behavior. We also discuss the possible interpretations of these findings in light of the current scientific discussion regarding the relation between masked presentation, subliminal perception and awareness measurement methods.	[Goldstein, Ariel] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Goldstein, Ariel; Rivlin, Ido] Hebrew Univ Jerusalem, Cognit Sci Dept, Jerusalem, Israel; [Goldstein, Alon; Pertzov, Yoni] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Hassin, Ran R.] Hebrew Univ Jerusalem, Dept Psychol, James Marshall Chair Psychol, Jerusalem, Israel; [Hassin, Ran R.] Hebrew Univ Jerusalem, Federmann Ctr Study Rational, Jerusalem, Israel	Princeton University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goldstein, A (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Goldstein, A (corresponding author), Hebrew Univ Jerusalem, Cognit Sci Dept, Jerusalem, Israel.	ariel.y.goldstein@gmail.com			Lev-Tzion scholarship	Lev-Tzion scholarship	Council for higher education that awarded the Lev-Tzion scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2004, J PERS SOC PSYCHOL, V87, P23, DOI 10.1037/0022-3514.87.1.23; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; [Anonymous], 2002, SCNJ, V9-11, P1; [Anonymous], 2014, PSYCHOL CONSCIOUS; [Anonymous], 2009, FORMULAIC LANGUAGE V, DOI DOI 10.1075/TSL.83.14KAP; Ansorge U, 2016, J EXP PSYCHOL LEARN, V42, P925, DOI 10.1037/xlm0000217; Armstrong AM, 2013, CONSCIOUS COGN, V22, P1022, DOI 10.1016/j.concog.2013.06.010; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baier D, 2020, VIS COGN, V28, P10, DOI 10.1080/13506285.2019.1704957; Balas B, 2007, VIS COGN, V15, P765, DOI 10.1080/13506280701295453; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bargh JA, 2012, TRENDS COGN SCI, V16, P593, DOI 10.1016/j.tics.2012.10.002; Bauer F, 2009, P NATL ACAD SCI US; Berger J, 2019, J CONSCIOUSNESS STUD, V26, P8; Bischoff-Grethe A, 2000, J NEUROSCI, V20, P1975; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridgeman B, 2011, COGN NEUROSCI-UK, V2, P115, DOI 10.1080/17588928.2011.585228; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Cheesman J, 1984, PERCEPT PSYCHOPHYS; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Teixeira NAD, 2013, J EXP PSYCHOL HUMAN, V39, P1690, DOI 10.1037/a0031777; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DeLucia PR, 2006, HUM FACTORS, V48, P666, DOI 10.1518/001872006779166352; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Dienes Z, 2015, BEHAV METHODS CONSCI; Dienes Z, 2010, CONSCIOUS COGN; Dosher BA, 1998, J EXP PSYCHOL GEN; Eitam B, 2009, Q J EXP PSYCHOL, V62, P228, DOI 10.1080/17470210802479113; Faivre N, 2014, COGNITION, V131, P404, DOI 10.1016/j.cognition.2014.02.008; Faivre N, 2014, PSYCHOL SCI, V25, P2006, DOI 10.1177/0956797614547916; Farooqui AA, 2015, PSYCHOL SCI, V26, P325, DOI 10.1177/0956797614564191; FINKE RA, 1988, J EXP PSYCHOL LEARN, V14, P112, DOI 10.1037/0278-7393.14.1.112; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Francken JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17725; FREYD JJ, 1990, J EXP PSYCHOL LEARN, V16, P1107, DOI 10.1037/0278-7393.16.6.1107; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Gayet S, 2014, ATTEN PERCEPT PSYCHO, V76, P489, DOI 10.3758/s13414-013-0580-4; Gilbert D., 2007, PSYCHOLOGY, V37, P336; Goldstein A, 2020, ACCURATELY MEASURING; Goldstein A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01230; GREENWALD AG, 1995, J EXP PSYCHOL GEN, V124, P22, DOI 10.1037/0096-3445.124.1.22; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Hassin RR, 2013, PERSPECT PSYCHOL SCI, V8, P195, DOI 10.1177/1745691612460684; Hassin RR, 2009, CONSCIOUS COGN, V18, P665, DOI 10.1016/j.concog.2009.04.003; Hassin RR, 2009, ANN NY ACAD SCI, V1167, P135, DOI 10.1111/j.1749-6632.2009.04734.x; Hassin RR, 2005, J EXP SOC PSYCHOL, V41, P129, DOI 10.1016/j.jesp.2004.06.008; Hassin RR, 2002, J EXP SOC PSYCHOL, V38, P515, DOI 10.1016/S0022-1031(02)00016-1; Hassin RR, 2014, DUAL PROCESS THEORIE, P299; Hassin RR, 2004, NEW UNCONSCIOUS; Hawkins J, 2004, NEURAL NETWORKS; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hesselmann G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00584; Hsieh PJ, 2012, J EXP PSYCHOL HUM PE; Hsieh PJ, 2011, PSYCHOL SCI, V22, P1220, DOI 10.1177/0956797611419302; Hubbard TL, 2015, PSYCHOL BULL, V141, P1081, DOI 10.1037/bul0000016; Hubbard TL, 2010, PERCEPTION, V39, P851, DOI 10.1068/p6538; Hubbard TL, 2018, SPATIAL BIASES IN PERCEPTION AND COGNITION, P1, DOI 10.1017/9781316651247; HUBBARD TL, 1988, PERCEPT PSYCHOPHYS, V44, P211, DOI 10.3758/BF03206290; HUBBARD TL, 1990, MEM COGNITION, V18, P299, DOI 10.3758/BF03213883; Hubbard TL, 1994, AM J PSYCHOL; Hubbard TL, 2010, SPACE TIME PERCEPTIO; Hubbard TL, 2002, FORCE APPEARANCE GAM, P209; Hubbard TL, 2015, PSYCHOL B VARIETIES; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Hume D, 1888, TREATISE HUMAN NATUR, V26; Kahneman D, 1973, AM J PSYCHOL, V88, DOI [10.2307/1421603, DOI 10.2307/1421603]; Kaunitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060787; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Kawakami N, 2015, CONSCIOUS COGN, V33, P53, DOI 10.1016/j.concog.2014.12.001; KELLY MH, 1987, COGNITIVE PSYCHOL, V19, P369, DOI 10.1016/0010-0285(87)90009-0; Kerzel D, 2001, J EXP PSYCHOL HUMAN, V27, P829, DOI 10.1037//0096-1523.27.4.829; Kerzel D, 2000, VISION RES, V40, P3703, DOI 10.1016/S0042-6989(00)00226-1; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kopetz C, 2011, J PERS SOC PSYCHOL, V100, P810, DOI 10.1037/a0022980; Kok P, 2018, J NEUROSCI, V38, P6888, DOI 10.1523/JNEUROSCI.0163-18.2018; Kouider S, 2009, EXP PSYCHOL; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lamy D, 2015, PSYCHOL SCI; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; LIBET B, 1991, BRAIN, V114, P1731, DOI 10.1093/brain/114.4.1731; Lin ZC, 2013, J VISION, V13, DOI 10.1167/13.11.12; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Llinas R, 2002, I OF THE VORTEX; Lupianez J, 2006, COGN NEUROPSYCHOL, V23, P1003, DOI 10.1080/02643290600588095; Maoz K, 2012, PSYCHOPHYSIOLOGY, V49, P1610, DOI 10.1111/j.1469-8986.2012.01470.x; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Matzke D, 2017, COLLABRA-PSYCHOL, V3, DOI 10.1525/collabra.78; McCormick PA, 1997, J EXP PSYCHOL HUM PE; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; MCKOON G, 1986, J EXP PSYCHOL LEARN, V12, P82, DOI 10.1037/0278-7393.12.1.82; Miller J, 2000, J EXP PSYCHOL HUMAN, V26, P1461, DOI 10.1037//0096-1523.26.4.1461; Moors P, 2019, TRENDS COGN SCI, V23, P267, DOI 10.1016/j.tics.2019.01.008; Moors P, 2017, TRENDS COGN SCI, V21, P719, DOI 10.1016/j.tics.2017.06.005; Moors P, 2016, PSYCHOL SCI, V27, P945, DOI 10.1177/0956797616642525; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Mulckhuyse M, 2007, VIS COGN; Nagai M, 2001, MEM COGNITION, V29, P91, DOI 10.3758/BF03195744; Nakamoto H, 2015, ATTEN PERCEPT PSYCHO, V77, P961, DOI 10.3758/s13414-014-0818-9; Nissen MJ, 1987, COGN PSYCHOL; Overgaard M, 2010, CONSCIOUS COGN, V19, P682, DOI 10.1016/j.concog.2009.12.018; Oxner M, 2018, VIS COGN; Payne BK, 2016, J EXP PSYCHOL GEN; Persuh M, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02320; Pertzov Y, 2009, J VISION, V9, DOI 10.1167/9.6.6; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Posner MI, 1978, MODES PERCEIVING PRO, P137; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; Rabagliati H, 2018, J EXP PSYCHOL GEN, V147, P190, DOI 10.1037/xge0000348; Rahnev D, 2012, ATTEN PERCEPT PSYCHO, V74, P521, DOI 10.3758/s13414-011-0246-z; Rao HY, 2004, NEUROIMAGE, V23, P98, DOI 10.1016/j.neuroimage.2004.05.016; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Reed CL, 1996, J EXP PSYCHOL HUMAN, V22, P839, DOI 10.1037/0096-1523.22.4.839; Reingold EM, 2004, PERCEPT PSYCHOPHYS, V66, P882, DOI 10.3758/BF03194981; Reingold EM, 1988, PERCEPT PSYCHOPHYS; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Rose M, 2005, J COGNITIVE NEUROSCI, V17, P918, DOI 10.1162/0898929054021193; Rothkirch M, 2015, COGNITION; Rouder JN, 2009, PSYCHONOMIC B REV; RSC NSA, 2011, RATION PHARMACOTHER, V7, P107; Saenz-Moncaleano C, 2018, J SPORT EXERCISE PSY, V40, P49, DOI 10.1123/jsep.2017-0253; Salomon R, 2016, J VISION, V16, DOI 10.1167/16.8.12; Sand A, 2016, CONSCIOUS COGN, V44, P29, DOI 10.1016/j.concog.2016.06.012; Sandberg K, 2013, CONSCIOUS COGN, V22, P806, DOI 10.1016/j.concog.2013.04.015; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Schmiedchen K, 2013, ATTEN PERCEPT PSYCHO, V75, P1507, DOI 10.3758/s13414-013-0495-0; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Shanks DR, 2017, PSYCHON B REV, DOI 10.3758/s13423-016-1170-y; Sheller M, 2007, SMALL AXE, V11, P16, DOI 10.1215/-11-3-16; Shiffrin RM, 2008, COGNITIVE SCI; Singer RN, 1996, J APPL SPORT PSYCHOL; Sklar A, 2020, REGRESSION MEAN DOES; Sklar AY, 2018, TRENDS COGN SCI, V22, P956, DOI 10.1016/j.tics.2018.07.003; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Snyder JJ, 2009, J EXP PSYCHOL HUMAN, V35, P1726, DOI 10.1037/a0016885; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Spalek TM, 2004, PERCEPT PSYCHOPHYS, V66, P219, DOI 10.3758/BF03194874; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Stevens C, 2007, MUSIC PERCEPT, V24, P511, DOI 10.1525/MP.2007.24.5.511; Taya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071371; Timmermans B, 2010, CONSCIOUS COGN, V19, P1081, DOI 10.1016/j.concog.2010.05.006; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Turk-browne NB, 2011, IMPLICIT PERCEPTUAL, V30, P11177; Uleman JS, 2008, ANNU REV PSYCHOL, V59, P329, DOI 10.1146/annurev.psych.59.103006.093707; ULEMAN JS, 1987, PERS SOC PSYCHOL B, V13, P337, DOI 10.1177/0146167287133004; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Vetter P, 2019, ELIFE, V8, DOI 10.7554/eLife.43467; Weingarten E, 2016, CURR OPIN PSYCHOL, V12, P53, DOI 10.1016/j.copsyc.2016.04.015; Yeshurun Y, 2011, PERCEPTION, V40, P905, DOI 10.1068/p7016; Zacks JM, 2011, J COGNITIVE NEUROSCI, V23, P4057, DOI 10.1162/jocn_a_00078	158	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0239839	10.1371/journal.pone.0239839	http://dx.doi.org/10.1371/journal.pone.0239839			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OU2PV	33156880	Green Published, gold			2022-12-26	WOS:000591376400053
J	Prevost, A; Delanoe, F; Cavallier, Z; Muller, S; Lopez, R; Lauwers, F				Prevost, Alice; Delanoe, Franck; Cavallier, Zoe; Muller, Samuel; Lopez, Raphael; Lauwers, Frederic			Surgical benefit of mandibular morphometric analysis: A new tool to standardize mandibular reconstruction	PLOS ONE			English	Article							FIBULA FREE-FLAP; SEXUAL-DIMORPHISM; OSTEOTOMY; OUTCOMES; SURGERY	Purpose The gold-standard for reconstruction of large mandibular defects is the use of free flaps of vascularized autologous bone with the fibula as the preferred donor site. The use of "custom cutting guides" for this indication is becoming increasingly prevalent. But cost of the procedure averages around 2,500 dollars per patient excluding treatment and entails selection criteria. We think it is possible to standardize mandibular reconstructions from an anatomical mean. The objective of this study was to perform a mandibular morphometric analysis in order to obtain a set of "mean" measurements, which can be used by all surgeons interested in mandibular reconstruction. Methods We performed a morphometric analysis consisting of three-dimensional mandibular reconstructions of 30 men and 30 women. Several reference points were set and defined to evaluate specific lengths and angles of interest. We conducted an intra and inter-sexual descriptive analysis of measurements obtained. Results We did not identify any major intra-sexual differences within each group. The gonial angle is more open in women and the measurements characterizing the basilar contour are more prominent in men. We did not identify any differences in alveolar region parameters. Conclusion The results of this study constitute a morphological tool for surgeons, from bone graft to free flap. These results also confirm us that the use of << custom cutting guides >> for mandibular reconstruction may be excessive. It is pertinent to examine the value of "custom made" mandibular reconstructions since the differences observed are of the order of millimeters.	[Prevost, Alice; Delanoe, Franck; Cavallier, Zoe; Lauwers, Frederic] Univ Hosp Ctr Toulouse, Plast & Maxillofacial Surg Dept, Toulouse, France; [Muller, Samuel] Clin Union, Plast & Maxillofacial Surg Dept, St Jean, France; [Lopez, Raphael] Paul Sabatier Toulouse III Univ, Anat Lab, Toulouse, France	CHU de Toulouse	Prevost, A (corresponding author), Univ Hosp Ctr Toulouse, Plast & Maxillofacial Surg Dept, Toulouse, France.	prevost.a@chu-toulouse.fr	Alice, Prevost/AIA-0018-2022					Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Anonymous, 2014, Journal of Cetacean Research and Management, V15, P1; Antony AK, 2011, PLAST RECONSTR SURG, V128, P1080, DOI 10.1097/PRS.0b013e31822b6723; Avraham T, 2014, PLAST RECONSTR SURG, V134, p628E, DOI 10.1097/PRS.0000000000000513; Bahr W, 1998, J CRANIO MAXILL SURG, V26, P148, DOI 10.1016/S1010-5182(98)80004-8; BJORK A, 1969, AMER J ORTHODONTICS, V55, P585, DOI 10.1016/0002-9416(69)90036-0; BJORK ARNE, 1955, ACTA ODONTOL SCAND, V13, P9, DOI 10.3109/00016355509028170; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Chang EI, 2016, PLAST RECONSTR SURG, V137, P619, DOI 10.1097/01.prs.0000475796.61855.a7; Fichter AM, 2019, J RECONSTR MICROSURG, V35, P108, DOI 10.1055/s-0038-1667364; Gunz P, 2013, HYSTRIX IT J MAMM; Hidalgo DA, 2002, PLAST RECONSTR SURG, V110, P438, DOI 10.1097/00006534-200208000-00010; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; KILIARIDIS S, 1991, J DENT RES, V70, P1262, DOI 10.1177/00220345910700090601; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lim SH, 2016, HEAD FACE MED, V12, DOI 10.1186/s13005-016-0104-2; Matros E, 2013, J RECONSTR MICROSURG, V29, P619, DOI 10.1055/s-0033-1356645; Morrison SD, 2016, PLAST RECONSTR SURG, V137, P1759, DOI 10.1097/PRS.0000000000002171; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Nobis C-P, 2020, CLIN ORAL INVEST, P1, DOI [10.1007/s00784-019-03089-3, DOI 10.1007/S00784-019-03089-3]; Numajiri T, 2016, PRS-GLOB OPEN, V4, DOI 10.1097/GOX.0000000000000682; Orabona GD, 2018, SURG ONCOL, V27, P200, DOI 10.1016/j.suronc.2018.03.007; Pirgousis P, 2013, J ORAL MAXIL SURG, V71, P2169, DOI 10.1016/j.joms.2013.05.005; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Strackee SD, 2001, PLAST RECONSTR SURG, V108, P1915, DOI 10.1097/00006534-200112000-00010; Vinay G, 2013, J CLIN DIAGN RES, V7, P2671, DOI 10.7860/JCDR/2013/7621.3728; Wang YY, 2016, INT J ORAL MAX SURG, V45, P1400, DOI 10.1016/j.ijom.2016.06.015; Zhang WB, 2016, J CRANIO MAXILL SURG, V44, P1819, DOI 10.1016/j.jcms.2016.08.014	29	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2020	15	11							e0240558	10.1371/journal.pone.0240558	http://dx.doi.org/10.1371/journal.pone.0240558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PV	33156821	Green Published, gold			2022-12-26	WOS:000591376400028
J	Tan, IL; Arifa, RDN; Rallapalli, H; Kana, V; Lao, ZM; Sanghrajka, RM; Bayin, NS; Tanne, A; Wojcinski, A; Korshunov, A; Bhardwaj, N; Merad, M; Turnbull, DH; Lafaille, JJ; Joyner, AL				Tan, I-Li; Arifa, Raquel Duque Nascimento; Rallapalli, Harikrishna; Kana, Veronika; Lao, Zhimin; Sanghrajka, Reeti Mayur; Sumru Bayin, N.; Tanne, Antoine; Wojcinski, Alexandre; Korshunov, Andrey; Bhardwaj, Nina; Merad, Miriam; Turnbull, Daniel H.; Lafaille, Juan J.; Joyner, Alexandra L.			CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model	ONCOGENE			English	Article							MICROGLIA; EXPRESSION; LANDSCAPE; SYSTEM; GROWTH; BETA	The immune microenvironment of tumors can play a critical role in promoting or inhibiting tumor progression depending on the context. We present evidence that tumor-associated macrophages/microglia (TAMs) can promote tumor progression in the sonic hedgehog subgroup of medulloblastoma (SHH-MB). By combining longitudinal manganese-enhanced magnetic resonance imaging (MEMRI) and immune profiling of a sporadic mouse model of SHH-MB, we found the density of TAMs is higher in the similar to 50% of tumors that progress to lethal disease. Furthermore, reducing regulatory T cells or eliminating B and T cells in Rag1 mutants does not alter SHH-MB tumor progression. As TAMs are a dominant immune component in tumors and are normally dependent on colony-stimulating factor 1 receptor (CSF1R), we treated mice with a CSF1R inhibitor, PLX5622. Significantly, PLX5622 reduces a subset of TAMs, prolongs mouse survival, and reduces the volume of most tumors within 4 weeks of treatment. Moreover, concomitant with a reduction in TAMs the percentage of infiltrating cytotoxic T cells is increased, indicating a change in the tumor environment. Our studies in an immunocompetent preclinical mouse model demonstrate TAMs can have a functional role in promoting SHH-MB progression. Thus, CSF1R inhibition could have therapeutic potential for a subset of SHH-MB patients.	[Tan, I-Li; Lao, Zhimin; Sanghrajka, Reeti Mayur; Sumru Bayin, N.; Wojcinski, Alexandre; Joyner, Alexandra L.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Tan, I-Li; Sanghrajka, Reeti Mayur; Joyner, Alexandra L.] Cornell Univ, Weill Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10021 USA; [Arifa, Raquel Duque Nascimento; Rallapalli, Harikrishna; Turnbull, Daniel H.; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Kana, Veronika; Tanne, Antoine; Bhardwaj, Nina; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Tanne, Antoine] Agenus Inc, Lexington, MA USA; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Korshunov, Andrey] Univ Hosp, Dept Neuropathol, Heidelberg, Germany	Memorial Sloan Kettering Cancer Center; Cornell University; New York University; Icahn School of Medicine at Mount Sinai; Agenus Inc; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Joyner, AL (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Joyner, AL (corresponding author), Cornell Univ, Weill Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10021 USA.	joynera@mskcc.org		Kana, Veronika/0000-0002-9362-3156; Turnbull, Daniel/0000-0003-0889-5155; Bhardwaj, Nina/0000-0003-1865-4187	MSKCC Brain Tumor Center fellowship; National Cancer Institute Cancer Center Support Grant [P30 CA008748-48];  [R01CA192176]	MSKCC Brain Tumor Center fellowship; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 	We thank the Joyner lab members for helpful discussions and comments on the manuscript. We are grateful to Andrey Rymar and Parmveer Singh at Plexxikon for providing the PLX5622 used in these studies. We appreciate the technical assistance from Daniel Stephen, and Yu-Jung Chen. We also thank the Center for comparative medicine and pathology and the Integrated Genomics Operation (IGO) core facilities of MSKCC for outstanding technical support. This work was supported by the following grants: R01CA192176 (ALJ), MSKCC Brain Tumor Center fellowship (AW), and a National Cancer Institute Cancer Center Support Grant [P30 CA008748-48].	Archer TC, 2018, CANCER CELL, V34, P396, DOI 10.1016/j.ccell.2018.08.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bockmayr M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1462430; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; CELADA A, 1989, EUR J IMMUNOL, V19, P1103, DOI 10.1002/eji.1830190621; Corcoran RB, 2008, CANCER RES, V68, P8788, DOI 10.1158/0008-5472.CAN-08-2135; Gate D, 2014, P NATL ACAD SCI USA, V111, pE3458, DOI 10.1073/pnas.1412489111; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Gyori D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120631; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Kana V, 2019, J EXP MED, V216, P2265, DOI 10.1084/jem.20182037; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lee C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4457-8; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Margol AS, 2015, CLIN CANCER RES, V21, P1457, DOI 10.1158/1078-0432.CCR-14-1144; Martin Allison M, 2018, Oncotarget, V9, P19177, DOI 10.18632/oncotarget.24951; Maximov V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10458-9; McNeill KA, 2016, NEUROL CLIN, V34, P981, DOI 10.1016/j.ncl.2016.06.014; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Murata D, 2018, J NEUROSURG, V128, P710, DOI 10.3171/2016.11.JNS16991; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Pham CD, 2016, CLIN CANCER RES, V22, P582, DOI 10.1158/1078-0432.CCR-15-0713; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Rallapalli H, 2020, MAGN RESON MED, V83, P214, DOI 10.1002/mrm.27904; Ramaswamy V, 2017, J CLIN ONCOL, V35, P2355, DOI 10.1200/JCO.2017.72.7842; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan IL, 2018, P NATL ACAD SCI USA, V115, P3392, DOI 10.1073/pnas.1717815115; Tanori M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-53; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vermeulen JF, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1398877; Wang JY, 2001, ONCOGENE, V20, P3857, DOI 10.1038/sj.onc.1204532; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367; Yao MJ, 2020, CELL, V180, P502, DOI 10.1016/j.cell.2019.12.024; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	52	18	18	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					396	407		10.1038/s41388-020-01536-0	http://dx.doi.org/10.1038/s41388-020-01536-0		NOV 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33159168	Green Accepted			2022-12-26	WOS:000587081500001
J	Zheng, JY; Ding, JX; Liao, MY; Qiu, ZH; Yuan, QC; Mai, WQ; Dai, Y; Zhang, HR; Wu, HL; Wang, YX; Liao, YH; Chen, X; Cheng, X				Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang			Immunotherapy against angiotensin II receptor ameliorated insulin resistance in a leptin receptor-dependent manner	FASEB JOURNAL			English	Article						angiotensin II type 1 receptor; immunotherapy; insulin resistance; leptin receptor; skeletal muscle	METABOLIC SYNDROME; SKELETAL-MUSCLE; AT(1) RECEPTORS; OBESITY; HYPERTENSION; CELLS; VALSARTAN; MICE	The angiotensin II type 1 receptor (AT1R) signaling pathway is reported to modulate glucose metabolism. Targeting AT1R, our group invented ATRQ beta-001 vaccine, a novel immunotherapeutic strategy to block the activation of AT1R. Here, we evaluated the therapeutic efficacy of ATRQ beta-001 vaccine in insulin resistance, and investigated the mechanism. Our results showed that ATRQ beta-001 vaccine and specific monoclonal antibody against epitope ATR-001 (McAb-ATR) decreased fasting serum insulin concentration and improved glucose and insulin tolerance in ob/ob mice. These beneficial effects were verified in high-fat diet-induced obese mice. McAb-ATR activated insulin signaling in skeletal muscle and insulin-resistant C2C12 myotubes without affecting liver or white adipose tissue of ob/ob mice. Mechanistically, the favorable impact of McAb-ATR on insulin resistance was abolished in db/db mice and in C2C12 myotubes with leptin receptor knockdown. AT1R knockdown also eradicated the effects of McAb-ATR in C2C12 myotubes. Furthermore, McAb-ATR treatment was able to activate the leptin receptor-mediated JAK2/STAT3 signaling in skeletal muscle of ob/ob mice and C2C12 myotubes. Additionally, angiotensin II downregulated the leptin signaling in skeletal muscle of ob/ob and diet-induced obese mice. We demonstrated that ATRQ beta-001 vaccine and McAb-ATR improved whole-body insulin resistance and regulated glucose metabolism in skeletal muscle in a leptin receptor-dependent manner. Our data suggest that immunotherapy targeting AT1R is a novel strategy for treating insulin resistance.	[Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China; [Zheng, Jiayu; Ding, Jiaxing; Liao, Mengyang; Qiu, Zhihua; Yuan, Qingchen; Mai, Wuqian; Dai, Yong; Zhang, Hongrong; Wu, Hailang; Wang, Yingxuan; Liao, Yuhua; Chen, Xiao; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Mol Biol Targeted Therapies,Minist Educ, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, X; Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China.	skycreeper@126.com; nathancx@hust.edu.cn			National Natural Science Foundation of China (NSFC) [81974106, 91439207, 81670461]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974106, 91439207 and 81670461	Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Chen X, 2013, HYPERTENSION, V61, P408, DOI 10.1161/HYPERTENSIONAHA.112.201020; Claflin KE, 2017, J CLIN INVEST, V127, P1414, DOI 10.1172/JCI88641; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x; German JP, 2010, DIABETES, V59, P1626, DOI 10.2337/db09-1918; Hall JE, 2019, NAT REV NEPHROL, V15, P367, DOI 10.1038/s41581-019-0145-4; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Haywood NJ, 2017, DIABETES, V66, P287, DOI 10.2337/db16-0997; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Hilzendeger AM, 2010, J MOL MED, V88, P899, DOI 10.1007/s00109-010-0649-7; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Knowles JW, 2016, J AM COLL CARDIOL, V67, P1656, DOI 10.1016/j.jacc.2015.12.065; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Koo YD, 2019, METABOLISM, V95, P27, DOI 10.1016/j.metabol.2019.03.004; Li H, 2016, HYPERTENSION, V68, P478, DOI 10.1161/HYPERTENSIONAHA.116.07008; Li L, 2013, DIABETES, V62, P762, DOI 10.2337/db12-0570; Luther JM, 2011, TRENDS PHARMACOL SCI, V32, P734, DOI 10.1016/j.tips.2011.07.006; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moon HS, 2013, ENDOCR REV, V34, P377, DOI 10.1210/er.2012-1053; Muller-Fielitz H, 2015, BRIT J PHARMACOL, V172, P857, DOI 10.1111/bph.12949; Muller-Fielitz H, 2014, BRIT J PHARMACOL, V171, P746, DOI 10.1111/bph.12510; Nozhenko Y, 2015, CELL PHYSIOL BIOCHEM, V35, P92, DOI 10.1159/000369678; Roman EAFR, 2010, MOL CELL ENDOCRINOL, V314, P62, DOI 10.1016/j.mce.2009.08.007; Rong X, 2010, DIABETOLOGIA, V53, P1727, DOI 10.1007/s00125-010-1744-6; Rong X, 2009, J PHARMACOL EXP THER, V331, P1096, DOI 10.1124/jpet.109.157099; Savarese G, 2013, J AM COLL CARDIOL, V61, P131, DOI 10.1016/j.jacc.2012.10.011; Shiota A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-139; Skurk T, 2005, OBES RES, V13, P969, DOI 10.1038/oby.2005.113; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; van der Zijl NJ, 2011, DIABETES CARE, V34, P845, DOI 10.2337/dc10-2224; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Younis F, 2010, METABOLISM, V59, P1200, DOI 10.1016/j.metabol.2009.11.013; Zhang HR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012341; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005	42	3	3	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000300R	http://dx.doi.org/10.1096/fj.202000300R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33155736				2022-12-26	WOS:000592446700001
J	Brugnolaro, V; Fovino, LN; Calgaro, S; Putoto, G; Muhelo, AR; Gregori, D; Azzolina, D; Bressan, S; Dalt, L				Brugnolaro, Valentina; Fovino, Laura Nai; Calgaro, Serena; Putoto, Giovanni; Muhelo, Arlindo Rosario; Gregori, Dario; Azzolina, Danila; Bressan, Silvia; Dalt, Liviana			Pediatric emergency care in a low-income country: Characteristics and outcomes of presentations to a tertiary-care emergency department in Mozambique	PLOS ONE			English	Article							ILL CHILDREN; MORTALITY; INJURY; EPIDEMIOLOGY; SURVIVAL; UNDER-5; DEATHS; MODELS; TRIAGE; TIME	Background An effective pediatric emergency care (PEC) system is key to reduce pediatric mortality in low-income countries. While data on pediatric emergencies from these countries can drive the development and adjustment of such a system, they are very scant, especially from Africa. We aimed to describe the characteristics and outcomes of presentations to a tertiary-care Pediatric Emergency Department (PED) in Mozambique. Methods We retrospectively reviewed PED presentations to the "Hospital Central da Beira" between April 2017 and March 2018. Multivariable logistic regression was used to identify predictors of hospitalization and death. Results We retrieved 24,844 presentations. The median age was 3 years (IQR 1-7 years), and 92% lived in the urban area. Complaints were injury-related in 33% of cases and medical in 67%. Data on presenting complaints (retrieved from hospital paper-based registries) were available for 14,204 (57.2%) records. Of these, respiratory diseases (29.3%), fever (26.7%), and gastrointestinal disorders (14.2%) were the most common. Overall, 4,997 (20.1%) encounters resulted in hospitalization. Mortality in the PED was 1.6% (62% <= 4 hours from arrival) and was the highest in neonates (16%; 89% <= 4 hours from arrival). A younger age, especially younger than 28 days, living in the extra-urban area and being referred to the PED by a health care provider were all significantly associated with both hospitalization and death in the PED at the multivariable analysis. Conclusions Injuries were a common presentation to a referral PED in Mozambique. Hospitalization rate and mortality in the PED were high, with neonates being the most vulnerable. Optimization of data registration will be key to obtain more accurate data to learn from and guide the development of PEC in Mozambique. Our data can help build an effective PEC system tailored to the local needs.	[Brugnolaro, Valentina; Fovino, Laura Nai; Calgaro, Serena; Bressan, Silvia; Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, Pediat Residency Program, Padua, Italy; [Putoto, Giovanni] Doctors Africa CUAMM, Padua, Italy; [Muhelo, Arlindo Rosario] Beira Cent Hosp, Pediat Dept, Beira, Mozambique; [Gregori, Dario; Azzolina, Danila] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Epidemiol & Publ Hlth, Padua, Italy; [Bressan, Silvia; Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, Pediat Emergency Unit, Padua, Italy	University of Padua; University of Padua; University of Padua	Brugnolaro, V (corresponding author), Univ Padua, Dept Womans & Childs Hlth, Pediat Residency Program, Padua, Italy.	valentina.brugnolaro@gmail.com	Gregori, Dario/F-9974-2012; Azzolina, Danila/M-5100-2019	Gregori, Dario/0000-0001-7906-0580; Azzolina, Danila/0000-0002-8185-5742				[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; [Anonymous], 2015, J AM ACAD DERMATOL, V72, pAB11; Atiq H, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S11; Baker T, 2009, PEDIATR ANESTH, V19, P23, DOI 10.1111/j.1460-9592.2008.02868.x; Berhea TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202542; Biskup T, 2017, J PEDIATR INTENSIVE, V6, P60, DOI 10.1055/s-0036-1584678; Duru C, 2013, NIG J PEDIAT, V40, P232; Fajolu IB, 2011, NIGER J PAEDIAT, V38, P131; Fernandes QF, 2014, LANCET GLOB HEALTH, V2, pE468, DOI 10.1016/S2214-109X(14)70276-1; Gupta PP, 2017, J NEPAL MED ASSOC, V56, P331, DOI 10.31729/jnma.3096; Habib MI, 2018, EMERG MED J, V35, P52, DOI 10.1136/emermed-2016-205720; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hategeka C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173233; Hsia R, 2010, ANN EMERG MED, V56, P142, DOI 10.1016/j.annemergmed.2010.01.013; Hsia RY, 2012, HEALTH POLICY PLANN, V27, P234, DOI 10.1093/heapol/czr023; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Inquerito de indicadores de imunizacAo malaria e HIV/SIDA em Mocambique (IMASIDA) 2015, 2015, INQ IND IM MAL HIV S, V1, P77; Kassambara A., 2018, MACHINE LEARNING ESS, V1st; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lopez E, 2017, EUR J EMERG MED, V24, P392, DOI 10.1097/MEJ.0000000000000365; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nowacki AK, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-26; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Osifo OD, 2012, INJURY, V43, P1861, DOI 10.1016/j.injury.2011.07.016; Outwater AH, 2013, INT J BURNS TRAUMA, V3, P18; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Petersburgo DDS, 2010, INT J EMERG MED, V3, P157, DOI 10.1007/s12245-010-0182-z; Punchak M, 2018, PEDIATR CRIT CARE ME, V19, pE603, DOI 10.1097/PCC.0000000000001705; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Sankar MJ, 2016, J PERINATOL, V36, pS1, DOI 10.1038/jp.2016.27; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; Taylor S, 2015, LANCET, V386, P1213, DOI 10.1016/S0140-6736(15)00300-1; UN IGME, 2018, LEV TRENDS CHILD MOR, P1; UNICEF, 2018, EV CHILD EV RIGHT; UNICEF WHO The World Bank Group UN Population Division, 2017, LEVELS TRENDS CHILD, P40; van Buuren S, 2011, J STAT SOFTW, V45, P1; Willis K., 2018, ROUTLEDGE HDB LATIN, P121, DOI [10.4324/9781315162935-11, DOI 10.4324/9781315162935-11]; World Health Organization, 2018, MALN KEY FACTS, P1; World Health Organization, WORLD REPORT CHILD I; World Health Organization, 2016, GUID UPD PAED EM TRI	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241209	10.1371/journal.pone.0241209	http://dx.doi.org/10.1371/journal.pone.0241209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147242	Green Published, gold			2022-12-26	WOS:000589609300039
J	Choe, SA; Kim, S; Im, C; Kim, SY; Kim, YS; Yoon, TK; Kim, DK				Choe, Seung-Ah; Kim, Seulgi; Im, Changmin; Kim, Sun-Young; Kim, You Shin; Yoon, Tae Ki; Kim, Dae Keun			Nighttime environmental noise and semen quality: A single fertility center cohort study	PLOS ONE			English	Article							MALE-INFERTILITY; OCCUPATIONAL-EXPOSURE; AIR-POLLUTION; INDUSTRIAL; IMPACTS; WORKERS; STRESS; HEALTH; RISK	With increased population and urban development, there are growing concerns regarding health impacts of environmental noise. We assessed the relationship between nighttime environmental noise and semen quality of men who visited for fertility evaluation. This is a retrospective cohort study of 1,972 male patient who had undertaken semen analysis between 2016-2018 at a single fertility center of Seoul, South Korea. We used environmental noise data of National Noise Information System (NNIS), Korea. Using semiannual nighttime noise measurement closest to the time of semen sampling, individual noise exposures at each patient's geocoded address were estimated with empirical Bayesian kriging method. We explored the association between environmental noise and semen quality indicators (volume, concentration, % of progressive motility, vitality, normal morphology, total motile sperm count, oligozoospermia, asthenozoospermia, and severe teratozoospermia) using multivariable regression and generalized additive models. Estimated exposure to nighttime environmental noise level in the study population was 58.3 +/- 2.2 L-eq. Prevalence of oligozoospermia, asthenozoospermia, and severe teratozoospermia were 3.3%, 14.0%, and 10.1%. Highest quartile nighttime noise was associated with 3.5 times higher odds of oligozoospermia (95% CI: 1.18, 10.17) compared to lowest quartile. In men whose noise exposure is in 3(rd) quartile, odds ratio (OR) of severe teratozoospermia was 0.57 (95% CI: 0.33, 0.98). The OR for 4(th) quartile noise were toward null. In generalized additive model, the risk of oligozoospermia increases when the nighttime noise is 55 Leq dB or higher. Our study adds an evidence of potential impact of environmental noise on semen quality in men living in Seoul. Additional studies with more refined noise measurement will confirm the finding.	[Choe, Seung-Ah; Kim, You Shin; Yoon, Tae Ki] CHA Univ, CHA Fertil Ctr Seoul Stn, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Choe, Seung-Ah] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Kim, Seulgi] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Im, Changmin] Korea Univ, Dept Geog, Seoul, South Korea; [Kim, Sun-Young] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Gyunggi Do, South Korea; [Kim, Dae Keun] CHA Univ, CHA Fertil Ctr Seoul Stn, Dept Urol, Sch Med, Seoul, South Korea	Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Korea University; National Cancer Center - Korea (NCC); Pochon Cha University	Kim, DK (corresponding author), CHA Univ, CHA Fertil Ctr Seoul Stn, Dept Urol, Sch Med, Seoul, South Korea.	kdg070723@gmail.com		Im, Changmin/0000-0002-5254-0995	National Research Foundation of Korea - Korean Government [NRF-2016R1D1A1B03933410, 2018R1D1A1B07048821]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	SAC received research fundings (NRF-2016R1D1A1B03933410 and 2018R1D1A1B07048821) from the National Research Foundation of Korea (https://www.nrf.re.kr) which is funded by Korean Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SA, 2000, BRAZ J MED BIOL RES, V33, P1105, DOI 10.1590/S0100-879X2000000900019; [Anonymous], 2019, AUSTRAL J VET SCI, V51, pV; Aumond P, 2018, J ACOUST SOC AM, V143, P2847, DOI 10.1121/1.5034799; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Berglund B., 1999, GUIDELINES COMMUNITY; Chamkori A, 2016, CRESCENT J MED BIOL, V3, P45; Choe S, 2018, FERTIL STERIL, V110, pE276, DOI 10.1016/j.fertnstert.2018.07.781; Choe SA, 2018, HUM REPROD, V33, P1071, DOI 10.1093/humrep/dey076; Choe SA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2401-9; Choe SA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1982-z; Eisenberg ML, 2015, FERTIL STERIL, V103, P1271, DOI 10.1016/j.fertnstert.2015.02.010; Eriksson C., 2018, BIOL MECH RELATED CA; Europe WROcf, 2005, AIR QUAL GUID GLOB U; Europe WROf, 2011, BURDEN DIS ENV NOISE; Farzadinia P, 2016, ANDROLOGIA, V48, P869, DOI 10.1111/and.12524; Gabrielsen JS, 2016, ANDROLOGY-US, V4, P648, DOI 10.1111/andr.12198; Government SM, 2018, DEPR IND SEOUL 2018; Hamerezaee M, 2018, SAF HEALTH WORK-KR, V9, P232, DOI 10.1016/j.shaw.2017.07.003; Hansen C, 2010, ENVIRON HEALTH PERSP, V118, P203, DOI 10.1289/ehp.0901022; Jalali Maryam, 2012, J Hum Reprod Sci, V5, P48, DOI 10.4103/0974-1208.97801; Jensen TK, 2006, OCCUP MED-OXFORD, V56, P544, DOI 10.1093/occmed/kql116; Jurewicz J, 2014, SYST BIOL REPROD MED, V60, P227, DOI 10.3109/19396368.2014.907837; Jurewicz J, 2009, INT J OCCUP MED ENV, V22, P305, DOI 10.2478/v10001-009-0036-1; Korea S, 2018, KOREAN STANDARD CLAS; Liao DP, 2006, ENVIRON HEALTH PERSP, V114, P1374, DOI 10.1289/ehp.9169; Locher B, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010149; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Lusk SL, 2016, NURS OUTLOOK, V64, P395, DOI 10.1016/j.outlook.2016.06.001; Min JY, 2018, ENVIRON INT, V121, P1172, DOI 10.1016/j.envint.2018.10.035; Min KB, 2017, ENVIRON POLLUT, V226, P118, DOI 10.1016/j.envpol.2017.03.069; Naim F, 2018, RELATIONSHIP INDOOR, P2905; Nargund VH, 2015, NAT REV UROL, V12, P372, DOI 10.1038/nrurol.2015.112; Neitzel R, 2009, ANN OCCUP HYG, V53, P41, DOI 10.1093/annhyg/men071; NNIS, 2019, ENV NOIS AUT; Nobles CJ, 2018, ENVIRON RES, V163, P228, DOI 10.1016/j.envres.2018.02.004; Oliva A, 2001, HUM REPROD, V16, P1768, DOI 10.1093/humrep/16.8.1768; Ozawa N, 2002, J CLIN INVEST, V109, P457, DOI [10.1172/JCI0213190, 10.1172/JCI200213190]; Punab M, 2017, HUM REPROD, V32, P18, DOI 10.1093/humrep/dew284; Qiao PW, 2018, ENVIRON SCI POLLUT R, V25, P15597, DOI 10.1007/s11356-018-1552-y; Rauch U, 2013, CELL BIOL RES THER, V2, P1, DOI [10.4172/2324-9293.1000101, DOI 10.4172/2324-9293.1000101]; Spira A, 1998, HUM REPROD, V13, P2041, DOI 10.1093/humrep/13.8.2041; System NNI, NOIS VIBR GUID INCH; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Trussell JC, 2019, FERTIL STERIL, V111, P1129, DOI 10.1016/j.fertnstert.2019.01.034; Wang TT, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015640; World Health Organization, 2010, WHO LAB MAN EX PROC, V5; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zhang JZ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7528901	48	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240689	10.1371/journal.pone.0240689	http://dx.doi.org/10.1371/journal.pone.0240689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147280	gold, Green Published			2022-12-26	WOS:000589609300029
J	Mino, T; Kimura, S; Kitaura, A; Iwamoto, T; Yuasa, H; Chiba, Y; Nakao, S				Mino, Takashi; Kimura, Seishi; Kitaura, Atsuhiro; Iwamoto, Tatsushige; Yuasa, Haruyuki; Chiba, Yasutaka; Nakao, Shinichi			Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?	PLOS ONE			English	Article							ASYMPTOMATIC PATIENTS; NONCARDIAC SURGERY; PERIOPERATIVE RISK; STRAIN	Background Severe aortic stenosis (AS) is increasing in the aging society and is a serious condition for anesthetic management. However, approximately one-third of patients with severe AS are asymptomatic. Echocardiography is the most reliable method to detect AS, but it takes time and is costly. Methods Data were obtained retrospectively from patients who underwent surgery and preoperative transthoracic echocardiography (TTE). LVH on ECG was determined by voltage criteria (Sv(1) + Rv(5) or (6) >= 3.5 mV) and/or the strain pattern in V-5 and V-6. Severe AS was defined as a mean transaortic pressure gradient >= 40 mmHg or aortic valve area <= 1.0 cm(2) by TTE. Results Data for 470 patients aged 28-94 years old were obtained. One hundred and twenty-six patients had severe AS. LVH on ECG by voltage criteria alone was detected in 182 patients, LVH by strain pattern alone was detected in 80 patients and LVH by both was detected in 55 patients. Multivariable logistic analysis revealed that LVH by the strain pattern or voltage criteria, diabetes mellitus, and age were significantly associated with severe AS. The AUC for the ROC curve for LVH by voltage criteria alone was 0.675 and the cut-off value was 3.84 mm V, and the AUC for the ROC for age was 0.675 and the cut-off value was 74 years old. Conclusion Our study suggests that patients who are 74 years old or over with LVH on ECG, especially those with DM, should undergo preoperative TTE in order to detect severe AS.	[Mino, Takashi; Kimura, Seishi; Kitaura, Atsuhiro; Iwamoto, Tatsushige; Yuasa, Haruyuki; Nakao, Shinichi] Kindai Univ, Dept Anesthesiol, Fac Med, Sayama, Osaka, Japan; [Chiba, Yasutaka] Kindai Univ Hosp, Clin Res Ctr, Sayama, Osaka, Japan		Nakao, S (corresponding author), Kindai Univ, Dept Anesthesiol, Fac Med, Sayama, Osaka, Japan.	nakaos@med.kindai.ac.jp		Mino, Takashi/0000-0001-5638-4793				Agarwal S, 2013, CIRC-CARDIOVASC QUAL, V6, P193, DOI 10.1161/CIRCOUTCOMES.111.000091; Brown J, 2005, BJA EDUC, V5, P1, DOI 10.1093/bjaceaccp/mki001; Calleja AM, 2010, AM J CARDIOL, V105, P1159, DOI 10.1016/j.amjcard.2009.12.019; Ehara S, 2014, HEART VESSELS, V29, P638, DOI 10.1007/s00380-013-0408-0; Faggiano Pompilio, 2006, Cardiovasc Ultrasound, V4, P27, DOI 10.1186/1476-7120-4-27; Greve AM, 2012, CIRCULATION, V125, P346, DOI 10.1161/CIRCULATIONAHA.111.049759; Greve AM, 2011, AM J CARDIOL, V108, P541, DOI 10.1016/j.amjcard.2011.03.084; Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kertai MD, 2004, AM J MED, V116, P8, DOI 10.1016/j.amjmed.2003.07.012; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; Pislaru SV, 2015, CURR PROB CARDIOLOGY, V40, P483, DOI 10.1016/j.cpcardiol.2015.06.003; Samarendra P, 2015, J AM COLL CARDIOL, V65, P295, DOI 10.1016/j.jacc.2014.10.051; Shah ASV, 2014, CIRCULATION, V130, P1607, DOI 10.1161/CIRCULATIONAHA.114.011085; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Tashiro T, 2014, EUR HEART J, V35, P2372, DOI 10.1093/eurheartj/ehu044; Torsher LC, 1998, AM J CARDIOL, V81, P448, DOI 10.1016/S0002-9149(97)00926-0; Tribouilloy C, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011724; Verdecchia P, 2000, Ital Heart J, V1, P207	21	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241591	10.1371/journal.pone.0241591	http://dx.doi.org/10.1371/journal.pone.0241591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147268	Green Published, gold			2022-12-26	WOS:000589609300067
J	Moridi, M; Pazandeh, F; Hajian, S; Potrata, B				Moridi, Maryam; Pazandeh, Farzaneh; Hajian, Sepideh; Potrata, Barbara			Development and psychometric properties of Midwives' Knowledge and Practice Scale on Respectful Maternity Care (MKP-RMC)	PLOS ONE			English	Article								Objective To develop a scale for evaluating knowledge and practice of midwives on Respectful Maternity Care (RMC). Methods An exploratory sequential mixed method study was conducted from January 2018 to July 2019 in two non-teaching public hospitals in Tehran, Iran. In the first part of the study, a literature review and qualitative study were carried out in order to develop the preliminary item pool. Then face, content and construct validity and reliability (internal consistency and test-retest) were assessed. Results The MKP-RMC scale has 23-item in knowledge and 23-item in practice section that loaded in three factors: Giving emotional support, providing safe care and preventing mistreatment. Exploratory factor analysis accounted for 43.47% and 58.62% of observed variance in knowledge and practice sections, respectively. The internal consistency and internal correlation coefficient of both section of MKP-RMC indicated acceptable reliability. Conclusion The MKP-RMC is a valid and reliable tool for measuring midwives' knowledge and practice of respectful care during labor and childbirth. The MKP-RMC could be used in maternity services to evaluate and improve quality of childbirth care through development of educational interventions for effective behavioral change. Confirmation of validity and reliability of translated version of the scale in other maternity care providers and different contexts is recommended.	[Moridi, Maryam] Shahid Beheshti Univ Med Sci, Sch Nursing & Midwifery, Dept Midwifery & Reprod Hlth, Student Res Comm, Tehran, Iran; [Pazandeh, Farzaneh] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Pazandeh, Farzaneh; Hajian, Sepideh] Shahid Beheshti Univ Med Sci, Midwifery & Reprod Hlth Res Ctr, Sch Nursing & Midwifery, Tehran, Iran	Shahid Beheshti University Medical Sciences; University of Nottingham; Shahid Beheshti University Medical Sciences	Pazandeh, F (corresponding author), Univ Nottingham, Sch Hlth Sci, Nottingham, England.; Pazandeh, F (corresponding author), Shahid Beheshti Univ Med Sci, Midwifery & Reprod Hlth Res Ctr, Sch Nursing & Midwifery, Tehran, Iran.	Farzaneh.Pazandeh@nottingham.ac.uk		Pazandeh, Farzaneh/0000-0002-1955-5220				Afulani PA, 2019, LANCET, V394, P1692, DOI 10.1016/S0140-6736(19)32258-5; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2009, J APPL SOC PSYCHOL, V39, P1356, DOI 10.1111/j.1559-1816.2009.00485.x; Argimon-Pallas JM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-37; Ayoubi S, 2020, MIDWIFERY, V80, DOI 10.1016/j.midw.2019.102573; Aziato L, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0920-1; Behruzi R, 2014, HEALTH CARE WOMEN IN, V35, P127, DOI 10.1080/07399332.2013.857321; Bohren MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub6; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bradfield Z, 2019, WOMEN BIRTH, V32, P157, DOI 10.1016/j.wombi.2018.07.013; Cristobal E., 2007, MANAG SERV QUAL INT, V17, P317, DOI [10.1108/09604520710744326, DOI 10.1108/09604520710744326]; Dickson N, 1997, Aust Coll Midwives Inc J, V10, P23, DOI 10.1016/S1031-170X(97)80043-8; Fagermoen MS, 1997, J ADV NURS, V25, P434, DOI 10.1046/j.1365-2648.1997.1997025434.x; Halldorsdottir S, 2011, SCAND J CARING SCI, V25, P806, DOI 10.1111/j.1471-6712.2011.00886.x; Harrington D, 2009, CONFIRMATORY FACTOR, DOI DOI 10.1093/ACPROF:OSO/9780195339888.001.0001; Kumbani LC, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-30; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Mohale H, 2017, WOMEN BIRTH, V30, P298, DOI 10.1016/j.wombi.2016.11.011; Moridi M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229941; Ndwiga C, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0364-8; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Schellings G, 2011, METACOGN LEARN, V6, P83, DOI 10.1007/s11409-011-9081-9; Shakibazadeh E, 2018, BJOG-INT J OBSTET GY, V125, P932, DOI 10.1111/1471-0528.15015; Sheferaw ED, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0848-5; Van Lerberghe W, 2014, LANCET, V384, P1215, DOI 10.1016/S0140-6736(14)60919-3; Vedam S, 2017, SSM-POPUL HLTH, V3, P201, DOI 10.1016/j.ssmph.2017.01.005; Vogel JP, 2016, BJOG-INT J OBSTET GY, V123, P671, DOI 10.1111/1471-0528.13750; Waltz C.F., 2017, MEASUREMENT NURSING, V5th ed.; Warren CE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1288-6; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; WHO Reproductive Health Library, 2018, WHO REC EFF COMM MAT; World Health Organization, 2019, WHO REC RESP MAT CAR	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241219	10.1371/journal.pone.0241219	http://dx.doi.org/10.1371/journal.pone.0241219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8YL	33141835	Green Published, gold			2022-12-26	WOS:000588376700036
J	Natalia, F; Meidia, H; Afriliana, N; Young, JC; Yunus, RE; Al-Jumaily, M; Al-Kafri, A; Sudirman, S				Natalia, Friska; Meidia, Hira; Afriliana, Nunik; Young, Julio Christian; Yunus, Reyhan Eddy; Al-Jumaily, Mohammed; Al-Kafri, Ala; Sudirman, Sud			Automated measurement of anteroposterior diameter and foraminal widths in MRI images for lumbar spinal stenosis diagnosis	PLOS ONE			English	Article							BOUNDARY DELINEATION; SEGMENTATION; SHAPE	Lumbar Spinal Stenosis causes low back pain through pressures exerted on the spinal nerves. This can be verified by measuring the anteroposterior diameter and foraminal widths of the patient's lumbar spine. Our goal is to develop a novel strategy for assessing the extent of Lumbar Spinal Stenosis by automatically calculating these distances from the patient's lumbar spine MRI. Our method starts with a semantic segmentation of T1- and T2-weighted composite axial MRI images using SegNet that partitions the image into six regions of interest. They consist of three main regions-of-interest, namely the Intervertebral Disc, Posterior Element, and Thecal Sac, and three auxiliary regions-of-interest that includes the Area between Anterior and Posterior elements. A novel contour evolution algorithm is then applied to improve the accuracy of the segmentation results along important region boundaries. Nine anatomical landmarks on the image are located by delineating the region boundaries found in the segmented image before the anteroposterior diameter and foraminal widths can be measured. The performance of the proposed algorithm was evaluated through a set of experiments on the Lumbar Spine MRI dataset containing MRI studies of 515 patients. These experiments compare the performance of our contour evolution algorithm with the Geodesic Active Contour and Chan-Vese methods over 22 different setups. We found that our method works best when our contour evolution algorithm is applied to improve the accuracy of both the label images used to train the SegNet model and the automatically segmented image. The average error of the calculated right and left foraminal distances relative to their expert-measured distances are 0.28 mm (p = 0.92) and 0.29 mm (p = 0.97), respectively. The average error of the calculated anteroposterior diameter relative to their expert-measured diameter is 0.90 mm (p = 0.92). The method also achieves 96.7% agreement with an expert opinion on determining the severity of the Intervertebral Disc herniations.	[Natalia, Friska; Meidia, Hira; Afriliana, Nunik; Young, Julio Christian] Univ Multimedia Nusantara, Fac Engn & Informat, Serpong, Indonesia; [Yunus, Reyhan Eddy] Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Al-Jumaily, Mohammed] Dr Sulaiman Al Habib Hosp, Dubai, U Arab Emirates; [Al-Kafri, Ala; Sudirman, Sud] Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England	Multimedia Nusantara University; University of Indonesia; Liverpool John Moores University	Sudirman, S (corresponding author), Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England.	s.sudirman@ljmu.ac.uk	Natalia, Friska/AAW-2110-2021; Afriliana, Nunik/AAS-2514-2021	Natalia, Friska/0000-0002-3857-2405; Afriliana, Nunik/0000-0001-6314-6128; Sudirman, Sud/0000-0003-4083-0810; Al Kafri, Ala/0000-0002-6825-9110	Indonesian Ministry of Research, Technology and Higher Education [031/AKM/MONOPNT/2019]	Indonesian Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	FN Grant Number: 031/AKM/MONOPNT/2019 Funder: Indonesian Ministry of Research, Technology and Higher Education https://international.ristekdikti.go.id/Statement: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kafri AS, 2019, IEEE ACCESS, V7, P43487, DOI 10.1109/ACCESS.2019.2908002; Alomari RS, 2014, COMPUTATIONAL METHOD, P87, DOI DOI 10.1007/978-3-319-07269-2_8; [Anonymous], 2003, EFSA J, V14, P1; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bendazzoli S, 2019, PROC SPIE, V10949, DOI 10.1117/12.2512409; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Csurka G, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.32; Dai L Y, 1996, Eur Spine J, V5, P308, DOI 10.1007/BF00304345; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Fang LL, 2019, MULTIDIM SYST SIGN P, V30, P689, DOI 10.1007/s11045-018-0578-0; Ghosh S, 2014, COMPUT MED IMAG GRAP, V38, P639, DOI 10.1016/j.compmedimag.2014.03.005; Gopinathan P, 2015, J ORTHOP, V12, P123, DOI 10.1016/j.jor.2015.06.001; Hartman J, 2019, CUREUS, V11, DOI 10.7759/cureus.4268; He XX, 2017, MED IMAGE ANAL, V36, P22, DOI 10.1016/j.media.2016.10.009; Huang JW, 2020, SPINE J, V20, P590, DOI 10.1016/j.spinee.2019.11.010; Jamaludin A, 2017, MED IMAGE ANAL, V41, P63, DOI 10.1016/j.media.2017.07.002; Koh J, 2010, PROC SPIE, V7624, DOI 10.1117/12.844386; Lu J-T., 2018, DEEPSPINE AUTOMATED; Maninis KK, 2018, IEEE T PATTERN ANAL, V40, P819, DOI 10.1109/TPAMI.2017.2700300; Natalia F., 2020, TELKOMNIKA TELECOMMU, V18, P1621; Natalia F, 2019, INT C INT MED HLTH I, P53; Natalia F, 2018, IEEE 20TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS / IEEE 16TH INTERNATIONAL CONFERENCE ON SMART CITY / IEEE 4TH INTERNATIONAL CONFERENCE ON DATA SCIENCE AND SYSTEMS (HPCC/SMARTCITY/DSS), P1449, DOI 10.1109/HPCC/SmartCity/DSS.2018.00239; National Office for Statistics, 2014, NHS IM RAD ACT; NHS, 2017, Q DIAGN WAIT TIM; Nithila EE, 2019, BIOMED SIGNAL PROCES, V47, P57, DOI 10.1016/j.bspc.2018.08.008; Peloquin JM, 2014, J BIOMECH, V47, P2452, DOI 10.1016/j.jbiomech.2014.04.014; Powers D. M, 2011, ARXIV201016061; Ruder S., 2016, ARXIV; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sudirman S, 2019, LUMBAR SPINE MRI DAT; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; The Royal College of Radiologists, 2018, CLIN RAD UK WORKF CE; Waddell G, 2004, BACK PAIN REVOLUTION; Yates JP, 2010, SPINE, V35, P734, DOI 10.1097/BRS.0b013e3181ba3a60; Young JC, 2019, PROCEEDINGS OF 2019 5TH INTERNATIONAL CONFERENCE ON NEW MEDIA STUDIES (CONMEDIA 2019), P232, DOI 10.1109/CONMEDIA46929.2019.8981855; Zhang Q, 2017, LECT NOTES COMPUT SC, V10265, P210, DOI 10.1007/978-3-319-59050-9_17; Zhou ZH, 2010, COMPUT INTELL-US, V26, P232, DOI 10.1111/j.1467-8640.2010.00358.x	38	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2020	15	11							e0241309	10.1371/journal.pone.0241309	http://dx.doi.org/10.1371/journal.pone.0241309			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YA	33137112	Green Published, Green Accepted, gold			2022-12-26	WOS:000588375500048
J	Hou, TY; Zhang, F; Mao, XF; Deng, GH				Hou, Tianya; Zhang, Fan; Mao, Xiaofei; Deng, Guanghui			Chronotype and psychological distress among Chinese rural population: A moderated mediation model of sleep quality and age	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; GENDER-DIFFERENCES; DEPRESSIVE SYMPTOMS; CIRCADIAN-RHYTHMS; SOCIAL SUPPORT; LIFE-STYLE; ASSOCIATION; ANXIETY; HEALTH; RESILIENCE	Purposes Evidence suggests evening-type individuals have a higher risk of reporting psychological distress than morning-type individuals. However, less is known regarding the underlying processes that might mediate or moderate this association among Chinese rural population. This study aimed to evaluate the prevalence of psychological distress, investigate whether sleep quality would mediate the association between chronotype and psychological distress and explore whether age would moderate the direct or indirect effect of the mediation model. Methods The cross-sectional study utilized a sample of 884 rural residents from rural regions in Anqing City, Anhui Province, China. Morningness-Eveningness Questionnaire (MEQ), Pittsburgh Sleep Quality Index (PSQI) and 21-item Depression Anxiety Stress Scale (DASS-21) were used to measure chronotype, sleep quality and psychological distress, respectively. MacKinnon's four-step procedure was employed to examine the mediation effect, while Hayes PROCESS macro (model 59) was used to perform the moderated mediation analysis. Results The prevalence of psychological distress among Chinese rural population was 33.4%. The association between chronotype and psychological distress was partially mediated by sleep quality (indirect effect = - 0.05, 95% CI = [-0.08, -0.03]). In addition, age moderated the first stage (sleep quality-psychological distress) of the indirect effect, with the indirect effect being attenuated for older rural residents. As suggested by Johnson-Neyman technique, the association between sleep quality and psychological distress was only significant when the age of the participant was lower than 48.59. Conclusions The incidence of psychological distress among Chinese rural residents cannot be neglected. Interventions for the enhancement of sleep quality to prevent and reduce psychological distress should be prioritized to rural residents who are prone to eveningness, especially those who are younger.	[Hou, Tianya; Zhang, Fan; Mao, Xiaofei; Deng, Guanghui] Second Mil Med Univ, Naval Med Univ, Dept Psychol, Shanghai, Peoples R China	Naval Medical University	Hou, TY; Deng, GH (corresponding author), Second Mil Med Univ, Naval Med Univ, Dept Psychol, Shanghai, Peoples R China.	liumi9512@126.com; bfbedu@126.com						[Anonymous], 2016, PHI DELTA KAPPAN, V98, pK7, DOI 10.1177/0031721716666049; [Anonymous], 2015, J AM BOARD FAM ME S1; [Anonymous], 2011, J NATL COMPR CANC NE, V9; [Anonymous], 2014, SPINE PHILA PA 1976, V39, pE1411; Au J, 2017, J AFFECT DISORDERS, V218, P93, DOI 10.1016/j.jad.2017.04.021; Bailey SL, 2001, CHRONOBIOL INT, V18, P249, DOI 10.1081/CBI-100103189; Bauducco S, 2020, CURR OPIN PSYCHOL, V34, P77, DOI 10.1016/j.copsyc.2019.09.002; Baune BT, 2007, J PSYCHOSOM RES, V62, P109, DOI 10.1016/j.jpsychores.2006.09.014; Berdynaj D, 2016, CHRONOBIOL INT, V33, P406, DOI 10.3109/07420528.2016.1146739; BERKANOVIC E, 1988, SOC SCI MED, V27, P1215, DOI 10.1016/0277-9536(88)90351-6; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bourbonnais R, 1996, SCAND J WORK ENV HEA, V22, P139, DOI 10.5271/sjweh.122; Buysse D J, 1989, Psychiatry Res, V28, P193; Chen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-597; Chung RCY, 1998, J NERV MENT DIS, V186, P112, DOI 10.1097/00005053-199802000-00007; Cox RC, 2019, J AFFECT DISORDERS, V257, P321, DOI 10.1016/j.jad.2019.07.012; de Souza CM, 2015, CHRONOBIOL INT, V32, P341, DOI 10.3109/07420528.2014.979941; Doherty AM, 2014, SOC PSYCH PSYCH EPID, V49, P673, DOI 10.1007/s00127-014-0847-7; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Dunleavy G, 2020, BUILD ENVIRON, V175, DOI 10.1016/j.buildenv.2020.106799; EHLERS CL, 1988, ARCH GEN PSYCHIAT, V45, P948; Feng DJ, 2015, AUST J RURAL HEALTH, V23, P215, DOI 10.1111/ajr.12187; Feng DJ, 2013, AUST J RURAL HEALTH, V21, P13, DOI 10.1111/ajr.12009; Firdaus, 2017, IOP C SER EARTH ENV, V54, DOI 10.1088/1755-1315/54/1/012102; Fleig D, 2009, EAT BEHAV, V10, P115, DOI 10.1016/j.eatbeh.2009.03.002; Greaves-Lord K, 2007, ACTA PSYCHIAT SCAND, V116, P137, DOI 10.1111/j.1600-0447.2007.01001.x; Higher Education, 2015, CHRONICLE HIGHER ED, V52, pA1; Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x; Horne CM, 2018, NEUROIMAGE, V171, P355, DOI 10.1016/j.neuroimage.2018.01.025; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Hu R, 2018, J GUIZHOU NORMAL U S, V2, P41; Jamieson D, 2019, ASSOCIATIONS SLEEP Q; Jankowski KS, 2017, CHRONOBIOL INT, V34, P1105, DOI 10.1080/07420528.2017.1343341; Jeong HJ, 2015, PSYCHIAT RES, V229, P867, DOI 10.1016/j.psychres.2015.07.067; JoAo K, 2018, SLEEP MED, P46, DOI [10.1016/j.sleep.2017.12.020, DOI 10.1016/J.SLEEP.2017.12.020]; Kawasaki T, 1996, J HUM HYPERTENS, V10, P281; Kilkkinen A, 2007, AUST J RURAL HEALTH, V15, P114, DOI 10.1111/j.1440-1584.2007.00863.x; Kim SJ, 2010, J PSYCHOSOM RES, V68, P159, DOI 10.1016/j.jpsychores.2009.06.010; Kohn TP, 2020, TRANSL ANDROL UROL, V9, pS178, DOI 10.21037/tau.2019.11.07; Lederman O, 2019, J PSYCHIATR RES, V109, P96, DOI 10.1016/j.jpsychires.2018.11.004; Lee CY, 2015, J NURS RES, V23, P225, DOI 10.1097/jnr.0000000000000095; Lee Y, 2015, AGE, V37, DOI 10.1007/s11357-015-9759-z; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH, 1995, MANUAL DEPRESSION AN; MacKinnon D., 2008, INTRO STAT MEDIATION, V245; Masood A, 2016, BURNS, V42, P300, DOI 10.1016/j.burns.2015.10.006; Masse R, 1998, SOC INDIC RES, V45, P475, DOI 10.1023/A:1006992032387; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; National Bureau of Statistics of China, 2019, REP MON INV MIGR WOR; Rique GLN, 2014, SLEEP SCI, V7, P96, DOI 10.1016/j.slsci.2014.09.004; Nikhil J, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P229, DOI 10.1016/j.wjorl.2017.10.001; Nordstoga AL, 2019, SPINE, V44, pE423, DOI 10.1097/BRS.0000000000002860; Park CI, 2015, J AFFECT DISORDERS, V175, P256, DOI 10.1016/j.jad.2015.01.004; Matud MP, 2015, INT J SOC PSYCHIATR, V61, P560, DOI 10.1177/0020764014564801; Polo-Kantola P, 2011, MATURITAS, V68, P224, DOI 10.1016/j.maturitas.2010.12.009; Randler C, 2016, J BEHAV ADDICT, V5, P465, DOI 10.1556/2006.5.2016.056; Rash JA, 2019, SLEEP MED CLIN, V14, P209, DOI 10.1016/j.jsmc.2019.01.004; Selvi Y, 2018, J AFFECTIVE DISORDER, P235, DOI [10.1016/j.jad.2018.08.003, DOI 10.1016/J.JAD.2018.08.003]; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smidt AM, 2017, SLEEP, V40, pA413, DOI 10.1093/sleepj/zsx050.1108; Sonnega J, 2018, INNOV AGING, V2, P962; Soulsby L. K., 2015, PSYCHOLOGY, V6, P1349, DOI DOI 10.4236/PSYCH.2015.611132; Stickley A, 2015, J AFFECT DISORDERS, V178, P142, DOI 10.1016/j.jad.2015.02.020; Sun JB, 2019, CHRONOBIOL INT, V36, P1115, DOI 10.1080/07420528.2019.1619181; Tran TD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-24; Vlahov D, 2005, J URBAN HEALTH, V82, P1, DOI 10.1093/jurban/jti001; Vreeburg SA, 2013, PSYCHONEUROENDOCRINO, V38, P1494, DOI 10.1016/j.psyneuen.2012.12.017; Wang CF, 2014, INT J NURS STUD, V51, P51, DOI 10.1016/j.ijnurstu.2013.03.008; Wang HW, 2020, HEALTH PLACE, V64, DOI 10.1016/j.healthplace.2020.102354; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wong DFK, 2008, INT J SOC PSYCHIATR, V54, P131, DOI 10.1177/0020764007083877; Wu YY, 2019, LANCET, V394, P53; Yang JX, 2020, PSYCHIAT RES, V284, DOI 10.1016/j.psychres.2019.112686; Yun JA, 2015, CLIN PSYCHOPHARM NEU, V13, P201, DOI 10.9758/cpn.2015.13.2.201; Zanon C, 2021, ASSESSMENT, V28, P1531, DOI 10.1177/1073191119887449; Zeng CB, 2020, PSYCHOL HEALTH MED, V25, P446, DOI 10.1080/13548506.2019.1687921; [张斌 ZHANG Bin], 2006, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V15, P856; Zhang M, 2018, PSYCHIAT RES, V267, P409, DOI 10.1016/j.psychres.2018.06.038; Zheng B, 2016, Beijing Da Xue Xue Bao Yi Xue Ban, V48, P424	81	4	4	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241301	10.1371/journal.pone.0241301	http://dx.doi.org/10.1371/journal.pone.0241301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VN	33125424	Green Published, gold			2022-12-26	WOS:000588368900042
J	Bade, AB; Mega, TA				Bade, Asnake Balche; Mega, Teshale Ayele			Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study	PLOS ONE			English	Article							TREATMENT OUTCOMES	Background Although substantial progress has been made in combating the crisis of multi-drug resistance tuberculosis (MDR-TB), it remained the major public health threat globally. Objective To assess patients' survival and its predictors among patients receiving multi-drug resistance tuberculosis treatment at MDR-TB treatment centers of southern and southwestern Ethiopia. Methods A multicenter retrospective observational study was conducted from April 14 to May 14, 2019, among patients receiving MDR-TB treatment at three MDR-TB treatment centers, Butajira, Arbaminch and Shenengibe Hospitals, located in south and southwestern Ethiopia. A total of 200 records were reviewed using a check list adopted from the national MDR-TB treatment charts and other relevant documents. Data were entered into Epi-Data version 4.2.0 for cleaning and exported to STATA-13 for analysis. Descriptive analysis was carried out and results were presented by text, tables, and charts. Kaplan-Meier (log-rank test) and Cox regression were used to compare baseline survival experience and to determine predictors of patients' survival (death), respectively. The adjusted hazard ratio (AHR) was used to measure the strength of association and a p-value of <0.05 was considered to declare statistical significance. Results Of 200 patients, 108 (54%) of them were males. The mean (+ standard deviation) age of the study population was 32.9 +/- 9.5years. During follow-up, 22 (11%) deaths were reported. The overall incidence density of death was 11.99, 95% CI [7.89-18.21] per 100,000person-years. The median (interquartile range (IQR)) survival time was 375(249-457) days. Comorbidity (AHR = 23.68, 95% CI [4.85-115.46]), alcohol consumption (AHR = 4.53, 95% CI [1.21-16.97]), and history of poor adherence (AHR = 12.27, 95% CI [2.83-53.21]) were independently associated with patients' survival (death). Conclusion In this study, the incidence density of mortality was very high. Alcohol consumption, poor adherence, and the presence of comorbidity were independently associated with death. Hence, alcohol users, patients with comorbidity and poor adherence should be given due attention during therapy.	[Bade, Asnake Balche] Arba Minch Univ, Sch Pharm, Inst Hlth Sci, Arba Minch, Ethiopia; [Mega, Teshale Ayele] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Addis Ababa, Ethiopia	Arba Minch University; Addis Ababa University	Mega, TA (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Addis Ababa, Ethiopia.	tesh.ayu2016@gmail.com	MEGA, TESHALE AYELE/AAE-6330-2022					Alene KA, 2017, TROP MED INT HEALTH, V22, P351, DOI 10.1111/tmi.12826; Anderson LF, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.40.20601; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2015, WFP, V11, P712; [Anonymous], 2015, EUCONST; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Caminero J.A., 2013, GUIDELINES CLIN OPER, P1; Chung-Delgado K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119332; Girum T, 2017, ANN MED HEALTH SCI R, V7, P331; Helbling P, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14053; Kalandarova L., 2016, PUBLIC HLTH PANORAMA, V02, P21; Marais E, 2014, INFECTION, V42, P405, DOI 10.1007/s15010-013-0572-2; Mollel EW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/9241238; Myers B, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3396-y; Padayatchi N, 2015, INT J TUBERC LUNG D, V18, P564; Peykani P., 2018, CLIN DIABETOLOGY, V7, P1, DOI [DOI 10.1016/S1464-2859(18)30228-1, 10.5603/dk.2018.0001]; Putri FA, 2014, INT J TUBERC LUNG D, V18, P564, DOI 10.5588/ijtld.13.0602; Qazi F., 2017, UNION INT TUBERC, P32; Tola HH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56553-1; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; WHO, 2017, GLOB TUB REP; World Health Organization, 2021, 10 THREATS GLOB HLTH	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241684	10.1371/journal.pone.0241684	http://dx.doi.org/10.1371/journal.pone.0241684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166299	gold, Green Published			2022-12-26	WOS:000592382600013
J	Schmidt, J; Garcia, M; Brien, C; Kalambettu, P; Garnett, T; Fleury, D; Tricker, PJ				Schmidt, Jessica; Garcia, Melissa; Brien, Chris; Kalambettu, Priyanka; Garnett, Trevor; Fleury, Delphine; Tricker, Penny J.			Transcripts of wheat at a target locus on chromosome 6B associated with increased yield, leaf mass and chlorophyll index under combined drought and heat stress	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PHYSIOLOGICAL TRAITS; CROP YIELD; TOLERANCE; PROLINE; PLANTS; EXPRESSION; RESPONSES; GENE	Drought and heat stress constrain wheat (Triticum aestivum L.) yields globally. To identify putative mechanisms and candidate genes associated with combined drought and heat stress tolerance, we developed bread wheat near-isogenic lines (NILs) targeting a quantitative trait locus (QTL) on chromosome 6B which was previously associated with combined drought and heat stress tolerance in a diverse panel of wheats. Genotyping-by-sequencing was used to identify additional regions that segregated in allelic pairs between the recurrent and the introduced exotic parent, genome-wide. NILs were phenotyped in a gravimetric platform with precision irrigation and exposed to either drought or to combined drought and heat stress from three days after anthesis. An increase in grain weight in NILs carrying the exotic allele at 6B locus was associated with thicker, greener leaves, higher photosynthetic capacity and increased water use index after re-watering. RNA sequencing of developing grains at early and later stages of treatment revealed 75 genes that were differentially expressed between NILs across both treatments and timepoints. Differentially expressed genes coincided with the targeted QTL on chromosome 6B and regions of genetic segregation on chromosomes 1B and 7A. Pathway enrichment analysis showed the involvement of these genes in cell and gene regulation, metabolism of amino acids and transport of carbohydrates. The majority of these genes have not been characterized previously under drought or heat stress and they might serve as candidate genes for improved abiotic stress tolerance.	[Schmidt, Jessica; Garcia, Melissa; Brien, Chris; Kalambettu, Priyanka; Garnett, Trevor; Fleury, Delphine; Tricker, Penny J.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Brien, Chris; Garnett, Trevor] Univ Adelaide, Australian Plant Phen Facil, Plant Accelerator, Adelaide, SA, Australia; [Garnett, Trevor] Grains Res & Dev Corp, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Tricker, PJ (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.	Penny.tricker@adelaide.edu.au	Garnett, Trevor/AAJ-7474-2021; Brien, Chris/D-5630-2009; Tricker, Penny/A-8213-2015	Garnett, Trevor/0000-0003-1664-9659; Brien, Chris/0000-0003-0581-1817; Tricker, Penny/0000-0002-1626-3556	Australian Research Council (arc.gov.au) Industrial Transformation Research Hub for wheat in a hot and dry climate [IH130200027]	Australian Research Council (arc.gov.au) Industrial Transformation Research Hub for wheat in a hot and dry climate(Australian Research Council)	This work was supported by the grant from the Australian Research Council (arc.gov.au) Industrial Transformation Research Hub for wheat in a hot and dry climate (IH130200027) to TG, DF and PJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergel C, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11050520; Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, AM NURSE TODAY, V14, P2; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Aprile A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-821; Ben-Ari T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04087-x; BETSCHE T, 1983, PLANT PHYSIOL, V71, P961, DOI 10.1104/pp.71.4.961; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Boyd WJR, 2003, AUST J AGR RES, V54, P1277, DOI 10.1071/AR03014; Brien C, 2020, ASREMLPLUS AUGMENTS; Butler D.G., 2009, TECHNICAL REPORT; Casartelli A, 2019, PLANT MOL BIOL, V99, P477, DOI 10.1007/s11103-019-00831-z; Coast O, 2019, PLANT CELL ENVIRON, V42, P2133, DOI 10.1111/pce.13544; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Dobra J, 2010, J PLANT PHYSIOL, V167, P1360, DOI 10.1016/j.jplph.2010.05.013; Dodig D, 2016, EXP AGR, V52, P203, DOI 10.1017/S0014479715000034; Fabian A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00244; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Food and Agriculture Organization of the United Nations, 2019, WORLD FOOD SITUATION; [Food and Agriculture Organization of the United Nations (FAO) Food and Agriculture Organization of the United Nations], 2019, FAOSTAT TEMP CHANG; FRENCH RJ, 1984, AUST J AGR RES, V35, P743, DOI 10.1071/AR9840743; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Keeble-Gagnere G, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1475-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2018, FUNCT INTEGR GENOMIC, V18, P31, DOI 10.1007/s10142-017-0572-x; Kuzay S, 2019, THEOR APPL GENET, V132, P2689, DOI 10.1007/s00122-019-03382-5; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Cossani CM, 2012, PLANT PHYSIOL, V160, P1710, DOI 10.1104/pp.112.207753; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Miralles DG, 2014, NAT GEOSCI, V7, P345, DOI [10.1038/ngeo2141, 10.1038/NGEO2141]; Mitchell D, 2019, LANCET PLANET HEALTH, V3, pE290, DOI 10.1016/S2542-5196(19)30106-8; Okada T, 2019, THEOR APPL GENET, V132, P1965, DOI 10.1007/s00122-019-03329-w; Passioura JB, 2006, FUNCT PLANT BIOL, V33, P1075, DOI 10.1071/FP06223; Qaseem MF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43477-z; Qaseem MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199121; Richards RA, 2002, CROP SCI, V42, P111, DOI 10.2135/cropsci2002.0111; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rungrat Tepsuda, 2016, Arabidopsis Book, V14, pe0185, DOI 10.1199/tab.0185; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Sanchez-Bragado R, 2014, J EXP BOT, V65, P5401, DOI 10.1093/jxb/eru298; Schmidt J, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01800; Shirdelmoghanloo H, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0784-6; Silva-Perez V, 2019, WHEAT PHYSL PREDICTO; Silva-Perez V, 2018, J EXP BOT, V69, P483, DOI 10.1093/jxb/erx421; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Szabados L, 2009, TRENDS PLANT SCI, V15, P2; Toreti A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41932-5; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tricker PJ, 2018, J EXP BOT, V69, P3195, DOI 10.1093/jxb/ery081; Trnka M, 2014, NAT CLIM CHANGE, V4, P637, DOI [10.1038/NCLIMATE2242, 10.1038/nclimate2242]; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Voss-Fels KP, 2019, THEOR APPL GENET, V132, P2707, DOI 10.1007/s00122-019-03383-4; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241966	10.1371/journal.pone.0241966	http://dx.doi.org/10.1371/journal.pone.0241966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166353	Green Published, gold			2022-12-26	WOS:000592382600040
J	Vance, DJ; Poon, AY; Mantis, NJ				Vance, David J.; Poon, Amanda Y.; Mantis, Nicholas J.			Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies	PLOS ONE			English	Article							GALACTOSE-BINDING ABILITY; COMMUNIS AGGLUTININ; PROTECTIVE IMMUNITY; MUTATIONAL ANALYSIS; RETROTRANSLOCATION; CELLS; MICE	Ricin toxin's B subunit (RTB) is a multifunctional galactose (Gal)-/N-acetylgalactosamine (GalNac)-specific lectin that promotes uptake and intracellular trafficking of ricin's ribosome-inactivating subunit (RTA) into mammalian cells. Structurally, RTB consists of two globular domains (RTB-D1, RTB-D2), each divided into three homologous sub-domains (alpha, beta, gamma). The two carbohydrate recognition domains (CRDs) are situated on opposite sides of RTB (sub-domains 1 alpha and 2 gamma) and function non-cooperatively. Previous studies have revealed two distinct classes of toxin-neutralizing, anti-RTB monoclonal antibodies (mAbs). Type I mAbs, exemplified by SylH3, inhibit (similar to 90%) toxin attachment to cell surfaces, while type II mAbs, epitomized by 24B11, interfere with intracellular toxin transport between the plasma membrane and the trans-Golgi network (TGN). Localizing the epitopes recognized by these two classes of mAbs has proven difficult, in part because of RTB's duplicative structure. To circumvent this problem, RTB-D1 and RTB-D2 were expressed as pIII fusion proteins on the surface of filamentous phage M13 and subsequently used as "bait" in mAb capture assays. We found that SylH3 captured RTB-D1 (but not RTB-D2) in a dose-dependent manner, while 24B11 captured RTB-D2 (but not RTB-D1) in a dose-dependent manner. We confirmed these domain assignments by competition studies with an additional 8 RTB-specific mAbs along with a dozen a single chain antibodies (V(H)Hs). Collectively, these results demonstrate that type I and type II mAbs segregate on the basis of domain specificity and suggest that RTB's two domains may contribute to distinct steps in the intoxication pathway.	[Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12203 USA; [Poon, Amanda Y.; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Vance, DJ; Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12203 USA.; Mantis, NJ (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.	david.vance@health.ny.gov; nicholas.mantis@health.ny.gov	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	NIAID [HHSN272201400021C, AI125190]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID contract No. HHSN272201400021C and grant AI125190 to NJM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Cieslak TJ, 2018, MIL MED, V183, pE59, DOI 10.1093/milmed/usx004; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fu T, 1996, BIOCONJUGATE CHEM, V7, P651, DOI 10.1021/bc960056b; Gal Y, 2017, TOXINS, V9, DOI 10.3390/toxins9100311; HUSSAIN K, 1989, FEBS LETT, V244, P383, DOI 10.1016/0014-5793(89)80568-X; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Mooney B, 2019, J LEUKOCYTE BIOL, V106, P1161, DOI 10.1002/JLB.4A0419-123R; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; Noy-Porat T, 2016, TOXINS, V8, DOI 10.3390/toxins8030064; Poon AY, 2017, TOXINS, V9, DOI 10.3390/toxins9120378; Rong YH, 2020, TOXINS, V12, DOI 10.3390/toxins12040215; Rong YH, 2020, HUM VACC IMMUNOTHER, V16, P793, DOI 10.1080/21645515.2019.1664243; Rong YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180999; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Sapoznikov A, 2015, TOXINS, V7, P4817, DOI 10.3390/toxins7114817; Sepulveda J, 2008, J IMMUNOL METHODS, V332, P92, DOI 10.1016/j.jim.2007.12.014; Sowa-Rogozinska N, 2019, TOXINS, V11, DOI 10.3390/toxins11060350; SPHYRIS N, 1995, J BIOL CHEM, V270, P20292, DOI 10.1074/jbc.270.35.20292; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Suguitan Jr AL, 2011, PLOS ONE, V6; Sully EK, 2014, CLIN VACCINE IMMUNOL, V21, P777, DOI 10.1128/CVI.00003-14; SWIMMER C, 1992, P NATL ACAD SCI USA, V89, P3756, DOI 10.1073/pnas.89.9.3756; Toth RT, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00237-17; Van Slyke G, 2020, ENDPOINT EPITOPE SPE, DOI [10.1101/2020.05.06.081174, DOI 10.1101/2020.05.06.081174]; Vance DJ, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00236-17; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; WALES R, 1991, J BIOL CHEM, V266, P19172; WALES R, 1994, GLYCOCONJUGATE J, V11, P274, DOI 10.1007/BF00731198; Yao JZ, 2011, BIOCHEMISTRY-US, V50, P4097, DOI 10.1021/bi102021p; Yermakova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22721; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0236538	10.1371/journal.pone.0236538	http://dx.doi.org/10.1371/journal.pone.0236538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166282	Green Submitted, gold, Green Published			2022-12-26	WOS:000592382600016
J	Li, TT; Zhuang, YT; Yang, WQ; Xie, YL; Shang, WD; Su, S; Dong, X; Wu, JX; Jiang, WM; Zhou, Y; Li, Y; Zhou, X; Zhang, MY; Lu, YJ; Pan, ZW				Li, Tingting; Zhuang, Yuting; Yang, Wanqi; Xie, Yilin; Shang, Wendi; Su, Shuang; Dong, Xue; Wu, Jiaxu; Jiang, Wenmei; Zhou, Yang; Li, Ying; Zhou, Xin; Zhang, Mingyu; Lu, Yanjie; Pan, Zhenwei			Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts	FASEB JOURNAL			English	Article						cardiac fibrosis; m(6)A RNA modification; METTL3; myocardial infarction; TGF&#8208; &#946; 1	MESSENGER-RNA METHYLATION; M(6)A MODIFICATION; N-6-METHYLADENOSINE; DIFFERENTIATION; LEUKEMIA	Cardiac fibrosis is characterized by the activation of cardiac fibroblasts and accumulation of extracellular matrix. METTL3, a component of methyltransferase complex, participates in multiple biological processes associated with mammalian development and disease progression. However, the role of METTL3 in cardiac fibrosis is still unknown. We performed fibroblasts activation with TGF-beta 1 (20 ng/mL) in vitro and established in vivo mouse models with lentivirus to assess the effects of METTL3 on cardiac fibroblasts proliferation and collagen formation. Methylated RNA immunoprecipitation (MeRIP) was used to define the potential fibrosis-regulated gene. The expression level of METTL3 was increased in cardiac fibrotic tissue of mice with chronic myocardial infarction and cultured cardiac fibroblats (CFs) treated with TGF-beta 1. Enforced expression of METTL3 promoted proliferation and fibroblast-to-myofibroblast transition and collagens accumulation, while silence of METTL3 did the opposite. Silence of METTL3 by lentivirus carrying METTL3 siRNA markedly alleviated cardiac fibrosis in MI mice. Transcriptome and N6-methyladenosine (m(6)A) profiling analyses revealed that the expression and m(6)A level of collagen-related genes were altered after silence of METTL3. METTL3-mediated m(6)A modification is critical for the development of cardiac fibrosis, providing a molecular target for manipulating fibrosis and the associated cardiac diseases.	[Li, Tingting; Zhuang, Yuting; Yang, Wanqi; Xie, Yilin; Shang, Wendi; Su, Shuang; Dong, Xue; Wu, Jiaxu; Jiang, Wenmei; Zhou, Yang; Li, Ying; Zhang, Mingyu; Lu, Yanjie; Pan, Zhenwei] Harbin Med Univ, Coll Pharm, Minist Educ,Key Lab Cardiovasc Res, Dept Pharmacol,State Prov Key Labs Biomed Pharmac, Harbin, Peoples R China; [Zhou, Xin] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China; [Lu, Yanjie] Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Lu, YJ (corresponding author), Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Peoples R China.; Lu, YJ; Pan, ZW (corresponding author), Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin 150081, Heilongjiang, Peoples R China.	panzw@ems.hrbmu.edu.cn; panzw@ems.hrbmu.edu.cn	Zhang, mingyu/HGB-1069-2022		National Natural Science Foundation of China [81530010, 81872871, 81700219, 81703510, 81600192]; National Key R&D Program of China [2017YFC1307404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	The work was supported partly by the National Natural Science Foundation of China (No 81530010, 81872871, 81700219, 81703510, and 81600192) and National Key R&D Program of China (2017YFC1307404)	Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Bacmeister L, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0722-5; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Bokar JA, 1997, RNA, V3, P1233; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146; Du WJ, 2016, CELL PHYSIOL BIOCHEM, V39, P827, DOI 10.1159/000447793; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Hinderer S, 2019, ADV DRUG DELIVER REV, V146, P77, DOI 10.1016/j.addr.2019.05.011; Huang H, 2020, CANCER RES, V80, P3200, DOI 10.1158/0008-5472.CAN-19-4044; Janicki JS, 2002, J CARD FAIL, V8, pS319, DOI 10.1054/jcaf.2002.129260; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Li D, 2020, KOREAN J RADIOL, V21, pe37; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore-Morris T, 2016, J MOL CELL CARDIOL, V91, P1, DOI 10.1016/j.yjmcc.2015.12.031; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Nagpal V, 2016, CIRCULATION, V133, P291, DOI 10.1161/CIRCULATIONAHA.115.018174; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Song HW, 2019, AUTOPHAGY, V15, P1419, DOI 10.1080/15548627.2019.1586246; Tian C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030551; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xu H, 2020, NEURON, V105, P293, DOI 10.1016/j.neuron.2019.12.013; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yao YX, 2019, FASEB J, V33, P7529, DOI 10.1096/fj.201802644R; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yoon KJ, 2018, J CELL BIOL, V217, P1901, DOI 10.1083/jcb.201802117; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	45	39	39	8	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903169R	http://dx.doi.org/10.1096/fj.201903169R		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33150686				2022-12-26	WOS:000589711600001
J	Wollancho, W; Amdissa, D; Bamboro, S; Wasihun, Y; Tareke, KG; Gizaw, AT				Wollancho, Wadu; Amdissa, Demuma; Bamboro, Shemsedin; Wasihun, Yitbarek; Tareke, Kasahun Girma; Gizaw, Abraham Tamirat			Determining behavioral intention and its predictors towards cervical cancer screening among women in Gomma district, Jimma, Ethiopia: Application of the theory of planned behavior	PLOS ONE			English	Article								Background Cervical Cancer is the leading cause of cancer-related deaths among Ethiopian women. Despite many interventions were conducted, there is low uptake of cervical cancer screening services. Also, limited evidence was available on the women's intention and its predictors towards cervical cancer screening. Therefore, this study was aimed at determining the intention and predicators of behavioral intention toward cervical cancer screening. Methods A cross-sectional study was conducted in the Gomma district, Jimma, Ethiopia from August 1-30, 2019. The total sample sizes were 422 and a systematic random sampling technique was employed to select the samples. Data were collected through interviews using a structured questionnaire guide. Data were entered in epidata, and exported and analyzed using SPSS version 20.0 software. Descriptive, correlation, and multicollinearity analysis were done. Also, simple and multiple linear regression analysis were performed to identify the predictors for behavioral intention. The p-value<0.05 was used to declare a significant association. Result The response rate was 382 (90.5%). The mean age of the participants was of 26.45 (SD = 4.76). Direct attitude, subjective norm, and perceived behavioral control had a mean score of 16.78 (SD = 2.87), 15.61(SD = 1.92), and 12.86 (SD = 4.85), respectively. The intention has a mean score of 14.52 (SD = 4.01). From regression analysis, direct attitude (B = 0.346, p<0.001), direct subjective norm (B = 0.288, p = 0.008), direct perceived behavioral control (B = 0.132, p = 0.002) indirect attitude (B = 0.015, p = 0.019) and the indirect perceived behavioral control (B = 0.132, p = 0.002) were statistically significant with intention. Conclusion From this study, it was understood that women's intention towards cervical cancer screening was low. The predictors were the direct and indirect attitude, direct and indirect subjective norm, direct and indirect perceived behavioral control. This calls a need to develop strategies and take action to improve the attitude of women and their influential peoples and increase sense of control to improve their intention to screen for cervical cancer. Moreover, health care providers should have to conduct social and behavioral change communication to improve women's health seeking behavior towards cervical cancer screening applying the concept of theory of planned behavior.	[Wollancho, Wadu] Jimma Univ, Inst Hlth, Sch Nursing & Midwifery, Jimma, Ethiopia; [Amdissa, Demuma; Bamboro, Shemsedin; Wasihun, Yitbarek; Tareke, Kasahun Girma; Gizaw, Abraham Tamirat] Jimma Univ, Inst Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University; Jimma University	Tareke, KG (corresponding author), Jimma Univ, Inst Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia.	kasahungirmadera@gmail.com	Gizaw, Abraham/GPK-8246-2022	Gizaw, Abraham/0000-0001-6387-6278; Arebo, Shemsedin Bamboro/0000-0002-0548-5049; Girma, Kasahun/0000-0002-3832-2633				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alemayehu Y, CANC THREAT ETHIOPIA; Assefa AA, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4718-5; Bekele L, EVALUATION SEROLOGIC; Bruni L, 2019, 22 HUM PAP REL DIS W; Eshete M, 2020, OBSTET GYNECOL INT, V2020, DOI 10.1155/2020/2805936; Federal Democratic Republic of Ethiopia M of H, 2015, GUID CERV CANC PREV; Getahun T, 2020, J CANCER EPIDEMIOL, V2020, DOI 10.1155/2020/3024578; Ghiwot TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149363; Miri MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193638; Ng'ang'a A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6054-9; Nigussie T, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0826-y; Ogilvie GS, 2013, INT J CANCER, V133, P2934, DOI 10.1002/ijc.28324; Pan American Health Organization, 2018, PLAN ACT CERV CANC P; Roncancio AM, 2015, HEALTH EDUC BEHAV, V42, P621, DOI 10.1177/1090198115571364; Roncancio AM, 2013, BEHAV MED, V39, P66, DOI 10.1080/08964289.2013.799452; WHO, 2019, SCREEN TREATM PREC L; WHO World Health Organization, HUM PAP HPV CERV CAN; 2018, CURR OPIN TOXICOL, V10	19	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2020	15	11							e0238472	10.1371/journal.pone.0238472	http://dx.doi.org/10.1371/journal.pone.0238472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2PT	33151928	gold, Green Published			2022-12-26	WOS:000591376200002
J	Chen, WD; Peng, YF; Yu, GY				Chen, Weidong; Peng, Yufang; Yu, Guanyi			The influencing factors and spillover effects of interprovincial agricultural carbon emissions in China	PLOS ONE			English	Article							DIOXIDE EMISSIONS; DRIVING FACTOR; CLIMATE-CHANGE; IMPACT; ENERGY	Agricultural carbon emissions have become the constraints of agricultural low-carbon and circular economy development in China. China's agricultural production faces severe pressures and challenges in agricultural carbon reduction. In this paper, we take observation for the 31 provinces in china from 1997 to 2017, to explore the influencing factors and spatial spillover effects of agricultural by estimating spatial panel data models. The results show that China's agricultural carbon emissions will continue to increase in the future, because the growth of per capita gross domestic product (GDP) is the main driving force to accelerate the growth of agricultural carbon emissions, but the agricultural input factors will help to reduce the growth of carbon emissions. Moreover, it is proved that economic factors and agricultural input factors have direct effects and spatial spillover effects on agricultural carbon emissions except for agricultural environmental factors. In the short term, strengthening environmental protection may bring some pressure to the economic development of some places, but to achieve high-quality development, we must fundamentally solve the problem of environmental pollution. The conclusion provides important enlightenment and scientific basis for formulating effective policies to curb the growth of CO2 emissions in China.	[Chen, Weidong; Peng, Yufang] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China; [Yu, Guanyi] Tianjin Univ, Sch Architecture, Tianjin, Peoples R China	Tianjin University; Tianjin University	Peng, YF (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.	pengyufang_222@163.com	Chen, Wei/GZK-7348-2022	Peng, Yufang/0000-0001-7318-1779	National Social Science Fund of China [14ZDB135]; National Natural Science Foundation of China [71373173]; National Social Science Foundation of China [2014B10130]	National Social Science Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This study is funded by National Social Science Fund of China (No. 14ZDB135), the National Natural Science Foundation of China (No. 71373173) and the National Social Science Foundation of China (No. 2014B10130).	Baumann M, 2017, GLOBAL CHANGE BIOL, V23, P1902, DOI 10.1111/gcb.13521; Carlton JS, 2013, J ENVIRON MANAGE, V130, P32, DOI 10.1016/j.jenvman.2013.08.038; Castesana PS, 2020, CARBON MANAG, V11, P251, DOI 10.1080/17583004.2020.1750229; Chen JD, 2018, RENEW SUST ENERG REV, V94, P748, DOI 10.1016/j.rser.2018.06.050; Chen YH, 2019, ENERGIES, V12, DOI 10.3390/en12163102; Cui HR, 2018, POL J ENVIRON STUD, V27, P1449, DOI 10.15244/pjoes/77610; Gao C, 2020, COMPUT ENVIRON URBAN, V81, DOI 10.1016/j.compenvurbsys.2020.101459; Han HB, 2018, ENVIRON SCI POLLUT R, V25, P25280, DOI 10.1007/s11356-018-2589-7; He YanQiu, 2018, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V26, P1269; Hopkin J, 2011, GEOGRAPHY, V96, P116; Li ZW, 2011, ENRGY PROCED, V5, P1073, DOI 10.1016/j.egypro.2011.03.189; Liu X, 2017, J CLEAN PROD, V164, P1239, DOI 10.1016/j.jclepro.2017.07.086; Rappaport LM, 2020, STRUCT EQU MODELING, V27, P318, DOI 10.1080/10705511.2019.1620109; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Tian Y, 2014, J INTEGR AGR, V13, P1393, DOI 10.1016/S2095-3119(13)60624-3; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wen Y, 2019, IOP C SER MAT SCI EN, P592; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Wu XR, 2018, CHINA AGR ECON REV, V10, P558, DOI [10.1108/caer-04-2017-0063, 10.1108/CAER-04-2017-0063]; Xiong CH, 2020, GROWTH CHANGE, V51, P1401, DOI 10.1111/grow.12384; Xu B, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.122770; Yazdanpanah M, 2014, J ENVIRON MANAGE, V135, P63, DOI 10.1016/j.jenvman.2014.01.016; Zilli M, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.139384	23	9	9	14	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0240800	10.1371/journal.pone.0240800	http://dx.doi.org/10.1371/journal.pone.0240800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147231	gold, Green Published			2022-12-26	WOS:000589609300063
J	Choi, SB; Ahn, I				Choi, Soo Beom; Ahn, Insung			Forecasting imported COVID-19 cases in South Korea using mobile roaming data	PLOS ONE			English	Article							MIXED LOGIT MODEL; CRASH RATES; AIR-TRAVEL; SEVERITY	As the number of global coronavirus disease (COVID-19) cases increases, the number of imported cases is gradually rising. Furthermore, there is no reduction in domestic outbreaks. To assess the risks from imported COVID-19 cases in South Korea, we suggest using the daily risk score. Confirmed COVID-19 cases reported by John Hopkins University Center, roaming data collected from Korea Telecom, and the Oxford COVID-19 Government Response Tracker index were included in calculating the risk score. The risk score was highly correlated with imported COVID-19 cases after 12 days. To forecast daily imported COVID-19 cases after 12 days in South Korea, we developed prediction models using simple linear regression and autoregressive integrated moving average, including exogenous variables (ARIMAX). In the validation set, the root mean squared error of the linear regression model using the risk score was 6.2, which was lower than that of the autoregressive integrated moving average (ARIMA; 22.3) without the risk score as a reference. Correlation coefficient of ARIMAX using the risk score (0.925) was higher than that of ARIMA (0.899). A possible reason for this time lag of 12 days between imported cases and the risk score could be the delay that occurs before the effect of government policies such as closure of airports or lockdown of cities. Roaming data could help warn roaming users regarding their COVID-19 risk status and inform the national health agency of possible high-risk areas for domestic outbreaks.	[Choi, Soo Beom; Ahn, Insung] Korea Inst Sci & Technol Informat, Dept Data Ctr Problem Solving Res, Daejeon, South Korea; [Choi, Soo Beom; Ahn, Insung] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea	Korea Institute of Science & Technology Information (KISTI); Korea Research Institute of Chemical Technology (KRICT)	Ahn, I (corresponding author), Korea Inst Sci & Technol Informat, Dept Data Ctr Problem Solving Res, Daejeon, South Korea.; Ahn, I (corresponding author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea.	isahn@kisti.re.kr			National Research Council of Science and Technology grant by the Korea government (MSIP) [CRC-16-01-KRICT]; Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea [HG19C0682]	National Research Council of Science and Technology grant by the Korea government (MSIP); Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea	This work was supported by the National Research Council of Science and Technology grant by the Korea government (MSIP) (no. CRC-16-01-KRICT) for SBC and IA. This research was supported by Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea (no. HG19C0682) for SBC and IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, COVID 19 INF ACC GER; [Anonymous], 2020, 30000 S KOR RET HOM; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060609; Choi SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220423; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Girardin F, 2009, J LOCAT BASED SERV, V3, P210, DOI 10.1080/17489720903339676; Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708; Hale T., 2020, BLAVATNIK SCH GOV WO; IATA, 2020, MAY PASS DEM SHOWS S; KCDC, COR DIS 19; KCDC, 2020, UPD COVID 19 KOR; Kongcharoen C., 2013, 33 INT S FOR S KOR, P1; Korea's S., 2020, S KOR 1 EV PLAN HEAD; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee KT, 2020, JOINT RES PREDICTING; Lee S, 2020, SPARSE HP FILTER FIN, DOI [10.1016/j.jeconom.2020.08.008, DOI 10.1016/J.JEC0N0M.2020.08.008]; Shojaei A., 2018, INT J ADV SYST MEAS, V11, P36; Statista, MARK SHAR MOB PHON S; Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11114, DOI 10.1073/pnas.1423542112; WHITE KJ, 1992, REV ECON STAT, V74, P370, DOI 10.2307/2109675; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018	31	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241466	10.1371/journal.pone.0241466	http://dx.doi.org/10.1371/journal.pone.0241466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147252	gold, Green Published			2022-12-26	WOS:000589609300050
J	Lavrijssen, B; Baars, JP; Lugones, LG; Scholtmeijer, K; Telgerd, NS; Sonnenberg, ASM; van Peer, AF				Lavrijssen, Brian; Baars, Johan P.; Lugones, Luis G.; Scholtmeijer, Karin; Telgerd, Narges Sedaghat; Sonnenberg, Anton S. M.; van Peer, Arend F.			Interruption of an MSH4 homolog blocks meiosis in metaphase I and eliminates spore formation in Pleurotus ostreatus	PLOS ONE			English	Article							COPRINUS-CINEREUS; MUTS HOMOLOG; SCHIZOPHYLLUM-COMMUNE; EXPRESSION PATTERNS; EDIBLE MUSHROOM; TRANSFORMATION; MUTANTS; TRANSPOSONS; PULMONARIUS; MYCOVIRUS	Pleurotus ostreatus, one of the most widely cultivated edible mushrooms, produces high numbers of spores causing severe respiratory health problems for people, clogging of filters and spoilage of produce. A non-sporulating commercial variety (SPOPPO) has been successfully introduced into the market in 2006. This variety was generated by introgression breeding of a natural mutation into a commercial variety. Our cytological studies revealed that meiosis in the natural and derived sporeless strains was blocked in metaphase I, apparently resulting in a loss of spore formation. The gene(s) underlying this phenotype were mapped to an 80 kb region strongly linked to sporelessness and identified by transformation of wild type genes of this region into a sporeless strain. Sporulation was restored by re-introduction of the DNA sequence encoding the P. ostreatus meiotic recombination gene MSH4 homolog (poMSH4). Subsequent molecular analysis showed that poMSH4 in the sporeless P. ostreatus was interrupted by a DNA fragment containing a region encoding a CxC5/CxC6 cysteine cluster associated with Copia-type retrotransposons. The block of meiosis in metaphase I by a poMSH4 null mutant suggests that this protein plays an essential role in both Class I and II crossovers in mushrooms, similar to animals (mice), but unlike in plants. MSH4 was previously shown to be a target for breeding of sporeless varieties in P. pulmonarius, and the null mutant of the MSH4 homolog of S. commune (scMSH4) confers an extremely low level of spore formation. We propose that MSH4 homologs are likely to be a breeding target for sporeless strains both within Pleurotus sp. and in other Agaricales.	[Lavrijssen, Brian; Baars, Johan P.; Scholtmeijer, Karin; Telgerd, Narges Sedaghat; Sonnenberg, Anton S. M.; van Peer, Arend F.] Wageningen Univ & Res, Plant Breeding Dept, Wageningen, Netherlands; [Lugones, Luis G.] Univ Utrecht, Microbiol Fac Sci, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Scholtmeijer, K (corresponding author), Wageningen Univ & Res, Plant Breeding Dept, Wageningen, Netherlands.	karin.scholtmeijer@wur.nl	Sonnenberg, Anton/GRJ-0442-2022	Sonnenberg, Anton/0000-0002-1699-1481; Scholtmeijer, Karin/0000-0002-8510-1809; van Peer, Arend/0000-0001-7023-0045				Alfaro M, 2016, ENVIRON MICROBIOL, V18, P4710, DOI 10.1111/1462-2920.13360; [Anonymous], 2004, GIN PO DYPL, V32, P88; Baars JJP, 2000, SCIENCE AND CULTIVATION OF EDIBLE FUNGI, VOLS 1 AND 2, P317; Baars JJP, 2004, MUSHROOM SCI, VXVI, P139; Baars JJP, 2008, MUSHROOM SCI, VXVII, P774; BINNINGER DM, 1987, EMBO J, V6, P835, DOI 10.1002/j.1460-2075.1987.tb04828.x; Bocher T, 1999, CANCER RES, V59, P816; Bolcun-Filas E, 2018, BIOL REPROD, V99, P112, DOI 10.1093/biolre/ioy021; BROMBERG SK, 1977, CAN J GENET CYTOL, V19, P477, DOI 10.1139/g77-051; Chen WM, 2015, CURR MICROBIOL, V71, P204, DOI 10.1007/s00284-015-0819-5; COX A, 1988, EUR RESPIR J, V1, P466; Cummings WJ, 1999, CURR GENET, V36, P371, DOI 10.1007/s002940050512; de Jong JF, 2010, FEMS MICROBIOL LETT, V310, P91, DOI 10.1111/j.1574-6968.2010.02052.x; DONS JJM, 1979, BIOCHIM BIOPHYS ACTA, V563, P100, DOI 10.1016/0005-2787(79)90011-X; EGER G, 1976, THEOR APPL GENET, V47, P155, DOI 10.1007/BF00278373; GIBBINS AMV, 1982, CURR GENET, V5, P119, DOI 10.1007/BF00365702; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Grogan HM, 2003, MYCOL RES, V107, P147, DOI 10.1017/S0953756203007202; HASEBE K, 1991, MYCOLOGIA, V83, P354, DOI 10.2307/3759995; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hock B, 2006, SIGNAL TRANSDUCT, V6, P443, DOI [10.1002/sita.200600111, DOI 10.1002/SITA.200600111]; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; Imbernon M, 1989, MUSHROOM SCI, VXII, P109; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; Iyer LM, 2014, P NATL ACAD SCI USA, V111, P1676, DOI 10.1073/pnas.1321818111; KANDA T, 1989, MOL GEN GENET, V216, P526, DOI 10.1007/BF00334400; Kim YJ, 2008, J MICROBIOL, V46, P95, DOI 10.1007/s12275-007-0171-y; Kneitz B, 2000, GENE DEV, V14, P1085; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Larraya LM, 1999, APPL ENVIRON MICROB, V65, P3413; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Mercier R, 2015, ANNU REV PLANT BIOL, V66, P297, DOI 10.1146/annurev-arplant-050213-035923; Mikosch TSP, 2002, MYCOL RES, V106, P682, DOI 10.1017/S0953756202005877; Mikosch TSP, 2001, FUNGAL GENET BIOL, V33, P59, DOI 10.1006/fgbi.2001.1265; Milano CR, 2019, G3-GENES GENOM GENET, V9, P1839, DOI 10.1534/g3.119.400074; Murakami S, 1993, MUSHROOM BIOL MUSHRO, P63; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001083; Novak JE, 2001, GENETICS, V158, P1013; Obatake Y, 2006, NIHON KINGAKKAI NISH, V15, P18; Obatake Yasushi, 2003, Mycoscience, V44, P33, DOI 10.1007/s10267-002-0074-z; OHIRA I, 1979, T MYCOL SOC JPN, V20, P107; Ohm RA, 2010, WORLD J MICROB BIOT, V26, P1919, DOI 10.1007/s11274-010-0356-0; Okuda Y, 2013, APPL ENVIRON MICROB, V79, P4520, DOI 10.1128/AEM.00561-13; Pandey M, 2010, CURR SCI INDIA, V99, P1449; Ro HS, 2006, J VIROL METHODS, V138, P24, DOI 10.1016/j.jviromet.2006.07.016; Royse DJ, 2017, EDIBLE MED MUSHROOMS, P5; Sahin Ergin, 2018, VirusDisease, V29, P1, DOI 10.1007/s13337-018-0434-8; Sivolapova AB, 2012, RUSS J GENET+, V48, P383, DOI 10.1134/S1022795412040114; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sokolovsky V., 1990, FUNGAL GENET NEWSLET, V37, P41; SONNENBERG AS, 1988, CURR MICROBIOL, V17, P285, DOI 10.1007/BF01571330; SONNENBERG ASM, 1987, THEOR APPL GENET, V74, P654, DOI 10.1007/BF00288866; Sonnenberg ASM., 1996, CHAMPIGNONCULTUUR, V40, P269; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sugawara H, 2009, CHROMOSOMA, V118, P127, DOI 10.1007/s00412-008-0185-1; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; VANDERLENDE TR, 1995, FEMS MICROBIOL LETT, V125, P51, DOI 10.1016/0378-1097(94)00471-3; Yu HJ, 2003, VIROLOGY, V314, P9, DOI 10.1016/S0042-6822(03)00382-9	58	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241749	10.1371/journal.pone.0241749	http://dx.doi.org/10.1371/journal.pone.0241749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147286	Green Published, gold			2022-12-26	WOS:000589609300082
J	Niraula, PM; Sharma, K; McNeece, BT; Troell, HA; Darwish, O; Alkharouf, NW; Lawrence, KS; Klink, VP				Niraula, Prakash M.; Sharma, Keshav; McNeece, Brant T.; Troell, Hallie A.; Darwish, Omar; Alkharouf, Nadim W.; Lawrence, Katherine S.; Klink, Vincent P.			Mitogen activated protein kinase (MAPK)-regulated genes with predicted signal peptides function in the Glycine max defense response to the root pathogenic nematode Heterodera glycines	PLOS ONE			English	Article							UDP-GLUCOSE PYROPHOSPHORYLASE; DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; ARABINOGALACTAN-PROTEINS; TYROSINE PHOSPHORYLATION; BINDING-SITE; CELL-DEATH; EXPRESSION; HARPIN; MAPK	Glycine max has 32 mitogen activated protein kinases (MAPKs), nine of them exhibiting defense functions (defense MAPKs) to the plant parasitic nematode Heterodera glycines. RNA seq analyses of transgenic G. max lines overexpressing (OE) each defense MAPK has led to the identification of 309 genes that are increased in their relative transcript abundance by all 9 defense MAPKs. Here, 71 of those genes are shown to also have measurable amounts of transcript in H. glycines-induced nurse cells (syncytia) produced in the root that are undergoing a defense response. The 71 genes have been grouped into 7 types, based on their expression profile. Among the 71 genes are 8 putatively-secreted proteins that include a galactose mutarotase-like protein, pollen Ole e 1 allergen and extensin protein, endomembrane protein 70 protein, O-glycosyl hydrolase 17 protein, glycosyl hydrolase 32 protein, FASCICLIN-like arabinogalactan protein 17 precursor, secreted peroxidase and a pathogenesis-related thaumatin protein. Functional transgenic analyses of all 8 of these candidate defense genes that employ their overexpression and RNA interference (RNAi) demonstrate they have a role in defense. Overexpression experiments that increase the relative transcript abundance of the candidate defense gene reduces the ability that the plant parasitic nematode Heterodera glycines has in completing its life cycle while, in contrast, RNAi of these genes leads to an increase in parasitism. The results provide a genomic analysis of the importance of MAPK signaling in relation to the secretion apparatus during the defense process defense in the G. max-H. glycines pathosystem and identify additional targets for future studies.	[Niraula, Prakash M.; Sharma, Keshav; McNeece, Brant T.; Troell, Hallie A.; Klink, Vincent P.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Darwish, Omar] Texas Womens Univ, Dept Math & Comp Sci, Denton, TX USA; [Alkharouf, Nadim W.] Towson Univ, Dept Comp & Informat Sci, Towson, MD USA; [Lawrence, Katherine S.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL USA; [Klink, Vincent P.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Klink, Vincent P.] Mississippi State Univ, Ctr Computat Sci High Performance Comp Collab, Starkville, MS 39762 USA; [Niraula, Prakash M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Texas A&M AgriLife Res & Extens Ctr, Weslaco, TX USA; [Sharma, Keshav] Univ Minnesota, USDA ARS, Cereal Dis Lab, St Paul, MN 55108 USA; [McNeece, Brant T.] USDA ARS, Soybean & Nitrogen Fixat Unit, Raleigh, NC 27695 USA	Mississippi State University; Texas Womans University; University System of Maryland; Towson University; Auburn University System; Auburn University; Mississippi State University; Mississippi State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University Kingsville; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Klink, VP (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.; Klink, VP (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.; Klink, VP (corresponding author), Mississippi State Univ, Ctr Computat Sci High Performance Comp Collab, Starkville, MS 39762 USA.	heartwood27@hotmail.com		Lawrence, Kathy/0000-0002-5358-2011	College of Arts and Sciences at Mississippi State University [CAS-SRI-2018-1]	College of Arts and Sciences at Mississippi State University	The authors are thankful for an awarded competitive Special Research Initiative grant from the College of Arts and Sciences at Mississippi State University (VPK), CAS-SRI-2018-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Department of Biological Sciences, Mississippi State University. The authors are thankful to the Department of Biochemistry, Molecular Biology, Entomology and Plant Pathology, Mississippi State University for greenhouse space. The authors are thankful to Gary Lawrence at the Department of Biochemistry, Molecular Biology, Entomology and Plant Pathology, Mississippi State University for his continued support throughout these studies. The authors would like to thank a large contingent of undergraduate students who have contributed in important ways to these studies over the years. These students include Christina Jones, Dollie Welch, Priyanka Gadre, Katherine Thrash, Adrienne McMorris, Chase Robinson, Danielle Francis, Brittany Ginn, Kara Jackson, Suchit Salian, Olivia Long, Hannah Burson, Meghan Calhoun, Nishi Sunthwal, John Clune, Taylor Henry, Madison Milhoan, Kayla Moore, Neil Shannon, Ashley Dowdy, Katherine McCracken, Erin Curran, Annedrea McMillan, Austin Martindale, Keigero Fergusen, Alison Antee, Hannah Miller, Tineka Burkhead, Henry Pittman, Erin Ball, Jamelle Vance, Leslie Canale, Courtney Gagliano, Shelby Janeski, Lauren Langston, Eileen Modzeleski, Natalie Rentrop, Hannah Austin, Carolyn Chacon, Emily Carter, Erica Sowell, Jody Clark, Chelsea Tittle, Chrissy Miller, Hannah Stimson, Kathryn Stiglet, Ashlee Vargason, Robyn Beattie, Anna Bailey Britt, Harshini Sampathkumar, Henderson Rand, Aishwarya Dikshit, Dejanie Dilworth, Samantha Rushing, Kyle Winston, Meagan Young, Morgan Urich, Chase Nash, Makenzie Miller, Rebecca Waters, Anna-Marie Autrey, Maggie Kuhn, Kelvin Blade, Jesse Austin, Haleigh Smith, Alex Hammett, Caroline Knesal, Landon Heineck, Caleb Stallings, Santana Holloway, Candace Wyatt, Caroline Hoggard, Cassady Knudsen, Mathilda Lail, Ellen Condoure, Morgan Castaneda, Rebecca Billingsley, Seth Lenoir, Suraj Neupane, Jared Quave, Swechchha Tamang, Jilanna Simmons, Lukas Wicht, Emily Sosnowski, Courtney Borgognoni, Rashada Boler, Hannah Cox, Madison Baima, Murry Faulkner, Gill Goodloe, Sarah Heifner, Holeh Heydari, Drake Pace, Cameron Roach, Kim Anderson, Ngoc Pham, Ana Simal, Adam Crittenden, Anna Gaudin, Cassady Knudsen, Cheyenne Golden and Ryan Bolton. The authors are greatly thankful to the Shackouls Honors College.	Aljaafri WAR, 2017, PLANT PHYSIOL BIOCH, V121, P161, DOI 10.1016/j.plaphy.2017.10.004; Alshehri HA, 2019, BIOINFORMATION, V15, P338, DOI 10.6026/97320630015338; Andeme-Onzighi C, 2002, PLANTA, V215, P949, DOI 10.1007/s00425-002-0836-z; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; BROMFIELD KR, 1980, CROP SCI, V20, P254, DOI 10.2135/cropsci1980.0011183X002000020026x; Buscaill P, 2019, SCIENCE, V364, P145, DOI 10.1126/science.aav0748; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chivasa S, 2013, J PROTEOME RES, V12, P1743, DOI 10.1021/pr3010887; Daxberger A, 2007, PLANTA, V225, P1559, DOI 10.1007/s00425-006-0442-6; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Desikan R, 1999, PLANTA, V210, P97, DOI 10.1007/s004250050658; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Ding L, 1997, PLANTA, V203, P289, DOI 10.1007/s004250050194; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; GOLDEN A. M., 1970, Plant Disease Reporter, V54, P544; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klink VP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/491217; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu JZ, 2014, MOL PLANT MICROBE IN, V27, P824, DOI 10.1094/MPMI-11-13-0350-R; Liu JZ, 2011, PLANT PHYSIOL, V157, P1363, DOI 10.1104/pp.111.185686; Liu ZL, 2015, MOL PLANT MICROBE IN, V28, P408, DOI 10.1094/MPMI-09-14-0251-R; Liu ZX, 2013, P NATL ACAD SCI USA, V110, P6205, DOI 10.1073/pnas.1215543110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DP, 2010, PLANT SIGNAL BEHAV, V5, P598, DOI 10.4161/psb.11500; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; Matsye PD, 2011, PLANT MOL BIOL, V77, P513, DOI 10.1007/s11103-011-9828-3; McNeece BT, 2019, PLANT PHYSIOL BIOCH, V137, P25, DOI 10.1016/j.plaphy.2019.01.018; McNeece BT, 2017, PLANT PHYSIOL BIOCH, V114, P60, DOI 10.1016/j.plaphy.2017.02.022; Meng M, 2009, PLANT CELL PHYSIOL, V50, P998, DOI 10.1093/pcp/pcp052; Miles GP, 2005, ENVIRON POLLUT, V138, P230, DOI 10.1016/j.envpol.2005.04.017; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mohanta TK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1244-7; Neupane A, 2013, EVOL BIOINFORM, V9, P363, DOI 10.4137/EBO.S12526; Niggeweg R, 2000, J BIOL CHEM, V275, P19897, DOI 10.1074/jbc.M909267199; Nikolovski N, 2014, PLANT PHYSIOL, V166, P1033, DOI 10.1104/pp.114.245589; Pant SR, 2014, PLANT MOL BIOL, V85, P107, DOI 10.1007/s11103-014-0172-2; Pedley KF, 2019, MOL PLANT MICROBE IN, V32, P120, DOI 10.1094/MPMI-07-18-0198-FI; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; ROSS J. P., 1958, PHYTOPATH, V48, P578; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Scott A, 2007, FEMS YEAST RES, V7, P366, DOI 10.1111/j.1567-1364.2006.00204.x; Sharma K, 2016, J PLANT INTERACT, V11, P74, DOI 10.1080/17429145.2016.1195891; STURGILL TW, 1986, BIOCHEM BIOPH RES CO, V134, P565, DOI 10.1016/S0006-291X(86)80457-0; SUZUKI K, 1995, PLANT CELL, V7, P639, DOI 10.1105/tpc.7.5.639; Tian SN, 2020, PLANT SCI, V292, DOI 10.1016/j.plantsci.2019.110386; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wrather JA, 2006, J NEMATOL, V38, P173; Xu HY, 2018, PLANT PHYSIOL, V178, P907, DOI 10.1104/pp.18.00903; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P292, DOI 10.1093/pcp/pce034; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	73	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241678	10.1371/journal.pone.0241678	http://dx.doi.org/10.1371/journal.pone.0241678			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147292	Green Published, gold			2022-12-26	WOS:000589609300072
J	Rodriguez-Lobato, LG; Martinez-Roca, A; Castano-Diez, S; Palomino-Mosquera, A; Gutierrez-Garcia, G; Pedraza, A; Suarez-Lledo, M; Rovira, M; Martinez, C; de Larrea, CF; Cibeira, MT; Rosinol, L; Lozano, E; Marin, P; Cid, J; Lozano, M; Moreno-Castano, AB; Palomo, M; Diaz-Ricart, M; Gallego, C; Hernando, A; Segura, S; Carreras, E; Urbano-Ispizua, A; Blade, J; Fernandez-Aviles, F				Rodriguez-Lobato, Luis-Gerardo; Martinez-Roca, Alexandra; Castano-Diez, Sandra; Palomino-Mosquera, Alicia; Gutierrez-Garcia, Gonzalo; Pedraza, Alexandra; Suarez-Lledo, Maria; Rovira, Montserrat; Martinez, Carmen; Fernandez de Larrea, Carlos; Cibeira, Maria-Teresa; Rosinol, Laura; Lozano, Ester; Marin, Pedro; Cid, Joan; Lozano, Miquel; Belen Moreno-Castano, Ana; Palomo, Marta; Diaz-Ricart, Maribel; Gallego, Cristina; Hernando, Adelina; Segura, Susana; Carreras, Enric; Urbano-Ispizua, Alvaro; Blade, Joan; Fernandez-Aviles, Francesc			The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever	PLOS ONE			English	Article							ENGRAFTMENT SYNDROME; RISK-FACTORS; AUTO-SCT; BLOOD; RECOMMENDATIONS; COMPLICATIONS; CHEMOTHERAPY; DEFINITION; BACTEREMIA; GUIDELINES	Background Autologous stem cell transplantation (ASCT) remains the standard of care for young multiple myeloma (MM) patients; indeed, at-home ASCT has been positioned as an appropriate therapeutic strategy. However, despite the use of prophylactic antibiotics, neutropenic fever (NF) and hospital readmissions continue to pose as the most important limitations in the outpatient setting. It is possible that the febrile episodes may have a non-infectious etiology, and engraftment syndrome could play a more significant role. The aim of this study was to analyze the impact of both G-CSF withdrawal and the addition of primary prophylaxis with corticosteroids after ASCT. Methods Between January 2002 and August 2018, 111 MM patients conditioned with melphalan were managed at-home beginning +1 day after ASCT. Three groups were established: Group A (n = 33) received standard G-CSF post-ASCT; group B (n = 32) avoided G-CSF post-ASCT; group C (n = 46) avoided G-CSF yet added corticosteroid prophylaxis post-ASCT. Results The incidence of NF among the groups was reduced (64%, 44%, and 24%; P0.001), with a non-significant decrease in hospital readmissions as well (12%, 6%, and 2%; P = 0.07). The most important variables identified for NF were: HCT-CI >2 (OR 6.1; P = 0.002) and G-CSF avoidance plus corticosteroids (OR 0.1; P0.001); and for hospital readmission: age >= 60 years (OR 14.6; P = 0.04) and G-CSF avoidance plus corticosteroids (OR 0.07; P = 0.05). Conclusions G-CSF avoidance and corticosteroid prophylaxis post ASCT minimize the incidence of NF in MM patients undergoing at-home ASCT. This approach should be explored in a prospective randomized clinical trial.	[Rodriguez-Lobato, Luis-Gerardo; Martinez-Roca, Alexandra; Castano-Diez, Sandra; Palomino-Mosquera, Alicia; Gutierrez-Garcia, Gonzalo; Pedraza, Alexandra; Suarez-Lledo, Maria; Rovira, Montserrat; Martinez, Carmen; Rosinol, Laura; Gallego, Cristina; Hernando, Adelina; Segura, Susana; Urbano-Ispizua, Alvaro; Fernandez-Aviles, Francesc] Hosp Clin Barcelona, Dept Hematol, Home Care & Bone Marrow Transplantat Unit, Barcelona, Spain; [Rodriguez-Lobato, Luis-Gerardo; Fernandez de Larrea, Carlos; Cibeira, Maria-Teresa; Rosinol, Laura; Lozano, Ester; Blade, Joan] Hosp Clin Barcelona, Dept Hematol, Amyloidosis & Multiple Myeloma Unit, Barcelona, Spain; [Rodriguez-Lobato, Luis-Gerardo; Gutierrez-Garcia, Gonzalo; Suarez-Lledo, Maria; Rovira, Montserrat; Martinez, Carmen; Fernandez de Larrea, Carlos; Cibeira, Maria-Teresa; Rosinol, Laura; Lozano, Ester; Cid, Joan; Lozano, Miquel; Palomo, Marta; Diaz-Ricart, Maribel; Urbano-Ispizua, Alvaro; Blade, Joan; Fernandez-Aviles, Francesc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Marin, Pedro; Cid, Joan; Lozano, Miquel] Hosp Clin Barcelona, Dept Hemotherapy & Hemostasis, Apheresis & Cellular Therapy Unit, Barcelona, Spain; [Belen Moreno-Castano, Ana; Palomo, Marta; Diaz-Ricart, Maribel] Hosp Clin Barcelona, Biomed Diag Ctr CDB, Dept Hematopathol, Lab Hemostasis & Eritropathol, Barcelona, Spain; [Belen Moreno-Castano, Ana; Palomo, Marta; Diaz-Ricart, Maribel; Carreras, Enric] Josep Carreras Leukemia Res Inst, Barcelona Endothelium Team BET, Barcelona, Spain; [Palomo, Marta; Carreras, Enric] Univ Barcelona Campus, Josep Carreras Leukemia Res Inst, Hosp Clin, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; Hospital Clinic de Barcelona	Rodriguez-Lobato, LG (corresponding author), Hosp Clin Barcelona, Dept Hematol, Home Care & Bone Marrow Transplantat Unit, Barcelona, Spain.; Rodriguez-Lobato, LG (corresponding author), Hosp Clin Barcelona, Dept Hematol, Amyloidosis & Multiple Myeloma Unit, Barcelona, Spain.; Rodriguez-Lobato, LG (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	lgrodriguez@clinic.cat	Palomo, Marta/AAY-4484-2021; Cid, Joan/F-7778-2016; Lozano, Miquel/H-6749-2019; Carreras, Enric/AAY-4448-2021; Palomo, Marta/AAY-5510-2021; de Larrea, Carlos Fernández/ABG-9608-2020; Lozano, Ester/H-2215-2014	Palomo, Marta/0000-0002-3261-6577; Cid, Joan/0000-0001-5445-4508; Lozano, Miquel/0000-0003-2593-833X; Carreras, Enric/0000-0002-3134-9964; Lozano, Ester/0000-0002-6307-9807; Rodriguez-Lobato, Luis Gerardo/0000-0001-5694-0921; Martinez-Roca, Alexandra/0000-0003-2143-5356				[Anonymous], 2011, CLIN INFECT DIS S5, V52, pS397; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; Carreras E, 2010, BONE MARROW TRANSPL, V45, P1417, DOI 10.1038/bmt.2009.363; Cavo M, 2018, EXPERT REV HEMATOL, V11, P219, DOI 10.1080/17474086.2018.1437345; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, JJAAM, V28, ps1; Cornell RF, 2015, BIOL BLOOD MARROW TR, V21, P2061, DOI 10.1016/j.bbmt.2015.08.030; Cornell RF, 2013, BIOL BLOOD MARROW TR, V19, P1368, DOI 10.1016/j.bbmt.2013.06.017; Cox JE, 2014, BONE MARROW TRANSPL, V49, P219, DOI 10.1038/bmt.2013.149; Delgado J, 2014, HAEMATOLOGICA, V99, P1410, DOI 10.3324/haematol.2013.100784; Dispenzieri A, 2008, EUR J HAEMATOL, V80, P397, DOI 10.1111/j.1600-0609.2008.01037.x; Eleutherakis-Papaiakovou E, 2010, AM J HEMATOL, V85, P863, DOI 10.1002/ajh.21855; Faucher C, 2012, BONE MARROW TRANSPL, V47, P549, DOI 10.1038/bmt.2011.126; Faussner F, 2012, ANTICANCER RES, V32, P2103; Fernandez-Aviles F, 2006, J CLIN ONCOL, V24, P4855, DOI 10.1200/JCO.2006.06.4238; Gale RP, 2015, BONE MARROW TRANSPL, V50, P483, DOI 10.1038/bmt.2014.317; Gertz MA, 2011, BONE MARROW TRANSPL, V46, P956, DOI 10.1038/bmt.2010.233; Graff TM, 2015, BONE MARROW TRANSPL, V50, P947, DOI 10.1038/bmt.2015.46; Gutierrez-Garcia G, 2020, BONE MARROW TRANSPL, V55, P965, DOI 10.1038/s41409-019-0768-x; Gutierrez-Garcia G, 2019, BONE MARROW TRANSPL, V54, P1295, DOI 10.1038/s41409-019-0447-y; Gutierrez-Garcia G, 2018, BONE MARROW TRANSPL, V53, P1541, DOI 10.1038/s41409-018-0189-2; Holbro A, 2013, BIOL BLOOD MARROW TR, V19, P547, DOI 10.1016/j.bbmt.2012.12.006; Lisenko K, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3137-4; Ludwig H, 2014, LEUKEMIA, V28, P981, DOI 10.1038/leu.2013.293; Pinana JL, 2014, ANN HEMATOL, V93, P299, DOI 10.1007/s00277-013-1872-4; Maiolino A, 2003, BONE MARROW TRANSPL, V31, P393, DOI 10.1038/sj.bmt.1703855; Majhail NS, 2015, BIOL BLOOD MARROW TR, V21, P1863, DOI 10.1016/j.bbmt.2015.07.032; Marchesi F, 2017, BONE MARROW TRANSPL, V52, P154, DOI 10.1038/bmt.2016.207; Martinez-Cibrian N, 2016, BONE MARROW TRANSPL, V51, P593, DOI 10.1038/bmt.2015.287; Martino M, 2016, BONE MARROW TRANSPL, V51, P1032, DOI 10.1038/bmt.2016.79; Martino M, 2015, LEUKEMIA LYMPHOMA, V56, P801, DOI 10.3109/10428194.2014.931952; McCarthy PL, 2013, BIOL BLOOD MARROW TR, V19, P1116, DOI 10.1016/j.bbmt.2013.04.027; Mossad S, 2005, BONE MARROW TRANSPL, V35, P375, DOI 10.1038/sj.bmt.1704769; Openshaw H, 2002, BIOL BLOOD MARROW TR, V8, P233, DOI 10.1053/bbmt.2002.v8.pm12064360; Palomo M, 2010, BIOL BLOOD MARROW TR, V16, P985, DOI 10.1016/j.bbmt.2010.02.008; Palomo M, 2009, BIOL BLOOD MARROW TR, V15, P537, DOI 10.1016/j.bbmt.2009.01.013; Paul TM, 2015, CL LYMPH MYELOM LEUK, V15, P536, DOI 10.1016/j.clml.2015.05.006; Rodriguez-Lobato LG, 2020, LEUKEMIA LYMPHOMA, V61, P1565, DOI 10.1080/10428194.2020.1742901; Satlin MJ, 2015, BIOL BLOOD MARROW TR, V21, P1808, DOI 10.1016/j.bbmt.2015.06.017; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Solano C, 2005, BONE MARROW TRANSPL, V36, P59, DOI 10.1038/sj.bmt.1705005; Spitzer TR, 2015, BONE MARROW TRANSPL, V50, P469, DOI 10.1038/bmt.2014.296; Spitzer TR, 2001, BONE MARROW TRANSPL, V27, P893, DOI 10.1038/sj.bmt.1703015; Sureda A, 2015, BONE MARROW TRANSPL, V50, P1037, DOI 10.1038/bmt.2015.6; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241778	10.1371/journal.pone.0241778	http://dx.doi.org/10.1371/journal.pone.0241778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147257	Green Published, gold			2022-12-26	WOS:000589609300030
J	Souza, SS; Alves, BG; Alves, KA; Brandao, FAS; Brito, DCC; Gastal, MO; Rodrigues, APR; Figueireod, JR; Teixeira, DIA; Gastal, EL				Souza, Samara S.; Alves, Benner G.; Alves, Kele A.; Brandao, Fabiana A. S.; Brito, Danielle C. C.; Gastal, Melba O.; Rodrigues, Ana P. R.; Figueireod, Jose R.; Teixeira, Darcio I. A.; Gastal, Eduardo L.			Heterotopic autotransplantation of ovarian tissue in a large animal model: Effects of cooling and VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EQUINE PREANTRAL FOLLICLES; IN-VITRO CULTURE; HISTOLOGICAL-EVALUATION; FERTILITY PRESERVATION; FOLLICULAR DEVELOPMENT; ORGAN PRESERVATION; BIOPSY FRAGMENTS; ANGIOGENESIS; SURVIVAL	Heterotopic and orthotopic ovarian tissue autotransplantation techniques, currently used in humans, will become promising alternative methods for fertility preservation in domestic and wild animals. Thus, this study describes for the first time the efficiency of a heterotopic ovarian tissue autotransplantation technique in a large livestock species (i.e., horses) after ovarian fragments were exposed or not to a cooling process (4 degrees C/24 h) and/or VEGF before grafting. Ovarian fragments were collected in vivo via an ultrasound-guided biopsy pick-up method and surgically autografted in a subcutaneous site in both sides of the neck in each mare. The blood flow perfusion at the transplantation site was monitored at days 2, 4, 6, and 7 post-grafting using color-Doppler ultrasonography. Ovarian grafts were recovered 7 days post-transplantation and subjected to histological analyses. The exposure of the ovarian fragments to VEGF before grafting was not beneficial to the quality of the tissue; however, the cooling process of the fragments reduced the acute hyperemia post-grafting. Cooled grafts compared with non-cooled grafts contained similar values for normal and developing preantral follicles, vessel density, and stromal cell apoptosis; lower collagen type III fibers and follicular density; and higher stromal cell density, AgNOR, and collagen type I fibers. In conclusion, VEGF exposure before autotransplantation did not improve the quality of grafted tissues. However, cooling ovarian tissue for at least 24 h before grafting can be beneficial because satisfactory rates of follicle survival and development, stromal cell survival and proliferation, as well as vessel density, were obtained.	[Souza, Samara S.; Brandao, Fabiana A. S.; Teixeira, Darcio I. A.] Univ Estadual Ceara, Fac Vet Med, Lab Diagnost Imaging Appl Anim Reprod, Fortaleza, Ceara, Brazil; [Alves, Benner G.; Alves, Kele A.; Brito, Danielle C. C.; Rodrigues, Ana P. R.; Figueireod, Jose R.] Univ Estadual Ceara, Fac Vet Med, Lab Manipulat Oocytes & Preantral Follicles, Fortaleza, Ceara, Brazil; [Gastal, Melba O.; Gastal, Eduardo L.] Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA	Universidade Estadual do Ceara; Universidade Estadual do Ceara; Southern Illinois University System; Southern Illinois University	Gastal, EL (corresponding author), Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Gastal, Eduardo Leite/Q-9854-2017; Rodrigues, Ana/GYQ-6273-2022; Alves, Benner/D-3599-2014	Gastal, Eduardo Leite/0000-0002-8855-6980; Alves, Benner/0000-0001-9465-8054	Coordination for the Improvement of Higher Education Personnel (CAPES) [88881.064955/2014-01]; National Council for Scientific and Technological Development (CNPq), Brazil	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research supported by Coordination for the Improvement of Higher Education Personnel (CAPES; Special Visiting Researcher Grant #88881.064955/2014-01; E.L. Gastal and D.I.A. Teixeira). Samara S. de Souza was the recipient of a doctorate scholarship from the National Council for Scientific and Technological Development (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abir R, 2010, FERTIL STERIL, V93, P2337, DOI 10.1016/j.fertnstert.2009.01.111; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aerts JMJ, 2008, CRYOBIOLOGY, V57, P163, DOI 10.1016/j.cryobiol.2008.07.011; Aguiar FLN, 2017, RES VET SCI, V115, P155, DOI 10.1016/j.rvsc.2017.04.001; Alves BG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198108; Alves KA, 2017, REPROD FERT DEVELOP, V29, P867, DOI 10.1071/RD15402; Alves KA, 2015, THERIOGENOLOGY, V83, P1048, DOI 10.1016/j.theriogenology.2014.12.004; Alves KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149693; Amorim CA, 2016, J ASSIST REPROD GEN, V33, P617, DOI 10.1007/s10815-016-0681-9; [Anonymous], 2015, J INT ASS PROVIDE S1, V14, pS3; Asgari M., 2017, SCI REP, V7, P1; Barberino RS, 2016, ANIM REPROD, V13, P28, DOI 10.21451/1984-3143-AR772; Barberino RS, 2019, BIOPRESERV BIOBANK, V17, P84, DOI 10.1089/bio.2018.0057; Bashir ST, 2016, REPRODUCTION, V151, P271, DOI 10.1530/REP-15-0457; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Bruno JB, 2009, REPROD FERT DEVELOP, V21, P679, DOI 10.1071/RD08181; Caires KC, 2012, ENDOCRINOLOGY, V153, P887, DOI 10.1210/en.2011-1323; Campbell BK, 2014, HUM REPROD, V29, P1749, DOI 10.1093/humrep/deu144; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chacur MGM, 2015, ARQ BRAS MED VET ZOO, V67, P447, DOI 10.1590/1678-6695; Chaves RN, 2008, REPROD FERT DEVELOP, V20, P640, DOI 10.1071/RD07195; Comizzoli P, 2014, REPROD FERT DEVELOP, V26, P91, DOI 10.1071/RD13259; Commin L, 2012, REPROD FERT DEVELOP, V24, P461, DOI 10.1071/RD11166; Damous LL, 2016, REPROD SCI, V23, P803, DOI 10.1177/1933719115620493; Damous LL, 2015, J ASSIST REPROD GEN, V32, P1285, DOI 10.1007/s10815-015-0527-x; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; Dath C, 2010, HUM REPROD, V25, P1734, DOI 10.1093/humrep/deq131; Celestino JJD, 2008, ANIM REPROD SCI, V108, P309, DOI 10.1016/j.anireprosci.2007.08.016; Demeestere I, 2009, HUM REPROD UPDATE, V15, P649, DOI 10.1093/humupd/dmp021; Ding Y, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0401-4; Donfack NJ, 2018, REPROD FERT DEVELOP, V30, P1055, DOI [10.1071/RD17315, 10.1071/rd17315]; Donfack NJ, 2018, THERIOGENOLOGY, V116, P83, DOI 10.1016/j.theriogenology.2018.05.001; Donnez J, 2018, NEW ENGL J MED, V378, P400, DOI 10.1056/NEJMc1715731; Duncan FE, 2016, REPRODUCTION, V152, pR201, DOI 10.1530/REP-15-0598; Friedman O, 2012, HUM REPROD, V27, P474, DOI 10.1093/humrep/der385; Gao JM, 2013, HUM REPROD, V28, P2784, DOI 10.1093/humrep/det296; Gastal GDA, 2017, J EQUINE VET SCI, V53, P86, DOI 10.1016/j.jevs.2016.03.014; Gastal GDA, 2017, REPRODUCTION, V153, P577, DOI 10.1530/REP-16-0621; Gavish Z, 2018, J ASSIST REPROD GEN, V35, P61, DOI 10.1007/s10815-017-1079-z; Ginther OJ, 2012, THERIOGENOLOGY, V77, P818, DOI 10.1016/j.theriogenology.2011.09.025; Ginther OJ, 2004, BIOL REPROD, V71, P1195, DOI 10.1095/biolreprod.104.031054; Gomes RG, 2012, THERIOGENOLOGY, V78, P731, DOI 10.1016/j.theriogenology.2012.03.019; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Guo Bing-Qin, 2018, Oncotarget, V9, P30552, DOI 10.18632/oncotarget.25702; Haag KT, 2013, THERIOGENOLOGY, V79, P911, DOI 10.1016/j.theriogenology.2013.01.001; Haag KT, 2013, THERIOGENOLOGY, V79, P735, DOI 10.1016/j.theriogenology.2012.10.023; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Hernandez-Fonseca HJ, 2005, FERTIL STERIL, V83, P1180, DOI 10.1016/j.fertnstert.2004.07.985; Isachenko V, 2009, REPRODUCTION, V138, P319, DOI 10.1530/REP-09-0039; Israely T, 2006, HUM REPROD, V21, P1368, DOI 10.1093/humrep/del010; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Kang BJ, 2016, J ASSIST REPROD GEN, V33, P281, DOI 10.1007/s10815-015-0628-6; Kikuchi K, 2011, ANIM SCI J, V82, P495, DOI 10.1111/j.1740-0929.2011.00919.x; Kong HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184546; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Lan C, 2010, FERTIL STERIL, V93, P913, DOI 10.1016/j.fertnstert.2008.10.020; Langbeen A, 2016, ANIM REPROD SCI, V168, P73, DOI 10.1016/j.anireprosci.2016.02.029; Li SH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081237; Liu J, 2001, BIOL REPROD, V64, P171, DOI 10.1095/biolreprod64.1.171; Luyckx V, 2013, FERTIL STERIL, V100, P1350, DOI 10.1016/j.fertnstert.2013.07.202; Ma IT, 2017, ANN SURG ONCOL, V24, P77, DOI 10.1245/s10434-016-5479-6; Mineur P, 2007, J CELL BIOL, V179, P1261, DOI 10.1083/jcb.200703052; Nugent D, 1998, J REPROD FERTIL, V114, P341, DOI 10.1530/jrf.0.1140341; Oktay K, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.07.1072; Peterson AW, 2014, BIOMATER SCI-UK, V2, P1497, DOI 10.1039/c4bm00141a; Petrenko A, 2019, TRANSFUS MED HEMOTH, V46, P151, DOI 10.1159/000499610; Pinto Y, 2020, ANIM REPROD SCI, V215, DOI 10.1016/j.anireprosci.2020.106310; Piras AR, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0395-1; Quintana R, 2004, FERTIL STERIL, V82, P1101, DOI 10.1016/j.fertnstert.2004.03.036; Sanchez A, 2013, J ALZHEIMERS DIS, V34, P281, DOI 10.3233/JAD-121636; Scalercio SR, 2016, REPROD FERT DEVELOP, V28, P1854, DOI 10.1071/RD14454; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Shimizu T, 2006, J REPROD DEVELOP, V52, P23, DOI 10.1262/jrd.17072; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Tellado MN, 2014, ADV REPROD SCI, V2, P56, DOI [10.4236/arsci.2014.23007, DOI 10.4236/ARSCI.2014.23007]; Twardowski T, 2007, CURR PHARM DESIGN, V13, P3608, DOI 10.2174/138161207782794176; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Yang HY, 2006, REPRODUCTION, V131, P851, DOI 10.1530/rep.1.00916; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Youm HW, 2015, THERIOGENOLOGY, V83, P854, DOI 10.1016/j.theriogenology.2014.11.026; Zand-vakili M, 2016, ANIM CELLS SYST, V20, P260, DOI 10.1080/19768354.2016.1220976	89	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241442	10.1371/journal.pone.0241442	http://dx.doi.org/10.1371/journal.pone.0241442			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147235	Green Published, gold			2022-12-26	WOS:000589609300013
J	Vroomen, JLM; Kjellstadli, C; Allore, HG; van der Steen, JT; Husebo, B				Vroomen, Janet L. MacNeil; Kjellstadli, Camilla; Allore, Heather G.; van der Steen, Jenny T.; Husebo, Bettina			Reform influences location of death: Interrupted time-series analysis on older adults and persons with dementia	PLOS ONE			English	Article							OF-LIFE CARE; IN-PLACE; PEOPLE; PREDICTORS; FLANDERS; CANCER; TRENDS	Background Norway instituted a Coordination Reform in 2012 aimed at maximizing time at home by providing in-home care through community services. Dying in a hospital can be highly stressful for patients and families. Persons with dementia are particularly vulnerable to negative outcomes in hospital. This study aims to describe changes in the proportion of older adults with and without dementia dying in nursing homes, home, hospital and other locations over an 11-year period covering the reform. Methods and findings This is a repeated cross-sectional, population-level study using mortality data from the Norwegian Cause of Death Registry hosted by the Norwegian Institute of Public Health. Participants were Norwegian older adults 65 years or older with and without dementia who died from 2006 to 2017. The policy intervention was the 2012 Coordination Reform that increased care infrastructure into communities. The primary outcome was location of death listed as a nursing home, home, hospital or other location. The trend in the proportion of location of death, before and after the reform was estimated using an interrupted time-series analysis. All analyses were adjusted for sex and seasonality. Of the 417,862 older adult decedents, 61,940 (14.8%) had dementia identified on their death certificate. Nursing home deaths increased over time while hospital deaths decreased for the total population (adjusted Relative Risk Ratio (aRRR) 0.87, 95% CI 0.82-0.92) and persons with dementia (aRRR: 0.93, 95%CI 0.91-0.96) after reform implementation. Conclusion This study provides evidence that the 2012 Coordination Reform was associated with decreased older adults dying in hospital and increased nursing home death; however, the number of people dying at home did not change.	[Vroomen, Janet L. MacNeil] Univ Amsterdam, Dept Internal Med, Amsterdam Publ Hlth Res Inst, Amsterdam Univ,Med Ctr,Sect Geriatr Med, Amsterdam, North Holland, Netherlands; [Kjellstadli, Camilla; Husebo, Bettina] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Allore, Heather G.] Yale Univ, Sch Med, Dept Internal Med, Sect Geriatr, New Haven, CT 06510 USA; [Allore, Heather G.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [van der Steen, Jenny T.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [van der Steen, Jenny T.] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands; [Husebo, Bettina] Municipal Bergen, Bergen, Norway	University of Amsterdam; Vrije Universiteit Amsterdam; University of Bergen; Yale University; Yale University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Vroomen, JLM (corresponding author), Univ Amsterdam, Dept Internal Med, Amsterdam Publ Hlth Res Inst, Amsterdam Univ,Med Ctr,Sect Geriatr Med, Amsterdam, North Holland, Netherlands.	j.l.macneil-vroomen@amsterdamumc.nl	Kjellstadli, Camilla/AAN-6855-2021; Husebo, Bettina Sandgathe/AFP-1656-2022; Kjellstadli, Camilla/X-6977-2019; Husebø, Bettina Sandgathe/AFO-7402-2022; Kjellstadli, Camilla/HGU-8464-2022; van der Steen, Jenny T./E-5118-2016; Vroomen, Janet MacNeil/M-5358-2017	Husebo, Bettina Sandgathe/0000-0002-6037-2864; Kjellstadli, Camilla/0000-0002-1296-382X; van der Steen, Jenny T./0000-0002-9063-7501; Vroomen, Janet MacNeil/0000-0001-6400-7189	ZonMw career award [91619060]	ZonMw career award	JMV received a ZonMw career award, Veni grant #91619060. https://www.zonmw.nl/nl/onderzoek-resultaten/fundamenteel-onderzoek/programmas/programma-detail/veni/t/commissie13/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, BRAIN STIMUL MAR; Badrakalimuthu V, 2014, AGE AGEING, V43, P13, DOI 10.1093/ageing/aft151; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Bruvik F, 2017, SYKEPLEIEN FORSKNING, V12, P60613, DOI [10.4220/Sykepleienf.2017.60613, DOI 10.4220/SYKEPLEIENF.2017.60613]; C H A H., 2009, PROMOTING HIGH QUALI; Cohen J, 2015, BRIT J CANCER, V113, P1397, DOI 10.1038/bjc.2015.312; Dasch B, 2015, DTSCH ARZTEBL INT, V112, P496, DOI 10.3238/arztebl.2015.0496; Delamater PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054900; Faeo SE, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1171-6; Folkehelseinstituttet, 2019, FLEST SYK HJEMM 2018; Forskningsradet, 2016, SLUTTRAPPORT STYRING; Gao W, 2013, CHANGING PATTERNS PL, P1549; Gao W, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6030107; Gao W, 2014, SCI WORLD J, DOI 10.1155/2014/369798; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Helvik AS, 2015, DEMENT GERIATR COGN, V40, P166, DOI 10.1159/000433525; Hines Sonia, 2011, JBI Libr Syst Rev, V9, P960; Hoogerduijn JG, 2007, J CLIN NURS, V16, P46, DOI 10.1111/j.1365-2702.2006.01579.x; Houttekier D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-228; Husebo BS, 2020, AM J GERIAT PSYCHIAT, V28, P792, DOI 10.1016/j.jagp.2020.04.016; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Kaasa S, 2017, PALLIATIVE CARE SERI; Kaasa SA S, 2017, NOU201716 MIN HLTH C; Kalseth J, 2017, PALLIATIVE MED, V31, P964, DOI 10.1177/0269216317691259; Kjellstadli C, 2020, FAM PRACT, V37, P340, DOI 10.1093/fampra/cmz059; Kjellstadli C, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4536-9; Kjelvik J, 2017, 022017 NORW DIR HLTH; Kua EH, 2014, PSYCHOGERIATRICS, V14, P196, DOI 10.1111/psyg.12053; LaMantia MA, 2016, ALZ DIS ASSOC DIS, V30, P35, DOI 10.1097/WAD.0000000000000118; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Melby L., 2019, KARTLEGGING MEDISINS; MOrk EB S, 2016, SLO KONGSVINGER 2017; Norgwegian Directorate of Health, 2018, IS2836 NORGW DIR HLT; OECD, 2017, LONG TERM CAR BEDS I; OECD/European Observatory on Health Systems and Policies, 2019, EUR OBS HLTH SYST PO; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Reyniers T, 2015, J AM MED DIR ASSOC, V16, P165, DOI 10.1016/j.jamda.2014.11.003; Romoren Tor Inge, 2011, Int J Integr Care, V11, pe127; Sandvik RK, 2016, J AM MED DIR ASSOC, V17, P821, DOI 10.1016/j.jamda.2016.05.006; Saunders C, 2008, END LIF CAR STRAT PR; Smedslund G, 2014, 192014 NASJ KUNNSK H; Spasova S., 2018, Eurohealth, V24, P7; Statistics Norway, 2020, 09929 STAT NORW; Verhofstede R, 2017, J PAIN SYMPTOM MANAG, V53, P693, DOI 10.1016/j.jpainsymman.2016.10.363; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	46	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2020	15	11							e0241132	10.1371/journal.pone.0241132	http://dx.doi.org/10.1371/journal.pone.0241132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OR6WM	33147248	Green Published, gold			2022-12-26	WOS:000589609300025
J	Huang, JY; Milchenko, M; Rao, YJ; LaMontagne, P; Abraham, C; Robinson, CG; Huang, Y; Shimony, JS; Rich, KM; Benzinger, T				Huang, Jiayi; Milchenko, Mikhail; Rao, Yuan J.; LaMontagne, Pamela; Abraham, Christopher; Robinson, Clifford G.; Huang, Yi; Shimony, Joshua S.; Rich, Keith M.; Benzinger, Tammie			A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; SURGICAL RESECTION; RADIOTHERAPY; RADIATION; SURVIVAL; DIFFERENTIATION; THERAPY; MRI	Background To explore if early perfusion-weighted magnetic resonance imaging (PWI) may be a promising imaging biomarker to predict local recurrence (LR) of brain metastases after stereotactic radiosurgery (SRS). Methods This is a prospective pilot study of adult brain metastasis patients who were treated with SRS and imaged with PWI before and 1 week later. Relative cerebral blood volume (rCBV) parameter maps were calculated by normalizing to the mean value of the contralateral white matter on PWI. Cox regression was conducted to explore factors associated with time to LR, with Bonferroni adjusted p<0.0006 for multiple testing correction. LR rates were estimated with the Kaplan-Meier method and compared using the log-rank test. Results Twenty-three patients were enrolled from 2013 through 2016, with 22 evaluable lesions from 16 patients. After a median follow-up of 13.1 months (range: 3.0-53.7), 5 lesions (21%) developed LR after a median of 3.4 months (range: 2.3-5.7). On univariable analysis, larger tumor volume (HR 1.48, 95% CI 1.02-2.15, p = 0.04), lower SRS dose (HR 0.45, 95% CI 0.21-0.97, p = 0.04), and higher rCBV at week 1 (HR 1.07, 95% CI 1.003-1.14, p = 0.04) had borderline association with shorter time to LR. Tumors >2.0cm(3) had significantly higher LR than if <= 2.0cm(3): 54% vs 0% at 1 year, respectively, p = 0.008. A future study to confirm the association of early PWI and LR of the high-risk cohort of lesions >2.0cm(3) is estimated to require 258 patients. Conclusions PWI at week 1 after SRS may have borderline association with LR. Tumors <2.0cm(3) have low risk of LR after SRS and may be low-yield for predictive biomarker studies. Information regarding sample size and potential challenges for future imaging biomarker studies may be gleaned from this pilot study.	[Huang, Jiayi; Rao, Yuan J.; Abraham, Christopher; Robinson, Clifford G.; Huang, Yi] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; [Milchenko, Mikhail; LaMontagne, Pamela; Shimony, Joshua S.; Benzinger, Tammie] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Rich, Keith M.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Huang, JY (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA.	jiayi.huang@wustl.edu		Robinson, Cliff/0000-0002-1399-9904; Huang, Yi/0000-0002-2867-1477; Huang, Jiayi/0000-0002-5153-506X	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; Washington University Radiation Oncology Departmental Seed Grant; Siteman Cancer Center Early Phase Clinical Research Support (EPCRS); Neuroimaging Informatics and Analysis Center [1P30NS098577, R01 EB009352]	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Washington University Radiation Oncology Departmental Seed Grant; Siteman Cancer Center Early Phase Clinical Research Support (EPCRS); Neuroimaging Informatics and Analysis Center	Research reported in this publication was supported by a seed grant (JH) from the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), the Washington University Radiation Oncology Departmental Seed Grant (JH), and the Siteman Cancer Center Early Phase Clinical Research Support (EPCRS) Awards (JH). In addition, this study was supported in part by the Neuroimaging Informatics and Analysis Center (1P30NS098577, DM) and R01 EB009352 (DM). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia M, 2019, J NEUROSURG, V130, P804, DOI 10.3171/2017.11.JNS171273; Angelov L, 2018, J NEUROSURG, V129, P366, DOI 10.3171/2017.3.JNS162532; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Arvold ND, 2016, NEURO-ONCOLOGY, V18, P1043, DOI 10.1093/neuonc/now127; Baschnagel AM, 2013, J NEUROSURG, V119, P1139, DOI 10.3171/2013.7.JNS13431; Brown PD, 2018, J CLIN ONCOL, V36, P483, DOI 10.1200/JCO.2017.75.9589; Brown PD, 2016, JAMA-J AM MED ASSOC, V316, P401, DOI 10.1001/jama.2016.9839; Cao Y, 2006, INT J RADIAT ONCOL, V64, P876, DOI 10.1016/j.ijrobp.2005.09.001; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Essig M, 2003, RADIOLOGY, V228, P193, DOI 10.1148/radiol.2281020298; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Huang JY, 2012, INT J RADIAT ONCOL, V84, P485, DOI 10.1016/j.ijrobp.2011.11.053; Jakubovic R, 2014, CLIN ONCOL-UK, V26, P704, DOI 10.1016/j.clon.2014.06.010; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Likhacheva A, 2013, INT J RADIAT ONCOL, V85, P656, DOI 10.1016/j.ijrobp.2012.05.047; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; Milchenko M, 2016, NEUROINFORMATICS, V14, P305, DOI 10.1007/s12021-016-9296-7; Piantodosi S, 2005, CLIN TRIALS, V2, P182, DOI 10.1191/1740774505cn078oa; Soffietti R, 2013, J CLIN ONCOL, V31, P65, DOI 10.1200/JCO.2011.41.0639; Suh CH, 2018, AM J ROENTGENOL, V211, P1332, DOI 10.2214/AJR.18.19674; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tselikas L, 2015, NEURO-ONCOLOGY, V17, P895, DOI 10.1093/neuonc/nou332; Varlotto JM, 2003, INT J RADIAT ONCOL, V57, P452, DOI 10.1016/S0360-3016(03)00568-6	31	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0241835	10.1371/journal.pone.0241835	http://dx.doi.org/10.1371/journal.pone.0241835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141861	Green Published, gold			2022-12-26	WOS:000588376700012
J	Rashid, M; Silventoinen, A; Gleerup, KB; Andersen, PH				Rashid, Maheen; Silventoinen, Alina; Gleerup, Karina Bech; Andersen, Pia Haubro			Equine Facial Action Coding System for determination of pain-related facial responses in videos of horses	PLOS ONE			English	Article							EXPRESSIONS; SCALE	During the last decade, a number of pain assessment tools based on facial expressions have been developed for horses. While all tools focus on moveable facial muscles related to the ears, eyes, nostrils, lips, and chin, results are difficult to compare due to differences in the research conditions, descriptions and methodologies. We used a Facial Action Coding System (FACS) modified for horses (EquiFACS) to code and analyse video recordings of acute short-term experimental pain (n = 6) and clinical cases expected to be in pain or without pain (n = 21). Statistical methods for analyses were a frequency based method adapted from human FACS approaches, and a novel method based on co-occurrence of facial actions in time slots of varying lengths. We describe for the first time changes in facial expressions using EquiFACS in video of horses with pain. The ear rotator (EAD104), nostril dilation (AD38) and lower face behaviours, particularly chin raiser (AU17), were found to be important pain indicators. The inner brow raiser (AU101) and eye white increase (AD1) had less consistent results across experimental and clinical data. Frequency statistics identified AUs, EADs and ADs that corresponded well to anatomical regions and facial expressions identified by previous horse pain research. The co-occurrence based method additionally identified lower face behaviors that were pain specific, but not frequent, and showed better generalization between experimental and clinical data. In particular, chewing (AD81) was found to be indicative of pain. Lastly, we identified increased frequency of half blink (AU47) as a new indicator of pain in the horses of this study.	[Rashid, Maheen] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Silventoinen, Alina] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Gleerup, Karina Bech] Univ Copenhagen, Dept Clin Sci, Taastrup, Denmark; [Andersen, Pia Haubro] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	University of California System; University of California Davis; Swedish University of Agricultural Sciences; University of Copenhagen; Swedish University of Agricultural Sciences	Rashid, M (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.	mhnrashid@ucdavis.edu		Andersen, Pia Haubro/0000-0002-6039-7439	Swedish Research Council For Sustainable Development [2015-01423]	Swedish Research Council For Sustainable Development	This work was funded by the Swedish Research Council For Sustainable Development grant 2015-01423 awarded to PHA. https://formas.se/.	[Anonymous], **NON-TRADITIONAL**; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Ekman P., 2002, MANUAL INVESTIGATORS; Flecknell P, 2011, PAIN, V152, P963, DOI 10.1016/j.pain.2011.01.030; Gleerup KB, 2016, EQUINE VET EDUC, V28, P47, DOI 10.1111/eve.12383; Gleerup KB, 2015, VET ANAESTH ANALG, V42, P103, DOI 10.1111/vaa.12212; Gleerup KB, 2015, APPL ANIM BEHAV SCI, V171, P25, DOI 10.1016/j.applanim.2015.08.023; Graubner C, 2011, VET J, V188, P178, DOI 10.1016/j.tvjl.2010.04.029; Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9; Hampton AJD, 2015, PAIN, V156, P868, DOI 10.1097/j.pain.0000000000000126; Hintze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164017; Karmann AJ, 2016, J PAIN, V17, P383, DOI 10.1016/j.jpain.2015.12.002; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Kunz M, 2019, PAIN, V160, P535, DOI 10.1097/j.pain.0000000000001424; Lindegaard C, 2010, VET ANAESTH ANALG, V37, P171, DOI 10.1111/j.1467-2995.2009.00521.x; Merkies K, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080562; Price J, 2003, VET ANAESTH ANALG, V30, P124, DOI 10.1046/j.1467-2995.2003.00139.x; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Raekallio M., 1997, Journal of Veterinary Anaesthesia, V24, P17; Sayette MA, 2001, J NONVERBAL BEHAV, V25, P167, DOI 10.1023/A:1010671109788; Sellon DC, 2004, J VET INTERN MED, V18, P555, DOI 10.1892/0891-6640(2004)18&lt;555:EOCRII&gt;2.0.CO;2; van Loon JPAM, 2015, VET J, V206, P356, DOI 10.1016/j.tvjl.2015.08.023; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Wathan J, 2014, CURR BIOL, V24, pR677, DOI 10.1016/j.cub.2014.06.023	26	9	9	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2020	15	11							e0231608	10.1371/journal.pone.0231608	http://dx.doi.org/10.1371/journal.pone.0231608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8YL	33141852	gold, Green Submitted, Green Published			2022-12-26	WOS:000588376700019
J	Adhikari, JN; Bhattarai, BP; Rokaya, MB; Thapa, TB				Adhikari, Jagan Nath; Bhattarai, Bishnu Prasad; Rokaya, Maan Bahadur; Thapa, Tej Bahadur			Ethno-medicinal uses of vertebrates in the Chitwan-Annapurna Landscape, central Nepal	PLOS ONE			English	Article							ANIMAL-BASED MEDICINES; QUANTITATIVE ETHNOBOTANY; PLANTS; DISTRICT; PRODUCTS; CONSERVATION; ZOOTHERAPY; KNOWLEDGE; REMEDIES; AREAS	Traditional knowledge on the use of animal products to maintain human health is important since time immemorial. Although a few studies reported food and medicinal values of different animals, a comprehensive ethno-medicinal study of vertebrates in Nepal is still lacking. Thus, present study is aimed at documenting the ethno-medicinal knowledge related to vertebrate fauna among different ethnic communities in the Chitwan-Annapurna Landscape, central Nepal. Data was collected by using semi-structured questionnaires and analyzed by using Use Value (UV), Informant Consensus Factor (ICF) and Fidelity level (FL). Results showed a total of 58 (53 wild and 5 domestic) species of vertebrate animals. They were used to treat 62 types human ailments. Four animals were also used for veterinary diseases and agriculture benefits. The most widely used species was Felis chaus (UV = 0.25) with 3 use-reports by 10 informants. Cardiovascular and dental problems had the highest ICF value (0.974) with cardiovascular problems having 351 use-reports for 10 animal species and dental problems having 77 use-reports for 3 animal species. The least ICF was found in ophthalmological problems (ICF = 0.833, use reports = 7 for 2 species). We concluded that the different animals were an important part of traditional medicine for the local people living in the Chitwan-Annapurna Landscape. However, the majority of animals and most likely to be threatened due to their uses. The present documented ethnozoological knowledge can be used in conservation and management of vertebrates so that they could be protected for future generations.	[Adhikari, Jagan Nath; Bhattarai, Bishnu Prasad; Thapa, Tej Bahadur] Tribhuvan Univ, Cent Dept Zool, Inst Sci & Technol, Kathmandu, Nepal; [Adhikari, Jagan Nath] Tribhuvan Univ, Dept Zool, Birendra Multiple Campus, Bharatpur, Chitwan, Nepal; [Rokaya, Maan Bahadur] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Rokaya, Maan Bahadur] Czech Acad Sci, Global Change Res Inst, Dept Biodivers Res, Brno, Czech Republic	Tribhuvan University; Institute of Science & Technology (IoST) - Nepal; Tribhuvan University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Bhattarai, BP (corresponding author), Tribhuvan Univ, Cent Dept Zool, Inst Sci & Technol, Kathmandu, Nepal.	bpbhattarai@cdztu.edu.np	Rokaya, Maan/G-1527-2014; Rokaya, Maan B./ABH-1509-2021; Bhattarai, Dr. Bishnu Prasad/P-1239-2015	Rokaya, Maan/0000-0003-1459-093X; Bhattarai, Dr. Bishnu Prasad/0000-0001-5741-6179	Nepal Academy of Science and Technology, Kathmandu, Nepal; Idea Wild, USA	Nepal Academy of Science and Technology, Kathmandu, Nepal; Idea Wild, USA	Jagan Nath Adhikari received mini research grant from the Nepal Academy of Science and Technology, Kathmandu, Nepal and Idea Wild, USA for instrument support. The funders had no role in data analysis, preparation of the manuscript and decision to publish.	Agosta WC, 1996, BOMBARDIER BEETLES F; Altaf M, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0168-5; Alves R. R. N., 2018, Ethnozoology: animals in our lives, P513; Alves R. R. N., 2018, Ethnozoology: animals in our lives, P481; Alves RNN, 2013, ANIMALS TRADITIONAL, P25, DOI DOI 10.1007/978-3-642-29026-8_3; Alves RRN, 2007, J ETHNOPHARMACOL, V113, P541, DOI 10.1016/j.jep.2007.07.015; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI [10.1186/1746-4269-5-1, 10.1186/1746-4269-5-12]; Alves RRN, 2005, J ETHNOBIOL ETHNOMED, V1, DOI [10.1186/1746-4269-1-10, 10.1186/1746-4269-1-5]; Alves RRN, 2018, ROLE ETHNOZOOLOGY AN, P467; Amiguet VT, 2005, ECON BOT, V59, P29, DOI 10.1663/0013-0001(2005)059[0029:ACEOTQ]2.0.CO;2; Amin Rajan, 2018, Journal of Threatened Taxa, V10, P11361; Angmo K, 2012, J ETHNOPHARMACOL, V143, P621, DOI 10.1016/j.jep.2012.07.017; [Anonymous], 2004, RHEEDEA, V13, P19; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Bagde N., 2013, INT J LIFE SCI, V1, P278; Baral H.S., 2008, WILD MAMMALS NEPAL; Baral R, 2018, BIRDS ANNAPURNA CONS; Barboza RRD, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-32; BDMS (Bahir Dar Metrological Station), 2019, TEMP RAINF DAT UNPUB; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Bhattarai S, 2009, ECOL FOOD NUTR, V48, P1, DOI 10.1080/03670240802034996; Bhattarai S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-41; Bhuvan KC, 2019, J PHARM POLICY PRACT, V12, DOI 10.1186/s40545-019-0172-3; Boesi A, 2014, RIV STUDI ORIENTALI, P73; Boll Valerie, 2004, Anthropozoologica, V39, P61; Borah MP, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0167-6; Castillo L, 2018, ETHNOBIOL CONSERV, V8, DOI 10.15451/ec2019-01-8.02-1-23; Central Bureau of Statistics (CBS), 2012, NAT POP HOUS CENS 20; Chakravorty J, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-13; Chellappandian M, 2012, J ETHNOPHARMACOL, V143, P540, DOI 10.1016/j.jep.2012.07.014; CNCTHM, 1995, CHIN NAT CORP TRAD H; Costa-Neto EM, 2005, AN ACAD BRAS CIENC, V77, P33, DOI 10.1590/S0001-37652005000100004; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; DHM, 2017, OBS CLIM TREND AN NE; Drumond MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123913; Farooq A, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0323-2; Ferreira FS, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-21; Ferreira FS, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-17; Ferreira FS, 2016, REG ENVIRON CHANGE, V16, P543, DOI 10.1007/s10113-015-0767-4; Friant S, 2020, ECOHEALTH, V17, P125, DOI 10.1007/s10393-020-01473-0; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Gewali MB, 2010, ASPECTS TRADITIONAL, V1st; Ghimire SK, 2006, ENVIRON CONSERV, V33, P128, DOI 10.1017/S0376892906002943; Gonzalez JA, 2016, J ETHNOPHARMACOL, V191, P135, DOI 10.1016/j.jep.2016.06.025; Grimmett R., 2016, BIRDS NEPAL REVISED; Gupta L, 2003, USE ANIMALS ANIMAL P; Hazarika M, 2018, INT J HUMANITIES SOC; Heinrich M, 2012, J ETHNOPHARMACOL, V139, P691, DOI 10.1016/j.jep.2011.09.022; ICIMOD, 2013, LAND COV NEP 2010 DA; ISE, 2006, INT SOC ETHN ISE COD; Jaroli DP, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-6; Jnawali S.R., 2011, NATL RED LIST SERIES; Joshi KK, 2001, GENETIC HERITAGE MED; Kakai L. N., 2002, Journal of Human Ecology, V13, P419; KATHOL RG, 1981, J AFFECT DISORDERS, V3, P111, DOI 10.1016/0165-0327(81)90036-7; Kharel M, 2012, NEPALESE J BIOSCIENC, V2, P126; Kim H, 2013, J ETHNOPHARMACOL, V146, P75, DOI 10.1016/j.jep.2012.11.011; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Legesse A, 2017, CHEM SCI J, DOI [10.4172/2150-3494.1000171, DOI 10.4172/2150-3494.1000171]; Lev E, 2003, J ETHNOPHARMACOL, V85, P107, DOI 10.1016/S0378-8741(02)00377-X; Lohani U, 2012, STUD ETHNO-MED, V6, P45, DOI 10.1080/09735070.2012.11886420; Lohani U, 2011, STUD ETHNO-MED, V5, P115, DOI 10.1080/09735070.2011.11886398; Lohani U, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-31; Lohani U, 2008, INDIAN J TRADIT KNOW, V7, P634; Loko LEY, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0344-x; Mahawar MM, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-25; Manandhar N. P., 2002, Plants and people of Nepal; Nijman V, 2017, J ETHNOPHARMACOL, V206, P101, DOI 10.1016/j.jep.2017.05.010; Alves RRN, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4901329; Alves RRN, 2012, ETHNOBIOL CONSERV, V1, DOI [10.15451/ec2012-8-1.2-1-69, 10.15451/ec2012-8-1.7-1-21, 10.15451/ec2012-8-1.1-1-03]; Alves RRN, 2010, HUM ECOL REV, V17, P11; PHILLIPS O, 1994, CONSERV BIOL, V8, P225, DOI 10.1046/j.1523-1739.1994.08010225.x; Poudel M., 2016, J I SCI TECHNOLOGY, V21, P103; Quave CL, 2010, J ETHNOBIOL, V30, P92, DOI 10.2993/0278-0771-30.1.92; Quave CL, 2013, ANIMALS TRADITIONAL, P303; Rai R, 2015, J I SCI TECHNOL, V20, P127; Ripple WJ, 2017, P NATL ACAD SCI USA, V114, P10678, DOI 10.1073/pnas.1702078114; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rokaya MB, 2010, J ETHNOPHARMACOL, V130, P485, DOI 10.1016/j.jep.2010.05.036; Rosa I., 2013, ANIMALS TRADITIONAL, P109, DOI DOI 10.1007/978-3-642-29026-8; Setlalekgomo M. R., 2014, J ANIMAL SCI ADV, V4, P883; Shah K.B., 2004, HERPETOFAUNA NEPAL; Shrestha B, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0304-5; Shrestha N, 2014, J ETHNOPHARMACOL, V155, P1204, DOI 10.1016/j.jep.2014.07.002; Shrestha Nawal, 2012, Biodiversity (Ottawa), V13, P24, DOI 10.1080/14888386.2012.666715; Shrestha TK, 2018, ICHTHYOLOGY NEPAL, VSecond; Souto WMS, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0259-y; Singh AG, 2018, NEW ETHNOMEDICINAL C; Singh AG, 2018, INDIAN J TRADIT KNOW, V17, P499; Singh AG, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-19; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Soewu DA, 2013, ANIMALS TRADITIONAL, P347, DOI DOI 10.1007/978-3-642-29026-8_16; Souto WMS, 2012, AN ACAD BRAS CIENC, V84, P669, DOI 10.1590/S0001-37652012005000038; Souto WMS, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-30; Souto WMS, 2012, TRADITIONAL KNOWLEDG; Still J, 2003, COMPLEMENT THER MED, V11, P118, DOI 10.1016/S0965-2299(03)00055-4; Tamang P, 2014, J I SCI TECHNOL, V19, P45; Ter Braak CJF, 2012, CANOCO 5 WINDOWS REL; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Tuladhar-Douglas Will, 2008, Journal of Ethnobiology, V28, P69, DOI 10.2993/0278-0771(2008)28[69:TUOBAM]2.0.CO;2; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Van Vliet N, 2017, ETHNOBIOL CONSERV, V6, DOI 10.15451/ec2017-04-6.3-1-45; Vijayakumar S, 2015, J ETHNOPHARMACOL, V162, P296, DOI 10.1016/j.jep.2014.12.055; Wikramanayake ED, 2002, TERRESTRIAL ECOREGIO, DOI [10.1128/mcb.22.13.4863-4875.2002, DOI 10.1128/MCB.22.13.4863-4875.2002]; Wilson L., 2015, FATS OILS OPTIMUM HL; World Health Organization, 2013, WHO TRAD MED STRAT 2	107	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0240555	10.1371/journal.pone.0240555	http://dx.doi.org/10.1371/journal.pone.0240555			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125389	gold, Green Submitted, Green Published			2022-12-26	WOS:000588368900005
J	Elbere, I; Silamikelis, I; Dindune, II; Kalnina, I; Ustinova, M; Zaharenko, L; Silamikele, L; Rovite, V; Gudra, D; Konrade, I; Sokolovska, J; Pirags, V; Klovins, J				Elbere, Ilze; Silamikelis, Ivars; Dindune, Ilze Izabella; Kalnina, Ineta; Ustinova, Monta; Zaharenko, Linda; Silamikele, Laila; Rovite, Vita; Gudra, Dita; Konrade, Ilze; Sokolovska, Jelizaveta; Pirags, Valdis; Klovins, Janis			Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; SUCCINATE	Background The study was conducted to investigate the effects of metformin treatment on the human gut microbiome's taxonomic and functional profile in the Latvian population, and to evaluate the correlation of these changes with therapeutic efficacy and tolerance. Methods In this longitudinal observational study, stool samples for shotgun metagenomic sequencing-based analysis were collected in two cohorts. The first cohort included 35 healthy nondiabetic individuals (metformin dose 2x850mg/day) at three time-points during metformin administration. The second cohort was composed of 50 newly-diagnosed type 2 diabetes patients (metformin dose-determined by an endocrinologist) at two concordant times. Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by >= 12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%). Results Metformin reduced the alpha diversity of microbiota in healthy controls (p = 0.02) but not in T2D patients. At the species level, reduction in the abundance of Clostridium bartlettii and Barnesiella intestinihominis, as well as an increase in the abundance of Parabacteroides distasonis and Oscillibacter unclassified overlapped between both study groups. A large number of group-specific changes in taxonomic and functional profiles was observed. We identified an increased abundance of Prevotella copri (FDR = 0.01) in the Non-Responders subgroup, and enrichment of Enterococcus faecium, Lactococcus lactis, Odoribacter, and Dialister at baseline in the Responders group. Various taxonomic units were associated with the observed incidence of side effects in both cohorts. Conclusions Metformin effects are different in T2D patients and healthy individuals. Therapy induced changes in the composition of gut microbiome revealed possible mediators of observed short-term therapeutic effects. The baseline composition of the gut microbiome may influence metformin therapy efficacy and tolerance in T2D patients and could be used as a powerful prediction tool.	[Elbere, Ilze; Silamikelis, Ivars; Dindune, Ilze Izabella; Kalnina, Ineta; Ustinova, Monta; Zaharenko, Linda; Silamikele, Laila; Rovite, Vita; Gudra, Dita; Konrade, Ilze; Pirags, Valdis; Klovins, Janis] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Konrade, Ilze] Riga Stradins Univ, Riga, Latvia; [Sokolovska, Jelizaveta; Pirags, Valdis] Univ Latvia, Fac Med, Riga, Latvia	Latvian Biomedical Research & Study Centre; Riga Stradins University; University of Latvia	Klovins, J (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	klovins@biomed.lu.lv	Klovins, Janis/C-5695-2011	Silamikelis, Ivars/0000-0002-7932-1047; Elbere, Ilze/0000-0003-4381-885X; Sokolovska, Jelizaveta/0000-0003-0448-8229; Klovins, Janis/0000-0001-8362-5505	European Regional Development Fund [1.1.1.1/16/A/091]	European Regional Development Fund(European Commission)	The work was supported by the European Regional Development Fund under the project "Investigation of interplay between multiple determinants influencing response to metformin: search for reliable predictors for efficacy of type 2 diabetes therapy" (Project No. 1.1.1.1/16/A/091, https://ec.europa.eu/regional_policy/en/funding/erdf).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Asquith M, 2016, CURR OPIN RHEUMATOL, V28, P405, DOI 10.1097/BOR.0000000000000299; Brahe LK, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.9; Bryrup T, 2019, DIABETOLOGIA, V62, P1024, DOI 10.1007/s00125-019-4848-7; Burbach K, 2016, MICROBIOLOGYOPEN, V5, P70, DOI 10.1002/mbo3.312; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; CONNORS J, 2018, NUTRIENTS, V11, P1, DOI DOI 10.3390/nu11010025; De Filippis F, 2019, CELL HOST MICROBE, V25, P444, DOI 10.1016/j.chom.2019.01.004; de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Doumatey AP, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00063; Elbere I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204317; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Ganesan K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123720; Gerritsen J, 2014, INT J SYST EVOL MICR, V64, P1600, DOI 10.1099/ijs.0.059543-0; Gurung M, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.11.051; Haro C, 2016, J CLIN ENDOCR METAB, V101, P232, DOI 10.1210/jc.2015-3351; HAUPT E, 1991, DIABETES METAB, V17, P224; Janes VA, 2020, J MICROBIOL METH, V176, DOI 10.1016/j.mimet.2020.106005; Jones AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152428; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kashi Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151543; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Leite AZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01107; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Ma W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01336; Makizaki Y, 2020, BIOSCI MICROB FOOD H, V39, P145, DOI 10.12938/bmfh.2019-022; Olgun A, 2017, MED HYPOTHESES, V106, P33, DOI [10.1016/j.mehy.2017.07.009, 10.1016]; Palacios T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072041; Paley S, 2017, NUCLEIC ACIDS RES, V45, P12113, DOI 10.1093/nar/gkx910; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Petrosino JF, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0525-6; Porter KM, 2019, J CLIN ENDOCR METAB, V104, P4837, DOI 10.1210/jc.2018-01791; Rashid M, 2019, PAK J MED SCI, V35, P71, DOI 10.12669/pjms.35.1.100; Rosario D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00775; Rovite V, 2018, J EPIDEMIOL; Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727; Siljander H, 2019, EBIOMEDICINE, V46, P512, DOI 10.1016/j.ebiom.2019.06.031; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Torondel B, 2016, MICROB BIOTECHNOL, V9, P209, DOI 10.1111/1751-7915.12334; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Wakeman M, 2020, DIABET METAB SYND OB, V13, P2093, DOI 10.2147/DMSO.S237454; Walsh AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0437-0; Walter J, 2013, GUT MICROBES, V4, P340, DOI 10.4161/gmic.24707; Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028; Wang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172774; Weersma RK, 2020, GUT, V69, P1510, DOI 10.1136/gutjnl-2019-320204; Wei SY, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0318-3; Wexler AG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.26; Whang A, 2019, EBIOMEDICINE, V39, P591, DOI 10.1016/j.ebiom.2018.11.046; Wingfield B, 2019, IEEE ACM T COMPUT BI, V16, P2078, DOI 10.1109/TCBB.2018.2831212; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yamashita M, 2019, J DIABETES INVEST, V10, P1463, DOI 10.1111/jdi.13048; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Zeng Z, 2017, APPL MICROBIOL BIOT, V101, P7177, DOI 10.1007/s00253-017-8410-6; Zhang F, 2017, J DAIRY SCI, V100, P1618, DOI 10.3168/jds.2016-11870; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang Y, 2020, BIORXIV PREPRINT; Zheng PL, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3043; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102863	65	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241338	10.1371/journal.pone.0241338	http://dx.doi.org/10.1371/journal.pone.0241338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125401	gold, Green Published			2022-12-26	WOS:000588368900025
J	Tsai, PH; Chung, CH; Chien, WC; Chu, PL				Tsai, Ping-Huang; Chung, Chi-Hsiang; Chien, Wu-Chien; Chu, Pauling			Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY CALCIUM; SERUM PHOSPHATE; PHOSPHORUS; CALCIFICATION; RISK; METAANALYSIS; ASSOCIATION; BALANCE; PEOPLE	Background Hyperphosphatemia and calcium load were associated with vascular calcification. The role of calcium-containing phosphate binders (CCPBs) use as important determinants of death and cardiovascular events in predialysis hyperphosphatemic chronic kidney disease (CKD) patients remain unclear due to the absence of evidence for reduced mortality with CCPB use compared with placebo. We aimed to investigate the effect of using CCPBs or nonuse in all-cause mortality rates and cardiovascular events in CKD stage 5 patients between 2000 and 2005 in the Taiwanese National Health Insurance Research Database. Methods Patients with known coronary heart disease and those who had undergone dialysis or renal transplantation were excluded. The CCPB users were matched with nonusers by the propensity score model. Multivariable Cox proportional hazards model was used to estimate hazard ratios (HRs) of all-cause mortality and cardiovascular events. Results During a mean follow-up of 4.58 years, 879 CCPB users were matched with 3516 nonusers. CCPB use was an independent risk factor for cardiovascular events [adjusted hazard ratio (HR) 1.583, 95% confidence interval (CI) 1.393-1.799]. The increased cardiovascular risk was dose-dependent and consistent across all subgroup analyses. Compared with no use, CCPB use was associated with no significant all-cause mortality risk (1.74 vs. 1.75 events per 100 person-years, adjusted HR 0.964, 95% CI 0.692-1.310). Conclusions CCPB use in CKD stage 5 patients was associated with a significantly increased cardiovascular event risk compared with the nonusers, whereas the all-cause mortality risk was similar between the two groups. Whether these relationships are causal require further randomized controlled trials.	[Tsai, Ping-Huang; Chu, Pauling] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chu, PL (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	pauling.chu@gmail.com	Chung, Chi-Hsiang/AAY-3386-2021					Adeney KL, 2009, J AM SOC NEPHROL, V20, P381, DOI 10.1681/ASN.2008040349; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Di Micco L, 2013, BLOOD PURIFICAT, V36, P26, DOI 10.1159/000350582; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Felsenfeld AJ, 2015, SEMIN DIALYSIS, V28, P564, DOI 10.1111/sdi.12411; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Habbous S, 2017, NEPHROL DIAL TRANSPL, V32, P111, DOI 10.1093/ndt/gfw312; Hill KM, 2013, KIDNEY INT, V83, P959, DOI 10.1038/ki.2012.403; Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Hung SC, 2015, LANCET DIABETES ENDO, V3, P605, DOI 10.1016/S2213-8587(15)00123-0; Hung SC, 2014, NEPHROLOGY, V19, P735, DOI 10.1111/nep.12332; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kovesdy CP, 2010, AM J KIDNEY DIS, V56, P842, DOI 10.1053/j.ajkd.2010.06.011; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navaneethan SD, 2014, CLIN NEPHROL, V82, P16, DOI 10.5414/CN108144; Obi Y, 2016, J CLIN ENDOCR METAB, V101, P2440, DOI 10.1210/jc.2016-1369; Palmer SC, 2016, AM J KIDNEY DIS, V68, P691, DOI 10.1053/j.ajkd.2016.05.015; Patel L, 2016, CLIN J AM SOC NEPHRO, V11, P232, DOI 10.2215/CJN.06800615; Sekercioglu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156891; Seng JJB, 2018, INT UROL NEPHROL, V50, P1871, DOI 10.1007/s11255-018-1906-x; Spiegel DM, 2012, KIDNEY INT, V81, P1116, DOI 10.1038/ki.2011.490; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Winkelmayer WC, 2008, AM J KIDNEY DIS, V51, P362, DOI 10.1053/j.ajkd.2008.01.004; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P175, DOI 10.2215/CJN.05060610; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2020	15	10							e0241435	10.1371/journal.pone.0241435	http://dx.doi.org/10.1371/journal.pone.0241435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VN	33125428	Green Published, gold			2022-12-26	WOS:000588368900064
